PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Moll, V; Mariano, ER; Kitzman, JM; O'Reilly-Shah, VN; Jabaley, CS				Moll, Vanessa; Mariano, Edward R.; Kitzman, Jamie M.; O'Reilly-Shah, Vikas N.; Jabaley, Craig S.			Regional anesthesia educational material utilization varies by World Bank income category: A mobile health application data study	PLOS ONE			English	Article							IN-APP SURVEY; PEDIATRIC ANESTHESIA; RESOURCE; SERVICES; CARE	Introduction Regional anesthesia offers an alternative to general anesthesia and may be advantageous in low resource environments. There is a paucity of data regarding the practice of regional anesthesia in low- and middle-income countries. Using access data from a free Android app with curated regional anesthesia learning modules, we aimed to estimate global interest in regional anesthesia and potential applications to clinical practice stratified by World Bank income level. Methods We retrospectively analyzed data collected from the free Android app "Anesthesiologist" from December 2015 to April 2020. The app performs basic anesthetic calculations and provides links to videos on performing 12 different nerve blocks. Users of the app were classified on the basis of whether or not they had accessed the links. Nerve blocks were also classified according to major use (surgical block, postoperative pain adjunct, rescue block). Results Practitioners in low- and middle-income countries accessed the app more frequently than in high-income countries as measured by clicks. Users from low- and middle-income countries focused mainly on surgical blocks: ankle, axillary, infraclavicular, interscalene, and supraclavicular blocks. In high-income countries, more users viewed postoperative pain blocks: adductor canal, popliteal, femoral, and transverse abdominis plane blocks. Utilization of the app was constant over time with a general decline with the start of the COVID-19 pandemic. Conclusion The use of an in app survey and analytics can help identify gaps and opportunities for regional anesthesia techniques and practices. This is especially impactful in limited-resource areas, such as lower-income environments and can lead to targeted educational initiatives.	[Moll, Vanessa; Jabaley, Craig S.] Emory Univ, Sch Med, Dept Anesthesiol, Atlanta, GA 30322 USA; [Moll, Vanessa] Univ Hosp Zurich, Inst Anesthesiol, Zurich, Switzerland; [Mariano, Edward R.] Stanford Univ, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Stanford, CA 94305 USA; [Mariano, Edward R.] Vet Affairs Palo Alto Hlth Care Syst, Anesthesiol & Perioperat Care Serv, Palo Alto, CA USA; [Kitzman, Jamie M.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Dept Pediat Anesthesiol, Atlanta, GA USA; [O'Reilly-Shah, Vikas N.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA	Emory University; University of Zurich; University Zurich Hospital; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Children's Healthcare of Atlanta (CHOA); Emory University; University of Washington; University of Washington Seattle	O'Reilly-Shah, VN (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.	voreill@uw.edu	Moll, Vanessa/AAD-4331-2022	O'Reilly-Shah, Vikas/0000-0003-0741-0291; Mariano, Edward/0000-0003-2735-248X	Emory University Department of Anesthesiology	Emory University Department of Anesthesiology	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The Emory University Department of Anesthesiology supported this work with non-clinical time for the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, DIABETES CARE S1, V39, pS1, DOI 10.2337/dc16-S001; Ariyo P, 2016, ANESTHESIOLOGY, V124, P561, DOI 10.1097/ALN.0000000000000985; Barbour R, 2017, BJA EDUC, V17, P351, DOI 10.1093/bjaed/mkx030; Bensman RS, 2017, AM J TROP MED HYG, V97, P1285, DOI 10.4269/ajtmh.16-0936; Bourgouin S, 2017, HERNIA, V21, P749, DOI 10.1007/s10029-017-1631-x; Buckenmaier CC, 2003, REGION ANESTH PAIN M, V28, P321, DOI 10.1016/S1098-7339(03)00198-6; Burkholder TW, 2018, WEST J EMERG MED, V19, P600, DOI 10.5811/westjem.2018.3.36825; Chan TM, 2020, PERSPECT MED EDUC, V9, P20, DOI 10.1007/s40037-019-00542-7; Clevert A, 2019, INSIGHTS IMAGING, V10, DOI 10.1186/s13244-019-0775-x; Cozowicz C, 2016, REGION ANESTH PAIN M, V41, P43, DOI 10.1097/AAP.0000000000000342; Hadler RA, 2016, WORLD J SURG, V40, P1025, DOI 10.1007/s00268-016-3430-4; Ho M, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.152.17246; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Jabaley CS, 2018, THER ADV DRUG SAF, V9, P331, DOI 10.1177/2042098618769565; Kallander K, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2130; Kruse C, 2019, J MED INTERNET RES, V21, DOI 10.2196/13263; Kumar AH, 2020, INT ANESTHESIOL CLIN, V58, P52, DOI 10.1097/AIA.0000000000000287; Martinelli SM, 2019, ANESTHESIOLOGY, V131, P908, DOI 10.1097/ALN.0000000000002827; Mathais Q, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223497; O'Reilly-Shah VN, 2017, BRIT J ANAESTH, V119, P333, DOI 10.1093/bja/aex171; O'Reilly-Shah V, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000299; O'Reilly-Shah V, 2016, JMIR MHEALTH UHEALTH, V4, P17, DOI 10.2196/mhealth.5397; O'Reilly-Shah VN, 2018, PEDIATR ANESTH, V28, P167, DOI 10.1111/pan.13305; Ooms J., 2014, JSONLITE PACKAGE PRA; Palliam S, 2019, CUREUS, V11, DOI 10.7759/cureus.6223; R Core Team, 2021, R LANGUAGE ENV STAT; Raza A, 2017, INT J SURG, V44, P252, DOI 10.1016/j.ijsu.2017.06.081; Rukewe A, 2010, ANESTH ANALG, V110, P243, DOI 10.1213/ANE.0b013e3181c0f00e; Schwenk Eric S, 2017, Curr Anesthesiol Rep, V7, P238, DOI 10.1007/s40140-017-0213-x; Shrime MG, 2015, LANCET GLOB HEALTH, V3, pS8, DOI 10.1016/S2214-109X(14)70384-5; South A, 2011, R J, V3, P35; Suhre W, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-01036-4; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; Thurtle N, 2016, AFR J EMERG MED, V6, P12, DOI 10.1016/j.afjem.2015.10.005; Turbitt LR, 2020, ANAESTHESIA, V75, P293, DOI 10.1111/anae.14768; W.H. Organization, 2017, REPORT 3 GLOBAL SURV	36	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0244860	10.1371/journal.pone.0244860	http://dx.doi.org/10.1371/journal.pone.0244860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524031	Green Published, gold			2022-12-26	WOS:000616578400026
J	Moribe, F; Nishikori, M; Takashima, T; Taniyama, D; Onishi, N; Arima, H; Sasanuma, H; Akagawa, R; Elloumi, F; Takeda, S; Pommier, Y; Morii, E; Takaori-Kondo, A; Murai, J				Moribe, Fumiya; Nishikori, Momoko; Takashima, Tsuyoshi; Taniyama, Daiki; Onishi, Nobuyuki; Arima, Hiroshi; Sasanuma, Hiroyuki; Akagawa, Remi; Elloumi, Fathi; Takeda, Shunichi; Pommier, Yves; Morii, Eiichi; Takaori-Kondo, Akifumi; Murai, Junko			Epigenetic suppression of SLFN11 in germinal center B-cells during B-cell development	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; EXPRESSION; LYMPHOMA; QUANTIFICATION; SENSITIVITY; ACTIVATION; BLIMP-1; GENES; PAX5; AID	Background SLFN11 has recently been reported to execute cancer cells harboring replicative stress induced by DNA damaging agents. However, the roles of SLFN11 under physiological conditions remain poorly understood. Germinal center B-cells (GCBs) undergo somatic hypermutations and class-switch recombination, which can cause physiological genotoxic stress. Hence, we tested whether SLFN11 expression needs to be suppressed in GCBs during B-cell development. Objective To clarify the expression profile of SLFN11 in different developmental stages of B-cells and B-cell-derived cancers. Methods We analyzed the expression of SLFN11 by mining cell line databases for different stages of normal B-cells and various types of B-cell-derived cancer cell lines. We performed dual immunohistochemical staining for SLFN11 and B-cell specific markers in normal human lymphatic tissues. We tested the effects of two epigenetic modifiers, an EZH2 inhibitor, tazemetostat (EPZ6438) and a histone deacetylase inhibitor, panobinostat (LBH589) on SLFN11 expression in GCB-derived lymphoma cell lines. We also examined the therapeutic efficacy of these drugs in combination with cytosine arabinoside and the effects of SLFN11 on the efficacy of cytosine arabinoside in SLFN11-overexpressing cells. Results SLFN11 mRNA level was found low in both normal GCBs and GCB-DLBCL (GCB like-diffuse large B-cell lymphoma). Immunohistochemical staining showed low SLFN11 expression in GCBs and high SLFN11 expression in plasmablasts and plasmacytes. The EZH2 and HDAC epigenetic modifiers upregulated SLFN11 expression in GCB-derived lymphoma cells and made them more susceptible to cytosine arabinoside. SLFN11 overexpression further sensitized GCB-derived lymphoma cells to cytosine arabinoside. Conclusions The expression of SLFN11 is epigenetically suppressed in normal GCBs and GCB-derived lymphomas. GCB-derived lymphomas with low SLFN11 expression can be treated by the combination of epigenetic modifiers and cytosine arabinoside.	[Moribe, Fumiya; Nishikori, Momoko; Arima, Hiroshi; Takaori-Kondo, Akifumi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Takashima, Tsuyoshi; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka, Japan; [Taniyama, Daiki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol Pathol, Hiroshima, Japan; [Onishi, Nobuyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Sasanuma, Hiroyuki; Akagawa, Remi; Takeda, Shunichi] Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Kyoto, Japan; [Elloumi, Fathi; Pommier, Yves] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Elloumi, Fathi; Pommier, Yves] NCI, Lab Mol Pharmacol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Murai, Junko] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	Kyoto University; Osaka University; Hiroshima University; Keio University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Keio University	Nishikori, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan.; Murai, J (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.	nishikor@kuhp.kyoto-u.ac.jp; muraij@ttck.keio.ac.jp	Murai, Junko/AAU-9516-2021	TSUYOSHI, TAKASHIMA/0000-0003-1362-3883; Arima, Hiroshi/0000-0003-0609-846X; Takeda, Shunichi/0000-0002-7924-7991	Uehara Memorial Foundation [JP18K08324, JP19H03505]; Ministry of Education, Science, Sport and Culture (KAKENHI) [19K22561, 16H06306, 18H04900, 19H04267]; Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks; Center for Cancer Research, the Intramural Program of the National Cancer Institute [Z01-BC006150]; Yamagata prefectural government; City of Tsuruoka	Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Science, Sport and Culture (KAKENHI); Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for Cancer Research, the Intramural Program of the National Cancer Institute; Yamagata prefectural government; City of Tsuruoka	This work was supported by Grants-inAid for Scientific Research (JP18K08324 to M.N. and JP19H03505 to J.M.), a research grant from The Uehara Memorial Foundation (to J.M.), a Grant-in-Aid from the Ministry of Education, Science, Sport and Culture (KAKENHI 19K22561 and 16H06306 [to S.T.] and KAKENHI 18H04900 and 19H04267 [to H.S.]), the Japan Society for the Promotion of Science Core-to-Core Program, Advanced Research Networks (to S.T.) and the Center for Cancer Research, the Intramural Program of the National Cancer Institute (Z01-BC006150 to Y.P.) and research funds from the Yamagata prefectural government and the City of Tsuruoka (to J.M.).	Adis International Ltd, 2003, Drugs R D, V4, P249; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bustos O, 2009, GENE, V447, P1, DOI 10.1016/j.gene.2009.07.006; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Corcoran LM, 2016, CURR OPIN IMMUNOL, V39, P59, DOI 10.1016/j.coi.2015.12.008; Coussy F, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax2625; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Yebenes VG, 2006, TRENDS MOL MED, V12, P432, DOI 10.1016/j.molmed.2006.07.001; Di Matteo M, 2014, MOL THER, V22, P1614, DOI 10.1038/mt.2014.131; Dimitrova L, 2014, LEUKEMIA, V28, P213, DOI 10.1038/leu.2013.211; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hirai A, 2018, ONCOL LETT, V16, P5930, DOI 10.3892/ol.2018.9386; Hoy SM, 2020, DRUGS, V80, P513, DOI 10.1007/s40265-020-01288-x; Karami B, 2018, MECH ADV MATER STRUC, V25, P1047, DOI 10.1080/15376494.2017.1323143; KLEIN E, 1968, CANCER RES, V28, P1300; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Liu FR, 2018, CELL BIOL INT, V42, P2, DOI 10.1002/cbin.10778; Maesako Y, 2003, CANCER SCI, V94, P774, DOI 10.1111/j.1349-7006.2003.tb01518.x; Marzi L, 2018, MOL CANCER THER, V17, P1694, DOI 10.1158/1535-7163.MCT-18-0028; Mavrommatis E, 2013, J BIOL CHEM, V288, P33006, DOI 10.1074/jbc.M113.460741; Mavrommatis E, 2013, J INTERF CYTOK RES, V33, P206, DOI 10.1089/jir.2012.0133; Murai J, 2020, CELL REP, V30, P4137, DOI 10.1016/j.celrep.2020.02.117; Murai J, 2019, PHARMACOL THERAPEUT, V201, P94, DOI 10.1016/j.pharmthera.2019.05.009; Murai J, 2019, ANNU REV CANC BIOL, V3, P131, DOI 10.1146/annurev-cancerbio-030518-055914; Murai J, 2018, MOL CELL, V69, P371, DOI 10.1016/j.molcel.2018.01.012; Murai J, 2017, INT J CLIN ONCOL, V22, P619, DOI 10.1007/s10147-017-1145-7; Murai J, 2016, ONCOTARGET, V7, P76534, DOI 10.18632/oncotarget.12266; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Nogales V, 2016, ONCOTARGET, V7, P3084, DOI 10.18632/oncotarget.6413; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Petri A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138236; Pietanza MC, 2018, J CLIN ONCOL, V36, P2386, DOI 10.1200/JCO.2018.77.7672; Rajapakse VN, 2018, ISCIENCE, V10, P247, DOI 10.1016/j.isci.2018.11.029; Rathkey D, 2020, J THORAC ONCOL, V15, P843, DOI 10.1016/j.jtho.2020.01.012; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Takashima T, 2021, VIRCHOWS ARCH, V478, P569, DOI 10.1007/s00428-020-02840-6; Tang SW, 2018, CLIN CANCER RES, V24, P1944, DOI 10.1158/1078-0432.CCR-17-0443; Tang SW, 2015, CLIN CANCER RES, V21, P4184, DOI 10.1158/1078-0432.CCR-14-2112; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Valdez F, 2019, J VIROL, V93, DOI 10.1128/JVI.00104-19; Velichutina I, 2010, BLOOD, V116, P5247, DOI 10.1182/blood-2010-04-280149; Waibel M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7838; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; Wu HJ, 2018, CELL MOL IMMUNOL, V15, P676, DOI 10.1038/cmi.2017.133; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	56	11	11	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0237554	10.1371/journal.pone.0237554	http://dx.doi.org/10.1371/journal.pone.0237554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513156	Green Published, Green Submitted, gold			2022-12-26	WOS:000613891400030
J	Sushentsev, N; Kaggie, JD; Slough, RA; Carmo, B; Barrett, T				Sushentsev, Nikita; Kaggie, Joshua D.; Slough, Rhys A.; Carmo, Bruno; Barrett, Tristan			Reproducibility of magnetic resonance fingerprinting-based T-1 mapping of the healthy prostate at 1.5 and 3.0 T: A proof-of-concept study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; MULTIPARAMETRIC MRI; CANCER; PERFORMANCE; RELAXATION; BENIGN	Facilitating clinical translation of quantitative imaging techniques has been suggested as means of improving interobserver agreement and diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI) of the prostate. One such technique, magnetic resonance fingerprinting (MRF), has significant competitive advantages over conventional mapping techniques in terms of its multi-site reproducibility, short scanning time and inherent robustness to motion. It has also been shown to improve the detection of clinically significant prostate cancer when added to standard mpMRI sequences, however, the existing studies have all been conducted on 3.0 T MRI systems, limiting the technique's use on 1.5 T MRI scanners that are still more widely used for prostate imaging across the globe. The aim of this proof-of-concept study was, therefore, to evaluate the cross-system reproducibility of prostate MRF T-1 in healthy volunteers (HVs) using 1.5 and 3.0 T MRI systems. The initial validation of MRF T-1 against gold standard inversion recovery fast spin echo (IR-FSE) T-1 in the ISMRM/NIST MRI system revealed a strong linear correlation between phantom-derived MRF and IR-FSE T-1 values was observed at both field strengths (R-2 = 0.998 at 1.5T and R-2 = 0.993 at 3T; p = < 0.0001 for both). In young HVs, inter-scanner CVs demonstrated marginal differences across all tissues with the highest difference of 3% observed in fat (2% at 1.5T vs 5% at 3T). At both field strengths, MRF T-1 could confidently differentiate prostate peripheral zone from transition zone, which highlights the high quantitative potential of the technique given the known difficulty of tissue differentiation in this age group. The high cross-system reproducibility of MRF T-1 relaxometry of the healthy prostate observed in this preliminary study, therefore, supports the technique's prospective clinical validation as part of larger trials employing 1.5 T MRI systems, which are still widely used clinically for routine mpMRI of the prostate.	[Sushentsev, Nikita; Kaggie, Joshua D.; Slough, Rhys A.; Carmo, Bruno; Barrett, Tristan] Addenbrookes Hosp, Dept Radiol, Cambridge, England; [Sushentsev, Nikita; Kaggie, Joshua D.; Slough, Rhys A.; Carmo, Bruno; Barrett, Tristan] Univ Cambridge, Cambridge, England; [Barrett, Tristan] Addenbrookes Hosp, CamPARI Prostate Canc Grp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Sushentsev, N (corresponding author), Addenbrookes Hosp, Dept Radiol, Cambridge, England.; Sushentsev, N (corresponding author), Univ Cambridge, Cambridge, England.	ns784@medschl.cam.ac.uk	Sushentsev, Nikita/A-7794-2018	Sushentsev, Nikita/0000-0003-4500-9714; Barrett, Tristan/0000-0002-1180-1474	National Institute of Health Research Cambridge Biomedical Research Centre; Cancer Research UK (Cambridge Imaging Centre grant) [C197/A16465]; Engineering and Physical Sciences Research Council Imaging Centre in Cambridge and Manchester; Cambridge Experimental Cancer Medicine Centre	National Institute of Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK (Cambridge Imaging Centre grant); Engineering and Physical Sciences Research Council Imaging Centre in Cambridge and Manchester(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cambridge Experimental Cancer Medicine Centre	The authors acknowledge support from National Institute of Health Research Cambridge Biomedical Research Centre, Cancer Research UK (Cambridge Imaging Centre grant number C197/A16465), the Engineering and Physical Sciences Research Council Imaging Centre in Cambridge and Manchester, and the Cambridge Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN KS, 1989, AM J ROENTGENOL, V152, P77, DOI 10.2214/ajr.152.1.77; [Anonymous], STAND OP PROC MULT M; [Anonymous], EAU GUID PROST CANC; [Anonymous], 2017, MAGNETIC RESONANCE I; Appayya MB, 2018, BJU INT, V122, P13, DOI 10.1111/bju.14361; Barrett T, 2019, CLIN RADIOL, V74, P841, DOI 10.1016/j.crad.2019.05.019; Barrett T, 2021, BJU INT, V127, P304, DOI 10.1111/bju.15285; Barrett T, 2019, EUR J RADIOL, V110, P22, DOI 10.1016/j.ejrad.2018.11.014; Bell KJL, 2015, INT J CANCER, V137, P1749, DOI 10.1002/ijc.29538; Buonincontri G, 2019, NEUROIMAGE, V195, P362, DOI 10.1016/j.neuroimage.2019.03.047; Bura V, 2021, EUR RADIOL, V31, P4908, DOI 10.1007/s00330-020-07545-7; Burn PR, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2019.03.026; Caglic I, 2021, EUR RADIOL, V31, P2696, DOI 10.1007/s00330-020-07336-0; Caglic I, 2017, EUR J RADIOL, V90, P174, DOI 10.1016/j.ejrad.2017.02.029; CASTILLO A, 2019, CURR CARDIOL REP, P14, DOI DOI 10.1007/S11886-019-1086-Z; Davies C, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2019.09.129; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; de Rooij M, 2020, EUR RADIOL, V30, P5404, DOI 10.1007/s00330-020-06929-z; De Visschere PJL, 2017, EUR RADIOL, V27, P2095, DOI 10.1007/s00330-016-4479-z; Engels RRM, 2020, EUR UROL, V77, P457, DOI 10.1016/j.eururo.2019.09.021; Gaziev G, 2016, BJU INT, V117, P80, DOI 10.1111/bju.12892; Greer MD, 2019, AM J ROENTGENOL, V212, P1197, DOI 10.2214/AJR.18.20536; Hamilton JI, 2017, MAGN RESON MED, V77, P1446, DOI 10.1002/mrm.26216; Hegde JV, 2013, J MAGN RESON IMAGING, V37, P1035, DOI 10.1002/jmri.23860; Hsieh JJL, 2020, J MED RADIAT SCI, V67, P333, DOI 10.1002/jmrs.413; Jiang Y, 2015, MAGN RESON MED, V74, P1621, DOI 10.1002/mrm.25559; Kitzing YX, 2016, RADIOGRAPHICS, V36, P162, DOI 10.1148/rg.2016150030; Le JD, 2015, EUR UROL, V67, P569, DOI 10.1016/j.eururo.2014.08.079; Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971; Mason D, 2011, MED PHYS, V38, DOI 10.1118/1.3611983; McGivney DF, 2020, J MAGN RESON IMAGING, V51, P993, DOI 10.1002/jmri.26877; Mehta BB, 2019, MAGN RESON MED, V81, P25, DOI 10.1002/mrm.27403; Panda A, 2020, QUANTITATIVE IMAGING, P97, DOI [10.1007/978-3-319-99357-7_10, DOI 10.1007/978-3-319-99357-7_10]; Panda A, 2019, RADIOLOGY, V292, P685, DOI 10.1148/radiol.2019181705; Panda A, 2019, INVEST RADIOL, V54, P485, DOI 10.1097/RLI.0000000000000569; Poorman ME, 2020, J MAGN RESON IMAGING, V51, P675, DOI 10.1002/jmri.26836; Rosenkrantz AB, 2016, RADIOLOGY, V280, P793, DOI 10.1148/radiol.2016152542; Schieda N, 2021, J MAGN RESON IMAGING, V53, P1632, DOI 10.1002/jmri.27191; Shah ZK, 2015, ACAD RADIOL, V22, P467, DOI 10.1016/j.acra.2014.11.007; Slough RA, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2017.07.013; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Sushentsev N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77331-4; Sushentsev N, 2020, BRIT J RADIOL, V93, DOI 10.1259/bjr.20190929; Turkbey B, 2019, EUR UROL, V76, P340, DOI 10.1016/j.eururo.2019.02.033; Ullrich T, 2017, EUR J RADIOL, V90, P192, DOI 10.1016/j.ejrad.2017.02.044; van der Leest M, 2019, EUR UROL, V76, P574, DOI 10.1016/j.eururo.2019.05.029; Van Nieuwenhove S, 2019, BJU INT, V123, P411, DOI 10.1111/bju.14538; Yu AC, 2017, RADIOLOGY, V283, P728, DOI 10.1148/radiol.2017161599; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zawaideh JP, 2020, EUR RADIOL, V30, P4039, DOI 10.1007/s00330-020-06782-0; Zhang J, 2015, INT J CLIN EXP MED, V8, P11220	51	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245970	10.1371/journal.pone.0245970	http://dx.doi.org/10.1371/journal.pone.0245970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HH	33513165	Green Published, Green Submitted, gold			2022-12-26	WOS:000613892100001
J	Zuniga, MAL; Moreno-Moral, A; Ocana-Granados, A; Padilla-Moreno, FA; Castillo-Fernandez, AM; Guillamon-Fernandez, D; Ramirez-Sanchez, C; Sanchez-Palop, M; Martinez-Colmenero, J; Pimentel-Villar, MA; Blazquez-Rosello, S; Moreno-Sanchez, JJ; Lopez-Vilchez, M; Prior-Sanchez, I; Jodar-Moreno, R; Ruz, MAL				Lopez Zuniga, Miguel Angel; Moreno-Moral, Aida; Ocana-Granados, Ana; Padilla-Moreno, Francisco Andres; Castillo-Fernandez, Alba Maria; Guillamon-Fernandez, Dionisio; Ramirez-Sanchez, Carolina; Sanchez-Palop, Maria; Martinez-Colmenero, Justo; Pimentel-Villar, Maria Amparo; Blazquez-Rosello, Sara; Moreno-Sanchez, Jose Juan; Lopez-Vilchez, Maria; Prior-Sanchez, Inmaculada; Jodar-Moreno, Rosario; Lopez Ruz, Miguel Angel			High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response	PLOS ONE			English	Article								Objective Test whether high dose corticosteroid pulse therapy (HDCPT) with either methylprednisolone or dexamethasone is associated with increased survival in COVID-19 patients at risk of hyper-inflammatory response. Provide some initial diagnostic criteria using laboratory markers to stratify these patients. Methods This is a prospective observational study, 318 met the inclusion criteria. 64 patients (20.1%) were treated with HDCPT by using at least 1.5mg/kg/24h of methylprednisolone or dexamethasone equivalent. A multivariate Cox regression (controlling for co-morbidities and other therapies) was carried out to determine whether HDCPT (among other interventions) was associated with decreased mortality. We also carried out a 30-day time course analysis of laboratory markers between survivors and non-survivors, to identify potential markers for patient stratification. Results HDCPT showed a statistically significant decrease in mortality (HR = 0.087 [95% CI 0.021-0.36]; P < 0.001). 30-day time course analysis of laboratory marker tests showed marked differences in pro-inflammatory markers between survivors and non-survivors. As diagnostic criteria to define the patients at risk of developing a COVID-19 hyper-inflammatory response, we propose the following parameters (IL-6 > = 40 pg/ml, and/or two of the following: C-reactive protein > = 100 mg/L, D-dimer > = 1000 ng/ml, ferritin > = 500 ng/ml and lactate dehydrogenase > = 300 U/L). Conclusions HDCPT can be an effective intervention to increase COVID-19 survival rates in patients at risk of developing a COVID-19 hyper-inflammatory response, laboratory marker tests can be used to stratify these patients who should be given HDCPT. This study is not a randomized clinical trial (RCT). Future RCTs should be carried out to confirm the efficacy of HDCPT to increase the survival rates of COVID-19.	[Lopez Zuniga, Miguel Angel; Lopez Ruz, Miguel Angel] Hosp Univ Virgen Nieves, Infect Dis Unit, Granada, Spain; [Lopez Zuniga, Miguel Angel; Martinez-Colmenero, Justo] Univ Jaen, Grp Invest CTS 990 GEAPACECP, Jaen, Spain; [Ocana-Granados, Ana] Complejo Hosp Jaen, Allergol Serv, Jaen, Spain; [Padilla-Moreno, Francisco Andres; Castillo-Fernandez, Alba Maria; Martinez-Colmenero, Justo; Moreno-Sanchez, Jose Juan; Lopez-Vilchez, Maria] Complejo Hosp Jaen, Internal Med Serv, Jaen, Spain; [Guillamon-Fernandez, Dionisio] Hosp Univ San Cecilio, Otorhinolaryngol Serv, Granada, Spain; [Ramirez-Sanchez, Carolina] Hosp Univ Virgen Victoria, Pathol Anat Serv, Malaga, Spain; [Sanchez-Palop, Maria] Pneumol Serv Complejo Hosp Jaen, Jaen, Spain; [Pimentel-Villar, Maria Amparo] Complejo Hosp Jaen, Haematol Serv, Jaen, Spain; [Blazquez-Rosello, Sara] Complejo Hosp Jaen, Nephrol Serv, Jaen, Spain; [Prior-Sanchez, Inmaculada] Complejo Hosp Jaen, Endocrinol Serv, Jaen, Spain; [Jodar-Moreno, Rosario] Complejo Hosp Jaen, Otorhinolaryngol Serv, Jaen, Spain	Hospital Universitario Virgen de las Nieves; Universidad de Jaen; Complejo Hospitalario de Jaen; Complejo Hospitalario de Jaen; Hospital Universitario San Cecilio; Hospital Virgen de la Victoria; Complejo Hospitalario de Jaen; Complejo Hospitalario de Jaen; Complejo Hospitalario de Jaen; Complejo Hospitalario de Jaen	Zuniga, MAL (corresponding author), Hosp Univ Virgen Nieves, Infect Dis Unit, Granada, Spain.; Zuniga, MAL (corresponding author), Univ Jaen, Grp Invest CTS 990 GEAPACECP, Jaen, Spain.	miguelangellopezzuniga@gmail.com		Martinez Colmenero, Justo/0000-0003-2949-1854; Lopez Zuniga, Miguel Angel/0000-0002-2583-316X				Alunno A, 2020, RMD OPEN, V6, DOI 10.1136/rmdopen-2020-001295; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Campins L, 2020, CLIN EXP RHEUMATOL, V38, P578; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Dastan F, 2020, INT IMMUNOPHARMACOL, V85, DOI 10.1016/j.intimp.2020.106688; Fadel R, 2020, CLIN INFECT DIS, V71, P2114, DOI 10.1093/cid/ciaa601; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Henderson LA, 2020, ARTHRITIS RHEUMATOL, V72, P1059, DOI 10.1002/art.41285; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lerkvaleekul B, 2018, OPEN ACCESS RHEUMATO, V10, P117, DOI 10.2147/OARRR.S151013; Liu FF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70387-2; Luo P, 2020, J MED VIROL, V92, P814, DOI 10.1002/jmv.25801; Gimenez VMM, 2020, LIFE SCI, V254, DOI 10.1016/j.lfs.2020.117808; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; NIH, 2020, CLIN PRES PEOPL SARS; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rubio JLC, 2020, MED CLIN-BARCELONA, V155, P159, DOI 10.1016/j.medcli.2020.04.018; Ruiz-Irastorza G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239401; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Siddiqi HK, 2020, J HEART LUNG TRANSPL, V39, P405, DOI 10.1016/j.healun.2020.03.012; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Weir EK, 2020, CLIN MED, V20, pE107, DOI 10.7861/clinmed.2020-0301; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang SS, 2020, CAN J ANESTH, V67, P1462, DOI 10.1007/s12630-020-01700-w; Yao TT, 2020, J MED VIROL, V92, P556, DOI 10.1002/jmv.25729; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Zhang W, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108393	34	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0243964	10.1371/journal.pone.0243964	http://dx.doi.org/10.1371/journal.pone.0243964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507958	gold, Green Published			2022-12-26	WOS:000635021400014
J	Simsa, R; Rothenbucher, T; Gurbuz, H; Ghosheh, N; Emneus, J; Jenndahl, L; Kaplan, DL; Bergh, N; Serrano, AM; Fogelstrand, P				Simsa, Robin; Rothenbucher, Theresa; Gurbuz, Hakan; Ghosheh, Nidal; Emneus, Jenny; Jenndahl, Lachmi; Kaplan, David L.; Bergh, Niklas; Serrano, Alberto Martinez; Fogelstrand, Per			Brain organoid formation on decellularized porcine brain ECM hydrogels	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; CEREBRAL ORGANOIDS; RHEOLOGICAL CHARACTERIZATION; BIOLOGIC SCAFFOLDS; NEURITE OUTGROWTH; MODEL; SYSTEM; IMPACT; RECELLULARIZATION; ELASTICITY	Human brain tissue models such as cerebral organoids are essential tools for developmental and biomedical research. Current methods to generate cerebral organoids often utilize Matrigel as an external scaffold to provide structure and biologically relevant signals. Matrigel however is a nonspecific hydrogel of mouse tumor origin and does not represent the complexity of the brain protein environment. In this study, we investigated the application of a decellularized adult porcine brain extracellular matrix (B-ECM) which could be processed into a hydrogel (B-ECM hydrogel) to be used as a scaffold for human embryonic stem cell (hESC)-derived brain organoids. We decellularized pig brains with a novel detergent- and enzyme-based method and analyzed the biomaterial properties, including protein composition and content, DNA content, mechanical characteristics, surface structure, and antigen presence. Then, we compared the growth of human brain organoid models with the B-ECM hydrogel or Matrigel controls in vitro. We found that the native brain source material was successfully decellularized with little remaining DNA content, while Mass Spectrometry (MS) showed the loss of several brain-specific proteins, while mainly different collagen types remained in the B-ECM. Rheological results revealed stable hydrogel formation, starting from B-ECM hydrogel concentrations of 5 mg/mL. hESCs cultured in B-ECM hydrogels showed gene expression and differentiation outcomes similar to those grown in Matrigel. These results indicate that B-ECM hydrogels can be used as an alternative scaffold for human cerebral organoid formation, and may be further optimized for improved organoid growth by further improving protein retention other than collagen after decellularization.	[Simsa, Robin; Jenndahl, Lachmi] VERIGRAFT AB, Gothenburg, Sweden; [Simsa, Robin; Bergh, Niklas; Fogelstrand, Per] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Simsa, Robin; Bergh, Niklas; Fogelstrand, Per] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Simsa, Robin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Rothenbucher, Theresa; Serrano, Alberto Martinez] Univ Autonoma Madrid, Ctr Mol Biol Severo Ochoa UAM CSIC, Dept Mol Biol, Madrid, Spain; [Gurbuz, Hakan; Emneus, Jenny] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Gurbuz, Hakan] FELIXROBOTICS BV, Utrecht, Netherlands; [Ghosheh, Nidal] Univ Skovde, Syst Biol Res Ctr, Sch Biosci, Skovde, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Tufts University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Technical University of Denmark; University of Skovde	Simsa, R (corresponding author), VERIGRAFT AB, Gothenburg, Sweden.; Simsa, R; Bergh, N (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.; Simsa, R; Bergh, N (corresponding author), Sahlgrens Univ Hosp, Gothenburg, Sweden.; Simsa, R (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	robin.simsa@verigraft.com; niklas.bergh@gu.se	Emneus, Jenny/A-5763-2012	Emneus, Jenny/0000-0002-8061-201X; Gurbuz, Hakan/0000-0002-8839-431X	European Union's Horizon 2020 Research and Innovation Program under the Marie SklodowskaCurie Grant [722779]; AMS group (CBMSO-UAM) grant [MINECO SAF2017-83241-R]; ISC-III RETICS TerCel [RD16/0011/0032]; ASCTN597 Training [813851]; NIH [P41EB027062, R01NS092847]; VERIGRAFT AB; Felix Printers	European Union's Horizon 2020 Research and Innovation Program under the Marie SklodowskaCurie Grant; AMS group (CBMSO-UAM) grant; ISC-III RETICS TerCel; ASCTN597 Training; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VERIGRAFT AB(HOGANAS ABStatisticon AB); Felix Printers	This study was supported by the European Union's Horizon 2020 Research and Innovation Program under the Marie SklodowskaCurie Grant (No. 722779) awarded to RS; AMS group (CBMSO-UAM) grant (No. MINECO SAF2017-83241-R) awarded tp AMS, ISC-III RETICS TerCel (RD16/0011/0032) and ASCTN597 Training (No. 813851) awarded to AMS, and NIH grants ((P41EB027062 and R01NS092847) awarded to DLK. VERIGRAFT AB provided funding in the form of salary for RS. Felix Printers provided funding in the form of salary for HG. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alovskaya A, 2007, BIOMATERIALS TISSUE, V3; Antoine EE, 2014, TISSUE ENG PART B-RE, V20, P683, DOI [10.1089/ten.teb.2014.0086, 10.1089/ten.TEB.2014.0086]; Aubin Hug, 2013, Methods Mol Biol, V1036, P163, DOI 10.1007/978-1-62703-511-8_14; Aurand ER, 2012, J FUNCT BIOMATER, V3, P839, DOI 10.3390/jfb3040839; Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743; Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060; Bonandrini B, 2014, TISSUE ENG PT A, V20, P1486, DOI [10.1089/ten.tea.2013.0269, 10.1089/ten.TEA.2013.0269]; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Brown DA, 2007, BIOTECHNOL BIOENG, V97, P962, DOI 10.1002/bit.21295; Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044; Davis BH, 2007, ANN BIOMED ENG, V35, P1414, DOI 10.1007/s10439-007-9301-2; DeQuach JA, 2011, TISSUE ENG PT A, V17, P2583, DOI [10.1089/ten.tea.2010.0724, 10.1089/ten.TEA.2010.0724]; EDGAR D, 1984, EMBO J, V3, P1463, DOI 10.1002/j.1460-2075.1984.tb01997.x; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014; Freytes Donald O, 2014, Methods Mol Biol, V1181, P69, DOI 10.1007/978-1-4939-1047-2_7; Geerts S, 2016, TISSUE ENG PART C-ME, V22, P671, DOI [10.1089/ten.tec.2015.0571, 10.1089/ten.TEC.2015.0571]; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gilpin SE, 2014, J HEART LUNG TRANSPL, V33, P298, DOI 10.1016/j.healun.2013.10.030; Hoshiba T, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6397820; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Ijima H, 2018, GELS-BASEL, V4, DOI 10.3390/gels4020039; Jabbari E, 2016, MATER TODAY, V19, P190, DOI 10.1016/j.mattod.2015.10.005; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015; Keane TJ, 2015, METHODS, V84, P25, DOI 10.1016/j.ymeth.2015.03.005; Koh I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22681-3; Kucharz EJ., 1992, COLLAGENS BIOCH PATH, P261, DOI [10.1007/978-3-642-76197-3_19, DOI 10.1007/978-3-642-76197-3_19]; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kuljanin M, 2017, BIOMATERIALS, V144, P130, DOI 10.1016/j.biomaterials.2017.08.012; Lam D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40128-1; Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lin Q, 2017, INT J PHARMACEUT, V517, P383, DOI 10.1016/j.ijpharm.2016.12.028; Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040; Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062; Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010; Nicholson C, 1998, TRENDS NEUROSCI, V21, P207, DOI 10.1016/S0166-2236(98)01261-2; O'Brien JJ, 2018, ANN APPL STAT, V12, P2075, DOI 10.1214/18-AOAS1144; Oksdath M, 2018, APL BIOENG, V2, DOI 10.1063/1.5045124; Poornejad N, 2016, J BIOMATER APPL, V31, P521, DOI 10.1177/0885328216656099; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rauch U, 2007, BIOCHEM SOC T, V35, P656, DOI 10.1042/BST0350656; Ribatti D, 2003, BRAIN RES, V989, P9, DOI 10.1016/S0006-8993(03)03225-6; Rothenbucher TSP, 2019, FUTUR NEUROL, V14, DOI 10.2217/fnl-2018-0043; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Sackett SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28857-1; Saldin LT, 2017, ACTA BIOMATER, V49, P1, DOI 10.1016/j.actbio.2016.11.068; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Shayegan M, 2016, BIOPHYS J, V111, P2404, DOI 10.1016/j.bpj.2016.10.039; SHELLSWELL GB, 1979, FEBS LETT, V106, P305, DOI 10.1016/0014-5793(79)80520-7; Simsa R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220743; Simsa R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209269; Singelyn JM, 2011, MACROMOL BIOSCI, V11, P731, DOI 10.1002/mabi.201000423; Sood D, 2016, ACS BIOMATER SCI ENG, V2, P131, DOI 10.1021/acsbiomaterials.5b00446; Stachowiak EK, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/s41398-017-0054-x; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027; Tonge DA, 2012, BRAIN RES, V1453, P8, DOI 10.1016/j.brainres.2012.03.024; Ushakova GA, 2002, NEUROCHEM INT, V40, P277, DOI 10.1016/S0197-0186(01)00028-6; Wang JW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41042; Wechsler-Reya RJ, 2001, TRENDS NEUROSCI, V24, P680, DOI 10.1016/S0166-2236(00)02058-0; White LJ, 2017, ACTA BIOMATER, V50, P207, DOI 10.1016/j.actbio.2016.12.033; Wu Y, 2017, CELL TRANSPLANT, V26, P1224, DOI 10.1177/0963689717714090; Zuidema JM, 2014, J BIOMED MATER RES B, V102, P1063, DOI 10.1002/jbm.b.33088	72	16	16	14	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245685	10.1371/journal.pone.0245685	http://dx.doi.org/10.1371/journal.pone.0245685			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507989	Green Published, gold			2022-12-26	WOS:000635021400046
J	Strobel, P; Galaz, A; Villaroel-Espindola, F; Apaoblaza, A; Slebe, JC; Jerez-Timaure, N; Gallo, C; Ramirez-Reveco, A				Strobel, Pablo; Galaz, Alex; Villaroel-Espindola, Franz; Apaoblaza, Ariel; Carlos Slebe, Juan; Jerez-Timaure, Nancy; Gallo, Carmen; Ramirez-Reveco, Alfredo			Temperature, but not excess of glycogen, regulates "in vitro" AMPK activity in muscle samples of steer carcasses	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; EARLY POSTMORTEM; SKELETAL-MUSCLE; METABOLIC-RATE; GLYCOLYSIS; BEEF; GENE; PH; PHOSPHORYLATION; BRAIN	Postmortem muscle temperature affects the rate of pH decline in a linear manner from 37.5 degrees C to 0-2 degrees C. The pH decline is correlated with the enzymatic degradation of glycogen to lactate and this process includes the metabolic coupling between glycogenolysis and glycolysis, and that are strongly upregulated by the AMPK. In this study, we used 12 samples previously characterized by have different muscle glycogen concentration, lactate and AMPK activity, selected from 38 steers that produced high final pH (> 5.9) and normal final pH (<5.8) carcasses at 24 h postmortem. Moreover, we evaluated changes in the AMPK activity in samples from both categories incubated at 37, 25, 17 and 5 degrees C and supplemented with exogenous glycogen. Finally, we analysed if there were structural differences between polymers from both categories. Our results showed that "in vitro" enzymatic AMPK activity evaluated at both 0.5 or 24 h was greater in samples from normal then high pH categories (p < 0.01), and in all temperature of incubation analysed (17, 25 and 37 degrees C). For other hand, a greater AMPK activity were obtained in samples incubated at 17 that 25 or 37 degrees C, in normal carcasses at both 0.5 or 24 h (p < 0.01), as also in samples from carcasses categorized as high pH, but at 24 h (p < 0.05). Interestingly, AMPK activity was totally abolished at 5 degrees C, independent of final pH category of carcasses, and was confirmed that the incubation temperature at which the maximum activity was obtained (p < 0.01), at least in carcasses with a normal pH is at 17 degrees C. The enzymatic AMPK activity did not change in relation to excess glycogen (p > 0.05) and we did not detect structural differences in the polymers present in samples from both categories (p > 0.05), suggesting that postmortem AMPK activity may be highly sensitive to temperature and not to in vitro changes in glycogen concentration (p > 0.05). Our results allow concluding that normal concentrations of muscle glycogen immediately at the time of slaughter (0.5 h) and an adequate cooling managing of carcasses are relevant to let an efficient glycogenolytic/glycolytic flow required for lactate accumulation and pH decline, through the postmortem AMPK signalling pathway.	[Strobel, Pablo; Galaz, Alex; Apaoblaza, Ariel; Jerez-Timaure, Nancy; Gallo, Carmen; Ramirez-Reveco, Alfredo] Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile; [Villaroel-Espindola, Franz; Carlos Slebe, Juan] Univ Austral Chile, Fac Ciencias, Inst Bioquim & Microbiol, Valdivia, Chile; [Villaroel-Espindola, Franz] Fdn Arturo Lopez Perez Canc Ctr, Lab Med Traslac, Santiago, Chile; [Galaz, Alex] Ctr Estudios Cient, Lab Biol, Metab Energet, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Ramirez-Reveco, A (corresponding author), Univ Austral Chile, Fac Ciencias Vet, Inst Ciencia Anim, Valdivia, Chile.	alfredoramirez@uach.cl	Villarroel-Espindola, Franz/GLU-4201-2022; Ramirez, Alfredo/AAF-8536-2020; Jerez-Timaure, Nancy/T-3546-2019	Jerez-Timaure, Nancy/0000-0003-3894-2936; Ramirez, Alfredo/0000-0003-4782-4261	Conicyt, Chile [Fondecyt 1120757]; Direccion de Investigacion y Desarrollo, Universidad Austral de Chile [DID S-2017-26]	Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Direccion de Investigacion y Desarrollo, Universidad Austral de Chile	Grant Fondecyt 1120757 (Conicyt, Chile); Grant DID S-2017-26 (Direccion de Investigacion y Desarrollo, Universidad Austral de Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apaoblaza A, 2017, LIVEST SCI, V202, P101, DOI 10.1016/j.livsci.2017.05.028; Bartrons M, 2004, CRYOBIOLOGY, V49, P190, DOI 10.1016/j.cryobiol.2004.06.004; Bendall J. R., 1960, STRUCTURE FUNCTION M, V2, P243; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CASSENS RG, 1967, J FOOD SCI, V32, P13, DOI 10.1111/j.1365-2621.1967.tb01947.x; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cordova A, 2014, CRYOBIOLOGY, V69, P473, DOI 10.1016/j.cryobiol.2014.10.008; DALO NL, 1995, J EXP BIOL, V198, P1765; Devine C. E., 1996, P 42 INT C MEAT SCI, P396; Dick A, 2019, MEAT SCI, V153, P9, DOI 10.1016/j.meatsci.2019.02.024; Du M, 2005, J AGR FOOD CHEM, V53, P3235, DOI 10.1021/jf047913n; Ferguson DM, 2014, ANIM PROD SCI, V54, P464, DOI 10.1071/AN13088; Galaz A., 2014, THESIS U AUSTR CHILE; Gallo C., 2004, REV AM AM LATINA CAR, V41, P10; Genders AJ, 2019, AM J PHYSIOL-CELL PH, V316, pC404, DOI 10.1152/ajpcell.00214.2018; Hallows KR, 2005, CURR OPIN NEPHROL HY, V14, P464, DOI 10.1097/01.mnh.0000174145.14798.64; Hardie DG, 2004, REV ENDOCR METAB DIS, V5, P119, DOI 10.1023/B:REMD.0000021433.63915.bb; Hargreaves A., 2003, CIENC INVESTIG AGRAR, V3, P155; Hargreaves M, 2003, SCI TOTAL ENVIRON, V312, P89, DOI 10.1016/S0048-9697(03)00169-4; HELMREICH ERNST, 1965, ADVANCE ENZYME REGULAT, V3, P91, DOI 10.1016/0065-2571(65)90045-2; HILLMAN SS, 1988, PHYSIOL ZOOL, V61, P254, DOI 10.1086/physzool.61.3.30161238; Hwang IH, 2001, MEAT SCI, V58, P167, DOI 10.1016/S0309-1740(00)00147-9; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; KRISMAN CR, 1962, ANAL BIOCHEM, V4, P17, DOI 10.1016/0003-2697(62)90014-3; Leff T, 2003, BIOCHEM SOC T, V31, P224; Leyva-Garcia IA, 2012, ARCH MED VET, V44, P39, DOI 10.4067/S0301-732X2012000100006; LOCKER RH, 1963, J SCI FOOD AGR, V14, P787, DOI 10.1002/jsfa.2740141103; Lutz PL, 1997, J EXP BIOL, V200, P2913; Martin-Hidalgo D, 2013, THERIOGENOLOGY, V80, P285, DOI 10.1016/j.theriogenology.2013.02.015; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; NEWBOLD RP, 1967, BIOCHEM J, V105, P127, DOI 10.1042/bj1050127; Park BY, 2007, ASIAN AUSTRAL J ANIM, V20, P598, DOI 10.5713/ajas.2007.598; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Ramirez A, 2013, 23 REUN AS LAT PROD; Scott JW, 2014, CHEM BIOL, V21, P619, DOI 10.1016/j.chembiol.2014.03.006; Shen QW, 2007, J ANIM SCI, V85, P1054, DOI 10.2527/jas.2006-114; Shen QWW, 2008, MEAT SCI, V78, P323, DOI 10.1016/j.meatsci.2007.06.023; Shen QWW, 2006, J AGR FOOD CHEM, V54, P5583, DOI 10.1021/jf060411k; Shen QW, 2005, J SCI FOOD AGR, V85, P2401, DOI 10.1002/jsfa.2252; Siqueira TS, 2017, POULTRY SCI, V96, P2956, DOI 10.3382/ps/pex046; Storey J. M., 2005, FUNCTIONAL METABOLIS, P473; Storey KB, 2006, CRYOBIOLOGY, V52, P1, DOI 10.1016/j.cryobiol.2005.09.005; Storey KB, 2004, BIOL REV, V79, P207, DOI 10.1017/S1464793103006195; SWATLAND HJ, 1979, HISTOCHEM J, V11, P391, DOI 10.1007/BF01002767; TARRANT PV, 1977, J SCI FOOD AGR, V28, P739, DOI 10.1002/jsfa.2740280813; Thompson J, 2002, MEAT SCI, V62, P295, DOI 10.1016/S0309-1740(02)00126-2; Vidal R, 2009, 34 REUN AN SOC CHIL, P242; Villarroel-Espindola F, 2016, J CELL PHYSIOL, V231, P2142, DOI 10.1002/jcp.25315; YASMINEH WG, 1992, CLIN BIOCHEM, V25, P109, DOI 10.1016/0009-9120(92)80053-J; Zhao LP, 2016, FEBS LETT, V590, P3202, DOI 10.1002/1873-3468.12359; Zhu X, 2013, MEAT SCI, V93, P600, DOI 10.1016/j.meatsci.2012.11.011	52	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0229480	10.1371/journal.pone.0229480	http://dx.doi.org/10.1371/journal.pone.0229480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507943	Green Published, gold, Green Submitted			2022-12-26	WOS:000635021400001
J	Kizhisseri, MI; Mohamed, MM; El-Shorbagy, W; Chowdhury, R; McDonald, A				Kizhisseri, Mohamed, I; Mohamed, Mohamed M.; El-Shorbagy, Walid; Chowdhury, Rezaul; McDonald, Adrian			Development of a dynamic water budget model for Abu Dhabi Emirate, UAE	PLOS ONE			English	Article								In this study, a dynamic water budget model is developed for the Emirate of Abu Dhabi (EAD) in the United Arab Emirates (UAE). The model, called Abu Dhabi Water Budget Model (ADWBM), accounts for a number of drivers such as population growth, economic growth, consumption pattern and climatic factors. Model formulation, calibration, validation as well as simulation results for two future situations are presented in this paper. The two water simulations discuss demand-side options in response to different future water conditions until 2050. The first simulation, namely, baseline (BL) simulation examined water balance in the emirate assuming no change in both water production and consumption. BL simulation results highlight the expected shortages in water resources assuming no modification in the supply side. The second simulation, a more conservative and practical simulation considering water conservation options and sustainable improvements to the supply side was developed to achieve a balanced water budget by reducing the baseline consumption rates. The results show that a significant demand reduction is needed in all demand sectors, reaching 60% in the potable sectors and above 70% in non-potable sectors. Overall, results show that the ADWBM can be used as a numerical tool to produce accurate figures of water supply and demand for the sake of planning and decision making in the water sector of the EAD until 2050.	[Kizhisseri, Mohamed, I; Mohamed, Mohamed M.] United Arab Emirates Univ, Coll Engn, Civil & Environm Engn Dept, Al Ain, U Arab Emirates; [Mohamed, Mohamed M.] United Arab Emirates Univ, Natl Water Ctr, Al Ain, U Arab Emirates; [El-Shorbagy, Walid] Univ Arizona, Civil & Architectural Engn & Mech, Tucson, AZ USA; [Chowdhury, Rezaul] Univ Southern Queensland, Sch Civil Engn & Surveying, Toowoomba, Qld, Australia; [McDonald, Adrian] Univ Leeds, Fac Environm, Leeds, W Yorkshire, England	United Arab Emirates University; United Arab Emirates University; University of Arizona; University of Southern Queensland; University of Leeds	Mohamed, MM (corresponding author), United Arab Emirates Univ, Coll Engn, Civil & Environm Engn Dept, Al Ain, U Arab Emirates.; Mohamed, MM (corresponding author), United Arab Emirates Univ, Natl Water Ctr, Al Ain, U Arab Emirates.	m.mohamed@uaeu.ac.ae	mohamed, mostafa/AFE-7371-2022	mohamed, mostafa/0000-0002-1421-2667; Chowdhury, Rezaul/0000-0003-1631-9748				Abdollahi K., 2018, HDB ENV MAT MANAGEME, P1; Abu Dhabi City Municipality, 2014, GEOTECHNICAL GEOPHYS; Abu Dhabi City Municipality, 2015, STORM WAT SUBS DRAIN; Abu Dhabi Water and Electricity Company, 2018, ADWEC STAT REP YEARS; Al-Zubari W.K., 2009, EXPLOITING NATURAL R, P3; Bandoc G, 2015, J GEOGR SCI, V25, P1307, DOI 10.1007/s11442-015-1236-1; Camp MV, 2015, LUMPED PARAMETER BAL; Cheng L, 2014, J HYDROL, V519, P1350, DOI 10.1016/j.jhydrol.2014.09.020; Dawoud MA, 2007, GRC RES PAPERS; Deus D, 2013, REMOTE SENS-BASEL, V5, P1651, DOI 10.3390/rs5041651; Dougherty WW, 2009, CLIMATE CHANGE IMPAC; Duque C, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-017-7200-x; Ospina-Norena JE, 2017, ATMOSFERA, V30, P63, DOI [10.20937/ATM.2017.30.01.06, 10.20937/atm.2017.30.01.06]; Elhakeem A, 2015, J WATER RES PLAN MAN, V141, DOI 10.1061/(ASCE)WR.1943-5452.0000507; Environment Agency-Abu Dhabi, 2018, ANN REP 2017; Environment Agency-Abu Dhabi, 2012, ENV VIS 2030; Environment Agency-Abu Dhabi, 2014, WATER RESOURCES MANA; Environment Agency-Abu Dhabi, 2009, CLIMATE CHANGE IMPAC; Environment Agency-Abu Dhabi, 2009, AB DHAB WAT RES MAST; Gonzalez R, 2016, WATER-SUI, V8, DOI 10.3390/w8090415; Jazim A.A., 2006, J KING SAUD U ENG SC, V19, P65, DOI [10.1016/S1018-3639(18)30848-1, DOI 10.1016/S1018-3639(18)30848-1]; Karimi P, 2013, HYDROL EARTH SYST SC, V17, P2459, DOI 10.5194/hess-17-2459-2013; Lehmann P, 2019, GEOPHYS RES LETT, V46, P9648, DOI 10.1029/2019GL083932; Lindhe A, 2020, WATER-SUI, V12, DOI 10.3390/w12030721; Lutz W., 2014, WORLD POPULATION HUM; Lv MX, 2017, J HYDROL, V547, P585, DOI 10.1016/j.jhydrol.2017.02.027; Maloszewski P, 2000, IAHS-AISH P, P271; Mohamed MM, 2020, J HYDROL-REG STUD, V32, DOI 10.1016/j.ejrh.2020.100758; Mohamed MM, 2014, IAHS-AISH P, V364, P273; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Oroud IM, 2015, ENVIRON PROCESS, V2, P395, DOI 10.1007/s40710-015-0072-8; Perez-Sanchez J, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102872; Qaiser K, 2011, J ENVIRON MANAGE, V92, P2061, DOI 10.1016/j.jenvman.2011.03.031; Rockaway TD, 2011, J AM WATER WORKS ASS, V103, P76; Roy S, 2012, ASSESSMENT WATER BAL, V20, P10; RSB Abu Dhabi Waterwise, 2009, RES END US WAT PROJ; RTI International, 2015, EC VAL GROUNDW AB DH; RTI International, 2009, RES WAT BAS TECHN PO; RTI International, 2009, I WAT BAS TECHN POT; RTI International, 2009, COMM WAT BAS TECHN P; Scott RL, 2019, WATER RESOUR RES, V55, P574, DOI 10.1029/2018WR023477; Shimizu T, 2015, J HYDROL, V522, P250, DOI 10.1016/j.jhydrol.2014.12.021; Statistics Centre-Abu Dhabi, 2018, STAT YB ABU DHABI 20; Statistics Centre-Abu Dhabi, 2015, STAT YB ABU DHABI 20; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Tarnavsky E, 2013, REMOTE SENS-BASEL, V5, P6691, DOI 10.3390/rs5126691; Terrestrial Environment Research Centre, 2015, WAT RES STUD AI WATH; Thapa BR, 2017, J HYDROL-REG STUD, V9, P149, DOI 10.1016/j.ejrh.2016.12.080; Wang HL, 2014, J HYDROL, V511, P546, DOI 10.1016/j.jhydrol.2014.01.076; Wei T, 2016, J ENVIRON SCI, V50, P117, DOI 10.1016/j.jes.2016.06.034; Yao YJ, 2014, J HYDROL, V519, P50, DOI 10.1016/j.jhydrol.2014.06.046	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245140	10.1371/journal.pone.0245140	http://dx.doi.org/10.1371/journal.pone.0245140			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503021	gold, Green Published			2022-12-26	WOS:000613751800036
J	Jarvela, TS; Chaplot, K; Lindberg, I				Jarvela, Timothy S.; Chaplot, Kriti; Lindberg, Iris			A protease protection assay for the detection of internalized alpha-synuclein pre-formed fibrils	PLOS ONE			English	Article							TRANSMISSION	Alpha-synuclein pre-formed fibrils (PFFs) represent a promising model system for the study of cellular processes underlying cell-to-cell transmission of alpha-synuclein proteopathic aggregates. However, the ability to differentiate the fate of internalized PFFs from those which remain in the extracellular environment remains limited due to the propensity for PFFs to adhere to the cell surface. Removal of PFFs requires repeated washing and/or specific quenching of extracellular fluorescent PFF signals. In this paper we present a new method for analyzing the fate of internalized alpha-synuclein. We inserted a tobacco etch virus (TEV) protease cleavage site between alpha-synuclein and green fluorescent protein and subjected cells to brief treatment with TEV protease after incubation with tagged PFFs. As the TEV protease is highly specific, non-toxic, and active under physiological conditions, protection from TEV cleavage can be used to distinguish internalized PFFs from those which remain attached to the cell surface. Using this experimental paradigm, downstream intracellular events can be analyzed via live or fixed cell microscopy as well as by Western blotting. We suggest that this method will be useful for understanding the fate of PFFs after endocytosis under various experimental manipulations.	[Jarvela, Timothy S.; Chaplot, Kriti; Lindberg, Iris] Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Lindberg, I (corresponding author), Univ Maryland, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	ilindberg@som.umaryland.edu		Lindberg, Iris/0000-0002-1188-170X; Jarvela, Timothy/0000-0001-6364-0900; Chaplot, Kriti/0000-0002-8939-4696	NIH [AG062222]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant AG062222 to IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Cesaratto F, 2016, J BIOTECHNOL, V231, P239, DOI 10.1016/j.jbiotec.2016.06.012; Guedin S, 2000, J BIOL CHEM, V275, P30202, DOI 10.1074/jbc.M005515200; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Jarvela TS, 2016, P NATL ACAD SCI USA, V113, pE4708, DOI 10.1073/pnas.1601091113; Karpowicz RJ, 2017, J BIOL CHEM, V292, P13482, DOI 10.1074/jbc.M117.780296; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Paslawski W, 2016, METHODS MOL BIOL, V1345, P133, DOI 10.1007/978-1-4939-2978-8_9; Patterson JR, 2019, JOVE-J VIS EXP, DOI 10.3791/59758; Paumier KL, 2015, NEUROBIOL DIS, V82, P185, DOI 10.1016/j.nbd.2015.06.003; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Polinski NK, 2018, J PARKINSON DIS, V8, P303, DOI 10.3233/JPD-171248; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Uemura N, 2020, TRENDS MOL MED, V26, P936, DOI 10.1016/j.molmed.2020.03.012; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Wintgens JP, 2019, CELL MOL LIFE SCI, V76, P1185, DOI 10.1007/s00018-018-03003-2	19	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0241161	10.1371/journal.pone.0241161	http://dx.doi.org/10.1371/journal.pone.0241161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497415	Green Submitted, Green Published, gold			2022-12-26	WOS:000613707100005
J	Zhao, YZ; Yang, ZY; He, YH; Sun, RN; Yuan, HP				Zhao, Yuanzheng; Yang, Zhuoying; He, Yuanhong; Sun, Ruonan; Yuan, Heping			The KATP channel opener, nicorandil, ameliorates brain damage by modulating synaptogenesis after ischemic stroke	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; FOCAL CEREBRAL-ISCHEMIA; RECEPTOR ACTIVATION; GLOBAL-ISCHEMIA; NEUROGENESIS; EXPRESSION; INJURY; GAP-43; MODEL	With population growth and aging, more and more patients with cerebral infarction have varying degrees of disability. ATP-sensitive potassium (KATP) channels regulate many cellular functions by coupling metabolic status with cell membrane electrical activity. Nicorandil (N-(2-hydroxyethyl)-nicotinamide nitrate) is the first KATP channel opener approved for clinical use. It has been reported that it might exert protective effects on the cerebral infarction by increasing cerebral blood flow and reducing inflammation. However, only a few studies explored its role in synaptogenesis. We made the rat model of middle cerebral artery occlusion (MCAO). Nicorandil was administered to rats via oral administration immediately after the surgery at a dose of 7.5 mg/kg and then daily for the next days. Infarct volume, cerebral edema, neurological deficits, cognitive impairment, and the level of Synaptophysin (SYP)?Growth associated protein-43 (GAP43) and neuronal nuclear antigen (NeuN) levels were measured to evaluate the effect of nicorandil. Our data showed that nicorandil treatment could decrease brain damage, improve learning and memory, and increase SYP?GAP43 and NeuN level. Taken together, we propose that nicorandil, as an opener of the KATP channel, provides a neuroprotective role in MCAO by promoting synaptic connections.	[Zhao, Yuanzheng; Yang, Zhuoying; He, Yuanhong; Sun, Ruonan; Yuan, Heping] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China	Zhengzhou University	Zhao, YZ (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou, Henan, Peoples R China.	zdwfy00@163.com			Henan Province Medical Science and Technology Research Project [2018020225]	Henan Province Medical Science and Technology Research Project	This research was funded by Henan Province Medical Science and Technology Research Project, No. 2018020225. The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseenko AV, 2012, NEUROSCI LETT, V513, P238, DOI 10.1016/j.neulet.2012.02.051; [Anonymous], 2020, SPINE, V45, pE600; Azad TD, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15637; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Dong YF, 2013, CNS NEUROSCI THER, V19, P617, DOI 10.1111/cns.12117; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Fox GB, 2001, J NEUROPATH EXP NEUR, V60, P132, DOI 10.1093/jnen/60.2.132; Frey D, 2000, J CELL BIOL, V149, P1443, DOI 10.1083/jcb.149.7.1443; Gupta S, 2016, J STROKE CEREBROVASC, V25, P2717, DOI 10.1016/j.jstrokecerebrovasdis.2016.07.023; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; Hua K, 2015, ACTA PHARMACOL SIN, V36, P917, DOI 10.1038/aps.2015.31; Kong JJ, 2013, EUR NEUROL, V70, P233, DOI 10.1159/000351247; Kotoda M, 2018, J ANESTH, V32, P244, DOI 10.1007/s00540-018-2471-2; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Lee JH, 2014, ACTA BIOMATER, V10, P4425, DOI 10.1016/j.actbio.2014.06.023; Li Q, 2017, NEUROBIOL DIS, V108, P173, DOI 10.1016/j.nbd.2017.08.011; Li WN, 2015, EXP THER MED, V10, P2197, DOI 10.3892/etm.2015.2782; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Liu H, 2020, J ETHNOPHARMACOL, P113491, DOI [10.1016/j.jep.2020.11349133091490, DOI 10.1016/J.JEP.2020.11349133091490]; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Martinez-Moreno M, 2016, NEUROSCIENCE, V333, P229, DOI 10.1016/j.neuroscience.2016.07.032; Mayanagi K, 2007, BRAIN RES, V1168, P106, DOI 10.1016/j.brainres.2007.06.071; Mayanagi K, 2007, J CEREBR BLOOD F MET, V27, P348, DOI 10.1038/sj.jcbfm.9600345; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Othman FA, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110893; Ravindran S, 2017, ACTA NEUROBIOL EXP, V77, P57, DOI 10.21307/ane-2017-036; SchmidtKastner R, 1997, CELL TISSUE RES, V288, P225, DOI 10.1007/s004410050808; Speisman RB, 2013, NEUROBIOL AGING, V34, P263, DOI 10.1016/j.neurobiolaging.2012.05.023; Sun HS, 2013, ACTA PHARMACOL SIN, V34, P24, DOI 10.1038/aps.2012.138; Szeto V, 2018, ACTA PHARMACOL SIN, V39, P683, DOI 10.1038/aps.2018.10; Tarasenko A, 2012, NEUROCHEM INT, V61, P1044, DOI 10.1016/j.neuint.2012.07.021; Tinker A, 2018, COMPR PHYSIOL, V8, P1463, DOI 10.1002/cphy.c170048; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang L, 2011, NEUROSCI LETT, V491, P63, DOI 10.1016/j.neulet.2010.12.065; Wang T, 2018, J STROKE CEREBROVASC, V27, P2829, DOI 10.1016/j.jstrokecerebrovasdis.2018.06.018; Xiong XX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0260-8; Yang XR, 2019, J NANOBIOTECHNOL, V17, DOI 10.1186/s12951-019-0442-x; Zhan BM, 2020, BIOMED PHARMACOTHER, V127, DOI 10.1016/j.biopha.2020.110121; Zhang XY, 2019, CELL MOL NEUROBIOL, V39, P1151, DOI 10.1007/s10571-019-00709-0; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao WB, 2019, ANN CLIN TRANSL NEUR, V6, P186, DOI 10.1002/acn3.691; Zhu FF, 2018, EXP THER MED, V16, P37, DOI 10.3892/etm.2018.6136	44	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246019	10.1371/journal.pone.0246019	http://dx.doi.org/10.1371/journal.pone.0246019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497397	Green Published, gold			2022-12-26	WOS:000613707100004
J	Fukuda, Y; Tanaka, A; Homma, T; Kaneko, K; Uno, T; Fujiwara, A; Uchida, Y; Suzuki, S; Kotani, T; Sagara, H				Fukuda, Yosuke; Tanaka, Akihiko; Homma, Tetsuya; Kaneko, Keisuke; Uno, Tomoki; Fujiwara, Akiko; Uchida, Yoshitaka; Suzuki, Shintaro; Kotani, Toru; Sagara, Hironori			Utility of SpO(2)/FiO(2) ratio for acute hypoxemic respiratory failure with bilateral opacities in the ICU	PLOS ONE			English	Article							ACUTE LUNG INJURY; DISTRESS-SYNDROME; PAO(2)/FIO(2) RATIO; MORTALITY; OUTCOMES	Acute hypoxemic respiratory failure (AHRF) with bilateral opacities causes fatalities in the intensive care unit (ICU). It is often difficult to identify the causes of AHRF at the time of admission. The SpO(2) to FiO(2) (S/F) ratio has been recently used as a non-invasive and alternative marker of the PaO2/FiO(2) (P/F) ratio in acute respiratory failure. This retrospective cohort study was conducted from October 2010 to March 2019 at the Showa University Hospital, Tokyo, Japan. We enrolled 94 AHRF patients who had bilateral opacities and received mechanical ventilation in ICU to investigate their prognostic markers including S/F ratio. Significant differences were observed for APACHE II, S/F ratio, PaO2/FiO(2) (P/F) ratio, and ventilator-free-days at day 28 for ICU mortality, and for age, S/F ratio, P/F ratio, duration of mechanical ventilation, and ventilator-free days at day 28 for hospital mortality. Multivariate logistic regression analysis showed that the S/F ratio was significantly and independently associated with the risk of death during in ICU (p = 0.003) and hospitalization (p = 0.002). The area under the receiver operating characteristic curves (AUC) based on the S/F ratio were significantly greater than those based on simplified acute physiology score (SAPS) II and sequential organ failure assessment (SOFA) for ICU mortality (0.785 in S/F ratio vs. 0.575 in SAPS II, p = 0.012; 0.785 in S/F ratio vs 0.594 in SOFA, p = 0.021) and for hospital mortality (0.701 in S/F ratio vs. 0.502 in SAPS II, p = 0.012; 0.701 in S/F ratio vs. 0.503 in SOFA, p = 0.005). In the subanalysis for bacterial pneumonia and interstitial lung disease groups, the AUC based on the S/F ratio was the greatest among all prognostic markers, including APACHE II, SAPS II, and SOFA. The S/F ratio may be a useful and noninvasive predictive prognostic marker for acute hypoxemic respiratory failure with bilateral opacities in the ICU.	[Fukuda, Yosuke; Tanaka, Akihiko; Homma, Tetsuya; Kaneko, Keisuke; Uno, Tomoki; Fujiwara, Akiko; Uchida, Yoshitaka; Suzuki, Shintaro; Sagara, Hironori] Showa Univ, Div Resp Med & Allergol, Dept Med, Sch Med,Shinagawa Ku, Tokyo, Japan; [Kotani, Toru] Showa Univ, Dept Intens Care Med, Sch Med, Shinagawa Ku, Tokyo, Japan	Showa University; Showa University	Fukuda, Y (corresponding author), Showa Univ, Div Resp Med & Allergol, Dept Med, Sch Med,Shinagawa Ku, Tokyo, Japan.	y.f.0423@med.showa-u.ac.jp	Fukuda, Yosuke/AAH-8888-2021	Fukuda, Yosuke/0000-0002-7087-1595; TANAKA, AKIHIKO/0000-0003-3771-486X				Bass CM, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0995-5; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Bilan N, 2015, J CARDIOVASC THORAC, V7, P28, DOI 10.15171/jcvtr.2014.06; Chen W, 2015, CHEST, V148, P1477, DOI 10.1378/chest.15-0169; DesPrez K, 2017, CHEST, V152, P1151, DOI 10.1016/j.chest.2017.08.002; Fernandez-Perez ER, 2008, CHEST, V133, P1113, DOI 10.1378/chest.07-1481; Ghuman AK, 2012, PEDIATR CRIT CARE ME, V13, P11, DOI 10.1097/PCC.0b013e3182192c42; Goldhill DR, 1996, ANAESTHESIA, V51, P719, DOI 10.1111/j.1365-2044.1996.tb07882.x; Grimaldi D, 2018, ANN INTENSIVE CARE, V8, P82, DOI DOI 10.1186/s13613-018-0424-4; Kamo T, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0803-0; Kangelaris KN, 2016, CRIT CARE MED, V44, P120, DOI 10.1097/CCM.0000000000001359; Kao KC, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0440-4; Kwack WG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201632; Lu XF, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01455-4; Minne L, 2011, INTENS CARE MED, V37, P1258, DOI 10.1007/s00134-011-2265-6; Neto AS, 2013, J CRIT CARE, V28, P681, DOI 10.1016/j.jcrc.2013.04.005; Pandharipande PP, 2009, CRIT CARE MED, V37, P1317, DOI 10.1097/CCM.0b013e31819cefa9; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Pisani L, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0327-9; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Seeley E, 2008, THORAX, V63, P994, DOI 10.1136/thx.2007.093658; Sendagire C, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0304-8; Thompson BT, 2011, CRIT CARE CLIN, V27, P459, DOI 10.1016/j.ccc.2011.05.011; Zwier S, 2014, SEX MED-UK, V2, P16, DOI 10.1002/sm2.20	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245927	10.1371/journal.pone.0245927	http://dx.doi.org/10.1371/journal.pone.0245927			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493229	gold, Green Published			2022-12-26	WOS:000613081500026
J	Theau, JM; Lauzier-Hudon, E; Aube, L; Devillers, N				Theau, Jerome; Lauzier-Hudon, Etienne; Aube, Lydiane; Devillers, Nicolas			Estimation of forage biomass and vegetation cover in grasslands using UAV imagery	PLOS ONE			English	Article							LEAF-AREA INDEX; WATER-STRESS; CHLOROPHYLL	Grasslands are among the most widespread ecosystems on Earth and among the most degraded. Their characterization and monitoring are generally based on field measurements, which are incomplete spatially and temporally. The recent advent of unmanned aerial vehicles (UAV) provides data at unprecedented spatial and temporal resolutions. This study aims to test and compare three approaches based on multispectral imagery acquired by UAV to estimate forage biomass or vegetation cover in grasslands. The study site is composed of 30 pasture plots (25 x 50 m), 5 bare soil plots (25 x 50), and 6 control plots (5 x 5 m) on a 14-ha field maintained at various biomass levels by grazing rotations and clipping over a complete growing season. A total of 14 flights were performed. A first approach based on structure from motion was used to generate a volumetric-based biomass estimation model (R-2 of 0.93 and 0.94 for fresh biomass [FM] and dry biomass [DM], respectively). This approach is not very sensitive to low vegetation levels but is accurate for FM estimation greater than 0.5 kg/m(2) (0.1 kg DM/m(2)). The Green Normalized Difference Vegetation Index (GNDVI) was selected to develop two additional approaches. One is based on a regression biomass prediction model (R-2 of 0.80 and 0.66 for FM and DM, respectively) and leads to an accurate estimation at levels of FM lower than 3 kg/m(2) (0.6 kg DM/m(2)). The other approach is based on a classification of vegetation cover from clustering of GNDVI values in four classes. This approach is more qualitative than the other ones but more robust and generalizable. These three approaches are relatively simple to use and applicable in an operational context. They are also complementary and can be adapted to specific applications in grassland characterization.	[Theau, Jerome; Lauzier-Hudon, Etienne] Univ Sherbrooke, Dept Appl Geomat, Sherbrooke, PQ, Canada; [Aube, Lydiane; Devillers, Nicolas] Agr & Agri Food Canada, Sherbrooke Res & Dev Ctr, Sherbrooke, PQ, Canada; [Aube, Lydiane] Univ Clermont Auvergne, UMR Herbivores, Vetagro Sup, INRAE, St Genes Chapanelle, France	University of Sherbrooke; Agriculture & Agri Food Canada; INRAE; Universite Clermont Auvergne (UCA); VetAgro Sup	Theau, JM (corresponding author), Univ Sherbrooke, Dept Appl Geomat, Sherbrooke, PQ, Canada.	Jerome.Theau@USherbrooke.ca		Aube, Lydiane/0000-0002-6174-3743; Theau, Jerome/0000-0001-5052-6308	Agriculture and Agri-Food Canada [J-001357]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	This research was funded by Agriculture and Agri-Food Canada (project number J-001357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann JJ, 2019, J UNMANNED VEH SYST, V7, P54, DOI 10.1139/juvs-2018-0018; Aube L, ANIMAL; Ballester C, 2018, PRECIS AGRIC, V19, P178, DOI 10.1007/s11119-017-9512-y; Banhazi T. M., 2012, International Journal of Agricultural and Biological Engineering, V5, P1, DOI 10.3965/j.ijabe.20120503.001; Bareth G, 2018, PFG-J PHOTOGRAMM REM, V86, P157, DOI 10.1007/s41064-018-0055-2; Barnes E. M., 2000, Proceedings of the 5th International Conference on Precision Agriculture, Bloomington, Minnesota, USA, 16-19 July, 2000, P1; Bolinder MA, 2002, CAN J PLANT SCI, V82, P731, DOI 10.4141/P01-139; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; BUSCHMANN C, 1993, INT J REMOTE SENS, V14, P711, DOI 10.1080/01431169308904370; Cooper SD, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9060531; Corcoles JI, 2013, BIOSYST ENG, V115, P31, DOI 10.1016/j.biosystemseng.2013.02.002; Datt B, 1998, REMOTE SENS ENVIRON, V66, P111, DOI 10.1016/S0034-4257(98)00046-7; Dengler J., 2018, GRASSLANDS WORLD DIV; Duan MJ, 2011, CAN J REMOTE SENS, V37, P413, DOI 10.5589/m11-050; Fan XY, 2018, GRASSL SCI, V64, P145, DOI 10.1111/grs.12184; Felderhof L, 2011, CAN J REMOTE SENS, V37, P376, DOI 10.5589/m11-046; Gruner E, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9020054; HUETE AR, 1988, REMOTE SENS ENVIRON, V25, P295, DOI 10.1016/0034-4257(88)90106-X; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Insua JR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212773; Lee HyoWon, 2015, Journal of the Korean Society of Grassland and Forage Science, V35, P225; Liu H, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11050595; Lussem U, 2018, INT ARCH PHOTOGRAMM, VXLII-3, P1215, DOI [DOI 10.5194/ISPRS-ARCHIVES-XLII-3-1215-2018, 10.5194/isprs-archives-XLII-3-1215-2018]; Ma QQ, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020417; Maes WH, 2019, TRENDS PLANT SCI, V24, P152, DOI 10.1016/j.tplants.2018.11.007; Marino S, 2018, EUR J REMOTE SENS, V51, P266, DOI 10.1080/22797254.2017.1422280; Michez A, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11050473; Moeckel T, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010098; Murakami T, 2012, COMPUT ELECTRON AGR, V89, P70, DOI 10.1016/j.compag.2012.08.003; Mutanga O, 2004, INT J REMOTE SENS, V25, P3999, DOI 10.1080/01431160310001654923; Nasi R, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071082; O'Mara FP, 2012, ANN BOT-LONDON, V110, P1263, DOI 10.1093/aob/mcs209; Prabhakara K, 2015, INT J APPL EARTH OBS, V39, P88, DOI 10.1016/j.jag.2015.03.002; QI J, 1994, REMOTE SENS ENVIRON, V48, P119, DOI 10.1016/0034-4257(94)90134-1; Quebec, 2016, MET LID ACQ IN FRENC; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rouse JW, 1974, P 3 EARTH RES TECHN, P301; Rueda-Ayala VP, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19030535; Shahbazi M, 2014, GISCI REMOTE SENS, V51, P339, DOI 10.1080/15481603.2014.926650; Theau J, 2020, J UNMANNED VEH SYST, V8, P99, DOI 10.1139/juvs-2019-0009; Turner D, 2011, P 34 INT S REM SENS; Viljanen N, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8050070; Wachendorf M, 2018, GRASS FORAGE SCI, V73, P1, DOI 10.1111/gfs.12312; Wang DL, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17010180; Wang FL, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00453; Yao ZP, 2009, PROCEEDINGS OF THE ASME TURBO EXPO 2009, VOL 2, P603; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zhang HF, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060851	48	13	13	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245784	10.1371/journal.pone.0245784	http://dx.doi.org/10.1371/journal.pone.0245784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493223	gold, Green Published			2022-12-26	WOS:000613081500045
J	Amendola, L; Ratuski, A; Weary, DM				Amendola, Lucia; Ratuski, Anna; Weary, Daniel M.			Individual differences in rat sensitivity to CO2	PLOS ONE			English	Article							CARBON-DIOXIDE; 1ST-DEGREE RELATIVES; INHALATION; REACTIVITY; RESPONSES; AVERSION; BEHAVIOR; ANXIETY; AMPHETAMINE; CONSUMPTION	Feelings of fear, anxiety, dyspnea and panic when inhaling carbon dioxide (CO2) are variable among humans, in part due to differences in CO2 sensitivity. Rat aversion to CO2 consistently varies between individuals; this variation in aversion may reflect CO2 sensitivity, but other personality traits could also account for individual differences in aversion. The aims of this study were to 1) assess the stability of individual differences in rat aversion to CO2, 2) determine if individual differences in sweet reward motivation are associated with variation in aversion to CO2, and 3) assess whether variation in aversion to CO2 is related to individual differences in motivation to approach gains (promotion focus) or maintain safety (prevention focus). Twelve female Sprague Dawley rats were exposed multiple times at three different ages (3, 9 and 16 months old) to CO2 in approach-avoidance testing to assess motivation to avoid CO2 against motivation to gain sweet rewards. Rats were also tested for motivation to find hidden sweet rewards, and for their motivation to approach rewards or darkness. Tolerance to CO2 increased with repeated exposures and was higher at older ages. Individual differences in aversion to CO2 were highly repeatable but unrelated to motivation for sweet rewards or the strength of promotion and prevention focus. These results indicate that individual differences in aversion to CO2 reflect variation in CO2 sensitivity.	[Amendola, Lucia; Ratuski, Anna; Weary, Daniel M.] Univ British Columbia, Anim Welf Program, Vancouver, BC, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Anim Welf Program, Vancouver, BC, Canada.	dan.weary@ubc.ca	; Weary, Daniel/A-8868-2010	Amendola, Lucia/0000-0002-0743-5117; Weary, Daniel/0000-0002-0917-3982	Canada's Natural Science and Engineering Research Council [RGPIN-2016-04620]; CONACyT PhD scholarship [381124]; UBC Charles River Scholarship in Animal Welfare	Canada's Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); CONACyT PhD scholarship; UBC Charles River Scholarship in Animal Welfare	This study was funded by a Discovery grant (RGPIN-2016-04620) from Canada's Natural Science and Engineering Research Council to D.M. W. In addition, L.A. was supported by a CONACyT PhD scholarship (no. 381124) and the UBC Charles River Scholarship in Animal Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola L, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00936-w; Amendola L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55493-0; Amendola L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215808; Araya-Ajoy YG, 2015, METHODS ECOL EVOL, V6, P1462, DOI 10.1111/2041-210X.12430; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; BLANCHARD RJ, 1976, B PSYCHONOMIC SOC, V8, P179, DOI 10.3758/BF03335118; Brennan K, 2001, PSYCHOPHARMACOLOGY, V157, P269, DOI 10.1007/s002130100805; Cavigelli SA, 2003, P NATL ACAD SCI USA, V100, P16131, DOI 10.1073/pnas.2535721100; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chisholm J, 2013, LAB ANIM-UK, V47, P324, DOI 10.1177/0023677213493410; Colasanti A, 2012, CURR PHARM DESIGN, V18, P5627, DOI 10.2174/138161212803530745; Coryell W, 1999, BIOL PSYCHIAT, V45, P923, DOI 10.1016/S0006-3223(98)00241-8; DAVIS H, 1988, ANIM LEARN BEHAV, V16, P89, DOI 10.3758/BF03209048; DeSousa NJ, 1998, PHARMACOL BIOCHEM BE, V60, P841, DOI 10.1016/S0091-3057(98)00069-0; DeSousa NJ, 2000, PSYCHOPHARMACOLOGY, V148, P52, DOI 10.1007/s002130050024; Dingemanse NJ, 2020, J ANIM ECOL, V89, P601, DOI 10.1111/1365-2656.13122; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Eilam D, 2005, NEUROSCI BIOBEHAV R, V29, P1181, DOI 10.1016/j.neubiorev.2005.03.027; Eilam D, 2003, BEHAV BRAIN RES, V142, P53, DOI 10.1016/S0166-4328(02)00382-0; Fernandes C, 1996, PHARMACOL BIOCHEM BE, V54, P31, DOI 10.1016/0091-3057(95)02171-X; Franks B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095135; Franks B, 2012, J COMP PSYCHOL, V126, P347, DOI 10.1037/a0027244; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gorman JM, 2001, ARCH GEN PSYCHIAT, V58, P125, DOI 10.1001/archpsyc.58.2.125; Gosnell BA, 2000, PSYCHOPHARMACOLOGY, V149, P286, DOI 10.1007/s002130000375; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; Johnson PL, 2015, DEPRESS ANXIETY, V32, P671, DOI 10.1002/da.22403; Kirkden RD, 2008, APPL ANIM BEHAV SCI, V114, P216, DOI 10.1016/j.applanim.2008.03.001; KOTLER BP, 1990, J MAMMAL, V71, P591, DOI 10.2307/1381798; LAPIN IP, 1995, J PHARMACOL TOXICOL, V34, P73, DOI 10.1016/1056-8719(95)00025-D; Leach MC, 2004, ANIM WELFARE, V13, pS77; Leach MC, COMP MED JUN, V52, P249; Leibold NK, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.162; Li W, 2006, PHYSIOL BEHAV, V88, P47, DOI 10.1016/j.physbeh.2006.03.001; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McGregor IS, 2002, BEHAV BRAIN RES, V129, P1, DOI 10.1016/S0166-4328(01)00324-2; McMahon ME, 2002, J EXP BIOL, V205, P3937; Monkul ES, 2010, PSYCHIAT RES, V179, P194, DOI 10.1016/j.psychres.2009.06.015; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Niel L, 2008, APPL ANIM BEHAV SCI, V111, P183, DOI 10.1016/j.applanim.2007.06.004; Niel L, 2008, APPL ANIM BEHAV SCI, V109, P77, DOI 10.1016/j.applanim.2007.02.004; Niel L, 2006, APPL ANIM BEHAV SCI, V100, P295, DOI 10.1016/j.applanim.2005.12.001; Perna G, 1999, BIOL PSYCHIAT, V45, P365, DOI 10.1016/S0006-3223(98)00030-4; Poma SZ, 2005, J PSYCHOPHARMACOL, V19, P494, DOI 10.1177/0269881105056533; Pritchard LM, 2013, NEUROSCI LETT, V536, P47, DOI 10.1016/j.neulet.2012.12.048; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Roberson-Nay R, 2017, BIOL PSYCHOL, V124, P111, DOI 10.1016/j.biopsycho.2017.01.014; Romero RD, 2004, PHARMACOL BIOCHEM BE, V78, P675, DOI 10.1016/j.pbb.2004.04.033; Shah J, 1997, J PERS SOC PSYCHOL, V73, P447, DOI 10.1037/0022-3514.73.3.447; Sills TL, 1996, PHARMACOL BIOCHEM BE, V54, P665, DOI 10.1016/0091-3057(96)00024-X; SMITH RJ, 1995, J MAMMAL, V76, P189, DOI 10.2307/1382327; Smith W, 1997, LAB ANIM-UK, V31, P337, DOI 10.1258/002367797780596130; Steimer T, 1997, BEHAV GENET, V27, P503, DOI 10.1023/A:1021448713665; TOLMAN EC, 1955, PSYCHOL REV, V62, P315, DOI 10.1037/h0049079; Toissaar M, 2006, NEUROSCI LETT, V403, P119, DOI 10.1016/j.neulet.2006.04.023; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; van Beek N, 2000, BIOL PSYCHIAT, V47, P830, DOI 10.1016/S0006-3223(99)00265-6; VANDENHOUT MA, 1987, AM J PSYCHIAT, V144, P788; Verburg K, 1998, PSYCHIAT RES, V78, P207, DOI 10.1016/S0165-1781(98)00009-2; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; Winter A, 2017, NEUROSCIENCE, V346, P423, DOI 10.1016/j.neuroscience.2017.01.003; Wong D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1000	65	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245347	10.1371/journal.pone.0245347	http://dx.doi.org/10.1371/journal.pone.0245347			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481851	Green Published, gold			2022-12-26	WOS:000612929300156
J	Hoover, BA; Garcia-Reyes, M; Batten, SD; Gentemann, CL; Sydeman, WJ				Hoover, Brian A.; Garcia-Reyes, Marisol; Batten, Sonia D.; Gentemann, Chelle L.; Sydeman, William J.			Spatio-temporal persistence of zooplankton communities in the Gulf of Alaska	PLOS ONE			English	Article							SUB-ARCTIC PACIFIC; NORTHERN GULF; CLIMATE-CHANGE; MARINE; VARIABILITY; BIOMASS; SHELF; ECOSYSTEMS; PATTERNS; WATER	Spatial structuring of mid-trophic level forage communities in the Gulf of Alaska (GoA) is poorly understood, even though it has clear implications for the health of fisheries and marine wildlife populations. Here, we test the hypothesis that summertime (May-August) mesozooplankton communities are spatially-persistent across years of varying ocean conditions, including during the marine heatwave of 2014-2016. We use spatial ordinations and hierarchical clustering of Continuous Plankton Recorder (CPR) sampling over 17 years (2000-2016) to (1) characterize typical zooplankton communities in different regions of the GoA, and (2) investigate spatial structuring relative to variation in ocean temperatures and circulation. Five regional communities were identified, each representing distinct variation in the abundance of 18 primary zooplankton taxa: a distinct cluster of coastal taxa on the continental shelf north of Vancouver Island; a second cluster in the western GoA associated with strong currents and cold water east of Unimak Pass; a shelf break cluster rich in euphausiids found at both the eastern and western margins of the GoA; a broad offshore cluster of abundant pelagic zooplankton in the southern GoA gyre associated with stable temperature and current conditions; and a final offshore cluster exhibiting low zooplankton abundance concentrated along the northeastern arm of the subarctic gyre where ocean conditions are dominated by eddy activity. When comparing years of anomalous warm and cold sea surface temperatures, we observed change in the spatial structure in coastal communities, but little change (i.e., spatial persistence) in the northwestern GoA basin. Whereas previous studies have shown within-region variability in zooplankton communities in response to ocean climate, we highlight both consistency and change in regional communities, with interannual variability in shelf communities and persistence in community structure offshore. These results suggest greater variability in coastal food webs than in the central portion of the GoA, which may be important to energy exchange from lower to upper trophic levels in the meso-scale biomes of this ecosystem.	[Hoover, Brian A.; Garcia-Reyes, Marisol; Gentemann, Chelle L.; Sydeman, William J.] Farallon Inst, Petaluma, CA 94952 USA; [Batten, Sonia D.] CPR Survey, Marine Biol Assoc, Nanaimo, BC, Canada; [Gentemann, Chelle L.] Earth & Space Res, Seattle, WA USA; [Hoover, Brian A.] Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA	Chapman University System; Chapman University	Hoover, BA (corresponding author), Farallon Inst, Petaluma, CA 94952 USA.; Hoover, BA (corresponding author), Chapman Univ, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	bhoover@faralloninstitute.org		Hoover, Brian/0000-0003-1603-6932	NASA's Life in the Moving Oceans Initiative [80NSSC17K0557]	NASA's Life in the Moving Oceans Initiative	Funding for this study was provided to BH, WS, CG, and MGR by NASA's Life in the Moving Oceans Initiative (Award #80NSSC17K0557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Armstrong JL, 2005, DEEP-SEA RES PT II, V52, P247, DOI 10.1016/j.dsr2.2004.09.019; Bagnall A, 2014, J CLASSIF, V31, P154, DOI 10.1007/s00357-013-9135-6; Baier CT, 2003, J PLANKTON RES, V25, P771, DOI 10.1093/plankt/25.7.771; Batten SD, 2016, FISH OCEANOGR, V25, P420, DOI 10.1111/fog.12162; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Batten SD, 2007, FISH OCEANOGR, V16, P536, DOI 10.1111/j.1365-2419.2007.00448.x; Batten SD, 2006, DEEP-SEA RES PT II, V53, P270, DOI 10.1016/j.dsr2.2006.01.004; Batten SD, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00321; Batten SD, 2011, J PLANKTON RES, V33, P1643, DOI 10.1093/plankt/fbr065; Batten SD, 2018, FISH OCEANOGR, V27, P548, DOI 10.1111/fog.12276; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2018, ANNU REV MAR SCI, V10, P169, DOI 10.1146/annurev-marine-121916-063304; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Bedford J, 2018, MAR POLICY, V89, P109, DOI 10.1016/j.marpol.2017.12.021; Bertram DF, 2009, MAR ECOL PROG SER, V393, P199, DOI 10.3354/meps08223; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bonjean F, 2002, J PHYS OCEANOGR, DOI [10.1175/1520-0485(2002)0322938:DMAOT2.0, DOI 10.1175/1520-0485(2002)0322938:DMAOT2.0]; Brickley PJ, 2004, DEEP-SEA RES PT II, V51, P229, DOI 10.1016/j.dsr2.2003.06.003; Brodeur R.D., 1992, Fisheries Oceanography, V1, P32, DOI 10.1111/j.1365-2419.1992.tb00023.x; Brown J. H., 1995, MACROECOLOGY; Chiba S, 2015, ECOL EVOL, V5, P968, DOI 10.1002/ece3.1408; Coombes K. R, 2018, PCDIMENSION FINDING; Coyle KO, 2005, DEEP-SEA RES PT II, V52, P217, DOI 10.1016/j.dsr2.2004.09.025; Coyle KO, 2003, FISH OCEANOGR, V12, P327, DOI 10.1046/j.1365-2419.2003.00256.x; Cummins PF, 2007, PROG OCEANOGR, V75, P253, DOI 10.1016/j.pocean.2007.08.006; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Dohan K, 2017, J GEOPHYS RES-OCEANS, V122, P2647, DOI 10.1002/2017JC012961; Drew GF, 2013, N PACIFIC PELAGIC SE; Eden BR, 2009, DEEP-SEA RES PT I, V56, P1757, DOI 10.1016/j.dsr.2009.05.005; Eisner LB, 2014, DEEP-SEA RES PT II, V109, P157, DOI 10.1016/j.dsr2.2014.03.004; HOLLOWED AB, 1992, ICES MAR SC, V195, P433; Hooff RC, 2006, LIMNOL OCEANOGR, DOI [10.4319/lo.2006.51.3.1530, DOI 10.4319/LO.2006.51.3.1530]; Hristova HG, 2019, J GEOPHYS RES-OCEANS, V124, P5870, DOI 10.1029/2019JC015231; Hunt GL, 2005, DEEP-SEA RES PT II, V52, P781, DOI 10.1016/j.dsr2.2004.12.024; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Johnson WK, 2005, DEEP-SEA RES PT II, V52, P933, DOI 10.1016/j.dsr2.2004.08.017; Kaeriyama M, 2000, N PACIFIC ANADROMOUS; Kerr RA, 2007, SCIENCE, V316, P188, DOI 10.1126/science.316.5822.188; Kimmel DG, 2020, J PLANKTON RES, V42, P334, DOI 10.1093/plankt/fbaa019; Ladd C, 2005, DEEP-SEA RES PT II, V52, P667, DOI 10.1016/j.dsr2.2004.12.022; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mackas DL, 2005, DEEP-SEA RES PT II, V52, P707, DOI 10.1016/j.dsr2.2004.12.020; Mackas DL, 2004, DEEP-SEA RES PT II, V51, P875, DOI 10.1016/j.dsr2.2004.05.011; Mackas DL, 1999, PROG OCEANOGR, V43, P335, DOI 10.1016/S0079-6611(99)00012-9; Malick MJ, 2017, FISH OCEANOGR, DOI [10.1111/fog.12212, DOI 10.1111/FOG.12212]; Moku M, 2000, MAR ECOL PROG SER, V207, P129, DOI 10.3354/meps207129; Neal EG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042385; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; Reynolds R. W, 2008, NOAA OPTIMUM INTERPO; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Ruzicka JJ, 2012, PROG OCEANOGR, V102, P19, DOI 10.1016/j.pocean.2012.02.002; Shelden KEW, 2005, MAMMAL REV, V35, P129, DOI 10.1111/j.1365-2907.2005.00065.x; Sousa L, 2016, DEEP-SEA RES PT II, V132, P122, DOI 10.1016/j.dsr2.2016.04.006; SPRINGER AM, 1985, MAR ECOL PROG SER, V21, P229, DOI 10.3354/meps021229; Sugimoto T, 1997, FISH OCEANOGR, V6, P74, DOI 10.1046/j.1365-2419.1997.00031.x; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Sydeman WJ, 2010, J PLANKTON RES, V32, P1697, DOI 10.1093/plankt/fbq119; Tadokoro K, 1996, FISH OCEANOGR, DOI [10.1111/j.1365-2419, DOI 10.1111/J.1365-2419]; Tsuda A, 2004, FISH OCEANOGR, V13, P10, DOI 10.1111/j.1365-2419.2004.00315.x; Waite JN, 2013, PROG OCEANOGR, V116, P179, DOI 10.1016/j.pocean.2013.07.006; Whitney FA, 2007, PROG OCEANOGR, V75, P179, DOI 10.1016/j.pocean.2007.08.007; Witteveen BH, 2016, MAR MAMMAL SCI, V32, P1319, DOI 10.1111/mms.12333	67	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244960	10.1371/journal.pone.0244960	http://dx.doi.org/10.1371/journal.pone.0244960			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481844	Green Published, gold			2022-12-26	WOS:000612929300152
J	Zhang, SX; Garzan, A; Haese, N; Bostwick, R; Martinez-Gzegozewska, Y; Rasmussen, L; Streblow, DN; Haise, MT; Pathak, AK; Augelli-Szafran, CE; Wu, MS				Zhang, Sixue; Garzan, Atefeh; Haese, Nicole; Bostwick, Robert; Martinez-Gzegozewska, Yohanka; Rasmussen, Lynn; Streblow, Daniel N.; Haise, Mark T.; Pathak, Ashish K.; Augelli-Szafran, Corinne E.; Wu, Mousheng			Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design	PLOS ONE			English	Article							ACCURATE DOCKING; RNA; PATHOGENESIS; REPLICATION; POLYMERASE; INSIGHTS; DOMAINS; BINDING; GLIDE; MODEL	The macrodomain of nsP3 (nsP3MD) is highly conserved among the alphaviruses and ADP-ribosylhydrolase activity of Chikungunya Virus (CHIKV) nsP3MD is critical for CHIKV viral replication and virulence. No small molecule drugs targeting CHIKV nsP3 have been identified to date. Here we report small fragments that bind to nsP3MD which were discovered by virtually screening a fragment library and X-ray crystallography. These identified fragments share a similar scaffold, 2-pyrimidone-4-carboxylic acid, and are specifically bound to the ADP-ribose binding site of nsP3MD. Among the fragments, 2-oxo-5,6-benzopyrimidine-4-carboxylic acid showed anti-CHIKV activity with an IC50 of 23 mu M. Our fragment-based drug discovery approach provides valuable information to further develop a specific and potent nsP3 inhibitor of CHIKV viral replication based on the 2-pyrimidone-4-carboxylic acid scaffold. In silico studies suggest this pyrimidone scaffold could also bind to the macrodomains of other alphaviruses and coronaviruses and thus, have potential panantiviral activity.	[Zhang, Sixue; Garzan, Atefeh; Pathak, Ashish K.; Augelli-Szafran, Corinne E.; Wu, Mousheng] Southern Res, Drug Discovery Div, Chem Dept, Birmingham, AL 35205 USA; [Haese, Nicole; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Bostwick, Robert; Martinez-Gzegozewska, Yohanka; Rasmussen, Lynn] Southern Res, Drug Discovery Div, High Throughput Screening Ctr, Birmingham, AL USA; [Haise, Mark T.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27515 USA	Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Wu, MS (corresponding author), Southern Res, Drug Discovery Div, Chem Dept, Birmingham, AL 35205 USA.	mwu@southernreserch.org		Zhang, Sixue/0000-0002-2981-9154	NIAID/NIH [1U19AI142759-01, 1U19AI109680-01]	NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID/NIH (grants #1U19AI142759-01 and 1U19AI109680-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2018, P NATL ACAD SCI USA, V115, pE10457, DOI 10.1073/pnas.1812130115; Abu Bakar F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020071; AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; [Anonymous], 2019, SCHROD REL 2019 1; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Burt F, 2014, LANCET INFECT DIS, V14, P789, DOI 10.1016/S1473-3099(14)70869-2; Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1; Carr R, 2002, DRUG DISCOV TODAY, V7, P522, DOI 10.1016/S1359-6446(02)02245-6; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Chen MW, 2017, ANTIVIR RES, V143, P38, DOI 10.1016/j.antiviral.2017.04.001; Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002; Das PK, 2014, J BIOL CHEM, V289, P5635, DOI 10.1074/jbc.M113.503433; Davies TG, 2012, TOP CURR CHEM, V317, P33, DOI 10.1007/128_2011_179; Egloff MP, 2006, J VIROL, V80, P8493, DOI 10.1128/JVI.00713-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fehr AR, 2018, TRENDS MICROBIOL, V26, P598, DOI 10.1016/j.tim.2017.11.011; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Goertz GP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006958; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LASTARZA MW, 1994, J VIROL, V68, P5781, DOI 10.1128/JVI.68.9.5781-5791.1994; Law YS, 2019, P NATL ACAD SCI USA, V116, P9558, DOI 10.1073/pnas.1900656116; Lei J, 2018, ANTIVIR RES, V149, P58, DOI 10.1016/j.antiviral.2017.11.001; Li CQ, 2015, J VIROL, V89, P8292, DOI 10.1128/JVI.00599-15; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meshram CD, 2019, VIROLOGY, V534, P14, DOI 10.1016/j.virol.2019.05.016; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nienaber VL, 2000, NAT BIOTECHNOL, V18, P1105, DOI 10.1038/80319; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Pietla MK, 2017, VIRUS RES, V234, P44, DOI 10.1016/j.virusres.2017.01.007; Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001; Queyriaux B, 2008, LANCET INFECT DIS, V8, P2, DOI 10.1016/S1473-3099(07)70294-3; Rees DC, 2004, NAT REV DRUG DISCOV, V3, P660, DOI 10.1038/nrd1467; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109; Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64; Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009; Thoka B, 2018, VIRUS GENES, V54, P48, DOI 10.1007/s11262-017-1524-1; Tomar S, 2006, J VIROL, V80, P9962, DOI 10.1128/JVI.01067-06; Ziegler SA, 2008, AM J TROP MED HYG, V79, P133, DOI 10.4269/ajtmh.2008.79.133	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245013	10.1371/journal.pone.0245013	http://dx.doi.org/10.1371/journal.pone.0245013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33482665	Green Published, gold			2022-12-26	WOS:000612929300149
J	Li, F; Liu, C; Streckaite, S; Yang, CH; Xu, PQ; Llansola-Portoles, MJ; Ilioaia, C; Pascal, AA; Croce, R; Robert, B				Li, Fei; Liu, Cheng; Streckaite, Simona; Yang, Chunhong; Xu, Pengqi; Llansola-Portoles, Manuel J.; Ilioaia, Cristian; Pascal, Andrew A.; Croce, Roberta; Robert, Bruno			A new, unquenched intermediate of LHCII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING-COMPLEX; CIS-TRANS ISOMERS; RESONANCE RAMAN; PHOTOSYSTEM-II; BETA-CAROTENE; CHLOROPHYLL FLUORESCENCE; PHOTOSYNTHETIC BACTERIA; ELECTRONIC ABSORPTION; PIGMENT STRUCTURE; REACTION CENTERS	When plants are exposed to high-light conditions, the potentially harmful excess energy is dissipated as heat, a process called non-photochemical quenching. Efficient energy dissipation can also be induced in the major light-harvesting complex of photosystem II (LHCII) in vitro, by altering the structure and interactions of several bound cofactors. In both cases, the extent of quenching has been correlated with conformational changes (twisting) affecting two bound carotenoids, neoxanthin, and one of the two luteins (in site L1). This lutein is directly involved in the quenching process, whereas neoxanthin senses the overall change in state without playing a direct role in energy dissipation. Here we describe the isolation of an intermediate state of LHCII, using the detergent ndodecyl-alpha-D-maltoside, which exhibits the twisting of neoxanthin (along with changes in chlorophyll-protein interactions), in the absence of the L1 change or corresponding quenching. We demonstrate that neoxanthin is actually a reporter of the LHCII environment-probably reflecting a large-scale conformational change in the protein-whereas the appearance of excitation energy quenching is concomitant with the configuration change of the L1 carotenoid only, reflecting changes on a smaller scale. This unquenched LHCII intermediate, described here for the first time, provides for a deeper understanding of the molecular mechanism of quenching.	[Li, Fei; Liu, Cheng; Yang, Chunhong] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Streckaite, Simona; Llansola-Portoles, Manuel J.; Ilioaia, Cristian; Pascal, Andrew A.; Robert, Bruno] Univ Paris Saclay, CEA, CNRS, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Xu, Pengqi; Croce, Roberta] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, Amsterdam, Netherlands	Chinese Academy of Sciences; Institute of Botany, CAS; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Vrije Universiteit Amsterdam	Ilioaia, C; Robert, B (corresponding author), Univ Paris Saclay, CEA, CNRS, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	cristian.ilioaia@cea.fr; bruno.robert@cea.fr	Simona, Streckaite/CAA-2120-2022; Robert, Bruno/D-1264-2012; Croce, Roberta/HGU-9554-2022; pascal, andrew a/B-6186-2014; Croce, Roberta/ABG-3595-2021; Llansola-Portoles, Manuel J./ABI-1060-2020; Croce, Roberta/N-4067-2014	Simona, Streckaite/0000-0003-0541-5806; Robert, Bruno/0000-0001-5999-4538; Croce, Roberta/0000-0003-3469-834X; pascal, andrew a/0000-0002-1844-6065; Croce, Roberta/0000-0003-3469-834X; Llansola-Portoles, Manuel J./0000-0002-8065-9459; Croce, Roberta/0000-0003-3469-834X; ILIOAIA, Cristian/0000-0001-7505-1900	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05]; "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme [Ou Liu Jin [2016] 6313]; National Natural Science Foundation of China [31570236]; De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [86510013]; China Scholarship Council (CSC) [201604490129]	French Infrastructure for Integrated Structural Biology (FRISBI); "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-05 and the "Infrastructures en Biologie Sante et Agronomie" (IBiSA), Sino-French Cai Yuanpei Programme, Ou Liu Jin [2016] 6313, the National Natural Science Foundation of China (Grant No. 31570236), and De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) through a Vici grant (86510013) to R. C. F. L. was recipient of a China Scholarship Council grant (CSC NO. 201604490129).	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Akhtar P, 2015, J BIOL CHEM, V290, P4877, DOI 10.1074/jbc.M114.607770; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2009, EMBO J, V28, P3052, DOI 10.1038/emboj.2009.232; Chmeliov J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.45, 10.1038/nplants.2016.45]; Crisafi E, 2017, BBA-BIOMEMBRANES, V1859, P40, DOI 10.1016/j.bbamem.2016.10.010; Croce R, 2020, SCIENCE, V369, P933, DOI 10.1126/science.aay2058; DOLGANOV NAM, 1995, P NATL ACAD SCI USA, V92, P636, DOI 10.1073/pnas.92.2.636; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Fox KF, 2017, PHYS CHEM CHEM PHYS, V19, P22957, DOI 10.1039/c7cp03535g; Gall A, 2015, BBA-BIOENERGETICS, V1847, P12, DOI 10.1016/j.bbabio.2014.09.009; Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holzwarth AR, 2009, CHEM PHYS LETT, V483, P262, DOI 10.1016/j.cplett.2009.10.085; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; KOYAMA Y, 1982, BIOCHIM BIOPHYS ACTA, V680, P109, DOI 10.1016/0005-2728(82)90001-9; Koyama Y, 1999, ADV PHOTOSYNTH, V8, P161; KOYAMA Y, 1983, PHOTOBIOCH PHOTOBIOP, V5, P139; KOYAMA Y, 1988, J RAMAN SPECTROSC, V19, P37, DOI 10.1002/jrs.1250190107; Kruger TPJ, 2012, BIOPHYS J, V102, P2669, DOI 10.1016/j.bpj.2012.04.044; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; Liguori N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02239-z; Liguori N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Llansola-Portoles MJ, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2019.148078; Llansola-Portoles MJ, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0504; Llansola-Portoles MJ, 2017, PHOTOSYNTH RES, V134, P51, DOI 10.1007/s11120-017-0407-6; Llansola-Portoles MJ, 2017, J BIOL CHEM, V292, P1396, DOI 10.1074/jbc.M116.753723; Llansola-Portoles MJ, 2016, BBA-BIOENERGETICS, V1857, P1759, DOI 10.1016/j.bbabio.2016.08.006; LUTZ M, 1987, BIOCHIM BIOPHYS ACTA, V894, P423, DOI 10.1016/0005-2728(87)90121-6; Mascoli V, 2020, CHEM SCI, V11, P5697, DOI 10.1039/d0sc00781a; Mascoli V, 2019, CHEM-US, V5, P2900, DOI 10.1016/j.chempr.2019.08.002; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; MULLET JE, 1980, BIOCHIM BIOPHYS ACTA, V589, P100, DOI 10.1016/0005-2728(80)90135-8; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Park S, 2018, J AM CHEM SOC, V140, P11965, DOI 10.1021/jacs.8b04844; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Pinnola A, 2018, BIOCHEM SOC T, V46, P467, DOI [10.1042/BST20170307, 10.1042/bst20170307]; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; Robert B, 2009, PHOTOSYNTH RES, V101, P147, DOI 10.1007/s11120-009-9440-4; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2016, PLANT PHYSIOL, V170, P1903, DOI 10.1104/pp.15.01935; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; RUBAN AV, 1995, PLANT PHYSIOL, V108, P721, DOI 10.1104/pp.108.2.721; RUBAN AV, 1995, BIOCHEMISTRY-US, V34, P2333, DOI 10.1021/bi00007a029; Saccon F, 2020, J EXP BOT, V71, P3626, DOI 10.1093/jxb/eraa126; SAITO S, 1983, J RAMAN SPECTROSC, V14, P310, DOI 10.1002/jrs.1250140504; SALARES VR, 1977, J RAMAN SPECTROSC, V6, P282, DOI 10.1002/jrs.1250060605; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Son MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15074-6; Staleva H, 2015, NAT CHEM BIOL, V11, P287, DOI [10.1038/nchembio.1755, 10.1038/NCHEMBIO.1755]	53	3	3	7	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100322	10.1016/j.jbc.2021.100322	http://dx.doi.org/10.1016/j.jbc.2021.100322			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493515	gold, Green Published			2022-12-26	WOS:000672866400296
J	Balic, Z; Misra, S; Willard, B; Reinhardt, DP; Apte, SS; Hubmacher, D				Balic, Zerina; Misra, Saurav; Willard, Belinda; Reinhardt, Dieter P.; Apte, Suneel S.; Hubmacher, Dirk			Alternative splicing of the metalloprotease ADAMTS17 spacer regulates secretion and modulates autoproteolytic activity	FASEB JOURNAL			English	Article						ADAMTS proteases; fibrillin microfibrils; Weill&#8208; Marchesani syndrome; extracellular matrix; alternative splicing	PROTEOLYTIC ACTIVITIES; AGGRECAN DEGRADATION; FIBRILLIN-1; BINDING; ACTIVATION; TRANSCRIPT; PROTEINASE; MUTATIONS; EXOSITES; CLEAVAGE	ADAMTS proteases mediate biosynthesis and breakdown of secreted extracellular matrix (ECM) molecules in numerous physiological and disease processes. In addition to their catalytic domains, ADAMTS proteases contain ancillary domains, which mediate substrate recognition and ECM binding and confer distinctive properties and roles to individual ADAMTS proteases. Although alternative splicing can greatly expand the structural and functional diversity of ADAMTS proteases, it has been infrequently reported and functional consequences have been rarely investigated. Here, we characterize the structural and functional impact of alternative splicing of ADAMTS17, mutations in which cause Weill-Marchesani syndrome 4. Two novel ADAMTS17 splice variants, ADAMTS17A and ADAMTS17B, were investigated by structural modeling, mass spectrometry, and biochemical approaches. Our results identify a novel disulfide-bridged insertion in the ADAMTS17A spacer that originates from inclusion of a novel exon. This insertion results in differential autoproteolysis of ADAMTS17, and thus, predicts altered proteolytic activity against other substrates. The second variant, ADAMTS17B, results from an in-frame exon deletion and prevents ADAMTS17B secretion. Thus, alternative splicing of the ADAMTS spacer significantly regulates the physiologically relevant proteolytic activity of ADAMTS17, either by altering proteolytic specificity (ADAMTS17A) or by altering cellular localization (ADAMTS17B).	[Balic, Zerina; Hubmacher, Dirk] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Misra, Saurav] Kansas State Univ, Manhattan, KS 66506 USA; [Reinhardt, Dieter P.] McGill Univ, Montreal, PQ, Canada; [Willard, Belinda; Apte, Suneel S.] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Kansas State University; McGill University; Cleveland Clinic Foundation	Hubmacher, D (corresponding author), Icahn Sch Med Mt Sinai, Orthopaed Res Labs, Dept Orthopaed, 1 Gustave L Levy Pl, New York, NY 10029 USA.		Reinhardt, Dieter P/A-3102-2008	Reinhardt, Dieter P/0000-0001-6535-9872; Hubmacher, Dirk/0000-0003-1569-9451	NCRR NIH HHS [S10 RR031537] Funding Source: Medline; NEI NIH HHS [R01 EY021151] Funding Source: Medline; NIAMS NIH HHS [R01 AR070748] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akiyama M, 2013, J THROMB HAEMOST, V11, P1399, DOI 10.1111/jth.12279; Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bekhouche M, 2015, MATRIX BIOL, V44-46, P46, DOI 10.1016/j.matbio.2015.04.001; Bevitt DJ, 2005, GENE, V359, P99, DOI 10.1016/j.gene.2005.06.011; Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; Brouillard P, 2017, HUM MOL GENET, V26, P4095, DOI 10.1093/hmg/ddx297; Colige A, 1999, AM J HUM GENET, V65, P308, DOI 10.1086/302504; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Dupuis LE, 2019, ARTERIOSCL THROM VAS, V39, P2067, DOI 10.1161/ATVBAHA.119.313077; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans DR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66978-8; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Foulcer SJ, 2015, METHODS MOL BIOL, V1229, P587, DOI 10.1007/978-1-4939-1714-3_46; Foulcer SJ, 2014, J BIOL CHEM, V289, P27859, DOI 10.1074/jbc.M114.573287; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Hubmacher D, 2020, METHODS MOL BIOL, V2043, P195, DOI 10.1007/978-1-4939-9698-8_16; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Hubmacher D, 2015, MATRIX BIOL, V47, P34, DOI 10.1016/j.matbio.2015.05.004; Hubmacher D, 2014, BIOMACROMOLECULES, V15, P1456, DOI 10.1021/bm5000696; Jeanes Emily C, 2019, Canine Genet Epidemiol, V6, P5, DOI 10.1186/s40575-019-0071-6; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Karoulias SZ, 2020, MATRIX BIOL, V88, P1, DOI 10.1016/j.matbio.2019.11.001; Karoulias SZ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040596; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Khan AO, 2012, OPHTHALMIC GENET, V33, P235, DOI 10.3109/13816810.2012.666708; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Kutz WE, 2008, HUM MUTAT, V29, P1425, DOI 10.1002/humu.20797; Majumdar MK, 2007, ARTHRITIS RHEUM, V56, P3670, DOI 10.1002/art.23027; Mead TJ, 2018, MATRIX BIOL, V71-72, P225, DOI 10.1016/j.matbio.2018.06.002; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Nandadasa S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08520-7; Oichi T, 2019, CELL MOL LIFE SCI, V76, P4795, DOI 10.1007/s00018-019-03188-0; Oliver JAC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140436; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; Santamaria S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47494-w; Satz-Jacobowitz B, 2021, DEV DYNAM, V250, P8, DOI 10.1002/dvdy.248; Silva SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165061; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanley S, 2021, ANN NY ACAD SCI, V1490, P57, DOI 10.1111/nyas.14465; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Takeda S, 2016, TOXINS, V8, DOI 10.3390/toxins8050155; Tiedemann K, 2001, J BIOL CHEM, V276, P36035, DOI 10.1074/jbc.M104985200; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Wainwright SD, 2006, MATRIX BIOL, V25, P317, DOI 10.1016/j.matbio.2006.03.006; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	56	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21310	10.1096/fj.202001120RR	http://dx.doi.org/10.1096/fj.202001120RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484187	Bronze, Green Accepted			2022-12-26	WOS:000647789600048
J	Rodgers, LR; Streeter, AJ; Lin, N; Hamilton, W; Henley, WE				Rodgers, Lauren R.; Streeter, Adam J.; Lin, Nan; Hamilton, Willie; Henley, William E.			Impact of influenza vaccination on amoxicillin prescriptions in older adults: A retrospective cohort study using primary care data	PLOS ONE			English	Article							RATE RATIO ADJUSTMENT; EFFICACY; BIAS; MORTALITY; PHARMACOEPIDEMIOLOGY; IMMUNIZATION; METAANALYSIS; CHILDREN; BENEFITS; RISK	Background Bacterial infections of the upper and lower respiratory tract are a frequent complication of influenza and contribute to the widespread use of antibiotics. Influenza vaccination may help reduce both appropriate and inappropriate prescribing of antibiotics. Electronic health records provide a rich source of information for assessing secondary effects of influenza vaccination. Methods We conducted a retrospective study to estimate effects of influenza vaccine on antibiotic (amoxicillin) prescription in the elderly based on data from the Clinical Practice Research Datalink. The introduction of UK policy to recommend the influenza vaccine to older adults in 2000 led to a substantial increase in uptake, creating a natural experiment. Of 259,753 eligible patients that were unvaccinated in 1999 and aged >= 65y by January 2000, 88,519 patients received influenza vaccination in 2000. These were propensity score matched 1:1 to unvaccinated patients. Time-to-amoxicillin was analysed using the Prior Event Rate Ratio (PERR) Pairwise method to address bias from time-invariant measured and unmeasured confounders. A simulation study and negative control outcome were used to help strengthen the validity of results. Results Compared to unvaccinated patients, those from the vaccinated group were more likely to be prescribed amoxicillin in the year prior to vaccination: hazard ratio (HR) 1.90 (95% confidence interval 1.83, 1.98). Following vaccination, the vaccinated group were again more likely to be prescribed amoxicillin, HR 1.64 (1.58,1.71). After adjusting for prior differences between the two groups using PERR Pairwise, overall vaccine effectiveness was 0.86 (0.81, 0.92). Additional analyses suggested that provided data meet the PERR assumptions, these estimates were robust. Conclusions Once differences between groups were taken into account, influenza vaccine had a beneficial effect, lowering the frequency of amoxicillin prescribing in the vaccinated group. Ensuring successful implementation of national programmes of vaccinating older adults against influenza may help contribute to reducing antibiotic resistance.	[Rodgers, Lauren R.; Hamilton, Willie; Henley, William E.] Univ Exeter, Inst Hlth Res, Med Sch, Exeter, Devon, England; [Streeter, Adam J.] Univ Plymouth, Fac Hlth Med Dent & Human Sci, Med Stat, Plymouth, Devon, England; [Lin, Nan] Northumbria Univ, Dept Math Phys & Elect Engn, Newcastle Upon Tyne, Tyne & Wear, England	University of Exeter; University of Plymouth; Northumbria University	Rodgers, LR (corresponding author), Univ Exeter, Inst Hlth Res, Med Sch, Exeter, Devon, England.	L.R.Rodgers@exeter.ac.uk	; Rodgers, Lauren/I-1787-2017	Streeter, Adam/0000-0001-9921-2369; Rodgers, Lauren/0000-0002-5040-3073	MRC [G0902158] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainslie KEC, 2017, VACCINE, V35, P7297, DOI 10.1016/j.vaccine.2017.10.107; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Casanova L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016023; Darvishian M, 2014, J CLIN EPIDEMIOL, V67, P734, DOI 10.1016/j.jclinepi.2014.02.009; Dbaibo G, 2020, PEDIATR INFECT DIS J, V39, pE1, DOI 10.1097/INF.0000000000002504; GOV.UK,, 2017, IMMUNISATION INFECT; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; Groenwold RHH, 2009, EUR RESPIR J, V34, P56, DOI 10.1183/09031936.00190008; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Groenwold RHH, 2010, VALUE HEALTH, V13, P132, DOI 10.1111/j.1524-4733.2009.00584.x; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Guitor AK, 2018, CHEST, V154, P1202, DOI 10.1016/j.chest.2018.06.019; Gulliford MC, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-038767; Hak E, 2006, INT J EPIDEMIOL, V35, P800, DOI 10.1093/ije/dyl068; Haq K, 2014, CURR OPIN IMMUNOL, V29, P38, DOI 10.1016/j.coi.2014.03.008; Hardelid P, 2018, J ANTIMICROB CHEMOTH, V73, P779, DOI 10.1093/jac/dkx463; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Havers FP, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0243; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub3; Klugman KP, 2007, INT J ANTIMICROB AG, V29, pS6, DOI 10.1016/S0924-8579(07)70004-3; Klugman KP, 2018, P NATL ACAD SCI USA, V115, P12896, DOI 10.1073/pnas.1721095115; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Lee SS, 2014, INT J INFECT DIS, V24, P40, DOI 10.1016/j.ijid.2014.03.1384; Lin NX, 2016, STAT MED, V35, P5149, DOI 10.1002/sim.7051; Lone NI, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001019; Marchisio P, 2009, PEDIATR INFECT DIS J, V28, P855, DOI 10.1097/INF.0b013e3181a487b4; McElhaney JE, 2017, VACCINE, V35, P6269, DOI 10.1016/j.vaccine.2017.09.084; Monto AS, 2001, AM J EPIDEMIOL, V154, P155, DOI 10.1093/aje/154.2.155; Nelson JC, 2013, J CLIN EPIDEMIOL, V66, pS110, DOI 10.1016/j.jclinepi.2013.01.015; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Newall AT, 2014, VACCINE, V32, P1323, DOI 10.1016/j.vaccine.2014.01.017; NHS England, 2019, 2019 20 GEN MEDICAL; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Nowakowska M, 2019, J ANTIMICROB CHEMOTH, V74, P3371, DOI 10.1093/jac/dkz345; Ortqvist A, 2018, VACCINE, V36, P5556, DOI 10.1016/j.vaccine.2018.07.052; Public Health England, 2019, GREENBOOK IMMUNISATI; Ramsay LC, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1239-8; Rodgers LR, 2020, J CLIN EPIDEMIOL, V122, P78, DOI 10.1016/j.jclinepi.2020.03.007; Simonsen L, 2009, VACCINE, V27, P6300, DOI 10.1016/j.vaccine.2009.07.008; Streeter AJ, 2017, J CLIN EPIDEMIOL, V87, P23, DOI 10.1016/j.jclinepi.2017.04.022; Suguitan Jr AL, 2011, PLOS ONE, V6; Sullivan SG, 2016, VACCINE, V34, P4645, DOI 10.1016/j.vaccine.2016.08.003; Thommes EW, 2020, STAT MED, V39, P639, DOI 10.1002/sim.8435; Uddin MJ, 2016, INT J CLIN PHARM-NET, V38, P714, DOI 10.1007/s11096-016-0299-0; Uddin MJ, 2015, PHARMACOEPIDEM DR S, V24, P468, DOI 10.1002/pds.3724; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Yu MG, 2012, PHARMACOEPIDEM DR S, V21, P60, DOI 10.1002/pds.3235	49	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246156	10.1371/journal.pone.0246156	http://dx.doi.org/10.1371/journal.pone.0246156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513169	Green Published, gold, Green Accepted			2022-12-26	WOS:000613891400038
J	Ishiguro, S; Shinada, T; Wu, Z; Karimazawa, M; Uchidate, M; Nishimura, E; Yasuno, Y; Ebata, M; Sillapakong, P; Ishiguro, H; Ebata, N; Ni, JJ; Jiang, MZ; Goryo, M; Otsu, K; Harada, H; Suzuki, K				Ishiguro, Shinichi; Shinada, Tetsuro; Wu, Zhou; Karimazawa, Mayumi; Uchidate, Michimasa; Nishimura, Eiji; Yasuno, Yoko; Ebata, Makiko; Sillapakong, Piyamas; Ishiguro, Hiromi; Ebata, Nobuyoshi; Ni, Junjun; Jiang, Muzhou; Goryo, Masanobu; Otsu, Keishi; Harada, Hidemitsu; Suzuki, Koichi			A novel cyclic peptide (Naturido) modulates glia-neuron interactions in vitro and reverses ageing-related deficits in senescence-accelerated mice	PLOS ONE			English	Article								The use of agents that target both glia and neurons may represent a new strategy for the treatment of ageing disorders. Here, we confirmed the presence of the novel cyclic peptide Naturido that originates from a medicinal fungus (Isaria japonica) grown on domestic silkworm (Bombyx mon). We found that Naturido significantly enhanced astrocyte proliferation and activated the single copy gene encoding the neuropeptide VGFand the neuron-derived NGFgene. The addition of the peptide to the culture medium of primary hippocampal neurons increased dendrite length, dendrite number and axon length. Furthermore, the addition of the peptide to primary microglial cultures shifted CGA-activated microglia towards antiinflammatory and neuroprotective phenotypes. These findings of in vitro glia-neuron interactions led us to evaluate the effects of oral administration of the peptide on brain function and hair ageing in senescence-accelerated mice (SAMP8). In vivo analyses revealed that spatial learning ability and hair quality were improved in Naturido-treated mice compared with untreated mice, to the same level observed in the normal ageing control (SAMR1). These data suggest that Naturido may be a promising glia-neuron modulator for the treatment of not only senescence, but also Alzheimer's disease and other neurodegenerative diseases.	[Ishiguro, Shinichi; Karimazawa, Mayumi; Ebata, Makiko; Sillapakong, Piyamas; Ishiguro, Hiromi; Ebata, Nobuyoshi; Suzuki, Koichi] Biococoon Labs Inc, Morioka, Iwate, Japan; [Shinada, Tetsuro; Nishimura, Eiji; Yasuno, Yoko] Osaka City Univ, Grad Sch Sci, Sumiyoshi Ku, Osaka, Japan; [Wu, Zhou; Ni, Junjun; Jiang, Muzhou] Kyushu Univ, Fac Dent Sci, Dept Aging Sci & Pharmacol, Fukuoka, Japan; [Wu, Zhou] Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan; [Uchidate, Michimasa] Iwate Univ, Fac Sci & Engn, Morioka, Iwate, Japan; [Goryo, Masanobu; Suzuki, Koichi] Iwate Univ, Morioka, Iwate, Japan; [Otsu, Keishi; Harada, Hidemitsu] Iwate Med Univ, Dept Anat, Div Dev Biol & Regenerat Med, Yahaba, Iwate, Japan	Osaka Metropolitan University; Kyushu University; Kyushu University; Iwate University; Iwate University; Iwate Medical University	Suzuki, K (corresponding author), Biococoon Labs Inc, Morioka, Iwate, Japan.; Suzuki, K (corresponding author), Iwate Univ, Morioka, Iwate, Japan.	koichi@iwate-u.ac.jp		Yasuno, Yoko/0000-0001-6725-8610; Ni, Junjun/0000-0001-8486-8146	Japan Society for the Promotion of Science; DKS Co., Ltd. (the parent company of Biococoon Laboratories, Inc.)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); DKS Co., Ltd. (the parent company of Biococoon Laboratories, Inc.)	This study was supported by a grant from the Japan Society for the Promotion of Science to KS. DKS Co., Ltd. (the parent company of Biococoon Laboratories, Inc.) provided support for this study in the form of salaries for KS, SI, MK, ME, PS, HI and NE. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI K, 1995, BIOORG MED CHEM LETT, V5, P853, DOI 10.1016/0960-894X(95)00127-F; Alder J, 2003, J NEUROSCI, V23, P10800; Arranz AM, 2019, LANCET NEUROL, V18, P406, DOI 10.1016/S1474-4422(18)30490-3; Asanuma M, 2010, ANN NEUROL, V67, P239, DOI 10.1002/ana.21885; Barbarino P., 2018, CEO WORLD ALZH REP 2; Blanco-Suarez E, 2017, J PHYSIOL-LONDON, V595, P1903, DOI 10.1113/JP270988; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Costa Anna Maria, 2020, Cell Physiol Biochem, V54, P493, DOI 10.33594/000000232; Cummings J, 2019, ALZH DEMENT-TRCI, V5, P272, DOI 10.1016/j.trci.2019.05.008; Darreh-Shori T, 2008, NEUROBIOL AGING, V29, P168, DOI 10.1016/j.neurobiolaging.2006.09.020; Fields RD, 2006, SCI AM MIND, V17, P20; Flood JF, 1998, NEUROSCI BIOBEHAV R, V22, P1; Garwood CJ, 2017, NEUROPATH APPL NEURO, V43, P281, DOI 10.1111/nan.12338; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Jeong KH, 2011, SKIN RES TECHNOL, V17, P63, DOI 10.1111/j.1600-0846.2010.00466.x; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; LaTorre C, 2006, ULTRAMICROSCOPY, V106, P720, DOI 10.1016/j.ultramic.2005.11.010; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502, DOI 10.1002/jlb.60.4.502; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; Mehta Mona, 2012, Int J Alzheimers Dis, V2012, P728983, DOI 10.1155/2012/728983; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nair JJ, 2011, J ETHNOPHARMACOL, V137, P1102, DOI 10.1016/j.jep.2011.07.028; Nishimura Y, 2020, BIOCHEM BIOPH RES CO, V524, P340, DOI 10.1016/j.bbrc.2020.01.090; Nomura Y, 1999, NEUROBIOL AGING, V20, P111, DOI 10.1016/S0197-4580(99)00006-8; Ohta K, 2010, J NEUROL SCI, V291, P12, DOI 10.1016/j.jns.2010.01.013; Okumura Y, 2018, INT J GERIATR PSYCH, V33, P1286, DOI 10.1002/gps.4892; Ongali B, 2010, AM J PATHOL, V177, P3071, DOI 10.2353/ajpath.2010.100339; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Ramirez BG, 2005, J NEUROSCI, V25, P1904, DOI 10.1523/JNEUROSCI.4540-04.2005; Robel S, 2016, NAT NEUROSCI, V19, P28, DOI 10.1038/nn.4184; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339, DOI 10.1091/mbc.e04-05-0438; Sato Y, 2010, PEPTIDES, V31, P827, DOI 10.1016/j.peptides.2010.02.017; Schmid-Brunclik N, 2008, AM J PHYSIOL-REG I, V295, pR864, DOI 10.1152/ajpregu.00536.2007; Simpson JE, 2010, NEUROBIOL AGING, V31, P578, DOI 10.1016/j.neurobiolaging.2008.05.015; Sugimoto H, 2000, CURR MED CHEM, V7, P303, DOI 10.2174/0929867003375191; Suzuki K., 2017, Frontiers in Clinical Drug Research-Alzheimer Disorders, V6, P154, DOI 10.2174/ 9781681083391117060009; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Terayama Y, 2016, J IWATE MED ASS, V68, P223; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Toyomoto M, 2005, NEUROSCI LETT, V379, P185, DOI 10.1016/j.neulet.2004.12.063; Tsushima Masaaki, 2010, Journal of Insect Biotechnology and Sericology, V79, P45; Tay TL, 2017, J PHYSIOL-LONDON, V595, P1929, DOI 10.1113/JP272134; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Vinet J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082178; Wu Z, 2013, NEUROBIOL AGING, V34, P2715, DOI 10.1016/j.neurobiolaging.2013.05.018; Wu Z, 2008, NEUROBIOL DIS, V32, P543, DOI 10.1016/j.nbd.2008.09.002; Xu Ping, 2013, Journal of Traditional Medicines, V30, P229; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Yokoyama A, 2004, GLIA, V45, P96, DOI 10.1002/glia.10306; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	57	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245235	10.1371/journal.pone.0245235	http://dx.doi.org/10.1371/journal.pone.0245235			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503058	Green Published, gold			2022-12-26	WOS:000613751800055
J	Mohammadi, N; Alimohammadian, M; Feizesani, A; Poustchi, H; Alizadeh, A; Yaseri, M; Mansournia, MA; Sadjadi, A				Mohammadi, Neda; Alimohammadian, Masoomeh; Feizesani, Akbar; Poustchi, Hossein; Alizadeh, Ahad; Yaseri, Mehdi; Mansournia, Mohammad Ali; Sadjadi, Alireza			The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: An analysis of 49,946 cases in the Golestan Cohort Study, Iran	PLOS ONE			English	Article							EMERGING RISK-FACTOR; ESOPHAGEAL CANCER; SELECTION	Upper gastrointestinal (UGI) cancer, including esophageal and gastric, is one of the most common cancers in the world. Hence, the determination of risk factors of UGI helps to reduce the economic and social burden of this cancer in communities. In Iran, the consumption of opium because of its neighborhood with Afghanistan are considerable. In this study, we examine the causal effect of opium use on the time to UGI cancer death. Based on the Golestan Cohort Study (GCS) in northeastern of Iran, about 50000 adults were enrolled to the study for four years (2004-2008) and followed annually until July 2018. We used "parametric g-formula" to study the causal effect of opium use on the time to death due to UGI. In this study, the information of 49946 individuals due to missingness were analyzed. So the median of follow-up time was 144 months and the prevalence of opium use was 17% (about 8489 persons). During the follow-up period, 593 (1.2%) death from upper gastrointestinal cancer were reported. The study showed that the effect of opium use on the time to UGI death was statistically significant (adjusted risk-ratio based on parametric g-formula = 1.31, 95% CI: [1.04, 1.65]). Additionally, the Population Attributable Fraction (PAF) in UGI cancer deaths of opium use was estimated 5.3% (95% CI: [0.6%, 11.3%]). Our results showed a causal effect of opium use on the intensity of upper gastrointestinal cancer death.	[Mohammadi, Neda; Yaseri, Mehdi; Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Alimohammadian, Masoomeh; Feizesani, Akbar; Poustchi, Hossein; Sadjadi, Alireza] Univ Tehran Med Sci, Digest Dis Res Inst, Digest Oncol Res Ctr, Tehran, Iran; [Alimohammadian, Masoomeh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Human Ecol, Tehran, Iran; [Alizadeh, Ahad] Qazvin Univ Med Sci, Res Inst Prevent Noncommunicable Dis, Metab Dis Res Ctr, Qazvin, Iran; [Sadjadi, Alireza] No Way New Way Co, The Hague, Netherlands	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Qazvin University of Medical Sciences (QUMS)	Yaseri, M; Mansournia, MA (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran.	M.Yaseri@gmail.com; Mansournia_Ma@yahoo.com	, Alireza/AAE-4134-2022; Yaseri, Mehdi/I-1645-2018	, Alireza/0000-0003-0788-2491; Yaseri, Mehdi/0000-0002-4066-873X	No Way New Way Company	No Way New Way Company	No Way New Way Company provided funding in the form of salary for AS. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi J, 2003, SUBST USE MISUSE, V38, P151, DOI 10.1081/JA-120016571; [Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; [Anonymous], 2018, GLOB 2018 EST CANC I; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Budtz-Jorgensen E, 2007, ANN EPIDEMIOL, V17, P27, DOI 10.1016/j.annepidem.2006.05.007; GHADIRIAN P, 1985, INT J CANCER, V35, P593, DOI 10.1002/ijc.2910350505; Gharibzadeh S, 2016, ARCH IRAN MED, V19, P666, DOI 0161909/AIM.0011; Greenland S, 1996, EPIDEMIOLOGY, V7, P498, DOI 10.1097/00001648-199609000-00008; Groenwold RHH, 2007, EUR J EPIDEMIOL, V22, P413, DOI 10.1007/s10654-007-9126-1; Hadi F, 2014, VALUE HLTH, V17, pA784; Hernan MA, 2006, J EPIDEMIOL COMMUN H, V60, P578, DOI 10.1136/jech.2004.029496; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Hernan MA, 2017, CAUSAL INFERENCE; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Kamangar F, 2014, LANCET ONCOL, V15, pE69, DOI 10.1016/S1470-2045(13)70550-3; Malekzadeh MM, 2013, AM J GASTROENTEROL, V108, P1757, DOI 10.1038/ajg.2013.336; Mansournia MA, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k757; Mansournia MA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4587; Mansournia MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i189; Mansournia MA, 2015, EPIDEMIOLOGY, V26, P466, DOI 10.1097/EDE.0000000000000291; Mansournia MA, 2012, EPIDEMIOLOGY, V23, P631, DOI 10.1097/EDE.0b013e31824cc1c3; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Ray R., 2006, OPIUM ABUSE ITS MANA, P1; Rubin DB, 2007, STAT MED, V26, P20, DOI 10.1002/sim.2739; Sadjadi A, 2014, INT J CANCER, V134, P181, DOI 10.1002/ijc.28344; Shakeri R, 2013, INT J CANCER, V133, P455, DOI 10.1002/ijc.28018; Shakeri R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032711; Stein CJ, 2004, BRIT J CANCER, V90, P299, DOI 10.1038/sj.bjc.6601509; World Health Organization, 2019, WORLD HLTH STAT MON	30	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0246004	10.1371/journal.pone.0246004	http://dx.doi.org/10.1371/journal.pone.0246004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493241	Green Accepted, Green Published, gold			2022-12-26	WOS:000613081500065
J	Allman, R; Spaeth, E; Lai, J; Gross, SJ; Hopper, JL				Allman, Richard; Spaeth, Erika; Lai, John; Gross, Susan J.; Hopper, John L.			A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score	PLOS ONE			English	Article							WOMEN; CHEMOPREVENTION; ASSOCIATION; VALIDATION; MANAGEMENT; AMERICAN; SNPS	Five-year absolute breast cancer risk prediction models are required to comply with national guidelines regarding risk reduction regimens. Models including the Gail model are under-utilized in the general population for various reasons, including difficulty in accurately completing some clinical fields. The purpose of this study was to determine if a streamlined risk model could be designed without substantial loss in performance. Only the clinical risk factors that were easily answered by women will be retained and combined with an objective validated polygenic risk score (PRS) to ultimately improve overall compliance with professional recommendations. We first undertook a review of a series of 2,339 Caucasian, African American and Hispanic women from the USA who underwent clinical testing. We first used deidentified test request forms to identify the clinical risk factors that were best answered by women in a clinical setting and then compared the 5-year risks for the full model and the streamlined model in this clinical series. We used OPERA analysis on previously published case-control data from 11,924 Gail model samples to determine clinical risk factors to include in a streamlined model: first degree family history and age that could then be combined with the PRS. Next, to ensure that the addition of PRS to the streamlined model was indeed beneficial, we compared risk stratification using the Streamlined model with and without PRS for the existing case-control datasets comprising 1,313 cases and 10,611 controls of African-American (n = 7421), Caucasian (n = 1155) and Hispanic (n = 3348) women, using the area under the curve to determine model performance. The improvement in risk discrimination from adding the PRS risk score to the Streamlined model was 52%, 46% and 62% for African-American, Caucasian and Hispanic women, respectively, based on changes in log OPERA. There was no statistically significant difference in mean risk scores between the Gail model plus risk PRS compared to the Streamlined model plus PRS. This study demonstrates that validated PRS can be used to streamline a clinical test for primary care practice without diminishing test performance. Importantly, by eliminating risk factors that women find hard to recall or that require obtaining medical records, this model may facilitate increased clinical adoption of 5-year risk breast cancer risk prediction test in keeping with national standards and guidelines for breast cancer risk reduction.	[Allman, Richard; Lai, John] Genet Technol Phenogen Sci, Fitzroy, Vic, Australia; [Allman, Richard; Lai, John; Hopper, John L.] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia; [Spaeth, Erika; Gross, Susan J.] Phenogen Sci, Charlotte, NC USA; [Gross, Susan J.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	University of Melbourne; Icahn School of Medicine at Mount Sinai	Allman, R (corresponding author), Genet Technol Phenogen Sci, Fitzroy, Vic, Australia.; Allman, R (corresponding author), Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia.	richard.allman@gtglabs.com		Lai, John/0000-0002-8019-7012; Spaeth, Erika/0000-0002-5397-3493	Genetic Technologies	Genetic Technologies	Genetic Technologies funded this research. RA, ES, JL and SG are/were all employees of Genetic Technologies and had roles in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allman R, 2015, BREAST CANCER RES TR, V154, P583, DOI 10.1007/s10549-015-3641-7; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Crew Katherine D, 2015, Am Soc Clin Oncol Educ Book, pe50, DOI 10.14694/EdBook_AM.2015.35.e50; Dite GS, 2016, CANCER EPIDEM BIOMAR, V25, P359, DOI 10.1158/1055-9965.EPI-15-0838; Freedman AN, 2003, JNCI-J NATL CANCER I, V95, P526, DOI 10.1093/jnci/95.7.526; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Hartmann LC, 2015, NEW ENGL J MED, V372, P78, DOI 10.1056/NEJMsr1407164; Hopper JL, 2015, AM J EPIDEMIOL, V182, P863, DOI 10.1093/aje/kwv193; Huo DZ, 2016, HUM MOL GENET, V25, P4835, DOI 10.1093/hmg/ddw305; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; Mavaddat N, 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Michailidou K, 2017, NATURE, V551, P92, DOI 10.1038/nature24284; Milne RL, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2797; National Comprehensive Cancer Network (NCCN), 2011, NCCN CLIN PRACT GUID; NCCN. National Comprehensive Cancer Network. NCCN Cinical Practice Guidelines in Oncology, BREAST CANC SCREEN D; Owens DK, 2019, JAMA-J AM MED ASSOC, V322, P857, DOI 10.1001/jama.2019.11885; Ozanne EM, 2013, CANCER EPIDEM BIOMAR, V22, P146, DOI 10.1158/1055-9965.EPI-12-0570; Pankratz VS, 2008, J CLIN ONCOL, V26, P5374, DOI 10.1200/JCO.2007.14.8833; Ropka ME, 2010, J CLIN ONCOL, V28, P3090, DOI 10.1200/JCO.2009.27.8077; Ruiz-Narvaez EA, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00170; Sabatino SA, 2007, CANCER DETECT PREV, V31, P375, DOI 10.1016/j.cdp.2007.08.003; Sherman ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160966; Shieh Y, 2020, JNCI-J NATL CANCER I, V112, P590, DOI 10.1093/jnci/djz174; Smith SG, 2016, ANN ONCOL, V27, P575, DOI 10.1093/annonc/mdv590; StataCorp, 2016, STAT STAT SOFTW REL; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; Visvanathan K, 2013, J CLIN ONCOL, V31, P2942, DOI 10.1200/JCO.2013.49.3122; Yadav S., 2019, BMC CANCER, V19	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245375	10.1371/journal.pone.0245375	http://dx.doi.org/10.1371/journal.pone.0245375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481864	gold, Green Published			2022-12-26	WOS:000612929300150
J	Pearman, A; Neupert, SD; Ennis, GE				Pearman, Ann; Neupert, Shevaun D.; Ennis, Gilda E.			Age and extraversion differences in heart rate reactivity during working memory tasks	PLOS ONE			English	Article							RECURRENT SOCIAL STRESS; PERSONALITY; ENGAGEMENT; RESPONSES; SEX	Research and theory have shown a link between heart rate reactivity during cognitive testing and extraversion in younger adults; however, similar work has not been conducted with older adults. This study was designed to explore age and extraversion-related differences in within-person heart rate (HR) reactivity during two working memory tasks of varying difficulty using a multi-level modeling approach. Across 570 total within-person assessments of continuous HR monitoring, 28 younger adults (M = 19.76, SD = 1.15) and 29 older adults (M = 71.19, SD = 6.63) were administered two working memory tasks (backward digit span and n-back). There were no age differences in reactivity during the backward digit span. However, similar to previous findings, on the more difficult n-back task, younger adults low in extraversion showed a trend toward higher HR reactivity than young adults high in extraversion. Interestingly, the older adults showed the opposite pattern in that lower extraversion older adults were less reactive than the higher extraversion older adults who showed the steepest increase in HR. The HR increase of the older adults high in extraversion may be an indication of higher engagement in this more difficult task. Individual differences in extraversion need to be taken into account when administering working memory tasks in older adults.	[Pearman, Ann] Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA; [Neupert, Shevaun D.] North Carolina State Univ, Dept Psychol, Raleigh, NC USA; [Ennis, Gilda E.] Univ Wisconsin, Wisconsin Alzheimers Dis Res Ctr, Madison, WI USA	University System of Georgia; Georgia Institute of Technology; University of North Carolina; North Carolina State University; University of Wisconsin System; University of Wisconsin Madison	Pearman, A (corresponding author), Georgia Inst Technol, Sch Psychol, Atlanta, GA 30332 USA.	ann.pearman@psych.gatech.edu		Neupert, Shevaun/0000-0001-5994-3060; Ennis, Gilda/0000-0003-4329-0215	National Institute on Aging [R01 AG17920]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The data from this study was collected by Dr. Margie Lachman on a grant from the National Institute on Aging(R01 AG17920).	Artese A, 2017, PSYCHOL AGING, V32, P131, DOI 10.1037/pag0000158; Bibbey A, 2013, INT J PSYCHOPHYSIOL, V90, P28, DOI 10.1016/j.ijpsycho.2012.10.018; Christenfeld N, 2000, PSYCHOPHYSIOLOGY, V37, P543, DOI 10.1017/S0048577200982246; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Costa P T Jr, 1986, Psychol Aging, V1, P144, DOI 10.1037/0882-7974.1.2.144; Costache ME, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232187; De Rooij SR, 2010, PSYCHOPHYSIOLOGY, V47, P1172, DOI 10.1111/j.1469-8986.2010.01023.x; Dong SS, 2015, BRAIN RES, V1616, P146, DOI 10.1016/j.brainres.2015.05.003; EYSENCK H J, 1955, J Abnorm Psychol, V51, P94, DOI 10.1037/h0043564; Eysenck S. B. G., 1963, BRIT J SOC CLIN PSYC, V2, P46, DOI DOI 10.1111/J.2044-8260.1963.TB00375.X; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fink A, 2005, INT J PSYCHOPHYSIOL, V56, P129, DOI 10.1016/j.ijpsycho.2004.11.002; Gomez P, 2016, INT J PSYCHOPHYSIOL, V109, P51, DOI 10.1016/j.ijpsycho.2016.10.002; Gomez V, 2009, J RES PERS, V43, P345, DOI 10.1016/j.jrp.2008.12.014; Hertzog Christopher, 1996, P24; Hess TM, 2014, PERSPECT PSYCHOL SCI, V9, P388, DOI 10.1177/1745691614527465; Hess TM, 2012, J GERONTOL B-PSYCHOL, V67, P447, DOI 10.1093/geronb/gbr129; HINTON JW, 1977, BIOL PSYCHOL, V5, P23, DOI 10.1016/0301-0511(77)90026-6; Jonassaint CR, 2009, INT J PSYCHOPHYSIOL, V74, P274, DOI 10.1016/j.ijpsycho.2009.09.012; Kemper CJ, 2008, BIOL PSYCHOL, V78, P191, DOI 10.1016/j.biopsycho.2008.02.009; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Lachman ME, 1997, MIDLIFE DEV INVENTOR; Lai DWL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209154; Lakuta P, 2019, J PSYCHOL, V153, P599, DOI 10.1080/00223980.2019.1581723; Lieberman MD, 2001, J PERS SOC PSYCHOL, V80, P294, DOI 10.1037//0022-3514.80.2.294; Lu W, 2018, INT J PSYCHOPHYSIOL, V131, P144, DOI 10.1016/j.ijpsycho.2017.10.008; Lu W, 2017, PSYCHOPHYSIOLOGY, V54, P270, DOI 10.1111/psyp.12777; Maldonato NM, 2017, CLIN PRACTICE EPIDEM, V13; McPeek R, 2011, TRANSPORT RES F-TRAF, V14, P579, DOI 10.1016/j.trf.2011.06.001; Osmon DC, 2018, PERS INDIV DIFFER, V131, P51, DOI 10.1016/j.paid.2018.04.019; Pearman A, 2010, APPL PSYCHOPHYS BIOF, V35, P107, DOI 10.1007/s10484-009-9113-2; Pearman A, 2009, PERS INDIV DIFFER, V47, P357, DOI 10.1016/j.paid.2009.04.003; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Raudenbush SW., 2002, HIERARCHICAL LINEAR, V2nd ed, DOI [10.2466/pms.2002.94.2.671, DOI 10.2466/PMS.2002.94.2.671]; Rousseau FL, 2005, ACT ADAPT AGING, V29, P11, DOI 10.1300/J016v29n02_02; SAS Institute I, 2013, SAS STAT 9 4 US GUID; Scullin M.K., 2017, TRANSL ISSUES PSYCHO, V3, P328, DOI 10.1037/tps0000131.; Snijders Tom, 2005, ENCY STAT BEHAV SCI; Stafford LD, 2010, PERS INDIV DIFFER, V48, P827, DOI 10.1016/j.paid.2010.02.005; Tharp DT, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110211; Uchino BN, 2010, J GERONTOL B-PSYCHOL, V65, P154, DOI 10.1093/geronb/gbp127; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Zimprich D, 2012, PSYCHOL ASSESSMENT, V24, P173, DOI 10.1037/a0025265	44	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245539	10.1371/journal.pone.0245539	http://dx.doi.org/10.1371/journal.pone.0245539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481892	gold, Green Published			2022-12-26	WOS:000612929300057
J	Woldu, HG; Zalwango, S; Martinez, L; Castellanos, ME; Kakaire, R; Sekandi, JN; Kiwanuka, N; Whalen, CC				Woldu, Henok G.; Zalwango, Sarah; Martinez, Leonardo; Castellanos, Maria Eugenia; Kakaire, Robert; Sekandi, Juliet N.; Kiwanuka, Noah; Whalen, Christopher C.			Defining an intermediate category of tuberculin skin test: A mixture model analysis of two high-risk populations from Kampala, Uganda	PLOS ONE			English	Article							CALMETTE-GUERIN VACCINATION; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; PREVALENCE; ASSAY; CONVERSION	One principle of tuberculosis control is to prevent the development of tuberculosis disease by treating individuals with latent tuberculosis infection. The diagnosis of latent infection using the tuberculin skin test is not straightforward because of concerns about immunologic cross reactivity with the Bacille Calmette-Guerin (BCG) vaccine and environmental mycobacteria. To parse the effects of BCG vaccine and environmental mycobacteria on the tuberculin skin test, we estimated the frequency distribution of skin test results in two divisions of Kampala, Uganda, ten years apart. We then used mixture models to estimate parameters for underlying distributions and defined clinically meaningful criteria for latent infection, including an indeterminate category. Using percentiles of two underlying normal distributions, we defined two skin test readings to demarcate three ranges. Values of 10 mm or greater contained 90% of individuals with latent infection; values less than 7.2 mm contained 80% of individuals without infection. Contacts with values between 7.2 and 10 mm fell into an indeterminate zone where it was not possible to assign infection. We conclude that systematic tuberculin skin test surveys within populations at risk, combined with mixture model analysis, may be a reproducible, evidence-based approach to define meaningful criteria for latent tuberculosis infection.	[Woldu, Henok G.; Castellanos, Maria Eugenia; Kakaire, Robert; Sekandi, Juliet N.; Whalen, Christopher C.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA; [Zalwango, Sarah; Kiwanuka, Noah] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Martinez, Leonardo] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Castellanos, Maria Eugenia; Kakaire, Robert; Sekandi, Juliet N.; Whalen, Christopher C.] Univ Georgia, Global Hlth Inst, Coll Publ Hlth, Athens, GA 30602 USA; [Woldu, Henok G.] Ctr Hlth Analyt Natl & Global Equ CHANGE, Columbia, MO USA; [Martinez, Leonardo] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University System of Georgia; University of Georgia; Makerere University; Stanford University; University System of Georgia; University of Georgia; Boston University	Castellanos, ME (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.; Castellanos, ME (corresponding author), Univ Georgia, Global Hlth Inst, Coll Publ Hlth, Athens, GA 30602 USA.	mecastellanos@uga.edu		Castellanos, Maria Eugenia/0000-0002-8181-6321	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI093856, NO1-AI95383, D43-TW01004]; Schlumberger Foundation Faculty for the Future Fellowship	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Schlumberger Foundation Faculty for the Future Fellowship(Schlumberger)	CCW: R01 AI093856, NO1-AI95383, D43-TW01004. National Institute of Allergy and Infectious Diseases of the National Institutes of Health. https://www.niaid.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MEC: Schlumberger Foundation Faculty for the Future Fellowship. No Grant Number. https://www.slb.com/who-we-are/schlumberger-foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MMWR Recomm Rep, V49, P1; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Assembly UG, 2018, HIGH LEV M GEN ASS F; Auguste P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2301-4; Ayub Asad, 2004, Clin Med Res, V2, P191; Castellanos ME, 2018, INT J TUBERC LUNG D, V22, P1000, DOI 10.5588/ijtld.18.0073; Cobelens FG, 2006, CLIN INFECT DIS, V43, P634, DOI 10.1086/506432; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Davies GR, 2006, INT J TUBERC LUNG D, V10, P1023; Diel R, 2017, CHEST, V152, P235, DOI 10.1016/j.chest.2017.03.011; Doan TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188631; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Haghdoost AA, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15308; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Health UMo, 2018, CONSOLIDATED GUIDELI, P1; Jaki T, 2019, EDUC PSYCHOL MEAS, V79, P358, DOI 10.1177/0013164418791673; Kerkhoff AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049928; Kim EY, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-207; Macdonald P, 2010, PACKAGE MIXDIST; Mancuso JD, 2017, CHEST, V152, P282, DOI 10.1016/j.chest.2017.01.001; Martinez L, 2016, AM J RESP CRIT CARE, V194, P1152, DOI 10.1164/rccm.201511-2146OC; Maxim LD, 2014, INHAL TOXICOL, V26, P811, DOI 10.3109/08958378.2014.955932; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Mudido PM, 1999, INT J TUBERC LUNG D, V3, P891; Nayak Surajit, 2012, Indian Dermatol Online J, V3, P2, DOI 10.4103/2229-5178.93479; Neuenschwander BE, 2000, INT J TUBERC LUNG D, V4, P719; Neuenschwander BE, 2002, AM J EPIDEMIOL, V155, P654, DOI 10.1093/aje/155.7.654; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Park BJ, 2010, ACCIDENT ANAL PREV, V42, P741, DOI 10.1016/j.aap.2009.11.002; Rieder HL, 2011, INT J TUBERC LUNG D, V15, pS1; RIEDER HL, 1995, TUBERCLE LUNG DIS, V76, P114, DOI 10.1016/0962-8479(95)90552-9; ROSE DN, 1995, J GEN INTERN MED, V10, P635, DOI 10.1007/BF02602749; Ruhwald M, 2017, LANCET RESP MED, V5, P259, DOI [10.1016/s2213-2600(16)30436-2, 10.1016/S2213-2600(16)30436-2]; Sarstedt M, 2008, STUD CLASS DATA ANAL, P61, DOI 10.1007/978-3-540-78246-9_8; Sekandi JN, 2018, LOW PREVALENCE TUBER; Shah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026787; Sharma SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169539; Titterington D. M., 1985, STAT ANAL FINITE MIX; Villate JI, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-240; Whalen CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016137; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, 2018, 9241550236 WHO; World Health Organization, 2015, GEAR END TB INTR END	45	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245328	10.1371/journal.pone.0245328	http://dx.doi.org/10.1371/journal.pone.0245328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481816	Green Published, Green Accepted, gold			2022-12-26	WOS:000612929300089
J	Gous, A; Eardley, CD; Johnson, SD; Swanevelder, DZH; Willows-Munro, S				Gous, Annemarie; Eardley, Connal D.; Johnson, Steven D.; Swanevelder, Dirk Z. H.; Willows-Munro, Sandi			Floral hosts of leaf-cutter bees (Megachilidae) in a biodiversity hotspot revealed by pollen DNA metabarcoding of historic specimens	PLOS ONE			English	Article							POLLINATION; CONSERVATION; GENETICS; AFRICA; PLANTS	South Africa is a megadiverse country with three globally recognised biodiversity hotspots within its borders. Bees in particular show high diversity and endemism in the western part of the country. Not much is currently known about the floral host preferences of indigenous bees in South Africa, with data only available from observational studies. Pollen metabarcoding provides provenance information by utilising DNA analyses instead of floral visitation and traditional microscopic identification to identify pollinator food plants, which can be time consuming and imprecise. In this study, we sampled pollen from leaf-cutter bees (Megachilidae) specimens maintained in a historic insect collection (National Collection of Insects, South Africa) that were originally collected from two florally important areas in South Africa (Succulent Karoo and Savanna) and used metabarcoding to determine pollen provenance. We also sampled pollen from leafcutter bee species with wider distributions, that extend across many different biomes, to determine if these 'generalist' species show relaxed floral host specificity in some biomes. Metabarcoding involved sequencing of the nuclear internal transcribed spacer 2 (ITS2) region. Amplicons were compared to a sequence reference database to assign taxonomic classifications to family level. Sequence reads were also clustered to OTUs based on 97% sequence similarity to estimate numbers of plant species visited. We found no significant difference in the mean number of plant taxa visited in the Succulent Karoo and Savanna regions, but the widespread group visited significantly more floral hosts. Bees from the widespread group were also characterised by a significantly different composition in pollen assemblage. The time since specimens were collected did not have an effect on the mean number of taxa visited by any of the bee species studied. This study highlights national history collections as valuable sources of temporal and spatial biodiversity data.	[Gous, Annemarie; Swanevelder, Dirk Z. H.] Agr Res Council, Biotechnol Platform, Pretoria, South Africa; [Gous, Annemarie; Eardley, Connal D.; Johnson, Steven D.; Willows-Munro, Sandi] Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa	Agricultural Research Council of South Africa; University of Kwazulu Natal	Willows-Munro, S (corresponding author), Univ KwaZulu Natal, Sch Life Sci, Pietermaritzburg, South Africa.	willows-munro@ukzn.ac.za	Johnson, Steven/F-1146-2010	Johnson, Steven/0000-0002-5114-5862; Willows-Munro, Sandi/0000-0003-0572-369X				Bell KL, 2016, GENOME, V59, P629, DOI 10.1139/gen-2015-0200; BOGDAN A. V., 1962, PROC LINN SOC LONDON, V173, P57; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cowling RM, 1999, PLANT ECOL, V142, P3, DOI 10.1023/A:1009831308074; da Silva JM, 2016, AFR ZOOL, V51, P1, DOI 10.1080/15627020.2016.1151377; EARDLEY C, 2012, ZOOTAXA 0907, P1; Eardley C.D., 1989, Plant Protection Research Institute Bulletin, P1; Eardley C, 2010, ZOOTAXA, P1; Eardley C, 2013, ZOOTAXA, V3601, P1, DOI 10.11646/zootaxa.3601.1.1; Eardley CD, 2009, APIDOLOGIE, V40, P355, DOI 10.1051/apido/2009016; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Germishuizen G., 2003, PLANTS SO AFRICA ANN; Gess SK, 2014, WASPS BEES SO AFRICA; Gous A, 2019, EVOL APPL, V12, P187, DOI 10.1111/eva.12707; Hamer M, 2013, NATL STRATEGY ZOOLOG; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Johnson SD, 1997, BOT J LINN SOC, V123, P225, DOI 10.1006/bojl.1996.0082; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Koshy K.C., 2001, BAMBOO SCI CULT, V15, P1; Koshy KC, 2001, CURR SCI INDIA, V81, P833; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Kuhlmann M, 2009, S AFR J BOT, V75, P726, DOI 10.1016/j.sajb.2009.06.016; Low A.R., 1996, VEGETATION S AFRICA; Mcfrederick QS, 2016, MOL ECOL, V25, P2302, DOI 10.1111/mec.13608; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Packer L, 2005, CONSERV BIOL, V19, P195, DOI 10.1111/j.1523-1739.2005.00601.x; Pauw A, 2006, AM J BOT, V93, P917, DOI 10.3732/ajb.93.6.917; Pauw A, 2015, J BIOGEOGR, V42, P652, DOI 10.1111/jbi.12453; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; POJAR J, 1973, AM MIDL NAT, V89, P448, DOI 10.2307/2424049; Potter C, 2019, PEERJ, V7, DOI 10.7717/peerj.5999; R Core Team, 2020, R LANG ENV STAT COMP; Rahl Magdalena, 2008, V138, P263, DOI 10.1007/978-1-59745-366-0_22; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500043; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Scheper J, 2014, P NATL ACAD SCI USA, V111, P17552, DOI 10.1073/pnas.1412973111; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Snijman D.A., 2013, PLANTS GREATER CAPE, V2; SODERSTROM T R, 1971, Biotropica, V3, P1, DOI 10.2307/2989701; Stanley DA, 2020, ECOSPHERE, V11, DOI 10.1002/ecs2.2957; Steyn HM, 2013, S AFR J BOT, V88, P247, DOI 10.1016/j.sajb.2013.07.018; Suchan T, 2019, MOL ECOL RESOUR, V19, P149, DOI 10.1111/1755-0998.12948; Valentini A., 2010, Diversity, V2, P610; van Wyk AE., 2001, REGIONS FLORISTIC EN; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Welsford MR, 2012, ARTHROPOD-PLANT INTE, V6, P1, DOI 10.1007/s11829-011-9149-0; Wheeler A.D., 2010, IMPACTS DEGRADATION; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zayed A, 2009, APIDOLOGIE, V40, P237, DOI 10.1051/apido/2009026	53	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2021	16	1							e0244973	10.1371/journal.pone.0244973	http://dx.doi.org/10.1371/journal.pone.0244973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7NX	33476342	Green Published, gold			2022-12-26	WOS:000612928900006
J	Zhu, K; Yang, LT; Li, CX; Lakshmanan, P; Xing, YX; Li, YR				Zhu, Kai; Yang, Li-Tao; Li, Cheng-Xi; Lakshmanan, Prakash; Xing, Yong-Xiu; Li, Yang-Rui			A transcriptomic analysis of sugarcane response to Leifsonia xyli subsp. xyli infection	PLOS ONE			English	Article							RATOON STUNTING DISEASE; GENE-EXPRESSION; CAUSAL ORGANISM; RESISTANCE; STRESS; COLONIZATION; REVEALS; DEFENSE; GROWTH; FLUID	Sugarcane ratoon stunting disease (RSD) caused by Leifsonia xyli subsp. xyli (Lxx) is a common destructive disease that occurs around the world. Lxx is an obligate pathogen of sugarcane, and previous studies have reported some physiological responses of RSD-affected sugarcane. However, the molecular understanding of sugarcane response to Lxx infection remains unclear. In the present study, transcriptomes of healthy and Lxx-infected sugarcane stalks and leaves were studied to gain more insights into the gene activity in sugarcane in response to Lxx infection. RNA-Seq analysis of healthy and diseased plants transcriptomes identified 107,750 unigenes. Analysis of these unigenes showed a large number of differentially expressed genes (DEGs) occurring mostly in leaves of infected plants. Sugarcane responds to Lxx infection mainly via alteration of metabolic pathways such as photosynthesis, phytohormone biosynthesis, phytohormone action-mediated regulation, and plant-pathogen interactions. It was also found that cell wall defense pathways and protein phosphorylation/dephosphorylation pathways may play important roles in Lxx pathogeneis. In Lxx-infected plants, significant inhibition in photosynthetic processes through large number of differentially expressed genes involved in energy capture, energy metabolism and chloroplast structure. Also, Lxx infection caused down-regulation of gibberellin response through an increased activity of DELLA and down-regulation of GID1 proteins. This alteration in gibberellic acid response combined with the inhibition of photosynthetic processes may account for the majority of growth retardation occurring in RSD-affected plants. A number of genes associated with plant-pathogen interactions were also differentially expressed in Lxx-infected plants. These include those involved in secondary metabolite biosynthesis, protein phosphorylation/dephosphorylation, cell wall biosynthesis, and phagosomes, implicating an active defense response to Lxx infection. Considering the fact that RSD occurs worldwide and a significant cause of sugarcane productivity, a better understanding of Lxx resistance-related processes may help develop tools and technologies for producing RSD-resistant sugarcane varieties through conventional and/or molecular breeding.	[Zhu, Kai; Yang, Li-Tao; Li, Cheng-Xi; Xing, Yong-Xiu; Li, Yang-Rui] Guangxi Univ, Coll Agr, Nanning, Guangxi, Peoples R China; [Lakshmanan, Prakash; Li, Yang-Rui] Chinese Acad Agr Sci, Guangxi Key Lab Sugarcane Genet Improvement, Sugarcane Res Ctr,Guangxi Acad Agr Sci, Minist Agr,Key Lab Sugarcane Biotechnol & Genet I, Nanning, Guangxi, Peoples R China; [Lakshmanan, Prakash] Southwest Univ, Coll Resources & Environm, Interdisciplinary Ctr Agr Green Dev Yangtze River, Chongqing, Peoples R China; [Lakshmanan, Prakash] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia	Guangxi University; Chinese Academy of Agricultural Sciences; Guangxi Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Southwest University - China; University of Queensland	Xing, YX; Li, YR (corresponding author), Guangxi Univ, Coll Agr, Nanning, Guangxi, Peoples R China.; Li, YR (corresponding author), Chinese Acad Agr Sci, Guangxi Key Lab Sugarcane Genet Improvement, Sugarcane Res Ctr,Guangxi Acad Agr Sci, Minist Agr,Key Lab Sugarcane Biotechnol & Genet I, Nanning, Guangxi, Peoples R China.	document126@126.com; liyr@gxaas.net	li, yong/HDN-3885-2022; Li, Yang/GWM-7879-2022; Li, Yuan/GXV-1310-2022	Li, Yang-Rui/0000-0002-7559-9244	International Scientific Cooperation Program of China [2013DFA31600]; National Natural Science Foundation of China [31360293]; Guangxi Special Fund for Scientific Base and Talent [GKAD17195100]; Guangxi Special Funds for Bagui Scholars and Distinguished Experts [2013-3]; Guangxi Natural Science Fund [2011GXNSFF018002, 2012GXNSFDA053011]; Guangxi Sugarcane Innovation Team of National Agricultural Industry Technology System [gjnytxgxcxtd-03-01]	International Scientific Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Special Fund for Scientific Base and Talent; Guangxi Special Funds for Bagui Scholars and Distinguished Experts; Guangxi Natural Science Fund(National Natural Science Foundation of Guangxi Province); Guangxi Sugarcane Innovation Team of National Agricultural Industry Technology System	The present study was supported by International Scientific Cooperation Program of China (2013DFA31600), National Natural Science Foundation of China (31360293), Guangxi Special Fund for Scientific Base and Talent (GKAD17195100), Guangxi Special Funds for Bagui Scholars and Distinguished Experts (2013-3), Guangxi Natural Science Fund (2011GXNSFF018002, 2012GXNSFDA053011), and Guangxi Sugarcane Innovation Team of National Agricultural Industry Technology System (gjnytxgxcxtd-03-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brumbley SM, 2006, AUSTRALAS PLANT PATH, V35, P681, DOI 10.1071/AP06074; Brumbley SM, 2002, MOL PLANT MICROBE IN, V15, P262, DOI 10.1094/MPMI.2002.15.3.262; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Carvalho G, 2016, CROP PROT, V80, P51, DOI 10.1016/j.cropro.2015.10.029; Chen MingHui, 2013, Journal of South China Agricultural University, V34, P336; [陈明辉 Chen Minghui], 2013, [华中农业大学学报, Journal of Huazhong Agricultural University], V32, P57; Chen ZL, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1882-z; Comstock J., 2008, Journal - American Society of Sugar Cane Technologists, V28, P22; Comstock JC, 1996, PLANT DIS, V80, P704, DOI 10.1094/PD-80-0704; Croft BJ, 2002, AUSTRALAS PLANT PATH, V31, P63, DOI 10.1071/AP01067; Crossley N, 2008, THEOR CULT SOC, V25, P89, DOI 10.1177/0263276408095546; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; DAVIS MJ, 1980, SCIENCE, V210, P1365, DOI 10.1126/science.210.4476.1365; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRISHAM MP, 1991, PHYTOPATHOLOGY, V81, P337, DOI 10.1094/Phyto-81-337; Gross Andrew D., 2011, NEW INTERPRETERS DIC, V2, P83; Haapalainen M, 2000, PHYSIOL MOL PLANT P, V56, P147, DOI 10.1006/pmpp.2000.0260; Hao LM, 2001, J HEBEI AGR, V5, P73; Hassan A, 2012, GENET MOL RES, V11, P2381, DOI 10.4238/2012.May.10.1; Hu Shuai, 2012, Yichuan, V34, P560, DOI 10.3724/SP.J.1005.2012.00560; Huang N, 2018, GENE, V678, P207, DOI 10.1016/j.gene.2018.08.043; Ji H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110314; Jia JH, 2000, PROG BIOTECHNOL, V20, P21; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CN, 2016, SCI REP-UK, V6, DOI 10.1038/srep25698; Li M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4053-3; Li YR, 2015, SUGAR TECH, V17, P1, DOI 10.1007/s12355-014-0342-1; Liu XH, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1428-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mall TK, 2011, PLANT MOL BIOL, V75, P467, DOI 10.1007/s11103-011-9741-9; MARAMOROSCH K, 1973, Phytopathologische Zeitschrift, V77, P270; Martinelli F, 2015, SCI HORTIC-AMSTERDAM, V192, P409, DOI 10.1016/j.scienta.2015.06.037; Masaki S, 2007, PLANT CELL, V19, P2060; McDougall WA, 1948, CANE GROWERSQ B, V12, P31; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Monteiro-Vitorello CB, 2004, MOL PLANT MICROBE IN, V17, P827, DOI 10.1094/MPMI.2004.17.8.827; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Ntambo MS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246138; Perazzolli M, 2016, J PLANT PHYSIOL, V195, P59, DOI 10.1016/j.jplph.2016.03.007; Prasanth CN, 2017, SUGAR TECH, V19, P604, DOI 10.1007/s12355-017-0529-3; Que YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106476; Quecine MC, 2016, PLANT PATHOL, V65, P154, DOI 10.1111/ppa.12397; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Brigida ABS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166473; Shen Qian, 2012, Journal of Shanghai Jiaotong University - Agricultural Science, V30, P51; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Strauss T, 2012, P NATL ACAD SCI USA, V109, P19480, DOI 10.1073/pnas.1212415109; Tavares RG, 2018, J EXP BOT, V69, P3823, DOI 10.1093/jxb/ery180; Taylor P. W. J., 1988, Sugar Cane, P11; Taylor PWJ, 2003, AUSTRALAS PLANT PATH, V32, P367, DOI 10.1071/AP03036; Thirugnanasambandam PP, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1733-y; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Ubeda-Tomas S, 2008, NAT CELL BIOL, V10, P625, DOI 10.1038/ncb1726; Wu C. F., 1986, SUGARCANE CANE SUGAR, V3, P29; Xie XiaoNa, 2014, Journal of Southern Agriculture, V45, P1551; Xu J., 2014, THESIS; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Young AJ, 2016, PLANT PATHOL, V65, P1403, DOI 10.1111/ppa.12545; Zhang XQ, 2017, SUGAR TECH, V19, P394, DOI 10.1007/s12355-016-0479-1; Zhang XQ, 2016, PLANT DIS, V100, P2499, DOI 10.1094/PDIS-10-15-1134-RE; [张小秋 Zhang Xiaoqiu], 2015, [华中农业大学学报, Journal of Huazhong Agricultural University], V34, P042; Zhou XH, 2016, PLANT MOL BIOL REP, V34, P1193, DOI 10.1007/s11105-016-0998-7; Zhu K, 2018, J PHYTOPATHOL, V166, P44, DOI 10.1111/jph.12659; Zhu SF, 2005, PLANT PHYSIOL, V139, P1935, DOI 10.1104/pp.105.072306	70	5	5	10	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245613	10.1371/journal.pone.0245613	http://dx.doi.org/10.1371/journal.pone.0245613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529190	Green Published, gold			2022-12-26	WOS:000616736200020
J	Zhou, YF; Bennett, TM; Shiels, A				Zhou, Yuefang; Bennett, Thomas M.; Shiels, Alan			Mutation of the TRPM3 cation channel underlies progressive cataract development and lens calcification associated with pro-fibrotic and immune cell responses	FASEB JOURNAL			English	Article						cataract; calcium; lens; myofibroblast; macrophage; TRP&#8208; channel	POTENTIAL MELASTATIN 3; IN-VIVO; MODEL; MEMBRANE; POLYMORPHISMS; ACTIVATION; EXPRESSION; MUTANT; LOCUS; MICE	Transient-receptor-potential cation channel, subfamily M, member 3 (TRPM3) serves as a polymodal calcium sensor in diverse mammalian cell-types. Mutation of the human TRPM3 gene (TRPM3) has been linked with inherited forms of early-onset cataract with or without other eye abnormalities. Here, we have characterized the ocular phenotypes of germline "knock-in" mice that harbor a human cataract-associated isoleucine-to-methionine mutation (p.I65M) in TRPM3 (Trpm3-mutant) compared with germline "knock-out" mice that functionally lack TRPM3 (Trpm3-null). Despite strong expression of Trpm3 in lens epithelial cells, neither heterozygous (Trpm3(+/-)) nor homozygous (Trpm3(-/-)) Trpm3-null mice developed cataract; however, the latter exhibited a mild impairment of lens growth. In contrast, homozygous Trpm3-M/M mutants developed severe, progressive, anterior pyramid-like cataract with microphthalmia, whereas heterozygous Trpm3-I/M and hemizygous Trpm3-M/- mutants developed anterior pyramidal cataract with delayed onset and progression-consistent with a semi-dominant lens phenotype. Histochemical staining revealed abnormal accumulation of calcium phosphate-like deposits and collagen fibrils in Trpm3-mutant lenses and immunoblotting detected increased alpha II-spectrin cleavage products consistent with calpain hyper-activation. Immunofluorescent confocal microscopy of Trpm3-M/M mutant lenses revealed fiber cell membrane degeneration that was accompanied by accumulation of alpha-smooth muscle actin positive (alpha-SMA+ve) myofibroblast-like cells and macrosialin positive (CD68+ve) macrophage-like cells. Collectively, our mouse model data support an ocular disease association for TRPM3 in humans and suggest that (1) Trpm3 deficiency impaired lens growth but not lens transparency and (2) Trpm3 dysfunction resulted in progressive lens degeneration and calcification coupled with pro-fibrotic (alpha-SMA+ve) and immune (CD68+ve) cell responses.	[Zhou, Yuefang; Bennett, Thomas M.; Shiels, Alan] Washington Univ, Ophthalmol & Visual Sci, Sch Med, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Shiels, A (corresponding author), Washington Univ, Ophthalmol & Visual Sci, Sch Med, Box 8096,660 S Euclid Ave, St Louis, MO 63110 USA.	shiels@wustl.edu		Zhou, Yuefang/0000-0002-8517-1292	NEI NIH HHS [P30 EY002687, R01 EY028899] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Agathe JMD, 2020, EUR J MED GENET, V63, DOI 10.1016/j.ejmg.2020.103942; Alizadeh A, 2004, INVEST OPHTH VIS SCI, V45, P884, DOI 10.1167/iovs.03-0677; Alonso-Carbajo L, 2019, J MOL CELL CARDIOL, V129, P219, DOI 10.1016/j.yjmcc.2019.03.003; Alkozi HA, 2015, EXP EYE RES, V136, P34, DOI 10.1016/j.exer.2015.04.019; Badheka D, 2015, J GEN PHYSIOL, V146, P65, DOI 10.1085/jgp.201411336; Belvisi MG, 2017, EUR RESPIR J, V50, DOI [10.1183/13993003.00579-2017, 10.1183/13993003.01357-2016]; Bennett TM, 2016, BIOCHEM BIOPH RES CO, V478, P988, DOI 10.1016/j.bbrc.2016.08.068; Bennett TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104000; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Brown RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117615; Danysh BP, 2009, EXP EYE RES, V88, P151, DOI 10.1016/j.exer.2008.08.002; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; De Maria A, 2009, J BIOL CHEM, V284, P13542, DOI 10.1074/jbc.M900561200; DeDreu J, 2020, FASEB J, V34, P9316, DOI 10.1096/fj.202000289R; Dyment DA, 2019, EUR J HUM GENET, V27, P1611, DOI 10.1038/s41431-019-0462-x; Eldred JA, 2011, PHILOS T R SOC B, V366, P1301, DOI 10.1098/rstb.2010.0341; Forrester JV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00338; Fruhwald J, 2012, J BIOL CHEM, V287, P36663, DOI 10.1074/jbc.M112.396663; Gao JY, 2015, BIOPHYS J, V109, P1830, DOI 10.1016/j.bpj.2015.09.018; Gerhart J, 2019, INVEST OPHTH VIS SCI, V60, P1813, DOI 10.1167/iovs.19-26713; Gerhart J, 2018, EXP EYE RES, V171, P101, DOI 10.1016/j.exer.2018.03.016; Grebert C, 2019, CELL CALCIUM, V81, P29, DOI 10.1016/j.ceca.2019.05.007; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Held Katharina, 2015, Temperature (Austin), V2, P201, DOI 10.4161/23328940.2014.988524; Held K, 2015, P NATL ACAD SCI USA, V112, pE1363, DOI 10.1073/pnas.1419845112; Hughes S, 2012, EUR J NEUROSCI, V35, P34, DOI 10.1111/j.1460-9568.2011.07944.x; Hwangbo Y, 2018, J CLIN ENDOCR METAB, V103, P4384, DOI 10.1210/jc.2017-02439; Inoue R, 2019, SEMIN CELL DEV BIOL, V94, P40, DOI 10.1016/j.semcdb.2018.11.002; Irie S, 2014, HANDB EXP PHARMACOL, V222, P387, DOI 10.1007/978-3-642-54215-2_15; Janssen LJ, 2015, AM J RESP CELL MOL, V53, P135, DOI 10.1165/rcmb.2014-0269TR; Jo AO, 2016, P NATL ACAD SCI USA, V113, P3885, DOI 10.1073/pnas.1515895113; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112; Kim J, 2018, P NATL ACAD SCI USA, V115, pE7212, DOI 10.1073/pnas.1800455115; Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07; Kuniba H, 2009, J HUM GENET, V54, P304, DOI 10.1038/jhg.2009.30; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; LeFur N, 1996, GENOMICS, V37, P245; Li JY, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0828-0; Logan CM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16456-5; Mackay DS, 2014, HUM GENOMICS, V8, DOI 10.1186/s40246-014-0019-6; Marshall-Gradisnik S, 2016, APPL CLIN GENET, V9, P39, DOI 10.2147/TACG.S99405; MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22; Mirnezami SA, 2013, J LASERS MED SCI, V4, P175; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; Narayanankutty A, 2016, LUNG, V194, P273, DOI 10.1007/s00408-016-9852-9; Naylor J, 2010, CIRC RES, V106, P1507, DOI 10.1161/CIRCRESAHA.110.219329; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Oberwinkler J, 2014, HANDB EXP PHARMACOL, V222, P427, DOI 10.1007/978-3-642-54215-2_17; Oztuzcu S, 2015, IN VIVO, V29, P763; Pagnamenta AT, 2011, J NEURODEV DISORD, V3, P124, DOI 10.1007/s11689-011-9076-5; Park SH, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S13; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; Sandilands A, 2004, EXP EYE RES, V78, P109, DOI 10.1016/j.exer.2003.09.001; Shiels A, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00258-4; Shirai K, 2018, DEV DYNAM, V247, P340, DOI 10.1002/dvdy.24518; Shu DY, 2017, PROG RETIN EYE RES, V60, P44, DOI 10.1016/j.preteyeres.2017.08.001; Simirskii VN, 2006, INVEST OPHTH VIS SCI, V47, P4931, DOI 10.1167/iovs.06-0423; Toth BI, 2015, J GEN PHYSIOL, V146, P51, DOI 10.1085/jgp.201411339; van den Berg MCW, 2019, CELL REP, V27, P2837, DOI 10.1016/j.celrep.2019.05.029; Van Hoeymissen E, 2020, ELIFE, V9, DOI 10.7554/eLife.57190; Vandewauw I, 2018, NATURE, V555, P662, DOI 10.1038/nature26137; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wagner TFJ, 2008, NAT CELL BIOL, V10, P1421, DOI 10.1038/ncb1801; Wormstone IM, 2009, EXP EYE RES, V88, P257, DOI 10.1016/j.exer.2008.10.016; Xiao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08362; Yashin AI, 2010, AGING-US, V2, P612, DOI 10.18632/aging.100191; Zeitz C, 2015, PROG RETIN EYE RES, V45, P58, DOI 10.1016/j.preteyeres.2014.09.001; Zhao PY, 2015, INVEST OPHTH VIS SCI, V56, P1916, DOI 10.1167/iovs.14-15738; Zhao S, 2020, ELIFE, V9, DOI 10.7554/eLife.55634; Zhou YF, 2019, DIFFERENTIATION, V109, P16, DOI 10.1016/j.diff.2019.07.003; Zhou YF, 2016, BBA-MOL BASIS DIS, V1862, P1433, DOI 10.1016/j.bbadis.2016.05.003	74	8	8	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21288	10.1096/fj.202002037R	http://dx.doi.org/10.1096/fj.202002037R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484482	Green Accepted, Bronze			2022-12-26	WOS:000647789600069
J	Bekele, D; Tolossa, T; Tsegaye, R; Teshome, W				Bekele, Daniel; Tolossa, Tadesse; Tsegaye, Reta; Teshome, Wondesen			The knowledge and practice towards COVID-19 pandemic prevention among residents of Ethiopia. An online cross-sectional study	PLOS ONE			English	Article								Background The disease from the novel coronavirus (COVID-19) has been considered as an international concern and a pandemic starting from the declaration of the World Health Organization (WHO) as an outbreak disease. Objective The objective of this study is to assess the prevention of knowledge and practices towards the COVID-19 pandemic among the residents of Ethiopia. Methods An online cross-sectional study was conducted among a sample of Ethiopian residents via social platforms of the author's network with popular social media such as Facebook, Telegram, and email. The snowball sampling was employed to recruit participants. In doing so, we collected the responses of 341 participants successfully from April 15 to 22, 2020. The collected data were analyzed by STATA version 14 software and descriptive statistics were employed to summarize the knowledge and practices of the community towards the COVID-19 pandemic. Results The majority of respondents 80.5% were male. About 91.2% of the participants heard about the COVID-19 pandemic. Moreover, out of 341 participants 90.0%, 93.8% of them knew that the COVID-19 pandemic was prevented by maintaining social distance and frequent handwashing, respectively. This shows that the prevention knowledge of the participants towards the COVID-19 by maintaining social distance and frequent handwashing was high. However, out of 341 participants only 61%,84% of them practiced social distance and frequent handwashing toward COVID-19, respectively. Conclusions The majority of the participants knew the ways to protect themselves from the novel corona-virus (COVID-19), but there was a great problem of changing this prevention knowledge to practices. This shows that there is an action gap between having prevention knowledge of the COVID-19 and implementing it into practices to tackle the spread of the COVID-19 among communities. Therefore, the concerned body should be focused on providing awareness and education for the community regarding the implementation of prevention knowledge to practices.	[Bekele, Daniel; Teshome, Wondesen] Dire Dawa Univ, Coll Nat & Computat Sci, Dept Stat, Dire Dawa, Ethiopia; [Tolossa, Tadesse] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Tsegaye, Reta] Wollega Univ, Inst Hlth Sci, Dept Nursing, Nekemte, Ethiopia		Bekele, D (corresponding author), Dire Dawa Univ, Coll Nat & Computat Sci, Dept Stat, Dire Dawa, Ethiopia.	daniadvent12@gmail.com	Bekele, Daniel/AAJ-5957-2021	Bekele, Daniel/0000-0003-0092-3756				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; [Anonymous], 2020, GEOPOLL STUDY KNOWLE; Cascella M, 2020, STATPEARLS; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Ikhlaq A, 2020, PAK J MED SCI, V36, pS32, DOI 10.12669/pjms.36.COVID19-S4.2636; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Lau LS, 2020, NAT MED, V26, P647, DOI 10.1038/s41591-020-0851-2; Lee H, 2020, AFR J REPROD HEALTH, V24, P66, DOI 10.29063/ajrh2020/v24i2s.11; Nuwagira E, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00206-x; Nwafor JI, 2020, INT J GYNECOL OBSTET, V150, P121, DOI 10.1002/ijgo.13186; Olaimat AN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00254; Olapegba P.O, PRELIMINARY ASSESSME; Paintsil E, 2020, J CLIN INVEST, V130, P2741, DOI 10.1172/JCI138493; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Roy D, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102083; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Ssebuufu R, 2020, AWARENESS KNOWLEDGE, V8, P1; UNICEF, 2020, CREATING AWARENESS C; Vaidya B., KNOWLEDGE ATTITUDE P; World Health Organization, 2020, CRIT PREP READ RESP; World Health Organization, 2020, SURVEY TOOL GUIDANCE; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012	24	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0234585	10.1371/journal.pone.0234585	http://dx.doi.org/10.1371/journal.pone.0234585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507906	gold, Green Published, Green Submitted			2022-12-26	WOS:000635021400003
J	de Almeida, JM; Nunes, FO; Ceole, LF; Klimeck, TDF; da Cruz, LA; Tofoli, D; Borges, BS; Garcez, WS; Tozetti, IA; Medeiros, LCS; Garcez, FR; Ferreira, AMT				de Almeida, Julio Menta; Nunes, Felipe Oliveira; Ceole, Ligia Fernanda; Freitas Klimeck, Tabata D'Maiella; da Cruz, Leticia Alves; Tofoli, Danilo; Borges, Beatriz Santana; Garcez, Walmir Silva; Tozetti, Ines Aparecida; Soares Medeiros, Lia Carolina; Garcez, Fernanda Rodrigues; Teixeira Ferreira, Alda Maria			Synergistic effect and ultrastructural changes in Trypanosoma cruzi caused by isoobtusilactone A in short exposure of time	PLOS ONE			English	Article							HEP G2 CELLS; CHAGAS-DISEASE; IN-VITRO; ANTIPROTOZOAL ACTIVITY; SESQUITERPENE LACTONES; INDUCED APOPTOSIS; BENZNIDAZOLE; COMBINATION; DERIVATIVES; VIVO	Butanolides have shown a variety of biological effects including anti-inflammatory, antibacterial, and antiprotozoal effects against certain strains of Trypanosoma cruzi. Considering the lack of an effective drug to treat T. cruzi infections and the prominent results obtained in literature with this class of lactones, we investigated the anti-T. cruzi activity of five butanolides isolated from two species of Lauraceae, Aiouea trinervis and Mezilaurus crassiramea. Initially, the activity of these compounds was evaluated on epimastigote forms of the parasite, after a treatment period of 4 h, followed by testing on amastigotes, trypomastigotes, and mammalian cells. Next, the synergistic effect of active butanolides against amastigotes was evaluated. Further, metacyclogenesis inhibition and infectivity assays were performed for the most active compound, followed by ultrastructural analysis of the treated amastigotes and trypomastigotes. Among the five butanolides studied, majoranolide and isoobtusilactone A were active against all forms of the parasite, with good selectivity indexes in Vero cells. Both butanolides were more active than the control drug against trypomastigote and epimastigote forms and also had a synergic effect on amastigotes. The most active compound, isoobtusilactone A, which showed activity against all tested strains inhibited metacyclogenesis and infection of new host cells. In addition, ultrastructural analysis revealed that this butanolide caused extensive damage to the mitochondria of both amastigotes and trypomastigotes, resulting in severe morphological changes in the infective forms of the parasite. Altogether, our results highlight the potential of butanolides against the etiologic agent of Chagas disease and the relevance of isoobtusilactone A as a strong anti-T. cruzi drug, affecting different events of the life cycle and all evolutionary forms of parasite after a short period of exposure.	[de Almeida, Julio Menta; da Cruz, Leticia Alves; Tozetti, Ines Aparecida; Teixeira Ferreira, Alda Maria] Univ Fed Mato Grosso do Sul, Inst Biociencias, Lab Imunol Biol Mol & Bioensaios, Campo Grande, MS, Brazil; [Nunes, Felipe Oliveira; Tofoli, Danilo; Garcez, Walmir Silva; Garcez, Fernanda Rodrigues] Univ Fed Mato Grosso do Sul, Lab Pesquisa Prod Nat Bioativos, Inst Quim, Campo Grande, MS, Brazil; [Ceole, Ligia Fernanda; Freitas Klimeck, Tabata D'Maiella; Borges, Beatriz Santana; Soares Medeiros, Lia Carolina] Inst Carlos Chagas Fiocruz Parana, Lab Biol Celular, Curitiba, Parana, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso do Sul; Fundacao Oswaldo Cruz	Ferreira, AMT (corresponding author), Univ Fed Mato Grosso do Sul, Inst Biociencias, Lab Imunol Biol Mol & Bioensaios, Campo Grande, MS, Brazil.	alda.ferreira@ufms.br		Oliveira Nunes, Felipe/0000-0002-0170-5550; Tofoli, Danilo/0000-0001-9131-3587	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT [027159, 021683]; Fundacao Universidade Federal de Mato Grosso do Sul-UFMS/MEC-Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES [001]	Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Fundacao Universidade Federal de Mato Grosso do Sul-UFMS/MEC-Brazil; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The full and correct list of funders for our study is as follows: The authors gratefully acknowledge the Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul-FUNDECT (https://www.fundect.ms.gov.br/-grant numbers 027159 and 021683); Fundacao Universidade Federal de Mato Grosso do Sul-UFMS/MEC-Brazil (https://www.ufms.br/), and for the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (https://www.capes.gov.br/-Finance Code 001) for the grants awarded to JMA, LAC, DT and FON. Writing assistance: This manuscript was supported grammatical correction fees by Fundacao Universidade Federal de Mato Grosso do Sul-UFMS/MEC-Brazil. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera E, 2018, MEM I OSWALDO CRUZ, V113, P153, DOI 10.1590/0074-02760170267; Alonso-Padilla J, 2019, EXPERT REV ANTI-INFE, V17, P145, DOI 10.1080/14787210.2019.1577731; Conserva GAA, 2019, PHYTOMEDICINE, V54, P302, DOI 10.1016/j.phymed.2018.09.236; Araujo MSS, 2000, J ANTIMICROB CHEMOTH, V45, P819, DOI 10.1093/jac/45.6.819; Azeredo CMO, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-309; Batista CM, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0170-3; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; BRENER Z, 1965, ANN TROP MED PARASIT, V59, P19, DOI 10.1080/00034983.1965.11686277; Britta EA, 2015, PARASITOLOGY, V142, P978, DOI 10.1017/S0031182015000141; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Campo VA, 2017, INT J PARASITOL-DRUG, V7, P23, DOI 10.1016/j.ijpddr.2016.12.003; Cardoso J, 2010, MEM I OSWALDO CRUZ, V105, P1026, DOI 10.1590/S0074-02762010000800012; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; Chen CY, 2008, J NAT PROD, V71, P933, DOI 10.1021/np070620e; Chen CY, 2007, FOOD CHEM TOXICOL, V45, P1268, DOI 10.1016/j.fct.2007.01.008; Chen CY, 2012, J AGR FOOD CHEM, V60, P3533, DOI 10.1021/jf2051224; Chou T-C., 2018, SYNERGIE, V7, P49, DOI [DOI 10.1016/J.SYNRES.2018.04.001, 10.1016/j.synres.2018.04.001]; CHOU TC, 1983, TRENDS PHARMACOL SCI, V4, P450, DOI 10.1016/0165-6147(83)90490-X; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cogo J, 2012, PHYTOMEDICINE, V20, P59, DOI 10.1016/j.phymed.2012.09.011; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; Coura JR, 2015, MEM I OSWALDO CRUZ, V110, P277, DOI 10.1590/0074-0276140362; DA SILVA L. H. P., 1953, Folia Clinica et Biologica, V20, P191; De Araujo JS, 2014, ANTIMICROB AGENTS CH, V58, P4191, DOI 10.1128/AAC.01403-13; De Mieri M, 2017, J NAT PROD, V80, P459, DOI 10.1021/acs.jnatprod.6b00980; de Oliveira MT, 2017, ACTA TROP, V167, P108, DOI 10.1016/j.actatropica.2016.11.033; Diniz LD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002367; Duschak Vilma G, 2016, Recent Pat Antiinfect Drug Discov, V11, P74, DOI 10.2174/1574891X11666161024165304; Echeverria LE, 2020, REV SOC BRAS MED TRO, V53, DOI [10.1590/0037-8682-0477-2019, 10.1590/0037-8682-0477-2019.]; Ennes-Vidal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018371; Ennes-Vidal V, 2010, J ANTIMICROB CHEMOTH, V65, P1395, DOI 10.1093/jac/dkq154; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Martins TAF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128707; FOURNET A, 1993, PHYTOTHER RES, V7, P111, DOI 10.1002/ptr.2650070203; Goncalves-Santos E, 2019, INT IMMUNOPHARMACOL, V77, DOI [10.1016/j.Intimp.2019.105961, 10.1016/j.intimp.2019.105961]; Heemann LM, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3464237; Izumi E, 2011, NAT PROD REP, V28, P809, DOI 10.1039/c0np00069h; Kimani NM, 2018, J NAT PROD, V81, P124, DOI 10.1021/acs.jnatprod.7b00747; Lantos AB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005559; Laurella LC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005929; Laurentiz RS, 2018, MED CHEM RES, V27, P1074, DOI 10.1007/s00044-017-2129-x; Lourenco AM, 2018, REV SOC BRAS MED TRO, V51, P52, DOI 10.1590/0037-8682-0285-2017; Spina RM, 2018, PHYTOMEDICINE, V46, P111, DOI 10.1016/j.phymed.2018.04.032; Meira CS, 2016, EXP PARASITOL, V166, P108, DOI 10.1016/j.exppara.2016.04.007; Mucci J, 2017, TRENDS PARASITOL, V33, P102, DOI 10.1016/j.pt.2016.10.004; Gulin JEN, 2020, ACTA TROP, V211, DOI 10.1016/j.actatropica.2020.105606; Nunes FO, 2020, EXCLI J, V19, P323, DOI 10.17179/excli2020-1088; Souza ROO, 2020, MOLECULES, V25, DOI 10.3390/molecules25071628; Olivera MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185033; Pelizzaro-Rocha KJ, 2010, PHYTOMEDICINE, V18, P36, DOI 10.1016/j.phymed.2010.09.005; Perez-Mazliah DE, 2013, J ANTIMICROB CHEMOTH, V68, P424, DOI 10.1093/jac/dks390; Portapilla GB, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8301569; Quilles JC, 2020, EXP PARASITOL, V219, DOI 10.1016/j.exppara.2020.108032; Revollo S, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040197; Ribeiro V, 2020, INT J PARASITOL-DRUG, V12, P7, DOI 10.1016/j.ijpddr.2019.11.004; Saraiva J, 2007, PARASITOL RES, V100, P791, DOI 10.1007/s00436-006-0327-4; Schmidt TJ, 2009, MOLECULES, V14, P2062, DOI 10.3390/molecules14062062; Schmidt TJ, 2006, STUD NAT PROD CHEM, V33, P309; Schmidt TJ, 2002, PLANTA MED, V68, P750, DOI 10.1055/s-2002-33799; Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956; Simoes-Silva MR, 2019, PARASITOLOGY, V146, P1006, DOI 10.1017/S0031182019000234; Simoes-Silva MR, 2016, ANTIMICROB AGENTS CH, V60, P4701, DOI 10.1128/AAC.01788-15; Sueth-Santiago Vitor, 2017, World J Biol Chem, V8, P57, DOI 10.4331/wjbc.v8.i1.57; Sulsen VP, 2008, ANTIMICROB AGENTS CH, V52, P2415, DOI 10.1128/AAC.01630-07; Sulsen VP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150526; Gomes PATD, 2016, EUR J MED CHEM, V111, P46, DOI 10.1016/j.ejmech.2016.01.010; Timm BL, 2014, PARASITOLOGY, V141, P1272, DOI 10.1017/S0031182014000407; Tofoli D, 2016, PLANTA MED LETT, V3, pe14, DOI DOI 10.1055/s-0035-1568355; Trochine A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002844; Barbosa MDV, 2015, REV SOC BRAS MED TRO, V48, P27, DOI 10.1590/0037-8682-0258-2013; Veiga-Santos P, 2012, INT J ANTIMICROB AG, V40, P61, DOI 10.1016/j.ijantimicag.2012.03.009; Villamizar LH, 2017, MEM I OSWALDO CRUZ, V112, P131, DOI 10.1590/0074-02760160361; Walsh CT, 2017, NATURAL PRODUCT BIOS, DOI [10.1021/acs.chemrev.6b00478, DOI 10.1021/ACS.CHEMREV.6B00478]; Wu ZN, 2017, PHYTOCHEMISTRY, V137, P81, DOI 10.1016/j.phytochem.2017.01.020; Yasumura Y., 1963, NIHON RINSHO, V21, P1201; Zimmermann S, 2013, BIOORGAN MED CHEM, V21, P7202, DOI 10.1016/j.bmc.2013.08.052; Zingales B, 2014, MEM I OSWALDO CRUZ, V109, P828, DOI 10.1590/0074-0276140156	78	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245882	10.1371/journal.pone.0245882	http://dx.doi.org/10.1371/journal.pone.0245882			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507972	gold, Green Published			2022-12-26	WOS:000635021400059
J	Mazloom-Farsibaf, H; Farzam, F; Fazel, M; Wester, MJ; Meddens, MBM; Lidke, KA				Mazloom-Farsibaf, Hanieh; Farzam, Farzin; Fazel, Mohamadreza; Wester, Michael J.; Meddens, Marjolein B. M.; Lidke, Keith A.			Comparing lifeact and phalloidin for super-resolution imaging of actin in fixed cells	PLOS ONE			English	Article							F-ACTIN; RESOLUTION; BINDING; LOCALIZATION; CYTOSKELETON; MICROSCOPY; DYNAMICS; VISUALIZE; PROTEINS; REVEALS	Visualizing actin filaments in fixed cells is of great interest for a variety of topics in cell biology such as cell division, cell movement, and cell signaling. We investigated the possibility of replacing phalloidin, the standard reagent for super-resolution imaging of F-actin in fixed cells, with the actin binding peptide 'lifeact'. We compared the labels for use in single molecule based super-resolution microscopy, where AlexaFluor 647 labeled phalloidin was used in a dSTORM modality and Atto 655 labeled lifeact was used in a single molecule imaging, reversible binding modality. We found that imaging with lifeact had a comparable resolution in reconstructed images and provided several advantages over phalloidin including lower costs, the ability to image multiple regions of interest on a coverslip without degradation, simplified sequential super-resolution imaging, and more continuous labeling of thin filaments.	[Mazloom-Farsibaf, Hanieh; Farzam, Farzin; Fazel, Mohamadreza; Wester, Michael J.; Meddens, Marjolein B. M.; Lidke, Keith A.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Wester, Michael J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Lidke, Keith A.] Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA; [Mazloom-Farsibaf, Hanieh] Univ Texas Southwestern Med Ctr Dallas, Lyda Hill Dept Bioinformat, Dallas, TX 75390 USA; [Farzam, Farzin] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Fazel, Mohamadreza] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Meddens, Marjolein B. M.] Univ Med Ctr Utrecht, Dept Radiol & Nucl Med, Utrecht, Netherlands	University of New Mexico; University of New Mexico; University of New Mexico; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; Arizona State University; Arizona State University-Tempe; Utrecht University; Utrecht University Medical Center	Lidke, KA (corresponding author), Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA.; Lidke, KA (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA.	klidke@unm.edu		Wester, Michael/0000-0002-3520-7605; Fazel, Mohamadreza/0000-0002-6215-1336	NIH [R01GM109888, 1R21EB019589, P30CA118100]; New Mexico Spatiotemporal Modeling Center (NIH) [P50GM085273]; Rubicon grant from the Netherlands Organization for Scientific Research (NWO Rubicon) [825.14.020]; NWO Rubicon [825.14.020]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Mexico Spatiotemporal Modeling Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rubicon grant from the Netherlands Organization for Scientific Research (NWO Rubicon)(Netherlands Organization for Scientific Research (NWO)); NWO Rubicon(Netherlands Organization for Scientific Research (NWO))	This work was supported by NIH grants R01GM109888, 1R21EB019589 and the New Mexico Spatiotemporal Modeling Center (NIH P50GM085273). We gratefully acknowledge the use of the University of New Mexico Comprehensive Cancer Center fluorescence microscopy core, as well as the NIH P30CA118100 support for these cores. A Rubicon grant from the Netherlands Organization for Scientific Research (NWO Rubicon 825.14.020) supported M.B.M.M. R01GM109888 supported: Keith Lidke and Hanieh Mazloom-Farsibaf 1R21EB019589 supported: Keith Lidke and Mohamadreza Fazel P50GM085273 supported: Keith Lidke, Mohamadreza Fazel, and Michael Wester NWO Rubicon 825.14.020 supported: Marjolein Meddens P30CA118100 supported: Keith Lidke, Michael Wester The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, FAC APPL SCI DELFT U; Ashdown GW, 2017, BIOPHYS J, V112, P1703, DOI 10.1016/j.bpj.2017.01.038; Ballestrem C, 1998, J CELL SCI, V111, P1649; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; D'Este E, 2015, CELL REP, V10, P1246, DOI 10.1016/j.celrep.2015.02.007; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; Kiuchi T, 2015, NAT METHODS, V12, P743, DOI [10.1038/nmeth.3466, 10.1038/NMETH.3466]; Kristo I, 2016, HISTOCHEM CELL BIOL, V145, P373, DOI 10.1007/s00418-015-1400-9; Lopata A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24953-4; Melak M, 2017, J CELL SCI, V130, P1688, DOI 10.1242/jcs.204487; Munoz-Lasso DC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020358; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Pallikkuth S, 2018, BIOPHYS J, V114, p532A, DOI 10.1016/j.bpj.2017.11.2912; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rocchetti A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-12; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Schell MJ, 2001, J BIOL CHEM, V276, P37537, DOI 10.1074/jbc.M104101200; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Spracklen AJ, 2014, DEV BIOL, V393, P209, DOI 10.1016/j.ydbio.2014.06.022; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; Wester MJ, 2020, BIOPHYS J, V118, p147A; Wickramarachchi DC, 2010, AUTOIMMUNITY, V43, P64, DOI 10.3109/08916930903374634; WIELAND T, 1978, CRC CR REV BIOCH MOL, V5, P185, DOI 10.3109/10409237809149870; WINDER SJ, 1995, J CELL SCI, V108, P63; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Yan Q, 2014, CHEMPHYSCHEM, V15, P687, DOI 10.1002/cphc.201300757	41	11	11	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246138	10.1371/journal.pone.0246138	http://dx.doi.org/10.1371/journal.pone.0246138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508018	gold, Green Submitted, Green Published			2022-12-26	WOS:000635021400097
J	Mmbando, AS; Kaindoa, EW; Ngowo, HS; Swai, JK; Matowo, NS; Kilalangongono, M; Lingamba, GP; Mgando, JP; Namango, IH; Okumu, FO; Nelli, L				Mmbando, Arnold S.; Kaindoa, Emmanuel W.; Ngowo, Halfan S.; Swai, Johnson K.; Matowo, Nancy S.; Kilalangongono, Masoud; Lingamba, Godfrey P.; Mgando, Joseph P.; Namango, Isaac H.; Okumu, Fredros O.; Nelli, Luca			Fine-scale distribution of malaria mosquitoes biting or resting outside human dwellings in three low-altitude Tanzanian villages	PLOS ONE			English	Article							ANOPHELES-GAMBIAE COMPLEX; CARBON-DIOXIDE; TRANSMISSION; CULICIDAE; DIPTERA; VECTOR; IDENTIFICATION; FEMALES; FEVER; TRAP	Background While malaria transmission in Africa still happens primarily inside houses, there is a substantial proportion of Anopheles mosquitoes that bite or rest outdoors. This situation may compromise the performance of indoor insecticidal interventions such as insecticide-treated nets (ITNs). This study investigated the distribution of malaria mosquitoes biting or resting outside dwellings in three low-altitude villages in south-eastern Tanzania. The likelihood of malaria infections outdoors was also assessed. Methods Nightly trapping was done outdoors for 12 months to collect resting mosquitoes (using resting bucket traps) and host-seeking mosquitoes (using odour-baited Suna (R) traps). The mosquitoes were sorted by species and physiological states. Pooled samples of Anopheles were tested to estimate proportions infected with Plasmodium falciparum parasites, estimate proportions carrying human blood as opposed to other vertebrate blood and identify sibling species in the Anopheles gambiae complex and An. funestus group. Environmental and anthropogenic factors were observed and recorded within 100 meters from each trapping positions. Generalised additive models were used to investigate relationships between these variables and vector densities, produce predictive maps of expected abundance and compare outcomes within and between villages. Results A high degree of fine-scale heterogeneity in Anopheles densities was observed between and within villages. Water bodies covered with vegetation were associated with 22% higher densities of An. arabiensis and 51% lower densities of An. funestus. Increasing densities of houses and people outdoors were both associated with reduced densities of An. arabiensis and An. funestus. Vector densities were highest around the end of the rainy season and beginning of the dry seasons. More than half (14) 58.3% of blood-fed An. arabiensis had bovine blood, (6) 25% had human blood. None of the Anopheles mosquitoes caught outdoors was found infected with malaria parasites. Conclusion Outdoor densities of both host-seeking and resting Anopheles mosquitoes had significant heterogeneities between and within villages, and were influenced by multiple environmental and anthropogenic factors. Despite the high Anopheles densities outside dwellings, the substantial proportion of non-human blood-meals and absence of malaria-infected mosquitoes after 12 months of nightly trapping suggests very low-levels of outdoor malaria transmission in these villages.	[Mmbando, Arnold S.; Kaindoa, Emmanuel W.; Ngowo, Halfan S.; Swai, Johnson K.; Matowo, Nancy S.; Kilalangongono, Masoud; Lingamba, Godfrey P.; Mgando, Joseph P.; Namango, Isaac H.; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Ifakara, Tanzania; [Kaindoa, Emmanuel W.; Okumu, Fredros O.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Parktown, South Africa; [Ngowo, Halfan S.; Okumu, Fredros O.; Nelli, Luca] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Matowo, Nancy S.; Namango, Isaac H.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Matowo, Nancy S.; Namango, Isaac H.] Univ Basel, Basel, Switzerland; [Okumu, Fredros O.] Nelson Mandela African Inst Sci & Technol, Sch Life Sci & Bioengn, Arusha, Tanzania	Ifakara Health Institute; University of Witwatersrand; University of Glasgow; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Nelson Mandela African Institution of Science & Technology	Mmbando, AS (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci, Ifakara, Tanzania.	ammbando@ihi.or.tz	Ngowo, Halfan/AFS-8039-2022; cao, xiaoxiang/AAR-9291-2021	Ngowo, Halfan/0000-0003-2789-0261; Nelli, Luca/0000-0001-6091-4072; Mmbando, Arnold/0000-0002-5290-0970; Kaindoa, Dr. Emmanuel W/0000-0001-6170-5694; Matowo, Nancy/0000-0002-2302-3796	Wellcome Trust Intermediate Research Fellowship [WT102350/Z/13/Z]; Wellcome Trust Masters Fellowship in Public Health; Association of Physicians of Great Britain and Ireland [106356/Z/14/Z]	Wellcome Trust Intermediate Research Fellowship(Wellcome Trust); Wellcome Trust Masters Fellowship in Public Health(Wellcome Trust); Association of Physicians of Great Britain and Ireland	Fredros Okumu was funded by the Wellcome Trust Intermediate Research Fellowship (Grant number: WT102350/Z/13/Z) which funded this research. Arnold Mmbando was also supported by the Wellcome Trust Masters Fellowship in Public Health and the Association of Physicians of Great Britain and Ireland for funding this research (Grant number 106356/Z/14/Z).	Afrane YA, 2016, CURRENT TOPICS IN MALARIA, P473, DOI 10.5772/65359; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000401; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; BEIER JC, 1988, J MED ENTOMOL, V25, P9, DOI 10.1093/jmedent/25.1.9; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Charlwood JD, 1998, AFR ENTOMOL, V6, P1; COOSEMANS M, 1990, ANN SOC BELG MED TR, V70, P5; De Castro MC, 2004, AM J TROP MED HYG, V71, P103, DOI 10.4269/ajtmh.2004.71.103; Fornadel CM, 2011, VECTOR-BORNE ZOONOT, V11, P1173, DOI 10.1089/vbz.2010.0082; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Glunt KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024968; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Isaaks E.H, 1989, INTRO APPL GEOSTATIS; Kaindoa EW, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2450-y; Kaindoa EW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177807; Kaindoa EW, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1268-8; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kreppel KS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1066-0; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lwetoijera DW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-331; Mala AO, 2011, J VECTOR DIS, V48, P52; Matowo NS, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03331-4; Matowo NS, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3676-4; Matowo Nancy S, 2017, Wellcome Open Res, V2, P96, DOI 10.12688/wellcomeopenres.12617.1; Mboera L E G, 2005, Tanzan Health Res Bull, V7, P117; Mburu MM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2680-7; Mendis C, 2000, MED VET ENTOMOL, V14, P171, DOI 10.1046/j.1365-2915.2000.00228.x; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Monroe A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2855-2; Mugambi M, 1987, DTIC DOCUMENT; Mwangangi JM, 2003, J AM MOSQUITO CONTR, V19, P371; Mwangungulu SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156388; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; Nambunga IH, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03295-5; National Malaria Control Programme (Tanzania) WT Ifakara Health Institute (Tanzania), 2013, REPORT; Nelli L, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00209-1; Nelli L, 2020, STAT METHODS MED RES, V29, P1273, DOI 10.1177/0962280219856380; Ngowo Halfan S, 2017, Wellcome Open Res, V2, P102, DOI 10.12688/wellcomeopenres.12928.1; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Omumbo JA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-17; Pinda P, 2020, DOMINANT MALARIA VEC; R Core Team, 2020, R LANG ENV STAT COMP; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Russell TL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-187; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; SERVICE MW, 1977, B ENTOMOL RES, V67, P343, DOI 10.1017/S0007485300011184; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of Chief Government Statistician (OCGS) and ICF International Calverton, 2013, MARYLAND US TANZANIA; Thawer SG, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03250-4; Wilkes TJ, 1996, MED VET ENTOMOL, V10, P108, DOI 10.1111/j.1365-2915.1996.tb00092.x; Wood S. N., 2006, GEN ADDITIVE MODELS, P262; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245750	10.1371/journal.pone.0245750	http://dx.doi.org/10.1371/journal.pone.0245750			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507908	gold, Green Published, Green Accepted			2022-12-26	WOS:000635021400051
J	Shao, ML; Newman, C; Buesching, CD; Macdonald, DW; Zhou, ZM				Shao, Mei-Ling; Newman, Chris; Buesching, Christina D.; Macdonald, David W.; Zhou, Zhao-Min			Understanding wildlife crime in China: Socio-demographic profiling and motivation of offenders	PLOS ONE			English	Article							TRADE; CONSERVATION; CONSUMPTION; EDUCATION; GENDER; LAW	Wildlife crime presents a growing threat to the integrity of ecological communities. While campaigns have raised consumer awareness, little is known about the socio-demographic profile of wildlife offenders, or how to intervene. Using data from China Judgements Online (2014-2018), we documented 4,735 cases, involving 7,244 offenders who smuggled, hunted, transported, sold and/or purchased protected species in contravention of China's Criminal Law. Offenders were predominantly men (93.0% of 7,143 offenders), aged 30-44 (43.9% of 4,699), agricultural workers (48.4% of 3,960), with less schooling (78.6% of 4,699 < senior secondary school). Socio-economic profiles related to crime seriousness, the type of illegal activity, motivation and taxon involved. These generalizations reveal scope to tailor specific intervention and mitigation approaches to offender profiles, through public information campaigns, proactive incentives opposed by punitive disincentives, and provision of alternative incomes.	[Shao, Mei-Ling; Zhou, Zhao-Min] China West Normal Univ, Key Lab Southwest China Wildlife Resources Conser, Minist Educ, Nanchong, Peoples R China; [Newman, Chris; Macdonald, David W.] Univ Oxford, Recanati Kaplan Ctr, Dept Zool, Wildlife Conservat Res Unit, Oxford, England; [Newman, Chris; Buesching, Christina D.] Cooks Lake Farming Forestry & Wildlife Inc Ecol C, Queens Cty, NS, Canada; [Buesching, Christina D.] Univ British Columbia, Dept Biol, Irving K Barber Sch Arts & Sci Unit 2, Okanagen, BC, Canada	China West Normal University; University of Oxford; University of British Columbia	Zhou, ZM (corresponding author), China West Normal Univ, Key Lab Southwest China Wildlife Resources Conser, Minist Educ, Nanchong, Peoples R China.	zhouzm81@gmail.com		Zhou, Zhao-Min/0000-0003-4824-7371	scientific research foundations of China West Normal University [16E013, 17BO10]; H.N. Southern Memorial Fellowship	scientific research foundations of China West Normal University; H.N. Southern Memorial Fellowship	ZMZ acknowledges support from the scientific research foundations of China West Normal University (16E013, 17BO10). CN thanks the H.N. Southern Memorial Fellowship.	[Anonymous], 2014, COMRADES BODHISATTVA; Baker SE, 2013, BIOSCIENCE, V63, P928, DOI 10.1525/bio.2013.63.12.6; Biggs D, 2017, CONSERV BIOL, V31, P5, DOI 10.1111/cobi.12796; Blumm MC, 2005, ENVIRON LAW, V35, P673; Braden K, 2014, EURASIAN GEOGR ECON, V55, P457, DOI 10.1080/15387216.2015.1020320; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown M, 2018, SOCIOL COMPASS, V12, DOI 10.1111/soc4.12580; Buonanno P, 2008, INT REV LAW ECON, V28, P89, DOI 10.1016/j.irle.2008.02.005; Challender DWS, 2015, GLOB ECOL CONSERV, V3, P129, DOI 10.1016/j.gecco.2014.11.010; Chang CH, 2019, BIOL CONSERV, V234, P100, DOI 10.1016/j.biocon.2019.03.004; Chang CH, 2017, ECOL SOC, V22, DOI [10.5751/ES-09072-220143, 10.5751/es-09072-220143]; Chen TH, 2009, CHELONIAN CONSERV BI, V8, P11, DOI 10.2744/CCB-0747.1; Choy O, 2017, CRIMINOLOGY, V55, P465, DOI 10.1111/1745-9125.12138; Cooney R, 2018, COMBATING ILLEGAL WI; Courchamp F, 2006, PLOS BIOL, V4, P2405, DOI 10.1371/journal.pbio.0040415; Duffy R, 2016, CONSERV BIOL, V30, P14, DOI 10.1111/cobi.12622; Eliason Stephen L., 2004, Human Dimensions of Wildlife, V9, P119, DOI 10.1080/10871200490441775; Entorf H, 2000, INT REV LAW ECON, V20, P75, DOI 10.1016/S0144-8188(00)00022-3; FARRINGTON DP, 1986, BRIT J CRIMINOL, V26, P335, DOI 10.1093/oxfordjournals.bjc.a047626; Gao YF, 2016, BIOL CONSERV, V201, P343, DOI 10.1016/j.biocon.2016.08.001; Gao YF, 2014, BIOL CONSERV, V180, P23, DOI 10.1016/j.biocon.2014.09.020; Goodey J, 1997, BRIT J CRIMINOL, V37, P401; Graham-Rowe D, 2011, NATURE, V480, pS101, DOI 10.1038/480S101a; Gubbi S., 2012, J BOMBAY NAT HIST SO, V109, P165; Harris RB, 1997, MT RES DEV, V17, P171, DOI 10.2307/3673832; HEBERLEIN TA, 1987, ENVIRONMENT, V29, P6, DOI 10.1080/00139157.1987.9931338; Hjalmarsson R, 2015, ECON J, V125, P1290, DOI 10.1111/ecoj.12204; Kross SM, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12364; Kumpel NF, 2009, ANIM CONSERV, V12, P531, DOI 10.1111/j.1469-1795.2009.00279.x; Leavitt K, 2021, DEVIANT BEHAV, V42, P1256, DOI 10.1080/01639625.2020.1738643; LEE LT, 1978, HASTINGS LAW J, V29, P1307; li TG, 2015, ADV APPL SOCIOLOGY, V5, P1; Li YM, 2000, BIODIVERS CONSERV, V9, P901; Li YM, 2005, BIOSCIENCE, V55, P147, DOI 10.1641/0006-3568(2005)055[0147:TTVSIC]2.0.CO;2; Lindberg E., 2010, HUNTER DEMOGRAPHY TR; Liu S, 2021, ORYX, V55, P352, DOI 10.1017/S0030605319001030; Liu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145901; Lochner L, 2004, INT ECON REV, V45, P811, DOI 10.1111/j.0020-6598.2004.00288.x; Louie K., 2014, NORMA, V9, P18; Louie K., 2002, THEORISING CHINESE M; Lowther J, 2002, CRIME PUNISHMENT WIL; LUECK D, 1995, NAT RESOUR J, V35, P625; Macdonald DW, 2019, J INT WILDL LAW POLI, V22, P1, DOI DOI 10.1080/13880292.2019.1616379; MATTHEWS OP, 1986, WILDLIFE SOC B, V14, P459; McCorquodale SM, 1997, WILDLIFE SOC B, V25, P568; McCready S, 2005, OCCAS PAP, P1; Moorhouse TP, 2017, CONSERV LETT, V10, P337, DOI 10.1111/conl.12270; Moreto William D., 2017, P45; Moyle B, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P41; MUSGRAVE RS, 1993, NAT RESOUR J, V33, P978; Muth RM, 1998, SOC NATUR RESOUR, V11, P9, DOI 10.1080/08941929809381058; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nurse A., 2011, PAPERS BRIT CRIMINOL, V11, P38; Nurse A, 2015, PALG STUD GREEN CRIM, P129; Nurse A, 2013, CRIT CRIM PERSP, P127; Nurse A, 2013, CRIME LAW SOCIAL CH, V59, P305, DOI 10.1007/s10611-013-9417-2; Nyhus PJ, 2005, CONSERV BIOL SER, V9, P107; Pastore F, 2006, INT MIGR, V44, P95, DOI 10.1111/j.1468-2435.2006.00381.x; Patel NG, 2015, P NATL ACAD SCI USA, V112, P7948, DOI 10.1073/pnas.1500862112; Rosen GE, 2010, ECOHEALTH, V7, P24, DOI 10.1007/s10393-010-0317-y; Schaedla WH, 2016, HDB TRANSLATIONAL EN, P45; Sharpe D., 2015, PRACT ASSESS RES EVA, V20, P8, DOI [10.7275/tbfa-x148, DOI 10.7275/TBFA-X148]; Shaw VN, 2010, J CONTEMP CRIM JUST, V26, P53; Sollund R, 2020, SOC SCI-BASEL, V9, DOI 10.3390/socsci9060093; Spierenburg M, 2014, J CONTEMP AFR STUD, V32, P151, DOI 10.1080/09637494.2014.937164; Steffensmeier D, 1996, ANNU REV SOCIOL, V22, P459, DOI 10.1146/annurev.soc.22.1.459; Steffensmeier D, 2017, CRIMINOLOGY, V55, P377, DOI 10.1111/1745-9125.12139; SYKES GM, 1957, AM SOCIOL REV, V22, P664, DOI 10.2307/2089195; Thomas-Walters L, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.248; Travers H, 2019, CONSERV BIOL, V33, P1296, DOI 10.1111/cobi.13330; Treves A, 2020, CONSERV BIOL, V34, P811, DOI 10.1111/cobi.13472; VanUhm DP, 2016, STUD ORGANIZE CRIME, V15, P1, DOI 10.1007/978-3-319-42129-2; von Essen E, 2017, CRIM LAW PHILOS, V11, P213, DOI 10.1007/s11572-014-9364-8; Vucetich JA, 2018, BIOL CONSERV, V221, P23, DOI 10.1016/j.biocon.2018.02.022; Wallen KE, 2018, NAT CONSERV-BULGARIA, P55, DOI 10.3897/natureconservation.26.22725; Warchol GL, 2004, CRIM JUSTICE STUD CR, V1, P57, DOI DOI 10.1080/08884310420001679334; Wellsmith M, 2011, EUR J CRIM POLICY RE, V17, P125, DOI 10.1007/s10610-011-9140-4; Wilson L, 2020, BIOL CONSERV, V251, DOI 10.1016/j.biocon.2020.108810; Wong R.W., 2019, ILLEGAL WILDLIFE TRA; Wong RWY, 2019, PALG STUD GREEN CRIM, P1, DOI 10.1007/978-3-030-13666-6; Wyatt T., 2013, WILDLIFE TRAFFICKING, DOI DOI 10.1057/9781137269249; Wyatt T, 2020, TRENDS ORGAN CRIME, V23, P350, DOI 10.1007/s12117-020-09385-9; Xiao H, 2007, CHINA REV INT, V14, P175; Ye YC, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.161; Yin RY, 2020, GLOB ECOL CONSERV, V23, DOI 10.1016/j.gecco.2020.e01047; Zhang L, 2008, BIODIVERS CONSERV, V17, P1493, DOI 10.1007/s10531-008-9358-8; Zhou ZM, 2020, NATURE, V578, P217, DOI 10.1038/d41586-020-00378-w; Zhou ZM, 2016, CONSERV LETT, V9, P313, DOI 10.1111/conl.12289; Zhou ZM, 2015, FRONT ECOL ENVIRON, V13, P353, DOI 10.1890/15.WB.014; Zhou ZM, 2014, FRONT ECOL ENVIRON, V12, P97, DOI 10.1890/14.WB.001; Zimmerman, 2003, VANDERBILT J TRANSNA, V36, P1657	91	11	11	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246081	10.1371/journal.pone.0246081	http://dx.doi.org/10.1371/journal.pone.0246081			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33508005	Green Published, gold			2022-12-26	WOS:000635021400084
J	Sukenik, N; Iluz, D; Amar, Z; Varvak, A; Shamir, O; Ben-Yosef, E				Sukenik, Naama; Iluz, David; Amar, Zohar; Varvak, Alexander; Shamir, Orit; Ben-Yosef, Erez			Early evidence of royal purple dyed textile from Timna Valley (Israel)	PLOS ONE			English	Article							TYRIAN PURPLE; CHEMICAL-ANALYSIS; SLAVES HILL; IDENTIFICATION; INSIGHTS; INDUSTRY	In the context of a broad study aimed at examining dyeing technologies in the Timna textiles collection, three samples of prestigious fibers dyed with murex sea snail were identified. Our identification is based on the presence of 6-monobromoindigotin and 6,6-dibromoindigotin components (detected using HPLC analysis), which is considered unequivocal evidence for the use of murex-derived purple dyestuff. Furthermore, by comparing the analytical results with those obtained in a series of controlled dyeing experiments we were able to shed more light on the specific species used in the dyeing process and glean insights into the ancient dyeing technology. The samples originated from excavations at the extensive Iron Age copper smelting site of "Slaves' Hill" (Site 34), which is tightly dated by radiocarbon to the late 11th-early 10th centuries BCE. While evidence for the important role of purple dyes in the ancient Mediterranean goes back to the Middle Bronze Age (early 2nd millennium BCE), finds of dyed textiles are extremely rare, and those from Timna are the oldest currently known in the Southern Levant. In conjunction with other observations of the very high quality of the Timna textiles, this provides an exceptional opportunity to address questions related to social stratification and organization of the nomadic society operating the mines (early Edom), the "fashion" of elite in the region during the early Iron Age, trade connections, technological capabilities, and more.	[Sukenik, Naama; Shamir, Orit] Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel; [Iluz, David; Varvak, Alexander] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Iluz, David] Beit Berl Coll, Environm Sci & Agr Dept, Beit Berl, Israel; [Amar, Zohar] Bar Ilan Univ, Martin Szusz Dept Land Israel Studies & Archaeol, Ramat Gan, Israel; [Ben-Yosef, Erez] Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel; [Sukenik, Naama; Shamir, Orit] Beth Shemesh Storage & Res Facil, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh, Israel	Bar Ilan University; Bar Ilan University; Tel Aviv University	Sukenik, N (corresponding author), Israel Antiqu Author, Natl Treasures Dept, Jerusalem, Israel.; Ben-Yosef, E (corresponding author), Tel Aviv Univ, Dept Archaeol & Ancient Near Eastern Cultures, Tel Aviv, Israel.; Sukenik, N (corresponding author), Beth Shemesh Storage & Res Facil, Natl Treasures Dept, Israel Antiqu Author, Beth Shemesh, Israel.	naamasuk@gmail.com; ebenyose@tauex.tau.ac.il			Israel Science Foundation [1143/19, 1880/17]	Israel Science Foundation(Israel Science Foundation)	The research was supported by funding by the Israel Science Foundation (Grant 1143/19; 1880/17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti ME, 2008, **DROPPED REF**, V5, P73; Alfaro GC, 2014, PRODUCTION TRADE TEX, P149; Alfaro Giner C, 2008, PURPUREAE VESTES S I, P195; Alfaro Giner C, 2013, LUXURY DRESS POLITIC, P75, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Amar Z., 2014, ARGAMAN PURPLE PORPH; [Anonymous], 2005, DYE HIST ARCHAEOL; [Anonymous], 2004, COLOURFUL ORIGINS CH; Astour M. C., 1965, J NEAR E STUDIES, V24, P346; Ben-Yosef E., 2018, MONOGRAPH SERIES, V37, P28; Ben-Yosef E, IN PRESS; Ben-Yosef E, CENTRAL TIMNA VALLEY; Ben-Yosef E., 2016, B AM SCH ORIENT RES, V376, P169, DOI [10.5615/bullamerschoorie.376.0169, DOI 10.5615/BULLAMERSCHOORIE.376.0169]; Ben-Yosef E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221967; Ben-Yosef E, 2019, VETUS TESTAMENTUM, V69, P361, DOI 10.1163/15685330-12341370; Ben-Yosef E, 2019, P NATL ACAD SCI USA, V116, P5843, DOI 10.1073/pnas.1901885116; Ben-Yosef E, 2017, J ARCHAEOL SCI-REP, V11, P411, DOI 10.1016/j.jasrep.2016.12.010; Bertman Stephen, 1961, BIBLIC ARCHAEOL, V24, P119; Boesken Kanold I, 2005, DYE HIST ARCHAEOL, V20, P26; Born W., 1937, CIBA REV, V1, P111; Bosch DT, 1995, SEASHELLS E ARABIA; Brunello F., 1973, ART DYEING HIST MANK; Carannante A., 2014, MOLUSCO PU RPURA CON, DOI [DOI 10.1128/AAC.00103-14, 10.1128/AAC.00103-14]; Cardon D, 2011, PURPUREAE VESTES 3 T, P197; Cardon D, 2007, NATURAL DYES SOURCES; CLARK RJH, 1993, ENDEAVOUR, V17, P191, DOI 10.1016/0160-9327(93)90062-8; Cline E. H., 2014, YEAR CIVILIZATION CO; Cooksey CJ, 2001, MOLECULES, V6, P736, DOI 10.3390/60900736; Doumet J., 1890, STUDY ANCIENT PURPLE; Dye TD, 2013, MATERN CHILD HLTH J, V17, P7, DOI 10.1007/s10995-012-1212-7; Elsner O, 1985, P 7 INT WOOL TEXT RE, P118; Gillis C., 2010, TANKEMO FESTSKRIFT E, P84; Gleba M, 2014, PRODUCTION TRADE TEX, P167; Good I, 2001, ANNU REV ANTHROPOL, V30, P209, DOI 10.1146/annurev.anthro.30.1.209; Graves DE., 2017, NEAR E ARCHAEOLOGICA, V62, P3; Holladay JS, 2006, CONFRONTING ARCHAEOL, P309; James MA, 2009, ANTIQUITY, V83, P1109, DOI 10.1017/S0003598X00099397; Jidejian N., 1969, TYRE AGES; Kalaitzaki A, 2017, MEDITERR ARCHAEOL AR, V17, P103, DOI 10.5281/zenodo.160967; Karapanagiotis I, 2019, ARACHNE, V5, P64; Karapanagiotis I, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11133595; Karapanagiotis I, 2013, MICROCHEM J, V110, P70, DOI 10.1016/j.microc.2013.02.008; KARMON N, 1988, ISRAEL EXPLOR J, V38, P184; Karmon N., 1987, ROYAL PURPLE BIBLICA, P147; Kemp B.J., 2001, ANCIENT TEXTILE IND; Kleiman S, 2017, TEL AVIV, V44, P232, DOI 10.1080/03344355.2017.1357313; Koch I, NOMADISM MONARCHY TH; Kolonas L, 2017, P 16 INT AG C U IOAN, P533; Koren Z., 2013, E PRESERV SCI, V10, P27; Koren Z.C., 2008, P NON DESTR INV MICR; Koren ZC, INDIRUBIN RED SHADE; Koren ZC, 2018, OUT BLUE, P87; Koren ZC, 1997, AM I CONSERV TEXT SP, V7, P23; Koren ZC, 1995, DYE HIST ARCHAEOL, V13, P27; Koren ZC, 2008, MICROCHIM ACTA, V162, P381, DOI 10.1007/s00604-007-0862-4; Koren ZC, 2013, ACS SYM SER, V1147, P43; KUBIAK W, 1991, MANAGE SCI, V37, P121, DOI 10.1287/mnsc.37.1.121; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; Levy T.E., 2014, NEW INSIGHTS IRON AG, DOI 10.2307/j.ctvdjrq5c; Levy TE, BIBLE RADIOCARBON DA; MacDonald N., CLOTHING NUDITY HEBR; Mantzouris D, 2014, DYES PIGMENTS, V104, P194, DOI 10.1016/j.dyepig.2014.01.011; Marin-Aguilera B, 2018, J MEDITERR ARCHAEOL, V31, P127, DOI 10.1558/jma.38080; MCGOVERN PE, 1985, ANAL CHEM, V57, P1514, DOI 10.1021/ac00291a002; Meiers F, 2017, TREASURES SEA SEA SI, P138; Michel RH, 1987, ARCHEOMATERIALS, V1, P135; Michel RM., 1992, ARCHEOMATERIALS, V6, P69; MORAN W., 1992, AMARNA LETT; Murphy E, WOOL EC ANCIENT NEAR, V17; PALAIMA Th., 1991, AEGAEUM, V7, P273; Peck AL, 1965, HIST ANIM; Pfister R., 1937, REV ARTS ASIATIQUES, V11, P207; Plinius H., 1963, NATURALIS HIST; Plutarch A., 1959, PLUTARCH LIVES; Pollard MUDO, 2006, UT ESTADOS ANALYTICA, DOI [10.1017/CBO9780511607431, DOI 10.1017/CBO9780511607431]; Quillien L., 2019, VALUE COLOUR MAT EC, P201, DOI [10.12968/prps.2008.1.89.38150, DOI 10.12968/PRPS.2008.1.89.38150]; Ramasamy S, 2003, J MAR BIOL ASSOC IND, V45, P208; Reese D. S., 1987, ANNU BRIT SCH ATHENS, V82, P201, DOI [10.1017/S0068245400020438, DOI 10.1017/S0068245400020438]; Reese DS, 2010, MEDITERR ARCHAEOL AR, V10, P113; Reinhold M., 1970, COLLECT LATOMUS, V116, P1; Ruscillo Deborah, 2005, P99; Rusmore-Villaume M.L., 2008, SEASHELLS EGYPTIAN R; Sagiv G., 2015, CONT JEW, V35, P285, DOI [10.1007/s12397-015-9138-1, DOI 10.1007/S12397-015-9138-1]; Sapir-Hen L., 2018, MINING ANCIENT COPPE, P64; Sapir-Hen L, 2014, ANTIQUITY, V88, P775, DOI 10.1017/S0003598X00050687; Schorie K., 2010, B ARCHEOL LINE, V1, P44; Shamir O., 2019, REV DETHNOE PRIME CO, P0, DOI [10.4000/ethnoecologie.4176, DOI 10.4000/ETHNOECOLOGIE.4176]; Shamir O., TEXTILES TRADE THEOR; Shamir O., 2014, GLOBAL TEXTILE ENCOU; Shamir O, 2013, HOARDS GENIZOT CHAPT, P76; Sheffer A, 1994, MASADA 4, P153; Soriga E., 2017, ANCIENT TEXTILES SER, P79; Sotiropoulou S, 2006, INDIRUBIN, THE RED SHADE OF INDIGO, P71; SPANIER E, 1986, J ARCHAEOL SCI, V13, P463, DOI 10.1016/0305-4403(86)90015-4; Spanier E., 1987, ROYAL PURPLE BIBLICA, P179; STIEGLITZ RR, 1994, BIBLIC ARCHAEOL, V57, P46, DOI 10.2307/3210395; Strand EA, 2010, EUR J ARCHAEOL, V13, P149, DOI 10.1177/1461957110365513; Sukenik N, 2017, ARCHAEOMETRY, V59, P775, DOI 10.1111/arcm.12290; Sukenik N., 2019, GLASS WAX METAL LIGH, P203, DOI [10.2307/j.ctvndv5k4, DOI 10.2307/J.CTVNDV5K4]; Sukenik N., 2013, THESIS BAR LLAN U; Sukenik N, 2016, ANCIENT TEXTILES DYE, P263; Sukenik N., 2018, OUT BLUE, P100; Sukenik N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179014; Sukenik N, 2015, J ARCHAEOL SCI-REP, V3, P565, DOI 10.1016/j.jasrep.2015.08.003; Susmann N., 2015, ARCHAEOLOGICAL TEXTI, V59, P89; Taylor GW, 1986, REV PROG COLOR RELAT, V16, P53, DOI [DOI 10.1111/J.1478-4408.1986.TB03744.X, 10.1111/j.1478-4408.1986.tb03744.x]; Thavapalan S., 2016, J ANCIENT NEAR E HIS, V3, P163, DOI [10.1515/janeh-2017-0007, DOI 10.1515/JANEH-2017-0007]; Thomason A, 2019, CLOTHING NUDITY HEBR, P87; Vajanto K, 2014, FENNOSCANDIA ARCHAEO, VXXXI, P61; Vasileiadou A, 2016, J CHROMATOGR A, V1448, P67, DOI 10.1016/j.chroma.2016.04.046; Ventris MG., 1973, DOCUMENTS MYCEAEAN G; Verhecken A., 2007, METHODS DATING ANCIE, P206; Vitruvius F., 1931, ARCHITECTURE; Wang W., 2018, MILITARY MED RES, V121, DOI [DOI 10.1016/S1473-3099(20)30134-1, DOI 10.1186/S40779-020-0233-6]; Workman VA, 2016, THESIS TEL AVIV U; WOUTERS J, 1991, J SOC DYERS COLOUR, V107, P266; Wouters J., 1991, DYE HIST ARCH 10 ANN, P17; Yadin Y, 1963, IEJ; Ziderman I., 1990, BIBLIC ARCHAEOL, V53, P98; Ziderman I. I., 2008, DYES HIST ARCHAEOLOG, V21, P36; Ziderman II, 2001, DYE HIST ARCHAEOL, V16, P87	120	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245897	10.1371/journal.pone.0245897	http://dx.doi.org/10.1371/journal.pone.0245897			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33507987	Green Published, gold			2022-12-26	WOS:000635021400061
J	Das, MK; Arora, NK; Gaikwad, H; Chellani, H; Debata, P; Rasaily, R; Meena, KR; Kaur, G; Malik, P; Joshi, S; Kumari, M				Das, Manoja Kumar; Arora, Narendra Kumar; Gaikwad, Harsha; Chellani, Harish; Debata, Pradeep; Rasaily, Reeta; Meena, K. R.; Kaur, Gurkirat; Malik, Prikanksha; Joshi, Shipra; Kumari, Mahisha			Grief reaction and psychosocial impacts of child death and stillbirth on bereaved North Indian parents: A qualitative study	PLOS ONE			English	Article								Background Grief following stillbirth and child death are one of the most traumatic experience for parents with psychosomatic, social and economic impacts. The grief profile, severity and its impacts in Indian context are not well documented. This study documented the grief and coping experiences of the Indian parents following stillbirth and child death. Methods This exploratory qualitative study in Delhi (India) included in-depth interviews with parents (50 mothers and 49 fathers), who had stillbirth or child death, their family members (n = 41) and community representatives (n = 12). Eight focus group discussions were done with community members (n = 72). Inductive data analysis included thematic content analysis. Perinatal Grief Scale was used to document the mother's grief severity after 6-9 months of loss. Results The four themes emerged were grief anticipation and expression, impact of the bereavement, coping mechanism, and sociocultural norms and practices. The parents suffered from disbelief, severe pain and helplessness. Mothers expressed severe grief openly and some fainted. Fathers also had severe grief, but didn't express openly. Some parents shared self-guilt and blamed the hospital/healthcare providers, themselves or family. Majority had no/positive change in couple relationship, but few faced marital disharmony. Majority experienced sleep, eating and psychological disturbances for several weeks. Mothers coped through engaging in household work, caring other child(ren) and spiritual activities. Fathers coped through avoiding discussion and work and professional engagement. Fathers resumed work after 5-20 days and mothers took 2-6 weeks to resume household chores. Unanticipated loss, limited family support and financial strain affected the severity and duration of grief. 57.5% of all mothers and 80% mothers with stillbirth had severe grief after 6-9 months. Conclusions Stillbirth and child death have lasting psychosomatic, social and economic impacts on parents, which are usually ignored. Sociocultural and religion appropriate bereavement support for the parents are needed to reduce the impacts.	[Das, Manoja Kumar; Arora, Narendra Kumar; Kaur, Gurkirat; Malik, Prikanksha; Joshi, Shipra; Kumari, Mahisha] INCLEN Trust Int, New Delhi, India; [Gaikwad, Harsha] Safdarjung Hosp & Vardhman Mahavir Med Coll, Dept Obstet & Gynaecol, New Delhi, India; [Chellani, Harish; Debata, Pradeep; Meena, K. R.] Safdarjung Hosp & Vardhman Mahavir Med Coll, Dept Pediat, New Delhi, India; [Rasaily, Reeta] Indian Council Med Res, Div Div Reprod Biol Maternal & Child Hlth, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; Indian Council of Medical Research (ICMR)	Das, MK (corresponding author), INCLEN Trust Int, New Delhi, India.	manoj@inclentrust.org	Das, Manoja/I-2558-2017	Das, Manoja/0000-0002-8559-5837	Bill and Melinda Gates Foundation [OPP1184205]; Indian Council of Medical Research [5/7/1504/2016-CH]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This study is funded to The INCLEN Trust International by Bill and Melinda Gates Foundation (OPP1184205) through Indian Council of Medical Research (no 5/7/1504/2016-CH). The funders had no role in study planning, conduct, analysis and manuscript preparation.	Aho Anna Liisa, 2006, Issues Ment Health Nurs, V27, P647, DOI 10.1080/01612840600643008; Aho AL, 2009, AM J MENS HEALTH, V3, P93, DOI 10.1177/1557988307302094; Alam R, 2012, DEATH STUD, V36, P1, DOI 10.1080/07481187.2011.553312; Altijani N, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022583; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Boyle FM, 1996, SOC SCI MED, V43, P1273, DOI 10.1016/0277-9536(96)00039-1; Burden C, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0800-8; Camacho-Avila M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2666-z; Charmaz K, 2008, HDB CONSTRUCTIONIST, V1, P397, DOI DOI 10.1016/J.DESTUD.2004.08.003; Christ GH, 2003, BEREAVEMENT EXPERIEN, P553; Cowles KV, 1996, J ADV NURS, V23, P287, DOI 10.1111/j.1365-2648.1996.tb02669.x; Das MK, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05693-6; Das MK, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0665-1; Downe S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002237; DYREGROV A, 1987, SCAND J PSYCHOL, V28, P16, DOI 10.1111/j.1467-9450.1987.tb00901.x; Goldstein RD, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3651; Gopichandran V, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1742-0; HARMON RJ, 1984, J AM ACAD CHILD PSY, V23, P68, DOI 10.1097/00004583-198401000-00009; Harper M, 2014, PSYCHOL HEALTH MED, V19, P247, DOI 10.1080/13548506.2013.811274; Huberty J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0391-1; Janssen HJEM, 1997, ARCH GEN PSYCHIAT, V54, P56; Kersting Anette, 2012, Dialogues Clin Neurosci, V14, P187; Kersting A, 2011, J AFFECT DISORDERS, V131, P339, DOI 10.1016/j.jad.2010.11.032; Lang A, 2011, OMEGA-J DEATH DYING, V63, P183, DOI 10.2190/OM.63.2.e; Laungani P, 1995, BEREAVE CARE, V14, P5; Leon IG, 2009, GLOB LIB WOMENS MED; Liu L, 2019, LANCET GLOB HEALTH, V7, pE721, DOI 10.1016/S2214-109X(19)30080-4; Marwah S, 2019, J OBSTET GYN INDIA, V69, P232, DOI 10.1007/s13224-018-1173-x; Mehta L, 1990, Indian J Pediatr, V57, P607, DOI 10.1007/BF02728696; Meyer AC, 2018, OMEGA-J DEATH DYING, V77, P267, DOI 10.1177/0030222816629165; Michon Bruno, 2003, Paediatr Child Health, V8, P363; Milic J, 2017, J AGING HEALTH, V29, P1288, DOI 10.1177/0898264317720715; Nuzum D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191635; POTVIN L, 1989, J PSYCHOPATHOL BEHAV, V11, P29, DOI 10.1007/BF00962697; Prigerson HG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000121; Roberts L, 2016, INTERDISCIP J BEST P, V2; Roberts LR, 2015, ISSUES MENT HEALTH N, V36, P222, DOI 10.3109/01612840.2014.962676; Roberts LR, 2012, INT J CHILDBIRTH, V2, P187, DOI 10.1891/2156-5287.2.3.187; Roberts LR, 2014, HEALTH CARE WOMEN IN, V35, P285, DOI 10.1080/07399332.2013.801483; Ryninks K, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-203; Stroebe M, 2013, PSYCHOL SCI, V24, P395, DOI 10.1177/0956797612457383; Toedter LJ, 2001, DEATH STUD, V25, P205, DOI 10.1080/074811801750073251; United Nations Inter-agency Group for Child Mortality Estimation, 2019, UN LEVELS TRENDS CHI; Vance JC, 1995, BRIT J PSYCHIAT, V167, P806, DOI 10.1192/bjp.167.6.806; Wood JD, 2001, DEATH STUD, V25, P635, DOI 10.1080/713769895; Youngblut JM, 2017, J LOSS TRAUMA, V22, P77, DOI 10.1080/15325024.2016.1187049	46	8	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0240270	10.1371/journal.pone.0240270	http://dx.doi.org/10.1371/journal.pone.0240270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503017	gold, Green Published			2022-12-26	WOS:000613751800006
J	Rodriguez-Cruz, LA; Niles, MT				Rodriguez-Cruz, Luis Alexis; Niles, Meredith T.			Awareness of climate change's impacts and motivation to adapt are not enough to drive action: A look of Puerto Rican farmers after Hurricane Maria	PLOS ONE			English	Article								Understanding how perceptions around motivation, capacity, and climate change's impacts relate to the adoption of adaptation practices in light of experiences with extreme weather events is important in assessing farmers' adaptive capacity. However, very little of this work has occurred in islands, which may have different vulnerabilities and capacities for adaptation. Data of surveyed farmers throughout Puerto Rico after Hurricane Maria (n = 405, 87% response rate) were used in a structural equation model to explore the extent to which their adoption of agricultural practices and management strategies was driven by perceptions of motivation, vulnerability, and capacity as a function of their psychological distance of climate change. Our results show that half of farmers did not adopt any practice or strategy, even though the majority perceived themselves capable and motivated to adapt to climate change, and understood their farms to be vulnerable to future extreme events. Furthermore, adoption was neither linked to these adaptation perceptions, nor to their psychological distance of climate change, which we found to be both near and far. Puerto Rican farmers' showed a broad awareness of climate change's impacts both locally and globally in different dimensions (temporal, spatial, and social), and climate distance was not linked to reported damages from Hurricane Maria or to previous extreme weather events. These results suggest that we may be reaching a tipping point for extreme events as a driver for climate belief and action, especially in places where there is a high level of climate change awareness and continued experience of compounded impacts. Further, high perceived capacity and motivation are not linked to actual adaptation behaviors, suggesting that broadening adaptation analyses beyond individual perceptions and capacities as drivers of climate adaptation may give us a better understanding of the determinants to strengthen farmers' adaptive capacity.	[Rodriguez-Cruz, Luis Alexis; Niles, Meredith T.] Univ Vermont, Food Syst Grad Program, Burlington, VT 05405 USA; [Rodriguez-Cruz, Luis Alexis; Niles, Meredith T.] Univ Vermont, Gund Inst Environm, Burlington, VT 05405 USA; [Niles, Meredith T.] Univ Vermont, Dept Nutr & Food Sci, Burlington, VT USA	University of Vermont; University of Vermont; University of Vermont	Rodriguez-Cruz, LA (corresponding author), Univ Vermont, Food Syst Grad Program, Burlington, VT 05405 USA.; Rodriguez-Cruz, LA (corresponding author), Univ Vermont, Gund Inst Environm, Burlington, VT 05405 USA.	lrodrig2@uvm.edu		Rodriguez-Cruz, Luis Alexis/0000-0002-2229-8448; Niles, Meredith/0000-0002-8323-1351	College of Agriculture and Life Science; Food Systems Graduate Program of the University of Vermont	College of Agriculture and Life Science; Food Systems Graduate Program of the University of Vermont	MTN allocated funding from this study, which came from the College of Agriculture and Life Science and the Food Systems Graduate Program of the University of Vermont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharibasam JW, 2018, CLIM RISK MANAG, V21, P16, DOI 10.1016/j.crm.2018.04.002; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Adger WN, 2005, CR GEOSCI, V337, P399, DOI 10.1016/j.crte.2004.11.004; Adger WN, 2003, ECON GEOGR, V79, P387; Albright EA, 2019, CLIMATIC CHANGE, V155, P1, DOI 10.1007/s10584-019-02461-2; Alvarez-Berrios NL, 2018, RENEW AGR FOOD SYST, V33, P279, DOI 10.1017/S174217051800011X; [Anonymous], NEW YORK TIMES; Bagagnan AR, 2019, CLIMATE, V7, DOI 10.3390/cli7010013; Bang N.B., 2019, AM J CLIM CHANG, V8, P454, DOI [10.4236/ajcc.2019.84025, DOI 10.4236/AJCC.2019.84025]; Borges-Mendez Ramon., 2019, J EXTREME EVENTS, V6, DOI [10.1142/S2345737619400013, DOI 10.1142/S2345737619400013]; Brooks N., 2005, ADAPTATION POLICY FR, P165; Brugger A, 2020, GLOBAL ENVIRON CHANG, V60, DOI 10.1016/j.gloenvcha.2019.102023; Brugger A, 2016, J ENVIRON PSYCHOL, V46, P125, DOI 10.1016/j.jenvp.2016.04.004; Bueno R., 2008, The Caribbean and climate change: the costs of inaction; Bueno R., 2017, CLIMATE POLICY BRIEF; Campbell D, 2011, APPL GEOGR, V31, P146, DOI 10.1016/j.apgeog.2010.03.007; Carro-Figueroa V., 2002, CARIBBEAN STUD, V30, P77; Chatrchyan AM, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.469; Comas-Pagan M., 2014, Plan de sguridad alimentaria, P40; Debela N, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1012-9; Demuth JL, 2018, RISK ANAL, V38, P1921, DOI 10.1111/risa.12983; Demuth JL, 2016, WEATHER CLIM SOC, V8, P327, DOI 10.1175/WCAS-D-15-0074.1; Departamento de Recursos Naturales de Puerto Rico, 2018, ESTUDIO PERCEPCIO PR, P95; DiazRolon A., 2019, VOCERO PUERTO RICO; FAO, 2014, POLICY PAPER, P16; Felix G.F., 2017, FOOD 1 BACKGROUNDERS, V23, P1; Fernandez M, 2019, AGROECOL SUST FOOD, V43, P579, DOI 10.1080/21683565.2018.1530326; Forero Emma Lucía, 2014, rev.udcaactual.divulg.cient., V17, P73; Gallup Inc, 2020, WORLD RISK POLL REVE; Gardezi M, 2020, ENVIRON BEHAV, V52, P82, DOI 10.1177/0013916518793482; Gebrehiwot T, 2015, ENVIRON MANAGE, V55, P588, DOI 10.1007/s00267-014-0415-7; Grothmann T, 2005, GLOBAL ENVIRON CHANG, V15, P199, DOI 10.1016/j.gloenvcha.2005.01.002; Haden V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052882; Harvey C. A., 2018, Agriculture & Food Security, V7, P57, DOI 10.1186/s40066-018-0209-x; Holt-Gimenez E, 2002, AGR ECOSYST ENVIRON, V93, P87, DOI 10.1016/S0167-8809(02)00006-3; Iacobucci D, 2009, J CONSUM PSYCHOL, V19, P673, DOI 10.1016/j.jcps.2009.09.002; Irizarry-Ruiz C., 2016, RETOS QUE CONLLEVA R; Jones C, 2017, RISK ANAL, V37, P331, DOI 10.1111/risa.12601; Lai KK, 2018, STRUCT EQU MODELING, V25, P600, DOI 10.1080/10705511.2017.1392248; Larcom S, 2019, NAT CLIM CHANGE, V9, P370, DOI 10.1038/s41558-019-0460-6; Lee TM, 2015, NAT CLIM CHANGE, V5, P1014, DOI 10.1038/NCLIMATE2728; Leiserowitz A., 2020, CLIMATE CHANGE AM MI; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Lopez-Marrero T., 2012, CARIBBEAN STUD, V40, P129, DOI [DOI 10.1353/CRB.2012.0034, 10.1353/crb.2012.0034]; Lopez-Marrero T, 2019, NATURAL HAZARDS INTE, DOI [10.1007/s11069-019-03584-6, DOI 10.1007/S11069-019-03584-6]; Lopez-Marrero T, ACTIVIDAD CICLONICA, DOI [10. 1107/S1600577518007166, DOI 10.1107/S1600577518007166]; Lopez-Marrero T, 2010, GEOGR J, V176, P150, DOI 10.1111/j.1475-4959.2010.00353.x; Lowitt K, 2015, REG ENVIRON CHANGE, V15, P1367, DOI 10.1007/s10113-015-0805-2; McDonald RI, 2015, J ENVIRON PSYCHOL, V44, P109, DOI 10.1016/j.jenvp.2015.10.003; Rosset PM, 2011, J PEASANT STUD, V38, P161, DOI 10.1080/03066150.2010.538584; Moulton A. A., 2019, J EXTREME EVENTS, V6; Niles MT, 2016, GLOBAL ENVIRON CHANG, V39, P133, DOI 10.1016/j.gloenvcha.2016.05.002; Niles MT, 2016, CLIMATIC CHANGE, V135, P277, DOI 10.1007/s10584-015-1558-0; Niles MT, 2015, AGR ECOSYST ENVIRON, V200, P178, DOI 10.1016/j.agee.2014.11.010; Nunnally J., 1978, PSYCHOMETRIC THEORY; Perfecto I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51416-1; Prokopy LS, 2019, J SOIL WATER CONSERV, V74, P520, DOI 10.2489/jswc.74.5.520; Prokopy LS, 2015, ENVIRON MANAGE, V56, P492, DOI 10.1007/s00267-015-0504-2; Ranjan P, 2019, SOC NATUR RESOUR, V32, P1171, DOI 10.1080/08941920.2019.1648710; Ray A, 2017, GLOBAL ENVIRON CHANG, V46, P104, DOI 10.1016/j.gloenvcha.2017.07.002; Ribot J, 2014, J PEASANT STUD, V41, P667, DOI 10.1080/03066150.2014.894911; Saint Ville AS, 2017, INSTITUTIONAL ANAL F, DOI [10.1016/j.jrurstud.2017.03.004, DOI 10.1016/J.JRURSTUD.2017.03.004]; Santos-Burgoa C, 2018, ACERTAINMENT ESTIMAT; Scandurra G, 2018, ECOL INDIC, V84, P382, DOI 10.1016/j.ecolind.2017.09.016; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Shinbrot XA, 2019, ENVIRON MANAGE, V63, P583, DOI 10.1007/s00267-019-01152-z; Singh AS, 2017, ENVIRON SCI POLICY, V73, P93, DOI 10.1016/j.envsci.2017.04.011; Smit B, 2006, GLOBAL ENVIRON CHANG, V16, P282, DOI 10.1016/j.gloenvcha.2006.03.008; Spence A, 2011, NAT CLIM CHANGE, V1, P46, DOI [10.1038/NCLIMATE1059, 10.1038/nclimate1059]; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Stancioff CE, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9120459; Steele, 2015, CARIBBEAN REGIONAL C, P67; Tang JW, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10114186; Luu TA, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11102993; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; USDA NASS, 2020, 2017 CENS AGR PUERT 2017 CENS AGR PUERT, P117; USDA NASS, 2020, USDA RELEASES 2018 P; van Valkengoed AM, 2019, NAT CLIM CHANGE, V9, P158, DOI 10.1038/s41558-018-0371-y; Viguera B, 2019, AGRON MESOAM, V30; Viguera B, 2019, AGRON MESOAM, V1, P333; Waldman KB, 2019, CLIMATIC CHANGE, V156, P527, DOI 10.1007/s10584-019-02498-3; Weis T, 2007, RACE CLASS, V49, P112, DOI 10.1177/03063968070490020607; Wilson RS, 2020, NAT CLIM CHANGE, V10, P200, DOI 10.1038/s41558-020-0691-6; Wisner B., 2004, AT RISK; Wisner B., 2012, HDB HAZARDS DISASTER; Zanocco C, 2018, CLIMATIC CHANGE, V149, P349, DOI 10.1007/s10584-018-2251-x	86	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0244512	10.1371/journal.pone.0244512	http://dx.doi.org/10.1371/journal.pone.0244512			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503036	gold, Green Published			2022-12-26	WOS:000613751800005
J	Tsega, G; Getaneh, G; Taddesse, G				Tsega, Gebeyehu; Getaneh, Gebremariam; Taddesse, Getasew			Are Ethiopian diabetic patients protected from financial hardship?	PLOS ONE			English	Article								Background Globally, diabetes mellitus exerts an economic burden on patients and their families. However, the economic burden of diabetes mellitus and its associated factors were not well studied in Ethiopia. Therefore, the aim of this study is to assess the economic burden of diabetes mellitus and its associated factors among diabetic patients in public hospitals of Bahir Dar city administration, Ethiopia. Methods Across sectional study was conducted on 422 diabetic patients. The patients were selected by simple random sampling method. The prevalence-based model was used to estimate the costs on patients' perspective. Bottom up and human capital approaches were used to estimate the direct and indirect costs of the patients respectively. Wealth index was constructed using principal component analysis by SPSS. Forty percent of nonfood threshold level was used to measure catastrophic diabetic care expenditure of diabetic patients. Whereas, the World Bank poverty line (the $1.90-a-day poverty line) was used to measure impoverishment of patients due to expenses of diabetes mellitus care. Data were entered by Epi data version 3.1and exported to SPSS version 23 for analysis. Simple and multiple logistic regressions were used. Results Four hundred one respondents were interviewed with response rate of 95%. We found that 239 (59.6%) diabetic patients incurred catastrophic diabetic care expenditure at 40% non-food threshold level. Whereas, 20 (5%) diabetic patients were impoverished by diabetic care spending at the $1.90-a-day poverty line. Educational status of respondent, educational status of the head of household, occupation and wealth status were statistically associated with the catastrophic diabetic care expenditure. Conclusions The study revealed that the economic burden of diabetic care is very disastrous among the less privileged populations: the less educated, the poorest and unemployed. Therefore, all concerned stakeholders should design ways that can reduce the financial hardship of diabetic care among diabetic patients.	[Tsega, Gebeyehu; Getaneh, Gebremariam; Taddesse, Getasew] Bahir Dar Univ, Sch Publ Hlth, Dept Hlth Syst Management & Hlth Econ, Bahir Dar, Ethiopia	Bahir Dar University	Tsega, G (corresponding author), Bahir Dar Univ, Sch Publ Hlth, Dept Hlth Syst Management & Hlth Econ, Bahir Dar, Ethiopia.	gebishts@gmail.com			Felegehiwot Hospital; AdisAlem Hospital	Felegehiwot Hospital; AdisAlem Hospital	We would like to thank Bahir Dar University, study participants, data collectors and supervisors for their contributions for the study. We also thank Felegehiwot and AdisAlem Hospitals for their support during the process of the study.	Adhikari SR, 2009, HEALTH POLICY PLANN, V24, P129, DOI 10.1093/heapol/czn052; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alemu A., 2019, INT J HIGH ENERGY PH, V4, P29, DOI [10.11648/j.hep.20190401.14, DOI 10.11648/J.HEP.20190401.14]; Assembly G, 2015, SUSTAINABLE DEV GOAL, P2030; Babikir A, 2018, J EC FINANCIAL SCI, V11, P1; Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962; Byford S, 2000, BRIT MED J, V320, P1335, DOI 10.1136/bmj.320.7245.1335; Chatterjee S, 2011, HEALTH SOC CARE COMM, V19, P289, DOI 10.1111/j.1365-2524.2010.00981.x; Dagnaw W, ETHIOPIAN NATL GUIDE; Federal Democratic Republic of Ethiopia Ministry of Health, 2019, ETHIOPIA HLTH ACCOUN; Fedration I, 2017, IDF DIABETES ATLAS 8, V8, P1; FMoH E, 2015, HSTP 2015 16 2019 20; Hailemichael Y, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7239-6; Jha R., 2004, INT J DIABETES DEV C, V24, P29; Jing ZY, 2019, J DIABETES INVEST, V10, P283, DOI 10.1111/jdi.12901; Kimani DN, 2016, EUROPEAN SCI J, V12; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Li HF, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/9626413; Mutyambizi C, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-0977-3; Mutyambizi C, 2018, GLOBALIZATION HEALTH, V14, DOI 10.1186/s12992-017-0318-5; Mwai D, 2016, EPIDEMIOL BIOSTAT PU, V13, DOI 10.2427/11519; Ng CS, 2014, DIABETES RES CLIN PR, V105, P151, DOI 10.1016/j.diabres.2014.03.020; Okoronkwo Ijeoma L, 2015, BMC Res Notes, V8, P527, DOI 10.1186/s13104-015-1489-x; Onyiriuka N, 2012, J I MED, V34, P2; Quaye Ernest Attuquaye, 2015, Value Health Reg Issues, V7, P49, DOI 10.1016/j.vhri.2015.08.005; Saksena P, 2009, TECHNICAL BRIEFS POL, V1; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Sombol I., 2017, CATASTROPHIC HLTH EX; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organization, 2019, PRIMARY HLTH CARE RO; World Health Organization, GLOBAL MONITORING RE; World Health Organization, 2017, TRACKING UNIVERSAL H; World Health Organization, 2014, WHO AFRICAN REGION E	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245839	10.1371/journal.pone.0245839	http://dx.doi.org/10.1371/journal.pone.0245839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503048	gold, Green Published			2022-12-26	WOS:000613751800013
J	Espinosa-Tamez, P; Lajous, M; Cantu-Brito, C; Lopez-Ridaura, R; Monge, A; Yunes, E; Rodriguez, BL; Espinosa, L; Sifuentes-Osornio, J; Catzin-Kuhlmann, A				Espinosa-Tamez, Priscilla; Lajous, Martin; Cantu-Brito, Carlos; Lopez-Ridaura, Ruy; Monge, Adriana; Yunes, Elsa; Rodriguez, Beatriz L.; Espinosa, Luis; Sifuentes-Osornio, Jose; Catzin-Kuhlmann, Andres			Association of recurrent common infections and subclinical cardiovascular disease in Mexican women	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; ACUTE MYOCARDIAL-INFARCTION; CYTOMEGALOVIRUS-INFECTION; CAROTID ATHEROSCLEROSIS; RISK-FACTOR; BURDEN; INFLUENZA; STROKE; PLAQUE; TUBERCULOSIS	Background Acute and agent-specific chronic infections have been associated with increased cardiovascular risk, however data on the burden of common recurrent infections on cardiovascular disease is limited. We hypothesized women with greater exposure to uncomplicated common infectious events had an increased risk of subclinical cardiovascular disease (sCVD). Methods In a cross-sectional study, we assessed the relation of recurrent infections and carotid artery intima-media thickness (IMT) in 1946 disease-free women from the Mexican Teachers' Cohort. Through 2012-2016, participants answered structured questions on respiratory, urinary and vaginal infections during the previous year and their IMT was measured using ultrasound by standardized neurologists. We defined sCVD as mean right and left IMT >= 0.8 mm or the presence of atheromatous plaque. Multivariable linear and logistic regression analyses were used to evaluate the association of infectious events with IMT and sCVD adjusting for age, sociodemographic, and cardiovascular risk factors. Results Among participants (50 +/- 5 years) 13% reported no infections, 20% one infection and 67% three or more episodes. Overall prevalence of sCVD was 12%(n = 240). Adjusted models for logistic regression showed that women with 2 or more infections had 91% higher odds of sCVD (OR 1.91; 95%CI 1.16, 3.13) compared to women without infections (p-trend:0.015). Sub-analyses by type of infection resulted not significant. Linear regression analysis did not show a significant association between mean IMT and recurrent infections. Conclusions Recurrent infectious events in young adult women are associated with greater sCVD, which supports the hypothesis of low-grade chronic inflammation in the pathophysiology of cardiovascular disease.	[Espinosa-Tamez, Priscilla; Lajous, Martin; Lopez-Ridaura, Ruy; Monge, Adriana; Yunes, Elsa] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Mexico City, DF, Mexico; [Lajous, Martin] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Cantu-Brito, Carlos] Natl Inst Med Sci & Nutr Salvador Zubiran, Div Neurol & Psychiat, Mexico City, DF, Mexico; [Cantu-Brito, Carlos; Monge, Adriana; Espinosa, Luis; Catzin-Kuhlmann, Andres] Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico; [Rodriguez, Beatriz L.] Univ Hawaii, Dept Geriatr Med, Honolulu, HI 96822 USA; [Sifuentes-Osornio, Jose; Catzin-Kuhlmann, Andres] Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Harvard University; Harvard T.H. Chan School of Public Health; Tecnologico de Monterrey; University of Hawaii System	Catzin-Kuhlmann, A (corresponding author), Tecnol Monterrey, Escuela Med & Ciencias Salud, Monterrey, Nuevo Leon, Mexico.; Catzin-Kuhlmann, A (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico.	acatzink@post.harvard.edu		Monge, Adriana/0000-0001-6997-1719; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Cantu-Brito, Carlos/0000-0001-7494-2015; Espinosa-Tamez, Priscilla/0000-0001-9741-2404; Catzin-Kuhlmann, Andres/0000-0002-6021-9763	AstraZeneca [ISSNPCV0022]; National Council of Science and Technology's Fund for Health Research and Social Security [CONACYT-SALUD 161786]	AstraZeneca(AstraZeneca); National Council of Science and Technology's Fund for Health Research and Social Security	This work was supported by an unrestricted investigator-initiated grant from AstraZeneca (ISSNPCV0022); https://www.astrazeneca.com/country-sites/mexico.html and by the National Council of Science and Technology's Fund for Health Research and Social Security (CONACYT-SALUD 161786); https://www.conacyt.gob.mx/index.php/el-conacyt/desarrollo-cientifico/redes-tematicas-conacyt/directorio-de-redestematicas-conacyt/category/salud.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1756, REV MONTHLY REV LIT, V15, P655; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2005, CHINA ANIMAL HUSBAND, V32, P29; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2013, BMC MED, V11, P117, DOI [10.1186/1741-7015-11-117, DOI 10.1186/1741-7015-11-117]; [Anonymous], 2016, THE TOTAL AUDIENCE R; Auer Johann, 2002, Heart Dis, V4, P349, DOI 10.1097/00132580-200211000-00003; Barnes M, 2015, HEART, V101, P1738, DOI 10.1136/heartjnl-2015-307691; Bea JW, 2018, OBESITY, V26, P1594, DOI 10.1002/oby.22265; Boehme AK, 2018, ANN CLIN TRANSL NEUR, V5, P456, DOI 10.1002/acn3.545; British Thoracic Society & Scottish Intercollegiate Guidelines Network, 2014, THORAX, V69, pS1; Cassone A, 2007, INFECT IMMUN, V75, P4675, DOI 10.1128/IAI.00083-07; Elkind MSV, 2020, STROKE, V51, P3156, DOI 10.1161/STROKEAHA.120.030429; Elkind MSV, 2010, STROKE, V41, pE117, DOI 10.1161/STROKEAHA.109.571299; Elkind MSV, 2010, ARCH NEUROL-CHICAGO, V67, P33, DOI 10.1001/archneurol.2009.271; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25; Expert Panel, 2000, BIOL THERAPIES DENTI, V16, P17; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Fidel Jr PL, 2002, MED MYCOL; Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Guglietta A, 2017, FUTURE MICROBIOL, V12, P239, DOI 10.2217/fmb-2016-0145; Hemmat N, 2018, EUR J CLIN MICROBIOL, V37, P2225, DOI 10.1007/s10096-018-3370-z; Hsich E, 2001, ATHEROSCLEROSIS, V156, P23, DOI 10.1016/S0021-9150(00)00608-0; Huaman MA, 2018, CLIN INFECT DIS, V66, P886, DOI 10.1093/cid/cix910; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Ji YN, 2012, MOL BIOL REP, V39, P6537, DOI 10.1007/s11033-012-1482-6; Kearns A, 2017, J AM COLL CARDIOL, V69, P3084, DOI 10.1016/j.jacc.2017.05.012; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Lajous M, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv123; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; Mills BB, 2017, OBSTET GYN CLIN N AM, V44, P159, DOI 10.1016/j.ogc.2017.02.010; Mohammad MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236866; Monge A, 2016, J NUTR, V146, P1365, DOI 10.3945/jn.115.227264; Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137; Nagel MA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0534-4; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Nikitskaya E, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003759; Passioti M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0413-5; Pedicino D, 2013, INT J CARDIOL, V166, P572, DOI 10.1016/j.ijcard.2012.05.098; Petta S, 2012, HEPATOLOGY, V55, P1317, DOI 10.1002/hep.25508; Prasad A, 2002, CIRCULATION, V106, P184, DOI 10.1161/01.CIR.0000021125.83697.21; Roivainen M, 2000, CIRCULATION; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Sheu JJ, 2010, STROKE, V41, P244, DOI 10.1161/STROKEAHA.109.567735; Shi Y, 2002, PATHOL INT, V52, P31, DOI 10.1046/j.1440-1827.2002.01312.x; Smeeth L, 2004, N ENGL J MED; Smeeth L, 2007, EUR HEART J, V28, P1178, DOI 10.1093/eurheartj/ehm073; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Tufano A, 2012, SEMIN THROMB HEMOST, V38, P515, DOI 10.1055/s-0032-1315759; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Wang HT, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.04.009; Warren-Gash C, 2009, LANCET INFECT DIS, V9, P601, DOI 10.1016/S1473-3099(09)70233-6; Zhu JH, 2000, J INFECT DIS, V182, P1583, DOI 10.1086/317613; Zhu JH, 2000, AM J CARDIOL, V85, P140, DOI 10.1016/S0002-9149(99)00653-0	60	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246047	10.1371/journal.pone.0246047	http://dx.doi.org/10.1371/journal.pone.0246047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497395	gold, Green Published			2022-12-26	WOS:000613707100030
J	Sanda, GM; Stancu, CS; Deleanu, M; Toma, L; Niculescu, LS; Sima, AV				Sanda, Gabriela M.; Stancu, Camelia S.; Deleanu, Mariana; Toma, Laura; Niculescu, Loredan S.; Sima, Anca V.			Aggregated LDL turn human macrophages into foam cells and induce mitochondrial dysfunction without triggering oxidative or endoplasmic reticulum stress	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; SMOOTH-MUSCLE-CELLS; LOW-DENSITY-LIPOPROTEIN; GLYCATED LDL; EXPRESSION; ACCUMULATION; RETENTION	Uptake of modified lipoproteins by macrophages turns them into foam cells, the hallmark of the atherosclerotic plaque. The initiation and progression of atherosclerosis have been associated with mitochondrial dysfunction. It is known that aggregated low-density lipoproteins (agLDL) induce massive cholesterol accumulation in macrophages in contrast with native LDL (nLDL) and oxidized LDL (oxLDL). In the present study we aimed to assess the effect of agLDL on the mitochondria and ER function in macrophage-derived foam cells, in an attempt to estimate the potential of these cells, known constituents of early fatty streaks, to generate atheroma in the absence of oxidative stress. Results show that agLDL induce excessive accumulation of free (FC) and esterified cholesterol in THP-1 macrophages and determine mitochondrial dysfunction expressed as decreased mitochondrial membrane potential and diminished intracellular ATP levels, without generating mitochondrial reactive oxygen species (ROS) production. AgLDL did not stimulate intracellular ROS (superoxide anion or hydrogen peroxide) production, and did not trigger endoplasmic reticulum stress (ERS) or apoptosis. In contrast to agLDL, oxLDL did not modify FC levels, but stimulated the accumulation of 7-ketocholesterol in the cells, generating oxidative stress which is associated with an increased mitochondrial dysfunction, ERS and apoptosis. Taken together, our results reveal that agLDL induce foam cells formation and mild mitochondrial dysfunction in human macrophages without triggering oxidative or ERS. These data could partially explain the early formation of fatty streaks in the intima of human arteries by interaction of monocyte-derived macrophages with non-oxidatively aggregated LDL generating foam cells, which cannot evolve into atherosclerotic plaques in the absence of the oxidative stress.	[Sanda, Gabriela M.; Stancu, Camelia S.; Deleanu, Mariana; Toma, Laura; Niculescu, Loredan S.; Sima, Anca V.] Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Lipid Dept, Bucharest, Romania; [Deleanu, Mariana] Univ Agron Sci & Vet Med, Fac Biotechnol, Bucharest, Romania	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; University of Agronomic Science & Veterinary Medicine - Bucharest	Sima, AV (corresponding author), Romanian Acad, Inst Cellular Biol & Pathol Nicolae Simionescu, Lipid Dept, Bucharest, Romania.	anca.sima@icbp.ro	Sanda, Gabriela Maria/C-2561-2011; Sima, Anca Volumnia/C-3904-2011; Toma, Laura/AAC-3068-2021; Niculescu, Loredan Stefan/F-2591-2010; Stancu, Camelia Sorina/C-3882-2011	Niculescu, Loredan Stefan/0000-0002-1394-9085; Sanda, Gabriela Maria/0000-0001-5368-4264; Sima, Anca V./0000-0003-1932-8965; Toma, Laura/0000-0003-1245-079X; Stancu, Camelia Sorina/0000-0002-2988-9961	Romanian Academy	Romanian Academy(Romanian Academy of Sciences)	This work was supported by the Romanian Academy. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmis R, 2003, CIRC RES, V92, pE20, DOI 10.1161/01.RES.0000051886.43510.90; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; Deleanu M, 2016, REV CHIM-BUCHAREST, V67, P8; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; Hakala JK, 2001, ARTERIOSCL THROM VAS, V21, P1053, DOI 10.1161/01.ATV.21.6.1053; Jarc E, 2019, YALE J BIOL MED, V92, P435; KHOO JC, 1988, ARTERIOSCLEROSIS, V8, P348, DOI 10.1161/01.ATV.8.4.348; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kruth HS, 2002, CURR OPIN LIPIDOL, V13, P483, DOI 10.1097/00041433-200210000-00003; Lara-Guzman OJ, 2018, REDOX BIOL, V15, P1, DOI 10.1016/j.redox.2017.11.017; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Liu ML, 2007, ARTERIOSCL THROM VAS, V27, P430, DOI 10.1161/01.ATV.0000254674.47693.e8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 2002, ARTERIOSCL THROM VAS, V22, P387, DOI 10.1161/hq0302.105367; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; McLennan HR, 2000, J BIOENERG BIOMEMBR, V32, P153, DOI 10.1023/A:1005507913372; NISTOR A, 1987, ATHEROSCLEROSIS, V68, P159, DOI 10.1016/0021-9150(87)90106-7; Orso E, 2011, CHEM PHYS LIPIDS, V164, P479, DOI 10.1016/j.chemphyslip.2011.06.001; Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552; Persson J, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-17; Sanda GM, 2017, J CELL BIOCHEM, V118, P661, DOI 10.1002/jcb.25637; Seljeskog E, 2006, CLIN BIOCHEM, V39, P947, DOI 10.1016/j.clinbiochem.2006.03.012; Sima AV, 2010, J CELL MOL MED, V14, P2790, DOI 10.1111/j.1582-4934.2009.00933.x; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; Sung HJ, 2012, MOL BIOL REP, V39, P3001, DOI 10.1007/s11033-011-1062-1; Toma L, 2020, LIFE SCI, V249, DOI 10.1016/j.lfs.2020.117518; Toma L, 2017, BIOFACTORS, V43, P685, DOI 10.1002/biof.1373; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; Williams KJ, 2001, CURR OPIN LIPIDOL, V12, P477, DOI 10.1097/00041433-200110000-00002; Yao ST, 2013, J ATHEROSCLER THROMB, V20, P94, DOI 10.5551/jat.13425; Zamora DA, 2015, ATHEROSCLEROSIS, V241, P69, DOI 10.1016/j.atherosclerosis.2015.04.805; Zhang WY, 2000, J BIOL CHEM, V275, P33176, DOI 10.1074/jbc.M908714199	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245797	10.1371/journal.pone.0245797	http://dx.doi.org/10.1371/journal.pone.0245797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493198	Green Published, gold			2022-12-26	WOS:000613081500050
J	Belhadj, S; Rentsch, A; Schwede, F; Paquet-Durand, F				Belhadj, Soumaya; Rentsch, Andreas; Schwede, Frank; Paquet-Durand, Francois			Fluorescent detection of PARP activity in unfixed tissue	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; APOPTOSIS; OLAPARIB; DEATH	Poly-ADP-ribose-polymerase (PARP) relates to a family of enzymes that can detect DNA breaks and initiate DNA repair. While this activity is generally seen as promoting cell survival, PARP enzymes are also known to be involved in cell death in numerous pathologies, including in inherited retinal degeneration. This ambiguous role of PARP makes it attractive to have a simple and fast enzyme activity assay, that allows resolving its enzymatic activity in situ, in individual cells, within complex tissues. A previously published two-step PARP activity assay uses biotinylated NAD(+) and streptavidin labelling for this purpose. Here, we used the fluorescent NAD(+) analogues epsilon-NAD(+) and 6-Fluo-10-NAD(+) to assess PARP activity directly on unfixed tissue sections obtained from wild-type and retinal degeneration-1 (rd1) mutant retina. In standard UV microscopy epsilon-NAD(+) incubation did not reveal PARP specific signal. In contrast, 6-Fluo-10-NAD(+) resulted in reliable detection of in situ PARP activity in rd1 retina, especially in the degenerating photoreceptor cells. When the 6-Fluo-10-NAD(+) based PARP activity assay was performed in the presence of the PARP specific inhibitor olaparib, the activity signal was completely abolished, attesting to the specificity of the assay. The incubation of live organotypic retinal explant cultures with 6-Fluo-10-NAD(+), did not produce PARP specific signal, indicating that the fluorescent marker may not be sufficiently membrane-permeable to label living cells. In summary, we present a new, rapid, and simple to use fluorescence assay for the cellular resolution of PARP activity on unfixed tissue, for instance in complex neuronal tissues such as the retina.	[Belhadj, Soumaya; Paquet-Durand, Francois] Eberhard Karls Univ Tubingen, Inst Ophthalm Res, Cell Death Mech Grp, Tubingen, Germany; [Rentsch, Andreas; Schwede, Frank] Biolog Life Sci Inst GmbH & Co KG, Bremen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Paquet-Durand, F (corresponding author), Eberhard Karls Univ Tubingen, Inst Ophthalm Res, Cell Death Mech Grp, Tubingen, Germany.	francois.paquet-durand@klinikum.uni-tuebingen.de	Paquet-Durand, Francois/G-6709-2015	Paquet-Durand, Francois/0000-0001-7355-5742	European Union [H2020-MSCA765441]; Charlotte and Tistou Kerstan Foundation; German research council (DFG) [PA1751/8-1, PA1751/10-1]	European Union(European Commission); Charlotte and Tistou Kerstan Foundation; German research council (DFG)(German Research Foundation (DFG))	This research was funded by grants from the European Union (transMed; H2020-MSCA765441), the Charlotte and Tistou Kerstan Foundation, and the German research council (DFG; PA1751/8-1, 10-1). The funders provided support in the form of salaries for authors SB and FPD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biolog Life Science Institute GmbH & Co. KG provided support in the form of salary for authors AR and FS, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Arango-Gonzalez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112142; Belhadj S, 2020, JOVE-J VIS EXP, DOI 10.3791/61868; Bixel K, 2015, PHARMACOGEN PERS MED, V8, P127, DOI 10.2147/PGPM.S62809; Caffe AR, 2001, INVEST OPHTH VIS SCI, V42, P275; Cordeiro MF, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.3; Cordeiro MF, 2017, BRAIN, V140, P1757, DOI 10.1093/brain/awx088; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Davis RE, 1998, J HISTOCHEM CYTOCHEM, V46, P1279, DOI 10.1177/002215549804601108; DESNOYERS S, 1994, ANAL BIOCHEM, V218, P470, DOI 10.1006/abio.1994.1212; Ekstrom PAR, 2014, CURR MED CHEM, V21, P3478, DOI 10.2174/0929867321666140601201337; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Himawan E, 2019, DRUG DISCOV TODAY, V24, P1637, DOI 10.1016/j.drudis.2019.03.004; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; Power M, 2020, PROG RETIN EYE RES, V74, DOI 10.1016/j.preteyeres.2019.07.005; ROMIJN HJ, 1988, BIOL CELL, V63, P263, DOI 10.1016/0248-4900(88)90116-5; Sahaboglu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39537; Sahaboglu A, 2014, ADV EXP MED BIOL, V801, P463, DOI 10.1007/978-1-4614-3209-8_59; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sharma R, 2017, INVEST OPHTH VIS SCI, V58, P604, DOI 10.1167/iovs.16-20061; Shuhendler AJ, 2019, BIOCONJUGATE CHEM, V30, P1331, DOI 10.1021/acs.bioconjchem.9b00089; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Tolone A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060453; Vighi E, 2018, P NATL ACAD SCI USA, V115, pE2997, DOI 10.1073/pnas.1718792115; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wigle TJ, 2020, CELL CHEM BIOL, V27, P877, DOI 10.1016/j.chembiol.2020.06.009; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Yuan ZG, 2017, BIOORGAN MED CHEM, V25, P4100, DOI 10.1016/j.bmc.2017.05.058	34	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245369	10.1371/journal.pone.0245369	http://dx.doi.org/10.1371/journal.pone.0245369			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481867	gold, Green Published			2022-12-26	WOS:000612929300128
J	Jyothi, P; Aralimarad, P; Wali, V; Dave, S; Bheemanna, M; Ashoka, J; Shivayogiyappa, P; Lim, KS; Chapman, JW; Sane, SP				Jyothi, Patil; Aralimarad, Prabhuraj; Wali, Vijaya; Dave, Shivansh; Bheemanna, M.; Ashoka, J.; Shivayogiyappa, Patil; Lim, Ka S.; Chapman, Jason W.; Sane, Sanjay P.			Evidence for facultative migratory flight behavior in Helicoverpa armigera (Noctuidae: Lepidoptera) in India	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; TETHERED-FLIGHT; DISPERSAL ABILITY; COTTON-BOLLWORM; PERFORMANCE; BUTTERFLIES; MORPHOLOGY; MOTHS; ORIENTATION; STRATEGIES	Despite its deleterious impact on farming and agriculture, the physiology and energetics of insect migration is poorly understood due to our inability to track their individual movements in the field. Many insects, e.g. monarch butterflies, Danaus plexippus (L.), are facultative migrants. Hence, it is important to establish whether specific insect populations in particular areas migrate. The polyphagous insect, Helicoverpa armigera (Hubner), is especially interesting in this regard due to its impact on a variety of crops. Here, we used a laboratory-based flight mill assay to show that Helicoverpa armigera populations clearly demonstrate facultative migration in South India. Based on various flight parameters, we categorized male and female moths as long, medium or short distance fliers. A significant proportion of moths exhibited long-distance flight behavior covering more than 10 km in a single night, averaging about 8 flight hours constituting 61% flight time in the test period. The maximum and average flight speeds of these long fliers were greater than in the other categories. Flight activity across sexes also varied; male moths exhibited better performance than female moths. Wing morphometric parameters including forewing length, wing loading, and wing aspect ratio were key in influencing long-distance flight. Whereas forewing length positively correlated with flight distance and duration, wing loading was negatively correlated.	[Jyothi, Patil; Aralimarad, Prabhuraj; Bheemanna, M.; Ashoka, J.; Shivayogiyappa, Patil] Univ Agr Sci, Dept Agr Entomol, Raichur, Karnataka, India; [Wali, Vijaya] Univ Agr Sci, Dept Agr Stat, Raichur, Karnataka, India; [Dave, Shivansh; Sane, Sanjay P.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, GKVK Campus, Bengaluru, India; [Lim, Ka S.] Rothamsted Res, Dept Agroecol, Harpenden, Herts, England; [Chapman, Jason W.] Univ Exeter, Ctr Ecol & Conservat, Penryn, Cornwall, England; [Chapman, Jason W.] Nanjing Agr Univ, Coll Plant Protect, Dept Entomol, Nanjing, Peoples R China	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter; Nanjing Agricultural University	Aralimarad, P (corresponding author), Univ Agr Sci, Dept Agr Entomol, Raichur, Karnataka, India.	prabhusha2014@gmail.com		Aralimarad, Prabhuraj/0000-0001-7703-4266				Alerstam T, 2011, P ROY SOC B-BIOL SCI, V278, P3074, DOI 10.1098/rspb.2011.0058; Anderson RC, 2009, J TROP ECOL, V25, P347, DOI 10.1017/S0266467409006087; ARMES NJ, 1991, PHYSIOL ENTOMOL, V16, P131, DOI 10.1111/j.1365-3032.1991.tb00549.x; Arnemann JA, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028292; BEERWINKLE KR, 1995, ENVIRON ENTOMOL, V24, P1122, DOI 10.1093/ee/24.5.1122; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Berwaerts K, 2006, BIOL J LINN SOC, V89, P675, DOI 10.1111/j.1095-8312.2006.00699.x; BETTS CR, 1988, J EXP BIOL, V138, P271; Bhatnagar VS, 1980, ALL IND WORKSH CONS; Bhatnagar VS, 1978, OR ENT WORKSH POP EC; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Buden DW, 2010, PAC SCI, V64, P141, DOI 10.2984/64.1.141; Catala R., 1940, ARCH MUS NATN HIST N, V17; Chapman JW, 2008, CURR BIOL, V18, pR908, DOI 10.1016/j.cub.2008.08.014; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; COLVIN J, 1993, PHYSIOL ENTOMOL, V18, P16, DOI 10.1111/j.1365-3032.1993.tb00444.x; Coombs M, 1997, AUST J ZOOL, V45, P409, DOI 10.1071/ZO96064; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; DeVries PJ, 2010, J ANIM ECOL, V79, P1077, DOI 10.1111/j.1365-2656.2010.01710.x; DINGLE H, 1972, SCIENCE, V175, P1327, DOI 10.1126/science.175.4028.1327; Dingle H., 2014, MIGRATION BIOL LIFE, P2; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Dorhout DL, 2008, ENVIRON ENTOMOL, V37, P1280, DOI 10.1603/0046-225X(2008)37[1280:EFOMFB]2.0.CO;2; Drake VA, 1990, 5 AUSTR COTT C NARR, P295; DUDLEY R, 1990, J EXP BIOL, V150, P37; FARROW RA, 1987, AUST J ZOOL, V35, P1, DOI 10.1071/ZO9870001; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Murua MG, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew052; Hashiyama A, 2013, J ECON ENTOMOL, V106, P690, DOI 10.1603/EC12272; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; HWANG Guan-huei, 1966, Acta Entomologica Sinica, V15, P96; Jayaraj S., 1982, P17; Jones CM, 2019, ANNU REV ENTOMOL, V64, P277, DOI 10.1146/annurev-ento-011118-111959; Jones CM, 2015, MOL ECOL, V24, P4901, DOI 10.1111/mec.13362; Jones HBC, 2016, ECOL EVOL, V6, P181, DOI 10.1002/ece3.1861; KING ABS, 1990, ENTOMOL EXP APPL, V55, P257, DOI 10.1111/j.1570-7458.1990.tb01370.x; Kriticos DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133224; Lee D, 1991, J LEPID SOC, V45, P296; Lim KS, 2013, Patent No. [PCT/GB2014/052466., 2014052466]; Luo LZ, 2002, ENVIRON ENTOMOL, V31, P1, DOI 10.1603/0046-225X-31.1.1; Minter M, 2018, ECOL ENTOMOL, V43, P397, DOI 10.1111/een.12521; PEDGLEY DE, 1987, INSECT SCI APPL, V8, P599, DOI 10.1017/S1742758400022669; R Core Team, 2013, R LANG ENV STAT COMP; Rajapakse CNK, 2007, ARTHROPOD-PLANT INTE, V1, P17, DOI 10.1007/s11829-007-9003-6; Richa Arora, 2005, Journal of SAT Agricultural Research, V1, P1; Riley JR, 1987, PRELIMINARY REPORT S; ROSE DJW, 1985, ECOL ENTOMOL, V10, P299, DOI 10.1111/j.1365-2311.1985.tb00727.x; Saito O, 2000, APPL ENTOMOL ZOOL, V35, P53, DOI 10.1303/aez.2000.53; Saito O, 2000, PHYSIOL ENTOMOL, V25, P112, DOI 10.1046/j.1365-3032.2000.00172.x; SAPPINGTON TW, 1992, ENVIRON ENTOMOL, V21, P677, DOI 10.1093/ee/21.4.677; Sarate PJ, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4201; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Sekar S, 2012, J ANIM ECOL, V81, P174, DOI 10.1111/j.1365-2656.2011.01909.x; Sharma HC, 2001, BIOL MANAGEMENT; SHOWERS WB, 1989, ECOLOGY, V70, P987, DOI 10.2307/1941366; Stevens VM, 2012, ECOL LETT, V15, P74, DOI 10.1111/j.1461-0248.2011.01709.x; The Math Works Inc, 2012, MATLAB 8 0 STAT TOOL; Tipping C., 1995, LONGEST MIGRATION; Tu YG, 2010, INSECT SCI, V17, P53, DOI 10.1111/j.1744-7917.2009.01281.x; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Williams C. B., 1930, MIGRATION BUTTERFLIE; WILLIAMS CB, 1957, ANNU REV ENTOMOL, V2, P163, DOI 10.1146/annurev.en.02.010157.001115; WINKLER H, 1992, IBIS, V134, P21; Yao Qing, 2001, Entomologia Sinica, V8, P183; Zhao XY, 2016, B ENTOMOL RES, V106, P740, DOI 10.1017/S000748531600047X	67	4	4	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245665	10.1371/journal.pone.0245665	http://dx.doi.org/10.1371/journal.pone.0245665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481893	Green Published, gold			2022-12-26	WOS:000612929300105
J	Lewandowsky, S; Dennis, S; Perfors, A; Kashima, Y; White, JP; Garrett, P; Little, DR; Yesilada, M				Lewandowsky, Stephan; Dennis, Simon; Perfors, Andrew; Kashima, Yoshihisa; White, Joshua P.; Garrett, Paul; Little, Daniel R.; Yesilada, Muhsin			Public acceptance of privacy-encroaching policies to address the COVID-19 pandemic in the United Kingdom	PLOS ONE			English	Article							PERSONAL INFORMATION; DISCLOSURE; BEHAVIOR; PARADOX	The nature of the COVID-19 pandemic may require governments to use privacy-encroaching technologies to help contain its spread. One technology involves co-location tracking through mobile Wi-Fi, GPS, and Bluetooth to permit health agencies to monitor people's contact with each other, thereby triggering targeted social-distancing when a person turns out to be infected. The effectiveness of tracking relies on the willingness of the population to support such privacy encroaching measures. We report the results of two large surveys in the United Kingdom, conducted during the peak of the pandemic, that probe people's attitudes towards various tracking technologies. The results show that by and large there is widespread acceptance for co-location tracking. Acceptance increases when the measures are explicitly time-limited and come with opt-out clauses or other assurances of privacy. Another possible future technology to control the pandemic involves "immunity passports", which could be issued to people who carry antibodies for the COVID-19 virus, potentially implying that they are immune and therefore unable to spread the virus to other people. Immunity passports have been considered as a potential future step to manage the pandemic. We probe people's attitudes towards immunity passports and find considerable support overall, although around 20% of the public strongly oppose passports.	[Lewandowsky, Stephan; Yesilada, Muhsin] Univ Bristol, Bristol, Avon, England; [Lewandowsky, Stephan] Univ Western Australia, Perth, WA, Australia; [Dennis, Simon; Perfors, Andrew; Kashima, Yoshihisa; White, Joshua P.; Garrett, Paul; Little, Daniel R.] Univ Melbourne, Melbourne, Vic, Australia	University of Bristol; University of Western Australia; University of Melbourne	Lewandowsky, S (corresponding author), Univ Bristol, Bristol, Avon, England.; Lewandowsky, S (corresponding author), Univ Western Australia, Perth, WA, Australia.	stephan.lewandowsky@bristol.ac.uk	White, Joshua/GVR-9120-2022; Yesilada, Muhsin/AAN-8270-2021; Little, Daniel/J-5034-2019; White, Joshua/AAF-1804-2021; Lewandowsky, Stephan/H-5285-2014	Little, Daniel/0000-0003-3607-5525; White, Joshua/0000-0003-3129-5473; Lewandowsky, Stephan/0000-0003-1655-2013	Elizabeth Blackwell Institute, University of Bristol; University's alumni and friends; Humboldt Foundation in Germany	Elizabeth Blackwell Institute, University of Bristol; University's alumni and friends; Humboldt Foundation in Germany	This work was supported by the Elizabeth Blackwell Institute, University of Bristol, with funding from the University's alumni and friends. The first author was supported by a Humboldt Award from the Humboldt Foundation in Germany during part of this work.	Abeler Johannes, 2020, SUPPORT UK APP BASED; Acquisti A, 2015, SCIENCE, V347, P509, DOI 10.1126/science.aaa1465; [Anonymous], STAT RESP IS PHON TR; Bachtiger P, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-00357-5; Barth S, 2017, TELEMAT INFORM, V34, P1038, DOI 10.1016/j.tele.2017.04.013; Degirmenci K, 2020, INT J INFORM MANAGE, V50, P261, DOI 10.1016/j.ijinfomgt.2019.05.010; Dienlin T, 2016, J COMPUT-MEDIAT COMM, V21, P368, DOI 10.1111/jcc4.12163; French M, 2020, SURVEILL SOC, V18, P1; Gu J, 2017, DECIS SUPPORT SYST, V94, P19, DOI 10.1016/j.dss.2016.10.002; Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x; Hall MA, 2020, JAMA; Hamilton IA, 2020, BUSINESS INSIDER; Johnson B., 2020, TECH REV; Kofler N, 2020, NATURE, V581, P379, DOI 10.1038/d41586-020-01451-0; Kokolakis S, 2017, COMPUT SECUR, V64, P122, DOI 10.1016/j.cose.2015.07.002; Kozyreva A, 2020, ARTIF INTELL, DOI [10.17617/2.3188061, DOI 10.17617/2.3188061]; Langford E., 2020, POLITICSHOME; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Norberg PA, 2007, J CONSUM AFF, V41, P100, DOI 10.1111/j.1745-6606.2006.00070.x; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Persad G, 2020, JAMA-J AM MED ASSOC, V323, P2241, DOI 10.1001/jama.2020.8102; Skinner G, 2014, PRISMS SURVEY; Skovgaard LL, 2019, HEALTH POLICY, V123, P564, DOI 10.1016/j.healthpol.2019.03.012; Studdert DM, 2020, NEW ENGL J MED, V383, P102, DOI 10.1056/NEJMp2007637; Sweney M., 2020, GUARDIAN; Voo TC, 2020, J INFECT DIS, V222, P715, DOI 10.1093/infdis/jiaa352; Wang T, 2016, INT J INFORM MANAGE, V36, P531, DOI 10.1016/j.ijinfomgt.2016.03.003; Wnuk A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238973	28	29	29	8	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245740	10.1371/journal.pone.0245740	http://dx.doi.org/10.1371/journal.pone.0245740			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481877	gold, Green Published, Green Submitted			2022-12-26	WOS:000612929300073
J	Shaw, AK; White, LA; Michalska-Smith, M; Borer, ET; Craft, ME; Seabloom, EW; Snell-Rood, EC; Travisano, M				Shaw, Allison K.; White, Lauren A.; Michalska-Smith, Matthew; Borer, Elizabeth T.; Craft, Meggan E.; Seabloom, Eric W.; Snell-Rood, Emilie C.; Travisano, Michael			Lessons from movement ecology for the return to work: Modeling contacts and the spread of COVID-19	PLOS ONE			English	Article							TRANSMISSION; SENSITIVITY; UNCERTAINTY	Human behavior (movement, social contacts) plays a central role in the spread of pathogens like SARS-CoV-2. The rapid spread of SARS-CoV-2 was driven by global human movement, and initial lockdown measures aimed to localize movement and contact in order to slow spread. Thus, movement and contact patterns need to be explicitly considered when making reopening decisions, especially regarding return to work. Here, as a case study, we consider the initial stages of resuming research at a large research university, using approaches from movement ecology and contact network epidemiology. First, we develop a dynamical pathogen model describing movement between home and work; we show that limiting social contact, via reduced people or reduced time in the workplace are fairly equivalent strategies to slow pathogen spread. Second, we develop a model based on spatial contact patterns within a specific office and lab building on campus; we show that restricting on-campus activities to labs (rather than labs and offices) could dramatically alter (modularize) contact network structure and thus, potentially reduce pathogen spread by providing a workplace mechanism to reduce contact. Here we argue that explicitly accounting for human movement and contact behavior in the workplace can provide additional strategies to slow pathogen spread that can be used in conjunction with ongoing public health efforts.	[Shaw, Allison K.; Borer, Elizabeth T.; Seabloom, Eric W.; Snell-Rood, Emilie C.; Travisano, Michael] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [White, Lauren A.] Natl Socioenvironm Synth Ctr, Annapolis, MD USA; [Michalska-Smith, Matthew; Craft, Meggan E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Michalska-Smith, Matthew] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Travisano, Michael] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA; [White, Lauren A.] USAID, AAAS Sci & Technol Policy, Off HIV AIDS, Washington, DC USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Agency for International Development (USAID)	Shaw, AK (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	ashaw@umn.edu	White, Lauren/AAB-2099-2020; Shaw, Allison/E-7161-2010	White, Lauren/0000-0003-3852-5374; Shaw, Allison/0000-0001-7969-8365	University of Minnesota's Office of Academic Clinical Affairs COVID-19 Rapid Response Grant; National Science Foundation [DEB-2030509, DEB-1654609, DEB-1556649]; National Socio Environmental Synthesis Center (SESYNC) [NSF DBI 1639145]	University of Minnesota's Office of Academic Clinical Affairs COVID-19 Rapid Response Grant; National Science Foundation(National Science Foundation (NSF)); National Socio Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based in part upon work supported by the University of Minnesota's Office of Academic Clinical Affairs COVID-19 Rapid Response Grant (https://clinicalaffairs.umn.edu/umn-covid-19-research) (to MEC, LAW, and MMS), by the National Science Foundation (https://www.nsf.gov/) under Grants DEB-2030509 (to MEC and MMS), DEB-1654609 (to AKS and MEC) and DEB-1556649 (to EWS and ETB) and by the National Socio Environmental Synthesis Center (SESYNC) under funding received from the NSF DBI 1639145. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents in this article are those of the authors and do not necessarily reflect the view of the U.S. President's Emergency Plan for AIDS Relief, the U.S. Agency for International Development or the U.S. Government.	Altieri N., 2020, ARXIV, V2005; [Anonymous], 2020, INDOOR AIR 1120; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Balilla J., 2020, SSRN ELECT J, DOI DOI 10.2139/SSRN.3556346; Begon M, 2002, EPIDEMIOL INFECT, V129, P147, DOI 10.1017/S0950268802007148; Binning SA, 2017, INTEGR COMP BIOL, V57, P267, DOI 10.1093/icb/icx024; Block P, 2020, NAT HUM BEHAV, V4, P588, DOI 10.1038/s41562-020-0898-6; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Boulinier T, 2016, INTEGR COMP BIOL, V56, P330, DOI 10.1093/icb/icw015; Britton T, 2020, SCIENCE, V369, P846, DOI 10.1126/science.abc6810; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P9; Daversa DR, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1807; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Duque D, 2020, P NATL ACAD SCI USA, V117, P19873, DOI 10.1073/pnas.2009033117; Enns EA, 2020, MODELING IMPACT SOCI, P16; Enright J, 2018, EPIDEMICS-NETH, V24, P88, DOI 10.1016/j.epidem.2018.04.003; Ghinai I, 2020, MMWR-MORBID MORTAL W, V69, P446, DOI 10.15585/mmwr.mm6915e1; Hadjidemetriou Georgios M, 2020, Transp Res Interdiscip Perspect, V6, P100167, DOI 10.1016/j.trip.2020.100167; Heape W, 1931, EMIGRATION MIGRATION; Johns S, 2016, POPUL ECOL, V58, P213, DOI 10.1007/s10144-015-0518-x; Karin O., 2020, CYCLIC EXIT STRATEGI, DOI [10.1101/2020.04.04.20053579, DOI 10.1101/2020.04.04.20053579]; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Keeling MJ, 2000, J THEOR BIOL, V203, P51, DOI 10.1006/jtbi.1999.1064; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Levinson M, 2020, NEW ENGL J MED, V383, P981, DOI 10.1056/NEJMms2024920; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; Li W, 2020, CLIN INFECT DIS, V71, P1943, DOI 10.1093/cid/ciaa450; Ling Y, 2020, CHINESE MED J-PEKING, V133, P1039, DOI 10.1097/CM9.0000000000000774; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Lu JY, 2020, EMERG INFECT DIS, V26, P1628, DOI 10.3201/eid2607.200764; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Mei S, 2020, Lancet Infect Dis, V20, P911; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; MN Department of Health, 2020, SIT UPD COR DIS 2019; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Moyer M. W, 2020, NEW YORK TIMES; Naven Narayanan, 2020, OIKOS, V129, P1493, DOI 10.1111/oik.07188; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Pedersen TL, 2020, ggraph: An Implementation of Grammar of Graphics for Graphs and Networks; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Servedio MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002017; Shaw AK, 2020, J ANIM ECOL, V89, P1448, DOI 10.1111/1365-2656.13195; Shaw AK, 2019, J ANIM ECOL, V88, P1601, DOI 10.1111/1365-2656.13050; Shaw AK, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.2147; Sonderskov KM, 2020, ACTA NEUROPSYCHIATR, V32, P226, DOI 10.1017/neu.2020.15; Tian L, 2020, PREPRINT, P31; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; Wei WE, 2020, MMWR-MORBID MORTAL W, V69, P411, DOI 10.15585/mmwr.mm6914e1; Woody S, 2020, PROJECTIONS 1 WAVE C, DOI 10.1101/2020.04.16.20068163; Wu J, 2020, NEUROCOMPUTING, V395, P78, DOI 10.1016/j.neucom.2020.02.017; Zhang Juanjuan, 2020, medRxiv, DOI 10.1101/2020.08.03.20167056; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001; Zhang S, 2020, INT J INFECT DIS, V93, P201, DOI 10.1016/j.ijid.2020.02.033	68	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0242955	10.1371/journal.pone.0242955	http://dx.doi.org/10.1371/journal.pone.0242955			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481803	Green Published, gold, Green Submitted			2022-12-26	WOS:000612929300113
J	Rosazlina, R; Jacobsen, N; Orgaard, M; Othman, AS				Rosazlina, Rusly; Jacobsen, Niels; Orgaard, Marian; Othman, Ahmad Sofiman			Molecular evidence of the hybrid origin of Cryptocoryne xpurpurea Ridl. nothovar. purpurea (Araceae)	PLOS ONE			English	Article							DNA-SEQUENCES; HYBRIDIZATION; NUCLEAR	Natural hybridization has been considered a source of taxonomic complexity in Cryptocoryne. A combined study of DNA sequencing data from the internal transcribed spacer (ITS) of nuclear ribosomal DNA and the trnK-matK region of chloroplast DNA was used to identify the parents of Cryptocoryne putative hybrids from Peninsular Malaysia. Based on the intermediate morphology and sympatric distribution area, the plants were tentatively identified as the hybrid Cryptocoryne xpurpurea nothovar. purpurea. The plants were pollen sterile and had long been considered as hybrids, supposedly between two related and co-existing species, C. cordata var. cordata and C. griffithii. The status of C. xpurpurea nothovar. purpurea was independently confirmed by the presence of an additive ITS sequence pattern from these two parental species in hybrid individuals. An analysis of the chloroplast trnK-matK sequences showed that the hybridization is bidirectional with the putative hybrids sharing identical sequences from C. cordata var. cordata and C. griffithii, indicating that both putative parental species had been the maternal parent in different accessions.	[Rosazlina, Rusly; Othman, Ahmad Sofiman] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Jacobsen, Niels; Orgaard, Marian] Univ Copenhagen, Sect Organismal Biol, Dept Plant & Environm Sci, Fac Sci, Copenhagen C, Denmark	Universiti Sains Malaysia; University of Copenhagen	Rosazlina, R; Othman, AS (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.	rosazlinarusly@usm.my; sofiman@usm.my	Othman, Ahmad Sofiman/GVT-4237-2022; Orgaard, Marian/I-3014-2014	Othman, Ahmad Sofiman/0000-0002-4944-4177; Orgaard, Marian/0000-0002-0067-3913; RUSLY, ROSAZLINA/0000-0002-8057-3217	Short Term Grant from Universiti Sains Malaysia [304/PBIOLOGI/6315202]	Short Term Grant from Universiti Sains Malaysia(Universiti Sains Malaysia)	This project was funded by Short Term Grant from Universiti Sains Malaysia (304/PBIOLOGI/6315202).	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; [Anonymous], 1981, AQUA PL; [Anonymous], 2010, J TROP BIOL CONSERV; [Anonymous], 2002, AQUA PL; [Anonymous], 2013, AQUA PL; [Anonymous], 1987, REVISED HDB FLORA CE; ARENDS J C, 1982, Nordic Journal of Botany, V2, P453, DOI 10.1111/j.1756-1051.1982.tb01208.x; Arnold M. L., 2006, EVOLUTION GENETIC EX; Bastmeijer Jan D., 2001, Gardens' Bulletin (Singapore), V53, P9; Bastmeijer JD, CRYPTS PAGES; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; de Wit HCD, 1990, AQUARIENPFLANZEN, V2nd; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du ZY, 2009, AQUAT BOT, V91, P47, DOI 10.1016/j.aquabot.2009.02.006; Ellstrand NC, 1996, P NATL ACAD SCI USA, V93, P5090, DOI 10.1073/pnas.93.10.5090; Harrison RG, 2014, J HERED, V105, P795, DOI 10.1093/jhered/esu033; Hodkinson TR, 2002, AM J BOT, V89, P279, DOI 10.3732/ajb.89.2.279; Ipor IB, 2015, WILLDENOWIA, V45, P183, DOI 10.3372/wi.45.45204; JACOBSEN N, 1977, BOT NOTISER, V130, P71; Jacobsen N, 2020, AQUA PL, V45, P128; Jacobsen N., 2020, AROIDEANA, V43, P255; Jacobsen N, 1980, MISC PAP LANDBOUWHOG, V19, P183; Jacobsen N., 2019, AROIDEANA, V42, P76; Jacobsen N, 2020, AROIDEANA, V43, P240; Jacobsen N., 2016, THAI FOREST B BOT, V44, P53; Jacobsen N, 2019, AROIDEANA, V42, P107; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Morley RJ, 1982, TASEK BERA ECOLOGY F, P12; Naidoo K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059355; Othman AS, 2007, TROP LIFE SCI RES, V18, P99; Othman AS, 1997, THESIS; Othman AS, 2009, CRYPTOCORYNE PENINSU; Popp M, 2001, MOL PHYLOGENET EVOL, V20, P474, DOI 10.1006/mpev.2001.0977; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Shi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147825; Shin H, 2014, J PLANT BIOL, V57, P174, DOI 10.1007/s12374-014-0135-9; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tang L, 2015, NORD J BOT, V33, P109, DOI 10.1111/j.1756-1051.2012.00108.x; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wongso S, 2020, AROIDEANA, V43, P285; Wongso S, 2020, AQUA PL, V45, P44; Wongso S, 2020, NORD J BOT, V38, DOI 10.1111/njb.02716; Wongso S, 2019, TAIWANIA, V64, P326, DOI 10.6165/tai.2019.64.326; Wongso S, 2017, WILLDENOWIA, V47, P325, DOI 10.3372/wi.47.47314; Zhou SX, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227625; Zou PS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00673	49	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2021	16	1							e0239499	10.1371/journal.pone.0239499	http://dx.doi.org/10.1371/journal.pone.0239499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7NX	33476321	Green Published, gold, Green Submitted			2022-12-26	WOS:000612928900005
J	Yue, JJ; Dai, Q; Hao, SH; Zhu, SQ; Liu, XX; Tang, ZQ; Li, M; Fang, HT; Lin, CQ; Luo, ZJ				Yue, Junjie; Dai, Qian; Hao, Shaohua; Zhu, Shiqi; Liu, Xiaoxu; Tang, Zhiqun; Li, Meng; Fang, Haitong; Lin, Chengqi; Luo, Zhuojuan			Suppression of the NTS-CPS1 regulatory axis by AFF1 in lung adenocarcinoma cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOME CONFORMATION CAPTURE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ELONGATION COMPLEX; NEUROTENSIN RECEPTORS; NERVOUS-SYSTEM; CANCER; AF4; TRANSCRIPTION; ACTIVATION; CHROMATIN	Upregulation of the neuropeptide neurotensin (NTS) in a subgroup of lung cancers has been linked to poor prognosis. However, the regulatory pathway centered on NTS in lung cancer remains unclear. Here we identified the NTS-specific enhancer in lung adenocarcinoma cells. The AF4/FMR2 (AFF) family protein AFF1 occupies the NTS enhancer and inhibits NTS transcription. Clustering analysis of lung adenocarcinoma gene expression data demonstrated that NTS expression is highly positively correlated with the expression of the oncogenic factor CPS1. Detailed analyses demonstrated that the IL6 pathway antagonizes NTS in regulating CPS1. Thus, our analyses revealed a novel NTS-centered regulatory axis, consisting of AFF1 as a master transcription suppressor and IL6 as an antagonist in lung adenocarcinoma cells.	[Yue, Junjie; Dai, Qian; Hao, Shaohua; Zhu, Shiqi; Liu, Xiaoxu; Li, Meng; Fang, Haitong; Lin, Chengqi; Luo, Zhuojuan] Southeast Univ, Sch Life Sci & Technol, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China; [Tang, Zhiqun] Singapore Eye Res Inst, Singapore, Singapore; [Lin, Chengqi; Luo, Zhuojuan] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China	Southeast University - China; National University of Singapore; Singapore National Eye Center; Nantong University	Lin, CQ; Luo, ZJ (corresponding author), Southeast Univ, Sch Life Sci & Technol, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China.; Lin, CQ; Luo, ZJ (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.	cqlin@seu.edu.cn; zjluo@seu.eau.cn		Fang, Haitong/0000-0003-1174-9191; Lin, Chengqi/0000-0002-2121-584X; Dai, Qian/0000-0002-5774-7469	National Key R&D Program of China [2018YFA0800100, 2018YFA0800103]; National Natural Science Foundation of China [32030017, 31970617, 31970626]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Studies in this article were supported by funds provided by National Key R&D Program of China (2018YFA0800100 to C. L.; 2018YFA0800103 to Z. L.), National Natural Science Foundation of China (32030017, 31970617 to C. L.; 31970626 to Z. L.).	Alifano M, 2010, CLIN CANCER RES, V16, P4401, DOI 10.1158/1078-0432.CCR-10-0659; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Behm FG, 1996, BLOOD, V87, P2870, DOI 10.1182/blood.V87.7.2870.bloodjournal8772870; Beilharz EJ, 1998, J NEUROSCI, V18, P9780; Bitoun E, 2009, CEREBELLUM, V8, P175, DOI 10.1007/s12311-009-0101-0; Bose P, 2015, PEPTIDES, V73, P43, DOI 10.1016/j.peptides.2015.08.008; Brunetti J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/173507; Carranza C, 2013, CANCER GENET-NY, V206, P227, DOI 10.1016/j.cancergen.2013.05.017; Celiktas M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw231; Cen H, 2012, IMMUNOGENETICS, V64, P935, DOI 10.1007/s00251-012-0650-0; Chen FX, 2017, SCIENCE, V357, P1294, DOI 10.1126/science.aan3269; Choi S, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-27; Erfurth F, 2004, LEUKEMIA, V18, P92, DOI 10.1038/sj.leu.2403200; Ernst A, 2006, PEPTIDES, V27, P1787, DOI 10.1016/j.peptides.2006.01.021; Evers BM, 2006, PEPTIDES, V27, P2424, DOI 10.1016/j.peptides.2006.01.028; Fernandez-Minan A, 2016, METHOD CELL BIOL, V135, P413, DOI 10.1016/bs.mcb.2016.02.008; Huang HY, 2017, CANCER RES, V77, P5769, DOI 10.1158/0008-5472.CAN-17-0449; Isaacs AM, 2003, J NEUROSCI, V23, P1631; Johansson B, 1998, LEUKEMIA, V12, P779, DOI 10.1038/sj.leu.2401012; Jones SA, 2018, NAT REV IMMUNOL, V18, P773, DOI 10.1038/s41577-018-0066-7; Kampmann M, 2018, ACS CHEM BIOL, V13, P406, DOI 10.1021/acschembio.7b00657; Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359; Kleczkowska P, 2013, EUR J PHARMACOL, V716, P54, DOI 10.1016/j.ejphar.2013.03.004; Kumari N, 2019, P NATL ACAD SCI USA, V116, P22140, DOI 10.1073/pnas.1907097116; Kurihara T, 2008, DIABETES, V57, P2191, DOI 10.2337/db07-1281; Kuzmina A, 2017, TRANSCR-AUSTIN, V8, P133, DOI 10.1080/21541264.2017.1295831; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Li L, 2019, NATURE, V567, P253, DOI 10.1038/s41586-019-0996-7; Lin CQ, 2013, CELL, V152, P144, DOI 10.1016/j.cell.2012.12.015; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; Lu HS, 2014, P NATL ACAD SCI USA, V111, pE15, DOI 10.1073/pnas.1318503111; Luo ZJ, 2016, GENE DEV, V30, P92, DOI 10.1101/gad.270413.115; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Matelot M, 2016, METHODS MOL BIOL, V1480, P223, DOI 10.1007/978-1-4939-6380-5_20; MILLER DC, 1990, HUM PATHOL, V21, P271, DOI 10.1016/0046-8177(90)90226-U; Moody TW, 2015, PEPTIDES, V72, P106, DOI 10.1016/j.peptides.2015.03.018; Moody TW, 2014, LIFE SCI, V100, P25, DOI 10.1016/j.lfs.2014.01.072; Mouritzen MV, 2018, J PEPT SCI, V24, DOI 10.1002/psc.3093; Okuda H, 2017, J CLIN INVEST, V127, P1918, DOI 10.1172/JCI91406; Oliver PL, 2004, P NATL ACAD SCI USA, V101, P14901, DOI 10.1073/pnas.0406196101; Ouyang Q, 2017, CLIN EXP PHARMACOL P, V44, P841, DOI 10.1111/1440-1681.12787; Ouyang Q, 2016, NEURO-ONCOLOGY, V18, P216, DOI 10.1093/neuonc/nov114; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Pham-Danis C, 2019, MOL CANCER RES, V17, P1351, DOI 10.1158/1541-7786.MCR-18-1068; REINECKE M, 1985, PROG HISTOCHEM CYTOC, V16, P1; Schwerd T, 2017, J EXP MED, V214, P2547, DOI 10.1084/jem.20161810; Seufferlein T, 1996, CANCER RES, V56, P5758; Sheng LM, 2013, INT J CANCER, V133, P2720, DOI 10.1002/ijc.28284; Souaze F, 2006, CANCER RES, V66, P6243, DOI 10.1158/0008-5472.CAN-06-0450; Su ZJ, 2019, GENE, V687, P143, DOI 10.1016/j.gene.2018.10.062; THEODORSSONNORHEIM E, 1983, GASTROENTEROLOGY, V85, P881; Torruella-Suarez ML, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.108005; Wang XF, 2006, CLIN CANCER RES, V12, P5346, DOI 10.1158/1078-0432.CCR-06-0968; Wang Y, 2017, NUCLEIC ACIDS RES, V45, P1177, DOI 10.1093/nar/gkw1051; Wu ZR, 2019, CANCER LETT, V444, P147, DOI 10.1016/j.canlet.2018.12.007; Wu ZR, 2017, CANCER LETT, V388, P73, DOI 10.1016/j.canlet.2016.11.032; Xiao P, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440166; Zhang Y, 2019, J MOL CELL BIOL, V11, P761, DOI [10.1093/jmcb/mjy074, 10.1093/jmcb/mjyz074]; Zhou CC, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.44; Zhu SM, 2019, ONCOGENE, V38, P4875, DOI 10.1038/s41388-019-0750-5	61	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100319	10.1016/j.jbc.2021.100319	http://dx.doi.org/10.1016/j.jbc.2021.100319			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493519	gold, Green Published			2022-12-26	WOS:000672866400293
J	Das, S; Ghosh, P; Banerjee, S; Pyne, S; Chattopadhyay, J; Mukhopadhyay, I				Das, Sarmistha; Ghosh, Pramit; Banerjee, Sandip; Pyne, Saumyadipta; Chattopadhyay, Joydev; Mukhopadhyay, Indranil			Determination of critical community size from an HIV/AIDS model	PLOS ONE			English	Article							RELIABLE NUMERICAL-ANALYSIS; EPIDEMIC MODEL; PERIODICITY; MEASLES	After an epidemic outbreak, the infection persists in a community long enough to engulf the entire susceptible population. Local extinction of the disease could be possible if the susceptible population gets depleted. In large communities, the tendency of eventual damp down of recurrent epidemics is balanced by random variability. But, in small communities, the infection would die out when the number of susceptible falls below a certain threshold. Critical community size (CCS) is considered to be the mentioned threshold, at which the infection is as likely as not to die out after a major epidemic for small communities unless reintroduced from outside. The determination of CCS could aid in devising systematic control strategies to eradicate the infectious disease from small communities. In this article, we have come up with a simplified computation based approach to deduce the CCS of HIV disease dynamics. We consider a deterministic HIV model proposed by Silva and Torres, and following Nasell, introduce stochasticity in the model through time-varying population sizes of different compartments. Besides, Metcalf's group observed that the relative risk of extinction of some infections on islands is almost double that in the mainlands i.e. infections cease to exist at a significantly higher rate in islands compared to the mainlands. They attributed this phenomenon to the greater recolonization in the mainlands. Interestingly, the application of our method on demographic facts and figures of countries in the AIDS belt of Africa led us to expect that existing control measures and isolated locations would assist in temporary eradication of HIV infection much faster. For example, our method suggests that through systematic control strategies, after 7.36 years HIV epidemics will temporarily be eradicated from different communes of island nation Madagascar, where the population size falls below its CCS value, unless the disease is reintroduced from outside.	[Das, Sarmistha; Mukhopadhyay, Indranil] Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India; [Ghosh, Pramit] Deben Mahata Govt Med Coll & Hosp, Purulia, W Bengal, India; [Banerjee, Sandip] Indian Inst Technol, Dept Math, Roorkee, Uttarakhand, India; [Pyne, Saumyadipta] Univ Pittsburgh, Grad Sch Publ Hlth, Publ Hlth Dynam Lab, Pittsburgh, PA USA; [Pyne, Saumyadipta] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Pyne, Saumyadipta] Hlth Analyt Network, Pittsburgh, PA USA; [Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indian Statistical Institute; Indian Statistical Institute Kolkata	Mukhopadhyay, I (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, W Bengal, India.	indranil@isical.ac.in		GHOSH, PRAMIT/0000-0002-1542-4135	NIH Fogarty International Center Award [R25 TW009717, R25 TW009717-02S1]	NIH Fogarty International Center Award	This work was supported by the NIH Fogarty International Center Award #R25 TW009717 and #R25 TW009717-02S1. IM received this award. NO -The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2000, J MATH BIOL, V41, P559, DOI 10.1007/s002850000060; Arif MS, 2019, IRAN J SCI TECHNOL A, V43, P2477, DOI 10.1007/s40995-019-00726-0; Arif MS, 2019, CMC-COMPUT MATER CON, V59, P787, DOI 10.32604/cmc.2019.04655; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Das S, 2020, STAT APPL, V18, P181; Dietz K, 1975, EPIDEMIOLOGY, V104, P121; Djordjevic J, 2018, APPL MATH LETT, V84, P168, DOI 10.1016/j.aml.2018.05.005; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Metcalf CJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074696; Nasell I, 2002, MATH BIOSCI, V179, P1, DOI 10.1016/S0025-5564(02)00098-6; Nasell I, 2005, THEOR POPUL BIOL, V67, P203, DOI 10.1016/j.tpb.2005.01.002; Nasell I, 1999, J R STAT SOC B, V61, P309, DOI 10.1111/1467-9868.00178; Raza A, 2019, ADV DIFFER EQU-NY, DOI 10.1186/s13662-019-1958-y; Silva CJ, 2018, COMMUN FAC SCI UNIV, V67, P93, DOI 10.1501/Commual_0000000833; Silva CJ, 2015, DISCRETE CONT DYN-A, V35, P4639, DOI 10.3934/dcds.2015.35.4639; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0244543	10.1371/journal.pone.0244543	http://dx.doi.org/10.1371/journal.pone.0244543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507898	gold, Green Published			2022-12-26	WOS:000635021400018
J	Espinoza, GZ; Angelo, RM; Oliveira, PR; Honorio, KM				Espinoza, Gabriel Z.; Angelo, Rafaela M.; Oliveira, Patricia R.; Honorio, Kathia M.			Evaluating Deep Learning models for predicting ALK-5 inhibition	PLOS ONE			English	Article							NEURAL-NETWORKS; QSAR	Computational methods have been widely used in drug design. The recent developments in machine learning techniques and the ever-growing chemical and biological databases are fertile ground for discoveries in this area. In this study, we evaluated the performance of Deep Learning models in comparison to Random Forest, and Support Vector Regression for predicting the biological activity (pIC(50)) of ALK-5 inhibitors as candidates to treat cancer. The generalization power of the models was assessed by internal and external validation procedures. A deep neural network model obtained the best performance in this comparative study, achieving a coefficient of determination of 0.658 on the external validation set with mean square error and mean absolute error of 0.373 and 0.450, respectively. Additionally, the relevance of the chemical descriptors for the prediction of biological activity was estimated using Permutation Importance. We can conclude that the forecast model obtained by the deep neural network is suitable for the problem and can be employed to predict the biological activity of new ALK-5 inhibitors.	[Espinoza, Gabriel Z.; Angelo, Rafaela M.; Oliveira, Patricia R.; Honorio, Kathia M.] Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil; [Honorio, Kathia M.] Fed Univ ABC, Santo Andre, SP, Brazil	Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Oliveira, PR; Honorio, KM (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Sao Paulo, SP, Brazil.; Honorio, KM (corresponding author), Fed Univ ABC, Santo Andre, SP, Brazil.	proliveira@usp.br; kmhonorio@usp.br	Honorio, Kathia M/D-4998-2012; Honorio, Kathia/AAG-9844-2020	Honorio, Kathia M/0000-0002-6938-0676; Honorio, Kathia/0000-0002-6938-0676; de Angelo, Rafaela/0000-0002-4738-8378	FAPESP; CNPq; CAPES; Reitoria de Pesquisa - USP	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Reitoria de Pesquisa - USP	This research was supported in part by grants from FAPESP, CNPq, CAPES and ProReitoria de Pesquisa - USP.	Abadi  M., 2016, ARXIV160304467; Arjaans M, 2012, PHARMACOL THERAPEUT, V135, P123, DOI 10.1016/j.pharmthera.2012.05.001; Awad M, 2015, EFFICIENT LEARNING M, P67, DOI DOI 10.1007/978-1-4302-5990-9_4; Breiman L., 2001, MACH LEARN, V45, P5; Bruce CL, 2007, J CHEM INF MODEL, V47, P219, DOI 10.1021/ci600332j; Carpenter KA, 2018, FUTURE MED CHEM, V10, P2557, DOI 10.4155/fmc-2018-0314; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; CP Wild, 2014, WORLD CANC REPORT 20; de Angelo RM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123728; Drucker H, 1997, ADV NEUR IN, V9, P155; Fourches D, 2010, J CHEM INF MODEL, V50, P1189, DOI 10.1021/ci100176x; Gaulton A, 2017, NUCLEIC ACIDS RES, V45, pD945, DOI 10.1093/nar/gkw1074; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Glorot X., 2011, P 14 INT C ART INT S, P315, DOI DOI 10.1177/1753193410395357; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; Hochreiter S, 1998, INT J UNCERTAIN FUZZ, V6, P107, DOI 10.1142/S0218488598000094; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Instituto Nacional de Cancer Jose Alencar Gomes da Silva, 2014, EST 2014 INC CANC BR; Jimenez J, 2018, J CHEM INF MODEL, V58, P287, DOI [10.1002/jpln.201800201, 10.1021/acs.jcim.7b00650]; Jorde L. B., 2004, GENETICA MED, V3; Kadam SS., 2008, PRINCIPLES MED CHEM; Kadurin A, 2017, MOL PHARMACEUT, V14, P3098, DOI 10.1021/acs.molpharmaceut.7b00346; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Knowles MA, 2005, INTRO CELLULAR MOL B; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Lima AN, 2016, EXPERT OPIN DRUG DIS, V11, P225, DOI 10.1517/17460441.2016.1146250; Mckinney W., 2010, P PYTH SCI C, P51, DOI DOI 10.25080/MAJORA-92BF1922-00A; Mitchell JBO, 2014, WIRES COMPUT MOL SCI, V4, P468, DOI 10.1002/wcms.1183; Moriwaki H, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0258-y; Muratov EN, 2020, CHEM SOC REV, V49, P3525, DOI 10.1039/d0cs00098a; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; OECD, 2007, OECD SER TEST ASS, V69; Oliphant T.E., 2015, GUIDE NUMPY, V2nd edn; Pandita R, 2014, INT LETT NAT SCI, V17, P139, DOI 10.18052/www.scipress.com/ILNS.17.139; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Rampasek Ladislav, 2016, Cell Syst, V2, P12, DOI 10.1016/j.cels.2016.01.009; Raschka S., 2018, J OPEN SOURCE SOFTW, V3, P638, DOI [10.21105/joss.00638, DOI 10.21105/JOSS.00638]; Robnik-Sikonja M., 1997, MACHINE LEARNING P 1, P296, DOI [10.5555/645526.657141, DOI 10.1119/1.880454]; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Skalic M, 2019, BIOINFORMATICS, V35, P1237, DOI 10.1093/bioinformatics/bty758; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stokes JM, 2020, CELL, V180, P688, DOI 10.1016/j.cell.2020.01.021; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xia ZH, 2020, J COMPUT AID MOL DES, V34, P769, DOI 10.1007/s10822-019-00242-8; Yue LZ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90932; Zhavoronkov A, 2019, NAT BIOTECHNOL, V37, P1038, DOI 10.1038/s41587-019-0224-x	49	4	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246126	10.1371/journal.pone.0246126	http://dx.doi.org/10.1371/journal.pone.0246126			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508008	Green Published, gold			2022-12-26	WOS:000635021400095
J	Newell, KL; Clemmer, DC; Cox, JB; Kayode, YI; Zoccoli-Rodriguez, V; Taylor, HE; Endy, TP; Wilmore, JR; Winslow, GM				Newell, Krista L.; Clemmer, Deanna C.; Cox, Justin B.; Kayode, Yetunde, I; Zoccoli-Rodriguez, Victoria; Taylor, Harry E.; Endy, Timothy P.; Wilmore, Joel R.; Winslow, Gary M.			Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration	PLOS ONE			English	Article							T-BET; RESPONSES; EXPRESSION	Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the pandemic human respiratory illness COVID-19, is a global health emergency. While severe acute disease has been linked to an expansion of antibody-secreting plasmablasts, we sought to identify B cell responses that correlated with positive clinical outcomes in convalescent patients. We characterized the peripheral blood B cell immunophenotype and plasma antibody responses in 40 recovered non-hospitalized COVID-19 subjects that were enrolled as donors in a convalescent plasma treatment study. We observed a significant negative correlation between the frequency of peripheral blood memory B cells and the duration of symptoms for convalescent subjects. Memory B cell subsets in convalescent subjects were composed of classical CD24(+) class-switched memory B cells, but also activated CD24-negative and natural unswitched CD27(+) IgD(+) IgM(+) subsets. Memory B cell frequency was significantly correlated with both IgG1 and IgM responses to the SARS-CoV-2 spike protein receptor binding domain (RBD) in most seropositive subjects. IgM(+) memory, but not switched memory, directly correlated with virus-specific antibody responses, and remained stable over 3 months. Our findings suggest that the frequency of memory B cells is a critical indicator of disease resolution, and that IgM+ memory B cells may play an important role in SARS-CoV-2 immunity.	[Newell, Krista L.; Clemmer, Deanna C.; Cox, Justin B.; Kayode, Yetunde, I; Zoccoli-Rodriguez, Victoria; Taylor, Harry E.; Endy, Timothy P.; Wilmore, Joel R.; Winslow, Gary M.] Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA; [Endy, Timothy P.] Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Winslow, GM (corresponding author), Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.	winslowg@upstate.edu		Zoccoli-Rodriguez, Victoria/0000-0002-5487-6521	U.S. Department of Health and Human Services [R01AI114545]; SUNY Office of Research and Economic Development [20-03-COVID 202077]; SUNY Upstate Medical University	U.S. Department of Health and Human Services; SUNY Office of Research and Economic Development; SUNY Upstate Medical University	This work was supported by U.S. Department of Health and Human Services (www.hhs.gov) Grant #R01AI114545 (G.M.W.), SUNY Office of Research and Economic Development (https://www.suny.edu/impact/research/) seed grant RFP #20-03-COVID 202077 (J.R.W. and G. M.W.), and internal funding from SUNY Upstate Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnara D, 2015, J IMMUNOL, V195, P3716, DOI 10.4049/jimmunol.1500753; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Center for Systems Science and Engineering (CSSE), COVID 19 DASHBOARD; De Biasi S, 2020, EUR J IMMUNOL, V50, P1283, DOI 10.1002/eji.202048838; Jenks SA, 2019, IMMUNOL REV, V288, P136, DOI 10.1111/imr.12741; Kaneko N, 2020, CELL, V183, P143, DOI 10.1016/j.cell.2020.08.025; Kenderes KJ, 2018, CELL REP, V24, P824, DOI 10.1016/j.celrep.2018.06.074; Knox JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92943; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; Levack RC, 2020, J IMMUNOL, V205, P1050, DOI 10.4049/jimmunol.2000206; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Popescu M, 2019, J IMMUNOL, V203, P2415, DOI 10.4049/jimmunol.1900484; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Rodda LB, 2020, CELL, DOI [10.1016/j.cell, DOI 10.1016/J.CELL]; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Sanz I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02458; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Weill JC, 2020, CURR OPIN IMMUNOL, V63, P1, DOI 10.1016/j.coi.2019.09.003; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]	22	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0244855	10.1371/journal.pone.0244855	http://dx.doi.org/10.1371/journal.pone.0244855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507994	Green Submitted, Green Published, gold			2022-12-26	WOS:000635021400022
J	Phumee, A; Intayot, P; Sor-suwan, S; Jittmittraphap, A; Siriyasatien, P				Phumee, Atchara; Intayot, Proawpilart; Sor-suwan, Sriwatapron; Jittmittraphap, Akanitt; Siriyasatien, Padet			Molecular detection of Indian Ocean Lineage Chikungunya virus RNA in field collected Culex quinquefasciatus Say from Bangkok, Thailand but no evidence of virus replication	PLOS ONE			English	Article							AEDES-AEGYPTI L.; CULICIDAE VECTOR COMPETENCE; VERTICAL TRANSMISSION; BLOOD MEALS; IDENTIFICATION; MOSQUITO; OUTBREAK	Following an outbreak of chikungunya virus (CHIKV) infections in Thailand in 2019, numerous cases of CHIKV infection have been diagnosed in Bangkok, the capital of the country. In our previous investigation of the vectors for disease transmission, we found natural infection of CHIKV in both male and female Aedes aegypti mosquitoes collected from the outbreak areas in Bangkok. Some reports mentioned the detection of CHIKV in Culex mosquitoes. In Thailand, the Culex quinquefasciatus Say mosquito is a common species found in urban and rural settings that coexists with Ae. aegypti. However, the role of Cx. quinquefasciatus mosquitoes in the spread of the Indian Ocean Lineage (IOL) of CHIKV in Thailand has never been investigated. In this study, Cx. quinquefasciatus were collected (16 males and 27 females) from an outbreak area in Bangkok. Eight of the 27 in field-caught female Cx. quinquefasciatus were positive for IOL CHIKV RNA, and 99-100% identity and full 100% coverage of sequences similar to CHIKV isolated from female Ae. aegypti in Bangkok, Thailand, whereas viral RNA was not detected in male samples using nested-RT-PCR. To determine whether CHIKV is able to replicate in Cx. quinquefasciatus, the laboratory strain of Cx. quinquefasciatus was allowed to feed on blood containing IOL CHIKV isolated from patient serum. The nested-RT-PCR, virus isolation, and immunofluorescence assay (IFA) were performed for CHIKV detection and replication. The results showed that CHIKV RNA was detected in Cx. quinquefasciatus until day 4 post infection. CHIKV did not produce any remarkable signs of infection, dissemination, or transmission in Cx. quinquefasciatus, and cytopathic effect ( CPE) was not observed in C6/36 cells when infected with supernatant obtained from Cx. quinquefasciatus at days 7, 10, 14, and 21 post infection when compared to Ae. aegypti. The data from this study infer that CHIKV may be detected in Cx. quinquefasciatus but that the mosquito is not able to transmit CHIKV in Thailand.	[Phumee, Atchara] Walailak Univ, Sch Allied Hlth Sci, Dept Med Technol, Nakhon Si Thamarat, Thailand; [Intayot, Proawpilart] Chulalongkorn Univ, Fac Med, Med Sci Program, Bangkok, Thailand; [Sor-suwan, Sriwatapron; Siriyasatien, Padet] Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand; [Jittmittraphap, Akanitt] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Mahidol University	Siriyasatien, P (corresponding author), Chulalongkorn Univ, Fac Med, Dept Parasitol, Vector Biol & Vector Borne Dis Res Unit, Bangkok, Thailand.	padet.s@chula.ac.th	PHUMEE, ATCHARA/AAG-4881-2020; siriyasatien, padet/F-3936-2012; Jittmittraphap, Akanitt/V-8811-2019	PHUMEE, ATCHARA/0000-0001-8243-7406; Jittmittraphap, Akanitt/0000-0001-5155-2727; Siriyasatien, Padet/0000-0002-9248-1678	Second Century Fund (C2F), Chulalongkorn University; new strategic research project (P2P), Walailak University, Thailand; National Research Council of Thailand (NRCT) [NRCT5-RSA6300103]; Health Systems Research Institute [63-017]; Rachadapisek Sompote Fund [RA/MF 21/63]; Thailand Research Fund; Program Management Unit for Human Resources & Institutional Development, Research and Innovation - CU [B16F630071]; TSRI Fund [CU_FRB640001_01_30_1]; Chulalongkorn University;  [NIH/NIAID/CREID/07-049-7012-52338]	Second Century Fund (C2F), Chulalongkorn University; new strategic research project (P2P), Walailak University, Thailand; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Health Systems Research Institute; Rachadapisek Sompote Fund; Thailand Research Fund(Thailand Research Fund (TRF)); Program Management Unit for Human Resources & Institutional Development, Research and Innovation - CU; TSRI Fund; Chulalongkorn University(Chulalongkorn University); 	This study was supported by the Second Century Fund (C2F), Chulalongkorn University, the new strategic research project (P2P), Walailak University, Thailand, National Research Council of Thailand (NRCT): (Grant No. NRCT5-RSA6300103), Health Systems Research Institute (Grant No. 63-017), Rachadapisek Sompote Fund (RA/MF 21/63), the Thailand Research Fund and Chulalongkorn University, the Program Management Unit for Human Resources & Institutional Development, Research and Innovation - CU (Grant No. B16F630071), TSRI Fund (Grant No. CU_FRB640001_01_30_1), and NIH/NIAID/CREID/07-049-7012-52338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000; Bessaud M, 2006, EMERG INFECT DIS, V12, P1604, DOI 10.3201/eid1210.060596; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand, CHIK; Chansaenroj J, 2020, ARCH VIROL, V165, P445, DOI 10.1007/s00705-019-04509-1; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Chompoosri J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1505-6; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Intayot P, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8030121; JUPP PG, 1981, T ROY SOC TROP MED H, V75, P15, DOI 10.1016/0035-9203(81)90005-5; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Lee JH, 2002, AM J TROP MED HYG, V66, P599, DOI 10.4269/ajtmh.2002.66.599; McINTOSH B. M., 1963, S AFRICAN JOUR MED SCI, V28, P45; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Phumee A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41727-8; Pongsiri P, 2010, TROP BIOMED, V27, P167; Pothikasikorn J, 2010, J VECTOR ECOL, V35, P149, DOI 10.1111/j.1948-7134.2010.00041.x; Potiwat R, 2011, SE ASIAN J TROP MED, V42, P1388; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Cruz ACR, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080853; Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Richards SL, 2009, AM J TROP MED HYG, V81, P264, DOI 10.4269/ajtmh.2009.81.264; ROSS R. W., 1956, JOUR HYG, V54, P177; Rozendaal JA, 2007, VECTOR CONTROL METHO; Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43; Thavara U, 2009, SE ASIAN J TROP MED, V40, P951; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Wanlapakorn N, 2014, EMERG INFECT DIS, V20, P1404, DOI 10.3201/eid2008.140481; Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246026	10.1371/journal.pone.0246026	http://dx.doi.org/10.1371/journal.pone.0246026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507923	Green Published, gold			2022-12-26	WOS:000635021400074
J	de Kluijver, A; Nierop, KGJ; Morganti, TM; Bart, MC; Slaby, BM; Hanz, U; de Goeij, JM; Mienis, F; Middelburg, JJ				de Kluijver, Anna; Nierop, Klaas G. J.; Morganti, Teresa M.; Bart, Martijn C.; Slaby, Beate M.; Hanz, Ulrike; de Goeij, Jasper M.; Mienis, Furu; Middelburg, Jack J.			Bacterial precursors and unsaturated long-chain fatty acids are biomarkers of North-Atlantic deep-sea demosponges	PLOS ONE			English	Article								Sponges produce distinct fatty acids (FAs) that (potentially) can be used as chemotaxonomic and ecological biomarkers to study endosymbiont-host interactions and the functional ecology of sponges. Here, we present FA profiles of five common habitat-building deep-sea sponges (class Demospongiae, order Tetractinellida), which are classified as high microbial abundance (HMA) species. Geodia hentscheli, G. parva, G. atlantica, G. barretti, and Stelletta rhaphidiophora were collected from boreal and Arctic sponge grounds in the NorthAtlantic Ocean. Bacterial FAs dominated in all five species and particularly isomeric mixtures of mid-chain branched FAs (MBFAs, 8- and 9-Me-C-16:0 and 10- and 11Me C-18:0) were found in high abundance (together >= 20% of total FAs) aside more common bacterial markers. In addition, the sponges produced long-chain linear, mid- and a(i)-branched unsaturated FAs (LCFAs) with a chain length of 24-28 C atoms and had predominantly the typical Delta(5,9) unsaturation, although the Delta(9,19) and (yet undescribed) Delta(11,21) unsaturations were also identified. G. parva and S. rhaphidiophora each produced distinct LCFAs, while G. atlantica, G. barretti, and G. hentscheli produced similar LCFAs, but in different ratios. The different bacterial precursors varied in carbon isotopic composition (delta C-13), with MBFAs being more enriched compared to other bacterial (linear and a(i)-branched) FAs. We propose biosynthetic pathways for different LCFAs from their bacterial precursors, that are consistent with small isotopic differences found in LCFAs. Indeed, FA profiles of deep-sea sponges can serve as chemotaxonomic markers and support the concept that sponges acquire building blocks from their endosymbiotic bacteria.	[de Kluijver, Anna; Nierop, Klaas G. J.; Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Dept Earth Sci, Utrecht, Netherlands; [Morganti, Teresa M.] Max Planck Inst Marine Microbiol, Bremen, Germany; [Bart, Martijn C.; de Goeij, Jasper M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Freshwater & Marine Ecol, Amsterdam, Netherlands; [Slaby, Beate M.] GEOMAR Helmholtz Ctr Ocean Res Kiel, Kiel, Germany; [Hanz, Ulrike; Mienis, Furu] NIOZ Royal Netherlands Inst Sea Res, Den Burg, Texel, Netherlands; [Hanz, Ulrike; Mienis, Furu] Univ Utrecht, Den Burg, Texel, Netherlands	Utrecht University; Max Planck Society; University of Amsterdam; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	de Kluijver, A (corresponding author), Univ Utrecht, Fac Geosci, Dept Earth Sci, Utrecht, Netherlands.	a.dekluijver@uu.nl; k.g.j.nierop@uu.nl	Morganti, Teresa Maria/AAH-9827-2019; Middelburg, Jack/B-4951-2011	Morganti, Teresa Maria/0000-0001-6928-9496; Middelburg, Jack/0000-0003-3601-9072; Slaby, Beate/0000-0002-9480-1460; de Kluijver, Anna/0000-0001-8288-7466; Bart, Martijn/0000-0002-7624-5480; Nierop, Klaas G.J./0000-0002-4482-6109	European Union's Horizon 2020 research and innovation programme [679849]; ERC [715513]; Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant) [0.16.161.360]; DFG Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen [49926684]; ERC Adv Grant ABYSS, both to Prof. Antje Boetius [294757]	European Union's Horizon 2020 research and innovation programme; ERC(European Research Council (ERC)European Commission); Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant); DFG Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen; ERC Adv Grant ABYSS, both to Prof. Antje Boetius	This research has been performed in the scope of the EU SponGES project, which received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 679849. This document reflects only the authors' views and the Executive Agency for Small and Medium-sized Enterprises (EASME) is not responsible for any use that may be made of the information it contains. Further support included ERC starting grant agreement No. 715513 to Dr. J. M. de Goeij and the Netherlands Earth System Science Center to Prof. J. J. Middelburg. Dr. F. Mienis is supported by the Innovational Research Incentives Scheme of the Netherlands Organisation for Scientific Research (NWO-VIDI grant no. 0.16.161.360). Additional funds come from the DFG Cluster of Excellence "The Ocean in the Earth System" at the University of Bremen (grant. 49926684) and from the ERC Adv Grant ABYSS, both to Prof. Antje Boetius (grant no. 294757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnathan G, 1996, LIPIDS, V31, P193, DOI 10.1007/BF02522620; Bart M, 2020, LIMNOL OCEANOGR, P1; Bart MC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74670-0; Berge J-P, 2005, Mar Biotechnol, V1, P51; BERGQUIST PR, 1984, BIOCHEM SYST ECOL, V12, P63, DOI 10.1016/0305-1978(84)90012-7; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOON JJ, 1977, J BACTERIOL, V129, P1183, DOI 10.1128/JB.129.3.1183-1191.1977; BOSCHKER H. T. S., 2004, MOL MICROBIAL ECOLOG, P1673; Busch K, 2020, BIOGEOSCIENCES, V17, P3471, DOI 10.5194/bg-17-3471-2020; CARBALLEIRA N, 1986, J ORG CHEM, V51, P2751, DOI 10.1021/jo00364a024; CARBALLEIRA NM, 1994, J NAT PROD, V57, P1152, DOI 10.1021/np50110a004; Cardenas P, 2013, ZOOL J LINN SOC-LOND, V169, P312; Christie W.W., 1993, ADV LIPID METHODOLOG, P69, DOI DOI 10.1016/0009-3084(94)02308-5; Djerassi C, 1991, ACC CHEM RES, V24, P69; Fieseler L, 2004, APPL ENVIRON MICROB, V70, P3724, DOI 10.1128/aem.70.6.3724-3732.2004; GILLAN FT, 1988, LIPIDS, V23, P1139, DOI 10.1007/BF02535280; Griffith DR, 2012, BIOGEOSCIENCES, V9, P1217, DOI 10.5194/bg-9-1217-2012; HAHN S, 1988, J AM CHEM SOC, V110, P8117, DOI 10.1021/ja00232a025; Hochmuth T, 2010, CHEMBIOCHEM, V11, P2572, DOI 10.1002/cbic.201000510; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; HOUGAARD L, 1991, BIOCHEM SYST ECOL, V19, P223, DOI 10.1016/0305-1978(91)90006-L; Murillo FJ, 2012, MAR BIOL RES, V8, P842, DOI 10.1080/17451000.2012.682583; KERGER BD, 1986, FEMS MICROBIOL ECOL, V38, P67, DOI 10.1016/0378-1097(86)90144-8; Klitgaard AB, 2004, PROG OCEANOGR, V61, P57, DOI 10.1016/j.pocean.2004.06.002; Knudby A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082306; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Kool DM, 2012, APPL ENVIRON MICROB, V78, P8650, DOI 10.1128/AEM.02099-12; Koopmans M, 2015, MAR BIOTECHNOL, V17, P43, DOI 10.1007/s10126-014-9594-8; Kornprobst JM, 2010, MAR DRUGS, V8, P2569, DOI 10.3390/md8102569; Kutti T, 2013, CONT SHELF RES, V69, P21, DOI 10.1016/j.csr.2013.09.011; LAWSON MP, 1988, LIPIDS, V23, P741, DOI 10.1007/BF02536215; Leys SP, 2018, LIMNOL OCEANOGR, P1; Lipski A, 2001, SYST APPL MICROBIOL, V24, P377, DOI 10.1078/0723-2020-00049; LITCHFIELD C, 1976, LIPIDS, V11, P567, DOI 10.1007/BF02532903; Luter HM, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix074; Makarieva TN, 2002, LIPIDS, V37, P75, DOI 10.1007/s11745-002-0866-6; Mishra PM, 2015, SPRINGER HANDBOOK OF MARINE BIOTECHNOLOGY, P851; MORALES RW, 1977, LIPIDS, V12, P570, DOI 10.1007/BF02533383; MORALES RW, 1976, BIOCHIM BIOPHYS ACTA, V431, P206, DOI 10.1016/0005-2760(76)90140-5; Nechev J, 2002, EUR J LIPID SCI TECH, V104, P800, DOI 10.1002/1438-9312(200212)104:12<800::AID-EJLT800>3.0.CO;2-E; NICHOLS PD, 1986, J MICROBIOL METH, V5, P49, DOI 10.1016/0167-7012(86)90023-0; Pape T., 2004, THESIS U HAMBURG; Parzanini C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207395; Pita L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0428-1; R Core Team, 2021, R LANG ENV STAT; Radax R, 2012, ENVIRON MICROBIOL, V14, P1308, DOI 10.1111/j.1462-2920.2012.02714.x; Radax R, 2012, ENVIRON MICROBIOL, V14, P909, DOI 10.1111/j.1462-2920.2011.02661.x; RAEDERSTORFF D, 1987, J ORG CHEM, V52, P2337, DOI 10.1021/jo00388a001; Rezanka T, 2009, PROG LIPID RES, V48, P206, DOI 10.1016/j.plipres.2009.03.003; Ribes M, 2012, ENVIRON MICROBIOL, V14, P1224, DOI 10.1111/j.1462-2920.2012.02701.x; Rix L, 2016, SCI REP-UK, V6, DOI 10.1038/srep18715; Roberts EM, 2018, DEEP-SEA RES PT I, V138, P98, DOI 10.1016/j.dsr.2018.06.007; Rod'kina S.A., 2005, RUSSIAN J MAR BIOL, V31, pS49, DOI [10.1007/s11179-006-0015-3, DOI 10.1007/S11179-006-0015-3]; Rubin-Blum M, 2019, ISME J, V13, P1209, DOI 10.1038/s41396-019-0346-7; Schottner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055505; Schwab VF, 2017, BIOGEOSCIENCES, V14, P2697, DOI 10.5194/bg-14-2697-2017; Siegl A, 2011, ISME J, V5, P61, DOI 10.1038/ismej.2010.95; Soetaert K., 2015, RLIMS R FUNCTIONS LA, V1.03; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Thiel V, 2002, NATURWISSENSCHAFTEN, V89, P60, DOI 10.1007/s00114-001-0284-9; Thiel V, 1999, ORG GEOCHEM, V30, P1, DOI 10.1016/S0146-6380(98)00200-9; Thurber AR, 2007, MAR ECOL PROG SER, V351, P77, DOI 10.3354/meps07122; van Duyl FC, 2020, MAR BIOL RES, V16, P1, DOI 10.1080/17451000.2019.1704019; van Duyl FC, 2011, MAR BIOL, V158, P1653, DOI 10.1007/s00227-011-1681-z; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; Veuger B, 2013, BIOGEOSCIENCES, V10, P1775, DOI 10.5194/bg-10-1775-2013; VINCENTI M, 1987, ANAL CHEM, V59, P694, DOI 10.1021/ac00132a003; WALKUP RD, 1981, LIPIDS, V16, P631, DOI 10.1007/BF02535058; Wassmann P, 2010, POLAR BIOL, V33, P1641, DOI 10.1007/s00300-010-0839-3; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0	71	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0241095	10.1371/journal.pone.0241095	http://dx.doi.org/10.1371/journal.pone.0241095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503057	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000613751800017
J	Schafer, A; Haenig, B; Erupathil, J; Strickner, P; Sabato, D; Welford, RWD; Klaeyle, L; Simon, E; Krepler, C; Brafford, P; Xiao, M; Herlyn, M; Gstaiger, M; Lehembre, F; Renz, I				Schaefer, Alexander; Haenig, Benedicte; Erupathil, Julie; Strickner, Panja; Sabato, Daniela; Welford, Richard W. D.; Klaeyle, Lheanna; Simon, Elise; Krepler, Clemens; Brafford, Patricia; Xiao, Min; Herlyn, Meenhard; Gstaiger, Matthias; Lehembre, Francois; Renz, Imke			Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma	ONCOGENE			English	Article							METASTATIC MELANOMA; CONFERS RESISTANCE; CELLS; EXPRESSION; APOPTOSIS; ANTAGONIST; SURVIVAL; BEHAVIOR; THERAPY; GROWTH	The clinical benefit of MAPK pathway inhibition in melanoma patients carrying BRAF mutations is temporal. After the initial response to treatment, the majority of tumors will develop resistance and patients will relapse. Here we demonstrate that the endothelin-endothelin receptor B (ETBR) signaling pathway confers resistance to MAPK pathway inhibitors in BRAF mutated melanoma. MAPK blockade, in addition to being anti-proliferative, induces a phenotypic change which is characterized by increased expression of melanocyte-specific genes including ETBR. In the presence of MAPK inhibitors, activation of ETBR by endothelin enables the sustained proliferation of melanoma cells. In mouse models of melanoma, including patient-derived xenograft models, concurrent inhibition of the MAPK pathway and ETBR signaling resulted in a more effective anti-tumor response compared to MAPK pathway inhibition alone. The combination treatment significantly reduced tumor growth and prolonged survival compared to therapies with MAPK pathway inhibitors alone. The phosphoproteomic analysis revealed that ETBR signaling did not induce resistance towards MAPK pathway inhibitors by restoring MAPK activity, but instead via multiple alternative signaling pathways downstream of the small G proteins GNAq/11. Together these data indicate that a combination of MAPK pathway inhibitors with ETBR antagonists could have a synergistically beneficial effect in melanoma patients with hyperactivated MAPK signaling pathways.	[Schaefer, Alexander; Gstaiger, Matthias] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Otto Stern Weg 3, CH-8093 Zurich, Switzerland; [Haenig, Benedicte; Erupathil, Julie; Strickner, Panja; Sabato, Daniela; Welford, Richard W. D.; Klaeyle, Lheanna; Simon, Elise; Lehembre, Francois; Renz, Imke] Idorsia Pharmaceut Ltd, Drug Discovery Biol, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland; [Krepler, Clemens; Brafford, Patricia; Xiao, Min; Herlyn, Meenhard] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program & Melanoma Res, 3601 Spruce St, Philadelphia, PA 19104 USA; [Schaefer, Alexander] Swiss BioQuant AG, CH-4153 Reinach, Switzerland; [Simon, Elise] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Krepler, Clemens] Merck, N Wales, PA 19454 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Idorsia Pharmaceuticals Ltd; The Wistar Institute; Novartis	Renz, I (corresponding author), Idorsia Pharmaceut Ltd, Drug Discovery Biol, Hegenheimermattweg 91, CH-4123 Allschwil, Switzerland.	imke.renz@idorsia.com			Idorsia Pharmaceuticals Ltd.	Idorsia Pharmaceuticals Ltd.	The study was funded by Idorsia Pharmaceuticals Ltd.	Asundi J, 2014, MOL CANCER THER, V13, P1599, DOI 10.1158/1535-7163.MCT-13-0446; Asundi J, 2011, CLIN CANCER RES, V17, P965, DOI 10.1158/1078-0432.CCR-10-2340; Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Borrull A, 2016, MABS-AUSTIN, V8, P1371, DOI 10.1080/19420862.2016.1208865; Chiriboga L, 2016, MELANOMA RES, V26, P236, DOI 10.1097/CMR.0000000000000235; Christensen C, 2005, ONCOGENE, V24, P6292, DOI 10.1038/sj.onc.1208758; Demunter A, 2001, VIRCHOWS ARCH, V438, P485, DOI 10.1007/s004280000362; Faiao-Flores F, 2019, CLIN CANCER RES, V25, P5686, DOI 10.1158/1078-0432.CCR-18-3382; Haq R, 2013, P NATL ACAD SCI USA, V110, P4321, DOI 10.1073/pnas.1205575110; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Jankov RP, 2006, PEDIATR RES, V60, P245, DOI 10.1203/01.pdr.0000233056.37254.0b; Johannessen CM, 2013, NATURE, V504, P138, DOI 10.1038/nature12688; Johnson DB, 2015, EUR J CANCER, V51, P2792, DOI 10.1016/j.ejca.2015.08.022; Kakadia S, 2018, ONCOTARGETS THER, V11, P7095, DOI 10.2147/OTT.S182721; Kefford R, 2007, INVEST NEW DRUG, V25, P247, DOI 10.1007/s10637-006-9014-7; Kefford RF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-69; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Lahav R, 2004, CANCER RES, V64, P8945, DOI 10.1158/0008-5472.CAN-04-1510; Lahav R, 1999, P NATL ACAD SCI USA, V96, P11496, DOI 10.1073/pnas.96.20.11496; Lin NX, 2007, J HUAZHONG U SCI-MED, V27, P611, DOI 10.1007/s11596-007-0535-x; Luebker SA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00268; Maffei R, 2017, ONCOTARGET, V8, P90013, DOI 10.18632/oncotarget.21341; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nelson JB, 2005, NEOPLASIA, V7, P631, DOI 10.1593/neo.04787; Paulitschke V, 2019, EMBO J, V38, DOI 10.15252/embj.201695874; Rosano L, 2004, J CARDIOVASC PHARM, V44, pS136, DOI 10.1097/01.fjc.0000166247.35992.dd; Rosano L, 2013, NAT REV CANCER, V13, P637, DOI 10.1038/nrc3546; Sandhu S, 2020, INVEST NEW DRUG, V38, P844, DOI 10.1007/s10637-019-00832-1; Sato-Jin K, 2008, FASEB J, V22, P1155, DOI 10.1096/fj.07-9080com; Schafer A, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20198828; Schorlemmer A, 2008, TRENDS CARDIOVAS MED, V18, P233, DOI 10.1016/j.tcm.2008.11.005; Shoushtari AN, 2014, MELANOMA RES, V24, P525, DOI 10.1097/CMR.0000000000000121; Smith MP, 2017, EMBO MOL MED, V9, P1011, DOI 10.15252/emmm.201607156; Smith MP, 2016, CANCER CELL, V29, P270, DOI 10.1016/j.ccell.2016.02.003; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Tang L, 2008, J CUTAN MED SURG, V12, P64, DOI 10.2310/7750.2008.06164; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Wu-Wong JR, 2002, CLIN SCI, V103, p107S, DOI 10.1042/CS103S107S; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; YOHN JJ, 1994, BIOCHEM BIOPH RES CO, V201, P449, DOI 10.1006/bbrc.1994.1722	44	5	5	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1659	1673		10.1038/s41388-020-01628-x	http://dx.doi.org/10.1038/s41388-020-01628-x		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33500549				2022-12-26	WOS:000611934200001
J	Perry, RI; Young, K; Galbraith, M; Chandler, P; Velez-Espino, A; Baillie, S				Perry, R. Ian; Young, Kelly; Galbraith, Moira; Chandler, Peter; Velez-Espino, Antonio; Baillie, Steve			Zooplankton variability in the Strait of Georgia, Canada, and relationships with the marine survivals of Chinook and Coho salmon	PLOS ONE			English	Article							TIME-SERIES; BRITISH-COLUMBIA; INTERANNUAL VARIABILITY; ONCORHYNCHUS-KISUTCH; TEMPORAL SCALES; CLIMATE; PRODUCTIVITY; PATTERNS; BIOMASS; MODELS	The Strait of Georgia, Canada, has complex interactions among natural and human pressures that confound understanding of changes in this system. We report on the interannual variability in biomass of 12 zooplankton taxonomic groups in the deep (bottom depths greater than 50 m) central and northern Strait of Georgia from 1996 to 2018, and their relationships with 10 physical variables. Total zooplankton biomass was dominated (76%) by large-sized crustaceans (euphausiids, large and medium size calanoid copepods, amphipods). The annual anomaly of total zooplankton biomass was highest in the late 1990s, lowest in the mid-2000s, and generally above its climatological (1996-2010) average after 2011, although many individual groups had different patterns. Two latent trends (derived from dynamic factor analyses) described the variability of annual biomass anomalies underlying all zooplankton groups: a U-shaped trend with its minimum in the mid-2000s, and a declining trend from 2001 to 2011. Two latent trends also described the physical variables. The variability represented by these four latent trends clustered into two periods: 1996-2006, with generally declining zooplankton biomass and increasing salinities, and 2007-2018, with increasing zooplankton biomass and decreasing salinities. ARIMA modelling showed sea surface salinity at Entrance Island in the middle Strait of Georgia, the Pacific Decadal Oscillation, and the peak date of the spring phytoplankton bloom were significantly related to the two latent zooplankton trends. ARIMA models comparing zooplankton and physical variables with the marine survivals of four salmon populations which enter the Strait as juveniles (Chinook: Cowichan River, Puntledge River, Harrison River; Coho: Big Qualicum River) all included zooplankton groups consistent with known salmon prey; prominent among the physical variables were sea surface salinity and variables representing the flow from the Fraser River. These regressions explained (R-adj(2)) 38 to 85% of the annual variability in marine survival rates of these salmon populations over the study time period. Although sea temperature was important in some relationships between zooplankton biomass and salmon marine survival, salinity was a more frequent and more important variable, consistent with its influence on the hydrodynamics of the Strait of Georgia system.	[Perry, R. Ian; Velez-Espino, Antonio; Baillie, Steve] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada; [Perry, R. Ian; Young, Kelly; Galbraith, Moira; Chandler, Peter] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada	Perry, RI (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.; Perry, RI (corresponding author), Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada.	Ian.Perry@dfo-mpo.gc.ca		Perry, Ian/0000-0002-8855-7078	Pacific Salmon Foundation; Fisheries and Oceans Canada	Pacific Salmon Foundation; Fisheries and Oceans Canada	This work was funded in part by grants to RIP from the Pacific Salmon Foundation (www.psf.ca), and by funding from Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S, 2018, CAN TECH REP FISH AQ, V3266, P164; [Anonymous], 2020, BR J ANAESTH ADV, V125; Araujo HA, 2013, PROG OCEANOGR, V115, P41, DOI 10.1016/j.pocean.2013.05.022; Bakun A, 2010, J MARINE SYST, V79, P361, DOI 10.1016/j.jmarsys.2008.12.008; Batchelder HP, 2012, PROG OCEANOGR, V97, P15, DOI 10.1016/j.pocean.2011.11.010; Beamish R, 2010, NPAFC DOC, V1282; Beamish R.J., 2014, SEA US AMAZING STRAI; Beamish RJ, 2004, T AM FISH SOC, V133, P26, DOI 10.1577/T03-028; Bennett KD, 1996, NEW PHYTOL, V132, P155, DOI 10.1111/j.1469-8137.1996.tb04521.x; BRODEUR RD, 1987, J FISH BIOL, V31, P465, DOI 10.1111/j.1095-8649.1987.tb05252.x; Chandler P, 2019, CAN TECH REP FISH AQ, V3314, P39; Chittenden CM, 2018, ESTUAR COAST SHELF S, V200, P335, DOI 10.1016/j.ecss.2017.11.021; Collins AK, 2009, CAN J FISH AQUAT SCI, V66, P1597, DOI 10.1139/F09-071; Costalago D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65557-1; Daly EA, 2010, MAR BIOL, V157, P1975, DOI 10.1007/s00227-010-1466-9; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; Di Lorenzo E, 2016, NAT CLIM CHANGE, V6, P1042, DOI [10.1038/NCLIMATE3082, 10.1038/nclimate3082]; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; El-Sabaawi R, 2009, MAR ECOL PROG SER, V382, P151, DOI 10.3354/meps07915; Ford JKB, 2010, BIOL LETTERS, V6, P139, DOI 10.1098/rsbl.2009.0468; Haro-Garay MJ, 2003, CRUSTACEANA, V76, P1291, DOI 10.1163/156854003323009821; Holmes E., 2018, MARSS MULTIVARIATE A; Holmes EE, 2012, R J, V4, P11; Hu XK, 2017, INT SYMP DISTR COMPU, P3, DOI 10.1109/DCABES.2017.8; Hyndman R. J., 2019, FORECAST FORECASTING; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Johannessen S, 2010, DFO CAN SCI ADVIS SE; Johannessen SC, 2009, CLIM RES, V40, P1, DOI 10.3354/cr00819; Keen E, 2015, NET SAVVY PRACTICAL, V545; King JC, 2000, NUTRITION AND IMMUNOLOGY, P65; Kuhn M, 2019, CARET CLASSIFICATION; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Li LB, 2013, PROG OCEANOGR, V115, P90, DOI 10.1016/j.pocean.2013.05.025; Litzow MA, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1855; Mackas DL, 2012, PROG OCEANOGR, V97, P31, DOI 10.1016/j.pocean.2011.11.005; Mackas D, 2013, PROG OCEANOGR, V115, P129, DOI 10.1016/j.pocean.2013.05.019; Mahara N, 2021, ESTUAR COAST SHELF S, V249, DOI 10.1016/j.ecss.2020.107103; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Masson D, 2007, CONT SHELF RES, V27, P634, DOI 10.1016/j.csr.2006.10.009; Masson D, 2013, PROG OCEANOGR, V115, P1, DOI 10.1016/j.pocean.2013.05.009; McKinnell SM, 2003, FISH OCEANOGR, V12, P126, DOI 10.1046/j.1365-2419.2003.00227.x; Muhling BA, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00589; Nelson BW, 2019, CAN J FISH AQUAT SCI, V76, P447, DOI 10.1139/cjfas-2017-0481; Neville C, 1999, NPAFC DOC, V435; Newman M, 2016, J CLIMATE, V29, P4399, DOI 10.1175/JCLI-D-15-0508.1; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; OBrien T., 2013, ICES COOP RES REP, P6; Pawlowicz R, 2007, ATMOS OCEAN, V45, P173, DOI 10.3137/ao.450401; Perry RI, 2013, PROG OCEANOGR, V115, P14, DOI 10.1016/j.pocean.2013.05.021; R Core Team, 2021, R LANGUAGE ENV STAT; Riche O, 2014, J MARINE SYST, V131, P36, DOI 10.1016/j.jmarsys.2013.11.003; Ruff CP, 2017, FISH OCEANOGR, V26, P625, DOI 10.1111/fog.12222; Schweigert JF, 2013, PROG OCEANOGR, V115, P103, DOI 10.1016/j.pocean.2013.05.017; Sharma R, 2013, FISH OCEANOGR, V22, P14, DOI 10.1111/fog.12001; Shaw W, 1998, MAR ECOL PROG SER, V175, P143, DOI 10.3354/meps175143; SMITH SD, 1988, J GEOPHYS RES-OCEANS, V93, P15467, DOI 10.1029/JC093iC12p15467; Snauffer EL, 2014, FISH OCEANOGR, V23, P375, DOI 10.1111/fog.12072; Suchy KD, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.102134; TCCHINOOK, 2020, 2001 TCCHINOOK; Thomson R. E., 1981, CAN SPEC PUBL FISH A, V56, P291; Walker Robert V., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P193; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Young K, 2020, CAN TECH REP FISH AQ, V3377, P181; Zimmerman MS, 2015, MAR COAST FISH, V7, P116, DOI 10.1080/19425120.2015.1012246	66	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245941	10.1371/journal.pone.0245941	http://dx.doi.org/10.1371/journal.pone.0245941			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33494097	gold, Green Published			2022-12-26	WOS:000613081500029
J	Sato, N; Hopper, LS				Sato, Nahoko; Hopper, Luke S.			Judges' evaluation reliability changes between identifiable and anonymous performance of hip-hop dance movements	PLOS ONE			English	Article							BIOLOGICAL MOTION; PERCEPTION	Hip-hop competitions are performed across the world. In the recent inclusion in the 2018 Youth Olympic Games, the assessment of hip-hop performance is undertaken by a panel of judges. The purpose of this study was to determine the reliability of different visualisation tools utilised in the assessment of the hip-hop dance movements. Ten dancers performed basic rhythmic hip-hop movements which were captured using a motion capture system and video camera. Humanoid and stick figure animations of the dancers' movements were created from the motion capture data. Ten judges then assessed 20 dance trials through observation using three different visualisation tools on a computer display, each of which provided different representations of a given hip-hop performance: (1) the actual video of the dancers; (2) an anonymous stick figure animation; (3) an anonymous humanoid animation. Judges were not informed that they were repeating an assessment of the performances across the three visualisation tools. The humanoid animation demonstrated the highest inter-class correlation coefficients among the three methods. Despite the stick figure animation demonstrating moderate to high reliability, both the humanoid animation and the video demonstrated very high reliability in the intra-class correlation coefficient. It is recommended that further research is undertaken exploring the use of humanoid animation as a formative assessment tool in the evaluation of hip-hop dance and the evolution of hip-hop into a respected artistic athletic discipline.	[Sato, Nahoko] Nagoya Gakuin Univ, Fac Rehabil Sci, Dept Phys Therapy, Nagoya, Aichi, Japan; [Hopper, Luke S.] Edith Cowan Univ, Western Australian Acad Performing Arts, Perth, WA, Australia	Edith Cowan University	Sato, N (corresponding author), Nagoya Gakuin Univ, Fac Rehabil Sci, Dept Phys Therapy, Nagoya, Aichi, Japan.	nsato@ngu.ac.jp		Sato, Nahoko/0000-0002-4052-7240	Nagoya Gakuin University Grant (2019)	Nagoya Gakuin University Grant (2019)	NS received Nagoya Gakuin University Grant (2019) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD HIP HOP DANC C; Bucar M, 2012, EUR J SPORT SCI, V12, P207, DOI 10.1080/17461391.2010.551416; Canal-Bruland R, 2010, EXP PSYCHOL, V57, P320, DOI 10.1027/1618-3169/a000038; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; Dallas G, 2010, SCI GYMNAST J, V2, P49; Fan JT, 2004, P ROY SOC B-BIOL SCI, V271, P347, DOI 10.1098/rspb.2003.2613; Hopper L, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND VIRTUAL REALITY (AIVR), P237, DOI 10.1109/AIVR.2018.00054; Huys R, 2008, PERCEPT PSYCHOPHYS, V70, P1217, DOI 10.3758/PP.70.7.1217; isu.org, INT SKAT UN HDB SING; Khaw MW, 2018, ACTA PSYCHOL, V188, P213, DOI 10.1016/j.actpsy.2018.04.018; Kondo A, 2013, ATTEN PERCEPT PSYCHO, V75, P1347, DOI 10.3758/s13414-013-0533-y; Leskosek B, 2010, SCI GYMNAST J, V2, P25; Lew R., 2010, AM J BIOSTAT, V1, P1, DOI [10.3844/amjbsp.2010.1.8, DOI 10.3844/AMJBSP.2010.1.8]; Lockwood K.L., 2005, AVANTE, V11, P1; Mishima K, 2014, J CRANIO MAXILL SURG, V42, P428, DOI 10.1016/j.jcms.2013.05.035; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Sato N, 2018, P 36 C INT SOC BIOM; Sato N, 2015, J APPL BIOMECH, V31, P1, DOI [10.1123/JAB.2014-0027, 10.1123/jab.2014-0027]; Sato N, 2014, J APPL BIOMECH, V30, P439, DOI 10.1123/jab.2013-0190; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Troje NF, 2005, PERCEPT PSYCHOPHYS, V67, P667, DOI 10.3758/BF03193523; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; worlddancesprt.org, BUEN AIR 2018 YOUTH	23	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245861	10.1371/journal.pone.0245861	http://dx.doi.org/10.1371/journal.pone.0245861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493189	Green Published, gold			2022-12-26	WOS:000613081500044
J	Couillard, CM; Maltais, D; Belley, R				Couillard, Catherine M.; Maltais, Domynick; Belley, Renald			Morphometrics and processing yield of Cucumaria frondosa (Holothuroidea) from the St. Lawrence Estuary, Canada	PLOS ONE			English	Article							SEA-CUCUMBERS; REPRODUCTIVE-BIOLOGY; GROWTH; ECHINODERMATA; WEIGHT; DIET; GAMETOGENESIS; BEHAVIOR; SIZE	Sea cucumber Cucumaria frondosa have highly variable whole body mass and length, and are usually sold to Asian markets as dried gutted body wall. Understanding the relation between size and yield of dry product is essential for resource conservation and for economic purposes. In this study, stock-specific mass and length recovery rates were estimated for C. frondosa captured by dredging or diving at various depths and seasons on the South shore of the St. Lawrence Estuary, along Gaspe ' Peninsula, and processed in a commercial plant. The processing yield in dry product mass per sea cucumber was more than 1.5 times larger for sea cucumbers collected at 26-47 m depth compared to those collected at 9-16 m depth. Within each strata, there was little variation in the processed body mass, seasonally or spatially. Recovery rates based on gutted mass for this stock (13.4-14.5%) varied little among depths and seasons, despite observed seasonal and bathymetric variation in reproductive status. In contrast, recovery rates based on whole body mass and length were highly variable both seasonally and spatially. Stress related to dredging or post-capture handling induced important variable body contraction and water content, leading to variation in body length, mass and shape of sea cucumbers having the same processed body mass. Gutted mass was the best metric to predict processed body mass and to estimate size whereas whole body length was the least reliable. New stock-specific information on variability of body mass, length, and recovery rates induced by capture, and on seasonal and bathymetric variation in reproductive status and processing yields will be used for the design of future stock assessment surveys, and for stock conservation.	[Couillard, Catherine M.; Maltais, Domynick; Belley, Renald] Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ, Canada	Fisheries & Oceans Canada	Couillard, CM (corresponding author), Fisheries & Oceans Canada, Maurice Lamontagne Inst, Mont Joli, PQ, Canada.	Catherine.Couillard@dfo-mpo.gc.ca		Catherine, Couillard/0000-0001-9323-6482	Fisheries Science Collaborative Program, Fisheries and Oceans Canada [4ST-217]	Fisheries Science Collaborative Program, Fisheries and Oceans Canada	Funding was provided by the Fisheries Science Collaborative Program, Fisheries and Oceans Canada (Project 4ST-217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors did not receive a salary from the funding program.	[Anonymous], 2014, R LANG ENV STAT COMP; Baillon S, 2011, DEEP-SEA RES PT I, V58, P260, DOI 10.1016/j.dsr.2010.12.010; Blais M., 2019, 2019009 DFO CAN SCI; Brown NAW, 2019, CURR ZOOL, V65, P685, DOI 10.1093/cz/zoy100; Campagna S, 2005, 26200 FISH OC CAN; Conand C, 2012, FAO SPECIES CATAL FI; David VMM, 2002, J MAR BIOL ASSOC UK, V82, P141, DOI 10.1017/S0025315402005258; Department of Fisheries and Oceans Canada [DFO], 2017, DFO CAN SCI ADV SEC; Feindel S., 2002, STATUS MAINE SEA CUC; Gianasi BL, 2017, AQUAC RES, V48, P3413, DOI 10.1111/are.13168; Gianasi BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127884; Gonzalez-Wanguemert M, 2019, INDIAN J GEO-MAR SCI, V48, P1715; Grant SM, 2006, P169 FISH MAR I CTR; Gudimova E.N., 2004, P269, DOI 10.1201/9780203970881.ch46; Hair CA, 2018, AQUACULTURE, V483, P63, DOI 10.1016/j.aquaculture.2017.09.044; Hamel J. F., 2008, FAO Fisheries and Aquaculture Technical Paper, P257; Hamel J. F., 2008, FAO Fisheries and Aquaculture Technical Paper, P293; Hamel J-F, 1996, SPC BECHE DE MER INF, V8, P22; Hamel JF, 2019, J ANIM ECOL, V88, P820, DOI 10.1111/1365-2656.12943; Hamel JF, 1998, CAN J ZOOL, V76, P1194, DOI 10.1139/cjz-76-6-1194; Hamel JF, 1996, ECOLOGY, V77, P1600, DOI 10.2307/2265555; Hamel JF, 1996, CAN J FISH AQUAT SCI, V53, P253, DOI 10.1139/cjfas-53-2-253; Hannah L, 2012, N AM J FISH MANAGE, V32, P167, DOI 10.1080/02755947.2012.663455; Jordan AJ, 1972, THESIS; KE PJ, 1987, CAN I FOOD SC TECH J, V20, P4, DOI 10.1016/S0315-5463(87)70661-0; Lee D, 2014, J ELECTR ENG TECHNOL, V9, P2154, DOI 10.5370/JEET.2014.9.6.2154; LEGAULT C, 1993, J EXP MAR BIOL ECOL, V170, P55, DOI 10.1016/0022-0981(93)90129-C; MECHETA A, 2019, BECHE INF BULL, V39, P65; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; Molinet C, 2012, REV BIOL MAR OCEANOG, V47, P257, DOI 10.4067/S0718-19572012000200008; Motokawa T., 2019, J AERO AQUA BIOMECH, V8, P2; Neil DM, 2012, J INVERTEBR PATHOL, V110, P267, DOI 10.1016/j.jip.2012.03.009; Nelson EJ, 2012, REV FISH SCI, V20, P212, DOI 10.1080/10641262.2012.719043; NGALUAFE P, 2013, BECHE INF BULL, V33, P3; Peters-Didier J, 2018, J MAR BIOL ASSOC UK, V98, P311, DOI [10.1017/S0025315416001193, 10.1017/s0025315416001193]; Purcell S.W., 2010, FAO FISHERIES AQUACU; Purcell SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095075; Purcell SW, 2009, SPC BECHE DE MER INF, V29, P3; Ram R, 2016, REG STUD MAR SCI, V8, P59, DOI 10.1016/j.rsma.2016.09.003; Ross DAN, 2013, DEEP-SEA RES PT II, V94, P333, DOI 10.1016/j.dsr2.2013.03.005; Schram E, 2019, C04019 WAG MAR RES; Sheehan EV, 2019, J ANIM ECOL, V88, P816, DOI 10.1111/1365-2656.13006; Singh R, 2001, INVERTEBR REPROD DEV, V40, P125, DOI 10.1080/07924259.2001.9652713; Skewes T, 2004, R021195 AFMA; So JJ, 2010, FISHERIES MANAG ECOL, V17, P473, DOI 10.1111/j.1365-2400.2010.00747.x; So JJ, 2009, THESIS; Starr M., 2002, 2002067 DFO CAN SCI; Tuset VM, 2003, J APPL ICHTHYOL, V19, P88, DOI 10.1046/j.1439-0426.2003.00344.x; Xu C, 2018, J FUNCT FOODS, V49, P73, DOI 10.1016/j.jff.2018.08.009; Yamana Y, 2006, FISHERIES SCI, V72, P585, DOI 10.1111/j.1444-2906.2006.01187.x	50	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245238	10.1371/journal.pone.0245238	http://dx.doi.org/10.1371/journal.pone.0245238			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481788	gold, Green Published			2022-12-26	WOS:000612929300170
J	Ferstl, PG; Filmann, N; Heilgenthal, EM; Schnitzbauer, AA; Bechstein, WO; Kempf, VAJ; Villinger, D; Schultze, TG; Hogardt, M; Stephan, C; Mutlak, H; Weiler, N; Mucke, MM; Trebicka, J; Zeuzem, S; Waidmann, O; Welker, MW				Ferstl, Philip G.; Filmann, Natalie; Heilgenthal, Eva-Maria; Schnitzbauer, Andreas A.; Bechstein, Wolf O.; Kempf, Volkhard A. J.; Villinger, David; Schultze, Tilman G.; Hogardt, Michael; Stephan, Christoph; Mutlak, Haitham; Weiler, Nina; Muecke, Marcus M.; Trebicka, Jonel; Zeuzem, Stefan; Waidmann, Oliver; Welker, Martin-Walter			Colonization with multidrug-resistant organisms is associated with in increased mortality in liver transplant candidates	PLOS ONE			English	Article							RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; INFECTION; PREVALENCE; SPECTRUM; IMPACT; MRSA; VRE	Objectives Rising prevalence of multidrug-resistant organisms (MDRO) is a major health problem in patients with liver cirrhosis. The impact of MDRO colonization in liver transplantation (LT) candidates and recipients on mortality has not been determined in detail. Methods Patients consecutively evaluated and listed for LT in a tertiary German liver transplant center from 2008 to 2018 underwent screening for MDRO colonization including methicillin-resistant Staphylococcus aureus (MRSA), multidrug-resistant gram-negative bacteria (MDRGN), and vancomycin-resistant enterococci (VRE). MDRO colonization and infection status were obtained at LT evaluation, planned and unplanned hospitalization, three months upon graft allocation, or at last follow-up on the waiting list. Results In total, 351 patients were listed for LT, of whom 164 (47%) underwent LT after a median of 249 (range 0-1662) days. Incidence of MDRO colonization increased during waiting time for LT, and MRDO colonization was associated with increased mortality on the waiting list (HR = 2.57, p<0.0001. One patients was colonized with a carbapenem-resistant strain at listing, 9 patients acquired carbapenem-resistant gram-negative bacteria (CRGN) on the waiting list, and 4 more after LT. In total, 10 of these 14 patients died. Conclusions Colonization with MDRO is associated with increased mortality on the waiting list, but not in short-term follow-up after LT. Moreover, colonization with CRGN seems associated with high mortality in liver transplant candidates and recipients.	[Ferstl, Philip G.; Heilgenthal, Eva-Maria; Weiler, Nina; Muecke, Marcus M.; Trebicka, Jonel; Zeuzem, Stefan; Waidmann, Oliver; Welker, Martin-Walter] Goethe Univ, Univ Hosp, Dept Internal Med & Gastroenterol & Hepatol, Frankfurt, Germany; [Filmann, Natalie] Goethe Univ, Inst Biostat & Math Modeling, Frankfurt, Germany; [Schnitzbauer, Andreas A.; Bechstein, Wolf O.] Goethe Univ, Univ Hosp, Dept Gen & Visceral Surg, Frankfurt, Germany; [Kempf, Volkhard A. J.; Villinger, David; Schultze, Tilman G.; Hogardt, Michael] Goethe Univ, Univ Hosp, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Kempf, Volkhard A. J.; Villinger, David; Schultze, Tilman G.; Hogardt, Michael] Goethe Univ, Univ Hosp Frankfurt, Univ Ctr Infect Dis UCI, Frankfurt, Germany; [Kempf, Volkhard A. J.; Villinger, David; Schultze, Tilman G.; Hogardt, Michael] Univ Ctr Competence Infect Control State Hesse, Frankfurt, Germany; [Stephan, Christoph] Goethe Univ, Univ Hosp, Dept Internal Med 2, Infect Dis, Frankfurt, Germany; [Mutlak, Haitham] Goethe Univ, Univ Hosp, Dept Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Ferstl, PG (corresponding author), Goethe Univ, Univ Hosp, Dept Internal Med & Gastroenterol & Hepatol, Frankfurt, Germany.	philip.ferstl@kgu.de	Stephan, Christoph/D-1305-2014	Stephan, Christoph/0000-0003-3777-9006; Filmann, Natalie/0000-0003-0424-2317				Adam R, 2018, TRANSPL INT, V31, P1293, DOI 10.1111/tri.13358; Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Bahra M, 2011, LANGENBECK ARCH SURG, V396, P461, DOI 10.1007/s00423-011-0766-y; Belga S, 2019, EXPERT REV ANTI-INFE, V17, P363, DOI 10.1080/14787210.2019.1607297; Bert F, 2012, EMERG INFECT DIS, V18, P908, DOI 10.3201/eid1806.110139; Fernandez J, 2019, J HEPATOL, V70, P398, DOI 10.1016/j.jhep.2018.10.027; Fernandez J, 2018, GUT, V67, P1870, DOI 10.1136/gutjnl-2017-314240; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; Ferstl PG, 2017, LIVER INT, V37, P1488, DOI 10.1111/liv.13438; Giannella M, 2019, CLIN MICROBIOL INFEC, V25, P1525, DOI 10.1016/j.cmi.2019.04.014; Giannella M, 2015, AM J TRANSPLANT, V15, P1708, DOI 10.1111/ajt.13136; Hagen EA, 2003, AM J TRANSPLANT, V3, P902, DOI 10.1034/j.1600-6143.2003.00169.x; Heudorf U, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000270; Koch C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235576; Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Massa E, 2019, TRANSPL P, V51, P454, DOI 10.1016/j.transproceed.2019.01.076; Medina E, 2016, CURR TOP MICROBIOL, V398, P3, DOI 10.1007/82_2016_492; Mucke MM, 2018, LIVER INT, V38, P645, DOI 10.1111/liv.13568; Mucke VT, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040991; Piano S, 2019, GASTROENTEROLOGY, V156, P1368, DOI 10.1053/j.gastro.2018.12.005; Reinheimer C, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.2.30110; Russell DL, 2008, AM J TRANSPLANT, V8, P1737, DOI 10.1111/j.1600-6143.2008.02304.x; Salerno F, 2017, LIVER INT, V37, P71, DOI 10.1111/liv.13195; Shi SH, 2010, CLIN TRANSPLANT, V24, P758, DOI 10.1111/j.1399-0012.2009.01184.x; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Tacke F, 2016, LIVER TRANSPLANT, V22, P1136, DOI 10.1002/lt.24461; Taniguchi S, 2012, ADVANCES IN TRANSPORTATION GEOTECHNICS II, P400; Weiler N, 2017, J CLIN PHARMACOL, V57, P837, DOI 10.1002/jcph.871; Zhong L, 2012, J INFECTION, V64, P299, DOI 10.1016/j.jinf.2011.12.005; Ziakas PD, 2014, AM J TRANSPLANT, V14, P1887, DOI 10.1111/ajt.12784	32	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245091	10.1371/journal.pone.0245091	http://dx.doi.org/10.1371/journal.pone.0245091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481811	Green Published, gold			2022-12-26	WOS:000612929300063
J	Fiseha, T; Gebreweld, A				Fiseha, Temesgen; Gebreweld, Angesom			Renal function in a cohort of HIV-infected patients initiating antiretroviral therapy in an outpatient setting in Ethiopia	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RISK-FACTORS; ASSOCIATION; IMMUNODEFICIENCY; NEPHROPATHY; DYSFUNCTION; PROGRESSION; IMPAIRMENT; MORTALITY; TENOFOVIR	Aim To evaluate the prevalence and associated factors of abnormal renal function among Ethiopian HIV-infected patients at baseline prior to initiation of antiretroviral therapy (ART) and during follow-up. Methods We conducted a retrospective observational cohort study of HIV infected patients who initiated ART at the outpatient ART clinic of Mehal Meda Hospital of North Shewa, Ethiopia from January 2012 to August 2018. Demographic and clinical data were abstracted from the medical records of patients. Renal function was assessed by estimated glomerular filtration rate (eGFR) calculated using the Modification of Diet in Renal Disease (MDRD) equation. Univariate and multivariate analysis were conducted to determine the factors associated with abnormal renal function at baseline and during follow-up. Results Among 353 patients, 70 (19.8%) had baseline eGFR < 60 ml/min/1.73m(2) and 102 (28.9%) had eGFR = 60-89.9 ml/min/1.73m(2). Factors associated with baseline renal impairment (eGFR < 60 ml/min/1.73m(2)) included female sex (AOR = 3.52, CI 1.75-7.09), CD4 count < 200 cells/mm(3) (AOR = 2.75, CI 1.40-5.42), BMI < 25 Kg/m(2) (AOR = 3.04, CI 1.15-8.92), low hemoglobin (AOR = 2.19, CI 1.16-4.09) and high total cholesterol (AOR = 3.15, CI 1.68-5.92). After a median of 3.0 years of ART, the mean eGFR declined from 112.9 +/- 81.2 ml/min/1.73m(2) at baseline to 93.9 +/- 60.6 ml/min/1.73m(2) (P < 0.001). The prevalence of renal impairment increased from 19.8% at baseline to 22.1% during follow-up. Of 181 patients with baseline normal renal function, 49.7% experienced some degree of renal impairment. Older age (AOR = 3.85, 95% CI 2.03-7.31), female sex (AOR = 4.18, 95% CI 2.08-8.40), low baseline CD4 (AOR = 2.41, 95% CI 1.24-4.69), low current CD4 count (AOR = 2.32, 95% CI 1.15-4.68), high BMI (AOR = 2.91, 95% CI 1.49-5.71), and low hemoglobin (AOR = 3.38, 95% CI 2.00-7.46) were the factors associated with renal impairment during follow-up. Conclusion Impaired renal function was common in HIV-infected patients initiating ART in an outpatient setting in Ethiopia, and there appears to be a high prevalence of renal impairment after a median ART follow-up of 3 years. There is a need for assessment of renal function at baseline before ART initiation and regular monitoring of renal function for patients with HIV during follow-up.	[Fiseha, Temesgen] Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia; [Gebreweld, Angesom] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia	Mekelle University	Fiseha, T (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia.	temafiseha@gmail.com						Abraham AG, 2015, J INFECT DIS, V212, P1100, DOI 10.1093/infdis/jiv159; Achhra AC, SHORT TERM WEIGHT GA; Adedeji Tewogbade Adeoye, 2015, J Int Assoc Provid AIDS Care, V14, P434, DOI 10.1177/2325957415587570; Assaram S, 2018, S AFR J HIV MED, V19, DOI 10.4102/sajhivmed.v19i1.770; Atta MG, 2006, NEPHROL DIAL TRANSPL, V21, P2809, DOI 10.1093/ndt/gfl337; Baynes HW, 2017, HIV AIDS-RES PALLIAT, V9, P1, DOI 10.2147/HIV.S120979; Behar DM, 2006, AM J KIDNEY DIS, V47, P88, DOI 10.1053/j.ajkd.2005.09.023; Behar DM, 2011, AM J NEPHROL, V34, P452, DOI 10.1159/000332378; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; Choi AI, 2009, AIDS, V23, P2143, DOI 10.1097/QAD.0b013e3283313c91; Ding Y, 2019, HIV MED, V20, P591, DOI 10.1111/hiv.12763; Domingo P, 2019, NEFROLOGIA, V39, P497, DOI 10.1016/j.nefro.2019.01.009; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Estrella MM, 2010, JAIDS-J ACQ IMM DEF, V55, P217, DOI 10.1097/QAI.0b013e3181e674f4; Gardner LI, 2003, JAIDS-J ACQ IMM DEF, V34, P320, DOI 10.1097/00126334-200311010-00011; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hou J, 2018, CURR OPIN NEPHROL HY, V27, P144, DOI 10.1097/MNH.0000000000000400; Ibrahim F, 2012, AM J KIDNEY DIS, V60, P539, DOI 10.1053/j.ajkd.2012.03.006; Ibrahim F, 2010, AIDS, V24, P2239, DOI 10.1097/QAD.0b013e32833c85d6; Juega-Marino J, 2017, MEDICINE, V96, P37; Jung O, 2013, DEUT MED WOCHENSCHR, V138, P1887, DOI 10.1055/s-0033-1349438; Kabore NF, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1335-9; Kooij KW, 2017, J INFECT DIS, V216, P622, DOI 10.1093/infdis/jix202; Kyaw NTT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135188; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Mapesi H, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy072; Mocroft A, 2007, AIDS, V21, P1119, DOI 10.1097/QAD.0b013e3280f774ee; Mocroft A, 2016, LANCET HIV, V3, pE23, DOI 10.1016/S2352-3018(15)00211-8; Mocroft A, 2014, AIDS, V28, P727, DOI 10.1097/QAD.0000000000000134; Mpondo BCT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089573; Msango L, 2011, AIDS, V25, P1421, DOI 10.1097/QAD.0b013e328348a4b1; Mtisi TJ, 2019, AIDS RES THER, V16, DOI 10.1186/s12981-019-0227-1; Nadkarni GN, 2014, CURR OPIN HIV AIDS, V9, P340, DOI 10.1097/COH.0000000000000067; Obiri-Yeboah D, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-1130-z; Obirikorang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099469; Peters PJ, 2008, KIDNEY INT, V74, P925, DOI 10.1038/ki.2008.305; Phalane E, 2018, AFR J HIV MED, V19, pa813; Phalane Edith, 2018, South. Afr. j. HIV med. (Online), V19, P1, DOI 10.4102/sajhivmed.v19i1.813; Roling J, 2006, CLIN INFECT DIS, V42, P1488, DOI 10.1086/503566; Ryom L, 2013, J INFECT DIS, V207, P1359, DOI 10.1093/infdis/jit043; Salome T, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0113-z; Suzuki S, 2017, AIDS PATIENT CARE ST, V31, P105, DOI 10.1089/apc.2016.0286; Szczech LA, 2004, CLIN INFECT DIS, V39, P1199, DOI 10.1086/424013; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Tanaka H, 2013, J PHARM PHARM SCI, V16, P405, DOI 10.18433/J32P5C; Tordato F, 2011, HIV MED, V12, P4, DOI 10.1111/j.1468-1293.2010.00855.x; Trevisan R, 2006, J AM SOC NEPHROL, V17, pS145, DOI 10.1681/ASN.2005121320; Wearne Nicola, 2020, Drugs Context, V9, DOI 10.7573/dic.2019-11-1; Winston JA, 2001, NEW ENGL J MED, V344, P1979, DOI 10.1056/NEJM200106283442604; Yazie TS, 2019, INT J NEPHROL, V2019, DOI 10.1155/2019/9172607; Zhao Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135462	51	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245500	10.1371/journal.pone.0245500	http://dx.doi.org/10.1371/journal.pone.0245500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481839	gold, Green Published			2022-12-26	WOS:000612929300066
J	Hasegawa, M; Iwasaki, J; Sugiyama, S; Ishihara, T; Yamamoto, Y; Asada, H; Koide, S; Hayashi, H; Takahashi, K; Inaguma, D; Yuzawa, Y; Tsuboi, N				Hasegawa, Midori; Iwasaki, Jin; Sugiyama, Satoshi; Ishihara, Takuma; Yamamoto, Yoshihiro; Asada, Hiroaki; Koide, Shigehisa; Hayashi, Hiroki; Takahashi, Kazuo; Inaguma, Daijo; Yuzawa, Yukio; Tsuboi, Naotake			Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement	PLOS ONE			English	Article							ATHEROSCLEROSIS; CALCIFICATION; MANAGEMENT; DISEASE; INFLAMMATION; EVENTS; RISK	Introduction Degenerative aortic valve stenosis (AS) is a chronic progressive disease that resembles atherosclerosis development. Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is reportedly associated with accelerated atherosclerosis. This study aimed to examine the development of AS in patients with myeloperoxidase-AAV (MPO-AAV) with renal involvement at more than 1 year after the onset of vasculitis. Methods We performed a retrospective review of clinical records of MPO-AAV patients with renal involvement without AS at the onset of vasculitis who were treated in three hospitals and three dialysis clinics. Results The study included 97 MPO-AAV patients with renal involvement and 230 control patients with chronic kidney disease (CKD). Among them, 64 patients had AS. The prevalence rates of AS were 28.9% and 15.7% in MPO-AAV and control patients, respectively (p = 0.006). The multivariable logistic regression analysis showed that MPO-AAV, dialysis dependence, and hypertension were independently associated factors for AS. In MPO-AAV patients, systolic blood pressure was positively significantly associated with AS, whereas glucocorticoid dose of induction therapy was negatively significantly associated. The use of cyclophosphamide tended to be negatively associated with AS. The survival rate was significantly lower for patients with AS than for those without AS. Conclusions The AS prevalence rate was significantly higher in MPO-AAV patients at more than 1 year after the onset of vasculitis than in control CKD patients. Therefore, regular monitoring of echocardiography during MPO-AAV treatment is suggested.	[Hasegawa, Midori; Koide, Shigehisa; Hayashi, Hiroki; Takahashi, Kazuo; Yuzawa, Yukio; Tsuboi, Naotake] Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan; [Iwasaki, Jin] Tokoname City Hosp, Tokoname, Aichi, Japan; [Sugiyama, Satoshi] Kanayama Clin, Nagoya, Aichi, Japan; [Ishihara, Takuma] Gifu Univ Hosp, Innovat & Clin Res Promot Ctr, Gifu, Gifu, Japan; [Yamamoto, Yoshihiro] Toyota Mem Hosp, Toyota, Aichi, Japan; [Asada, Hiroaki] Okazaki City Hosp, Okazaki, Aichi, Japan; [Takahashi, Kazuo] Fujita Hlth Univ, Dept Biomed Mol Sci, Sch Med, Toyoake, Aichi, Japan; [Inaguma, Daijo] Fujita Hlth Univ, Dept Internal Med, Bantane Hosp, Nagoya, Aichi, Japan	Fujita Health University; Gifu University; Fujita Health University; Fujita Health University	Hasegawa, M (corresponding author), Fujita Hlth Univ, Dept Nephrol, Sch Med, Toyoake, Aichi, Japan.	mhase@fujita-hu.ac.jp						Arimura Y, 2016, CLIN EXP NEPHROL, V20, P322, DOI 10.1007/s10157-015-1218-8; Candellier A, 2021, PERITON DIALYSIS INT, V41, P158, DOI 10.1177/0896860820941371; Cui L, 2017, J CELL PHYSIOL, V232, P2985, DOI 10.1002/jcp.25935; del Rincon I, 2014, ARTHRITIS RHEUMATOL, V66, P264, DOI 10.1002/art.38210; Franchimont D, 2002, NEUROIMMUNOMODULAT, V10, P247, DOI 10.1159/000069969; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Houben E, 2018, RHEUMATOLOGY, V57, P555, DOI 10.1093/rheumatology/kex338; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kiani AN, 2006, LUPUS, V15, P873, DOI 10.1177/0961203306071709; Kleinauskiene R, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54020024; Kurtz CE, 2010, MEDICINE, V89, P349, DOI 10.1097/MD.0b013e3181fe5648; Linefsky JP, 2011, J AM COLL CARDIOL, V58, P291, DOI 10.1016/j.jacc.2010.11.073; Mourguet M, 2019, J AUTOIMMUN, V96, P134, DOI 10.1016/j.jaut.2018.09.004; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Pagnoux C, 2007, ANN NY ACAD SCI, V1107, P11, DOI 10.1196/annals.1381.002; Patel KK, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.009980; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Sada KE, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4550; Vavilis G, 2019, J AM COLL CARDIOL, V73, P305, DOI 10.1016/j.jacc.2018.10.068; Walsh M, 2010, ARTHRIT CARE RES, V62, P1166, DOI 10.1002/acr.20176; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Yan AT, 2017, J AM COLL CARDIOL, V69, P1523, DOI 10.1016/j.jacc.2017.01.025; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133; Zycinska K, 2018, KARDIOL POL, V76, P77, DOI 10.5603/KP.a2017.0187	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245869	10.1371/journal.pone.0245869	http://dx.doi.org/10.1371/journal.pone.0245869			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481903	gold, Green Published			2022-12-26	WOS:000612929300069
J	Mutabazi, JC; Bonong, PRE; Trottier, H; Ware, LJ; Norris, SA; Murphy, K; Levitt, N; Zarowsky, C				Mutabazi, Jean Claude; Bonong, Pascal Roland Enok; Trottier, Helen; Ware, Lisa Jayne; Norris, Shane A.; Murphy, Katherine; Levitt, Naomi; Zarowsky, Christina			Integrating gestational diabetes and type 2 diabetes care into primary health care: Lessons from prevention of mother-to-child transmission of HIV in South Africa - A mixed methods study	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; MELLITUS; PMTCT; PREGNANCY; IMPLEMENTATION; INTERVENTIONS; PREVALENCE; DIAGNOSIS; IMPACT; WOMEN	Background Implementation of the programmes for the Prevention of Mother to Child Transmission (PMTCT) of Human Immunodeficiency Virus (HIV) into antenatal care over the last three decades could inform implementation of interventions for other health challenges such as gestational diabetes mellitus (GDM). This study assessed PMTCT outcomes, and how GDM screening, care, and type 2 diabetes (T2DM) prevention were integrated into PMTCT in Western Cape (WC), South Africa. Methods A convergent mixed methods and triangulation design were used. Content and thematic analysis of PMTCT-related policy documents and of 30 semi-structured interviews with HIV/PMTCT experts, health care workers and women under PMTC diagnosed with GDM complement quantitative longitudinal analysis of PMTCT implementation indicators across the WC for 2012-2017. Results Provincial PMTCT and Post Natal Care (PNC) documents emphasized the importance of PMTCT, but GDM screening and T2DM prevention were not covered. Data on women with both HIV and GDM were not available and GDM screening was not integrated into PMTCT. Women who attended HIV counselling and testing annually increased at 17.8% (95% CI: 12.9% - 22.0%), while women who delivered under PMTCT increased at 3.1% (95% CI: 0.6% - 5.9%) annually in the WC. All 30 respondents favour integrating GDM screening and T2DM prevention initiatives into PMTCT. Conclusion PMTCT programmes have not yet integrated GDM care. However, Western Cape PMTCT integration experience suggests that antenatal GDM screening and post-partum initiatives for preventing or delaying T2DM can be successfully integrated into PMTCT and primary care.	[Mutabazi, Jean Claude; Bonong, Pascal Roland Enok; Trottier, Helen; Zarowsky, Christina] Univ Montreal, Dept Med Sociale & Prevent, Ecole Sante Publ, Montreal, PQ, Canada; [Mutabazi, Jean Claude; Zarowsky, Christina] Univ Montreal, Ctr Rech Sante Publ CReSP, Montreal, PQ, Canada; [Mutabazi, Jean Claude; Zarowsky, Christina] CIUSSS Ctr Sud De lIle De Montreal, Montreal, PQ, Canada; [Mutabazi, Jean Claude; Bonong, Pascal Roland Enok; Trottier, Helen] Univ St Justine, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada; [Ware, Lisa Jayne; Norris, Shane A.] Univ Witwatersrand, Sch Clin Med, Dept Paediat, SAMRC Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Murphy, Katherine; Levitt, Naomi] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Endocrinol,Chron Dis Initiat Africa, Cape Town, South Africa; [Zarowsky, Christina] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa	Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Witwatersrand; University of Cape Town; University of the Western Cape	Mutabazi, JC (corresponding author), Univ Montreal, Dept Med Sociale & Prevent, Ecole Sante Publ, Montreal, PQ, Canada.; Mutabazi, JC (corresponding author), Univ Montreal, Ctr Rech Sante Publ CReSP, Montreal, PQ, Canada.; Mutabazi, JC (corresponding author), CIUSSS Ctr Sud De lIle De Montreal, Montreal, PQ, Canada.; Mutabazi, JC (corresponding author), Univ St Justine, Ctr Rech, Ctr Hosp, Montreal, PQ, Canada.	mutajeanc@yahoo.fr	Ware, Lisa Jayne/J-7182-2016; Norris, Shane/C-4664-2014	Ware, Lisa Jayne/0000-0002-9762-4017; Norris, Shane/0000-0001-7124-3788; Zarowsky, Christina/0000-0002-0850-6212; Levitt, Naomi/0000-0001-6480-8066	CIHR grant	CIHR grant(Canadian Institutes of Health Research (CIHR))	This manuscript results from research conducted under a PhD scholarship included in CIHR grant for the IINDIAGO study; no additional funding was received for this part of the study.	Abuogi LL, 2018, J VIRUS ERAD, V4, P33; Adam S, 2017, SAMJ S AFR MED J, V107, P523, DOI [10.7196/samj.2017.v107i6.12043, 10.7196/SAMJ.2017.v107i6.12043]; Adam S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2849346; Aizire J, 2013, CURR HIV RES, V11, P144, DOI 10.2174/1570162X11311020007; Akinleye O, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00071; American Diabetes Association, 2004, DIABETES CARE S1, V27, pS88, DOI [10.2337/diacare.27.2007.S88, DOI 10.2337/DIACARE.27.2007.S88]; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Atun R, 2010, HEALTH POLICY PLANN, V25, P104, DOI 10.1093/heapol/czp055; Atun R, 2010, HEALTH POLICY PLANN, V25, P1, DOI 10.1093/heapol/czp053; Barron P, 2013, B WORLD HEALTH ORGAN, V91, P70, DOI 10.2471/BLT.12.106807; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Both JMC, 2010, BJOG-INT J OBSTET GY, V117, P1444, DOI 10.1111/j.1471-0528.2010.02692.x; Bowen GA, 2009, QUAL RES J, V9, P27, DOI 10.3316/QRJ0902027; Burton R, 2015, OBSTET MED, V8, P5, DOI 10.1177/1753495X15570994; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Chivese T, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002865; Creswell J.W., 2007, DESIGNING CONDUCTING; Delobelle P., 2013, S AFRICA FOCUS EC PO, P159; Dias S, 2019, SAMJ S AFR MED J, V109, P457, DOI [10.7196/SAMJ.2019.v109i7.14064, 10.7196/samj.2019.v109i7.14064]; Drukker DM, 2013, STATA J, V13, P242, DOI 10.1177/1536867X1301300202; Dunning L, 2017, PEDIATR INFECT DIS J, V36, P1159, DOI 10.1097/INF.0000000000001677; Ebonwu J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191903; Ekama SO, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/851810; Etoori D, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5258-3; Feuillet T., 2018, CYBERGEO EUROPEAN J; Gonzalez L, 2016, HEALTH24 0512; GRIFFITH DA, 1983, PROG HUM GEOG, V7, P149, DOI 10.1177/030913258300700115; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Hussein J, 2017, OBSTET MED, V10, P26, DOI 10.1177/1753495X16684709; Jayanna K, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6735-z; Kachimanga C, 2017, MALAWI MED J, V29, P78, DOI 10.4314/mmj.v29i2.1; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Kontomanolis EN, 2017, HIV AIDS-RES PALLIAT, V9, P111, DOI 10.2147/HIV.S129992; Larsen A, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.021001; Macaulay S, 2018, DIABETES RES CLIN PR, V139, P278, DOI 10.1016/j.diabres.2018.03.012; Mamabolo RL, 2007, DIABETIC MED, V24, P233, DOI 10.1111/j.1464-5491.2006.02073.x; Mandala J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-314; McIntyre D, 2002, HEALTH POLICY PLANN, V17, P30, DOI 10.1093/heapol/17.suppl_1.30; Mepham S, 2011, AIDS CARE, V23, P741, DOI 10.1080/09540121.2010.516341; Metzger B.E, 1998, DIABETES CARE, V21, pB1; Moosa A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4410-8; MORAN PAP, 1950, BIOMETRIKA, V37, P178, DOI 10.1093/biomet/37.1-2.178; Muhwava LS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225431; Muhwava LS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3175-x; Mutabazi JC, 2017, PUBLIC HEALTH REV, V38, DOI 10.1186/s40985-017-0072-5; Muyunda B, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00401; Neethling I, 2019, SAMJ S AFR MED J, V109, P597, DOI [10.7196/SAMJ.2019.v109i8.13796, 10.7196/samj.2019.v109i8.13796]; Ngobeni V, 2020, COST EFFECT RESOUR A, V18, DOI 10.1186/s12962-020-0199-y; O'Leary Z., 2014, ESSENTIAL GUIDE DOIN, P201; Okafor II, 2014, ANN MED HEALTH SCI R, V4, P615, DOI 10.4103/2141-9248.139344; Okoli JC, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.154.4225; Paille P., 2015, ANAL QUALITATIVE SCI; Pattinson R.C., 2007, BASIC ANTENATAL CARE; Provincial Government of the Western Cape, 2016, POSTN CAR POL; Puren A., 2019, 2017 NATL ANTENATAL; Shigayeva A, 2010, HEALTH POLICY PLANN, V25, pi4, DOI 10.1093/heapol/czq060; South Africa National AIDS Council (SANAC), 2017, LET OUR ACT COUNT S; Steele F, 2014, MULTILEVEL MODELLING, p[15, 1]; Stinson K, 2014, S AFR J HIV MED, V15, P30, DOI [10.7196/sajhivmed.1025, 10.7196/SAJHIVMED.1025]; Turan JM, 2015, JAIDS-J ACQ IMM DEF, V69, pe172, DOI 10.1097/QAI.0000000000000678; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; Weiss Stephen M, 2014, J Int Assoc Provid AIDS Care, V13, P269, DOI 10.1177/2325957413488203; WHO, 2007, EV BUS STRENGTH HLTH; Woldesenbet SA, 2017, JAIDS-J ACQ IMM DEF, V74, P523, DOI 10.1097/QAI.0000000000001289; World Health Organization, 2013, COUNS MAT NEWB HLTH; World Health Organization, 2020, LICENCE 200 BY NC SA; Yin RK, 2013, EVALUATION-US, V19, P321, DOI 10.1177/1356389013497081	67	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245229	10.1371/journal.pone.0245229	http://dx.doi.org/10.1371/journal.pone.0245229			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481855	Green Published, gold			2022-12-26	WOS:000612929300160
J	Sciabola, S; Xi, HL; Cruz, D; Cao, Q; Lawrence, C; Zhang, TH; Rotstein, S; Hughes, JD; Caffrey, DR; Stanton, RV				Sciabola, Simone; Xi, Hualin; Cruz, Dario; Cao, Qing; Lawrence, Christine; Zhang, Tianhong; Rotstein, Sergio; Hughes, Jason D.; Caffrey, Daniel R.; Stanton, Robert, V			PFRED: A computational platform for siRNA and antisense oligonucleotides design	PLOS ONE			English	Article							SEQUENCE MOTIFS; DOUBLE-BLIND; RNAI; PREDICTION; EFFICACY; SELECTION; SOFTWARE; DATABASE; HELM	PFRED a software application for the design, analysis, and visualization of antisense oligonucleotides and siRNA is described. The software provides an intuitive user-interface for scientists to design a library of siRNA or antisense oligonucleotides that target a specific gene of interest. Moreover, the tool facilitates the incorporation of various design criteria that have been shown to be important for stability and potency. PFRED has been made available as an open-source project so the code can be easily modified to address the future needs of the oligonucleotide research community. A compiled version is available for downloading at https://github.com/pfred/pfred-gui/releases/tag/v1.0 as a java Jar file. The source code and the links for downloading the precompiled version can be found at https://github.com/pfred.	[Sciabola, Simone; Cruz, Dario] Biogen, Med Chem, Cambridge, MA USA; [Xi, Hualin] Rgenta, Cambridge, MA USA; [Cruz, Dario] Northeastern Univ, Chem Engn, Boston, MA 02115 USA; [Cao, Qing] Ra Pharmaceut, Med Chem, Cambridge, MA USA; [Lawrence, Christine; Zhang, Tianhong; Rotstein, Sergio] Pfizer, Business Technol, Cambridge, MA USA; [Hughes, Jason D.] Fdn Med, Computat Biol, Cambridge, MA USA; [Caffrey, Daniel R.] Univ Massachusetts, Med Sch, Dept Med, Worcester, MA 01605 USA; [Stanton, Robert, V] Pfizer, Simulat & Modeling Sci, Cambridge, MA 02139 USA	Biogen; Northeastern University; Pfizer; Foundation Medicine; University of Massachusetts System; University of Massachusetts Worcester; Pfizer	Stanton, RV (corresponding author), Pfizer, Simulat & Modeling Sci, Cambridge, MA 02139 USA.	Robert.Stanton@pfizer.com						Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; Agarwal S, 2020, CLIN PHARMACOL THER, V108, P63, DOI 10.1002/cpt.1802; Akdim F, 2010, AM J CARDIOL, V105, P1413, DOI 10.1016/j.amjcard.2010.01.003; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Benson MD, 2018, NEW ENGL J MED, V379, P22, DOI 10.1056/NEJMoa1716793; Bo XC, 2006, NUCLEIC ACIDS RES, V34, pD664, DOI 10.1093/nar/gkj065; Burdick AD, 2014, NUCLEIC ACIDS RES, V42, P4882, DOI 10.1093/nar/gku142; Camps-Valls G, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-135; Chalk AM, 2002, BIOINFORMATICS, V18, P1567, DOI 10.1093/bioinformatics/18.12.1567; Chi X, 2017, DRUG DISCOV TODAY, V22, P823, DOI 10.1016/j.drudis.2017.01.013; Cui WW, 2004, COMPUT METH PROG BIO, V75, P67, DOI 10.1016/j.cmpb.2003.09.002; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Far RKK, 2005, OLIGONUCLEOTIDES, V15, P223, DOI 10.1089/oli.2005.15.223; Fogacci F, 2019, DRUGS, V79, P751, DOI 10.1007/s40265-019-01114-z; Frazier KS, 2015, TOXICOL PATHOL, V43, P78, DOI 10.1177/0192623314551840; GenScript siRNA Target Finder, GENSCRIPT; Giddings MC, 2000, BIOINFORMATICS, V16, P843, DOI 10.1093/bioinformatics/16.9.843; Hajeri PB, 2009, DRUG DISCOV TODAY, V14, P851, DOI 10.1016/j.drudis.2009.06.001; Holen T, 2006, RNA, V12, P1620, DOI 10.1261/rna.81006; Hoy SM, 2018, DRUGS, V78, P1625, DOI 10.1007/s40265-018-0983-6; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liao Li, 2007, In Silico Biology, V7, P527; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Luck S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01023; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Matveeva OV, 2003, NUCLEIC ACIDS RES, V31, P4211, DOI 10.1093/nar/gkg476; Matveeva OV, 2000, NUCLEIC ACIDS RES, V28, P2862, DOI 10.1093/nar/28.15.2862; Milton J, 2017, J CHEM INF MODEL, V57, P1233, DOI 10.1021/acs.jcim.6b00442; Mysara M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025642; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Noy A, 2008, J AM CHEM SOC, V130, P3486, DOI 10.1021/ja076734u; Prakash V, 2017, GENE THER, V24, P497, DOI 10.1038/gt.2017.59; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOINFORMATICS, V20, P3055, DOI 10.1093/bioinformatics/bth364; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Sciabola S, 2013, NUCLEIC ACIDS RES, V41, P1383, DOI 10.1093/nar/gks1191; Sehgal A, 2015, NAT MED, V21, P492, DOI 10.1038/nm.3847; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Shao Y, 2006, NUCLEIC ACIDS RES, V34, P5660, DOI 10.1093/nar/gkl715; siDESIGN Center, HOR DISC; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Watts JK, 2010, BIOORG MED CHEM LETT, V20, P3203, DOI 10.1016/j.bmcl.2010.03.109; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhang TH, 2012, J CHEM INF MODEL, V52, P2796, DOI 10.1021/ci3001925	52	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0238753	10.1371/journal.pone.0238753	http://dx.doi.org/10.1371/journal.pone.0238753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481821	Green Published, Green Submitted, gold			2022-12-26	WOS:000612929300015
J	Wong, YK; Tong, CKY; Lui, M; Wong, ACN				Wong, Yetta Kwailing; Tong, Christine Kong-Yan; Lui, Ming; Wong, Alan C-N			Perceptual expertise with Chinese characters predicts Chinese reading performance among Hong Kong Chinese children with developmental dyslexia	PLOS ONE			English	Article							FUSIFORM FACE AREA; ATTENTION SPAN DEFICIT; VISUAL WORD RECOGNITION; MORPHOLOGICAL AWARENESS; OBJECT RECOGNITION; LANGUAGE-DEVELOPMENT; FAMILIAL RISK; FORM AREA; DISCRIMINATION; LITERACY	This study explores the theoretical proposal that developmental dyslexia involves a failure to develop perceptual expertise with words despite adequate education. Among a group of Hong Kong Chinese children diagnosed with developmental dyslexia, we investigated the relationship between Chinese word reading and perceptual expertise with Chinese characters. In a perceptual fluency task, the time of visual exposure to Chinese characters was manipulated and limited such that the speed of discrimination of a short sequence of Chinese characters at an accuracy level of 80% was estimated. Pair-wise correlations showed that perceptual fluency for characters predicted speeded and non-speeded word reading performance. Exploratory hierarchical regressions showed that perceptual fluency for characters accounted for 5.3% and 9.6% variance in speeded and non-speeded reading respectively, in addition to age, non-verbal IQ, phonological awareness, morphological awareness, rapid automatized naming (RAN) and perceptual fluency for digits. The findings suggest that perceptual expertise with words plays an important role in Chinese reading performance in developmental dyslexia, and that perceptual training is a potential remediation direction.	[Wong, Yetta Kwailing] Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Peoples R China; [Tong, Christine Kong-Yan; Wong, Alan C-N] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Peoples R China; [Lui, Ming] Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Wong, YK (corresponding author), Chinese Univ Hong Kong, Dept Educ Psychol, Hong Kong, Peoples R China.	yetta.wong@gmail.com		WONG, Kwai Ling Yetta/0000-0002-8243-2047; Wong, Alan C.-N./0000-0002-2129-3485; Lui, Ming/0000-0001-7996-0386	Standing Committee on Language Education and Research (SCOLAR), Hong Kong SAR; Direct Grant for Research at the Chinese University of Hong Kong	Standing Committee on Language Education and Research (SCOLAR), Hong Kong SAR; Direct Grant for Research at the Chinese University of Hong Kong	This work was supported by the Language Fund under Research and Development Projects 2018-19 of the Standing Committee on Language Education and Research (SCOLAR), Hong Kong SAR (to Y.W.), and the Direct Grant for Research at the Chinese University of Hong Kong (to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098971; Antzaka A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15119-9; APA American Journal of Psychiatry American Psychiatric Association, 2013, AM J PSYCHIAT, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596]; Aravena S, 2013, J EXP CHILD PSYCHOL, V115, P691, DOI 10.1016/j.jecp.2013.03.009; Bernard JB, 2011, J VISION, V11, DOI 10.1167/11.8.1; Bilalic M, 2011, J NEUROSCI, V31, P10206, DOI 10.1523/JNEUROSCI.5727-10.2011; Boggan AL, 2012, J EXP PSYCHOL GEN, V141, P37, DOI 10.1037/a0024236; Bosse ML, 2007, COGNITION, V104, P198, DOI 10.1016/j.cognition.2006.05.009; BOUMA H, 1970, NATURE, V226, P177, DOI 10.1038/226177a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunswick N, 2010, LEARN INDIVID DIFFER; Carlisle J. F., 1995, MORPHOLOGICAL ASPECT, P189, DOI DOI 10.4236/PSYCH.2014.58103; Chan S.D., 2007, CHARACTER LEXICAL LI; Chen NT, 2019, READ WRIT, V32, P639, DOI 10.1007/s11145-018-9882-1; Chua KW, 2015, J EXP PSYCHOL GEN, V144, P723, DOI 10.1037/xge0000063; Chung KKH, 2011, READ WRIT, V24, P835, DOI 10.1007/s11145-010-9227-1; Chung STL, 2003, VISION RES, V43, P669, DOI 10.1016/S0042-6989(02)00628-4; Chung STL, 2007, VISION RES, V47, P3150, DOI 10.1016/j.visres.2007.08.017; Chung WL, 2007, READ WRIT, V20, P441, DOI 10.1007/s11145-006-9037-7; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Engel SA, 2009, ACTIVITY FUSIFORM FA, V7263, P1, DOI [10.1523/JNEUROSCI.1873-06.2006, DOI 10.1523/JNEUROSCI.1873-06.2006]; Franceschini S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05826-8; Franceschini S, 2013, CURR BIOL, V23, P462, DOI 10.1016/j.cub.2013.01.044; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Frost R, 2012, BEHAV BRAIN SCI, V35, P310, DOI 10.1017/S0140525X12000635; Gabay Y, 2017, BRAIN LANG, V173, P41, DOI 10.1016/j.bandl.2017.06.004; Galuschka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089900; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gauthier I, 2009, PERCEPTUAL EXPERTISE, DOI [10.1093/acprof:oso/9780195309607.001.0001/acprof-9780195309607, DOI 10.1093/ACPROF:OSO/9780195309607.001.0001/ACPROF-9780195309607]; Gauthier I, 2018, CURR DIR PSYCHOL SCI, V27, P97, DOI 10.1177/0963721417737151; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Gori S, 2015, J VISION, V15, DOI 10.1167/15.1.8; Goswami U., 1990, PHONOLOGICAL SKILLS; Goswami U, 2015, NAT REV NEUROSCI, V16, P43, DOI 10.1038/nrn3836; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Grainger J, 2004, TRENDS COGN SCI, V8, P58, DOI 10.1016/j.tics.2003.11.006; Grainger J, 2008, LANG COGNITIVE PROC, V23, P1, DOI 10.1080/01690960701578013; Guttorm TK, 2005, CORTEX, V41, P291, DOI 10.1016/S0010-9452(08)70267-3; Hagen S, 2014, J VISION, V14, DOI 10.1167/14.9.9; Hancock R, 2017, TRENDS COGNITIVE SCI; Hari R, 2001, TRENDS COGN SCI, V5, P525, DOI 10.1016/S1364-6613(00)01801-5; Helenius P, 1999, CEREB CORTEX, V9, P476, DOI 10.1093/cercor/9.5.476; Ho C.S.-H., 2000, HONG KONG TEST SPECI; Ho CSH, 2014, READ WRIT, V27, P1673, DOI 10.1007/s11145-014-9515-2; Ho CSH, 1997, READ RES QUART, V32, P276, DOI 10.1598/RRQ.32.3.3; Ho CSH, 2004, COGNITION, V91, P43, DOI 10.1016/S0010-0277(03)00163-X; Ho CSH, 2002, DEV PSYCHOL, V38, P543, DOI 10.1037//0012-1649.38.4.543; Hussain Z, 2012, J NEUROSCI, V32, P474, DOI 10.1523/JNEUROSCI.3845-11.2012; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Kang BW., 2003, STUDY CHINESE CHARAC; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Katz L., 1992, ADV PSYCHOL, V94, P67, DOI [10.1016/S0166-4115(08)62789-2, DOI 10.1016/S0166-4115(08)62789-2]; Konen CS, 2008, NAT NEUROSCI, V11, P224, DOI 10.1038/nn2036; Kronbichler M, 2006, NEUROPSYCHOLOGIA, V44, P1822, DOI 10.1016/j.neuropsychologia.2006.03.010; Kronschnabel J, 2013, NEUROIMAGE, V74, P58, DOI 10.1016/j.neuroimage.2013.02.014; Lanthier SN, 2009, PSYCHON B REV, V16, P67, DOI 10.3758/PBR.16.1.67; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Liu PD, 2010, J EDUC PSYCHOL, V102, P62, DOI 10.1037/a0016933; LIVINGSTONE MS, 1991, P NATL ACAD SCI USA, V88, P7943, DOI 10.1073/pnas.88.18.7943; Lobier M, 2012, CORTEX, V48, P768, DOI 10.1016/j.cortex.2011.09.003; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; MATTINGLY IG, 1972, AM SCI, V60, P327; McBride-Chang C, 2000, J EDUC PSYCHOL, V92, P50, DOI 10.1037/0022-0663.92.1.50; McBride-Chang C, 2003, J EDUC PSYCHOL, V95, P743, DOI 10.1037/0022-0663.95.4.743; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McGugin RW, 2012, VISION RES, V69, P10, DOI 10.1016/j.visres.2012.07.014; McGugin RW, 2011, COGNITIVE SCI, V35, P330, DOI 10.1111/j.1551-6709.2010.01148.x; McGugin RW, 2012, P NATL ACAD SCI USA, V109, P17063, DOI 10.1073/pnas.1116333109; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Norton ES, 2012, ANNU REV PSYCHOL, V63, P427, DOI 10.1146/annurev-psych-120710-100431; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pelli DG, 2003, NATURE, V423, P752, DOI 10.1038/nature01516; Peng P, 2017, EDUC PSYCHOL REV, V29, P513, DOI 10.1007/s10648-016-9366-2; Pennington BF, 2006, COGNITION, V101, P385, DOI 10.1016/j.cognition.2006.04.008; Perry C, 2019, PSYCHOL SCI, V30, P386, DOI 10.1177/0956797618823540; Peterson LR, 1959, J EXP PSYCHOL, V61, P12; Peterson RL, 2015, ANNU REV CLIN PSYCHO, V11, P283, DOI 10.1146/annurev-clinpsy-032814-112842; Polat U, 2012, SCI REP-UK, V2, DOI 10.1038/srep00278; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Rapp B, 1997, J EXP PSYCHOL HUMAN, V23, P1130, DOI 10.1037/0096-1523.23.4.1130; Roembke TC, 2019, J EDUC PSYCHOL, V111, P314, DOI 10.1037/edu0000279; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; SCARBOROUGH HS, 1990, CHILD DEV, V61, P1728, DOI 10.1111/j.1467-8624.1990.tb03562.x; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Seidenberg MS, 1992, ADV PSYCHOL, DOI [10.1037/0096-1523.23.4.1130, DOI 10.1037/0096-1523.23.4.1130]; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; Shaywitz BA, 2007, ANN NEUROL, V61, P363, DOI 10.1002/ana.21093; Shu H, 2006, J EDUC PSYCHOL, V98, P122, DOI 10.1037/0022-0663.98.1.122; Siegel Linda S, 2006, Paediatr Child Health, V11, P581; Sigurdardottir HM, 2019, VISION RES, V158, P146, DOI 10.1016/j.visres.2019.02.010; Sigurdardottir HM, 2018, COGNITION, V175, P157, DOI 10.1016/j.cognition.2018.02.017; Sigurdardottir HM, 2015, NEUROPSYCHOLOGY, V29, P739, DOI 10.1037/neu0000188; Singleton C, 2005, J RES READ, V28, P365, DOI 10.1111/j.1467-9817.2005.00275.x; STAHL SA, 1994, J EDUC PSYCHOL, V86, P221, DOI 10.1037/0022-0663.86.2.221; Stein J, 1997, TRENDS NEUROSCI, V20, P147, DOI 10.1016/S0166-2236(96)01005-3; Stein J, 2012, VISUAL ASPECTS DYSLE, DOI [10.1093/acprof:oso/9780199589814.001.0001/acprof-9780199589814, DOI 10.1093/ACPROF:OSO/9780199589814.001.0001/ACPROF-9780199589814]; Szwed M, 2009, VISION RES, V49, P718, DOI 10.1016/j.visres.2009.01.003; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Tong XL, 2009, SCI STUD READ, V13, P426, DOI 10.1080/10888430903162910; Torppa M, 2010, J LEARN DISABIL-US, V43, P308, DOI 10.1177/0022219410369096; Tsushima Y, 2006, SCIENCE, V314, P1786, DOI 10.1126/science.1133197; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; Vaessen A, 2010, J EDUC PSYCHOL, V102, P827, DOI 10.1037/a0019465; Valdois S, 2014, COREVA VA SPAN INTER; Valdois S, 2014, CORTEX, V53, P120, DOI 10.1016/j.cortex.2013.11.006; Vellutino F.R., 1979, DYSLEXIA THEORY RES; Vidyasagar TR, 2010, TRENDS COGN SCI, V14, P57, DOI 10.1016/j.tics.2009.12.003; WAGNER RK, 1987, PSYCHOL BULL, V101, P192, DOI 10.1037/0033-2909.101.2.192; Wang H, 2014, J VISION, V14, DOI 10.1167/14.8.6; Wang LC, 2011, RES DEV DISABIL, V32, P1052, DOI 10.1016/j.ridd.2011.01.028; Watanabe T, 2001, NATURE, V413, P844, DOI 10.1038/35101601; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Weisberg J, 2007, CEREB CORTEX, V17, P513, DOI 10.1093/cercor/bhj176; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Wong AC-N, 2019, J VIS; Wong ACN, 2019, J EXP PSYCHOL HUMAN, V45, P82, DOI 10.1037/xhp0000590; Wong ACN, 2012, J VISION, V12, DOI 10.1167/12.13.7; Wong ACN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008405; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Wong ACN, 2009, COGN NEUROPSYCHOL, V26, P111, DOI 10.1080/02643290802340972; Wong A, 2008, 2008 IAPR WORKSHOP ON PATTERN RECOGNITION IN REMOTE SENSING, P1; Wong YK, 2012, J EXP PSYCHOL GEN, V141, P682, DOI 10.1037/a0027822; Wong YK, 2011, J VISION, V11, DOI 10.1167/11.14.3; Wong YK, 2018, PSYCHON B REV, V25, P1373, DOI 10.3758/s13423-018-1483-0; Wong YK, 2016, J VISION, V16, DOI 10.1167/16.8.15; Wong YK, 2014, J COGNITIVE NEUROSCI, V26, P1629, DOI 10.1162/jocn_a_00616; Wong YK, 2012, PSYCHON B REV, V19, P594, DOI 10.3758/s13423-012-0242-x; Wong YK, 2010, COGN AFFECT BEHAV NE, V10, P541, DOI 10.3758/CABN.10.4.541; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Yeung PS, 2013, APPL PSYCHOLINGUIST, V34, P1245, DOI 10.1017/S0142716412000239; Zhang JY, 2009, VISION RES, V49, P44, DOI 10.1016/j.visres.2008.09.021; Zhao J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21578-5; Ziegler JC, 2010, DEVELOPMENTAL SCI, V13, pF8, DOI 10.1111/j.1467-7687.2010.00983.x	148	2	2	9	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0243440	10.1371/journal.pone.0243440	http://dx.doi.org/10.1371/journal.pone.0243440			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481782	Green Published, gold			2022-12-26	WOS:000612929300072
J	Sinegubova, MV; Orlova, NA; Kovnir, SV; Dayanova, LK; Vorobiev, II				Sinegubova, Maria, V; Orlova, Nadezhda A.; Kovnir, Sergey, V; Dayanova, Lutsia K.; Vorobiev, Ivan I.			High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector	PLOS ONE			English	Article							SARS-COV; SPIKE; RESPONSES; LINE; MERS	The spike (S) protein is one of the three proteins forming the coronaviruses' viral envelope. The S protein of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has a spatial structure similar to the S proteins of other mammalian coronaviruses, except for a unique receptor-binding domain (RBD), which is a significant inducer of host immune response. Recombinant SARS-CoV-2 RBD is widely used as a highly specific minimal antigen for serological tests. Correct exposure of antigenic determinants has a significant impact on the accuracy of such tests-the antigen has to be correctly folded, contain no potentially antigenic non-vertebrate glycans, and, preferably, should have a glycosylation pattern similar to the native S protein. Based on the previously developed p1.1 vector, containing the regulatory sequences of the Eukaryotic translation elongation factor 1 alpha gene (EEF1A1) from Chinese hamster, we created two expression constructs encoding SARS-CoV-2 RBD with C-terminal c-myc and polyhistidine tags. RBDv1 contained a native viral signal peptide, RBDv2 -human tPA signal peptide. We transfected a CHO DG44 cell line, selected stably transfected cells, and performed a few rounds of methotrexate-driven amplification of the genetic cassette in the genome. For the RBDv2 variant, a high-yield clonal producer cell line was obtained. We developed a simple purification scheme that consistently yielded up to 30 mg of RBD protein per liter of the simple shake flask cell culture. Purified proteins were analyzed by polyacrylamide gel electrophoresis in reducing and non-reducing conditions and gel filtration; for RBDv2 protein, the monomeric form content exceeded 90% for several series. Deglycosylation with PNGase F and mass spectrometry confirmed the presence of N-glycosylation. The antigen produced by the described technique is suitable for serological tests and subunit vaccine studies.	[Sinegubova, Maria, V; Orlova, Nadezhda A.; Kovnir, Sergey, V; Vorobiev, Ivan I.] Russian Acad Sci, Inst Bioengn, Lab Mammalian Cell Bioengn, Res Ctr Biotechnol, Moscow, Russia; [Dayanova, Lutsia K.; Vorobiev, Ivan I.] Russian Acad Sci, Lab Glycoprot Biotechnol, Inst Bioorgan Chem, Moscow, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Orlova, NA (corresponding author), Russian Acad Sci, Inst Bioengn, Lab Mammalian Cell Bioengn, Res Ctr Biotechnol, Moscow, Russia.	nobiol@gmail.com	Sinegubova, Maria/ABG-1718-2021; Vorobiev, Ivan/ABF-6809-2021; Orlova, Nadezhda/AAE-8279-2020	Sinegubova, Maria/0000-0002-8950-6061; Vorobiev, Ivan/0000-0003-0064-4458; Orlova, Nadezhda/0000-0001-9483-2892				Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; [Anonymous], 2020, SARS COV 2 DIAGNOSTI; Arbeitman CR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78711-6; Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; Burrell CJ, 2017, FENNER WHITES MED VI, Vxix; Chen WH, 2014, HUM VACC IMMUNOTHER, V10, P648, DOI 10.4161/hv.27464; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Dai LP, 2020, CELL, V182, P722, DOI 10.1016/j.cell.2020.06.035; de Assis RR, 2021, NAT COMMUN, V12, DOI [10.1038/s41467-020-20095-2, 10.1101/2020.04.15.043364]; Dong YT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00352-y; Du LY, 2010, VIRAL IMMUNOL, V23, P211, DOI 10.1089/vim.2009.0090; Grant OC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71748-7; Greenfield EA, 2014, ANTIBODIES LAB MANUA, Vxxi; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; He YX, 2006, J VIROL, V80, P5757, DOI 10.1128/JVI.00083-06; Jiang HW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17488-8; Kang DH, 2002, B KOREAN CHEM SOC, V23, P1511; Kilic T, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101406; Kovnir SV, 2018, ACTA NATURAE, V10, P51, DOI 10.32607/20758251-2018-10-151-65; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Maache M, 2006, CLIN VACCINE IMMUNOL, V13, P409, DOI 10.1128/CVI.13.3.409-414.2006; Nyon MP, 2018, VACCINE, V36, P1853, DOI 10.1016/j.vaccine.2018.02.065; Orlova NA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219434; Orlova NA, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-017-0353-6; Orlova NA, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-56; Parcells M.S., 2020, SARS COV 2 RECEPTOR, DOI [10.1101/2020.04.10.036418, DOI 10.2139/SSRN.3575134, 10.2139/ssrn.3575134]; Plotnik D, 2017, J VIROL, V91, DOI 10.1128/JVI.01005-17; Premkumar L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc8413; Rattanapisit K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74904-1; Rosadas C, 2020, LANCET, V396, pE23, DOI 10.1016/S0140-6736(20)31830-4; Shajahan Asif, 2020, Glycobiology, V30, P981, DOI 10.1093/glycob/cwaa042; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Tan CW, 2020, NAT BIOTECHNOL, V38, P1073, DOI 10.1038/s41587-020-0631-z; Tee KL, 2020, PURIFICATION RECOMBI, DOI [10.1101/2020.07.31.231282, DOI 10.1101/2020.07.31.231282]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang SX, 2005, J VIROL, V79, P1906, DOI 10.1128/JVI.79.3.1906-1910.2005; Xu WX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.565278; Yamaoka Y, 2021, CLIN INFECT DIS, V72, P1291, DOI 10.1093/cid/ciaa637; Yang JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18319-6; Zhang Y, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.RA120.002295	41	17	17	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0242890	10.1371/journal.pone.0242890	http://dx.doi.org/10.1371/journal.pone.0242890			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529230	Green Published, Green Submitted, gold			2022-12-26	WOS:000616736200002
J	Machcinska, S; Kopcewicz, M; Bukowska, J; Walendzik, K; Gawronska-Kozak, B				Machcinska, Sylwia; Kopcewicz, Marta; Bukowska, Joanna; Walendzik, Katarzyna; Gawronska-Kozak, Barbara			Impairment of the Hif-1 alpha regulatory pathway in Foxn1-deficient (Foxn1(-/-)) mice affects the skin wound healing process	FASEB JOURNAL			English	Article						Foxn1; hypoxia; Hif&#8208; 1&#945; skin; scarless healing	HYPOXIA-INDUCIBLE FACTOR; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; MOUSE; FETAL; FACTOR-1-ALPHA; REPAIR; CELLS; HIF-1	Hypoxia and hypoxia-regulated factors (eg, hypoxia-inducible factor-1 alpha [Hif-1 alpha], factor inhibiting Hif-1 alpha [Fih-1], thioredoxin-1 [Trx-1], aryl hydrocarbon receptor nuclear translocator 2 [Arnt-2]) have essential roles in skin wound healing. Using Foxn1(-/-) mice that can heal skin injuries in a unique scarless manner, we investigated the interaction between Foxn1 and hypoxia-regulated factors. The Foxn1(-/-) mice displayed impairments in the regulation of Hif-1 alpha, Trx-1, and Fih-1 but not Arnt-2 during the healing process. An analysis of wounded skin showed that the skin of the Foxn1(-/-) mice healed in a scarless manner, displaying rapid re-epithelialization and an increase in transforming growth factor beta (Tgf beta-3) and collagen III expression. An in vitro analysis revealed that Foxn1 overexpression in keratinocytes isolated from the skin of the Foxn1(-/-) mice led to reduced Hif-1 alpha expression in normoxic but not hypoxic cultures and inhibited Fih-1 expression exclusively under hypoxic conditions. These data indicate that in the skin, Foxn1 affects hypoxia-regulated factors that control the wound healing process and suggest that under normoxic conditions, Foxn1 is a limiting factor for Hif-1 alpha.	[Machcinska, Sylwia; Kopcewicz, Marta; Bukowska, Joanna; Walendzik, Katarzyna; Gawronska-Kozak, Barbara] Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Gawronska-Kozak, B (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Tuwima 10, PL-10748 Olsztyn, Poland.	b.kozak@pan.olsztyn.pl	KOPCEWICZ, Marta/H-7199-2017; GAWRONSKA-KOZAK, Barbara/A-2980-2017; WISNIEWSKA, Joanna/H-7164-2017	KOPCEWICZ, Marta/0000-0002-9776-4941; MACHCINSKA-ZIELINSKA, Sylwia/0000-0003-3892-4519; WALENDZIK, Katarzyna/0000-0001-8349-6387; GAWRONSKA-KOZAK, Barbara/0000-0002-2006-8534; WISNIEWSKA, Joanna/0000-0001-5887-450X				Andrikopoulou E, 2011, CURR MOL MED, V11, P218, DOI 10.2174/156652411795243414; Ansell DM, 2014, WOUND REPAIR REGEN, V22, P281, DOI 10.1111/wrr.12148; Aragona M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14684; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Brissette JL, 1996, GENE DEV, V10, P2212, DOI 10.1101/gad.10.17.2212; Bukowska J, 2018, CELL TISSUE RES, V374, P149, DOI 10.1007/s00441-018-2836-8; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Chen R, 2011, ONCOGENE, V30, P2570, DOI 10.1038/onc.2010.623; Chen W, 2005, WOUND REPAIR REGEN, V13, P68, DOI 10.1111/j.1067-1927.2005.130109.x; Gonzalez ACD, 2016, AN BRAS DERMATOL, V91, P614, DOI 10.1590/abd1806-4841.20164741; Deng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063777; Elson DA, 2000, CANCER RES, V60, P6189; Fosen KM, 2014, ANTIOXID REDOX SIGN, V21, P1634, DOI 10.1089/ars.2014.5940; Frank J, 1999, NATURE, V398, P473, DOI 10.1038/18997; Gawronska-Kozak B, 2004, TISSUE ENG, V10, P1251, DOI 10.1089/ten.2004.10.1251; Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x; Gawronska-Kozak B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150635; Gawronska-Kozak B, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-7; Gawronska-Kozak B, 2011, MATRIX BIOL, V30, P290, DOI 10.1016/j.matbio.2011.04.004; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gorlach A, 2001, CIRC RES, V89, P47, DOI 10.1161/hh1301.092678; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hong WX, 2014, ADV WOUND CARE, V3, P390, DOI 10.1089/wound.2013.0520; Kalucka J, 2013, MOL CELL BIOL, V33, P3426, DOI 10.1128/MCB.00609-13; Karlenius Therese Christina, 2010, Cancers (Basel), V2, P209, DOI 10.3390/cancers2020209; Kopcewicz M, 2020, AGING-US, V12, P7066, DOI 10.18632/aging.103064; Kopcewicz MM, 2017, WOUND REPAIR REGEN, V25, P248, DOI 10.1111/wrr.12524; Kur-Piotrowska A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23794-5; Lee D, 1999, DEV BIOL, V208, P362, DOI 10.1006/dbio.1999.9221; LEVINE JH, 1993, AM J PATHOL, V143, P368; Li J, 2007, DIFFERENTIATION, V75, P694, DOI 10.1111/j.1432-0436.2007.00176.x; Lo DD, 2012, BIRTH DEFECTS RES C, V96, P237, DOI 10.1002/bdrc.21018; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Manuel JA, 2006, MATRIX BIOL, V25, P505, DOI 10.1016/j.matbio.2006.07.008; Mori H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21520; Mori K, 2010, CELL IMMUNOL, V260, P66, DOI 10.1016/j.cellimm.2009.09.007; Naranjo-Suarez S, 2013, MOL CELLS, V36, P151, DOI 10.1007/s10059-013-0121-y; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Niu GL, 2008, MOL CANCER RES, V6, P1099, DOI 10.1158/1541-7786.MCR-07-2177; Occleston NL, 2008, J BIOMAT SCI-POLYM E, V19, P1047, DOI 10.1163/156856208784909345; Page EL, 2002, J BIOL CHEM, V277, P48403, DOI 10.1074/jbc.M209114200; Page EL, 2008, MOL BIOL CELL, V19, P86, DOI 10.1091/mbc.E07-06-0612; Pakyari M, 2013, ADV WOUND CARE, V2, P215, DOI 10.1089/wound.2012.0406; Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Ramirez H, 2014, ADV WOUND CARE, V3, P482, DOI 10.1089/wound.2013.0466; Rezvani HR, 2011, J CELL SCI, V124, P4172, DOI 10.1242/jcs.082370; Rong Y, 2006, CANCER RES, V66, P7067, DOI 10.1158/0008-5472.CAN-06-0346; ROWLATT U, 1979, VIRCHOWS ARCH A, V381, P353, DOI 10.1007/BF00432477; Ruthenborg RJ, 2014, MOL CELLS, V37, P637, DOI 10.14348/molcells.2014.0150; Scheid A, 2002, FASEB J, V16, P411, DOI 10.1096/fj.01-0496fje; Scheid A, 2000, PEDIATR SURG INT, V16, P232, DOI 10.1007/s003830050735; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x; SHAH M, 1995, J CELL SCI, V108, P985; Shaikh IA, 2017, J SURG RES, V216, P158, DOI 10.1016/j.jss.2017.04.019; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Taylor CT, 2010, PHYSIOLOGY, V25, P272, DOI 10.1152/physiol.00029.2010; Tracy LE, 2016, ADV WOUND CARE, V5, P119, DOI 10.1089/wound.2014.0561; Walendzik K, 2020, J INVEST DERMATOL, V140, P1166, DOI 10.1016/j.jid.2019.11.010; Wang D, 2016, IUBMB LIFE, V68, P748, DOI 10.1002/iub.1537; Weiner L, 2007, CELL, V130, P932, DOI 10.1016/j.cell.2007.07.024; Wen Y, 2019, ONCOGENE, V38, P1845, DOI 10.1038/s41388-018-0552-1; WHITBY DJ, 1991, DEVELOPMENT, V112, P651; Xia JH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051022; Xiong AJ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00326; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yamawaki H, 2003, CIRC RES, V93, P1029, DOI 10.1161/01.RES.0000102869.39150.23; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	75	4	4	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21289	10.1096/fj.202001907R	http://dx.doi.org/10.1096/fj.202001907R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475195	Green Submitted, hybrid			2022-12-26	WOS:000647789600064
J	Kim, JY; Shin, MS; Seo, C; Eo, SH; Hong, S				Kim, Jin-Yong; Shin, Man-Seok; Seo, Changwan; Eo, Soo Hyung; Hong, Seungbum			Testing the causal mechanism of the peninsular effect in passerine birds from South Korea	PLOS ONE			English	Article							SPECIES-DIVERSITY; HABITAT FRAGMENTATION; PATTERNS; LANDSCAPE; ABUNDANCE; RICHNESS; DENSITY; FORESTS; MODIS	The peninsular effect is a geographical phenomenon that explains patterns of species richness. Given that spatial variation in species richness along a peninsular may be driven by multiple processes, we aimed to identify the sources of latitudinal patterns in passerine species richness and test hypotheses regarding (1) recent deterministic processes (climate, primary productivity, forest area, and habitat diversity), (2) anthropogenic processes (habitat fragmentation), and (3) stochastic processes (migration influence) in the Korean peninsula. We used the distribution data of 147 passerine species from 2006 to 2012. Single regression between passerine species richness and latitude supported the existence of the peninsular effect. Mean temperature increased with decreasing latitude, as did habitat diversity but leaf area index and forest area decline. However, mean temperature and forest area only influenced passerine species richness. Although habitat diversity influenced passerine species richness, it was counter to the expectations associated with peninsular effect. The number of habitat patches decreased as latitude increased but it had no effect on passerine species richness. Ratio of migrant species richness showed no significant relationship with leaf area index, forest area, and habitat diversity. However, the ratio of migrant species richness increased with decreasing mean temperature and that contributed to the increase in passerine species. Overall, our finding indicate that the observed species richness pattern in peninsulas with the tip pointing south (in the northern hemisphere) counter to the global latitudinal gradient. These results were caused by the peninsular effect associated with complex mechanism that interact with climate, habitat area, and migrant species inflow.	[Kim, Jin-Yong] Res Ctr Endangered Species, Div Restorat Res, Yeongyang, South Korea; [Shin, Man-Seok] Natl Inst Ecol, Div Ecol Informat, Seocheon, South Korea; [Seo, Changwan] Natl Inst Ecol, Div Ecol Assessment, Seocheon, South Korea; [Eo, Soo Hyung] Kongju Natl Univ, Dept Forest Resources, Chungnam, South Korea; [Hong, Seungbum] Natl Inst Ecol, Div Climate & Ecol Res, Seocheon, South Korea	National Institute of Ecology; National Institute of Ecology; Kongju National University; National Institute of Ecology	Hong, S (corresponding author), Natl Inst Ecol, Div Climate & Ecol Res, Seocheon, South Korea.	sbhong@nie.re.kr			National Institute of Ecology [NIE-BR-2020-11, NIE-BR-2011-35]; Climate Change Response Technology Project of the Ministry of Environment, Republic of Korea [2014001310009]	National Institute of Ecology; Climate Change Response Technology Project of the Ministry of Environment, Republic of Korea	This study was funded by the Assessment of Climate Change Risk for Ecosystems in Korea (NIE-BR-2020-11) and the Study of adaptation capacity to climate change risk for ecosystem(NIE-BR-2011-35) from the National Institute of Ecology and supported by the Climate Change Response Technology Project of the Ministry of Environment, Republic of Korea (2014001310009).	Ali A, 2020, FOREST ECOL MANAG, V461, DOI 10.1016/j.foreco.2020.117968; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 1999, MODIS LAND SURFACE T; Bailey SA, 2004, ECOGRAPHY, V27, P207, DOI 10.1111/j.0906-7590.2004.03631.x; Battisti C, 2014, J NAT HIST, V48, P2701, DOI 10.1080/00222933.2014.925599; Choe H, 2019, ECOL EVOL, V9, P1353, DOI 10.1002/ece3.4851; Choi SW, 2004, J BIOGEOGR, V31, P587, DOI 10.1046/j.1365-2699.2003.01007.x; Clark DB, 2008, ECOL LETT, V11, P163, DOI 10.1111/j.1461-0248.2007.01134.x; Contoli L, 2000, ITAL J ZOOL, V67, P329, DOI 10.1080/11250000009356334; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P129, DOI 10.1111/j.1466-8238.2006.00279.x; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; Fahrig L, 2019, BIOL CONSERV, V230, P179, DOI 10.1016/j.biocon.2018.12.026; Fletcher RJ, 2018, BIOL CONSERV, V226, P9, DOI 10.1016/j.biocon.2018.07.022; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; FULLER RJ, 1992, IBIS, V134, P14; HERRERA CM, 1978, AUK, V95, P496; Jenkins DG, 2008, J BIOGEOGR, V35, P2128, DOI 10.1111/j.1365-2699.2008.01943.x; KIESTER AR, 1971, SYST ZOOL, V20, P127, DOI 10.2307/2412053; Kim JY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0203511; Kocher SD, 2000, J BIOGEOGR, V27, P785, DOI 10.1046/j.1365-2699.2000.00454.x; LAWLOR TE, 1983, AM NAT, V121, P432, DOI 10.1086/284071; MACARTHUR RH, 1964, AM NAT, V98, P387, DOI 10.1086/282334; MILNE BT, 1986, ECOLOGY, V67, P967, DOI 10.2307/1939819; Rabinovich JE., 1975, J BIOGEOGR, V2, P141, DOI [DOI 10.2307/3037987, 10.2307/3037987]; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; SCHWARTZ MW, 1988, J BIOGEOGR, V15, P759, DOI 10.2307/2845338; Seo S-G, 2015, J NATL PARK RES; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Skeels A, 2020, GLOBAL ECOL BIOGEOGR, V29, P454, DOI 10.1111/geb.13044; Smith AL, 2001, MEXICO1, V33, P18, DOI [10.1111/j.1744-7429.2001.tb00165.x, DOI 10.1111/J.1744-7429.2001.TB00165.X]; TAYLOR RJ, 1987, OIKOS, V48, P232, DOI 10.2307/3565860; TELLERIA JL, 1993, J BIOGEOGR, V20, P235, DOI 10.2307/2845675; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; The Lancet Global Health, 2018, LANCET GLOB HEALTH, V6, pE593; Tian YH, 2000, IEEE T GEOSCI REMOTE, V38, P2387, DOI 10.1109/36.868894; Tubelis DP, 2007, J ZOOL, V271, P11, DOI 10.1111/j.1469-7998.2006.00174.x; Wiggins DA, 1999, ECOGRAPHY, V22, P542, DOI 10.1111/j.1600-0587.1999.tb00543.x; WILLIG M. R., 2017, ENCY ANTHROPOCENE, P13; 2006, CLIN BIOCH REV, V27	41	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245958	10.1371/journal.pone.0245958	http://dx.doi.org/10.1371/journal.pone.0245958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513166	Green Published, gold			2022-12-26	WOS:000613891400048
J	Mose, A; Dheresa, M; Mengistie, B; Wassihun, B; Abebe, H				Mose, Ayenew; Dheresa, Merga; Mengistie, Bezatu; Wassihun, Biresaw; Abebe, Haimanot			Colostrum avoidance practice and associated factors among mothers of children aged less than six months in Bure District, Amhara Region, North West, Ethiopia: A community-based cross-sectional study	PLOS ONE			English	Article								Introduction The World Health Organization and the United Nations International Children's Emergency Fund jointly recommend colostrum feeding immediately following delivery of the newborn. Colostrum avoidance is the practice of discarding colostrum at least once within the first three days after delivery of the newborn. Colostrum contains antibodies that protect the newborn against disease. Despite this fact, many Ethiopian mothers see colostrum feeding as a cause of neonatal morbidity and mortality, and they believe colostrum should be discarded to alleviate its effects. However, the cause of this misconception about colostrum is not well researched in Ethiopia, particularly in the study area. Objective To assess the prevalence of colostrum avoidance and associated factors among mothers of children aged less than six months in Bure district, Amhara Region, North West, Ethiopia. Methods A community-based cross-sectional study was conducted from March 1(st) to 30(th), 2019 in Bure district. Structured questionnaires and face to face interviews were used to collect data from 621 study participants. Multistage sampling technique was used to select study participants. Data were entered into Epi Data version 4.2.0 and then exported to Statistical Package for the Social Sciences version 23. Bivariate and multivariate logistic regression analyses were performed to identify predictors of colostrum avoidance practice. Results Six hundred twenty-one (621) mothers of children aged less than six months participated. The prevalence of colostrum avoidance was 14.5% (95%CI; 11.5-17.4). The multivariate analysis indicated that home delivery [AOR = 3.350, (95%CI; 2.517-14.847)], giving birth through cesarean section [AOR = 3.368, (95%CI; 1.339-8.471)], no participation in an antenatal care group [AOR = 1.889, (95%CI; 1.144-3.533)], poor knowledge of mothers about colostrum [AOR = 3.44, (95%CI; 2.45-4.977)], and poor attitude of mothers towards colostrum [AOR = 3.053, (95%CI; 1.157-8.054)] were important predictors of colostrum avoidance practice. Conclusion and recommendations Home delivery, giving birth through cesarean section, no participation in an antenatal care group, poor knowledge of mothers about colostrum, and poor attitude of mothers towards colostrum were significantly associated with colostrum avoidance practice. Therefore, health care workers in the district should promote institutional delivery, reduce the magnitude of cesarean section, encourage pregnant mothers to participate in an antenatal care group, and enhance maternal awareness about the merits of colostrum feeding. Moreover, health educations for mothers to have a positive attitude towards colostrum are important recommendations to be taken to prevent the further practice of colostrum avoidance.	[Mose, Ayenew] Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia; [Dheresa, Merga] Haramaya Univ, Coll Hlth Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Mengistie, Bezatu] Haramaya Univ, Coll Hlth Sci, Sch Publ Hlth, Harar, Ethiopia; [Wassihun, Biresaw] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia; [Abebe, Haimanot] Wolkite Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Wolkite, Ethiopia	Haramaya University; Haramaya University; Arba Minch University	Mose, A (corresponding author), Wolkite Univ, Coll Med & Hlth Sci, Dept Midwifery, Wolkite, Ethiopia.	ayenew8484@gmail.com	Dheresa, Merga/ABG-4003-2021; Mose, Ayenew/AAZ-6731-2021	Mose, Ayenew/0000-0003-4353-7791				Adem A, 2018, J PREGNANCY CHILD HL, P374; Chaudhary N, 2016, INT J ADV MED HLTH R, V3, P78; Ethiopian Health and Nutrition Institute (EHNR), 2010, NUTR BAS SURV REP NA; FMOH, 2004, NAT STRAT INF YOUNG; Gebreyesus H, 2017, MEDICO RES CHRONICLE, V4, P545; Hadgu T, 2016, WORLD J PHARM MED RE, V2, P33; Hoche S, 2018, ETHIOP J HEALTH SCI, V28, P49, DOI 10.4314/ejhs.v28i1.7; Huffman SL, 2001, MIDWIFERY, V17, P80, DOI 10.1054/midw.2001.0253; Legesse M, 2015, J TROP PEDIATRICS, V61, P357, DOI 10.1093/tropej/fmv039; Liben ML, 2016, EUR J CLIN BIOMED SC, V2, P87, DOI DOI 10.11648/J.EJCBS.20160206.15; Rogers NL, 2011, PUBLIC HEALTH NUTR, V14, P2029, DOI 10.1017/S1368980011000073; Shewasinad S., 2017, J PREGNANCY CHILD HL, V4, P348; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; Weldesamuel Girmay Teklay, 2018, BMC Res Notes, V11, P601, DOI 10.1186/s13104-018-3712-z; WHO, 2003, GLOB STRAT INF YOUNG; Who U. World Bank, 2009, STAT WORLDS VACC IMM, P130; World Health Organization, WHO REC ANT CAR CONT; World Health Organization (WHO), BAB FRIENDL HOSP IN; Yimer NB, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0134-4	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245233	10.1371/journal.pone.0245233	http://dx.doi.org/10.1371/journal.pone.0245233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513154	Green Published, gold			2022-12-26	WOS:000613891400051
J	Galvez-Sanchez, CM; de la Coba, P; Colmenero, JM; del Paso, GAR; Duschek, S				Galvez-Sanchez, Carmen M.; de la Coba, Pablo; Colmenero, Jose M.; del Paso, Gustavo A. Reyes; Duschek, Stefan			Attentional function in fibromyalgia and rheumatoid arthritis	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; PAIN; PERFORMANCE; CRITERIA; FATIGUE; IMPACT	Concentration difficulties, forgetfulness and mental slowness are common in fibromyalgia syndrome (FMS); initial findings suggest that rheumatoid arthritis (RA) may also be accompanied by cognitive impairments. This study aimed to compare attentional performance between patients with FMS and RA. Attention was quantified in the domains of alerting, orienting and executive control using the Attentional Network Test-Interaction (ANT-I) in 56 women with FMS, 41 women with RA and 50 healthy women. Pain severity was statistically controlled in the group comparison. While FMS patients exhibited longer reaction times and made more errors on the ANT-I than RA patients and healthy women, performance did not differ between RA patients and healthy women. The magnitude of group differences did not vary by the experimental conditions of the ANT-I, suggesting a general attentional deficit in FMS rather than specific impairments in the domains of alerting, orienting and executive control. Differences between patient groups may relate to the different pathogenetic mechanisms involved in the disorders, i.e. inflammatory processes in RA and central nervous sensitization in FMS. In FMS, heightened activity in the pain neuromatrix may interfere with attention, because it requires enhanced neural resources in brain areas that are involved in both pain and attentional processing.	[Galvez-Sanchez, Carmen M.; de la Coba, Pablo; Colmenero, Jose M.; del Paso, Gustavo A. Reyes] Univ Jaen, Dept Psychol, Jaen, Spain; [Duschek, Stefan] UMIT Univ Hlth Sci Med Informat & Technol, Inst Psychol, Hall In Tirol, Austria	Universidad de Jaen; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH	Galvez-Sanchez, CM (corresponding author), Univ Jaen, Dept Psychol, Jaen, Spain.	cgalvez@ujaen.es	Reyes del Paso, Gustavo A./G-4179-2011; Galvez Sánchez, Carmen/AAG-9709-2019; de la Coba Gonzalez, Pablo/G-5609-2019	Reyes del Paso, Gustavo A./0000-0002-2188-8673; Galvez Sánchez, Carmen/0000-0002-1927-0292; de la Coba Gonzalez, Pablo/0000-0001-6469-3553	Spanish Ministry of Science, Innovation and Universities; FEDER funds [RTI2018-095830-B-I00]; Spanish Ministry of Education, Culture and Sport [FPU2014-02808]	Spanish Ministry of Science, Innovation and Universities(Spanish Government); FEDER funds(European Commission); Spanish Ministry of Education, Culture and Sport(Spanish Government)	This research was supported by a grant from the Spanish Ministry of Science, Innovation and Universities co-financed by FEDER funds (RTI2018-095830-B-I00) and a FPU pre-doctoral contract (ref: FPU2014-02808) from a grant of the Spanish Ministry of Education, Culture and Sport.	Akdogan S, 2013, J MUSCULOSKELET PAIN, V21, P135, DOI 10.3109/10582452.2013.806977; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartolini M, 2002, CLIN EXP RHEUMATOL, V20, P491; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell T, 2018, J CLIN EXP NEUROPSYC, V40, P698, DOI 10.1080/13803395.2017.1422699; Bilgici A, 2014, J CLIN ANAL MED, V5, P214, DOI 10.4328/JCAM.1181; Bobes J., 2000, PSICOTHEMA, V12, P107; Brown SC, 2002, PAIN, V96, P279, DOI 10.1016/S0304-3959(01)00457-2; Bulbena A., 2000, MEDICI N 150 NICA PS; Callejas A, 2004, BRAIN COGNITION, V54, P225, DOI 10.1016/j.bandc.2004.02.012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Coluccia D, 2008, J NEUROSCI, V28, P3474, DOI 10.1523/JNEUROSCI.4893-07.2008; de la Coba P, 2018, PSYCHOSOM MED, V80, P573, DOI 10.1097/PSY.0000000000000599; Dick B, 2002, ARTHRIT RHEUM-ARTHR, V47, P639, DOI 10.1002/art.10800; Duschek S, 2013, BEHAV MED, V39, P11, DOI 10.1080/08964289.2012.708684; First M.B., 1999, ENTREVISTA 150 NICA; Galvez-Sanchez CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201488; Galvez-Sanchez CM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00377; Gracely RH, 2011, BEST PRACT RES CL RH, V25, P271, DOI 10.1016/j.berh.2011.02.003; Hauser W, 2012, CNS DRUGS, V26, P297, DOI 10.2165/11598970-000000000-00000; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lazaro C., 1994, EUR J PSYCHOL ASSESS, V10, P145; Meade T, 2018, ARTHRIT CARE RES, V70, P39, DOI 10.1002/acr.23243; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; de Guevara CML, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196329; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; del Paso GAR, 2012, EUR J PAIN, V16, P421, DOI 10.1002/j.1532-2149.2011.00032.x; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Schneider W., 2002, E PRIME USERS GUIDE; Scott David L, 2010, Lancet, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shin S, 2012, GERONTOLOGIST, V52, P98; Shin SY, 2012, ARTHRIT CARE RES, V64, P1144, DOI 10.1002/acr.21683; Spering M, 2005, COGNITION EMOTION, V19, P1252, DOI 10.1080/02699930500304886; Spielberger C.D., 1982, MANUAL CUESTIONARIO; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Teodoro T, 2018, J NEUROL NEUROSUR PS, V89, P1308, DOI 10.1136/jnnp-2017-317823; Vazquez C., 1999, CLIN SALUD, V1, P59; Veldhuijzen DS, 2012, J PAIN, V13, P507, DOI 10.1016/j.jpain.2012.02.011; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wu YL, 2018, PSYCHOSOM MED, V80, P432, DOI 10.1097/PSY.0000000000000575	40	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246128	10.1371/journal.pone.0246128	http://dx.doi.org/10.1371/journal.pone.0246128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503065	Green Published, gold			2022-12-26	WOS:000613751800043
J	Zhang, HY; Gao, ZQ; Xue, JF; Lin, W; Sun, M; Sihi, D				Zhang, Huiyu; Gao, Zhiqiang; Xue, Jianfu; Lin, Wen; Sun, Min; Sihi, Debjani			Subsoiling during summer fallow in rainfed winter-wheat fields enhances soil organic carbon sequestration on the Loess Plateau in China	PLOS ONE			English	Article								Scientific management of the soil organic carbon (SOC) pool, e.g., through a reasonable tillage system, is a potential way to mitigate global climate change. There is scarce information about the effect of tillage during the summer fallow period on the SOC pool in rainfed winter-wheat fields. The present study was designed to evaluate the effects of tillage practices, i.e., plow tillage (PTF), subsoiling (STF) and no tillage (NTF), during the summer fallow period on SOC sequestration in winter-wheat fields in the rainfed area of the eastern Loess Plateau of China. The SOC, mineral-associated organic carbon (MOC), permanganate-oxidizable organic carbon (POxC) and particulate organic carbon (POC) concentrations were determined after four years of tillage implementation during the summer fallow period. Our results showed that in comparison to the adoption of NTF, the adoption of STF significantly increased POxC, POC and MOC concentrations by 56.6-111.2%, 45.7-118.7% and 26.2-29.4%, respectively, at the 10-20 and 30-40 cm soil depths before sowing (P < 0.05). The POxC and MOC concentrations under STF at depths of 0-10, 10-20, 20-30 and 30-50 cm were significantly greater than those under PTF and NTF after harvesting (P < 0.05). In addition, the SOC concentration and SOC stock under STF were significantly greater than those under NTF at the 0-10, 10-20, 20-30 and 30-40 cm soil depths before sowing and after harvesting (P < 0.05). Furthermore, in comparison to PTF and NTF, STF resulted in significantly higher SOC stocks by 12.0-25.3% and 7.1-19.2% than PTF and NTF, respectively, in the 0-10, 0-20, 0-30, 0-40 and 0-50 cm soil profiles at harvesting (P < 0.05). In summary, the adoption of STF could be beneficial to the management of the SOC pool in the 0-50 cm soil profile in the rainfed area of winter-wheat on the Loess Plateau of China.	[Zhang, Huiyu; Gao, Zhiqiang; Xue, Jianfu; Lin, Wen; Sun, Min; Sihi, Debjani] Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China	Shanxi Agricultural University	Gao, ZQ; Xue, JF (corresponding author), Shanxi Agr Univ, Coll Agr, Taigu, Shanxi, Peoples R China.	gaosxau@163.com; fudange95@sxau.edu.cn			National Natural Science Fund of China [31801305, 31771727]; China Postdoctoral Science Foundation [2015M581322, 2017T100169]; Scientific and Technological Innovation Fund of Shanxi Agricultural University [2017YJ25]; National Modern Agricultural Industry Technology System [CARS 03-01-24]; Postgraduate Innovation Project of Shanxi Province [2019BY068]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific and Technological Innovation Fund of Shanxi Agricultural University; National Modern Agricultural Industry Technology System; Postgraduate Innovation Project of Shanxi Province	This research was supported by Project Funded by National Natural Science Fund of China (31801305, 31771727), China Postdoctoral Science Foundation (2015M581322, 2017T100169), Scientific and Technological Innovation Fund of Shanxi Agricultural University (2017YJ25), and National Modern Agricultural Industry Technology System (CARS 03-01-24), Postgraduate Innovation Project of Shanxi Province (2019BY068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; BLAIR GJ, 1995, AUST J AGR RES, V46, P1459, DOI 10.1071/AR9951459; Blanco-Canqui H, 2008, SOIL SCI SOC AM J, V72, P693, DOI 10.2136/sssaj2007.0233; Blanco-Moure N, 2013, SOIL USE MANAGE, V29, P250, DOI 10.1111/sum.12039; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Chen LF, 2016, CATENA, V147, P300, DOI 10.1016/j.catena.2016.07.009; Chenu C, 2019, SOIL TILL RES, V188, P41, DOI 10.1016/j.still.2018.04.011; Dou F, 2008, SOIL SCI SOC AM J, V72, P1445, DOI 10.2136/sssaj2007.0230; Ellert BH, 1995, CABADIAN J SOIL SCI, V4, P10; Ferreira LB, 2018, SOIL RES, V56, P846, DOI 10.1071/SR18167; Gonzalez-Ubierna S, 2015, SOIL TILL RES, V153, P48, DOI 10.1016/j.still.2015.05.002; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; Guo YF, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111908; Haddaway NR, 2017, SYSTEMATIC REV; Haddix ML, 2016, GLOBAL CHANGE BIOL, V22, P2301, DOI 10.1111/gcb.13237; Han Y, 2017, CHEM BIOL TECHNOL AG, V4; Hu J, 2016, SOIL SCI SOC AM J, V80, P783, DOI 10.2136/sssaj2015.10.0381; Huang JP, 2016, NAT CLIM CHANGE, V6, P166, DOI [10.1038/nclimate2837, 10.1038/NCLIMATE2837]; Hydbom S, 2017, APPL SOIL ECOL, V119, P104, DOI 10.1016/j.apsoil.2017.05.032; Jun W, 2019, J ARID LAND, V11, P1; Kahlon MS, 2013, SOIL TILL RES, V126, P151, DOI 10.1016/j.still.2012.08.001; Lal R, 2019, CURR CLIM CHANGE REP, V5, P221, DOI 10.1007/s40641-019-00132-z; Lal R, 2014, INT SOIL WATER CONSE, V2, P36, DOI 10.1016/S2095-6339(15)30021-6; Li YJ, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050456; Pinheiro EFM, 2015, AGR SYST, V132, P35, DOI 10.1016/j.agsy.2014.08.008; Martinez JM, 2017, SOIL TILL RES, V169, P71, DOI 10.1016/j.still.2017.02.001; Mei Y, 2018, J ARID LAND, V10, P149; Modak K, 2019, SOIL TILL RES, V195, DOI 10.1016/j.still.2019.104370; Mu XY, 2016, EUR J AGRON, V78, P32, DOI 10.1016/j.eja.2016.04.010; Pengthamkeerati P, 2011, APPL SOIL ECOL, V48, P71, DOI 10.1016/j.apsoil.2011.01.005; Plaza C, 2013, SOIL BIOL BIOCHEM, V57, P124, DOI 10.1016/j.soilbio.2012.07.026; Plaza-Bonilla D, 2014, SOIL TILL RES, V139, P19, DOI 10.1016/j.still.2014.01.006; Prasad JVNS, 2016, SOIL TILL RES, V156, P131, DOI 10.1016/j.still.2015.10.013; Qian J, 2018, ECOL ENG, V112, P82, DOI 10.1016/j.ecoleng.2017.12.015; Quiroga AR, 1996, SOIL SCI, V161, P104, DOI 10.1097/00010694-199602000-00004; Rainer R, 2018, PLANT SOIL; Singh P, 2015, SCI TOTAL ENVIRON, V518, P337, DOI 10.1016/j.scitotenv.2015.03.027; Stewart CE, 2012, SOIL SCI SOC AM J, V76, P1257, DOI 10.2136/sssaj2011.0165; Sun M, 2018, FIELD CROP RES, V218, P24, DOI 10.1016/j.fcr.2017.12.021; Virto I, 2012, BIOGEOCHEMISTRY, V108, P17, DOI 10.1007/s10533-011-9600-4; Wang H, 2018, LAND DEGRAD DEV, V29, P2880, DOI 10.1002/ldr.3015; Wang QY, 2014, SOIL TILL RES, V143, P1, DOI 10.1016/j.still.2014.05.004; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006; Xue LZ, 2019, SOIL TILL RES, V191, P66, DOI 10.1016/j.still.2019.03.014; Yang SH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17010333; Zhang Y, 2018, GEODERMA, V330, P204, DOI 10.1016/j.geoderma.2018.05.037; Zuber SM, 2015, AGRON J, V107, P971, DOI 10.2134/agronj14.0465	48	1	1	6	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245484	10.1371/journal.pone.0245484	http://dx.doi.org/10.1371/journal.pone.0245484			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503033	Green Published, gold			2022-12-26	WOS:000613751800009
J	Crouser, ED; Julian, MW; Bicer, S; Ghai, V; Kim, TK; Maier, LA; Gillespie, M; Hamzeh, NY; Wang, K				Crouser, Elliott D.; Julian, Mark W.; Bicer, Sabahattin; Ghai, Vikas; Kim, Taek-Kyun; Maier, Lisa A.; Gillespie, May; Hamzeh, Nabeel Y.; Wang, Kai			Circulating exosomal microRNA expression patterns distinguish cardiac sarcoidosis from myocardial ischemia	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BIOMARKERS; DIAGNOSIS	Objective Cardiac sarcoidosis is difficult to diagnose, often requiring expensive and inconvenient advanced imaging techniques. Circulating exosomes contain genetic material, such as microRNA (miRNA), that are derived from diseased tissues and may serve as potential disease-specific biomarkers. We thus sought to determine whether circulating exosome-derived miRNA expression patterns would distinguish cardiac sarcoidosis (CS) from acute myocardial infarction (AMI). Methods Plasma and serum samples conforming to CS, AMI or disease-free controls were procured from the Biologic Specimen and Data Repository Information Coordinating Center repository and National Jewish Health. Next generation sequencing (NGS) was performed on exosome-derived total RNA (n = 10 for each group), and miRNA expression levels were compared after normalization using housekeeping miRNA. Quality assurance measures excluded poor quality RNA samples. Differentially expressed (DE) miRNA patterns, based upon >2-fold change (p < 0.01), were established in CS compared to controls, and in CS compared to AMI. Relative expression of several DE-miRNA were validated by qRT-PCR. Results Despite the advanced age of the stored samples (similar to 5-30 years), the quality of the exosome-derived miRNA was intact in similar to 88% of samples. Comparing plasma exosomal miRNA in CS versus controls, NGS yielded 18 DE transcripts (12 up-regulated, 6 down-regulated), including miRNA previously implicated in mechanisms of myocardial injury (miR-92, miR-21) and immune responses (miR-618, miR-27a). NGS further yielded 52 DE miRNA in serum exosomes from CS versus AMI: 5 up-regulated in CS; 47 up-regulated in AMI, including transcripts previously detected in AMI patients (miR-1-1, miR-133a, miR-208b, miR-423, miR-499). Five miRNAs with increased DE in CS included two isoforms of miR-624 and miR-144, previously reported as markers of cardiomyopathy. Conclusions MiRNA patterns of exosomes derived from CS and AMI patients are distinct, suggesting that circulating exosomal miRNA patterns could serve as disease biomarkers. Further studies are required to establish their specificity relative to other cardiac disorders.	[Crouser, Elliott D.; Julian, Mark W.; Bicer, Sabahattin] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Internal Med, Div Pulm Crit Care & Sleep Med,Wexner Med Ctr, Columbus, OH 43210 USA; [Ghai, Vikas; Kim, Taek-Kyun; Wang, Kai] Inst Syst Biol, Seattle, WA USA; [Maier, Lisa A.; Gillespie, May] Natl Jewish Hlth, Div Environm & Occupat Hlth Sci, Dept Med, Denver, CO USA; [Hamzeh, Nabeel Y.] Univ Iowa, Dept Internal Med, Div Pulm Crit Care & Occupat Med, Carver Coll Med, Iowa City, IA USA	University System of Ohio; Ohio State University; Institute for Systems Biology (ISB); National Jewish Health; University of Iowa	Crouser, ED (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Dept Internal Med, Div Pulm Crit Care & Sleep Med,Wexner Med Ctr, Columbus, OH 43210 USA.	elliott.crouser@osumc.edu	Crouser, Elliott/ABC-2602-2021	Hamzeh, Nabeel/0000-0001-7296-8975; Crouser, Elliott/0000-0003-3197-6746	National Institutes of Health [R21HL140012, UL1TR002535, U01HL112695, U01HL112707, R01DA040395, UG3TR002884]; U.S. Department of Defense [W81XWH-16-1-0301, W911NF-17-2-0086]; Foundation for Sarcoidosis Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Foundation for Sarcoidosis Research	Grant Support: This work was supported by the National Institutes of Health (nih.gov) grants [R21HL140012 (EDC), UL1TR002535, U01HL112695 and U01HL112707 (LAM, NYH) and R01DA040395 and UG3TR002884 (KW)], U.S. Department of Defense (dod.defense.gov) grants [W81XWH-16-1-0301 and W911NF-17-2-0086 (KW)], and the Foundation for Sarcoidosis Research (stopsarcoidosis.org) (EDC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1213-9; Alipoor SD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00819; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; [Anonymous], 1989, NEW ENGL J MED, V320, P618; [Anonymous], 2015, BMJ, V2015, ph1887; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Backes C, 2016, NUCLEIC ACIDS RES, V44, pW110, DOI 10.1093/nar/gkw345; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Bravo PE, 2017, INT J CARDIOL, V241, P457, DOI 10.1016/j.ijcard.2017.03.033; Bukauskas T, 2019, MED SCI MONITOR, V25, P3925, DOI 10.12659/MSM.913743; Campbell JD, 2015, RNA, V21, P164, DOI 10.1261/rna.046060.114; Crouser ED, 2020, AM J RESP CRIT CARE, V201, pE26, DOI 10.1164/rccm.202002-0251ST; Crouser ED, 2017, AM J RESP CRIT CARE, V196, P931, DOI 10.1164/rccm.201611-2183LE; Eryilmaz U, 2016, ANATOL J CARDIOL, V16, P392, DOI 10.5152/AnatolJCardiol.2015.6603; Ferreira J.A., 2007, INT J BIOSTAT, V3, DOI [10.2202/1557-4679.1065, DOI 10.2202/1557-4679.1065]; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Halushka PV, 2019, ANNU REV PATHOL-MECH, V14, P211, DOI 10.1146/annurev-pathmechdis-012418-012827; Izumi T, 2011, CIRC J, V75, DOI 10.1253/circj.CJ-88-0008; JAYACHANDRAN M, 2007, INDIAN J SCI TECHNOL, V1; Judson MA, 2014, SARCOIDOSIS VASC DIF, V31, P19; Jung M, 2019, BASIC RES CARDIOL, V114, DOI 10.1007/s00395-018-0712-z; Kandolin R, 2015, CIRCULATION, V131, P624, DOI 10.1161/CIRCULATIONAHA.114.011522; Lynch JP, 2014, SEMIN RESP CRIT CARE, V35, P372, DOI 10.1055/s-0034-1376889; Marinas MB, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041536; Metpally Raghu Prasad Rao, 2013, Frontiers in Genetics, V4, P20, DOI 10.3389/fgene.2013.00020; Moller DR, 2015, ANN AM THORAC SOC, V12, P1561, DOI 10.1513/AnnalsATS.201503-172OT; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Navickas R, 2016, CARDIOVASC RES, V111, P322, DOI 10.1093/cvr/cvw174; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sekhri V, 2011, ARCH MED SCI, V7, P546, DOI 10.5114/aoms.2011.24118; Sondermeijer BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025946; Takahashi K, 2015, J ARRYTHM, V31, P58, DOI 10.1016/j.joa.2014.05.004; Tao LC, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01149; Uijlings R, 2012, J CARDIOVASC MED, V13, P277, DOI 10.2459/JCM.0b013e32833b4ca2; Van Giau V, 2016, J NEUROL SCI, V360, P141, DOI 10.1016/j.jns.2015.12.005; WAIT JL, 1989, THORAX, V44, P391, DOI 10.1136/thx.44.5.391; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Wu N, 2018, AM J TRANSL RES, V10, P4082	40	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246083	10.1371/journal.pone.0246083	http://dx.doi.org/10.1371/journal.pone.0246083			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497386	Green Published, gold			2022-12-26	WOS:000613707100034
J	Goh, CJ; Hahn, Y				Goh, Chul Jun; Hahn, Yoonsoo			Analysis of proteolytic processing sites in potyvirus polyproteins revealed differential amino acid preferences of NIa-Pro protease in each of seven cleavage sites	PLOS ONE			English	Article							MOSAIC-VIRUS; EXPRESSION; SEQUENCE; BIOLOGY	Potyviruses encode a large polyprotein that undergoes proteolytic processing, producing 10 mature proteins: P1, HC-Pro, P3, 6K1, CI, 6K2, VPg, NIa-Pro, NIb-RdRp, and CP. While P1/HC-Pro and HC-Pro/P3 junctions are cleaved by P1 and HC-Pro, respectively, the remaining seven are processed by NIa-Pro. In this study, we analyzed 135 polyprotein sequences from approved potyvirus species and deduced the consensus amino acid residues at five positions (from -4 to +1, where a protease cleaves between -1 and +1) in each of nine cleavage sites. In general, the newly deduced consensus sequences were consistent with the previous ones. However, seven NIa-Pro cleavage sites showed distinct amino acid preferences despite being processed by the same protease. At position -2, histidine was the dominant amino acid residue in most cleavage sites (57.8-60.7% of analyzed sequences), except for the NIa-Pro/NIb-RdRp junction where it was absent. At position -1, glutamine was highly dominant in most sites (88.2-97.8%), except for the VPg/NIa-Pro junction where glutamic acid was found in all the analyzed proteins (100%). At position +1, serine was the most abundant residue (47.4-86.7%) in five out of seven sites, while alanine (52.6%) and glycine (82.2%) were the most abundant in the P3/6K1 and 6K2/VPg junctions, respectively. These findings suggest that each NIa-Pro cleavage site is finely tuned for differential characteristics of proteolytic reactions. The newly deduced consensus sequences may be useful resources for the development of models and methods to accurately predict potyvirus polyprotein processing sites.	[Goh, Chul Jun; Hahn, Yoonsoo] Chung Ang Univ, Dept Life Sci, Seoul, South Korea	Chung Ang University	Hahn, Y (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul, South Korea.	hahny@cau.ac.kr		HAHN, YOONSOO/0000-0003-4273-9842	National Research Foundation of Korea (NRF) - Government of Korea [2018R1A5A1025077, 2020R1A2C1013403]	National Research Foundation of Korea (NRF) - Government of Korea	This work was supported by the National Research Foundation of Korea (NRF), funded by the Government of Korea, under grant Nos. 2018R1A5A1025077 and 2020R1A2C1013403 to Yoonsoo Hahn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; CARRINGTON JC, 1992, VIROLOGY, V187, P308, DOI 10.1016/0042-6822(92)90319-K; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gadhave KR, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070773; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Han HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015645; Honda M, 1999, J VIROL, V73, P1165, DOI 10.1128/JVI.73.2.1165-1174.1999; Jebasingh T, 2013, J BIOMOL STRUCT DYN, V31, P602, DOI 10.1080/07391102.2012.706078; Kendall A, 2008, J VIROL, V82, P9546, DOI 10.1128/JVI.00895-08; Kim TK, 2012, EXP MOL MED, V44, P740, DOI 10.3858/emm.2012.44.12.082; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Mathur C, 2012, VIROLOGY, V422, P254, DOI 10.1016/j.virol.2011.10.009; Merits A, 2002, J GEN VIROL, V83, P1211, DOI 10.1099/0022-1317-83-5-1211; Miller WA, 2000, VIROLOGY, V273, P1, DOI 10.1006/viro.2000.0421; Nibert ML, 2016, VIROLOGY, V498, P201, DOI 10.1016/j.virol.2016.07.002; Nigam D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01439; Park D, 2017, ACTA VIROL, V61, P479, DOI 10.4149/av_2017_410; Revers F, 2015, ADV VIRUS RES, V92, P101, DOI 10.1016/bs.aivir.2014.11.006; Sicard A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005819; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Su X, 2016, SCI REP-UK, V6, DOI 10.1038/srep26741; Wamaitha MJ, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0999-2; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Worrall EA, 2015, ADV VIRUS RES, V93, P1, DOI 10.1016/bs.aivir.2015.04.002; Wylie SJ, 2017, J GEN VIROL, V98, P352, DOI 10.1099/jgv.0.000740	30	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245853	10.1371/journal.pone.0245853	http://dx.doi.org/10.1371/journal.pone.0245853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493199	Green Published, gold			2022-12-26	WOS:000613081500007
J	Beg, M; Zhang, W; McCourt, AC; Enerback, S				Beg, Muheeb; Zhang, Wei; McCourt, Andrew C.; Enerback, Sven			ATGL activity regulates GLUT1-mediated glucose uptake and lactate production via TXNIP stability in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING MECHANISMS; INSULIN; GLUT4; INVOLVEMENT; METABOLISM; LIPOLYSIS; PATHWAY	Traditionally, lipolysis has been regarded as an enzymatic activity that liberates fatty acids as metabolic fuel. However, recent work has shown that novel substrates, including a variety of lipid compounds such as fatty acids and their derivatives, release lipolysis products that act as signaling molecules and transcriptional modulators. While these studies have expanded the role of lipolysis, the mechanisms underpinning lipolysis signaling are not fully defined. Here, we uncover a new mechanism regulating glucose uptake, whereby activation of lipolysis, in response to elevated cAMP, leads to the stimulation of thioredoxin-interacting protein (TXNIP) degradation. This, in turn, selectively induces glucose transporter 1 surface localization and glucose uptake in 3T3-L1 adipocytes and increases lactate production. Interestingly, cAMP-induced glucose uptake via degradation of TXNIP is largely dependent upon adipose triglyceride lipase (ATGL) and not hormone-sensitive lipase or monoacylglycerol lipase. Pharmacological inhibition or knockdown of ATGL alone prevents cAMP-dependent TXNIP degradation and thus significantly decreases glucose uptake and lactate secretion. Conversely, overexpression of ATGL amplifies the cAMP response, yielding increased glucose uptake and lactate production. Similarly, knockdown of TXNIP elicits enhanced basal glucose uptake and lactate secretion, and increased cAMP further amplifies this phenotype. Overexpression of TXNIP reduces basal and cAMP-stimulated glucose uptake and lactate secretion. As a proof of concept, we replicated these findings in human primary adipocytes and observed TXNIP degradation and increased glucose uptake and lactate secretion upon elevated cAMP signaling. Taken together, our results suggest a crosstalk between ATGL-mediated lipolysis and glucose uptake.	[Beg, Muheeb; Zhang, Wei; McCourt, Andrew C.; Enerback, Sven] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden	University of Gothenburg	Enerback, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	sven.enerback@medgen.gu.se		Enerback, Sven/0000-0003-2911-9710	Swedish Research Council [2019-00773, 2018-02537]; Knut and Alice Wallenberg Foundation; Sahlgrenska's University Hospital; Novo Nordisk; Novo Nordisk Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Sahlgrenska's University Hospital; Novo Nordisk(Novo Nordisk); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	S. E. is supported by the Swedish Research Council (2019-00773 and 2018-02537), The Knut and Alice Wallenberg Foundation, Sahlgrenska's University Hospital (under the LUA-ALF agreement), Novo Nordisk, and Novo Nordisk Foundation.	Alhawiti NM, 2017, CURR DRUG TARGETS, V18, P1095, DOI 10.2174/1389450118666170130145514; AMRI EZ, 1994, J LIPID RES, V35, P930; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Czech MP, 2013, DIABETOLOGIA, V56, P949, DOI 10.1007/s00125-013-2869-1; Dube JJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE879, DOI 10.1152/ajpendo.00530.2014; Eichmann TO, 2015, CELL MOL LIFE SCI, V72, P3931, DOI 10.1007/s00018-015-1982-3; EZAKI O, 1990, DIABETES, V39, P1543, DOI 10.2337/diabetes.39.12.1543; Haber EP, 2003, FEBS LETT, V544, P185, DOI 10.1016/S0014-5793(03)00503-9; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; Kalinovich A, 2020, DIABETOLOGIA, V63, P1603, DOI 10.1007/s00125-020-05171-y; Klip A, 2019, J BIOL CHEM, V294, P11369, DOI 10.1074/jbc.REV119.008351; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Mayer N, 2013, NAT CHEM BIOL, V9, P785, DOI [10.1038/NCHEMBIO.1359, 10.1038/nchembio.1359]; Nugent C, 2001, J BIOL CHEM, V276, P9149, DOI 10.1074/jbc.M009817200; Rabinowitz JD, 2020, NAT METAB, V2, P566, DOI 10.1038/s42255-020-0243-4; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sato M, 2014, DIABETES, V63, P4115, DOI 10.2337/db13-1860; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Schreiber R, 2019, BBA-MOL CELL BIOL L, V1864, P880, DOI 10.1016/j.bbalip.2018.10.008; Schweiger M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14859, 10.1038/ncomms15490]; Sokolowska E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00577; Sukonina V, 2019, NATURE, V566, P279, DOI 10.1038/s41586-019-0900-5; VOGT B, 1991, BIOCHEM J, V275, P597, DOI 10.1042/bj2750597; Waldhart AN, 2017, CELL REP, V19, P2005, DOI 10.1016/j.celrep.2017.05.041; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	29	6	7	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100332	10.1016/j.jbc.2021.100332	http://dx.doi.org/10.1016/j.jbc.2021.100332			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508319	gold, Green Published			2022-12-26	WOS:000672866400306
J	Klyuyeva, AV; Belyaeva, OV; Goggans, KR; Krezel, W; Popov, KM; Kedishvili, NY				Klyuyeva, Alla, V; Belyaeva, Olga, V; Goggans, Kelli R.; Krezel, Wojciech; Popov, Kirill M.; Kedishvili, Natalia Y.			Changes in retinoid metabolism and signaling associated with metabolic remodeling during fasting and in type I diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ACID BIOSYNTHESIS; DEHYDROGENASE 10; CYP26A1; EXPRESSION; ENZYME; RDH10; GENE; HOMEOSTASIS	Liver is the central metabolic hub that coordinates carbohydrate and lipid metabolism. The bioactive derivative of vitamin A, retinoic acid (RA), was shown to regulate major metabolic genes including phosphoenolpyruvate carboxykinase, fatty acid synthase, carnitine palmitoyltransferase 1, and glucokinase among others. Expression levels of these genes undergo profound changes during adaptation to fasting or in metabolic diseases such as type 1 diabetes (T1D). However, it is unknown whether the levels of hepatic RA change during metabolic remodeling. This study investigated the dynamics of hepatic retinoid metabolism and signaling in the fed state, in fasting, and in T1D. Our results show that fed-to-fasted transition is associated with significant decrease in hepatic retinol dehydrogenase (RDH) activity, the rate-limiting step in RA biosynthesis, and downregulation of RA signaling. The decrease in RDH activity correlates with the decreased abundance and altered subcellular distribution of RDH10 while Rdh10 transcript levels remain unchanged. In contrast to fasting, untreated T1D is associated with upregulation of RA signaling and an increase in hepatic RDH activity, which correlates with the increased abundance of RDH10 in microsomal membranes. The dynamic changes in RDH10 protein levels in the absence of changes in its transcript levels imply the existence of posttranscriptional regulation of RDH10 protein. Together, these data suggest that the downregulation of hepatic RA biosynthesis, in part via the decrease in RDH10, is an integral component of adaptation to fasting. In contrast, the upregulation of hepatic RA biosynthesis and signaling in T1D might contribute to metabolic inflexibility associated with this disease.	[Klyuyeva, Alla, V; Belyaeva, Olga, V; Goggans, Kelli R.; Popov, Kirill M.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Krezel, Wojciech] Univ Strasbourg, INSERM, Inst Genet & Mol & Cellular Biol IGBMC, Strasbourg, France	University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Popov, KM; Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	kpopov@uab.edu; nkedishvili@uab.edu	Goggans, Kelli/HHS-2351-2022; Krezel, Wojciech/H-9080-2017	Krezel, Wojciech/0000-0003-1605-3185; Goggans, Kelli/0000-0002-7008-7506; Beliaeva, Olga/0000-0003-2512-925X	National Institutes of Health [R01AR076924, R01GM051262]; University of Alabama at Birmingham School of Medicine AMC21 Research Support	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham School of Medicine AMC21 Research Support	The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was supported by grants from the National Institutes of Health R01AR076924 (N. Y. K.), R01GM051262 (K. M. P.), and the University of Alabama at Birmingham School of Medicine AMC21 Research Support (N. Y. K.).	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Amengual J, 2010, CELL PHYSIOL BIOCHEM, V25, P657, DOI 10.1159/000315085; Ashique AM, 2012, GENESIS, V50, P415, DOI 10.1002/dvg.22002; Ashton A, 2018, MOL NEUROBIOL, V55, P8219, DOI 10.1007/s12035-018-0964-5; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bar-El Dadon S, 2017, CRIT REV FOOD SCI, V57, P2404, DOI 10.1080/10408398.2015.1060940; Belyaeva OV, 2008, J BIOL CHEM, V283, P20299, DOI 10.1074/jbc.M800019200; Belyaeva OV, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010005; Belyaeva OV, 2018, J BIOL CHEM, V293, P6996, DOI 10.1074/jbc.RA117.001646; Belyaeva OV, 2017, J BIOL CHEM, V292, P5884, DOI 10.1074/jbc.M117.776914; Billings SE, 2013, FASEB J, V27, P4877, DOI 10.1096/fj.13-227967; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Chen W, 2014, J CLIN MED, V3, P453, DOI 10.3390/jcm3020453; Drager U C, 2001, Prog Brain Res, V131, P579; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Hebert SL, 2010, CLIN NUTR, V29, P13, DOI 10.1016/j.clnu.2009.09.001; Henne WM, 2018, EMBO J, V37, DOI 10.15252/embj.201898947; Hogarth CA, 2011, TRENDS ENDOCRIN MET, V22, P136, DOI 10.1016/j.tem.2011.01.001; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kasus-Jacobi A, 2003, J BIOL CHEM, V278, P32380, DOI 10.1074/jbc.M304969200; Kim CH, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e1; Kramer DA, 2018, J PROTEOMICS, V181, P213, DOI 10.1016/j.jprot.2018.04.024; Kuang HQ, 2019, BIOCHEM CELL BIOL, V97, P545, DOI 10.1139/bcb-2018-0284; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Li Y, 2018, AM J PATHOL, V188, P1833, DOI 10.1016/j.ajpath.2018.04.015; LUCAS PC, 1991, P NATL ACAD SCI USA, V88, P2184, DOI 10.1073/pnas.88.6.2184; Ma YL, 2021, HEPATOLOGY, V73, P1701, DOI 10.1002/hep.31517; Ma YL, 2019, HEPATOLOGY, V69, P1504, DOI 10.1002/hep.30350; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Moore T, 1937, BIOCHEM J, V31, P155, DOI 10.1042/bj0310155; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; Napoli JL, 1998, METH MOL B, V89, P29; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Obrochta KM, 2015, J BIOL CHEM, V290, P7259, DOI 10.1074/jbc.M114.609313; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Ozpolat B, 2005, LEUKEMIA LYMPHOMA, V46, P1497, DOI 10.1080/10428190500174737; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Ransom J, 2014, J NEUROCHEM, V129, P366, DOI 10.1111/jnc.12620; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Ross AC, 2004, J NUTR, V134, p269S, DOI 10.1093/jn/134.1.269S; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Shannon SR, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.264; Shin DJ, 1997, J NUTR, V127, P1274, DOI 10.1093/jn/127.7.1274; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Topletz AR, 2012, BIOCHEM PHARMACOL, V83, P149, DOI 10.1016/j.bcp.2011.10.007; Trasino Steven E, 2015, Diabetes Manag (Lond), V5, P359; Urvalek A, 2014, SUBCELL BIOCHEM, V70, P129, DOI 10.1007/978-94-017-9050-5_7; Wei LN, 2012, BBA-MOL CELL BIOL L, V1821, P206, DOI 10.1016/j.bbalip.2011.03.003; WOLF G, 1958, Prog Nucl Energy 6 Biol Sci, V2, P457; Yang D, 2018, DIABETES, V67, P662, DOI 10.2337/db17-0946; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang Y, 2010, GENE, V464, P32, DOI 10.1016/j.gene.2010.05.004; Zhong G, 2019, J BIOL CHEM, V294, P11166, DOI 10.1074/jbc.RA119.009023	63	5	5	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100323	10.1016/j.jbc.2021.100323	http://dx.doi.org/10.1016/j.jbc.2021.100323			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485967	Green Published, gold			2022-12-26	WOS:000672866400297
J	Johnston, SC; Ricks, KM; Jay, A; Raymond, JL; Rossi, F; Zeng, XK; Scruggs, J; Dyer, D; Frick, O; Koehler, JW; Kuehnert, PA; Clements, TL; Shoemaker, CJ; Coyne, SR; Delp, KL; Moore, J; Berrier, K; Esham, H; Shamblin, J; Sifford, W; Fiallos, J; Klosterman, L; Stevens, S; White, L; Bowling, P; Garcia, T; Jensen, C; Ghering, J; Nyakiti, D; Bellanca, S; Kearney, B; Giles, W; Alli, N; Paz, F; Akers, K; Danner, D; Barth, J; Johnson, JA; Durant, M; Kim, R; Hooper, JW; Smith, JM; Kugelman, JR; Beitzel, BF; Gibson, KM; Pitt, MLM; Minogue, TD; Nalca, A				Johnston, Sara C.; Ricks, Keersten M.; Jay, Alexandra; Raymond, Jo Lynne; Rossi, Franco; Zeng, Xiankun; Scruggs, Jennifer; Dyer, David; Frick, Ondraya; Koehler, Jeffrey W.; Kuehnert, Paul A.; Clements, Tamara L.; Shoemaker, Charles J.; Coyne, Susan R.; Delp, Korey L.; Moore, Joshua; Berrier, Kerry; Esham, Heather; Shamblin, Joshua; Sifford, Willie; Fiallos, Jimmy; Klosterman, Leslie; Stevens, Stephen; White, Lauren; Bowling, Philip; Garcia, Terrence; Jensen, Christopher; Ghering, Jeanean; Nyakiti, David; Bellanca, Stephanie; Kearney, Brian; Giles, Wendy; Alli, Nazira; Paz, Fabian; Akers, Kristen; Danner, Denise; Barth, James; Johnson, Joshua A.; Durant, Matthew; Kim, Ruth; Hooper, Jay W.; Smith, Jeffrey M.; Kugelman, Jeffrey R.; Beitzel, Brett F.; Gibson, Kathleen M.; Pitt, Margaret L. M.; Minogue, Timothy D.; Nalca, Aysegul			Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure	PLOS ONE			English	Article							TRANSMISSION; WUHAN	Airborne transmission is predicted to be a prevalent route of human exposure with SARS-CoV-2. Aside from African green monkeys, nonhuman primate models that replicate airborne transmission of SARS-CoV-2 have not been investigated. A comparative evaluation of COVID-19 in African green monkeys, rhesus macaques, and cynomolgus macaques following airborne exposure to SARS-CoV-2 was performed to determine critical disease parameters associated with disease progression, and establish correlations between primate and human COVID-19. Respiratory abnormalities and viral shedding were noted for all animals, indicating successful infection. Cynomolgus macaques developed fever, and thrombocytopenia was measured for African green monkeys and rhesus macaques. Type II pneumocyte hyperplasia and alveolar fibrosis were more frequently observed in lung tissue from cynomolgus macaques and African green monkeys. The data indicate that, in addition to African green monkeys, macaques can be successfully infected by airborne SARS-CoV-2, providing viable macaque natural transmission models for medical countermeasure evaluation.	[Johnston, Sara C.; Hooper, Jay W.; Smith, Jeffrey M.] USA Med Res Inst Infect Dis, Virol Div, Frederick, MD USA; [Ricks, Keersten M.; Koehler, Jeffrey W.; Kuehnert, Paul A.; Clements, Tamara L.; Shoemaker, Charles J.; Coyne, Susan R.; Delp, Korey L.; Minogue, Timothy D.] USA Med Res Inst Infect Dis, Diagnost Syst Div, Frederick, MD USA; [Jay, Alexandra; Rossi, Franco; Dyer, David; Frick, Ondraya; Moore, Joshua; Berrier, Kerry; Esham, Heather; Shamblin, Joshua; Sifford, Willie; Fiallos, Jimmy; Klosterman, Leslie; Stevens, Stephen; White, Lauren; Bowling, Philip; Garcia, Terrence; Jensen, Christopher; Ghering, Jeanean; Nyakiti, David; Bellanca, Stephanie; Giles, Wendy; Alli, Nazira; Paz, Fabian] USA Med Res Inst Infect Dis, Vet Med Div, Frederick, MD USA; [Raymond, Jo Lynne; Zeng, Xiankun; Scruggs, Jennifer] USA Med Res Inst Infect Dis, Pathol Div, Frederick, MD USA; [Kearney, Brian; Akers, Kristen; Danner, Denise; Barth, James; Johnson, Joshua A.; Durant, Matthew; Kim, Ruth; Gibson, Kathleen M.] USA Med Res Inst Infect Dis, Core Lab Serv Div, Frederick, MD USA; [Kugelman, Jeffrey R.; Beitzel, Brett F.] USA Med Res Inst Infect Dis, Mol Biol Div, Frederick, MD USA; [Pitt, Margaret L. M.] USA Med Res Inst Infect Dis, Off Sci Advisor, Frederick, MD USA; [Nalca, Aysegul] USA Med Res Inst Infect Dis, Core Support Directorate, Frederick, MD 21702 USA		Nalca, A (corresponding author), USA Med Res Inst Infect Dis, Core Support Directorate, Frederick, MD 21702 USA.	sara.c.johnston2.civ@mail.mil; aysegul.nalca.civ@mail.mil	Hooper, Jay/K-2362-2017	Hooper, Jay/0000-0002-4475-0415; Ricks, Keersten/0000-0002-2854-9308; Zeng, Xiankun (Kevin)/0000-0003-3526-8755; Pitt, Margaret Louise/0000-0003-0080-3260; Bowling, Philip/0000-0003-0624-2193; Alli, Nazira A./0000-0002-1680-1895	Military Infectious Diseases Research Program [150154769]	Military Infectious Diseases Research Program	Funding for this effort was provided by the Military Infectious Diseases Research Program under project number 150154769.	Blair R. V., 2020, BIORXIV, DOI [10.1101/2020.06.18.157933, DOI 10.1101/2020.06.18.157933]; Borak J, 2020, OCCUP MED-OXFORD, V70, P297, DOI 10.1093/occmed/kqaa080; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen WX, 2020, BRIT J HAEMATOL, V190, P179, DOI 10.1111/bjh.16885; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng W, 2020, SCIENCE, V369, P818, DOI 10.1126/science.abc5343; Ephraim G.P., 1988, Veterinary Student, V50, P8; Finch Courtney L, 2020, bioRxiv, DOI 10.1101/2020.05.14.096727; Pollitt KJG, 2020, HUM GENOMICS, V14, DOI 10.1186/s40246-020-00267-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartman AL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008903; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liu JY, 2020, EMERG INFECT DIS, V26, P1320, DOI 10.3201/eid2606.200239; Liu J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.139042; Lu S, 2020, JAMA-J AM MED ASSOC, DOI [10.1101/2020.04.08.031807, DOI 10.1001/JAMA.2020.3786]; Lu SY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00269-6; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Ricks KM, 2019, J VIROL METHODS, V270, P12, DOI 10.1016/j.jviromet.2019.04.013; Rockx Barry, 2020, Science, V368, P1012, DOI 10.1126/science.abb7314; Setti L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082932; Shan C, 2020, CELL RES, V30, P670, DOI 10.1038/s41422-020-0364-z; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; WHO, 2019, REP WHO CHIN JOINT M; Woolsey Courtney, 2020, bioRxiv, DOI 10.1101/2020.05.17.100289; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zheng HW, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008949; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	33	29	29	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246366	10.1371/journal.pone.0246366	http://dx.doi.org/10.1371/journal.pone.0246366			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529233	gold, Green Published, Green Submitted			2022-12-26	WOS:000616736200065
J	Truman, JP; Ruiz, CF; Trayssac, M; Mao, CG; Hannun, YA; Obeid, LM				Truman, Jean-Philip; Ruiz, Christian F.; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.			Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation	FASEB JOURNAL			English	Article						serine; sphingolipids; sphingosine; sphingosine kinase 1	MITOCHONDRIAL DYSFUNCTION; CANCER; METABOLISM; STRESS; CELLS; SPHINGOSINE-1-PHOSPHATE; SPHINGOLIPIDS; DOXORUBICIN; INHIBITORS; LEUKEMIA	It has been well-established that cancer cells often display altered metabolic profiles, and recent work has concentrated on how cancer cells adapt to serine removal. Serine can be either taken exogenously or synthesized from glucose, and its regulation forms an important mechanism for nutrient integration. One of the several important metabolic roles for serine is in the generation of bioactive sphingolipids since it is the main substrate for serine palmitoyltransferase, the initial and rate-limiting enzyme in the synthesis of sphingolipids. Previously, serine deprivation has been connected to the action of the tumor suppressor p53, and we have previously published on a role for p53 regulating sphingosine kinase 1 (SK1), an enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). SK1 is a key enzyme in sphingolipid synthesis that functions in pro-survival and tumor-promoting pathways and whose expression is also often elevated in cancers. Here we show that SK1 was degraded during serine starvation in a time and dose-dependent manner, which led to sphingosine accumulation. This was independent of effects on p53 but required the action of the proteasome. Furthermore, we show that overexpression of SK1, to compensate for SK1 loss, was detrimental to cell growth under conditions of serine starvation, demonstrating that the suppression of SK1 under these conditions is adaptive. Mitochondrial oxygen consumption decreased in response to SK1 degradation, and this was accompanied by an increase in intracellular reactive oxygen species (ROS). Suppression of ROS with N-acteylcysteine resulted in suppression of the metabolic adaptations and in decreased cell growth under serine deprivation. The effects of SK1 suppression on ROS were mimicked by D-erythro-sphingosine, whereas S1P was ineffective, suggesting that the effects of loss of SK1 were due to the accumulation of its substrate sphingosine. This study reveals a new mechanism for regulating SK1 levels and a link of SK1 to serine starvation as well as mitochondrial function.	[Truman, Jean-Philip; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Truman, Jean-Philip; Trayssac, Magali; Mao, Cungui; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Ruiz, Christian F.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Yale University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu		Ruiz, Christian/0000-0003-1470-8061	HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R35GM118128] Funding Source: Medline; NCI NIH HHS [P01 CA097132] Funding Source: Medline; NIGMS NIH HHS [R01 GM130878] Funding Source: Medline	HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahan CE, 2010, INVEST OPHTH VIS SCI, V51, P1171, DOI 10.1167/iovs.09-3909; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Bonhoure E, 2006, LEUKEMIA, V20, P95, DOI 10.1038/sj.leu.2404023; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Byun HS, 2013, MEDCHEMCOMM, V4, P1394, DOI [10.1039/c3md00201b, 10.1039/C3MD00201B]; Carroll BL, 2018, FEBS OPEN BIO, V8, P27, DOI 10.1002/2211-5463.12344; Chen W, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1323-0; Cheung EC, 2016, GENE DEV, V30, P52, DOI 10.1101/gad.271130.115; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Diers AR, 2013, REDOX BIOL, V1, P1, DOI 10.1016/j.redox.2012.11.003; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Duan JJ, 2015, J BIOL CHEM, V290, P15380, DOI 10.1074/jbc.R115.658823; Folmes CDL, 2013, STEM CELLS, V31, P1298, DOI 10.1002/stem.1389; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Han Y, 2018, FREE RADICAL RES, V52, P1271, DOI 10.1080/10715762.2018.1459594; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harijith A, 2013, AM J PATHOL, V183, P1169, DOI 10.1016/j.ajpath.2013.06.018; Hassoun SM, 2006, MITOCHONDRION, V6, P149, DOI 10.1016/j.mito.2006.05.001; Hernandez-Corbacho MJ, 2017, BBA-MOL CELL BIOL L, V1862, P56, DOI 10.1016/j.bbalip.2016.09.019; Huwiler A, 2011, BRIT J PHARMACOL, V162, P532, DOI 10.1111/j.1476-5381.2010.01053.x; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kim S, 2018, CELL REP, V24, P2932, DOI 10.1016/j.celrep.2018.08.037; Liu GL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-495; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Lucas S, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800036; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Momose I, 2016, INT IMMUNOPHARMACOL, V37, P23, DOI 10.1016/j.intimp.2015.11.013; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Muthusamy T, 2020, NATURE, V586, P790, DOI 10.1038/s41586-020-2609-x; Norris GH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111180; Novgorodov SA, 2014, J BIOL CHEM, V289, P13142, DOI 10.1074/jbc.M113.530311; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Powell JA, 2019, BIOCHEM J, V476, P3211, DOI 10.1042/BCJ20190245; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Ravez S, 2017, J MED CHEM, V60, P1227, DOI 10.1021/acs.jmedchem.6b01167; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sobue S, 2006, LEUKEMIA, V20, P2042, DOI 10.1038/sj.leu.2404386; Song LB, 2011, CLIN CANCER RES, V17, P1839, DOI 10.1158/1078-0432.CCR-10-0720; Spinelli JB, 2018, NAT CELL BIOL, V20, P745, DOI 10.1038/s41556-018-0124-1; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Taha TA, 2004, J BIOL CHEM, V279, P20546, DOI 10.1074/jbc.M401259200; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Takahashi N, 2018, CANCER CELL, V33, P985, DOI 10.1016/j.ccell.2018.05.001; Vadas M, 2008, BBA-MOL CELL BIOL L, V1781, P442, DOI 10.1016/j.bbalip.2008.06.007; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wang Q, 2017, CELL CHEM BIOL, V24, P55, DOI 10.1016/j.chembiol.2016.11.013; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yi JK, 2016, ONCOTARGET, V7, P21124, DOI 10.18632/oncotarget.8195; Yu HY, 2012, BIOCHEM BIOPH RES CO, V417, P1242, DOI 10.1016/j.bbrc.2011.12.117	66	4	4	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21284	10.1096/fj.202001814RR	http://dx.doi.org/10.1096/fj.202001814RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484475	Bronze, Green Accepted			2022-12-26	WOS:000647789600080
J	Bruce-Vanderpuije, P; Megson, D; Ryu, SH; Choi, GH; Park, SW; Kim, BS; Kim, JH; Lee, HS				Bruce-Vanderpuije, Pennante; Megson, David; Ryu, Song-Hee; Choi, Geun-Hyoung; Park, Sang-Won; Kim, Byung-Seok; Kim, Jin Hyo; Lee, Hyo-Sub			A comparison of the effectiveness of QuEChERS, FaPEx and a modified QuEChERS method on the determination of organochlorine pesticides in ginseng	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; GAS-CHROMATOGRAPHY; SAMPLE PREPARATION; MASS-SPECTROMETRY; RESIDUES; EXPOSURE; FRUITS; VALIDATION; VEGETABLES	This study provides a review of methods used in the determination of organochlorine pesticides (OCPs) in ginseng and compares the effectiveness of three extraction methods (Quick, Easy, Cheap, Effective, Rugged, and Safe (QuEChERS), a modified QuEChERS and a Fast Pesticide Extraction (FaPEx)) in the analyses of 20 OCPs in ginseng root samples. For each method, sample mass, solvent volume and sorbent mass were varied to identify the optimum combination to effectively isolate analytes of interest from the complex sample matrix. Extracts were analyzed using the gas chromatography-mu-electron capture detector (GC-mu-ECD), and confirmatory analyses performed by gas chromatography-tandem-mass spectrometry (GC-MS/MS). Eighteen out of 20 OCPs spiked onto in-house prepared ginseng samples produced acceptable recoveries (51-156%) when extracted using QuEChERS and FaPEx. All 20 analytes, including dichlorodiphenyldichloroethane (p, p'- DDD) and dichlorodiphenyltrichloroethane (o, p'-DDT), produced acceptable recoveries (51-129%) with the use of a modified QuEChERS method. The applicability of the modified QuEChERS method was demonstrated through the analysis of ginseng samples grown in endosulfan-treated soil. The samples were analyzed by both GC-mu-ECD and GC-MS/MS with no significant difference identified in the results of each analytical method. This study highlights the applicability of the modified QuEChERS method, in combination with GC- mu-ECD, to determine organochlorine pesticides in ginseng. This may be especially useful for laboratories in developing countries and less advanced institutions without access to MS/MS instrumentation.	[Bruce-Vanderpuije, Pennante; Ryu, Song-Hee; Choi, Geun-Hyoung; Park, Sang-Won; Kim, Byung-Seok; Lee, Hyo-Sub] Rural Dev Adm, Chem Safety Div, Natl Inst Agr Sci, Wonju, South Korea; [Bruce-Vanderpuije, Pennante] CSIR Water Res Inst, Accra, Ghana; [Megson, David] Manchester Metropolitan Univ, Ecol & Environm Res Ctr, Manchester, Lancs, England; [Kim, Jin Hyo] Gyeonsang Natl Univ, Dept Agr Chem, Jinju, South Korea	National Institute of Agricultural Sciences; Rural Development Administration (RDA); Manchester Metropolitan University; Gyeongsang National University	Lee, HS (corresponding author), Rural Dev Adm, Chem Safety Div, Natl Inst Agr Sci, Wonju, South Korea.	lhs8255@korea.kr		Bruce-Vanderpuije, Pennante Naa/0000-0002-3211-3849	National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea [PJ01448701]	National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea	The study was supported by Grants from the research fund of the National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea, under the Project Number PJ01448701.	Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7; Anastassiades M, 2003, J AOAC INT, V86, P412; Anderson SE, 2014, ENVIRON HEALTH INSIG, V8, P51, DOI 10.4137/EHI.S15258; Atwood D., 2017, PESTICIDES IND SALES; Baeg IH, 2013, J GINSENG RES, V37, P1, DOI 10.5142/jgr.2013.37.1; Bedson P., 1996, TRACE ANAL STRUCTURE, V2; Benijts T, 2004, J CHROMATOGR A, V1029, P153, DOI 10.1016/j.chroma.2003.12.022; Carvalho FP, 2006, ENVIRON SCI POLICY, V9, P685, DOI 10.1016/j.envsci.2006.08.002; Cha ES, 2014, J AGROMEDICINE, V19, P281, DOI 10.1080/1059924X.2014.917349; Chambers E, 2007, J CHROMATOGR B, V852, P22, DOI 10.1016/j.jchromb.2006.12.030; Chen LN, 2012, J CHROMATOGR A, V1225, P132, DOI 10.1016/j.chroma.2011.12.071; Chuang W.-C., 2019, J AOAC INT; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Ferrer C, 2011, J CHROMATOGR A, V1218, P7634, DOI 10.1016/j.chroma.2011.07.033; Food and Agricultural Organization and World Health Organization, 2019, PEST RES FOOD 2018 2; Food and Agricultural Organization of the United Nationals (FAO), 2017, PEST FAOSTAT DAT; Hayward DG, 2011, J AOAC INT, V94, P1741, DOI 10.5740/jaoacint.SGEHayward; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Kim S., 2010, CURRENT STATUS STRAT; Kmellar B, 2008, J CHROMATOGR A, V1215, P37, DOI 10.1016/j.chroma.2008.10.121; Lee KG, 2012, FOOD CHEM, V134, P2497, DOI 10.1016/j.foodchem.2012.04.094; Lehotay SJ, 2005, J AOAC INT, V88, P595; Lehotay SJ, 2010, J CHROMATOGR A, V1217, P2548, DOI 10.1016/j.chroma.2010.01.044; Liu J, 2016, J CHROMATOGR B, V1017, P233, DOI 10.1016/j.jchromb.2016.03.003; Liu XX, 2019, J FOOD PROTECT, V82, P1625, DOI [10.4315/0362-028X.JFP-18-490, 10.4315/0362-028x.jfp-18-490]; Lopez-Avila V, 1999, CRIT REV ANAL CHEM, V29, P195, DOI 10.1080/10408349891199392; Mostafalou S, 2013, TOXICOL APPL PHARM, V268, P157, DOI 10.1016/j.taap.2013.01.025; Park YS, 2007, BIOMED CHROMATOGR, V21, P29, DOI 10.1002/bmc.713; Patel S, 2019, ENVIRON SCI POLLUT R, V26, P91, DOI 10.1007/s11356-018-3642-2; Quan C, 2004, J SUPERCRIT FLUID, V31, P149, DOI 10.1016/j.supflu.2003.11.003; SHAHRAJABIAN MH, 2019, MIDDLE E J SCI RES, V27, P64, DOI DOI 10.5829/IDOSI.MEJSR.2019.64.71; Tsai CW, 2012, BIOMEDICINE-TAIWAN, V2, P17, DOI 10.1016/j.biomed.2011.12.002; UNEP, 2001, STOCKH CONV SECR; USEPA US EPA, 1996, 3665A USEPA; Wong JW, 2007, J AGR FOOD CHEM, V55, P1117, DOI 10.1021/jf062774q; Wong JW, 2010, J AGR FOOD CHEM, V58, P5884, DOI 10.1021/jf903851h; Wu JM, 2010, J CHROMATOGR A, V1217, P1471, DOI 10.1016/j.chroma.2009.12.074; Xu XW, 2016, FOOD ANAL METHOD, V9, P2231, DOI 10.1007/s12161-016-0400-2; Zhao XS, 2016, J CHROMATOGR B, V1017, P211, DOI 10.1016/j.jchromb.2016.03.009; 김성단, 2008, [Korean Journal of Food Science and Technology, 한국식품과학회지], V40, P123	40	4	4	7	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246108	10.1371/journal.pone.0246108	http://dx.doi.org/10.1371/journal.pone.0246108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513159	Green Published, Green Accepted, gold			2022-12-26	WOS:000613891400014
J	Diaz-Rubio, GI; Corona-Meraz, FI; Madrigal-Ruiz, PM; Robles-De Anda, JA; Gomez-Banuelos, E; Castro-Albarran, J; Flores-Alvarado, LJ; Vazquez-Del Mercado, M; Perez-Vazquez, FD; Pizano-Martinez, OE; Navarro-Hernandez, RE				Ignacio Diaz-Rubio, Gustavo; Corona-Meraz, Fernanda-Isadora; Madrigal-Ruiz, Perla-Monserrat; Robles-De Anda, Jesus-Aureliano; Gomez-Banuelos, Eduardo; Castro-Albarran, Jorge; Flores-Alvarado, Luis-Javier; Vazquez-Del Mercado, Monica; De Jesus Perez-Vazquez, Felipe; Pizano-Martinez, Oscar-Enrique; Navarro-Hernandez, Rosa-Elena			CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis	PLOS ONE			English	Article							ADIPOSE-TISSUE; RESOLVIN E1; WAIST CIRCUMFERENCE; HUMAN-BODY; OBESITY; FAT; INDEX; TRANSPLANTATION; PATHOGENESIS; INFLAMMATION	Rheumatoid arthritis (RA) has been associated with insulin resistance (IR). Due to an excess in storage of white adipose tissue, IR has an inflammatory process that overlaps with RA. This is performed by the activation/migration of monocytes carried out by the CCR2/CCL2 and CMKLR1/RvE1 chemokines systems. Furthermore, these can potentiate chronic inflammation which is the central axis in the immunopathogenesis of RA. We evaluated the association between the relative expression of CCR2 and CMKLR1 and the serum levels of their ligands CCL2 and RvE1, in the context of adiposity status with IR as a comorbidity in RA. We studied 138 controls and 138 RA-patients classified with and without IR. We evaluated adiposity, RA activity, IR status and immunometabolic profiles by routine methods. Insulin, CCL2 and RvE1 serum levels were determined by ELISA. Relative expression of CCR2, CMKLR1 and RPS28 as constitutive gene by SYBR green RT-qPCR and 2-..C T method. Increased measurements were observed of body adiposity and metabolic status as follows: RA with IR>control group with IR>RA without IR> control group without IR. CCR2 and CMKLR1 relative expression was increased in RA without IR versus control without IR. CCR2: 2.3- and 1.3-fold increase and CMKLR1: 3.5- and 2.7-fold increase, respectively. Whereas, CCR2 expression correlates with CMKLR1 expression (rho = 0.331) and IR status (rho = 0.497 to 0.548). CMKLR1 expression correlates with inflammation markers (rho = 0.224 to 0.418). CCL2 levels were increased in the RA groups but levels of RvE1 were increased in RA without IR. We conclude that in RA with IR, the chemokine receptors expression pattern showed a parallel increase with their respective ligands. RA and IR in conjunction with the pathological distribution of body fat mass might exacerbate chronic inflammation. These results suggest that high CCL2 levels and compensatory RvE1 levels might not be enough to resolve the inflammation by themselves.	[Ignacio Diaz-Rubio, Gustavo; Robles-De Anda, Jesus-Aureliano; Navarro-Hernandez, Rosa-Elena] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Doctorado Ciencias Biol Mol Med, Guadalajara, Jalisco, Mexico; [Ignacio Diaz-Rubio, Gustavo; Corona-Meraz, Fernanda-Isadora; Madrigal-Ruiz, Perla-Monserrat; Robles-De Anda, Jesus-Aureliano; Castro-Albarran, Jorge; Flores-Alvarado, Luis-Javier; Navarro-Hernandez, Rosa-Elena] Univ Guadalajara, Ctr Univ Ciencias Salud, Inmunometabolismo Enfermedades Complejas & Enveje, Dept Biol Mol & Genom,UDG CA 701, Guadalajara, Jalisco, Mexico; [Corona-Meraz, Fernanda-Isadora] Ctr Univ Tonala, Dept Ciencias Biomed, Div Ciencias Salud, Tonala, Jalisco, Mexico; [Madrigal-Ruiz, Perla-Monserrat; Flores-Alvarado, Luis-Javier; Navarro-Hernandez, Rosa-Elena] Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Guadalajara, Jalisco, Mexico; [Gomez-Banuelos, Eduardo] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA; [Castro-Albarran, Jorge] Ctr Univ Costa, Dept Ciencias Salud & Ecol Humana, Div Desarrollo Reg, Autlan De Navarro, Jalisco, Mexico; [Vazquez-Del Mercado, Monica; De Jesus Perez-Vazquez, Felipe; Pizano-Martinez, Oscar-Enrique] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculo Esquelet, Dept Biol Mol & Genom, Guadalajara, Jalisco, Mexico; [Vazquez-Del Mercado, Monica] Hosp Civil Dr Juan & Menchaca, Serv Reumatol, Div Med Interna, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Johns Hopkins University; Universidad de Guadalajara	Navarro-Hernandez, RE (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Doctorado Ciencias Biol Mol Med, Guadalajara, Jalisco, Mexico.; Navarro-Hernandez, RE (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Inmunometabolismo Enfermedades Complejas & Enveje, Dept Biol Mol & Genom,UDG CA 701, Guadalajara, Jalisco, Mexico.; Navarro-Hernandez, RE (corresponding author), Univ Guadalajara, Ctr Univ Ciencias Salud, Dept Biol Mol & Genom, Guadalajara, Jalisco, Mexico.	rosa.navarro@academicos.udg.mx	del Mercado, Monica Vazquez/F-5856-2017; Hernández, Rosa/GRF-5998-2022; Pizano, Oscar/AGR-5765-2022; NAVARRO-HERNANDEZ, ROSA-ELENA/B-3242-2015	del Mercado, Monica Vazquez/0000-0002-3823-4676; Perez-Vazquez, Felipe/0000-0003-0697-9371; NAVARRO-HERNANDEZ, ROSA-ELENA/0000-0001-5531-5403; Corona-Meraz, Fernanda-Isadora/0000-0002-7267-1482; Castro-Albarran, Jorge/0000-0002-3355-067X; PIZANO, OSCAR/0000-0003-3635-7071; Gomez-Banuelos, Eduardo/0000-0001-9730-1851	Grant Secretaria de Educacion Publica [245256]; Grant PRO-SNI 2017-2019 [237086/242991/248576]; Doctoral Training in Molecular Biology [596020]	Grant Secretaria de Educacion Publica; Grant PRO-SNI 2017-2019; Doctoral Training in Molecular Biology	This work was supported by Grant Secretaria de Educacion Publica, 245256 PRODEP 2018 to PhD Perla Montserrat Madrigal Ruiz. Grant PRO-SNI 2017-2019 [No. 237086/242991/248576] to Rosa Elena Navarro Hernandez/Jorge Castro Albarran/Fernanda Isadora Corona Meraz/Luis Javier Flores Alvarado. Doctoral Training in Molecular Biology to Gustavo Ignacio Diaz Rubio 2016-2019 Scholarship [No. 596020].	Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Chen DY, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0559-8; Chen Y, 2019, INT REV IMMUNOL, V38, P249, DOI 10.1080/08830185.2019.1645138; Chimenti MS, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.246; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cope AP, 2019, CLIN IMMUNOL, VFifth; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dimova R, 2019, DIABETES RES CLIN PR, V158, DOI 10.1016/j.diabres.2019.107911; DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Foster MT, 2012, ADIPOCYTE, V1, P192, DOI 10.4161/adip.21756; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885; Futo G, 2014, CLIN RHEUMATOL, V33, P623, DOI 10.1007/s10067-014-2559-5; Garaulet M, 2006, OBESITY, V14, P1181, DOI 10.1038/oby.2006.135; Giannini D, 2020, CLIN EXP RHEUMATOL, V38, P387; Giles JT, 2018, ARTHRIT CARE RES, V70, P175, DOI 10.1002/acr.23253; Giles JT, 2015, ARTHRITIS RHEUMATOL, V67, P626, DOI 10.1002/art.38986; Goossens GH, 2017, OBESITY FACTS, V10, P207, DOI 10.1159/000471488; Guzman-Ornelas MO, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5675739; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Salinas MJH, 2013, JCR-J CLIN RHEUMATOL, V19, P439, DOI 10.1097/RHU.0000000000000039; Herova M, 2015, J IMMUNOL, V194, P2330, DOI 10.4049/jimmunol.1402166; Hocking SL, 2008, DIABETOLOGIA, V51, P900, DOI 10.1007/s00125-008-0969-0; Vasques ACJ, 2009, ARQ BRAS CARDIOL, V93, P473; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kunicki M, 2018, GINEKOL POL, V89, P364, DOI 10.5603/GP.a2018.0062; Kurowska W, 2017, CENT EUR J IMMUNOL, V42, P390, DOI 10.5114/ceji.2017.72807; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lemaitre RN, 2018, DIABETES, V67, P1663, DOI 10.2337/db17-1449; LUKASKI HC, 1987, AM J CLIN NUTR, V46, P537, DOI 10.1093/ajcn/46.4.537; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; McGivern B, 2015, SIGARCH COMPUT ARCH, V39, P514, DOI [DOI 10.1145/1186736.1186737, 10.1145/1186736.1186737]; Medina G, 2018, PHARMACOL RES, V133, P277, DOI 10.1016/j.phrs.2018.01.009; Mirjafari H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3476; Muller R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9584720; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Nicolau J, 2017, JOINT BONE SPINE, V84, P411, DOI 10.1016/j.jbspin.2016.09.001; Niculescu DA, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00637; Petri MH, 2019, J TRANSLATIONAL SCI, V5, P11, DOI [10.15761/ JTS.1000323, DOI 10.15761/JTS.1000323]; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rehman K, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0303-y; Ruytinx P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01930; Saaristo T., 2018, INT J CLIN RHEUMATOL, V13, P346; Shahin L, 2020, CURR DIABETES REV, V16, P483, DOI 10.2174/1573399815666190823151222; Shen SW, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep43046; Sima C, 2018, CRIT REV IMMUNOL, V38, P343, DOI 10.1615/CritRevImmunol.2018026750; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Uchiyama T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081960; van der Woude D, 2018, BEST PRACT RES CL RH, V32, P174, DOI 10.1016/j.berh.2018.10.005; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Veale DJ, 2017, SEMIN IMMUNOPATHOL, V39, P343, DOI 10.1007/s00281-017-0633-1; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; WINTROBE MM, 1990, J LAB CLIN MED, V115, P374; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14251-w; Yap HY, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100161; Yoshimura T, 2011, EXP CELL RES, V317, P674, DOI 10.1016/j.yexcr.2010.10.023; Zhang L, 2015, YONSEI MED J, V56, P1134, DOI 10.3349/ymj.2015.56.4.1134; Ziraldo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079804	63	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246054	10.1371/journal.pone.0246054	http://dx.doi.org/10.1371/journal.pone.0246054			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508012	Green Published, gold			2022-12-26	WOS:000635021400078
J	Prazuck, T; Van, JP; Sinturel, F; Levray, F; Elie, A; Camera, D; Pialoux, G				Prazuck, Thierry; Van, Jean Phan; Sinturel, Florence; Levray, Frederique; Elie, Allan; Camera, Denise; Pialoux, Gilles			Evaluation of the practicability of a finger-stick whole-blood SARS-Cov-2 self-test adapted for the general population	PLOS ONE			English	Article								Background COVID-19 (COronaVIrus Disease 2019) is an infectious respiratory disease caused by the novel SARS-CoV-2 virus. Point of Care (POC) tests have been developed to detect specific antibodies, IgG and IgM, to SARS-CoV-2 virus in human whole blood. They need to be easily usable by the general population in order to alleviate the lockdown that many countries have initiated in response to the growing COVID-19 pandemic. A real-life study has been conducted in order to evaluate the performance of the COVID-PRESTO (R) POC test and the results were recently published. Even if this test showed very high sensitivity and specificity in a laboratory setting when used by trained professionals, it needs to be further evaluated for practicability when used by the general public in order to be approved by health authorities for in-home use. Methods 143 participants were recruited between March 2020 and April 2020 among non-medical populations in central France (nuclear plant workers, individuals attending the Orleans University Hospital vaccination clinic and Orleans University Hospital non-medical staff). Instructions for use, with or without a tutorial video, were made available to the volunteers. Two separate objectives were pursued: evaluation of the capability of participants to obtain an interpretable result, and evaluation of the users' ability to read the results. Results 88.4% of the test users judged the instructions for use leaflet to be clear and understandable. 99.3% of the users obtained a valid result and, according to the supervisors, 92.7% of the tests were properly performed by the users. Overall, 95% of the users gave positive feedback on the COVID PRESTO (R) as a potential self-test. Neither age nor education had an influence. Conclusion COVID-PRESTO (R) was successfully used by an overwhelming majority of participants and its use was judged very satisfactory, therefore showing promising potential as a self-test to be used by the general population. This POC test can become an easy-to-use tool to help detect whether individuals are protected or not, particularly in the context of a second wave or a mass vaccination program.	[Prazuck, Thierry] CHR Orleans, Dept Infect & Trop Dis, Orleans, France; [Van, Jean Phan] EDF Nucl Plant, St Laurent Des Eaux, France; [Sinturel, Florence; Levray, Frederique; Elie, Allan] EDF Nucl Plant, Dampierre En Burly, France; [Camera, Denise; Pialoux, Gilles] Sorbonne Univ, Hop Tenon, AP HP, Dept Infect Dis, Paris, France	Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Prazuck, T (corresponding author), CHR Orleans, Dept Infect & Trop Dis, Orleans, France.	thierry.prazuck@chr-orleans.fr			AAZ-LMB	AAZ-LMB	This study was funded by AAZ-LMB who provided the Presto rapid test but did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Electricite de France (EDF) provided support for this study in the form of salaries for authors [JPV, FS, FL, AE, DC] but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. No additional external funding was received for this study.	European Commission, 2020, GUID COVID 19 VITR D; Fafi-Kremer S., 2020, EBIOMEDICINE, V59; FIND, SARS COV 2 DIAGN PIP; Food and Drug Administration, POL COR DIS 2019 TES; Haute Autorite, HAS SE PRONONCE TEST; Prazuck T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237694; Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755; Randolph HE, 2020, IMMUNITY, V52, P737, DOI 10.1016/j.immuni.2020.04.012; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00797-20; Venter M, 2020, J CLIN PATHOL, V73, P370, DOI 10.1136/jclinpath-2020-206685	11	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245848	10.1371/journal.pone.0245848	http://dx.doi.org/10.1371/journal.pone.0245848			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508007	Green Published, Green Submitted, gold			2022-12-26	WOS:000635021400056
J	Lee, M; Park, H; Heo, JM; Choi, HJ; Seo, S				Lee, Mingyung; Park, Hyesun; Heo, Jung Min; Choi, Ho Jun; Seo, Seongwon			Multi-tissue transcriptomic analysis reveals that L-methionine supplementation maintains the physiological homeostasis of broiler chickens than D-methionine under acute heat stress	PLOS ONE			English	Article								The objective of this study was to compare the effects of supplementation with two methionine isoforms, L-methionine (L-Met) or D-methionine (D-Met), on transcriptome expression in broiler chickens under acute heat stress. A total of 240 one-day-old chicks were randomly assigned to one of four treatments in a 2 x 2 factorial arrangement: thermo-neutral vs. acute heat-stress and L-Met vs. D-Met supplementation. On day 14, the heat-stressed group was exposed to 32 degrees C for 5 h, while the others remained at 25 degrees C. Six chicks were randomly selected per treatment and total RNA was isolated from whole blood, ileum, and liver tissues. Two RNA samples from each tissue of each treatment group were randomly selected and pooled in equal amounts. A total of 1.87 billion raw reads obtained from 36 samples (four treatments x three tissues x three composited replicates) were mapped to the reference genome build (Gallus_gallus-5.0) and used to identify differentially expressed genes (DEGs) using DESeq2. Functional enrichment of DEGs was tested using DAVID. Comparing the two isoforms of supplemented methionine, two, three, and ten genes were differentially expressed (> 1 or < -1 log(2) fold change) in whole blood, ileum, and liver, respectively. A total of 38, 71, and 16 genes were differentially expressed in response to the interaction between heat stress and Met isoforms in the blood, ileum, and liver, respectively. Three-tissue-specific DEGs were functionally enriched for regulation of cholesterol homeostasis and metabolism, glucose metabolism, and vascular patterning. Chicks fed with L-Met had lower immune (e.g., 1L4l1 and SERPINI1) and intestinal angiogenic responses (e.g., FLT1 and FGD5), and stable glucose and lipid metabolism (e.g., PCK1 and LDLR) under heat stress conditions. In conclusion, unlike D-Met, L-Met supplementation seems to help maintain physiological homeostasis and enhances cellular defense systems against external stresses like high environmental temperature.	[Lee, Mingyung; Park, Hyesun; Heo, Jung Min; Seo, Seongwon] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Choi, Ho Jun] CJ Cheiljedang Co Ltd, Seoul, South Korea	Chungnam National University	Seo, S (corresponding author), Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea.	swseo@cnu.kr		Seo, Seongwon/0000-0002-4131-0545	CJ Cheiljedang Co. Ltd. (Seoul, Republic of Korea)	CJ Cheiljedang Co. Ltd. (Seoul, Republic of Korea)	This work performed by the Chungnam National University was financially supported by the CJ Cheiljedang Co. Ltd. (Seoul, Republic of Korea). The funds were used for the purchase of experimental animals and materials, and RNA-sequencing analysis costs. The L-methionine product used in this study is a commercial product invented by CJ Cheiljedang Co. The funder provided support in the form of research material and analysis cost for authors [M.L., H.P., J.M.H., and S.S.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. H.J.C. is an employee of CJ Cheiljedang Co., but was not the inventor of the product used in the research. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERG CP, 1953, PHYSIOL REV, V33, P145, DOI 10.1152/physrev.1953.33.2.145; Boisen S, 2000, LIVEST PROD SCI, V64, P239, DOI 10.1016/S0301-6226(99)00146-3; Brosnan JT, 2006, J NUTR, V136, p1636S, DOI 10.1093/jn/136.6.1636S; CAHANER A, 1992, POULTRY SCI, V71, P1237, DOI 10.3382/ps.0711237; Cindrova-Davies T, 2011, CARDIOVASC RES, V89, P671, DOI 10.1093/cvr/cvq346; Del Vesco AP, 2014, J ANIM SCI, V92, P806, DOI 10.2527/jas.2013-6829; Del Vesco AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115821; Del Vesco AP, 2015, BRIT J NUTR, V113, P549, DOI 10.1017/S0007114514003535; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; DONKOH A, 1989, INT J BIOMETEOROL, V33, P259, DOI 10.1007/BF01051087; DUPUIS L, 1989, BRIT J NUTR, V62, P63, DOI 10.1079/BJN19890008; GOLDSTEIN JL, 1982, MED CLIN N AM, V66, P335, DOI 10.1016/S0025-7125(16)31424-9; Habashy WS, 2018, MOL BIOL REP, V45, P389, DOI 10.1007/s11033-018-4173-0; Habibian M, 2014, INT J BIOMETEOROL, V58, P741, DOI 10.1007/s00484-013-0654-y; Hall DM, 1999, AM J PHYSIOL-GASTR L, V276, pG1195, DOI 10.1152/ajpgi.1999.276.5.G1195; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Jastrebski SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181900; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kobayashi M, 2012, NUCL MED BIOL, V39, P1213, DOI 10.1016/j.nucmedbio.2012.06.006; Kulski JK, 2002, IMMUNOL REV, V190, P95, DOI 10.1034/j.1600-065X.2002.19008.x; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Lewis A. J., 1995, Bioavailability of nutrients for animals: amino acids, minerals, and vitamins., P67, DOI 10.1016/B978-012056250-3/50030-5; LIU JS, 1991, J BIOL CHEM, V266, P19095; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma BB, 2021, POULTRY SCI, V100, P215, DOI 10.1016/j.psj.2020.09.090; Metz K, 1996, FEBS LETT, V385, P25, DOI 10.1016/0014-5793(96)00341-9; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Mohsenifar Afshin, 2007, Iran Biomed J, V11, P41; Mujahid A, 2005, POULTRY SCI, V84, P307, DOI 10.1093/ps/84.2.307; Ohtsu H, 2015, J POULT SCI, V52, P282, DOI 10.2141/jpsa.0150062; Rad MR, 2013, CELL PROLIFERAT, V46, P58, DOI 10.1111/cpr.12004; Sahin K, 2002, BIOL TRACE ELEM RES, V89, P53, DOI 10.1385/BTER:89:1:53; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Star L, 2008, POULTRY SCI, V87, P1031, DOI 10.3382/ps.2007-00143; Wickramasuriya SS, 2019, J POULT SCI, V56, P195, DOI 10.2141/jpsa.0180072; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu Q, 2015, MOL MED REP, V12, P5891, DOI 10.3892/mmr.2015.4117; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yepes M, 2000, BLOOD, V96, P569; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117269	44	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246063	10.1371/journal.pone.0246063	http://dx.doi.org/10.1371/journal.pone.0246063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503037	Green Published, gold			2022-12-26	WOS:000613751800027
J	Shalash, AS; Hamid, E; Elrassas, H; Bahbah, EI; Mansour, AH; Mohamed, H; Elbalkimy, M				Shalash, Ali S.; Hamid, Eman; Elrassas, Hanan; Bahbah, Eshak, I; Mansour, Alia H.; Mohamed, Hadeer; Elbalkimy, Mahmoud			Non-motor symptoms in essential tremor, akinetic rigid and tremor-dominant subtypes of Parkinson's disease	PLOS ONE			English	Article								Objectives To compare non-motor symptoms (NMSs) among patients with essential tremor (ET), Parkinson's disease (PD) subtypes (akinetic-rigid type (ART) and tremor-dominant type (TDT)), and healthy controls. Patients and methods This retrospective study included 129 participants, 72 PD (33 PD-ART, 33 PD-TDT, and 6 Mixed), 29 ET patients, and 28 controls. PD patients were assessed by the unified Parkinson's disease rating scale (UPDRS), Hoehn, and Yahr scale (H&Y), while ET patients were evaluated by the Fahn Tolosa Marin Tremor Rating Scale. All subjects were evaluated by non-motor symptoms scale (NMSS) for NMSs and Beck depression inventory (BDI) for depression. Results PD subtypes groups, ET, and controls were age and gender-matched. Compared to controls, all PD, PD subtypes, and ET showed significantly worse most of NMSs (p<0.001) and depression. Compared to ET, all PD and PD-ART had significantly worse gastrointestinal (p = 0.002), urinary symptoms (p = 0.001, p = 0.003) and depression (p = 0.002) and PD-TDT worse depression, while ET patients showed worse memory/attention than PD subtypes. Total NMSS of ET is highly correlated to depression and moderately to tremor severity and age of onset, while total of NMSS is highly correlated to depression, disease severity, and disability. Conclusion The current study demonstrated several comparable domains of NMSs of PD subtypes and ET, except worse gastrointestinal and urinary symptoms among PD-ART. Identifying different NMSs profiles is important for predicting, better assessing, and tailoring management of ET and PD subtypes.	[Shalash, Ali S.; Hamid, Eman; Mansour, Alia H.; Mohamed, Hadeer; Elbalkimy, Mahmoud] Ain Shams Univ, Fac Med, Dept Neurol, Cairo, Egypt; [Elrassas, Hanan] Ain Shams Univ, Okasha Inst Psychiat, Cairo, Egypt; [Bahbah, Eshak, I] Al Azhar Univ, Fac Med, Dumyat, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Al Azhar University	Shalash, AS (corresponding author), Ain Shams Univ, Fac Med, Dept Neurol, Cairo, Egypt.	drali_shalash@med.asu.edu.eg	Bahbah, Eshak I/I-4504-2019	Bahbah, Eshak I/0000-0002-6168-9134; MANSOUR, ALIA/0000-0002-8806-9429; Shalash, Ali/0000-0001-7012-5907				Abbas MM, 2018, MOV DISORD CLIN PRAC, V5, P14, DOI 10.1002/mdc3.12568; Abdel-Khalek AM, 1998, PSYCHOL REP, V82, P264, DOI 10.2466/PR0.82.1.264-266; Algarni M, 2018, PARKINSONISM RELAT D, V46, pS101, DOI 10.1016/j.parkreldis.2017.07.006; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belvisi D, 2017, PARKINSONISM RELAT D, V36, P41, DOI 10.1016/j.parkreldis.2016.12.012; Bhatia KP, 2018, MOVEMENT DISORD, V33, P75, DOI 10.1002/mds.27121; Chaudhuri KR, 2008, EUR J NEUROL, V15, P2, DOI 10.1111/j.1468-1331.2008.02212.x; Chaudhuri KR, 2018, MOVEMENT DISORD, V33, P909, DOI 10.1002/mds.27386; Choi SM, 2018, PARKINSONISM RELAT D, V54, P74, DOI 10.1016/j.parkreldis.2018.04.021; Cohen O, 2003, ARCH NEUROL-CHICAGO, V60, P405, DOI 10.1001/archneur.60.3.405; Damian A, 2012, PARKINSONISM RELAT D, V18, P1089, DOI 10.1016/j.parkreldis.2012.06.008; Dirkx MF, 2018, NEUROLOGY, V90, pE1095, DOI 10.1212/WNL.0000000000005215; Gerbin M, 2012, PARKINSONISM RELAT D, V18, P279, DOI 10.1016/j.parkreldis.2011.11.004; Giorelli M, 2014, PARKINSONISM RELAT D, V20, P17, DOI 10.1016/j.parkreldis.2013.09.004; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jellinger KA, 2015, J NEURAL TRANSM, V122, P1429, DOI 10.1007/s00702-015-1405-5; Kang GA, 2005, MOVEMENT DISORD, V20, P1133, DOI 10.1002/mds.20513; Khedr EM, 2013, CLIN NEUROL NEUROSUR, V115, P673, DOI 10.1016/j.clineuro.2012.07.032; Konno T, 2018, J NEUROL SCI, V386, P39, DOI 10.1016/j.jns.2018.01.013; Kuo SH, 2017, ACTA NEUROPATHOL, V133, P121, DOI 10.1007/s00401-016-1626-1; Kwon KY, 2016, J NEUROL SCI, V361, P34, DOI 10.1016/j.jns.2015.12.016; Lacerte A, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D82V2D91; Lageman SK, 2014, TREMOR OTHER HYPERK, V4, DOI 10.7916/D8RF5S4J; Lee D, 2018, PARKINSONISM RELAT D, V51, P24, DOI 10.1016/j.parkreldis.2018.02.032; Lee SM, 2015, J NEUROL SCI, V349, P168, DOI 10.1016/j.jns.2015.01.012; LOU JS, 1991, NEUROLOGY, V41, P234, DOI 10.1212/WNL.41.2_Part_1.234; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Louis ED, 2009, MOVEMENT DISORD, V24, P1600, DOI 10.1002/mds.22567; Marras C, 2016, MOVEMENT DISORD, V31, P1095, DOI 10.1002/mds.26510; Miller KM, 2007, MOVEMENT DISORD, V22, P666, DOI 10.1002/mds.21376; Peng JX, 2020, ACTA NEUROL SCAND, V142, P74, DOI 10.1111/ane.13242; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Puertas-Martin V, 2016, TREMOR OTHER HYPERK, V6, DOI 10.7916/D86H4HRN; Rajput AH, 2012, PARKINSONISM RELAT D, V18, P626, DOI 10.1016/j.parkreldis.2012.01.013; Rajput AH, 2011, PARKINSONISM RELAT D, V17, P410, DOI 10.1016/j.parkreldis.2011.05.008; Sengul Y, 2015, ACTA NEUROL BELG, V115, P289, DOI 10.1007/s13760-014-0408-6; Shalash AS, 2019, TREMOR OTHER HYPERK, V9, DOI 10.7916/tohm.v0.736; Shalash AS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00357; Smeltere L, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.781; Symanski C, 2014, MOVEMENT DISORD, V29, P496, DOI 10.1002/mds.25845; Tarakad A, 2019, TREMOR OTHER HYPERK, V9, DOI 10.7916/D8MD0GVR; Thenganatt MA, 2016, PARKINSONISM RELAT D, V22, pS162, DOI 10.1016/j.parkreldis.2015.09.032; Titova N, 2017, J NEURAL TRANSM, V124, P907, DOI 10.1007/s00702-016-1667-6; Tolosa E., 1993, PARKINSONS DIS MOVEM; Wojtala J, 2019, J NEUROL NEUROSUR PS, V90, P171, DOI 10.1136/jnnp-2018-319008; Wu YW, 2016, PARKINSONISM RELAT D, V22, P15, DOI 10.1016/j.parkreldis.2015.10.617; Xu CP, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00365	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245918	10.1371/journal.pone.0245918	http://dx.doi.org/10.1371/journal.pone.0245918			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503062	Green Published, gold			2022-12-26	WOS:000613751800016
J	Podlasz, P; Wasowicz, K				Podlasz, Piotr; Wasowicz, Krzysztof			Effect of partial hysterectomy on the neurons of the paracervical ganglion (PCG) of the pig	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; SUPERIOR CERVICAL-GANGLION; NERVE GROWTH-FACTOR; AXOTOMY-INDUCED CHANGES; DORSAL-ROOT GANGLIA; RAT SYMPATHETIC NEURONS; NEUROPEPTIDE-Y; SUBSTANCE-P; SPINAL-CORD; AXONAL DEGENERATION	Autonomic neurons innervating uterine horn is probably the only nerve cell population capable of periodical physiological degeneration and regeneration. One of the main sources of innervation of the uterus is paracervical ganglion (PCG). PCG is a unique structure of the autonomic nervous system. It contains components of both the sympathetic and parasympathetic nervous system. The present study examines the response of neurons of PCG innervating uterine horn to axotomy caused by partial hysterectomy in the domestic pig animal model. The study was performed using a neuronal retrograde tracing and double immunofluorescent staining for tyrosine hydroxylase (TH), dopamine beta-hydroxylase (D beta H), choline acetyltransferase (ChAT), vesicular acetylcholine transporter (VAChT), neuronal nictric oxide synthase (nNOS), galanin, neuropeptide Y (NPY), vasoactive intestinal peptide (VIP), pituitary adenylate cyclase-activating peptide (PACAP), somatostatin and substance P (SP). Our study showed that virtually all neurons of the porcine PCG innervating uterine horn are adrenergic and we did not confirm that PCG is the source of cholinergic fibers innervating uterine horn of the pig. After axotomy there was a decrease in expression of catecholamine-synthesizing enzymes (TH, D beta H) and a strong increase in the galanin expression. The increase of the number of NPY-IR neurons in the ganglia after axotomy was observed. There were no changes in the expression of other studied substances in the PCG neurons innervating the uterine horn, what was often found in rodents studies. This indicates that neurons can respond to damage in a species-specific way.	[Podlasz, Piotr; Wasowicz, Krzysztof] Univ Warmia & Mazury, Dept Pathophysiol Forens Vet Med & Adm, Fac Vet Med, Olsztyn, Poland	University of Warmia & Mazury	Podlasz, P (corresponding author), Univ Warmia & Mazury, Dept Pathophysiol Forens Vet Med & Adm, Fac Vet Med, Olsztyn, Poland.	piotr.podlasz@uwm.edu.pl		Podlasz, Piotr/0000-0002-9162-5449	Polish Committee for Scientific Research [3P06K 034 24]	Polish Committee for Scientific Research(Polish State Committee for Scientific Research)	PP. Supported by grant 3P06K 034 24, from the Polish Committee for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM P, 1980, CELL TISSUE RES, V205, P337; ALM P, 1988, HISTOCHEM J, V20, P414, DOI 10.1007/BF01002427; ALM P, 1988, HISTOCHEM J, V20, P290, DOI 10.1007/BF01745608; ALM P, 1986, NEUROSCIENCE, V18, P713, DOI 10.1016/0306-4522(86)90065-5; Alm P, 1988, CELL TISSUE RES, P254, DOI [10.1007/BF00226501, DOI 10.1007/BF00226501]; ATKINSON ME, 1986, REGUL PEPTIDES, V16, P69, DOI 10.1016/0167-0115(86)90195-3; BELL C, 1968, CIRC RES, V23, P279, DOI 10.1161/01.RES.23.2.279; Bergner AJ, 2000, NEUROSCIENCE, V96, P611, DOI 10.1016/S0306-4522(99)00576-X; Czaja K, 2001, Folia Morphol (Warsz), V60, P205; DZIEGIELEWSKA KM, 1976, ACTA PHYSIOL SCAND, V96, P486, DOI 10.1111/j.1748-1716.1976.tb10218.x; GARDMARK S, 1971, AM J OBSTET GYNECOL, V109, P997, DOI 10.1016/0002-9378(71)90279-1; GOLD BG, 1992, ARCH TOXICOL, V66, P57, DOI 10.1007/BF02307271; Gonkowski S, 2010, ACTA VET HUNG, V58, P91, DOI 10.1556/AVet.58.2010.1.10; HAPPOLA O, 1990, HISTOCHEMISTRY, V93, P479, DOI 10.1007/BF00266404; HENDRY IA, 1975, BRAIN RES, V90, P235, DOI 10.1016/0006-8993(75)90304-2; HENDRY IA, 1976, J NEUROCYTOL, V5, P351, DOI 10.1007/BF01175120; HENDRY IA, 1975, BRAIN RES, V94, P87, DOI 10.1016/0006-8993(75)90879-3; HENDRY IA, 1971, BRAIN RES, V29, P159, DOI 10.1016/0006-8993(71)90429-X; HILL CE, 1985, DEV BRAIN RES, V23, P121, DOI 10.1016/0165-3806(85)90011-2; Holmberg K, 2001, EXP NEUROL, V167, P290, DOI 10.1006/exnr.2000.7552; HYATTSACHS H, 1993, J NEUROSCI, V13, P1642; KEAST JR, 1995, NEUROSCIENCE, V66, P655, DOI 10.1016/0306-4522(94)00595-V; Klimaschewski L, 1997, ANAT EMBRYOL, V196, P269, DOI 10.1007/s004290050096; Klimaschewski L, 1996, NEUROSCIENCE, V72, P265, DOI 10.1016/0306-4522(95)00551-X; KLIMASCHEWSKI L, 1994, MICROSC RES TECHNIQ, V29, P120, DOI 10.1002/jemt.1070290209; Klimaschewski L, 1996, CELL TISSUE RES, V285, P419, DOI 10.1007/s004410050658; KNYIHARCSILLIK E, 1991, ACTA HISTOCHEM, V91, P77, DOI 10.1016/S0065-1281(11)80299-0; Kroesen S, 1997, NEUROSCIENCE, V78, P251, DOI 10.1016/S0306-4522(96)00587-8; Landry M, 2000, EXP NEUROL, V162, P361, DOI 10.1006/exnr.1999.7329; LUNDBERG JM, 1982, ACTA PHYSIOL SCAND, V116, P477, DOI 10.1111/j.1748-1716.1982.tb07171.x; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Majewski M, 2002, FOLIA HISTOCHEM CYTO, V40, P261; Majewski M, 2002, FOLIA HISTOCHEM CYTO, V40, P151; Majewski M., 1997, ACTA ACAD AGR TECHCO, VB24, P3; McCarthy CJ, 2016, BRAIN STRUCT FUNCT, V221, P1985, DOI 10.1007/s00429-015-1019-6; MITCHELL BS, 1993, HISTOCHEM J, V25, P51, DOI 10.1007/BF00161044; Mohney RP, 1998, J NEUROSCI, V18, P5285, DOI 10.1523/JNEUROSCI.18-14-05285.1998; MOHNEY RP, 1994, J NEUROBIOL, V25, P108, DOI 10.1002/neu.480250203; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; OTTEN U, 1979, BRAIN RES, V176, P79, DOI 10.1016/0006-8993(79)90871-0; OWMAN C, 1975, AM J OBSTET GYNECOL, V122, P961, DOI 10.1016/0002-9378(75)90356-7; Owman C, 1980, Adv Biochem Psychopharmacol, V25, P313; OWMAN CHRISTER, 1967, LIFE SCI, V6, P2549, DOI 10.1016/0024-3205(67)90320-7; PAPKA RE, 1995, CELL TISSUE RES, V279, P339, DOI 10.1007/BF00318490; Perlman RL, 2016, EVOL MED PUBLIC HLTH, P170, DOI 10.1093/emph/eow014; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; Podlasz P, 2008, VET MED PRAHA, V53; RAO MS, 1993, J NEUROBIOL, V24, P571, DOI 10.1002/neu.480240504; Reimer M, 1999, EUR J NEUROSCI, V11, P3415, DOI 10.1046/j.1460-9568.1999.00757.x; SCHREIBER RC, 1994, NEUROSCIENCE, V60, P17, DOI 10.1016/0306-4522(94)90200-3; Serghini R, 1997, J AUTONOM NERV SYST, V67, P38, DOI 10.1016/S0165-1838(97)00091-X; Shadiack AM, 1998, NEUROPEPTIDES, V32, P257, DOI 10.1016/S0143-4179(98)90045-2; SHADIACK AM, 1995, NEUROSCIENCE, V65, P1119, DOI 10.1016/0306-4522(95)00022-B; Skobowiat C, 2011, EXP MOL PATHOL, V90, P13, DOI 10.1016/j.yexmp.2010.11.004; STROMBERG I, 1987, CELL TISSUE RES, V250, P267; Sun Y, 1996, MOL CELL NEUROSCI, V7, P152, DOI 10.1006/mcne.1996.0012; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; THILANDER G, 1989, J VET MED A, V36, P585, DOI 10.1111/j.1439-0442.1989.tb00769.x; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; VILLAR MJ, 1991, EXP NEUROL, V112, P29, DOI 10.1016/0014-4886(91)90111-O; Viswanathan A, 2009, NEUROSURGERY, V65, pA44, DOI 10.1227/01.NEU.0000339124.49566.F2; Wasowicz K, 1998, J AUTONOM NERV SYST, V74, P13, DOI 10.1016/S0165-1838(98)00112-X; Wasowicz K, 2003, ANAT HISTOL EMBRYOL, V32, P154, DOI 10.1046/j.1439-0264.2003.00449.x; Wasowicz K., 2003, Polish Journal of Veterinary Sciences, V6, P147; Wasowicz K., 2003, Polish Journal of Veterinary Sciences, V6, P131; Wasowicz K., 2003, Polish Journal of Veterinary Sciences, V6, P161; Wasowicz Krzysztof, 2002, Folia Morphol (Warsz), V61, P15; Wojtkiewicz J, 2013, J MOL NEUROSCI, V51, P99, DOI 10.1007/s12031-013-0007-7; ZHANG X, 1993, J NEUROCYTOL, V22, P342, DOI 10.1007/BF01195558; ZHANG X, 1995, EUR J NEUROSCI, V7, P367, DOI 10.1111/j.1460-9568.1995.tb00332.x; ZHANG X, 1995, J NEUROSCI, V15, P2733; Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x; Zoubina EV, 2000, AUTON NEUROSCI-BASIC, V84, P176, DOI 10.1016/S1566-0702(00)00209-5; Zoubina EV, 1998, J COMP NEUROL, V397, P561	74	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245974	10.1371/journal.pone.0245974	http://dx.doi.org/10.1371/journal.pone.0245974			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497400	gold, Green Published			2022-12-26	WOS:000613707100009
J	Chang, CG; Hsu, CH; Soong, K				Chang, Chun-Gin; Hsu, Chia-Hsuan; Soong, Keryea			Navigation in darkness: How the marine midge (Pontomyia oceana) locates hard substrates above the water level to lay eggs	PLOS ONE			English	Article							MOSQUITO; METAMORPHOSIS; ECOLOGY	Finding suitable habitats for specific functions such as breeding provides examples of key biotic adaptation. The adult marine midge Pontomyia oceana requires an extremely specific habitat, i.e., hard substrates above water in shallow water, to deposit fertilized eggs. We investigated how these sea surface-skimming insects accomplished this with a stringent time constraint of 1-2 h of the adult life span in the evenings. We observed that in artificial containers, midges aggregated at bright spots only if the light was not in the direction of the sea. This behavior could potentially attract midges toward the shore and away from the open water. Experiments were performed in the intertidal zone in southern Taiwan to test three hypotheses explaining such behavior: gradients of temperature and CO2, and soundscape. No differences were observed in moving directions or aggregation of midges under artificial temperature and CO2 gradients. However, midges preferred sounds at 75 Hz compared with other frequencies (all <= 300 Hz) as observed in a field experiment involving floating traps with loudspeakers. Moreover, when background noise was experimentally masked using white noise of all frequencies, midges were significantly more likely to aggregate at bright spots in the direction of the sea than in the absence of white noise. These results establish that sound is used by midges to navigate in dark seas and move toward the shore where exposed hard substrates are in abundance. Marine mammals present well-known cases of sound pollution at sea; here the finding in the insignificant marine midge is just the harbinger of the potential effects noise at shore may have to affect critical reproductive stages of marine organisms.	[Chang, Chun-Gin; Hsu, Chia-Hsuan; Soong, Keryea] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan	National Sun Yat Sen University	Soong, K (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	keryea@g-mail.nsysu.edu.tw		Soong, Keryea/0000-0002-4371-7103; Hsu, Chia-Hsuan/0000-0002-5128-5902	Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The funding was from Ministry of Science and Technology, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczewska AM, 2001, BIOL BULL, V200, P305, DOI 10.2307/1543512; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; CAREY WM, 1993, NATURAL PHYSICAL SOURCES OF UNDERWATER SOUND, P277; Dittman AH, 1996, J EXP BIOL, V199, P83; Fuxjager MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1218; Gebauer P, 2003, REV CHIL HIST NAT, V76, P169; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; Hirabayashi K, 1999, ENTOMOL EXP APPL, V92, P233, DOI 10.1023/A:1003525016180; Hirabayashi K, 2002, P 4 INT C URB PESTS; IDSO SB, 1969, J GEOPHYS RES, V74, P5397, DOI 10.1029/JC074i023p05397; Jinks RN, 2002, NATURE, V420, P68, DOI 10.1038/nature01144; Krieger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049809; Liu HC, 2007, ZOOL STUD, V46, P347; Lohmann KJ, 2008, J EXP BIOL, V211, P1719, DOI 10.1242/jeb.015792; Malme C, 1986, BEHAV RESPONSES GRAY; Sarrat C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008107; Silva DM, 2019, NEOTROP ENTOMOL, V48, P340, DOI 10.1007/s13744-018-0640-5; Soong K, 1999, ZOOL STUD, V38, P466; Soong K, 2012, CHRONOBIOL INT, V29, P1329, DOI 10.3109/07420528.2012.728548; Soong K, 2011, MAR ECOL PROG SER, V433, P121, DOI 10.3354/meps09181; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Thums M, 2013, J EXP MAR BIOL ECOL, V440, P156, DOI 10.1016/j.jembe.2012.12.006; Venter GJ, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.994; Webster B, 2015, J CHEM ECOL, V41, P59, DOI 10.1007/s10886-014-0542-x; Wiltschko R, 2003, ANIM BEHAV, V65, P257, DOI 10.1006/anbe.2003.2054	25	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0246060	10.1371/journal.pone.0246060	http://dx.doi.org/10.1371/journal.pone.0246060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493219	Green Published, gold			2022-12-26	WOS:000613081500024
J	Sun, CC; Zhang, J; Wei, J; Zheng, XL; Zhao, XY; Fang, ZJ; Xu, DM; Yuan, HQ; Liu, YP				Sun, Chuancai; Zhang, Jian; Wei, Jiao; Zheng, Xiaoli; Zhao, Xianyang; Fang, Zengjun; Xu, Dongmei; Yuan, Huiqing; Liu, Yipeng			Screening, simulation, and optimization design of small molecule inhibitors of the SARS-CoV-2 spike glycoprotein	PLOS ONE			English	Article							CORONAVIRUS; PROTEIN; VIRUSES; WUHAN	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak is a public health emergency of international concern. The spike glycoprotein (S protein) of SARS-CoV-2 is a key target of antiviral drugs. Focusing on the existing S protein structure, molecular docking was used in this study to calculate the binding energy and interaction sites between 14 antiviral molecules with different structures and the SARS-CoV-2 S protein, and the potential drug candidates targeting the SARS-CoV-2 S protein were analyzed. Tizoxanide, dolutegravir, bictegravir, and arbidol were found to have high binding energies, and they effectively bind key sites of the S1 and S2 subunits, inhibiting the virus by causing conformational changes in S1 and S2 during the fusion of the S protein with host cells. Based on the interactions among the drug molecules, the S protein and the amino acid environment around the binding sites, rational structure-based optimization was performed using the molecular connection method and bioisosterism strategy to obtain Ti-2, BD-2, and Ar-3, which have much stronger binding ability to the S protein than the original molecules. This study provides valuable clues for identifying S protein inhibitor binding sites and the mechanism of the anti-SARS-CoV-2 effect as well as useful inspiration and help for the discovery and optimization of small molecule S protein inhibitors.	[Sun, Chuancai; Zhao, Xianyang; Xu, Dongmei; Liu, Yipeng] Shandong First Med Univ, Affiliated Hosp 1, Dept Nephrol, Jinan, Peoples R China; [Sun, Chuancai; Wei, Jiao; Zhao, Xianyang; Xu, Dongmei; Liu, Yipeng] Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China; [Sun, Chuancai; Zhao, Xianyang; Xu, Dongmei; Liu, Yipeng] Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Nephrol, Jinan, Peoples R China; [Zhang, Jian; Yuan, Huiqing] Shandong Univ, Inst Med Sci, Cheeloo Coll Med, Hosp 2, Jinan, Peoples R China; [Wei, Jiao] Shandong First Med Univ, Affiliated Hosp 1, Dept Neurosurg, Jinan, Peoples R China; [Zheng, Xiaoli] Shandong First Med Univ, Shandong Prov Hosp, Dept Emergency, Jinan, Peoples R China; [Fang, Zengjun] Shandong Univ, Dept Pharm, Cheeloo Coll Med, Hosp 2, Jinan, Peoples R China; [Xu, Dongmei; Liu, Yipeng] Nephrol Res Inst Shandong Prov, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Liu, YP (corresponding author), Shandong First Med Univ, Affiliated Hosp 1, Dept Nephrol, Jinan, Peoples R China.; Liu, YP (corresponding author), Shandong Prov Qianfoshan Hosp, Jinan, Peoples R China.; Liu, YP (corresponding author), Shandong Univ, Shandong Prov Qianfoshan Hosp, Dept Nephrol, Jinan, Peoples R China.; Yuan, HQ (corresponding author), Shandong Univ, Inst Med Sci, Cheeloo Coll Med, Hosp 2, Jinan, Peoples R China.; Liu, YP (corresponding author), Nephrol Res Inst Shandong Prov, Jinan, Peoples R China.	lyuanhq@sdu.edu.cn; liuyipeng@sdhospital.com.cn			National Natural Science Foundation of China [81500555, 81970615]; Young Taishan Scholars Program [tsqn201812143]; Academic Promotion Programme of Shandong First Medical University [2019RC013]; Third Project of Jinan City Science and Technology Development Plan [201503002]; Natural Science Foundation of Shandong Province [ZR2019MH038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Taishan Scholars Program; Academic Promotion Programme of Shandong First Medical University; Third Project of Jinan City Science and Technology Development Plan; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by grants from National Natural Science Foundation of China (81500555, 81970615), the Young Taishan Scholars Program (tsqn201812143), Academic Promotion Programme of Shandong First Medical University (2019RC013), the Third Project of Jinan City Science and Technology Development Plan (201503002) and Natural Science Foundation of Shandong Province (ZR2019MH038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin SA, 2020, EUR J MED CHEM, V201, DOI 10.1016/j.ejmech.2020.112559; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Fuhrmann J, 2010, J COMPUT CHEM, V31, P1911, DOI 10.1002/jcc.21478; Furuta Y, 2009, ANTIVIR RES, V82, P95, DOI 10.1016/j.antiviral.2009.02.198; Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135; Hall DC, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101646; He JH, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040428; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Khezri A, 2018, INT J BIOL MACROMOL, V114, P972, DOI 10.1016/j.ijbiomac.2018.03.100; Krajczyk Anna, 2014, Antiviral Chemistry & Chemotherapy, V23, P161, DOI 10.3851/IMP2564; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Liang CY, 2020, EUR J MED CHEM, V201, DOI 10.1016/j.ejmech.2020.112527; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Musarrat F, 2020, J MED VIROL, V92, P2087, DOI 10.1002/jmv.25985; Pepperrell T, 2020, J VIRUS ERAD, V6, P52; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Thuillier J, 2021, INT J CONTROL, V94, P2640, DOI 10.1080/00207179.2020.1727958; Tilmanis D, 2017, ANTIVIR RES, V147, P142, DOI 10.1016/j.antiviral.2017.10.002; Valentina S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20246; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2017, P NATL ACAD SCI USA, V114, P11157, DOI 10.1073/pnas.1708727114; Wang D, 2020, J AEROSPACE ENG, V33, DOI 10.1061/(ASCE)AS.1943-5525.0001149; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; World Health Organization, 2021, NOV COR 2019 NCOV SI; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xia S, 2020, CELL MOL IMMUNOL, V17, P765, DOI 10.1038/s41423-020-0374-2; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Zhu Z, 2020, J INFECTION, V81, pE21, DOI 10.1016/j.jinf.2020.03.060	33	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245975	10.1371/journal.pone.0245975	http://dx.doi.org/10.1371/journal.pone.0245975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493227	gold, Green Published			2022-12-26	WOS:000613081500017
J	Aboobacker, FN; Dixit, G; Lakshmi, KM; Korula, A; Abraham, A; George, B; Mathews, V; Srivastava, A				Aboobacker, Fouzia N.; Dixit, Gaurav; Lakshmi, Kavitha M.; Korula, Anu; Abraham, Aby; George, Biju; Mathews, Vikram; Srivastava, Alok			Outcome of iron reduction therapy in exthalassemics	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; BETA-THALASSEMIA MAJOR; PEDIATRIC-PATIENTS; DEFERASIROX; PHLEBOTOMY; CHIMERISM; OVERLOAD; CHILDREN; STORES	There is limited data on iron reduction therapy (IRT) after successful allogeneic haematopoietic stem cell transplantation (aHSCT) for patients with thalassemia major (TM). We present the long term outcome of IRT in 149 patients with TM who underwent aHSCT during January, 2001-December, 2012. The median age was 7 years (range:1-18) and 92 (61.7%) belonged to Pesaro class 3 with a median ferritin at aHSCT of 2480ng/ml (range:866-8921). IRT was reinitiated post-aHSCT at a median of 14 months (range:5-53) post aHSCT with phlebotomy alone in 10 (6.7%) patients or iron chelation alone in 60 (40.3%) patients while 79 (53%) were treated with the combination. Reduction in serum ferritin/month [absolute quantity (ng/ml/month) was as follows: 87 (range:33-195), 130 (range:17-1012) and 147 (range:27.7-1427) in the phlebotomy, chelation and combination therapy groups, respectively (p = 0.038). With a median follow up of 80 months (range:37-182), target ferritin level of < 300ng/ml was achieved in 59(40%) while a level < 500ng/ml was achieved in 88 patients (59%) in a median duration of 41 months of IRT (range: 3-136). Patients in class III risk category and higher starting serum ferritin levels (> 2500ng/ml) were associated with delayed responses to IRT. Our data shows that IRT may be needed for very long periods in ex-thalassaemics to achieve target ferritin levels and should therefore be carefully planned and initiated as soon as possible after aHSCT. A combination of phlebotomy and iron chelators is more effective in reducing iron overload.	[Aboobacker, Fouzia N.; Dixit, Gaurav; Lakshmi, Kavitha M.; Korula, Anu; Abraham, Aby; George, Biju; Mathews, Vikram; Srivastava, Alok] Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India; [Dixit, Gaurav] Act Canc Hosp, Delhi, India	Christian Medical College & Hospital (CMCH) Vellore	Srivastava, A (corresponding author), Christian Med Coll & Hosp, Dept Haematol, Vellore, Tamil Nadu, India.	alok@cmcvellore.ac.in		Mathews, Vikram/0000-0001-9417-2353; Srivastava, Alok/0000-0001-5032-5020; George, Biju/0000-0002-9847-9501				Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Angelucci E, 1997, BLOOD, V90, P994, DOI 10.1182/blood.V90.3.994.994_994_998; Borgna-Pignatti C, 2004, SURVIVAL COMPLICATIO, V7; BRISSOT P, 1981, GASTROENTEROLOGY, V80, P557; BRITTENHAM GM, 1993, AM J HEMATOL, V42, P81, DOI 10.1002/ajh.2830420116; Cappellini MD., 2014, GUIDELINES MANAGEMEN, V3; Fischer Roland, 2009, Hematology Am Soc Hematol Educ Program, P215, DOI 10.1182/asheducation-2009.1.215; Giardini C, 2008, BRIT J HAEMATOL, V89, P868; Inati A, 2017, PEDIATR BLOOD CANCER, V64, P188, DOI 10.1002/pbc.26213; Li CK, 2000, BONE MARROW TRANSPL, V25, P653, DOI 10.1038/sj.bmt.1702212; Lucarelli G, 1996, BLOOD, V87, P2082, DOI 10.1182/blood.V87.5.2082.bloodjournal8752082; LUCARELLI G, 1990, NEW ENGL J MED, V322, P417, DOI 10.1056/NEJM199002153220701; LUCARELLI G, 1993, LANCET, V342, P1388, DOI 10.1016/0140-6736(93)92753-G; Mathews V, 2007, BIOL BLOOD MARROW TR, V13, P889, DOI 10.1016/j.bbmt.2007.05.004; Musallam KM, 2011, HAEMATOL-HEMATOL J, V96, P1605, DOI 10.3324/haematol.2011.047852; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Puliyel M, 2014, AM J HEMATOL, V89, P391, DOI 10.1002/ajh.23650; Sellathamby S, 2006, BONE MARROW TRANSPL, V37, P751, DOI 10.1038/sj.bmt.1705317; Taher A., 2013, GUIDELINES MANAGEMEN; Unal S, 2010, PEDIATR HEMAT ONCOL, V27, P482, DOI 10.3109/08880018.2010.493573; Yesilipek MA, 2010, PEDIATR HEMAT ONCOL, V27, P374, DOI 10.3109/08880011003739463; Yesilipek MA, 2018, BIOL BLOOD MARROW TR, V24, P613, DOI 10.1016/j.bbmt.2017.11.006	22	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0238793	10.1371/journal.pone.0238793	http://dx.doi.org/10.1371/journal.pone.0238793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481797	gold, Green Published			2022-12-26	WOS:000612929300051
J	Lanni, F; Burton, N; Harris, D; Fotheringham, S; Clark, S; Skinner, O; Wiblin, N; Dennis, M; Armstrong, S; Davies, G; Williams, A				Lanni, Faye; Burton, Neil; Harris, Debbie; Fotheringham, Susan; Clark, Simon; Skinner, Oliver; Wiblin, Nathan; Dennis, Mike; Armstrong, Stuart; Davies, Geraint; Williams, Ann			The potential of microdialysis to estimate rifampicin concentrations in the lung of guinea pigs	PLOS ONE			English	Article							SKELETAL-MUSCLE; TUBERCULOSIS; PENETRATION; PHARMACODYNAMICS; PHARMACOKINETICS; AGENTS; MODEL	Optimised pre-clinical models are required for TB drug development to better predict the pharmacokinetics of anti-tuberculosis (anti-TB) drugs to shorten the time taken for novel drugs and combinations to be approved for clinical trial. Microdialysis can be used to measure unbound drug concentrations in awake freely moving animals in order to describe the pharmacokinetics of drugs in the organs as a continuous sampling technique. The aim of this work was to develop and optimise the microdialysis methodology in guinea pigs to better understand the pharmacokinetics of rifampicin in the lung. In vitro experiments were performed before progressing into in vivo studies because the recovery (concentration of the drug in the tissue fluid related to that in the collected dialysate) of rifampicin was dependent on a variety of experimental conditions. Mass spectrometry of the dialysate was used to determine the impact of flow rate, perfusion fluid and the molecular weight cut-off and membrane length of probes on the recovery of rifampicin at physiologically relevant concentrations. Following determination of probe efficiency and identification of a correlation between rifampicin concentrations in the lung and skeletal muscle, experiments were conducted to measure rifampicin in the sacrospinalis of guinea pigs using microdialysis. Lung concentrations of rifampicin were estimated from the rifampicin concentrations measured in the sacrospinalis. These studies suggest the potential usefulness of the microdialysis methodology to determine drug concentrations of selected anti-TB drugs to support new TB drug development.	[Lanni, Faye; Harris, Debbie; Fotheringham, Susan; Clark, Simon; Skinner, Oliver; Wiblin, Nathan; Dennis, Mike; Williams, Ann] Publ Hlth England, Salisbury, Wilts, England; [Burton, Neil] Porton Sci Pk Incubator Ctr, Q3 Analyt, Salisbury, Wilts, England; [Armstrong, Stuart] DSTL, Salisbury, Wilts, England; [Davies, Geraint] Univ Liverpool, Clin Infect Microbiol & Immunol, Brownlow Hill, Liverpool, Merseyside, England; [Lanni, Faye] Ctr Discovery & Innovat, Nutley, NJ 07110 USA	Public Health England; Defence Science & Technology Laboratory; University of Liverpool	Lanni, F (corresponding author), Publ Hlth England, Salisbury, Wilts, England.; Lanni, F (corresponding author), Ctr Discovery & Innovat, Nutley, NJ 07110 USA.	faye.lanni@hmh-cdi.org		Armstrong, Stuart/0000-0002-5628-0481; Lanni, Faye/0000-0002-4305-7176	Department of Health, UK	Department of Health, UK	This work was supported by the Department of Health, UK. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Author Neil Burton is affiliated to Q3 Analytical but provided his time for this study for free. Q3 Analytical provided support in the form of salaries for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahmad Z, 2010, J ANTIMICROB CHEMOTH, V65, P729, DOI 10.1093/jac/dkq007; Alghamdi WA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00641-18; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gupta UD, 2005, TUBERCULOSIS, V85, P277, DOI 10.1016/j.tube.2005.08.008; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Kjellsson MC, 2012, ANTIMICROB AGENTS CH, V56, P446, DOI 10.1128/AAC.05208-11; Liu L, 2010, J MED CHEM, V53, P2882, DOI 10.1021/jm901858n; Liu P, 2005, EUR J PHARM SCI, V25, P439, DOI 10.1016/j.ejps.2005.04.012; Mindermann T, 1998, ANTIMICROB AGENTS CH, V42, P2626, DOI 10.1128/AAC.42.10.2626; Muller M, 2004, ANTIMICROB AGENTS CH, V48, P1441, DOI 10.1128/AAC.48.5.1441-1453.2004; Mumford H, 2013, CHEM-BIOL INTERACT, V203, P160, DOI 10.1016/j.cbi.2012.08.018; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Orme IM, 2016, TUBERCULOSIS TUBERCL, P143; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Podell BK, 2015, TUBERCULOSIS, LEPROSY AND MYCOBACTERIAL DISEASES OF MAN AND ANIMALS: THE MANY HOSTS OF MYCOBACTERIA, P419, DOI 10.1079/9781780643960.0419; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Sorensen O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-469; Strydom N, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002773; Tasso L, 2008, INT J PHARMACEUT, V358, P96, DOI 10.1016/j.ijpharm.2008.02.023; Taylor J.R., 1997, INTRO ERROR ANAL STU, P181; WHO, 2019, GLOB TUB REP; Zhang Q, 2010, J INTERNET SERV APPL, V1, P7, DOI 10.1007/s13174-010-0007-6	22	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245922	10.1371/journal.pone.0245922	http://dx.doi.org/10.1371/journal.pone.0245922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481939	gold, Green Published			2022-12-26	WOS:000612929300131
J	MacGlashan, D				MacGlashan, Donald, Jr.			The relationship between released soluble FceRI-alpha and its cell surface density on human basophils	PLOS ONE			English	Article							FC-EPSILON-RI; MAST-CELLS; EXPRESSION; IGE	Background The IgE-mediated activation of mast cells and basophils results in the secretion of many substances, including the release of FceRI-alpha subunit. This released alpha subunit can bind IgE and it may act as a down-regulator of subsequent IgE-dependent reactions. However, previous studies do not observe loss of the mass of FceRI-alpha associated with the cells, at least not for human basophils. This study was designed to understand the basis for the discordant observations. Methods Purified human basophils were stimulated with multiple activating secretagogues and super-natants were examined for histamine and released FceRI-alpha. In addition, cell surface IgE densities (occupied and unoccupied) were measured by flow cytometry and total cellular content of mature and immature FceRI-alpha determined with Western blots. Results Released FceRI-alpha, on average, represented 7% of the total surface FceRI before the reaction. The molecular weight of the soluble FceRI-alpha was approximately 54 kD, larger than immature subunit and somewhat smaller than surface subunit. In addition, 1) release ceased long before internalized FceRI-alpha was processed, 2) release was insensitive to Bafilomycin A, 3) release was independent of the starting density of FceRI and 4) release occurred more effectively with non-IgE-dependent stimuli, FMLP or C5a. Conclusions There appears to be relatively constant amount of nearly mature FceRI-alpha that is susceptible to secretion events induced by any form of stimulation. The amount, on average, represents about 7% of the mature form of FceRI-alpha.	[MacGlashan, Donald, Jr.] Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA	Johns Hopkins University	MacGlashan, D (corresponding author), Johns Hopkins Univ, Dept Med, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	dmacglas@jhmi.edu			National Institute of Health [AI AI139326]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	For these studies, DM and the studies were supported by National Institute of Health (https://www.nih.gov) grant AI AI139326. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dehlink E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019098; DVORAK AM, 1991, LAB INVEST, V64, P234; GILBERT HS, 1975, BLOOD, V46, P279; LAWRENCE ID, 1987, J IMMUNOL, V139, P3062; Lexmond W, 2011, J IMMUNOL METHODS, V373, P192, DOI 10.1016/j.jim.2011.08.018; MACGLASHAN D, 1983, J IMMUNOL, V130, P2337; MacGlashan DW, 2007, J LEUKOCYTE BIOL, V82, P1003, DOI 10.1189/jlb.0207103; MacGlashan DW, 2007, J ALLERGY CLIN IMMUN, V119, P626, DOI 10.1016/j.jaci.2006.09.040; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; MACGLASHAN DW, 1983, FED PROC, V42, P2504; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Monino-Romero S, 2020, J ALLER CL IMM-PRACT, V8, P2085, DOI 10.1016/j.jaip.2020.01.047; Monino-Romero S, 2019, ALLERGY, V74, P1381, DOI 10.1111/all.13734; PETERS SP, 1982, AM REV RESPIR DIS, V126, P1034; PRUZANSKY JJ, 1983, J IMMUNOL, V131, P1949; Romero S, 2019, ALLERGY, V74, P236, DOI [10.1111/all.13567, DOI 10.1111/ALL.13567]; SCHULMAN ES, 1983, J IMMUNOL, V131, P1936; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; WITTIG HJ, 1980, J ALLERGY CLIN IMMUN, V66, P305, DOI 10.1016/0091-6749(80)90026-3; Zaidi AK, 2010, J ALLERGY CLIN IMMUN, V125, P902, DOI 10.1016/j.jaci.2009.12.996	20	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245942	10.1371/journal.pone.0245942	http://dx.doi.org/10.1371/journal.pone.0245942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481953	Green Published, gold			2022-12-26	WOS:000612929300030
J	Quaglia, F; Krishn, SR; Wang, YQ; Goodrich, DW; McCue, P; Kossenkov, AV; Mandigo, AC; Knudsen, KE; Weinreb, PH; Corey, E; Kelly, WK; Languino, LR				Quaglia, Fabio; Krishn, Shiv Ram; Wang, Yanqing; Goodrich, David W.; McCue, Peter; Kossenkov, Andrew, V; Mandigo, Amy C.; Knudsen, Karen E.; Weinreb, Paul H.; Corey, Eva; Kelly, William K.; Languino, Lucia R.			Differential expression of alpha V beta 3 and alpha V beta 6 integrins in prostate cancer progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; NEUROENDOCRINE DIFFERENTIATION; ALPHA(NU)BETA(3) INTEGRIN; ALPHA(V)BETA(3) INTEGRIN; CELL-MIGRATION; PROTEIN; ROLES; RB1; CARCINOMA; PROMOTES	Neuroendocrine prostate cancer (NEPrCa) arises de novo or after accumulation of genomic alterations in pre-existing adenocarcinoma tumors in response to androgen deprivation therapies. We have provided evidence that small extracellular vesicles released by PrCa cells and containing the alpha V beta 3 integrin promote neuroendocrine differentiation of PrCa in vivo and in vitro. Here, we examined alpha V beta 3 integrin expression in three murine models carrying a deletion of PTEN (SKO), PTEN and RB1 (DKO), or PTEN, RB1 and TRP53 (TKO) genes in the prostatic epithelium; of these three models, the DKO and TKO tumors develop NEPrCa with a gene signature comparable to those of human NEPrCa. Immunostaining analysis of SKO, DKO and TKO tumors shows that alpha V beta 3 integrin expression is increased in DKO and TKO primary tumors and metastatic lesions, but absent in SKO primary tumors. On the other hand, SKO tumors show higher levels of a different alpha V integrin, alpha V beta 6, as compared to DKO and TKO tumors. These results are confirmed by RNA-sequencing analysis. Moreover, TRAMP mice, which carry NEPrCa and adenocarcinoma of the prostate, also have increased levels of alpha V beta 3 in their NEPrCa primary tumors. In contrast, the alpha V beta 6 integrin is only detectable in the adenocarcinoma areas. Finally, analysis of 42 LuCaP patient-derived xenografts and primary adenocarcinoma samples shows a positive correlation between alpha V beta 3, but not alpha V beta 6, and the neuronal marker synaptophysin; it also demonstrates that alpha V beta 3 is absent in prostatic adenocarcinomas. In summary, we demonstrate that alpha V beta 3 integrin is upregulated in NEPrCa primary and metastatic lesions; in contrast, the alpha(V)beta 6 integrin is confined to adenocarcinoma of the prostate. Our findings suggest that the alpha V beta 3 integrin, but not alpha V beta 6, may promote a shift in lineage plasticity towards a NE phenotype and might serve as an informative biomarker for the early detection of NE differentiation in prostate cancer.	[Quaglia, Fabio; Krishn, Shiv Ram; Languino, Lucia R.] Thomas Jefferson Univ, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA; [Quaglia, Fabio; Krishn, Shiv Ram; Mandigo, Amy C.; Knudsen, Karen E.; Languino, Lucia R.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Wang, Yanqing; Goodrich, David W.] Roswell Pk Comprehens Canc Ctr, Dept Pharmacol & Therapeut, Buffalo, NY USA; [McCue, Peter] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Kossenkov, Andrew, V] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Weinreb, Paul H.] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA; [Corey, Eva] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Kelly, William K.] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University; The Wistar Institute; Biogen; University of Washington; University of Washington Seattle; Jefferson University	Languino, LR (corresponding author), Thomas Jefferson Univ, Prostate Canc Discovery & Dev Program, Philadelphia, PA 19107 USA.; Languino, LR (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA.	lucia.languino@jefferson.edu			National Cancer Institute [R01-CA224769, P01-CA140043, R01-CA207757, R01-CA176401]; Philadelphia Prostate Cancer Biome Project [6/01/19-5/31/23]; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health [SAP 4100072566]; Pacific Northwest Prostate Cancer SPORE [P50CA97186]; Department of Defense Prostate Cancer Biorepository Network [W81XWH-14-2-0183]; National Cancer Institute (NCI) [P01 CA163227]; National Cancer Institute of the National Institutes of Health [P30CA056036]; NIH	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Philadelphia Prostate Cancer Biome Project; Commonwealth University Research Enhancement Program grant; Pennsylvania Department of Health; Pacific Northwest Prostate Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Prostate Cancer Biorepository Network(United States Department of Defense); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Cancer Institute in the form of grants awarded to LRL (R01-CA224769, P01-CA140043), DWG (R01-CA207757), and KEK (R01-CA176401) and Philadelphia Prostate Cancer Biome Project in the form of funds awarded to WKK (6/01/19-5/31/23). This project was also funded, in part, under a Commonwealth University Research Enhancement Program grant with the Pennsylvania Department of Health (H.R.) awarded to LRL (SAP 4100072566). The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. The establishment and characterization of the LuCaP PDXs was supported by the Pacific Northwest Prostate Cancer SPORE in the form of a grant awarded to EC (P50CA97186), the Department of Defense Prostate Cancer Biorepository Network in the form of a grant awarded to EC (W81XWH-14-2-0183), and National Cancer Institute (NCI) in the form of a grant awarded to EC (P01 CA163227). The research reported in this publication utilized the shared flow cytometry, histopathology, and bioimaging facilities at the Sidney Kimmel Cancer Center (Thomas Jefferson University, Philadelphia, PA) that are supported by the National Cancer Institute of the National Institutes of Health in the form of a grant awarded to KEK (P30CA056036). NIH grants partially support the salaries of FQ, SRK, YW, DWG, AM, KEK, EC, LRL. Biogen Inc. provided support in the form of a salary for PW. The specific roles of this author are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2018, J CLIN ONCOL, V36, P2492, DOI 10.1200/JCO.2017.77.6880; Beltran H, 2019, CLIN CANCER RES, V25, P6916, DOI 10.1158/1078-0432.CCR-19-1423; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Bhagirath D, 2019, CLIN CANCER RES, V25, P6532, DOI 10.1158/1078-0432.CCR-19-0498; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; Cooper CR, 2002, NEOPLASIA, V4, P191, DOI 10.1038/sj.neo.7900224; CRESS AE, 1995, CANCER METAST REV, V14, P219, DOI 10.1007/BF00690293; Dardenne E, 2016, CANCER CELL, V30, P563, DOI 10.1016/j.ccell.2016.09.005; de Bono J, 2020, NEW ENGL J MED, V382, P2091, DOI 10.1056/NEJMoa1911440; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Drivalos A, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2015.10.016; Dutta A, 2014, CANCER RES, V74, P1598, DOI 10.1158/0008-5472.CAN-13-1796; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Engel BE, 2015, CELL HEALTH CYTOSKEL, V7, P1, DOI 10.2147/CHC.S28079; Fornaro M, 2001, CANCER METAST REV, V20, P321, DOI 10.1023/A:1015547830323; Garlick DS, 2012, AM J TRANSL RES, V4, P165; Gelman IH, 2016, CANCER RES, V76, P6137, DOI 10.1158/0008-5472.CAN-16-2636; Goel HL, 2008, ENDOCR-RELAT CANCER, V15, P657, DOI 10.1677/ERC-08-0019; Goel HL, 2013, J CELL PHYSIOL, V228, P1601, DOI 10.1002/jcp.24323; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hamidi H, 2018, NAT REV CANCER, V18, P532, DOI 10.1038/s41568-018-0038-z; Hsu EC, 2020, P NATL ACAD SCI USA, V117, P2032, DOI 10.1073/pnas.1905384117; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; Jin H, 2004, BRIT J CANCER, V90, P561, DOI 10.1038/sj.bjc.6601576; Knowles LM, 2013, CANCER RES, V73, P6175, DOI 10.1158/0008-5472.CAN-13-0602; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Krishn SR, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1763594; Krishn SR, 2019, MATRIX BIOL, V77, P41, DOI 10.1016/j.matbio.2018.08.004; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Lu HM, 2018, MATRIX BIOL, V70, P20, DOI 10.1016/j.matbio.2018.03.009; Lu HM, 2016, CANCER RES, V76, P5163, DOI 10.1158/0008-5472.CAN-16-0543; McCabe NP, 2007, ONCOGENE, V26, P6238, DOI 10.1038/sj.onc.1210429; McNair C, 2018, J CLIN INVEST, V128, P341, DOI 10.1172/JCI93566; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Nguyen HM, 2017, PROSTATE, V77, P654, DOI 10.1002/pros.23313; Nieberler M, 2017, CANCERS, V9, DOI 10.3390/cancers9090116; Niu J, 2017, CANCER LETT, V403, P128, DOI 10.1016/j.canlet.2017.06.012; Palmgren JS, 2007, SEMIN ONCOL, V34, P22, DOI 10.1053/j.seminoncol.2006.10.026; Parimi V, 2014, AM J CLIN EXP UROL, V2, P273; Pecheur I, 2002, FASEB J, V16, P1266, DOI 10.1096/fj.01-0911fje; Quaglia F., 2020, J EXTRACELL VESICLES, V9, DOI [10.1080/20013078.2020.1761072, DOI 10.1080/20013078.2020.1761072]; Rader C, 2002, FASEB J, V16, P2000, DOI 10.1096/fj.02-0281fje; Sigrist CJA, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104759; Sloan EK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1398; Sosa-Garcia B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013954; Stucci S, 2015, CRIT REV ONCOL HEMAT, V96, P183, DOI 10.1016/j.critrevonc.2015.05.018; Sun HF, 2011, P NATL ACAD SCI USA, V108, P704, DOI 10.1073/pnas.1015027108; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vlachostergios PJ, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0593-6; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wei YW, 2014, J VIROL, V88, P4338, DOI 10.1128/JVI.03491-13; Weinreb PH, 2004, J BIOL CHEM, V279, P17875, DOI 10.1074/jbc.M312103200; Williams CH, 2004, J VIROL, V78, P6967, DOI 10.1128/JVI.78.13.6967-6973.2004; Zhang W, 2018, CLIN CANCER RES, V24, P696, DOI 10.1158/1078-0432.CCR-17-1872; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499; Zheng DQ, 1999, CANCER RES, V59, P1655; Zheng DQ, 2000, J BIOL CHEM, V275, P24565, DOI 10.1074/jbc.M002646200	64	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244985	10.1371/journal.pone.0244985	http://dx.doi.org/10.1371/journal.pone.0244985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481853	Green Published, gold			2022-12-26	WOS:000612929300040
J	Stuckey, JI; Cantone, NR; Cote, A; Arora, S; Vivat, V; Ramakrishnan, A; Mertz, JA; Khanna, A; Brenneman, J; Gehling, VS; Moine, L; Sims, RJ; Audia, JE; Trojer, P; Levell, JR; Cummings, RT				Stuckey, Jacob, I; Cantone, Nico R.; Cote, Alexandre; Arora, Shilpi; Vivat, Valerie; Ramakrishnan, Ashwin; Mertz, Jennifer A.; Khanna, Avinash; Brenneman, Jehrod; Gehling, Victor S.; Moine, Ludivine; Sims, Robert J.; Audia, James E.; Trojer, Patrick; Levell, Julian R.; Cummings, Richard T.			Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE EZH2; CARBOXYPEPTIDASE-A; BINDING; NONCOVALENT; AFFINITIES; COMPLEXES; CHROMATIN; MUTATION; ENHANCER; OPINION	The histone methyltransferase EZH2 has been the target of numerous small-molecule inhibitor discovery efforts over the last 10+ years. Emerging clinical data have provided early evidence for single agent activity with acceptable safety profiles for first-generation inhibitors. We have developed kinetic methodologies for studying EZH2-inhibitor-binding kinetics that have allowed us to identify a unique structural modification that results in significant increases in the drug-target residence times of all EZH2 inhibitor scaffolds we have studied. The unexpected residence time enhancement bestowed by this modification has enabled us to create a series of second-generation EZH2 inhibitors with sub-pM binding affinities. We provide both biophysical evidence validating this sub-pM potency and biological evidence demonstrating the utility and relevance of such high-affinity interactions with EZH2.	[Stuckey, Jacob, I; Cantone, Nico R.; Cote, Alexandre; Arora, Shilpi; Vivat, Valerie; Ramakrishnan, Ashwin; Mertz, Jennifer A.; Khanna, Avinash; Brenneman, Jehrod; Gehling, Victor S.; Moine, Ludivine; Sims, Robert J.; Audia, James E.; Trojer, Patrick; Levell, Julian R.; Cummings, Richard T.] Constellat Pharmaceut, Cambridge, MA 02142 USA		Cummings, RT (corresponding author), Constellat Pharmaceut, Cambridge, MA 02142 USA.	richard.cummings@constellationpharma.com	Ramakrishnan, Ashwin/AAF-8638-2021	Ramakrishnan, Ashwin/0000-0003-1569-6664				Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Beno BR, 2015, J MED CHEM, V58, P4383, DOI 10.1021/jm501853m; Benson S. W., 1960, FDN CHEM KINETICS; BOEKER EA, 1984, EXPERIENTIA, V40, P453, DOI 10.1007/BF01952382; Bratkowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27175-w; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Copeland RA, 2016, NAT REV DRUG DISCOV, V15, P87, DOI 10.1038/nrd.2015.18; Copeland RA, 2011, ANAL BIOCHEM, V416, P206, DOI 10.1016/j.ab.2011.05.029; Danishuddin, 2019, DRUG DISCOV TODAY, V24, P179, DOI 10.1016/j.drudis.2018.07.002; Gan L, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0122-2; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; Gulati N, 2018, LEUKEMIA LYMPHOMA, V59, P1574, DOI 10.1080/10428194.2018.1430795; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; He YP, 2017, NAT CHEM BIOL, V13, P389, DOI 10.1038/nchembio.2306; Honma D, 2017, CANCER SCI, V108, P2069, DOI 10.1111/cas.13326; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAPLAN AP, 1991, BIOCHEMISTRY-US, V30, P8165, DOI 10.1021/bi00247a011; Khanna A, 2020, ACS MED CHEM LETT, V11, P1205, DOI 10.1021/acsmedchemlett.0c00045; KIM HD, 1991, BIOCHEMISTRY-US, V30, P8171, DOI 10.1021/bi00247a012; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Koschmann C, 2017, CANCER RES, V77, P227, DOI 10.1158/0008-5472.CAN-16-2301; Kung PP, 2018, J MED CHEM, V61, P650, DOI 10.1021/acs.jmedchem.7b01375; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Majer CR, 2012, FEBS LETT, V586, P3448, DOI 10.1016/j.febslet.2012.07.066; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; MCPHERSON RA, 1975, ANAL BIOCHEM, V64, P501, DOI 10.1016/0003-2697(75)90460-1; MOTULSKY HJ, 1984, MOL PHARMACOL, V25, P1; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Qi W, 2017, NAT CHEM BIOL, V13, P381, DOI 10.1038/nchembio.2304; Quinn JG, 2018, J MED CHEM, V61, P5154, DOI 10.1021/acs.jmedchem.7b01829; SCHLOSS JV, 1988, J BIOL CHEM, V263, P4145; Smith AJT, 2009, J MED CHEM, V52, P225, DOI 10.1021/jm800498e; Stazi G, 2017, EXPERT OPIN THER PAT, V27, P797, DOI 10.1080/13543776.2017.1316976; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanaka M, 2015, PHARM PAT ANAL, V4, P261, DOI [10.4155/ppa.15.16, 10.4155/PPA.15.16]; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van Aller GS, 2014, ACS CHEM BIOL, V9, P622, DOI 10.1021/cb4008748; Vaswani RG, 2016, J MED CHEM, V59, P9928, DOI 10.1021/acs.jmedchem.6b01315; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Zhao L, 2018, CURR TOP MED CHEM, V18, P2395, DOI 10.2174/1568026619666181224095449	48	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100349	10.1016/j.jbc.2021.100349	http://dx.doi.org/10.1016/j.jbc.2021.100349			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524394	Green Published, gold			2022-12-26	WOS:000672866400323
J	Ko, YF; Cheng, KS				Ko, Yen-Fen; Cheng, Kuo-Sheng			Semi-Siamese U-Net for separation of lung and heart bioimpedance images: A simulation study of thorax EIT	PLOS ONE			English	Article							MECHANICAL VENTILATION; PULMONARY; PERFUSION; VOLUME	Electrical impedance tomography (EIT) is widely used for bedside monitoring of lung ventilation status. Its goal is to reflect the internal conductivity changes and estimate the electrical properties of the tissues in the thorax. However, poor spatial resolution affects EIT image reconstruction to the extent that the heart and lung-related impedance images are barely distinguishable. Several studies have attempted to tackle this problem, and approaches based on decomposition of EIT images using linear transformations have been developed, and recently, U-Net has become a prominent architecture for semantic segmentation. In this paper, we propose a novel semi-Siamese U-Net specifically tailored for EIT application. It is based on the state-of-the-art U-Net, whose structure is modified and extended, forming shared encoder with parallel decoders and has multi-task weighted losses added to adapt to the individual separation tasks. The trained semi-Siamese U-Net model was evaluated with a test dataset, and the results were compared with those of the classical U-Net in terms of Dice similarity coefficient and mean absolute error. Results showed that compared with the classical U-Net, semi-Siamese U-Net exhibited performance improvements of 11.37% and 3.2% in Dice similarity coefficient, and 3.16% and 5.54% in mean absolute error, in terms of heart and lung-impedance image separation, respectively.	[Ko, Yen-Fen; Cheng, Kuo-Sheng] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan	National Cheng Kung University	Cheng, KS (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan.	kscheng@mail.ncku.edu.tw		Ko, Yen-Fen/0000-0003-2986-9984; Cheng, Kuo-Sheng/0000-0002-0913-246X	Ministry of Science and Technology of Taiwan [109-2221-E-006 -073 -MY2, 108-2221-E-006 -176, 107-2221-E-006 -047, 106-2221-E-006 -045]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	All funding from research grant 109-2221-E-006 -073 -MY2, 108-2221-E-006 -176, 107-2221-E-006 -047, and 106-2221-E-006 -045 from the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Alom MZ, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.1.014006; Ammari H, 2004, RECONSTRUCTION SMALL; Carlisle HR, 2010, INTENS CARE MED, V36, P2101, DOI 10.1007/s00134-010-2049-4; Cheon S, 2021, PROC SPIE, V11313, DOI 10.1117/12.2549152; Deibele JM, 2008, PHYSIOL MEAS, V29, pS1, DOI 10.1088/0967-3334/29/6/S01; Diakogiannis FI, 2020, ISPRS J PHOTOGRAMM, V162, P94, DOI 10.1016/j.isprsjprs.2020.01.013; Dong H, 2017, ARXIV170503820CS; Drozdzal M, 2016, LECT NOTES COMPUT SC, V10008, P179, DOI 10.1007/978-3-319-46976-8_19; Erlandsson K, 2006, ACTA ANAESTH SCAND, V50, P833, DOI 10.1111/j.1399-6576.2006.01079.x; Eyuboglu B M, 1988, Clin Phys Physiol Meas, V9 Suppl A, P43, DOI 10.1088/0143-0815/9/4A/008; EYUBOGLU BM, 1989, IEEE ENG MED BIOL, V8, P39, DOI 10.1109/51.32404; Frerichs I, 2009, RESPIRATION, V77, P282, DOI 10.1159/000193994; Graf M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188313; Grant CA, 2011, CRIT CARE, V15, DOI 10.1186/cc9985; Hamilton SJ, 2018, IEEE T MED IMAGING, V37, P2367, DOI 10.1109/TMI.2018.2828303; Hamilton SJ, 2017, IEEE T MED IMAGING, V36, P457, DOI 10.1109/TMI.2016.2613511; Ibtehaz N, 2020, NEURAL NETWORKS, V121, P74, DOI 10.1016/j.neunet.2019.08.025; Jha D, 2019, ARXIV191107067CSEESS; Kerrouche N, 2001, PHYSIOL MEAS, V22, P147, DOI 10.1088/0967-3334/22/1/318; Lampinen J., 1999, IJCNN'99. International Joint Conference on Neural Networks. Proceedings (Cat. No.99CH36339), P3942, DOI 10.1109/IJCNN.1999.830787; LEATHARD AD, 1994, PHYSIOL MEAS, V15, pA137, DOI 10.1088/0967-3334/15/2A/018; Martin S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188993; McArdle F J, 1988, Clin Phys Physiol Meas, V9 Suppl A, P87, DOI 10.1088/0143-0815/9/4A/015; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Peng DF, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11111382; Pikkemaat R., 2010, Journal of Physics: Conference Series, V224, DOI 10.1088/1742-6596/224/1/012028; Rahman T., 2019, J ELECT BIOIMPEDANCE, V4, P38, DOI [DOI 10.5617/jeb.553, 10.5617/jeb.553, DOI 10.5617/JEB.553]; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; Ronneberger O., 2015, P MICCAI MUN GERM 5, P234, DOI DOI 10.1007/978-3-319-24574-4_28; Seo JK, 2019, SIAM J IMAGING SCI, V12, P1275, DOI 10.1137/18M1222600; Simon BA, 2006, AM J PHYSIOL-LUNG C, V291, pL851, DOI 10.1152/ajplung.00463.2005; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Smit HJ, 2006, RESPIRATION, V73, P597, DOI 10.1159/000088694; Wrigge H, 2008, CRIT CARE MED, V36, P903, DOI 10.1097/CCM.0B013E3181652EDD; ZADEHKOOCHAK M, 1992, CLIN PHYS PHYSIOL M, V13, P191, DOI 10.1088/0143-0815/13/A/037; Zhou Z., 2018, ARXIV180710165CSEESS	39	1	1	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246071	10.1371/journal.pone.0246071	http://dx.doi.org/10.1371/journal.pone.0246071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529234	Green Published, gold			2022-12-26	WOS:000616736200049
J	Roozen, GVT; Meel, R; Peper, J; Venter, WDF; Barth, RE; Grobbee, DE; Klipstein-Grobusch, K; Vos, AG				Roozen, Geert V. T.; Meel, Ruchika; Peper, Joyce; Venter, William D. F.; Barth, Roos E.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin; Vos, Alinda G.			Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-INFARCTION; ANTIRETROVIRAL THERAPY; CARDIOVASCULAR-DISEASE; DIASTOLIC FUNCTION; HEART-FAILURE; QTC INTERVAL; RISK-FACTORS; INFECTION	Background Studies from high income countries report that HIV-positive people have an impaired systolic and diastolic cardiac function compared to HIV-negative people. It is unclear if results can be translated directly to the Sub-Saharan Africa context. This study assesses electro- and echocardiographic characteristics in an urban African population, comparing HIV-positive people (treated and not yet treated) with HIV-negative controls. Methods We conducted a cross-sectional study in Johannesburg, South Africa. We enrolled HIV-positive participants from three randomized controlled trials that had recruited participants from routine HIV testing programs. HIV-negative controls were recruited from the community. Data were collected on demographics, cardiovascular risk factors, medical history and electrocardiographic and echocardiographic characteristics. Results In total, 394 HIV-positive participants and 153 controls were enrolled. The mean age of HIV-positive participants was 40 +/- 9 years (controls: 35 +/- 10 years), and 34% were male (controls: 50%). Of HIV-positive participants 36% were overweight or obese (controls: 44%), 23% had hypertension (controls: 28%) and 12% were current smoker (controls: 37%). Median time since HIV diagnosis was 6.0 years (IQR 2.3-10.0) and median treatment duration was 4.0 years (IQR 0.0-8.0), 50% had undetectable viral load. The frequency of anatomical cardiac abnormalities was low and did not differ between people with and without HIV. We observed no relation between HIV or anti-retroviral therapy (ART) and systolic or diastolic heart function. There was an association between ART use and corrected QT interval: +11.8 ms compared to HIV-negative controls (p<0.01) and +18.9 ms compared to ART-naive participants (p = 0.01). We also observed a higher left ventricular mass index in participants on ART (+7.8 g/m(2), p<0.01), but this association disappeared after adjusting for CD4 cell count, viral load and HIV-duration. Conclusion The low number of major cardiac abnormalities in this relatively young, well managed urban African HIV-positive population is reassuring. The increase in corrected QT interval and left ventricular mass may contribute to higher cardiac mortality and morbidity in people living with HIV in the long term.	[Roozen, Geert V. T.; Grobbee, Diederick E.; Klipstein-Grobusch, Kerstin; Vos, Alinda G.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Meel, Ruchika] Chris Hani Baragwanath Hosp, Dept Internal Med, Div Cardiol, Johannesburg, South Africa; [Meel, Ruchika] Univ Witwatersrand, Johannesburg, South Africa; [Peper, Joyce] St Antonius Hosp, Dept Cardiol, Nieuwegein, Netherlands; [Venter, William D. F.; Vos, Alinda G.] Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Ezintsha, Johannesburg, South Africa; [Barth, Roos E.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Infect Dis, Utrecht, Netherlands; [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; St. Antonius Hospital Utrecht; University of Witwatersrand; Utrecht University; Utrecht University Medical Center; University of Witwatersrand	Vos, AG (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.; Vos, AG (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Wits Reprod Hlth & HIV Inst, Ezintsha, Johannesburg, South Africa.	a.g.vos-8@umcutrecht.nl	Klipstein-Grobusch, Kerstin/F-5555-2016; Roozen, Geert/ABC-5070-2021	Klipstein-Grobusch, Kerstin/0000-0002-5462-9889; Roozen, Geert/0000-0002-3979-4616; Peper, Joyce/0000-0002-4008-1656; Venter, Willem/0000-0002-4157-732X; Vos, Alinda/0000-0002-9551-6223				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alfakih K, 2004, HYPERTENSION, V44, P175, DOI 10.1161/01.HYP.0000135249.66192.30; [Anonymous], 2017, COMMUN MATH STAT, V5, P1, DOI DOI 10.1007/S40304-017-0103-Z; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Bloomfield GS, 2015, JACC-HEART FAIL, V3, P579, DOI 10.1016/j.jchf.2015.05.003; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Butt AA, 2011, ARCH INTERN MED, V171, P737, DOI 10.1001/archinternmed.2011.151; Chinello P, 2007, J INFECTION, V54, P597, DOI 10.1016/j.jinf.2006.11.001; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Department of Health South Africa, 2016, NAT HIV TEST SERV PO; Fettig J, 2014, INFECT DIS CLIN N AM, V28, P323, DOI 10.1016/j.idc.2014.05.001; Fontes-Carvalho R, 2015, CARDIOVASC DRUG THER, V29, P31, DOI 10.1007/s10557-015-6573-x; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2016, EUR J PREV CARDIOL, V23, P214, DOI 10.1177/2047487315579291; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; Hemkens LG, 2014, EUR HEART J, V35, P1373, DOI 10.1093/eurheartj/eht528; Hsue PY, 2010, CIRC-HEART FAIL, V3, P132, DOI 10.1161/CIRCHEARTFAILURE.109.854943; International Physical Activity Questionnaire (IPAQ), 2005, IPAQ SCOR PROT; Isasti G, 2013, AIDS RES HUM RETROV, V29, P20, DOI [10.1089/AID.2012.0096, 10.1089/aid.2012.0096]; Islam FM, 2012, HIV MED, V13, P453, DOI 10.1111/j.1468-1293.2012.00996.x; Jensen AMR, 2018, EUR HEART J, V39, P1116; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Lang S, 2012, CLIN INFECT DIS, V55, P600, DOI 10.1093/cid/cis489; LEVY D, 1988, ANN INTERN MED, V108, P7, DOI 10.7326/0003-4819-108-1-7; Longo-Mbenza B, 1998, INT J CARDIOL, V64, P63, DOI 10.1016/S0167-5273(97)00321-5; Manga P, 2017, J AM COLL CARDIOL, V69, P83, DOI 10.1016/j.jacc.2016.09.977; Mansoor A, 2009, AIDS RES HUM RETROV, V25, P475, DOI 10.1089/aid.2008.0170; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Ntsekhe M, 2005, CIRCULATION, V112, P3602, DOI 10.1161/CIRCULATIONAHA.105.549220; Nzuobontane D, 2002, POSTGRAD MED J, V78, P678, DOI 10.1136/pmj.78.925.678; Ogunmodede JA, 2017, NIGER J CLIN PRACT, V20, P716, DOI 10.4103/1119-3077.208954; Okeke NL, 2018, J CARD FAIL, V24, P496, DOI 10.1016/j.cardfail.2018.06.003; Reinsch N, 2017, INFECTION, V45, P659, DOI 10.1007/s15010-017-1053-9; Reinsch N, 2013, J CARDIOVASC MED, V14, P733, DOI 10.2459/JCM.0b013e32835dc953; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Thienemann F, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005950; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2018, UNAIDS DAT 2018; Venter F, 2018, J INT AIDS SOC, V21, P156; Venter WDF, 2019, NEW ENGL J MED, V381, P803, DOI 10.1056/NEJMoa1902824; Venter WDF, 2019, JAIDS-J ACQ IMM DEF, V80, P224, DOI 10.1097/QAI.0000000000001908; World Health Organization, STEPS INSTR SUPP MAT; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Wu KC, 2019, HEART, V105, P559, DOI 10.1136/heartjnl-2018-313667; Zhang YY, 2011, EPIDEMIOLOGY, V22, P660, DOI 10.1097/EDE.0b013e318225768b	47	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0244742	10.1371/journal.pone.0244742	http://dx.doi.org/10.1371/journal.pone.0244742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529208	gold, Green Published			2022-12-26	WOS:000616736200054
J	Hu, Y; Yang, QY; Gu, YY				Hu, Yang; Yang, Qingyang; Gu, Yingyu			One-spot synthesis of FeOOH/rGO composites by ferrous-ion-induced self-assembly of graphene oxides with different degrees of oxidation	PLOS ONE			English	Article							ANODE; PERFORMANCE; SYSTEMS	In this study, graphene oxide sheets with different oxidation degrees were reduced by ferrous ion for coating FeOOH nano particles on reduced graphene oxide (rGO) matrix to synthesize FeOOH/rGO composites. The effect of the degree of oxidation on the morphology and chemical structure of FeOOH/rGO was studied using scanning electron microscopy, Raman spectroscopy, thermogravimetric analysis, and Brunauer-Emmett-Teller surface area analysis. The particle size of FeOOH crystallites was approximately 100 nm, and they were distributed uniformly on the surface and in the pores of FeOOH/rGO. FeOOH/rGO prepared with mildly oxidized graphite had fewer defects, higher specific surface area, and higher FeOOH content than FeOOH/rGO prepared with highly oxidized graphite. These features resulted in better electrochemical properties, such as larger specific capacitance and lower charge transfer resistance.	[Hu, Yang; Yang, Qingyang; Gu, Yingyu] Univ Sci & Technol Beijing, Sch Civil & Resources Engn, Beijing, Peoples R China	University of Science & Technology Beijing	Hu, Y (corresponding author), Univ Sci & Technol Beijing, Sch Civil & Resources Engn, Beijing, Peoples R China.	huyang178@hotmail.com			National Natural Science Foundation of China [51804021]; Fundamental Research Funds for the Central Universities [FRF-TP-18-022A1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financial supported by National Natural Science Foundation of China, 51804021, Dr. Yang Hu, Fundamental Research Funds for the Central Universities, FRF-TP-18-022A1, Dr. Yang Hu.	Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Ghasemi S, 2015, J POWER SOURCES, V289, P129, DOI 10.1016/j.jpowsour.2015.04.159; Hu Y, 2019, NANOTECHNOLOGY, V30, DOI 10.1088/1361-6528/ab432d; Hu Y, 2015, J COLLOID INTERF SCI, V450, P68, DOI 10.1016/j.jcis.2015.02.059; Li F, 2016, RSC ADV, V6, P3335, DOI 10.1039/c5ra22969c; Li XQ, 2019, CARBON, V146, P320, DOI 10.1016/j.carbon.2019.02.007; Lin FJ, 2019, ELECTROCHIM ACTA, V320, DOI 10.1016/j.electacta.2019.134580; Ma J, 2020, CHEM ENG J, V380, DOI 10.1016/j.cej.2019.122387; Nihtianov S, 2014, WOODH PUB SER ELECT, P1; Pavlidis IV, 2014, TRENDS BIOTECHNOL, V32, P312, DOI 10.1016/j.tibtech.2014.04.004; Qi H, 2016, ACS APPL MATER INTER, V8, P35253, DOI 10.1021/acsami.6b11840; Saito R, 2011, ADV PHYS, V60, P413, DOI 10.1080/00018732.2011.582251; Shahzad F, 2017, ACS APPL MATER INTER, V9, P24179, DOI 10.1021/acsami.7b05021; Shahzad F, 2017, SENSOR ACTUAT B-CHEM, V241, P716, DOI 10.1016/j.snb.2016.10.144; Shao YL, 2015, CHEM SOC REV, V44, P3639, DOI 10.1039/c4cs00316k; Shen YK, 2019, ELECTROCHIM ACTA, V321, DOI 10.1016/j.electacta.2019.134661; Singh N, 2019, ACS APPL NANO MATER, V2, P7379, DOI 10.1021/acsanm.9b01909; Singh V, 2011, PROG MATER SCI, V56, P1178, DOI 10.1016/j.pmatsci.2011.03.003; Smith Andrew T., 2019, Nano Materials Science, V1, P31, DOI 10.1016/j.nanoms.2019.02.004; Villarroel-Rocha J, 2014, MICROPOR MESOPOR MAT, V200, P68, DOI 10.1016/j.micromeso.2014.08.017; Wasalathilake KC, 2020, J ENERGY CHEM, V42, P91, DOI 10.1016/j.jechem.2019.06.016; Xu YX, 2010, ACS NANO, V4, P4324, DOI 10.1021/nn101187z; Yang D, 2017, BIOCHEM ENG J, V117, P52, DOI 10.1016/j.bej.2016.11.001; Zhang Y, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803342	24	0	0	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246386	10.1371/journal.pone.0246386	http://dx.doi.org/10.1371/journal.pone.0246386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524047	Green Published, gold			2022-12-26	WOS:000616578400023
J	Killoy, KM; Pehar, M; Harlan, BA; Vargas, MR				Killoy, Kelby M.; Pehar, Mariana; Harlan, Benjamin A.; Vargas, Marcelo R.			Altered expression of clock and clock-controlled genes in a hSOD1-linked amyotrophic lateral sclerosis mouse model	FASEB JOURNAL			English	Article						circadian; neurodegeneration; Nampt; Sirt6; astrocytes	BODY-MASS INDEX; MOTOR-NEURON DEGENERATION; REV-ERB-ALPHA; CIRCADIAN TRANSCRIPTION; HSOD1(G93A) MICE; SPINAL-CORD; SIRT6; METABOLISM; ASTROCYTES; PATHWAY	Most physiological processes in mammals are subjected to daily oscillations that are governed by a circadian system. The circadian rhythm orchestrates metabolic pathways in a time-dependent manner and loss of circadian timekeeping has been associated with cellular and system-wide alterations in metabolism, redox homeostasis, and inflammation. Here, we investigated the expression of clock and clock-controlled genes in multiple tissues (suprachiasmatic nucleus, spinal cord, gastrocnemius muscle, and liver) from mutant hSOD1-linked amyotrophic lateral sclerosis (ALS) mouse models. We identified tissue-specific changes in the relative expression, as well as altered daily expression patterns, of clock genes, sirtuins (Sirt1, Sirt3, and Sirt6), metabolic enzymes (Pfkfb3, Cpt1, and Nampt), and redox regulators (Nrf2, G6pd, and Pgd). In addition, astrocytes transdifferentiated from induced pluripotent stem cells from SOD1-linked and FUS RNA binding protein-linked ALS patients also displayed altered expression of clock genes. Overall, our results raise the possibility of disrupted cross-talk between the suprachiasmatic nucleus and peripheral tissues in hSOD1(G93A) mice, preventing proper peripheral clock regulation and synchronization. Since these changes were observed in symptomatic mice, it remains unclear whether this dysregulation directly drives or it is a consequence of the degenerative process. However, because metabolism and redox homeostasis are intimately entangled with circadian rhythms, our data suggest that altered expression of clock genes may contribute to metabolic and redox impairment in ALS. Since circadian dyssynchrony can be rescued, these results provide the groundwork for potential disease-modifying interventions.	[Killoy, Kelby M.; Harlan, Benjamin A.] Med Univ South Carolina, Biomed Sci Training Program, Charleston, SC 29425 USA; [Pehar, Mariana] Univ Wisconsin, Dept Med, Div Geriatr & Gerontol, Madison, WI 53792 USA; [Vargas, Marcelo R.] Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA	Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vargas, MR (corresponding author), Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA.	mvargas@wisc.edu			NINDS NIH HHS [R01 NS089640, R21 NS102599] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barca-Mayo O, 2020, GLIA, V68, P1131, DOI 10.1002/glia.23764; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Baxter PS, 2016, FREE RADICAL BIO MED, V100, P147, DOI 10.1016/j.freeradbiomed.2016.06.027; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Braun MC, 2019, EXP NEUROL, V311, P305, DOI 10.1016/j.expneurol.2018.07.008; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Fidler JA, 2011, FASEB J, V25, P4369, DOI 10.1096/fj.11-190819; FISMAN M, 1987, ARCH NEUROL-CHICAGO, V44, P997, DOI 10.1001/archneur.1987.00520220007005; Funalot B, 2009, AMYOTROPH LATERAL SC, V10, P113, DOI 10.1080/17482960802295192; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Harlan BA, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113219; Harlan BA, 2019, FASEB J, V33, P7084, DOI 10.1096/fj.201802752R; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kraft AD, 2007, EXP NEUROL, V207, P107, DOI 10.1016/j.expneurol.2007.05.026; Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197; Lim MA, 2014, HUM MOL GENET, V23, P4995, DOI 10.1093/hmg/ddu214; Lundsgaard AM, 2018, TRENDS ENDOCRIN MET, V29, P18, DOI 10.1016/j.tem.2017.10.011; Marin B, 2016, NEURODEGENER DIS, V16, P225, DOI 10.1159/000442444; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Mattis J, 2016, TRENDS ENDOCRIN MET, V27, P192, DOI 10.1016/j.tem.2016.02.003; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Monachelli Gisella Gargiulo, 2011, Horm Mol Biol Clin Investig, V6, P167, DOI 10.1515/HMBCI.2011.006; Morselli LL, 2006, CLIN ENDOCRINOL, V65, P385, DOI 10.1111/j.1365-2265.2006.02609.x; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Patacchioli FR, 2003, J ENDOCRINOL INVEST, V26, pRC23, DOI 10.1007/BF03349149; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2016, CELL METAB, V24, P462, DOI 10.1016/j.cmet.2016.07.024; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Spataro R, 2015, J NEUROL SCI, V358, P282, DOI 10.1016/j.jns.2015.09.011; Spiga F, 2015, MOL CELL ENDOCRINOL, V408, P227, DOI 10.1016/j.mce.2015.02.005; Steyn FJ, 2012, ENDOCRINOLOGY, V153, P3735, DOI 10.1210/en.2011-2171; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tevy MF, 2013, TRENDS ENDOCRIN MET, V24, P229, DOI 10.1016/j.tem.2012.12.002; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vargas MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056625; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Videnovic A, 2014, NAT REV NEUROL, V10, P683, DOI 10.1038/nrneurol.2014.206; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wible RS, 2018, ELIFE, V7, DOI 10.7554/eLife.31656; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	75	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21343	10.1096/fj.202000386RR	http://dx.doi.org/10.1096/fj.202000386RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508151	Green Accepted, Bronze			2022-12-26	WOS:000647789600030
J	Nelson, JW; Phillips, SC; Ganesh, BP; Petrosino, JF; Durgan, DJ; Bryan, RM				Nelson, James W.; Phillips, Sharon C.; Ganesh, Bhanu P.; Petrosino, Joseph F.; Durgan, David J.; Bryan, Robert M.			The gut microbiome contributes to blood-brain barrier disruption in spontaneously hypertensive stroke prone rats	FASEB JOURNAL			English	Article						cerebral small vessel disease; gut microbiome; hypertension; microbiota&#8208; gut&#8208; brain axis; vascular cognitive impairment; vascular dementia; white matter disease	SMALL VESSEL DISEASE; WHITE-MATTER; MODEL; PATHOGENESIS; DYSFUNCTION; SHIFT	In recent years, it has become apparent that the gut microbiome can influence the functioning and pathological states of organs and systems throughout the body. In this study, we tested the hypothesis that the gut microbiome has a major role in the disruption of the blood-brain barrier (BBB) in the spontaneously hypertensive stroke prone rats (SHRSP), an animal model for hypertensive cerebral small vessel disease (CSVD). Loss of BBB is thought to be an early and initiating component to the full expression of CSVD in animal models and humans. To test this hypothesis, newly born SHRSP pups were placed with foster dams of the SHRSP strain or dams of the WKY strain, the control strain that does not demonstrate BBB dysfunction or develop hypertensive CSVD. Similarly, WKY pups were placed with foster dams of the same or opposite strain. The rationale for cross fostering is that the gut microbiomes are shaped by environmental bacteria of the foster dam and the nesting surroundings. Analysis of the bacterial genera in feces, using 16S rRNA analysis, demonstrated that the gut microbiome in the rat pups was influenced by the foster dam. SHRSP offspring fostered on WKY dams had systolic blood pressures (SBPs) that were significantly decreased by 26 mmHg (P < .001) from 16-20 weeks, compared to SHRSP offspring fostered on SHRSP dams. Similarly WKY offspring fostered on SHRSP dams had significantly increased SBP compared to WKY offspring fostered on WKY dams, although the magnitude of SBP change was not as robust. At ~20 weeks of age, rats fostered on SHRSP dams showed enhanced inflammation in distal ileum regardless of the strain of the offspring. Disruption of BBB integrity, an early marker of CSVD onset, was improved in SHRSPs that were fostered on WKY dams when compared to the SHRSP rats fostered on SHRSP dams. Although SHRSP is a genetic model for CSVD, environmental factors such as the gut microbiota of the foster dam have a major influence in the loss of BBB integrity.	[Nelson, James W.; Phillips, Sharon C.; Durgan, David J.; Bryan, Robert M.] Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; [Nelson, James W.] Baylor Coll Med, Integrated Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Ganesh, Bhanu P.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Durgan, David J.; Bryan, Robert M.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Petrosino, Joseph F.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bryan, RM (corresponding author), Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA.	rbryan@bcm.edu		Ganesh, Bhanu/0000-0003-1575-7914	NCI NIH HHS [P30 CA125123] Funding Source: Medline; NHLBI NIH HHS [R01 HL134838] Funding Source: Medline; NIDDK NIH HHS [P30 DK056338] Funding Source: Medline; NIGMS NIH HHS [T32 GM008231] Funding Source: Medline; NINDS NIH HHS [R01 NS102594, R21 NS094806, R56 NS102594] Funding Source: Medline; HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK56338 to the Texas Medical Center Digestive Disease Center] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)		Adnan S, 2017, PHYSIOL GENOMICS, V49, P96, DOI 10.1152/physiolgenomics.00081.2016; Bailey EL, 2011, NEUROPATH APPL NEURO, V37, P711, DOI 10.1111/j.1365-2990.2011.01170.x; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bridges LR, 2014, J NEUROPATH EXP NEUR, V73, P1026, DOI 10.1097/NEN.0000000000000124; Brittain JF, 2013, J CEREBR BLOOD F MET, V33, P760, DOI 10.1038/jcbfm.2013.14; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Daft JG, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0080-y; Durgan DJ, 2019, STROKE, V50, P2270, DOI 10.1161/STROKEAHA.119.025140; Durgan DJ, 2016, HYPERTENSION, V67, P469, DOI 10.1161/HYPERTENSIONAHA.115.06672; Faraco G, 2018, NAT NEUROSCI, V21, P240, DOI 10.1038/s41593-017-0059-z; FREDRIKSSON K, 1987, ACTA NEUROPATHOL, V74, P259, DOI 10.1007/BF00688190; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Ganesh BP, 2018, HYPERTENSION, V72, P1141, DOI 10.1161/HYPERTENSIONAHA.118.11695; Ihara M, 2016, STROKE, V47, P554, DOI 10.1161/STROKEAHA.115.009627; Jalal FY, 2015, J CEREBR BLOOD F MET, V35, P1145, DOI 10.1038/jcbfm.2015.21; Kim MS, 2020, GUT, V69, P283, DOI 10.1136/gutjnl-2018-317431; Krafft PR, 2012, INT J STROKE, V7, P398, DOI 10.1111/j.1747-4949.2012.00838.x; Marini S, 2020, STROKE, V51, P12, DOI 10.1161/STROKEAHA.119.024151; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Osadchiy V, 2019, CLIN GASTROENTEROL H, V17, P322, DOI 10.1016/j.cgh.2018.10.002; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Pasi M, 2020, STROKE, V51, P47, DOI 10.1161/STROKEAHA.119.024148; Rosenberg GA, 2016, J CEREBR BLOOD F MET, V36, P6, DOI 10.1038/jcbfm.2015.172; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sanchez-Rodriguez E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030605; Schmidtke K, 2005, J NEUROL SCI, V229, P13, DOI 10.1016/j.jns.2004.11.048; Schrijver IA, 2001, BRAIN, V124, P1544, DOI 10.1093/brain/124.8.1544; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Tonomura S, 2020, J CEREBR BLOOD F MET, V40, P1368, DOI 10.1177/0271678X20918031; Toral M, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13285; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Weaver CT, 2013, ANNU REV PATHOL-MECH, V8, P477, DOI 10.1146/annurev-pathol-011110-130318; Welling MM, 2015, ALZHEIMERS DEMENT, V11, P51, DOI 10.1016/j.jalz.2013.12.020; YAMORI Y, 1977, STROKE, V8, P456, DOI 10.1161/01.STR.8.4.456	36	14	14	4	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21201	10.1096/fj.202001117R	http://dx.doi.org/10.1096/fj.202001117R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496989	Green Accepted			2022-12-26	WOS:000647789600065
J	Meneguci, CAG; Meneguci, J; Sasaki, JE; Tribess, S; Virtuoso, JS				Garcia Meneguci, Cintia Aparecida; Meneguci, Joilson; Sasaki, Jeffer Eidi; Tribess, Sheilla; Virtuoso Junior, Jair Sindra			Physical activity, sedentary behavior and functionality in older adults: A cross-sectional path analysis	PLOS ONE			English	Article							INSTRUMENTAL ACTIVITIES; SELF-ESTEEM; CARDIORESPIRATORY FITNESS; ACTIVITY INTERVENTION; COMBINED ASSOCIATIONS; DEPRESSIVE SYMPTOMS; ELDERLY POPULATION; NUTRITIONAL-STATUS; DISABILITY; RISK	Disability is negatively associated with the health of older adults, and it can be mediated by healthy lifestyles and behaviors throughout one's life. In this context, understanding the interrelationships between sedentary behavior, physical activity and functionality may assist in the implementation of effective public health actions. Thus, the aim of the present study was to investigate the relationships between both physical activity and sedentary behavior and functionality in older adults and the possible mediators. The variables analyzed were selected according to the content analysis of International Classification of Functioning, Disability and Health model, and included activity, participation, health conditions, body functions and structures, environmental factors and personal factors. 419 individuals participated in the study. Physical activity was directly associated with disability in instrumental activities of daily living (IADL), and the association was mediated by self-esteem, aerobic endurance, and agility/balance. Sedentary behavior was indirectly associated with IADL disability, and the association was mediated by aerobic resistance, nutritional status, and agility/balance. Regarding the basic activities of daily living (BADL), physical activity showed an indirect association mediated by aerobic resistance and IADL. The association of sedentary behavior with BADL was mediated by aerobic resistance and lower limb flexibility. These results reinforce the idea that functionality is multidimensional, and the mediating factors must be considered when strategies for promoting physical activity and reducing sedentary behavior are designed.	[Garcia Meneguci, Cintia Aparecida; Meneguci, Joilson; Virtuoso Junior, Jair Sindra] Fed Univ Triangulo Mineiro UFTM, Grad Program Hlth Care, Uberaba, MG, Brazil; [Sasaki, Jeffer Eidi; Tribess, Sheilla; Virtuoso Junior, Jair Sindra] Fed Univ Triangulo Mineiro UFTM, Grad Program Phys Educ, Uberaba, MG, Brazil	Universidade Federal do Triangulo Mineiro; Universidade Federal do Triangulo Mineiro	Meneguci, CAG (corresponding author), Fed Univ Triangulo Mineiro UFTM, Grad Program Hlth Care, Uberaba, MG, Brazil.	cintiaagar@hotmail.com		Garcia-Meneguci, Cintia Aparecida/0000-0002-5305-4024	Brazilian National Council for Scientific and Technological Development [448184/2014-1]	Brazilian National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Brazilian National Council for Scientific and Technological Development according to the MCTI/CNPQ/Universal 14/2014 Public Call, process n degrees 448184/2014-1, under the concession of researcher Jair Sindra Virtuoso Junior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LC, 2008, CIENC SAUDE COLETIVA, V13, P1199, DOI 10.1590/S1413-81232008000400016; [Anonymous], 2005, BRAZ J PHYS THER IMP; Artaud F, 2015, J AM GERIATR SOC, V63, P1129, DOI 10.1111/jgs.13442; Auais M, 2016, ARCH GERONTOL GERIAT, V66, P147, DOI 10.1016/j.archger.2016.05.012; Awick EA, 2017, PSYCHOSOM MED, V79, P71, DOI 10.1097/PSY.0000000000000358; Brito LBB, 2013, AM J PHYS MED REHAB, V92, P241, DOI 10.1097/PHM.0b013e3182744203; Beissner KL, 2000, PHYS THER, V80, P556, DOI 10.1093/ptj/80.6.556; Benedetti Tânia R. Bertoldo, 2007, Rev Bras Med Esporte, V13, P11, DOI 10.1590/S1517-86922007000100004; Benedetti TB, 2004, REV BRAS CIENC MOV, V12, P25, DOI DOI 10.18511/RBCM.V12I1.538; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Boyle PA, 2002, INT J GERIATR PSYCH, V17, P164, DOI 10.1002/gps.539; Camilo BD, 2018, REV BRAS MED ESPORTE, V24, P310, DOI 10.1590/1517-869220182404183390; Carter S, 2017, EXERC SPORT SCI REV, V45, P80, DOI 10.1249/JES.0000000000000106; Cebolla EC, 2015, BRAZ J PHYS THER, V19, P146, DOI 10.1590/bjpt-rbf.2014.0085; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chase JAD, 2017, J AGING PHYS ACTIV, V25, P149, DOI 10.1123/japa.2016-0040; Chen T, 2016, J PHYS ACT HEALTH, V13, P303, DOI 10.1123/jpah.2015-0090; Chief Medical Officers (CMOs) of England Scotland, 2018, START ACT STAY ACT R; Cipriani Natália Cristina Santos, 2010, Rev. bras. cineantropom. desempenho hum., V12, P106, DOI 10.5007/1980-0037.2010v12n2p106; Cooper AJM, 2017, INT J EPIDEMIOL, V46, P141, DOI 10.1093/ije/dyw054; Cooper AJM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126465; Cooper R, 2011, AM J PREV MED, V41, P376, DOI 10.1016/j.amepre.2011.06.035; Corona LP, 2014, PUBLIC HEALTH NUTR, V17, P390, DOI 10.1017/S1368980012005319; Davis MG, 2014, J AGING PHYS ACTIV, V22, P474, DOI [10.1123/japa.2013-0042, 10.1123/JAPA.2013-0042]; de Menezes TN, 2014, CIENC SAUDE COLETIVA, V19, P3451, DOI 10.1590/1413-81232014198.15072013; Medeiros HBD, 2013, AGE, V35, P2399, DOI 10.1007/s11357-013-9525-z; Dodge HH, 2006, J GERONTOL A-BIOL, V61, P1330, DOI 10.1093/gerona/61.12.1330; dos Santos RL., 2008, REV BRAS PROMOC SAUD, V21, P290, DOI [DOI 10.5020/575, 10.5020/575]; Tavares DMD, 2016, CIENC SAUDE COLETIVA, V21, P3557, DOI 10.1590/1413-812320152111.03032016; Dunlop DD, 2015, J PHYS ACT HEALTH, V12, P93, DOI 10.1123/jpah.2013-0311; Dutra FCMS, 2016, BRAZ J PHYS THER, V20, P384, DOI 10.1590/bjpt-rbf.2014.0168; Eriksen L, 2016, SCAND J MED SCI SPOR, V26, P1435, DOI 10.1111/sms.12608; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Goncalves DM, 2008, CAD SAUDE PUBLICA, V24, P380, DOI 10.1590/S0102-311X2008000200017; Gouveia ER, 2013, J AGING PHYS ACTIV, V21, P1, DOI 10.1123/japa.21.1.1; Guigoz Y, 2006, J NUTR HEALTH AGING, V10, P466; Hardy SE, 2011, J GEN INTERN MED, V26, P130, DOI 10.1007/s11606-010-1543-2; Heiland EG, 2016, AGE AGEING, V45, P812, DOI 10.1093/ageing/afw076; Hobbs M, 2015, BRIT J SPORT MED, V49, P1179, DOI 10.1136/bjsports-2014-093754; Houston DK, 2005, AM J CLIN NUTR, V81, P515; IBGE, 2018, PORT IBGE; Jin YC, 2019, J AGING HEALTH, V31, P1339, DOI 10.1177/0898264318778417; Jin YC, 2017, J GERONTOL A-BIOL, V72, P1710, DOI 10.1093/gerona/glw329; Jung HG, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0120-8; Kahraman T, 2021, PHYSIOTHER THEOR PR, V37, P527, DOI 10.1080/09593985.2019.1633715; Knaeps S, 2018, BRIT J SPORT MED, V52, P1063, DOI 10.1136/bjsports-2016-096083; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Kohler Renan, 2016, Rev. bras. geriatr. gerontol., V19, P603, DOI 10.1590/1809-98232016019.150092; Kulinski JP, 2014, MAYO CLIN PROC, V89, P1063, DOI 10.1016/j.mayocp.2014.04.019; Kulmala J, 2019, J AM GERIATR SOC, V67, P1138, DOI 10.1111/jgs.15837; Levy BR, 2012, JAMA-J AM MED ASSOC, V308, P1972, DOI 10.1001/jama.2012.14541; Liao Y, 2016, INT J BEHAV MED, V23, P402, DOI 10.1007/s12529-015-9484-0; Lin SI, 2017, J FORMOS MED ASSOC, V116, P72, DOI 10.1016/j.jfma.2016.01.011; Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P713, DOI [10.5123/S1679-49742016000400005, 10.5123/s1679-49742016000400005]; Matos FS, 2018, CIENC SAUDE COLETIVA, V23, P3393, DOI 10.1590/1413-812320182310.23382016; McAuley Edward, 2005, J Gerontol B Psychol Sci Soc Sci, V60, pP268; McMullan II, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5265-4; Meneguci Joilson, 2015, Motri., V11, P160, DOI 10.6063/motricidade.3178; Mesa-Fernandez M, 2019, CIENC SAUDE COLETIVA, V24, P115, DOI 10.1590/1413-81232018241.35302016; Meurer ST., 2015, REV BRAS ATIV FISICA, V20, P57, DOI [10.12820/rbafs.v.20n1p57, DOI 10.12820/RBAFS.V.20N1P57]; Michele J, 2019, AGING MENT HEALTH, V23, P77, DOI 10.1080/13607863.2017.1394442; Milanovic Z, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S44112; Miranda Gabriella Morais Duarte, 2016, Rev. bras. geriatr. gerontol., V19, P507, DOI 10.1590/1809-98232016019.150140; de Castro KCM, 2008, ARQ NEURO-PSIQUIAT, V66, P809, DOI 10.1590/S0004-282X2008000600006; Nonaka H, 2002, GAIT POSTURE, V15, P236, DOI 10.1016/S0966-6362(01)00191-6; Nourhashemi F, 2001, J GERONTOL A-BIOL, V56, pM448, DOI 10.1093/gerona/56.7.M448; O'Keeffe M, 2019, CLIN NUTR, V38, P2477, DOI 10.1016/j.clnu.2018.12.007; Opdenacker J, 2009, J SPORT EXERCISE PSY, V31, P743, DOI 10.1123/jsep.31.6.743; Oppewal A, 2015, RES DEV DISABIL, V41-42, P76, DOI 10.1016/j.ridd.2015.05.002; Oppewal A, 2014, RES DEV DISABIL, V35, P2299, DOI 10.1016/j.ridd.2014.05.027; Orr R, 2010, EUR J PHYS REHAB MED, V46, P183; Persson M, 2007, CLIN NUTR, V26, P216, DOI 10.1016/j.clnu.2006.12.002; Pollard B, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-97; Rabiee R, 2015, J EPIDEMIOL COMMUN H, V69, P266, DOI 10.1136/jech-2014-204851; Reid N, 2018, OSTEOPOROSIS INT, V29, P1341, DOI 10.1007/s00198-018-4428-6; Reynolds SL, 2003, SOC SCI MED, V57, P1875, DOI 10.1016/S0277-9536(03)00053-4; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Sampaio RF, 2009, CAD SAUDE PUBLICA, V25, P475, DOI 10.1590/S0102-311X2009000300002; Sani SHZ, 2016, NEUROPSYCH DIS TREAT, V12, DOI 10.2147/NDT.S116811; Santos DA, 2012, EXP GERONTOL, V47, P908, DOI 10.1016/j.exger.2012.07.011; Santos DAT, 2017, ISSUES MENT HEALTH N, V38, P272, DOI 10.1080/01612840.2016.1263695; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Sardinha LB, 2015, J GERONTOL A-BIOL, V70, P119, DOI 10.1093/gerona/glu193; Sekaran NK, 2013, J AM GERIATR SOC, V61, P96, DOI 10.1111/jgs.12071; Shephard RJ, 2009, BRIT J SPORT MED, V43, P342, DOI 10.1136/bjsm.2007.044800; Sowa A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1520-5; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Stathokostas Liza, 2013, J Aging Res, V2013, P743843, DOI 10.1155/2013/743843; Storeng SH, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018942; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Toraman A, 2010, ARCH GERONTOL GERIAT, V51, P222, DOI 10.1016/j.archger.2009.10.012; Van der Horst K, 2007, MED SCI SPORT EXER, V39, P1241, DOI 10.1249/mss.0b013e318059bf35; van der Velde JHPM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00242; Vaughan L, 2010, PSYCHOL AGING, V25, P343, DOI 10.1037/a0017729; Virtuoso JS, 2012, REV LAT-AM ENFERM, V20, P259, DOI 10.1590/S0104-11692012000200007; Volkert D, 2011, WIEN MED WOCHENSCHR, V161, P409, DOI 10.1007/s10354-011-0910-x; von Bonsdorff MB, 2011, EUR REV AGING PHYS A, V8, P23, DOI 10.1007/s11556-010-0070-9; Wang BWE, 2002, ARCH INTERN MED, V162, P2285, DOI 10.1001/archinte.162.20.2285; WHO, 2001, WHO INT CLASS FUNCT	100	13	13	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246275	10.1371/journal.pone.0246275	http://dx.doi.org/10.1371/journal.pone.0246275			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QB1HB	33513196	gold, Green Published			2022-12-26	WOS:000613891400035
J	You, BS; Sun, Y; Luo, J; Wang, KL; Liu, Q; Fang, RZ; Liu, BM; Chou, FJ; Wang, RH; Meng, JL; Huang, CP; Yeh, SY; Chang, CS; Xu, WH				You, Bosen; Sun, Yin; Luo, Jie; Wang, Keliang; Liu, Qing; Fang, Ruizhe; Liu, Bingmei; Chou, Fuju; Wang, Ronghao; Meng, Jialin; Huang, Chi-Ping; Yeh, Shuyuan; Chang, Chawnshang; Xu, Wanhai			Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR	ONCOGENE			English	Article							MESSENGER-RNA DECAY; LONG NONCODING RNAS; GASTRIC-CANCER; METASTASIS; PATTERNS; UPF1	While the androgen receptor (AR) may influence the progression of clear cell renal cell carcinoma (ccRCC), its role to impact vasculogenic mimicry (VM) to alter the ccRCC progression and metastasis remains obscure. Here, we demonstrated that elevated AR expression was positively correlated with tumor-originated vasculogenesis in ccRCC patients. Consistently, in vitro research revealed AR promoted VM formation in ccRCC cell lines via modulating lncRNA-TANAR/TWIST1 signals. Mechanism dissection showed that AR could increase lncRNA-TANAR (TANAR) expression through binding to the androgen response elements (AREs) located in its promoter region. Moreover, we found that TANAR could impede nonsense-mediated mRNA decay (NMD) of TWIST1 mRNA by direct interaction with TWIST1 5'UTR. A preclinical study using in vivo mouse model with orthotopic xenografts of ccRCC cells further confirmed the in vitro data. Together, these results illustrated that AR-mediated TANAR signals might play a crucial role in ccRCC VM formation and metastasis, and targeting this newly identified AR/TANAR/TWIST1 signaling may help in the development of a novel anti-angiogenesis therapy to better suppress the ccRCC progression.	[You, Bosen; Wang, Keliang; Fang, Ruizhe; Xu, Wanhai] Harbin Med Univ, Affiliated Hosp 4, Dept Urol, Harbin 150001, Peoples R China; [You, Bosen; Liu, Qing] Harbin Med Univ, Affiliated Hosp 2, Dept Urol, Harbin 150001, Peoples R China; [You, Bosen; Sun, Yin; Luo, Jie; Wang, Keliang; Liu, Qing; Fang, Ruizhe; Chou, Fuju; Wang, Ronghao; Meng, Jialin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14646 USA; [You, Bosen; Sun, Yin; Luo, Jie; Wang, Keliang; Liu, Qing; Fang, Ruizhe; Chou, Fuju; Wang, Ronghao; Meng, Jialin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14646 USA; [You, Bosen; Sun, Yin; Luo, Jie; Wang, Keliang; Liu, Qing; Fang, Ruizhe; Chou, Fuju; Wang, Ronghao; Meng, Jialin; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14646 USA; [Liu, Bingmei] Heilongjiang Prov Hosp, Dept Pathol & Cutaneous Oncol, Harbin 150001, Peoples R China; [Huang, Chi-Ping; Chang, Chawnshang] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan; [Huang, Chi-Ping; Chang, Chawnshang] China Med Univ Hosp, Dept Urol, Taichung 404, Taiwan	Harbin Medical University; Harbin Medical University; University of Rochester; University of Rochester; University of Rochester; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Xu, WH (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Dept Urol, Harbin 150001, Peoples R China.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14646 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14646 USA.; Chang, CS (corresponding author), Univ Rochester, Med Ctr, Wilmot Canc Inst, Rochester, NY 14646 USA.; Chang, CS (corresponding author), China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan.; Chang, CS (corresponding author), China Med Univ Hosp, Dept Urol, Taichung 404, Taiwan.	chang@urmc.rochester.edu; xuwanhai@hrbmu.edu.cn	Wang, Ronghao/AAV-9769-2021; You, Bosen/AHC-2523-2022; Meng, Jialin/L-8480-2019; liu, qingqing/HHD-0360-2022	Meng, Jialin/0000-0002-4622-833X; you, bosen/0000-0002-9037-2136; Chang, Chawnshang/0000-0001-8510-3516	NIH [CA155477]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant (CA155477).	Adelaiye-Ogala R, 2018, CANCER RES, V78, P2886, DOI 10.1158/0008-5472.CAN-17-3386; Bai J, 2018, J UROLOGY, V199, pE1200; Bao ZQ, 2018, INT J CLIN EXP PATHO, V11, P3656; Cao LM, 2017, ELIFE, V6, DOI 10.7554/eLife.30433; Cui YF, 2015, ONCOTARGET, V6, P11087, DOI 10.18632/oncotarget.3571; Delgado-Bellido D, 2019, CELL DEATH DIFFER, V26, P348, DOI 10.1038/s41418-018-0125-4; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Flippot R, 2019, NAT REV UROL, V16, P484, DOI 10.1038/s41585-019-0195-1; Franks TM, 2010, CELL, V143, P938, DOI 10.1016/j.cell.2010.11.043; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gong WC, 2016, ONCOTARGET, V7, P70152, DOI 10.18632/oncotarget.12161; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guo JQ, 2018, MOL THER-NUCL ACIDS, V10, P170, DOI 10.1016/j.omtn.2017.11.011; Han SH, 2020, MOL ONCOL, V14, P1074, DOI 10.1002/1878-0261.12631; Hendrix MJC, 2016, PHARMACOL THERAPEUT, V159, P83, DOI 10.1016/j.pharmthera.2016.01.006; Hendrix MJC, 2003, NAT REV CANCER, V3, P411, DOI 10.1038/nrc1092; Higgins JPT, 2003, AM J PATHOL, V162, P925, DOI 10.1016/S0002-9440(10)63887-4; Hu ZY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15943; Huang QB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00701-6; Imamachi N, 2017, GENOME RES, V27, P407, DOI 10.1101/gr.206060.116; Karam R, 2008, ONCOGENE, V27, P4255, DOI 10.1038/onc.2008.62; Khatiwada P, 2020, PEERJ, V8, DOI 10.7717/peerj.8921; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kotecha RR, 2019, NAT REV CLIN ONCOL, V16, P621, DOI 10.1038/s41571-019-0209-1; Li R.-H., 2018, CELL DEATH DIS, V9, P1, DOI DOI 10.1038/s41419-017-0012-9; Lopez D, 2009, ARCH BIOCHEM BIOPHYS, V482, P77, DOI 10.1016/j.abb.2008.11.016; Lucca I, 2015, NAT REV UROL, V12, P585, DOI 10.1038/nrurol.2015.232; Luo J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09784-9; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Melero R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10585; Meng J, 2019, ONCOGENE, V38, P228, DOI 10.1038/s41388-018-0428-4; Motzer RJ, 2013, NEW ENGL J MED, V369, P722, DOI 10.1056/NEJMoa1303989; Popp MW, 2018, CURR OPIN GENET DEV, V48, P44, DOI 10.1016/j.gde.2017.10.007; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Rasti A, 2018, CLIN EXP MED, V18, P177, DOI 10.1007/s10238-017-0481-2; Serova M, 2016, ONCOTARGET, V7, P38467, DOI 10.18632/oncotarget.9542; Shang ZQ, 2019, NUCLEIC ACIDS RES, V47, P4211, DOI 10.1093/nar/gkz108; Sun T, 2011, HEPATOLOGY, V54, P1690, DOI 10.1002/hep.24543; Tao W, 2018, BIOCHEM BIOPH RES CO, V504, P629, DOI 10.1016/j.bbrc.2018.08.122; Vartanian AA, 2009, CAN J UROL, V16, P4726; Velez DO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01556-7; Wang CF, 2019, P NATL ACAD SCI USA, V116, P14620, DOI 10.1073/pnas.1903432116; Wang KF, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1330-x; Wang L, 2015, ONCOTARGET, V6, P11492, DOI 10.18632/oncotarget.3416; Xia Y, 2019, INT J CANCER, V144, P2227, DOI 10.1002/ijc.31958; Xiao T, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0902-5; Xie XN, 2019, CLIN SCI, V133, P1457, DOI 10.1042/CS20181061; Yang J, 2017, ONCOTARGET, V8, P47801, DOI 10.18632/oncotarget.17999; Yochum ZA, 2019, ONCOGENE, V38, P656, DOI 10.1038/s41388-018-0482-y; Yochum ZA, 2017, MOL CANCER RES, V15, P1764, DOI 10.1158/1541-7786.MCR-17-0298; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhai W, 2017, CELL DEATH DIFFER, V24, P1502, DOI 10.1038/cdd.2017.74; Zhang JX, 2017, ONCOTARGETS THER, V10, P2923, DOI 10.2147/OTT.S135477; Zhang YH, 2013, J SURG ONCOL, V108, P414, DOI 10.1002/jso.23402; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542; Zund D, 2013, NAT STRUCT MOL BIOL, V20, P936, DOI 10.1038/nsmb.2635	59	11	11	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1674	1689		10.1038/s41388-020-01616-1	http://dx.doi.org/10.1038/s41388-020-01616-1		JAN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33510354	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000612563100003
J	Amornsriwatanakul, A; Lester, L; Rosenberg, M; Bull, F				Amornsriwatanakul, Areekul; Lester, Leanne; Rosenberg, Michael; Bull, Fiona			School policies and practices associated with Thai children's overall and domain specific physical activity	PLOS ONE			English	Article							REPORT CARD GRADES; SEDENTARY BEHAVIOR; ENVIRONMENT; YOUTH; EDUCATION	School has a significant role in providing opportunities for children to engage in physical activity (PA) through policies and practices. This study aimed to identify the prevalence of school policies and practices related to physical activity (PA) and their association with Thai students' overall and domain specific PA. This cross-sectional analysis included 5,830 students aged 6-17 years from 136 schools recruited though a multi-stage stratified cluster sampling across Thailand. Student's PA data were assessed using a student survey and school data were collected by a principal survey. Associations between students' PA and school variables were examined using logistic regressions. Despite a high prevalence of Thai schools reporting many policies and practices promoting PA in different areas, students reported low levels of PA. None of the school PA policies and practices was associated with students' overall and domain specific activities, with active transport as the one exception. When schools had an active transport policy, students were 40% (OR = 1.40, p = 0.01) more likely to travel actively to/from school. The identified positive relationship between school active transport policy and students' active travel behavior suggests a potential wider adoption of the policy promoting school active transport aiming to increase student's PA levels among all Thai schools. Intervention studies are necessary to confirm this finding. Our study also reflected that, for greater levels of children's school-based PA, strategies to translate the existing school PA policies into effective implementation should be an emphasis for Thai schools.	[Amornsriwatanakul, Areekul] Mahidol Univ, Coll Sports Sci & Technol, Phutthamonthon, Nakhon Pathom, Thailand; [Amornsriwatanakul, Areekul; Lester, Leanne; Rosenberg, Michael] Univ Western Australia, Sch Human Sci Exercise & Sport Sci, Perth, WA, Australia; [Bull, Fiona] Univ Western Australia, Ctr Built Environm & Hlth, Sch Human Sci, Perth, WA, Australia	Mahidol University; University of Western Australia; University of Western Australia	Amornsriwatanakul, A (corresponding author), Mahidol Univ, Coll Sports Sci & Technol, Phutthamonthon, Nakhon Pathom, Thailand.; Amornsriwatanakul, A (corresponding author), Univ Western Australia, Sch Human Sci Exercise & Sport Sci, Perth, WA, Australia.	areekulk@gmail.com			Thai Health Promotion Foundation	Thai Health Promotion Foundation	The authors thank Thai Health Promotion Foundation for the research funding granted and managed through Thailand Physical Activity Research Centre (PARC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajja R, 2014, PREV MED, V69, pS49, DOI 10.1016/j.ypmed.2014.09.010; Amornsriwatanakul A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0529-4; Amornsriwatanakul A, 2016, J PHYS ACT HEALTH, V13, pS291, DOI 10.1123/jpah.2016-0316; [Anonymous], 2010, NUMB STUD LEV PROV 2; Aubert S, 2018, J PHYS ACT HEALTH, V15, pS251, DOI 10.1123/jpah.2018-0472; AUDREY S, 2014, EUR J PUBLIC HLTH S2, V20, DOI DOI 10.1093/EURPUB/CKU165.054; Beets MW, 2013, HEALTH EDUC BEHAV, V40, P296, DOI 10.1177/1090198112459051; Children and Youth Physical Activity Studies (CYPAS), 2019, THAIL PHYS ACT CHILD; Department of Health, 2019, PHYS ACT POL PROP NA, P66; Durant N, 2009, J SCHOOL HEALTH, V79, P153, DOI 10.1111/j.1746-1561.2008.00384.x; Faber L, 2007, JOPERD, V78, P1; Faulkner G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-20; Ferreira I, 2007, OBES REV, V8, P129, DOI 10.1111/j.1467-789X.2006.00264.x; Galan I, 2014, PREV SCI, V15, P588, DOI 10.1007/s11121-013-0407-5; Ganzar LA, 2019, J PHYS ACT HEALTH, V16, P340, DOI 10.1123/jpah.2018-0057; Hardman K, 2008, KINESIOLOGY, V40, P5; Haug E, 2010, HEALTH PROMOT INT, V25, P63, DOI 10.1093/heapro/dap040; Hobin E, 2012, INT J PUBLIC HEALTH, V57, P699, DOI 10.1007/s00038-012-0336-2; Hollein T, 2017, J TRANSP HEALTH, V6, P306, DOI 10.1016/j.jth.2017.07.008; Katzmarzyk PT, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-900; Larouche R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-497; Lee H, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0165-9; Lounsbery M.A.F., 2017, KINESIOLOGY REV, V6, P51, DOI [10.1123/kr.2016-0038, DOI 10.1123/KR.2016-0038, https://doi.org/10.1123/kr.2016-0038]; Lounsbery MAF, 2019, TRANSL J AM COLL SPO, V4, P173, DOI 10.1249/TJX.0000000000000103; Lounsbery MAF, 2013, J PHYS ACT HEALTH, V10, P496, DOI 10.1123/jpah.10.4.496; de Rezende LFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131342; Martin K, 2014, J PHYS ACT HEALTH, V11, P553, DOI 10.1123/jpah.2011-0443; Martin KE, 2010, SCH CLASSROOM CHILD; Ministry of Education, 2008, NAT COR CURR BAS ED; Morgan K, 2016, BMC PUBLIC HEALTH, V16, P1; Morton KL, 2016, OBES REV, V17, P142, DOI 10.1111/obr.12352; Naiman DI, 2015, CAN J PUBLIC HEALTH, V106, pE290, DOI 10.17269/cjph.106.4899; Nichol ME, 2009, J SCHOOL HEALTH, V79, P247, DOI 10.1111/j.1746-1561.2009.00406.x; Puggina A, 2018, EUR J PUBLIC HEALTH, V28, P105, DOI 10.1093/eurpub/ckx174; Punnoose A., 2012, JAMA, V2355; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Schoeppe S, 2013, J SCI MED SPORT, V16, P312, DOI 10.1016/j.jsams.2012.11.001; Tremblay MS, 2016, J PHYS ACT HEALTH, V13, pS343, DOI 10.1123/jpah.2016-0594; UNESCO, 2015, INT CHART PHYS ED PH; UNESCO, 2017, SHS20175 UNESCO REV; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2017, HLTH PROM SCH EXP W; World Health Organization (WHO), 2018, MOR ACT PEOPL HEALTH	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245906	10.1371/journal.pone.0245906	http://dx.doi.org/10.1371/journal.pone.0245906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481937	Green Published, gold			2022-12-26	WOS:000612929300174
J	Compagnon, A; Nguyen, L; Antoun, Z; Stach, B; Zanetti, C; Le Guillou, F				Compagnon, Anne; Nguyen, Laurent; Antoun, Zeina; Stach, Bruno; Zanetti, Christophe; Le Guillou, Frederic			Management of acute COPD exacerbations in France: A qualitative survey in a private practice setting	PLOS ONE			English	Article								Background The current prevalence of chronic obstructive pulmonary disease (COPD) in France is estimated to be 2.6 million and is predicted to increase to 2.8 million by 2025. Presently, there is a lack of data on COPD management within the private healthcare setting. The aim of this study was to investigate the management of COPD exacerbations by pulmonologists within private practices in France. Methods A prospective, online, qualitative survey was distributed to private practice pulmonologists in France. The survey covered all aspects of COPD management from diagnosis and therapeutic management, to secondary prevention and organization of care. Survey responses were collected between 27 January 2018 and 18 June 2018 and all data were summarized descriptively. Results The survey had a response rate of 20.6%, with 116 out of 563 pulmonologists providing responses. Overall, 87.4% of respondents stated that the management of COPD represented over 15% of their total clinical activity. Most respondents indicated that they work closely with general practitioners and a large multidisciplinary team to manage patients with numerous comorbidities. Following a COPD exacerbation, the majority of respondents (78.4%) were in favor of using respiratory-connected devices (class 2a-connected medical device according to the French HAS classification and available on medical prescription) to assist with patient follow-up at home. Conclusions COPD management forms part of the core clinical activity for pulmonologists within the private practice setting in France. Patients with COPD generally have multiple comorbidities and are managed by a multidisciplinary team in line with French guidelines. The use of respiratory-connected devices was highlighted as an important new strategy for improving patient care following a COPD exacerbation.	[Compagnon, Anne] GlaxoSmithKline, Med Dept, Rueil Malmaison, France; [Nguyen, Laurent; Stach, Bruno; Zanetti, Christophe; Le Guillou, Frederic] Assoc Reflex Parcours Soins Milieu Resp, La Rochelle, France; [Antoun, Zeina] GlaxoSmithKline, Global Specialty & Primary Care, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline	Compagnon, A (corresponding author), GlaxoSmithKline, Med Dept, Rueil Malmaison, France.	anne.a.compagnon@gsk.com		Compagnon, Anne/0000-0002-4442-787X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This survey was funded by GlaxoSmithKline, who had a role in the design of the survey, data analysis, data interpretation, and writing of the report. GlaxoSmithKline also provided support in the form of salaries for AC and ZA. The specific roles of these authors are articulated in the 'author contributions' section. Editorial support (in the form of writing assistance, assembling figures, collating author comments, grammatical editing and referencing) was provided by Katie Baker, PhD, at Fishawack Indicia Ltd, UK, and was funded by GlaxoSmithKline.	Burgel PR, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0827-7; Cousse S, 2019, INT J CHRONIC OBSTR, V14, P289, DOI 10.2147/COPD.S178147; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2019, POCK GUID COPD DIAGN; Gulati S, 2017, DRUGS, V77, P651, DOI 10.1007/s40265-017-0713-5; Jouneau S, 2017, REV MAL RESPIR, V34, P282, DOI 10.1016/j.rmr.2017.03.034; Le Guillou F, 2017, REV MAL RESPIR, V34, P410, DOI 10.1016/j.rmr.2017.03.025; Molinari N, 2015, COPD, V12, P621, DOI 10.3109/15412555.2015.1007931; Piquet J, 2013, EUR RESPIR J, V42, P946, DOI 10.1183/09031936.00180312; Raherison C, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0684-7; The Breath Foundation, 2018, MAK COPD PUBL HLTH E, P1	11	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245373	10.1371/journal.pone.0245373	http://dx.doi.org/10.1371/journal.pone.0245373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481869	gold, Green Published			2022-12-26	WOS:000612929300148
J	Fattahi, N; Rezaei, N; Asadi-Lari, M; Yousefi, M; Madadi, Z; Gohari, K; Sheidaei, A; Mohammadi, E; Rezaei, N; Parsaeian, M; Kompani, F; Farzadfar, F				Fattahi, Nima; Rezaei, Negar; Asadi-Lari, Mohsen; Yousefi, Moein; Madadi, Zahra; Gohari, Kimiya; Sheidaei, Ali; Mohammadi, Esmaeil; Rezaei, Nazila; Parsaeian, Mahboubeh; Kompani, Farzad; Farzadfar, Farshad			Hepatocellular carcinoma incidence at national and provincial levels in Iran from 2000 to 2016: A meta-regression analysis	PLOS ONE			English	Article							TRENDS	Background The incidence of Hepatocellular carcinoma (HCC), the most common primary liver cancer with high mortality, is undergoing global change due to evolving risk factor profiles. We aimed to describe the epidemiologic incidence of HCC in Iran by sex, age, and geographical distribution from 2000 to 2016. Methods We used the Iran Cancer Registry to extract cancer incidence data and applied several statistical procedures to overcome the dataset's incompleteness and misclassifications. Using Spatio-temporal and random intercept mixed effect models, we imputed missing values for cancer incidence by sex, age, province, and year. Besides, we addressed case duplicates and geographical misalignments in the data. Results Age-standardized incidence rate (ASIR) increased 1.17 times from 0.57 (95% UI: 0.37-0.78) per 100,000 population in 2000 to 0.67 (0.50-0.85) in 2016. It had a 21.8% total percentage change increase during this time, with a 1.28 annual percentage change in both sexes. Male to female ASIR ratio was 1.51 in 2000 and 1.57 in 2016. Overall, after the age of 50 years, HCC incidence increased dramatically with age and increased from 1.19 (0.98-1.40) in the 50-55 age group to 6.65 (5.45-7.78) in the >85 age group. The geographical distribution of this cancer was higher in the central, southern, and southwestern regions of Iran. Conclusion The HCC incidence rate increased from 2000 to 2016, with a more significant increase in subgroups such as men, individuals over 50 years of age, and the central, southern, and southwestern regions of the country. We recommend health planners and policymakers to adopt more preventive and screening strategies for high-risk populations and provinces in Iran.	[Fattahi, Nima; Rezaei, Negar; Yousefi, Moein; Madadi, Zahra; Mohammadi, Esmaeil; Rezaei, Nazila; Farzadfar, Farshad] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran; [Rezaei, Negar; Farzadfar, Farshad] Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran; [Asadi-Lari, Mohsen] Iran Univ Med Sci, Sch Publ Hlth, Dept Epidemiol, Tehran, Iran; [Asadi-Lari, Mohsen] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran; [Gohari, Kimiya] Tarbiat Modares Univ, Fac Med Sci, Dept Biostat, Tehran, Iran; [Sheidaei, Ali; Parsaeian, Mahboubeh] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Kompani, Farzad] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Ctr Excellence, Div Hematol & Oncol, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Tarbiat Modares University; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Farzadfar, F (corresponding author), Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Populat Sci Inst, Tehran, Iran.; Farzadfar, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Clin Sci Inst, Endocrinol & Metab Res Ctr, Tehran, Iran.	f-farzadfar@turns.ac.ir	gohari, kimiya/GLU-7941-2022; Mohammadi, Esmaeil/AAO-6835-2020; Rezaei, Negar/AAS-8147-2020; Sheidaei, Ali/AAU-2165-2020; Fattahi, Nima/ABG-6252-2021; fattahi, nima/Q-2280-2016; Gohari, Kimiya/AAD-9042-2019	gohari, kimiya/0000-0001-5792-7956; Mohammadi, Esmaeil/0000-0001-9592-2611; Rezaei, Negar/0000-0001-7047-7638; Sheidaei, Ali/0000-0002-0480-5768; fattahi, nima/0000-0002-5518-3129; Gohari, Kimiya/0000-0001-5792-7956; Farzadfar, Farshad/0000-0001-8288-4046				Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Alavian SM, 2016, RELATIVE IMPORTANCE; Beal EW, 2018, WORLD J SURG, V42, P835, DOI 10.1007/s00268-017-4194-1; Fattahi N., 2018, Govaresh, V23, P107; Gao S, 2012, EUR J EPIDEMIOL, V27, P39, DOI 10.1007/s10654-011-9636-8; Hajizadeh N, 2017, WORLD J HEPATOL, V9, P704, DOI 10.4254/wjh.v9.i15.704; Hassanipour S, 2019, J GASTROINTEST CANC, V50, P193, DOI 10.1007/s12029-019-00207-y; Hosseini SYS, 2011, HEPAT MON, V11, P666, DOI 10.5812/kowsar.1735143X.710; Jepsen P, 2017, LIVER INT, V37, P871, DOI 10.1111/liv.13340; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; Moghaddam SD, 2010, HEPAT MON, V10, P270; Parker C, 2014, MED J AUSTRALIA, V201, P470, DOI 10.5694/mja13.11117; Pascual S, 2019, WORLD J CLIN CASES, V7, P2269, DOI 10.12998/wjcc.v7.i16.2269; Rich NE, 2020, CLIN GASTROENTEROL H, V18, P242, DOI 10.1016/j.cgh.2019.04.043; Roy N, INT J PHARM SCI RES; Shabani M, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01428; Wallace MC, 2019, LIVER INT, V39, P522, DOI 10.1111/liv.13966; White DL, 2017, GASTROENTEROLOGY, V152, P812, DOI 10.1053/j.gastro.2016.11.020; Yeesoonsang S, 2017, CANCER RES TREAT, V49, P54, DOI 10.4143/crt.2016.045	20	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245468	10.1371/journal.pone.0245468	http://dx.doi.org/10.1371/journal.pone.0245468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481849	Green Published, gold			2022-12-26	WOS:000612929300157
J	Johnson, DK; Reynolds, KM; Poole, BD; Montierth, MD; Todd, VM; Barnado, A; Davis, MF				Johnson, Deborah K.; Reynolds, Kaylia M.; Poole, Brian D.; Montierth, Matthew D.; Todd, Vera M.; Barnado, April; Davis, Mary F.			Contribution of viral infection to risk for cancer in systemic lupus erythematosus and multiple sclerosis	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; BREAST-CANCER; LYMPHOMA	Patients with autoimmune disorders (AD) have altered cancer risks compared to the general population. Systemic lupus erythematosus and multiple sclerosis lead to a heightened risk for hematological malignancies and decreased risk for breast, ovarian, and prostate malignancies. Often patients with autoimmune disease have dysregulated antiviral immune responses, including against oncogenic viruses. To uncover the relationship between viral incidence and cancer risk in the context of autoimmune disease, we extracted electronic health records (EHR) from Vanderbilt University. ICD-9/10 codes and laboratory values were collected for hematological, lung, anal-vaginal, thyroid, hepatobiliary, bladder, prostate, and breast cancers; and viruses including Epstein Barr virus (EBV), Human papilloma virus (HPV), and Hepatitis A/B/C (Hep). Only viral infections that led to a physician visit or laboratory test were entered into the EMR; therefore, only clinically relevant cases were noted and considered positive in this study. The relationship between virus infection and cancer in an SLE cohort (SLE-cases n = 2,313, and SLE-controls n = 5,702) and an MS cohort (MS-case n = 7,277, MS-control n = 7,277) was examined by multilinear logistic regression. Viral infection was strongly associated with increased risk for cancer overall. SLE and MS patients were more susceptible to all viral infections. MS patients trended toward increased risk for cancers overall, while decreased risk for hormone-based cancers in SLE patients non-significantly reduced their risk for overall cancer. Both SLE and MS patients had increased clinically relevant EBV infection, which was associated with risk for hematological cancers. Preventing viral infections by vaccination may be especially helpful in controlling risk for cancer in SLE and MS patients.	[Johnson, Deborah K.; Reynolds, Kaylia M.; Poole, Brian D.; Montierth, Matthew D.; Todd, Vera M.; Davis, Mary F.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Barnado, April] Vanderbilt Univ, Med Ctr, Div Rheumatol & Immunol, Nashville, TN USA; [Davis, Mary F.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA	Brigham Young University; Vanderbilt University; Vanderbilt University	Davis, MF (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.; Davis, MF (corresponding author), Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA.	mary_davis@byu.edu	Johnson, Deborah K/AAK-3809-2021	Todd, Vera/0000-0002-3791-9606; Montierth, Matthew/0000-0002-0860-1420; Poole, Brian/0000-0002-3205-640X	NIH/NIAMS [1K08 AR072757-01]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	AB was funded by NIH/NIAMS 1K08 AR072757-01 (Barnado). www.niams.gov The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript No other authors received specific funding for this work.	AbuShakra M, 1996, ARTHRITIS RHEUM, V39, P1050, DOI 10.1002/art.1780390625; Bahmanyar S, 2009, NEUROLOGY, V72, P1170, DOI 10.1212/01.wnl.0000345366.10455.62; Barnado A, 2018, ARTHRIT CARE RES, V70, P1630, DOI 10.1002/acr.23553; Barnado A, 2017, ARTHRIT CARE RES, V69, P687, DOI 10.1002/acr.22989; Bernatsky S, 2017, LUPUS, V26, P311, DOI 10.1177/0961203316664595; Bernatsky S, 2011, INT J CANCER, V129, P2966, DOI 10.1002/ijc.25956; Bernatsky S, 2014, ANN RHEUM DIS, V73, P138, DOI 10.1136/annrheumdis-2012-202099; Bernatsky S, 2013, J AUTOIMMUN, V42, P130, DOI 10.1016/j.jaut.2012.12.009; Bichile T, 2014, CURR OPIN RHEUMATOL, V26, P111, DOI 10.1097/BOR.0000000000000026; Choi MY, 2017, BEST PRACT RES CL RH, V31, P373, DOI 10.1016/j.berh.2017.09.013; Davis MF, 2013, J AM MED INFORM ASSN, V20, pE334, DOI 10.1136/amiajnl-2013-001999; Draborg AH, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6473204; Draborg AH, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000015; Draborg AH, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/370516; Esposito S, 2014, EUR J CLIN MICROBIOL, V33, P1467, DOI 10.1007/s10096-014-2098-7; Gayed M, 2009, LUPUS, V18, P479, DOI 10.1177/0961203309102556; Gladman DD, 2002, LUPUS, V11, P234, DOI 10.1191/0961203302lu170oa; Goobie GC, 2015, CURR OPIN RHEUMATOL, V27, P454, DOI 10.1097/BOR.0000000000000202; Hauser SL, 2013, ANN NEUROL, V74, P317, DOI 10.1002/ana.24009; Huggins ML, 2005, RHEUMATOL INT, V25, P183, DOI 10.1007/s00296-003-0420-2; James JA, 2012, CURR OPIN RHEUMATOL, V24, P383, DOI 10.1097/BOR.0b013e3283535801; Kang KY, 2010, CLIN RHEUMATOL, V29, P381, DOI 10.1007/s10067-009-1332-7; Khaliq W, 2015, BREAST CANCER RES TR, V151, P465, DOI 10.1007/s10549-015-3412-5; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Marrie RA, 2015, MULT SCLER J, V21, P294, DOI 10.1177/1352458514564489; Melamed E, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02954; Mitarnun Winyou, 2002, Journal of the Medical Association of Thailand, V85, P552; Moon UY, 2004, ARTHRITIS RES THER, V6, pR295, DOI 10.1186/ar1181; Moormann AM, 2016, CURR OPIN VIROL, V20, P78, DOI 10.1016/j.coviro.2016.09.006; Niller HH, 2008, AUTOIMMUNITY, V41, P298, DOI 10.1080/08916930802024772; Pender MP, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/189096; PETTERSSON T, 1992, ANN RHEUM DIS, V51, P437, DOI 10.1136/ard.51.4.437; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Schairer C, 2018, INT J CANCER, V142, P1202, DOI 10.1002/ijc.31148; Shannon-Lowe C, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0271; Tsang HHL, 2010, LUPUS, V19, P330, DOI 10.1177/0961203309347921	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0243150	10.1371/journal.pone.0243150	http://dx.doi.org/10.1371/journal.pone.0243150			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481783	Green Published, gold			2022-12-26	WOS:000612929300099
J	Meyer, A; Fermaut, M; Drouin, J; Carbonnel, F; Weill, A				Meyer, Antoine; Fermaut, Marion; Drouin, Jerome; Carbonnel, Franck; Weill, Alain			Drug use for gastrointestinal symptoms during pregnancy: A French nationwide study 2010-2018	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; SUDDEN CARDIAC DEATH; VENTRICULAR-ARRHYTHMIA; HYPEREMESIS GRAVIDARUM; PRESCRIPTION; MANAGEMENT; DOMPERIDONE; MEDICATION; DISEASES; DATABASE	Purpose To describe drug prescription for gastrointestinal symptoms during pregnancy. Methods Using the French national health database, we identified pregnancies ending with a birth between April 2010 and December 2018, in France. We studied prescription of antacids, antispasmodics, antinauseants, laxatives and antidiarrheals during pregnancy, between two trimesters before and two trimesters after delivery. We also assessed hospitalization for gastrointestinal symptoms during pregnancy. Results Among 6,365,471 pregnancies, 4,452,779 (74.0%) received at least one gastrointestinal drug during pregnancy; 2,228,275 (37.0%) received an antacid, 3,096,858 (51.5%) an antispasmodic, 1,861,731 (31.0%) an antinauseant, 919,116 (15.3%) a laxative and 617,808 (10.3%) an antidiarrheal. Prescription of proton pump inhibitors doubled from 12.2% in 2010 to 26.0% in 2018, while domperidone use decreased from 18.3% in 2010 to 2.2% in 2018. In addition, prescription of antacids increased from 7.0% during the trimester before pregnancy to 11.8% during the 1st trimester, 17.0% during the 2nd trimester and 23.4% during the 3rd trimester. Antispasmodic use was 10.6% during the trimester before pregnancy, 23.1% during the 1st trimester, 25.2% during the 2nd trimester and 24.0% during the 3rd trimester. Prescription of antinauseant drugs increased from 5.0% during the trimester before pregnancy to 25.7% during the 1st trimester, then decreased to 6.4% during the 2nd trimester and 3.2% during the 3rd trimester. Nausea/vomiting was the most common cause of hospitalization for gastrointestinal symptoms or diseases during pregnancy, although it accounted for only 1.0% of pregnancies. Conclusions Approximately three-quarters of women use drugs for gastrointestinal symptoms during pregnancy in France. Prescription of gastrointestinal drugs during pregnancy should be the subject of more detailed risk-benefit assessment and recommendations.	[Meyer, Antoine; Drouin, Jerome; Weill, Alain] ANSM CNAM, Epidemiol Produits Sante, GIS EPIPHARE, 42 Bd Liberat, St Denis, France; [Meyer, Antoine; Carbonnel, Franck] Hop Bicetre, AP HP, Le Kremlin Bicetre, France; [Meyer, Antoine; Carbonnel, Franck] Univ Paris Sud, Le Kremlin Bicetre, France; [Fermaut, Marion] Hop Jean Verdier, AP HP, Bondy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	Meyer, A (corresponding author), ANSM CNAM, Epidemiol Produits Sante, GIS EPIPHARE, 42 Bd Liberat, St Denis, France.; Meyer, A (corresponding author), Hop Bicetre, AP HP, Le Kremlin Bicetre, France.; Meyer, A (corresponding author), Univ Paris Sud, Le Kremlin Bicetre, France.	antoinemeyer@gmail.com	Meyer, Antoine/AAZ-6032-2021	Weill, Alain/0000-0001-8687-9092; Meyer, Antoine/0000-0003-1156-9289				Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], 2018, REC INT REL HEARTB P; ANSM: Agence nationale de securite du medicament et des produits de sante, RUPT STOCK VOGALENE; AstraZeneca, 2012, PRIL; Begaud B., DONNE VIE REELLE ENJ; Berard A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219095; Blotiere PO, 2019, NEUROLOGY, V93, pE167, DOI 10.1212/WNL.0000000000007696; Blotiere PO, 2018, PHARMACOEPIDEM DR S, V27, P763, DOI 10.1002/pds.4556; Body C, 2016, GASTROENTEROL CLIN N, V45, P267, DOI 10.1016/j.gtc.2016.02.005; Bottomley C, 2009, BEST PRACT RES CL OB, V23, P549, DOI 10.1016/j.bpobgyn.2008.12.012; Cleary BJ, 2010, PHARMACOEPIDEM DR S, V19, P408, DOI 10.1002/pds.1906; Coste J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74409-x; Damase-Michel C, 2014, THERAPIE, V69, P91, DOI 10.2515/therapie/2014005; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; Diav-Citrin O, 2005, ALIMENT PHARM THER, V21, P269, DOI 10.1111/j.1365-2036.2005.02306.x; Donati S, 2000, EUR J CLIN PHARMACOL, V56, P323, DOI 10.1007/s002280000149; French National Agency for Medicines and Health Products Safety, 2014, AN VENT MED FRANC 20; Gagne JJ, 2008, EUR J CLIN PHARMACOL, V64, P1125, DOI 10.1007/s00228-008-0546-y; Goueslard K, 2020, STUD HEALTH TECHNOL, V270, P213, DOI 10.3233/SHTI200153; Haas DM, 2018, OBSTET GYNECOL, V131, P789, DOI 10.1097/AOG.0000000000002579; Johannes CB, 2010, PHARMACOEPIDEM DR S, V19, P881, DOI 10.1002/pds.2016; Kallen BAJ, 2001, EUR J OBSTET GYN R B, V96, P63, DOI 10.1016/S0301-2115(00)00388-2; Kirchgesner J, 2017, ALIMENT PHARM THER, V45, P37, DOI 10.1111/apt.13835; Lacroix I, 2000, LANCET, V356, P1735, DOI 10.1016/S0140-6736(00)03209-8; Lassalle M, 2020, EUR J CLIN PHARMACOL, V76, P449, DOI 10.1007/s00228-019-02810-1; Li CM, 2020, ALIMENT PHARM THER, V51, P410, DOI 10.1111/apt.15610; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; Matok I, 2012, DIGEST DIS SCI, V57, P699, DOI 10.1007/s10620-011-1940-3; MCBRIDE WG, 1961, LANCET, V2, P1358; McParlin C, 2016, JAMA-J AM MED ASSOC, V316, P1392, DOI 10.1001/jama.2016.14337; Meyer A, 2020, ALIMENT PHARM THER, V52, P1480, DOI 10.1111/apt.16074; Meyer A, 2019, ANN INTERN MED, V170, P99, DOI 10.7326/M18-1512; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; National Health Service (NHS Digital), 2017, PRESCR COST AN ENGL; Olesen C, 2006, EUR J CLIN PHARMACOL, V62, P547, DOI 10.1007/s00228-006-0119-x; Phupong V, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011379.pub2; Quantin C, 2014, J GYNECOL OBST BIO R, V43, P680, DOI 10.1016/j.jgyn.2013.09.004; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Stokholm J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082932; Tuppin P, 2017, REV EPIDEMIOL SANTE, V65, pS149, DOI 10.1016/j.respe.2017.05.004; Tuppin P, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819853790; van der Woude CJ, 2014, GUT, V63, P1014, DOI 10.1136/gutjnl-2013-305418; van Noord C, 2010, DRUG SAFETY, V33, P1003, DOI 10.2165/11536840-000000000-00000; Weill A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2002	45	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245854	10.1371/journal.pone.0245854	http://dx.doi.org/10.1371/journal.pone.0245854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481904	Green Published, gold			2022-12-26	WOS:000612929300020
J	Nowicki, S; deLaurent, ZR; de Villiers, EP; Githinji, G; Charles, KJ				Nowicki, Saskia; deLaurent, Zaydah R.; de Villiers, Etienne P.; Githinji, George; Charles, Katrina J.			The utility of Escherichia coli as a contamination indicator for rural drinking water: Evidence from whole genome sequencing	PLOS ONE			English	Article							POPULATION-STRUCTURE; MICROBIOLOGICAL CONTAMINATION; MICROBIAL-CONTAMINATION; DEVELOPING-COUNTRIES; FECAL CONTAMINATION; GENETIC DIVERSITY; COMMENSAL; SURVIVAL; PERSISTENCE; TEMPERATE	Across the water sector, Escherichia coli is the preferred microbial water quality indicator and current guidance upholds that it indicates recent faecal contamination. This has been challenged, however, by research demonstrating growth of E. coli in the environment. In this study, we used whole genome sequencing to investigate the links between E. coli and recent faecal contamination in drinking water. We sequenced 103 E. coli isolates sampled from 9 water supplies in rural Kitui County, Kenya, including points of collection (n = 14) and use (n = 30). Biomarkers for definitive source tracking remain elusive, so we analysed the phylogenetic grouping, multi-locus sequence types (MLSTs), allelic diversity, and virulence and antimicrobial resistance (AMR) genes of the isolates for insight into their likely source. Phylogroup B1, which is generally better adapted to water environments, is dominant in our samples (n = 69) and allelic diversity differences (z = 2.12, p = 0.03) suggest that naturalised populations may be particularly relevant at collection points with lower E. coli concentrations (< 50 / 100mL). The strains that are more likely to have originated from human and/or recent faecal contamination (n = 50), were found at poorly protected collection points (4 sites) or at points of use (12 sites). We discuss the difficulty of interpreting health risk from E. coli grab samples, especially at household level, and our findings support the use of E. coli risk categories and encourage monitoring that accounts for sanitary conditions and temporal variability.	[Nowicki, Saskia; Charles, Katrina J.] Univ Oxford, Sch Geog & Environm, Oxford, England; [deLaurent, Zaydah R.; de Villiers, Etienne P.; Githinji, George] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [de Villiers, Etienne P.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England; [de Villiers, Etienne P.] Pwani Univ, Dept Publ Hlth, Kilifi, Kenya	University of Oxford; University of Oxford; Pwani University	Nowicki, S (corresponding author), Univ Oxford, Sch Geog & Environm, Oxford, England.	saskia.nowicki@ouce.ox.ac.uk		Nowicki, Saskia/0000-0001-9011-6901; de Villiers, Etienne/0000-0001-9878-1009	REACH programme - UK Aid from the UK Foreign, Commonwealth and Development Office (FCDO) [201880]; Commonwealth Scholarship Commission in the UK; National Institute for Health Research - UK Aid (FCDO) [17/63/82]	REACH programme - UK Aid from the UK Foreign, Commonwealth and Development Office (FCDO); Commonwealth Scholarship Commission in the UK; National Institute for Health Research - UK Aid (FCDO)	S.N. and K.C. are supported by the REACH programme funded by UK Aid from the UK Foreign, Commonwealth and Development Office (FCDO | https://www.gov.uk/government/organisations/foreign-commonwealthdevelopment-office) for the benefit of developing countries (Programme Code 201880). S.N. is further supported by the Commonwealth Scholarship Commission in the UK (https://www.gov.uk/government/organisations/commonwealthscholarship-commission-in-the-uk). G.G.is funded by the National Institute for Health Research (project reference 17/63/82) funded by UK Aid (FCDO) to support global health research. However, the views expressed and information contained in this article are not necessarily those of or endorsed by the FCDO, which can accept no responsibility for such views or information, or for any reliance placed on them. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm EW, POPULATION GENETICS; [Anonymous], 2002, MANAGING WATER HOME; Arnold BF, 2018, LANCET GLOB HEALTH, V6, pE616, DOI 10.1016/S2214-109X(18)30229-8; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beghain J, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000192; Ben Fekih I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02473; Bergholz PW, 2011, APPL ENVIRON MICROB, V77, P211, DOI 10.1128/AEM.01880-10; Berthe T, 2013, APPL ENVIRON MICROB, V79, P4684, DOI 10.1128/AEM.00698-13; Blyton MDJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169445; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burke-Gaffney HJOD, 1932, J HYG-CAMBRIDGE, V32, P85, DOI 10.1017/S002217240001785X; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; Carstea EM, 2020, SCI TOTAL ENVIRON, V699, DOI 10.1016/j.scitotenv.2019.134361; Charles KJ, 2020, NPJ CLEAN WATER, V3, P1; Chaudhuri RR, 2012, INFECT GENET EVOL, V12, P214, DOI 10.1016/j.meegid.2012.01.005; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Clermont O, 2019, ENVIRON MICROBIOL, V21, P3107, DOI 10.1111/1462-2920.14713; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Daniel D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072172; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Devane ML, 2020, WATER RES, V185, DOI 10.1016/j.watres.2020.116204; Dufour A., 2012, ANIMAL WASTE WATER Q; Feachem R., 1978, WATER HLTH DEV INTER; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Ferguson AS, 2011, J WATER HEALTH, V9, P708, DOI 10.2166/wh.2011.106; Ferrie JE, 2014, INT J EPIDEMIOL, V43, P977, DOI 10.1093/ije/dyu152; Gordon DM, 2002, MICROBIOL-SGM, V148, P1513, DOI 10.1099/00221287-148-5-1513; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Haberecht HB, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/3862949; Hamzah L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020608; Hothorn T, 2008, J STAT SOFTW, V28, P1; Ingle DJ, 2011, APPL ENVIRON MICROB, V77, P2695, DOI 10.1128/AEM.02401-10; Iramiot JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231852; Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101; Jang J, 2017, J APPL MICROBIOL, V123, P570, DOI 10.1111/jam.13468; JMP, 2020, WATER QUALITY MONITO; Julian Timothy R, 2015, Appl Environ Microbiol, V81, P1735, DOI 10.1128/AEM.03214-14; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kelly ER, 2020, SCI TOTAL ENVIRON, V718, DOI 10.1016/j.scitotenv.2020.137237; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Leclerc H, 2001, ANNU REV MICROBIOL, V55, P201, DOI 10.1146/annurev.micro.55.1.201; Levy K, 2008, ENVIRON HEALTH PERSP, V116, P1533, DOI 10.1289/ehp.11296; Luby SP, 2015, AM J TROP MED HYG, V93, P904, DOI 10.4269/ajtmh.15-0274; Mainda G, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01114; Matthews RL, 2014, J WATER HEALTH, V12, P113, DOI 10.2166/wh.2013.076; McLellan SL, 2004, APPL ENVIRON MICROB, V70, P4658, DOI 10.1128/AEM.70.8.4658-4665.2004; Meric G, 2013, ENVIRON MICROBIOL, V15, P487, DOI 10.1111/j.1462-2920.2012.02852.x; MOE CL, 1991, B WORLD HEALTH ORGAN, V69, P305; Momba MNB, 2002, WATER RES, V36, P3023, DOI 10.1016/S0043-1354(02)00011-8; Montealegre MC, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00704-19; Nandakafle G, 2020, NICHE PREFERENCE ESC; NEI M, 1978, GENETICS, V89, P583; Nowicki S, 2019, SCI TOTAL ENVIRON, V646, P782, DOI 10.1016/j.scitotenv.2018.07.274; Orsi RH, 2007, J WATER HEALTH, V5, P323, DOI 10.2166/wh.2007.028; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Perchec-Merien AM, 2013, FEMS MICROBIOL ECOL, V83, P494, DOI 10.1111/1574-6941.12010; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P5736, DOI 10.1021/es300022c; Power ML, 2005, ENVIRON MICROBIOL, V7, P631, DOI 10.1111/j.1462-2920.2005.00729.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ratajczak M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-222; Robb K, 2017, AM J TROP MED HYG, V97, P1020, DOI 10.4269/ajtmh.16-0508; Robins-Browne RM, 2004, EMERG INFECT DIS, V10, P1797, DOI 10.3201/eid1010.031086; Rozen Y, 2001, FEMS MICROBIOL REV, V25, P513, DOI 10.1016/S0168-6445(01)00065-1; Sahl JW, 2012, APPL ENVIRON MICROB, V78, P4884, DOI 10.1128/AEM.00929-12; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Shields KF, 2015, ENVIRON HEALTH PERSP, V123, P1222, DOI 10.1289/ehp.1409002; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smati M, 2015, MICROBIOLOGYOPEN, V4, P604, DOI 10.1002/mbo3.266; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Texier S, 2008, J ENVIRON QUAL, V37, P2299, DOI 10.2134/jeq2008.0028; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; Trevett Andrew Francis, 2005, Journal of Water and Health, V3, P259; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; Weber, 1999, MATH METHODS STAT, V8, P220, DOI DOI 10.1007/s10551-011-0925-7; White AP, 2011, APPL ENVIRON MICROB, V77, P7620, DOI 10.1128/AEM.05909-11; WHITTAM TS, 1989, A VAN LEEUW J MICROB, V55, P23, DOI 10.1007/BF02309616; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wolf J, 2019, INT J HYG ENVIR HEAL, V222, P270, DOI 10.1016/j.ijheh.2018.11.005; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; World Health Organization, 2017, DEPR OTH COMM MENT D; Wright J, 2004, TROP MED INT HEALTH, V9, P106, DOI 10.1046/j.1365-3156.2003.01160.x; Yandrapalli N, 2020, MICROMACHINES-BASEL, V11, DOI 10.3390/mi11030285; Zhi S, 2019, WATER RES, V156, P208, DOI 10.1016/j.watres.2019.03.024; Zhou ZM, 2020, GENOME RES, V30, P138, DOI 10.1101/gr.251678.119; Zhou ZM, 2018, GENOME RES, V28, P1395, DOI 10.1101/gr.232397.117; 2013, ESCH COL PATH PRINC, P1	91	17	17	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245910	10.1371/journal.pone.0245910	http://dx.doi.org/10.1371/journal.pone.0245910			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481909	Green Published, gold			2022-12-26	WOS:000612929300169
J	Kitano, M; Kizuka, Y; Sobajima, T; Nakano, M; Nakajima, K; Misaki, R; Itoyama, S; Harada, Y; Harada, A; Miyoshi, E; Taniguchi, N				Kitano, Masato; Kizuka, Yasuhiko; Sobajima, Tomoaki; Nakano, Miyako; Nakajima, Kazuki; Misaki, Ryo; Itoyama, Saki; Harada, Yoichiro; Harada, Akihiro; Miyoshi, Eiji; Taniguchi, Naoyuki			Rab11-mediated post-Golgi transport of the sialyltransferase ST3GAL4 suggests a new mechanism for regulating glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-GLYCANS; FUNCTIONAL ASSOCIATION; NUCLEOTIDE SUGARS; PROTEIN; RAB11; LOCALIZATION; COMPLEX; DOMAIN; EXPRESSION; PLATFORM	Glycosylation, the most common posttranslational modification of proteins, is a stepwise process that relies on tight regulation of subcellular glycosyltransferase location to control the addition of each monosaccharide. Glycosyltransferases primarily reside and function in the endoplasmic reticulum (ER) and the Golgi apparatus; whether and how they traffic beyond the Golgi, how this trafficking is controlled, and how it impacts glycosylation remain unclear. Our previous work identified a connection between N-glycosylation and Rab11, a key player in the post-Golgi transport that connects recycling endosomes and other compartments. To learn more about the specific role of Rab11, we knocked down Rab11 in HeLa cells. Our findings indicate that Rab11 knockdown results in a dramatic enhancement in the sialylation of N-glycans. Structural analyses of glycans using lectins and LC-MS revealed that alpha 2,3-sialylation is selectively enhanced, suggesting that an alpha 2,3-sialyltransferase that catalyzes the sialyation of glycoproteins is activated or upregulated as the result of Rab11 knockdown. ST3GAL4 is the major alpha 2,3-sialyltransferase that acts on N-glycans; we demonstrated that the localization of ST3GAL4, but not the levels of its mRNA, protein, or donor substrate, was altered by Rab11 depletion. In knockdown cells, ST3GAL4 is densely distributed in the trans-Golgi network, compared with the wider distribution in the Golgi and in other peripheral puncta in control cells, whereas the alpha 2,6-sialyltransferase ST6GAL1 is predominantly localized to the Golgi regardless of Rab11 knockdown. This indicates that Rab11 may negatively regulate alpha 2,3-sialylation by transporting ST3GAL4 to post-Golgi compartments (PGCs), which is a novel mechanism of glycosyltransferase regulation.	[Kitano, Masato; Kizuka, Yasuhiko; Harada, Yoichiro; Taniguchi, Naoyuki] Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan; [Kitano, Masato; Sobajima, Tomoaki; Itoyama, Saki; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan; [Kizuka, Yasuhiko] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan; [Kizuka, Yasuhiko] Gifu Univ, Inst Glycocore Res iGCORE, Gifu, Japan; [Nakano, Miyako] Hiroshima Univ, Grad Sch Integrated Sci Life, Hiroshima, Japan; [Nakajima, Kazuki] Fujita Hlth Univ, Toyoake, Aichi, Japan; [Misaki, Ryo] Osaka Univ, Int Ctr Biotechnol, Osaka, Japan; [Harada, Akihiro] Osaka Univ, Grad Sch Med, Dept Cell Biol, Osaka, Japan; [Sobajima, Tomoaki] Univ Oxford, Dept Biochem, Oxford, England	Osaka University; Gifu University; Gifu University; Hiroshima University; Fujita Health University; Osaka University; Osaka University; University of Oxford	Taniguchi, N (corresponding author), Osaka Int Canc Inst, Dept Glycooncol & Med Biochem, Chuo Ku, Osaka, Japan.; Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Osaka, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp; glycotani@mc.pref.osaka.jp	; Taniguchi, Naoyuki/I-4182-2014	Kizuka, Yasuhiko/0000-0002-3181-9743; Taniguchi, Naoyuki/0000-0001-5889-5968; Sobajima, Tomoaki/0000-0002-0753-5361	Japan Society for the Promotion of Science (JSPS) [18K06914, 19K06546, 17K07356, 20H03207, 19H03562]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [16811705]; CREST grant from JST [18070267]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST grant from JST	This work was partially supported by a Grant-in-Aid for Scientific Research (C) to N. T. (18K06914), Y. H. (19K06546), and Y. K. (17K07356), a Grant-in-Aid for Scientific Research (B) to Y. K. (20H03207) and E. M. (19H03562) from the Japan Society for the Promotion of Science (JSPS), a Leading Initiative for Excellent Young Researchers (LEADER) project to Y. K. (16811705) from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a CREST grant ([18070267] to Y. K.) from JST.	Agrawal P, 2017, CANCER CELL, V31, P804, DOI 10.1016/j.ccell.2017.05.007; Akasaka-Manya K, 2006, J BIOL CHEM, V281, P19339, DOI 10.1074/jbc.M601091200; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Bhuin T, 2015, INT J MOL CELL MED, V4, P1; Campa Carlo Cosimo, 2017, Advances in Biological Regulation, V63, P132, DOI 10.1016/j.jbior.2016.09.002; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Fisher P, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00015; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Hales CM, 2002, J BIOL CHEM, V277, P50415, DOI 10.1074/jbc.M209270200; Harada Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236074; Hathaway HJ, 2003, J CELL SCI, V116, P4319, DOI 10.1242/jcs.00720; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Ito J, 2014, ANAL BIOCHEM, V448, P14, DOI 10.1016/j.ab.2013.11.026; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kizuka Y, 2016, PROTEOMICS, V16, P2854, DOI 10.1002/pmic.201600053; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kizuka Y, 2009, J BIOL CHEM, V284, P9247, DOI 10.1074/jbc.M807517200; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Li PT, 2012, FERTIL STERIL, V97, P1206, DOI 10.1016/j.fertnstert.2012.02.019; Li XY, 2010, J NEUROSCI, V30, P4552, DOI 10.1523/JNEUROSCI.5865-09.2010; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Maccioni HJF, 2011, J NEUROCHEM, V117, P589, DOI 10.1111/j.1471-4159.2011.07232.x; Matsuzaki F, 2011, MOL BIOL CELL, V22, P4602, DOI 10.1091/mbc.E11-01-0068; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mondal N, 2015, BLOOD, V125, P687, DOI 10.1182/blood-2014-07-588590; Moremen KW, 2019, NAT CHEM BIOL, V15, P853, DOI 10.1038/s41589-019-0350-2; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M., 2020, INT J MOL SCI, V21, P1; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Nakano M, 2019, MOL CELL PROTEOMICS, V18, P2044, DOI 10.1074/mcp.RA119.001534; Nakano M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009001; Nguyen K, 2018, MOL CANCER THER, V17, P2689, DOI 10.1158/1535-7163.MCT-18-0399; Nozaki S, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00660-18; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pabst M, 2007, ANAL CHEM, V79, P5051, DOI 10.1021/ac070363i; Parmar HB, 2016, MOL BIOL CELL, V27, P1320, DOI 10.1091/mbc.E15-12-0845; Petrosyan A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.C112.403006; Pinho SS, 2015, NAT REV CANCER, V15, P540, DOI 10.1038/nrc3982; Puri C, 2018, DEV CELL, V45, P114, DOI 10.1016/j.devcel.2018.03.008; Qi F, 2020, FASEB J, V34, P881, DOI 10.1096/fj.201901793R; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Seko A, 2005, GLYCOBIOLOGY, V15, P943, DOI 10.1093/glycob/cwi082; Shen X, 2007, P NATL ACAD SCI USA, V104, P1230, DOI 10.1073/pnas.0610535104; Shestakova A, 2006, TRAFFIC, V7, P191, DOI 10.1111/j.1600-0854.2005.00376.x; Sobajima T, 2018, J CELL BIOL, V217, P1777, DOI 10.1083/jcb.201709123; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Stanley P., 2017, ESSENTIALS GLYCOBIOL; Takahashi M, 2016, MOL ASPECTS MED, V51, P56, DOI 10.1016/j.mam.2016.04.008; Tomida S, 2020, J BIOL CHEM, V295, P7992, DOI 10.1074/jbc.RA120.013079; Tran DT, 2012, J BIOL CHEM, V287, P20967, DOI 10.1074/jbc.M112.370387; Udayar V, 2013, CELL REP, V5, P1536, DOI 10.1016/j.celrep.2013.12.005; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Vilcaes AA, 2011, J BIOL CHEM, V286, P31437, DOI 10.1074/jbc.M111.257196; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yu SY, 2014, J BIOL CHEM, V289, P32030, DOI 10.1074/jbc.M113.538223; Zhao W, 2006, J BIOL CHEM, V281, P31106, DOI 10.1074/jbc.M605564200	67	7	7	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100354	10.1016/j.jbc.2021.100354	http://dx.doi.org/10.1016/j.jbc.2021.100354			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524390	Green Published, gold			2022-12-26	WOS:000672866400328
J	Mai, QN; Shenoy, P; Quach, T; Retamal, JS; Gondin, AB; Yeatman, HR; Aurelio, L; Conner, JW; Poole, DP; Canals, M; Nowell, CJ; Graham, B; Davis, TP; Briddon, SJ; Hill, SJ; Porter, CJH; Bunnett, NW; Halls, ML; Veldhuis, NA				Mai, Quynh N.; Shenoy, Priyank; Quach, Tim; Retamal, Jeffri S.; Gondin, Arisbel B.; Yeatman, Holly R.; Aurelio, Luigi; Conner, Joshua W.; Poole, Daniel P.; Canals, Meritxell; Nowell, Cameron J.; Graham, Bim; Davis, Thomas P.; Briddon, Stephen J.; Hill, Stephen J.; Porter, Christopher J. H.; Bunnett, Nigel W.; Halls, Michelle L.; Veldhuis, Nicholas A.			A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; CONVERTING ENZYME 1; SUBSTANCE-P; ADENYLYL-CYCLASE; BETA-ARRESTINS; ASSOCIATION; BINDING; INTERNALIZATION; LOCALIZATION; TACHYKININS	G-protein-coupled receptors (GPCRs) are traditionally known for signaling at the plasma membrane, but they can also signal from endosomes after internalization to control important pathophysiological processes. In spinal neurons, sustained endosomal signaling of the neurokinin 1 receptor (NK1R) mediates nociception, as demonstrated in models of acute and neuropathic pain. An NK1R antagonist, Spantide I (Span), conjugated to cholestanol (Span-Chol), accumulates in endosomes, inhibits endosomal NK1R signaling, and causes prolonged antinociception. However, the extent to which the Chol-anchor influences long-term location and activity is poorly understood. Herein, we used fluorescent correlation spectroscopy and targeted biosensors to characterize Span-Chol over time. The Chol-anchor increased local concentration of probe at the plasma membrane. Over time we observed an increase in NK1R-binding affinity and more potent inhibition of NK1R-mediated calcium signaling. Span-Chol, but not Span, caused a persistent decrease in NK1R recruitment of beta-arrestin and receptor internalization to early endosomes. Using targeted biosensors, we mapped the relative inhibition of NK1R signaling as the receptor moved into the cell. Span selectively inhibited cell surface signaling, whereas Span-Chol partitioned into endosomal membranes and blocked endosomal signaling. In a preclinical model of pain, Span-Chol caused prolonged antinociception (>9 h), which is attributable to a three-pronged mechanism of action: increased local concentration at membranes, a prolonged decrease in NK1R endocytosis, and persistent inhibition of signaling from endosomes. Identifying the mechanisms that contribute to the increased preclinical efficacy of lipid-anchored NK1R antagonists is an important step toward understanding how we can effectively target intracellular GPCRs in disease	[Mai, Quynh N.; Shenoy, Priyank; Gondin, Arisbel B.; Yeatman, Holly R.; Aurelio, Luigi; Poole, Daniel P.; Nowell, Cameron J.; Bunnett, Nigel W.; Halls, Michelle L.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia; [Mai, Quynh N.; Quach, Tim; Retamal, Jeffri S.; Davis, Thomas P.; Porter, Christopher J. H.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam Theme, Parkville, Vic, Australia; [Mai, Quynh N.; Shenoy, Priyank; Retamal, Jeffri S.; Gondin, Arisbel B.; Conner, Joshua W.; Poole, Daniel P.; Davis, Thomas P.; Porter, Christopher J. H.; Bunnett, Nigel W.; Veldhuis, Nicholas A.] Monash Univ, Monash Inst Pharmaceut Sci, Australian Res Council Ctr Excellence Convergent, Parkville, Vic, Australia; [Mai, Quynh N.; Aurelio, Luigi; Conner, Joshua W.; Graham, Bim] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem Theme, Parkville, Vic, Australia; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Div Physiol Pharmacol & Neurosci, Med Sch, Nottingham, England; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Birmingham, Ctr Membrane Prot & Receptors, Birmingham, W Midlands, England; [Canals, Meritxell; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Ctr Membrane Prot & Receptors, Nottingham, England; [Davis, Thomas P.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia; [Bunnett, Nigel W.] NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10003 USA; [Mai, Quynh N.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Monash University; Monash University; Monash University; Monash University; University of Nottingham; University of Birmingham; University of Nottingham; University of Queensland; University of Melbourne; New York University; University of California System; University of California San Francisco	Bunnett, NW; Halls, ML; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic, Australia.; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam Theme, Parkville, Vic, Australia.; Bunnett, NW; Veldhuis, NA (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Australian Res Council Ctr Excellence Convergent, Parkville, Vic, Australia.; Bunnett, NW (corresponding author), Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic, Australia.; Bunnett, NW (corresponding author), NYU, Dept Mol Pathobiol, Coll Dent, New York, NY 10003 USA.	nwb2@nyu.edu; michelle.halls@monash.edu; nicholas.veldhuis@monash.edu	Davis, Thomas/B-6395-2008; Poole, Daniel/AET-6645-2022; Porter, Christopher JH/C-6333-2011; Hill, Stephen/N-6753-2013	Davis, Thomas/0000-0003-2581-4986; Poole, Daniel/0000-0002-6168-8422; Porter, Christopher JH/0000-0003-3474-7551; Hill, Stephen/0000-0002-4424-239X; Canals, Meritxell/0000-0002-7942-5006; Batista Gondin, Arisbel/0000-0002-1751-4062; Mai, Quynh/0000-0002-6199-2096; Veldhuis, Nicholas/0000-0002-8902-9365; Retamal, Jeffri S./0000-0003-4984-4530; Bunnett, Nigel W./0000-0003-3367-0644	National Institutes of Health [NS102722, DE026806, DE029951, DK118971]; Department of Defence [W81XWH1810431]; National Health and Medical Research Council [63303, 1049682, 1031886, 1083054]; ARC Centre of Excellence in Convergent BioNano Science and Technology [CE14100036]; Medical Research Council [MR/N020081/1]; NHMRC [1061687]; Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK); MRC [MR/N020081/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent BioNano Science and Technology(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the National Institutes of Health (NS102722, DE026806, DE029951, DK118971 to N. W. B), Department of Defence (W81XWH1810431 to N. W. B.), National Health and Medical Research Council (63303 to N. W. B., 1049682 to N. W. B. and B. G., 1031886 to N. W. B. and D. P. P, 1083054 to N. W. B., M. L. H., M. C., C. J. P., and T. P. D.), ARC Centre of Excellence in Convergent BioNano Science and Technology (CE14100036 to N. W. B., T. P. D., C. J. P., N. A. V.), and Medical Research Council (MR/N020081/1 to S. J. B., S. J. H.). M. L. H. was an NHMRC RD Wright Fellow (1061687). Q. N. M. was part of the Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK).	Alemi F, 2013, J CLIN INVEST, V123, P1513, DOI 10.1172/JCI64551; Arshavsky Vadim Y, 2014, Cell Logist, V4, pe29390; Ayling LJ, 2012, J CELL SCI, V125, P869, DOI 10.1242/jcs.091090; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cattaruzza F, 2009, BRIT J PHARMACOL, V156, P730, DOI 10.1111/j.1476-5381.2008.00039.x; Civciristov S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1188; Collazos A, 2006, MOL CELL BIOL, V26, P2247, DOI 10.1128/MCB.26.6.2247-2261.2006; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Diener HC, 2003, CEPHALALGIA, V23, P183, DOI 10.1046/j.1468-2982.2003.00496.x; Dionne RA, 1998, CLIN PHARMACOL THER, V64, P562, DOI 10.1016/S0009-9236(98)90140-0; Eichel K, 2018, NATURE, V557, P381, DOI 10.1038/s41586-018-0079-1; Gherbi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21100-x; Goldstein DJ, 1997, CEPHALALGIA, V17, P785, DOI 10.1046/j.1468-2982.1997.1707785.x; GREENO EW, 1993, J EXP MED, V177, P1269, DOI 10.1084/jem.177.5.1269; Halls Michelle L, 2015, Methods Mol Biol, V1335, P131, DOI 10.1007/978-1-4939-2914-6_10; Hargreaves R, 2002, J CLIN PSYCHIAT, V63, P18; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Huang WJ, 2020, NATURE, V579, P303, DOI 10.1038/s41586-020-1953-1; Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jarcho JM, 2013, PAIN, V154, P987, DOI 10.1016/j.pain.2013.02.026; Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Jensen DD, 2014, J BIOL CHEM, V289, P20283, DOI 10.1074/jbc.M114.578179; Jensen DD, 2013, J BIOL CHEM, V288, P22942, DOI 10.1074/jbc.M113.455774; Jimenez-Vargas NN, 2020, P NATL ACAD SCI USA, V117, P15281, DOI 10.1073/pnas.2000500117; Johannessen L, 2011, CHEMBIOCHEM, V12, P914, DOI 10.1002/cbic.201000563; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Latorraca NR, 2017, CHEM REV, V117, P139, DOI 10.1021/acs.chemrev.6b00177; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Liang YL, 2020, ACS PHARMACOL TRANSL, V3, P263, DOI 10.1021/acsptsci.9b00080; Linning P, 2012, ORG BIOMOL CHEM, V10, P8216, DOI 10.1039/c2ob26103k; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Merriam LA, 2013, J NEUROSCI, V33, P4614, DOI 10.1523/JNEUROSCI.4999-12.2013; Mukherjee A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00045; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nowell C. J., 2020, FRET ANAL STACK CREA; Pelayo JC, 2011, J PHYSIOL-LONDON, V589, P5213, DOI 10.1113/jphysiol.2011.214452; Pinto FM, 2004, EUR J PHARMACOL, V494, P233, DOI 10.1016/j.ejphar.2004.05.016; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Rajendran L, 2012, TRAFFIC, V13, P759, DOI 10.1111/j.1600-0854.2012.01332.x; Ramirez-Garcia PD, 2019, NAT NANOTECHNOL, V14, P1150, DOI 10.1038/s41565-019-0568-x; Renzi D, 2000, AM J PATHOL, V157, P1511, DOI 10.1016/S0002-9440(10)64789-X; Rose RH, 2012, BRIT J PHARMACOL, V165, P1789, DOI 10.1111/j.1476-5381.2011.01640.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Stoddart LA, 2015, NEUROPHARMACOLOGY, V98, P68, DOI 10.1016/j.neuropharm.2015.04.013; Stoddart LA, 2012, CHEM BIOL, V19, P1105, DOI 10.1016/j.chembiol.2012.07.014; Sykes DA, 2014, MOL PHARMACOL, V85, P608, DOI 10.1124/mol.113.090209; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; Wu FJ, 2020, J BIOL CHEM, V295, P7404, DOI 10.1074/jbc.RA120.012842; Yarwood RE, 2017, P NATL ACAD SCI USA, V114, P12309, DOI 10.1073/pnas.1706656114; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	64	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100345	10.1016/j.jbc.2021.100345	http://dx.doi.org/10.1016/j.jbc.2021.100345			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515548	Green Published, gold			2022-12-26	WOS:000672866400319
J	Szabo, A; Toldi, V; Gazda, LD; Demcsak, A; Tozser, J; Sahin-Toth, M				Szabo, Andras; Toldi, Vanda; Gazda, Livia Diana; Demcsak, Alexandra; Tozser, Jozsef; Sahin-Toth, Miklos			Defective binding of SPINK1 variants is an uncommon mechanism for impaired trypsin inhibition in chronic pancreatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE INHIBITOR; HUMAN CATIONIC TRYPSINOGEN; HUMAN ANIONIC TRYPSINOGEN; FUNCTIONAL-ANALYSIS; MISSENSE MUTATIONS; INTRONIC VARIANTS; HUMAN MESOTRYPSIN; ACINAR-CELLS; KAZAL TYPE-1; GENE	The serine protease inhibitor Kazal type 1 (SPINK1) protects the pancreas from intrapancreatic trypsin activation that can lead to pancreatitis. Loss-of-function genetic variants of SPINK1 increase the risk for chronic pancreatitis, often by diminishing inhibitor expression or secretion. Variants that are secreted normally have been presumed to be pathogenic because of defective trypsin inhibition, but evidence has been lacking. Here, we report quantitative studies on the inhibition of human trypsins by wildtype SPINK1 and seven secreted missense variants. We found that tyrosine sulfation of human trypsins weakens binding of SPINK1 because of altered interactions with Tyr43 in the SPINK1 reactive loop. Using authentic sulfated human trypsins, we provide conclusive evidence that SPINK1 variants N34S, N37S, R65Q, and Q68R have unimpaired inhibitory activity, whereas variant P55S exhibits a small and clinically insignificant binding defect. In contrast, rare variants K41N and I42M that affect the reactive-site peptide bond of SPINK1 decrease inhibitor binding by 20,000- to 30,000-fold and three- to sevenfold, respectively. Taken together, the observations indicate that defective trypsin inhibition by SPINK1 variants is an uncommon mechanism in chronic pancreatitis. The results also strengthen the notion that a decline in inhibitor levels explains pancreatitis risk associated with the large majority of SPINK1 variants.	[Szabo, Andras; Toldi, Vanda; Gazda, Livia Diana; Tozser, Jozsef] Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary; [Szabo, Andras; Sahin-Toth, Miklos] Boston Univ, Ctr Exocrine Disorders, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Toldi, Vanda; Gazda, Livia Diana] Univ Debrecen, Doctoral Sch Mol Cell & Immune Biol, Debrecen, Hungary; [Demcsak, Alexandra; Sahin-Toth, Miklos] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	University of Debrecen; Boston University; University of Debrecen; University of California System; University of California Los Angeles	Szabo, A (corresponding author), Univ Debrecen, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary.; Szabo, A; Sahin-Toth, M (corresponding author), Boston Univ, Ctr Exocrine Disorders, Dept Mol & Cell Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.; Sahin-Toth, M (corresponding author), Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA.	andrasszabo@med.unideb.hu; msahintoth@mednet.ucla.edu		Demcsak, Alexandra/0000-0002-5391-6931; Szabo, Andras/0000-0001-8687-470X; Sahin-Toth, Miklos/0000-0003-4513-9922; Toldi, Vanda/0000-0002-0446-027X	National Institutes of Health [R01 DK117809, R01 DK058088]; National Research Development and Innovation Office of Hungary [PD120960, FK127942]; University of Debrecen OTKA Bridging Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant [BO/00514/19/5]; New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund [UNKP-20-5]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Development and Innovation Office of Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); University of Debrecen OTKA Bridging Fund; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant; New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund	This work was supported by the National Institutes of Health grants R01 DK117809 and R01 DK058088 (to M. S.-T.), the National Research Development and Innovation Office of Hungary grants PD120960 and FK127942, the University of Debrecen OTKA Bridging Fund, the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences grant (BO/00514/19/5), and the UNKP-20-5 New National Excellence Program of the Ministry for Innovation and Technology of Hungary from the source of the National Research, Development and Innovation Fund (to A. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beer S, 2014, GUT, V63, P860, DOI 10.1136/gutjnl-2013-305981; Boulling A., 2012, WEBMEDCENTRAL GENE, V3; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Boulling A, 2017, HUM MUTAT, V38, P1014, DOI 10.1002/humu.23269; Boulling A, 2012, PANCREAS, V41, P329, DOI 10.1097/MPA.0b013e3182277b83; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2009, GUT, V58, P478, DOI 10.1136/gut.2008.170191; COLLINS J, 1990, BIOL CHEM H-S, V371, P29; Drenth JPH, 2002, GUT, V50, P687, DOI 10.1136/gut.50.5.687; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Hamoir C, 2013, DIGESTION, V87, P229, DOI 10.1159/000348439; HECHT HJ, 1991, J MOL BIOL, V220, P711, DOI 10.1016/0022-2836(91)90112-J; Hegyi E, 2017, DIGEST DIS SCI, V62, P1692, DOI 10.1007/s10620-017-4601-3; Hirota Masahiko, 2003, JOP, V4, P83; Kereszturi E, 2009, GUT, V58, P545, DOI 10.1136/gut.2008.164947; Kereszturi E, 2017, PANCREAS, V46, pE54, DOI 10.1097/MPA.0000000000000817; KIKUCHI N, 1989, J BIOCHEM-TOKYO, V106, P1059, DOI 10.1093/oxfordjournals.jbchem.a122964; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Kiraly O, 2007, HUM MUTAT, V28, P469, DOI 10.1002/humu.20471; Kiraly O, 2011, METHODS MOL BIOL, V705, P175, DOI 10.1007/978-1-61737-967-3_10; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Kume K, 2006, GUT, V55, P1214, DOI 10.1136/gut.2006.095752; Kuwata K, 2002, J GASTROENTEROL, V37, P928, DOI 10.1007/s005350200156; Lasher D, 2019, AM J GASTROENTEROL, V114, P974, DOI 10.14309/ajg.0000000000000051; LASKOWSKI M, 1953, J BIOL CHEM, V204, P797; Le Marechal C, 2004, Hum Mutat, V23, P205, DOI 10.1002/humu.9212; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Masamune A, 2007, PANCREAS, V34, P423, DOI 10.1097/mpa.0b013e3180335fd0; Nemoda Z, 2006, J BIOL CHEM, V281, P11879, DOI 10.1074/jbc.M600124200; Ohmuraya M, 2005, GASTROENTEROLOGY, V129, P696, DOI 10.1053/j.gastro.2005.05.057; Ohmuraya M, 2006, PANCREAS, V33, P104, DOI 10.1097/01.mpa.0000226889.86322.9b; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Ronai Z, 2009, BIOCHEM J, V418, P155, DOI 10.1042/BJ20081848; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; Sahin-Toth M, 2006, FEBS J, V273, P5044, DOI 10.1111/j.1742-4658.2006.05501.x; Sahin-Toth Miklos, 2017, Hum Mutat, V38, P1619, DOI 10.1002/humu.23352; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; SCHNEIDE.SL, 1974, J BIOL CHEM, V249, P2009; SCHNEIDER SL, 1973, J BIOL CHEM, V248, P7207; Szabo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102063; Szabo A, 2011, J BIOL CHEM, V286, P22535, DOI 10.1074/jbc.M111.235754; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Terlizzi V, 2013, MINERVA PEDIATR, V65, P669; Toldi V, 2020, J BIOL CHEM, V295, P3447, DOI 10.1074/jbc.RA120.012526; Venet T, 2017, HUM MUTAT, V38, P1660, DOI 10.1002/humu.23343; Werlin S, 2015, J PEDIATR GASTR NUTR, V60, P675, DOI 10.1097/MPG.0000000000000623; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Wu H, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100263; Wu H, 2017, GUT, V66, P2195, DOI 10.1136/gutjnl-2017-313948; Zou WB, 2016, GUT, V65, P884, DOI 10.1136/gutjnl-2015-311168	55	11	11	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100343	10.1016/j.jbc.2021.100343	http://dx.doi.org/10.1016/j.jbc.2021.100343			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515547	Green Accepted, Green Published, gold			2022-12-26	WOS:000672866400317
J	Muller, LRF; Gossmann, K; Schmid, RF; Rosner, R; Unterhitzenberger, J				Mueller, Lauritz Rudolf Floribert; Gossmann, Katharina; Schmid, Regina F.; Rosner, Rita; Unterhitzenberger, Johanna			A pilot study on ecological momentary assessment in asylum-seeking children and adolescents resettled to Germany: Investigating compliance, post-migration factors, and the relation between daily mood, sleep patterns, and mental health	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CHILDHOOD SEXUAL-ABUSE; REFUGEE CHILDREN; AMBULATORY ASSESSMENT; TRAUMA; YOUTH; DISCRIMINATION; INTERVENTIONS; ACCULTURATION; FEASIBILITY	Background Asylum-seeking children and adolescents (ASCs) resettled to western countries show elevated levels of psychological distress. While research on the mental health of ASCs is increasing, less is known about their day-to-day living experiences such as their daily mood, sleep patterns, and post-migration factors. Moreover, no examination in situ, using smartphone-assisted ecological momentary assessment (EMA), has been conducted up to now among ASCs. Furthermore, we do not know if screening measures succeed in reflecting the daily mood of ASCs experienced in everyday life. Methods We undertook a smartphone-assisted EMA study over a two-week period with 3 measurements a day. Participants were N = 40 ASCs from 10 different countries who had resettled to Germany. They completed standardized questionnaires screening for history of trauma and clinical symptoms (post-traumatic stress symptoms, depression, and anxiety) that were carried out in interview-like settings, and they participated in the subsequent EMA where they rated mood, sleep parameters, and post-migration factors on a daily basis. Multilevel models of clinical symptoms, daily mood, and sleep parameters were computed based on a total of 680 measurements. Results The multiply traumatized and highly distressed participants reported different levels of discrimination, and various social activities and contacts in the EMA. The overall compliance rate was shown to be 40.5%. Higher PTSS and anxiety scores were associated with lower levels of daily mood and poorer outcomes of some sleep parameters. Depression scores were not associated with any of the variables assessed in the EMA. Conclusions Smartphone-assisted EMA among ASCs resettled to Germany proved to be implementable despite a rather low compliance rate. Not only do ASCs show high symptom levels, they are also affected by these symptoms in their daily lives. The results emphasize the need for concise screenings and psychological treatment for this high-risk population. Limitations include the convenient nature of the sample and the lack of a comparison group.	[Mueller, Lauritz Rudolf Floribert; Gossmann, Katharina; Schmid, Regina F.; Rosner, Rita; Unterhitzenberger, Johanna] Catholic Univ Eichstatt Ingolstadt, Dept Psychol, Eichstatt, Germany		Muller, LRF (corresponding author), Catholic Univ Eichstatt Ingolstadt, Dept Psychol, Eichstatt, Germany.	lauritz.mueller@ku.de		Gossmann, Katharina/0000-0003-0608-0534	proFOR+ grant [2316]; German Research Foundation (DFG)	proFOR+ grant; German Research Foundation (DFG)(German Research Foundation (DFG))	JU received a proFOR+ grant for the conduct of the study (ID 2316). proFOR+ is a funding program of the Catholic University of Eichstatt-Ingolstadt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.ku.de/forschung/forschungsfoerderung/profor This work was supported by the German Research Foundation (DFG) within the funding programme Open Access Publishing.	Aalsma MC, 2002, J SEX RES, V39, P259, DOI 10.1080/00224490209552149; Alisic E, 2014, BRIT J PSYCHIAT, V204, P335, DOI 10.1192/bjp.bp.113.131227; Almqvist K, REFUGEE CHILDREN SWE; American Psychiatric Association, DIAGN STAT MAN MENT; Bean TM, HSCL 37A USERS MANUA; Beiser M, 2016, J NERV MENT DIS, V204, P464, DOI 10.1097/NMD.0000000000000516; Berliner L, 2014, INSTRUCTIONS CATS CH; Bhui K, 2003, BRIT J PSYCHIAT, V183, P184, DOI 10.1192/bjp.183.3.184; Bronstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056156; Bronstein I, 2011, CLIN CHILD FAM PSYCH, V14, P44, DOI 10.1007/s10567-010-0081-0; CHRISTENSENSZALANSKI JJJ, 1991, ORGAN BEHAV HUM DEC, V48, P147, DOI 10.1016/0749-5978(91)90010-Q; Cormack F, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/12814; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; CRONBACH LJ, 1955, PSYCHOL BULL, V52, P281, DOI 10.1037/h0040957; Derluyn I, 2004, LANCET, V363, P861, DOI 10.1016/S0140-6736(04)15734-6; Derluyn I, 2009, J ADOLESCENT HEALTH, V44, P291, DOI 10.1016/j.jadohealth.2008.07.016; Doherty A., 2007, Leisure/Loisir, V31, P27, DOI 10.1080/14927713.2007.9651372; Douglass S, 2016, CULT DIVERS ETHN MIN, V22, P69, DOI 10.1037/cdp0000041; Duffy A, 2019, BIPOLAR DISORD, V21, P159, DOI 10.1111/bdi.12721; Ebner-Priemer UW, 2009, EUR PSYCHOL, V14, P109, DOI 10.1027/1016-9040.14.2.109; Ehntholt KA, 2006, J CHILD PSYCHOL PSYC, V47, P1197, DOI 10.1111/j.1469-7610.2006.01638.x; Ellis BH, 2008, J CONSULT CLIN PSYCH, V76, P184, DOI 10.1037/0022-006X.76.2.184; Fazel M, 2018, LANCET CHILD ADOLESC, V2, P121, DOI 10.1016/S2352-4642(17)30147-5; Fazel M, 2012, LANCET, V379, P266, DOI 10.1016/S0140-6736(11)60051-2; Federal Office for Migration and Refugees (Bundesamt fur Migration und Fluchtlinge), 2015, AKT ZAHL AS; Federal Office for Migration and Refugees (Bundesamt fur Migration und Fluchtlinge), 2016, AKT ZAHL AS; Federal Office for Migration and Refugees (Bundesamt fur Migration und Fluchtlinge), 2017, AKT ZAHL AS; Forster SD, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00115; Fredriksen K, 2004, CHILD DEV, V75, P84, DOI 10.1111/j.1467-8624.2004.00655.x; Frounfelker RL, 2020, ANNU REV PUBL HEALTH, V41, P159, DOI 10.1146/annurev-publhealth-040119-094230; Gadeberg AK, 2017, EUR J PUBLIC HEALTH, V27, P439, DOI 10.1093/eurpub/ckx034; Ha JP, 2013, S AFR J RES SPORT PH, V35, P121; Heptinstall E, 2004, EUR CHILD ADOLES PSY, V13, P373, DOI 10.1007/s00787-004-0422-y; Heron KE, 2017, J PEDIATR PSYCHOL, V42, P1087, DOI 10.1093/jpepsy/jsx078; Hinz A, 2012, PSYCHOTHER PSYCH MED, V62, P52, DOI 10.1055/s-0031-1297960; Hodes M, 2008, J CHILD PSYCHOL PSYC, V49, P723, DOI 10.1111/j.1469-7610.2008.01912.x; Holmes EA, 2017, BEHAV COGN PSYCHOTH, V45, P97, DOI 10.1017/S135246581600062X; Horlings A, 2018, EUR J PEDIATR, V177, P163, DOI 10.1007/s00431-017-3027-4; Huppert FA, 2009, APPL PSYCHOL-HLTH WE, V1, P137, DOI 10.1111/j.1758-0854.2009.01008.x; Jakobsen M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015157; Jakobsen Marianne, 2014, Clin Pract Epidemiol Ment Health, V10, P53, DOI 10.2174/1745017901410010053; Koch T, 2020, COGN THER RES, V16, P1247; Koenig J, 2021, EUR CHILD ADOLES PSY, V30, P1299, DOI 10.1007/s00787-020-01626-0; Liao Y, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4954; Miller KE, 2004, MENTAL HEALTH OF REFUGEES, P1; Mohr DC, 2014, LANCET PSYCHIAT, V1, P326, DOI 10.1016/S2215-0366(14)70261-5; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Morina N, 2017, CONFL HEALTH, V11, DOI 10.1186/s13031-017-0120-2; Morren M, 2009, EUR J PAIN, V13, P354, DOI 10.1016/j.ejpain.2008.05.010; Muller LRF, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7263-6; Muller LRF, 2019, CHILD ADOL PSYCH MEN, V13, DOI 10.1186/s13034-019-0268-1; Nezlek J. B., 2011, MULTILEVEL MODELING; Ni Raghallaigh M, 2010, CHILD FAM SOC WORK, V15, P226, DOI 10.1111/j.1365-2206.2009.00663.x; Ohly S, 2010, J PERS PSYCHOL, V9, P79, DOI 10.1027/1866-5888/a000009; Oppedal B, 2015, SCAND J PSYCHOL, V56, P203, DOI 10.1111/sjop.12194; Ouimette P, 2006, ADDICT BEHAV, V31, P1415, DOI 10.1016/j.addbeh.2005.11.010; Owens JA, 2017, MINERVA PEDIATR, V69, P326, DOI 10.23736/S0026-4946.17.04914-3; Paalman CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063109; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Pfeiffer E, 2018, J CHILD PSYCHOL PSYC, V59, P1171, DOI 10.1111/jcpp.12908; Priebe K, 2013, PSYCHOL ASSESSMENT, V25, P1370, DOI 10.1037/a0033816; Prince M, 2008, EPIDEMIOL PSICHIAT S, V17, P211, DOI 10.1017/S1121189X00001305; Randler C, 2016, J BEHAV ADDICT, V5, P465, DOI 10.1556/2006.5.2016.056; Rassenhofer M, 2016, PRAX KINDERPSYCHOL K, V65, P97, DOI 10.13109/prkk.2016.65.2.97; Roberts RE, 2009, J ADOLESCENCE, V32, P1045, DOI 10.1016/j.adolescence.2009.03.007; Roese NJ, 2012, PERSPECT PSYCHOL SCI, V7, P411, DOI 10.1177/1745691612454303; Runyan JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071325; Sachser C, 2017, J AFFECT DISORDERS, V210, P189, DOI 10.1016/j.jad.2016.12.040; SACK WH, 1993, J AM ACAD CHILD PSY, V32, P431, DOI 10.1097/00004583-199303000-00027; Salkind NJ, 2010, ENCY RES DESIGN, DOI [10.1097/SMJ.0b013e3181eab419, DOI 10.1097/SMJ.0B013E3181EAB419]; Santangelo PS, 2017, J ABNORM CHILD PSYCH, V45, P1429, DOI 10.1007/s10802-016-0249-2; Schwartz S, 2016, J AFFECT DISORDERS, V191, P88, DOI 10.1016/j.jad.2015.11.013; Seybold KS, 2001, CURR DIR PSYCHOL SCI, V10, P21, DOI 10.1111/1467-8721.00106; Sierau S, 2019, EUR CHILD ADOLES PSY, V28, P769, DOI 10.1007/s00787-018-1246-5; Sleijpen M, 2016, ETHNIC HEALTH, V21, P158, DOI 10.1080/13557858.2015.1044946; Spinhoven P, 2006, J TRAUMA STRESS, V19, P663, DOI 10.1002/jts.20152; Steyer, 1997, MEHRDIMENSIONALE BEF; Tam SY, 2017, TRAUMA VIOLENCE ABUS, V18, P377, DOI 10.1177/1524838015622437; Trull TJ, 2020, J ABNORM PSYCHOL, V129, P56, DOI 10.1037/abn0000473; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; Unterhitzenberger J, 2019, CHILD ADOL PSYCH MEN, V13, DOI 10.1186/s13034-019-0282-3; van Giezen AE, 2005, CLIN PSYCHOL REV, V25, P935, DOI 10.1016/j.cpr.2005.04.011; Wen D, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6874; Whitley M. A., 2016, Leisure/Loisir, V40, P175; Wilhelm P, 2007, EUR J PSYCHOL ASSESS, V23, P258, DOI 10.1027/1015-5759.23.4.258; Williams D R, 1997, J Health Psychol, V2, P335, DOI 10.1177/135910539700200305	86	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246069	10.1371/journal.pone.0246069	http://dx.doi.org/10.1371/journal.pone.0246069			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524043	gold, Green Published			2022-12-26	WOS:000616578400025
J	Williams, CM; Calderon, JH; Hock, E; Jimenez, Y; Barringer, K; Carbonaro, M; Molina-Portela, MD; Thurston, G; Li, Z; Daly, C				Williams, Courtney M.; Calderon, Jessica Harper; Hock, E.; Jimenez, Yasalp; Barringer, Kevin; Carbonaro, Marisa; Molina-Portela, Maria del Pilar; Thurston, Gavin; Li, Zhe; Daly, Christopher			Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function	FASEB JOURNAL			English	Article						bile; carcinogenesis; FGFR4 protein; FGF19 protein; hepatocytes; hepatocellular carcinoma; liver regeneration; structure&#8208; activity relationship	FIBROBLAST-GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; LIVER-REGENERATION; MOUSE; FGF19; FIBROSIS; MICE	Human Fibroblast Growth Factor 19 (FGF19) and mouse ortholog Fgf15 play similar roles in liver regeneration and metabolism via the activation of Fgfr4/b-klotho (Klb). Monomeric FGF19 and dimeric Fgf15 are both necessary for liver regeneration and proper bile acid (BA) metabolism. FGF19 elicits stronger effects than Fgf15 on glucose and fatty acid metabolism and only FGF19 induces hepatocellular carcinoma (HCC). However, inhibiting FGF19/FGFR4 signaling in HCC patients is associated with toxicity due to elevated BA levels. Here, we examine the structure/function relationship in Fgf15/FGF19 to better understand the molecular basis for their distinct functions. We demonstrate that FGF19 is a more effective activator of Fgfr4 and of downstream signaling (Erk, Plcg1) than Fgf15. Furthermore, we use site-directed mutagenesis to show that the presence or absence of an unpaired cysteine in Fgf15/19 modulates ligand structure and determines the ability of these molecules to induce hepatocyte proliferation, with monomers being more potent activators. Consistent with these findings, an engineered dimeric variant of FGF19 is less effective than wild-type FGF19 at inducing liver growth in cooperation with the Wnt-enhancer RSPO3. In contrast to effects on proliferation, monomeric and dimeric ligands equally inhibited the expression of Cyp7a1, the enzyme catalyzing the rate limiting step in BA production. Thus, structure and function of Fgf15/FGF19 are intricately linked, explaining why FGF19, but not Fgf15, induces liver tumorigenesis. Our data provide insight into FGF19/FGFR4 signaling and may inform strategies to target this pathway while limiting on-target toxicity due to dysregulation of BA production or induction of hepatocyte proliferation.	[Williams, Courtney M.; Calderon, Jessica Harper; Hock, E.; Jimenez, Yasalp; Barringer, Kevin; Carbonaro, Marisa; Molina-Portela, Maria del Pilar; Thurston, Gavin; Li, Zhe; Daly, Christopher] Regeneron Pharmaceut Inc, Oncol & Angiogenesis Dept, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA	Regeneron	Williams, CM (corresponding author), Regeneron Pharmaceut Inc, Oncol & Angiogenesis Dept, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	courtney.williams@regeneron.com		Thurston, Gavin/0000-0002-4105-5919; Williams, Courtney/0000-0001-8618-8320				Alberts R, 2018, GUT, V67, P1517, DOI 10.1136/gutjnl-2016-313598; Hammad S, 2014, ARCH TOXICOL, V88, P1161, DOI 10.1007/s00204-014-1243-5; Harrison SA, 2020, HEPATOLOGY, V71, P1198, DOI 10.1002/hep.30590; Harrison SA, 2018, LANCET, V391, P1174, DOI 10.1016/S0140-6736(18)30474-4; Hirschfield GM, 2019, J HEPATOL, V70, P483, DOI 10.1016/j.jhep.2018.10.035; Kaibori M, 2016, ONCOTARGET, V7, P49091, DOI 10.18632/oncotarget.10077; Kim RD, 2019, CANCER DISCOV, V9, P1696, DOI 10.1158/2159-8290.CD-19-0555; Kong B, 2014, AM J PHYSIOL-GASTR L, V306, pG893, DOI 10.1152/ajpgi.00337.2013; Li Q, 2018, J PHYSIOL BIOCHEM, V74, P247, DOI 10.1007/s13105-018-0610-8; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mayo MJ, 2018, HEPATOL COMMUN, V2, P1037, DOI 10.1002/hep4.1209; Naugler WE, 2015, GASTROENTEROLOGY, V149, P728, DOI 10.1053/j.gastro.2015.05.043; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Nishikawa K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103103; Pai R, 2012, TOXICOL SCI, V126, P446, DOI 10.1093/toxsci/kfs011; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Uriarte I, 2015, INT J CANCER, V136, P2469, DOI 10.1002/ijc.29287; Wilson DH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14283-3; Wright TJ, 2004, DEV BIOL, V269, P264, DOI 10.1016/j.ydbio.2004.02.003; WU JC, 1994, P NATL ACAD SCI USA, V91, P674, DOI 10.1073/pnas.91.2.674; Xie MH, 1999, CYTOKINE, V11, P729, DOI 10.1006/cyto.1999.0485; Zhang MJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229445; Zhou M, 2017, HEPATOL COMMUN, V1, P1024, DOI 10.1002/hep4.1108; Zhou M, 2017, J HEPATOL, V66, P1182, DOI 10.1016/j.jhep.2017.01.027; Zhou M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15433; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208	26	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21286	10.1096/fj.202002203R	http://dx.doi.org/10.1096/fj.202002203R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484478	hybrid			2022-12-26	WOS:000647789600072
J	Ahmed, W; Huang, J; Liu, KL; Ali, S; Han, TF; Sun, G; Chen, J; Qaswar, M; Du, JX; Mahmood, S; Maitlo, AA; Khan, ZH; Zhang, HM; Chen, DY				Ahmed, Waqas; Huang Jing; Liu Kailou; Ali, Sehrish; Han Tianfu; Sun Geng; Chen Jin; Qaswar, Muhammad; Du Jiangxue; Mahmood, Sajid; Maitlo, Ali Akbar; Khan, Zulqarnain Haider; Zhang, Huimin; Chen, Di-Yun			Impacts of long-term inorganic and organic fertilization on phosphorus adsorption and desorption characteristics in red paddies in southern China	PLOS ONE			English	Article							SOIL-PHOSPHORUS; PHOSPHATE SORPTION; CLAY-MINERALS; IRON-OXIDE; BIOCHAR; MATTER; AVAILABILITY; CHARGE; FRACTIONS; RETENTION	Soil phosphorus (P) adsorption and desorption occur in an important endogenous cycle linked with soil fertility problems and relevant to the environmental risk assessment of P. In our study, the effect of long-term inorganic and organic fertilization on P adsorption and desorption characteristics in relation to changes in soil properties was evaluated by selecting three long-term experimental sites in southern China. The selected treatments at each site were CK (unfertilized), NPK (synthetic nitrogen, phosphorus and potassium) and NPKM (synthetic NPK plus manure). The adsorption and desorption characteristics of P were evaluated using Langmuir and Freundlich isotherms. The results showed that long-term application of NPK plus manure significantly increased soil organic carbon (SOC), total P and available P at all three sites compared with the NPK and CK treatments. All three treatments fit these equations well. The maximum adsorption capacity (Q(m)) of P increased with NPKM treatment, and the binding energy of P (K) and the maximum buffering capacity (MBC) showed increasing trends. NPKM showed the highest Q(m) (2346.13 mg kg(-1)) at the Jinxian site, followed by Nanchang (221.16 mg kg(-1)) and Ningxiang (2219.36 mg kg(-1)). Compared to CK and NPK, the NPKM treatment showed a higher MBC as 66.64, 46.93 and 44.39 L kg(-1) at all three sites. The maximum desorption capacity (D-m) of P in soil was highest with the NPKM treatment (157.58, 166.76, 143.13 mg kg(-1)), showing a better ability to release P in soil. The correlation matrix showed a significant positive correlation of SOC, total and available P with Q(m), D-m and MBC. In conclusion, it is suggested that manure addition is crucial to improve P utilization in red paddy soils within the recommended range to avoid the risk of environmental pollution.	[Ahmed, Waqas; Huang Jing; Ali, Sehrish; Han Tianfu; Qaswar, Muhammad; Du Jiangxue; Maitlo, Ali Akbar; Zhang, Huimin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China; [Ahmed, Waqas; Mahmood, Sajid; Chen, Di-Yun] Guangzhou Univ, Sch Environm Sci & Engn, Guangdong Prov Key Lab Radionuclides Pollut Contr, Guangzhou, Peoples R China; [Ahmed, Waqas; Mahmood, Sajid; Chen, Di-Yun] Guangzhou Univ, Sch Civil Engn, Guangzhou, Peoples R China; [Liu Kailou] Jiangxi Inst Red Soil, Natl Engn & Technol Res Ctr Red Soil Improvement, Nanchang, Jiangxi, Peoples R China; [Sun Geng; Chen Jin] Hunan Acad Agr Sci, Hunan Inst Soil & Fertilizer, Changsha, Peoples R China; [Maitlo, Ali Akbar] Agr Res Ctr, Soil Fertil Res Inst, Tandojam, Pakistan; [Maitlo, Ali Akbar] Govt Sindh, Dept Agr, Karachi, Pakistan; [Khan, Zulqarnain Haider] Minist Agr China, Agroenvironm Protect Inst, Tianjin, Peoples R China; [Khan, Zulqarnain Haider] Chinese Acad Agr Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Guangzhou University; Guangzhou University; Hunan Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences	Zhang, HM (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Engn Lab Improving Qual Arable Land, Beijing, Peoples R China.; Chen, DY (corresponding author), Guangzhou Univ, Sch Environm Sci & Engn, Guangdong Prov Key Lab Radionuclides Pollut Contr, Guangzhou, Peoples R China.; Chen, DY (corresponding author), Guangzhou Univ, Sch Civil Engn, Guangzhou, Peoples R China.	zhanghuimin@caas.cn; cdy@gzhu.edu.cn	Mehmood, Sajid/CAI-9590-2022; Tianfu, Han/GQQ-1239-2022; Qaswar, Muhammad/ABF-5905-2021; 韩, 天富/ABB-6633-2021	Qaswar, Muhammad/0000-0002-0288-6250; Ge, Mingxv/0000-0003-4730-0804	National Key Research and Development Program of China [2016YFD0300901]; Fundamental Research Funds for Central Non-profit Scientific Institutions of China [1610132019035, 1610132020023]; National Natural Science Foundation of China [41561070]; Project of Guangdong Provincial Key Laboratory of radioactive contamination control and resources [2017B030314182]; Science and Technology Program of Guangzhou, China [201804020072]	National Key Research and Development Program of China; Fundamental Research Funds for Central Non-profit Scientific Institutions of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Guangdong Provincial Key Laboratory of radioactive contamination control and resources; Science and Technology Program of Guangzhou, China	This research was supported by the National Key Research and Development Program of China (2016YFD0300901), the Fundamental Research Funds for Central Non-profit Scientific Institutions of China (1610132019035 and 1610132020023), the National Natural Science Foundation of China (41561070), the Project of Guangdong Provincial Key Laboratory of radioactive contamination control and resources (2017B030314182), and Science and Technology Program of Guangzhou, China (201804020072).	Abdala DB, 2012, AGR ECOSYST ENVIRON, V162, P15, DOI 10.1016/j.agee.2012.08.004; AHMED W, 2019, AGRONOMY-BASEL, V9, DOI DOI 10.3390/AGRONOMY9120784; Ahmed W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216881; Arias M, 2006, J COLLOID INTERF SCI, V295, P65, DOI 10.1016/j.jcis.2005.08.001; BACHE BW, 1971, J SOIL SCI, V22, P289, DOI 10.1111/j.1365-2389.1971.tb01617.x; Bera R, 2006, ENVIRON GEOL, V51, P399, DOI 10.1007/s00254-006-0335-9; Bhadha JH, 2012, GEODERMA, V173, P209, DOI 10.1016/j.geoderma.2011.12.027; Bhattacharyya P, 2015, CROP J, V3, P387, DOI 10.1016/j.cj.2015.03.009; Borno ML, 2018, SCI TOTAL ENVIRON, V627, P963, DOI 10.1016/j.scitotenv.2018.01.283; Cai AD, 2018, NUTR CYCL AGROECOSYS, V111, P61, DOI 10.1007/s10705-018-9918-6; Cole CV, 1954, J CHEM INF MODEL, DOI DOI 10.1017/CBO9781107415324.004; Debicka M, 2016, ARCH AGRON SOIL SCI, V62, P840, DOI 10.1080/03650340.2015.1083981; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Fageria NK, 2010, COMMUN SOIL SCI PLAN, V41, P1565, DOI 10.1080/00103624.2010.485237; Fang HW, 2017, SCI TOTAL ENVIRON, V605, P357, DOI 10.1016/j.scitotenv.2017.05.133; Fink JR, 2016, SOIL TILL RES, V155, P62, DOI 10.1016/j.still.2015.07.017; Gerard F, 2016, GEODERMA, V262, P213, DOI 10.1016/j.geoderma.2015.08.036; Gerard-Marchanti P, 2006, HYDROL EARTH SYST SC, V10, P245, DOI 10.5194/hess-10-245-2006; Gilbert N, 2009, NATURE, V461, P716, DOI 10.1038/461716a; Gou XM, 2020, J SOIL SEDIMENT, V20, P1371, DOI 10.1007/s11368-019-02493-2; Guedes RS, 2016, SOIL TILL RES, V162, P46, DOI 10.1016/j.still.2016.04.018; Heidari S, 2017, GEODERMA, V305, P275, DOI 10.1016/j.geoderma.2017.06.012; Holford ICR, 1997, AUST J SOIL RES, V35, P227, DOI 10.1071/S96047; Jiang J, 2008, CHEMOSPHERE, V71, P1469, DOI 10.1016/j.chemosphere.2007.12.012; Lai DY, 2009, ECOL ENG, V35, P735, DOI 10.1016/j.ecoleng.2008.11.009; Lair GJ, 2009, GEODERMA, V149, P39, DOI 10.1016/j.geoderma.2008.11.011; Lan ZM, 2012, BIOL FERT SOILS, V48, P579, DOI 10.1007/s00374-011-0650-5; Lin JW, 2017, ENVIRON SCI POLLUT R, V24, P12195, DOI 10.1007/s11356-017-8873-0; Liu SN, 2017, APPL SOIL ECOL, V116, P12, DOI 10.1016/j.apsoil.2017.03.020; Liu Y, 2018, CHEMOSPHERE, V207, P267, DOI 10.1016/j.chemosphere.2018.05.086; Lu HY, 2014, ENVIRON SCI POLLUT R, V21, P8782, DOI 10.1007/s11356-014-2813-z; McDonald GJ, 2019, SCI TOTAL ENVIRON, V660, P876, DOI 10.1016/j.scitotenv.2019.01.059; Messiga AJ, 2011, GEODERMA, V164, P225, DOI 10.1016/j.geoderma.2011.06.014; MOSHI AO, 1974, GEODERMA, V11, P275, DOI 10.1016/0016-7061(74)90054-8; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; QASWAR M, 2019, AGRONOMY-BASEL, V9, DOI DOI 10.3390/AGRONOMY9120780; [李仁英 Qiu Yixuan], 2013, [土壤通报, Journal of Soil Science], V44, P1134; Quesada CA, 2011, BIOGEOSCIENCES, V8, P1415, DOI 10.5194/bg-8-1415-2011; Siddique MT, 2004, SOIL SCI SOC AM J, V68, P1421, DOI 10.2136/sssaj2004.1421; Sui YB, 2000, SOIL SCI SOC AM J, V64, P164, DOI 10.2136/sssaj2000.641164x; Tellen V. A., 2018, Environmental Systems Research, V7, DOI 10.1186/s40068-018-0106-0; van der Salm C, 2017, SOIL USE MANAGE, V33, P2, DOI 10.1111/sum.12333; Walkley A, 1935, J AGR SCI, V25, P598, DOI 10.1017/S0021859600019687; Wang JB, 2011, PLANT SOIL ENVIRON, V57, P251, DOI 10.17221/437/2010-PSE; Wang LQ, 2014, CHEMOSPHERE, V103, P148, DOI 10.1016/j.chemosphere.2013.11.050; Wang SiQi, 2011, Research of Environmental Sciences, V24, P756; Wang YanLing, 2012, Acta Pedologica Sinica, V49, P552; WILLIAMS EG, 1956, J SOIL SCI, V7, P91, DOI 10.1111/j.1365-2389.1956.tb00866.x; Withers PJA, 2001, SOIL USE MANAGE, V17, P139, DOI 10.1079/SUM200181; Wu QH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176437; Xu RK, 2016, ADV AGRON, V135, P1, DOI 10.1016/bs.agron.2015.09.001; Yan JL, 2016, J ENVIRON SCI, V42, P152, DOI 10.1016/j.jes.2015.08.008; Yan X, 2013, AGR ECOSYST ENVIRON, V175, P47, DOI 10.1016/j.agee.2013.05.009; Yang XY, 2019, SOIL TILL RES, V187, P85, DOI 10.1016/j.still.2018.11.016; Yokoyama D, 2018, SOIL SCI PLANT NUTR, V64, P218, DOI 10.1080/00380768.2017.1421018; [张维理 Zhang Weili], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3214; Zhang YH, 2019, J SOIL SEDIMENT, V19, P1306, DOI 10.1007/s11368-018-2122-0; [钟晓英 Zhong Xiaoying], 2004, [生态学报, Acta Ecologica Sinica], V24, P2275; Zhou QX, 2003, GEODERMA, V115, P45, DOI 10.1016/S0016-7061(03)00074-0; Zhu J, 2018, SCI TOTAL ENVIRON, V612, P522, DOI 10.1016/j.scitotenv.2017.08.095	60	6	6	13	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246428	10.1371/journal.pone.0246428	http://dx.doi.org/10.1371/journal.pone.0246428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513183	Green Published, gold			2022-12-26	WOS:000613891400019
J	Fujishima, A; Takahashi, K; Goto, M; Hirakawa, T; Iwasawa, T; Togashi, K; Maeda, E; Shirasawa, H; Miura, H; Sato, W; Kumazawa, Y; Terada, Y				Fujishima, Akiko; Takahashi, Kazumasa; Goto, Mayumi; Hirakawa, Takeo; Iwasawa, Takuya; Togashi, Kazue; Maeda, Eri; Shirasawa, Hiromitsu; Miura, Hiroshi; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro			Live visualisation of electrolytes during mouse embryonic development using electrolyte indicators	PLOS ONE			English	Article							BLASTOCYST	Studies have shown that some electrolytes, including Na+ and K+, play important roles in embryonic development. However, these studies evaluated these electrolytes by using inhibitors or knockout mice, with no mention on the changes in the intracellular electrolyte concentrations during embryogenesis. In this study, we used the electrolyte indicators CoroNa Green AM and ION Potassium Green-2 AM to directly visualise intracellular concentrations of Na+ and K+, respectively, at each embryonic developmental stage in mouse embryos. We directly observed intracellular electrolyte concentrations at the morula, blastocyst, and hatching stages. Our results revealed dynamic changes in intracellular electrolyte concentrations; we found that the intracellular Na+ concentration decreased, while K+ concentration increased during blastocoel formation. The degree of change in intensity in response to ouabain, an inhibitor of Na+/K+ ATPase, was considered to correspond to the degree of Na+/K+ ATPase activity at each developmental stage. Additionally, after the blastocyst stage, trophectoderm cells in direct contact with the blastocoel showed higher K+ concentrations than in direct contact with inner cell mass, indicating that Na+/K+ ATPase activity differs depending on the location in the trophectoderm. This is the first study to use CoroNa Green AM and ION Potassium Green-2 AM in mouse embryos and visualise electrolytes during embryonic development. The changes in electrolyte concentration observed in this study were consistent with the activity of Na+/K+ ATPase reported previously, and it was possible to image more detailed electrolyte behaviour in embryo cells. This method can be used to improve the understanding of cell physiology and is useful for future embryonic development studies.	[Fujishima, Akiko; Takahashi, Kazumasa; Goto, Mayumi; Hirakawa, Takeo; Togashi, Kazue; Shirasawa, Hiromitsu; Miura, Hiroshi; Sato, Wataru; Kumazawa, Yukiyo; Terada, Yukihiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan; [Iwasawa, Takuya] Omagari Kousei Med Ctr, Dept Obstet & Gynecol, Akita, Japan; [Maeda, Eri] Akita Univ, Grad Sch Med, Dept Environm Hlth Sci & Publ Hlth, Akita, Japan	Akita University; Akita University	Fujishima, A (corresponding author), Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita, Japan.	fujishimaa@med.akita-u.ac.jp	Fujishima, Akiko/AAG-3412-2021	Fujishima, Akiko/0000-0002-8609-484X	Japan Society for the Promotion of Science [18H02942]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research (B) [Grant Number 18H02942].	Armant DR, 2015, ADV EXP MED BIOL, V843, P151, DOI 10.1007/978-1-4939-2480-6_6; BECKER DL, 1995, MICROSC RES TECHNIQ, V31, P364, DOI 10.1002/jemt.1070310506; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Day ML, 2001, REPROD FERT DEVELOP, V13, P69, DOI 10.1071/RD00048; Dean M, 2001, J LIPID RES, V42, P1007; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Giannatselis H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023704; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Hur CG, 2012, REPRODUCTION, V143, P625, DOI 10.1530/REP-11-0225; Iamshanova O, 2016, EUR BIOPHYS J BIOPHY, V45, P765, DOI 10.1007/s00249-016-1173-7; Kawagishi R, 2004, J EXP ZOOL PART A, V301A, P767, DOI 10.1002/jez.a.90; Marikawa Yusuke, 2012, Results Probl Cell Differ, V55, P165, DOI 10.1007/978-3-642-30406-4_9; Meier SD, 2006, J NEUROSCI METH, V155, P251, DOI 10.1016/j.jneumeth.2006.01.009; Niimura S, 2003, J REPROD DEVELOP, V49, P413, DOI 10.1262/jrd.49.413; Onodera Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175150; Saiz N, 2013, REPRODUCTION, V145, pR65, DOI 10.1530/REP-12-0381; Sediqi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204611; Sekar Ponarulselvam, 2018, Oncotarget, V9, P12718, DOI 10.18632/oncotarget.24331; Tosti E, 2016, BIRTH DEFECTS RES C, V108, P6, DOI 10.1002/bdrc.21125; Violette MI, 2006, DEV BIOL, V289, P406, DOI 10.1016/j.ydbio.2005.11.004; Watson AJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD708, DOI 10.2741/Watson; Yu LL, 2009, FERTIL STERIL, V91, P611, DOI 10.1016/j.fertnstert.2007.11.072	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246337	10.1371/journal.pone.0246337	http://dx.doi.org/10.1371/journal.pone.0246337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513193	Green Published, gold			2022-12-26	WOS:000613891400001
J	Miyata, K; Yoshikawa, T; Harano, A; Ueda, T; Ogata, N				Miyata, Kimie; Yoshikawa, Tadanobu; Harano, Akihiro; Ueda, Tetsuo; Ogata, Nahoko			Effects of visual impairment on mobility functions in elderly: Results of Fujiwara-kyo Eye Study	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; OLDER-ADULTS; WALKING SPEED; GAIT SPEED; SUBSEQUENT DISABILITY; STANDING BALANCE; FIELD LOSS; ASSOCIATION; PERFORMANCE; PREDICTOR	The aim of this study was to determine whether there is a significant association between a visual impairment (VI) and mobility functions in an elderly Japanese cohort. The subjects of this study were part of the Fujiwara-kyo Eye Study, a cross sectional epidemiological study of elderly individuals conducted by Nara Medical University. Participants were >= 70-years who lived in the Nara Prefecture. All underwent comprehensive ophthalmological examinations, and a VI was defined as a best-corrected visual acuity (BCVA) worse than 20/40 in the better eye. The associations between the BCVA and walking speed and one-leg standing time were determined. The medical history and health conditions were evaluated by a self-administered questionnaire. A total of the 2,809 subjects whose mean age was 76.3 +/- 4.8 years (+/- standard deviation) were studied. The individuals with a VI (2.1%) had significantly slower walking speeds and shorter one-leg standing times than that of the non-VI individuals (1.5 +/- 0.4 vs 1.7 +/- 0.4 m/sec, P<0.01; 17.1 +/- 19.6 vs 27.6 +/- 21.3 sec, P<0.01, respectively). Univariate logistic regression found that the odds ratio (OR) for the slower walking speed (<1 m/sec) in the VI individuals was significantly higher at 7.40 (3.36-16.30;95% CI, P <0.001) than in non-VI individuals. It was still significantly higher at 4.50 (1.87-10.85;95% CI, P = 0.001) in the multivariate logistic regression model after adjusting for the BCVA, age, sex, current smoking habit, and health conditions. Our results indicate that the walking speed and one-leg standing times were significantly associated with VI.	[Miyata, Kimie; Yoshikawa, Tadanobu; Ueda, Tetsuo; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Kashihara, Nara, Japan; [Harano, Akihiro] Yamatotakada Municipal Hosp, Dept Orthoped, Yamatotakada, Japan	Nara Medical University	Ogata, N (corresponding author), Nara Med Univ, Dept Ophthalmol, Kashihara, Nara, Japan.	ogata@naramed-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [24592637]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grant Number 24592637. JSPS had no role in the design or conduct of this research.	American Academy of Ophthalmology (AAO), 2010, PREF PRACT PATT VIS; Ayaki M, 2013, REJUV RES, V16, P35, DOI 10.1089/rej.2012.1369; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Chen LK, 2020, J AM MED DIR ASSOC, V21, P300, DOI 10.1016/j.jamda.2019.12.012; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Drusini AG, 2002, AGING CLIN EXP RES, V14, P42; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Freeman EE, 2007, INVEST OPHTH VIS SCI, V48, P4445, DOI 10.1167/iovs.07-0326; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Jacobs JM, 2005, AGING CLIN EXP RES, V17, P281; LAUKKANEN P, 1995, AGE AGEING, V24, P468, DOI 10.1093/ageing/24.6.468; Mine M, 2016, BIORESEARCH OPEN ACC, V5, P228, DOI 10.1089/biores.2016.0023; Miyata K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192677; Nezu S, 2014, J EPIDEMIOL, V24, P259, DOI 10.2188/jea.JE20130131; Niihata K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195806; Okamoto N, 2015, J ALZHEIMERS DIS, V44, P777, DOI 10.3233/JAD-141665; Ostir GV, 1998, J GERONTOL A-BIOL, V53, pM491, DOI 10.1093/gerona/53A.6.M491; Patel I, 2006, INVEST OPHTH VIS SCI, V47, P65, DOI 10.1167/iovs.05-0582; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Sakamoto K, 2006, J ORTHOP SCI, V11, P467, DOI 10.1007/s00776-006-1057-2; Satake S., 2019, RES REPORT FACTORS W; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Swenor BK, 2014, J AM GERIATR SOC, V62, P1540, DOI 10.1111/jgs.12937; Swenor BK, 2014, AM J EPIDEMIOL, V179, P313, DOI 10.1093/aje/kwt257; Swenor BK, 2013, INVEST OPHTH VIS SCI, V54, P7683, DOI 10.1167/iovs.13-12869; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Turano KA, 2004, OPTOMETRY VISION SCI, V81, P298, DOI 10.1097/01.opx.0000134903.13651.8e; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; West SK, 2002, ARCH OPHTHALMOL-CHIC, V120, P774	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0244997	10.1371/journal.pone.0244997	http://dx.doi.org/10.1371/journal.pone.0244997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QB1HB	33513151	gold, Green Published			2022-12-26	WOS:000613891400002
J	Robinson, M; Carter, KW; Pennell, CE; Jacoby, P; Moore, HC; Zubrick, SR; Burgner, D				Robinson, Monique; Carter, Kim W.; Pennell, Craig E.; Jacoby, Peter; Moore, Hannah C.; Zubrick, Stephen R.; Burgner, David			Maternal prenatal stress exposure and sex-specific risk of severe infection in offspring	PLOS ONE			English	Article							PSYCHOSOCIAL STRESS; EARLY ADVERSITY; DATA-LINKAGE; LIFE; PREGNANCY; DISEASES; OUTCOMES; EVENTS; ASTHMA; BIRTH	Background Maternal stressful life events during pregnancy have been associated with immune dysregulation and increased risk for asthma and atopy in offspring. Few studies have investigated whether prenatal stress is associated with increased overall or specific infectious diseases in childhood, nor explored sex differences. We sought to examine the relationship between the nature and timing of maternal stress in pregnancy and hospitalisation with infection in offspring. Methods Between 1989 and 1992, exposure data on stressful life events were collected from pregnant women (Gen1) in the Raine Study at 18 and 34 weeks' gestation and linked to statutory state-wide hospital morbidity data. We examined associations between the number, category and timing of maternal prenatal stress events and overall and clinical groups of offspring (Gen2) infection-related hospitalisation until age 16 years, adjusting for maternal age, education, and smoking in pregnancy in addition to the presence of siblings at birth. Results Of 2,141 offspring with complete stress in pregnancy data available, 1,089 had at least one infection-related hospitalisation, with upper respiratory tract infections the most common (n = 556). Each additional stressful life event during pregnancy was associated with increased risk in male offspring for hospitalisation with all infection types. There was little evidence of these associations in girls. Conclusions Increased exposure to stressful life events in utero is associated with sex-specific infection-related hospitalisations in childhood. Prenatal stress may adversely affect early immune development for boys and increase the risk of more severe infections. Mechanistic understanding would inform preventative interventions.	[Robinson, Monique; Carter, Kim W.; Jacoby, Peter; Moore, Hannah C.; Zubrick, Stephen R.] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Robinson, Monique; Zubrick, Stephen R.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Pennell, Craig E.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Moore, Hannah C.] Univ Western Australia, Wesfarmers Ctr Vaccines & Infect Dis, Telethon Kids Inst, Perth, WA, Australia; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Burgner, David] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Burgner, David] Monash Univ, Dept Paediat, Clayton, Vic, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Newcastle; Telethon Kids Institute; University of Western Australia; Wesfarmers Limited; Murdoch Children's Research Institute; University of Melbourne; Monash University	Robinson, M (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.; Robinson, M (corresponding author), Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia.	monique.robinson@telethonkids.org.au	Zubrick, Stephen R/CAI-1970-2022; Moore, Hannah/AHH-1092-2022	Zubrick, Stephen R/0000-0002-6369-1713; Moore, Hannah/0000-0001-6434-8290	Raine Medical Research Foundation; University of Western Australia (UWA); Telethon Kids Institute; UWA Faculty of Medicine, Dentistry and Health Science; Women and Infants Research Foundation; Curtin University; National Health and Medical Research Council of Australia (NHMRC) [963209, 211912, 003209, 353514]; Australian Health Management; Telstra Foundation; Western Australian Health Promotion Foundation; National Heart Foundation of Australia; Beyond Blue; NHMRC; Australian Research Council Centre of Excellence for Children and Families over the Life Course [CE140100027]	Raine Medical Research Foundation; University of Western Australia (UWA); Telethon Kids Institute; UWA Faculty of Medicine, Dentistry and Health Science; Women and Infants Research Foundation; Curtin University; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Health Management; Telstra Foundation; Western Australian Health Promotion Foundation; National Heart Foundation of Australia(National Heart Foundation of Australia); Beyond Blue; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence for Children and Families over the Life Course(Australian Research Council)	We acknowledge the support via core funding from the Raine Medical Research Foundation, The University of Western Australia (UWA), the Telethon Kids Institute, the UWA Faculty of Medicine, Dentistry and Health Science, the Women and Infants Research Foundation and Curtin University. The Raine Study is also funded by the National Health and Medical Research Council of Australia (NHMRC; Grants #963209, #211912, #003209 and #353514), Australian Health Management, the Telstra Foundation, the Western Australian Health Promotion Foundation, the National Heart Foundation of Australia and Beyond Blue. Drs. Robinson, Moore, and Burgner are funded for this research by the NHMRC. Prof Zubrick is funded by the Australian Research Council Centre of Excellence for Children and Families over the Life Course (CE140100027).	Avitsur R, 2015, STRESS, V18, P289, DOI 10.3109/10253890.2015.1017464; Ban L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-799; Beijers R, 2014, EUR CHILD ADOLES PSY, V23, P943, DOI 10.1007/s00787-014-0566-3; Beijers R, 2010, PEDIATRICS, V126, pE401, DOI 10.1542/peds.2009-3226; Bronson SL, 2014, ENDOCRINOLOGY, V155, P2635, DOI 10.1210/en.2014-1040; Burgner DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125342; Carmichael SL, 2007, EPIDEMIOLOGY, V18, P356, DOI 10.1097/01.ede.0000259986.85239.87; Challis J, 2013, PLACENTA, V34, P95, DOI 10.1016/j.placenta.2012.11.007; Davis EP, 2014, PSYCHONEUROENDOCRINO, V49, P11, DOI 10.1016/j.psyneuen.2014.06.014; de Marco R, 2012, PEDIAT ALLERG IMM-UK, V23, P724, DOI 10.1111/j.1399-3038.2012.01346.x; Dipietro JA, 2017, NEUROSCIENCE, V342, P4, DOI 10.1016/j.neuroscience.2015.07.068; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Fang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027202; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Henriksen RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137304; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Khashan AS, 2012, PSYCHOSOM MED, V74, P635, DOI 10.1097/PSY.0b013e31825ac5e7; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Korhonen LS, 2019, J PEDIATR-US, V208, P229, DOI 10.1016/j.jpeds.2018.12.050; Li J, 2008, ACTA PAEDIATR, V97, P221, DOI 10.1111/j.1651-2227.2007.00602.x; Li JH, 2013, J PEDIATR-US, V162, P483, DOI 10.1016/j.jpeds.2012.09.007; Martino D, 2011, CHEST, V139, P640, DOI 10.1378/chest.10-1800; McKnight CM, 2012, MED J AUSTRALIA, V197, P608, DOI 10.5694/mja12.10698; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller JE, 2016, LANCET INFECT DIS, V16, P952, DOI 10.1016/S1473-3099(16)00150-X; Moore HC, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028710; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Nielsen NM, 2011, AM J EPIDEMIOL, V173, P990, DOI 10.1093/aje/kwq492; Phelan AL, 2015, MATERN CHILD HLTH J, V19, P2587, DOI 10.1007/s10995-015-1777-z; Robinson M, 2011, DEV PSYCHOPATHOL, V23, P507, DOI 10.1017/S0954579411000241; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Seckl JR, 2007, NAT CLIN PRACT ENDOC, V3, P479, DOI 10.1038/ncpendmet0515; Solano ME, 2016, SEMIN IMMUNOPATHOL, V38, P739, DOI 10.1007/s00281-016-0575-z; Tegethoff M, 2011, ENVIRON HEALTH PERSP, V119, P1647, DOI 10.1289/ehp.1003253; TENNANT C, 1976, AUST NZ J PSYCHIAT, V10, P27, DOI 10.3109/00048677609159482; Veru F, 2014, STRESS, V17, P133, DOI 10.3109/10253890.2013.876404; World Health Organization, 1986, INT STAT CLASS DIS R; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC; Yu Y, 2017, PSYCHOL MED, V47, P389, DOI [10.1017/S003329171600266X, 10.1017/s003329171600266x]; Zazara DE, 2019, SEMIN IMMUNOPATHOL, V41, P137, DOI 10.1007/s00281-018-0713-x	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245747	10.1371/journal.pone.0245747	http://dx.doi.org/10.1371/journal.pone.0245747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QB1HB	33513152	gold, Green Published			2022-12-26	WOS:000613891400032
J	Gronlien, HK; Fontaine, R; Hodne, K; Tysseng, I; Ager-Wick, E; Weltzien, FA; Haug, TM				Gronlien, Heidi Kristine; Fontaine, Romain; Hodne, Kjetil; Tysseng, Isabelle; Ager-Wick, Eirill; Weltzien, Finn-Arne; Haug, Trude Marie			Long extensions with varicosity-like structures in gonadotrope Lh cells facilitate clustering in medaka pituitary culture	PLOS ONE			English	Article							GROWTH CONE MOTILITY; ANTERIOR-PITUITARY; PLASTICITY; HORMONE; DYNAMICS; AXIS; PROLIFERATION; ORGANIZATION; MECHANISMS; EXPRESSION	Accumulating evidence indicates that some pituitary cell types are organized in complex networks in both mammals and fish. In this study, we have further investigated the previously described cellular extensions formed by the medaka (Oryzias latipes) luteinizing hormone gonadotropes (Lh cells). Extensions, several cell diameters long, with varicosity-like swellings, were common both in vitro and in vivo. Some extensions approached other Lh cells, while others were in close contact with blood vessels in vivo. Gnrh further stimulated extension development in vitro. Two types of extensions with different characteristics could be distinguished, and were classified as major or minor according to size, origin and cytoskeleton protein dependance. The varicosity-like swellings appeared on the major extensions and were dependent on both microtubules and actin filaments. Immunofluorescence revealed that Lh beta protein was mainly located in these swellings and at the extremity of the extensions. We then investigated whether these extensions contribute to network formation and clustering, by following their development in primary cultures. During the first two days in culture, the Lh cells grew long extensions that with time physically attached to other cells. Successively, tight cell clusters formed as cell somas that were connected via extensions migrated towards each other, while shortening their extensions. Laser photolysis of caged Ca2+ showed that Ca2+ signals originating in the soma propagated from the soma along the major extensions, being particularly visible in each swelling. Moreover, the Ca2+ signal could be transferred between densely clustered cells (sharing soma-soma border), but was not transferred via extensions to the connected cell. In summary, Lh gonadotropes in medaka display a complex cellular structure of hormone-containing extensions that are sensitive to Gnrh, and may be used for clustering and possibly hormone release, but do not seem to contribute to communication between cells themselves.	[Gronlien, Heidi Kristine] Ostfold Univ Coll, Fac Hlth & Welf, Halden, Norway; [Fontaine, Romain; Hodne, Kjetil; Ager-Wick, Eirill; Weltzien, Finn-Arne] Norwegian Univ Life Sci, Fac Vet Med, Physiol Unit, Oslo, Norway; [Tysseng, Isabelle] Univ Oslo, Fac Nat Sci, Dept Biosci, Oslo, Norway; [Haug, Trude Marie] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway	Ostfold University College; Norwegian University of Life Sciences; University of Oslo; University of Oslo	Haug, TM (corresponding author), Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway.	t.m.haug@odont.uio.no	; FONTAINE, Romain/N-6596-2018	Ager-Wick, Eirill/0000-0001-8368-2008; Haug, Trude/0000-0003-3776-5077; FONTAINE, Romain/0000-0003-1123-9773	Norwegian Research Council [184851, 191825]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	Supported by grants from the Norwegian Research Council (https://www.forskningsradet.no/en/): 184851 (FAW) and 191825 (TMH) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1980, PROC R SOC SER B-BIO, V207, P129, DOI 10.1098/rspb.1980.0017; Ager-Wick E, 2018, JOVE-J VIS EXP, DOI 10.3791/58159; Alim Z, 2012, ENDOCRINOLOGY, V153, P4729, DOI 10.1210/en.2012-1360; Antanaviciute I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099196; Bonnefont X, 2005, P NATL ACAD SCI USA, V102, P16880, DOI 10.1073/pnas.0508202102; Bornschlogl T, 2013, CYTOSKELETON, V70, P590, DOI 10.1002/cm.21130; Budry L, 2011, P NATL ACAD SCI USA, V108, P12515, DOI 10.1073/pnas.1105929108; Burow S, 2019, GEN COMP ENDOCR, V272, P93, DOI 10.1016/j.ygcen.2018.12.006; Chang JP, 2018, MOL CELL ENDOCRINOL, V463, P142, DOI 10.1016/j.mce.2017.06.002; CHILDS GV, 1983, PEPTIDES, V4, P549, DOI 10.1016/0196-9781(83)90061-X; CHILDS GV, 1985, PEPTIDES, V6, P103, DOI 10.1016/0196-9781(85)90084-1; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Edelstein Arthur D, 2014, J Biol Methods, V1; Edwards BS, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00223; Eom DS, 2015, ELIFE, V4, DOI 10.7554/eLife.12401; Fontaine R, 2020, J ENDOCRINOL, V245, P21, DOI 10.1530/JOE-19-0405; Fontaine R, 2020, GEN COMP ENDOCR, V287, DOI 10.1016/j.ygcen.2019.113344; Fontaine R, 2019, JOVE-J VIS EXP, DOI 10.3791/59768; Fontaine R, 2019, J ENDOCRINOL, V240, P361, DOI 10.1530/JOE-18-0412; Godoy J, 2011, MOL ENDOCRINOL, V25, P810, DOI 10.1210/me.2010-0352; Gongrich C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmol.2076.00065, 10.3389/fnmol.2016.00065]; Golan M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24426; Golan M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23777; Golan M, 2015, ENDOCRINOLOGY, V156, P4163, DOI 10.1210/en.2015-1150; Golan M, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00182; Gomez TM, 2014, J NEUROCHEM, V129, P221, DOI 10.1111/jnc.12506; Hildahl J, 2012, DEV DYNAM, V241, P1665, DOI 10.1002/dvdy.23860; Hodne K, 2019, ENDOCRINOLOGY, V160, P3018, DOI 10.1210/en.2019-00595; Hodne K, 2013, ENDOCRINOLOGY, V154, P3319, DOI 10.1210/en.2013-1164; Hodne K, 2012, GEN COMP ENDOCR, V178, P206, DOI 10.1016/j.ygcen.2012.06.005; Kanda S, 2011, GEN COMP ENDOCR, V173, P253, DOI 10.1016/j.ygcen.2011.05.015; Kornberg TB, 2014, TRENDS CELL BIOL, V24, P370, DOI 10.1016/j.tcb.2014.01.003; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Le Tissier PR, 2015, ADV EXP MED BIOL, V846, P139, DOI 10.1007/978-3-319-12114-7_6; Le Tissier P, 2017, NAT REV ENDOCRINOL, V13, P257, DOI 10.1038/nrendo.2016.193; Leduc C, 2015, CURR OPIN CELL BIOL, V32, P102, DOI 10.1016/j.ceb.2015.01.005; Levavi-Sivan B, 2005, ENDOCRINOLOGY, V146, P1048, DOI 10.1210/en.2004-1415; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Malkinson G, 2010, EXP NEUROL, V225, P140, DOI 10.1016/j.expneurol.2010.06.005; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Mollard P, 2012, TRENDS ENDOCRIN MET, V23, P261, DOI 10.1016/j.tem.2012.02.004; Musumeci G, 2015, ACTA HISTOCHEM, V117, P355, DOI 10.1016/j.acthis.2015.02.008; Navratil AM, 2007, ENDOCRINOLOGY, V148, P1736, DOI 10.1210/en.2006-1153; Navratil AM, 2014, ENDOCRINOLOGY, V155, P548, DOI 10.1210/en.2012-1924; Nguyen KA, 2004, MOL ENDOCRINOL, V18, P1301, DOI 10.1210/me.2003-0478; Pope C, 2006, DEV BIOL, V297, P172, DOI 10.1016/j.ydbio.2006.05.005; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulz RW, 1997, BIOL REPROD, V57, P139, DOI 10.1095/biolreprod57.1.139; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SMITH SJ, 1988, SCIENCE, V242, P708, DOI 10.1126/science.3055292; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Stojilkovic SS, 2012, CELL CALCIUM, V51, P212, DOI 10.1016/j.ceca.2011.11.003; Strandabo RAU, 2016, GEN COMP ENDOCR, V229, P19, DOI 10.1016/j.ygcen.2016.02.019; Strandabo RAU, 2013, MOL CELL ENDOCRINOL, V372, P128, DOI 10.1016/j.mce.2013.03.022; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; van Beuningen SFB, 2016, CURR OPIN NEUROBIOL, V39, P1, DOI 10.1016/j.conb.2016.02.003; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; Weltzien FA, 2014, MOL CELL ENDOCRINOL, V385, P18, DOI 10.1016/j.mce.2013.10.016; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	61	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245462	10.1371/journal.pone.0245462	http://dx.doi.org/10.1371/journal.pone.0245462			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507913	gold, Green Published			2022-12-26	WOS:000635021400035
J	Larbi, RT; Atiglo, DY; Peterson, MB; Biney, AAE; Dodoo, ND; Dodoo, FNA				Larbi, Reuben Tete; Atiglo, D. Yaw; Peterson, Maame B.; Biney, Adriana A. E.; Dodoo, Naa Dodua; Dodoo, F. Nii-Amoo			Household food sources and diarrhoea incidence in poor urban communities, Accra Ghana	PLOS ONE			English	Article							DRINKING-WATER; STREET FOODS; CONTAMINATION; SANITATION; HYGIENE; SETTINGS; CHILDREN; DISEASE; BURDEN; SAFETY	Diarrhoeal diseases remain a significant cause of morbidity and mortality, particularly in poor urban communities in the Global South. Studies on food access and safety have however not considered the sources of discrete food categories and their propensity to harbour and transmit diarrhoeal disease pathogens in poor urban settings. We sought to contribute to knowledge on urban food environment and enteric infections by interrogating the sources and categories of common foods and their tendency to transmit diarrhoea in low-income communities in Accra. We modelled the likelihood of diarrhoea transmission through specific food categories sourced from home or out of home after controlling for alternate transmission pathways and barriers. We used structured interviews where households that participated in the study were selected through a multi-stage systematic sampling approach. We utilized data on 506 households from 3 low-income settlements in Accra. These settlements have socio-economic characteristics mimicking typical low-income communities in the Global South. The results showed that the incidence of diarrhoea in a household is explained by type and source of food, source of drinking water, wealth and the presence of children below five years in the household. Rice-based staples which were consumed by 94.5% of respondents in the week preceding the survey had a higher likelihood of transmitting diarrhoeal diseases when consumed out of home than when eaten at home. Sources of hand-served dumpling-type foods categorized as "staple balls" had a nuanced relationship with incidence of diarrhoea. These findings reinforce the need for due diligence in addressing peculiar needs of people in vulnerable conditions of food environment in poor urban settlements in order to reap a co-benefit of reduced incidence of diarrhoea while striving to achieve the global development goal on ending hunger.	[Larbi, Reuben Tete; Atiglo, D. Yaw; Peterson, Maame B.; Biney, Adriana A. E.; Dodoo, Naa Dodua] Univ Ghana, Reg Inst Populat Studies RIPS, Legon, Accra, Ghana; [Dodoo, F. Nii-Amoo] Penn State Univ, Dept Sociol & Criminol, State Coll, PA USA; [Larbi, Reuben Tete] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Peterson, Maame B.] African Inst Dev Policy AFIDEP, Lilongwe, Malawi	University of Ghana; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Lancaster University	Biney, AAE (corresponding author), Univ Ghana, Reg Inst Populat Studies RIPS, Legon, Accra, Ghana.	abinay@ug.edu.gh	Biney, Adriana Andrea Ewurabena/O-1477-2018	Biney, Adriana Andrea Ewurabena/0000-0002-7188-0135; Atiglo, D Yaw/0000-0001-6298-6475	William and Flora Hewlett Foundation; International Development Research Centre (IDRC); Research on Obesity and Diabetes among African Migrants (RODAM)	William and Flora Hewlett Foundation; International Development Research Centre (IDRC); Research on Obesity and Diabetes among African Migrants (RODAM)	FNAD received a William and Flora Hewlett Foundation grant which partly covered this study. Other partial funders include International Development Research Centre (IDRC) and Research on Obesity and Diabetes among African Migrants (RODAM). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababio P. F., 2012, INTERNET J FOOD SAFE, V14, P35; Ababio PF, 2015, FOOD CONTROL, V47, P92, DOI 10.1016/j.foodcont.2014.06.041; Abu M, 2018, INT J ENV RES PUB HE, V15, DOI [10.3390/ijerph15122830, 10.3390/ijerph15]; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Almagro-Moreno S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004787; Annan-Prah A, 2011, AFR J MICROBIOL RES, V5, P1629; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Asiedu AB, 2008, NORSK GEOGR TIDSSKR, V62, P191, DOI 10.1080/00291950802335806; Cairncross S., 2018, ENV HLTH ENG TROPICS; Carvajal-Velez L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3475-1; Codjoe SNA, 2016, FOOD NUTR BULL, V37, P202, DOI 10.1177/0379572116631882; Codjoe SNA, 2015, NAT HAZARDS, V77, P787, DOI 10.1007/s11069-015-1624-y; Dake FAA, 2016, J URBAN HEALTH, V93, P438, DOI 10.1007/s11524-016-0044-y; Dapaah EK, 2017, GEOFORUM, V82, P26, DOI 10.1016/j.geoforum.2017.03.011; Donkor ES, 2009, INT J ENV RES PUB HE, V6, P2833, DOI 10.3390/ijerph6112833; Dzotsi E K, 2015, Ghana Med J, V49, P65, DOI 10.4314/gmj.v49i2.1; Fegloi P, 2012, J MED BIOMED SCI, V1, P1; Fobil JN, 2012, J URBAN HEALTH, V89, P977, DOI 10.1007/s11524-012-9702-x; Ghana Standard Authority, GSA 2013; Ghana Statistical Service, 2016, HLTH CHILDR WOM GHAN; Ghana Statistical Service, 2013, 2010 POP HOUS CENS; Ghana Statistical Service, 2012, FIN REP POP HOUS CEN; Guerrant RL, 2013, NAT REV GASTRO HEPAT, V10, P220, DOI 10.1038/nrgastro.2012.239; Gupta V, 2016, J NUTR EDUC BEHAV, V48, P269, DOI 10.1016/j.jneb.2015.11.006; Habitat U.N., 2016, WORLD CIT REP 2016 U; HENRY FJ, 1990, EPIDEMIOL INFECT, V104, P253, DOI 10.1017/S0950268800059422; Hogan D., 2015, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6; Jensen PK, 2002, TROP MED INT HEALTH, V7, P604, DOI 10.1046/j.1365-3156.2002.00901.x; Kirk MD, 2017, B WORLD HEALTH ORGAN, V95, P233, DOI [10.2471/BLT.16.173229, 10.2471/blt.16.173229]; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Korpe PS, 2019, CLIN INFECT DIS, V68, P1073, DOI 10.1093/cid/ciy593; Larcombe S, 2016, TRENDS MICROBIOL, V24, P463, DOI 10.1016/j.tim.2016.02.001; Luthi C, 2010, INT J URBAN SUSTAIN, V1, P49, DOI 10.1080/19463131003654764; Machdar E, 2013, SCI TOTAL ENVIRON, V449, P134, DOI 10.1016/j.scitotenv.2013.01.048; Mensah P, 2002, B WORLD HEALTH ORGAN, V80, P546; Monney I., 2013, Journal of Environment and Earth Science, V3, P72; Ogbo FA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171792; Patzi-Vargas S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003510; Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8; Pinkerton R, 2016, AM J TROP MED HYG, V95, P1004, DOI 10.4269/ajtmh.16-0150; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Rane S, 2011, INDIAN J MICROBIOL, V51, P100, DOI 10.1007/s12088-011-0154-x; Rheinlander T, 2008, J URBAN HEALTH, V85, P952, DOI 10.1007/s11524-008-9318-3; Tortoe C., 2013, Food and Public Health, V3, P59; Wagner E. G., 1958, MONOGRAPH SERIES; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wasihun AG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207743; Wierzba TF, 2018, LANCET GLOB HEALTH, V6, pE230, DOI 10.1016/S2214-109X(18)30047-0; Wolf J, 2019, INT J HYG ENVIR HEAL, V222, P270, DOI 10.1016/j.ijheh.2018.11.005; World Health Organization [WHO], 2015, ESTIMATES GLOBAL BUR; World Health Organization (WHO) and the United Nations Children's Fund (UNICEF), 2017, PROGR DRINKING WATER; Yeboah-Manu D., 2010, Research Journal of Microbiology, V5, P130	52	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245466	10.1371/journal.pone.0245466	http://dx.doi.org/10.1371/journal.pone.0245466			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508014	Green Published, gold			2022-12-26	WOS:000635021400036
J	Luo, ZZ; Ding, Y; Yuan, J; Tian, LS; Zhang, L; Wu, QH; Mou, JS				Luo, Zhenzhou; Ding, Yi; Yuan, Jun; Tian, Lishan; Zhang, Li; Wu, Qiuhong; Mou, Jinsong			Predictors of serological cure after penicillin therapy in HIV-negative patients with early syphilis in Shenzhen, China	PLOS ONE			English	Article							TREPONEMA-PALLIDUM	Background Syphilis is a common infectious disease worldwide. Serological monitoring is important for syphilis management. We currently know little about the characteristics of this seronegative response. The aim of this study was to explore the factors associated with serological cure after treatment of early syphilis. Methods A retrospective cohort study was conducted and the data of patients with early syphilis in a clinic in Shenzhen from 2011 to 2019 were retrieved. Univariable and multiple Cox proportional hazard regression models were utilized to identify factors associated with a serological cure state among syphilis patients with early syphilis two years after treatment. Results A total of 346 (85.9%) syphilis patients achieved serological cure. The multivariate analysis results revealed that having a baseline TRUST titer > 1:8 was associated with an increased probability of serological cure, compared with having a baseline TRUST titer <= 1:8 (HR = 1.43, 95% CI = 1.10-1.85, P< 0.01); primary syphilis was positively associated with serological cure, compared with participants with latent early syphilis (HR = 1.72, 95% CI = 1.272.33, P< 0.001). Conclusions Two years after treatment, a higher percentage of early syphilis patients achieved serological cure. The study indicated that the syphilis stage and baseline serum titer were crucial factors associated with serological cure.	[Luo, Zhenzhou; Ding, Yi; Yuan, Jun; Tian, Lishan; Zhang, Li; Wu, Qiuhong] Shenzhen Nanshan Ctr Chron Dis Control, Shenzhen, Peoples R China; [Mou, Jinsong] Shenzhen Pingshan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China		Mou, JS (corresponding author), Shenzhen Pingshan Maternal & Child Hlth Hosp, Shenzhen, Peoples R China.	moujs@foxmail.com			Shenzhen Healthcare Research Project [SZGW2018001]	Shenzhen Healthcare Research Project	Shenzhen Healthcare Research Project [SZGW2018001] supported the study.	BAKERZANDER SA, 1993, J INFECT DIS, V167, P1100, DOI 10.1093/infdis/167.5.1100; Chen XS, 2019, NAT HIV STD HEP C PR; Ghanem KG, 2007, SEX TRANSM INFECT, V83, P97, DOI 10.1136/sti.2006.021402; Goh BT, 2005, SEX TRANSM INFECT, V81, P448, DOI 10.1136/sti.2005.015875; Hook EW, 2017, LANCET, V389, P1550, DOI 10.1016/S0140-6736(16)32411-4; Knaute DF, 2012, CLIN INFECT DIS, V55, P1615, DOI 10.1093/cid/cis757; Lan LiNa, 2015, China Tropical Medicine, V15, P700; Li J, 2013, SEX TRANSM INFECT, V89, P69, DOI 10.1136/sextrans-2012-050711; PETTIT DE, 1983, J CLIN MICROBIOL, V18, P1141, DOI 10.1128/JCM.18.5.1141-1145.1983; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; ROMANOWSKI B, 1991, ANN INTERN MED, V114, P1005, DOI 10.7326/0003-4819-114-12-1005; Salazar JC, 2002, MICROBES INFECT, V4, P1133, DOI 10.1016/S1286-4579(02)01638-6; Sena AC, 2011, CLIN INFECT DIS, V53, P1092, DOI 10.1093/cid/cir671; Tong ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070102; WHO, 2015, WHO GUIDELINES TREAT; Wong NS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27173-y; Wu XB, 2012, SEX TRANSM INFECT, V88, P325, DOI 10.1136/sextrans-2011-050397; Yang LG, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-793; Yang SG, 2017, LANCET INFECT DIS, V17, P716, DOI 10.1016/S1473-3099(17)30227-X; [邹亚明 Zou Yaming], 2016, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V37, P142	20	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245812	10.1371/journal.pone.0245812	http://dx.doi.org/10.1371/journal.pone.0245812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508015	gold, Green Published			2022-12-26	WOS:000635021400054
J	Olmos, C; Campana, G; Monreal, V; Pidal, P; Sanchez, N; Airola, C; Sanhueza, D; Tapia, P; Munoz, AM; Corvalan, F; Hurtado, S; Meneses, C; Orellana, A; Montecino, M; Arriagada, G; Bustos, FJ				Olmos, Claudio; Campana, Gonzalo; Monreal, Victor; Pidal, Paola; Sanchez, Nannet; Airola, Constanza; Sanhueza, Dayan; Tapia, Patricio; Munoz, Ana Maria; Corvalan, Felipe; Hurtado, Sebastian; Meneses, Claudio; Orellana, Ariel; Montecino, Martin; Arriagada, Gloria; Bustos, Fernando Jose			SARS-CoV-2 infection in asymptomatic healthcare workers at a clinic in Chile	PLOS ONE			English	Article								Asymptomatic SARS-CoV-2 infection of healthcare workers (HCWs) has been reported as a key player in the nosocomial spreading of COVID-19. Early detection of infected HCWs can prevent spreading of the virus in hospitals among HCWs and patients. We conducted a cross-sectional study to determine the asymptomatic infection of HCWs in a private clinic in the city of Santiago, Chile. Our study was conducted during a period of 5 weeks at the peak of transmission of SARS-CoV-2 in Chile. Nasopharyngeal samples were obtained from 413 HCWs and tested for the presence of SARS-CoV-2 using RT-qPCR. We found that a 3.14% of HCWs were positive for the presence of SARS-CoV-2 (14/413). Out of these, 7/14 were completely asymptomatic and did not develop symptoms within 3 weeks of testing. Sequencing of viral genomes showed the predominance of the GR clade; however, sequence comparison demonstrated numerous genetic differences among them suggesting community infection as the main focus of transmission among HCWs. Our study demonstrates that the protocols applied to protect HCWs and patients have been effective as no infection clusters due to asymptomatic carriers were found in the clinic. Together, these data suggest that infection with SARS-CoV-2 among HCWs of this health center is not nosocomial.	[Olmos, Claudio; Campana, Gonzalo; Monreal, Victor; Pidal, Paola; Sanchez, Nannet; Airola, Constanza; Munoz, Ana Maria; Corvalan, Felipe; Hurtado, Sebastian] Clin INDISA, Santiago, Chile; [Olmos, Claudio; Campana, Gonzalo; Monreal, Victor] Univ Andres Bello, Fac Med, Santiago, Chile; [Sanhueza, Dayan; Tapia, Patricio; Meneses, Claudio; Orellana, Ariel] Univ Andres Bello, Fac Ciencias Vida, Ctr Biotecnol Vegetal, Santiago, Chile; [Tapia, Patricio; Meneses, Claudio; Orellana, Ariel; Montecino, Martin] FONDAP Ctr Genome Regulat, Santiago, Chile; [Montecino, Martin; Arriagada, Gloria; Bustos, Fernando Jose] Univ Andres Bello, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Montecino, Martin; Arriagada, Gloria; Bustos, Fernando Jose] Univ Andres Bello, Fac Ciencias Vida, Santiago, Chile	Clinica Indisa; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello; Universidad Andres Bello	Bustos, FJ (corresponding author), Univ Andres Bello, Fac Med, Inst Ciencias Biomed, Santiago, Chile.; Bustos, FJ (corresponding author), Univ Andres Bello, Fac Ciencias Vida, Santiago, Chile.	fernando.bustos@unab.cl	Orellana, Ariel/E-2166-2014; Arriagada, Gloria/AAS-1427-2021	Orellana, Ariel/0000-0002-9243-808X; Tapia-Reyes, Patricio/0000-0001-8797-6206	Fondecyt [1180705, 11180540]; FONDAP CRG [15090007]; CONICYT-PAI [77180077]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP CRG(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CONICYT-PAI	This work was supported by Fondecyt 11180540 (to FJB), CONICYT-PAI 77180077 (to FJB and MM), Fondecyt 1180705 (to GA), FONDAP CRG 15090007 (to MM, AO and CM).	Evans S., 2020, MEDRXIV, DOI [10.1101/2020.05.12.20095562, DOI 10.1101/2020.05.12.20095562]; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2013; Jones NK, 2020, ELIFE, V9, DOI 10.7554/eLife.59391; Kenyon C, 2020, INT J INFECT DIS, V97, P21, DOI 10.1016/j.ijid.2020.05.102; Kluytmans-van den Bergh M, 2020, SARS COV 2 INFECT 86, DOI [10.1101/2020.03.23.20041913, DOI 10.1101/2020.03.23.20041913]; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lucey M, 2021, CLIN INFECT DIS, V72, pE727, DOI 10.1093/cid/ciaa1433; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Treibel TA, 2020, LANCET, V395, P1608, DOI 10.1016/S0140-6736(20)31100-4; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Zhou Q, 2020, NOSOCOMIAL INFECTION, V2020, DOI [10.1101/2020.04.14.20065730, DOI 10.1101/2020.04.14.20065730]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	15	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245913	10.1371/journal.pone.0245913	http://dx.doi.org/10.1371/journal.pone.0245913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507981	Green Published, gold			2022-12-26	WOS:000635021400063
J	Shang, YD; Inthavong, K; Qiu, DS; Singh, N; He, FJ; Tu, JY				Shang, Yidan; Inthavong, Kiao; Qiu, Dasheng; Singh, Narinder; He, Fajiang; Tu, Jiyuan			Prediction of nasal spray drug absorption influenced by mucociliary clearance	PLOS ONE			English	Article							IN-VITRO TESTS; NANOPARTICLE DEPOSITION; PHARMACEUTICAL AEROSOLS; INHALED NANOPARTICLES; OLFACTORY DEPOSITION; PARTICLE DEPOSITION; DELIVERY; MUCUS; PARAMETERS; SUSPENSION	Evaluation of nasal spray drug absorption has been challenging because deposited particles are consistently transported away by mucociliary clearance during diffusing through the mucus layer. This study developed a novel approach combining Computational Fluid Dynamics (CFD) techniques with a 1-D mucus diffusion model to better predict nasal spray drug absorption. This integrated CFD-diffusion approach comprised a preliminary simulation of nasal airflow, spray particle injection, followed by analysis of mucociliary clearance and drug solute diffusion through the mucus layer. The spray particle deposition distribution was validated experimentally and numerically, and the mucus velocity field was validated by comparing with previous studies. Total and regional drug absorption for solute radius in the range of 1 - 110nm were investigated. The total drug absorption contributed by the spray particle deposition was calculated. The absorption contribution from particles that deposited on the anterior region was found to increase significantly as the solute radius became larger (diffusion became slower). This was because the particles were consistently moved out of the anterior region, and the delayed absorption ensured more solute to be absorbed by the posterior regions covered with respiratory epithelium. Future improvements in the spray drug absorption model were discussed. The results of this study are aimed at working towards a CFD-based integrated model for evaluating nasal spray bioequivalence.	[Shang, Yidan; He, Fajiang] Shanghai Univ Engn Sci, Coll Air Transportat, Shanghai, Peoples R China; [Shang, Yidan; Inthavong, Kiao; Tu, Jiyuan] RMIT Univ, Sch Engn, Bundoora, Vic, Australia; [Qiu, Dasheng] Hubei Canc Hosp, Dept Nucl Med Positron Emiss Tomog Computed Tomog, Wuhan, Hubei, Peoples R China; [Singh, Narinder] Westmead Hosp, Dept Otolaryngol Head & Neck Surg, Sydney, NSW, Australia; [Singh, Narinder] Univ Sydney, Sch Med, Sydney, NSW, Australia	Shanghai University of Engineering Science; Royal Melbourne Institute of Technology (RMIT); University of Sydney; University of Sydney	Inthavong, K (corresponding author), RMIT Univ, Sch Engn, Bundoora, Vic, Australia.; Qiu, DS (corresponding author), Hubei Canc Hosp, Dept Nucl Med Positron Emiss Tomog Computed Tomog, Wuhan, Hubei, Peoples R China.	kiao.inthavong@rmit.edu.au; hbpetct@163.com	Shang, Yidan/A-4512-2018; inthavong, kiao/B-3526-2012	inthavong, kiao/0000-0003-0476-0237; Shang, Yidan/0000-0001-8705-1625	National Natural Science Foundation of China [91643102, 81800096]; Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council [DP160101953]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Garnett Passe and Rodney Williams Memorial Foundation; Australian Research Council(Australian Research Council)	This study was funded by the: 1. National Natural Science Foundation of China (Grant No. 81800096 to Yidan Shang, http://www.nsfc.gov.cn/english/site_1/index.html); 2. National Natural Science Foundation of China (Grant No. 91643102 to Jiyuan Tu, http://www.nsfc.gov.cn/english/site_ 1/index.html); 3. Garnett Passe and Rodney Williams Memorial Foundation Conjoint Grant 2019 (Inthavong-Singh granted to Kiao Inthavong and Narinder Singh, https://gprwmf.org.au/); 4. Australian Research Council (Project ID: DP160101953 granted to Jiyuan Tu, https://www.arc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouali O, 2012, RESP PHYSIOL NEUROBI, V181, P335, DOI 10.1016/j.resp.2012.03.002; Amsden B, 1999, MACROMOLECULES, V32, P874, DOI 10.1021/ma980922a; Asgharian B, 2007, INHAL TOXICOL, V19, P1045, DOI 10.1080/08958370701626501; Azimi M., 2015, RESP DRUG DELIVERY E, P121; Basu S, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2946; Chen XL, 2018, AEROSOL SCI TECH, V52, P900, DOI 10.1080/02786826.2018.1476751; Crank J., 1979, MATH DIFFUSION; Cu Y, 2009, ADV DRUG DELIVER REV, V61, P101, DOI 10.1016/j.addr.2008.09.006; Dayal P, 2004, J PHARM SCI-US, V93, P1725, DOI 10.1002/jps.20090; Djupesland PG, 2013, DRUG DELIV TRANSL RE, V3, P42, DOI 10.1007/s13346-012-0108-9; Dong JL, 2016, TOXICOL SCI, V152, P284, DOI 10.1093/toxsci/kfw087; Erickson AM, 2015, BIOPHYS J, V109, P164, DOI 10.1016/j.bpj.2015.05.034; Garcia GJM, 2009, J AEROSOL MED PULM D, V22, P139, DOI 10.1089/jamp.2008.0713; Gizurarson S, 2015, BIOL PHARM BULL, V38, P497, DOI 10.1248/bpb.b14-00398; Gu X, 2019, EXP COMPUT MULTI FLO, V1, P39, DOI 10.1007/s42757-019-0007-0; Inthavong K, 2008, COMPUT BIOL MED, V38, P713, DOI 10.1016/j.compbiomed.2008.03.008; Inthavong K, 2006, AEROSOL SCI TECH, V40, P1034, DOI 10.1080/02786820600924978; Inthavong K, 2011, J AEROSOL SCI, V42, P100, DOI 10.1016/j.jaerosci.2010.11.008; Inthavong K, 2014, RESP PHYSIOL NEUROBI, V190, P54, DOI 10.1016/j.resp.2013.09.004; Islam MS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17020380; Kolanjiyil AV, 2019, RESP PHYSIOL NEUROBI, V260, P82, DOI 10.1016/j.resp.2018.11.003; Liu YA, 2010, J AEROSOL SCI, V41, P569, DOI 10.1016/j.jaerosci.2010.02.014; MORSI SA, 1972, J FLUID MECH, V55, P193, DOI 10.1017/S0022112072001806; Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4; Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79; Pirhadi M, 2018, J AEROSOL SCI, V118, P64, DOI 10.1016/j.jaerosci.2018.01.010; PUCHELLE E, 1987, BIORHEOLOGY, V24, P557; Rygg A, 2016, J AEROSOL MED PULM D, V29, P416, DOI 10.1089/jamp.2015.1252; Rygg A, 2016, PHARM RES-DORDR, V33, P909, DOI 10.1007/s11095-015-1837-5; Schroeter JD, 2006, J AEROSOL MED, V19, P301, DOI 10.1089/jam.2006.19.301; Shah SA, 2015, ALLERGY ASTHMA PROC, V36, P48, DOI 10.2500/aap.2015.36.3817; Shang Y, 2017, EUR J MECH B-FLUID, V61, P160, DOI 10.1016/j.euromechflu.2016.09.024; Shang YD, 2019, J BIOMECH, V85, P74, DOI 10.1016/j.jbiomech.2019.01.015; Si XHA, 2013, RESP PHYSIOL NEUROBI, V186, P22, DOI 10.1016/j.resp.2012.12.005; Siu J, 2020, COMPUT BIOL MED, V116, DOI 10.1016/j.compbiomed.2019.103573; Suman JD, 2006, J AEROSOL MED, V19, P510, DOI 10.1089/jam.2006.19.510; Taherali F, 2018, ADV DRUG DELIVER REV, V124, P16, DOI 10.1016/j.addr.2017.10.014; Tian L, 2017, J AEROSOL SCI, V113, P189, DOI 10.1016/j.jaerosci.2017.08.006; Tian L, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-017-0203-7; Tong XW, 2016, COMPUT BIOL MED, V77, P40, DOI 10.1016/j.compbiomed.2016.08.002; Tu J., 2012, COMPUTATIONAL FLUID; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Xi JX, 2018, EUR J PHARM SCI, V118, P113, DOI 10.1016/j.ejps.2018.03.027	43	16	16	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246007	10.1371/journal.pone.0246007	http://dx.doi.org/10.1371/journal.pone.0246007			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507973	Green Published, gold			2022-12-26	WOS:000635021400072
J	Bentall, RP; Lloyd, A; Bennett, K; McKay, R; Mason, L; Murphy, J; McBride, O; Hartman, TK; Gibson-Miller, J; Levita, L; Martinez, AP; Stocks, TVA; Butter, S; Vallieres, F; Hyland, P; Karatzias, T; Shevlin, M				Bentall, Richard P.; Lloyd, Alex; Bennett, Kate; McKay, Ryan; Mason, Liam; Murphy, Jamie; McBride, Orla; Hartman, Todd K.; Gibson-Miller, Jilly; Levita, Liat; Martinez, Anton P.; Stocks, Thomas V. A.; Butter, Sarah; Vallieres, Frederique; Hyland, Philip; Karatzias, Thanos; Shevlin, Mark			Pandemic buying: Testing a psychological model of over-purchasing and panic buying using data from the United Kingdom and the Republic of Ireland during the early phase of the COVID-19 pandemic	PLOS ONE			English	Article								The over-purchasing and hoarding of necessities is a common response to crises, especially in developed economies where there is normally an expectation of plentiful supply. This behaviour was observed internationally during the early stages of the Covid-19 pandemic. In the absence of actual scarcity, this behaviour can be described as 'panic buying' and can lead to temporary shortages. However, there have been few psychological studies of this phenomenon. Here we propose a psychological model of over-purchasing informed by animal foraging theory and make predictions about variables that predict over-purchasing by either exacerbating or mitigating the anticipation of future scarcity. These variables include additional scarcity cues (e.g. loss of income), distress (e.g. depression), psychological factors that draw attention to these cues (e.g. neuroticism) or to reassuring messages (eg. analytical reasoning) or which facilitate over-purchasing (e.g. income). We tested our model in parallel nationally representative internet surveys of the adult general population conducted in the United Kingdom (UK: N = 2025) and the Republic of Ireland (Rol: N = 1041) 52 and 31 days after the first confirmed cases of COVID-19 were detected in the UK and Rol, respectively. About three quarters of participants reported minimal over-purchasing. There was more over-purchasing in Rol vs UK and in urban vs rural areas. When overpurchasing occurred, in both countries it was observed across a wide range of product categories and was accounted for by a single latent factor. It was positively predicted by house-hold income, the presence of children at home, psychological distress (depression, death anxiety), threat sensitivity (right wing authoritarianism) and mistrust of others (paranoia). Analytic reasoning ability had an inhibitory effect. Predictor variables accounted for 36% and 34% of the variance in over-purchasing in the UK and Rol respectively. With some caveats, the data supported our model and points to strategies to mitigate over-purchasing in future crises.	[Bentall, Richard P.; Hartman, Todd K.; Gibson-Miller, Jilly; Levita, Liat; Martinez, Anton P.; Stocks, Thomas V. A.; Butter, Sarah] Univ Sheffield, Sheffield, S Yorkshire, England; [Lloyd, Alex; McKay, Ryan] Royal Holloway Univ London, Egham, Surrey, England; [Bennett, Kate] Univ Liverpool, Liverpool, Merseyside, England; [Mason, Liam] UCL, London, England; [Murphy, Jamie; McBride, Orla; Shevlin, Mark] Ulster Univ, Coleraine, Londonderry, North Ireland; [Vallieres, Frederique] Trinity Coll Dublin, Dublin, Ireland; [Hyland, Philip] Maynooth Univ, Maynooth, Kildare, Ireland; [Karatzias, Thanos] Edinburgh Napier Univ, Edinburgh, Midlothian, Scotland	University of Sheffield; University of London; Royal Holloway University London; University of Liverpool; University of London; University College London; Ulster University; Trinity College Dublin; Maynooth University; Edinburgh Napier University	Bentall, RP (corresponding author), Univ Sheffield, Sheffield, S Yorkshire, England.	r.bentall@sheffield.ac.uk	McKay, Ryan/C-2160-2008; Lloyd, Alex/AAC-3043-2020	McKay, Ryan/0000-0001-7781-1539; Lloyd, Alex/0000-0003-0627-0952; Bennett, kate/0000-0003-3164-6894; Levita, Liat/0000-0001-6002-6817; Butter, Sarah/0000-0001-9735-9156; Hartman, Todd/0000-0001-9136-2784; Mason, Liam/0000-0003-3957-1436	University of Sheffield (Department of Psychology); University of Sheffield (Sheffield Methods Institute); University of Sheffield (Higher Education Innovation Fund via an Impact Acceleration grant); Faculty of Life and Health Sciences at Ulster University; ESRC [ES/V004379/1]; MRC [MR/S006613/1] Funding Source: UKRI	University of Sheffield (Department of Psychology); University of Sheffield (Sheffield Methods Institute); University of Sheffield (Higher Education Innovation Fund via an Impact Acceleration grant); Faculty of Life and Health Sciences at Ulster University; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The initial stages of this project were supported by start-up funds from the University of Sheffield (Department of Psychology, the Sheffield Methods Institute and the Higher Education Innovation Fund via an Impact Acceleration grant administered by the university) and by the Faculty of Life and Health Sciences at Ulster University. The research was subsequently supported by the ESRC under grant number ES/V004379/1 and awarded to RPB, TKH, LL, JGM, MS, JM, OM, KB and LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addicott MA, 2017, NEUROPSYCHOPHARMACOL, V42, P1931, DOI 10.1038/npp.2017.108; Anderson JE, 2011, ANNU REV ECON, V3, P133, DOI 10.1146/annurev-economics-111809-125114; [Anonymous], 2017, INT J POPUL RES, DOI [10.1155/2017/6310683, DOI 10.1155/2017/6310683]; Anselme P, 2019, BEHAV BRAIN SCI, V42, DOI 10.1017/S0140525X18000948; BBC, 2020, BBC NEWS; Birrell J, 2011, CLIN PSYCHOL REV, V31, P1198, DOI 10.1016/j.cpr.2011.07.009; Bizumic B, 2018, J SOC POLIT PSYCHOL, V6, P129, DOI 10.5964/jspp.v6i1.835; Bronstein MV, 2019, J APPL RES MEM COGN, V8, P108, DOI 10.1016/j.jarmac.2018.09.005; Buhr K, 2002, BEHAV RES THER, V40, P931, DOI 10.1016/S0005-7967(01)00092-4; Carleton RN, 2007, BEHAV RES THER, V45, P2307, DOI 10.1016/j.brat.2007.04.006; Chadwick J., 2020, DAILY MAIL; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Columbus S., 2020, PSYARXIV PREPRINT; Costa PT, 2007, REVISED NEO PERSONAL; Cypryanska M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241464; David N, 2020, GUARDIAN; Dickins TE, 2020, LEARN MOTIV, V72, DOI 10.1016/j.lmot.2020.101681; Ding H., 2014, RHETORIC GLOBAL EPID; Duckitt J, 2010, J PERS, V78, P1861, DOI 10.1111/j.1467-6494.2010.00672.x; Elahi A, 2018, J SOC CLIN PSYCHOL, V37, P159; Federal Emergency Management Agency [FEMA], 2004, FOOD WATER EMERGENCY; Feldman S, 1997, POLIT PSYCHOL, V18, P741, DOI 10.1111/0162-895X.00077; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gabay AS, 2021, SOC COGN AFFECT NEUR, V16, P782, DOI 10.1093/scan/nsaa037; Garbe L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234232; Gupta S, 2016, INT REV RETAIL DISTR, V26, P260, DOI 10.1080/09593969.2016.1147476; Hale W, 2016, J PERS ASSESS, V98, P200, DOI 10.1080/00223891.2015.1070355; Hamilton R, 2019, J ACAD MARKET SCI, V47, P532, DOI 10.1007/s11747-018-0604-7; Harper R, 2003, MEASURING SOCIAL CAP; Hartman TK, 2021, SOC PSYCHOL PERS SCI, V12, P1274, DOI 10.1177/1948550620978023; Hinz A, 2017, J AFFECT DISORDERS, V210, P338, DOI 10.1016/j.jad.2016.12.012; Honigsbaum M, 2013, MED HIST, V57, P165, DOI 10.1017/mdh.2012.101; Hori M., 2014, JPN POLIT EC, V40, P69, DOI [10.2753/JES2329-194X400103, DOI 10.2753/JES2329-194X400103]; HUFF DL, 1964, J MARKETING, V28, P34, DOI 10.1177/002224296402800307; Iverach L, 2014, CLIN PSYCHOL REV, V34, P580, DOI 10.1016/j.cpr.2014.09.002; IYENGAR S, 1993, COMMUN RES, V20, P365, DOI 10.1177/009365093020003002; Jaspal R, 2020, COGENT PSYCHOL, V7, DOI 10.1080/23311908.2020.1800924; Jolly W, 2020, NEW DATA SHOWS MASSI; Jones L, 2020, BBC NEWS; Knowles M, 2016, MATERN CHILD HLTH J, V20, P25, DOI 10.1007/s10995-015-1797-8; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Laran J, 2013, PSYCHOL SCI, V24, P167, DOI 10.1177/0956797612450033; Lee K, 2008, J PERS, V76, P1001, DOI 10.1111/j.1467-6494.2008.00512.x; Lenow JK, 2017, J NEUROSCI, V37, P5681, DOI 10.1523/JNEUROSCI.3618-16.2017; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; McBride O, 2021, INT J METH PSYCH RES, V30, DOI 10.1002/mpr.1861; McElroy E, 2019, CLIN PSYCHOL SCI, V7, P719, DOI 10.1177/2167702619830640; McIntyre JC, 2018, SCHIZOPHRENIA BULL, V44, P681, DOI 10.1093/schbul/sbx110; Melo S, 2009, PSYCHOL PSYCHOTHER-T, V82, P247, DOI 10.1348/147608308X398337; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Muthen L., 2018, MPLUS USERS GUIDE; Nettle D, 2017, BEHAV BRAIN SCI, V40, DOI 10.1017/S0140525X16000947; OConnell M, 2020, PREPARING PANDEMIC S; Parker JR, 2011, J RETAILING, V87, P142, DOI 10.1016/j.jretai.2011.02.001; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; Photopoulos J., 2020, SCIENTISTS OPINION I; Prentice C, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102203; Rad MS, 2018, P NATL ACAD SCI USA, V115, P11401, DOI 10.1073/pnas.1721165115; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Robinson PL, 2013, J HEALTH CARE POOR U, V24, P172, DOI 10.1353/hpu.2013.0049; SAPP SG, 1993, PSYCHOL REP, V72, P539, DOI 10.2466/pr0.1993.72.2.539; Savage DA, 2019, DISASTERS, V43, P771, DOI 10.1111/disa.12408; Seo M, 2012, COMMUN RES, V39, P3, DOI 10.1177/0093650210388407; Shapiro DH, 1996, AM PSYCHOL, V51, P1213, DOI 10.1037/0003-066X.51.12.1213; Sheu JB, 2020, INT J DISAST RISK RE, V44, DOI 10.1016/j.ijdrr.2019.101430; Sim K, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113015; Sirota M, 2018, BEHAV RES METHODS, V50, P2511, DOI 10.3758/s13428-018-1029-4; SMITH EA, 1983, CURR ANTHROPOL, V24, P625, DOI 10.1086/203066; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stenner K., 2005, AUTHORITARIAN DYNAMI; Stephens D.W., 1986, pi; Sterman JD, 2015, J OPER MANAG, V39-40, P6, DOI 10.1016/j.jom.2015.07.002; Swami V, 2014, COGNITION, V133, P572, DOI 10.1016/j.cognition.2014.08.006; Tackett JL, 2017, NEUROTICISM, P39; Thomas JA, 2014, NAT HAZARDS, V74, P477, DOI 10.1007/s11069-014-1187-3; Tomas-Sabado J, 2005, PSYCHOL REP, V97, P793, DOI 10.2466/PR0.97.7.793-796; Toplak ME, 2014, THINK REASONING, V20, P147, DOI 10.1080/13546783.2013.844729; Turrin C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11763-3; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Whitaker RC, 2006, PEDIATRICS, V118, pE859, DOI 10.1542/peds.2006-0239; Wilkes J., 2020, HIST EXTRA; Yuen KF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103513; Zheng R, 2021, OMEGA-INT J MANAGE S, V101, DOI 10.1016/j.omega.2020.102238	83	28	28	19	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246339	10.1371/journal.pone.0246339	http://dx.doi.org/10.1371/journal.pone.0246339			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503049	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000613751800004
J	Zhao, YH; Zhang, X; Yao, JC				Zhao, Yonghui; Zhang, Xiang; Yao, Junchao			Comprehensive analysis of PLOD family members in low-grade gliomas using bioinformatics methods	PLOS ONE			English	Article								Low-grade gliomas (LGGs) is a primary invasive brain tumor that grows slowly but is incurable and eventually develops into high malignant glioma. Novel biomarkers for the tumorigenesis and lifetime of LGG are critically demanded to be investigated. In this study, the expression levels of procollagen-lysine, 2-oxoglutarate 5-dioxygenases (PLODs) were analyzed by ONCOMINE, HPA and GEPIA. The GEPIA online platform was applied to evaluate the interrelation between PLODs and survival index in LGG. Furthermore, functions of PLODs and co-expression genes were inspected by the DAVID. Moreover, we used TIMER, cBioportal, GeneMINIA and Network-Analyst analysis to reveal the mechanism of PLODs in LGG. We found that expression levels of each PLOD family members were upregulated in patients with LGG. Higher expression of PLODs was closely related to shorter disease-free survival (DFS) and overall survival (OS). The findings showed that LGG cases with or without alterations were significantly correlated with the OS and DFS. The mechanism of PLODs in LGG may be involved in response to hypoxia, oxidoreductase activity, Lysine degradation and immune cell infiltration. In general, this research has investigated the values of PLODs in LGG, which could serve as biomarkers for diagnosis, prognosis and potential therapeutic targets of LGG patients.	[Zhao, Yonghui; Zhang, Xiang; Yao, Junchao] Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Hebei, Peoples R China		Zhao, YH (corresponding author), Cangzhou Cent Hosp, Dept Neurosurg, Cangzhou, Hebei, Peoples R China.	zhaoyonghui@mail.sdu.edu.cn		hui, zhao/0000-0002-9419-6766				Ah-Kim H, 2000, CYTOKINE, V12, P142, DOI 10.1006/cyto.1999.0539; Baek JH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1186-5; Baumann S, 2016, J BIOL CHEM, V291, P18514, DOI 10.1074/jbc.M116.723379; Bernstock JD, 2020, J NEUROSURG, V133, P655, DOI 10.3171/2019.5.JNS19364; Boonsongserm P, 2019, ONCOL LETT, V18, P3039, DOI 10.3892/ol.2019.10638; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Cao F, 2019, Zhonghua Zhong Liu Za Zhi, V41, P435, DOI 10.3760/cma.j.issn.0253-3766.2019.06.007; Chen P, 2019, ONCOL REP, V41, P939, DOI 10.3892/or.2018.6901; Du HZ, 2017, BIOMED PHARMACOTHER, V90, P670, DOI 10.1016/j.biopha.2017.04.023; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gjaltema RAF, 2015, J BIOL CHEM, V290, P28465, DOI 10.1074/jbc.M114.634311; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Hu HL, 2019, INT J CLIN EXP PATHO, V12, P1015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim B, 2020, ACTA NEUROPATHOL, V139, P703, DOI 10.1007/s00401-020-02124-y; Kumthekar P, 2015, CANCER TREAT RES, V163, P75, DOI 10.1007/978-3-319-12048-5_5; Laviv Yosef, 2019, Harefuah, V158, P601; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li LW, 2017, AM J TRANSL RES, V9, P3741; Li SS, 2020, J CANCER, V11, P121, DOI 10.7150/jca.35763; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Lin Y, 2019, AGING-US, V11, P11157, DOI 10.18632/aging.102518; Masui K, 2016, BRAIN TUMOR PATHOL, V33, P161, DOI 10.1007/s10014-016-0265-5; Morshed RA, 2019, J NEUROSURG SCI, V63, P450, DOI 10.23736/S0390-5616.19.04701-5; Qi YF, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00066; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rickman DS, 2001, CANCER RES, V61, P6885; Ross JA, 2020, CLIN CHEM LAB MED, V58, P980, DOI 10.1515/cclm-2019-0626; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Scietti L, 2019, J BONE MINER RES, V34, P1376, DOI 10.1002/jbmr.3692; Shai R, 2003, ONCOGENE, V22, P4918, DOI 10.1038/sj.onc.1206753; Shen Q, 2018, HEPATOLOGY, V67, P1360, DOI 10.1002/hep.29606; Song Y, 2017, ONCOTARGET, V8, P41947, DOI 10.18632/oncotarget.16710; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Trong PD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102903; Tsai Chia-Kuang, 2018, Oncotarget, V9, P15705, DOI 10.18632/oncotarget.24594; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang B, 2019, CLIN LAB, V65, DOI [10.7754/Clin.Lab.2018, DOI 10.7754/CLIN.LAB.2018]; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu YY, 2017, ONCOTARGET, V8, P23401, DOI 10.18632/oncotarget.15581; Yamada Y, 2019, MOL ONCOL, V13, P1898, DOI 10.1002/1878-0261.12532; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240; Zhou Y, 2020, CANCER LETT, V475, P79, DOI 10.1016/j.canlet.2020.01.027; Zhu HF, 2020, PATHOL ONCOL RES, V26, P2135, DOI 10.1007/s12253-019-00759-1	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246097	10.1371/journal.pone.0246097	http://dx.doi.org/10.1371/journal.pone.0246097			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503035	gold, Green Submitted, Green Published			2022-12-26	WOS:000613751800008
J	Demeny, A; Rinyu, L; Nemeth, P; Czuppon, G; Enyedi, N; Makk, J; Leel-Ossy, S; Kesjar, D; Kovacs, I				Demeny, Attila; Rinyu, Laszlo; Nemeth, Peter; Czuppon, Gyorgy; Enyedi, Nora; Makk, Judit; Leel-Ossy, Szabolcs; Kesjar, Dora; Kovacs, Ivett			Bacterial and abiogenic carbonates formed in caves-no vital effect on clumped isotope compositions	PLOS ONE			English	Article							MASS-SPECTROMETRY; OXYGEN; FRACTIONATION; CALIBRATION; WATER; SPELEOTHEMS; DELTA-O-18	Speleothems (dominated by cave-hosted carbonate deposits) are valuable archives of paleoclimate conditions. As such, they are potential targets of clumped isotope analyses that may yield quantified data about past temperature variations. Clumped isotope analyses of stalagmites, however, seldom provide useful temperature values due to various isotope fractionation processes. This study focuses on the determination of the microbially induced vital effect, i.e., the isotope fractionation processes related to bacterial carbonate production. A cave site with biologically mediated amorphous calcium carbonate precitation was selected as a natural laboratory. Calcite deposits were farmed under a UV lamp to prevent bacterial activity, as well as under control conditions. Microbiological analyses and morphological investigations using scanning electron microscopy showed that the UV lamp treatment effectively reduced the number of bacterial cells, and that bacterial carbonate production strongly influenced the carbonate's morphology. Stable oxygen isotope analyses of calcite and drip waters, as well as clumped isotope measurements revealed that, although most of the studied carbonates formed close to oxygen isotope equilibrium, clumped isotope Delta(47) values varied widely from equilibrium to strongly fractionated data. Site-specific kinetic fractionations played a dominant role in the distribution of Delta(47) values, whereas bacterial carbonate production did not result in a detectable clumped isotope effect.	[Demeny, Attila; Czuppon, Gyorgy; Kovacs, Ivett] Res Ctr Astron & Earth Sci, Inst Geol & Geochem Res, Budapest, Hungary; [Rinyu, Laszlo; Kesjar, Dora] Inst Nucl Res, Isotope Climatol & Environm Res Ctr ICER, Debrecen, Hungary; [Nemeth, Peter] Inst Mat & Environm Chem, Res Ctr Nat Sci, Budapest, Hungary; [Nemeth, Peter] Univ Pannonia, Dept Earth & Environm Sci, Veszprem, Hungary; [Enyedi, Nora; Makk, Judit] Eotvos Lorand Univ, Dept Microbiol, Budapest, Hungary; [Leel-Ossy, Szabolcs] Eotvos Lorand Univ, Dept Phys & Appl Geol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; Institute for Geological & Geochemical Research - HAS; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Pannonia; Eotvos Lorand University; Eotvos Lorand University	Demeny, A (corresponding author), Res Ctr Astron & Earth Sci, Inst Geol & Geochem Res, Budapest, Hungary.	demeny@geochem.hu	Makk, Judit/G-9636-2017	Makk, Judit/0000-0001-5768-7622; Czuppon, Gyorgy/0000-0002-7231-6042; Lange-Enyedi, Nora Tunde/0000-0002-1366-9470; Demeny, Attila/0000-0003-0522-9018	National Research, Development and Innovation Office, Hungary [FK123871, PD 121387]; Hungarian Academy of Sciences [KEP-8/2018]; Hungarian Academy of Sciences (Janos Bolyai Research Scholarship); Eotvos Lorand Research Network [KEP-1/2020]; Ministry for Innovation and Technology [UNKP-20-3-II-ELTE-260]; European Union; State of Hungary; European Regional Development Fund [GINOP-2.3.215-2016-00009]	National Research, Development and Innovation Office, Hungary(National Research, Development & Innovation Office (NRDIO) - Hungary); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian Academy of Sciences (Janos Bolyai Research Scholarship); Eotvos Lorand Research Network; Ministry for Innovation and Technology; European Union(European Commission); State of Hungary; European Regional Development Fund(European Commission)	The study was financially supported by the National Research, Development and Innovation Office, Hungary (FK123871 and PD 121387), the Hungarian Academy of Sciences (KEP-8/2018 to AD, and the Janos Bolyai Research Scholarship to PN), and the Eotvos Lorand Research Network (KEP-1/2020 to AD). The work of Nora Enyedi was supported by the UNKP-20-3-II-ELTE-260 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund. The clumped isotope facility of the Institute for Nuclear Research was funded by the European Union and the State of Hungary, as well as co-financed by the European Regional Development Fund in the project of GINOP-2.3.215-2016-00009 `ICER'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2014, GEOCHIM COSMOCHIM AC, V143, P303, DOI 10.1016/j.gca.2014.08.008; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; ARRAGE AA, 1993, APPL ENVIRON MICROB, V59, P3545, DOI 10.1128/AEM.59.11.3545-3550.1993; Assonov SS, 2003, RAPID COMMUN MASS SP, V17, P1017, DOI 10.1002/rcm.1011; BAERTSCHI P, 1976, EARTH PLANET SC LETT, V31, P341, DOI 10.1016/0012-821X(76)90115-1; Bajnai D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17501-0; Bernasconi SM, 2018, GEOCHEM GEOPHY GEOSY, V19, P2895, DOI 10.1029/2017GC007385; Brand WA, 2010, PURE APPL CHEM, V82, P1719, DOI 10.1351/PAC-REP-09-01-05; Chacko T, 2008, GEOCHIM COSMOCHIM AC, V72, P3642, DOI 10.1016/j.gca.2008.06.001; Coplen TB, 2007, GEOCHIM COSMOCHIM AC, V71, P3948, DOI 10.1016/j.gca.2007.05.028; Czuppon G, 2018, INT J SPELEOL, V47, P13, DOI 10.5038/1827-806X.47.1.2110; Daeron M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08336-5; Daeron M, 2011, GEOCHIM COSMOCHIM AC, V75, P3303, DOI 10.1016/j.gca.2010.10.032; Demeny A., 2017, CENT EUR GEOL, V60, P1, DOI DOI 10.1556/24.60.2017.001; Demeny A, 2019, QUATERN INT, V512, P99, DOI 10.1016/j.quaint.2019.02.014; Demeny A, 2017, QUATERNARY SCI REV, V161, P68, DOI 10.1016/j.quascirev.2017.02.012; Demeny A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39602; Dorale JA, 2004, STUDIES CAVE SEDIMEN, P177, DOI [10.1126/science.1091220 15105497, DOI 10.1007/978-1-4419-9118-8_10]; Eiler JM, 2007, EARTH PLANET SC LETT, V262, P309, DOI 10.1016/j.epsl.2007.08.020; Enyedi NT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65667-w; Enyedi NT, 2019, ACTA MICROBIOLOGICA, V66; Fairchild I.J., 2012, SPELEOTHEM SCI PROCE; Ghosh P, 2006, GEOCHIM COSMOCHIM AC, V70, P1439, DOI 10.1016/j.gca.2005.11.014; Gonfiantini R., 1995, REFERENCE INTERCOMPA, P13, DOI DOI 10.1029/2001JD001156; Goosen N, 2008, DNA REPAIR, V7, P353, DOI 10.1016/j.dnarep.2007.09.002; Horita J, 2007, GEOCHIM COSMOCHIM AC, V71, P3131, DOI 10.1016/j.gca.2005.11.033; Hu B, 2014, RAPID COMMUN MASS SP, V28, P1413, DOI 10.1002/rcm.6909; Jautzy JJ, 2020, GEOCHEM PERSPECT LET, V14, P36, DOI 10.7185/geochemlet.2021; John CM, 2016, RAPID COMMUN MASS SP, V30, P2285, DOI 10.1002/rcm.7720; Kele S, 2015, GEOCHIM COSMOCHIM AC, V168, P172, DOI 10.1016/j.gca.2015.06.032; Kim ST, 1997, GEOCHIM COSMOCHIM AC, V61, P3461, DOI 10.1016/S0016-7037(97)00169-5; Kluge T, 2015, GEOCHIM COSMOCHIM AC, V157, P213, DOI 10.1016/j.gca.2015.02.028; Lis G, 2008, ANAL CHEM, V80, P287, DOI 10.1021/ac701716q; Meckler AN, 2014, RAPID COMMUN MASS SP, V28, P1705, DOI 10.1002/rcm.6949; Meijer HAJ, 1998, ISOT ENVIRON HEALT S, V34, P349, DOI 10.1080/10256019808234072; Muller IA, 2017, RAPID COMMUN MASS SP, V31, P1057, DOI 10.1002/rcm.7878; Peral M, 2018, GEOCHIM COSMOCHIM AC, V239, P1, DOI 10.1016/j.gca.2018.07.016; Petersen SV, 2019, GEOCHEM GEOPHY GEOSY, V20, P3495, DOI 10.1029/2018GC008127; Piasecki A, 2019, GEOCHEM GEOPHY GEOSY, V20, P2082, DOI 10.1029/2018GC007961; Schmid TW, 2010, RAPID COMMUN MASS SP, V24, P1955, DOI 10.1002/rcm.4598; Thaler C, 2020, BIOGEOSCIENCES, V17, P1731, DOI 10.5194/bg-17-1731-2020; Tremaine DM, 2011, GEOCHIM COSMOCHIM AC, V75, P4929, DOI 10.1016/j.gca.2011.06.005	42	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245621	10.1371/journal.pone.0245621	http://dx.doi.org/10.1371/journal.pone.0245621			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493213	Green Accepted, gold, Green Published			2022-12-26	WOS:000613081500030
J	O'Kane, SH; Ehrsson, HH				O'Kane, Sophie H.; Ehrsson, H. Henrik			The contribution of stimulating multiple body parts simultaneously to the illusion of owning an entire artificial body	PLOS ONE			English	Article							TEMPORAL BINDING WINDOW; RUBBER-HAND; MULTISENSORY INTEGRATION; ILLUSORY OWNERSHIP; REFLECT; TIME; LIMITS; BRAIN; SPACE; TOUCH	The full-body ownership illusion exploits multisensory perception to induce a feeling of ownership of an entire artificial body. Although previous research has shown that synchronous visuotactile stimulation of a single body part is sufficient for illusory ownership of the whole body, the effect of combining multisensory stimulation across multiple body parts remains unknown. Therefore, 48 healthy adults participated in a full-body ownership illusion with conditions involving synchronous (illusion) or asynchronous (control) visuotactile stimulation to one, two, or three body parts simultaneously (2x3 design). We used questionnaires to isolate illusory ownership of five specific body parts (left arm, right arm, trunk, left leg, right leg) from the full-body ownership experience and sought to test not only for increased ownership in synchronous versus asynchronous conditions but also for potentially varying degrees of full-body ownership illusion intensity related to the number of body parts stimulated. Illusory full-body ownership and all five body-part ownership ratings were significantly higher following synchronous stimulation than asynchronous stimulation (p-values < .01). Since non-stimulated body parts also received significantly increased ownership ratings following synchronous stimulation, the results are consistent with an illusion that engages the entire body. Furthermore, we noted that ownership ratings for right body parts (which were often but not always stimulated in this experiment) were significantly higher than ownership ratings for left body parts (which were never stimulated). Regarding the effect of stimulating multiple body parts simultaneously on explicit full-body ownership ratings, there was no evidence of a significant main effect of the number of stimulations (p = .850) or any significant interaction with stimulation synchronicity (p = .160), as assessed by linear mixed modelling. Instead, median ratings indicated a moderate affirmation (+1) of an illusory full-body sensation in all three synchronous conditions, a finding mirrored by comparable full-body illusion onset times. In sum, illusory full-body ownership appears to be an 'all-or-nothing' phenomenon and depends upon the synchronicity of visuotactile stimulation, irrespective of the number of stimulated body parts.	[O'Kane, Sophie H.; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet	O'Kane, SH; Ehrsson, HH (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	sophie.okane@ki.se; henrik.ehrsson@ki.se			Swedish Research Council; European Research Council; Goran Gustafssons Stiftelser; Karolinska Institutet KID	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Goran Gustafssons Stiftelser; Karolinska Institutet KID(Karolinska Institutet)	The work was supported by the Swedish Research Council (https://www.vr.se/) "Distinguished Professor Grant" (HE), the European Research Council (https://erc.europa.eu/) "SELF-UNITY" (HE), Goran Gustafssons Stiftelser (https://gustafssonsstiftelser.se/) (HE), Karolinska Institutet KID (https://staff.ki.se/kid-funding) (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2011, J KOREAN SURG SOC, V80, pS71, DOI 10.4174/jkss.2011.80.Suppl1.S71; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Badde S, 2019, CURR BIOL, V29, P1491, DOI 10.1016/j.cub.2019.02.060; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergstrom I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148060; BOLL TJ, 1974, NEUROPSYCHOLOGIA, V12, P235, DOI 10.1016/0028-3932(74)90008-6; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brandman T, 2016, CEREB CORTEX, V26, P530, DOI 10.1093/cercor/bhu205; Caggiano P, 2018, NEUROPSYCHOL REV, V28, P417, DOI 10.1007/s11065-018-9394-4; Carey M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39168-4; Chancel M, 2020, WHICH HAND IS MINE D, P1; Costantini M, 2016, COGNITION, V157, P39, DOI 10.1016/j.cognition.2016.08.010; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Crucianelli L, 2018, CORTEX, V104, P180, DOI 10.1016/j.cortex.2017.04.018; Crucianelli Laura, 2013, Front Psychol, V4, P703, DOI 10.3389/fpsyg.2013.00703; Dawson M.E., 2000, HDB PSYCHOPHYSIOLOGY, V2, P200; de Haan AM, 2017, ACTA PSYCHOL, V179, P68, DOI 10.1016/j.actpsy.2017.07.003; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2019, P NATL ACAD SCI USA, V116, P19771, DOI 10.1073/pnas.1914000116; Ehrsson HH, 2020, MULTISENSORY PERCEPTION: FROM LABORATORY TO CLINIC, P179, DOI 10.1016/B978-0-12-812492-5.00008-5; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fahey S, 2018, CAN J EXP PSYCHOL, V72, P244, DOI 10.1037/cep0000152; Garfinkel SN, 2015, BIOL PSYCHOL, V104, P65, DOI 10.1016/j.biopsycho.2014.11.004; Gentile G, 2015, NEUROIMAGE, V109, P328, DOI 10.1016/j.neuroimage.2015.01.008; Guterstam A, 2019, CEREB CORTEX, V29, P1328, DOI 10.1093/cercor/bhy285; Guterstam A, 2015, CURR BIOL, V25, P1416, DOI 10.1016/j.cub.2015.03.059; Guterstam A, 2015, SCI REP-UK, V5, DOI 10.1038/srep09831; Guterstam A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017208; Holmes NP, 2005, CURR BIOL, V15, pR762, DOI 10.1016/j.cub.2005.08.058; Kalckert A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00344; Kalckert A, 2014, CONSCIOUS COGN, V26, P117, DOI 10.1016/j.concog.2014.02.003; Kawakami S, 2020, J AUTISM DEV DISORD, V50, P1561, DOI 10.1007/s10803-018-3762-z; Keenaghan S, 2020, CONSCIOUS COGN, V78, DOI 10.1016/j.concog.2020.102882; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Koffka K, 1936, J ED PSYCHOL, V27, P310; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Koller M, 2016, J STAT SOFTW, V75, P1, DOI 10.18637/jss.v075.i06; Lloyd DM, 2007, BRAIN COGNITION, V64, P104, DOI 10.1016/j.bandc.2006.09.013; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Maselli A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00693; Maselli A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00083; McDonald J.H., 2014, HDB BIOL STAT; Noel JP, 2019, CORTEX, V120, P169, DOI 10.1016/j.cortex.2019.05.018; Park HD, 2019, TRENDS COGN SCI, V23, P377, DOI 10.1016/j.tics.2019.02.002; Petkova VI, 2011, CURR BIOL, V21, P1118, DOI 10.1016/j.cub.2011.05.022; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Preston C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199426; Preston C, 2016, CEREB CORTEX, V26, P4450, DOI 10.1093/cercor/bhw313; Preston C, 2015, SCI REP-UK, V5, DOI 10.1038/srep18345; Preuss N, 2018, J EXPT PSYCHOL HUMAN; Quintana DS, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1761-4; R Core Team, 2020, R LANG ENV STAT COMP; Radziun D, 2018, J EXP PSYCHOL HUMAN, V44, P1012, DOI 10.1037/xhp0000508; Rohde M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080688; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; Samad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117178; Schmalzl L, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00034; SHIELDS SA, 1989, J PERS ASSESS, V53, P802, DOI 10.1207/s15327752jpa5304_16; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Tacikowski P, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101429; Tame L, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00291; Taylor JC, 2007, J NEUROPHYSIOL, V98, P1626, DOI 10.1152/jn.00012.2007; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2017, Q J EXP PSYCHOL, V70, P597, DOI 10.1080/17470218.2016.1181768; Tsakiris M, 2011, P ROY SOC B-BIOL SCI, V278, P2470, DOI 10.1098/rspb.2010.2547; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005	80	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0233243	10.1371/journal.pone.0233243	http://dx.doi.org/10.1371/journal.pone.0233243			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ9QF	33493178	Green Published, Green Submitted, gold			2022-12-26	WOS:000613081500047
J	Guo, JL; Yu, YL; Wu, GJ; Ma, MY				Guo, Julan; Yu, Yilei; Wu, Gaojie; Ma, Muyuan			Characteristics of surface water quality and stable isotopes in Bamen Bay watershed, Hainan Province, China	PLOS ONE			English	Article							RIVER-BASIN; NORTHERN XINJIANG; NITROGEN REMOVAL; CHEMISTRY; GEOCHEMISTRY; SHRIMP; PATTERNS; SYSTEM; IMPACT; EUTROPHICATION	Bamen Bay is located at the intersection of the Wenjiao River and Wenchang River in Hainan Province (China), where mangroves have been facing a threat of water quality deterioration. Therefore, it is imperative to study the characteristics of the surface water quality on a watershed scale. Water samples were collected three times from 36 monitoring sites from 2015 to 2016. It was found that nitrate was the main inorganic nitrogen form and all the surface water types were alkaline. Meanwhile, aquaculture water had high content of nitrogen, total phosphorus, chlorophyll a (Chl.a), total organic carbon (TOC), and chemical oxygen demand (COD). Significant spatial and temporal variations were found for most parameters. However, stable isotopes of delta D and delta O-18 indicated that river water mainly originated from atmospheric precipitation and experienced strong evaporation. The water chemistry and isotopes of the Bamen Bay, mangroves, and aquaculture water were initially affected by the mixing of fresh water and seawater, followed by evaporation. The river and reservoir water chemistry were mainly controlled by water-rock interactions and cation exchange as deduced from the ionic relationships and Gibbs plots. These interactions involved the dissolution of calcite-, bicarbonate-, carbonate-, and calcium-containing minerals. Oxidized environments (river, reservoir, and Bamen Bay) were conducive for nitrification, while anaerobic conditions (mangrove and aquaculture water) were beneficial to the reduced nitrogen forms.	[Guo, Julan; Yu, Yilei; Wu, Gaojie; Ma, Muyuan] Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China; [Guo, Julan; Yu, Yilei; Wu, Gaojie; Ma, Muyuan] Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China	Chinese Academy of Forestry; Institute of Wetland Research, CAF; Chinese Academy of Forestry; Institute of Wetland Research, CAF	Yu, YL (corresponding author), Chinese Acad Forestry, Inst Wetland Res, Beijing, Peoples R China.; Yu, YL (corresponding author), Beijing Key Lab Wetland Serv & Restorat, Beijing, Peoples R China.	yuyilei1222@126.com			National Forestry Industry Research Special Funds for Public Welfare Projects [201504419]; National Natural Science Foundation of China [41601037]; Ministry of Natural Resource of the People's Republic of China	National Forestry Industry Research Special Funds for Public Welfare Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Natural Resource of the People's Republic of China	This research was financially supported by National Forestry Industry Research Special Funds for Public Welfare Projects (No. 201504419) and the National Natural Science Foundation of China (NO. 41601037). Julan Guo hosts the first project and Yilei Yu hosts the second one. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would also like to thank Ministry of Natural Resource of the People's Republic of China, Landsat for the data and support. Website are as follows: http://www.mnr.gov.cn/and http://landsat.visibleearth.nasa.gov/.We wish to thank all the anonymous reviewers for their invaluable comments and constructive suggestions that were used to improve the quality of the manuscript. All authors read and approved the final manuscript.	Abowei J. F. N., 2010, Advance Journal of Food Science & Technology, V2, P36; Administration TSEP, 2002, WAT WAST MON AN METH; Akbal F, 2011, WATER AIR SOIL POLL, V216, P21, DOI 10.1007/s11270-010-0511-0; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Alongi DM, 2002, MAR BIOL, V140, P855, DOI 10.1007/s00227-001-0757-6; [Anonymous], 2002, GB3838; Avnimelech Y, 2003, AQUACULTURE, V220, P549, DOI 10.1016/S0044-8486(02)00641-5; Bardach JE, 1997, Q REV BIOL, V60, P242; Bucker A, 2010, AQUAT GEOCHEM, V16, P127, DOI 10.1007/s10498-009-9073-4; Cao YJ, 2012, J ENVIRON MONITOR, V14, P2624, DOI 10.1039/c2em30032j; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chen J, 1993, GEOGRAPHY SCI, V13, P273; Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Davies BR, 1994, RIVERS HDB, V2, P484, DOI DOI 10.1002/9781444313871.CH25; Davis SE, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P9, DOI 10.1007/978-90-481-2406-0_2; Drever J.I., 2005, SURFACE GROUND WATER, V1st; Drever JI, 1988, GEOCHEMISTRY NATURAL, DOI [10.1097/00006534-198806000-00059, DOI 10.1097/00006534-198806000-00059]; Duke N. C., 2006, AUSTR MANGROVES; Edmond JM, 1996, GEOCHIM COSMOCHIM AC, V60, P2949, DOI 10.1016/0016-7037(96)00142-1; Fan BL, 2014, J ASIAN EARTH SCI, V96, P17, DOI 10.1016/j.jseaes.2014.09.005; Frohlich HL, 2008, HYDROL PROCESS, V22, P2028, DOI 10.1002/hyp.6804; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garrels, 1975, CHEM CYCLES GLOBAL E; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Goddard S, 1996, FEED MANAGEMENT INTE, P1; Gomez-Velez JD, 2015, NAT GEOSCI, V8, P941, DOI [10.1038/NGEO2567, 10.1038/ngeo2567]; Gong P, 2019, SCI BULL, V64, P370, DOI 10.1016/j.scib.2019.03.002; Guntur G, 2018, IOP C SER EARTH ENV, V106, DOI 10.1088/1755-1315/106/1/012041; Han X, 2009, TROPICAL FORESTRY, V37, P50; Hatha AAM, 2010, WORLD ATLAS MANGROVE; HU MH, 1982, NATURE, V298, P550, DOI 10.1038/298550a0; Huang JS, 2017, WATER-SUI, V9, DOI 10.3390/w9070520; Huang X, 2009, SCI TOTAL ENVIRON, V407, P6242, DOI 10.1016/j.scitotenv.2009.09.001; Inoue T, CHARACTERISTICS WATE, P199; Jackson C, 2003, AQUACULTURE, V218, P397, DOI 10.1016/S0044-8486(03)00014-0; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Karim A, 2000, CHEM GEOL, V170, P153, DOI 10.1016/S0009-2541(99)00246-6; Kennish Michael J, 2001, PRACTICAL HDB MARINE; Kim H, 2001, WATER ENVIRON RES, V73, P95, DOI 10.2175/106143001X138741; Kishida N, 2003, J BIOSCI BIOENG, V96, P285, DOI 10.1016/S1389-1723(03)80195-0; Koklu R, 2010, WATER RESOUR MANAG, V24, P959, DOI 10.1007/s11269-009-9481-7; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; Kumarasamy P, 2014, ENVIRON EARTH SCI, V71, P2441, DOI 10.1007/s12665-013-2644-0; Li SY, 2010, HYDROLOG SCI J, V55, P1385, DOI 10.1080/02626667.2010.530096; Li YH, 2016, DESALIN WATER TREAT, V57, P5350, DOI 10.1080/19443994.2014.1003606; Liu BJ, 2013, APPL GEOCHEM, V31, P265, DOI 10.1016/j.apgeochem.2013.01.015; Liu Jian-bo, 2014, Journal of Tropical Oceanography, V33, P24, DOI 10.3969/j.issn.1009-5470.2014.03.004; Menasveta Piamsak, 1997, World Aquaculture, V28, P36; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meybeck M, 2005, TREATISE GEOCHEM, V5, P207; Meybeck M, 1995, WATER QUALITY WORLD; MILLIMAN JD, 1983, J GEOL, V91, P1, DOI 10.1086/628741; Moon S, 2007, GEOCHIM COSMOCHIM AC, V71, P1411, DOI 10.1016/j.gca.2006.12.004; Mortatti J, 2003, CHEM GEOL, V197, P177, DOI 10.1016/S0009-2541(02)00349-2; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; Paez-Osuna F, 2001, ENVIRON MANAGE, V28, P131, DOI 10.1007/s002670010212; Perez-Fuentetaja A, 2000, AQUATIC ECOLOGY, V34, P127; PROBST JL, 1992, J HYDROL, V135, P237, DOI 10.1016/0022-1694(92)90090-I; Qu B, 2015, ENVIRON EARTH SCI, V74, P6443, DOI 10.1007/s12665-015-4174-4; Reddy AGS, 2012, ENVIRON MONIT ASSESS, V184, P3557, DOI 10.1007/s10661-011-2208-2; Riedel GF, 2000, ESTUARIES, V23, P521, DOI 10.2307/1353143; Rivera-Monroy VH, 2010, J WORLD AQUACULTURE, V30, P12; Roy S, 1999, GEOCHIM COSMOCHIM AC, V63, P1277, DOI 10.1016/S0016-7037(99)00099-X; Singh M, 2007, ENVIRON MONIT ASSESS, V129, P421, DOI 10.1007/s10661-006-9374-7; Smolders AJP, 2004, APPL GEOCHEM, V19, P1745, DOI 10.1016/j.apgeochem.2004.05.001; Strauss EA, 2004, J N AM BENTHOL SOC, V23, P1, DOI 10.1899/0887-3593(2004)023&lt;0001:NITUMR&gt;2.0.CO;2; Thomas J, 2015, APPL GEOCHEM, V63, P456, DOI 10.1016/j.apgeochem.2015.03.018; Thomas Y, 2010, MAR POLLUT BULL, V61, P387, DOI 10.1016/j.marpolbul.2010.07.005; Varol M, 2012, RIVER RES APPL, V28, P1428, DOI 10.1002/rra.1533; Verhoeven JTA, 2006, TRENDS ECOL EVOL, V21, P96, DOI 10.1016/j.tree.2005.11.015; Volz RK, 2008, ACTA HORTIC, P469, DOI 10.17660/ActaHortic.2008.800.59; Wan J, 2013, ENVIRON EARTH SCI, V69, P909, DOI 10.1007/s12665-012-1976-5; Wang Dao-ru, 2011, Journal of Tropical Oceanography, V30, P18; Wecker B, 2006, CLIN INFECT DIS OFFI, V35; Weissenbacher N, 2007, WATER RES, V41, P397, DOI 10.1016/j.watres.2006.10.034; WHITE AF, 1995, GEOCHIM COSMOCHIM AC, V59, P1729, DOI 10.1016/0016-7037(95)00078-E; Wu Y, 1996, WATER RES, V30, P178, DOI 10.1016/0043-1354(95)00140-G; Yan WJ, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003984; Yang JJ, 2016, J CHEM TECHNOL BIOT, V91, P2582, DOI [10.1002/jctb.4849, 10.1002/jc]; Yang ZY, 2017, CHINESE J TROPICAL A, V37, P48; Yao WY, 2013, ENVIRON EARTH SCI, V70, P1389, DOI 10.1007/s12665-013-2223-4; Yu YL, 2017, WATER-SUI, V9, DOI 10.3390/w9070453; Yurtsever Y, 1975, ISOTOPE HRDROLOGY; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493; Zheng D, 1995, RES DYNAMIC DEV MANG; Zhu BQ, 2013, J ASIAN EARTH SCI, V66, P277, DOI 10.1016/j.jseaes.2013.02.005; Zhu BQ, 2012, GEOMORPHOLOGY, V153, P102, DOI 10.1016/j.geomorph.2012.02.014; Zhu LP, 2010, J GEOGR SCI, V20, P109, DOI 10.1007/s11442-010-0109-x; Ziemann DA, 2010, J WORLD AQUACULTURE, V23, P180; Zou F, 2005, WETLAND HAINAN ISLAN	92	1	1	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245438	10.1371/journal.pone.0245438	http://dx.doi.org/10.1371/journal.pone.0245438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481890	gold, Green Published			2022-12-26	WOS:000612929300124
J	Ohira, S; Kanayama, N; Wada, K; Ikawa, T; Hirata, T; Kishi, N; Karino, T; Washio, H; Ueda, Y; Miyazaki, M; Koizumi, M; Teshima, T				Ohira, Shingo; Kanayama, Naoyuki; Wada, Kentaro; Ikawa, Toshiki; Hirata, Takero; Kishi, Noriko; Karino, Tsukasa; Washio, Hayate; Ueda, Yoshihiro; Miyazaki, Masayoshi; Koizumi, Masahiko; Teshima, Teruki			Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography	PLOS ONE			English	Article							LIVER-TUMORS; CT; DELINEATION; RADIOTHERAPY; LESIONS	To assess the objective and subjective image quality, and respiratory motion of hepatocellular carcinoma with portal vein tumor thrombosis (PVTT) using the contrast-enhanced four-dimensional dual-energy computed tomography (CE-4D-DECT). For twelve patients, the virtual monochromatic image (VMI) derived from the CE-4D-DECT with the highest contrast to noise ratio (CNR) was determined as the optimal VMI (O-VMI). To assess the objective and subjective image quality, the CNR and five-point score of the O-VMI were compared to those of the standard VMI at 77 keV (S-VMI). The respiratory motion of the PVTT and diaphragm was measured based on the exhale and inhale phase images. The VMI at 60 keV yielded the highest CNR (4.8 +/- 1.4) which was significantly higher (p = 0.02) than that in the S-VMI (3.8 +/- 1.2). The overall image quality (4.0 +/- 0.6 vs 3.1 +/- 0.5) and tumor conspicuity (3.8 +/- 0.8 vs 2.8 +/- 0.6) of the O-VMI determined by three radiation oncologists was significantly higher (p < 0.01) than that of the S-VMI. The diaphragm motion in the L-R (3.3 +/- 2.5 vs 1.2 +/- 1.1 mm), A-P (6.7 +/- 4.0 vs 1.6 +/- 1.3mm) and 3D (8.8 +/- 3.5 vs 13.1 +/- 4.9 mm) directions were significantly larger (p < 0.05) compared to the tumor motion. The improvement of objective and subjective image quality was achieved in the O-VMI. Because the respiratory motion of the diaphragm was larger than that of the PVTT, we need to be pay attention for localizing target in radiotherapy.	[Ohira, Shingo; Kanayama, Naoyuki; Wada, Kentaro; Ikawa, Toshiki; Hirata, Takero; Kishi, Noriko; Karino, Tsukasa; Washio, Hayate; Ueda, Yoshihiro; Miyazaki, Masayoshi; Teshima, Teruki] Osaka Int Canc Inst, Dept Radiat Oncol, Osaka, Japan; [Ohira, Shingo; Koizumi, Masahiko] Osaka Univ, Dept Med Phys & Engn, Grad Sch Med, Suita, Osaka, Japan; [Kishi, Noriko] Kyoto Univ, Grad Sch Med, Dept Radiat Oncol & Image Appl Therapy, Kyoto, Japan	Osaka University; Kyoto University	Ohira, S (corresponding author), Osaka Int Canc Inst, Dept Radiat Oncol, Osaka, Japan.; Ohira, S (corresponding author), Osaka Univ, Dept Med Phys & Engn, Grad Sch Med, Suita, Osaka, Japan.	oohira-si@mc.pref.osaka.jp	Kishi, Noriko/AAV-5188-2020	Kishi, Noriko/0000-0001-5007-8808; Kentaro, Wada/0000-0002-0369-0049; IKAWA, TOSHIKI/0000-0001-9097-0227; Kanayama, Naoyuki/0000-0003-0016-2213; Ohira, Shingo/0000-0002-6170-1471	JSPS KAKENHI [19K17285]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant (Grant-in-Aid for Young Scientists 19K17285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2020, LIVER CANCER, V9, P293, DOI 10.1159/000505191; Beddar AS, 2008, RADIOTHER ONCOL, V87, P445, DOI 10.1016/j.radonc.2007.12.009; Catalano OA, 2010, RADIOLOGY, V254, P154, DOI 10.1148/radiol.09090304; Choi BO, 2008, BMC CANCER, V8, P1, DOI [10.1186/1471-2407-8-1, DOI 10.1186/1471-2407-8-1]; Connolly GC, 2008, THROMB RES, V122, P299, DOI 10.1016/j.thromres.2007.10.009; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; Fernandes AT, 2015, INT J RADIAT ONCOL, V91, P1034, DOI 10.1016/j.ijrobp.2014.12.048; Husarik DB, 2015, INVEST RADIOL, V50, P695, DOI 10.1097/RLI.0000000000000171; Il Yu J, 2016, WORLD J GASTROENTERO, V22, P6851, DOI 10.3748/wjg.v22.i30.6851; Jensen NKG, 2014, RADIOTHER ONCOL, V111, P153, DOI 10.1016/j.radonc.2014.01.026; Kim JH, 2016, RADIOLOGY, V279, P773, DOI 10.1148/radiol.2015150124; Kim TH, 2007, INT J RADIAT ONCOL, V67, P225, DOI 10.1016/j.ijrobp.2006.08.015; Liver Cancer Study Group of Japan, 2009, GEN RULES CLIN PATHO, V5th; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; Mileto A, 2016, RADIOLOGY, V279, P269, DOI 10.1148/radiol.2015150919; Ohira S, 2018, RADIOTHER ONCOL, V129, P105, DOI 10.1016/j.radonc.2018.01.012; Rossi S, 2008, EUR RADIOL, V18, P1749, DOI 10.1007/s00330-008-0931-z; Schoniger-Hekele M, 2001, GUT, V48, P103, DOI 10.1136/gut.48.1.103; Shui YJ, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1136-5; Shuman WP, 2014, AM J ROENTGENOL, V203, P601, DOI 10.2214/AJR.13.11337; Yagi M, 2013, J APPL CLIN MED PHYS, V14, P173, DOI 10.1120/jacmp.v14i5.4335; Yang J, 2014, INT J RADIAT ONCOL, V90, P952, DOI 10.1016/j.ijrobp.2014.07.028; Zhang D, 2011, MED PHYS, V38, P1178, DOI 10.1118/1.3551999	24	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244079	10.1371/journal.pone.0244079	http://dx.doi.org/10.1371/journal.pone.0244079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481820	Green Published, gold			2022-12-26	WOS:000612929300012
J	Black, MH; Osinski, A; Park, GJ; Gradowski, M; Servage, KA; Pawlowski, K; Tagliabracci, VS				Black, Miles H.; Osinski, Adam; Park, Gina J.; Gradowski, Marcin; Servage, Kelly A.; Pawlowski, Krzysztof; Tagliabracci, Vincent S.			A Legionella effector ADP-ribosyltransferase inactivates glutamate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR GROWTH; PNEUMOPHILA; UBIQUITINATION; RIBOSYLATION; METABOLISM; SEQUENCE; ENZYMES; AUTOPHAGOSOMES; PURIFICATION; CATALYZES	ADP-ribosyltransferases (ARTs) are a widespread superfamily of enzymes frequently employed in pathogenic strategies of bacteria. Legionella pneumophila, the causative agent of a severe form of pneumonia known as Legionnaire's disease, has acquired over 330 translocated effectors that showcase remarkable biochemical and structural diversity. However, the ART effectors that influence L. pneumophila have not been well defined. Here, we took a bioinformatic approach to search the Legionella effector repertoire for additional divergent members of the ART superfamily and identified an ART domain in Legionella pneumophila gene0181, which we hereafter refer to as Legionella ADP-Ribosyltransferase 1 (Lart1) (Legionella ART 1). We show that L. pneumophila Lart1 targets a specific class of 120-kDa NAD+-dependent glutamate dehydrogenase (GDH) enzymes found in fungi and protists, including many natural hosts of Legionella. Lart1 targets a conserved arginine residue in the NAD+-binding pocket of GDH, thereby blocking oxidative deamination of glutamate. Therefore, Lart1 could be the first example of a Legionella effector which directly targets a host metabolic enzyme during infection.	[Black, Miles H.; Osinski, Adam; Park, Gina J.; Servage, Kelly A.; Pawlowski, Krzysztof; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gradowski, Marcin; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Inst Biol, Warsaw, Poland; [Servage, Kelly A.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dept Mol Biol, Dallas, TX USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Warsaw University of Life Sciences; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	vincent.tagliabracci@utsouthwestern.edu	Gradowski, Marcin/AHC-8195-2022; Pawlowski, Krzysztof/C-2949-2013	Gradowski, Marcin/0000-0001-7695-5434; Osinski, Adam Krzysztof/0000-0003-0010-0733; Black, Miles/0000-0002-2864-1710; Park, Gina/0000-0002-2513-8917; Pawlowski, Krzysztof/0000-0002-5367-0935; Tagliabracci, Vincent/0000-0002-9735-4678	National Institutes of Health [DP2GM137419, F30HL143859-02]; Welch Foundation [I1911]; Polish National Agency for Scientific Exchange Scholarship [PPN/BEK/2018/1/00431]; Polish National Science Centre grant [2019/33/B/NZ2/01409]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Polish National Agency for Scientific Exchange Scholarship; Polish National Science Centre grant	This work was supported by National Institutes of Health Grants DP2GM137419 (to V. S. T.), and F30HL143859-02 (to M. H. B.), Welch Foundation Grants I1911 (to V. S. T.), the Polish National Agency for Scientific Exchange Scholarship PPN/BEK/2018/1/00431 (to K. P.) and Polish National Science Centre grant 2019/33/B/NZ2/01409 (to K. P.). V. S. T. is the Michael L. Rosenberg Scholar in Medical Research, a Cancer Prevention Research Institute of Texas Scholar (RR150033), and a Searle Scholar. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Akturk A, 2018, NATURE, V557, P729, DOI 10.1038/s41586-018-0147-6; Andersson JO, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-14; Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Best A, 2019, TRENDS MICROBIOL, V27, P550, DOI 10.1016/j.tim.2018.12.012; Bhogaraju S, 2019, NATURE, V572, P382, DOI 10.1038/s41586-019-1440-8; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Black MH, 2019, SCIENCE, V364, P787, DOI 10.1126/science.aaw7446; Bock FJ, 2015, MOL CELL, V58, P911, DOI 10.1016/j.molcel.2015.06.012; Burstein D, 2016, NAT GENET, V48, P167, DOI 10.1038/ng.3481; Chen Y, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003382; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Corda D, 2003, EMBO J, V22, P1953, DOI 10.1093/emboj/cdg209; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Domenighini M, 1996, MOL MICROBIOL, V21, P667, DOI 10.1046/j.1365-2958.1996.321396.x; Dong YA, 2018, NATURE, V557, P674, DOI 10.1038/s41586-018-0146-7; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fey P, 2009, NUCLEIC ACIDS RES, V37, pD515, DOI 10.1093/nar/gkn844; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gan NH, 2019, NATURE, V572, P387, DOI 10.1038/s41586-019-1439-1; Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398; Gomez-Valero L, 2019, P NATL ACAD SCI USA, V116, P2265, DOI 10.1073/pnas.1808016116; Gutierrez MG, 2005, AUTOPHAGY, V1, P179, DOI 10.4161/auto.1.3.2063; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HELLEBUST JA, 1988, J PROTOZOOL, V35, P498, DOI 10.1111/j.1550-7408.1988.tb04136.x; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Kalayil S, 2018, NATURE, V557, P734, DOI 10.1038/s41586-018-0145-8; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kent U M, 1999, Methods Mol Biol, V115, P11; Kim L, 2018, J MOL BIOL, V430, P2843, DOI 10.1016/j.jmb.2018.05.043; Kotewicz KM, 2017, CELL HOST MICROBE, V21, P169, DOI 10.1016/j.chom.2016.12.007; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; LANGRIDGE WHR, 1977, ARCH BIOCHEM BIOPHYS, V178, P581, DOI 10.1016/0003-9861(77)90229-6; Lyons B, 2016, J BIOL CHEM, V291, P11198, DOI 10.1074/jbc.M115.707653; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Minambres B, 2000, J BIOL CHEM, V275, P39529, DOI 10.1074/jbc.M005136200; MOFFAT JF, 1992, INFECT IMMUN, V60, P296, DOI 10.1128/IAI.60.1.296-301.1992; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Park JM, 2020, NAT MICROBIOL, V5, P599, DOI 10.1038/s41564-019-0663-7; POULIN R, 1987, J EXP ZOOL, V243, P365, DOI 10.1002/jez.1402430303; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Qiu JZ, 2016, NATURE, V533, P120, DOI 10.1038/nature17657; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Schaap P, 2018, MICROBIOL-SGM, V164, P727, DOI 10.1099/mic.0.000653; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Smith HQ, 2019, NEUROCHEM RES, V44, P117, DOI 10.1007/s11064-017-2428-0; Sreelatha A, 2020, J BIOL CHEM, V295, P6214, DOI 10.1074/jbc.RA120.013067; Sreelatha A, 2018, CELL, V175, P809, DOI 10.1016/j.cell.2018.08.046; Sulpizio A, 2019, ELIFE, V8, DOI 10.7554/eLife.51162; Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818; UNO I, 1984, J BIOL CHEM, V259, P1288; Wang Y, 2018, CELL, V173, P1231, DOI 10.1016/j.cell.2018.04.023; WEEKERS PHH, 1993, J EUKARYOT MICROBIOL, V40, P251, DOI 10.1111/j.1550-7408.1993.tb04912.x; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Zhu WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017638	70	5	6	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100301	10.1016/j.jbc.2021.100301	http://dx.doi.org/10.1016/j.jbc.2021.100301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476647	Green Published, gold			2022-12-26	WOS:000672866400275
J	Mohd-Kipli, F; Claridge, JK; Habjanic, J; Jiang, A; Schnell, JR				Mohd-Kipli, Faiz; Claridge, Jolyon K.; Habjanic, Jelena; Jiang, Alex; Schnell, Jason R.			Conformational triggers associated with influenza matrix protein 1 polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS M1 PROTEIN; SEASONAL INFLUENZA; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; WATER ACTIVITY; MEMBRANE; BINDING; IDENTIFICATION; LOCALIZATION; RESIDUES	A central role for the influenza matrix protein 1 (M1) is to form a polymeric coat on the inner leaflet of the host membrane that ultimately provides shape and stability to the virion. M1 polymerizes upon binding membranes, but triggers for conversion of M1 from a water-soluble component of the nucleus and cytosol into an oligomer at the membrane surface are unknown. While full-length M1 is required for virus viability, the N-terminal domain (M1NT) retains membrane binding and pH-dependent oligomerization. We studied the structural plasticity and oligomerization of M1NT in solution using NMR spectroscopy. We show that the isolated domain can be induced by sterol-containing compounds to undergo a conformational change and self-associate in a pH-dependent manner consistent with the stacked dimer oligomeric interface. Surface-exposed residues at one of the stacked dimer interfaces are most sensitive to sterols. Several perturbed residues are at the interface between the N-terminal subdomains and are also perturbed by changes in pH. The effects of sterols appear to be indirect and most likely mediated by reduction in water activity. The local changes are centered on strictly conserved residues and consistent with a priming of the N-terminal domain for polymerization. We hypothesize that M1NT is sensitive to changes in the aqueous environment and that this sensitivity is part of a mechanism for restricting polymerization to the membrane surface. Structural models combined with information from chemical shift perturbations indicate mechanisms by which conformational changes can be transmitted from one polymerization interface to the other.	[Mohd-Kipli, Faiz; Claridge, Jolyon K.; Habjanic, Jelena; Jiang, Alex; Schnell, Jason R.] Univ Oxford, Dept Biochem, Oxford, England; [Mohd-Kipli, Faiz] Univ Brunei Darussalam, Fac Sci, Gadong, Brunei	University of Oxford; University Brunei Darussalam	Schnell, JR (corresponding author), Univ Oxford, Dept Biochem, Oxford, England.	Jason.Schnell@bioch.ox.ac.uk		Jiang, Alex/0000-0002-2928-7530	Chancellor's Scholarship; UK Medical Research Council [L018578]; MRC [MR/L018578/1] Funding Source: UKRI	Chancellor's Scholarship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Chancellor's Scholarship to FMK and a grant from the UK Medical Research Council (L018578).	Arzt S, 2001, VIROLOGY, V279, P439, DOI 10.1006/viro.2000.0727; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Chiang MJ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.96; COMPANS RW, 1970, VIROLOGY, V42, P880, DOI 10.1016/0042-6822(70)90337-5; Damodaran Srinivasan, 2015, Subcell Biochem, V71, P233, DOI 10.1007/978-3-319-19060-0_10; Darapaneni V., 2015, AM J CURR MICROBIOL, V3, P1; Das SC, 2012, J VIROL, V86, P1522, DOI 10.1128/JVI.06230-11; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Halder UC, 2013, J BIOL CHEM, V288, P14554, DOI 10.1074/jbc.M112.447086; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; Hass MAS, 2015, ANNU REV BIOPHYS, V44, P53, DOI 10.1146/annurev-biophys-083012-130351; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hofer CT, 2019, BBA-BIOMEMBRANES, V1861, P1123, DOI 10.1016/j.bbamem.2019.03.013; Hom N, 2019, J VIROL, V93, DOI 10.1128/JVI.00161-19; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Keller R., 2004, THESIS SWISS FEDERAL; Kerviel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165421; Kordyukova LV, 2019, J BIOMOL STRUCT DYN, V37, P671, DOI 10.1080/07391102.2018.1436089; Lai YT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501855; Li S, 2014, BIOPHYS J, V106, P1447, DOI 10.1016/j.bpj.2014.02.018; Marcolli C, 2005, ATMOS CHEM PHYS, V5, P1545, DOI 10.5194/acp-5-1545-2005; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PARSEGIAN VA, 1984, J CELL BIOL, V99, pS196, DOI 10.1083/jcb.99.1.196s; Peukes J, 2020, NATURE, V587, P495, DOI 10.1038/s41586-020-2696-8; Reed C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118369; Reinhardt J, 2000, VET MICROBIOL, V74, P87, DOI 10.1016/S0378-1135(00)00169-3; Rolfes MA, 2018, INFLUENZA OTHER RESP, V12, P132, DOI 10.1111/irv.12486; Ruigrok RWH, 2000, VIROLOGY, V267, P289, DOI 10.1006/viro.1999.0134; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Scianimanico S, 2000, EMBO J, V19, P6732, DOI 10.1093/emboj/19.24.6732; Selzer L, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000827; Sha BD, 1997, NAT STRUCT BIOL, V4, P239, DOI 10.1038/nsb0397-239; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shilova LA, 2017, BIOCHEM MOSC SUPPL S, V11, P225, DOI 10.1134/S1990747817030072; Shishkov AV, 1999, P NATL ACAD SCI USA, V96, P7827, DOI 10.1073/pnas.96.14.7827; Shtykova EV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16986-y; Vemula SV, 2017, EXPERT REV VACCINES, V16, P1141, DOI 10.1080/14760584.2017.1379396; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WHITTAKER G, 1995, J VIROL, V69, P439, DOI 10.1128/JVI.69.1.439-445.1995; Xie H, 2013, J VIROL, V87, P345, DOI 10.1128/JVI.02024-12; Xiong J., 2020, BIORXIV; Zhang K, 2015, CELL MICROBIOL, V17, P1583, DOI 10.1111/cmi.12457; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037786; Zhang WT, 2017, P NATL ACAD SCI USA, V114, P8550, DOI 10.1073/pnas.1701747114; Zhu HJ, 1996, INT J PHARM, V135, P151, DOI 10.1016/0378-5173(95)04466-3	53	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100316	10.1016/j.jbc.2021.100316	http://dx.doi.org/10.1016/j.jbc.2021.100316			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33516724	Green Published, gold			2022-12-26	WOS:000672866400290
J	Graham-Clarke, E; Rushton, A; Marriott, J				Graham-Clarke, Emma; Rushton, Alison; Marriott, John			A Delphi study to explore and gain consensus regarding the most important barriers and facilitators affecting physiotherapist and pharmacist non-medical prescribing	PLOS ONE			English	Article							UK	Non-medical prescribing was introduced into the United Kingdom to improve patient care, but early research indicated a third of Allied Health Professionals may not use their prescribing qualification. A previous literature review, highlighting factors influencing prescribing, identified only papers with nursing and pharmacy participants. This investigation explored consensus on factors affecting physiotherapist and pharmacist non-medical prescribers. A three round Delphi study was conducted with pharmacist and physiotherapist prescribers. Round One comprised information gathering on facilitators and barriers to prescribing participants had experienced, and underwent content analysis. This was followed by two sequential consensus seeking rounds with participants asked to rate the importance of statements to themselves. Consensus criteria were determined a priori, including median, interquartile range, percentage agreement and Kendall's Coefficient of Concordance (W). Statements reaching consensus were ranked for importance in Round Three and analysed to produce top ten ranks for all participants and for each professional group. Participants, recruited October 2018, comprised 24 pharmacists and 18 physiotherapists. In Round One, content analysis of 172 statements regarding prescribing influences revealed 24 themes. 127 statements were included in Round Two for importance rating (barriers = 68, facilitators = 59). After Round Two, 29 statements reached consensus (barriers = 1, facilitators = 28), with no further statements reaching consensus following Round Three. The highest ranked statement in Round Three overall was: "Being able to prescribe to patients is more effective and really useful working [in my area]". Medical support and improved patient care factors appeared the most important. Differences were noted between physiotherapist and pharmacist prescribers regarding the top ten ranked statements, for example team working which pharmacists ranked higher than physiotherapists. Differences may be explained by the variety of practice areas and relative newness of physiotherapy prescribing. Barriers appear to be post or person specific, whereas facilitators appear universal.	[Graham-Clarke, Emma; Marriott, John] Univ Birmingham, Coll Med & Dent Sci, Sch Pharm, Inst Clin Sci, Birmingham, W Midlands, England; [Rushton, Alison] Western Univ, Sch Phys Therapy, London, ON, Canada; [Rushton, Alison] Univ Birmingham, Coll Life & Environm Sci, Ctr Precis Rehabil Spinal Pain, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Birmingham; Western University (University of Western Ontario); University of Birmingham	Graham-Clarke, E (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Pharm, Inst Clin Sci, Birmingham, W Midlands, England.	EMG315@bham.ac.uk	Graham-Clarke, Emma/GZG-8429-2022; Graham-Clarke, Emma/U-1559-2019; Rushton, Alison/V-1260-2017	Graham-Clarke, Emma/0000-0001-5657-778X; Rushton, Alison/0000-0001-8114-7669				[Anonymous], 1998, BEST PRACTICE EVIDEN, V2, P1; [Anonymous], 2016, PRESCR SURV REP, P54; Campbell SM, 2001, J CLIN PHARM THER, V26, P5, DOI 10.1046/j.1365-2710.2001.00331.x; Courtenay M, 2008, J ADV NURS, V61, P291, DOI 10.1111/j.1365-2648.2007.04512.x; Courtenay M, 2007, INT J NURS STUD, V44, P1093, DOI 10.1016/j.ijnurstu.2006.04.005; Courtenay M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-138; Department of Health, 1999, REV PRESCR SUPPL ADM; Department of Health, 2006, CAR HOM IND PHARM PR; Department of Health, 2005, 4941 DEP HLTH; Dorer, 2010, EVALUATION NURSE PHA; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Graham-Clarke E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214630; Graham-Clarke E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196471; Hacking S, 2010, EVALUATION SCOPE PRA; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hasson F, 2011, TECHNOL FORECAST SOC, V78, P1695, DOI 10.1016/j.techfore.2011.04.005; Health & Care Professions Council, PHYS 2015; Hicks C. M., 2009, RES METHODS CLIN THE; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hung HL, 2008, EVAL PROGRAM PLANN, V31, P191, DOI 10.1016/j.evalprogplan.2008.02.005; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Keeney S., 2011, DELPHI TECHNIQUE NUR; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McColl E, 2001, Health Technol Assess, V5, P1; McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Pope C., 2007, SYNTHESIZING QUALITA; Ritchie J, 2014, SOC JUSTICE, P111; Rushton AB, 2014, MANUAL THER, V19, P445, DOI 10.1016/j.math.2014.04.013; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; von der Gracht HA, 2012, TECHNOL FORECAST SOC, V79, P1525, DOI 10.1016/j.techfore.2012.04.013; Weiss M.C., 2006, EXPLORING INNOVATION; Wiangkham T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011764; Zambaldi M, 2017, BRIT J SPORT MED, V51, P1221, DOI 10.1136/bjsports-2016-097131	37	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246273	10.1371/journal.pone.0246273	http://dx.doi.org/10.1371/journal.pone.0246273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529197	Green Published, gold			2022-12-26	WOS:000616736200038
J	Diaw, Y; Tollon-Cordet, C; Charcosset, A; Nicolas, SD; Madur, D; Ronfort, J; David, J; Gouesnard, B				Diaw, Yacine; Tollon-Cordet, Christine; Charcosset, Alain; Nicolas, Stephane D.; Madur, Delphine; Ronfort, Joelle; David, Jacques; Gouesnard, Brigitte			Genetic diversity of maize landraces from the South-West of France	PLOS ONE			English	Article							POPULATION-STRUCTURE; RFLP DIVERSITY; MAYS L.; DNA; INDIVIDUALS; DOMESTICATION; VARIABILITY; EUROPE; NUMBER; RACES	From the 17th century until the arrival of hybrids in 1960s, maize landraces were cultivated in the South-West of France (SWF), a traditional region for maize cultivation. A set of landraces were collected in this area between the 1950s and 1980s and were then conserved ex situ in a germplam collection. Previous studies using molecular markers on approx. twenty landraces from this region suggested that they belonged to a Pyrenees-Galicia Flint genetic group and originated from hybridizations between Caribbean and Northern Flint germplasms introduced to Europe. In this study, we assessed the structure and genetic diversity of 194 SWF maize landraces to better elucidate their origin, using a 50K SNP array and a bulk DNA approach. We identified two weakly differentiated genetic groups, one in the Western part and the other in the Eastern part of the studied region. We highlighted the existence of a longitudinal gradient along the SWF area that was probably maintained through the interplay between genetic drifts and restricted gene flows. The contact zone between the two groups observed near the Garonne valley may be the result of these evolutionnary forces. We found in landraces from the East part of the region significant cases of admixture between landraces from the Northern Flint group and landraces from either the Caribbean, Andean or Italian groups. We then assumed that SWF landraces had a multiple origin with a predonderance of Northern Flint germplasm for the two SWF groups, notably for the East part.	[Diaw, Yacine] ISRA CNRA Bambey, Inst Senegalais Rech Agr, Dakar, Senegal; [Diaw, Yacine; Tollon-Cordet, Christine; Ronfort, Joelle; David, Jacques; Gouesnard, Brigitte] Univ Montpellier, Inst Agro, INRAE, CIRAD,AGAP, Montpellier, France; [Charcosset, Alain; Nicolas, Stephane D.; Madur, Delphine] Univ Paris Saclay, GQE Le Moulon, AgroParisTech, CNRS,INRAE, Gif Sur Yvette, France	CIRAD; INRAE; Institut Agro; Universite de Montpellier; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gouesnard, B (corresponding author), Univ Montpellier, Inst Agro, INRAE, CIRAD,AGAP, Montpellier, France.	brigitte.gouesnard@inrae.fr	Nicolas, Stephane/N-6886-2017	Nicolas, Stephane/0000-0003-0758-9930	West African Agricultural Productivity Program (WAAPP) by Institut Senegalais de Recherches Agricoles (ISRA); Agence Nationale de la Recherche [Amaizing ANR-10-BTBR_01]	West African Agricultural Productivity Program (WAAPP) by Institut Senegalais de Recherches Agricoles (ISRA); Agence Nationale de la Recherche(French National Research Agency (ANR))	YD received a grant from West African Agricultural Productivity Program (WAAPP, http://www.waapp-ppaao.org/en) given by Institut Senegalais de Recherches Agricoles (ISRA, https://www.isra.sn/).AC and BG received a grant from project Amaizing ANR-10-BTBR_01 (https://amaizing.fr/en/) of "Agence Nationale de la Recherche, https://anr.fr/".The both funders played a role in decision to publish.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arca M, 2021, FRONTIERS PLANT SCI, P11; Bedoya CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173488; Beigbeder J, 2018, MAIS ANCIENS PYRENEE; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Brandenburg JT, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006666; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Carraretto M., 2005, HIST MAIS DIVINITE A; Charrier O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092976; Conord C, 2012, ECOL EVOL, V2, P2595, DOI 10.1002/ece3.350; Dallard J., 2000, Plant Genetic Resources Newsletter, P35; Derryberry EP, 2014, MOL ECOL RESOUR, V14, P652, DOI 10.1111/1755-0998.12209; DOEBLEY J, 1988, ECON BOT, V42, P120, DOI 10.1007/BF02859042; Dubreuil P, 2006, MAYDICA, V51, P281; Dubreuil P, 1999, PLANT MOL BIOL REP, V17, P123, DOI 10.1023/A:1007571101815; Eschholz TW, 2008, GENET RESOUR CROP EV, V55, P971, DOI 10.1007/s10722-007-9304-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freche G., 1969, ANN MIDI, P17; Freitas FO, 2003, J ARCHAEOL SCI, V30, P901, DOI 10.1016/S0305-4403(02)00269-8; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gauthier P, 2002, THEOR APPL GENET, V105, P91, DOI 10.1007/s00122-002-0903-7; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; INRA, 2017, MAIZ DAT; Labate JA, 2003, CROP SCI, V43, P80, DOI 10.2135/cropsci2003.0080; MANTEL N, 1967, CANCER RES, V27, P209; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Mauro F., 1968, CARAVELLE CAHIERS MO, P151; Millet Vouette I., 2007, BUCKWHEAT MAIZE SORG; Mir C, 2013, THEOR APPL GENET, V126, P2671, DOI 10.1007/s00122-013-2164-z; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Oromi N, 2012, ECOL EVOL, V2, P2018, DOI 10.1002/ece3.323; Patto MCV, 2004, EUPHYTICA, V137, P63, DOI 10.1023/B:EUPH.0000040503.48448.97; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rebourg C, 2003, THEOR APPL GENET, V106, P895, DOI 10.1007/s00122-002-1140-9; Rebourg C, 1999, MAYDICA, V44, P237; Rebourg C, 2001, HEREDITY, V86, P574, DOI 10.1046/j.1365-2540.2001.00869.x; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reif JC, 2005, THEOR APPL GENET, V111, P906, DOI 10.1007/s00122-005-0016-1; Renoux J., 2014, MAIS PLANTE LINTENSI; Revilla P, 1998, MAYDICA, V43, P175; Revilla P, 2003, MAYDICA, V48, P141; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Rouch M., 1986, ECOLE FRANCAISE ROME, V94, P693; Rousset F, 1997, GENETICS, V145, P1219; Segovia-Lerma A, 2003, GENOME, V46, P51, DOI 10.1139/G02-100; Sharma L, 2010, GENETICA, V138, P619, DOI 10.1007/s10709-010-9436-1; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Valbuena-Urena E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200214; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Weisstein E.W., 2020, MATHWORLD WOLFRAM WE; Wright S., 1978, EVOLUTION GENETICS P	58	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0238334	10.1371/journal.pone.0238334	http://dx.doi.org/10.1371/journal.pone.0238334			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524023	Green Published, Green Submitted, gold			2022-12-26	WOS:000616578400017
J	Hum, M; Tan, HJ; Yang, YX; Srivastava, S; Teh, M; Lim, YP				Hum, Melissa; Tan, Hock Jin; Yang, Yixuan; Srivastava, Supriya; Teh, Ming; Lim, Yoon Pin			WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway	FASEB JOURNAL			English	Article						cell migration; gastric cancer; Hippo pathway; LATS2; WBP2	PROTEIN-INTERACTION NETWORK; DOMAIN-BINDING PROTEIN-2; YES-ASSOCIATED PROTEIN; WW-DOMAIN; BREAST-CANCER; TYROSINE PHOSPHORYLATION; FAMILY PROTEINS; EMERGING ROLE; E-CADHERIN; PROLIFERATION	Dysregulation of signaling pathways is responsible for many human diseases. The lack of understanding of the molecular etiology of gastric cancer (GC) poses a substantial challenge to the development of effective cancer therapy. To better understand the molecular mechanisms underlying the pathogenesis of GC, which will facilitate the identification and development of effective therapeutic approaches to improve patient outcomes, mass spectrometry-based phosphoproteomics analysis was performed to map the global molecular changes in GC. A total of 530 proteins with altered phosphorylation levels were detected across a panel of 15 normal and GC cell lines. WW domain-binding protein 2 (WBP2) was validated to be upregulated in a subset of GC cell lines. WBP2 is overexpressed in 61% cases of GC compared to non-cancer tissues and high WBP2 expression correlates with poor clinical outcomes. WBP2 was found to be required for GC cell migration but is dispensable for cell growth and proliferation. WBP2 knockdown increased p-LATS2 with a concomitant increase in p-YAP, resulting in the cytoplasmic retention of YAP and ultimately the inhibition of YAP/TEAD activity and downregulation of TEAD target genes--CTGF and CYR61. Importantly, the loss of LATS2 reversed the activation of Hippo pathway caused by WBP2 knockdown, indicating that WBP2 acts through LATS2 to exert its function on the Hippo pathway. Moreover, WBP2 interacted with LATS2 to inhibit its phosphorylation and activity. In conclusion, our study established a pivotal role for WBP2 in the promotion of GC cell migration via a novel mechanism that inactivates the Hippo pathway transducer LATS2.	[Hum, Melissa; Tan, Hock Jin; Yang, Yixuan; Lim, Yoon Pin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4 01-03D,5 Sci Dr 2, Singapore 117545, Singapore; [Srivastava, Supriya] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Teh, Ming] Natl Univ Hlth Syst, Dept Pathol, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Canc Inst, Singapore, Singapore; [Lim, Yoon Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore	Lim, YP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, MD4 01-03D,5 Sci Dr 2, Singapore 117545, Singapore.	bchlyp@nus.edu.sg	yang, yx/GZM-0464-2022; Srivastava, Supriya/HDJ-9671-2022					Ajani JA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.36; Apicella M, 2017, ONCOTARGET, V8, P57654, DOI 10.18632/oncotarget.14825; Arash EH, 2014, EMBO J, V33, P2997, DOI 10.15252/embj.201490230; Arienti C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01308; Aylon Y, 2016, GENE DEV, V30, P786, DOI 10.1101/gad.274167.115; Bang YJ, 2010, LANCET, V376, P1302; Bichsel SJ, 2004, J BIOL CHEM, V279, P35228, DOI 10.1074/jbc.M404542200; Boku N, 2014, GASTRIC CANCER, V17, P1, DOI 10.1007/s10120-013-0252-z; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chan SW, 2011, ONCOGENE, V30, P600, DOI 10.1038/onc.2010.438; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0376-5; Chen YH, 2007, MOL CELL PROTEOMICS, V6, P2072, DOI 10.1074/mcp.M700395-MCP200; Chen Y, 2007, PROTEOMICS, V7, P2384, DOI 10.1002/pmic.200600968; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Deng J, 2015, TUMOR BIOL, V36, P6823, DOI 10.1007/s13277-015-3364-8; Dhananjayan SC, 2006, MOL ENDOCRINOL, V20, P2343, DOI 10.1210/me.2005-0533; Dillon R, 2011, J PROTEOME RES, V10, P5084, DOI 10.1021/pr200498v; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Furth N, 2017, CELL DEATH DIFFER, V24, P1488, DOI 10.1038/cdd.2017.99; Gao J, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109466; Gogl G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002146; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Hollestelle A, 2013, BREAST CANCER RES TR, V138, P47, DOI 10.1007/s10549-013-2415-3; Hu XB, 2014, PATHOL ONCOL RES, V20, P805, DOI 10.1007/s12253-014-9757-y; Jagannathan R, 2016, MOL CELL BIOL, V36, P2526, DOI 10.1128/MCB.00136-16; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kang W, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0134-0; Kang W, 2016, WORLD J GASTROENTERO, V22, P1279, DOI 10.3748/wjg.v22.i3.1279; Kang W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0323-3; Kawakami H, 2016, GASTRIC CANCER, V19, P687, DOI 10.1007/s10120-015-0585-x; Konstantinou D, 2016, CURR OPIN PHARMACOL, V31, P76, DOI 10.1016/j.coph.2016.09.003; Lee WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27903; Li J, 2015, INT J MOL MED, V36, P1451, DOI 10.3892/ijmm.2015.2390; Lim SK, 2016, CANCER RES, V76, P6278, DOI 10.1158/0008-5472.CAN-15-3537; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Lim YP, 2003, MOL CANCER THER, V2, P1369; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Matsui Y, 2008, CIRC RES, V103, P1309, DOI 10.1161/CIRCRESAHA.108.180042; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Nilsson GMA, 2014, INT J ONCOL, V45, P82, DOI 10.3892/ijo.2014.2424; Nitsch R, 2004, BIOCHEM J, V377, P553, DOI 10.1042/BJ20031233; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Plouffe SW, 2016, MOL CELL, V64, P993, DOI 10.1016/j.molcel.2016.10.034; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Sitarz R, 2018, CANCER MANAG RES, V10, P239, DOI 10.2147/CMAR.S149619; Sokolova O, 2017, TOXINS, V9, DOI 10.3390/toxins9040119; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Sun D, 2016, ONCOTARGET, V7, P81062, DOI 10.18632/oncotarget.13188; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Walko G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14744; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang WQ, 2014, MOL CELL PROTEOMICS, V13, P119, DOI 10.1074/mcp.M113.030049; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200; Yang DY, 2011, J GASTROINTEST ONCOL, V2, P77, DOI 10.3978/j.issn.2078-6891.2010.025; Zhang J, 2012, INT J IMMUNOPATH PH, V25, P583, DOI 10.1177/039463201202500304; Zhang X, 2011, CELL DEATH DIFFER, V18, P1346, DOI 10.1038/cdd.2011.6; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou GX, 2013, ASIAN PAC J CANCER P, V14, P5199, DOI 10.7314/APJCP.2013.14.9.5199; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	72	4	4	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21290	10.1096/fj.202000393R	http://dx.doi.org/10.1096/fj.202000393R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475198				2022-12-26	WOS:000647789600019
J	Wang, ZH; Atakan, MM; Yan, X; Turnagol, HH; Duan, HL; Peng, L				Wang, Zhenhuan; Atakan, Muhammed M.; Yan, Xu; Turnagoel, Hueseyin H.; Duan, Honglei; Peng, Li			Graded exercise test with or without load carriage similarly measures maximal oxygen uptake in young males and females	PLOS ONE			English	Article							ENERGY-EXPENDITURE; CARDIORESPIRATORY FITNESS; PHYSIOLOGICAL-RESPONSES; TREADMILL WALKING; CARRYING LOADS; COST; CYCLE; PERFORMANCE; CONSUMPTION; MECHANICS	The aim of this was to compare the effects of the graded exercise test (GXT) with or without load carriage on maximal oxygen uptake ((V) over dotO(2max)) heart rate (HR), and expired ventilation (VE) and blood lactate in young healthy males and females. The study included ten females (age:20.2 +/- 0.7 yrs) and ten males (age:19.5 +/- 0.7 yrs) who performed the modified Bruce protocol at five load conditions; unloaded, 5, 10, 15, and 20% of body weight (BW) (kg). All the tests were performed in random order, at least 48 hours apart. During the GXTs, HR, (V) over dotO(2max), (V) over dotE, workload and test duration were recorded and blood lactate concentration was measured before and immediately after the GXTs. (V) over dotO(2max) remained unchanged during the GXTs in load and unloaded conditions for both sexes (p>0.05). Test duration was significantly less in females during the GXT with 15% BW (15.9 +/- 0.51 min vs. 18.1 +/- 1.14 min; p = 0.014) and 20% BW load carriage (15.2 +/- 0.75 min vs. 18.1 +/- 1.14 min; p = 0.020), compared to the unloaded GXT. Males showed significant decrease in the test duration during the GXT with load 15% BW (20.5 +/- 0.53 min vs. 22.8 +/- 0.61 min; p = 0.047) and with 20% BW (19.6 +/- 0.42 min vs. 22.8 +/- 0.71 min; p = 0.004), compared to the GXT with 5% BW. VE statistically decreased in female subjects only at 15% BW compared to 20% BW (15% BW = 77.9 +/- 10.5 L/min vs. 15% BW = 72.0 +/- 10.9 L/min; p = 0.045). There was no difference observed in maximal HR and blood lactate concentration between the GXTs in load and unloaded conditions. This study indicates that no matter the load % used during the GXT, (V) over dotO(2max), but not total exercise time, remains the same in young males and females.	[Wang, Zhenhuan; Duan, Honglei; Peng, Li] Southwest Univ, Key Lab Gen Adm Sport, Chongqing, Peoples R China; [Wang, Zhenhuan; Atakan, Muhammed M.; Yan, Xu] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Atakan, Muhammed M.; Turnagoel, Hueseyin H.] Hacettepe Univ, Fac Sport Sci, Div Nutr & Metab Exercise, Ankara, Turkey; [Yan, Xu] Victoria Univ, Coll Hlth & Biomed, Melbourne, Vic, Australia	Southwest University - China; Victoria University; Hacettepe University; Victoria University	Peng, L (corresponding author), Southwest Univ, Key Lab Gen Adm Sport, Chongqing, Peoples R China.	804455169@qq.com	vandoni, matteo/AAS-7299-2021	vandoni, matteo/0000-0002-3405-9364; Yan, Xu/0000-0001-8547-4210	Southwest University Innovation Team Research Project [SWU1909105]	Southwest University Innovation Team Research Project	LP was supported for this work by Southwest University Innovation Team Research Project (Project ID:SWU1909105).	Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Astorino T, 2004, REINVESTIGATION OPTI, V7, DOI [10.1519/13723.115574105, DOI 10.1519/13723.115574105]; Atakan MM, 2021, J SPORT HEALTH SCI, V10, P478, DOI 10.1016/j.jshs.2020.06.008; Bastien GJ, 2005, EUR J APPL PHYSIOL, V94, P76, DOI 10.1007/s00421-004-1286-z; Beltz Nicholas M, 2016, J Sports Med (Hindawi Publ Corp), V2016, P3968393, DOI 10.1155/2016/3968393; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Bouwsema MM, 2017, J APPL PHYSIOL, V122, P460, DOI 10.1152/japplphysiol.00389.2016; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Chatterjee S, 2018, MILITARY MED RES, V5, DOI 10.1186/s40779-018-0171-8; DATTA SR, 1971, ERGONOMICS, V14, P269, DOI 10.1080/00140137108931244; DAVIS JA, 1982, MED SCI SPORT EXER, V14, P339; Dokumaci B, 2019, RES Q EXERCISE SPORT, V90, P318, DOI 10.1080/02701367.2019.1599800; Dominelli PB, 2012, EUR J APPL PHYSIOL, V112, P2001, DOI 10.1007/s00421-011-2177-8; EPSTEIN Y, 1988, EUR J APPL PHYSIOL O, V57, P243, DOI 10.1007/BF00640670; Fagundes AD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189516; FAIRSHTER RD, 1983, MED SCI SPORT EXER, V15, P549; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Grenier JG, 2012, MED SCI SPORT EXER, V44, P1131, DOI 10.1249/MSS.0b013e3182456057; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Hall MM, 2016, PM&R, V8, pS8, DOI 10.1016/j.pmrj.2015.10.018; Hazir T, 2007, ISOKINET EXERC SCI, V15, P253, DOI 10.3233/IES-2007-0281; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Hong YL, 2000, ERGONOMICS, V43, P717, DOI 10.1080/001401300404698; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Huang TWP, 2014, J EXP BIOL, V217, P605, DOI 10.1242/jeb.091587; Iannetta D, 2019, J APPL PHYSIOL, V127, P1519, DOI 10.1152/japplphysiol.00508.2019; Iannetta D, 2020, MED SCI SPORT EXER, V52, P466, DOI 10.1249/MSS.0000000000002147; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; LEBRUN CM, 1995, MED SCI SPORT EXER, V27, P437; Lepretre PM, 2004, MED SCI SPORT EXER, V36, P1357, DOI 10.1249/01.MSS.0000135977.12456.8F; Li SSW, 2019, HUM FACTORS, V61, P203, DOI 10.1177/0018720818799190; Lidstone DE, 2017, J APPL BIOMECH, V33, P248, DOI 10.1123/jab.2016-0185; Lloyd R, 2000, EUR J APPL PHYSIOL, V81, P486, DOI 10.1007/s004210050072; Luong MW, 2016, B C MED J, V58, P70; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0; Mattu AT, 2020, SCAND J MED SCI SPOR, V30, P472, DOI 10.1111/sms.13590; Mauger AR, 2013, APPL PHYSIOL NUTR ME, V38, P1211, DOI 10.1139/apnm-2012-0384; McCole SD, 2001, MED SCI SPORT EXER, V33, P1265, DOI 10.1097/00005768-200108000-00004; Millet GP, 2009, SPORTS MED, V39, P179, DOI 10.2165/00007256-200939030-00002; Mullins AK, 2015, ERGONOMICS, V58, P770, DOI 10.1080/00140139.2014.984775; Murias JM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00143; Murias JM, 2010, J APPL PHYSIOL, V108, P621, DOI 10.1152/japplphysiol.01152.2009; Murray J, 2018, J SPORT MED PHYS FIT, V58, P17, DOI 10.23736/S0022-4707.16.06825-0; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Noakes TD, 2012, BRIT J SPORT MED, V46, P1, DOI 10.1136/bjsports-2011-090811; O'Connor SM, 2012, GAIT POSTURE, V36, P102, DOI 10.1016/j.gaitpost.2012.01.014; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Phillips DB, 2016, EUR J APPL PHYSIOL, V116, P275, DOI 10.1007/s00421-015-3280-z; Phillips DB, 2019, EUR J APPL PHYSIOL, V119, P441, DOI 10.1007/s00421-018-4042-5; Phillips DB, 2016, EUR J APPL PHYSIOL, V116, P1725, DOI 10.1007/s00421-016-3427-6; Phillips DB, 2016, APPL PHYSIOL NUTR ME, V41, P741, DOI 10.1139/apnm-2016-0002; PIMENTAL NA, 1979, ERGONOMICS, V22, P963, DOI 10.1080/00140137908924670; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Reed KE, 2017, J SCI MED SPORT, V20, P386, DOI 10.1016/j.jsams.2016.09.005; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Smirmaul BPC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00203; SOLAL AC, 1990, J AM COLL CARDIOL, V16, P80, DOI 10.1016/0735-1097(90)90460-7; SOULE RG, 1978, ERGONOMICS, V21, P373, DOI 10.1080/00140137808931734; Soydan TA, 2018, ISOKINET EXERC SCI, V26, P73, DOI 10.3233/IES-180171191; Tan WC, 2011, CAN RESPIR J, V18, P321, DOI 10.1155/2011/540396; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73; Taylor NAS, 2012, EUR J APPL PHYSIOL, V112, P2913, DOI 10.1007/s00421-011-2267-7; Wagner P D, 2000, Exerc Sport Sci Rev, V28, P10; Wang LY, 2004, MED SCI SPORT EXER, V36, P780, DOI 10.1249/01.MSS.0000126386.12402.F5; Yoon BK, 2007, MED SCI SPORT EXER, V39, P1186, DOI 10.1249/mss.0b13e318054e304	68	0	0	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246303	10.1371/journal.pone.0246303	http://dx.doi.org/10.1371/journal.pone.0246303			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524068	Green Published, gold			2022-12-26	WOS:000616578400018
J	Kim, SK; Goughnour, PC; Lee, EJ; Kim, MH; Chae, HJ; Yun, GY; Kim, YR; Choi, JW				Kim, Sun Kyung; Goughnour, Peter C.; Lee, Eui Jin; Kim, Myeong Hyun; Chae, Hee Jin; Yun, Gwang Yeul; Kim, Yi Rang; Choi, Jin Woo			Identification of drug combinations on the basis of machine learning to maximize anti-aging effects	PLOS ONE			English	Article							CONNECTIVITY MAP; CELL-DEATH; INHIBITORS; DISCOVERY; METFORMIN; TRICHOSTATIN; MECHANISMS; SENESCENCE; PREDICTION; SIGNATURES	Aging is a multifactorial process that involves numerous genetic changes, so identifying anti-aging agents is quite challenging. Age-associated genetic factors must be better understood to search appropriately for anti-aging agents. We utilized an aging-related gene expression pattern-trained machine learning system that can implement reversible changes in aging by linking combinatory drugs. In silico gene expression pattern-based drug repositioning strategies, such as connectivity map, have been developed as a method for unique drug discovery. However, these strategies have limitations such as lists that differ for input and drug-inducing genes or constraints to compare experimental cell lines to target diseases. To address this issue and improve the prediction success rate, we modified the original version of expression profiles with a stepwise-filtered method. We utilized a machine learning system called deep-neural network (DNN). Here we report that combinational drug pairs using differential expressed genes (DEG) had a more enhanced anti-aging effect compared with single independent treatments on leukemia cells. This study shows potential drug combinations to retard the effects of aging with higher efficacy using innovative machine learning techniques.	[Kim, Sun Kyung; Goughnour, Peter C.; Lee, Eui Jin; Choi, Jin Woo] Kyung Hee Univ, Coll Pharm, Seoul, South Korea; [Kim, Myeong Hyun; Chae, Hee Jin; Yun, Gwang Yeul; Kim, Yi Rang] Oncocross Ltd, Ctr Res & Dev, Seoul, South Korea; [Kim, Yi Rang] Yuseong Sun Hosp, Dept Hematol Oncol, Daejeon, South Korea; [Choi, Jin Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Choi, JW (corresponding author), Kyung Hee Univ, Coll Pharm, Seoul, South Korea.; Kim, YR (corresponding author), Oncocross Ltd, Ctr Res & Dev, Seoul, South Korea.; Kim, YR (corresponding author), Yuseong Sun Hosp, Dept Hematol Oncol, Daejeon, South Korea.; Choi, JW (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	99yirang@gmail.com; jinwoo.ch@khu.ac.kr		Choi, Jin Woo/0000-0003-1177-598X; Chae, Hee Jin/0000-0003-3297-9738	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea [HA17C0039]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Republic of Korea [NRF2017R1A5A2014768, 2017R1C1B5017615]	National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Republic of Korea	This research was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea to YRK and JWC (HA17C0039), and the Basic Science Research Program through the National Research Foundation of Korea (NRF2017R1A5A2014768) funded by the Ministry of Education, Republic of Korea (2017R1C1B5017615). Oncocross Ltd. provided support for this study in the form of salaries for MHK, HJC, GYY, and YRK. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blagosklonny MV, 2009, AGING-US, V1, P281, DOI 10.18632/aging.100034; Boolell M, 1996, Int J Impot Res, V8, P47; BRETZA JA, 1980, ARCH INTERN MED, V140, P1379, DOI 10.1001/archinte.140.10.1379; Calvert S, 2016, AGING CELL, V15, P256, DOI 10.1111/acel.12432; Chen QM, 2000, J CELL SCI, V113, P4087; De Bastiani MA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00697; Eetemadi A, 2019, BIOINFORMATICS, V35, P2226, DOI 10.1093/bioinformatics/bty945; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Ghorab MM, 2014, INT J MOL SCI, V15, P7539, DOI 10.3390/ijms15057539; Goel S, 2020, EUR UROL ONCOL, V3, P10, DOI 10.1016/j.euo.2019.08.001; Heim Steven W, 2005, Ann Fam Med, V3 Suppl 2, pS65, DOI 10.1370/afm.360; Huff RG, 2005, CHEM BIODIVERS, V2, P1533, DOI 10.1002/cbdv.200590125; Janssens GE, 2019, CELL REP, V27, P467, DOI 10.1016/j.celrep.2019.03.044; Jasek E, 2012, ANTICANCER RES, V32, P2791; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Johnson RJK, 2005, J MOL BIOL, V352, P823, DOI 10.1016/j.jmb.2005.07.040; Kerepesi C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22240-w; Klimaszewska-Wisniewska A, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0288-3; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landstedt-Hallin L, 1999, J CLIN ENDOCR METAB, V84, P3140, DOI 10.1210/jc.84.9.3140; Levri KM, 2005, ANN FAM MED, V3, P457, DOI 10.1370/afm.343; Lin B, 2014, SCI REP-UK, V4, DOI 10.1038/srep07041; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; Mocali A, 2005, J GERONTOL A-BIOL, V60, P695, DOI 10.1093/gerona/60.6.695; Musa A, 2018, BRIEF BIOINFORM, V19, P506, DOI 10.1093/bib/bbw112; Nemade H, 2018, ARCH TOXICOL, V92, P1507, DOI 10.1007/s00204-018-2170-7; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Ortega FJ, 2013, J CEREBR BLOOD F MET, V33, P356, DOI 10.1038/jcbfm.2012.166; Pan YY, 2017, BIOCHEM PHARMACOL, V126, P34, DOI 10.1016/j.bcp.2016.11.024; POWERS BJ, 1986, ARCH INTERN MED, V146, P1183, DOI 10.1001/archinte.146.6.1183; Raghavan R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3149-5; Rampasek Ladislav, 2016, Cell Syst, V2, P12, DOI 10.1016/j.cels.2016.01.009; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Shim JS, 2014, INT J BIOL SCI, V10, P654, DOI 10.7150/ijbs.9224; Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053766; Smalley JL, 2010, TOXICOLOGY, V268, P143, DOI 10.1016/j.tox.2009.09.014; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Tao YF, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0405-y; Thomas GW, 2007, FERTIL STERIL, V88, P1065, DOI 10.1016/j.fertnstert.2006.11.179; Townsley DM, 2016, NEW ENGL J MED, V374, P1922, DOI 10.1056/NEJMoa1515319; Valencia WM, 2017, DIABETOLOGIA, V60, P1630, DOI 10.1007/s00125-017-4349-5; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Yang JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15145; Yu WB, 2017, ONCOTARGET, V8, P7977, DOI 10.18632/oncotarget.13939	53	0	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246106	10.1371/journal.pone.0246106	http://dx.doi.org/10.1371/journal.pone.0246106			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507975	Green Published, gold			2022-12-26	WOS:000635021400090
J	Haar, S; Sundar, G; Faisal, AA				Haar, Shlomi; Sundar, Guhan; Faisal, A. Aldo			Embodied virtual reality for the study of real-world motor learning	PLOS ONE			English	Article								Motor-learning literature focuses on simple laboratory-tasks due to their controlled manner and the ease to apply manipulations to induce learning and adaptation. Recently, we introduced a billiards paradigm and demonstrated the feasibility of real-world-neuroscience using wearables for naturalistic full-body motion-tracking and mobile-brain-imaging. Here we developed an embodied virtual-reality (VR) environment to our real-world billiards paradigm, which allows to control the visual feedback for this complex real-world task, while maintaining sense of embodiment. The setup was validated by comparing real-world ball trajectories with the trajectories of the virtual balls, calculated by the physics engine. We then ran our short-term motor learning protocol in the embodied VR. Subjects played billiard shots when they held the physical cue and hit a physical ball on the table while seeing it all in VR. We found comparable short-term motor learning trends in the embodied VR to those we previously reported in the physical real-world task. Embodied VR can be used for learning real-world tasks in a highly controlled environment which enables applying visual manipulations, common in laboratory-tasks and rehabilitation, to a real-world full-body task. Embodied VR enables to manipulate feedback and apply perturbations to isolate and assess interactions between specific motor-learning components, thus enabling addressing the current questions of motor-learning in real-world tasks. Such a setup can potentially be used for rehabilitation, where VR is gaining popularity but the transfer to the real-world is currently limited, presumably, due to the lack of embodiment.	[Haar, Shlomi; Sundar, Guhan; Faisal, A. Aldo] Imperial Coll London, Dept Bioengn, Brain & Behav Lab, London, England; [Faisal, A. Aldo] Imperial Coll London, Dept Comp, London, England; [Faisal, A. Aldo] Imperial Coll London, UKRI Ctr Doctoral Training Healthcare, London, England; [Faisal, A. Aldo] Imperial Coll London, MRC, London Inst Med Sci, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Haar, S; Faisal, AA (corresponding author), Imperial Coll London, Dept Bioengn, Brain & Behav Lab, London, England.; Faisal, AA (corresponding author), Imperial Coll London, Dept Comp, London, England.; Faisal, AA (corresponding author), Imperial Coll London, UKRI Ctr Doctoral Training Healthcare, London, England.; Faisal, AA (corresponding author), Imperial Coll London, MRC, London Inst Med Sci, London, England.	s.haar@imperial.ac.uk; aldo.faisal@imperial.ac.uk	Haar, Shlomi/I-7498-2019; Faisal, Aldo/A-2367-2009	Haar, Shlomi/0000-0003-2213-6585; Faisal, Aldo/0000-0003-0813-7207	Royal Society-Kohn International Fellowship [NF170650]	Royal Society-Kohn International Fellowship	The study was enabled by financial support to a Royal Society-Kohn International Fellowship (https://royalsociety.org/grantsschemes-awards/grants/newton-international/; NF170650; SH & AAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglin JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45469; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Avraham G, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0179-17.2017; Belic JJ, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00027; Borrego A, 2018, GAMES HEALTH J, V7, P151, DOI 10.1089/g4h.2017.0114; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botzer L, 2013, EUR J NEUROSCI, V38, P2108, DOI 10.1111/ejn.12211; Bromberg Z, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0308-19.2019; Brudner SN, 2016, J NEUROPHYSIOL, V115, P1499, DOI 10.1152/jn.00066.2015; Carnegie K, 2015, IEEE COMPUT GRAPH, V35, P34, DOI 10.1109/MCG.2015.98; Carter A., 2016, J INTELLECT DISABIL, V4, P170; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; Deutsch KM, 2004, J EXP CHILD PSYCHOL, V88, P319, DOI 10.1016/j.jecp.2004.04.003; Diedrichsen J, 2005, J NEUROSCI, V25, P9919, DOI 10.1523/JNEUROSCI.1874-05.2005; Dockx K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010760.pub2; Mendes FAD, 2012, PHYSIOTHERAPY, V98, P217, DOI 10.1016/j.physio.2012.06.001; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Faisal A, 2017, NATURE, V551, P298, DOI 10.1038/551298a; Faisal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013718; Guo CC, 2010, J NEUROSCI, V30, P16241, DOI 10.1523/JNEUROSCI.3569-10.2010; Haar S., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Haar S, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00354; Haar S, 2020, J COGNITIVE NEUROSCI, V32, P1823, DOI 10.1162/jocn_a_01602; Haar S, 2015, J NEUROSCI, V35, P6813, DOI 10.1523/JNEUROSCI.0182-15.2015; Hecht EE, 2015, BRAIN STRUCT FUNCT, V220, P2315, DOI 10.1007/s00429-014-0789-6; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; Holden M.K, 2002, HDB VIRTUAL ENV DESI, V44, P1; Holden MK, 2005, CYBERPSYCHOL BEHAV, V8, P187, DOI 10.1089/cpb.2005.8.187; Honda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037900; Howard IS, 2015, CURR BIOL, V25, P397, DOI 10.1016/j.cub.2014.12.037; Huber ME, 2016, ACTA PSYCHOL, V169, P79, DOI 10.1016/j.actpsy.2016.05.010; Jack D, 2001, IEEE T NEUR SYS REH, V9, P308, DOI 10.1109/7333.948460; Kageyama M, 2014, J SPORT SCI MED, V13, P742; Kelly JW, 2017, ACM T APPL PERCEPT, V15, DOI 10.1145/3106155; Kilteni K, 2012, PRESENCE-TELEOP VIRT, V21, P373, DOI 10.1162/PRES_a_00124; Krakauer JW, 2019, COMPR PHYSIOL, V9, P613, DOI 10.1002/cphy.c170043; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Kramida G, 2016, IEEE T VIS COMPUT GR, V22, P1912, DOI 10.1109/TVCG.2015.2473855; Ktena SI, 2015, I IEEE EMBS C NEUR E, P236, DOI 10.1109/NER.2015.7146603; Lanier J., 2017, DAWN NEW EVERYTHING; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Lenggenhager B, 2009, CONSCIOUS COGN, V18, P110, DOI 10.1016/j.concog.2008.11.003; Levac DE, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0587-8; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Lima IR, 2020, SCI REP-UK, V10, P1; Lindgren R, 2013, EDUC RESEARCHER, V42, P445, DOI 10.3102/0013189X13511661; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Makin TR, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0014; Massetti T, 2016, MULT SCLER RELAT DIS, V8, P107, DOI 10.1016/j.msard.2016.05.014; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Mirelman A, 2011, J GERONTOL A-BIOL, V66, P234, DOI 10.1093/gerona/glq201; Muller H, 2004, J EXP PSYCHOL HUMAN, V30, P212, DOI 10.1037/0096-1523.30.1.212; Oliver GD, 2010, J STRENGTH COND RES, V24, P3241, DOI 10.1519/JSC.0b013e3181cc22de; Peled A, 2012, J MOTOR BEHAV, V44, P185, DOI 10.1080/00222895.2012.672349; Quadrado VH, 2019, DISABIL REHABIL-ASSI, V14, P12, DOI 10.1080/17483107.2017.1389998; Ravi DK, 2017, PHYSIOTHERAPY, V103, P245, DOI 10.1016/j.physio.2016.08.004; Rehm F, 2015, GITHUB REPOSITORY; Renner RS, 2013, ACM COMPUT SURV, V46, DOI 10.1145/2543581.2543590; Rizzo A., 2000, Proceedings IEEE Virtual Reality 2000 (Cat. No.00CB37048), P63, DOI 10.1109/VR.2000.840364; Rose FD, 2000, ERGONOMICS, V43, P494, DOI 10.1080/001401300184378; Shabbott BA, 2010, EXP BRAIN RES, V203, P75, DOI 10.1007/s00221-010-2209-3; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shmuelof L, 2012, J NEUROPHYSIOL, V108, P578, DOI 10.1152/jn.00856.2011; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Sternad D, 2018, CURR OPIN BEHAV SCI, V20, P183, DOI 10.1016/j.cobeha.2018.01.004; Stodden DF, 2006, RES Q EXERCISE SPORT, V77, P417; Taylor JA, 2014, J NEUROSCI, V34, P3023, DOI 10.1523/JNEUROSCI.3619-13.2014; Taylor JA, 2013, J NEUROPHYSIOL, V109, P202, DOI 10.1152/jn.00247.2012; Thomik AAC, 2016, STRUCTURE NATURAL HU; Vienne C, 2014, VISION RES, V100, P124, DOI 10.1016/j.visres.2014.04.017; Wilks SS, 1932, BIOMETRIKA, V24, P471; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Xiloyannis M, 2017, IEEE T NEUR SYS REH, V25, P1785, DOI 10.1109/TNSRE.2017.2699598; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X	74	6	6	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245717	10.1371/journal.pone.0245717	http://dx.doi.org/10.1371/journal.pone.0245717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503022	Green Submitted, Green Published, gold			2022-12-26	WOS:000613751800015
J	Beh, KH; Chuah, KH; Rappek, NAM; Mahadeva, S				Beh, Keng Hau; Chuah, Kee Huat; Rappek, Nurul Azmi Mahamad; Mahadeva, Sanjiv			The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL DISORDERS; ROME III; SWEDISH POPULATION; HOSPITAL ANXIETY; DEPRESSION SCALE; IV CRITERIA; SYMPTOMS; VALIDATION; MALAYSIA	Background and aim The association between body mass index (BMI) and functional gastrointestinal disorders (FGIDs) has been inconsistent. We aimed to explore the association of BMI with FGIDs in a primary care setting to provide more data in this area. Methods A cross-sectional study of consecutive Asian adults attending a primary healthcare setting was conducted. This study was conducted in 2 phases: The association between BMI and common FGIDs (functional diarrhea/FD, irritable bowel syndrome/IBS, functional diarrhea and functional constipation/FC) was studied initially. The influence of anxiety and depression on BMI and FGIDs was additionally explored in phase 2. Results A total of 1002 subjects (median age 32 years, 65.4% females, 90.7% Malay ethnicity, 73.2% higher than secondary level education) were recruited between August 2019 to January 2020. The majority of subjects were obese (39.2%), and had central obesity (51.7%), while 6.1% had metabolic syndrome. The prevalence of FD, IBS, functional diarrhea and FC were 7.5% (n = 75), 4.0% (n = 40), 1.2% (n = 12) and 10.5% (n = 105) respectively, based on the Rome III criteria. Among individual FGIDs, FD subjects had more underweight adults (BMI<18.5kg/m(2)) compared to controls (13.3% vs 3.5%, P = 0.002) and being underweight remained as an independent association with FD [OR = 3.648 (95%CI 1.494-8.905), P = 0.004] at multi-variate analysis. There were no independent associations between BMI and other FGIDs. When psychological morbidity was additionally explored, anxiety (OR 2.032; 95%CI = 1.034-3.991, p = 0.040), but not depression, and a BMI<18.5kg/m(2) (OR 3.231; 95%CI = 1.066-9.796, p = 0.038) were found to be independently associated with FD. Conclusions FD, but not other FGIDs, is associated with being underweight. This association is independent of the presence of anxiety.	[Beh, Keng Hau] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Chuah, Kee Huat; Mahadeva, Sanjiv] Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Kuala Lumpur, Malaysia; [Rappek, Nurul Azmi Mahamad] Univ Malaya, Staff & Student Hlth Clin, Med Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Beh, KH (corresponding author), Univ Malaya, Dept Med, Kuala Lumpur, Malaysia.	chuah319@yahoo.com	Chuah, Kee Huat/P-7852-2018; Mahadeva, Sanjiv/E-1711-2011	Chuah, Kee Huat/0000-0001-9811-7546; Mahadeva, Sanjiv/0000-0001-5824-0590; Beh, Keng Hau/0000-0003-3001-4051	University Malaya Specialist Centre (UMSC) C.A.R.E Research Fund [PV039-2019]	University Malaya Specialist Centre (UMSC) C.A.R.E Research Fund	Author who received the grant: KHC. This study was funded by the University Malaya Specialist Centre (UMSC) C.A.R.E Research Fund (Project No.: PV039-2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasbrenn M, 2018, J OBES, V2018, DOI 10.1155/2018/3732753; Akhondi N, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13549; Analysis of Energy Consumption and Behavior of Television in Resident Houses in Thailand, 2011, RAK SKUNPONGB P ENG, V8, P115; Andoy-Galvan Jo Ann, 2020, F1000Res, V9, P160, DOI 10.12688/f1000research.22236.1; [Anonymous], 2016, Med J Malaysia, V71, P1; Aro P, 2015, GASTROENTEROLOGY, V148, P928, DOI 10.1053/j.gastro.2015.01.039; Aro P, 2009, GASTROENTEROLOGY, V137, P94, DOI 10.1053/j.gastro.2009.03.039; Ballou S, 2019, ALIMENT PHARM THER, V50, P1019, DOI 10.1111/apt.15500; Bouchoucha M, 2016, J GASTROENTEROL, V51, P337, DOI 10.1007/s00535-015-1111-y; Chang JY, 2010, AM J GASTROENTEROL, V105, P822, DOI 10.1038/ajg.2010.40; Choi MG, 2011, J NEUROGASTROENTEROL, V17, P245, DOI 10.5056/jnm.2011.17.3.245; Chuah KH, 2018, J NEUROGASTROENTEROL, V24, P536, DOI 10.5056/jnm18064; Cremonini F, 2006, NEUROGASTROENT MOTIL, V18, P987, DOI 10.1111/j.1365-2982.2006.00816.x; Darmaraj SR, 2019, ASIAN ECON PAP, V18, P155, DOI 10.1162/asep_a_00670; DeJesus Ramona S, 2016, Clin Pract Epidemiol Ment Health, V12, P67, DOI 10.2174/1745017901612010067; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fatt QK, 2007, INT J IMPOT RES, V19, P321, DOI 10.1038/sj.ijir.3901528; Ghoshal UC, 2017, J NEUROGASTROENTEROL, V23, P334, DOI 10.5056/jnm17020; Ghoshal UC, 2015, J NEUROGASTROENTEROL, V21, P83, DOI 10.5056/jnm14045; Jung JG, 2016, J GASTROEN HEPATOL, V31, P567, DOI 10.1111/jgh.13146; Koloski NA, 2012, GUT, V61, P1284, DOI 10.1136/gutjnl-2011-300474; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lee YS, 2016, SINGAP MED J, V57, P292, DOI 10.11622/smedj.2016103; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Mahadeva S, 2012, J NEUROGASTROENTEROL, V18, P43, DOI 10.5056/jnm.2012.18.1.43; Martin J, 2019, EUR EAT DISORD REV, V27, P603, DOI 10.1002/erv.2677; Oka P, 2020, LANCET GASTROENTEROL, V5, P908, DOI 10.1016/S2468-1253(20)30217-X; Oshima T, 2015, J NEUROGASTROENTEROL, V21, P320, DOI 10.5056/jnm14165; Pickett-Blakely Octavia, 2014, Gastroenterol Hepatol (N Y), V10, P411; Sato Y, 2015, CLIN J GASTROENTEROL, V8, P255, DOI 10.1007/s12328-015-0611-x; Sperber AD, 2021, GASTROENTEROLOGY, V160, P99, DOI 10.1053/j.gastro.2020.04.014; Stanghellini V, 2016, GASTROENTEROLOGY, V150, P1380, DOI 10.1053/j.gastro.2016.02.011; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Tambucci R, 2019, J PEDIATR GASTR NUTR, V68, P517, DOI 10.1097/MPG.0000000000002208; Verma RK, 2013, J CLIN DIAGN RES, V7, P3124, DOI 10.7860/JCDR/2013/7860.3883; West R, 2017, PSYCHOL HEALTH, V32, P1018, DOI 10.1080/08870446.2017.1325890; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915	38	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245511	10.1371/journal.pone.0245511	http://dx.doi.org/10.1371/journal.pone.0245511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA8QK	33497382	Green Published, gold			2022-12-26	WOS:000613707100028
J	Fadaak, R; Davies, JM; Blaak, MJ; Conly, J; Haslock, J; Kenny, A; Pinto, N; Leslie, M				Fadaak, Raad; Davies, Jan M.; Blaak, Marlot Johanna; Conly, John; Haslock, Joanne; Kenny, Ashley; Pinto, Nicole; Leslie, Myles			Rapid conversion of an in-patient hospital unit to accommodate COVID-19: An interdisciplinary human factors, ethnography, and infection prevention and control approach	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; QUALITY	Background In response to the Coronavirus disease-19 (COVID-19) pandemic, in-patient units in hospitals around the world have altered their patient care routines and Infection Prevention and Control (IPC) practices. Our interdisciplinary team of applied Human Factors (HF), ethnography, and IPC experts assisted one Unit, normally serving general surgical and orthopedic patients, as it rapidly converted to deliver COVID-19-specific care. This paper describes the conversion experience of the Unit, and outlines broader lessons for other acute care teams faced with similar issues. Methods We deployed walkthroughs, simulations, and ethnography to identify important safety gaps in care delivery processes on the Unit. These interventions were undertaken using interdisciplinary theories of implementation that combined systems-level HF perspectives, ethnographic approaches, and individual-level IPC perspectives. Timely recommendations were developed and delivered to Unit staff for feedback and implementation. Results We describe three interventions on the Unit: 1) the de-cluttering and re-organization of personal protective equipment (PPE); 2) the reconfiguring of designated 'dirty' tray tables and supplies; and 3) the redesign of handling pathways for 'dirty' linens and laundry. Each of these interventions was implemented to varying degrees, but all contributed to discussions of safety and IPC implementation that extended beyond the Unit and into the operations of the broader hospital. Conclusions Leveraging our team's interdisciplinary expertise and blended approaches to implementation, the interventions assisted in the Unit's rapid conversion towards providing COVID-19-specific care. The deployment and implementation of the interventions highlight the potential of collaboration between HF, ethnography, and IPC experts to support frontline healthcare delivery under pandemic conditions in an effort to minimize nosocomial transmission potential in the acute healthcare setting.	[Fadaak, Raad; Pinto, Nicole; Leslie, Myles] Univ Calgary, Sch Publ Policy, Calgary, AB, Canada; [Davies, Jan M.; Blaak, Marlot Johanna; Conly, John] Univ Calgary, W21C Res & Innovat Ctr, Calgary, AB, Canada; [Davies, Jan M.] Univ Calgary, Cumming Sch Med, Dept Anesthesiol Perioperat & Pain Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Dept Med, Cumming Sch Med, Calgary, AB, Canada; [Conly, John] Univ Calgary, Cumming Sch Med, Dept Microbiol, Calgary, AB, Canada; [Conly, John] Univ Calgary, Cumming Sch Med, Dept Immunol, Calgary, AB, Canada; [Conly, John] Univ Calgary, Cumming Sch Med, Dept Infect Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, Snyder Inst Chron Dis, Calgary, AB, Canada; [Conly, John] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Conly, John] Alberta Hlth Serv, Infect Prevent & Control, Calgary, AB, Canada; [Haslock, Joanne; Kenny, Ashley] Alberta Hlth Serv, Foothills Med Ctr, Calgary, AB, Canada; [Leslie, Myles] Univ Calgary, Dept Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary	Fadaak, R (corresponding author), Univ Calgary, Sch Publ Policy, Calgary, AB, Canada.	raad.fadaak@ucalgary.ca		Fadaak, Raad/0000-0002-7560-3397; Leslie, Myles/0000-0001-5759-7993	Government of Canada, through the Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Social Sciences and Humanities Research Council (SSHRC); Canada Research Coordinating Committee (CRCC) through the New Frontiers in Research Fund (NFRF); International Development Research Centre (IDRC); Genome Canada (GC); Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity [202002COV]	Government of Canada, through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Coordinating Committee (CRCC) through the New Frontiers in Research Fund (NFRF); International Development Research Centre (IDRC); Genome Canada (GC)(Genome Canada); Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity	This work is supported by the Government of Canada, through the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), the Canada Research Coordinating Committee (CRCC) through the New Frontiers in Research Fund (NFRF), the International Development Research Centre (IDRC) and Genome Canada (GC). Funding supplied through the Canadian 2019 Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity, #202002COV: Dr. Myles Leslie and Dr. John Conly The sponsors had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; nor the decision to submit the manuscript for publication.	Alberta Health Services, 2014, TAK DOFF PERS PROT E; Anderson J, 2010, CRIT CARE MED, V38, pS269, DOI 10.1097/CCM.0b013e3181e6a058; Aveling EL, 2016, SOCIOL HEALTH ILL, V38, P216, DOI 10.1111/1467-9566.12370; Bader MK, 2020, CRIT CARE NURSE, V40, pE1, DOI 10.4037/ccn2020799; Baers JH, 2018, ERGON DES, V6, P4; Barrett K, 2020, CAN MED ASSOC J, V192, pE640, DOI 10.1503/cmaj.200715; Baugh JJ, 2020, AM J EMERG MED, V38, P1535, DOI 10.1016/j.ajem.2020.04.057; Blumenthal D, 2020, NEW ENGL J MED, V383, P1483, DOI 10.1056/NEJMsb2021088; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; Caspari L, 2017, AM J INFECT CONTROL, V45, P648, DOI 10.1016/j.ajic.2017.01.004; Davidoff F, 2015, BMJ QUAL SAF, V24, P228, DOI 10.1136/bmjqs-2014-003627; De Greene KB, 1970, SYSTEMS PSYCHOL; Dixon-Woods M., 2003, QUAL SAF HEALTH CARE, V12, P2; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; Drews FA, 2019, HUM FACTORS, V61, P693, DOI 10.1177/0018720819833214; FROST DW, 2020, CMAJ, V192, pE72, DOI DOI 10.1503/; Hallihan G, 2015, HUMAN FACTORS EVALUA; Iedema R., 2019, VIDEO REFLEXIVE ETHN, V1st ed.; Jog S, 2020, INDIAN J CRIT CARE M, V24, P385, DOI 10.5005/jp-journals-10071-23416; Leslie Myles, 2020, BMJ Glob Health, V5, DOI 10.1136/bmjgh-2020-002672; Leslie M, 2014, BMJ QUAL SAF, V23, P99, DOI 10.1136/bmjqs-2013-002335; Mockel M, 2020, EUR J EMERG MED, V27, P161, DOI 10.1097/MEJ.0000000000000703; Morris AM, 2019, INFECT CONT HOSP EP, V40, P1334, DOI 10.1017/ice.2019.276; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Patey C, 2020, CMAJ, V192, pE510, DOI [10.1503/CMAJ.200609, DOI 10.1503/CMAJ.200609]; Philips K, 2020, J PEDIATR-US, V222, P22, DOI 10.1016/j.jpeds.2020.04.060; Reason J, 2000, WESTERN J MED, V172, P393, DOI 10.1136/ewjm.172.6.393; Reiman J, 1995, CHI 95 C COMP MOS CR; Rosala M., 2020, TASK ANAL SUPPORT US; Royal Academy of Engineers, 2017, ENG BETT CAR SYST AP; Sampson CS, 2020, AM J EMERG MED, V38, P1531, DOI 10.1016/j.ajem.2020.04.031; Silvagni E, 2020, J POPUL THER CLIN PH, V27, pE11, DOI 10.15586/jptcp.v27iSP1.690; Stanton NA, 2006, APPL ERGON, V37, P55, DOI 10.1016/j.apergo.2005.06.003; Storr J, 2013, INTEGRATING HUMAN FA; Szymczak JE, 2018, BMJ QUAL SAF, V27, P763, DOI 10.1136/bmjqs-2018-008512; The Center for Health Design, 2014, SAF RISK ASS TOOLK P; Tosoni A, 2020, EUR REV MED PHARMACO, V24, P8202, DOI 10.26355/eurrev_202008_22509; Urbach DR, 2020, CAN MED ASSOC J, V192, pE585, DOI 10.1503/cmaj.200791; Warning J., 2011, SOCIOCULTURAL PERSPE; Weiss CH., 1995, NEW APPROACHES EVALU, P65, DOI DOI 10.1177/1356389003094007; Wellcome Trust, 2020, PEOPL CTR EP PREP RE; World Health Organization, 2017, GLOB M INT SOC SCI I	42	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245212	10.1371/journal.pone.0245212	http://dx.doi.org/10.1371/journal.pone.0245212			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481807	Green Published, gold			2022-12-26	WOS:000612929300102
J	Honda, M; Naoe, H; Gushima, R; Miyamoto, H; Tateyama, M; Sakurai, K; Oda, Y; Murakami, Y; Tanaka, Y				Honda, Munenori; Naoe, Hideaki; Gushima, Ryosuke; Miyamoto, Hideaki; Tateyama, Masakuni; Sakurai, Kouichi; Oda, Yasushi; Murakami, Yoshitaka; Tanaka, Yasuhito			Risk stratification for advanced colorectal neoplasia based on the findings of the index and first surveillance colonoscopies	PLOS ONE			English	Article							POST-POLYPECTOMY; CLINICAL IMPACT; CANCER; ADENOMAS; SOCIETY; UPDATE; YIELD	Risk stratification by index colonoscopy is well established for first surveillance endoscopy, but whether the previous two colonoscopies affect the subsequent advanced neoplasias has not been established. Therefore, the subsequent risk based on the findings of the index and first surveillance colonoscopies were investigated. This retrospective, cohort study was conducted in two clinics and included participants who had undergone two or more colonoscopies after index colonoscopy. High-risk was defined as advanced adenoma (>= 1 cm, or tubulovillous or villous histology, or high-grade dysplasia). Based on the findings of the index and first surveillance colonoscopies, patients were classified into four categories: category A (both colonoscopy findings were normal), category B (no high-risk findings both times), category C (one time high-risk finding), and category D (high-risk findings both times). The incidence of subsequent advanced neoplasia was examined in each category. A total of 13,426 subjects were included and surveyed during the study periods. The subjects in category D had the highest risk of advanced neoplasia (27.4%, n = 32/117). The subjects in category A had the lowest risk (4.0%, n = 225/5,583). The hazard ratio for advanced neoplasia of category D compared to category A was 9.90 (95% Confidence interval 6.82-14.35, P<0.001). Classification based on the findings of index and first surveillance colonoscopies more effectively stratifies the risk of subsequent advanced neoplasia, resulting in more proper allocation of colonoscopy resources after two consecutive colonoscopies.	[Honda, Munenori; Naoe, Hideaki; Gushima, Ryosuke; Miyamoto, Hideaki; Tateyama, Masakuni; Tanaka, Yasuhito] Kumamoto Univ Hosp, Dept Gastroenterol & Hepatol, Kumamoto, Japan; [Sakurai, Kouichi] Hattori Clin, Kumamoto, Japan; [Oda, Yasushi] Oda GI Endoscopy & Gastroenterol Clin, Kumamoto, Japan; [Murakami, Yoshitaka] Toho Univ, Dept Med Stat, Tokyo, Japan	Kumamoto University; Toho University	Naoe, H (corresponding author), Kumamoto Univ Hosp, Dept Gastroenterol & Hepatol, Kumamoto, Japan.	naoh@kumamoto-u.ac.jp						Anderson JC, 2020, GASTROINTEST ENDOSC, V92, P387, DOI 10.1016/j.gie.2020.04.034; Anderson JC, 2020, GASTROINTEST ENDOSC, V91, P669, DOI 10.1016/j.gie.2019.11.023; Anderson R, 2020, GASTROENTEROLOGY, V158, P1287, DOI 10.1053/j.gastro.2019.12.031; Anwar S, 2021, J GASTROEN HEPATOL, V36, P1620, DOI 10.1111/jgh.15328; Bonnington SN, 2019, ENDOSCOPY, V51, pS153; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Burr NE, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6090; Cancer Council Australia, CLIN PRACT GUID SURV; Cross AJ, 2020, GUT, V69, P1645, DOI 10.1136/gutjnl-2019-320036; Gupta N, 2012, GASTROINTEST ENDOSC, V75, P1022, DOI 10.1016/j.gie.2012.01.020; Gupta S, 2020, GASTROENTEROLOGY, V158, P1131, DOI 10.1053/j.gastro.2019.10.026; Hassan C, 2020, ENDOSCOPY, V52, P687, DOI 10.1055/a-1185-3109; Hotta K, 2020, DIGEST ENDOSC, V32, P824, DOI 10.1111/den.13663; Hsu L, 2015, GASTROENTEROLOGY, V148, P1330, DOI 10.1053/j.gastro.2015.02.010; Imperiale TF, 2014, GASTROINTEST ENDOSC, V80, P471, DOI 10.1016/j.gie.2014.03.042; Lieberman D, 2020, GASTROENTEROLOGY, V158, P436, DOI 10.1053/j.gastro.2019.10.008; Morelli MS, 2013, ENDOSCOPY, V45, P821, DOI 10.1055/s-0033-1344582; Ninomiya Y, 2017, DIGEST ENDOSC, V29, P773, DOI 10.1111/den.12877; Pinsky PF, 2009, CLIN GASTROENTEROL H, V7, P86, DOI 10.1016/j.cgh.2008.07.014; Ponugoti PL, 2017, DIGEST LIVER DIS, V49, P34, DOI 10.1016/j.dld.2016.06.025; Robertson DJ, 2009, ANN INTERN MED, V151, P103, DOI 10.7326/0003-4819-151-2-200907210-00007; Rutter MD, 2020, GUT, V69, P201, DOI 10.1136/gutjnl-2019-319858; Subramaniam K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026138; Suh KH, 2014, J GASTROEN HEPATOL, V29, P1985, DOI 10.1111/jgh.12650; Sullivan BA, 2020, AM J GASTROENTEROL, V115, P1275, DOI 10.14309/ajg.0000000000000677; Sumimoto K, 2017, GASTROINTEST ENDOSC, V85, P816, DOI 10.1016/j.gie.2016.07.035; Tanaka S, 2015, J GASTROENTEROL, V50, P252, DOI 10.1007/s00535-014-1021-4; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	28	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245211	10.1371/journal.pone.0245211	http://dx.doi.org/10.1371/journal.pone.0245211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481809	Green Published, gold			2022-12-26	WOS:000612929300101
J	Nishi, T; Morioka, K; Kawaguchi, R; Yamada, M; Ikezawa, M; Fukai, K				Nishi, Tatsuya; Morioka, Kazuki; Kawaguchi, Rie; Yamada, Manabu; Ikezawa, Mitsutaka; Fukai, Katsuhiko			Quantitative analysis of infection dynamics of foot-and-mouth disease virus strain O/CATHAY in pigs and cattle	PLOS ONE			English	Article							VIRAL PATHWAYS; PATHOGENESIS; INTRANASAL; TAIWANESE; 3A	Foot-and-mouth disease virus (FMDV) serotype O, topotype CATHAY is a known porcinophilic virus that has caused devastating damage to the pig industry. However, the minimum infectious dose via a natural infection route in pigs, the infection dynamics in cattle, and risk of viral transmission from infected cattle to pigs have not been quantitatively analyzed. The FMDV strain O/HKN/1/2015 was serially diluted and inoculated into pigs via an intraoral route to determine the infectious dose. We found that a 10(4.0) tissue culture infectious dose (TCID50) of the virus was insufficient, but 10(5.5) TCID50 was sufficient to infect pigs via the oral route. While cows inoculated with the strain showed increased temperature in their feet, typical clinical signs including vesicular development were not observed. The cows showed short-term and low levels of viremia and virus excretion only before the detection of virus neutralizing antibodies. FMDV genes were not detected in esophageal-pharyngeal fluid from cows after 14 days post inoculation. No genetic insertions that could be associated with host adaptation were observed in viruses isolated from infected cows. These findings indicate that cows infected with FMDV of O/CATHAY have a low risk of viral transmission or persistence. Information on the dynamics of virus infection is essential for ensuring the rapid and accurate diagnosis of this disease, and its surveillance.	[Nishi, Tatsuya; Morioka, Kazuki; Kawaguchi, Rie; Fukai, Katsuhiko] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Kodaira, Tokyo, Japan; [Yamada, Manabu; Ikezawa, Mitsutaka] Natl Agr & Food Res Org, Div Pathol & Pathophysiol, Natl Inst Anim Hlth, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Fukai, K (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Kodaira, Tokyo, Japan.	fukai@affrc.go.jp		Fukai, Katsuhiko/0000-0002-8422-1681	Ministry of Agriculture, Forestry and Fisheries, Japan	Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	Ministry of Agriculture, Forestry and Fisheries, Japan.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2002, MICROBES INFECT, V4, P1099, DOI 10.1016/S1286-4579(02)01634-9; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00365-18, 10.1128/msphere.00365-18]; Beard CW, 2000, J VIROL, V74, P987, DOI 10.1128/JVI.74.2.987-991.2000; Biswal JK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214832; Brito BP, 2017, TRANSBOUND EMERG DIS, V64, P316, DOI 10.1111/tbed.12373; Callahan JD, 2002, J AM VET MED ASSOC, V220, P1636, DOI 10.2460/javma.2002.220.1636; Di Nardo A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0090-y; Dunn CS, 1997, VET REC, V141, P174, DOI 10.1136/vr.141.7.174; Fukai K, 2020, TRANSBOUND EMERG DIS, V67, P223, DOI 10.1111/tbed.13344; Fukai K, 2015, ARCH VIROL, V160, P129, DOI 10.1007/s00705-014-2239-4; Henderson W. M., 1949, AGR RES COUNCIL REP, V8, P1; Knowles NJ, 2001, J VIROL, V75, P1551, DOI 10.1128/JVI.75.3.1551-1556.2001; LaRocco M, 2015, J CLIN MICROBIOL, V53, P755, DOI 10.1128/JCM.03220-14; LaRocco M, 2013, J CLIN MICROBIOL, V51, P1714, DOI 10.1128/JCM.03370-12; Lee SH, 2009, TRANSBOUND EMERG DIS, V56, P189, DOI 10.1111/j.1865-1682.2009.01079.x; Manual Terrestrial,, 2019, MANUAL DIAGNOSTIC TE, P433; Onozato H, 2014, ARCH VIROL, V159, P2901, DOI 10.1007/s00705-014-2135-y; Pacheco JM, 2013, VIROLOGY, V446, P260, DOI 10.1016/j.virol.2013.08.003; Rainwater-Lovett K, 2009, VET J, V180, P317, DOI 10.1016/j.tvjl.2008.01.003; Sellers R, 2008, VET J, V177, P159, DOI 10.1016/j.tvjl.2007.03.009; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Yamakawa M, 2002, TOP ANIM HLTH RES, V2, P49; Zhu ZX, 2019, J VIROL, V93, DOI [10.1128/jvi.02039-18, 10.1128/JVI.02039-18]	26	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245781	10.1371/journal.pone.0245781	http://dx.doi.org/10.1371/journal.pone.0245781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481934	Green Published, gold			2022-12-26	WOS:000612929300114
J	Tsui, TL; Huang, YT; Kan, WC; Huang, MS; Lai, MY; Ueng, KC; Shiao, CC				Tsui, Tung-Lin; Huang, Ya-Ting; Kan, Wei-Chih; Huang, Mao-Sheng; Lai, Min-Yu; Ueng, Kwo-Chang; Shiao, Chih-Chung			A novel procalcitonin-based score for detecting sepsis among critically ill patients	PLOS ONE			English	Article							INFECTION; PROBABILITY; EXPRESSION; BIOMARKERS; MORTALITY; REVISION; MARKER; GENE; IPS	Background Procalcitonin (PCT) has been widely investigated as an infection biomarker. The study aimed to prove that serum PCT, combining with other relevant variables, has an even better sepsis-detecting ability in critically ill patients. Methods We conducted a retrospective cohort study in a regional teaching hospital enrolling eligible patients admitted to intensive care units (ICU) between July 1, 2016, and December 31, 2016, and followed them until March 31, 2017. The primary outcome measurement was the occurrence of sepsis. We used multivariate logistic regression analysis to determine the independent factors for sepsis and constructed a novel PCT-based score containing these factors. The area under the receiver operating characteristics curve (AUROC) was applied to evaluate sepsis-detecting abilities. Finally, we validated the score using a validation cohort. Results A total of 258 critically ill patients (70.9 +/- 16.3 years; 55.4% man) were enrolled in the derivation cohort and further subgrouped into the sepsis group (n = 115) and the non-sepsis group (n = 143). By using the multivariate logistic regression analysis, we disclosed five independent factors for detecting sepsis, namely, "serum PCT level," "albumin level" and "neutrophil-lymphocyte ratio" at ICU admission, along with "diabetes mellitus," and "with vasopressor." We subsequently constructed a PCT-based score containing the five weighted factors. The PCT-based score performed well in detecting sepsis with the cut-points of 8 points (AUROC 0.80; 95% confidence interval (CI) 0.74-0.85; sensitivity 0.70; specificity 0.76), which was better than PCT alone, C-reactive protein and infection probability score. The findings were confirmed using an independent validation cohort (n = 72, 69.2 +/- 16.7 years, 62.5% men) (cut-point: 8 points; AUROC, 0.79; 95% CI 0.69-0.90; sensitivity 0.64; specificity 0.87). Conclusions We proposed a novel PCT-based score that performs better in detecting sepsis than serum PCT levels alone, C-reactive protein, and infection probability score.	[Tsui, Tung-Lin] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Tsui, Tung-Lin] Camillian St Marys Hosp Luodong, Intens Care Unit, Dept Internal Med, Yilan, Taiwan; [Tsui, Tung-Lin] Camillian St Marys Hosp Luodong, Div Cardiol, Dept Internal Med, Yilan, Taiwan; [Huang, Ya-Ting; Lai, Min-Yu] Camillian St Marys Hosp Luodong, Dept Nursing, Yilan, Taiwan; [Huang, Ya-Ting; Shiao, Chih-Chung] St Marys Jr Coll Med Nursing & Management, Yilan, Taiwan; [Kan, Wei-Chih] Chi Mei Med Ctr, Dept Nephrol, Dept Internal Med, Tainan, Taiwan; [Kan, Wei-Chih] Chung Hwa Univ Med Technol, Dept Biol Sci & Technol, Tainan, Taiwan; [Huang, Mao-Sheng] Camillian St Marys Hosp Luodong, Dept Lab Med, Yilan, Taiwan; [Ueng, Kwo-Chang] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Ueng, Kwo-Chang] Chung Shan Med Univ Hosp, Dept Internal Med, Div Cardiol, Taichung, Taiwan; [Shiao, Chih-Chung] Camillian St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan	Chung Shan Medical University; Chi Mei Hospital; Chung Hua University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Shiao, CC (corresponding author), St Marys Jr Coll Med Nursing & Management, Yilan, Taiwan.; Shiao, CC (corresponding author), Camillian St Marys Hosp Luodong, Div Nephrol, Dept Internal Med, Yilan, Taiwan.	chungyy2001@yahoo.com.tw	Shiao, Chih-Chung/AAM-2716-2020	Shiao, Chih-Chung/0000-0003-2220-7574	Saint Mary's Hospital Research Fund [SMHRF-105009]	Saint Mary's Hospital Research Fund	The research was supported by a grant from Saint Mary's Hospital Research Fund (#SMHRF-105009). This fund provides to Y.T. Huang initially. No funding bodies had any role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Akirov A, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2017.07.020; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Baglam T, 2015, INT J PEDIATR OTORHI, V79, P1421, DOI 10.1016/j.ijporl.2015.06.016; Bloos F, 2011, CRIT CARE, V15, DOI 10.1186/cc10087; Bota DP, 2003, CRIT CARE MED, V31, P2579, DOI 10.1097/01.CCM.0000094223.92746.56; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cortes-Poch I, 2016, AM J RESP CRIT CARE, V194, P16, DOI 10.1164/rccm.201604-0734ED; Curran-Everett D, 2018, ADV PHYSIOL EDUC, V42, P343, DOI 10.1152/advan.00018.2018; Daoud JI, 2018, J PHYS CONF SER, V949, DOI 10.1088/1742-6596/949/1/012009; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ferrandino RM, 2020, HEAD NECK-J SCI SPEC, V42, P2830, DOI 10.1002/hed.26329; Godinez-Vidal AR, 2020, CIR CIR, V88, P150, DOI [10.24875/CIRU.19000993, 10.24875/ciru.19000993]; Gurol G, 2015, J MICROBIOL BIOTECHN, V25, P521, DOI 10.4014/jmb.1408.08060; Hameed I, 2015, WORLD J DIABETES, V6, P598, DOI 10.4239/wjd.v6.i4.598; Henderson AR, 2006, CLIN CHIM ACTA, V366, P112, DOI 10.1016/j.cca.2005.11.007; Hoffmann G, 2002, CRIT CARE MED, V30, P2091, DOI 10.1097/00003246-200209000-00023; Kibe S, 2011, J ANTIMICROB CHEMOTH, V66, pII33, DOI 10.1093/jac/dkq523; Liu D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129450; Ma AJ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03007-0; Martini A, 2008, J INFECTION, V56, P313, DOI 10.1016/j.jinf.2008.02.015; Meisner M, 2002, CLIN CHIM ACTA, V323, P17, DOI 10.1016/S0009-8981(02)00101-8; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; Nakamura Y, 2015, J INFECT CHEMOTHER, V21, P257, DOI 10.1016/j.jiac.2014.12.001; Poddar B, 2015, INDIAN J CRIT CARE M, V19, P140, DOI 10.4103/0972-5229.152755; Reinhart K, 2011, CRIT CARE CLIN, V27, P253, DOI 10.1016/j.ccc.2011.01.002; Rhee C, 2019, CRIT CARE MED, V47, P1169, DOI 10.1097/CCM.0000000000003817; Rynecki ND, 2020, J ORTHOP, V21, P253, DOI 10.1016/j.jor.2020.03.006; Schuetz P, 2019, CLIN CHEM LAB MED, V57, P1308, DOI 10.1515/cclm-2018-1181; Schuetz P, 2017, CRIT CARE MED, V45, P781, DOI [10.1097/CCM.0000000000002321, 10.1097/ccm.0000000000002321]; Schuetz P, 2013, CRIT CARE, V17, DOI 10.1186/cc12787; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soeters PB, 2019, JPEN-PARENTER ENTER, V43, P181, DOI 10.1002/jpen.1451; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Vijayan AL, 2017, J INTENSIVE CARE, V5, DOI 10.1186/s40560-017-0246-8; Vincent JL, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2478-6; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Wang ZZ, 2020, DIABETES RES CLIN PR, V164, DOI 10.1016/j.diabres.2020.108214; Yang Y, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0153-5; Zhou Y, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3377	41	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245748	10.1371/journal.pone.0245748	http://dx.doi.org/10.1371/journal.pone.0245748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481913	Green Published, gold			2022-12-26	WOS:000612929300071
J	Abril, YLN; Fernandez, IR; Hong, JY; Chiang, YL; Kutateladze, DA; Zhao, QJ; Yang, M; Hu, J; Sadhukhan, S; Li, B; He, B; Remick, B; Bai, JJ; Mullmann, J; Wang, FY; Maymi, V; Dhawan, R; Auwerx, J; Southard, T; Cerione, RA; Lin, HN; Weiss, RS				Abril, Yashira L. Negron; Fernandez, Irma R.; Hong, Jun Young; Chiang, Ying-Ling; Kutateladze, Dennis A.; Zhao, Qingjie; Yang, Min; Hu, Jing; Sadhukhan, Sushabhan; Li, Bo; He, Bin; Remick, Brenna; Bai, Jessica Jingyi; Mullmann, James; Wang, Fangyu; Maymi, Viviana; Dhawan, Ravi; Auwerx, Johan; Southard, Teresa; Cerione, Richard A.; Lin, Hening; Weiss, Robert S.			Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer	ONCOGENE			English	Article							PROTEIN; DESUCCINYLATION; ANTIOXIDANT; SUCCINYLATION; MALONYLATION; DEMALONYLASE; PROGRESSION; METABOLISM; EXPRESSION; REGULATORS	SIRT5 is a member of the sirtuin family of NAD(+)-dependent protein lysine deacylases implicated in a variety of physiological processes. SIRT5 removes negatively charged malonyl, succinyl, and glutaryl groups from lysine residues and thereby regulates multiple enzymes involved in cellular metabolism and other biological processes. SIRT5 is overexpressed in human breast cancers and other malignancies, but little is known about the therapeutic potential of SIRT5 inhibition for treating cancer. Here we report that genetic SIRT5 disruption in breast cancer cell lines and mouse models caused increased succinylation of IDH2 and other metabolic enzymes, increased oxidative stress, and impaired transformation and tumorigenesis. We, therefore, developed potent, selective, and cell-permeable small-molecule SIRT5 inhibitors. SIRT5 inhibition suppressed the transformed properties of cultured breast cancer cells and significantly reduced mammary tumor growth in vivo, in both genetically engineered and xenotransplant mouse models. Considering that Sirt5 knockout mice are generally normal, with only mild phenotypes observed, these data establish SIRT5 as a promising target for treating breast cancer. The new SIRT5 inhibitors provide useful probes for future investigations of SIRT5 and an avenue for targeting SIRT5 as a therapeutic strategy.	[Abril, Yashira L. Negron; Fernandez, Irma R.; Remick, Brenna; Mullmann, James; Maymi, Viviana; Dhawan, Ravi; Southard, Teresa; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Fernandez, Irma R.; Hong, Jun Young; Chiang, Ying-Ling; Kutateladze, Dennis A.; Zhao, Qingjie; Yang, Min; Hu, Jing; Sadhukhan, Sushabhan; Li, Bo; He, Bin; Bai, Jessica Jingyi; Cerione, Richard A.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Li, Bo; Mullmann, James; Wang, Fangyu; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne EPFL, Inst Bioengn, Lab Integrat Syst Physiol, CH-1015 Lausanne, Switzerland; [Lin, Hening] Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [He, Bin] Guizhou Med Univ, Sch Pharm, Guiyang 550004, Peoples R China	Cornell University; Cornell University; Cornell University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Howard Hughes Medical Institute; Guizhou Medical University	Weiss, RS (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.; Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.; Lin, HN (corresponding author), Cornell Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	hl379@cornell.edu; rsw26@cornell.edu	Auwerx, Johan/ABE-9307-2021; Chiang, Ying-Ling/N-3259-2014	Kutateladze, Dennis/0000-0002-5706-7092; Hong, Jun Young/0000-0002-5257-6525; Maymi, Viviana/0000-0002-1575-3510; Auwerx, Johan/0000-0002-5065-5393; Dhawan, Ravi/0000-0002-2544-341X; Wang, Fangyu/0000-0002-6388-1461; Chiang, Ying-Ling/0000-0001-5591-6209; Negron Abril, Yashira/0000-0002-5922-9999; Weiss, Robert/0000-0003-3327-1379; Sadhukhan, Sushabhan/0000-0002-3302-5875	NIH [CA163255, CA223534]; NIH/NIGMS [T32GM007273, 5T32GM008500]; Cornell Deans Excellence Fellowship; HHMI Gilliam Fellowship; Ecole Polytechnique Federale de Lausanne (EPFL); Swiss National Science Foundation (SNSF) [31003A_179435]; NSF through MRI award [CHE-1531632]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cornell Deans Excellence Fellowship; HHMI Gilliam Fellowship; Ecole Polytechnique Federale de Lausanne (EPFL); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NSF through MRI award	The authors thank the NCI Physical SciencesOncology Network Bioresource Core Facility (PBCF) for MDAMB-231 cells, and Drs. Ruchika Bhawal and Sheng Zhang from the Cornell Proteomics and Metabolomics Facility for technical assistance. This work was supported in part by NIH R01 grants CA163255 and CA223534. YLNA was supported by NIH/NIGMS grant 5T32GM008500, and IRF was supported by NIH/NIGMS grant T32GM007273, a Cornell Deans Excellence Fellowship, and an HHMI Gilliam Fellowship. JA was supported by grants from the Ecole Polytechnique Federale de Lausanne (EPFL), and the Swiss National Science Foundation (SNSF 31003A_179435). This work utilized the Cornell University NMR facility, which is supported in part by the NSF through MRI award CHE-1531632.	Bheda P, 2016, ANNU REV BIOCHEM, V85, P405, DOI 10.1146/annurev-biochem-060815-014537; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Chang L, 2018, MOL MED REP, V17, P342, DOI 10.3892/mmr.2017.7875; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Farooqi AS, 2019, J MED CHEM, V62, P4131, DOI 10.1021/acs.jmedchem.9b00191; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greene KS, 2019, P NATL ACAD SCI USA, V116, P26625, DOI 10.1073/pnas.1911954116; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Harbeck N, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0122-z, 10.1038/s41572-019-0111-2]; He B, 2012, J AM CHEM SOC, V134, P1922, DOI 10.1021/ja2090417; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hirschey MD, 2015, MOL CELL PROTEOMICS, V14, P2308, DOI 10.1074/mcp.R114.046664; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Igci M, 2016, GENE, V586, P123, DOI 10.1016/j.gene.2016.04.023; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Jiang YH, 2020, MED CHEM, V16, P358, DOI 10.2174/1573406415666190603101937; Jing H, 2016, CANCER CELL, V29, P297, DOI 10.1016/j.ccell.2016.02.007; Kalbas D, 2018, J MED CHEM, V61, P2460, DOI 10.1021/acs.jmedchem.7b01648; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Lin ZF, 2013, BIOCHEM BIOPH RES CO, V441, P191, DOI 10.1016/j.bbrc.2013.10.033; Liu JJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21091217; Lu WD, 2014, TUMOR BIOL, V35, P10699, DOI 10.1007/s13277-014-2372-4; Maurer B, 2012, ACS MED CHEM LETT, V3, P1050, DOI 10.1021/ml3002709; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Park J, 2013, MOL CELL, V50, P919, DOI 10.1016/j.molcel.2013.06.001; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Rajabi N, 2017, ANGEW CHEM INT EDIT, V56, P14836, DOI 10.1002/anie.201709050; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Sadhukhan S, 2016, P NATL ACAD SCI USA, V113, P4320, DOI 10.1073/pnas.1519858113; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Spiegelman NA, 2019, CHEMMEDCHEM, V14, P744, DOI 10.1002/cmdc.201800715; Spiegelman NA, 2018, CHEMMEDCHEM, V13, P1890, DOI 10.1002/cmdc.201800391; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Unterlass JE, 2019, EXPERT REV MOL MED, V21, DOI 10.1017/erm.2019.4; Wagner GR, 2017, CELL METAB, V25, P823, DOI 10.1016/j.cmet.2017.03.006; Wagner GR, 2014, MOL CELL, V54, P5, DOI 10.1016/j.molcel.2014.03.027; Wang YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02951-4; Xu L, 2018, ONCOL REP, V39, P2315, DOI 10.3892/or.2018.6319; Yang X, 2018, CANCER RES, V78, P372, DOI 10.1158/0008-5472.CAN-17-1912; Ye XY, 2017, ONCOTARGET, V8, P6984, DOI 10.18632/oncotarget.14346; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	52	22	24	2	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1644	1658		10.1038/s41388-020-01637-w	http://dx.doi.org/10.1038/s41388-020-01637-w		JAN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33479498	Green Accepted			2022-12-26	WOS:000609352300002
J	Eastep, GN; Ghanam, RH; Green, TJ; Saad, JS				Eastep, Gunnar N.; Ghanam, Ruba H.; Green, Todd J.; Saad, Jamil S.			Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PLASMA-MEMBRANE ASSOCIATION; SIZE-DISTRIBUTION ANALYSIS; GP41 CYTOPLASMIC TAIL; ANALYTICAL ULTRACENTRIFUGATION; MOLECULAR DETERMINANTS; TRIMERIZATION DOMAIN; MYRISTATE EXPOSURE; ENV INCORPORATION; GAG	During the late phase of HIV-1 infection, viral Gag polyproteins are targeted to the plasma membrane (PM) for assembly. Gag localization at the PM is a prerequisite for the incorporation of the envelope protein (Env) into budding particles. Gag assembly and Env incorporation are mediated by the N-terminal myristoylated matrix (MA) domain of Gag. Nonconservative mutations in the trimer interface of MA (A45E, T70R, and L75G) were found to impair Env incorporation and infectivity, leading to the hypothesis that MA trimerization is an obligatory step for Env incorporation. Conversely, Env incorporation can be rescued by a compensatory mutation in the MA trimer interface (Q63R). The impact of these MA mutations on the structure and trimerization properties of MA is not known. In this study, we employed NMR spectroscopy, X-ray crystallography, and sedimentation techniques to characterize the structure and trimerization properties of HIV-1 MA A45E, Q63R, T70R, and L75G mutant proteins. NMR data revealed that these point mutations did not alter the overall structure and folding of MA but caused minor structural perturbations in the trimer interface. Analytical ultracentrifugation data indicated that mutations had a minimal effect on the MA monomer-trimer equilibrium. The high-resolution X-ray structure of the unmyristoylated MA Q63R protein revealed hydrogen bonding between the side chains of adjacent Arg-63 and Ser-67 on neighboring MA molecules, providing the first structural evidence for an additional intermolecular interaction in the trimer interface. These findings advance our knowledge of the interplay of MA trimerization and Env incorporation into HIV-1 particles.	[Eastep, Gunnar N.; Ghanam, Ruba H.; Green, Todd J.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484; Green, Todd/0000-0003-1158-4710; Eastep, Gunnar/0000-0003-3567-8500	NIH [5R01GM117837, 9R01AI150901, 1S10RR026478]; O'Neal comprehensive cancer center (NIH) [P30 CA013148]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Neal comprehensive cancer center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants 5R01GM117837 and 9R01AI150901 from the NIH to J. S. S. The High-Field NMR facility at the University of Alabama at Birmingham was established through the NIH (1S10RR026478) and is currently supported by the O'Neal comprehensive cancer center (NIH grant P30 CA013148). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akari H, 2000, J VIROL, V74, P4891, DOI 10.1128/JVI.74.10.4891-4893.2000; Alfadhi A, 2009, VIROLOGY, V387, P466, DOI 10.1016/j.virol.2009.02.048; Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Alfadhli A, 2019, J VIROL, V93, DOI 10.1128/JVI.01079-19; Alfadhli A, 2016, J VIROL, V90, P5657, DOI 10.1128/JVI.00509-16; Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; Anraku K, 2010, BIOCHEMISTRY-US, V49, P5109, DOI 10.1021/bi9019274; Barros M, 2016, J VIROL, V90, P4544, DOI 10.1128/JVI.02820-15; Brown LA, 2015, VIRUSES-BASEL, V7, P2210, DOI 10.3390/v7052210; Chan J, 2011, J VIROL, V85, P10851, DOI 10.1128/JVI.00760-11; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen B, 2019, TRENDS MICROBIOL, V27, P878, DOI 10.1016/j.tim.2019.06.002; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2013, J VIROL, V87, P7155, DOI 10.1128/JVI.00075-13; Chukkapalli V, 2011, J MOL BIOL, V410, P512, DOI 10.1016/j.jmb.2011.04.015; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cole JL, 2004, METHOD ENZYMOL, V384, P212; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dick RA, 2018, NATURE, V560, P509, DOI 10.1038/s41586-018-0396-4; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes F, 2011, TRAFFIC, V12, P438, DOI 10.1111/j.1600-0854.2010.01153.x; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2012, ADV EXP MED BIOL, V726, P441, DOI 10.1007/978-1-4614-0980-9_20; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Hamard-Peron E, 2010, J VIROL, V84, P503, DOI 10.1128/JVI.01134-09; Hendrix J, 2015, J CELL BIOL, V210, P629, DOI 10.1083/jcb.201504006; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079; Mercredi PY, 2016, J MOL BIOL, V428, P1637, DOI 10.1016/j.jmb.2016.03.005; Mucksch F, 2017, ELIFE, V6, DOI 10.7554/eLife.25287; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murphy RE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050548; Murphy RE, 2019, J BIOL CHEM, V294, P18600, DOI 10.1074/jbc.RA119.010997; Murphy RE, 2017, STRUCTURE, V25, P1708, DOI 10.1016/j.str.2017.09.010; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 1997, J VIROL, V71, P4409, DOI 10.1128/JVI.71.6.4409-4418.1997; Ono A, 2010, VACCINE, V28, pB55, DOI 10.1016/j.vaccine.2009.10.021; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pak AJ, 2017, P NATL ACAD SCI USA, V114, pE10056, DOI 10.1073/pnas.1706600114; Pezeshkian N, 2019, P NATL ACAD SCI USA, V116, P25269, DOI 10.1073/pnas.1910008116; Piai A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16165-0; Prchal J, 2012, J MOL BIOL, V423, P427, DOI 10.1016/j.jmb.2012.07.021; Purohit P, 2001, RNA, V7, P576, DOI 10.1017/S1355838201002023; Racine J, 2006, J APPL ECONOMET, V21, P133, DOI 10.1002/jae.885; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stansell E, 2007, J VIROL, V81, P8977, DOI 10.1128/JVI.00657-07; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2020, J VIROL, V94, DOI 10.1128/JVI.01526-19; Tedbury PR, 2016, P NATL ACAD SCI USA, V113, pE182, DOI 10.1073/pnas.1516618113; Tedbury PR, 2015, J MOL BIOL, V427, P1413, DOI 10.1016/j.jmb.2015.01.018; Tedbury PR, 2015, PROG MOL BIOL TRANSL, V129, P253, DOI 10.1016/bs.pmbts.2014.10.009; Tedbury PR, 2014, TRENDS MICROBIOL, V22, P372, DOI 10.1016/j.tim.2014.04.012; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Vlach J, 2018, J BIOL CHEM, V293, P18828, DOI 10.1074/jbc.RA118.003944; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Waheed AA, 2009, VIRUS RES, V143, P162, DOI 10.1016/j.virusres.2009.04.007; Wang Q, 2020, TRENDS MICROBIOL, V28, P655, DOI 10.1016/j.tim.2020.03.007; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992	87	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100321	10.1016/j.jbc.2021.100321	http://dx.doi.org/10.1016/j.jbc.2021.100321			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485964	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400295
J	Li, YL; Yao, YX; Zhao, YM; Di, YQ; Zhao, XF				Li, Yan-Li; Yao, You-Xiang; Zhao, Yu-Meng; Di, Yu-Qin; Zhao, Xiao-Fan			The steroid hormone 20-hydroxyecdysone counteracts insulin signaling via insulin receptor dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; WING IMAGINAL DISKS; DOUBLE-STRANDED-RNA; PROTHORACIC GLAND; TOBACCO HORNWORM; MANDUCA-SEXTA; DROSOPHILA; GROWTH; SIZE; CELL	The insulin receptor (INSR) binds insulin to promote body growth and maintain normal blood glucose levels. While it is known that steroid hormones such as estrogen and 20-hydroxyecdysone counteract insulin function, the molecular mechanisms responsible for this attenuation remain unclear. In the present study, using the agricultural pest lepidopteran Helicoverpa armigera as a model, we proposed that the steroid hormone 20-hydroxyecdysone (20E) induces dephosphorylation of INSR to counteract insulin function. We observed high expression and phosphorylation of INSR during larval feeding stages that decreased during metamorphosis. Insulin upregulated INSR expression and phosphorylation, whereas 20E repressed INSR expression and induced INSR dephosphorylation in vivo. Protein tyrosine phosphatase 1B (PTP1B, encoded by Ptpn1) dephosphorylated INSR in vivo. PTEN (phosphatase and tensin homolog deleted on chromosome 10) was critical for 20E-induced INSR dephosphorylation by maintaining the transcription factor Forkhead box O (FoxO) in the nucleus, where FoxO promoted Ptpn1 expression and repressed Insr expression. Knockdown of Ptpn1 using RNA interference maintained INSR phosphorylation, increased 20E production, and accelerated pupation. RNA interference of Insr in larvae repressed larval growth, decreased 20E production, delayed pupation, and accumulated hemolymph glucose levels. Taken together, these results suggest that a high 20E titer counteracts the insulin pathway by dephosphorylating INSR to stop larval growth and accumulate glucose in the hemolymph.	[Li, Yan-Li; Yao, You-Xiang; Zhao, Yu-Meng; Di, Yu-Qin; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao, Peoples R China	Shandong University	Zhao, XF (corresponding author), Shandong Univ, Sch Life Sci, Shandong Prov Key Lab Anim Cells & Dev Biol, Qingdao, Peoples R China.	xfzhao@sdu.edu.cn	Zhao, Xiao-Fan/AGW-9886-2022	Li, Yan-Li/0000-0003-2919-7647	National Natural Science Foundation of China [31730083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31730083).	Alvarez-Rendon JP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1417528; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Bass J, 2000, P NATL ACAD SCI USA, V97, P11905, DOI 10.1073/pnas.97.22.11905; Brown MR, 1998, J BIOL CHEM, V273, P3967, DOI 10.1074/jbc.273.7.3967; Cai MJ, 2016, DEVELOPMENT, V143, P1005, DOI 10.1242/dev.128694; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; COMPTON SJ, 1985, ANAL BIOCHEM, V151, P369, DOI 10.1016/0003-2697(85)90190-3; CZECH M P, 1985, Diabetes Metabolism Reviews, V1, P33; Das D, 2017, MOL REPROD DEV, V84, P444, DOI 10.1002/mrd.22806; De Franca IR, 2018, INTERV MED APPL SCI, V10, P226, DOI 10.1556/1646.10.2018.44; Di YQ, 2021, AUTOPHAGY, V17, P1170, DOI 10.1080/15548627.2020.1752497; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Elena C, 2018, CURR PHARM BIOTECHNO, V19, P1210, DOI 10.2174/1389201020666190102145305; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gabbouj S, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00629; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; GIORGINO F, 1993, J CLIN INVEST, V91, P2020, DOI 10.1172/JCI116424; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Hakim RS, 2010, ANNU REV ENTOMOL, V55, P593, DOI 10.1146/annurev-ento-112408-085450; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herrera NA, 2020, FREE RADICAL BIO MED, V152, P689, DOI 10.1016/j.freeradbiomed.2020.01.012; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hwang JL, 2014, DIABETES-METAB RES, V30, P96, DOI 10.1002/dmrr.2486; Hyun S, 2013, CELL MOL LIFE SCI, V70, P2351, DOI 10.1007/s00018-013-1313-5; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kang XL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008331; Kannan K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00288; Koyama T, 2004, MOL CELL ENDOCRINOL, V213, P155, DOI 10.1016/j.mce.2003.10.063; Kumar D, 2008, EUR J ENTOMOL, V105, P591, DOI 10.14411/eje.2008.079; Langelan RE, 2000, DEV BIOL, V227, P481, DOI 10.1006/dbio.2000.9895; Li YB, 2016, INSECT BIOCHEM MOLEC, V79, P73, DOI 10.1016/j.ibmb.2016.10.004; Lin F, 2017, AUST J CHEM, V70, P208, DOI [10.1071/ch16626, 10.1071/CH16626]; Lin XY, 2019, PEPTIDES, V122, DOI 10.1016/j.peptides.2018.02.001; Liu CY, 2015, CELL CYCLE, V14, P3045, DOI 10.1080/15384101.2015.1053664; Liu CY, 2013, APOPTOSIS, V18, P171, DOI 10.1007/s10495-012-0784-4; Liu ML, 2011, BIOTECHNOL PROGR, V27, P1407, DOI 10.1002/btpr.666; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mohammadiarani H, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00068; Nassel DR, 2016, CELL MOL LIFE SCI, V73, P271, DOI 10.1007/s00018-015-2063-3; Nijhout HF, 2007, DEV BIOL, V302, P569, DOI 10.1016/j.ydbio.2006.10.023; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1975, BIOL BULL, V149, P214, DOI 10.2307/1540491; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Nussey S, 2001, ENDOCRINOLOGY INTEGR; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Pan J, 2018, J BIOL CHEM, V293, P18613, DOI [10.1074/jbc.RA118.004891, 10.1074/jbc.ra118.004891]; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rewitz KF, 2006, MOL CELL ENDOCRINOL, V247, P166, DOI 10.1016/j.mce.2005.12.053; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Schultz H, 2018, NEURO-ONCOL PRACT, V5, P170, DOI 10.1093/nop/npx027; Shao HL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003127; Smith WA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00019; Tatulian SA, 2015, BIOCHEMISTRY-US, V54, P5523, DOI 10.1021/acs.biochem.5b00805; Tawfik AI, 1997, J INSECT PHYSIOL, V43, P485, DOI 10.1016/S0022-1910(96)00116-3; Verdu J, 1999, NAT CELL BIOL, V1, P500, DOI 10.1038/70293; Wang D, 2016, CELL CALCIUM, V60, P1, DOI 10.1016/j.ceca.2016.05.003; Wang JL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-76; Xu J, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100088; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zhang XQ, 2015, CELL SIGNAL, V27, P878, DOI 10.1016/j.cellsig.2015.01.016; Zhao WL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29205; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0; Zhao XF, 2020, J INTEGR AGR, V19, P1417, DOI 10.1016/S2095-3119(19)62860-1; Zhou XF, 2004, J EXP BIOL, V207, P1151, DOI 10.1242/jeb.00855	68	5	5	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100318	10.1016/j.jbc.2021.100318	http://dx.doi.org/10.1016/j.jbc.2021.100318			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33484713	gold, Green Published			2022-12-26	WOS:000672866400292
J	Ishida, S; Kondo, S; Funakoshi, S; Satoh, A; Maeda, T; Kawazoe, M; Yoshimura, C; Tada, K; Takahashi, K; Ito, K; Yasuno, T; Masutani, K; Nakashima, H; Arima, H				Ishida, Shintaro; Kondo, Seiji; Funakoshi, Shunsuke; Satoh, Atsushi; Maeda, Toshiki; Kawazoe, Miki; Yoshimura, Chikara; Tada, Kazuhiro; Takahashi, Koji; Ito, Kenji; Yasuno, Tetsuhiko; Masutani, Kosuke; Nakashima, Hitoshi; Arima, Hisatomi			White blood cell count and incidence of hypertension in the general Japanese population: ISSA-CKD study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LYMPHOCYTE RATIO; PRESSURE; RISK; NEUTROPHIL; OBESITY; ASSOCIATIONS; INFLAMMATION; DISEASE	Objectives This study aimed to clarify the relationship between the white blood cell (WBC) count and hypertension in the general Japanese population. Methods We conducted a population-based retrospective cohort study using annual health check-up data of residents of Iki City, Nagasaki Prefecture, Japan. A total of 2935 participants without hypertension at baseline were included in the present analysis. WBC counts were classified as tertile 1 (<4700/mu L), tertile 2 (4700-5999/mu L), and tertile 3 (>= 6000/mu L). The outcome was incident hypertension (blood pressure >= 140 mmHg). Multivariable-adjusted hazard ratios and 95% confidence intervals (95% CIs) were estimated using the Cox proportional hazards model. Result During an average follow-up of 4.5 years, 908 participants developed hypertension. The incidence (per 100 person-years) of hypertension increased with an elevation in the WBC count (6.3 in tertile 1, 7.0 in tertile 2, and 7.4 in tertile 3). This association was significant, even after adjustment for other risk factors, including age, sex, current smoking habits, current alcohol intake, exercise habits, obesity, elevated blood pressure, diabetes mellitus, and dyslipidemia. The hazard ratios were 1.07 for tertile 2 (95% CI 0.90-1.26) and 1.27 for tertile 3 (95% CI 1.06-1.51) compared with the reference group of tertile 1 (p = 0.009). Conclusion The WBC count was associated with future development of hypertension in the general Japanese population.	[Ishida, Shintaro; Kondo, Seiji] Fukuoka Univ, Fac Med, Dept Oral & Maxillofacial Surg, Fukuoka, Japan; [Funakoshi, Shunsuke; Satoh, Atsushi; Maeda, Toshiki; Kawazoe, Miki; Yoshimura, Chikara; Arima, Hisatomi] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Japan; [Tada, Kazuhiro; Takahashi, Koji; Ito, Kenji; Yasuno, Tetsuhiko; Masutani, Kosuke; Nakashima, Hitoshi] Fukuoka Univ, Fac Med, Dept Internal Med, Div Nephrol & Rheumatol, Fukuoka, Japan	Fukuoka University; Fukuoka University; Fukuoka University	Ishida, S (corresponding author), Fukuoka Univ, Fac Med, Dept Oral & Maxillofacial Surg, Fukuoka, Japan.	shin0723@adm.fukuoka-u.ac.jp	; Kondo, Seiji/I-4332-2017	ji cun, li/0000-0003-1639-8458; Kondo, Seiji/0000-0001-9341-5069	 [180424];  [190595];  [200492]	; ; 	This study was supported by research grants from Iki City (Grant numbers 180424, 190595 and 200492; recipients HA, HN and KM).	Agita A, 2017, ACTA MED INDONES, V49, P158; Belen E, 2015, J CLIN HYPERTENS, V17, P532, DOI 10.1111/jch.12533; Dinh QN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406960; Ebong IA, 2016, MENOPAUSE, V23, P662, DOI 10.1097/GME.0000000000000609; Fantin F, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071667; Fujiyoshi A, 2012, HYPERTENS RES, V35, P947, DOI 10.1038/hr.2012.87; Furuncuoglu Y, 2016, EUR REV MED PHARMACO, V20, P1300; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jayedi A, 2019, HEART, V105, P686, DOI 10.1136/heartjnl-2018-314216; Jung CH, 2013, YONSEI MED J, V54, P615, DOI 10.3349/ymj.2013.54.3.615; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Kinoshita M, 2018, J ATHEROSCLER THROMB, V25, P846, DOI 10.5551/jat.GL2017; Lakoski SG, 2011, J HUM HYPERTENS, V25, P73, DOI 10.1038/jhh.2010.91; Lakoski SG, 2005, J AM COLL CARDIOL, V46, P1869, DOI 10.1016/j.jacc.2005.07.050; Maeda T, 2019, J HUM HYPERTENS, V33, P873, DOI 10.1038/s41371-019-0198-7; Martin D, 2014, EUR J VASC ENDOVASC, V47, P422, DOI 10.1016/j.ejvs.2013.12.020; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Nakanishi N, 2002, J HYPERTENS, V20, P851, DOI 10.1097/00004872-200205000-00018; Satoh A, 2017, J HYPERTENS, V35, P401, DOI 10.1097/HJH.0000000000001169; Siedlinski M, 2020, CIRCULATION, V141, P1307, DOI 10.1161/CIRCULATIONAHA.119.045102; Tatsukawa Y, 2008, HYPERTENS RES, V31, P1391, DOI 10.1291/hypres.31.1391; The Japan Diabetes Society, 2018, MANAGEMENT DIABETES; The Japanese Society of Cardiovascular Disease Prevention, 2014, HDB CARDIOVASCULAR P; Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9; Wang H, 2017, J CLIN HYPERTENS, V19, P780, DOI 10.1111/jch.13002; Whelton WP, 2017, J AM COLL CARDIOL	26	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246304	10.1371/journal.pone.0246304	http://dx.doi.org/10.1371/journal.pone.0246304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529192	Green Published, gold			2022-12-26	WOS:000616736200015
J	Zywicki, K; Bartkowiak, T; Kujawinska, A				Zywicki, Krzysztof; Bartkowiak, Tomasz; Kujawinska, Agnieszka			Application of a simulation model to the prognosis of material loss in wood processing	PLOS ONE			English	Article							SYSTEMS	The article discusses the influence of a sample size on the credibility of a simulation model created for the estimation of material loss in the production of a middle layer of a wooden floorboard. The study was conducted in a production company operating in the wood processing industry. Geometric characteristics of input material were captured and used to derive statistical distributions, which were then included in the simulation model. The conducted experiments indicated that the quality of the simulation model was significantly affected by the quality and quantity of the sample, on the basis of which the stochastic model is estimated. It was shown that small sample for wood processing data was insufficient to capture process variability. On the other hand, excessive sample size (80 or more observations) for the material with high natural geometric variability, involves taking into account outliers, which may lower the overall prognostic quality of the simulation model. Based on the conducted simulation experiments, the recommended sample size which allows development of a reliable model for estimation of material loss in the analyzed manufacturing process, ranges from 40 to 60 measurements.	[Zywicki, Krzysztof; Bartkowiak, Tomasz; Kujawinska, Agnieszka] Poznan Univ Tech, Fac Mech Engn, Poznan, Poland	Poznan University of Technology	Kujawinska, A (corresponding author), Poznan Univ Tech, Fac Mech Engn, Poznan, Poland.	agnieszka.kujawinska@put.poznan.pl	Bartkowiak, Tomasz/F-8927-2014; Kujawinska, Agnieszka/M-3344-2014	Bartkowiak, Tomasz/0000-0002-4715-6358; Kujawinska, Agnieszka/0000-0003-3615-3837	Faculty of Mechanical Engineering, Poznan University of Technology, Poland [2/298950/1/ NCBR/2016]; National Center for Research and Development (NCBR) from BIOSTRATEG program	Faculty of Mechanical Engineering, Poznan University of Technology, Poland; National Center for Research and Development (NCBR) from BIOSTRATEG program	We declare that the results of the presented research were financed as part of the project titled "Improvement of raw wood efficiency in the industrial production processes, BIOSTRATEG", project number 2/298950/1/ NCBR/2016, run by the Faculty of Mechanical Engineering, Poznan University of Technology, Poland (in cooperation with Barlinek Inwestycje Sp. Z oo, a floorboard manufacturer in Poland), supported by the National Center for Research and Development (NCBR) from the financial means within the BIOSTRATEG program.	Bai X, 2015, INT J PROD RES, P7543; BAILEY A, 1995, BEST PAP PROC, P2; Bartkowiak T, 2016, WINT SIMUL C PROC, P2912, DOI 10.1109/WSC.2016.7822326; Bartkowiak T, 2014, PROCEEDINGS OF THE ASME 12TH BIENNIAL CONFERENCE ON ENGINEERING SYSTEMS DESIGN AND ANALYSIS - 2014, VOL 3, DOI 10.1115/ESDA2014-20141; BOROTA M, 1994, 1994 SYMPOSIUM ON VLSI CIRCUITS, P1; Brey P., 2008, HDB INFORM COMPUTER, V3, P61, DOI [10.1002/97804702818, DOI 10.1002/9780470281819.CH15]; Central Statistical Office of Poland, 2016, REG DAT BANK; Csanady E, 2019, OPTIM DES MANUF WOOD; Evans M., 1993, STAT DISTRIBUTIONS; Jegatheswaran Ratnasingam Chin KA, 2017, FOREST PROD J, V56, P25; Kujawinska A, 2017, ADV INTELL SYST, V571, P499, DOI 10.1007/978-3-319-56541-5_51; LEE HL, 1988, OPER RES, V36, P269, DOI 10.1287/opre.36.2.269; LEE TS, 1987, DECISION SCI, V18, P292, DOI 10.1111/j.1540-5915.1987.tb01523.x; Meyer B, 2006, ECOL ECON, V63, P193; Mourtzis D, 2014, PROC CIRP, V25, P213, DOI 10.1016/j.procir.2014.10.032; Mula J, 2007, FUZZY SET SYST, V158, P783, DOI 10.1016/j.fss.2006.11.003; Orowski KA, 2013, WOOD, P189; Pedgen CD, 1995, INTRO SIMULATION USI; Sandak J, 2020, DRVNA IND, V71, P193, DOI 10.5552/drvind.2020.1970; Sandvik, 1999, PROD US MAINT WOOD B; Straka M, 2020, ADV PROD ENG MANAG, V15, P18, DOI 10.14743/apem2020.1.346; Straka M, 2016, PRZEM CHEM, V95, P773, DOI 10.15199/62.2016.4.12; Xiande Zhao, 1993, Journal of Operations Management, V11, P185, DOI 10.1016/0272-6963(93)90022-H; ywicki K, 2016, BIOSTRATEG22989501NC; Zulch G, 2002, INT J PROD ECON, V77, P39, DOI 10.1016/S0925-5273(01)00198-0	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246325	10.1371/journal.pone.0246325	http://dx.doi.org/10.1371/journal.pone.0246325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529236	gold, Green Published			2022-12-26	WOS:000616736200053
J	Chen, LJ; Hu, B; Han, ZQ; Liu, W; Zhu, JH; Chen, XX; Li, ZP; Zhou, H				Chen, Li-Juan; Hu, Bin; Han, Zhi-Qiang; Liu, Wei; Zhu, Jian-Hua; Chen, Xue-Xing; Li, Zi-Ping; Zhou, Hao			Repression of FBXW7 by HES5 contributes to inactivation of the TGF-beta signaling pathway and alleviation of endometriosis	FASEB JOURNAL			English	Article						endometriosis; F&#8208; box and WD repeat domain containing 7; HES family bHLH transcription factor 5; transforming growth factor beta&#8208; induced factor 1	TUMOR-SUPPRESSOR; MOUSE MODEL; CANCER; PROLIFERATION; EXPRESSION; FIBROSIS; WOMEN	Endometriosis (EMS) is a gynecologic disorder associated with infertility and characterized by the endometrial-type mucosa outside the uterine cavity. Currently available treatment modalities are limited to undesirable effects. Thus, in the present study, we sought to study the pathogenesis mechanism of EMS. For this purpose, the ectopic and eutopic endometrial tissues were resected from 86 patients with EMS and 54 infertile patients without EMS, respectively. The regulatory mechanism among HES family bHLH transcription factor 5 (HES5), transforming growth factor-beta (TGF-beta)-induced factor 1 (TGIF1), F-box, and WD repeat domain containing 7 (FBXW7) was studied by performing co-immunoprecipitation, dual-luciferase reporter gene assay, and chromatin immunoprecipitation, respectively. A mouse model of EMS was established to verify the aforementioned regulatory mechanism in vivo. Upregulation of HES5 and TGIF1, as well as downregulation of FBXW7, was observed in EMS endometrial tissues and human endometrial stromal cells (hESCs), respectively. The overexpression of HES5 was found to suppress the FBXW7 transcription and TGIF1 degradation, resulting in the inactivation of the TGF-beta signaling pathway, as well as inhibition of hESC proliferation and invasion, thereby enhancing apoptosis. Results from a mouse model of EMS showed that the presence of HES5 contributed to the alleviation of EMS. Collectively, we attempted to provide a mechanistic insight into the unrecognized roles of the HES5/FBXW7 in EMS progression.	[Chen, Li-Juan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Hu, Bin] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Han, Zhi-Qiang] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Obstet & Gynecol, Wuhan, Peoples R China; [Liu, Wei] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Stem Cell Res & Applicat, Wuhan, Peoples R China; [Zhu, Jian-Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan 1 Hosp, Lab Clin Immunol, Wuhan, Peoples R China; [Chen, Xue-Xing; Li, Zi-Ping; Zhou, Hao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, H (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan 430022, Peoples R China.	zhouhao@hust.edu.cn						Alotaibi FT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219064; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Buigues A, 2018, BIOL REPROD, V99, P326, DOI 10.1093/biolre/ioy057; Cai JT, 2018, PROTEIN CELL, V9, P754, DOI 10.1007/s13238-017-0486-3; Chen X, 2018, NEOPLASMA, V65, P201, DOI 10.4149/neo_2018_170228N149; Gellersen B, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106724; Greaves E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44169; Greaves E, 2014, AM J PATHOL, V184, P1930, DOI 10.1016/j.ajpath.2014.03.011; Gu SD, 2017, ONCOL REP, V37, P474, DOI 10.3892/or.2016.5268; Guca E, 2018, NUCLEIC ACIDS RES, V46, P9220, DOI 10.1093/nar/gky680; Guo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022387; Heinen A, 2012, GLIA, V60, P1696, DOI 10.1002/glia.22388; Herreros-Villanueva M, 2019, CLIN CHIM ACTA, V493, P63, DOI 10.1016/j.cca.2019.02.016; Hickey M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1752; Jiang YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13735; Kim HS, 2014, BRIT J CANCER, V110, P1878, DOI 10.1038/bjc.2014.29; Kondo N, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201708547; Lupini L, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13137; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Potlog-Nahari C, 2004, FERTIL STERIL, V82, P86, DOI 10.1016/j.fertnstert.2003.11.059; Rutkowski TP, 2016, J CELL SCI, V129, P2145, DOI 10.1242/jcs.181271; Sailo BL, 2019, CANCERS, V11, DOI 10.3390/cancers11020246; Salilew-Wondim D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2513-9; Sancho R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001586; Shi LB, 2017, BIOL REPROD, V97, P873, DOI 10.1093/biolre/iox140; Skrzypczak Jana, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS143; Soni UK, 2019, BIOL REPROD, V100, P917, DOI 10.1093/biolre/ioy242; Su RW, 2015, J CLIN ENDOCR METAB, V100, pE433, DOI 10.1210/jc.2014-3720; Suda K, 2018, CELL REP, V24, P1777, DOI 10.1016/j.celrep.2018.07.037; Tan WZ, 2018, APOPTOSIS, V23, P667, DOI 10.1007/s10495-018-1484-5; Tanaka Y O, 1996, Radiat Med, V14, P111; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang Y, 2017, WORLD J GASTROENTERO, V23, P2330, DOI 10.3748/wjg.v23.i13.2330; Xiao GD, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12473; Yeh CH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0857-2; Yen-Ping J, 2010, FERTIL STERIL, V94, P1078, DOI 10.1016/j.fertnstert.2009.05.001; Yotova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170859; Young VJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106773; Zhou H, 2010, AUTOIMMUNITY, V43, P299, DOI 10.3109/08916930903405875; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	41	5	6	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e20938	10.1096/fj.202000438RRR	http://dx.doi.org/10.1096/fj.202000438RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496006				2022-12-26	WOS:000647789600095
J	Goshayeshi, L; Taemeh, SY; Dehdilani, N; Nasiri, M; Seno, MMG; Dehghani, H				Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Nasiri, Mohammadreza; Seno, Mohammad M. Ghahramani; Dehghani, Hesam			CRISPR/dCas9-mediated transposition with specificity and efficiency of site-directed genomic insertions	FASEB JOURNAL			English	Article						CRISPR&#8208; associated protein 9; gene insertion; Insertional mutagenesis; piggyBac transposase; transposases	HYPERACTIVE PIGGYBAC TRANSPOSASE; SLEEPING-BEAUTY; GENE-EXPRESSION; IN-VIVO; INTEGRATION; NUCLEASES; LOCUS; MECHANISM; SELECTION; IMPROVES	The ability and efficiency of targeted nucleases to perform sequence replacements or insertions into the genome are limited. This limited efficiency for sequence replacements or insertions can be explained by the dependency on DNA repair pathways, the possibility of cellular toxicity, and unwanted activation of proto-oncogenes. The piggyBac (PB) transposase uses a very efficient enzymatic mechanism to integrate DNA fragments into the genome in a random manner. In this study, we fused an RNA-guided catalytically inactive Cas9 (dCas9) to the PB transposase and used dual sgRNAs to localize this molecule to specific genomic targets. We designed and used a promoter/reporter complementation assay to register and recover cells harboring-specific integrations, where only by complementation upon correct genomic integration, the reporter can be activated. Using an RNA-guided piggyBac transposase and dual sgRNAs, we were able to achieve site-directed integrations in the human ROSA26 safe harbor region in 0.32% of cells. These findings show that the methodology used in this study can be used for targeting genomic regions. An application for this finding could be in cancer cells to insert sequences into specific target regions that are intended to be destroyed, or to place promoter cargos behind the tumor suppressor genes to activate them.	[Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Seno, Mohammad M. Ghahramani; Dehghani, Hesam] Ferdowsi Univ Mashhad, Fac Vet Med, Div Biotechnol, Mashhad, Razavi Khorasan, Iran; [Goshayeshi, Lena; Taemeh, Sara Yousefi; Dehdilani, Nima; Dehghani, Hesam] Ferdowsi Univ Mashhad, Res Inst Biotechnol, Stem Cell Biol & Regenerat Med Res Grp, Mashhad, Razavi Khorasan, Iran; [Nasiri, Mohammadreza] Ferdowsi Univ Mashhad, Res Inst Biotechnol, Recombinant Prot Res Grp, Mashhad, Razavi Khorasan, Iran; [Nasiri, Mohammadreza] Ferdowsi Univ Mashhad, Dept Anim Sci, Mashhad, Razavi Khorasan, Iran; [Seno, Mohammad M. Ghahramani; Dehghani, Hesam] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Razavi Khorasan, Iran	Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad; Ferdowsi University Mashhad	Dehghani, H (corresponding author), Ferdowsi Univ Mashhad, Res Inst Biotechnol, Azadi Sq, Mashhad 9177943369, Razavi Khorasan, Iran.	dehghani@um.ac.ir	Dehghani, Hesam/D-1421-2010; Taemeh, Sara Yousefi/ABD-5803-2020	Dehghani, Hesam/0000-0001-6750-0040; 				Bhatt S, 2019, NUCLEIC ACIDS RES, V47, P8126, DOI 10.1093/nar/gkz552; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Chen QJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17128-1; Chen SP, 2019, CRISPR J, V2, P376, DOI 10.1089/crispr.2019.0030; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Di Matteo M, 2012, EXPERT OPIN BIOL TH, V12, P841, DOI 10.1517/14712598.2012.684875; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Eckermann KN, 2018, INSECT BIOCHEM MOLEC, V98, P16, DOI 10.1016/j.ibmb.2018.04.001; Frock RL, 2015, NAT BIOTECHNOL, V33, P179, DOI 10.1038/nbt.3101; Fung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020514; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gogol-Doring A, 2016, MOL THER, V24, P592, DOI 10.1038/mt.2016.11; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Hew BE, 2019, SYN BIOL, V4, DOI 10.1093/synbio/ysz018; Hickman AB, 2016, CHEM REV, V116, P12758, DOI 10.1021/acs.chemrev.6b00003; Ihry RJ, 2018, NAT MED, V24, P939, DOI 10.1038/s41591-018-0050-6; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Ju HuiMing, 2015, Journal of Food, Agriculture & Environment, V13, P149; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kimura Y, 2019, STEM CELL TRANSL MED, V8, P627, DOI 10.1002/sctm.18-0039; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Kovac A, 2020, ELIFE, V9, DOI 10.7554/eLife.53868; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li MA, 2013, MOL CELL BIOL, V33, P1317, DOI 10.1128/MCB.00670-12; Li MA, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr764; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu X., 2012, TRANSGENIC RES, V81, P165; Luo WT, 2017, NUCLEIC ACIDS RES, V45, P8411, DOI 10.1093/nar/gkx572; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10124; Mitra R, 2008, EMBO J, V27, P1097, DOI 10.1038/emboj.2008.41; Morellet N, 2018, NUCLEIC ACIDS RES, V46, P2660, DOI 10.1093/nar/gky044; Nakanishi H, 2010, MOL THER, V18, P707, DOI 10.1038/mt.2009.302; Negoua A, 2013, GENETICA, V141, P369, DOI 10.1007/s10709-013-9736-3; Olsen PA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-35; Ordovas L, 2018, STEM CELL REP, V10, P673, DOI 10.1016/j.stemcr.2018.01.034; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Owens JB, 2013, NUCLEIC ACIDS RES, V41, P9197, DOI 10.1093/nar/gkt677; Owens JB, 2012, NUCLEIC ACIDS RES, V40, P6978, DOI 10.1093/nar/gks309; Palais G, 2009, PHYSIOL GENOMICS, V37, P140, DOI 10.1152/physiolgenomics.90328.2008; Pellenz S, 2019, HUM GENE THER, V30, P814, DOI 10.1089/hum.2018.169; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Radecke S, 2010, MOL THER, V18, P743, DOI 10.1038/mt.2009.304; Sadelain M, 2012, NAT REV CANCER, V12, P51, DOI 10.1038/nrc3179; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Saridey SK, 2009, MOL THER, V17, P2115, DOI 10.1038/mt.2009.234; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Wilson MH, 2005, FEBS LETT, V579, P6205, DOI 10.1016/j.febslet.2005.10.004; Woodard LE, 2015, TRENDS BIOTECHNOL, V33, P525, DOI 10.1016/j.tibtech.2015.06.009; Wu M., 2016, SCI REP-UK, V6, P1; Wu SCY, 2006, P NATL ACAD SCI USA, V103, P15008, DOI 10.1073/pnas.0606979103; Yang Y, 2016, NAT BIOTECHNOL, V34, P334, DOI 10.1038/nbt.3469; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Ye L., 2015, SCI REP-UK, V5, P749; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zare K, 2018, BIOL PROCED ONLINE, V20, DOI 10.1186/s12575-018-0086-5	65	3	3	6	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21359	10.1096/fj.202001830RR	http://dx.doi.org/10.1096/fj.202001830RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496003				2022-12-26	WOS:000647789600098
J	Kou, GN; Li, PY; Hu, YC; Chen, HA; Amoah, AN; Traore, SS; Cui, ZW; Lyu, QJ				Kou, Guangning; Li, Peiyuan; Hu, Youchun; Chen, Huanan; Amoah, Adwoa Nyantakyiwaa; Traore, Stanislav Seydou; Cui, Zhenwei; Lyu, Quanjun			Nobiletin activates thermogenesis of brown and white adipose tissue in high-fat diet-fed C57BL/6 mice by shaping the gut microbiota	FASEB JOURNAL			English	Article						gut microbiome; nobiletin; obesity; short&#8208; chain fatty acids; thermogenesis	INDUCED OBESITY; ADIPOGENESIS; ANGIOGENESIS; POPULATION; METABOLISM; DISEASE; MOUSE	Increasing energy expenditure by activating thermogenesis in brown and beige adipocytes is a critical approach to protect against obesity. Here, we investigated the action and mechanism of a natural polymethoxyflavone on adaptive thermogenesis in high-fat diet-induced obesity mouse model. Nobiletin treatment significantly ameliorated obesity, alleviated the whitening of brown adipose tissue, and promoted browning of white adipose tissue in mice fed a high-fat diet. Gut microbiota analysis and metabolomic profiling revealed that nobiletin treatment resulted in a composition shift in the gut microbiota thereby altering fermentation products acetate levels in the host feces and serum. Further, transplantation of the microbiota from nobiletin-treated mice to microbiota-depleted mice activated brown adipose tissue activity, promoted beige adipocytes formation, and improved high-fat diet-induced obesity. Our results indicate that nobiletin could be used as a dietary therapy to prevent HFD-induced obesity, and provide a potential target-specific gut microbial species-driven mechanism for activating thermogenesis in brown and beige adipocytes.	[Kou, Guangning; Li, Peiyuan; Cui, Zhenwei] Zhengzhou Univ, Ctr Sport Nutr & Hlth, Sch Phys Educ, Zhengzhou, Peoples R China; [Kou, Guangning; Li, Peiyuan; Hu, Youchun; Chen, Huanan; Amoah, Adwoa Nyantakyiwaa; Traore, Stanislav Seydou; Lyu, Quanjun] Zhengzhou Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou 450001, Peoples R China; [Lyu, Quanjun] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University	Cui, ZW (corresponding author), Zhengzhou Univ, Ctr Sport Nutr & Hlth, Sch Phys Educ, Zhengzhou, Peoples R China.; Lyu, QJ (corresponding author), Zhengzhou Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou 450001, Peoples R China.	cuizw0808@zzu.edu.cn; lqjnutr@zzu.edu.cn						Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Borody Thomas J, 2013, Curr Gastroenterol Rep, V15, P337, DOI 10.1007/s11894-013-0337-1; Chang CJ, 2015, NAT COMMUN, V6, DOI [10.1038/ncomms8489, 10.1038/ncomms8216]; Chevalier C, 2015, CELL, V163, P1360, DOI 10.1016/j.cell.2015.11.004; Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005; Chou YC, 2018, J AGR FOOD CHEM, V66, P9697, DOI 10.1021/acs.jafc.8b02719; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Hu JM, 2016, ENDOCRINOLOGY, V157, P1881, DOI 10.1210/en.2015-1944; Jiang RH, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106010; Ke ZL, 2018, J FUNCT FOODS, V47, P28, DOI 10.1016/j.jff.2018.05.032; Kim YJ, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600889; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li GL, 2017, CELL METAB, V26, P672, DOI 10.1016/j.cmet.2017.08.019; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Mestdagh R, 2012, J PROTEOME RES, V11, P620, DOI 10.1021/pr200938v; Nakajima A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143380; Nguyen-Ngo C, 2020, CLIN SCI, V134, P571, DOI 10.1042/CS20191099; Nohara K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11926-y; Pei L, 2018, BIOMED PHARMACOTHER, V105, P625, DOI 10.1016/j.biopha.2018.06.018; Pi-Sunyer FX, 2002, OBES SURG, V12, p6S, DOI 10.3810/pgm.2009.11.2074; Razaz N, 2020, LANCET DIABETES ENDO, V8, P572, DOI 10.1016/S2213-8587(20)30151-0; Saigusa D, 2011, ANAL BIOANAL CHEM, V400, P3635, DOI 10.1007/s00216-011-5031-2; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Takeda K, 2016, NAT REV IMMUNOL, V16, P206, DOI 10.1038/nri.2016.18; Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Vanhoecke BW, 2005, IN VIVO, V19, P103; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu LY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00122; Yoshida H, 2019, ARCH BIOCHEM BIOPHYS, V672, DOI 10.1016/j.abb.2019.07.022; Yuan XX, 2017, FASEB J, V31, P333, DOI [10.1096/fj.201600459RR, 10.1096/fj.201600459rr]; Zeng SL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax6208; Zhang X, 2016, INT J OBESITY, V40, P1841, DOI 10.1038/ijo.2016.108; Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089; Zietak M, 2016, CELL METAB, V23, P1216, DOI 10.1016/j.cmet.2016.05.001	47	6	6	11	47	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21267	10.1096/fj.202002197R	http://dx.doi.org/10.1096/fj.202002197R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475201				2022-12-26	WOS:000647789600087
J	Alatrista-Salas, H; Gauthier, V; Nunez-del-Prado, M; Becker, M				Alatrista-Salas, Hugo; Gauthier, Vincent; Nunez-del-Prado, Miguel; Becker, Monique			Impact of natural disasters on consumer behavior: Case of the 2017 El Nino phenomenon in Peru	PLOS ONE			English	Article							SEQUENCES	El Nino is an extreme weather event featuring unusual warming of surface waters in the eastern equatorial Pacific Ocean. This phenomenon is characterized by heavy rains and floods that negatively affect the economic activities of the impacted areas. Understanding how this phenomenon influences consumption behavior at different granularity levels is essential for recommending strategies to normalize the situation. With this aim, we performed a multi-scale analysis of data associated with bank transactions involving credit and debit cards. Our findings can be summarized into two main results: Coarse-grained analysis reveals the presence of the El Nino phenomenon and the recovery time in a given territory, while fine-grained analysis demonstrates a change in individuals' purchasing patterns and in merchant relevance as a consequence of the climatic event. The results also indicate that society successfully withstood the natural disaster owing to the economic structure built over time. In this study, we present a new method that may be useful for better characterizing future extreme events.	[Alatrista-Salas, Hugo; Nunez-del-Prado, Miguel] Univ Pacifico, Lima, Peru; [Gauthier, Vincent; Becker, Monique] Inst Polytech Paris, Lab SAMOVAR, Telecom SudParis, Palaiseau, France	Universidad del Pacifico Peru	Nunez-del-Prado, M (corresponding author), Univ Pacifico, Lima, Peru.; Gauthier, V (corresponding author), Inst Polytech Paris, Lab SAMOVAR, Telecom SudParis, Palaiseau, France.	vincent.gauthier@telecom-sudparis.eu; m.nunezdelpradoc@up.edu.pe		Becker, Monique/0000-0002-0614-6647; Alatrista-Salas, Hugo/0000-0001-5252-4728; Nunez del Prado Cortez, Miguel/0000-0001-7997-1739	3rd Programme d'Investissements d'Avenir [ANR-18-EUR-0006]; STIC AMSUD program [04-2017 PEDESTAL]	3rd Programme d'Investissements d'Avenir(French National Research Agency (ANR)); STIC AMSUD program	VG, MB: The 3rd Programme d'Investissements d'Avenir ANR-18-EUR-0006, NO, https://anr.fr/VG, HA, MNP: The STIC AMSUD program through the 04-2017 PEDESTAL project, NO, http://www.sticmathamsud.org/	Adams S, 2019, ANN ONCOL, V30, P397, DOI 10.1093/annonc/mdy517; Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Ahmed SA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034004; [Anonymous], NTR; [Anonymous], NTR; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Borgatti SP, 1999, SOC NETWORKS, V21, P375; Brodersen KH, 2015, ANN APPL STAT, V9, P247, DOI 10.1214/14-AOAS788; Carleton TA, 2016, SCIENCE, V353, DOI 10.1126/science.aad9837; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Di Clemente R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05690-8; (ERCC) ERCC, 2017, 3103 2017 PER SEV WE; Eyre R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15405-7; Gambs S, 2014, J COMPUT SYST SCI, V80, P1597, DOI 10.1016/j.jcss.2014.04.024; Gambs Sebastien, 2010, P 3 ACM SIGSPATIAL I, P34; Garcia Torres D., 2018, MANUAL EVALUACION NO; Guan XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167267; Guidotti R, 2018, EPJ DATA SCI, V7, DOI 10.1140/epjds/s13688-018-0133-0; Hallegatte S, 2007, ECOL ECON, V62, P330, DOI 10.1016/j.ecolecon.2006.06.006; Holme P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046111; Kusen E, 2019, APPL NETW SCI, V4, DOI 10.1007/s41109-019-0115-6; Langville A. N., 2012, WHOS 1 SCI RATING RA; Leo Y, 2018, SOC NETW ANAL MIN, V8, DOI 10.1007/s13278-018-0486-1; Leo Y, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0598; Ma A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119678; Malinowski S, 2013, LECT NOTES COMPUT SC, V8207, P273, DOI 10.1007/978-3-642-41398-8_24; Martinez EA, 2016, DATA GOOD EXCHANGE; NevillManning CG, 1997, J ARTIF INTELL RES, V7, P67, DOI 10.1613/jair.374; Niles MT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210484; Nunez-del Prado M., 2019, J AMBIENT INTELL HUM, P1, DOI [10.1007/s12652-019-01371-6, DOI 10.1007/S12652-019-01371-6]; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peixoto TP, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.118703; Pennacchioli D, 2014, EPJ DATA SCI, V3, DOI 10.1140/epjds/s13688-014-0033-x; Nguyen P, 2019, SCI DATA, V6, DOI 10.1038/sdata.2018.296; Schanzenbach DW, 2016, DOES ALL MONEY GO SH; Sobolevsky S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146291; Tavenard R, 2017, TSLEARN MACHINE LEAR; Verma T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10441; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Xu CG, 2019, IEEE T INF FOREN SEC, V14, P2358, DOI 10.1109/TIFS.2019.2897874; Youn H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.0937	41	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0244409	10.1371/journal.pone.0244409	http://dx.doi.org/10.1371/journal.pone.0244409			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507933	Green Submitted, gold, Green Published			2022-12-26	WOS:000635021400017
J	Ward, LM; Shih, PM				Ward, Lewis M.; Shih, Patrick M.			Granick revisited: Synthesizing evolutionary and ecological evidence for the late origin of bacteriochlorophyll via ghost lineages and horizontal gene transfer	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; ANOXYGENIC PHOTOSYNTHESIS; CHLOROPHYLL BIOSYNTHESIS; PHOTOTROPHY; GREEN; PROTOCHLOROPHYLLIDE; OXIDATION; TREE; DIVERSIFICATION; ENDOSYMBIOSIS	Photosynthesis-both oxygenic and more ancient anoxygenic forms-has fueled the bulk of primary productivity on Earth since it first evolved more than 3.4 billion years ago. However, the early evolutionary history of photosynthesis has been challenging to interpret due to the sparse, scattered distribution of metabolic pathways associated with photosynthesis, long timescales of evolution, and poor sampling of the true environmental diversity of photosynthetic bacteria. Here, we reconsider longstanding hypotheses for the evolutionary history of phototrophy by leveraging recent advances in metagenomic sequencing and phylogenetics to analyze relationships among phototrophic organisms and components of their photosynthesis pathways, including reaction centers and individual proteins and complexes involved in the multi-step synthesis of (bacterio)-chlorophyll pigments. We demonstrate that components of the photosynthetic apparatus have undergone extensive, independent histories of horizontal gene transfer. This suggests an evolutionary mode by which modular components of phototrophy are exchanged between diverse taxa in a piecemeal process that has led to biochemical innovation. We hypothesize that the evolution of extant anoxygenic photosynthetic bacteria has been spurred by ecological competition and restricted niches following the evolution of oxygenic Cyanobacteria and the accumulation of O-2 in the atmosphere, leading to the relatively late evolution of bacteriochlorophyll pigments and the radiation of diverse crown group anoxygenic phototrophs. This hypothesis expands on the classic "Granick hypothesis" for the stepwise evolution of biochemical pathways, synthesizing recent expansion in our understanding of the diversity of phototrophic organisms as well as their evolving ecological context through Earth history.	[Ward, Lewis M.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Shih, Patrick M.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Shih, Patrick M.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Shih, Patrick M.] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA 94608 USA; [Shih, Patrick M.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Harvard University; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Davis	Ward, LM (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.; Shih, PM (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.; Shih, PM (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.; Shih, PM (corresponding author), Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA 94608 USA.; Shih, PM (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	lewis_ward@fas.harvard.edu; pmshih@ucdavis.edu			Agouron Institute Postdoctoral Fellowship; Simons Foundation Postdoctoral Fellowship in Marine Microbial Ecology	Agouron Institute Postdoctoral Fellowship; Simons Foundation Postdoctoral Fellowship in Marine Microbial Ecology	LMW was supported by an Agouron Institute Postdoctoral Fellowship and a Simons Foundation Postdoctoral Fellowship in Marine Microbial Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JM, 2015, CURR BIOL, V25, pR911, DOI 10.1016/j.cub.2015.07.055; Atamna-Ismaeel N, 2012, ENV MICROBIOL REP, V4, P209, DOI 10.1111/j.1758-2229.2011.00323.x; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Brinkmann H., 2018, ISME J, V1; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Bryant DA, 2007, SCIENCE, V317, P523, DOI 10.1126/science.1143236; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canfield DE, 2006, PHILOS T R SOC B, V361, P1819, DOI 10.1098/rstb.2006.1906; Cardona T, 2015, PHOTOSYNTH RES, V126, P111, DOI 10.1007/s11120-014-0065-x; Chen JW, 2013, BBA-BIOENERGETICS, V1827, P136, DOI 10.1016/j.bbabio.2012.10.002; Cheng Q, 2005, BIOCHEM BIOPH RES CO, V329, P966, DOI 10.1016/j.bbrc.2005.02.064; Chew AGM, 2007, J BIOL CHEM, V282, P2967, DOI 10.1074/jbc.M609730200; Chistoserdova L, 2011, ENVIRON MICROBIOL, V13, P2603, DOI 10.1111/j.1462-2920.2011.02464.x; Crockford PW, 2018, NATURE, V559, P613, DOI 10.1038/s41586-018-0349-y; Doolittle R. F., 1986, URFS ORFS PRIMER ANA; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; FENCHEL T, 1971, OIKOS, V22, P172, DOI 10.2307/3543723; Gan F, 2014, SCIENCE, V345, P1312, DOI 10.1126/science.1256963; Gibson TM, 2018, GEOLOGY, V46, P135, DOI 10.1130/G39829.1; GRANICK S., 1965, P67; Gumsley AP, 2017, P NATL ACAD SCI USA, V114, P1811, DOI 10.1073/pnas.1608824114; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Hao J., 2020, GEOCHIM COSMOCHIM AC; Ho MY, 2016, SCIENCE, V353, DOI 10.1126/science.aaf9178; Hodgskiss MSW, 2019, P NATL ACAD SCI USA, V116, P17207, DOI 10.1073/pnas.1900325116; Holland-Moritz H, 2018, ENVIRON MICROBIOL, V20, P2625, DOI 10.1111/1462-2920.14288; Hug LA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.48, 10.1038/nmicrobiol.2016.48]; Igarashi N, 2001, J MOL EVOL, V52, P333, DOI 10.1007/s002390010163; Imhoff JF, 2014, PROKARYOTES OTHER MA, V4th, P501; Johnson JE, 2014, GEOL SOC AM BULL, V126, P813, DOI 10.1130/B30949.1; Johnson JE, 2013, P NATL ACAD SCI USA, V110, P11238, DOI 10.1073/pnas.1305530110; Kaschner M, 2014, MOL MICROBIOL, V93, P1066, DOI 10.1111/mmi.12719; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; KIMBLE LK, 1995, ARCH MICROBIOL, V163, P259, DOI 10.1007/BF00393378; Klatt CG, 2011, ISME J, V5, P1262, DOI 10.1038/ismej.2011.73; Larkum AWD, 2018, PHOTOSYNTHETICA, V56, P11, DOI 10.1007/s11099-018-0792-x; LaRoche J, 1996, P NATL ACAD SCI USA, V93, P15244; Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; Louca S, 2018, NAT ECOL EVOL, V2, P1458, DOI 10.1038/s41559-018-0625-0; MADIGAN MT, 1995, ANOXYGENIC PHOTOSYNT, P17, DOI DOI 10.1007/0-306-47954-0_2; Magnabosco C, 2018, GEOBIOLOGY, V16, P179, DOI 10.1111/gbi.12273; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; MEYER TE, 1986, P NATL ACAD SCI USA, V83, P217, DOI 10.1073/pnas.83.2.217; Nagashima S, 2013, ADV BOT RES, V66, P151, DOI 10.1016/B978-0-12-397923-0.00005-9; NORELL MA, 1993, AM J SCI, V293A, P407, DOI 10.2475/ajs.293.A.407; Norell Mark A., 1992, P89; Orf GS, 2018, PHOTOSYNTH RES, V138, P11, DOI 10.1007/s11120-018-0503-2; Ozaki K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10872-z; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; PIERSON B, 1987, FEMS MICROBIOL ECOL, V45, P365, DOI 10.1111/j.1574-6968.1987.tb02412.x; Raven JA, 2009, AQUAT MICROB ECOL, V56, P177, DOI 10.3354/ame01315; Reyes-Prieto A, 2006, CURR BIOL, V16, P2320, DOI 10.1016/j.cub.2006.09.063; Schirrmeister BE, 2013, P NATL ACAD SCI USA, V110, P1791, DOI 10.1073/pnas.1209927110; Shih PM, 2017, GEOBIOLOGY, V15, P19, DOI 10.1111/gbi.12200; Shih PM, 2017, P NATL ACAD SCI USA, V114, P10749, DOI 10.1073/pnas.1710798114; Shih PM, 2013, P NATL ACAD SCI USA, V110, P12355, DOI 10.1073/pnas.1305813110; Shih PM, 2013, P NATL ACAD SCI USA, V110, P1053, DOI 10.1073/pnas.1217107110; Sleep NH, 2007, GEOBIOLOGY, V5, P101, DOI 10.1111/j.1472-4669.2007.00105.x; Sousa FL, 2013, GENOME BIOL EVOL, V5, P200, DOI 10.1093/gbe/evs127; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Swithers Kristen S, 2012, Int J Evol Biol, V2012, P418964, DOI 10.1155/2012/418964; Tank M., 2017, MODERN TOPICS PHOTOT, P87, DOI [10.1007/978-3-319-46261-5_3, DOI 10.1007/978-3-319-46261-5_3]; Tice MM, 2006, GEOLOGY, V34, P37, DOI 10.1130/G22012.1; Tice MM, 2004, NATURE, V431, P549, DOI 10.1038/nature02888; Trembath-Reichert E, 2016, J SEDIMENT RES, V86, P629, DOI 10.2110/jsr.2016.40; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; Ward L.M., 2019, GENOMIC EVIDENCE PHO; Ward LM, 2020, ENVIRON MICROBIOME, V15, DOI 10.1186/s40793-020-00357-8; Ward LM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01658; Ward LM, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.00821-17; Ward LM, 2019, J GEOPHYS RES-BIOGEO, V124, P211, DOI 10.1029/2018JG004679; Ward LM, 2019, FREE RADICAL BIO MED, V140, P188, DOI 10.1016/j.freeradbiomed.2019.01.049; Ward LM, 2018, BIOINFORMATICS, V34, P4284, DOI 10.1093/bioinformatics/bty510; Ward LM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00260; Ward LM, 2016, ORIGINS LIFE EVOL B, V46, P51, DOI 10.1007/s11084-015-9460-3; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiong J, 2000, SCIENCE, V289, P1724, DOI 10.1126/science.289.5485.1724; Yamazaki S, 2006, PLANT PHYSIOL, V142, P911, DOI 10.1104/pp.106.086090; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075; Zeng YH, 2014, P NATL ACAD SCI USA, V111, P7795, DOI 10.1073/pnas.1400295111	87	7	7	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0239248	10.1371/journal.pone.0239248	http://dx.doi.org/10.1371/journal.pone.0239248			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507911	Green Submitted, Green Published, gold			2022-12-26	WOS:000635021400005
J	Zhou, CY; Cui, GJ; Yin, H; Yu, L; Xu, GK; Liu, Z; Zhang, LH				Zhou, Cuiying; Cui, Guangjun; Yin, Hao; Yu, Lei; Xu, Gankai; Liu, Zhen; Zhang, Lihai			Study of soil expansion characteristics in rainfall-induced red-bed shallow landslides: Microscopic and macroscopic perspectives	PLOS ONE			English	Article							HYDRATION; MODEL; DEGRADATION; BENTONITE; MECHANISM; CLAYS	The main cause of rainfall-induced red-bed shallow landslides is the tendency of red-bed weathered soil to expand when it meets water. However, studies on the expansion mechanism of expansive soil have not considered the effects of hydration and particle orientation. In this study, the hydration force of soil was determined according to the electric double-layer theory, the particle direction of soil was determined by analyzing images of soil obtained by scanning electron microscopy, and, finally, a microscopic model of the electrical double layer of red-bed weathered expansive soil was established in which the hydration force and soil-particle orientation were taken into account. The results showed that the expansion of red-bed weathered expansive soil is the result of hydration forces and repulsive forces in the electric double layer. The grain orientation of the soil strongly influenced the microscopic model. The unloading expansion rate of red-bed weathered expansive soil decreased with an increase in cation concentration and a decrease in pH value. It increased with an increase in the hydration cation radius. These experiments indicate the reliability of the microscopic model and provide a theoretical basis for the prevention and control of rainfall-induced red-bed shallow landslides.	[Zhou, Cuiying; Cui, Guangjun; Yin, Hao; Yu, Lei; Xu, Gankai; Liu, Zhen] Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Guangdong, Peoples R China; [Zhou, Cuiying; Cui, Guangjun; Yin, Hao; Yu, Lei; Liu, Zhen] Sun Yat Sen Univ, Guangdong Engn Res Ctr Major Infrastruct Safety, Guangzhou, Guangdong, Peoples R China; [Zhang, Lihai] Univ Melbourne, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; University of Melbourne	Liu, Z (corresponding author), Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Guangdong, Peoples R China.; Liu, Z (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Major Infrastruct Safety, Guangzhou, Guangdong, Peoples R China.	liuzh8@mail.sysu.edu.cn	Zhang, Lihai/F-6823-2014	Zhang, Lihai/0000-0002-1282-992X	Ministry of Science and Technology of The people's Republic of China [2017YFC1501203, 2017YFC1501201]; National Natural Science Foundation of China [41530638, 41977230]; Guangdong Science and Technology Department [2015B090925016, 2016B010124007]	Ministry of Science and Technology of The people's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department	This research was funded by Ministry of Science and Technology of The people ' s Republic of China (http://www.most.gov.cn/), grant numbers 2017YFC1501203 and 2017YFC1501201; National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant numbers 41530638 and 41977230; and Guangdong Science and Technology Department (http://gdstc.gd.gov.cn/), grant numbers 2015B090925016 and 2016B010124007.The authors who received each award is C.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HR, 2018, GEOMECH GEOENGIN, V13, P115, DOI 10.1080/17486025.2018.1434240; Alonso EE, 1999, ENG GEOL, V54, P173, DOI 10.1016/S0013-7952(99)00079-4; Cao FZ, 2018, CONSTR BUILD MATER, V183, P234, DOI 10.1016/j.conbuildmat.2018.06.164; Dai SB, 2005, J WUHAN UNIV TECHNOL, V20, P109; Du JP, 2020, J PHYS CHEM C, V124, P14672, DOI 10.1021/acs.jpcc.0c03376; El Yaakoubi A, 2014, MATEC WEB CONF, V11, DOI 10.1051/matecconf/20141102011; Erguler ZA, 2009, INT J ROCK MECH MIN, V46, P355, DOI 10.1016/j.ijrmms.2008.07.002; Fan XM, 2017, ENG GEOL, V228, P337, DOI 10.1016/j.enggeo.2017.09.003; Feng D, 2018, APPL CLAY SCI, V155, P126, DOI 10.1016/j.clay.2018.01.017; Gan FL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196657; Gimmi T, 2019, APPL CLAY SCI, V175, P169, DOI 10.1016/j.clay.2019.03.035; Hu W, 2018, ENG GEOL, V237, P1, DOI 10.1016/j.enggeo.2018.02.005; Jiang NJ, 2016, CAN GEOTECH J, V53, P373, DOI 10.1139/cgj-2015-0245; Kamal MS, 2019, J PET EXPLOR PROD TE, V9, P593, DOI 10.1007/s13202-018-0507-7; Li H, 2018, INT J ROCK MECH MIN, V110, P257, DOI 10.1016/j.ijrmms.2018.07.011; Li Y, 2011, ADV MATER RES-SWITZ, V148-149, P7, DOI 10.4028/www.scientific.net/AMR.148-149.7; Lin BT, 2012, B ENG GEOL ENVIRON, V71, P71, DOI 10.1007/s10064-011-0410-7; Liu Z, 2020, ACTA GEOTECH, V15, P1219, DOI 10.1007/s11440-019-00823-9; Navarro V, 2014, ENG GEOL, V181, P190, DOI 10.1016/j.enggeo.2014.07.014; Paunov VN, 2001, J COLLOID INTERF SCI, V240, P640, DOI 10.1006/jcis.2001.7671; Puppala AJ, 2017, J ENG MECH, V143, DOI 10.1061/(ASCE)EM.1943-7889.0001292; Rahromostaqim M, 2019, J PHYS CHEM C, V123, P4243, DOI 10.1021/acs.jpcc.8b11589; Ruckenstein E, 2002, LANGMUIR, V18, P7584, DOI 10.1021/la020435v; Sanchez M, 2005, INT J NUMER ANAL MET, V29, P751, DOI 10.1002/nag.434; Sheng DC, 2008, COMPUT GEOTECH, V35, P810, DOI 10.1016/j.compgeo.2008.08.011; Tang R, 2020, COLD REG SCI TECHNOL, V170, DOI 10.1016/j.coldregions.2019.102943; Tuller M, 2003, J HYDROL, V272, P50, DOI 10.1016/S0022-1694(02)00254-8; Valle-Delgado JJ, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1954747; Xu YF, 2003, APPL CLAY SCI, V22, P197, DOI 10.1016/S0169-1317(02)00159-X; Yin ZY, 2017, ACTA GEOTECH, V12, P1395, DOI 10.1007/s11440-017-0556-y; Zhou CY, 2020, INT J GEOMECH, V20, DOI 10.1061/(ASCE)GM.1943-5622.0001774; Zhou MM, 2018, ACTA GEOTECH, V13, P175, DOI 10.1007/s11440-017-0538-0; Zhou SQ, 2019, J MOL LIQ, V273, P155, DOI 10.1016/j.molliq.2018.09.138	33	0	0	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246214	10.1371/journal.pone.0246214	http://dx.doi.org/10.1371/journal.pone.0246214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508022	gold, Green Published			2022-12-26	WOS:000635021400110
J	Prayitno, A; Supriyatno, B; Munasir, Z; Karuniawati, A; Hadinegoro, SRS; Prihartono, J; Safari, D; Sundoro, J; Khoeri, MM				Prayitno, Ari; Supriyatno, Bambang; Munasir, Zakiudin; Karuniawati, Anis; Hadinegoro, Sri Rezeki S.; Prihartono, Joedo; Safari, Dodi; Sundoro, Julitasari; Khoeri, Miftahuddin Majid			Pneumococcal nasopharyngeal carriage in Indonesia infants and toddlers post-PCV13 vaccination in a 2+1 schedule: A prospective cohort study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; CHILDREN; DISEASE; SEROTYPES; ACQUISITION	Background The PCV13 immunization demonstration program began in October 2017 in Indonesia. The aim of this study is to assess the dynamic changes of pneumococcal serotype before and after PCV13 administration, with two primary and one booster doses. Methods The prospective cohort study was conducted as a follow up study measuring the impact of PCV13 demonstration program by the Indonesian Ministry of Health in Lombok Island, West Nusa Tenggara, Indonesia, from March 2018 to June 2019. The subjects were two-month-old healthy infants who were brought to the primary care facility for routine vaccination and followed until 18 months of age. We use convenience sampling method. There were 115 infants in the control group and 118 infants in the vaccine group, and the PCV immunization was given on a 2+1 schedule. Nasopharyngeal (NP) swabs were collected four times during the vaccination periods by trained medical staff. Specimens were analyzed by culture methods to detect S. pneumonia colonization and multiplex polymerase chain reaction (mPCR) to determine serotype. The most frequently detected serotypes will be named as dominant serotypes. Descriptive analysis of demographic characteristics, the prevalence of overall and serotype colonization, and the distribution of serotypes were performed. The prevalence of both cohort groups were compared using chi-square test. Statistical significance was set at p < 0.05. Results Two hundred and thirty three infants age two months old were recruited, with 48.9% of the subjects were male and 51.1% of the subjects were female. Sociodemographic data in both cohort groups were relatively equal. Nasopharyngeal pneumococcal colonization before PCV13 administration occurred in 19.1% of the control and 22.9% of the vaccine group. The prevalence increased with increasing age in both groups. The prevalence of VT serotypes in control groups aged 2 months, 4 months, 12 months, and 18 months was 40.9%, 44.2%, 53.8%, and 54.3%, respectively, and in the vaccine group, 25.9%, 40.4%, 38.0%, and 22.6%, respectively. The most common VT serotypes in both groups were 6A/6B, 19F, 23F, and 14. The prevalence of VT serotypes decreased significantly compared to non-vaccine type serotypes after three doses of the PCV13 vaccine (p < 0.001). Another notable change was the decline in prevalence of serotype 6A/6B after PCV13 administration using the 2+1 schedule. Conclusions This study shows lower prevalence of VT and 6A/6B serotypes in the nasopharynx among children who were PCV13 vaccinated compared with those who were unvaccinated. The result from this study will be the beginning of future vaccine evaluation in larger population and longer period of study.	[Prayitno, Ari; Supriyatno, Bambang; Munasir, Zakiudin; Hadinegoro, Sri Rezeki S.] Univ Indonesia, Dept Pediat, Cipto Mangunkusumo Hosp, Fac Med, Jakarta, Indonesia; [Karuniawati, Anis] Univ Indonesia, Dept Microbiol, Fac Med, Jakarta, Indonesia; [Prihartono, Joedo] Univ Indonesia, Dept Community Med, Fac Med, Jakarta, Indonesia; [Safari, Dodi; Khoeri, Miftahuddin Majid] Eijkman Inst Mol Biol, Mol Bacteriol, Jakarta, Indonesia; [Sundoro, Julitasari] Indonesian Tech Advisory Grp Immunizat, Jakarta, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; Eijkman Institute	Prayitno, A (corresponding author), Univ Indonesia, Dept Pediat, Cipto Mangunkusumo Hosp, Fac Med, Jakarta, Indonesia.	ariprayitno@yahoo.com		Khoeri, Miftahuddin Majid/0000-0002-8862-6707; prayitno, ari/0000-0001-9107-239X				Abdullahi O, 2012, J INFECT DIS, V206, P1020, DOI 10.1093/infdis/jis447; Adebanjo T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199363; Budijanto D, 2016, PROF KES IND 2015; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Choi YH, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002845; Cohen C, 2017, LANCET GLOB HEALTH, V5, pE359, DOI 10.1016/S2214-109X(17)30043-8; Cohen O, 2017, PNEUMOCOCCAL CONJUGA; Dagan R, 2016, VACCINE, V34, P4313, DOI 10.1016/j.vaccine.2016.06.075; Ercan TE, 2011, PEDIATR INT, V53, P224, DOI 10.1111/j.1442-200X.2010.03212.x; Fadlyana E, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0058-1; Flasche S, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001839; Gentile A, 2012, INT J INFECT DIS, V16, pE5, DOI 10.1016/j.ijid.2011.09.013; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; Hadinegoro SR, 2016, SE ASIAN J TROP MED, V47, P485; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Heinsbroek E, 2018, VACCINE, V36, P7369, DOI 10.1016/j.vaccine.2018.10.021; Kartasasmita C, 2006, PAEDIATR RESPIR REV, V7, pS323; Kisakye A, 2009, CLIN INFECT DIS, V48, pS153, DOI 10.1086/596495; McAllister DA, 2019, LANCET GLOB HEALTH, V7, pE47, DOI 10.1016/S2214-109X(18)30408-X; Murad C, 2019, INT J INFECT DIS, V86, P73, DOI 10.1016/j.ijid.2019.06.024; Navne JE, 2017, INT J CIRCUMPOL HEAL, V76, DOI 10.1080/22423982.2017.1309504; Nie ZZ, 2014, FOREIGN LIT STUD, V36, P8; Nurhonen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056079; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Safari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110526; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Sime WT, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4024-1; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Song JY, 2013, J KOREAN MED SCI, V28, P4, DOI 10.3346/jkms.2013.28.1.4; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Wardlaw TM, 2006, PNEUMONIA FORGOTTEN; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093	35	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245789	10.1371/journal.pone.0245789	http://dx.doi.org/10.1371/journal.pone.0245789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497405	Green Published, gold			2022-12-26	WOS:000613707100022
J	Kurkov, A; Guller, A; Fayzullin, A; Fayzullina, N; Plyakin, V; Kotova, S; Timashev, P; Frolova, A; Kurtak, N; Paukov, V; Shekhter, A				Kurkov, Alexandr; Guller, Anna; Fayzullin, Alexey; Fayzullina, Nafisa; Plyakin, Vladimir; Kotova, Svetlana; Timashev, Petr; Frolova, Anastasia; Kurtak, Nikita; Paukov, Vyacheslav; Shekhter, Anatoly			Amianthoid transformation of costal cartilage matrix in children with pectus excavatum and pectus carinatum	PLOS ONE			English	Article							KEELED CHEST; COLLAGEN; FIBERS; RAVITCH; REPAIR; NUSS	Background It is unclear if amianthoid transformation (AT) of costal cartilage extracellular matrix (ECM) has an impact on the development of pectus excavatum (PE) and pectus carinatum (PC). Methods AT foci were examined in intrasurgical biopsy specimens of costal cartilages of children (8-17 years old) with PE (n = 12) and PC (n = 12) and in age-matching autopsy control samples (n = 10) using histological and immunohistochemical staining, atomic force and nonlinear optical microscopy, transmission and scanning electron microscopy, morphometry and statistics. Results AT areas were identified in the costal cartilage ECM in children with normal chest, PE and PC. Each type of the AT areas ("canonical", "intertwined", "fine-fibred" and "intralacunary") had a unique morphological pattern of thickness and alignment of amianthoid fibers (AFs). AFs were formed via lateral aggregation of collagen type II fibrils in the intact ECM. Foci of the AT were observed significantly more frequently in the PE and PC groups. The AT areas had unique quantitative features in each study group. Conclusion AT is a structurally diverse form of ECM alteration present in healthy and pathological costal cartilage. PE and PC are associated with specific AT disorders.	[Kurkov, Alexandr; Guller, Anna; Fayzullin, Alexey; Kotova, Svetlana; Timashev, Petr; Frolova, Anastasia; Shekhter, Anatoly] Sechenov First Moscow State Med Univ, Inst Regenerat Med, Moscow, Russia; [Kurkov, Alexandr; Paukov, Vyacheslav] Sechenov First Moscow State Med Univ, AI Strukov Dept Anat Pathol, Moscow, Russia; [Guller, Anna] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Fayzullin, Alexey; Timashev, Petr] Sechenov First Moscow State Med Univ, World Class Res Ctr Digital Biodesign & Personali, Moscow, Russia; [Fayzullina, Nafisa] Minist Healthcare Russian Federat, Natl Med Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia; [Plyakin, Vladimir] Clin & Res Inst Emergency Pediat Surg & Traumatol, Moscow, Russia; [Kotova, Svetlana; Timashev, Petr] NN Semenov Inst Chem Phys, Dept Polymers & Composites, Moscow, Russia; [Timashev, Petr] Lomonosov Moscow State Univ, Chem Dept, Moscow, Russia; [Kurtak, Nikita] Minist Hlth Russian Federat, FSBI Academician VI Shumakov Fed Res Ctr Transpla, Moscow, Russia	Sechenov First Moscow State Medical University; Sechenov First Moscow State Medical University; University of New South Wales Sydney; Sechenov First Moscow State Medical University; Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Russian Academy of Sciences; N.N. Semenov Federal Research Centre for Chemical Physics, Russian Academy of Sciences; Lomonosov Moscow State University; Ministry of Health of the Russian Federation	Fayzullin, A (corresponding author), Sechenov First Moscow State Med Univ, Inst Regenerat Med, Moscow, Russia.; Fayzullin, A (corresponding author), Sechenov First Moscow State Med Univ, World Class Res Ctr Digital Biodesign & Personali, Moscow, Russia.	a.l.fayzullin@gmail.com	Frolova, Anastasia/T-5372-2017; Fayzullin, Alexey/HDM-9231-2022; Guller, Anna E./E-9143-2012	Frolova, Anastasia/0000-0003-1073-2611; Guller, Anna E./0000-0002-8866-9838; Kurkov, Alexandr/0000-0002-6258-3067	Ministry of Science and Higher education of Russian Federation [075-15-2020-926]	Ministry of Science and Higher education of Russian Federation	This work was supported by the Ministry of Science and Higher education of Russian Federation to AF and PT within the framework of state support for the creation and development of World-Class Research Centers "Digital biodesign and personalized healthcare" (N. 075-15-2020-926).	Bardakhch'ian E., 2001, ARK PATOL, V64, P40; Bhatnagar Veereshwar, 2019, J Indian Assoc Pediatr Surg, V24, P252, DOI 10.4103/jiaps.JIAPS_68_18; CLAASSEN H, 1995, CELL TISSUE RES, V280, P349, DOI 10.1007/BF00307807; Cobben JM, 2014, EUR J MED GENET, V57, P414, DOI 10.1016/j.ejmg.2014.04.017; Coelho Marlos de Souza, 2007, J. bras. pneumol., V33, P463, DOI 10.1590/S1806-37132007000400017; Creswick HA, 2006, J PEDIATR SURG, V41, P1699, DOI 10.1016/j.jpedsurg.2006.05.071; DEARDEN LC, 1978, CELL TISSUE RES, V189, P67; Desmarais TJ, 2013, CURR OPIN PEDIATR, V25, P375, DOI 10.1097/MOP.0b013e3283604088; Emil S, 2018, EUR J PEDIATR SURG, V28, P347, DOI 10.1055/s-0038-1667297; Eyden B, 2001, MICRON, V32, P287, DOI 10.1016/S0968-4328(00)00045-7; Fokin AA, 2009, SEMINARS THORACIC CA; GHADIALLY FN, 1979, VIRCHOWS ARCH B, V31, P81, DOI 10.1007/BF02889926; GHADIALLY FN, 1980, J PATHOL, V130, P147, DOI 10.1002/path.1711300302; Gottardi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163552; Hass GM, 1943, ARCH PATHOL, V35, P275; HOUGH AJ, 1973, AM J PATHOL, V73, P201; HUKINS DWL, 1976, SCIENCE, V194, P622, DOI 10.1126/science.982030; Jablonska S, 2000, PEDIATR DERMATOL, V17, P105, DOI 10.1046/j.1525-1470.2000.01724.x; Kanagaratnam A, 2016, ANN CARDIOTHORAC SUR, V5, P409, DOI 10.21037/acs.2016.08.06; Kelly RE, 2018, SEMIN PEDIATR SURG, V27, P170, DOI 10.1053/j.sempedsurg.2018.05.003; Kuehnel W, 2003, HISTOLOGY MICROSCOPI; Kurkov A. V, 2018, Arkhiv Patologii, V80, P8, DOI 10.17116/patol2018800518; Kurkov A. V., 2017, Arkhiv Patologii, V79, P57, DOI 10.17116/patol201779557-62; Kurkov A. V., 2016, Arkhiv Patologii, V78, P30, DOI 10.17116/patol201678630-37; LIPPIELLO L, 1977, J CLIN INVEST, V59, P593, DOI 10.1172/JCI108676; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; MALLINGER R, 1988, AM J ANAT, V181, P23, DOI 10.1002/aja.1001810104; Mao YZ, 2017, J PEDIATR SURG, V52, P1545, DOI 10.1016/j.jpedsurg.2017.05.028; McHam B, 2019, PECTUS CARINATUM PIG, DOI [10.1016/j.biortech.2018.11.078, DOI 10.1016/J.BI0RTECH.2018.11.078]; Nsour E, 2019, INT J SURG CASE REP, V64, P72, DOI 10.1016/j.ijscr.2019.09.042; Rejtarova O, 2009, FORENSIC SCI INT, V193, P72, DOI 10.1016/j.forsciint.2009.09.009; Scarci Marco, 2016, J Vis Surg, V2, P50, DOI 10.21037/jovs.2016.02.15; Sharma G, 2019, STATPEARLS	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245159	10.1371/journal.pone.0245159	http://dx.doi.org/10.1371/journal.pone.0245159			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493174	gold, Green Published			2022-12-26	WOS:000613081500051
J	Qi, F; Xu, ZS; Zhang, H; Wang, R; Wang, YN; Jia, XR; Lin, P; Geng, MY; Huang, YQ; Li, SP; Yang, J				Qi, Fei; Xu, Zhenshi; Zhang, Hua; Wang, Rui; Wang, Yani; Jia, Xiaorong; Lin, Peng; Geng, Meiyun; Huang, Yiqing; Li, Shanpeng; Yang, Jun			Predicting the mortality of smoking attributable to cancer in Qingdao, China: A time-series analysis	PLOS ONE			English	Article							TOBACCO CONTROL; TRENDS	Smoking is the leading preventable cause of death and disability from cancer in China. To provide a scientific basis for tobacco control strategies and measures, this study investigated cancer deaths attributed to smoking from 2005 to 2017 and predicted mortality trends from 2018 to 2020 in Qingdao. We used time series analysis to evaluate the number of deaths attributed to smoking among residents over 35 years old in Qingdao and predicted mortality trends. The number of cancer deaths attributed to smoking in Qingdao from 2005 to 2016 was between 170 and 407, showing an upward trend and a certain periodicity. The best model is the ARIMA (2,1,0)x(3,1,0)(12), with the lowest BIC (6.640) and the highest stationary R-2 (0.500). The predicted cancer deaths curve attributed to smoking in 2017 is consistent with the actual curve, with an average relative error of 5.74%. Applying this model to further predict the number of cancer deaths attributed to smoking in Qingdao from January 2018 to December 2020, the predicted results were 5,249, 5,423 and 6,048, respectively. The findings emphasized the need to further strengthen tobacco control measures to reduce the burden of disease caused by tobacco.	[Qi, Fei; Zhang, Hua; Wang, Rui; Wang, Yani; Jia, Xiaorong; Lin, Peng; Geng, Meiyun; Li, Shanpeng] Qingdao Municipal Ctr Dis Control & Prevent, Qingdao, Shandong, Peoples R China; [Xu, Zhenshi] Qingdao Mental Hlth Ctr, Qingdao, Shandong, Peoples R China; [Huang, Yiqing] Qingdao Univ, Med Coll, Qingdao, Shandong, Peoples R China; [Yang, Jun] Qingdao Municipal Hlth Commiss, Qingdao, Shandong, Peoples R China	Qingdao University	Li, SP (corresponding author), Qingdao Municipal Ctr Dis Control & Prevent, Qingdao, Shandong, Peoples R China.; Yang, J (corresponding author), Qingdao Municipal Hlth Commiss, Qingdao, Shandong, Peoples R China.	lspeng@163.com; 18505321196@126.com		Xu, Zhenshi/0000-0002-0259-5250	International Union Against Tuberculosis and Lung Disease [CHINA-22-01]; Shandong Medical and Health Technology Development Plan [2018WS254]	International Union Against Tuberculosis and Lung Disease; Shandong Medical and Health Technology Development Plan	This project has received funding from the International Union Against Tuberculosis and Lung Disease(CHINA-22-01), and Shandong Medical and Health Technology Development Plan (2018WS254). Shanpeng Li, Fei Qi, Zhenshi Xu, Rui Wang, Yani Wang, Xiaorong Jia, Peng Lin, Meiyun Geng received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Box GE, 1976, TIME SERIES ANAL FOR, V2nd; Chen LS, 2018, J FORMOS MED ASSOC, V117, P3, DOI 10.1016/j.jfma.2017.05.003; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Feliu A, 2019, TOB CONTROL, V28, P101, DOI 10.1136/tobaccocontrol-2017-054119; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Jeon J, 2018, ANN INTERN MED, V169, P684, DOI [10.7326/M18-1250, 10.7326/m18-1250]; Kuipers MAG, 2014, ADDICTION, V109, P1750, DOI 10.1111/add.12637; Lee YO, 2014, PREV MED, V62, P14, DOI 10.1016/j.ypmed.2014.01.014; Lee YO, 2015, PEDIATRICS, V135, P409, DOI 10.1542/peds.2014-3202; Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5; Liang X, 2016, GLOBAL TIMES 0919; Liang XF, 2015, REPORT CHINA CITY AD; Lortet-Tieulent J, 2016, JAMA INTERN MED, V176, P1792, DOI 10.1001/jamainternmed.2016.6530; National Bureau of Statistics of China, 2010, CHIN STAT YB 2010; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Qi F, 2016, Zhonghua Yu Fang Yi Xue Za Zhi, V50, P652, DOI 10.3760/cma.j.issn.0253-9624.2016.07.017; Qi F, 2016, CHINESE J PREVENTIVE, V07, P652; [綦斐 Qi Fei], 2018, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V22, P354; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Wang JB, 2010, CANCER CAUSE CONTROL, V21, P959, DOI 10.1007/s10552-010-9523-8; Wang SY, 2011, HLTH HARMONIOUS LIFE; World Health Organization, 2017, BILL CHIN CANN AFF H; Xu ZS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204221; Yang G, 2018, TOBACCO CONTROL CHIN; Yang GH, 2015, LANCET, V385, P1019, DOI 10.1016/S0140-6736(15)60174-X; Yang J, 2015, SURVEY REPORT ENFCOR; Yang TZ, 2011, HEALTH PLACE, V17, P954, DOI 10.1016/j.healthplace.2011.04.003	27	1	1	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245769	10.1371/journal.pone.0245769	http://dx.doi.org/10.1371/journal.pone.0245769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493221	gold, Green Published			2022-12-26	WOS:000613081500003
J	Shiina, A; Niitsu, T; Iyo, M				Shiina, Akihiro; Niitsu, Tomihisa; Iyo, Masaomi			Need for self-medication using over-the-counter psychoactive agents: A national survey in Japan	PLOS ONE			English	Article							COMMUNITY	Self-medication using over-the-counter (OTC) drugs is an option for the autonomous treatment of several health problems. However, the use of OTC drugs to treat psychiatric conditions remains controversial. To clarify opinions regarding the use of OTC drugs to treat psychiatric problems, we conducted an anonymous online survey of 3000 people in Japan. Participants were stratified into three groups according to their history of mental health problems. Few participants had engaged in self-medication using OTC drugs for psychiatric symptoms, with the exception of insomnia. Participants who had used OTC drugs reported feeling less satisfied with their experience compared with those who had consulted a specialist. Participants who had used sleeping pills were likely to hold relatively positive opinions regarding the use of OTC psychiatric drugs. In conclusion, the need for self-medication of psychiatric symptoms appears to be limited. Education and further research may be necessary to promote self-medication for proper treatment of psychiatric conditions in Japan.	[Shiina, Akihiro] Chiba Univ, Ctr Forens Mental Hlth, Div Med Care & Treatment, Chiba, Japan; [Niitsu, Tomihisa; Iyo, Masaomi] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Japan	Chiba University; Chiba University	Shiina, A (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Med Care & Treatment, Chiba, Japan.	shiina-akihiro@faculty.chiba-u.jp	Shiina, Akihiro/E-8450-2011	Shiina, Akihiro/0000-0003-0158-3941	public interest OTC drug self-medication promotion foundation	public interest OTC drug self-medication promotion foundation	This work was supported by the public interest OTC drug self-medication promotion foundation (http://www.otc-spf.jp/) in Japan. We have no other conflicts of interest to report regarding this study.	Apaydin EA, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0325-2; Chung KF, 2002, GEN HOSP PSYCHIAT, V24, P430, DOI 10.1016/S0163-8343(02)00210-4; Hallahan B, 2016, BRIT J PSYCHIAT, V209, P192, DOI 10.1192/bjp.bp.114.160242; Johnson EO, 1998, SLEEP, V21, P178, DOI 10.1093/sleep/21.2.178; Kamijo Y, 2018, INTERNAL MED, V57, P2141, DOI 10.2169/internalmedicine.0333-17; Kawamura K, 2013, YAKUGAKU ZASSHI, V133, P631, DOI 10.1248/yakushi.13-00056-3; Khan M M, 1998, J Pak Med Assoc, V48, P293; Klose M, 2004, Arch Womens Ment Health, V7, P133, DOI 10.1007/s00737-004-0047-7; Matsumoto T, 2020, CHIRYO, V102, P328; Nishida A, 2008, SCHIZOPHR RES, V99, P125, DOI 10.1016/j.schres.2007.11.038; Ohayon MM, 1998, J CLIN EPIDEMIOL, V51, P273, DOI 10.1016/S0895-4356(97)00238-2; Orriols L, 2009, DRUG SAFETY, V32, P859, DOI 10.2165/11316590-000000000-00000; Parker GB, 2017, J AFFECT DISORDERS, V208, P56, DOI 10.1016/j.jad.2016.08.082; Patel V, 2018, LANCET, V392, P1553, DOI 10.1016/S0140-6736(18)31612-X; Saraceno B., 2009, NEW OXFORD TXB PSYCH, V1, P10; Stoehr GP, 1997, J AM GERIATR SOC, V45, P158, DOI 10.1111/j.1532-5415.1997.tb04501.x; Trautmann S, 2016, EMBO REP, V17, P1245, DOI 10.15252/embr.201642951; van Rijswijk E, 2000, GEN HOSP PSYCHIAT, V22, P236, DOI 10.1016/S0163-8343(00)00078-5; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	19	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245866	10.1371/journal.pone.0245866	http://dx.doi.org/10.1371/journal.pone.0245866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ9QF	33493194	Green Published, gold			2022-12-26	WOS:000613081500033
J	Takehana, S; Murata, Y; Jo, J; Tabata, Y				Takehana, Sho; Murata, Yuki; Jo, Jun-ichiro; Tabata, Yasuhiko			Complexation design of cationized gelatin and molecular beacon to visualize intracellular mRNA	PLOS ONE			English	Article							SMALL INTERFERING RNA; TRANSFECTION EFFICIENCY; PLASMID DNA; NANOCHANNEL ELECTROPORATION; GENE-TRANSFER; IN-VITRO; CELLS; DELIVERY; CANCER; NANOCLUSTERS	The objective of this study is to prepare cationized gelatin-molecular beacon (MB) complexes for the visualization of intracellular messenger RNA (mRNA). The complexes were prepared from cationized gelatins with different extents of cationization and different mixing ratios of MB to cationized gelatin. The apparent size of complexes was almost similar, while the zeta potential was different among the complexes. Irrespective of the preparation conditions, the complexes had a sequence specificity against the target oligonucleotides in hybridization. The cytotoxicity and the amount of complexes internalized into cells increased with an increase in the cationization extent and the concentration of cationized gelatin. After the incubation with complexes prepared from cationized gelatin with the highest extent of cationization and at mixing ratios of 10 and 20 pmole MB/mu g cationized gelatin, a high fluorescent intensity was detected. On the other hand, the complex prepared with the mixing ratio at 20 pmole/mu g did not show any cytotoxicity. The complex was the most effective to visualize the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA endogenously present. In addition, even for enhanced green fluorescent protein (EGFP) mRNA exogenously transfected, the complex permitted to effectively detect it as well. It is concluded that both the endogenous and exogenous mRNA can be visualized in living cells by use of cationized gelatin-MB complexes designed.	[Takehana, Sho; Murata, Yuki; Jo, Jun-ichiro; Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Biomat, Kyoto, Japan	Kyoto University	Tabata, Y (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Lab Biomat, Kyoto, Japan.	yasuhiko@infront.kyoto-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [20H04515, 17H04736]; JSPS [18J21579]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (B) (20H04515 to J.J.), Young Scientists (A) (17H04736 to J.J.), and JSPS Research Fellow (DC1) (18J21579 to Y.M.). There was no additional external funding received for this study.	Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Boukany PE, 2011, NAT NANOTECHNOL, V6, P747, DOI [10.1038/nnano.2011.164, 10.1038/NNANO.2011.164]; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brgles M, 2012, INT J NANOMED, V7, P393, DOI 10.2147/IJN.S27471; Cardarelli F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25879; Catrina IE, 2012, ACS CHEM BIOL, V7, P1586, DOI 10.1021/cb300178a; Chen AK, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm593; Chen AK, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn331; Chen JX, 2018, JOVE-J VIS EXP, DOI 10.3791/57774; Cordeiro RA, 2017, ACTA BIOMATER, V47, P113, DOI 10.1016/j.actbio.2016.10.015; Csobonyeiova M, 2016, CAN J PHYSIOL PHARM, V94, P687, DOI 10.1139/cjpp-2015-0459; di Domenico A, 2019, STEM CELL REP, V12, P213, DOI 10.1016/j.stemcr.2018.12.011; Doss MX, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050403; Gao KL, 2016, MOL THER, V24, P956, DOI 10.1038/mt.2016.6; Halo TL, 2014, P NATL ACAD SCI USA, V111, P17104, DOI 10.1073/pnas.1418637111; Han D, 2018, TALANTA, V181, P24, DOI 10.1016/j.talanta.2017.12.049; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Hu LF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020360; Hu SC, 2017, CHEM SCI, V8, P1021, DOI 10.1039/c6sc03048c; Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5; Jo J, 2010, J BIOMAT SCI-POLYM E, V21, P225, DOI 10.1163/156856209X415549; Jo SM, 2013, BIOSENS BIOELECTRON, V46, P142, DOI 10.1016/j.bios.2013.02.037; Kam Y, 2012, MOL PHARMACEUT, V9, P685, DOI 10.1021/mp200505k; Kim KH, 2015, SMALL, V11, P6215, DOI 10.1002/smll.201502151; Kushibiki T, 2006, J BIOMAT SCI-POLYM E, V17, P645, DOI 10.1163/156856206777346278; Kushibiki T, 2006, J CONTROL RELEASE, V112, P249, DOI 10.1016/j.jconrel.2006.02.003; Li BZ, 2017, ANAL CHEM, V89, P7316, DOI 10.1021/acs.analchem.7b00055; Li N, 2012, ANGEW CHEM INT EDIT, V51, P7426, DOI 10.1002/anie.201203767; Liu W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40125; Maiti B, 2018, ORG BIOMOL CHEM, V16, P1983, DOI 10.1039/c7ob02835k; Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033; Mima H, 2005, J GENE MED, V7, P888, DOI 10.1002/jgm.735; Mohamad NA, 2018, J SCI FOOD AGR, V98, P4570, DOI 10.1002/jsfa.8985; Mohr A, 2018, CANCER LETT, V414, P239, DOI 10.1016/j.canlet.2017.11.025; Murata Y, 2019, TISSUE ENG PT A, V25, P1527, DOI [10.1089/ten.tea.2019.0017, 10.1089/ten.TEA.2019.0017]; Murata Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33231-2; Oshima K, 2004, FASEB J, V18, P212, DOI 10.1096/fj.03-0567fje; Qiu LP, 2013, J AM CHEM SOC, V135, P12952, DOI 10.1021/ja406252w; Saito T, 2012, J DRUG TARGET, V20, P864, DOI 10.3109/1061186X.2012.725170; Shao XR, 2015, CELL PROLIFERAT, V48, P465, DOI 10.1111/cpr.12192; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V300, P464, DOI 10.1016/S0006-291X(02)02807-3; SNYDER SL, 1975, ANAL BIOCHEM, V64, P284, DOI 10.1016/0003-2697(75)90431-5; Spees JL, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0363-7; Takada S, 2018, J ALLERGY CLIN IMMUN, V141, P339, DOI 10.1016/j.jaci.2017.04.013; Tanei T, 2019, ADV SCI, V6, DOI 10.1002/advs.201801479; Thabit QQ, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02389; Thakor D, 2007, MOL THER, V15, P2124, DOI 10.1038/sj.mt.6300256; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; UMEZAWA A, 1992, J CELL PHYSIOL, V151, P197, DOI 10.1002/jcp.1041510125; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; Wiraja C, 2018, SMALL, V14, DOI 10.1002/smll.201703440; Zhang Y, 2012, PHARM RES-DORDR, V29, P1627, DOI 10.1007/s11095-012-0676-x	52	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245899	10.1371/journal.pone.0245899	http://dx.doi.org/10.1371/journal.pone.0245899			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493232	Green Published, gold			2022-12-26	WOS:000613081500013
J	Huang, SC; Ng, KF; Chang, IYF; Chang, CJ; Chao, YC; Chang, SC; Chen, MC; Ta-Sen Yeh; Chen, TC				Huang, Shih-Chiang; Ng, Kwai-Fong; Chang, Ian Yi-Feng; Chang, Chee-Jen; Chao, Yi-Chun; Chang, Shu-Chen; Chen, Min-Chi; Ta-Sen Yeh; Chen, Tse-Ching			The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes	PLOS ONE			English	Article							EXPRESSION; COMPLEXES; ARID1A; CARCINOMAS; ROLES; BRM	The clinicopathological significance of altered SWI/SNF complex has not been well evaluated in gastric cancer (GC). We examined SMARCA2, SMARCA4, SMARCB1 and ARID1A expression by immunohistochemistry in 1224 surgically resected GCs with subtyping into Epstein-Barr virus (EBV), microsatellite instability (MSI) and non-EBV/MSI Lauren histotypes. SWI/SNF mutations were investigated using the GC dataset of the TCGA Pan-Cancer Atlas. Clinicopathological association was assessed by statistical analysis. There were 427 cases (35%) of SWI/SNF-attenuated GC, including 344 SMARCA2 (28%), 28 SMARCA4 (2%), 11 SMARCB1 (1%) and 197 ARID1A (16%) cases. Simultaneous alterations of multiple subunits were observed. Compared to SWI/SNF-retained cases, SWI/ SNF-attenuated GC exhibited a significant predilection to older ages, EBV and MSI genotypes, higher lymphatic invasion and less hematogenous recurrence (P < 0.05). SWI/SNF attenuation was an independent risk factor for short overall survival (P = 0.001, hazard ratio 1.360, 95% confidence interval 1.138-1.625). The survival impact stemmed from SMARCA2-attenuated GCs in stage III and non-EBV/MSI diffuse/mixed subtypes (P = 0.019 and < 0.001, respectively). ARID1A-lost/heterogeneous GCs were more aggressive in the EBV genotype (P = 0.016). SMARCB1 or SMARCA4 loss was not restricted to rhabdoid/undifferentiated carcinoma. In the TCGA dataset, 223 of 434 GCs (52%) harbored deleterious SWI/SNF mutations, including ARID1A (27%), SMARCA2 (9%), ARID2 (9%), ARID1B (8%), PBRM1 (7%), and SMARCA4 (7%). SWI/SNF-mutated GCs displayed a favorable outcome owing to the high percentage with the MSI genotype. In conclusion, SWI/SNF-altered GCs are common and the clinicopathological significance is related to the genotype.	[Huang, Shih-Chiang; Ng, Kwai-Fong; Chao, Yi-Chun; Chen, Tse-Ching] Chang Gung Univ, Linkou Chang Gung Mem Hosp, Coll Med, Dept Anat Pathol, Taoyuan, Taiwan; [Huang, Shih-Chiang; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Ian Yi-Feng] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Chang, Chee-Jen; Chang, Shu-Chen] Chang Gung Univ, Res Serv Ctr Hlth Informat, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Linkou Chang Gung Mem Hosp, Coll Med, Dept Cardiol, Taoyuan, Taiwan; [Chen, Min-Chi] Chang Gung Univ, Coll Med, Biostat Consulting Ctr, Dept Publ Hlth, Taoyuan, Taiwan; [Chen, Min-Chi] Chang Gung Univ, Chiayi Chang Gung Mem Hosp, Coll Med, Dept Hematol & Oncol, Chiayi, Taiwan; [Ta-Sen Yeh] Chang Gung Univ, Linkou Chang Gung Mem Hosp, Coll Med, Dept Surg, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, TC (corresponding author), Chang Gung Univ, Linkou Chang Gung Mem Hosp, Coll Med, Dept Anat Pathol, Taoyuan, Taiwan.	ctc323@cgmh.org.tw		Huang, Shih-Chiang/0000-0002-5092-4434; Chang, Ian/0000-0001-5840-2051	Ministry of Science and Technology [108-2320-B-182A-018, 106-2320-B-182A-011-MY3, 105-2320-B-182A-014]; Chang Gung Memorial Hospital [CMRPG3F2073, CMRPG5J0091, CIRPG3D0153, CMRP3C1323, CMRPG3G0553]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the Ministry of Science and Technology (108-2320-B-182A-018, 106-2320-B-182A-011-MY3 and 105-2320-B-182A-014) and the Chang Gung Memorial Hospital (CMRPG3F2073, CMRPG5J0091, CIRPG3D0153, CMRP3C1323 and CMRPG3G0553). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All the funding or sources of support were received during this study and there was no additional external funding received for this study.	Abe H, 2012, VIRCHOWS ARCH, V461, P367, DOI 10.1007/s00428-012-1303-2; Agaimy A, 2016, AM J SURG PATHOL, V40, P544, DOI 10.1097/PAS.0000000000000554; Agaimy A, 2014, AM J SURG PATHOL, V38, P910, DOI 10.1097/PAS.0000000000000173; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Braun DA, 2019, JAMA ONCOL, V5, P1631, DOI 10.1001/jamaoncol.2019.3158; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Chen H, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01954-z; Deribe YL, 2018, NAT MED, V24, P1047, DOI 10.1038/s41591-018-0019-5; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Glaros S, 2007, ONCOGENE, V26, P7058, DOI 10.1038/sj.onc.1210514; Herpel E, 2017, ANN DIAGN PATHOL, V26, P47, DOI 10.1016/j.anndiagpath.2016.10.006; Hoy SM, 2020, DRUGS, V80, P513, DOI 10.1007/s40265-020-01288-x; Hsu JT, 2011, ONCOLOGIST, V16, P1706, DOI 10.1634/theoncologist.2011-0199; Huang SC, 2020, HISTOPATHOLOGY, V77, P250, DOI 10.1111/his.14117; Huang SC, 2019, INT J CANCER, V145, P3218, DOI 10.1002/ijc.32215; Huang SC, 2016, GASTRIC CANCER, V19, P176, DOI 10.1007/s10120-014-0453-0; Huang SC, 2014, ONCOL REP, V32, P530, DOI 10.3892/or.2014.3234; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kim YB, 2016, HUM PATHOL, V49, P61, DOI 10.1016/j.humpath.2015.10.008; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; Mittal P, 2020, NAT REV CLIN ONCOL, V17, P435, DOI 10.1038/s41571-020-0357-3; St Pierre R, 2017, CURR OPIN GENET DEV, V42, P56, DOI 10.1016/j.gde.2017.02.004; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Yang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28919; Yarnamichi N, 2007, CANCER RES, V67, P10727, DOI 10.1158/0008-5472.CAN-07-2601	29	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245356	10.1371/journal.pone.0245356	http://dx.doi.org/10.1371/journal.pone.0245356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481850	gold, Green Published			2022-12-26	WOS:000612929300173
J	Preda, M; Mihai, MM; Popa, LI; Ditu, LM; Holban, AM; Manolescu, LSC; Popa, GL; Muntean, AA; Gheorghe, I; Chifiriuc, CM; Popa, MI				Preda, Madalina; Mihai, Mara Madalina; Popa, Laura Ioana; Ditu, Lia-Mara; Holban, Alina Maria; Manolescu, Loredana Sabina Cornelia; Popa, Gabriela-Loredana; Muntean, Andrei-Alexandru; Gheorghe, Irina; Chifiriuc, Carmen Mariana; Popa, Mircea-Ioan			Phenotypic and genotypic virulence features of staphylococcal strains isolated from difficult-to-treat skin and soft tissue infections	PLOS ONE			English	Article							CLINICAL STRAINS; AUREUS; COAGULASE; GENES; PCR	Chronic infections represent an important burden on the healthcare system and have a significant impact on the patients' quality of life. While Staphylococcus spp. are commensal bacteria, they can become pathogenic, leading to various types of infections. In this study we aimed to characterize the virulence profiles of staphylococcal strains involved in difficult-to-treat skin and soft tissue infections, from both phenotypic and genotypic points of view. Phenotypic ability of the strains to secrete soluble virulence factors was assessed by a culturing dependent assay and their capacity to develop biofilms on inert substrate was screened by an adapted crystal violet microtiter method. We also tested the presence of several virulence genes by PCR. Most of the studied strains were isolated from purulent secretions of acne lesions and frequently secreted two or three soluble virulence factors. Most frequently secreted soluble virulence factors were caseinase (89%), lipase (71%) and lecithinase (67%). Almost half of the strains produced a well-represented biofilm. The molecular characterization showed the presence of the genes cna, hlg, clfA, and clfB. Staphylococcal strains that produce difficult-to-treat skin and soft tissue infections seem to be characterized by an enhanced ability to produce different soluble virulence factors and to develop biofilms in vitro. Further studies need to be developed in other Staphylococcus spp. infections in order to confirm this hypothesis.	[Preda, Madalina; Manolescu, Loredana Sabina Cornelia] Carol Davila Univ Med & Pharm, Fac Midwives & Nursing, Dept Microbiol Parasitol & Virol, Bucharest, Romania; [Preda, Madalina; Muntean, Andrei-Alexandru; Popa, Mircea-Ioan] Cantacuzino Natl Medicomil Res & Dev Inst, Bucharest, Romania; [Mihai, Mara Madalina] Carol Davila Univ Med & Pharm, Dept Oncol Dermatol, Bucharest, Romania; [Mihai, Mara Madalina] Elias Univ, Dept Dermatol, Emergency Hosp, Bucharest, Romania; [Popa, Laura Ioana] Natl Inst Res & Dev Biol Sci, Dept Bioinformat, Bucharest, Romania; [Popa, Laura Ioana; Ditu, Lia-Mara; Holban, Alina Maria; Gheorghe, Irina; Chifiriuc, Carmen Mariana] Res Inst Univ Bucharest ICUB, Bucharest, Romania; [Ditu, Lia-Mara; Holban, Alina Maria; Gheorghe, Irina; Chifiriuc, Carmen Mariana] Univ Bucharest, Fac Biol, Dept Microbiol, Bucharest, Romania; [Popa, Gabriela-Loredana] Carol Davila Univ Med & Pharm, Fac Dent Med, Dept Microbiol, Bucharest, Romania; [Popa, Mircea-Ioan] Carol Davila Univ Med & Pharm, Fac Med, Dept Microbiol, Bucharest, Romania	Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy; National Research Institute for Biological Sciences; University of Bucharest; Carol Davila University of Medicine & Pharmacy; Carol Davila University of Medicine & Pharmacy	Mihai, MM (corresponding author), Carol Davila Univ Med & Pharm, Dept Oncol Dermatol, Bucharest, Romania.; Mihai, MM (corresponding author), Elias Univ, Dept Dermatol, Emergency Hosp, Bucharest, Romania.; Popa, LI (corresponding author), Natl Inst Res & Dev Biol Sci, Dept Bioinformat, Bucharest, Romania.; Popa, LI (corresponding author), Res Inst Univ Bucharest ICUB, Bucharest, Romania.	mara.mihai@umfcd.ro; lpbio_laura@yahoo.com	Popa, Mircea Ioan/A-4830-2011; Mihai, Mara M/K-1349-2014; Manolescu, Loredana/AAC-5584-2020; Popa, Gabriela Loredana/AAC-9743-2020; Muntean, Andrei-Alexandru/AAL-8965-2021; Chifiriuc, Mariana Carmen/AFP-0825-2022; Popa, Laura Ioana/AAA-5121-2020	Popa, Mircea Ioan/0000-0002-0794-9329; Mihai, Mara M/0000-0002-1436-0088; Manolescu, Loredana/0000-0001-8694-6195; Popa, Gabriela Loredana/0000-0002-8285-7176; Muntean, Andrei-Alexandru/0000-0002-4124-2909; Chifiriuc, Mariana Carmen/0000-0001-6098-1857; Preda, Madalina/0000-0002-5927-7069; Holban, Alina/0000-0002-1257-5042	Selection and dissemination of antibiotic resistance genes from wastewater treatment plants into the aquatic environment and clinical reservoirs [PN-III-P4-ID-PCCF2016-0114]; Ministry of Education and Research [12.659/20.05.2019]; University of Medicine and Pharmacy "Carol Davila", Bucharest Romania	Selection and dissemination of antibiotic resistance genes from wastewater treatment plants into the aquatic environment and clinical reservoirs; Ministry of Education and Research; University of Medicine and Pharmacy "Carol Davila", Bucharest Romania	M.C.C. "Selection and dissemination of antibiotic resistance genes from wastewater treatment plants into the aquatic environment and clinical reservoirs"; Grant number: PN-III-P4-ID-PCCF2016-0114. Funder: Ministry of Education and Research, https://uefiscdi.gov.ro/M.P.Grant number: 12.659/20.05.2019; Funder: University of Medicine and Pharmacy "Carol Davila", Bucharest Romania; https://umfcd.ro/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghazadeh Z, 2019, BIOINTERFACE RES APP, V9, P4534, DOI 10.33263/BRIAC96.5534538; Ansari S, 2019, INFECT DRUG RESIST, V12, P1243, DOI 10.2147/IDR.S175014; Argemi X, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051215; Askarian F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22134; Baur S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004089; Bayston R, 2006, J HOSP INFECT, V62, P127, DOI 10.1016/j.jhin.2005.06.015; Blicharz L, 2019, POSTEP DERM ALERGOL, V36, P11, DOI 10.5114/ada.2019.82821; Cadieux B, 2014, J BACTERIOL, V196, P4044, DOI 10.1128/JB.02044-14; Cotar AI, 2010, INT J MOL SCI, V11, P5274, DOI 10.3390/ijms11125273; Crabbe A, 2019, TRENDS MICROBIOL, V27, P850, DOI 10.1016/j.tim.2019.05.003; Demos M, 2012, BRIT J DERMATOL, V167, P725, DOI 10.1111/j.1365-2133.2012.11151.x; Ducu R, 2019, BIOINTERFACE RES APP, V9, P4699, DOI 10.33263/BRIAC96.699704; Gheorghe I, 2019, STAPHYLOCOCCUS AUREU, DOI [10.5772/intechopen.75191, DOI 10.5772/INTECHOPEN.75191]; Gheorghe I, 2017, ROM BIOTECH LETT, V22, P12321; Haney EF, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020029; Heilmann C, 2019, CLIN MICROBIOL INFEC, V25, P1071, DOI 10.1016/j.cmi.2018.11.012; Herman-Bausier P, 2017, MBIO, V8, DOI 10.1128/mBio.01067-17; Hrynkiewicz K, 2008, FEMS MICROBIOL LETT, V286, P1, DOI 10.1111/j.1574-6968.2008.01245.x; Ionescu B, 2015, ROM BIOTECH LETT, V20, P10536; Javid F, 2018, VET WORLD, V11, P423, DOI 10.14202/vetworld.2018.423-430; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kot B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113487; Lacey KA, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010022; Leber AL, 2016, CLIN MICROBIOLOGY PR; Lee EY, 2017, CAN FAM PHYSICIAN, V63, P114; Lin YC, 2010, EXPERT REV CLIN PHAR, V3, P753, DOI 10.1586/ECP.10.121; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Loges LA, 2020, MICROB PATHOGENESIS, V143, DOI 10.1016/j.micpath.2020.104066; MCDEVITT D, 1992, INFECT IMMUN, V60, P1514, DOI 10.1128/IAI.60.4.1514-1523.1992; Mihai MM, 2019, MATERIALS, V12, DOI 10.3390/ma12132176; Mihai MM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041179; Mihai MM, 2015, CURR TOP MED CHEM, V15, P1552; Miller LS, 2020, FEMS MICROBIOL REV, V44, P123, DOI 10.1093/femsre/fuz030; Moran MC, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00616-19; Mullarky IK, 2001, INFECT IMMUN, V69, P45, DOI 10.1128/IAI.69.1.45-51.2001; Nowicka D, 2019, DERMATOLOGY, V235, P295, DOI 10.1159/000499184; Olver WJ, 2005, J HOSP INFECT, V60, P87, DOI 10.1016/j.jhin.2004.10.006; Park YJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030718; Parlet CP, 2019, TRENDS MICROBIOL, V27, P497, DOI 10.1016/j.tim.2019.01.008; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; dos Santos LDR, 2018, BIOINTERFACE RES APP, V8, P3565; Sabouni Farah, 2014, Osong Public Health Res Perspect, V5, P96, DOI 10.1016/j.phrp.2014.03.002; Saviuc C., 2013, LETT APPL NANOBIOSCI, V2, P91; Schiller JL, 2020, ACTA BIOMATER, V107, P91, DOI 10.1016/j.actbio.2020.03.002; Shamsudin MN, 2009, EVALUATION MODIFIED; Shrestha LB, 2018, INFECT DRUG RESIST, V11, P607, DOI 10.2147/IDR.S159764; Sina H, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-188; Smole SC, 1998, J CLIN MICROBIOL, V36, P1109, DOI 10.1128/JCM.36.4.1109-1112.1998; Tavora IG, 2019, AN BRAS DERMATOL, V94, P298, DOI 10.1590/abd1806-4841.20197687; Torres-Sangiao E, 2016, MOLECULES, V21, DOI 10.3390/molecules21070867; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; VANDENESCH F, 1993, LANCET, V342, P995, DOI 10.1016/0140-6736(93)92045-U; VANNUFFEL P, 1995, J CLIN MICROBIOL, V33, P2864, DOI 10.1128/JCM.33.11.2864-2867.1995; Wang FD, 2019, J MICROBIOL IMMUNOL, V52, P426, DOI 10.1016/j.jmii.2019.01.001; Wang LX, 2013, GENET MOL RES, V12, P646, DOI 10.4238/2013.March.11.12; Williams MR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat8329; 2018, J INT FINANC MARK I, V54, P27	57	6	6	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246478	10.1371/journal.pone.0246478	http://dx.doi.org/10.1371/journal.pone.0246478			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529240	Green Published, gold			2022-12-26	WOS:000616736200046
J	Coates, MS; Alton, EWFW; Rapeport, GW; Davies, JC; Ito, K				Coates, Matthew S.; Alton, Eric W. F. W.; Rapeport, Garth W.; Davies, Jane C.; Ito, Kazuhiro			Pseudomonas aeruginosa induces p38MAP kinase-dependent IL-6 and CXCL8 release from bronchial epithelial cells via a Syk kinase pathway	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; CYSTIC-FIBROSIS; DOUBLE-BLIND; AIRWAY INFLAMMATION; SIGNALING PATHWAY; IN-VITRO; INHIBITOR; ACTIVATION; MAPK	Pseudomonas aeruginosa (Pa) infection is a major cause of airway inflammation in immunocompromised and cystic fibrosis (CF) patients. Mitogen-activated protein (MAP) and tyrosine kinases are integral to inflammatory responses and are therefore potential targets for novel anti-inflammatory therapies. We have determined the involvement of specific kinases in Pa-induced inflammation. The effects of kinase inhibitors against p38MAPK, MEK 1/2, JNK 1/2, Syk or c-Src, a combination of a p38MAPK with Syk inhibitor, or a novel narrow spectrum kinase inhibitor (NSKI), were evaluated against the release of the proinflammatory cytokine/chemokine, IL-6 and CXCL8 from BEAS-2B and CFBE41o- epithelial cells by Pa. Effects of a Syk inhibitor against phosphorylation of the MAPKs were also evaluated. IL-6 and CXCL8 release by Pa were significantly inhibited by p38MAPK and Syk inhibitors (p<0.05). Phosphorylation of HSP27, but not ERK or JNK, was significantly inhibited by Syk kinase inhibition. A combination of p38MAPK and Syk inhibitors showed synergy against IL-6 and CXCL8 induction and an NSKI completely inhibited IL-6 and CXCL8 at low concentrations. Pa-induced inflammation is dependent on p38MAPK primarily, and Syk partially, which is upstream of p38MAPK. The NSKI suggests that inhibiting specific combinations of kinases is a potent potential therapy for Pa-induced inflammation.	[Coates, Matthew S.; Alton, Eric W. F. W.; Rapeport, Garth W.; Davies, Jane C.; Ito, Kazuhiro] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Rapeport, Garth W.; Ito, Kazuhiro] Pulmocide Ltd, London, England; [Davies, Jane C.] Royal Brompton Hosp, Dept Paediat Resp Med, London, England	Imperial College London; Royal Brompton Hospital	Coates, MS (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	m.coates12@imperial.ac.uk	Rapeport, Garth William/AAE-2935-2021	Rapeport, Garth William/0000-0002-5795-6500; Davies, Jane/0000-0003-3506-1199; Alton, Eric WFW/0000-0003-3852-6764; Coates, Matthew/0000-0001-6304-675X	Respivert Ltd.	Respivert Ltd.	Matthew S. Coates received funding for this project from Respivert Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. During the period of the research Garth W. Rapeport and Kazuhiro Ito were cofounders/employed by Pulmocide Ltd. The funder provided support in the form of salaries for authors [GWR and KI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Aki D, 2005, GENES CELLS, V10, P357, DOI 10.1111/j.1365-2443.2005.00839.x; Alam J, 2017, JPAD-J PREV ALZHEIM, V4, P273, DOI 10.14283/jpad.2017.41; Alhazmi A, 2018, J INNATE IMMUN, V10, P255, DOI 10.1159/000489863; Alhazmi A, 2018, CAN J PHYSIOL PHARM, V96, P182, DOI 10.1139/cjpp-2017-0307; Anand P, 2011, EUR J PAIN, V15, P1040, DOI 10.1016/j.ejpain.2011.04.005; [Anonymous], 2017, JLSRF, V3, pA104; Assi K, 2006, IMMUNOLOGY, V118, P112, DOI 10.1111/j.1365-2567.2006.02349.x; BEDARD M, 1993, AM J RESP CELL MOL, V9, P455, DOI 10.1165/ajrcmb/9.4.455; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernabe R, 2016, FUTURE ONCOL, V12, P2545, DOI 10.2217/fon-2016-0132; Berube J, 2010, J BIOL CHEM, V285, P22299, DOI 10.1074/jbc.M109.098566; BIRRER P, 1994, AM J RESP CRIT CARE, V150, P207, DOI 10.1164/ajrccm.150.1.7912987; Black HR, 1998, AM J RESP CELL MOL, V19, P210, DOI 10.1165/ajrcmb.19.2.3053; Blohmke CJ, 2012, J IMMUNOL, V189, P5467, DOI 10.4049/jimmunol.1103661; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Bussel J, 2018, AM J HEMATOL, V93, P921, DOI 10.1002/ajh.25125; Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; Cho HJ, 2020, AGING-US, V12, P8221, DOI 10.18632/aging.103135; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Coates M., 2017, CELLULAR PATHOGEN RE; Coburn B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10241; Cohen SB, 2009, ARTHRITIS RHEUM, V60, P335, DOI 10.1002/art.24266; Cortes JE, 2018, J CLIN ONCOL, V36, P231, DOI 10.1200/JCO.2017.74.7162; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Damjanov N, 2009, ARTHRITIS RHEUM-US, V60, P1232, DOI 10.1002/art.24485; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; DIMANGO E, 1995, J CLIN INVEST, V96, P2204, DOI 10.1172/JCI118275; Dosunmu EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176640; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Elizur A, 2008, CHEST, V133, P489, DOI 10.1378/chest.07-1631; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Genovese MC, 2011, J RHEUMATOL, V38, P846, DOI 10.3899/jrheum.100602; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; Hall JP, 2002, J CELL BIOCHEM, V86, P1, DOI 10.1002/jcb.10187; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Hope HR, 2009, J PHARMACOL EXP THER, V331, P882, DOI 10.1124/jpet.109.158329; Inoue T, 2006, P NATL ACAD SCI USA, V103, P5484, DOI 10.1073/pnas.0509188103; Kantarjian H, 2006, NAT REV DRUG DISCOV, V5, P717, DOI 10.1038/nrd2135; Knobloch J, 2018, J ALLERGY CLIN IMMUN, V141, P1122, DOI 10.1016/j.jaci.2017.09.026; Kong M, 2013, VIRUSES-BASEL, V5, P2260, DOI 10.3390/v5092260; Kosorok MR, 2001, PEDIATR PULM, V32, P277, DOI 10.1002/ppul.2009.abs; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Lam JS, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00118; Lee HM, 2007, J PHARMACOL SCI, V103, P427, DOI 10.1254/jphs.FP0070039; Li J, 2002, AM J PHYSIOL-LUNG C, V283, pL690, DOI 10.1152/ajplung.00060.2002; MacNee W, 2013, THORAX, V68, P738, DOI 10.1136/thoraxjnl-2012-202744; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; Mullard A, 2018, NAT REV DRUG DISCOV, V17, P385, DOI 10.1038/nrd.2018.96; Na HG, 2016, AM J RHINOL ALLERGY, V30, P89, DOI 10.2500/ajra.2016.30.4276; Nygaard HB, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0119-0; O'Brien S, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-0941-6; Onions ST, 2016, J MED CHEM, V59, P1727, DOI 10.1021/acs.jmedchem.5b01029; Page TH, 2009, CURR MOL MED, V9, P69, DOI 10.2174/156652409787314507; Park SH, 2015, EUR J INFLAMM, V13, P183, DOI 10.1177/1721727X15619185; Patel Naimish, 2015, ADV THERAPY, pA6741; Patel NR, 2018, INT J CHRONIC OBSTR, V13, P1009, DOI 10.2147/COPD.S150576; PAWSON T, 1994, FASEB J, V8, P1112, DOI 10.1096/fasebj.8.14.7958615; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Pomerantz JL, 2002, MOL CELL, V10, P693, DOI 10.1016/S1097-2765(02)00697-4; Ratner AJ, 2001, J BIOL CHEM, V276, P19267, DOI 10.1074/jbc.M007703200; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Riss TL, 2004, CELL VIABILITY ASSAY; Ruffin M, 2018, AM J PHYSIOL-LUNG C, V314, P1635, DOI 10.1152/ajplung.00198.2017; Rzhepishevska O, 2018, ACTA BIOMATER, V76, P99, DOI 10.1016/j.actbio.2018.06.019; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Scheltens P, 2018, ANN CLIN TRANSL NEUR, V5, P464, DOI 10.1002/acn3.549; Schreiber S, 2006, CLIN GASTROENTEROL H, V4, P325, DOI 10.1016/j.cgh.2005.11.013; Schulz C, 2002, SCAND J IMMUNOL, V56, P294, DOI 10.1046/j.1365-3083.2002.01137.x; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Smith RS, 2001, J IMMUNOL, V167, P366, DOI 10.4049/jimmunol.167.1.366; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Strong P, 2018, DRUG DISCOV TODAY, V23, P1705, DOI 10.1016/j.drudis.2018.05.017; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; To WS, 2015, BRIT J PHARMACOL, V172, P3805, DOI 10.1111/bph.13170; Ulanova M, 2006, BIOCHEM BIOPH RES CO, V351, P431, DOI 10.1016/j.bbrc.2006.10.073; Van Ziffle JA, 2009, BLOOD, V114, P4871, DOI 10.1182/blood-2009-05-220806; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang XM, 2006, J IMMUNOL, V177, P6859, DOI 10.4049/jimmunol.177.10.6859; Weinblatt ME, 2014, ARTHRITIS RHEUMATOL, V66, P3255, DOI 10.1002/art.38851; Weinblatt ME, 2013, J RHEUMATOL, V40, P369, DOI 10.3899/jrheum.120923; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yi YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/270302; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005; Zhang Z, 2007, INFECT IMMUN, V75, P5985, DOI 10.1128/IAI.00678-07	92	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246050	10.1371/journal.pone.0246050	http://dx.doi.org/10.1371/journal.pone.0246050			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524056	Green Published, gold			2022-12-26	WOS:000616578400015
J	Lopes, FPPL; Kitamura, FC; Prado, GF; Kuriki, PED; Garcia, MRT				Proenca Lobo Lopes, Flavia Paiva; Kitamura, Felipe Campos; Prado, Gustavo Faibischew; de Aguiar Kuriki, Paulo Eduardo; Taveira Garcia, Marcio Ricardo		COVID-AI-Brasil	Machine learning model for predicting severity prognosis in patients infected with COVID-19: Study protocol from COVID-AI Brasil	PLOS ONE			English	Article								The new coronavirus, which began to be called SARS-CoV-2, is a single-stranded RNA beta coronavirus, initially identified in Wuhan (Hubei province, China) and currently spreading across six continents causing a considerable harm to patients, with no specific tools until now to provide prognostic outcomes. Thus, the aim of this study is to evaluate possible findings on chest CT of patients with signs and symptoms of respiratory syndromes and positive epidemiological factors for COVID-19 infection and to correlate them with the course of the disease. In this sense, it is also expected to develop specific machine learning algorithm for this purpose, through pulmonary segmentation, which can predict possible prognostic factors, through more accurate results. Our alternative hypothesis is that the machine learning model based on clinical, radiological and epidemiological data will be able to predict the severity prognosis of patients infected with COVID-19. We will perform a multicenter retrospective longitudinal study to obtain a large number of cases in a short period of time, for better study validation. Our convenience sample (at least 20 cases for each outcome) will be collected in each center considering the inclusion and exclusion criteria. We will evaluate patients who enter the hospital with clinical signs and symptoms of acute respiratory syndrome, from March to May 2020. We will include individuals with signs and symptoms of acute respiratory syndrome, with positive epidemiological history for COVID-19, who have performed a chest computed tomography. We will assess chest CT of these patients and to correlate them with the course of the disease. Primary outcomes:1) Time to hospital discharge; 2) Length of stay in the ICU; 3) orotracheal intubation;4) Development of Acute Respiratory Discomfort Syndrome. Secondary outcomes:1) Sepsis; 2) Hypotension or cardiocirculatory dysfunction requiring the prescription of vasopressors or inotropes; 3) Coagulopathy; 4) Acute Myocardial Infarction; 5) Acute Renal Insufficiency; 6) Death. We will use the AUC and F1-score of these algorithms as the main metrics, and we hope to identify algorithms capable of generalizing their results for each specified primary and secondary outcome.	[Proenca Lobo Lopes, Flavia Paiva; Kitamura, Felipe Campos; de Aguiar Kuriki, Paulo Eduardo; Taveira Garcia, Marcio Ricardo] Diagnost Amer Dasa, Dept Radiol, Sao Paulo, SP, Brazil; [Prado, Gustavo Faibischew] Hosp Alemao Oswaldo Cruz, Dept Innovat, Sao Paulo, SP, Brazil		Kitamura, FC (corresponding author), Diagnost Amer Dasa, Dept Radiol, Sao Paulo, SP, Brazil.	kitamura.felipe@gmail.com	Kitamura, Felipe Campos/AAC-7075-2021; Lopes, Flavia/AAY-4899-2021	Kitamura, Felipe Campos/0000-0002-9992-5630; Kuriki, Paulo/0000-0002-1485-5750	Diagnosticos da America (DASA)	Diagnosticos da America (DASA)	This study was funded by Diagnosticos da America (DASA). The funder provided support in the form of salaries for authors FPPLL, FCK, PEAK, MRTG, VPSR, MRFM, RZP, RASO, LGPD, PRTPD, and RVO, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Adly AS, 2020, J MED INTERNET RES, V22, DOI 10.2196/19104; Chartrand G, 2017, RADIOGRAPHICS, V37, P2113, DOI 10.1148/rg.2017170077; Choy G, 2018, RADIOLOGY, V288, P318, DOI 10.1148/radiol.2018171820; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Langham RG, 2014, NEPHROLOGY, V19, P261, DOI 10.1111/nep.12220; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Liu FJ, 2020, THERANOSTICS, V10, P5613, DOI 10.7150/thno.45985; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Nsoesie EO, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2658; Park SH, 2018, RADIOLOGY, V286, P800, DOI 10.1148/radiol.2017171920; Pendleton SD, 2017, MACHINES, V5, DOI 10.3390/machines5010006; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Xiong W, 2017, IEEE-ACM T AUDIO SPE, V25, P2410, DOI 10.1109/TASLP.2017.2756440; Yang Ran, 2020, Radiol Cardiothorac Imaging, V2, pe200047, DOI 10.1148/ryct.2020200047; Yuan ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230548; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	19	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245384	10.1371/journal.pone.0245384	http://dx.doi.org/10.1371/journal.pone.0245384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524039	Green Published, gold			2022-12-26	WOS:000616578400009
J	Kolay, J; Bera, S; Mukhopadhyay, R				Kolay, Jayeeta; Bera, Sudipta; Mukhopadhyay, Rupa			How stable are the collagen and ferritin proteins for application in bioelectronics?	PLOS ONE			English	Article							STATE ELECTRON-TRANSPORT; OPTICAL LOGIC GATES; HORSE SPLEEN; APOFERRITIN CAVITY; THERMAL-STABILITY; BIOFUEL CELLS; BEHAVIOR; CU; METALLOPROTEIN; HYDROXYPROLINE	One major obstacle in development of biomolecular electronics is the loss of function of biomolecules upon their surface-integration and storage. Although a number of reports on solid-state electron transport capacity of proteins have been made, no study on whether their functional integrity is preserved upon surface-confinement and storage over a long period of time (few months) has been reported. We have investigated two specific cases-collagen and ferritin proteins, since these proteins exhibit considerable potential as bioelectronic materials as we reported earlier. Since one of the major factors for protein degradation is the proteolytic action of protease, such studies were made under the action of protease, which was either added deliberately or perceived to have entered in the reaction vial from ambient environment. Since no significant change in the structural characteristics of these proteins took place, as observed in the circular dichroism and UV-visible spectrophotometry experiments, and the electron transport capacity was largely retained even upon direct protease exposure as revealed from the current sensing atomic force spectroscopy experiments, we propose that stable films can be formed using the collagen and ferritin proteins. The observed protease-resistance and robust nature of these two proteins support their potential application in bioelectronics.	[Kolay, Jayeeta; Bera, Sudipta; Mukhopadhyay, Rupa] Indian Assoc Cultivat Sci, Sch Biol Sci, Kolkata, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Mukhopadhyay, R (corresponding author), Indian Assoc Cultivat Sci, Sch Biol Sci, Kolkata, India.	bcrm@iacs.res.in			IACS, Kolkata; DST-SERB, Govt. of India [SB/SO/BB-33/2014]; CSIR, Govt. of India; DST-INSPIRE, Govt. of India	IACS, Kolkata; DST-SERB, Govt. of India(Department of Science & Technology (India)Science Engineering Research Board (SERB), India); CSIR, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); DST-INSPIRE, Govt. of India	R. Mukhopadhyay acknowledges support from IACS, Kolkata, and DST-SERB, Govt. of India [Equipment grant, Grant no. SB/SO/BB-33/2014] and the research fellowships of J. Kolay and S. Bera from CSIR, Govt. of India and IACS, Kolkata, and DST-INSPIRE, Govt. of India, respectively.	Aguilella VM, 2009, NAT NANOTECHNOL, V4, P403, DOI 10.1038/nnano.2009.168; Artes JM, 2012, NANO LETT, V12, P2679, DOI 10.1021/nl2028969; Axford DN, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145502; Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k; Bera S, 2019, J MATER CHEM C, V7, P9038, DOI 10.1039/c9tc01744e; Bera S, 2017, LANGMUIR, V33, P1951, DOI 10.1021/acs.langmuir.6b04120; Bozec L, 2011, BIOPHYS J, V101, P228, DOI 10.1016/j.bpj.2011.04.033; Brazdaru L, 2015, CR CHIM, V18, P160, DOI 10.1016/j.crci.2014.07.007; Ciesielski PN, 2010, BIORESOURCE TECHNOL, V101, P3047, DOI 10.1016/j.biortech.2009.12.045; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; Creusot N, 2007, J AGR FOOD CHEM, V55, P9241, DOI 10.1021/jf071584s; D'Amico S, 2004, IEE Proc Nanobiotechnol, V151, P173, DOI 10.1049/ip-nbt:20041032; Drzewiecki KE, 2016, BIOPHYS J, V111, P2377, DOI 10.1016/j.bpj.2016.10.023; Elmas SNK, 2018, BIOSENS BIOELECTRON, V103, P19, DOI 10.1016/j.bios.2017.12.011; FRERE V, 1995, J BIOL CHEM, V270, P17502, DOI 10.1074/jbc.270.29.17502; Galvez N, 2005, DALTON T, P2492, DOI 10.1039/b506290j; Granick S, 1942, J BIOL CHEM, V146, P0451; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUSTAVSON KH, 1955, NATURE, V175, P70, DOI 10.1038/175070a0; Ha S, 2012, TOP CATAL, V55, P1181, DOI 10.1007/s11244-012-9903-2; HALL DA, 1957, NATURE, V180, P243, DOI 10.1038/180243a0; Huard DJE, 2013, NAT CHEM BIOL, V9, P169, DOI [10.1038/NCHEMBIO.1163, 10.1038/nchembio.1163]; KADIR FHA, 1990, FEBS LETT, V276, P81, DOI 10.1016/0014-5793(90)80512-H; Kim SW, 2001, BIOCHEM BIOPH RES CO, V289, P125, DOI 10.1006/bbrc.2001.5931; Kolay J, 2018, LANGMUIR, V34, P3126, DOI 10.1021/acs.langmuir.7b04356; Kolay J, 2019, LANGMUIR, V35, P11950, DOI 10.1021/acs.langmuir.9b01685; Koralewski M, 2018, ACS APPL MATER INTER, V10, P7777, DOI 10.1021/acsami.7b18304; Li DB, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395705; LISTOWSKY I, 1972, BIOCHEMISTRY-US, V11, P2176, DOI 10.1021/bi00761a026; MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B; Minary-Jolandan M, 2009, BIOMACROMOLECULES, V10, P2565, DOI 10.1021/bm900519v; Moreno S, 2015, ADV ELECTRON MATER, V1, DOI 10.1002/aelm.201500154; Ostatna V, 2012, ANAL CHIM ACTA, V735, P31, DOI 10.1016/j.aca.2012.05.012; Otte J, 1997, J AGR FOOD CHEM, V45, P4889, DOI 10.1021/jf9704571; PARSELL DA, 1989, J BIOL CHEM, V264, P7590; Pompa PP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.032901; PUU G, 1995, BIOSENS BIOELECTRON, V10, P463, DOI 10.1016/0956-5663(95)96892-3; Qi PW, 2015, RSC ADV, V5, P87180, DOI 10.1039/c5ra14423j; Rakshit T, 2010, LANGMUIR, V26, P16005, DOI 10.1021/la101776m; Rakshit T, 2013, LANGMUIR, V29, P12511, DOI 10.1021/la402522m; Rakshit T, 2012, J COLLOID INTERF SCI, V388, P282, DOI 10.1016/j.jcis.2012.08.028; Rakshit T, 2011, LANGMUIR, V27, P9681, DOI 10.1021/la202045a; Rao DVGLN, 1996, OPT COMMUN, V127, P193, DOI 10.1016/0030-4018(96)00180-0; Reshetilov AN, 2015, APPL BIOCHEM MICRO+, V51, P264, DOI 10.1134/S0003683815020167; Ron I, 2010, ACCOUNTS CHEM RES, V43, P945, DOI 10.1021/ar900161u; Ron I, 2010, J AM CHEM SOC, V132, P4131, DOI 10.1021/ja907328r; Schmidt-Bleek F, 2001, SECOND INTERNATIONAL SYMPOSIUM ON ENVIRONMENTALLY CONSCIOUS DESIGN AND INVERSE MANUFACTURING, PROCEEDINGS, P1, DOI 10.1109/ECODIM.2001.992306; Shin YS, 2010, J PHYS CHEM C, V114, P5985, DOI 10.1021/jp911004a; Takai Toshiro, 2011, Allergology International, V60, P25, DOI 10.2332/allergolint.10-RAI-0273; Tang XY, 2010, APPL BIOCHEM BIOTECH, V160, P1017, DOI 10.1007/s12010-009-8665-1; Techatanawat S, 2011, ASIAN BIOMED, V5, P787, DOI 10.5372/1905-7415.0506.111; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; VARO G, 1983, BIOPHYS J, V43, P47, DOI 10.1016/S0006-3495(83)84322-7; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; Watt GD, 2012, J NANOTECHNOL, V2012, DOI 10.1155/2012/516309; Willner I, 2001, TRENDS BIOTECHNOL, V19, P222, DOI 10.1016/S0167-7799(01)01634-1; Xu DG, 2005, NANO LETT, V5, P571, DOI 10.1021/nl048218x; Zhang B, 2005, INORG CHEM, V44, P3738, DOI 10.1021/ic049085l; Zhang TH, 2000, OPT ENG, V39, P527, DOI 10.1117/1.602400; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	60	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246180	10.1371/journal.pone.0246180	http://dx.doi.org/10.1371/journal.pone.0246180			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513177	Green Published, gold			2022-12-26	WOS:000613891400027
J	Nyumba, TO; Sang, CC; Olago, DO; Marchant, R; Waruingi, L; Githiora, Y; Kago, F; Mwangi, M; Owira, G; Barasa, R; Omangi, S; Lotters, S				Nyumba, Tobias Ochieng; Sang, Catherine Chebet; Olago, Daniel Ochieng; Marchant, Robert; Waruingi, Lucy; Githiora, Yvonne; Kago, Francis; Mwangi, Mary; Owira, George; Barasa, Rosemary; Omangi, Sherlyne; Lotters, Stefan			Assessing the ecological impacts of transportation infrastructure development: A reconnaissance study of the Standard Gauge Railway in Kenya	PLOS ONE			English	Article							ROAD DEVELOPMENT; PLANT INVASIONS; HABITAT USE; FOREST; BIODIVERSITY; DISTURBANCE; MITIGATION; MANAGEMENT; PATHWAYS; EASTERN	Transportation infrastructure, such as railways, roads and power lines, contribute to national and regional economic, social and cultural growth and integration. Kenya, with support from the Chinese government, is currently constructing a standard gauge railway (SGR) to support the country's Vision 2030 development agenda. Although the actual land area affected by the SGR covers only a small proportion along the SGR corridor, a significant proportion of the area supports a wide range of ecologically fragile and important ecosystems in the country, with potential wider impacts. This study used a qualitative content analysis approach to gain an understanding and perceptions of stakeholders on the potential ecological impacts of the interactions between the SGR and the traversed ecological systems in Kenya. Three dominant themes emerged: 1) ecosystem degradation; 2) ecosystem fragmentation; and 3) ecosystem destruction. Ecosystem degradation was the most commonly cited impact at while ecosystem destruction was of the least concern and largely restricted to the physical SGR construction whereas the degradation and fragmentation have a much wider footprint. The construction and operation of the SGR degraded, fragmented and destroyed key ecosystems in the country including water towers, protected areas, community conservancies and wildlife dispersal areas. Therefore, we recommend that project proponents develop sustainable and ecologically sensitive measures to mitigate the key ecosystem impacts.	[Nyumba, Tobias Ochieng; Waruingi, Lucy; Kago, Francis; Mwangi, Mary] African Conservat Ctr, Nairobi, Kenya; [Nyumba, Tobias Ochieng; Sang, Catherine Chebet; Olago, Daniel Ochieng; Githiora, Yvonne; Owira, George; Barasa, Rosemary; Omangi, Sherlyne; Lotters, Stefan] Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya; [Marchant, Robert] Univ York, York Inst Trop Ecosyst, Dept Geog & Environm, York, N Yorkshire, England	University of Nairobi; University of York - UK	Nyumba, TO (corresponding author), African Conservat Ctr, Nairobi, Kenya.; Nyumba, TO (corresponding author), Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya.	tnyumba@uonbi.ac.ke	Nyumba, Tobias Ochieng/AAD-3583-2021	Nyumba, Tobias Ochieng/0000-0002-7821-5197; Githiora, Yvonne/0000-0001-6274-4791; Olago, Daniel/0000-0001-6080-5802	Development Corridors Partnership (DCP) project; UK Research and Innovation's Global Challenges Research Fund (GCRF) [ES/P011500/1]; ESRC [ES/P011500/1] Funding Source: UKRI	Development Corridors Partnership (DCP) project; UK Research and Innovation's Global Challenges Research Fund (GCRF); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All the authors of this paper are jointly funded under the Development Corridors Partnership (DCP) project. The DCP is a UK Research and Innovation's Global Challenges Research Fund (GCRF) funded project (project number: ES/P011500/1). The DCP aims to generate decision-relevant evidence and feeding into key decision-making processes in order to improve the sustainable development outcomes and investments in infrastructure projects.	Alamgir M, 2017, CURR BIOL, V27, pR1130, DOI 10.1016/j.cub.2017.08.067; Angelstam P, 2017, J ENVIRON MANAGE, V193, P300, DOI 10.1016/j.jenvman.2017.02.017; [Anonymous], 2011, WILEY PERIODICALS IN, DOI [10.1002/dhe.20041, DOI 10.1044/LEADER.PPL.16152011.36]; [Anonymous], 2017, RAILWAY ECOLOGY, DOI DOI 10.1007/978-3-319-57496-7_10; AWEMAC, 2012, PROP MOMB NAIR STAND; BARNES RFW, 1991, AFR J ECOL, V29, P54, DOI 10.1111/j.1365-2028.1991.tb00820.x; BARRETT GW, 1991, LANDSCAPE LINKAGES AND BIODIVERSITY, P149; Bertch B, 2010, BLACK BEAR MORTALITI; Borda-de-Agua L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04126-5; BRODY AJ, 1989, WILDLIFE SOC B, V17, P5; Broennimann O, 2014, J BIOGEOGR, V41, P1126, DOI 10.1111/jbi.12274; Catford JA, 2012, PERSPECT PLANT ECOL, V14, P231, DOI 10.1016/j.ppees.2011.12.002; Child Kenneth N., 1991, Alces, V27, P41; Clauzel C, 2015, BIOL CONSERV, V192, P207, DOI 10.1016/j.biocon.2015.09.029; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; COLEMAN JS, 1989, J WILDLIFE MANAGE, V53, P782, DOI 10.2307/3809213; CPCS Transcom International Limited, 2009, E AFR RAILW MAST PLA; Cvetkovich G, 2003, ENVIRON BEHAV, V35, P286, DOI 10.1177/0013916502250139; DCP Kenya, 2019, DEV CORR KEN SCOP ST; Derobertmasure A, 2014, QUAL QUANT, V48, P2255, DOI 10.1007/s11135-013-9890-9; Dorsey B, 2015, HANDBOOK OF ROAD ECOLOGY, P219; ESRI, 2011, ARCGIS DESKT REL 10; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Ferraro PJ, 2014, P NATL ACAD SCI USA, V111, P4332, DOI 10.1073/pnas.1307712111; Fonteyn ME, 2008, APPL NURS RES, V21, P165, DOI 10.1016/j.apnr.2006.08.005; Forman RTT, 2000, CONSERV BIOL, V14, P36, DOI 10.1046/j.1523-1739.2000.99088.x; Gelbard JL, 2003, CONSERV BIOL, V17, P420, DOI 10.1046/j.1523-1739.2003.01408.x; Ghent C., 2018, CONSILIENCE, V19, P58; Gornig M, 2015, DIW EC B, V5, P561; GROVER KE, 1986, J WILDLIFE MANAGE, V50, P466, DOI 10.2307/3801107; Hansen MJ, 2005, BIOL CONSERV, V125, P249, DOI 10.1016/j.biocon.2005.03.024; Herzog C, 2016, LANDSC ECOL ENG, V12, P141, DOI 10.1007/s11355-013-0233-8; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jha N, 2014, INT J MODEL SIMUL SC, V5, DOI 10.1142/S1793962313500189; Jongman R, 2002, HABITAT FRAGM DUE TR; Karlson M, 2014, ENVIRON IMPACT ASSES, V48, P10, DOI 10.1016/j.eiar.2014.04.002; Kibuti T, 2010, E AFRICAN J HUMANIT, V10; Krippendorff K., 2012, CONTENT ANAL INTRO I; Laurance WF, 2015, CURR BIOL, V25, P3202, DOI 10.1016/j.cub.2015.10.046; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Mandle L, 2015, FRONT ECOL ENVIRON, V13, P309, DOI 10.1890/140337; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Okita-Ouma B, 2017, PACHYDERM, V57, P109; Olson KA, 2013, SAIGA CROSSING OPTIO; Olson KA, 2015, HANDBOOK OF ROAD ECOLOGY, P472; Paloniemi R, 2012, NAT CONSERV-BULGARIA, P7, DOI 10.3897/natureconservation.2.3144; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Planners Habitat, 2016, PROP STAND GAUG RAIL, VI; Popp JN, 2017, BASIC APPL ECOL, V19, P84, DOI 10.1016/j.baae.2016.11.006; Potapov I.I., 2016, ENV EC, V1, P15; Profillidis VA., 2006, RAILWAY MANAGEMENT E, VThird; Provalis Research, 2019, QDA MIN QUAL MIX MET; Rangarajan M., 2010, SECURING FUTURE ELEP; Ricciardi A, 2007, CONSERV BIOL, V21, P329, DOI 10.1111/j.1523-1739.2006.00615.x; Roy Mukti, 2009, Gajah, V31, P36; Sarma UK, 2006, 24 WILDL TRUST IND; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Sidle RC, 2004, HYDROL PROCESS, V18, P703, DOI 10.1002/hyp.1364; Sidle RC, 2012, NAT GEOSCI, V5, P437, DOI 10.1038/ngeo1512; Skorobogatova O, 2017, PROCEDIA ENGINEER, V178, P319, DOI 10.1016/j.proeng.2017.01.056; Southerland M., 1994, EVALUATION ECOLOGICA; Suarez-Esteban A, 2016, LANDSCAPE ECOL, V31, P721, DOI 10.1007/s10980-015-0329-7; Sugiyama, 2008, RAILROAD VEHICLE DYN; Trombulak SC, 2000, REV ECOLOGICAL EFFEC, V14; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0	65	7	7	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246248	10.1371/journal.pone.0246248	http://dx.doi.org/10.1371/journal.pone.0246248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QB1HB	33513202	gold, Green Published			2022-12-26	WOS:000613891400042
J	Lopez, K; Arriaga, MB; Aliaga, JG; Barreda, NN; Sanabria, OM; Huang, CC; Zhang, ZB; Garcia-de-la-Guarda, R; Lecca, L; Carvalho, ACC; Kritski, AL; Calderon, RI				Lopez, Kattya; Arriaga, Maria B.; Aliaga, Juan G.; Barreda, Nadia N.; Sanabria, Oswaldo M.; Huang, Chuan-Chin; Zhang, Zibiao; Garcia-de-la-Guarda, Ruth; Lecca, Leonid; Carvalho, Anna Cristina Calcada; Kritski, Afranio L.; Calderon, Roger, I			Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of Nort Lima-Peru	PLOS ONE			English	Article							DIABETES-MELLITUS; PREVALENCE; COMPLEX; IDENTIFICATION; SEVERITY; STRAINS	This study was performed to investigate the role of dysglycemia on the genetic diversity of Mycobacterium tuberculosis (MTB) among pulmonary tuberculosis (TB) patients to build scientific evidence about the possible mechanisms of TB transmission. MTB isolates obtained of patients affected by pulmonary tuberculosis from health care facilities of North Lima-Peru, were analyzed using whole genome sequencing and 24-locus mycobacterial interspersed repetitive-unit -variable-number tandem repeats (MIRU-VNTR). Subsequently, clinical and epidemiological characteristics were associated with clustering, lineages and comorbid conditions. The analysis carried out 112 pulmonary TB patients from various health centers in North Lima, 17 (15%) had diabetes mellitus (DM) and 33 (29%) had pre-diabetes (PDM). Latin American-Mediterranean, Haarlem and Beijing were the most frequent MTB lineages found in those patients. Previous TB (adjusted odds ratio [aOR] = 3.65; 95%CI: 1.32-17.81), age (aOR = 1.12; 95%CI: 1.03-1.45) and Beijing lineage (aOR = 3.53; 95%CI: 1.08-13.2) were associated with TB-DM comorbidity. Alcoholism (aOR = 2.92; 95%CI: 1.10-8.28), age (aOR = 1.05; 95%CI: 1.03-1.12) and Haarlem lineage (aOR = 2.54; 95%CI: 1.04-6.51) were associated with TB-PDM comorbidity. Beijing and Haarlem lineages were independently associated with TB-DM and TB-PDM comorbidities, respectively. Although these findings may be surprising, we must be cautious to suggest that dysglycemia could be associated with a highly clustering and predisposition of MTB lineages related to a serious impact on the severity of TB disease, which requires further research.	[Lopez, Kattya; Aliaga, Juan G.; Barreda, Nadia N.; Sanabria, Oswaldo M.; Lecca, Leonid; Calderon, Roger, I] Socios Salud Sucursal Peru, Lima, Peru; [Lopez, Kattya; Garcia-de-la-Guarda, Ruth] Univ Nacl Mayor San Marcos, Fac Ciencias Biol, Lima, Peru; [Lopez, Kattya] Harvard Med Sch, Div Rheumatol Immun & Inflammat, Brigham & Womens Hosp, Boston, MA USA; [Arriaga, Maria B.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil; [Arriaga, Maria B.] Univ Fed Bahia, Fac Med, Salvador, BA, Brazil; [Arriaga, Maria B.] Fdn Jose Silveira, Inst Brasileiro Invest TB, Salvador, BA, Brazil; [Huang, Chuan-Chin] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA USA; [Zhang, Zibiao] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Carvalho, Anna Cristina Calcada] Fundacao Oswaldo Cruz, Lab Inovacoes Terapias Ensino & Bioprod, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Kritski, Afranio L.; Calderon, Roger, I] Univ Fed Rio Janeiro, Programa Acad TB, Fac Med, Rio De Janeiro, Brazil	Universidad Nacional Mayor de San Marcos; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fundacao Oswaldo Cruz; Universidade Federal da Bahia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Fundacao Oswaldo Cruz	Calderon, RI (corresponding author), Socios Salud Sucursal Peru, Lima, Peru.; Calderon, RI (corresponding author), Univ Fed Rio Janeiro, Programa Acad TB, Fac Med, Rio De Janeiro, Brazil.	rcalderon_ses@pih.org	de la Guarda, Ruth Garcia/AAJ-3594-2020; Carvalho, Anna C.C./K-2662-2016; Kritski, Afranio/I-6760-2016	de la Guarda, Ruth Garcia/0000-0003-4801-5642; Carvalho, Anna C.C./0000-0002-0128-942X; Arriaga Gutierrez, Maria Belen/0000-0001-6883-8422; Lecca, Leonid/0000-0003-1363-3985	National Council of Science, Technology and Technological Innovation (CONCYTEC-Peru)/National Fund for Scientific, Technological Development and Technological Innovation (FONDECYT) [173]; Fundacao de Amparo a Pesquisa da Bahia (FAPESB)	National Council of Science, Technology and Technological Innovation (CONCYTEC-Peru)/National Fund for Scientific, Technological Development and Technological Innovation (FONDECYT); Fundacao de Amparo a Pesquisa da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by the National Council of Science, Technology and Technological Innovation (CONCYTEC-Peru)/National Fund for Scientific, Technological Development and Technological Innovation (FONDECYT) (grant number 173, 2015). MBA receives a fellowship from the Fundacao de Amparo a Pesquisa da Bahia (FAPESB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; American Diabetes Association, 2017, Clin Diabetes, V35; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Barletta F, 2015, J CLIN MICROBIOL, V53, P1854, DOI 10.1128/JCM.03585-14; Barletta F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-397; Blanco-Guillot F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193911; Blanco-Guillot F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184675; Caceres O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112789; Calderon RI, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4416-2; Chae HS, 2018, J MICROBIOL, V56, P300, DOI 10.1007/s12275-018-8041-3; Chen HX, 2018, SCI CHINA LIFE SCI, V61, P651, DOI 10.1007/s11427-017-9243-0; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cohen T, 2011, EMERG INFECT DIS, V17, P969, DOI [10.3201/eid1706.101471, 10.3201/eid/1706.101471]; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coscolla M, 2017, ADV EXP MED BIOL, V1019, P95, DOI 10.1007/978-3-319-64371-7_5; Ford CB, 2013, NAT GENET, V45, P784, DOI 10.1038/ng.2656; Gil-Santana L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146876; Grandjean L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126271; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; Huangfu P, 2019, INT J TUBERC LUNG D, V23, P283, DOI 10.5588/ijtld.18.0359; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Jeon CY, 2010, TROP MED INT HEALTH, V15, P1300, DOI 10.1111/j.1365-3156.2010.02632.x; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kumar NP, 2019, ELIFE, V8, DOI 10.7554/eLife.46477; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lin YHAD., 2019, MANAGEMENT DIABETES; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Ministerio de Salud Peru, 2013, NORM CNIC SAL AT INT; Barreda NN, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4843-0; Noubiap JJ, 2019, LANCET GLOB HEALTH, V7, pE448, DOI 10.1016/S2214-109X(18)30487-X; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Podell BK, 2014, AM J PATHOL, V184, P1104, DOI 10.1016/j.ajpath.2013.12.015; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Restrepo BI, 2007, CLIN INFECT DIS, V45, P436, DOI 10.1086/519939; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Shariff NM, 2015, INT J MYCOBACT, V4, P323, DOI 10.1016/j.ijmyco.2015.09.003; Sheen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065873; Taype CA, 2012, INFECT GENET EVOL, V12, P577, DOI 10.1016/j.meegid.2012.02.002; Ugarte-Gil C, 2020, CLIN INFECT DIS, V70, P780, DOI 10.1093/cid/ciz284; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; World Health Organization, 2018, GLOB TUB REP 2018	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0243184	10.1371/journal.pone.0243184	http://dx.doi.org/10.1371/journal.pone.0243184			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507930	Green Submitted, Green Published, gold			2022-12-26	WOS:000635021400011
J	Sanchez-Romero, M; di Lego, V; Prskawetz, A; Queiroz, BL				Sanchez-Romero, Miguel; di Lego, Vanessa; Prskawetz, Alexia; Queiroz, Bernardo L.			An indirect method to monitor the fraction of people ever infected with COVID-19: An application to the United States	PLOS ONE			English	Article							EPIDEMICS	The number of COVID-19 infections is key for accurately monitoring the pandemics. However, due to differential testing policies, asymptomatic individuals and limited large-scale testing availability, it is challenging to detect all cases. Seroprevalence studies aim to address this gap by retrospectively assessing the number of infections, but they can be expensive and time-intensive, limiting their use to specific population subgroups. In this paper, we propose a complementary approach that combines estimated (1) infection fatality rates (IFR) using a Bayesian melding SEIR model with (2) reported case-fatality rates (CFR) in order to indirectly estimate the fraction of people ever infected (from the total population) and detected (from the ever infected). We apply the technique to the U.S. due to their remarkable regional diversity and because they count with almost a quarter of all global confirmed cases and deaths. We obtain that the IFR varies from 1.25% (0.39-2.16%, 90% CI) in Florida, the most aged population, to 0.69% in Utah (0.21-1.30%, 90% CI), the youngest population. By September 8, 2020, we estimate that at least five states have already a fraction of people ever infected between 10% and 20% (New Jersey, New York, Massachussets, Connecticut, and District of Columbia). The state with the highest estimated fraction of people ever infected is New Jersey with 17.3% (10.0, 55.8, 90% CI). Moreover, our results indicate that with a probability of 90 percent the fraction of detected people among the ever infected since the beginning of the epidemic has been less than 50% in 15 out of the 20 states analyzed in this paper. Our approach can be a valuable tool that complements sero-prevalence studies and indicates how efficient have testing policies been since the beginning of the outbreak.	[Sanchez-Romero, Miguel; di Lego, Vanessa; Prskawetz, Alexia] Univ Vienna, Vienna Inst Demog, Wittgenstein Ctr Demog & Global Human Capital, IIASA,OeAW,Austrian Acad Sci, Vienna, Austria; [Prskawetz, Alexia] TU Wien, Inst Stat & Math Methods Econ, Vienna, Austria; [Queiroz, Bernardo L.] Univ Fed Minas Gerais, Cedeplar, Belo Horizonte, MG, Brazil	Austrian Academy of Sciences; International Institute for Applied Systems Analysis (IIASA); University of Vienna; Technische Universitat Wien; Universidade Federal de Minas Gerais	di Lego, V (corresponding author), Univ Vienna, Vienna Inst Demog, Wittgenstein Ctr Demog & Global Human Capital, IIASA,OeAW,Austrian Acad Sci, Vienna, Austria.	Vanessa.DiLego@oeaw.ac.at		Prskawetz, Alexia/0000-0002-2850-6682; di Lego, Vanessa/0000-0002-1317-3037; Sanchez-Romero, Miguel/0000-0002-5999-6522				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 2020, ESTIMATING MORTALITY; [Anonymous], US MORTALITY DATA BA; Atkeson A., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Atkeson A., 2020, WHAT WILL BE EC IMPA, DOI [10.3386/w26867, DOI 10.3386/W26867]; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Baker S. R., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Balilla J, 2020, SSRN ELECT J; Bao L, 2015, STAT INTERFACE, V8, P125, DOI 10.4310/SII.2015.v8.n2.a1; Bao L, 2012, SEX TRANSM INFECT, V88, pI3, DOI 10.1136/sextrans-2012-050637; Bao L, 2010, SEX TRANSM INFECT, V86, pI93, DOI 10.1136/sti.2010.044529; Basu A, 2020, HEALTH AFFAIR, V39, P1229, DOI 10.1377/hlthaff.2020.00455; Bhopal R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1366; Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; CDC, 2020, COR DIS 2019 COVID 1; CDC, 2020, COVID DAT TRACK TREN; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Clouston SAP, 2021, MEDRXIV; Cohen J, 2020, SCIENCE, V367, P1287, DOI 10.1126/science.367.6484.1287; Cohen MS, 2020, NEW ENGL J MED, V383, P585, DOI 10.1056/NEJMe2020388; Desjardins MR, 2020, APPL GEOGR, V118, DOI 10.1016/j.apgeog.2020.102202; di Lego V., 2020, AGE GENDER COVID 19, DOI 10.1101/2020.05.24.20111765; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Dudel C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238904; Ferguson N., 2020, IMPERIAL COLL COVID, V16; Goldstein JR, 2020, P NATL ACAD SCI USA, V117, P22035, DOI 10.1073/pnas.2006392117; Goldstein Joshua Robert, 2020, medRxiv, DOI 10.1101/2020.05.21.20109116; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hallal P, 2020, REMARKABLE VARIABILI; Hanlon Peter, 2020, Wellcome Open Res, V5, P75, DOI 10.12688/wellcomeopenres.15849.1; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Hepburn M, 2020, IMMUNITY; Hernandez AV, 2020, ANN INTERN MED, V173, P287, DOI 10.7326/M20-2496; Huang AT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18450-4; Jin JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00152; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Kuchler T, 2020, GEOGRAPHIC SPREAD CO; Lachmann A, 2020, CORRECTING UNDER REP; Lee J, 2018, J GERONTOL A-BIOL, V73, P1519, DOI 10.1093/gerona/glx224; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Marquez EJ, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00183-z; Mollalo A, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138884; Nasiri MJ, 2020, FRONT MED-LAUSANNE, DOI DOI 10.3389/fmed.2020.00459; Nussbaumer-Streit B, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013574; OECD, 2020, COVID 19 FOOD AGR SE; Pell R, 2020, LANCET PUBLIC HEALTH, V5, pE474, DOI 10.1016/S2468-2667(20)30180-8; Perez-Saez J, 2020, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099(20)30584-3; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Sanyaolu Adekunle, 2020, SN Compr Clin Med, V2, P1069, DOI 10.1007/s42399-020-00363-4; Spagnolo PA, 2020, ANN INTERN MED, V173, P385, DOI 10.7326/M20-1941; Swaminathan A, 2020, GEROSCIENCE, V42, P1445, DOI 10.1007/s11357-020-00253-6; Tang B, 2020, INT J INFECT DIS, V95, P288, DOI 10.1016/j.ijid.2020.03.018; Tzen M, 2020, 3 COVID 19 MORTALITY; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Weinstein MC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2017739; WHO (World Health Organization, 2020, ESTIMATING MORTALITY; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P510, DOI 10.1001/jama.2020.11787; Wrigley-Field E, 2020, P NATL ACAD SCI USA, V117, P21854, DOI 10.1073/pnas.2014750117; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Xu XL, 2020, NEUROL RES, V42, P83, DOI 10.1080/01616412.2019.1710403; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	69	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245845	10.1371/journal.pone.0245845	http://dx.doi.org/10.1371/journal.pone.0245845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508030	gold, Green Accepted, Green Published			2022-12-26	WOS:000635021400055
J	Hao, YC; Jia, LM; Wang, YH; He, ZC				Hao, Yucheng; Jia, Limin; Wang, Yanhui; He, Zhichao			Modelling cascading failures in networks with the harmonic closeness	PLOS ONE			English	Article							SCALE-FREE NETWORKS; INTERDEPENDENT NETWORKS; ROBUSTNESS; VULNERABILITY; PROBABILITY	Many studies on cascading failures adopt the degree or the betweenness of a node to define its load. From a novel perspective, we propose an approach to obtain initial loads considering the harmonic closeness and the impact of neighboring nodes. Based on simulation results for different adjustable parameter theta, local parameter delta and proportion of attacked nodes f, it is found that in scale-free networks (SF networks), small-world networks (SW networks) and Erdos-Renyi networks (ER networks), there exists a negative correlation between optimal theta and delta. By the removal of the low load node, cascading failures are more likely to occur in some cases. In addition, we find a valuable result that our method yields better performance compared with other methods in SF networks with an arbitrary f, SW and ER networks with large f. Moreover, the method concerning the harmonic closeness makes these three model networks more robust for different average degrees. Finally, we perform the simulations on twenty real networks, whose results verify that our method is also effective to distribute the initial load in different real networks.	[Hao, Yucheng; Jia, Limin; Wang, Yanhui; He, Zhichao] Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China; [Hao, Yucheng; Jia, Limin; Wang, Yanhui; He, Zhichao] Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China; [Jia, Limin; Wang, Yanhui] Beijing Jiaotong Univ, Beijing Res Ctr Urban Traff Informat Sensing & Se, Beijing, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Beijing Jiaotong University	Jia, LM (corresponding author), Beijing Jiaotong Univ, State Key Lab Rail Traff Control & Safety, Beijing, Peoples R China.; Jia, LM (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, Beijing, Peoples R China.; Jia, LM (corresponding author), Beijing Jiaotong Univ, Beijing Res Ctr Urban Traff Informat Sensing & Se, Beijing, Peoples R China.	17120764@bjtu.edu.cn		Hao, Yucheng/0000-0002-3680-0398	State Key Laboratory Traffic Control and Safety, Beijing Jiaotong University [RCS2021ZZ003]	State Key Laboratory Traffic Control and Safety, Beijing Jiaotong University	This work was supported by the State Key Laboratory Traffic Control and Safety, Beijing Jiaotong University (grant No. RCS2021ZZ003).	[Anonymous], 1960, B INT STATIST INST; [Anonymous], 2020, OBSTET GYNECOL, V135, pe1; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Chen Z, 2015, CHAOS SOLITON FRACT, V80, P7, DOI 10.1016/j.chaos.2015.03.005; Dou BL, 2010, PHYSICA A, V389, P2310, DOI 10.1016/j.physa.2010.02.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.108701; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hao Y, 2019, C COMPL NETW THEIR A, P709; Hao YC, 2020, PHYSICA A, V541, DOI 10.1016/j.physa.2019.123373; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056109; Hong S, 2016, J PHYS A-MATH THEOR, V49, DOI 10.1088/1751-8113/49/19/195101; Kabir MN, 2018, INT J CRIT INFR PROT, V20, P16, DOI 10.1016/j.ijcip.2017.11.002; Liu HR, 2017, NEUROCOMPUTING, V260, P443, DOI 10.1016/j.neucom.2017.04.042; Liu J, 2016, PHYSICA A, V456, P302, DOI 10.1016/j.physa.2016.03.040; Liu LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164777; Macdonald PJ, 2005, EUROPHYS LETT, V72, P308, DOI 10.1209/epl/i2005-10232-x; Mirzasoleiman B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046114; Motter A, 2008, J PHYS A, V41, P4539; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Peng XZ, 2015, NONLINEAR DYNAM, V82, P97, DOI 10.1007/s11071-015-2141-y; Qian YS, 2015, NONLINEAR DYNAM, V80, P413, DOI 10.1007/s11071-014-1878-z; Ren WD, 2018, IEEE T CIRCUITS-II, V65, P632, DOI 10.1109/TCSII.2018.2822049; Reynolds-Barredo JM, 2016, CHAOS, V26, DOI 10.1063/1.4967736; Tan F, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.052809; Tan F, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/28009; Tian M, 2015, EPL-EUROPHYS LETT, V111, DOI 10.1209/0295-5075/111/18007; Wang JW, 2011, SAFETY SCI, V49, P807, DOI 10.1016/j.ssci.2010.10.003; Wang JW, 2009, SAFETY SCI, V47, P1332, DOI 10.1016/j.ssci.2009.02.002; Wang JW, 2009, PHYSICA A, V388, P1289, DOI 10.1016/j.physa.2008.12.067; Wang JW, 2008, PHYSICA A, V387, P6671, DOI 10.1016/j.physa.2008.08.037; Wang JW, 2015, PHYSICA A, V430, P242, DOI 10.1016/j.physa.2015.02.072; Wang J, 2014, NONLINEAR DYNAM, V78, P37, DOI 10.1007/s11071-014-1420-3; Wang JW, 2012, NONLINEAR DYNAM, V70, P1959, DOI 10.1007/s11071-012-0587-8; Wang WX, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026101; Wang Y., 2018, NONLINEAR DYN, V92, P1; Wu JJ, 2007, PHYSICA A, V386, P407, DOI 10.1016/j.physa.2007.08.034; Wu JJ, 2007, PHYSICA A, V378, P505, DOI 10.1016/j.physa.2006.12.003; Wu Z, 2008, J STAT MECH THEOR E, V2008, P202; Yagan O, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.062811; Yan J, 2015, IEEE T POWER SYST, V30, P285, DOI 10.1109/TPWRS.2014.2322082; Yang R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026112; Yang Y, 2017, SCIENCE, V358, DOI 10.1126/science.aan3184; Zeng Y, 2014, INT J PROD RES, V52, P6938, DOI 10.1080/00207543.2014.917769; Zhang JH, 2015, SAFETY SCI, V80, P156, DOI 10.1016/j.ssci.2015.08.002	49	3	3	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0243801	10.1371/journal.pone.0243801	http://dx.doi.org/10.1371/journal.pone.0243801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493179	Green Published, gold			2022-12-26	WOS:000613081500037
J	Ehelepola, NDB; Ariyaratne, K; Dissanayake, DS				Ehelepola, N. D. B.; Ariyaratne, Kusalika; Dissanayake, D. S.			The interrelationship between meteorological parameters and leptospirosis incidence in Hambantota district, Sri Lanka 2008-2017 and practical implications	PLOS ONE			English	Article							NINO-SOUTHERN-OSCILLATION; SEROVAR BATAVIAE; EPIDEMIOLOGY; CARRIER; TIME; RAT	Background Leptospirosis is a bacterial zoonosis. Leptospirosis incidence (LI) in Sri Lanka is high. Infected animals pass leptospires to the environment with their urine. Leprospires' survival in the environment to infect a new host depends on meteorological factors. El Nino Southern Oscillation (ENSO) and Indian Ocean Dipole (IOD) modulate the weather in Sri Lanka. Objectives The determination of interrelationship between the LI in the Hambantota District, and local meteorological parameters, ENSO and IOD. Methods We acquired notified leptospirosis cases in the Hambantota District and population data. We calculated weekly leptospirosis incidences for 2008 to 2017. Weather data from two weather stations was obtained, averaged and converted into weekly data. We plotted time series graphs and observed the correlation between seven aggregated weather parameters and LI. We estimated cross-correlations between those weather parameters and LI. As our principal analysis we determined correlation between LI and seven local weather parameters, Nino 3.4, Nino4 and Dipole Mode Index (DMI) indices using wavelet analysis. Results Our wavelet analysis results showed troughs of minimum, maximum, mean temperatures, soil temperature, the evaporation rate, the duration of sunshine were followed by peaks in LI and peaks of rainfall followed by peaks of LI, all after lag periods. Our time series graphs and cross-correlation determination results are generally in agreement with these results. However there was no significant correlation between rainfall and LI in the cross-correlation analysis. There were peaks of LI following both peaks and troughs of DMI. There was no clear correlation between both Nino indices and LI. Discussion This may be the first long-term study demonstrating soil temperature, evaporation rate and IOD are correlating with LI. The correlation pattern of LI with temperature parameters differs from similar past studies and we explain the reasons. We propose ways to control high LI we observed after periods of weather favorable for transmission of leptospirosis.	[Ehelepola, N. D. B.] Teaching Gen Hosp Peradeniya, Peradeniya, Sri Lanka; [Ariyaratne, Kusalika] Lanka Hydraul Inst, Moratuwa, Sri Lanka; [Dissanayake, D. S.] Univ Peradeniya, Fac Med, Peradeniya, Sri Lanka	University of Peradeniya	Ehelepola, NDB (corresponding author), Teaching Gen Hosp Peradeniya, Peradeniya, Sri Lanka.	drehelepola@gmail.com						Abd Rahim MA, 2018, MALAYSIAN J APPL SCI, V3, P46; Agampodi SB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002626; Andersen-Ranberg EU, 2016, J WILDLIFE DIS, V52, P468, DOI 10.7589/2014-10-245; [Anonymous], 2003, HUM LEPT GUID DIAGN; Arias-Monsalve CS, 2019, J INFECT DEV COUNTR, V13, P1108, DOI 10.3855/jidc.11702; Bambaradeniya CNB, 2004, BIODIVERS CONSERV, V13, P1715, DOI 10.1023/B:BIOC.0000029331.92656.de; Bandara JMRS, 2010, TOXICOL LETT, V198, P33, DOI 10.1016/j.toxlet.2010.04.016; Barragan Veronica, 2017, Appl Environ Microbiol, V83, DOI 10.1128/AEM.01190-17; Benacer D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1400-1; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Burt TP, 2014, CLIMATE, V2, P242, DOI 10.3390/cli2040242; Casanovas-Massana A, 2018, APPL ENVIRON MICROB, V84, DOI [10.1128/aem.00507-18, 10.1128/AEM.00507-18]; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chadsuthi S, 2010, AFR J BIOTECHNOL, V9, P3196; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Dhewantara PW, 2019, ZOONOSES PUBLIC HLTH, V66, P185, DOI 10.1111/zph.12549; Director General of Sri Lanka Disaster Management Center, 2011, AS C DIS RED JUN 13; Ehelepola NDB, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2018.1553283; Ehelepola NDB, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0075-8; Ehelepola ND, 2018, J TROPICAL MED; Ellis WA, 2015, CURR TOP MICROBIOL, V387, P99, DOI 10.1007/978-3-662-45059-8_6; Epidemiology Unit Ministry of Health-Sri Lanka, 2011, WEEKLY EPIDEMIOLOGIC, V38; Epidemiology Unit.Ministry of Health-Sri Lanka, 2016, NAT GUID MAN LEPT; Fall MW, 2015, RODENT CONTROL PRACT; Fonseka CL, 2019, J TROPICAL MED, DOI [10.1155/2156587214525402, DOI 10.1155/2156587214525402]; Gamage CD, 2014, TRANSBOUND EMERG DIS, V61, P91, DOI 10.1111/tbed.12014; Gamage CD, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008437; Goarant C., GLOBAL WATER PATHOGE; Golden I, 2014, J EVID-BASED INTEGR, V19, P155, DOI 10.1177/2156587214525402; Grinsted A, APPL CROSS WAVELET T; Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012; Jayakody P.M., 2015, SRI LANKA J METEOROL, V1; Jevrejeva S, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003417; Kumar KV, 2020, DETECTION PATHOGENIC, DOI [10.1101/2020.05.03.074963, DOI 10.1101/2020.05.03.074963]; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Mwachui MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003843; Naotunna C, 2016, ASIAN PAC J TROP MED, V9, P381, DOI 10.1016/j.apjtm.2016.03.009; Orrock JL, 2009, ETHOLOGY, V115, P641, DOI 10.1111/j.1439-0310.2009.01654.x; Parajuli NP, 2017, CASE REP INFECT DIS, V2017, P1, DOI 10.1155/2017/1862320; Premdas AK., 2019, INT J COMMUNITY MED, V6, P4857, DOI [10.18203/2394-6040.ijcmph20195068, DOI 10.18203/2394-6040.IJCMPH20195068]; Punyawardena R., 2013, SPATIAL VARIATION CL; Reason J, 2000, BMJ-BRIT MED J, V320, P768, DOI 10.1136/bmj.320.7237.768; Robertson C, 2012, EPIDEMIOL INFECT, V140, P731, DOI 10.1017/S0950268811001014; Schonning MH, 2019, ECOHEALTH, V16, P534, DOI 10.1007/s10393-019-01448-w; Soo ZMP, 2020, ACTA TROP, V201, DOI 10.1016/j.actatropica.2019.105183; Storck CH, 2008, EPIDEMIOL INFECT, V136, P1407, DOI 10.1017/S0950268807000052; THIERMANN AB, 1981, J WILDLIFE DIS, V17, P39, DOI 10.7589/0090-3558-17.1.39; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tun MMN, 2020, J CLIN VIROL, V125, DOI 10.1016/j.jcv.2020.104304; Warnasekara JN, 2017, SRI LANKAN J INFECT, V7, DOI [10.4038/sljid.v7i2.8155, DOI 10.4038/SLJID.V7I2.8155]; Yapa A, 2013, FIELD ORNITHOLOGY GR, DOI [10.1186/s40249-019-0617-6, DOI 10.1186/S40249-019-0617-6]; Zinsstag J, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00757-5; ZUBAIR L, 2003, GEOPHYS RES LETT, V30, DOI DOI 10.1007/S00442-008-0993-2; Zubair L, 2008, INT J CLIMATOL, V28, P91, DOI 10.1002/joc.1514	55	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245366	10.1371/journal.pone.0245366	http://dx.doi.org/10.1371/journal.pone.0245366			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481868	gold, Green Published			2022-12-26	WOS:000612929300138
J	Bayati, A; Kumar, R; Francis, V; McPherson, PS				Bayati, Armin; Kumar, Rahul; Francis, Vincent; McPherson, Peter S.			SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; VIRUS ENTRY; RECEPTOR; PNEUMONIA; ACE2; COVID-19; BINDING; PROTEIN; SPIKE	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of COVID-19, so understanding its biology and infection mechanisms is critical to facing this major medical challenge. SARS-CoV-2 is known to use its spike glycoprotein to interact with the cell surface as a first step in the infection process. As for other coronaviruses, it is likely that SARS-CoV-2 next undergoes endocytosis, but whether or not this is required for infectivity and the precise endocytic mechanism used are unknown. Using purified spike glycoprotein and lentivirus pseudotyped with spike glycoprotein, a common model of SARS-CoV-2 infectivity, we now demonstrate that after engagement with the plasma membrane, SARS-CoV-2 undergoes rapid, clathrin-mediated endocytosis. This suggests that transfer of viral RNA to the cell cytosol occurs from the lumen of the endosomal system. Importantly, we further demonstrate that knockdown of clathrin heavy chain, which blocks clathrin-mediated endocytosis, reduces viral infectivity. These discoveries reveal that SARS-CoV-2 uses clathrin-mediated endocytosis to gain access into cells and suggests that this process is a key aspect of virus infectivity.	[Bayati, Armin; Kumar, Rahul; Francis, Vincent; McPherson, Peter S.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	peter.mcpherson@mcgill.ca		Bayati, Armin/0000-0002-5960-0479; Kumar, Rahul/0000-0002-7762-807X	Natural Sciences and Engineering Research Council; Parkinson Society of Canada; ALS Canada; Fonds de recherche du Quebec-Sante	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Parkinson Society of Canada; ALS Canada; Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Natural Sciences and Engineering Research Council to P. S. M. A. B. is supported by a studentship from the Parkinson Society of Canada. R. K. is supported by a studentship from ALS Canada. V. F. was supported by a fellowship from the Fonds de recherche du Quebec-Sante. P. S. M. is a James McGill Professor and a Fellow of the Royal Society of Canada.	Burkard C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004502; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Davies J, 2020, MOL MED REP, V22, P4221, DOI 10.3892/mmr.2020.11510; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Ghosh S, 2020, CELL, V183, P1520, DOI 10.1016/j.cell.2020.10.039; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hu TY, 2020, NAT NANOTECHNOL, V15, P247, DOI 10.1038/s41565-020-0674-9; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Kang Yuan-Lin, 2020, Proc Natl Acad Sci U S A, V117, P20803, DOI [10.1101/2020.04.21.053058, 10.1073/pnas.2007837117]; Kiesslich S, 2020, J BIOTECHNOL, V310, P32, DOI 10.1016/j.jbiotec.2020.01.015; Kim ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017158; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lemmon SK, 2012, TRAFFIC, V13, P511, DOI 10.1111/j.1600-0854.2011.01321.x; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li HS, 2005, TRAFFIC, V6, P324, DOI 10.1111/j.1600-0854.2005.00274.x; Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Milewska A, 2018, J VIROL, V92, DOI 10.1128/JVI.01933-17; Miller SE, 2015, DEV CELL, V33, P163, DOI 10.1016/j.devcel.2015.03.002; Nature, 2021, NATURE; Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004; Owczarek K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25640-0; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Plaze M, 2020, ENCEPHALE, V46, P169, DOI 10.1016/j.encep.2020.05.006; Stoorvogel W, 1991, Targeted Diagn Ther, V4, P267; Sun H, 2020, P NATL ACAD SCI USA, V117, P17204, DOI [10.1073/pnas.1921186117, DOI 10.1073/pnas.1921186117]; Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weston S, 2020, J VIROL, V94, DOI 10.1128/JVI.01218-20; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yamauchi Y, 2013, J CELL SCI, V126, P1289, DOI 10.1242/jcs.119685; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	49	143	143	13	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100306	10.1016/j.jbc.2021.100306	http://dx.doi.org/10.1016/j.jbc.2021.100306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476648	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400280
J	Kluge, MG; Maltby, S; Walker, N; Bennett, N; Aidman, E; Nalivaiko, E; Walker, FR				Kluge, Murielle G.; Maltby, Steven; Walker, Nicole; Bennett, Neanne; Aidman, Eugene; Nalivaiko, Eugene; Walker, Frederick Rohan			Development of a modular stress management platform (Performance Edge VR) and a pilot efficacy trial of a bio-feedback enhanced training module for controlled breathing	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; VIRTUAL-REALITY; COGNITIVE PERFORMANCE; COMMITMENT THERAPY; PACED RESPIRATION; BIOFEEDBACK; ACCEPTANCE; MEMORY	This paper describes the conceptual design of a virtual reality-based stress management training tool and evaluation of the initial prototype in a pilot efficacy study. Performance Edge virtual-reality (VR) was co-developed with the Australian Defence Force (ADF) to address the need for practical stress management training for ADF personnel. The VR application is biofeedback-enabled and contains key stress management techniques derived from acceptance and commitment and cognitive behavioural therapy in a modular framework. End-user-provided feedback on usability, design, and user experience was positive, and particularly complimentary of the respiratory biofeedback functionality. Training of controlled breathing delivered across 3 sessions increased participants' self-reported use of breath control in everyday life and progressively improved controlled breathing skills (objectively assessed as a reduction in breathing rate and variability). Thus the data show that a biofeedback-enabled controlled breathing protocol delivered through Performance Edge VR can produce both behaviour change and objective improvement in breathing metrics. These results confirm the validity of Performance Edge VR platform, and its Controlled Breathing module, as a novel approach to tailoring VR-based applications to train stress management skills in a workplace setting.	[Kluge, Murielle G.; Maltby, Steven; Nalivaiko, Eugene; Walker, Frederick Rohan] Univ Newcastle, Fac Hlth & Med, Ctr Adv Training Syst, Callaghan, NSW, Australia; [Kluge, Murielle G.; Maltby, Steven; Aidman, Eugene; Nalivaiko, Eugene; Walker, Frederick Rohan] Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Walker, Nicole] Army Sch Hlth, Bonegilla, Vic, Australia; [Bennett, Neanne] Dept Def, Canberra, ACT, Australia; [Aidman, Eugene] Def Sci & Technol Grp, Land Div, Edinburgh, SA, Australia; [Aidman, Eugene] Univ Sydney, Sch Psychol, Sydney, NSW, Australia	University of Newcastle; University of Newcastle; Defence Science & Technology; Defence Science & Technology; University of Sydney	Walker, FR (corresponding author), Univ Newcastle, Fac Hlth & Med, Ctr Adv Training Syst, Callaghan, NSW, Australia.; Walker, FR (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia.	rohan.walker@newcastle.edu.au	Bennett, Neanne/GWM-6383-2022	Maltby, Steven/0000-0003-1240-5964; AIDMAN, Eugene/0000-0002-7711-794X	Australian Defence Innovation Hub [CTD 2017-5]	Australian Defence Innovation Hub	Funding for this project was provided by the Australian Defence Innovation Hub (https://www.innovationhub.defence.gov.au/; Contract CTD 2017-5; authors EN & FRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidman E, 2020, FRONT HUM NEUROSCI, V13, DOI 10.3389/fnhum.2019.00466; Andersen JP, 2016, SAGE OPEN, V6, DOI 10.1177/2158244016638708; Andersen JP, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015590446; [Anonymous], 2010, J OBSTET GYNAECOLOGY; Baars M, 2018, LEARN INDIVID DIFFER, V64, P125, DOI 10.1016/j.lindif.2018.05.007; Botella C, 2015, NEUROPSYCH DIS TREAT, V11, P2533, DOI 10.2147/NDT.S89542; Brady M, 2020, ETR&D-EDUC TECH RES, V68, P2853, DOI 10.1007/s11423-020-09800-6; CLARK ME, 1990, BIOFEEDBACK SELF-REG, V15, P273, DOI 10.1007/BF01011109; Crawford C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/747694; de Bruin EI, 2016, MINDFULNESS, V7, P1182, DOI 10.1007/s12671-016-0561-5; Dessy E, 2018, J COGN ENHANCE, V2, P12, DOI 10.1007/s41465-017-0039-y; Engert V, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700495; Girotti M, 2018, PROG NEURO-PSYCHOPH, V85, P161, DOI 10.1016/j.pnpbp.2017.07.004; Grossman E, 2001, J HUM HYPERTENS, V15, P263, DOI 10.1038/sj.jhh.1001147; Heilman KJ, 2008, APPL PSYCHOPHYS BIOF, V33, P83, DOI 10.1007/s10484-008-9054-1; Jester DJ, 2019, AGING MENT HEALTH, V23, P574, DOI 10.1080/13607863.2018.1432031; Kaplan JB, 2017, MINDFULNESS, V8, P1373, DOI 10.1007/s12671-017-0713-2; Kennedy L, 2019, COGN TECHNOL WORK, V21, P161, DOI 10.1007/s10111-018-0487-x; Kiselev A. B., 2012, Vestnik Otorinolaringologii, P44; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Lerner D, 2020, JMIR SERIOUS GAMES, V8, DOI 10.2196/18822; Ley R, 1999, BEHAV MODIF, V23, P441, DOI 10.1177/0145445599233006; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Maarsingh BM, 2019, GAMES HEALTH J, V8, P326, DOI 10.1089/g4h.2018.0145; Makransky G, 2018, ETR&D-EDUC TECH RES, V66, P1141, DOI 10.1007/s11423-018-9581-2; Mattingly V, 2019, HUM RESOUR MANAGE R, V29, P140, DOI 10.1016/j.hrmr.2018.03.002; MCCAUL KD, 1979, J PERS SOC PSYCHOL, V37, P564, DOI 10.1037/0022-3514.37.4.564; Meredith Lisa S, 2011, Rand Health Q, V1, P2; Ost LG, 2014, BEHAV RES THER, V61, P105, DOI 10.1016/j.brat.2014.07.018; Pallavicini F, 2016, AEROSP MED HUM PERF, V87, P1021, DOI 10.3357/AMHP.4596.2016; Pizzoli SFM, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00479; Powers MB, 2009, PSYCHOTHER PSYCHOSOM, V78, P73, DOI 10.1159/000190790; Prinsloo GE, 2013, APPL PSYCHOPHYS BIOF, V38, P81, DOI 10.1007/s10484-013-9210-0; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Rizzo A, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1414560; Rockstroh C, 2019, INT J HUM-COMPUT ST, V130, P209, DOI 10.1016/j.ijhcs.2019.06.011; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Russo MA, 2017, BREATHE, V13, P298, DOI 10.1183/20734735.009817; Schein MH, 2001, J HUM HYPERTENS, V15, P271, DOI 10.1038/sj.jhh.1001148; Schwabe L, 2012, NEUROSCI BIOBEHAV R, V36, P1740, DOI 10.1016/j.neubiorev.2011.07.002; Silverman WK, 2008, J CLIN CHILD ADOLESC, V37, P105, DOI 10.1080/15374410701817907; SISTO SA, 1995, CLIN AUTON RES, V5, P139, DOI 10.1007/BF01826195; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stetz MC, 2011, MIL MED, V176, P1065, DOI 10.7205/MILMED-D-10-00393; Sutarto AP, 2013, WORK, V44, P231, DOI 10.3233/WOR-121499; van den Hout MA, 2011, J BEHAV THER EXP PSY, V42, P423, DOI 10.1016/j.jbtep.2011.03.004; van Dixhoorn Jan, 2015, ERJ Open Res, V1; Vaschillo EG, 2006, APPL PSYCHOPHYS BIOF, V31, P129, DOI 10.1007/s10484-006-9009-3; Wood KH, 2015, NEUROIMAGE, V119, P371, DOI 10.1016/j.neuroimage.2015.06.086; Yackle K, 2017, SCIENCE, V355, P1411, DOI 10.1126/science.aai7984; Zaccaro A, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00353	52	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245068	10.1371/journal.pone.0245068	http://dx.doi.org/10.1371/journal.pone.0245068			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529187	gold, Green Published			2022-12-26	WOS:000616736200043
J	Xu, ZJ; Zhang, DX; Xu, D; Li, X; Xie, YJ; Sun, W; Lee, EKP; Yip, BHK; Mo, PKH; Xiao, SY; Wong, SYS				Xu, Zijun; Zhang, Dexing; Xu, Dong; Li, Xue; Xie, Yao Jie; Sun, Wen; Lee, Eric Kam-Pui; Yip, Benjamin Hon-Kei; Mo, Phoenix Kit-Han; Xiao, Shuiyuan; Wong, Samuel Yeung-Shan			Physical and mental health outcomes including behavior and attitudes in people having social contacts with COVID-19 patients	PLOS ONE			English	Article							QUESTIONNAIRE; RELIABILITY; DEPRESSION; VALIDITY; VERSION	The novel coronavirus (COVID-19) infection has spread worldwide since late 2019. People who have social contacts with COVID-19 patients might be at higher risk of physical or mental health problems. This study investigated whether people who had social contacts with COVID-19 patients would have poorer physical or mental outcomes, and different attitudes and behaviors. Chinese adults were recruited to fill in an online survey using snowball sampling during 21(st)-26(nd) February 2020. Physical symptoms, psychological outcomes, quality of life, COVID-19 related attitudes, and behaviors were measured. The differences in the outcomes between participants who had COVID-19 social contacts and those who had not were analyzed. The survey included 1,447 non-infected eligible participants. Among those, 173 (12.0%) reported at least one confirmed/suspected case in their social contacts. In the multiple regression adjusted for demographic data, the presence of confirmed/suspected infection cases in one's social contacts was significantly associated with poorer physical and mental outcomes, lower health-related quality of life, and different COVID-19 related attitudes and behaviors (p<0.05). In conclusion, people who had social contacts with COVID-19 patients were at risk of adverse health outcomes. Future studies are needed to understand the long-term impacts. Similarly, strategies to improve health outcomes for these people are needed.	[Xu, Zijun; Zhang, Dexing; Sun, Wen; Lee, Eric Kam-Pui; Yip, Benjamin Hon-Kei; Mo, Phoenix Kit-Han; Wong, Samuel Yeung-Shan] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China; [Xu, Dong] Sun Yat Sen Univ, Sch Publ Hlth, Global Hlth Inst, Guangzhou, Peoples R China; [Xu, Dong] Sun Yat Sen Univ, Inst State Governance, Guangzhou, Peoples R China; [Li, Xue] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Peoples R China; [Li, Xue] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Peoples R China; [Xie, Yao Jie] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China; [Xiao, Shuiyuan] Cent South Univ, Xiangya Sch Publ Hlth, Changsha, Peoples R China	Chinese University of Hong Kong; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; Central South University	Zhang, DX (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China.	zhangdxdaisy@cuhk.edu.hk	Xu, Dong/Z-1502-2019; Lee, Kam Pui Eric/I-3685-2018; Yip, Benjamin/AAC-7845-2019; Xie, Yao Jie/K-7001-2014	Xu, Dong/0000-0001-7438-632X; Lee, Kam Pui Eric/0000-0001-8267-9384; Yip, Benjamin/0000-0002-4749-7611; Xie, Yao Jie/0000-0001-9289-4985; ZHANG, Dexing/0000-0003-0073-4752; Sun, Wen/0000-0001-9951-405X				Alonzi S, 2020, PSYCHOL TRAUMA-US, V12, pS236, DOI 10.1037/tra0000840; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; Chen Y, 2020, CHINESE PHYS C, V44, DOI 10.1088/1674-1137/44/8/083108; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Greenberg J, 2019, BRAIN IMAGING BEHAV, V13, P366, DOI 10.1007/s11682-018-9858-4; Hollander JE, 2020, NEW ENGL J MED, V382, P1679, DOI 10.1056/NEJMp2003539; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee S, 2011, J PSYCHOSOM RES, V71, P69, DOI 10.1016/j.jpsychores.2011.01.016; Liu LY, 2009, J TRADIT CHIN MED, V29, P271, DOI 10.1016/S0254-6272(09)60080-7; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Luo N, 2003, ANN ACAD MED SINGAP, V32, P685; Lupe SE, 2020, CURR OPIN GASTROEN, V36, P295, DOI 10.1097/MOG.0000000000000646; Ma Fei, 2016, J Gerontol A Biol Sci Med Sci, V71, P1376, DOI 10.1093/gerona/glv183; Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Stankovska G., 2020, SOC REGISTER, V4, P33, DOI [DOI 10.14746/SR.2020.4.2.03, 10.14746/sr.2020.4.2.03]; Sun LC, 2020, IEEE C EVOL COMPUTAT; Tong X, 2016, EPILEPSY RES, V120, P31, DOI 10.1016/j.eplepsyres.2015.11.019; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Wang WZ, 2014, GEN HOSP PSYCHIAT, V36, P539, DOI 10.1016/j.genhosppsych.2014.05.021; Yang L, 2018, CONTEMP NURSE, V54, P630, DOI 10.1080/10376178.2018.1552525; Zhang DX, 2018, J AFFECT DISORDERS, V227, P795, DOI 10.1016/j.jad.2017.11.082; ZHANG JX, 1995, PSYCHOLOGIA, V38, P174	32	3	3	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245945	10.1371/journal.pone.0245945	http://dx.doi.org/10.1371/journal.pone.0245945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529204	Green Published, gold			2022-12-26	WOS:000616736200036
J	Kim, HG; Huot, JR; Pin, F; Guo, B; Bonetto, A; Nader, GA				Kim, Hyo-Gun; Huot, Joshua R.; Pin, Fabrizio; Guo, Bin; Bonetto, Andrea; Nader, Gustavo A.			Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia	FASEB JOURNAL			English	Article						anabolic deficit; cancer cachexia; muscle wasting; rDNA transcription; ribosome biogenesis; RNA Polymerase 1	RNA GENES; MEASURED INVIVO; BEARING; TUMOR; DEGRADATION; TURNOVER; SURVIVAL; LIVER; PREVALENCE; METABOLISM	Muscle wasting in cancer is associated with deficits in protein synthesis, yet, the mechanisms underlying this anabolic impairment remain poorly understood. The capacity for protein synthesis is mainly determined by the abundance of muscle ribosomes, which is in turn regulated by transcription of the ribosomal (r)RNA genes (rDNA). In this study, we investigated whether muscle loss in a preclinical model of ovarian cancer is associated with a reduction in ribosomal capacity and was a consequence of impaired rDNA transcription. Tumor bearing resulted in a significant loss in gastrocnemius muscle weight and protein synthesis capacity, and was consistent with a significant reduction in rDNA transcription and ribosomal capacity. Despite the induction of the ribophagy receptor NUFIP1 mRNA and the loss of NUFIP1 protein, in vitro studies revealed that while inhibition of autophagy rescued NUFIP1, it did not prevent the loss of rRNA. Electrophoretic analysis of rRNA fragmentation from both in vivo and in vitro models showed no evidence of endonucleolytic cleavage, suggesting that rRNA degradation may not play a major role in modulating muscle ribosome abundance. Our results indicate that in this model of ovarian cancer-induced cachexia, the ability of skeletal muscle to synthesize protein is compromised by a reduction in rDNA transcription and consequently a lower ribosomal capacity. Thus, impaired ribosomal production appears to play a key role in the anabolic deficits associated with muscle wasting in cancer cachexia.	[Kim, Hyo-Gun; Guo, Bin; Nader, Gustavo A.] Penn State Univ, Dept Kinesiol, 101 Noll Lab, University Pk, PA 16802 USA; [Huot, Joshua R.; Bonetto, Andrea] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Pin, Fabrizio; Bonetto, Andrea] Indiana Univ Sch Med, Dept Anat & Cell Biol & Physiol, Indianapolis, IN 46202 USA; [Bonetto, Andrea] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Nader, Gustavo A.] Penn State Univ, Penn State Canc Inst, University Pk, PA 16802 USA; [Nader, Gustavo A.] Indiana Univ Sch Med, Indiana Ctr Musculoskeletal Hlth, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Indiana University System; Indiana University Bloomington	Nader, GA (corresponding author), Penn State Univ, Dept Kinesiol, 101 Noll Lab, University Pk, PA 16802 USA.	gan11@psu.edu						Aust S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140403; Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643; BARACOS VE, 1995, AM J PHYSIOL-ENDOC M, V268, pE996, DOI 10.1152/ajpendo.1995.268.5.E996; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bronger H, 2017, INT J GYNECOL CANCER, V27, P223, DOI 10.1097/IGC.0000000000000867; Burckart K, 2010, CURR OPIN CLIN NUTR, V13, P410, DOI 10.1097/MCO.0b013e328339fdd2; Choi RH, 2019, FASEB J, V33, P5654, DOI 10.1096/fj.201802145RR; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Cui CH, 2004, BIOTECHNIQUES, V36, P134, DOI 10.2144/04361RR04; Durham WJ, 2009, CURR OPIN CLIN NUTR, V12, P72, DOI 10.1097/MCO.0b013e32831cef61; Dworzak F, 1998, CANCER, V82, P42, DOI 10.1002/(SICI)1097-0142(19980101)82:1<42::AID-CNCR5>3.0.CO;2-M; EMERY PW, 1984, CANCER RES, V44, P2779; EMERY PW, 1984, BRIT MED J, V289, P584, DOI 10.1136/bmj.289.6445.584; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; GOODLAD GAJ, 1988, BIOCHIM BIOPHYS ACTA, V950, P296, DOI 10.1016/0167-4781(88)90125-X; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Hannan Katherine M., 1998, Frontiers in Bioscience, V3, pD376; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; Huang CY, 2020, J CACHEXIA SARCOPENI, V11, P534, DOI 10.1002/jcsm.12524; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; King KL, 2000, CELL DEATH DIFFER, V7, P994, DOI 10.1038/sj.cdd.4400731; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Li M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0502; LOPES MN, 1989, BIOCHEM J, V264, P713, DOI 10.1042/bj2640713; Machida M, 2012, J CELL PHYSIOL, V227, P1569, DOI 10.1002/jcp.22871; Mathis AD, 2017, MOL CELL PROTEOMICS, V16, P243, DOI 10.1074/mcp.M116.063255; MILLWARD DJ, 1973, NATURE, V241, P204, DOI 10.1038/241204a0; MILLWARD DJ, 1976, BIOCHEM J, V156, P185, DOI 10.1042/bj1560185; MILLWARD DJ, 1975, BIOCHEM J, V150, P235, DOI 10.1042/bj1500235; Millward DJ., 1980, CIBA FDN S, P307; MOSS T, 1995, PROG NUCLEIC ACID RE, V50, P25, DOI 10.1016/S0079-6603(08)60810-7; Mueller O., 2004, AGIL APPL NOTE, V2011, P1, DOI DOI 10.1186/1471-2199-7-3; NIKOLOV EN, 1983, BIOSCIENCE REP, V3, P781, DOI 10.1007/BF01120990; Paule MR, 1998, TRANSCRIPTION RIBOSO; Pin F, 2018, J CACHEXIA SARCOPENI, V9, P685, DOI 10.1002/jcsm.12311; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2011, CURR OPIN CLIN NUTR, V14, P250, DOI 10.1097/MCO.0b013e3283455d45; Ramachandran KV, 2018, MOL CELL, V71, P169, DOI 10.1016/j.molcel.2018.06.013; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; Rosa-Caldwell ME, 2020, J APPL PHYSIOL, V128, P25, DOI 10.1152/japplphysiol.00622.2019; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Rutten IJG, 2016, J CACHEXIA SARCOPENI, V7, P458, DOI 10.1002/jcsm.12107; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; SVANINGER G, 1983, J NATL CANCER I, V71, P341; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1; TESSITORE L, 1993, ARCH BIOCHEM BIOPHYS, V306, P52, DOI 10.1006/abbi.1993.1479; Thoresen L, 2013, CLIN NUTR, V32, P65, DOI 10.1016/j.clnu.2012.05.009; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tseng H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001843; von Walden F, 2016, AM J PHYSIOL-CELL PH, V311, pC663, DOI 10.1152/ajpcell.00144.2016; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; WOOL IG, 1967, P NATL ACAD SCI USA, V58, P2401, DOI 10.1073/pnas.58.6.2401; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Yan SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010210	63	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21335	10.1096/fj.202002257R	http://dx.doi.org/10.1096/fj.202002257R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33527503	Green Accepted			2022-12-26	WOS:000647789600014
J	Becker, EF; Crowley, DW				Becker, Earl F.; Crowley, David W.			Estimating brown bear abundance and harvest rate on the southern Alaska Peninsula	PLOS ONE			English	Article							LINE-TRANSECT; MARK-RECAPTURE; SPATIAL MODELS	Abundance estimation of hunted brown bear populations should occur on the same geographic scale as harvest data analyses for estimation of harvest rate. Estimated harvest rates are an important statistic for managing hunted bear populations. In Alaska, harvest data is collected over large geographic units, called Game Management Units (GMUs) and sub-GMUs. These sub GMUs often exceed 10,000 km(2). In the spring of 2002, we conducted an aerial survey of GMU 9D (12,600 km(2)) and GMU 10 (4,070 km(2)) using distance sampling with mark-resight data. We used a mark-resight distance sampling method with a two-piece normal detection function to estimate brown bear abundance as 1,682.9 (SE = 174.29) and 316.9 (SE = 48.25) for GMU 9D and GMU 10, respectively. We used reported hunter harvest to estimate harvest rates of 4.35% (SE = 0.45%) and 3.06% (SE = 0.47%) for GMU 9D and GMU 10, respectively. Management objective for these units support sustained, high quality hunting opportunity which harvest data indicate are met with an annual harvest rate of approximately 5-6% or less.	[Becker, Earl F.] Alaska Dept Fish & Game, Div Wildlife Conservat, Anchorage, AK USA; [Crowley, David W.] Alaska Dept Fish & Game, Div Wildlife Conservat, King Salmon, AK 99613 USA	Alaska Department of Fish & Game; Alaska Department of Fish & Game	Crowley, DW (corresponding author), Alaska Dept Fish & Game, Div Wildlife Conservat, King Salmon, AK 99613 USA.	dave.crowley@alaska.gov			Pittman-Robertson grants; Izembek National Wildlife Refuge, USFWS	Pittman-Robertson grants; Izembek National Wildlife Refuge, USFWS	The authors and project were supported by funds from Pittman-Robertson grants to the Alaska Department of Fish and Game. Additional project funding was provided by Izembek National Wildlife Refuge, USFWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Rebecca Strauch, Alaska Department of Fish and Game (ADF&G) provided invaluable GIS support for this project. Additional GIS support was provided by Kenneth Mathews and Joshua Mumms, ADF&G. We thank pilots: G. Dobson, US Fish and Wildlife Service (USFWS); A. Greenblatt; M. Litzen; R. Schuh; and D. Sowards, USF&WS for their safe and expert survey flying. We also thank backseat observers: G. Collins, USFWS; H. Reynolds, ADF & G; R. Sellers, ADF & G; and K. Sowl, USFWS for their untiring efforts in collecting the data. We are grateful to J. Stetz, ADF&G, for his helpful comments and suggestions on an early draft of this manuscript. We thank Academic Editor T. Mousseau and 2 anonymous reviewers for their many helpful suggestions. We thank The Centre of Research into Ecological and Environmental Monitoring, University of St. Andrews, and ADF&G Commissioners C. Campbell and D. Vincent-Lang for supporting the senior authors' collaboration efforts with S. Buckland.	AlpizarJara R, 1996, ENVIRON ECOL STAT, V3, P311, DOI 10.1007/BF00539369; Becker EF, 2009, J AGR BIOL ENVIR ST, V14, P207, DOI 10.1198/jabes.2009.0013; Becker E, 2019, ECOL EVOL, V9, P6157, DOI 10.1002/ece3.5134; Becker EF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136403; Borchers DL, 1998, BIOMETRICS, V54, P1207, DOI 10.2307/2533651; Borchers DL, 2006, BIOMETRICS, V62, P372, DOI 10.1111/j.1541-0420.2005.00493.x; Buckland S.T., 2001, pi; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Buckland ST, 2010, BIOMETRICS, V66, P169, DOI 10.1111/j.1541-0420.2009.01239.x; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham KP, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P307; Burt ML, 2014, METHODS ECOL EVOL, V5, P1180, DOI 10.1111/2041-210X.12294; DRUMMER TD, 1987, BIOMETRICS, V43, P13, DOI 10.2307/2531944; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Laake J, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P137; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; MAINDONALD J, 2010, DATA ANAL GRAPHICS U; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Marshall L., 2020, DSSD DISTANCE SAMPLI; Miller DL, 2013, METHODS ECOL EVOL, V4, P1001, DOI 10.1111/2041-210X.12105; Nash JC, 2014, J STAT SOFTW, V60, P1; Nash JC, 2011, J STAT SOFTW, V43, P1; Obbard ME, 2015, POLAR BIOL, V38, P1713, DOI 10.1007/s00300-015-1737-5; Quang PX, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P87; Sellers RA., 2003, BROWN BEAR MANAGEMEN, P103; Strindberg S, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P190; Strindberg S, 2004, J AGR BIOL ENVIR ST, V9, P443, DOI 10.1198/108571104X15601	29	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245367	10.1371/journal.pone.0245367	http://dx.doi.org/10.1371/journal.pone.0245367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513142	gold, Green Published			2022-12-26	WOS:000613891400009
J	Getaneh, DK; Hordofa, LO; Ayana, DA; Tessema, TS; Regassa, LD				Getaneh, Dawit Kassaye; Hordofa, Lemessa Oljira; Ayana, Desalegn Admassu; Tessema, Tesfaye Sisay; Regassa, Lemma Demissie			Prevalence of Escherichia coli O157:H7 and associated factors in under-five children in Eastern Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; DRINKING-WATER; ACUTE DIARRHEA; O157-H7 INFECTION; IDENTIFICATION; FREQUENCY; COMMUNITY; OUTBREAKS; DISTRICT; MANURE	Background Escherichia coli O157:H7 (E. coli O157:H7) is one of the most potent zoonotic pathogens that causes mild diarrhea and leads to hemolytic uremic syndrome or death. This study was aimed to assess the prevalence and determinants of E. coli O157:H7 related to diarrhea among under-five children with acute diarrhea. Methods A cross-sectional study design was carried out in 2018 on 378 under-five-year children recruited randomly from hospitals in Eastern Ethiopia. Stool specimens were collected and processed using enrichment, differential and selective medium. Among isolates, E. coli O157:H7 was confirmed using latex test (Oxoid, Basingstoke, Hants, England). Factors associated with E. coli O157:H7 infection were identified using binary and multivariable logistic regression. Associations were reported by odds ratio with 95% confidence interval. Results The prevalence of E. coli O157:H7 related diarrhea was 15.3% (95%CI: 11.8-19.5). The E. coli O157:H7 infection was positively associated with rural residence (AOR;3.75, 95% CI:1.26-11.20), consumption of undercooked meat (AOR;3.95, 95%CI: 1.23-12.67), raw vegetables and/or fruit juice (AOR;3.37, 95%CI:1.32-8.62), presence of bloody diarrhea (AOR;4.42, 95% CI:1.78-10.94), number of under-five children in a household (AOR;7.16, 95%CI: 2.90-17.70), presence of person with diarrhea in a household (AOR;4.22, 95% CI: 1.84-12.69), owning domestic animal (AOR;3.87, 95% CI: 1.48-10.12) and uneducated mother (AOR;3.14, 95%CI: 1.05-9.42). Conclusion The Prevalence of E. coli O157:H7 related diarrhea among under-five children is relatively high in Eastern Ethiopia. The E. coli infection was associated with sanitation and hygiene in a household. Thus, education focused on food cooking and handling, child care, and house-hold sanitation associated with animal manure in rural resident children are helpful in.	[Getaneh, Dawit Kassaye] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia; [Hordofa, Lemessa Oljira; Ayana, Desalegn Admassu; Regassa, Lemma Demissie] Haramaya Univ, Coll Hlth & Med Sci, Dire Dawa, Ethiopia; [Tessema, Tesfaye Sisay] Addis Ababa Univ, Inst Biotechnol, Addis Ababa, Ethiopia	Haramaya University; Haramaya University; Addis Ababa University	Regassa, LD (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Dire Dawa, Ethiopia.	esraeldemiss@gmail.com	Regassa, Lemma Demissie/V-3091-2019	Regassa, Lemma Demissie/0000-0002-5461-5348; Ayana, Desalegn Admassu/0000-0002-1544-7492; Sisay Tessema, Tesfaye/0000-0002-4103-5029	Haramaya University	Haramaya University	We would like to extend our deepest appreciation to Haramaya University for the support given to us to undertake the full laboratory work. We are grateful to Haramaya University IHRERC for their immense contribution in reviewing the methods and assurance to proceed with the work. We are thankful to HDH and HFSUH medical directors who allowed us to conduct this research. The authors also thank all participants who were involved in this study and the data collectors.	Abdissa R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2372-2; Abong'o BO, 2008, J APPL MICROBIOL, V105, P424, DOI 10.1111/j.1365-2672.2008.03756.x; Abong'o BO, 2009, FOOD MICROBIOL, V26, P173, DOI 10.1016/j.fm.2008.10.001; Adugna A, 2015, AFR HEALTH SCI, V15, P656, DOI 10.4314/ahs.v15i2.45; Ahmed MO, 2014, LIBYAN J MED, V9; Alebel A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199684; Rivero MA, 2010, J MED MICROBIOL, V59, P345, DOI 10.1099/jmm.0.015560-0; [Anonymous], 1994, NOM109SSA11994 DIAR; Anteneh ZA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4021-5; Belongia EA, 2003, J INFECT DIS, V187, P1460, DOI 10.1086/374622; Ben Salem-Ben Nejma I, 2014, IRAN J PUBLIC HEALTH, V43, P947; Berhe H., 2016, INT J THER APPL, V31, P32, DOI [10.20530/IJTA_31_32-37, DOI 10.20530/IJTA_31_32-37]; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Bielaszewska M, 1997, EPIDEMIOL INFECT, V119, P299, DOI 10.1017/S0950268897008297; Bobe Fiseha Wadillo Wada Tesfahun Molla, 2017, AM J LIFE SCI, V5, P46; Brandal LT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1017-6; Byrne L, 2015, EPIDEMIOL INFECT, V143, P3475, DOI 10.1017/S0950268815000746; Carroll AM, 2016, DIAGN MICR INFEC DIS, V85, P1, DOI 10.1016/j.diagmicrobio.2015.12.011; Central Statistics Agency (CSA), 2016, ETH DEM HLTH SURV; Darbandi A, 2016, IRAN J MICROBIOL, V8, P352; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; Esumeh F. I., 2011, Journal of Microbiology and Biotechnology Research, V1, P1; Friesema IHM, 2015, EPIDEMIOL INFECT, V143, P1360, DOI 10.1017/S0950268814002349; Ghuliani A, 1995, Indian Pediatr, V32, P539; Gould LH, 2017, EMERG INFECT DIS, V23, P525, DOI 10.3201/eid2303.161462; Holmes KK, 2017, MAJOR INFECT DIS; HOMAYOON M, 2014, MOL IDENTIFICATION A; Ibrahim EME, 2019, SCI TOTAL ENVIRON, V648, P1297, DOI 10.1016/j.scitotenv.2018.08.275; Isibor JO, 2013, AM J RES COMMUN, V1, P35, DOI [10.1002/2052-2975.31, DOI 10.1002/2052-2975.31]; Jaros P, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-450; Kargar M, 2015, ASIAN PAC J TROP MED, V8, P24, DOI 10.1016/S1995-7645(14)60182-6; Kunadu APH, 2018, INT J FOOD MICROBIOL, V277, P41, DOI 10.1016/j.ijfoodmicro.2018.04.025; Langendorf C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120275; Litt PK, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/7013236; Luffman I, 2014, GEOSCIENCES, V4, P202, DOI 10.3390/geosciences4030202; Luna S, 2018, MMWR-MORBID MORTAL W, V67, P659, DOI 10.15585/mmwr.mm6723a2; Lye Y, 2013, RISK ESCHERICHIA COL, V20; Lyimo B, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0870-9; McKee RS, 2018, J PEDIAT INF DIS SOC, V7, pE116, DOI 10.1093/jpids/piy025; Navab-Daneshmand T, 2018, AM J TROP MED HYG, V98, P803, DOI 10.4269/ajtmh.17-0521; Ohaiseadha C, 2017, EPIDEMIOL INFECT, V145, P95, DOI 10.1017/S095026881600193X; Prasanthi TN, 2016, MATER DESIGN, V93, P180, DOI 10.1016/j.matdes.2015.12.120; Quinn PJ, 2011, VET MICROBIOLOGY MIC, P357; Rivas M, 2008, EMERG INFECT DIS, V14, P763, DOI 10.3201/eid1405.071050; Saxena T, 2015, DIAGN MICR INFEC DIS, V82, P249, DOI 10.1016/j.diagmicrobio.2015.03.015; Shrivastava AK, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0166-0; Slutsker L, 1998, J INFECT DIS, V177, P962, DOI 10.1086/515258; Soderstrom A, 2008, FOODBORNE PATHOG DIS, V5, P339, DOI 10.1089/fpd.2007.0065; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Suardana IW, 2017, ACTA TROP, V172, P223, DOI 10.1016/j.actatropica.2017.05.019; Tamminen LM, 2019, PREV VET MED, V170, DOI 10.1016/j.prevetmed.2019.104726; Treacy J, 2019, EUROSURVEILLANCE, V24, P7, DOI 10.2807/1560-7917.ES.2019.24.16.1800191; Voetsch AC, 2007, EPIDEMIOL INFECT, V135, P993, DOI 10.1017/S0950268806007564; Werber D, 2007, AM J EPIDEMIOL, V165, P425, DOI 10.1093/aje/kwk023; WHO UJSWHO, 2017, PROGR DRINKING WATE; Yao ZY, 2014, APPL ENVIRON MICROB, V80, P70, DOI 10.1128/AEM.03046-13	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246024	10.1371/journal.pone.0246024	http://dx.doi.org/10.1371/journal.pone.0246024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508023	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000635021400073
J	Minicucci, J; Alfond, M; Demuro, A; Gerberry, D; Latulippe, J				Minicucci, Joseph; Alfond, Molly; Demuro, Angelo; Gerberry, David; Latulippe, Joe			Quantifying the dose-dependent impact of intracellular amyloid beta in a mathematical model of calcium regulation in xenopus oocyte	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; ALZHEIMERS-DISEASE; ENDOPLASMIC-RETICULUM; CA2+ RELEASE; OSCILLATIONS; HYPOTHESIS; BRAIN; DYSREGULATION; MECHANISM; DYNAMICS	Alzheimer's disease (AD) is a devastating illness affecting over 40 million people worldwide. Intraneuronal rise of amyloid beta in its oligomeric forms (iA beta Os), has been linked to the pathogenesis of AD by disrupting cytosolic Ca2+ homeostasis. However, the specific mechanisms of action are still under debate and intense effort is ongoing to improve our understanding of the crucial steps involved in the mechanisms of A beta Os toxicity. We report the development of a mathematical model describing a proposed mechanism by which stimulation of Phospholipase C (PLC) by iA beta O, triggers production of IP3 with consequent abnormal release of Ca2+ from the endoplasmic reticulum (ER) through activation of IP3 receptor (IP3R) Ca2+ channels. After validating the model using experimental data, we quantify the effects of intracellular rise in iA beta Os on model solutions. Our model validates a dose-dependent influence of iA beta Os on IP3-mediated Ca2+ signaling. We investigate Ca2+ signaling patterns for small and large iA beta Os doses and study the role of various parameters on Ca2+ signals. Uncertainty quantification and partial rank correlation coefficients are used to better understand how the model behaves under various parameter regimes. Our model predicts that iA beta O alter IP3R sensitivity to IP3 for large doses. Our analysis also shows that the upstream production of IP3 can influence A beta-driven solution patterns in a dose-dependent manner. Model results illustrate and confirm the detrimental impact of iA beta Os on IP3 signaling.	[Minicucci, Joseph] Norwich Univ, Dept Chem & Biochem, Northfield, VT USA; [Alfond, Molly; Latulippe, Joe] Norwich Univ, Dept Math, Northfield, VT 05663 USA; [Demuro, Angelo] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Gerberry, David] Xavier Univ, Dept Math, Cincinnati, OH 45207 USA	University of California System; University of California Irvine; Xavier University	Latulippe, J (corresponding author), Norwich Univ, Dept Math, Northfield, VT 05663 USA.	jlatulip@norwich.edu			Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103449, R01 AG053988]; Norwich University	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; Norwich University	Research reported in this project was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103449 as well as grant number R01 AG053988. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH. Parts of this research was also supported by a Faculty Development grant from Norwich University.`	Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Bennett MR, 2005, BIOPHYS J, V89, P2235, DOI 10.1529/biophysj.105.062968; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Breslin K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006151; Cao PX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003783; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; Dehkordy SR, 2014, P ICEE ENG 22 IR C; Del Prete D, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-21; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Demuro A, 2013, J NEUROSCI, V33, P3824, DOI 10.1523/JNEUROSCI.4367-12.2013; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Di Garbo A, 2007, BIOSYSTEMS, V89, P74, DOI 10.1016/j.biosystems.2006.05.013; Dupont G., 2016, MODELS CALCIUM SIGNA; Fall CP., 2002, COMPUTATIONAL CELL B; Ferreiro E, 2004, J NEUROSCI RES, V76, P872, DOI 10.1002/jnr.20135; Friedrich O, 2014, J CELL MOL MED, V18, P1851, DOI 10.1111/jcmm.12313; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; HARKINS AB, 1993, BIOPHYS J, V65, P865, DOI 10.1016/S0006-3495(93)81112-3; Hartmann H, 1996, AMYLOID, V3, P234, DOI 10.3109/13506129609014370; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Jensen LE, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00036; Kawahara Masahiro, 2011, Int J Alzheimers Dis, V2011, P304583, DOI 10.4061/2011/304583; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KEENER J., 2009, MATH PHYSL CELLULAR; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; LaFerla FM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006320; Latulippe J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202503; LeBeau AP, 1999, J GEN PHYSIOL, V113, P851, DOI 10.1085/jgp.113.6.851; Lemon G, 2003, J THEOR BIOL, V223, P113, DOI 10.1016/S0022-5193(03)00080-8; LI YX, 1994, J THEOR BIOL, V166, P461, DOI 10.1006/jtbi.1994.1041; Liang JY, 2015, BIOSYSTEMS, V134, P1, DOI 10.1016/j.biosystems.2015.05.003; MAHAMA PA, 1994, BIOPHYS J, V67, P1345, DOI 10.1016/S0006-3495(94)80606-X; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; OTHMER HG, 1993, NATO ADV SCI INST SE, V259, P277; Parker I, 1996, CELL CALCIUM, V20, P105, DOI 10.1016/S0143-4160(96)90100-1; Pensalfini A, 2014, NEUROBIOL DIS, V71, P53, DOI 10.1016/j.nbd.2014.07.011; Placido AI, 2014, BBA-MOL BASIS DIS, V1842, P1444, DOI 10.1016/j.bbadis.2014.05.003; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Popugaeva E, 2014, NEURODEGENER DIS, V13, P139, DOI 10.1159/000354778; Ries M, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00160; Schneidereit D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164509; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Smith R.C, 2013, UNCERTAINTY QUANTIFI, V12, DOI DOI 10.1111/J.2517-6161.1996.TB02080.X; Sneyd J, 2003, BIOPHYS J, V85, P1392, DOI 10.1016/S0006-3495(03)74572-X; Sneyd J, 2002, P NATL ACAD SCI USA, V99, P2398, DOI 10.1073/pnas.032281999; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toglia P, 2018, CELL CALCIUM, V76, P23, DOI 10.1016/j.ceca.2018.09.003; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Ullah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137357; Ullah G, 2012, J GEN PHYSIOL, V140, P159, DOI 10.1085/jgp.201110753	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246116	10.1371/journal.pone.0246116	http://dx.doi.org/10.1371/journal.pone.0246116			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508037	Green Published, gold			2022-12-26	WOS:000635021400092
J	Park, ES; Fujita, O; Kimura, M; Hotta, A; Imaoka, K; Shimojima, M; Saijo, M; Maeda, K; Morikawa, S				Park, Eun-Sil; Fujita, Osamu; Kimura, Masanobu; Hotta, Akitoyo; Imaoka, Koichi; Shimojima, Masayuki; Saijo, Masayuki; Maeda, Ken; Morikawa, Shigeru			Diagnostic system for the detection of severe fever with thrombocytopenia syndrome virus RNA from suspected infected animals	PLOS ONE			English	Article							MOLECULAR-DETECTION; SOUTH-KOREA; BUNYAVIRUS; CATS	Background Severe fever with thrombocytopenia syndrome virus (SFTSV) causes severe hemorrhagic fever in humans and cats. Clinical symptoms of SFTS-infected cats resemble those of SFTS patients, whereas SFTS-contracted cats have high levels of viral RNA loads in the serum and body fluids. Due to the risk of direct infection from SFTS-infected cats to human, it is important to diagnose SFTS-suspected animals. In this study, a reverse transcription polymerase chain reaction (RT-PCR) was newly developed to diagnose SFTS-suspected animals without non-specific reactions. Methodology/principle findings Four primer sets were newly designed from consensus sequences constructed from 108 strains of SFTSV. A RT-PCR with these four primer sets successfully and specifically detected four clades of SFTSV. Their limits of detection are 1-10 copies/reaction. Using this RT-PCR, 5 cat cases among 56 SFTS-suspected animal cases were diagnosed as SFTS. From these cats, IgM or IgG against SFTSV were detected by enzyme-linked immunosorbent assay (ELISA), but not neutralizing antibodies by plaque reduction neutralization titer (PRNT) test. This phenomenon is similar to those of fatal SFTS patients. Conclusion/significance This newly developed RT-PCR could detect SFTSV RNA of several clades and from SFTS-suspected animals. In addition to ELISA and PRNT test, the useful laboratory diagnosis systems of SFTS-suspected animals has been made in this study.	[Park, Eun-Sil; Fujita, Osamu; Kimura, Masanobu; Hotta, Akitoyo; Imaoka, Koichi; Maeda, Ken; Morikawa, Shigeru] Natl Inst Infect Dis, Dept Vet Sci, Shinju Ku, Tokyo, Japan; [Shimojima, Masayuki; Saijo, Masayuki] Natl Inst Infect Dis, Dept Virol 1, Shinju Ku, Tokyo, Japan; [Maeda, Ken] Yamaguchi Univ, Lab Vet Microbiol, Yamaguchi, Japan; [Morikawa, Shigeru] Okayama Univ Sci, Fac Vet Med, Dept Microbiol, Imabari, Ehime, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Yamaguchi University; Okayama University of Science	Morikawa, S (corresponding author), Natl Inst Infect Dis, Dept Vet Sci, Shinju Ku, Tokyo, Japan.; Morikawa, S (corresponding author), Okayama Univ Sci, Fac Vet Med, Dept Microbiol, Imabari, Ehime, Japan.	morikawa@nih.go.jp		Saijo, Masayuki/0000-0001-5458-7298; Maeda, Ken/0000-0002-3488-5439	Japan Agency for Medical Rersearch and Development (AMED) [20fk0108069, 20fk0108081, 19K06395]	Japan Agency for Medical Rersearch and Development (AMED)	The work was partly supported by Japan Agency for Medical Rersearch and Development (AMED) under Grant Number 20fk0108069, 20fk0108081 and Grants-in-Aid for Scientific Research under grant Number 19K06395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Diang SJ, 2014, JPN J INFECT DIS, V67, P1, DOI 10.7883/yoken.67.1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hwang J, 2017, TICKS TICK-BORNE DIS, V8, P9, DOI 10.1016/j.ttbdis.2016.08.005; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Kimura T, 2018, J INFECT CHEMOTHER, V24, P802, DOI 10.1016/j.jiac.2018.06.007; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee SH, 2017, TICKS TICK-BORNE DIS, V8, P626, DOI 10.1016/j.ttbdis.2017.04.008; Lin TL, 2020, EMERG MICROBES INFEC, V9, P148, DOI 10.1080/22221751.2019.1710436; Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776; Matsuno K, 2018, EMERG INFECT DIS, V24, P1726, DOI 10.3201/eid2409.171667; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Park ES, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48317-8; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tran XC, 2019, EMERG INFECT DIS, V25, P1029, DOI 10.3201/eid2505.181463; Xing XS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002533; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144; Yoshikawa T, 2014, J CLIN MICROBIOL, V52, P3325, DOI 10.1128/JCM.00742-14; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	19	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0238671	10.1371/journal.pone.0238671	http://dx.doi.org/10.1371/journal.pone.0238671			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507990	gold, Green Published			2022-12-26	WOS:000635021400004
J	Partin, TG; Schrenzel, MD; Braun, J; Witte, CL; Kubiski, SV; Lee, J; Rideout, BA				Partin, Teagen G.; Schrenzel, Mark D.; Braun, Josephine; Witte, Carmel L.; Kubiski, Steven, V; Lee, Justin; Rideout, Bruce A.			Herpesvirus surveillance and discovery in zoo-housed ruminants	PLOS ONE			English	Article							MALIGNANT-CATARRHAL-FEVER; ALCELAPHINE HERPESVIRUS-1; MOLECULAR PHYLOGENY; OVINE HERPESVIRUS-2; VIRUS GROUP; DISEASE; GAMMAHERPESVIRUS; PCR; POPULATIONS; PERFORMANCE	Gammaherpesvirus infections are ubiquitous in captive and free-ranging ruminants and are associated with a variety of clinical diseases ranging from subclinical or mild inflammatory syndromes to fatal diseases such as malignant catarrhal fever. Gammaherpesvirus infections have been fully characterized in only a few ruminant species, and the overall diversity, host range, and biologic effects of most are not known. This study investigated the presence and host distribution of gammaherpesviruses in ruminant species at two facilities, the San Diego Zoo and San Diego Zoo Safari Park. We tested antemortem (blood, nasal or oropharyngeal swabs) or postmortem (internal organs) samples from 715 healthy or diseased ruminants representing 96 species and subspecies, using a consensus-based herpesvirus PCR for a segment of the DNA polymerase (DPOL) gene. Among the 715 animals tested, 161 (22.5%) were PCR and sequencing positive for herpesvirus, while only 11 (6.83%) of the PCR positive animals showed clinical signs of malignant catarrhal fever. Forty-four DPOL genotypes were identified of which only 10 have been reported in GenBank. The data describe viral diversity within species and individuals, identify host ranges of potential new viruses, and address the proclivity and consequences of interspecies transmission during management practices in zoological parks. The discovery of new viruses with wide host ranges and presence of co-infection within individual animals also suggest that the evolutionary processes influencing Gammaherpesvirus diversity are more complex than previously recognized.	[Partin, Teagen G.; Braun, Josephine; Witte, Carmel L.; Kubiski, Steven, V; Rideout, Bruce A.] San Diego Zoo Global, Dis Invest, Escondido, CA 92027 USA; [Schrenzel, Mark D.] Hybla Valley Vet Hosp, Alexandria, VA USA; [Lee, Justin] Colorado State Univ, Dept Microbiol Immunol & Pathol, Coll Vet Med & Biomed Sci, Ft Collins, CO USA	Colorado State University	Partin, TG (corresponding author), San Diego Zoo Global, Dis Invest, Escondido, CA 92027 USA.	Teagen.Gray.Partin@gmail.com		Partin, Teagen/0000-0003-2395-0570	Bud Heller Foundation of San Diego; Ellen Browning Scripps Foundation	Bud Heller Foundation of San Diego; Ellen Browning Scripps Foundation	The authors would like to thank Charles and Shirley Sykes, the Bud Heller Foundation of San Diego, and the Ellen Browning Scripps Foundation for their financial support. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, VET MICROBIOL, V113, P211, DOI 10.1016/j.vetmic.2005.11.008; Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5; Bagrinovsch G, 2014, WIEN TIERARZTL MONAT, V101, P142; BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849; BLAKE JE, 1990, J AM VET MED ASSOC, V196, P1141; Campos FS, 2014, VET MICROBIOL, V171, P182, DOI 10.1016/j.vetmic.2014.03.012; Cavallo ML, SYSTEMIC SEVERE INFE; Cooley AJ, 2008, J ZOO WILDLIFE MED, V39, P380, DOI 10.1638/2007-0181.1; Crawford TB, 2002, J AM VET MED ASSOC, V221, P843, DOI 10.2460/javma.2002.221.843; Cunha CW, 2009, J CLIN MICROBIOL, V47, P2586, DOI 10.1128/JCM.00997-09; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davison A, 2005, 8 REPORT INT COMMITT; Davison AJ, 2002, VET MICROBIOL, V86, P69, DOI 10.1016/S0378-1135(01)00492-8; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Dewals B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001627; EDINGTON N, 1980, RES VET SCI, V28, P384, DOI 10.1016/S0034-5288(18)32729-2; Ehlers B, 2008, J VIROL, V82, P3509, DOI 10.1128/JVI.02646-07; Ensser A, 1997, J VIROL, V71, P6517, DOI 10.1128/JVI.71.9.6517-6525.1997; Flach EJ, 2002, RES VET SCI, V73, P93, DOI 10.1016/S0034-5288(02)00094-2; Gasper D, 2012, VET PATHOL, V49, P492, DOI 10.1177/0300985811429306; Group ISAS, 2018, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2017-2.RLTS.T22057A50197212.en, DOI 10.2305/IUCN.UK.2017-2.RLTS.T22057A50197212.EN]; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hossain M, 2009, GENOMIC ANNOTATION O; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussy D, 2001, CLIN DIAGN LAB IMMUN, V8, P123, DOI 10.1128/CDLI.8.1.123-128.2001; Jacobsen B, 2007, VET MICROBIOL, V124, P353, DOI 10.1016/j.vetmic.2007.04.037; Jia J, 2014, J GEN VIROL, V95, P1790, DOI 10.1099/vir.0.066951-0; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katz J, 1991, J Vet Diagn Invest, V3, P193; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Klieforth R, 2002, J CLIN MICROBIOL, V40, P3381, DOI 10.1128/JCM.40.9.3381-3390.2002; Lankester F, 2016, VACCINE, V34, P831, DOI 10.1016/j.vaccine.2015.12.009; Li H, 2005, J GEN VIROL, V86, P3021, DOI 10.1099/vir.0.81238-0; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2003, J WILDLIFE DIS, V39, P875, DOI 10.7589/0090-3558-39.4.875; Li H, 2000, J CLIN MICROBIOL, V38, P1313, DOI 10.1128/JCM.38.4.1313-1318.2000; Li H, 2003, J VET DIAGN INVEST, V15, P46, DOI 10.1177/104063870301500110; Li H, 2001, J GEN VIROL, V82, P227, DOI 10.1099/0022-1317-82-1-227; Li H, 2013, J ZOO WILDLIFE MED, V44, P484, DOI 10.1638/2012-0087R.1; Loken T, 1998, VET REC, V143, P464, DOI 10.1136/vr.143.17.464; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McGeoch DJ, 2005, J GEN VIROL, V86, P307, DOI 10.1099/vir.0.80588-0; MCGEOCH DJ, 1994, J MOL BIOL, V238, P9, DOI 10.1006/jmbi.1994.1264; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Meier-Trummer CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006265; Nei M., 2000, MOL EVOLUTION PHYLOG; Nordengrahn A, 2002, VET RES, V33, P251, DOI 10.1051/vetres:2002013; Okeson DM, 2007, J ZOO WILDLIFE MED, V38, P460, DOI 10.1638/06-046.1; Patel JR, 2008, J S AFR VET ASSOC, V79, P8; Plowright W., 1984, Latent herpesvirus infections in veterinary medicine, P279; REID HW, 1984, P ROY SOC EDINB B, V82, P261, DOI 10.1017/S026972700000378X; Schultheiss PC, 2000, J VET DIAGN INVEST, V12, P497, DOI 10.1177/104063870001200602; Sood R, 2013, INDIAN J VIROL, V24, P321, DOI 10.1007/s13337-013-0163-y; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; Taus NS, 2007, J GEN VIROL, V88, P40, DOI 10.1099/vir.0.82285-0; Taus NS, 2014, VET MICROBIOL, V172, P318, DOI 10.1016/j.vetmic.2014.04.003; THAM KM, 1994, ARCH VIROL, V135, P355, DOI 10.1007/BF01310020; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; White JA, 2011, COMPARATIVE MED, V61, P60	61	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246162	10.1371/journal.pone.0246162	http://dx.doi.org/10.1371/journal.pone.0246162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508038	gold, Green Published			2022-12-26	WOS:000635021400100
J	Petrovich, GD; Corradi, GR; Pavan, CH; Truant, SN; Adamo, HP				Petrovich, Guido D.; Corradi, Gerardo R.; Pavan, Carlos H.; Noli Truant, Sofia; Adamo, Hugo P.			Highly exposed segment of the Spf1p P5A-ATPase near transmembrane M5 detected by limited proteolysis	PLOS ONE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ALPHA-SUBUNIT; CHYMOTRYPTIC CLEAVAGE; STRUCTURAL-ANALYSIS; ATPASE; NA+,K+-ATPASE; DOMAINS; PUMP; PARKINSONISM; ORGANIZATION	The yeast Spf1p protein is a primary transporter that belongs to group 5 of the large family of P-ATPases. Loss of Spf1p function produces ER stress with alterations of metal ion and sterol homeostasis and protein folding, glycosylation and membrane insertion. The amino acid sequence of Spf1p shows the characteristic P-ATPase domains A, N, and P and the transmembrane segments M1-M10. In addition, Spf1p exhibits unique structures at its N-terminus (N-T region), including two putative additional transmembrane domains, and a large insertion connecting the P domain with transmembrane segment M5 (D region). Here we used limited proteolysis to examine the structure of Spf1p. A short exposure of Spf1p to trypsin or proteinase K resulted in the cleavage at the N and C terminal regions of the protein and abrogated the formation of the catalytic phosphoenzyme and the ATPase activity. In contrast, limited proteolysis of Spf1p with chymotrypsin generated a large N-terminal fragment containing most of the M4-M5 cytosolic loop, and a minor fragment containing the C-terminal region. If lipids were present during chymotryptic proteolysis, phosphoenzyme formation and ATPase activity were preserved. ATP slowed Spf1p proteolysis without detectable changes of the generated fragments. The analysis of the proteolytic peptides by mass spectrometry and Edman degradation indicated that the preferential chymotryptic site was localized near the cytosolic end of M5. The susceptibility to proteolysis suggests an unexpected exposure of this region of Spf1p that may be an intrinsic feature of P5A-ATPases.	[Petrovich, Guido D.; Corradi, Gerardo R.; Pavan, Carlos H.; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl & Nvestigac Cient & Tecn CONICET Uni, Inst Quit Nice & Fisicoquim Biol IQUIFIB,Dept Qui, Buenos Aires, DF, Argentina; [Noli Truant, Sofia] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Inmunol & Inst Estudios Inmunidad Humoral, UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Adamo, HP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl & Nvestigac Cient & Tecn CONICET Uni, Inst Quit Nice & Fisicoquim Biol IQUIFIB,Dept Qui, Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049; Corradi, Gerardo Raul/0000-0003-0354-7709; Noli Truant, Sofia/0000-0002-5490-9186; Petrovich, Guido Daniel/0000-0003-3908-2544	ANPCyT [PICT 1690]	ANPCyT(ANPCyT)	HPA Grant ANPCyT PICT 1690 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo HP, 2000, BBA-BIOMEMBRANES, V1464, P127, DOI 10.1016/S0005-2736(99)00253-9; Anand N, 2020, NEUROBIOL DIS, V139, DOI 10.1016/j.nbd.2020.104786; ANDERSEN JP, 1986, J MEMBRANE BIOL, V93, P85, DOI 10.1007/BF01871021; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; BAGINSKI ES, 1967, CLIN CHIM ACTA, V15, P155, DOI 10.1016/0009-8981(67)90340-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; CAPASSO JM, 1992, J BIOL CHEM, V267, P1150; Champeil P, 1998, J BIOL CHEM, V273, P6619, DOI 10.1074/jbc.273.12.6619; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085519; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Corradi GR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232476; Corradi GR, 2016, J BIOL CHEM, V291, P7767, DOI 10.1074/jbc.M115.695122; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; Cronin SR, 2002, J CELL BIOL, V157, P1017, DOI 10.1083/jcb.200203052; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Pinto FD, 2018, NEUROCHEM INT, V112, P108, DOI 10.1016/j.neuint.2017.11.008; Demirsoy S, 2017, HUM MOL GENET, V26, P1656, DOI 10.1093/hmg/ddx070; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Estrada-Cuzcano A, 2017, BRAIN, V140, P287, DOI 10.1093/brain/aww307; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hatori Y, 2007, J BIOL CHEM, V282, P25213, DOI 10.1074/jbc.M703520200; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Ivanov A, 1997, FEBS LETT, V420, P107, DOI 10.1016/S0014-5793(97)01493-2; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; JORGENSEN PL, 1986, BIOCHIM BIOPHYS ACTA, V860, P570, DOI 10.1016/0005-2736(86)90555-9; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lustoza ACDM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027843; LUTSENKO S, 1995, P NATL ACAD SCI USA, V92, P7936, DOI 10.1073/pnas.92.17.7936; Lyons JA, 2020, CURR OPIN STRUC BIOL, V63, P65, DOI 10.1016/j.sbi.2020.04.001; Mazzitelli LR, 2014, J BIOL CHEM, V289, P10761, DOI 10.1074/jbc.M113.535583; McKenna MJ, 2020, SCIENCE, V369, P1583, DOI 10.1126/science.abc5809; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; OVCHINNIKOV YA, 1987, FEBS LETT, V217, P269, DOI 10.1016/0014-5793(87)80676-2; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Qin Q, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108363; Qu YM, 2020, CURR GENET, V66, P385, DOI 10.1007/s00294-019-01030-5; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Sorensen DM, 2019, MOL BIOL CELL, V30, P1069, DOI 10.1091/mbc.E18-06-0365; Sorensen DM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193228; Sorensen DM, 2015, BBA-GEN SUBJECTS, V1850, P524, DOI 10.1016/j.bbagen.2014.05.008; Sorensen DM, 2010, BBA-BIOENERGETICS, V1797, P846, DOI 10.1016/j.bbabio.2010.04.010; Suzuki C, 1999, MOL MICROBIOL, V32, P813, DOI 10.1046/j.1365-2958.1999.01400.x; Sweadner KJ, 2001, BIOCHEM J, V356, P685, DOI 10.1042/0264-6021:3560685; Timcenko M, 2019, NATURE, V571, P366, DOI 10.1038/s41586-019-1344-7; Tipper DJ, 2002, MOL BIOL CELL, V13, P1158, DOI 10.1091/mbc.01-10-0488; van Veen S, 2020, NATURE, V578, P419, DOI 10.1038/s41586-020-1968-7; Vashist S, 2002, MOL BIOL CELL, V13, P3955, DOI 10.1091/mbc.02-06-0090; Yu QL, 2012, MICROBIOL-SGM, V158, P2272, DOI 10.1099/mic.0.057232-0; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012	55	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245679	10.1371/journal.pone.0245679	http://dx.doi.org/10.1371/journal.pone.0245679			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507968	Green Published, gold			2022-12-26	WOS:000635021400044
J	Clabaut, A; Grare, C; Rolland-Valognes, G; Letarouilly, JG; Bourrier, C; Andersen, TL; Sikjaer, T; Rejnmark, L; Ejersted, C; Pastoureau, P; Hardouin, P; Sabatini, M; Broux, O				Clabaut, Aline; Grare, Celine; Rolland-Valognes, Gaelle; Letarouilly, Jean-Guillaume; Bourrier, Chantal; Andersen, Thomas L.; Sikjaer, Tanja; Rejnmark, Lars; Ejersted, Charlotte; Pastoureau, Philippe; Hardouin, Pierre; Sabatini, Massimo; Broux, Odile			Adipocyte-induced transdifferentiation of osteoblasts and its potential role in age-related bone loss	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENRICHMENT ANALYSIS; GENE LISTS; MARROW; DIFFERENTIATION; TISSUE; PLASTICITY; CD36; FAT	Our preliminary findings have lead us to propose bone marrow adipocyte secretions as new contributors to bone loss. Indeed, using a coculture model based on human bone marrow stromal cells, we previously showed that soluble factors secreted by adipocytes induced the conversion of osteoblasts towards an adipocyte-like phenotype. In this study, microarray gene expression profiling showed profound transcriptomic changes in osteoblasts following coculture and confirmed the enrichment of the adipocyte gene signature. Double immunofluorescence microscopic analyses demonstrated the coexpression of adipogenic and osteoblastic specific markers in individual cells, providing evidence for a transdifferentiation event. At the molecular level, this conversion was associated with upregulated expression levels of reprogramming genes and a decrease in the DNA methylation level. In line with these in vitro results, preliminary immunohistochemical analysis of bone sections revealed adipogenic marker expression in osteoblasts from elderly subjects. Altogether, these data suggest that osteoblast transdifferentiation could contribute to decreased bone mass upon ageing.	[Clabaut, Aline; Grare, Celine; Letarouilly, Jean-Guillaume; Hardouin, Pierre; Broux, Odile] Univ Littoral Cote dOpale, Marrow Adipos & Bone Lab, MABLab, ULR4490, Boulogne Sur Mer, France; [Clabaut, Aline; Grare, Celine; Letarouilly, Jean-Guillaume; Hardouin, Pierre; Broux, Odile] Univ Lille, Lille, France; [Clabaut, Aline; Grare, Celine; Letarouilly, Jean-Guillaume; Hardouin, Pierre; Broux, Odile] CHU Lille, Lille, France; [Rolland-Valognes, Gaelle; Bourrier, Chantal] Servier Res Inst, CentExBiotechnol, Croissy Sur Seine, France; [Andersen, Thomas L.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Andersen, Thomas L.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Andersen, Thomas L.] Univ Southern Denmark, Dept Mol Med, Odense, Denmark; [Andersen, Thomas L.] Aarhus Univ, Dept Forens Med, Aarhus, Denmark; [Sikjaer, Tanja; Rejnmark, Lars] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Ejersted, Charlotte] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Pastoureau, Philippe; Sabatini, Massimo] Servier Res Inst, CTI Immunoinflammatory Dis, Croissy Sur Seine, France	Universite du Littoral-Cote-d'Opale; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Servier; Institut de Recherches Internationales Servier; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Servier; Institut de Recherches Internationales Servier	Clabaut, A (corresponding author), Univ Littoral Cote dOpale, Marrow Adipos & Bone Lab, MABLab, ULR4490, Boulogne Sur Mer, France.; Clabaut, A (corresponding author), Univ Lille, Lille, France.; Clabaut, A (corresponding author), CHU Lille, Lille, France.	aline.clabaut@univ-littoral.fr	Levin Andersen, Thomas/AAY-6777-2021; Sikjaer, Tanja/B-6183-2018	Levin Andersen, Thomas/0000-0002-6981-7276; Sikjaer, Tanja/0000-0002-9074-9570; CLABAUT, ALINE/0000-0003-1869-3338	CentEx Biotechnology	CentEx Biotechnology	CentEx Biotechnology provided support for this study in the form of salaries for GRV and CB. The specific roles of these authors are articulated in the `author contributions' section. The funder participated in study design, data collection and analysis, and preparation of the manuscript, but did not have a role in the decision to publish the manuscript.	Balla B, 2008, CALCIFIED TISSUE INT, V82, P12, DOI 10.1007/s00223-007-9092-3; Berendsen AD, 2014, CELL MOL LIFE SCI, V71, P493, DOI 10.1007/s00018-013-1440-z; Calvo D, 1998, J LIPID RES, V39, P777; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chen Q, 2016, CELL DEATH DIFFER, V23, P1128, DOI 10.1038/cdd.2015.168; Clabaut A, 2010, DIFFERENTIATION, V80, P40, DOI 10.1016/j.diff.2010.04.004; Deng X, 2018, CELL STEM CELL, V23, P114, DOI 10.1016/j.stem.2018.05.022; Desiderio V, 2014, INT J BIOCHEM CELL B, V51, P75, DOI 10.1016/j.biocel.2014.03.025; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Elbaz A, 2010, J CELL MOL MED, V14, P982, DOI 10.1111/j.1582-4934.2009.00751.x; Gao B, 2014, INT J CLIN EXP PATHO, V7, P1834; Gao H, 2017, STEM CELLS, V35, P1799, DOI 10.1002/stem.2635; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; GIMBLE J M, 1990, New Biologist, V2, P304; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Granero-Molto F, 2008, EXPERT OPIN BIOL TH, V8, P255, DOI 10.1517/14712598.8.3.255 ; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hardouin P, 2014, JOINT BONE SPINE, V81, P313, DOI 10.1016/j.jbspin.2014.02.013; Hill PS, 2014, GENOMICS, V104, P324, DOI 10.1016/j.ygeno.2014.08.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Justesen J, 2001, BIOGERONTOLOGY, V2, P165, DOI 10.1023/A:1011513223894; Letarouilly JG, 2019, GENOMICS, V111, P793, DOI 10.1016/j.ygeno.2018.05.001; Lin DPL, 2018, J PHARM PHARMACOL, V70, P307, DOI 10.1111/jphp.12862; Liu T, 2019, INT J STEM CELLS, V12, P1, DOI 10.15283/ijsc18096; Marie PJ, 2014, J BONE MINER RES, V29, P1311, DOI 10.1002/jbmr.2190; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Maurin AC, 2002, BONE, V31, P260, DOI 10.1016/S8756-3282(02)00805-0; Maurin AC, 2000, BONE, V26, P485, DOI 10.1016/S8756-3282(00)00252-0; Merrell AJ, 2016, NAT REV MOL CELL BIO, V17, P413, DOI 10.1038/nrm.2016.24; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Muruganandan S, 2018, CURR OSTEOPOROS REP, V16, P434, DOI 10.1007/s11914-018-0451-y; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Owen M, 1998, J CELL SCI, V10, P63; Petecchia L, 2017, BIOPHYS CHEM, V229, P84, DOI 10.1016/j.bpc.2017.05.011; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poloni A, 2012, STEM CELLS, V30, P965, DOI 10.1002/stem.1067; QANMBER G, 2018, J COTTON RES, V1, DOI DOI 10.1159/000489053; Sancho-Martinez I, 2012, NAT CELL BIOL, V14, P892, DOI 10.1038/ncb2567; Schilling T, 2007, MOL CELL ENDOCRINOL, V271, P1, DOI 10.1016/j.mce.2007.03.004; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Wang C, 2016, MED SCI MONITOR, V22, P226, DOI 10.12659/MSM.897044; Wang DQ, 2013, BONE, V53, P520, DOI 10.1016/j.bone.2013.01.009; Zhang C, 2018, FASEB J, V32, P4444, DOI 10.1096/fj.201700208RR	50	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245014	10.1371/journal.pone.0245014	http://dx.doi.org/10.1371/journal.pone.0245014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497412	Green Published, gold			2022-12-26	WOS:000613707100020
J	Abadiga, M; Wakuma, B; Oluma, A; Fekadu, G; Hiko, N; Mosisa, G				Abadiga, Muktar; Wakuma, Bizuneh; Oluma, Adugna; Fekadu, Ginenus; Hiko, Nesru; Mosisa, Getu			Determinants of preterm birth among women delivered in public hospitals of Western Ethiopia, 2020: Unmatched case-control study	PLOS ONE			English	Article							RISK-FACTORS; OUTCOMES; AGE	Background Worldwide, preterm birth accounts for 1 million deaths of infants each year and 60% of these deaths occur in developing countries. In addition to the significant health consequences on the infant, preterm birth can lead to economic costs. There was a lack of study in western Ethiopia, and most of those studies conducted in other parts of a country were based on card review with a cross-sectional study design. The risk factors of preterm birth may vary from region to region within the same country due to variation in socioeconomic status and health care service coverage. Therefore, this study aimed to identify determinants of preterm birth in western Ethiopia. Methods An institutional-based case-control study was conducted from February 15 to April 15, 2020, in western Ethiopia. The eligible 188 cases and 377 controls were randomly selected for this study. Cases were women who gave birth after 28 weeks and before 37 completed weeks of gestation, and controls were women who gave birth at and after 37 weeks of gestation from the first day of the last normal menstrual period. Data were collected by a structured interviewer-administered questionnaire. The collected data were entered into Epi info version 7 and exported to SPSS version 21 for analysis. Multivariable logistic regression was used to identify determinants of preterm birth at P-value Results From a total of 565 eligible participants, 516 (172 cases and 344 controls) participated in this study with a response rate of 91.3%. The result of the multivariable analysis shows that mothers who developed pregnancy-induced hypertension (AOR = 3.13, 95% CI; 1.78, 5.50), only one time ANC visits (AOR = 5.99, 95% CI; 2.65, 13.53), experienced premature rupture of membrane (AOR = 3.57, 95% CI; 1.79, 7.13), birth interval less than two years (AOR = 2.96, 95% CI; 1.76, 4.98), developed anemia during the current pregnancy (AOR = 4.20, 95% CI; 2.13, 8.28) and didn't get dietary supplementation during the current pregnancy (AOR = 2.43, 95% CI; 1.51, 3.91) had statistically significant association with experiencing preterm birth. Conclusion Antenatal care service providers should focus on mothers with pregnancy-induced hypertension, premature rupture of membrane, and anemia during pregnancy, and refer to the senior experts for early management to reduce the risk of preterm delivery. Antenatal care services such as counseling the mother on the benefit of dietary supplementation during pregnancy, antenatal care follow up, and lengthening birth interval should be integrated into the existing health extension packages. New and inclusive strategies such as the establishment of comprehensive mobile clinic services should also be designed to reduce the burden of preterm birth among women living in the rural community. Lastly, we recommend future researchers to conduct longitudinal and community-based studies supplemented with qualitative methods.	[Abadiga, Muktar; Wakuma, Bizuneh; Oluma, Adugna; Hiko, Nesru; Mosisa, Getu] Wollega Univ, Sch Nursing & Midwifery, Inst Hlth Sci, Nekemte, Ethiopia; [Fekadu, Ginenus] Wollega Univ, Inst Hlth Sci, Sch Pharm, Nekemte, Ethiopia		Abadiga, M (corresponding author), Wollega Univ, Sch Nursing & Midwifery, Inst Hlth Sci, Nekemte, Ethiopia.	muktarabadiga@gmail.com	Fekadu, Ginenus/AAH-1203-2019; Kebebew, Getu Mosisa/ABI-5268-2020	Fekadu, Ginenus/0000-0002-4926-0685; Abadiga, Muktar/0000-0002-3006-3155	Wollega university	Wollega university	This study was funded by the Wollega university. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaraya M, 2018, PEDIATR HEALTH MED T, V9, P101, DOI 10.2147/PHMT.S174789; Adane AA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-90; Alabbasi KH, 2015, J PREGNANCY CHILD HL, V2, P3, DOI [10.4172/2376-127X.1000166, DOI 10.4172/2376-127X.1000166]; [Anonymous], 2009, GLOB REG TOLL MARCH; [Anonymous], 2017, GAPPS ACNM ETH PROF; Aregawi G, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4650-0; Arora CP, 2015, CROAT MED J, V56, P119, DOI 10.3325/cmj.2015.56.119; Aseidu EK, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2404-6; Authority CS, 2012, POP HOUS CENS ETH; Berhe T, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4307-z; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Central Statistical Agency (CSA), 2016, ETH DEM HLTH SURV IN; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Dayanithi M., 2018, INT J COMMUNITY MED, V5, P2277, DOI [10.18203/2394-6040.ijcmph20182086, DOI 10.18203/2394-6040.IJCMPH20182086]; Demmouche A., 2014, Journal of Nutrition and Food Sciences, V4, P292; Deressa AT, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1957-0; Dominique Haumont LZaSM, 2012, SITUATION CHALLENGES; Gebreslasie K, 2016, ADV IN NURSING, V2016, DOI [10.1155/2016/4703138, DOI 10.1155/2016/4703138]; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Harrison MS., 2016, GLOBAL BURDEN PREMAT; Kelkay B, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/4629101; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lu CQ, 2018, PREGNANCY HYPERTENS, V14, P68, DOI 10.1016/j.preghy.2018.06.008; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mekonen DG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-018-4037-7; Mekuriyaw AM, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/1854073; Mokuolu OA, 2010, PEDIATRIC REP, V2, P11, DOI 10.4081/pr.2010.e3; Moreira RS, 2014, J PEDIAT-BRAZIL, V90, P119, DOI 10.1016/j.jped.2013.05.010; Nerlander LM, 2015, MATERN CHILD HLTH J, V19, P850, DOI 10.1007/s10995-014-1583-z; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Rouget F, 2013, MATERN CHILD HLTH J, V17, P1103, DOI 10.1007/s10995-012-1112-x; Rubens CE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009871; Sifer S., 2019, J PEDIAT NEONATAL CA, V9, P180; Soltani M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2183-0; Teklay Girmay, 2018, BMC Res Notes, V11, P571, DOI 10.1186/s13104-018-3693-y; USAID, 2016, RWAND PROF PRET LOW; van den Broek NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090128; Wagura P, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1740-2; Weissmann-Brenner A, 2009, J PERINAT MED, V37, P232, DOI 10.1515/JPM.2009.078; WHO, 2014, HLTH TOP PRET BIRTH; WHO, 2012, BORN TOO SOON GLOB A, P128; WHO, 2016, PRET BIRTH FACT SHEE; Woday A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225060; Woldeyohannes D, 2019, CLIN MOTHER CHILD HL, V16, P317, DOI [10.24105/2090-7214.1000317, DOI 10.24105/2090-7214.1000317]	46	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245825	10.1371/journal.pone.0245825	http://dx.doi.org/10.1371/journal.pone.0245825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493193	gold, Green Published			2022-12-26	WOS:000613081500038
J	Contreras, EO; Dearing, CG; Ashinhurst, CA; Fish, BA; Hossain, SN; Rey, AM; Silva, PD; Thompson, S				Contreras, Ethan O.; Dearing, Carley G.; Ashinhurst, Crystal A.; Fish, Betty A.; Hossain, Sajila N.; Rey, Ariana M.; Silva, Primal D.; Thompson, Stewart			Pupillary reflex and behavioral masking responses to light as functional measures of retinal degeneration in mice	PLOS ONE			English	Article							VISUAL FUNCTION; IRRADIANCE DETECTION; LOCOMOTOR-ACTIVITY; GENE-TRANSFER; VISION; MELANOPSIN; ROD; MUTANTS; THERAPY; ACUITY	Background Pre-clinical testing of retinal pathology and treatment efficacy depends on reliable and valid measures of retinal function. The electroretinogram (ERG) and tests of visual acuity are the ideal standard, but can be unmeasurable while useful vision remains. Non-image-forming responses to light such as the pupillary light reflex (PLR) are attractive surrogates. However, it is not clear how accurately such responses reflect changes in visual capability in specific disease models. The purpose of this study was to test whether measures of non-visual responses to light correlate with previously determined visual function in two photoreceptor degenerations. Methods The sensitivity of masking behavior (light induced changes in running wheel activity) and the PLR were measured in 3-month-old wild-type mice (WT) with intact inner retinal circuitry, Pde6b-rd1/rd1 mice (rd1) with early and rapid loss of rods and cones, and Prph2-Rd2/Rd2 mice (Rd2) with a slower progressive loss of rods and cones. Results In rd1 mice, negative masking had increased sensitivity, positive masking was absent, and the sensitivity of the PLR was severely reduced. In Rd2 mice, positive masking identified useful vision at higher light levels, but there was a limited decrease in the irradiance sensitivity of negative masking and the PLR, and the amplitude of change for both underestimated the reduction in irradiance sensitivity of image-forming vision. Conclusions Together these data show that in a given disease, two responses to light can be affected in opposite ways, and that for a given response to light, the change in the response does not accurately represent the degree of pathology. However, the extent of the deficit in the PLR means that even a limited rescue of rod/cone function might be measured by increased PLR amplitude. In addition, positive masking has the potential to measure effective treatment in both models by restoring responses or shifting thresholds to lower irradiances.	[Contreras, Ethan O.; Dearing, Carley G.; Ashinhurst, Crystal A.; Fish, Betty A.; Hossain, Sajila N.; Rey, Ariana M.; Silva, Primal D.; Thompson, Stewart] New Mexico Inst Min & Technol, Dept Psychol, Socorro, NM 87801 USA; [Contreras, Ethan O.; Dearing, Carley G.; Ashinhurst, Crystal A.; Fish, Betty A.; Hossain, Sajila N.; Rey, Ariana M.; Silva, Primal D.; Thompson, Stewart] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA; [Dearing, Carley G.] Colorado State Univ, Coll Vet Med & Biomed Sci, Ft Collins, CO 80523 USA	New Mexico Institute of Mining Technology; New Mexico Institute of Mining Technology; Colorado State University	Thompson, S (corresponding author), New Mexico Inst Min & Technol, Dept Psychol, Socorro, NM 87801 USA.; Thompson, S (corresponding author), New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA.	stewart.thompson@nmt.edu			Robert Cormack Memorial award	Robert Cormack Memorial award	Robert Cormack Memorial award from Dr. Frank and Sheri Etscorn to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Agarwal N, 1990, J NEUROSCI, DOI [10.1523/JNEUROSCI.10-10-03275.1990, DOI 10.1523/JNEUROSCI.10-10-03275.1990]; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Care RA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107730; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2013, INVEST OPHTH VIS SCI, V54, P4974, DOI 10.1167/iovs.13-12289; Collison FT, 2016, DOC OPHTHALMOL, V132, P157, DOI 10.1007/s10633-016-9535-0; Crippa SV, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00669; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Greferath U, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00293; Grozdanic SD, 2007, INVEST OPHTH VIS SCI, V48, P5178, DOI 10.1167/iovs.07-0249; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Jansen HG, 1997, MICROSC RES TECHNIQ, DOI DOI 10.1002/(SICI)1097-0029(19970115)36:2<LESSTHAN>96::AID-JEMT3<GREATERTHAN>3.0.C0;2-T; Kardon R, 2009, OPHTHALMOLOGY, V116, P1564, DOI 10.1016/j.ophtha.2009.02.007; Kuburas A, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14784; Leinonen H, 2020, ELIFE, V9, DOI 10.7554/eLife.59422; Leinonen H, 2018, BEHAV BRAIN RES, V352, P172, DOI 10.1016/j.bbr.2017.07.040; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, ENDOCRINOLOGY, DOI [10.1210/endo.140.4.6672, DOI 10.1210/ENDO.140.4.6672]; Lucas RJ, 2014, TRENDS NEUROSCI, V37, P1, DOI 10.1016/j.tins.2013.10.004; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mrosovsky N, 2008, VISION RES, V48, P1270, DOI 10.1016/j.visres.2008.02.016; Mrosovsky N, 2003, CHRONOBIOL INT, V20, P989, DOI 10.1081/CBI-120026043; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Peachey NS, 2003, DOC OPHTHALMOL, V107, P13, DOI 10.1023/A:1024448314608; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Schmidt TM, 2011, J COMP NEUROL, V519, P1492, DOI 10.1002/cne.22579; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Storchi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46836-y; Storchi R, 2020, CURR BIOL, V30, P4619, DOI 10.1016/j.cub.2020.09.007; Thompson S, 2008, EUR J NEUROSCI, V28, P724, DOI 10.1111/j.1460-9568.2008.06388.x; Thompson S, 2008, INVEST OPHTH VIS SCI, V49, P2737, DOI 10.1167/iovs.07-1546; Thompson S, 2008, EUR J NEUROSCI, V27, P1973, DOI 10.1111/j.1460-9568.2008.06168.x; Thompson S, 2008, VISION RES, V48, P346, DOI 10.1016/j.visres.2007.07.020; Thompson S, 2014, INVEST OPHTH VIS SCI, V55, P1859, DOI 10.1167/iovs.13-13661; Thompson S, 2011, INVEST OPHTH VIS SCI, V52, P618, DOI 10.1167/iovs.10-6146; Thompson S, 2010, VET OPHTHALMOL, V13, P151, DOI 10.1111/j.1463-5224.2010.00772.x; Veleri S, 2015, DIS MODEL MECH, V8, P109, DOI 10.1242/dmm.017913; Wong AA, 2006, GENES BRAIN BEHAV, V5, P389, DOI 10.1111/j.1601-183X.2005.00173.x; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yao G, 2006, CURR EYE RES, V31, P925, DOI 10.1080/02713680600932308	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0244702	10.1371/journal.pone.0244702	http://dx.doi.org/10.1371/journal.pone.0244702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493166	gold, Green Published			2022-12-26	WOS:000613081500055
J	Liu, J; Huang, J; Liu, H; Chen, C; Xu, JY; Zhong, LW				Liu, Jia; Huang, Jin; Liu, Hu; Chen, Chang; Xu, Jianying; Zhong, Liangwei			Elevated serum 4HNE plus decreased serum thioredoxin: Unique feature and implications for acute exacerbation of chronic obstructive pulmonary disease	PLOS ONE			English	Article							MESSENGER-RNA DECAY; OXIDATIVE STRESS; MAMMALIAN THIOREDOXIN; REDUCTASE; APOPTOSIS; DEGRADATION; GLUTATHIONE; MECHANISM; SEVERITY; PRODUCT	Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a global problem with high mortality. Its pathogenesis is not fully understood. To reveal new serum feature of AECOPD and their potential implications, we have analyzed 180 serum samples, and found that in the serum of AECOPD patients, 4-hydroxy-2-nonenal (4HNE)-protein adducts are dynamically increased as partial pressure of oxygen (PaO2) drops, which is accompanied by progressively decreasing thioredoxin reductase (TrxR1) and thioredoxin (Trx1), as compared with those of healthy people. This phenomenon is unique, because acute hypoxia patients have 1.1-fold or 1.7-fold higher serum TrxR1 or Trx1 activity, respectively, than healthy people, in keeping with low 4HNE level. Moreover, serum 4HNE-protein adducts may form disulfide-linked complexes with high-molecular-weight, the amount of which is significantly increased during AECOPD. Serum 4HNE-protein adducts include 4HNE-Trx1 adduct and 4HNE-TrxR1 adduct, but only the former is significantly increased during AECOPD. Through cell biology, biochemistry and proteomics methods, we have demonstrated that extracellular 4HNE and 4HNE-Trx1 adduct affect human bronchial epithelial cells via different mechanisms. 4HNE-Trx1 adduct may significantly alter the expression of proteins involved mainly in RNA metabolism, but it has no effect on TrxR1/Trx1 expression and cell viability. On the other hand, low levels of 4HNE promote TrxR1/Trx1 expression and cell viability, while high levels of 4HNE inhibit TrxR1/Trx1 expression and cell viability, during which Trx1, at least in part, mediate the 4HNE action. Our data suggest that increasing serum 4HNE and decreasing serum Trx1 in AECOPD patients are closely related to the pathological processes of the disease. This finding also provides a new basis for AECOPD patients to use antioxidant drugs.	[Liu, Jia; Huang, Jin; Zhong, Liangwei] Univ Chinese Acad Sci, Med Sch, Beijing, Peoples R China; [Liu, Hu; Xu, Jianying] Shanxi Acad Med Sci, Resp Dept, Shanxi Bethune Hosp, Taiyuan, Peoples R China; [Chen, Chang] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhong, LW (corresponding author), Univ Chinese Acad Sci, Med Sch, Beijing, Peoples R China.; Xu, JY (corresponding author), Shanxi Acad Med Sci, Resp Dept, Shanxi Bethune Hosp, Taiyuan, Peoples R China.	xujyty@126.com; liazho@ucas.ac.cn			National Natural Science Foundation of China [30970629, 31170764, 81141041]; Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KSCX2-EW-J-29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from National Natural Science Foundation of China (Grants No. 30970629, 31170764, 81141041), and from Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences (Grant No. KSCX2-EW-J-29).	Araneda OF, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/856918; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bai Y, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129630; Bloomfield KL, 2003, GENE, V319, P107, DOI 10.1016/S0378-1119(03)00799-6; Bromfield EG, 2017, MOL HUM REPROD, V23, P91, DOI 10.1093/molehr/gaw074; Callister ME, 2006, THORAX, V61, P521, DOI 10.1136/thx.2005.053041; Castro JP, 2017, FREE RADICAL BIO MED, V111, P309, DOI 10.1016/j.freeradbiomed.2016.10.497; Celli BR, 2019, NEW ENGL J MED, V381, P1257, DOI 10.1056/NEJMra1900500; de Groot LES, 2019, AM J PHYSIOL-LUNG C, V316, pL369, DOI 10.1152/ajplung.00456.2018; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hashemy SI, 2008, J BIOL CHEM, V283, P21890, DOI 10.1074/jbc.M801047200; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Huang J, 2014, BIOCHIMIE, V97, P92, DOI 10.1016/j.biochi.2013.09.024; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Imazato T, 2014, BIOMED CHROMATOGR, V28, P891, DOI 10.1002/bmc.3204; Kenche H, 2013, FASEB J, V27, P965, DOI 10.1096/fj.12-216234; Kent BD, 2011, INT J CHRONIC OBSTR, V6, P199, DOI 10.2147/COPD.S10611; Ko FW, 2016, RESPIROLOGY, V21, P1152, DOI 10.1111/resp.12780; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Lehtonen ST, 2008, ANTIOXID REDOX SIGN, V10, P813, DOI 10.1089/ars.2007.1952; Li D, 2012, CHEM-BIOL INTERACT, V195, P25, DOI 10.1016/j.cbi.2011.09.007; Li JL, 2017, SCI BULL, V62, P752, DOI 10.1016/j.scib.2017.04.017; Lim KH, 2011, P NATL ACAD SCI USA, V108, P11093, DOI 10.1073/pnas.1101135108; Liu C, 2014, NAT MED, V20, P596, DOI 10.1038/nm.3548; Liu Hu, 2012, Zhonghua Jie He He Hu Xi Za Zhi, V35, P758; Liu W, 2000, J CELL SCI, V113, P635; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mantero M, 2017, INT J CHRONIC OBSTR, V12, P2687, DOI 10.2147/COPD.S145253; Neri S, 2011, INT J ANGIOL, V20, P149, DOI 10.1055/s-0031-1283218; Nguyen LS, 2013, HUM MOL GENET, V22, P1816, DOI 10.1093/hmg/ddt035; Ni L, 2015, FRONT PHYSIOL, V6, DOI [10.3339/fphys.2015.00294, 10.3389/fphys.2015.00294]; Pecorelli A, 2011, CLIN BIOCHEM, V44, P368, DOI 10.1016/j.clinbiochem.2011.01.007; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Rabe KF, 2017, LANCET, V389, P1931, DOI 10.1016/S0140-6736(17)31222-9; Rahman I, 2002, AM J RESP CRIT CARE, V166, P490, DOI 10.1164/rccm.2110101; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Shu N, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101400; Song J, 2014, INT J MOL SCI, V15, P2119, DOI 10.3390/ijms15022119; Sorge R, 2020, J EMERG MED, V59, P643, DOI 10.1016/j.jemermed.2020.07.001; Stolz D, 2018, RESPIRATION, V96, P382, DOI 10.1159/000490551; Takimoto T, 2012, BIOCHEM BIOPH RES CO, V420, P84, DOI 10.1016/j.bbrc.2012.02.119; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tanaka T, 1997, LAB INVEST, V77, P145; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang P, 2013, J BIOL CHEM, V288, P3346, DOI 10.1074/jbc.M112.418046; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Weber D, 2013, REDOX BIOL, V1, P226, DOI 10.1016/j.redox.2013.01.012; Wu MH, 2016, MOL NEUROBIOL, V53, P677, DOI 10.1007/s12035-014-9016-y; Wu WN, 2007, AM J PHYSIOL-LUNG C, V293, pL952, DOI 10.1152/ajplung.00203.2007; Wu YF, 2010, ATHEROSCLEROSIS, V212, P351, DOI 10.1016/j.atherosclerosis.2010.06.002; Yamada Y, 2003, IMMUNOL LETT, V86, P199, DOI 10.1016/S0165-2478(03)00006-3; Yu T, 2017, NEUROL RES, V39, P988, DOI 10.1080/01616412.2017.1359882; Zhong LW, 2002, METHOD ENZYMOL, V347, P236	64	2	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245810	10.1371/journal.pone.0245810	http://dx.doi.org/10.1371/journal.pone.0245810			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493155	gold, Green Published			2022-12-26	WOS:000613081500016
J	Zago, M; Massimiliano, L; Bonvini, B; Penna, G; Giraffa, G; Rescigno, M				Zago, Miriam; Massimiliano, Lucia; Bonvini, Barbara; Penna, Giuseppe; Giraffa, Giorgio; Rescigno, Maria			Functional characterization and immunomodulatory properties of Lactobacillus helveticus strains isolated from Italian hard cheeses	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; IN-VITRO; ACID; FERMENTATION; PROBIOTICS; BACTERIA; STARTER; MILK; MICROORGANISMS; PREBIOTICS	Lactobacillus helveticus carries many properties such as the ability to survive gastrointestinal transit, modulate the host immune response, accumulate biopeptides in milk, and adhere to the epithelial cells that could contribute to improving host health. In this study, the applicability as functional cultures of four L. helveticus strains isolated from Italian hard cheeses was investigated. A preliminary strain characterization showed that the ability to produce folate was generally low while antioxidant, proteolytic, peptidase, and beta-galactosidase activities resulted high, although very variable, between strains. When stimulated moDCs were incubated in the presence of live cells, a dose-dependent release of both the pro-inflammatory cytokine IL-12p70 and the anti-inflammatory cytokine IL-10, was shown for all the four strains. In the presence of cell-free culture supernatants (postbiotics), a dose-dependent, decrease of IL-12p70 and an increase of IL-10 was generally observed. The immunomodulatory effect took place also in Caciotta-like cheese made with strains SIM12 and SIS16 as bifunctional (i.e., immunomodulant and acidifying) starter cultures, thus confirming tests in culture media. Given that the growth of bacteria in the cheese was not necessary (they were killed by pasteurization), the results indicated that some constituents of non-viable bacteria had immunomodulatory properties. This study adds additional evidence for the positive role of L. helveticus on human health and suggests cheese as a suitable food for delivering candidate strains and modulating their anti-inflammatory properties.	[Zago, Miriam; Bonvini, Barbara; Giraffa, Giorgio] CREA Res Ctr Anim Prod & Aquaculture CREA ZA, Lodi, Italy; [Massimiliano, Lucia] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Penna, Giuseppe; Rescigno, Maria] IRCCS, Mucosal Immunol & Microbiota Unit, Humanitas Clin & Res Ctr, Rozzano, MI, Italy; [Rescigno, Maria] Humanitas Univ, Dept Biomed Sci, Pieve Emanuele, MI, Italy	IRCCS European Institute of Oncology (IEO); IRCCS Humanitas Research Hospital	Giraffa, G (corresponding author), CREA Res Ctr Anim Prod & Aquaculture CREA ZA, Lodi, Italy.	giorgio.giraffa@crea.gov.it	Penna, Giuseppe/AAB-8784-2019	Penna, Giuseppe/0000-0003-3534-7090; Giraffa, Giorgio/0000-0002-9650-7599; Massimiliano, Lucia/0000-0001-9128-4317				Amadoro C, 2018, LWT-FOOD SCI TECHNOL, V93, P376, DOI 10.1016/j.lwt.2018.03.056; Bayer AL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00315; Buriti FCA, 2005, INT DAIRY J, V15, P1279, DOI 10.1016/j.idairyj.2004.12.011; Burns P, 2010, J APPL MICROBIOL, V109, P1370, DOI 10.1111/j.1365-2672.2010.04761.x; Cecchi T, 2015, FOOD ANAL METHOD, V8, P312, DOI 10.1007/s12161-014-9886-7; CHURCH FC, 1983, J DAIRY SCI, V66, P1219, DOI 10.3168/jds.S0022-0302(83)81926-2; Dunand E, 2019, J APPL MICROBIOL, V127, P219, DOI 10.1111/jam.14276; Laino JE, 2013, LWT-FOOD SCI TECHNOL, V54, P1, DOI 10.1016/j.lwt.2013.05.035; Fortina MG, 2003, APPL ENVIRON MICROB, V69, P3238, DOI 10.1128/AEM.69.6.3238-3243.2003; Frece J, 2009, J DAIRY RES, V76, P98, DOI 10.1017/S0022029908003737; Gatti M, 2008, J DAIRY SCI, V91, P4129, DOI 10.3168/jds.2008-1069; Gatti M, 2004, J APPL MICROBIOL, V96, P223, DOI 10.1046/j.1365-2672.2003.02142.x; Giraffa G, 2012, ENG LIFE SCI, V12, P391, DOI 10.1002/elsc.201100118; Griffiths MW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00030; Gul K, 2016, CRIT REV FOOD SCI, V56, P2617, DOI 10.1080/10408398.2014.903384; Hayes Maria, 2007, Biotechnology Journal, V2, P426, DOI 10.1002/biot.200600246; Joo HM, 2012, INT IMMUNOPHARMACOL, V14, P39, DOI 10.1016/j.intimp.2012.05.023; Laffineur E, 1996, J DAIRY SCI, V79, P2112, DOI 10.3168/jds.S0022-0302(96)76585-2; Medici M, 2004, INT DAIRY J, V14, P611, DOI 10.1016/j.idairyj.2003.10.011; Milesi MM, 2009, FOOD RES INT, V42, P1186, DOI 10.1016/j.foodres.2009.06.005; Mileti E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007056; Misselwitz B, 2019, GUT, V68, P2080, DOI 10.1136/gutjnl-2019-318404; Ng KY, 2002, MILCHWISSENSCHAFT, V57, P66; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Ong L, 2009, LWT-FOOD SCI TECHNOL, V42, P1260, DOI 10.1016/j.lwt.2009.01.011; Perna A, 2015, J FOOD SCI, V80, pS1352, DOI 10.1111/1750-3841.12862; Sah BNP, 2014, FOOD CHEM, V156, P264, DOI 10.1016/j.foodchem.2014.01.105; Slattery L, 2010, J DAIRY SCI, V93, P4435, DOI 10.3168/jds.2010-3327; Stuknyte M, 2011, INT DAIRY J, V21, P763, DOI 10.1016/j.idairyj.2011.04.011; Sybesma W, 2003, APPL ENVIRON MICROB, V69, P4542, DOI 10.1128/AEM.69.8.4542-4548.2003; Tamime AY, 2005, PROBIOTIC DAIRY PROD, V3, P39, DOI [DOI 10.1002/9780470995785.CH3, 10.1002/9780470995785.ch3]; Taverniti V, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00392; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; Tidona F, 2016, J FOOD NUTR RES-SLOV, V55, P33; Tsilingiri K, 2013, BENEF MICROBES, V4, P101, DOI 10.3920/BM2012.0046; Tsilingiri K, 2012, GUT, V61, P1007, DOI 10.1136/gutjnl-2011-300971; Vinderola CG, 2003, FOOD RES INT, V36, P895, DOI 10.1016/S0963-9969(03)00098-X; Virtanen T, 2007, J APPL MICROBIOL, V102, P106, DOI 10.1111/j.1365-2672.2006.03072.x; Vitali B, 2012, ANAEROBE, V18, P386, DOI 10.1016/j.anaerobe.2012.04.014; Zagato E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087615; Zago M, 2017, BENEF MICROBES, V8, P597, DOI 10.3920/BM2016.0223	41	3	3	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245903	10.1371/journal.pone.0245903	http://dx.doi.org/10.1371/journal.pone.0245903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493208	Green Published, gold			2022-12-26	WOS:000613081500036
J	Valentin, D; Presas, A; Roehr, C; Mele, E; Biehl, C; Heiss, C; Bosbach, WA				Valentin, David; Presas, Alexandre; Roehr, Charline; Mele, Elisa; Biehl, Christoph; Heiss, Christian; Bosbach, Wolfram A.			On the quantification of local power densities in a new vibration bioreactor	PLOS ONE			English	Article							BACTERIAL ADHESION; ULTRASOUND; FREQUENCY; TUMORS	We investigate the power densities which are obtainable locally in a vibration bioreactor. These reactor systems are of great relevance for research about oncological or antibacterial therapies. Our focus lies on the local liquid pressure caused by resonance vibration in the fluid contained by the reactor's petri dish. We use for the excitation one piezoelectric patch which offer advantages concerning controllability and reproducibility, when compared to ultrasound. The experimental work is extended by finite element analyses of bioreactor details. The peaks of the vibration response for water, sodium chloride (0.1N Standard solution), and McCoy's 5A culture medium are in good alignment. Several natural frequencies can be observed. Local power density can reach multiple times the magnitude used in ultrasound studies. Based on the observed local power densities, we are planning future work for the exposure of cell cultures to mechanical vibration.	[Valentin, David; Presas, Alexandre] Polytech Univ Catalonia UPC, Ctr Ind Diagnost & Fluid Dynam CDIF, Barcelona, Spain; [Roehr, Charline; Biehl, Christoph; Heiss, Christian; Bosbach, Wolfram A.] Justus Liebig Univ Giessen, Expt Trauma Surg, Giessen, Germany; [Mele, Elisa] Loughborough Univ, Mat Dept, Loughborough, Leics, England; [Biehl, Christoph; Heiss, Christian; Bosbach, Wolfram A.] Univ Hosp Giessen, Dept Trauma Hand & Reconstruct Surg, Giessen, Germany	Universitat Politecnica de Catalunya; Justus Liebig University Giessen; Loughborough University; University Hospital of Giessen & Marburg	Valentin, D (corresponding author), Polytech Univ Catalonia UPC, Ctr Ind Diagnost & Fluid Dynam CDIF, Barcelona, Spain.	david.valentin@upc.edu	Bosbach, Wolfram/AAF-7965-2021	Bosbach, Wolfram/0000-0003-4182-3516; Mele, Elisa/0000-0003-3574-7684; Valentin, David/0000-0001-7125-0734; Biehl, Christoph/0000-0003-2981-5062	JustusLiebig fellowship of the Justus-Liebig University President (Giessen, Germany); Deutsche Forschungsgemeinschaft (DFG) [BO 4961/3-1]	JustusLiebig fellowship of the Justus-Liebig University President (Giessen, Germany); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was funded by the JustusLiebig fellowship of the Justus-Liebig University President (Giessen, Germany). The Deutsche Forschungsgemeinschaft (DFG) provided support for the attendance of two conferences by grant BO 4961/3-1.	ANSYS(R), 2018, ANSYS US MAN 18 0 CA; Bagherifard S, 2015, BIOMATERIALS, V73, P185, DOI 10.1016/j.biomaterials.2015.09.019; Bosbach WA, 2019, 2019 P 2 INT C TRAUM, P1, DOI [10.17863/CAM.45844, DOI 10.17863/CAM.45844]; Bosbach WA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07731-6; Bosbach WA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143011; Bowden G, 2013, OXFORD HDB ORTHOPAED; Carmen JC, 2005, AM J INFECT CONTROL, V33, P78, DOI 10.1016/j.ajic.2004.08.002; Deering J, 2020, J MECH BEHAV BIOMED, V106, DOI 10.1016/j.jmbbm.2020.103726; ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573; Evola FR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00150; Fassina L, 2007, ANN INT C IEEE ENG M; Fassina L, 2009, TISSUE ENG PART C-ME, V15, P233, DOI 10.1089/ten.tec.2008.0398; Hauser J, 2009, J ORTHOP RES, V27, P286, DOI 10.1002/jor.20741; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Imashiro C, 2019, IEEE T BIO-MED ENG, V66, P111, DOI 10.1109/TBME.2018.2835834; Li CX, 2010, CANCER-AM CANCER SOC, V116, P3934, DOI 10.1002/cncr.25192; Li CX, 2009, CANCER BIOL THER, V8, P1102, DOI 10.4161/cbt.8.12.8556; McCormick SM, 2006, ANN BIOMED ENG, V34, P436, DOI 10.1007/s10439-005-9057-5; Meng JX, 2014, CHEM-ASIAN J, V9, P2004, DOI 10.1002/asia.201402200; Naik T, 2003, SENSOR ACTUAT A-PHYS, V102, P240, DOI 10.1016/S0924-4247(02)00398-9; Norinder BS, 2011, INFECTION, V39, P571, DOI 10.1007/s15010-011-0199-0; Presas A, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030660; Qian Z, 1997, ANN BIOMED ENG, V25, P69, DOI 10.1007/BF02738539; RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Safavi AS, 2019, IN VITRO CELL DEV-AN, V55, P387, DOI 10.1007/s11626-019-00340-9; Torok ME, 2017, OXFORD HDB INFECT DI; Valentin D, 2014, J FLUID STRUCT, DOI [10.1016/j.jfluidstructs.2014.02.017, DOI 10.1016/J.JFLUIDSTRUCTS.2014.02.017]; Valentin D, 2019, 7 INT S SENS SCI 9 1; Valentin David, 2019, Sensors (Basel), V19, DOI 10.3390/s19020436; Valentin D, 2016, J VIB ACOUST, V138, DOI 10.1115/1.4032726; Wilkinson I, 2017, OXFORD HDB CLIN MED; Wu F, 2004, ULTRASOUND MED BIOL, V30, P245, DOI 10.1016/j.ultrasmedbio.2003.10.010; Yu WX, 2015, SURG ONCOL, V24, P9, DOI 10.1016/j.suronc.2014.10.001	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245768	10.1371/journal.pone.0245768	http://dx.doi.org/10.1371/journal.pone.0245768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481928	gold, Green Published, Green Submitted			2022-12-26	WOS:000612929300046
J	Makridis, CA; Wu, CR				Makridis, Christos A.; Wu, Cary			How social capital helps communities weather the COVID-19 pandemic	PLOS ONE			English	Article							HEALTH; TRUST; EPIDEMIC; SOCIETY; RATES	Why have the effects of COVID-19 been so unevenly geographically distributed in the United States? This paper investigates the role of social capital as a mediating factor for the spread of the virus. Because social capital is associated with greater trust and relationships within a community, it could endow individuals with a greater concern for others, thereby leading to more hygienic practices and social distancing. Using data for over 2,700 US counties, we investigate how social capital explains the level and growth rate of infections. We find that moving a county from the 25(th) to the 75(th) percentile of the distribution of social capital would lead to a 18% and 5.7% decline in the cumulative number of infections and deaths, as well as suggestive evidence of a lower spread of the virus. Our results are robust to many demographic characteristics, controls, and alternative measures of social capital.	[Makridis, Christos A.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85281 USA; [Makridis, Christos A.] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Wu, Cary] York Univ, Dept Sociol, Toronto, ON, Canada	Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); York University - Canada	Makridis, CA (corresponding author), Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85281 USA.; Makridis, CA (corresponding author), MIT, Sloan Sch Management, Cambridge, MA 02139 USA.; Wu, CR (corresponding author), York Univ, Dept Sociol, Toronto, ON, Canada.	makridis@mit.edu; carywu@yorku.ca		Wu, Cary/0000-0003-2652-5684	Canadian Institutes of Health Research [CIHR] [FRN-170368]	Canadian Institutes of Health Research [CIHR](Canadian Institutes of Health Research (CIHR))	This research was supported by a grant from the Canadian Institutes of Health Research [CIHR, FRN-170368; PI: Cary Wu].	Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; Aldrich DP., 2010, J HOMEL SECUR, V6, P1; Algan Y, 2014, HBK ECON, P49, DOI 10.1016/B978-0-444-53538-2.00002-2; Alonge O, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001257; [Anonymous], 2018, OXFORD HDB SOCIAL PO; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 1984, DISTINCTION SOCIAL C; ARROW KJ, 1972, PHILOS PUBLIC AFF, V1, P343; Bai John(Jianqiu)., 2020, SSRN ELECT J, DOI [https://doi.org/10.2139/ssrn.3609001, DOI 10.2139/SSRN.3609001]; Bailey M, 2018, J POLIT ECON, V126, P2224, DOI 10.1086/700073; Barrios J., 2020, CIVIC CAPITAL SOCIAL; Bartscher AK, 2020, SOCIAL CAPITAL SPREA; Bjornskov C, 2003, CORRUPTION SOCIAL CA; Bjornskov C, 2012, SOUTH ECON J, V78, P1346, DOI 10.4284/0038-4038-78.4.1346; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Borgonovi F, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113501; Brayne C, 2017, LANCET PLANET HEALTH, V1, pE86, DOI 10.1016/S2542-5196(17)30051-7; Brown P., 2020, INTERPERSONAL SOLIDA; Buonanno P, 2009, J LAW ECON, V52, P145, DOI 10.1086/595698; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Chen XH, 2011, J ECON LIT, V49, P901, DOI 10.1257/jel.49.4.901; Chetty R, 2014, Q J ECON, V129, P1553, DOI 10.1093/qje/qju022; Coleman J., 1990, FDN SOCIAL THEORY; COLEMAN JS, 1993, AM SOCIOL REV, V58, P1, DOI 10.2307/2096213; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Ding W., 2020, 27393 NAT BUR EC RES; Dynes Russell R., 2006, HOMELAND SECURITY AF, V2, P2; Ferlander S., 2003, INTERNET SOCIAL CAPI; Ferlander S, 2007, ACTA SOCIOL, V50, P115, DOI 10.1177/0001699307077654; Finke, 2000, ACTS FAITH EXPLAININ; Fraser T, 2020, BOWLING ALONE MASKIN; Fukuyama F., 1995, TRUST SOCIAL VIRTUES, V99; Gregson S, 2004, SOC SCI MED, V58, P2119, DOI 10.1016/j.socscimed.2003.09.001; Grootaert C., 2002, UNDERSTANDING MEASUR, DOI [10.1596/0-8213-5068-4, DOI 10.1596/0-8213-5068-4]; Guiso L, 2004, AM ECON REV, V94, P526, DOI 10.1257/0002828041464498; Helliwell JF, 2014, J HAPPINESS STUD, V15, P145, DOI 10.1007/s10902-013-9441-z; Holtgrave DR, 2004, AM J PREV MED, V26, P159, DOI 10.1016/j.amepre.2003.10.014; JEC, 2018, SOC CAP PROJ; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Kawachi I, 2006, INT J EPIDEMIOL, V35, P989, DOI 10.1093/ije/dyl117; Klinenberg E., 2003, HEAT WAVE SOCIAL AUT, VFirst; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Knack S, 2002, SOCIAL CAPITAL GROWT; Knowles S, 2007, STUD DEV ECON POLICY, P197; Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538; Kruk M. E., 2015, WHAT IS RESILIENT HL; Kuchler Theresa, 2020, NBER WORKING PAPER; Lee MR, 2000, SOC FORCES, V79, P683, DOI 10.2307/2675513; Lindstrom M, 2016, SOC SCI MED, V153, P71, DOI 10.1016/j.socscimed.2016.02.008; Makridis CA, 2021, J SCI STUD RELIG, V60, P252, DOI 10.1111/jssr.12700; Messner SF, 2004, AM SOCIOL REV, V69, P882, DOI 10.1177/000312240406900607; Mongey S., 2020, WHICH WORKERS BEAR B; Moore S, 2017, J EPIDEMIOL COMMUN H, V71, P513, DOI 10.1136/jech-2016-208313; Moore S, 2020, SOC SCI MED, V257, DOI 10.1016/j.socscimed.2019.02.023; Newton K, 1997, AM BEHAV SCI, V40, P575, DOI 10.1177/0002764297040005004; Newton K, 2001, INT POLIT SCI REV, V22, P201, DOI 10.1177/0192512101222004; Paxton P, 2002, AM SOCIOL REV, V67, P254, DOI 10.2307/3088895; Poortinga W, 2012, HEALTH PLACE, V18, P286, DOI 10.1016/j.healthplace.2011.09.017; Pronyk PM, 2008, SOC SCI MED, V67, P1559, DOI 10.1016/j.socscimed.2008.07.022; Putnam R., 1993, AM PROSPECT, V13, P4; Putnam RD., 2000, BOWLING ALONE COLLAP; Putnam RD, 2007, SCAND POLIT STUD, V30, P137, DOI 10.1111/j.1467-9477.2007.00176.x; Reininger BM, 2013, SOC SCI MED, V83, P50, DOI 10.1016/j.socscimed.2013.01.037; Rice TW, 2001, J URBAN AFF, V23, P375, DOI 10.1111/0735-2166.00095; Ryan P, 2019, INT MARKET REV, V36, P6, DOI 10.1108/IMR-03-2017-0061; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Sampson RJ, 2009, AM BEHAV SCI, V52, P1579, DOI 10.1177/0002764209331527; Sociedad Espanola de Hipertension, 2002, HIPERTENSION S3, V19, pS1; Song L., 2018, ELGAR COMPANION SOCI; Song LJ, 2009, J HEALTH SOC BEHAV, V50, P149, DOI 10.1177/002214650905000203; The Lancet Planetary Health, 2017, LANCET PLANET HEALTH, V1, pe209; Trapido J, 2019, LANCET INFECT DIS, V19, P457, DOI 10.1016/S1473-3099(19)30044-1; Varshney L. R., 2020, COVID 19 GROWTH RATE, DOI [10.1101/2020.04.23.20077321v1, DOI 10.1101/2020.04.23.20077321V1]; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Wilkinson A, 2017, CRIT PUBLIC HEALTH, V27, P14, DOI 10.1080/09581596.2016.1252034; World Health Organization, 2005, WHO OUTBR COMM GUID; Wu C., 2020, CONTEXTS; Wu C, 2021, CHINESE SOCIOL REV, V53, P27, DOI 10.1080/21620555.2020.1814139; Wu C, 2020, SOC SCI RES, V91, DOI 10.1016/j.ssresearch.2020.102449; Wu C, 2020, CHINESE SOCIOL REV, V52, P115, DOI 10.1080/21620555.2019.1665995; Wu C, 2018, INT J COMP SOCIOL, V59, P110, DOI 10.1177/0020715218761520; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027; Zoorob MJ, 2017, DRUG ALCOHOL DEPEN, V173, P1, DOI 10.1016/j.drugalcdep.2016.12.011	83	33	33	9	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245135	10.1371/journal.pone.0245135	http://dx.doi.org/10.1371/journal.pone.0245135			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QB1HB	33513146	Green Published, gold			2022-12-26	WOS:000613891400025
J	Mahrous, SA; Sidik, NAC; Saqr, KM				Mahrous, Samar A.; Sidik, Nor Azwadi Che; Saqr, Khalid M.			Numerical study on the energy cascade of pulsatile Newtonian and power-law flow models in an ICA bifurcation	PLOS ONE			English	Article							WALL SHEAR-STRESS; UNRUPTURED INTRACRANIAL ANEURYSMS; BLOOD-FLOW; CEREBRAL ANEURYSMS; HEMODYNAMICS; VISCOSITY; DYNAMICS; RUPTURE; ARTERIES; ASSUMPTION	The complex physics and biology underlying intracranial hemodynamics are yet to be fully revealed. A fully resolved direct numerical simulation (DNS) study has been performed to identify the intrinsic flow dynamics in an idealized carotid bifurcation model. To shed the light on the significance of considering blood shear-thinning properties, the power-law model is compared to the commonly used Newtonian viscosity hypothesis. We scrutinize the kinetic energy cascade (KEC) rates in the Fourier domain and the vortex structure of both fluid models and examine the impact of the power-law viscosity model. The flow intrinsically contains coherent structures which has frequencies corresponding to the boundary frequency, which could be associated with the regulation of endothelial cells. From the proposed comparative study, it is found that KEC rates and the vortex-identification are significantly influenced by the shear-thinning blood properties. Conclusively, from the obtained results, it is found that neglecting the non-Newtonian behavior could lead to underestimation of the hemodynamic parameters at low Reynolds number and overestimation of the hemodynamic parameters by increasing the Reynolds number. In addition, we provide physical insight and discussion onto the hemodynamics associated with endothelial dysfunction which plays significant role in the pathogenesis of intracranial aneurysms.	[Mahrous, Samar A.; Sidik, Nor Azwadi Che] Univ Teknol Malaysia, Dept Thermofluid, Skudai, Malaysia; [Mahrous, Samar A.; Saqr, Khalid M.] Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Alexandria, Egypt; [Sidik, Nor Azwadi Che] Univ Teknol Malaysia Kuala Lumpur, Malaysia Japan Int Inst Technol MJIIT, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport; Universiti Teknologi Malaysia	Mahrous, SA (corresponding author), Univ Teknol Malaysia, Dept Thermofluid, Skudai, Malaysia.; Mahrous, SA (corresponding author), Arab Acad Sci Technol & Maritime Transport, Coll Engn & Technol, Alexandria, Egypt.	samar.mahrous@aast.edu		Mahrous, Samar A./0000-0001-5655-2451	Center for Information and Communication Technology (CICT) in Universiti Teknologi Malaysia	Center for Information and Communication Technology (CICT) in Universiti Teknologi Malaysia	The authors would like to thank the Center for Information and Communication Technology (CICT) in Universiti Teknologi Malaysia for supporting and providing facilities and services of high-performance computing.	Ardakani VG, 2019, FLUIDS, V4, DOI 10.3390/fluids4020089; Asgharzadeh H, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/7412926; Avari H, 2016, CARDIOVASC ENG TECHN, V7, P44, DOI 10.1007/s13239-015-0250-x; Baek H, 2010, J R SOC INTERFACE, V7, P967, DOI 10.1098/rsif.2009.0476; Bernsdorf J, 2009, COMPUT MATH APPL, V58, P1024, DOI 10.1016/j.camwa.2009.02.019; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bluestein D, 2001, TECHNIQUES ANAL STAB; Boussel L, 2008, STROKE, V39, P2997, DOI 10.1161/STROKEAHA.108.521617; Brindise M, PATIENT SPECIFIC CER; Brindise MC, 2018, PHYS FLUIDS, V30, DOI 10.1063/1.5021472; Campo-Deano L, 2015, APPL MECH REV, V67, DOI 10.1115/1.4028946; Cebral JR, 2011, AM J NEURORADIOL, V32, P27, DOI 10.3174/ajnr.A2398; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Cornejo S, 2014, P I MECH ENG H, V228, P37, DOI 10.1177/0954411913512283; DELAMONTE SM, 1985, AM J MED, V78, P957, DOI 10.1016/0002-9343(85)90218-9; DELPLACE F, 1995, CHEM ENG J BIOCH ENG, V56, P33, DOI 10.1016/0923-0467(94)02849-6; Eckmann DM, 2000, ANESTH ANALG, V91, P539, DOI 10.1213/00000539-200009000-00007; Etminan N, 2016, NAT REV NEUROL, V12, P699, DOI 10.1038/nrneurol.2016.150; Evju O, 2015, MS A MOD SIMUL, V14, P177, DOI 10.1007/978-3-319-05230-4_7; Evju O, 2013, J BIOMECH, V46, P2802, DOI 10.1016/j.jbiomech.2013.09.004; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Frolov SV, 2016, TECHNOL HEALTH CARE, V24, P317, DOI 10.3233/THC-161132; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Gard AP, EVERY 18 MINUTES BRA; Gijsen FJH, 1999, J BIOMECH, V32, P601, DOI 10.1016/S0021-9290(99)00015-9; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; Hippelheuser JE, 2014, J BIOMECH, V47, P3695, DOI 10.1016/j.jbiomech.2014.09.027; Hoi YM, 2004, J NEUROSURG, V101, P676, DOI 10.3171/jns.2004.101.4.0676; HUSSAIN AKMF, 1986, J FLUID MECH, V173, P303, DOI 10.1017/S0022112086001192; Jain K, 2016, MED PHYS, V43, P6186, DOI 10.1118/1.4964793; Jamous MA, 2007, J NEUROSURG, V107, P405, DOI 10.3171/JNS-07/08/0405; Janela J, 2010, J COMPUT APPL MATH, V234, P2783, DOI 10.1016/j.cam.2010.01.032; Jeong WW, 2009, J MECH SCI TECHNOL, V23, P2424, DOI 10.1007/s12206-009-0627-6; Jeong W, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/782801; Jing LK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132494; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; JONES RT, 1969, ANNU REV FLUID MECH, V1, P223, DOI 10.1146/annurev.fl.01.010169.001255; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; Keedy Alexander, 2006, Mcgill J Med, V9, P141; Khan MO, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2836; Khan MO, 2015, AM J NEURORADIOL, V36, P1310, DOI 10.3174/ajnr.A4263; KIM C, 1993, ACTA NEUROCHIR, V121, P76, DOI 10.1007/BF01405187; Lee SW, 2007, J BIOMECH ENG-T ASME, V129, P273, DOI 10.1115/1.2540836; LIEPSCH DW, 1986, BIORHEOLOGY, V23, P395; Lindekleiv HM, 2010, GENDER MED, V7, P149, DOI 10.1016/j.genm.2010.03.003; Meng H, 2007, STROKE, V38, P1924, DOI 10.1161/STROKEAHA.106.481234; MERRILL EW, 1963, J APPL PHYSIOL, V18, P255, DOI 10.1152/jappl.1963.18.2.255; Mikhal J, 2011, PROCEDIA COMPUT SCI, V4, P811, DOI 10.1016/j.procs.2011.04.086; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Morales HG, 2013, J BIOMECH, V46, P2158, DOI 10.1016/j.jbiomech.2013.06.034; Nixon AM, 2010, J NEUROSURG, V112, P1240, DOI 10.3171/2009.10.JNS09759; Otani T, 2017, NIHON REOROJI GAKK, V45, P243; Pinto SIS, 2018, INT J NUMER METH BIO, V34, DOI 10.1002/cnm.2972; Sadamasa N, 2003, STROKE, V34, P2980, DOI 10.1161/01.STR.0000102556.55600.3B; Saqr KM, 2019, MED BIOL ENG COMPUT, V57, P1029, DOI 10.1007/s11517-018-1926-9; Saqr KM, 2019, WHAT DOES COMPUTATIO, P1, DOI [10.1177/0271678X19854640, DOI 10.1177/0271678X19854640]; SCANARINI M, 1978, ACTA NEUROCHIR, V43, P171, DOI 10.1007/BF01587953; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sforza DM, 2009, ANNU REV FLUID MECH, V41, P91, DOI 10.1146/annurev.fluid.40.111406.102126; Steinman DA, 2003, AM J NEURORADIOL, V24, P559; Suzuki T, 2017, TECHNOL HEALTH CARE, V25, P37, DOI 10.3233/THC-161245; Takao H, 2012, ANAL CEREBRAL ANEURY, P298; Valen-Sendstad K, 2014, J BIOMECH, V47, P3210, DOI 10.1016/j.jbiomech.2014.04.018; Valencia A, 2006, INT J NUMER METH FL, V50, P751, DOI 10.1002/fld.1078; Varble N, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4033477; WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023; Xiang JP, 2012, J NEUROINTERV SURG, V4, DOI 10.1136/neurintsurg-2011-010089; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu LJ, 2018, J BIOMECH, V72, P187, DOI 10.1016/j.jbiomech.2018.03.014; Yagi T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1031; Yamaguchi H, 2008, FLUID MECH APPL, V85, P1; Zhou G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05886-w; Zsolt Mihaly Kulcsar M, 2011, ROLE HEMODYNAMICS LI	78	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245775	10.1371/journal.pone.0245775	http://dx.doi.org/10.1371/journal.pone.0245775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493237	Green Published, gold			2022-12-26	WOS:000613081500010
J	Agbeno, EK; Osarfo, J; Ashong, J; Anane-Fenin, B; Okai, E; Ofori, AA; Aliyu, M; Opoku, DA; Ken-Amoah, S; Ashong, JA; Soltani, H				Agbeno, Evans Kofi; Osarfo, Joseph; Ashong, Joyce; Anane-Fenin, Betty; Okai, Emmanuel; Ofori, Anthony Amanfo; Aliyu, Mohammed; Opoku, Douglas Aninng; Ken-Amoah, Sebastian; Ashong, Joycelyn A.; Soltani, Hora			Determinants of preterm survival in a tertiary hospital in Ghana: A ten-year review	PLOS ONE			English	Review							ASPIRIN; BIRTH; RISK	Background Prematurity (gestational age <37 completed weeks) accounts for the majority of neonatal deaths worldwide and most of these occur in the low-resource countries. Understanding factors that determine the best chances of preterm survival is imperative in order to enhance the care of neonates and reduce adverse outcomes in such complicated births. Aim This was to find out the proportions of preterm babies who survived at the Special Care Baby Unit (SCBU) in the Cape Coast Teaching Hospital (CCTH) and the factors which influenced their survival. Method This was a retrospective review of data on all the live preterm babies seen at the SCBU of CCTH from 2010 to 2019. Data on 2,254 babies that met the inclusion criteria were extracted. Descriptive statistics were generated and tests of association done with chi-square and multivariable logistic regression. Outcome The main outcome measure was the proportion of live preterm neonates who were discharged after SCBU admissions. Results The CCTH had a total of 27,320 deliveries from 2010 to 2019. Of these, 1,282 were live preterm births, giving a prevalence of live preterm babies over the ten-year period of 4.7% (1,282/27,320). An increasing trend in prevalence was observed with 2019 recording the highest at 9% (271/3027). Most (48.8%) of the deliveries were vaginal, 39.2% were by caesarean section (CS); the mode of birth for 12% of the women were not documented. The mean gestational age was 31.8 (+/- 2.77) weeks. Of the birth weights documented, <1000g babies accounted for 11.9%, 1000-1499g babies made up 34.8%, while 1500g to 2499g babies accounted for 42.6%. The babies with weights >2500g made up only 3.7%. The average length of hospital stay was 8.3 (+/- 9.88) days. Regarding the main outcome variable, 67.6% were discharged alive, 27.6% died and 4.9% were unaccounted for due to incomplete documentation. Factors which influenced survival were: birth weight (p < 0.001); gestational age (p < 0.001); mode and place of delivery (p < 0.001 for both); APGAR scores at 1st and 5th minutes (p < 0.001); and length of stay at the SCBU (p < 0.001). No association was found for sex of the baby, maternal age and parity. Conclusion This study shows the possibility of achieving good preterm survival rates through the provision of specialised neonatal care, even in resource-constrained countries. This provides an updated benchmark for clinical decision-making and antenatal counselling. It also highlights the problem of inadequate data capture in our part of the world, which needs considerable improvement.	[Agbeno, Evans Kofi; Anane-Fenin, Betty; Ofori, Anthony Amanfo; Ken-Amoah, Sebastian; Ashong, Joycelyn A.] Univ Cape Coast, Sch Med Sci, Dept Obstet & Gynaecol, Cape Coast, Ghana; [Agbeno, Evans Kofi; Ashong, Joyce; Anane-Fenin, Betty; Okai, Emmanuel; Ofori, Anthony Amanfo; Ken-Amoah, Sebastian; Ashong, Joycelyn A.] Cape Coast Teaching Hosp, Cape Coast, Ghana; [Osarfo, Joseph] Asante Mampong Municipal Hosp, Ghana Hlth Serv, Mampong, Ashanti Region, Ghana; [Ashong, Joyce; Okai, Emmanuel] Univ Cape Coast, Sch Med Sci, Dept Paediat, Cape Coast, Ghana; [Aliyu, Mohammed; Opoku, Douglas Aninng] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Kumasi, Ghana; [Soltani, Hora] Sheffield Hallam Univ, Fac Hlth & Wellbeing, Sheffield, S Yorkshire, England	University of Cape Coast; University of Cape Coast; Kwame Nkrumah University Science & Technology; Sheffield Hallam University	Agbeno, EK (corresponding author), Univ Cape Coast, Sch Med Sci, Dept Obstet & Gynaecol, Cape Coast, Ghana.; Agbeno, EK (corresponding author), Cape Coast Teaching Hosp, Cape Coast, Ghana.	evans.agbeno@ucc.edu.gh	Opoku, Douglas Aninng/CAF-0150-2022	Opoku, Douglas Aninng/0000-0003-2321-387X; Agbeno, Evans Kofi/0000-0003-1725-2944; Ashong, Joyce/0000-0001-5371-104X; OSARFO, JOSEPH/0000-0002-5366-3997; Ken-Amoah, Sebastian/0000-0001-8293-6862				Adu-Bonsaffoh K, 2019, PLACENTA, V79, P62, DOI 10.1016/j.placenta.2019.01.007; AGOG, 2017, DEF TERM PREGN; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bourke J, 2019, J PEDIATR-US, V215, P90, DOI 10.1016/j.jpeds.2019.07.056; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Draper ES, 2009, ARCH DIS CHILD-FETAL, V94, pF158, DOI 10.1136/adc.2008.141531; Elder DE, 2009, AUST NZ J OBSTET GYN, V49, P407, DOI 10.1111/j.1479-828X.2009.01033.x; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Iyoke CA, 2015, NIGER J CLIN PRACT, V18, P744, DOI 10.4103/1119-3077.158141; Lawn JE, 2019, IRAN J NEONATOL, V10; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Liu B, 2016, LANCET, V388, P27, DOI 10.1016/S0140-6736(16)30771-1; Manuck TA, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.004; Mohamed MA, 2010, PEDIATRICS, V126, pE360, DOI 10.1542/peds.2009-2810; Ndelema Brigitte, 2016, BMC Res Notes, V9, P28, DOI 10.1186/s13104-015-1666-y; Nkyekyer K, 2010, GHANA MED J, V40, P93; O'Gorman N, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011801; Poon LC, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/297397; Raju TNK, 2016, LONG TERM HEALTHCARE, DOI [10.1016/jjpeds.2016.10.015, DOI 10.1016/JJPEDS.2016.10.015]; Roberge S, 2017, AM J OBSTET GYNECOL, V216, P110, DOI 10.1016/j.ajog.2016.09.076; Romero R, 2018, AM J OBSTET GYNECOL, V218, P161, DOI 10.1016/j.ajog.2017.11.576; Rylance S, 2013, PAEDIATR INT CHILD H, V33, P91, DOI 10.1179/2046905513Y.0000000053; Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMc1713798, 10.1056/NEJMoa1704559]; Soltani M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2183-0; TOWNSEL CD, 2017, FRONT PEDIATR, V5, DOI DOI 10.3389/IPED.2017.00006; WHO, 2018, WHO I NEW GLOB EST P; WHO, 2018, PRET BIRTH; You J, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1336-0	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0246005	10.1371/journal.pone.0246005	http://dx.doi.org/10.1371/journal.pone.0246005			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481960	Green Accepted, gold, Green Published			2022-12-26	WOS:000612929300041
J	Brambilla, CR; Scheins, J; Issa, A; Tellmann, L; Herzog, H; Kops, ER; Shah, NJ; Neuner, I; Lerche, CW				Brambilla, Claudia Regio; Scheins, Jurgen; Issa, Ahlam; Tellmann, Lutz; Herzog, Hans; Kops, Elena Rota; Shah, N. Jon; Neuner, Irene; Lerche, Christoph W.			Bias evaluation and reduction in 3D OP-OSEM reconstruction in dynamic equilibrium PET studies with C-11-labeled for binding potential analysis	PLOS ONE			English	Article							HIGH-RESOLUTION; LIKELIHOOD RECONSTRUCTION; ITERATIVE RECONSTRUCTION; BRAIN; C-11-ABP688; ALGORITHMS; VARIANCE; RANDOMS; HRRT	Iterative image reconstruction is widely used in positron emission tomography. However, it is known to contribute to quantitation bias and is particularly pronounced during dynamic studies with C-11-labeled radiotracers where count rates become low towards the end of the acquisition. As the strength of the quantitation bias depends on the counts in the reconstructed frame, it can differ from frame to frame of the acquisition. This is especially relevant in the case of neuro-receptor studies with simultaneous PET/MR when a bolus-infusion protocol is applied to allow the comparison of pre- and post-task effects. Here, count dependent changes in quantitation bias may interfere with task changes. We evaluated the impact of different framing schemes on quantitation bias and its propagation into binding potential (BP) using a phantom decay study with C-11 and 3D OP-OSEM. Further, we propose a framing scheme that keeps the true counts per frame constant over the acquisition time as constant framing schemes and conventional increasing framing schemes are unlikely to achieve stable bias values during the acquisition time range. For a constant framing scheme with 5 minutes frames, the BP bias was 7.13 +/- 2.01% (10.8% to 3.8%) compared to 5.63 +/- 2.85% (7.8% to 4.0%) for conventional increasing framing schemes. Using the proposed constant true counts framing scheme, a stabilization of the BP bias was achieved at 2.56 +/- 3.92% (3.5% to 1.7%). The change in BP bias was further studied by evaluating the linear slope during the acquisition time interval. The lowest slope values were observed in the constant true counts framing scheme. The constant true counts framing scheme was effective for BP bias stabilization at relevant activity and time ranges. The mean BP bias under these conditions was 2.56 +/- 3.92%, which represents the lower limit for the detection of changes in BP during equilibrium and is especially important in the case of cognitive tasks where the expected changes are low.	[Brambilla, Claudia Regio; Scheins, Jurgen; Issa, Ahlam; Tellmann, Lutz; Herzog, Hans; Kops, Elena Rota; Shah, N. Jon; Neuner, Irene; Lerche, Christoph W.] Forschungszentrum Julich, Inst Neurosci & Med, INM 4, Julich, Germany; [Brambilla, Claudia Regio; Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Shah, N. Jon] Forschungszentrum Julich, Inst Neurosci & Med, INM 11, Julich, Germany; [Shah, N. Jon; Neuner, Irene] Rhein Westfal TH Aachen, JARA BRAIN Translat Med, Aachen, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University; Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University	Brambilla, CR (corresponding author), Forschungszentrum Julich, Inst Neurosci & Med, INM 4, Julich, Germany.; Brambilla, CR (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.	c.regio-brambilla@fz-juelich.de	Shah, N. Jon/H-5849-2013	Shah, N. Jon/0000-0002-8151-6169; Regio Brambilla, Claudia/0000-0002-3735-8511; Tellmann, Lutz/0000-0002-1154-2847	EU-FP7 funded project TRIMAGE [602621]; DAAD [57299294]	EU-FP7 funded project TRIMAGE; DAAD(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the EU-FP7 funded project TRIMAGE (Nr. 602621), and Claudia Regio Brambilla thanks to DAAD for financial support (Nr. 57299294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus F, 2014, INT J NEUROPSYCHOPH, V17, P1915, DOI 10.1017/S1461145714000716; Ametamey SM, 2007, J NUCL MED, V48, P247; Association NEM, 2007, NEM STAND PUBL; Barrett HH, 1997, J OPT SOC AM A, V14, P2914, DOI 10.1364/JOSAA.14.002914; Belanger MJ, 2004, NEUROIMAGE, V21, P244, DOI 10.1016/j.neuroimage.2003.08.035; Brambilla CR, 2020, HUM BRAIN MAPP, V41, P2762, DOI 10.1002/hbm.24976; Burger C, 2010, NUCL MED BIOL, V37, P845, DOI 10.1016/j.nucmedbio.2010.04.107; Byars LG, 2005, IEEE NUCL SCI CONF R, P2622; Caldeira L, 2019, IEEE T RADIAT PLASMA, V3, P352, DOI 10.1109/TRPMS.2018.2863953; Chen TB, 2014, RADIAT PHYS CHEM, V96, P107, DOI 10.1016/j.radphyschem.2013.09.006; Cloquet C, 2013, IEEE T NUCL SCI, V60, P134, DOI 10.1109/TNS.2012.2217988; Comtat C, 2004, IEEE NUCL SCI CONF R, P3492; de Jong HWAM, 2007, PHYS MED BIOL, V52, P1505, DOI 10.1088/0031-9155/52/5/019; DeLorenzo C, 2017, J CEREBR BLOOD F MET, V37, P2716, DOI 10.1177/0271678X16673646; DeLorenzo C, 2015, BIOL PSYCHIAT, V77, P266, DOI 10.1016/j.biopsych.2014.06.024; Esterlis I, 2018, MOL PSYCHIATR, V23, P824, DOI 10.1038/mp.2017.58; Gunn RN, 2015, PHYS MED BIOL, V60, pR363, DOI 10.1088/0031-9155/60/22/R363; Haggstrom I, 2015, J NUCL MED TECHNOL, V43, P53, DOI 10.2967/jnmt.114.141754; Herzog H, 2011, NUKLEARMED-NUCL MED, V50, P74, DOI 10.3413/Nukmed-0347-10-09; Hong I, 2014, PHYS MED BIOL, V59, P5441, DOI 10.1088/0031-9155/59/18/5441; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Jian Y, 2015, PHYS MED BIOL, V60, P15, DOI 10.1088/0031-9155/60/1/15; Johansson J, 2007, IEEE NUCL SCI CONF R, P3463, DOI 10.1109/NSSMIC.2007.4436876; Karaoglanis K, 2015, HELL J NUCL MED, V18, P140, DOI 10.1967/s002449910209; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Liu X, 2001, IEEE T MED IMAGING, V20, P804, DOI 10.1109/42.938248; Milella MS, 2014, NEUROIMAGE, V98, P195, DOI 10.1016/j.neuroimage.2014.04.061; Otani T, 2019, AM J ROENTGENOL, V213, pW50, DOI 10.2214/AJR.18.20478; Planeta-Wilson Beata, 2008, IEEE Nucl Sci Symp Conf Rec (1997), V2008, P5121; Reilhac A, 2008, NEUROIMAGE, V39, P359, DOI 10.1016/j.neuroimage.2007.07.038; Rogasch JM, 2020, EJNMMI PHYS, V7, DOI 10.1186/s40658-020-0270-y; Shepp L A, 1982, IEEE Trans Med Imaging, V1, P113, DOI 10.1109/TMI.1982.4307558; TRAGARDH E, 2020, EJNMMI PHYS, V7, DOI DOI 10.1016/J.NUCMEDBIO.2010.04.107; Treyer V, 2007, J NUCL MED, V48, P1207, DOI 10.2967/jnumed.107.039578; Van Slambrouck K, 2015, IEEE T MED IMAGING, V34, P126, DOI 10.1109/TMI.2014.2347810; van Velden FHP, 2008, PHYS MED BIOL, V53, P3217, DOI 10.1088/0031-9155/53/12/010; van Velden FHP, 2009, J NUCL MED, V50, P72, DOI 10.2967/jnumed.108.052985; Walker MD, 2011, PHYS MED BIOL, V56, P931, DOI 10.1088/0031-9155/56/4/004; Watson CC, 2000, IEEE T NUCL SCI, V47, P1587, DOI 10.1109/23.873020	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245580	10.1371/journal.pone.0245580	http://dx.doi.org/10.1371/journal.pone.0245580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481896	gold, Green Published			2022-12-26	WOS:000612929300161
J	Yang, SL; Zhang, YB; Deng, J; Li, RD; Fan, X; Dao, JM; Quan, YJ; Bukhari, SAH				Yang, Shao-lin; Zhang, Yue-bin; Deng, Jun; Li, Ru-dan; Fan, Xian; Dao, Jing-mei; Quan, Yi-ji; Bukhari, Syed Asad Hussain			Effect of cutting depth during sugarcane (Saccharum spp. hybrid) harvest on root characteristics and yield	PLOS ONE			English	Article							FORAGE SUGARCANE; STUBBLE-HEIGHT; GROWTH; ACQUISITION; ELONGATION; DYNAMICS; KRFO93-1; TRAITS; NUMBER	Ratooning is an important cultivation practice in sugarcane production around the world, with underground buds on the remaining stalk acting as the source for establishment of a subsequent ratoon crop. However, the optimal depth of cutting during harvest in terms of yield and root growth remains unknown. We carried out a two-year field study to determine the effects of three cutting depths (0, 5 and 10 cm below the surface) ratoon cane root and yield. Results showed that cutting to a depth of 5 cm increased the root fresh weight and root volume by 21-59% and 41-127%, respectively, compared to cutting depths of 0 and 10 cm. Remarkably, cutting to a depth of 5 cm also had a significant effect on the development of fine roots, which is closely linked to cane yield. The effect was particularly noticeable in terms of two root traits, root volume and the surface area of roots with a diameter of 1.02.0mm, and root length and the number of root tips in roots with a diameter of 0-0.5mm. As a result, a cutting depth of 5 cm below the surface increased cane yield by 43 and 28% compared to depths of 0 and 10 cm below the surface, respectively. Overall, these findings suggest that a cutting depth of 5 cm is optimal in terms of sugarcane yield, largely due to the enhanced effect on root traits, especially the development of fine roots. These findings will help optimize sugarcane ratoon management and improve the ratoon cycle.	[Yang, Shao-lin; Zhang, Yue-bin; Deng, Jun; Li, Ru-dan; Fan, Xian; Dao, Jing-mei; Quan, Yi-ji] Yunnan Acad Agr Sci, Sugarcane Res Inst, Key Lab Sugarcane Genet Improvement, Kaiyuan, Yunnan, Peoples R China; [Bukhari, Syed Asad Hussain] Bahauddin Zakariya Univ, Dept Agron, Multan, Pakistan	Yunnan Academy of Agricultural Sciences; Bahauddin Zakariya University	Zhang, YB (corresponding author), Yunnan Acad Agr Sci, Sugarcane Res Inst, Key Lab Sugarcane Genet Improvement, Kaiyuan, Yunnan, Peoples R China.	ynzyb@sohu.com	Yang, Shao-lin/AAZ-3914-2021	Yang, Shao-lin/0000-0001-7562-3024	National sugar industry technical system [CARS-170205]	National sugar industry technical system	The study was funded by National sugar industry technical system (CARS-170205). Yes.	Arend M, 2011, TREE PHYSIOL, V31, P287, DOI 10.1093/treephys/tpr004; Choudhary RL, 2017, SUGAR TECH, V19, P33, DOI 10.1007/s12355-016-0438-x; Collet C, 1997, ANN SCI FOREST, V54, P65, DOI 10.1051/forest:19970106; Colombi T, 2017, PLANT PHYSIOL, V174, P2289, DOI 10.1104/pp.17.00357; [丁红 Ding Hong], 2013, [生态学报, Acta Ecologica Sinica], V33, P5169; Goins GD, 1996, PLANT SOIL, V185, P281, DOI 10.1007/BF02257534; Harrell DL, 2009, FIELD CROP RES, V114, P396, DOI 10.1016/j.fcr.2009.09.011; Hulugalle NR, 2015, SOIL TILL RES, V146, P313, DOI 10.1016/j.still.2014.10.004; HUNSIGI G, 1989, OUTLOOK AGR, V18, P175, DOI 10.1177/003072708901800407; Ishwar Singh, 2003, Sugar Tech, V5, P181, DOI 10.1007/BF02943632; Jain R, 2007, PLANT GROWTH REGUL, V53, P17, DOI 10.1007/s10725-007-9199-6; Jia YB, 2008, J ZHEJIANG UNIV-SC B, V9, P427, DOI 10.1631/jzus.B0710636; Kato Y, 2010, FIELD CROP RES, V118, P194, DOI 10.1016/j.fcr.2010.04.013; KAUPPI A, 1991, CAN J FOREST RES, V21, P528, DOI 10.1139/x91-073; Langworthy AD, 2019, CROP PASTURE SCI, V70, P183, DOI 10.1071/CP18313; Li YR, 2015, SUGAR TECH, V17, P1, DOI 10.1007/s12355-014-0342-1; Li Y, 2010, PROCEEDINGS OF ANNUAL CONFERENCE OF CHINA INSTITUTE OF COMMUNICATIONS, P313; Liu LP, 2010, CROP SCI, V50, P222, DOI 10.2135/cropsci2009.03.0156; Lu C., 2002, SUBTROP AGR RES, V9, P33; Lu ZL, 2005, GUANGXI SUGARCANE CA, V1, P3, DOI [10.3969/j.issn.1007-4732.2005.01.001, DOI 10.3969/J.ISSN.1007-4732.2005.01.001]; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Ma SC, 2016, T ASABE, V59, P813, DOI 10.13031/trans.59.11334; Marin FR, 2019, FIELD CROP RES, V240, P134, DOI 10.1016/j.fcr.2019.06.011; Miyahira E., 1984, B OKINAWA AGR EXPT S, V9, P59; Moore P.H., 2014, SUGARCANE PHYSL BIOC, P1, DOI DOI 10.1002/9781118771280.CH1; Nakano H, 2009, PLANT PROD SCI, V12, P124, DOI 10.1626/pps.12.124; Niu GF, 2007, GUANGXI SUGAR IND; OWENDE PMO, 1995, SOIL TILL RES, V33, P185, DOI 10.1016/0167-1987(94)00445-K; Pages L, 2011, PLANT CELL ENVIRON, V34, P1749, DOI 10.1111/j.1365-3040.2011.02371.x; Pawar B. N., 2000, Indian Sugar, V50, P147; Rajput MA, 2019, PAK J BOT, V51, P1891, DOI [10.30848/PJB2019-5(17), 10.30848/pjb2019-5(17)]; Raju Gomathi, 2013, American Journal of Plant Sciences, V4, P274, DOI 10.4236/ajps.2013.42036; RIDGMAN W. J., 1960, JOUR BRIT GRASSLAND SOC, V15, P291, DOI 10.1111/j.1365-2494.1960.tb00197.x; Saengwilai P, 2014, PLANT PHYSIOL, V166, P581, DOI 10.1104/pp.113.232603; Sakaigaichi T, 2017, PLANT PROD SCI, V20, P157, DOI [10.1080/1343943x.2017.1283239, 10.1080/1343943X.2017.1283239]; Sakaigaichi T, 2013, PLANT PROD SCI, V16, P183, DOI 10.1626/pps.16.183; Sharma B., 1991, INDIAN J GENET PLANT, V51, P480; Singh S. N., 2008, American-Eurasian Journal of Scientific Research, V3, P29; Smith DM, 2005, FIELD CROP RES, V92, P169, DOI 10.1016/j.fcr.2005.01.017; Smith SW, 2014, NEW PHYTOL, V203, P851, DOI 10.1111/nph.12845; Sun BR, 2018, PLANT PHYSIOL, V177, P90, DOI 10.1104/pp.18.00234; Tufekcioglu A, 1998, AGROFOREST SYST, V44, P163, DOI 10.1023/A:1006221921806; Wang Qing-hui, 2018, Yingyong Shengtai Xuebao, V29, P865, DOI 10.13287/j.1001-9332.201803.025; Yang ZP, 2020, J ENVIRON MANAGE, V253, DOI 10.1016/j.jenvman.2019.109745; Yin J, 2015, WATER RESOUR RES, V51, P8476, DOI 10.1002/2015WR017286; Zhao PF, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120830; Zhao PF, 2019, J PLANT REGIST, V13, P362, DOI 10.3198/jpr2018.10.0068crc	47	2	3	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0238085	10.1371/journal.pone.0238085	http://dx.doi.org/10.1371/journal.pone.0238085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481789	gold, Green Published, Green Submitted			2022-12-26	WOS:000612929300017
J	Lippert, LG; Ma, N; Ritt, M; Jain, A; Vaidehi, N; Sivaramakrishnan, S				Lippert, Lisa G.; Ma, Ning; Ritt, Michael; Jain, Abhinandan; Vaidehi, Nagarajan; Sivaramakrishnan, Sivaraj			Kinase inhibitors allosterically disrupt a regulatory interaction to enhance PKC alpha membrane translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; SUBSTRATE AFFINITY; ACCURATE DOCKING; PROTEIN; GLIDE; AUTOINHIBITION; ACTIVATION; MECHANISMS; DOMAINS; GROMACS	The eukaryotic kinase domain has multiple intrinsically disordered regions whose conformation dictates kinase activity. Small molecule kinase inhibitors (SMKIs) rely on disrupting the active conformations of these disordered regions to inactivate the kinase. While SMKIs are selected for their ability to cause this disruption, the allosteric effects of conformational changes in disordered regions is limited by a lack of dynamic information provided by traditional structural techniques. In this study, we integrated multiscale molecular dynamics simulations with FRET sensors to characterize a novel allosteric mechanism that is selectively triggered by SMKI binding to the protein kinase C alpha domain. The indole maleimide inhibitors BimI and sotrastaurin were found to displace the Gly-rich loop (G-loop) that normally shields the ATP-binding site. Displacement of the G-loop interferes with a newly identified, structurally conserved binding pocket for the C1a domain on the N lobe of the kinase domain. This binding pocket, in conjunction with the N-terminal regulatory sequence, masks a diacylglycerol (DAG) binding site on the C1a domain. SMK-Imediated displacement of the G-loop released C1a and exposed the DAG binding site, enhancing protein kinase C alpha translocation both to synthetic lipid bilayers and to live cell membranes in the presence of DAG. Inhibitor chemotype determined the extent of the observed allosteric effects on the kinase domain and correlated with the extent of membrane recruitment. Our findings demonstrate the allosteric effects of SMKIs beyond the confines of kinase catalytic conformation and provide an integrated computational-experimental paradigm to investigate parallel mechanisms in other kinases.	[Lippert, Lisa G.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Ma, Ning; Vaidehi, Nagarajan] City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Duarte, CA 91010 USA; [Jain, Abhinandan] CALTECH, Jet Prop Lab, Pasadena, CA USA	University of Minnesota System; University of Minnesota Twin Cities; City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sivaramakrishnan, S (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.; Vaidehi, N (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Computat & Quantitat Med, Duarte, CA 91010 USA.	Nvaidehi@coh.org; Sivaraj@umn.edu		Sivaramakrishnan, Sivaraj/0000-0002-9541-6994	NIH [R01GM117923, R35GM126940]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research in this publication is supported by NIH-R35GM126940 (to S. S.) and NIH-R01GM117923 (to N. V. and S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Antal CE, 2015, CELL REP, V12, P1252, DOI 10.1016/j.celrep.2015.07.039; Bazzoli A, 2017, PROTEINS, V85, P1994, DOI 10.1002/prot.25353; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Bonny M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36028; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fabbro D, 2015, MOL PHARMACOL, V87, P766, DOI 10.1124/mol.114.095489; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Komander D, 2004, STRUCTURE, V12, P215, DOI 10.1016/j.str.2004.01.005; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Larsen AB, 2014, J CHEM INF MODEL, V54, P508, DOI [10.1021/ci4004841, 10.1021/ci400484c]; Lee S, 2017, J BIOL CHEM, V292, P16300, DOI 10.1074/jbc.M117.804781; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Li H, 2014, J CHEM INF MODEL, V54, P1391, DOI [10.1021/ci400750x, 10.1021/ci40750x1]; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; Ma N, 2018, BIOCHEMISTRY-US, V57, P6387, DOI 10.1021/acs.biochem.8b00729; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Sommese RF, 2017, J BIOL CHEM, V292, P2873, DOI 10.1074/jbc.M116.768457; Sommese RF, 2016, J BIOL CHEM, V291, P21963, DOI 10.1074/jbc.M116.737601; Soriano EV, 2016, DEV CELL, V38, P384, DOI 10.1016/j.devcel.2016.07.018; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Swanson CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162331; Swanson CJ, 2014, J BIOL CHEM, V289, P17812, DOI 10.1074/jbc.M113.534750; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; Vaidehi N, 2015, J PHYS CHEM B, V119, P1233, DOI 10.1021/jp509136y; VARTANIAN T, 1989, GLIA, V2, P370, DOI 10.1002/glia.440020509; Wagner JR, 2013, J COMPUT CHEM, V34, P904, DOI 10.1002/jcc.23200; Wang CH, 2012, STRUCTURE, V20, P791, DOI 10.1016/j.str.2012.02.022	46	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100339	10.1016/j.jbc.2021.100339	http://dx.doi.org/10.1016/j.jbc.2021.100339			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508318	Green Published, gold			2022-12-26	WOS:000672866400313
J	Uchida, Y; Yamamoto, Y; Sakisaka, T				Uchida, Yasunori; Yamamoto, Yasunori; Sakisaka, Toshiaki			Trans-2-enoyl-CoA reductase limits Ca2+ accumulation in the endoplasmic reticulum by inhibiting the Ca2+ pump SERCA2b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID ELONGATION; SARCOPLASMIC-RETICULUM; CALCIUM-PUMP; TRANSCRIPTION FACTOR; MENTAL-RETARDATION; CRYSTAL-STRUCTURES; MOLECULAR-CLONING; GENE; RECEPTOR; NFAT	The endoplasmic reticulum (ER) contains various enzymes that metabolize fatty acids (FAs). Given that FAs are the components of membranes, FA metabolic enzymes might be associated with regulation of ER membrane functions. However, it remains unclear whether there is the interplay between FA metabolic enzymes and ER membrane proteins. Trans-2-enoyl-CoA reductase (TER) is an FA reductase present in the ER membrane and catalyzes the last step in the FA elongation cycle and sphingosine degradation pathway. Here we identify sarco(endo)plasmic reticulum Ca2+-ATPase 2b (SERCA2b), an ER Ca2+ pump responsible for Ca2+ accumulation in the ER, as a TER-binding protein by affinity purification from HEK293 cell lysates. We show that TER directly binds to SERCA2b by in vitro assays using recombinant proteins. Thapsigargin, a specific SERCA inhibitor, inhibits this binding. TER binds to SERCA2b through its conserved C-terminal region. TER overexpression suppresses SERCA2b ATPase activity in microsomal membranes of HEK293 cells. Depletion of TER increases Ca2+ storage in the ER and accelerates SERCA2b-dependent Ca2+ uptake to the ER after ligand-induced Ca2+ release. Moreover, depletion of TER reduces the Ca2+-dependent nuclear translocation of nuclear factor of activated T cells 4. These results demonstrate that TER is a negative regulator of SERCA2b, implying the direct linkage of FA metabolism and Ca2+ accumulation in the ER.	[Uchida, Yasunori; Yamamoto, Yasunori; Sakisaka, Toshiaki] Kobe Univ, Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo, Japan	Kobe University	Sakisaka, T (corresponding author), Kobe Univ, Sch Med, Dept Physiol & Cell Biol, Div Membrane Dynam, Kobe, Hyogo, Japan.	sakisaka@med.kobe-u.ac.jp			Japan Society for the Promotion of Sciences [18K14698, 18K06112, 16K15218]; GSK Japan Research Grant 2017; Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); GSK Japan Research Grant 2017; Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Sciences (18K14698, 18K06112, 16K15218) and also by GSK Japan Research Grant 2017 and the Setsuro Fujii Memorial, The Osaka Foundation for Promotion of Fundamental Medical Research.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arruda AP, 2015, CELL METAB, V22, P381, DOI 10.1016/j.cmet.2015.06.010; Caliskan M, 2011, HUM MOL GENET, V20, P1285, DOI 10.1093/hmg/ddq569; Cartier A, 2019, SCIENCE, V366, P323, DOI 10.1126/science.aar5551; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Devalla HD, 2016, EMBO MOL MED, V8, P1390, DOI 10.15252/emmm.201505719; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Inoue M, 2019, CELL REP, V27, P1221, DOI 10.1016/j.celrep.2019.03.106; INUI M, 1987, J BIOL CHEM, V262, P1740; JOHNSTON IG, 1992, J NEUROSCI RES, V32, P159, DOI 10.1002/jnr.490320205; JORGENSEN AO, 1988, CELL MOTIL CYTOSKEL, V9, P164, DOI 10.1002/cm.970090208; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Koshiba M., 2007, SOLUTION STRUCTURE N; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Li YK, 2004, J BIOL CHEM, V279, P37030, DOI 10.1074/jbc.M405195200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Moscu-Gregor A, 2020, J CARDIOVASC ELECTR, V31, P1527, DOI 10.1111/jce.14446; MOVSESIAN MA, 1994, CIRCULATION, V90, P653, DOI 10.1161/01.CIR.90.2.653; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nakahara K, 2012, MOL CELL, V46, P461, DOI 10.1016/j.molcel.2012.04.033; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Okada T, 1998, J BIOL CHEM, V273, P10279, DOI 10.1074/jbc.273.17.10279; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Paul S, 2007, J BIOL CHEM, V282, P19237, DOI 10.1074/jbc.M701774200; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Schachter JB, 1997, NEUROPHARMACOLOGY, V36, P1181, DOI 10.1016/S0028-3908(97)00138-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Stepanovska B, 2020, PHARMACOL RES, V154, DOI 10.1016/j.phrs.2019.02.009; Su WC, 2019, J CELL BIOL, V218, P3663, DOI 10.1083/jcb.201902072; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2013, CURR OPIN STRUC BIOL, V23, P507, DOI 10.1016/j.sbi.2013.06.005; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; Ushioda R, 2016, P NATL ACAD SCI USA, V113, pE6055, DOI 10.1073/pnas.1605818113; Vandecaetsbeek I, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004184; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; WU KD, 1995, AM J PHYSIOL-CELL PH, V269, pC775, DOI 10.1152/ajpcell.1995.269.3.C775; Xie LJ, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2019.01.018; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Zhang XX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09593-0; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993; Zimmermann H, 2016, PURINERG SIGNAL, V12, P25, DOI 10.1007/s11302-015-9483-2	68	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100310	10.1016/j.jbc.2021.100310	http://dx.doi.org/10.1016/j.jbc.2021.100310			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482198	Green Published, gold			2022-12-26	WOS:000672866400284
J	Han, JL; Guo, TT; Yue, YJ; Lu, ZK; Liu, JB; Yuan, C; Niu, CN; Yang, M; Yang, BH				Han, Jilong; Guo, Tingting; Yue, Yaojing; Lu, Zengkui; Liu, Jianbin; Yuan, Chao; Niu, Chune; Yang, Min; Yang, Bohui			Quantitative proteomic analysis identified differentially expressed proteins with tail/rump fat deposition in Chinese thin- and fat-tailed lambs	PLOS ONE			English	Article							ADIPOSE-TISSUE; LIPID-METABOLISM; SELECTION; OBESITY	Tail adipose as one of the important functional tissues can enhance hazardous environments tolerance for sheep. The objective of this study was to gain insight into the underlying development mechanisms of this trait. A quantitative analysis of protein abundance in ovine tail/rump adipose tissue was performed between Chinese local fat- (Kazakh, Hu and Lanzhou) and thin-tailed (Alpine Merino, Tibetan) sheep in the present study by using lable-free approach. Results showed that 3400 proteins were identified in the five breeds, and 804 were differentially expressed proteins, including 638 up regulated proteins and 83 down regulated proteins in the tail adipose tissues between fat- and thin-tailed sheep, and 8 clusters were distinguished for all the DEPs' expression patterns. The differentially expressed proteins are mainly associated with metabolism pathways and peroxisome proliferator activated receptor signaling pathway. Furthermore, the proteomics results were validated by quantitative real-time PCR and Western Blot. Our research has also suggested that the up-regulated proteins ACSL1, HSD17 beta 4, FABP4 in the tail adipose tissue might contribute to tail fat deposition by facilitating the proliferation of adipocytes and fat accumulation in tail/rump of sheep. Particularly, FABP4 highly expressed in the fat-tail will play an important role for tail fat deposition. Our study might provide a novel view to understanding fat accumulation in special parts of the body in sheep and other animals.	[Han, Jilong; Guo, Tingting; Yue, Yaojing; Lu, Zengkui; Liu, Jianbin; Yuan, Chao; Niu, Chune; Yang, Bohui] Chinese Acad Agr Sci CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China; [Han, Jilong; Yang, Min] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China; [Han, Jilong; Yang, Min; Yang, Bohui] CAAS, Key Lab Anim Poultry Genet Breeding & Reprod, Inst Anim Sci, Minist Agr & Rural Affairs, Beijing, Peoples R China; [Guo, Tingting; Yue, Yaojing; Lu, Zengkui; Liu, Jianbin; Yuan, Chao; Niu, Chune] CAAS, Engn Res Ctr Sheep & Goat Breeding, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Shihezi University; Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences	Yang, BH (corresponding author), Chinese Acad Agr Sci CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Lanzhou, Peoples R China.; Yang, M (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Peoples R China.; Yang, M; Yang, BH (corresponding author), CAAS, Key Lab Anim Poultry Genet Breeding & Reprod, Inst Anim Sci, Minist Agr & Rural Affairs, Beijing, Peoples R China.	yangmin2017@shzu.edu.cn; yangbohui@caas.cn			National Natural Science Foundation of China [31702092, 31802045, 32060745]; Modern China Wool & Cashmere Technology Research System [CARS39-02]; Agricultural Science and Technology Innovation Program for Genetic Resource and Breeding of Fine-Wool Sheep, CAAS [ASTIP-2015-LIHPS]; Special Funds for Basic Research of Young Scholars of Shihezi University [CXBJ201903, CXRC201808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern China Wool & Cashmere Technology Research System; Agricultural Science and Technology Innovation Program for Genetic Resource and Breeding of Fine-Wool Sheep, CAAS; Special Funds for Basic Research of Young Scholars of Shihezi University	This research was funded by the National Natural Science Foundation of China, grant numbers 31702092, 31802045 and 32060745; Modern China Wool & Cashmere Technology Research System, grant number CARS39-02; Agricultural Science and Technology Innovation Program for Genetic Resource and Breeding of Fine-Wool Sheep, CAAS, grant number ASTIP-2015-LIHPS; Special Funds for Basic Research of Young Scholars of Shihezi University, grant numbers CXBJ201903, CXRC201808. All these founding directly or indirectly provide the transportation fee for sample collection, labor costs, kit and reagents costs, and mass spectrometry analysis costs, as well as the publication fee of this research.	Ahbara A, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00699; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Bahnamiri HZ, 2018, GENE, V641, P203, DOI 10.1016/j.gene.2017.10.065; Bakhtiarizadeh MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45665-3; Bakhtiarizadeh MR, 2019, G3-GENES GENOM GENET, V9, P1263, DOI 10.1534/g3.118.201014; Bakhtiarizadeh MR, 2013, GENE, V521, P122, DOI 10.1016/j.gene.2013.03.045; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Dong KZ, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07210-9; Ellis JM, 2010, CELL METAB, V12, P53, DOI 10.1016/j.cmet.2010.05.012; Fan HY, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090655; Fang Y, 2015, J PROTEOME RES, V14, P4059, DOI 10.1021/acs.jproteome.5b00625; Farahani AHK, 2010, AFR J BIOTECHNOL, V9, P5989; Gallardo M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9020064; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guo TT, 2020, J PROTEOMICS, V223, DOI 10.1016/j.jprot.2020.103827; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Inoue S, 2008, J BIOMAT SCI-POLYM E, V19, P893, DOI 10.1163/156856208784613541; Kang DJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14967-9; Khaldari M, 2007, S AFR J ANIM SCI, V37, P51; Lafontan M, 2008, INT J OBESITY, V32, pS39, DOI 10.1038/ijo.2008.237; Li BJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4747-1; Li Q, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10010089; Li X, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16485-1; Lu ZK, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10040739; Lyu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117536; Ma L, 2018, ANIM GENET, V49, P483, DOI 10.1111/age.12699; Ma L, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00365; Mastrangelo S, 2019, ANIM PROD SCI, V59, P835, DOI 10.1071/AN17753; Mastrangelo S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209632; Miao XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18470; Miao XY, 2015, BIOCHEM BIOPH RES CO, V467, P413, DOI 10.1016/j.bbrc.2015.09.129; Moioli B, 2015, J ANIM SCI, V93, P4660, DOI 10.2527/jas.2015-9389; Moradi MH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-10; Pan YY, 2018, LIVEST SCI, V207, P7, DOI 10.1016/j.livsci.2017.11.007; Pan ZY, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5620-6; Rocha J, 2011, TROP ANIM HEALTH PRO, V43, P1237, DOI 10.1007/s11250-011-9854-9; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruoss S, 2018, J ORTHOP RES, V36, P272, DOI 10.1002/jor.23624; Sajic T, 2015, ANAL BIOCHEM, V484, P122, DOI 10.1016/j.ab.2015.05.015; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Seroussi E, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0296-3; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Vadgama N, 2019, MOL CELL BIOCHEM, V456, P157, DOI 10.1007/s11010-019-03501-2; Wang JJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092556; Wang LP, 2018, FOOD CONTROL, V90, P392, DOI 10.1016/j.foodcont.2018.03.015; Wang XL, 2014, GENE, V549, P252, DOI 10.1016/j.gene.2014.07.072; Wei CH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1384-9; Yuan Z, 2017, ANIM GENET, V48, P55, DOI 10.1111/age.12477; Yuan ZH, 2019, LIVEST SCI, V230, DOI 10.1016/j.livsci.2019.103832; Zhao FP, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050773; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6; Zhou GX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1857580	53	5	5	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246279	10.1371/journal.pone.0246279	http://dx.doi.org/10.1371/journal.pone.0246279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529214	gold, Green Published			2022-12-26	WOS:000616736200047
J	Gu, H; Zhou, Y; Yang, JZ; Li, JA; Peng, YX; Zhang, X; Miao, YL; Jiang, W; Bu, GW; Hou, LM; Li, T; Zhang, L; Xia, XL; Ma, ZY; Xiong, YZ; Zuo, B				Gu, Hao; Zhou, Ying; Yang, Jinzeng; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo			Targeted overexpression of PPAR gamma in skeletal muscle by random insertion and CRISPR/Cas9 transgenic pig cloning enhances oxidative fiber formation and intramuscular fat deposition	FASEB JOURNAL			English	Article						CRISPR; Cas9; intramuscular fat; muscle fiber types; PPAR&#947; transgenic pigs	ACTIVATED RECEPTOR-GAMMA; MEAT QUALITY TRAITS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; ACID-COMPOSITION; IN-VIVO; GENE; EXPRESSION; TRANSCRIPTION; ADIPOGENESIS	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a master regulator of adipogenesis and lipogenesis. To understand its roles in fiber formation and fat deposition in skeletal muscle, we successfully generated muscle-specific overexpression of PPAR gamma in two pig models by random insertion and CRISPR/Cas9 transgenic cloning procedures. The content of intramuscular fat was significantly increased in PPAR gamma pigs while had no changes on lean meat ratio. PPAR gamma could promote adipocyte differentiation by activating adipocyte differentiating regulators such as FABP4 and CCAAT/enhancer-binding protein (C/EBP), along with enhanced expression of LPL, FABP4, and PLIN1 to proceed fat deposition. Proteomics analyses demonstrated that oxidative metabolism of fatty acids and respiratory chain were activated in PPAR gamma pigs, thus, gathered more Ca2+ in PPAR gamma pigs. Raising of Ca2+ could result in increased phosphorylation of CAMKII and p38 MAPK in PPAR gamma pigs, which can stimulate MEF2 and PGC1 alpha to affect fiber type and oxidative capacity. These results support that skeletal muscle-specific overexpression of PPAR gamma can promote oxidative fiber formation and intramuscular fat deposition in pigs.	[Gu, Hao; Zhou, Ying; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Swine Genet & Breeding, Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China; [Gu, Hao; Zhou, Ying; Li, Jianan; Peng, Yaxin; Zhang, Xia; Miao, Yiliang; Jiang, Wei; Bu, Guowei; Hou, Liming; Li, Ting; Zhang, Lin; Xia, Xiaoliang; Ma, Zhiyuan; Xiong, Yuanzhu; Zuo, Bo] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China; [Yang, Jinzeng] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; University of Hawaii System; University of Hawaii Manoa	Zuo, B (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Technol, Key Lab Swine Genet & Breeding, Minist Agr & Rural Affairs, Wuhan, Hubei, Peoples R China.; Zuo, B (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China.	zuobo@mail.hzau.edu.cn	Ma, ZhiYuan/GWN-1061-2022	Peng, YaXin/0000-0002-2795-2648				Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; APPLEBAUMBOWDEN D, 1995, CURR OPIN LIPIDOL, V6, P130, DOI 10.1097/00041433-199506000-00004; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bawa AS, 2013, J FOOD SCI TECH MYS, V50, P1035, DOI 10.1007/s13197-012-0899-1; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brocks L, 1998, MEAT SCI, V50, P411, DOI 10.1016/S0309-1740(98)00053-9; Chan MHS, 2004, FASEB J, V18, P1785, DOI 10.1096/fj.03-1039fje; Chen Z, 2011, GENET MOL BIOL, V34, P56, DOI 10.1590/S1415-47572010005000107; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Cho IC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008279; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Conner AJ, 1999, MUTAT RES-GEN TOX EN, V443, P223, DOI 10.1016/S1383-5742(99)00020-4; Dalen KT, 2004, DIABETES, V53, P1243, DOI 10.2337/diabetes.53.5.1243; de Sa PM, 2017, COMPR PHYSIOL, V7, P635, DOI 10.1002/cphy.c160022; Doshi KB, 2009, DIABETES OBES METAB, V11, P102, DOI 10.1111/j.1463-1326.2008.00908.x; Elzi DJ, 2001, AM J PHYSIOL-CELL PH, V281, pC350; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Grady JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114462; Grindflek E, 1998, BIOCHEM BIOPH RES CO, V249, P713, DOI 10.1006/bbrc.1998.9212; Grindflek E, 2001, MAMM GENOME, V12, P299, DOI 10.1007/s003350010278; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Holm IE, 2016, J PATHOL, V238, P267, DOI 10.1002/path.4654; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang JL, 2012, TRANSGENIC RES, V21, P1311, DOI 10.1007/s11248-012-9615-1; Huang P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5063; Kahn D, 2021, DIABETOLOGIA, V64, P168, DOI 10.1007/s00125-020-05315-0; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee HY, 2017, DIABETES, V66, P2072, DOI 10.2337/db16-1334; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li XP, 2014, CELL RES, V24, P501, DOI 10.1038/cr.2014.15; Liu ZH, 2008, CHINESE SCI BULL, V53, P1035, DOI 10.1007/s11434-008-0168-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loviscach M, 2000, DIABETOLOGIA, V43, P304, DOI 10.1007/s001250050048; Manco M, 2000, METABOLISM, V49, P220, DOI 10.1016/S0026-0495(00)91377-5; Metzger K, 2020, IN VITRO CELL DEV-AN, V56, P193, DOI 10.1007/s11626-019-00428-2; Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710; Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200; NEMETH PM, 1984, J HISTOCHEM CYTOCHEM, V32, P1211, DOI 10.1177/32.11.6491255; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Renand G, 2001, MEAT SCI, V59, P49, DOI 10.1016/S0309-1740(01)00051-1; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan JX, 2015, SCI REP-UK, V5, DOI 10.1038/srep14253; Savage DB, 2019, J LIPID RES, V60, P1323, DOI 10.1194/jlr.M091942; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Silva WM, 2019, MICROB BIOTECHNOL, V12, P265, DOI 10.1111/1751-7915.13305; Son NH, 2018, J CLIN INVEST, V128, P4329, DOI [10.1172/JCI99315, 10.1172/jci99315]; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Tamori Y, 2002, DIABETES, V51, P2045, DOI 10.2337/diabetes.51.7.2045; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turpin SM, 2006, AM J PHYSIOL-ENDOC M, V291, pE1341, DOI 10.1152/ajpendo.00095.2006; Wang YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010011; WESTERBLAD H, 1991, AM J PHYSIOL, V261, pC195, DOI 10.1152/ajpcell.1991.261.2.C195; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Wood JD, 2004, MEAT SCI, V67, P651, DOI 10.1016/j.meatsci.2004.01.007; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Yang LH, 2015, SCIENCE, V350, P1101, DOI 10.1126/science.aad1191; Ying F, 2016, BIOCHEM BIOPH RES CO, V480, P669, DOI 10.1016/j.bbrc.2016.10.113; Zhang L, 2017, INT J BIOL SCI, V13, P1152, DOI 10.7150/ijbs.20132; Zhou XY, 2016, HUM MUTAT, V37, P110, DOI 10.1002/humu.22913; Zhu M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14718; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921; Zischewski J, 2017, BIOTECHNOL ADV, V35, P95, DOI 10.1016/j.biotechadv.2016.12.003; Zuo EW, 2020, NAT PROTOC, V15, P3009, DOI 10.1038/s41596-020-0361-1	78	8	8	8	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21308	10.1096/fj.202001812RR	http://dx.doi.org/10.1096/fj.202001812RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481304	Bronze			2022-12-26	WOS:000647789600043
J	Loers, G; Appel, D; Lutz, D; Congiu, L; Kleene, R; Hermans-Borgmeyer, I; Schafer, MKE; Schachner, M				Loers, Gabriele; Appel, Dominik; Lutz, David; Congiu, Ludovica; Kleene, Ralf; Hermans-Borgmeyer, Irm; Schaefer, Michael K. E.; Schachner, Melitta			Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics	FASEB JOURNAL			English	Article						cell adhesion molecule L1; L1 syndrome; neuritogenesis; neuronal cell migration; neuronal survival	ADHESION MOLECULE L1; X-LINKED HYDROCEPHALUS; CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; NEURITE OUTGROWTH; MISSENSE MUTATION; CORPUS-CALLOSUM; L1CAM; DOMAINS; BINDING	L1 syndrome is a rare developmental disorder characterized by hydrocephalus of varying severity, intellectual deficits, spasticity of the legs, and adducted thumbs. Therapy is limited to symptomatic relief. Numerous gene mutations in the L1 cell adhesion molecule (L1CAM, hereafter abbreviated L1) were identified in L1 syndrome patients, and those affecting the extracellular domain of this transmembrane type 1 glycoprotein show the most severe phenotypes. Previously analyzed rodent models of the L1 syndrome focused on L1-deficient animals or mouse mutants with abrogated cell surface expression of L1, making it difficult to test L1 function-triggering mimetic compounds with potential therapeutic value. To overcome this impasse, we generated a novel L1 syndrome mouse with a mutation of aspartic acid at position 201 in the extracellular part of L1 (p.D201N, hereafter termed L1-201) that displays a cell surface-exposed L1 accessible to the L1 mimetics. Behavioral assessment revealed an increased neurological deficit score and increased locomotor activity in male L1-201 mice carrying the mutation on the X-chromosome. Histological analyses of L1-201 mice showed features of the L1 syndrome, including enlarged ventricles and reduced size of the corpus callosum. Expression levels of L1-201 protein as well as extent of cell surface biotinylation and immunofluorescence labelling of cultured cerebellar neurons were normal. Importantly, treatment of these cultures with the L1 mimetic compounds duloxetine, crotamiton, and trimebutine rescued impaired cell migration and survival as well as neuritogenesis. Altogether, the novel L1 syndrome mouse model provides a first experimental proof-of-principle for the potential therapeutic value of L1 mimetic compounds.	[Loers, Gabriele; Lutz, David; Congiu, Ludovica; Kleene, Ralf; Hermans-Borgmeyer, Irm; Schachner, Melitta] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Appel, Dominik; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr Johannes Gutenberg, Dept Anesthesiol, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci, Mainz, Germany; [Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy, Mainz, Germany; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08554 USA; [Lutz, David] Ruhr Univ Bochum, Abt Ncuroanat & Mol Hirnforsch, Bochum, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Rutgers State University New Brunswick; Ruhr University Bochum	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, Dept Cell Biol & Neurosci, 604 Allison Rd, Piscataway, NJ 08554 USA.	schachner@dls.rutgers.edu	Lutz, David/AAX-1607-2021	Lutz, David/0000-0001-9171-4081				APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Behringer R, 2014, MANIPULATING MOUSE E, V4; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Christaller WAA, 2017, CLIN GENET, V91, P115, DOI 10.1111/cge.12763; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; De Angelis E, 2002, HUM MOL GENET, V11, P1, DOI 10.1093/hmg/11.1.1; Dong L, 2003, MOL CELL NEUROSCI, V22, P234, DOI 10.1016/S1044-7431(02)00033-7; Drescher B, 1996, EUR J NEUROSCI, V8, P2467, DOI 10.1111/j.1460-9568.1996.tb01541.x; Finckh U, 2000, AM J MED GENET, V92, P40, DOI 10.1002/(SICI)1096-8628(20000501)92:1<40::AID-AJMG7>3.0.CO;2-R; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; HARPER JR, 1991, J NEUROCHEM, V56, P797, DOI 10.1111/j.1471-4159.1991.tb01994.x; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; He YN, 2009, STRUCTURE, V17, P460, DOI 10.1016/j.str.2009.01.009; HLAVIN ML, 1991, GENOMICS, V11, P416, DOI 10.1016/0888-7543(91)90150-D; Hummel R, 2020, BRIT J PHARMACOL, V177, P5208, DOI 10.1111/bph.15259; Jakovcevski I, 2009, J COMP NEUROL, V513, P496, DOI 10.1002/cne.21981; Joseph TP, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00458; JOUET M, 1995, AM J HUM GENET, V56, P1304; KAEPERNICK L, 1994, CLIN GENET, V45, P181; Kanemura Y, 2006, J NEUROSURG, V105, P403, DOI 10.3171/ped.2006.105.5.403; Kataria H, 2016, MOL NEUROBIOL, V53, P4461, DOI 10.1007/s12035-015-9352-6; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Li R, 2018, PHARMACOL BIOCHEM BE, V171, P30, DOI 10.1016/j.pbb.2018.05.013; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2014, J NEUROCHEM, V128, P88, DOI 10.1111/jnc.12408; Lutz D, 2014, J BIOL CHEM, V289, P13503, DOI 10.1074/jbc.M113.530238; Magara F, 2000, NEUROSCI BIOBEHAV R, V24, P45, DOI 10.1016/S0149-7634(99)00051-2; Makhina T, 2009, MOL CELL NEUROSCI, V41, P206, DOI 10.1016/j.mcn.2009.02.010; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1994, GLIA, V10, P70, DOI 10.1002/glia.440100109; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Mehanna A, 2010, MOL THER, V18, P34, DOI 10.1038/mt.2009.235; Michelson P, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9096; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; Rolf B, 2001, BRAIN RES, V891, P247, DOI 10.1016/S0006-8993(00)03219-4; SADOUL K, 1988, J NEUROCHEM, V50, P510, DOI 10.1111/j.1471-4159.1988.tb02941.x; Schafer MKE, 2012, CELL TISSUE RES, V349, P39, DOI 10.1007/s00441-012-1345-4; SERVILLE F, 1992, EUR J PEDIATR, V151, P515, DOI 10.1007/BF01957757; Shaw M, 2015, EUR J MED GENET, V58, P364, DOI 10.1016/j.ejmg.2015.04.004; Sytnyk V, 2017, TRENDS NEUROSCI, V40, P295, DOI 10.1016/j.tins.2017.03.003; Sztriha L, 2000, J CHILD NEUROL, V15, P239, DOI 10.1177/088307380001500407; Sztriha L, 2002, PEDIATR NEUROL, V27, P293, DOI 10.1016/S0887-8994(02)00440-X; Tapanes-Castillo A, 2010, NEUROGENETICS, V11, P53, DOI 10.1007/s10048-009-0203-3; Vos YJ, 2010, HUM MUTAT, V31, pE1102, DOI 10.1002/humu.21172; Wei CH, 2012, EXP MOL MED, V44, P413, DOI 10.3858/emm.2012.44.7.050; Xu JP, 2017, DIS MODEL MECH, V10, P1117, DOI 10.1242/dmm.029801; Yoo SW, 2017, J COMP NEUROL, V525, P291, DOI 10.1002/cne.24064	48	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21329	10.1096/fj.202002163R	http://dx.doi.org/10.1096/fj.202002163R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484186	hybrid			2022-12-26	WOS:000647789600002
J	Ragimbeau, R; El Kebriti, L; Sebti, S; Fourgous, E; Boulahtouf, A; Arena, G; Espert, L; Turtoi, A; Gongora, C; Houede, N; Pattingre, S				Ragimbeau, Romain; El Kebriti, Leila; Sebti, Salwa; Fourgous, Elise; Boulahtouf, Abdelhay; Arena, Giuseppe; Espert, Lucile; Turtoi, Andrei; Gongora, Celine; Houede, Nadine; Pattingre, Sophie			BAG6 promotes PINK1 signaling pathway and is essential for mitophagy	FASEB JOURNAL			English	Article						BAG6; mitophagy; receptor; signaling	QUALITY-CONTROL; PROTEIN; MITOCHONDRIA; PARKIN; DEGRADATION; ELIMINATION; APOPTOSIS; UBIQUITIN; RESOURCE; HUB	Bcl-2-associated athanogen-6 (BAG6) is a nucleocytoplasmic shuttling protein involved in protein quality control. We previously demonstrated that BAG6 is essential for autophagy by regulating the intracellular localization of the acetyltransferase EP300, and thus, modifying accessibility to its substrates (TP53 in the nucleus and autophagy-related proteins in the cytoplasm). Here, we investigated BAG6 localization and function in the cytoplasm. First, we demonstrated that BAG6 is localized in the mitochondria. Specifically, BAG6 is expressed in the mitochondrial matrix under basal conditions, and translocates to the outer mitochondrial membrane after mitochondrial depolarization with carbonyl cyanide m-chlorophenyl hydrazine, a mitochondrial uncoupler that induces mitophagy. In SW480 cells, the deletion of BAG6 expression abrogates its ability to induce mitophagy and PINK1 accumulation. On the reverse, its ectopic expression in LoVo colon cancer cells, which do not express endogenous BAG6, reduces the size of the mitochondria, induces mitophagy, leads to the activation of the PINK1/PARKIN pathway and to the phospho-ubiquitination of mitochondrial proteins. Finally, BAG6 contains two LIR (LC3-interacting Region) domains specifically found in receptors for selective autophagy and responsible for the interaction with LC3 and for autophagosome selectivity. Site-directed mutagenesis showed that BAG6 requires wild-type LIRs domains for its ability to stimulate mitophagy. In conclusion, we propose that BAG6 is a novel mitophagy receptor or adaptor that induces PINK1/PARKIN signaling and mitophagy in a LIR-dependent manner.	[Ragimbeau, Romain; El Kebriti, Leila; Fourgous, Elise; Boulahtouf, Abdelhay; Turtoi, Andrei; Gongora, Celine; Houede, Nadine; Pattingre, Sophie] Univ Montpellier, IRCM, Inst Reg Canc Montpellier, INSERM,U1194, F-34298 Montpellier, France; [El Kebriti, Leila; Houede, Nadine] CHU Nimes, Nimes, France; [Sebti, Salwa] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Sebti, Salwa] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Arena, Giuseppe] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Belvaux, Luxembourg; [Espert, Lucile] Univ Montpellier, IRIM, UMR 9004, CNRS, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Universite de Montpellier; CHU de Nimes; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Luxembourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pattingre, S (corresponding author), Univ Montpellier, IRCM, Inst Reg Canc Montpellier, INSERM,U1194, F-34298 Montpellier, France.	sophie.pattingre@inserm.fr	Sebti, Salwa/AAB-3188-2020; Turtoi, Andrei/ABD-1271-2021; Arena, Giuseppe/ABE-8093-2021; Espert, Lucile/ABF-5614-2021	Turtoi, Andrei/0000-0003-3813-6635; Arena, Giuseppe/0000-0003-2398-5503; Sebti, Salwa/0000-0003-4327-1129; FOURGOUS, Elise/0000-0002-3626-250X				Bhujabal Z, 2017, EMBO REP, V18, P947, DOI 10.15252/embr.201643147; Che XQ, 2013, BIOCHEM BIOPH RES CO, V441, P488, DOI 10.1016/j.bbrc.2013.10.086; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; De Snoo ML, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2132-x; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gomes LC, 2013, BBA-MOL CELL RES, V1833, P205, DOI 10.1016/j.bbamcr.2012.02.012; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Hayashishita M, 2019, FEBS OPEN BIO, V9, P1281, DOI 10.1002/2211-5463.12677; Kalvari I, 2014, AUTOPHAGY, V10, P913, DOI 10.4161/auto.28260; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032; Morita M, 2017, MOL CELL, V67, P922, DOI 10.1016/j.molcel.2017.08.013; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Qu DB, 2015, J BIOL CHEM, V290, P30441, DOI 10.1074/jbc.M115.677815; Rambold AS, 2011, CELL CYCLE, V10, P4032, DOI 10.4161/cc.10.23.18384; Saita S, 2016, GENES CELLS, V21, P408, DOI 10.1111/gtc.12351; Sebti S, 2014, AUTOPHAGY, V10, P1341, DOI 10.4161/auto.28979; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tahrir FG, 2017, J CELL PHYSIOL, V232, P797, DOI 10.1002/jcp.25476; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Verma M, 2020, J BIOL CHEM, V295, P7865, DOI 10.1074/jbc.RA119.010474; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086276; Wei YJ, 2017, CELL, V168, P224, DOI 10.1016/j.cell.2016.11.042; Wu W, 2012, J CELL SCI, V125, P4219, DOI 10.1242/jcs.086553; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	39	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21361	10.1096/fj.202000930R	http://dx.doi.org/10.1096/fj.202000930R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33522017	Green Submitted			2022-12-26	WOS:000647789600111
J	Kim, HS; Kim, ET; Eom, JS; Choi, YY; Lee, SJ; Lee, SS; Chung, CD; Lee, SS				Kim, Hyun Sang; Kim, Eun Tae; Eom, Jun Sik; Choi, You Young; Lee, Shin Ja; Lee, Sang Suk; Chung, Chang Dae; Lee, Sung Sill			Exploration of metabolite profiles in the biofluids of dairy cows by proton nuclear magnetic resonance analysis	PLOS ONE			English	Article							URINARY-EXCRETION; MILK-COMPOSITION; METABOLOMICS; BLOOD; CATTLE; IDENTIFICATION; CREATINE; HYPOXANTHINE; SPECTROSCOPY; STRATEGIES	Studies that screen for metabolites produced in ruminants are actively underway. We aimed to evaluate the metabolic profiles of five biofluids (ruminal fluid, serum, milk, urine, and feces) in dairy cow by using proton nuclear magnetic resonance (H-1-NMR) and provide a list of metabolites in each biofluid for the benefit of future research. We analyzed the metabolites in five biofluids from lactating cows using proton nuclear magnetic resonance imaging; 96, 73, 88, 118, and 128 metabolites were identified in the five biofluids, respectively. In addition, 8, 6, 9, and 17 metabolites were unique to ruminal fluid, serum, milk, and urine, respectively. The metabolites present at high concentrations were: acetate, propionate, and butyrate in ruminal fluid; lactate, glucose, and acetate in serum; and lactose, guanidoacetate, and glucitol in milk. In addition, the following metabolites were present at high concentrations: hippurate, urea, and trimethylamine N-oxide in urine and acetate, propionate, and butyrate in feces. The score plots of the principal component analysis did not show clear distinctions among the five biofluid samples. The purpose of this study was to verify the ability of our metabolomics approaches to identify metabolites in the biofluids of dairy cows.	[Kim, Hyun Sang; Eom, Jun Sik; Choi, You Young; Lee, Sung Sill] Gyeongsang Natl Univ, Div Appl Life Sci BK21Four, Jinju, South Korea; [Kim, Eun Tae] Rural Dev Adm, Natl Inst Anim Sci, Cheonan, South Korea; [Lee, Shin Ja; Lee, Sung Sill] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Lee, Shin Ja; Lee, Sung Sill] Gyeongsang Natl Univ, Univ Ctr Labs, Jinju, South Korea; [Lee, Sang Suk; Chung, Chang Dae] Sunchon Natl Univ, Coll Bioind Sci, Ruminant Nutr & Anaerobe Lab, Sunchon, South Korea	Gyeongsang National University; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Gyeongsang National University; Gyeongsang National University; Sunchon National University	Lee, SS (corresponding author), Gyeongsang Natl Univ, Div Appl Life Sci BK21Four, Jinju, South Korea.; Lee, SS (corresponding author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea.; Lee, SS (corresponding author), Gyeongsang Natl Univ, Univ Ctr Labs, Jinju, South Korea.	lss@gnu.ac.kr		LEE, SUNGSILL/0000-0002-4621-4333	Rural Development Administration, Republic of Korea [PJ01503902]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science and Technology Development (Project No. PJ01503902)" Rural Development Administration, Republic of Korea.	Abeni F, 2007, INT J BIOMETEOROL, V52, P87, DOI 10.1007/s00484-007-0098-3; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; Arnould VMR, 2009, J APPL GENET, V50, P29, DOI 10.1007/BF03195649; BAKER JR, 1962, J BIOL CHEM, V237, P1309; Bamidele O., 2012, International Journal of AgriScience, V2, P192; Barcroft J, 1944, J EXP BIOL, V20, P120; Beckwith-Hall BM, 2003, ANALYST, V128, P814, DOI 10.1039/b302360p; Belenguer A, 2002, LIVEST PROD SCI, V77, P127, DOI 10.1016/S0301-6226(02)00081-7; Bralley J. A., 2004, INTEG MED, V3, P24; Causse E, 2007, ELECTROPHORESIS, V28, P381, DOI 10.1002/elps.200600205; Chesson A, 1999, J SCI FOOD AGR, V79, P373, DOI 10.1002/(SICI)1097-0010(19990301)79:3&lt;373::AID-JSFA257&gt;3.0.CO;2-6; Dahl G. E., 2000, Journal of Dairy Science, V83, P885, DOI 10.3168/jds.S0022-0302(00)74952-6; Deda O, 2017, J CHROMATOGR B, V1047, P115, DOI 10.1016/j.jchromb.2016.06.047; Dervishi E, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1379-z; Edison EE, 2013, BRIT J NUTR, V110, P1075, DOI 10.1017/S000711451300010X; Elgersma A, 2006, ANIM FEED SCI TECH, V131, P207, DOI 10.1016/j.anifeedsci.2006.06.012; Enjalbert F, 2001, J DAIRY SCI, V84, P583, DOI 10.3168/jds.S0022-0302(01)74511-0; Escalona EE, 2015, EQUINE VET J, V47, P721, DOI 10.1111/evj.12333; Feldstein TJ, 1996, PEDIATRICS, V97, P506; Foroutan A, 2020, METABOLITES, V10, DOI 10.3390/metabo10060233; FORSBERG NE, 1984, J DAIRY SCI, V67, P2247, DOI 10.3168/jds.S0022-0302(84)81572-6; Goldansaz SA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177675; GUSTAFSON GM, 1994, ACTA AGR SCAND A-AN, V44, P160, DOI 10.1080/09064709409410893; Hailemariam D, 2014, J DAIRY SCI, V97, P2680, DOI 10.3168/jds.2013-6803; HARRIS CI, 1981, BRIT J NUTR, V45, P411, DOI 10.1079/BJN19810116; HEALD PJ, 1951, BRIT J NUTR, V5, P84, DOI 10.1079/BJN19510010; Humer E, 2018, J DAIRY SCI, V101, P9559, DOI 10.3168/jds.2018-14744; Hurley WL, 2009, LACT BIOL WEBSITE, V22, P2011; Jeong J-Y, 1986, J ENV TOXICOL, V25, P295; Jung YS, 2016, ANAL CHIM ACTA, V934, P194, DOI 10.1016/j.aca.2016.04.054; Kajikawa H, 1997, APPL ENVIRON MICROB, V63, P1847, DOI 10.1128/AEM.63.5.1847-1851.1997; Karamitri A, 2019, NAT REV ENDOCRINOL, V15, P105, DOI 10.1038/s41574-018-0130-1; Keun HC, 2006, PHARMACOL THERAPEUT, V109, P92, DOI 10.1016/j.pharmthera.2005.06.008; Lamanna R, 2011, MAGN RESON CHEM, V49, pS22, DOI 10.1002/mrc.2807; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Liu XJ, 2017, TRENDS BIOCHEM SCI, V42, P274, DOI 10.1016/j.tibs.2017.01.004; Mao SY, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-237; Matysik S, 2016, TRENDS FOOD SCI TECH, V57, P244, DOI 10.1016/j.tifs.2016.05.011; Moran J., 2005, RUMEN WORKS TROP DAI, P41; Pang B, 2012, P NATL ACAD SCI USA, V109, P2319, DOI 10.1073/pnas.1118455109; Peterson SE, 2012, J DAIRY SCI, V95, P6557, DOI 10.3168/jds.2011-4808; Pontes JGM, 2017, ANAL METHODS-UK, V9, P1078, DOI [10.1039/c6ay03102a, 10.1039/C6AY03102A]; QURESHI GA, 1986, J CHROMATOGR, V374, P363, DOI 10.1016/S0378-4347(00)83293-4; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Saleem F, 2013, METABOLOMICS, V9, P360, DOI 10.1007/s11306-012-0458-9; Singh S, 2009, PROF DRUG SUB EXCIP, V34, P1, DOI [10.1016/S1871-5125(09)34001-7, 10.1016/S0099-5428(08)00001-4]; Stevens C. E., 1980, Digestive physiology and metabolism in ruminants, P685; Sun HZ, 2015, J PROTEOME RES, V14, P1287, DOI 10.1021/pr501305g; Sun LW, 2014, J DAIRY SCI, V97, P1552, DOI 10.3168/jds.2013-6757; Sundekilde UK, 2011, J AGR FOOD CHEM, V59, P7360, DOI 10.1021/jf202057x; Thomas FC, 2015, ACUTE PHASE PROTEINS; Vasilev B, 1977, Vet Med Nauki, V14, P95; Wang DS, 2013, LIVEST SCI, V155, P262, DOI 10.1016/j.livsci.2013.05.026; Wang H, 2009, J ANIM SCI, V87, P2355, DOI 10.2527/jas.2008-1544; Wang YH, 2016, ITAL J ANIM SCI, V15, P545, DOI 10.1080/1828051X.2016.1180643; WHEELOCK JV, 1966, J DAIRY RES, V33, P37, DOI 10.1017/S0022029900011699; Wishart DS, 2009, BIOANALYSIS, V1, P1579, DOI 10.4155/BIO.09.138; Wolstenholme GEW, 1956, CIBA FDN S JOINTLY P; WRENN TR, 1964, J DAIRY SCI, V47, P882, DOI 10.3168/jds.S0022-0302(64)88795-6; WRENN TR, 1963, J DAIRY SCI, V46, P1243, DOI 10.3168/jds.S0022-0302(63)89252-8; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Yang Q, 2019, RSC ADV, V9, P37245, DOI 10.1039/c9ra06697g; Zhang H, 2019, ASIAN AUSTRALASIAN J; Zhao S, 2014, LETT APPL MICROBIOL, V59, P79, DOI 10.1111/lam.12247; Zhu CL, 2019, METABOLITES, V9, DOI 10.3390/metabo9030041	65	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246290	10.1371/journal.pone.0246290	http://dx.doi.org/10.1371/journal.pone.0246290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513207	Green Published, gold			2022-12-26	WOS:000613891400012
J	Liu, MJ; Zhang, WJ; Yao, J; Niu, JL				Liu, Mengjian; Zhang, WenJu; Yao, Jun; Niu, Junli			Production, purification, characterization, and biological properties of Rhodosporidium paludigenum polysaccharide	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; STRUCTURAL-CHARACTERIZATION; CHEMICAL CHARACTERISTICS; ANTIOXIDANT; YEAST; OPTIMIZATION; EXTRACTION; FUNGUS; FRACTIONATION; BIOACTIVITIES	The yield of marine red yeast polysaccharide (MRYP) obtained from Rhodosporidium paludigenum was increased by optimizing fermentation conditions, and the pure polysaccharide was extracted by column chromatography. The molecular weight of pure MRYP and the ratio of mannose to glucose in components of MRYP were determined. Antioxidant and antibacterial abilities of MRYP were investigated in vitro and in vivo. The optimal fermentation parameters were as follows: Medium 4, pH = 6.72, temperature = 30.18 degrees C, blades speed = 461.36 r/min; the optimized yield reached 4323.90 mg/L, which was 1.31 times the original yield. The sequence of factors that affected the MRYP yield was the blades speed>pH>temperature. The main components of MRYP were MYH-1 and MYH-2. The molecular weights of MYH-1 and MYH-2 were 246.92 kDa and 21.88 kDa, respectively; they accounted for 53.60% and 28.75% of total polysaccharide. In MYH-1 and MYH-2, the proportion of glucose and mannose accounted for 46.94%, 38.46%, and 67.10%, 7.17%, respectively. In vitro, the ability of scavenging DPPH center dot, center dot OH, and center dot O2- radical was 32.26%, 24.34%, and 22.09%; the minimum inhibitory concentration (MIC) of MRYP was 480 mu g/mg. In vivo, MRYP improved the lambs' body weight, antioxidant enzyme activity, and the number of probiotics, but it reduced the feed/gain (F/G) ratio and the number of pathogenic bacteria in 60-days-old lambs.	[Liu, Mengjian; Zhang, WenJu; Yao, Jun; Niu, Junli] Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China	Shihezi University	Zhang, WJ (corresponding author), Shihezi Univ, Coll Anim Sci & Technol, Shihezi, Xinjiang, Peoples R China.	zhangwj1022@sina.com		Liu, Mengjian/0000-0002-9776-2153	National Key R&D Program of China [2018YFD0502100]	National Key R&D Program of China	National Key R&D Program of China (2018YFD0502100) https://service.most.gov.cn/	Abdelhedi O, 2016, CARBOHYD POLYM, V152, P605, DOI 10.1016/j.carbpol.2016.07.048; Abdelmohsen UR, 2010, MAR DRUGS, V8, P399, DOI 10.3390/md8030399; Alves MJ, 2012, PLANTA MED, V78, P1707, DOI 10.1055/s-0032-1315370; Anjum MF, 2016, J ANTIMICROB CHEMOTH, V71, P2306, DOI 10.1093/jac/dkw149; [Anonymous], 2016, STROKE, V47, pe262; [Anonymous], 2015, BMJ, V2015, ph1887; Beltran G, 2008, INT J FOOD MICROBIOL, V121, P169, DOI 10.1016/j.ijfoodmicro.2007.11.030; Bhosale SH, 2011, J ENVIRON BIOL, V32, P653; Blandon L. M., 2018, Bioactive Carbohydrates and Dietary Fibre, V16, P14, DOI 10.1016/j.bcdf.2018.02.001; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Buts JP, 2006, PEDIATR RES, V60, P24, DOI 10.1203/01.pdr.0000220322.31940.29; Cai Shi-qing, 2009, Journal of Tropical Oceanography, V28, P62; Candioti LV, 2014, TALANTA, V124, P123, DOI 10.1016/j.talanta.2014.01.034; Castex M, 2010, FISH SHELLFISH IMMUN, V28, P622, DOI 10.1016/j.fsi.2009.12.024; Chen XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208611; Chokboribal J, 2015, CARBOHYD POLYM, V133, P556, DOI 10.1016/j.carbpol.2015.07.039; Cordero RJB, 2011, MOL MICROBIOL, V79, P1101, DOI 10.1111/j.1365-2958.2010.07511.x; Feng L, 2016, INT J BIOL MACROMOL, V91, P946, DOI 10.1016/j.ijbiomac.2016.05.030; Fu RQ, 2019, ANIM NUTR, V5, P366, DOI 10.1016/j.aninu.2019.06.003; Greetham D, 2019, SUSTAIN ENERG FUELS, V3, P1545, DOI 10.1039/c9se00029a; Gu D, 2017, MOLECULES, V22, DOI 10.3390/molecules22050814; Guo SD, 2010, BIORESOURCE TECHNOL, V101, P4729, DOI 10.1016/j.biortech.2010.01.125; Hindu SV, 2018, FISH SHELLFISH IMMUN, V73, P112, DOI 10.1016/j.fsi.2017.12.007; Jin ML, 2012, CARBOHYD POLYM, V89, P713, DOI 10.1016/j.carbpol.2012.04.049; Khan A.A., 2018, BIOACTIVE CARBOHYDRA, V16, P1, DOI [10.1016/j.bcdf.2017.12.002, DOI 10.1016/J.BCDF.2017.12.002]; Kogan G., 2000, STUD NAT PROD CHEM, V23, P107; Li C, 2017, CARBOHYD POLYM, V155, P261, DOI 10.1016/j.carbpol.2016.08.075; Li TT, 2019, E3S WEB CONF, V78, DOI 10.1051/e3sconf/20197802004; Liu J, 2018, INT J BIOL MACROMOL, V107, P2242, DOI 10.1016/j.ijbiomac.2017.10.097; Marchiori D, 2017, IN VIVO, V31, P931, DOI 10.21873/invivo.11149; Meng X, 2019, INT J BIOL MACROMOL, V129, P608, DOI 10.1016/j.ijbiomac.2019.01.226; Palleschi G, 2017, ARCH ITAL UROL ANDRO, V89, P45, DOI 10.4081/aiua.2017.1.45; Park YS, 2014, FOOD CHEM, V165, P354, DOI 10.1016/j.foodchem.2014.05.114; Pu JB, 2015, MOLECULES, V20, P22220, DOI 10.3390/molecules201219837; Ren Z, 2014, INT J BIOL MACROMOL, V70, P590, DOI 10.1016/j.ijbiomac.2014.07.044; Sandula J, 1999, CARBOHYD POLYM, V38, P247, DOI 10.1016/S0144-8617(98)00099-X; Sellimi S, 2014, INT J BIOL MACROMOL, V66, P281, DOI 10.1016/j.ijbiomac.2014.02.041; Sharma S, 2016, NAT PROD RES, V30, P616, DOI 10.1080/14786419.2015.1030741; Shi MJ, 2017, FOOD CHEM, V215, P76, DOI 10.1016/j.foodchem.2016.07.151; Sun HH, 2009, CARBOHYD POLYM, V78, P117, DOI 10.1016/j.carbpol.2009.04.017; Tang MY, 2019, INT J BIOL MACROMOL, V131, P309, DOI 10.1016/j.ijbiomac.2019.03.065; Tang QL, 2017, INT J BIOL MACROMOL, V98, P216, DOI 10.1016/j.ijbiomac.2017.01.132; Tiago FCP, 2012, J MED MICROBIOL, V61, P1194, DOI 10.1099/jmm.0.042283-0; Tian SY, 2017, J FOOD DRUG ANAL, V25, P766, DOI 10.1016/j.jfda.2016.08.012; Tsuchida S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01540; Venugopalan A, 2016, BIORESOURCE TECHNOL, V206, P104, DOI 10.1016/j.biortech.2016.01.079; Vichasilp C, 2009, BIOSCI BIOTECH BIOCH, V73, P2684, DOI 10.1271/bbb.90543; Wang Q, 2017, MOLECULES, V22, DOI 10.3390/molecules22020257; [王晓飞 Wang Xiaofei], 2018, [极地研究, Chinese Journal of Polar Research], V30, P50; Wu Jian-ping, 2012, Journal of Food Science and Technology, V30, P57; Xu T, 2016, CHINA BREWING, V35, P180; Yang SP, 2010, AQUACULTURE, V309, P62, DOI 10.1016/j.aquaculture.2010.09.032; YANG YY, 2012, S CHINA FISHERIES SC, V08, P67, DOI [10.3969/j.issn.2095-0780.2012.01.011, DOI 10.3969/J.ISSN.2095-0780.2012.01.011]; Yilmaz C, 2017, BIOCHEM PHARMACOL, V133, P43, DOI 10.1016/j.bcp.2016.10.005; Zaky AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30660-x; Zaky AS, 2016, J MICROBIOL BIOTECHN, V26, P1891, DOI 10.4014/jmb.1605.05074; Zhang HJ, 2008, CARBOHYD POLYM, V71, P428, DOI 10.1016/j.carbpol.2007.06.012; Zhang Q, 2017, MYCOBIOLOGY, V45, P90, DOI 10.5941/MYCO.2017.45.2.90; Zhang ZF, 2015, CARBOHYD POLYM, V117, P185, DOI 10.1016/j.carbpol.2014.09.059; Zhao YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092486	60	5	5	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246148	10.1371/journal.pone.0246148	http://dx.doi.org/10.1371/journal.pone.0246148			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513164	gold, Green Published			2022-12-26	WOS:000613891400023
J	Zhao, BQ; Li, XM; Li, XZ; Quan, DQ; Zhang, F; Hu, BR				Zhao, Baoquan; Li, Xiaoman; Li, Xingzhou; Quan, Dongqin; Zhang, Fang; Hu, Burong			Ilomastat contributes to the survival of mouse after irradiation via promoting the recovery of hematopoietic system	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BONE-MARROW; MATRIX METALLOPROTEINASES; RADIATION; STEM; INJURY; MICE; APOPTOSIS; CELLS	Ilomastat, a broad-spectrum inhibitor of matrix metalloproteinases (MMPs), has drawn attentions for its function in alleviating radiation damage. However, the detailed mechanisms of Ilomastat's protection from animal model remain not fully clear. In this study, the C57BL/6 mice were pre-administrated with Ilomastat or vihicle for 2 h, and then total body of mice were exposed to 6 Gy of gamma-rays. The protective effect of Ilomastat on the hematopoietic system in the irradiated mice were investigated. We found that pretreatment with Ilomastat significantly reduced the level of TGF-beta 1 and TNF-alpha, and elevated the number of bone marrow (BM) mononuclear cells in the irradiated mice. Ilomastat pretreatment also increased the fraction of BM hematopoietic progenitor cells (HPCs) and hematopoietic stem cells (HSCs) at day 30 after irradiation, and protected the spleen of mouse from irradiation. These results suggest that Ilomastat promotes the recovery of hematopoietic injury in the irradiated mice, and thus contributes to the survival of mouse after irradiation.	[Zhao, Baoquan; Li, Xiaoman; Li, Xingzhou; Quan, Dongqin; Zhang, Fang] Acad Mil Med Sci, Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China; [Li, Xiaoman; Hu, Burong] Chinese Acad Sci, Inst Modern Phys, Lanzhou, Peoples R China; [Li, Xiaoman] Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Dept Radiat Med,Hlth Sci Ctr, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Peking University	Zhao, BQ (corresponding author), Acad Mil Med Sci, Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China.	baoquanzhao@126.com		Li, Xiaoman/0000-0002-0658-2414; Hu, Burong/0000-0003-0156-9154	Military Medical Scientific and Technological Project [AWS17J009, BWS16J007, 2018ZX09J18102]; National Natural Science Foundation of China [11635013]	Military Medical Scientific and Technological Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	BZ, XL(second) and DQ were supported by the Military Medical Scientific and Technological Project [AWS17J009, BWS16J007, 2018ZX09J18102], BH was supported by the National Natural Science Foundation of China [11635013]. Baoquan Zhao took charge of the experimental design, data analysis and manuscript revise. Xiaoman Li performed experiments, analyzed the results and wrote the manuscript. Xingzhou Li, Dongqin Quan and Fang Zhang helped with experiments, data interpretation and manuscript preparation. Burong Hu helped with the experimental design, data analysis and manuscript revise. All authors read and approved the final manuscript.	Asano S, 2012, INT J HEMATOL, V95, P227, DOI 10.1007/s12185-012-1027-8; Beaudeux JL, 2004, CLIN CHEM LAB MED, V42, P121, DOI 10.1515/CCLM.2004.024; Charrier S, 2004, BLOOD, V104, P978, DOI 10.1182/blood-2003-11-3828; Dekkers PEP, 1999, BLOOD, V94, P2252, DOI 10.1182/blood.V94.7.2252.419k25_2252_2258; Dorr H, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-126; Farese AM, 1996, BLOOD, V87, P581, DOI 10.1182/blood.V87.2.581.bloodjournal872581; Francis JM, 2000, J BIOL CHEM, V275, P39137, DOI 10.1074/jbc.M007212200; Gaugler MH, 1998, BRIT J HAEMATOL, V103, P980, DOI 10.1046/j.1365-2141.1998.01119.x; He QP, 2020, J MOL CELL BIOL, V12, P359, DOI 10.1093/jmcb/mjz092; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634; John Anitha, 2001, Pathology and Oncology Research, V7, P14; JOHNSON CS, 1988, BLOOD, V72, P1875; Khan S, 2015, FREE RADICAL RES, V49, P1344, DOI 10.3109/10715762.2015.1071485; Li XM, 2018, BIOMED ENVIRON SCI, V31, P467, DOI 10.3967/bes2018.062; Li XM, 2017, ONCOTARGET, V8, P60789, DOI 10.18632/oncotarget.18487; Liu MX, 2014, J ETHNOPHARMACOL, V152, P575, DOI 10.1016/j.jep.2014.02.012; Park E, 2008, FEBS LETT, V582, P925, DOI 10.1016/j.febslet.2008.02.031; Park E, 2010, INT J RADIAT BIOL, V86, P848, DOI 10.3109/09553002.2010.487011; Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635; Singh VK, 2015, EXPERT OPIN DRUG DIS, V10, P497, DOI 10.1517/17460441.2015.1023290; Spiegel A, 2008, BLOOD, V111, P4934, DOI 10.1182/blood-2007-10-116145; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; TRACEY KJ, 1988, J EXP MED, V167, P1211, DOI 10.1084/jem.167.3.1211; Venkateswaran K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37305; Vorotnikova E, 2004, RADIAT RES, V161, P174, DOI 10.1667/RR3107; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; WIKTORJEDRZEJCZAK W, 1979, J CELL PHYSIOL, V99, P31, DOI 10.1002/jcp.1040990105; Yu Q, 2000, GENE DEV, V14, P163; Yu XF, 2006, HISTOL HISTOPATHOL, V21, P519, DOI 10.14670/HH-21.519; Zou ZM, 2008, RADIAT RES, V169, P722, DOI 10.1667/RR1284.1	31	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0238209	10.1371/journal.pone.0238209	http://dx.doi.org/10.1371/journal.pone.0238209			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513143	Green Published, gold, Green Submitted			2022-12-26	WOS:000613891400029
J	Arnold, ME; Courcier, EA; Stringer, LA; McCormick, CM; Pascual-Linaza, AV; Collins, SF; Trimble, NA; Ford, T; Thompson, S; Corbett, D; Menzies, FD				Arnold, Mark E.; Courcier, Emily A.; Stringer, Lesley A.; McCormick, Carl M.; Pascual-Linaza, Ana, V; Collins, Shane F.; Trimble, Nigel A.; Ford, Tom; Thompson, Suzan; Corbett, David; Menzies, Fraser D.			A Bayesian analysis of a Test and Vaccinate or Remove study to control bovine tuberculosis in badgers (Meles meles)	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; IMMUNOLOGICAL RESPONSES; INFECTION; BCG; TRANSMISSION; DIAGNOSIS; SEVERITY; IMPACT; PROGRESSION; POPULATION	A novel five year Test and Vaccinate or Remove (TVR) wildlife research intervention project in badgers (Meles meles) commenced in 2014 in a 100km(2) area of Northern Ireland. It aimed to increase the evidence base around badgers and bovine TB and help create well-informed and evidence-based strategies to address the issue of cattle-to-cattle spread and spread between cattle and badgers. It involved real-time trap-side testing of captured badgers and vaccinating those that tested negative for bTB (BadgerBCG-BCG Danish 1331) and removal of those that tested bTB positive using the Dual-Path Platform VetTB test (DPP) for cervids (Chembio Diagnostic Systems, Medford, NY USA). Four diagnostic tests were utilised within the study interferon gamma release assay (IGRA), culture (clinical samples and post mortem), DPP using both whole blood and DPP using serum. BCG Sofia (SL222) was used in the final two years because of supply issues with BadgerBCG. Objectives for this study were to evaluate the performance of the DPP in field conditions and whether any trend was apparent in infection prevalence over the study period. A Bayesian latent class model of diagnostic test evaluation in the absence of a gold standard was applied to the data. Temporal variation in the sensitivity of DPP and interferon gamma release assay (IGRA) due to the impact of control measures was investigated using logistic regression and individual variability was assessed. Bayesian latent class analysis estimated DPP with serum to have a sensitivity of 0.58 (95% CrI: 0.40-0.76) and specificity of 0.97 (95% CrI: 0.95-0.98). The DPP with whole blood showed a higher sensitivity (0.69 (95% CrI: 0.48-0.88)) but similar specificity (0.98 (95% Crl: 0.96-0.99)). The change from BCG Danish to BCG Sofia significantly impacted on DPP serum test characteristics. In addition, there was weak evidence of increasing sensitivity of IGRA over time and differences in DPP test sensitivity between adults and cubs. An exponential decline model was an appropriate representation of the infection prevalence over the 5 years, with a starting prevalence of 14% (95% CrI: 0.10-0.20), and an annual reduction of 39.1% (95% CrI: 26.5-50.9). The resulting estimate of infection prevalence in year 5 of the study was 1.9% (95% CrI: 0.8-3.8). These results provide field evidence of a statistically significant reduction in badger TB prevalence supporting a TVR approach to badger intervention. They give confidence in the reliability and reproducibility in the DPP Whole Blood as a real time trap-side diagnostic test for badgers, and describe the effect of vaccination and reduced infection prevalence on test characteristics.	[Arnold, Mark E.; Pascual-Linaza, Ana, V] Anim & Plant Hlth Agcy Sutton Bonington, Loughborough, Leics, England; [Courcier, Emily A.; Stringer, Lesley A.; McCormick, Carl M.; Menzies, Fraser D.] Dept Agr Environm & Rural Affairs, Vet Epidemiol Unit, Belfast, Antrim, North Ireland; [McCormick, Carl M.; Ford, Tom; Thompson, Suzan; Corbett, David] Agrifood & Biosci Inst, Vet Sci Div, Belfast, Antrim, North Ireland; [Collins, Shane F.; Trimble, Nigel A.] Dept Agr Environm & Rural Affairs, TVR Field Implementat Unit, Newry, North Ireland	Animal & Plant Health Agency UK; Agri-Food & Biosciences Institute	Arnold, ME (corresponding author), Anim & Plant Hlth Agcy Sutton Bonington, Loughborough, Leics, England.	Mark.Arnold@apha.gov.uk		Arnold, Mark/0000-0002-3009-4672; Courcier, Emily/0000-0001-5522-8457	Department of Agriculture, Environment and Rural Affairs in Northern Ireland (DAERA)	Department of Agriculture, Environment and Rural Affairs in Northern Ireland (DAERA)	The study was funded by the Department of Agriculture, Environment and Rural Affairs in Northern Ireland (DAERA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford RT, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01329; Ashford RT, 2020, PREV VET MED, V180, DOI 10.1016/j.prevetmed.2020.105005; Aznar I, 2018, PREV VET MED, V149, P29, DOI 10.1016/j.prevetmed.2017.10.010; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Broughan JM, 2016, EPIDEMIOL INFECT, V144, P2899, DOI 10.1017/S095026881600131X; Brown E, 2013, IN PRACTICE, V35, P143, DOI 10.1136/inp.f1186; Buzdugan SN, 2016, EPIDEMIOL INFECT, V144, P1717, DOI 10.1017/S0950268815003210; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Chambers MA, 2008, J CLIN MICROBIOL, V46, P1498, DOI 10.1128/JCM.02117-07; Chambers MA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-42; Courcier EA, 2020, RES VET SCI, V130, P170, DOI 10.1016/j.rvsc.2020.03.007; Courcier EA, 2018, VET REC, V182, P259, DOI 10.1136/vr.103934; DAERA, 2020, TEST VACC REM TVR WI; Dalley D, 2008, TUBERCULOSIS, V88, P235, DOI 10.1016/j.tube.2007.11.001; Delahay RJ, 2013, EPIDEMIOL INFECT, V141, P1445, DOI 10.1017/S0950268813000721; Delahay R J, 2013, AHVLA NATL WILDLIFE, P81; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Drewe JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011196; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Godfray HCJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1634; Gormley E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168851; Graham J, 2013, EPIDEMIOL INFECT, V141, P1429, DOI 10.1017/S0950268812003019; Greenwald R, 2003, DIAGN MICR INFEC DIS, V46, P197, DOI 10.1016/S0732-8893(03)00046-4; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Houtsma E, 2018, VET REC, V183, P622, DOI 10.1136/vr.104642; Jenkins HE, 2008, EPIDEMIOL INFECT, V136, P1350, DOI 10.1017/S0950268807009909; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lesellier S, 2009, VACCINE, V27, P402, DOI 10.1016/j.vaccine.2008.10.068; Lesellier S, 2008, VET IMMUNOL IMMUNOP, V122, P35, DOI 10.1016/j.vetimm.2007.11.005; Martin LER, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1089-2; Menzies FD, 2020, VET REC; More SJ, 2019, IRISH VET J, V72, DOI 10.1186/s13620-019-0140-x; More SJ, 2015, VET MICROBIOL, V176, P209, DOI 10.1016/j.vetmic.2015.01.026; More SJ, 2009, VET J, V180, P275, DOI 10.1016/j.tvjl.2009.01.027; Nerette P, 2008, PREV VET MED, V85, P207, DOI 10.1016/j.prevetmed.2008.01.011; O'Connor CM, 2012, PREV VET MED, V104, P185, DOI 10.1016/j.prevetmed.2011.11.010; OKeeffe J.J. MSW, 2016, P WORLD BUIATR C DUB, P231; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Robinson PA, 2012, COMP IMMUNOL MICROB, V35, P277, DOI 10.1016/j.cimid.2012.01.009; Sheridan M, 2011, VET MICROBIOL, V151, P160, DOI 10.1016/j.vetmic.2011.02.040; Smith GC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167206; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stefanova T, 2003, J CLIN MICROBIOL, V41, P5349, DOI 10.1128/JCM.41.11.5349.2003; Strain S.A. MJ, 2011, BOVINE TUBERCULOSIS; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Tuyttens FAM, 2001, J APPL ECOL, V38, P1114, DOI 10.1046/j.1365-2664.2001.00665.x; Welsh MD, 2005, IMMUNOLOGY, V114, P101, DOI 10.1111/j.1365-2567.2004.02003.x; Wilkinson D, 2000, J ZOOL, V250, P389, DOI 10.1111/j.1469-7998.2000.tb00782.x	50	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246141	10.1371/journal.pone.0246141	http://dx.doi.org/10.1371/journal.pone.0246141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508004	gold, Green Published			2022-12-26	WOS:000635021400098
J	Zhang, XB; Hu, L; Ming, Q; Wei, XJ; Zhang, ZY; Chen, LD; Wang, MH; Yao, WZ; Huang, QF; Ye, ZQ; Cai, YQ; Zeng, HQ				Zhang, Xiao-Bin; Hu, Lan; Ming, Quan; Wei, Xiao-Jie; Zhang, Zhen-Yu; Chen, Li-Da; Wang, Ming-Hui; Yao, Weng-Zhen; Huang, Qiu-Fen; Ye, Zhang-Qiang; Cai, Yu-Qing; Zeng, Hui-Qing			Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis	PLOS ONE			English	Article								Purpose Since the outbreak in late December 2019 in Wuhan, China, coronavirus disease-2019 (COVID-19) has become a global pandemic. We analyzed and compared the clinical, laboratory, and radiological characteristics between survivors and non-survivors and identify risk factors for mortality. Methods Clinical and laboratory variables, radiological features, treatment approach, and complications were retrospectively collected in two centers of Hubei province, China. Cox regression analysis was conducted to identify the risk factors for mortality. Results A total of 432 patients were enrolled, and the median patient age was 54 years. The overall mortality rate was 5.09% (22/432). As compared with the survivor group (n = 410), those in the non-survivor group (n = 22) were older, and they had a higher frequency of comorbidities and were more prone to suffer from dyspnea. Several abnormal laboratory variables indicated that acute cardiac injury, hepatic damage, and acute renal insufficiency were detected in the non-survivor group. Non-surviving patients also had a high computed tomography (CT) score and higher rate of consolidation. The most common complication causing death was acute respiratory distress syndrome (ARDS) (18/22, 81.8%). Multivariate Cox regression analysis revealed that hemoglobin (Hb) <90 g/L (hazard ratio, 10.776; 95% confidence interval, 3.075-37.766; p<0.0001), creatine kinase (CK-MB) >8 U/L (9.155; 2.424-34.584; p = 0.001), lactate dehydrogenase (LDH) >245 U/L (5.963; 2.029-17.529; p = 0.001), procalcitonin (PCT) >0.5 ng/ml (7.080; 1.671-29.992; p = 0.008), and CT score >10 (39.503; 12.430-125.539; p< 0.0001) were independent risk factors for the mortality of COVID-19. Conclusions Low Hb, high LDH, PCT, and CT score on admission were the predictors for mortality and could assist clinicians in early identification of poor prognosis among COVID-19 patients.	[Zhang, Xiao-Bin; Wang, Ming-Hui; Yao, Weng-Zhen; Huang, Qiu-Fen; Ye, Zhang-Qiang; Cai, Yu-Qing; Zeng, Hui-Qing] Xiamen Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Xiamen, Fujian, Peoples R China; [Zhang, Xiao-Bin; Wang, Ming-Hui; Yao, Weng-Zhen; Huang, Qiu-Fen; Ye, Zhang-Qiang; Cai, Yu-Qing; Zeng, Hui-Qing] Fujian Med Univ, Teaching Hosp, Fuzhou, Fujian, Peoples R China; [Hu, Lan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gastroenterol,Opt Valley Div, Wuhan, Peoples R China; [Ming, Quan] SanXia Univ, Yichang Peoples Hosp 3, Peoples Hosp 3, Yichang, Peoples R China; [Wei, Xiao-Jie] Fujian Univ Tradit Chinese Med, Dept Pulm & Crit Care Med, Peoples Hosp 3, Fuzhou, Peoples R China; [Zhang, Zhen-Yu] Xiamen Univ, Zhongshan Hosp, Dept Geriatr, Xiamen, Fujian, Peoples R China; [Chen, Li-Da] Fujian Med Univ, Zhangzhou Hosp, Dept Pulm & Crit Care Med, Fuzhou, Fujian, Peoples R China	Xiamen University; Fujian Medical University; Huazhong University of Science & Technology; Fujian University of Traditional Chinese Medicine; Xiamen University; Fujian Medical University	Zhang, XB; Zeng, HQ (corresponding author), Xiamen Univ, Zhongshan Hosp, Dept Pulm & Crit Care Med, Xiamen, Fujian, Peoples R China.; Zhang, XB; Zeng, HQ (corresponding author), Fujian Med Univ, Teaching Hosp, Fuzhou, Fujian, Peoples R China.	zhangxiaobincn@xmu.edu.cn; zhq20071212@xmu.edu.cn			Fujian Provincial Health Bureau [20182-65]; Fujian Province Health Bureau [2020GGB057]; Natural Science Foundation of Fujian Province, China [2018J01393]	Fujian Provincial Health Bureau; Fujian Province Health Bureau; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	This work was supported by Grant 20182-65 for Youth Research Fund from Fujian Provincial Health Bureau, Grant 2020GGB057 for Young people training project from Fujian Province Health Bureau, and Grant 2018J01393 for Fund from Natural Science Foundation of Fujian Province, China.	Cao JL, 2020, CLIN INFECT DIS, V71, P748, DOI 10.1093/cid/ciaa243; Chung M, 2020, RADIOLOGY, V295, P202, DOI 10.1148/radiol.2020200230; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Feng Y, 2020, AM J RESP CRIT CARE, V201, P1380, DOI 10.1164/rccm.202002-0445OC; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Li KW, 2020, EUR RADIOL, V30, P4407, DOI 10.1007/s00330-020-06817-6; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li X, 2020, CLIN INFECT DIS, DOI [10.1016/j.jaci, DOI 10.1093/cid/ciaa248]; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; National Health Commission of the People's Republic of China, 2020, CHINESE MANAGEMENT G; Oudit GY, 2009, EUR J CLIN INVEST, V39, P618, DOI 10.1111/j.1365-2362.2009.02153.x; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang XH, 2020, RESEARCH-CHINA, V2020, DOI 10.34133/2020/2402961; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang F, 2020, J MED VIROL, V92, P2511, DOI 10.1002/jmv.25891; Yu Y., 2020, LANCET RESP MED, V8, P481; Zhang GQ, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104364; Zhang J, 2020, CLIN MICROBIOL INFEC, V26, P767, DOI 10.1016/j.cmi.2020.04.012; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	24	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246030	10.1371/journal.pone.0246030	http://dx.doi.org/10.1371/journal.pone.0246030			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507974	Green Published, gold			2022-12-26	WOS:000635021400075
J	Bosquet, JG; Zhang, Q; Cliby, WA; Bakkum-Gamez, JN; Cen, L; Dowdy, SC; Sherman, ME; Weroha, SJ; Clayton, AC; Kipp, BR; Halling, KC; Couch, FJ; Podratz, KC				Bosquet, Jesus Gonzalez; Zhang, Qing; Cliby, William A.; Bakkum-Gamez, Jamie N.; Cen, Ling; Dowdy, Sean C.; Sherman, Mark E.; Weroha, S. John; Clayton, Amy C.; Kipp, Benjamin R.; Halling, Kevin C.; Couch, Fergus J.; Podratz, Karl C.			Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options	PLOS ONE			English	Article								During the past decade, the age-adjusted mortality rate for endometrial cancer (EC) increased 1.9% annually with TP53 mutant (TP53-mu) EC disproportionally represented in advanced disease and deaths. Therefore, we aimed to assess pivotal molecular parameters that differentiate clinical outcomes in high- and low-risk EC. Using the Cancer Genome Atlas, we analyzed EC specimens with available DNA sequences and quantitative gene-specific RNA expression data. After polymerase epsilon (POLE)-mutant specimens were excluded, differential gene-specific mutations and mRNA expressions were annotated and integrated. Consequent to TP53-mu failure to induce p21, derepression of multiple oncogenes harboring promoter p21 repressive sites was observed, including CCNA2 and FOXM1 (P < .001 compared with TP53 wild type [TP53-wt]). TP53-wt EC with high CCNA2 expression (CCNA2-H) had a targeted transcriptomic profile similar to that of TP53-mu EC, suggesting CCNA2 is a seminal determinant for both TP53-wt and TP53-mu EC. CCNA2 enhances E2F1 function, upregulating FOXM1 and CIP2A, as observed in TP53-mu and CCNA2-H TP53-wt EC (P < .001). CIP2A inhibits protein phosphatase 2A, leading to AKT inactivation of GSK3 beta and restricted oncoprotein degradation; PPP2R1A and FBXW7 mutations yield similar results. Upregulation of FOXM1 and failed degradation of FOXM1 is evidenced by marked upregulation of multiple homologous recombination genes (P < .001). Integrating these molecular aberrations generated a molecular biomarker panel with significant prognostic discrimination (P = 5.8x10(-7)); adjusting for age, histology, grade, myometrial invasion, TP53 status, and stage, only CCNA2-H/E2F1-H (P = .0003), FBXW7-mu/PPP2R1A-mu (P = .0002), and stage (P = .017) were significant. The generated prognostic molecular classification system identifies dissimilar signaling aberrations potentially amenable to targetable therapeutic options.	[Bosquet, Jesus Gonzalez] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Zhang, Qing; Cliby, William A.; Bakkum-Gamez, Jamie N.; Dowdy, Sean C.; Podratz, Karl C.] Mayo Clin, Div Gynecol Oncol, Rochester, MN 55905 USA; [Cen, Ling] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Sherman, Mark E.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL USA; [Weroha, S. John] Mayo Clin, Div Med Oncol, Rochester, MN USA; [Clayton, Amy C.; Kipp, Benjamin R.; Halling, Kevin C.; Couch, Fergus J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Iowa; Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic; Mayo Clinic; Mayo Clinic	Podratz, KC (corresponding author), Mayo Clin, Div Gynecol Oncol, Rochester, MN 55905 USA.	podratz.karl@mayo.edu						Alvarez-Fernandez M, 2018, CELL DEATH DIFFER, V25, P828, DOI 10.1038/s41418-017-0024-0; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Bakkum-Gamez JN, 2014, GYNECOL ONCOL, V132, P578, DOI 10.1016/j.ygyno.2014.01.007; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Bosquet JG, 2014, CANCER RES, V74, P3902, DOI 10.1158/0008-5472.CAN-14-0186; Bosse T, 2013, MODERN PATHOL, V26, P1525, DOI 10.1038/modpathol.2013.96; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Broad Institute, CANC CELL LIN ENC 20; Cao J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002496; Chen YH, 2016, EMBO J, V35, P668, DOI 10.15252/embj.201592810; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cremona CA, 2016, SEMIN CANCER BIOL, V36, P52, DOI 10.1016/j.semcancer.2015.09.006; Damia G, 2019, CANCERS, V11, DOI 10.3390/cancers11010119; de Moraes GN, 2016, CURR DRUG TARGETS, V17, P164, DOI 10.2174/1389450115666141122211549; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Garrido G, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; He LL, 2008, J BIOL CHEM, V283, P31012, DOI 10.1074/jbc.M803547200; Hogberg T, 2010, EUR J CANCER, V46, P2422, DOI 10.1016/j.ejca.2010.06.002; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Khanna A, 2016, INT J CANCER, V138, P525, DOI 10.1002/ijc.29431; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Laine A, 2014, CLIN CANCER RES, V20, P3644, DOI 10.1158/1078-0432.CCR-13-1942; Laine A, 2013, CANCER DISCOV, V3, P182, DOI 10.1158/2159-8290.CD-12-0292; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mints M, 2016, ONCOTARGET, V7, P22150, DOI 10.18632/oncotarget.7905; Mori N, 2010, BRIT J CANCER, V103, P889, DOI 10.1038/sj.bjc.6605805; R Core Team, R LANG ENV STAT COMP; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Roworth AP, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.970480; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Shih HC, 2003, HUM PATHOL, V34, P471, DOI 10.1016/S0046-8177(03)00124-2; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Simon R, 2007, CANCER INFORM, V3, P11; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Suzuki A, 2010, J CELL MOL MED, V14, P2305, DOI 10.1111/j.1582-4934.2009.00839.x; Tortorella L, 2018, GYNECOL ONCOL, V149, P291, DOI 10.1016/j.ygyno.2018.02.022; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039	40	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245664	10.1371/journal.pone.0245664	http://dx.doi.org/10.1371/journal.pone.0245664			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503056	Green Published, gold			2022-12-26	WOS:000613751800039
J	Channathodiyil, P; Houseley, J				Channathodiyil, Prasanna; Houseley, Jonathan			Glyoxal fixation facilitates transcriptome analysis after antigen staining and cell sorting by flow cytometry	PLOS ONE			English	Article							GENE-EXPRESSION; RNA; FORMALIN; OPTIMIZATION; FORMALDEHYDE; INTEGRITY	A simple method for extraction of high quality RNA from cells that have been fixed, stained and sorted by flow cytometry would allow routine transcriptome analysis of highly purified cell populations and single cells. However, formaldehyde fixation impairs RNA extraction and inhibits RNA amplification. Here we show that good quality RNA can be readily extracted from stained and sorted mammalian cells if formaldehyde is replaced by glyoxal-a well-characterised fixative that is widely compatible with immunofluorescent staining methods. Although both formaldehyde and glyoxal efficiently form protein-protein crosslinks, glyoxal does not crosslink RNA to proteins nor form stable RNA adducts, ensuring that RNA remains accessible and amenable to enzymatic manipulation after glyoxal fixation. We find that RNA integrity is maintained through glyoxal fixation, permeabilisation with methanol or saponin, indirect immunofluorescent staining and flow sorting. RNA can then be extracted by standard methods and processed into RNA-seq libraries using commercial kits; mRNA abundances measured by poly(A)+ RNA-seq correlate well between freshly harvested cells and fixed, stained and sorted cells. We validate the applicability of this approach to flow cytometry by staining MCF-7 cells for the intracellular G2/M-specific antigen cyclin B1 (CCNB1), and show strong enrichment for G2/M-phase cells based on transcriptomic data. Switching to glyoxal fixation with RNA-compatible staining methods requires only minor adjustments of most existing staining and sorting protocols, and should facilitate routine transcriptomic analysis of sorted cells.	[Channathodiyil, Prasanna; Houseley, Jonathan] Babraham Inst, Epigenet Programme, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Houseley, J (corresponding author), Babraham Inst, Epigenet Programme, Cambridge, England.	jon.houseley@babraham.ac.uk		Houseley, Jonathan/0000-0001-8509-1500	Wellcome Trust [110216]; BBSRC [BI Epigenetics ISP] [BBS/E/B/000C0423]; BBSRC [BBS/E/B/000C0426, BBS/E/B/000C0423, BB/R00076X/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC [BI Epigenetics ISP]; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	PC and JH were funded by the Wellcome Trust [110216] and the BBSRC [BI Epigenetics ISP: BBS/E/B/000C0423]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alles J, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0383-5; Amamoto R, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkz968; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROUDE NE, 1971, BIOCHIM BIOPHYS ACTA, V254, P380, DOI 10.1016/0005-2787(71)90868-9; Burnett WV, 1997, BIOTECHNIQUES, V22, P668, DOI 10.2144/97224st01; Bussolati G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182965; Celikkan FT, 2019, GLYOXAL DOES NOT PRE, DOI [10.1101/625863, DOI 10.1101/625863]; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Cruz C, 2018, ELIFE, V7, DOI 10.7554/eLife.34081; Dapson RW, 2007, BIOTECH HISTOCHEM, V82, P161, DOI 10.1080/10520290701488113; Denisenko E, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02048-6; Douglas MP, 1998, MUTAT RES-FUND MOL M, V401, P77, DOI 10.1016/S0027-5107(97)00314-X; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; ESSER C, 1995, CYTOMETRY, V21, P382, DOI 10.1002/cyto.990210411; Evers DL, 2011, J MOL DIAGN, V13, P282, DOI 10.1016/j.jmoldx.2011.01.010; FINKE J, 1993, BIOTECHNIQUES, V14, P448; Hamatani K, 2006, J HISTOCHEM CYTOCHEM, V54, P773, DOI 10.1369/jhc.5A6859.2006; Hrvatin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089459; Jager SE, 2020, GLIA, V68, P1375, DOI 10.1002/glia.23785; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; Lewis F, 2001, J PATHOL, V195, P66, DOI 10.1002/1096-9896(200109)195:1<66::AID-PATH921>3.0.CO;2-F; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ly T, 2017, ELIFE, V6, DOI 10.7554/eLife.27574; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; MCGHEE JD, 1977, BIOCHEMISTRY-US, V16, P3276, DOI 10.1021/bi00634a002; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; Nicolet BP, 2020, P NATL ACAD SCI USA, V117, P6686, DOI 10.1073/pnas.1913940117; Nilsson H, 2014, J BIOTECHNOL, V192, P62, DOI 10.1016/j.jbiotec.2014.09.016; Noguchi M, 1997, PATHOL INT, V47, P685, DOI 10.1111/j.1440-1827.1997.tb04442.x; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Pan YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017536; Richardson GM, 2015, CYTOM PART A, V87A, P166, DOI 10.1002/cyto.a.22608; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; SURREY WS, 1977, P AM SOC INT LAW, P1; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wohnhaas CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46932-z; Xu X, 2018, ELIFE, V7, DOI 10.7554/eLife.37551	42	7	7	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0240769	10.1371/journal.pone.0240769	http://dx.doi.org/10.1371/journal.pone.0240769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481798	Green Submitted, gold, Green Published			2022-12-26	WOS:000612929300121
J	Garrett, PM; White, JP; Lewandowsky, S; Kashima, Y; Perfors, A; Little, DR; Geard, N; Mitchell, L; Tomko, M; Dennis, S				Garrett, Paul M.; White, Joshua P.; Lewandowsky, Stephan; Kashima, Yoshihisa; Perfors, Andrew; Little, Daniel R.; Geard, Nic; Mitchell, Lewis; Tomko, Martin; Dennis, Simon			The acceptability and uptake of smartphone tracking for COVID-19 in Australia	PLOS ONE			English	Article								In response to the COVID-19 pandemic, many Governments are instituting mobile tracking technologies to perform rapid contact tracing. However, these technologies are only effective if the public is willing to use them, implying that their perceived public health benefits must outweigh personal concerns over privacy and security. The Australian federal government recently launched the 'COVIDSafe' app, designed to anonymously register nearby contacts. If a contact later identifies as infected with COVID-19, health department officials can rapidly followup with their registered contacts to stop the virus' spread. The current study assessed attitudes towards three tracking technologies (telecommunication network tracking, a government app, and Apple and Google's Bluetooth exposure notification system) in two representative samples of the Australian public prior to the launch of COVIDSafe. We compared these attitudes to usage of the COVIDSafe app after its launch in a further two representative samples of the Australian public. Using Bayesian methods, we find widespread acceptance for all tracking technologies, however, observe a large intention-behaviour gap between people's stated attitudes and actual uptake of the COVIDSafe app. We consider the policy implications of these results for Australia and the world at large.	[Garrett, Paul M.; White, Joshua P.; Kashima, Yoshihisa; Perfors, Andrew; Little, Daniel R.; Dennis, Simon] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Lewandowsky, Stephan] Univ Bristol, Sch Psychol Sci, Bristol, Avon, England; [Geard, Nic] Univ Melbourne, Sch Comp & Informat Syst, Melbourne, Vic, Australia; [Geard, Nic] Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Mitchell, Lewis] Univ Adelaide, Sch Math Sci, Adelaide, SA, Australia; [Tomko, Martin] Univ Melbourne, Sch Elect Mech & Infrastruct Engn, Melbourne, Vic, Australia; [Dennis, Simon] Unforgettable Res Serv, Melbourne, Vic, Australia	University of Melbourne; University of Bristol; University of Melbourne; University of Adelaide; University of Melbourne	Garrett, PM (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	paul.garrett@unimelb.edu.au	White, Joshua/GVR-9120-2022; White, Joshua/AAF-1804-2021; Little, Daniel/J-5034-2019; Lewandowsky, Stephan/H-5285-2014; Mitchell, Lewis/W-1312-2018	White, Joshua/0000-0003-3129-5473; Little, Daniel/0000-0003-3607-5525; Tomko, Martin/0000-0002-5736-4679; Lewandowsky, Stephan/0000-0003-1655-2013; GARRETT, PAUL/0000-0002-8200-8377; Mitchell, Lewis/0000-0001-8191-1997; Geard, Nicholas/0000-0003-0069-2281	Peter Doherty Institute for Infection and Immunity	Peter Doherty Institute for Infection and Immunity	This work was supported by anonymous philanthropic funding to the Peter Doherty Institute for Infection and Immunity, awarded to S.D. (https://www.doherty.edu.au).The funder provided support in the form of salaries for the author P.G., and in the payment of participants, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; [Anonymous], 2020, SANLI NEWS; Australia Government Department of Health, 2020, COVIDSAFE APP; Australian Bureau of Statistics, 2017, 2016 CENS QUICKST; Australian Government Department of Health, 2020, BACKGR COVIDSAFE; Australian Government Department of Health, 2020, COVIDSALE NEW APP SL; Australian Government Department of Health, 2020, COVIDSAFE SOURC COD; Australian Government Department of Health, 2020, COR COVID 19 AUSTR P; Australian Government Department of Health, 2020, SHOULD MASKS BE WORN; Baath R., 2014, TEST FUNCTIONS R P U, V2014, P2; Biddle S., 2020, INVENTORS BLUETOOTH; Bogle A, 2020, GOOGLE APPLE RELEASE; Burkner PC, 2019, ADV METH PRACT PSYCH, V2, P77, DOI 10.1177/2515245918823199; Byambasuren O., 2020, J ASS MED MICROBIOL, V5, P223, DOI [10.3138/jammi-2020-0030, DOI 10.3138/JAMMI-2020-0030]; Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007; Dienlin T, 2016, J COMPUT-MEDIAT COMM, V21, P368, DOI 10.1111/jcc4.12163; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; French M, 2020, SURVEILL SOC, V18, P1; Garrett P, 2020, PSYARXIV; Gladstone N., 2020, COVIDSAFE APP YET TR; Google, 2020, EXP NOT US TECHN HEL; Grubb B., 2020, MOBILE PHONE LOCATIO; Kininmonth J, 2018, AUSTR C INF SYST 201; Lewandowsky S, 2020, PSYARXIV; Mahmoud E., 2020, COVIDSAFE TRACKING A; Martin Andrew D., 2011, MCMCPACK MARKOV CHAI; O'Neill P, 2020, NOW ITS TIME KEEP TR; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Open Government Deutschland, 2020, SUCC OP GOV RESP COV; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Samsung, 2018, WHAT IS MAXIMUM RANG; Trogh J, 2019, EURASIP J WIREL COMM, DOI 10.1186/s13638-019-1459-4; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van Souwe J, 2017, AUSTR COMMUNITY ATTI, P51; Wnuk A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238973; Woods J., 2020, TIMELINE KEY SOCIAL	38	28	28	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244827	10.1371/journal.pone.0244827	http://dx.doi.org/10.1371/journal.pone.0244827			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481841	Green Published, gold, Green Submitted			2022-12-26	WOS:000612929300140
J	Khaliq, A; Ravindran, R; Afzal, S; Jena, PK; Akhtar, MW; Ambreen, A; Wan, YJY; Malik, KA; Irfan, M; Khan, IH				Khaliq, Aasia; Ravindran, Resmi; Afzal, Samia; Jena, Prasant Kumar; Akhtar, Muhammad Waheed; Ambreen, Atiqa; Wan, Yu-Jui Yvonne; Malik, Kauser Abdulla; Irfan, Muhammad; Khan, Imran H.			Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting	PLOS ONE			English	Article							PLASMA ANTIBODY PROFILES; MYCOBACTERIUM-TUBERCULOSIS; HEPATIC INFLAMMATION; CANCER-RISK; BUTYRATE; DIET; BACTERIA; METABOLITES; IMMUNOLOGY; COMMUNITY	Tuberculosis (TB) is the largest infectious disease with 10 million new active-TB patients and 1.7 million deaths per year. Active-TB is an inflammatory disease and is increasingly viewed as an imbalance of immune responses to M. tb. infection. The mechanisms of a switch from latent infection to active disease is not well worked out but a shift in the immune responses is thought to be responsible. Increasingly, the role of gut microbiota has been described as a major influencer of the immune system. And because the gut is the largest immune organ, we aimed to analyze the gut microbiome in active-TB patients in a TB-endemic country, Pakistan. The study revealed that Ruminococcacea, Enetrobactericeae, Erysipelotrichaceae, Bifidobacterium, etc. were the major genera associated with active-TB, also associated with chronic inflammatory disease. Plasma antibody profiles against several M. tb. antigens, as specific biomarkers for active-TB, correlated closely with the patient gut microbial profiles. Besides, bcoA gene copy number, indicative of the level of butyrate production by the gut microbiome was five-fold lower in TB patients compared to healthy individuals. These findings suggest that gut health in TB patients is compromised, with implications for disease morbidity (e.g., severe weight loss) as well as immune impairment.	[Khaliq, Aasia; Akhtar, Muhammad Waheed] Univ Punjab, Sch Biol Sci, Lahore, Pakistan; [Ravindran, Resmi; Jena, Prasant Kumar; Wan, Yu-Jui Yvonne; Khan, Imran H.] Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA; [Afzal, Samia; Malik, Kauser Abdulla; Irfan, Muhammad] Forman Christian Coll, Kauser Abdulla Malik Sch Life Sci, Lahore, Pakistan; [Ambreen, Atiqa] Gulab Devi Hosp, Dept Microbiol, Lahore, Pakistan	University of Punjab; University of California System; University of California Davis	Khan, IH (corresponding author), Univ Calif Davis, Dept Pathol & Lab Med, Davis, CA 95616 USA.	ihkhan@ucdavis.edu	Nadeem, Muhammad Shahid/H-2372-2017; Khan, imran/GQQ-2176-2022; Khan, Imran Ali/GVT-0232-2022	Nadeem, Muhammad Shahid/0000-0003-4112-0925; Khan, Imran Ali/0000-0002-8774-2896; Khaliq, Aasia/0000-0003-1833-0940	National Academy of Sciences; U.S. Agency for International Development; U.S. Department of State; Higher Education Commission of Pakistan	National Academy of Sciences; U.S. Agency for International Development(United States Agency for International Development (USAID)); U.S. Department of State; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by funding to I. H.K., in whole or in part, from the National Academy of Sciences, the U.S. Agency for International Development, the U.S. Department of State, and the Higher Education Commission of Pakistan, and any opinions, findings, conclusions, or recommendations expressed are those of the authors and do not necessarily reflect the views of the project sponsors. The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Achkar JM, 2015, IMMUNOL REV, V264, P167, DOI 10.1111/imr.12276; Arakelyan A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187572; Aw W, 2018, J DIABETES INVEST, V9, P5, DOI 10.1111/jdi.12673; Bhute S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00660; Brahe LK, 2013, OBES REV, V14, P950, DOI 10.1111/obr.12068; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0299-7; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Clavel T., 2014, PROKARYOTES ACTINOBA, P201, DOI DOI 10.1007/978-3-642-30138-4_343; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979; de Muinck EJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0279-1; Deng ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03804-8; Dhakan DB, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz004; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dheda K, 2010, RESPIROLOGY, V15, P433, DOI 10.1111/j.1440-1843.2010.01739.x; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Esaiassen E, 2017, J CLIN MICROBIOL, V55, P2234, DOI [10.1128/JCM.00150-17, 10.1128/jcm.00150-17]; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Hu YF, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00090; Hu YF, 2019, J INFECTION, V78, P317, DOI 10.1016/j.jinf.2018.08.006; Jena PK, 2017, AM J PATHOL, V187, P1800, DOI 10.1016/j.ajpath.2017.04.019; Jena PK, 2018, J NUTR BIOCHEM, V57, P246, DOI 10.1016/j.jnutbio.2018.04.007; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kaufmann SHE, 2008, CELL HOST MICROBE, V4, P219, DOI 10.1016/j.chom.2008.08.002; Khaliq A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173359; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Krishna P, 2016, EUR J CLIN MICROBIOL, V35, P1205, DOI 10.1007/s10096-016-2654-4; Kumar J, 2016, GENOM PROTEOM BIOINF, V14, P371, DOI 10.1016/j.gpb.2016.06.002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lankelma JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005548; LEE BY, 1992, INFECT IMMUN, V60, P2066, DOI 10.1128/IAI.60.5.2066-2074.1992; Lee JY, 2019, GENES-BASEL, V10, DOI 10.3390/genes10100748; Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa; Lim MY, 2017, GUT, V66, P1031, DOI 10.1136/gutjnl-2015-311326; Lokesh D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30429-2; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833; Maji A, 2018, ENVIRON MICROBIOL, V20, P402, DOI 10.1111/1462-2920.14015; Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104; Namasivayam S, 2019, MBIO, V10, DOI 10.1128/mBio.01018-19; Namasivayam S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0286-2; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Organization W.H., 2017, GLOB TUB REP; Organization W.H., 2016, FACT SHEET WORLD MAL; Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ravindran R, 2014, J MED PRIMATOL, V43, P59, DOI 10.1111/jmp.12097; Ravindran R, 2013, CLIN VACCINE IMMUNOL, V20, P1283, DOI 10.1128/CVI.00213-13; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Sasindran SJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00002; Shankar V, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00169-16; Sheng LL, 2017, J PATHOL, V243, P431, DOI 10.1002/path.4983; Sheng LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01576-9; Takahashi K, 2016, DIGESTION, V93, P59, DOI 10.1159/000441768; Tanaka K, 2007, J IMMUNOL, V178, P5209, DOI 10.4049/jimmunol.178.8.5209; Ugarte-Torres A, 2018, CLIN INFECT DIS, V67, P221, DOI 10.1093/cid/ciy057; Wipperman MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10346-6; Wolf Andrea, 2012, Front Psychiatry, V3, P54, DOI 10.3389/fpsyt.2012.00054; Yang Y, 2014, DIS MODEL MECH, V7, P1131, DOI 10.1242/dmm.016428; Zeng HW, 2016, J NUTR BIOCHEM, V35, P30, DOI 10.1016/j.jnutbio.2016.05.015; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhou Jin-song, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P830	74	2	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245534	10.1371/journal.pone.0245534	http://dx.doi.org/10.1371/journal.pone.0245534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481833	Green Published, gold			2022-12-26	WOS:000612929300052
J	Kitani-Morii, F; Kasai, T; Horiguchi, G; Teramukai, S; Ohmichi, T; Shinomoto, M; Fujino, Y; Mizuno, T				Kitani-Morii, Fukiko; Kasai, Takashi; Horiguchi, Go; Teramukai, Satoshi; Ohmichi, Takuma; Shinomoto, Makiko; Fujino, Yuzo; Mizuno, Toshiki			Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan	PLOS ONE			English	Article							HEALTH; BURDEN; DEPRESSION; DISTRESS; SCALE	The worsening of neuropsychiatric symptoms such as depression, anxiety, and insomnia in patients with Parkinson's disease (PD) has been a concern during the COVID-19 pandemic, because most people worked in self-isolation for fear of infection. We aimed to clarify the impact of social restrictions imposed due to the COVID-19 pandemic on neuropsychiatric symptoms in PD patients and to identify risk factors associated with these symptoms. A cross-sectional, hospital-based survey was conducted from April 22, 2020 to May 15, 2020. PD patients and their family members were asked to complete paper-based questionnaires about neuropsychiatric symptoms by mail. PD patients were evaluated for motor symptoms using MDS-UPDRS part 2 by telephone interview. A total of 71 responders (39 PD patients and 32 controls) completed the study. Although there was no difference in the age distribution, the rate of females was significantly lower in PD patients (35%) than controls (84%) (P < 0.001). Participants with clinical depression (PHQ-9 score >= 10) were more common in PD patients (39%) than controls (6%) (P = 0.002). Multivariate logistic regression analysis revealed that an MDS-UPDRS part 2 score was correlated with the presence of clinical depression (PHQ-9 score >= 10) and clinical anxiety (GAD-7 score >= 7) (clinical depression: OR, 1.31; 95% CI, 1.04-1.66; P = 0.025; clinical anxiety: OR, 1.36; 95% CI, 1.07-1.72; P = 0.013). In the presence of social restrictions, more attention needs to be paid to the neuropsychiatric complications of PD patients, especially those with more severe motor symptoms.	[Kitani-Morii, Fukiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Kitani-Morii, Fukiko; Kasai, Takashi; Ohmichi, Takuma; Shinomoto, Makiko; Fujino, Yuzo; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Horiguchi, Go; Teramukai, Satoshi] Kyoto Prefectural Univ Med, Univ Hosp, Clin & Translat Res Ctr, Div Data Sci, Kyoto, Japan	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine	Kasai, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	kasaita@koto.kpu-m.ac.jp		Horiguchi, Go/0000-0001-6966-7215; Teramukai, Satoshi/0000-0003-2184-0597	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [18K07506, 20K16605]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (18K07506 to T.K.; 20K16605 to T.O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Allott R, 2005, BRIT J PSYCHIAT, V187, P182, DOI 10.1192/bjp.187.2.182; Brown RG, 2015, J PSYCHOSOM RES, V78, P143, DOI 10.1016/j.jpsychores.2014.09.021; Craske MG, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.24, 10.1038/nrdp.2017.100]; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Helmich RC, 2020, J PARKINSON DIS, V10, P351, DOI 10.3233/JPD-202038; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lara B, 2020, EUR J NEUROL, V27, P1744, DOI 10.1111/ene.14339; Lippi G, 2020, DIAGNOSIS, V7, P85, DOI 10.1515/dx-2020-0041; LOOI MK, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1447; Marinus J, 2018, LANCET NEUROL, V17, P559, DOI 10.1016/S1474-4422(18)30127-3; Martin SC, 2015, J NEUROSCI NURS, V47, P211, DOI 10.1097/JNN.0000000000000141; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P1673, DOI 10.1002/mds.22106; Mosley PE, 2017, J GERIATR PSYCH NEUR, V30, P235, DOI 10.1177/0891988717720302; Munezawa T., 2009, JPN J PSYCHIAT TREAT, V24, P219; Muramatsu K, 2014, NIIGATA SEIRYO U GRA, V7, P35, DOI [10.32147/00001605, DOI 10.32147/00001605]; Muramatsu K, 2007, PSYCHOL REP, V101, P952, DOI 10.2466/pr0.101.3.952-960; Oppo V, 2020, MOV DISORD CLIN PRAC, V7, P865, DOI 10.1002/mdc3.13030; Pfeiffer RF, 2016, PARKINSONISM RELAT D, V22, pS119, DOI 10.1016/j.parkreldis.2015.09.004; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Salari M, 2020, MOVEMENT DISORD, V35, P1095, DOI 10.1002/mds.28116; Sanyal J, 2015, J NEUROL SCI, V358, P276, DOI 10.1016/j.jns.2015.09.009; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P509, DOI 10.1038/nrn.2017.91; Shalash A, 2020, MOVEMENT DISORD, V35, P1097, DOI 10.1002/mds.28134; Song J, 2020, PARKINSONISM RELAT D, V80, P148, DOI 10.1016/j.parkreldis.2020.09.034; Subramanian I, 2020, NPJ PARKINSONS DIS, V6, DOI 10.1038/s41531-020-00128-9; Thompson AW, 2011, PARKINSONISM RELAT D, V17, P40, DOI 10.1016/j.parkreldis.2010.10.007; van der Heide A, 2020, J PARKINSON DIS, V10, P1355, DOI 10.3233/JPD-202251; Williams JR, 2012, NEUROLOGY, V78, P998, DOI 10.1212/WNL.0b013e31824d587f; Xia Y, 2020, SLEEP MED, V75, P428, DOI 10.1016/j.sleep.2020.09.011; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zipprich HM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061643	32	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245864	10.1371/journal.pone.0245864	http://dx.doi.org/10.1371/journal.pone.0245864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481879	Green Published, gold			2022-12-26	WOS:000612929300065
J	Liu, SH; Liu, YL; Zhong, H; Zou, JY; Yang, D				Liu, Shaohu; Liu Yuanliang; Zhong Hong; Zou Jiayan; Yang Dong			Experimental study on corrosion resistance of coiled tubing welds in high temperature and pressure environment	PLOS ONE			English	Article								Coiled tubing (CT) has been widely used for oil and gas exploitation, however corrosion of CT under high pressure and high temperature (HPHT) environment was often reported, also corrosion induced failures of CT welds were often observed to occur during service. Corrosion related behaviors of CT welds are not clear. Therefore, a study of the corrosion resistance of CT welds under HPHT environment is carried out. In order to efficiently evaluate the corrosion resistance of welds, some test samples were obtained by linear cutting out of a CT110 in service on the site. The water samples from gas field were used as the test reagent to simulate the actual corrosive medium. Based on the results of weight loss test under HPHT corrosive environment and tensile test under room conditions, the corrosion sensitivities of the welding seam and base material under various temperatures and partial pressures of CO2 as well as the mechanical properties of the corroded CT were compared and evaluated quantitatively, the corrosion morphologies and material products of the test samples were analyzed by scanning electron microscope (SEM). The test results showed that the corrosion rates of the welding seam in a HPHT caldron were 1.7, 2.0 and 1.2 times of the base metal's when the total pressure is 4MPa, and the temperature is 30 degrees C, 60 degrees C and 90 degrees C, respectively. The corrosion rates of the welding seam is 2.0, 2.1 and 2.0 times of the base metal's when the partial pressure of CO2 is 0.1MPa, 0.2MPa and 0.3MPa, respectively. The yield strength of the weld seam after corrosion test was found to be reduced by 4.8% (the yield strength of the base metal was reduced by 4.0%) and its tensile strength was reduced by 8.2% (the base metal was reduced by 7.1%). This indicates that CT weld seam is more susceptible to corrosion than CT base material under service condition.	[Liu, Shaohu; Liu Yuanliang; Yang Dong] Yangtze Univ, Sch Mech Engn, Jingzhou, Peoples R China; [Liu, Shaohu; Zhong Hong; Zou Jiayan] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China	Yangtze University; Southwest Petroleum University	Liu, SH (corresponding author), Yangtze Univ, Sch Mech Engn, Jingzhou, Peoples R China.; Liu, SH (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	liushaoh@yangtzeu.edu.cn		Zou, Jiayan/0000-0003-0635-2923	Natural Science Foundation of China [51974036, 51604039]; Yangtze Fund for Youth Teams of Science and Technology Innovation [2016cqt01]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yangtze Fund for Youth Teams of Science and Technology Innovation	This work of the paper was supported by the Natural Science Foundation of China (No. 51974036 and No. 51604039) and the Yangtze Fund for Youth Teams of Science and Technology Innovation (No. 2016cqt01).	American Petroleum Institute, 1994, API B, V5C3; Crabtree AR, 2005, SPE DRILL COMPLETION, V20, P71, DOI 10.2118/89614-PA; Fayong Yuan, 2018, ENG TECHNOLOGY COILE, P1; Fuyang Sun, 2015, STUDY CORROSION FATI; Huan Chen, 2016, STUDY CORROSION LIFE; Jian Zhu, 2018, STUDY FATIGUE LIFE W; [刘磊 Liu Lei], 2019, [中国海上油气, China Offshore Oil and Gas], V31, P132; Liu Ming, 2013, Corrosion Science and Protection Technology, V25, P213; Liu SH, 2020, J FAIL ANAL PREV, V20, P1964, DOI 10.1007/s11668-020-01007-4; Liu SH, 2019, ENG FAIL ANAL, V104, P1133, DOI 10.1016/j.engfailanal.2019.06.062; Liu SH, 2017, ENG FAIL ANAL, V79, P803, DOI 10.1016/j.engfailanal.2017.05.007; Luo D, 2012, MECH ENG MAT, V42, P68; Martin JR, 2003, SPE ICOTA CT C EXHIB; Meibao Chen, 2018, HOT WORKING PROCESS, V47; Ministry of mechanical and electronic industry of the people's Republic of China, 1992, MET COAT LAB FULL IM; Molero Nestor, 2007, SPE, V107108; Padron T, 2018, SPE ICOTA CT WELL IN; Qiu Xingdong, 2017, STUDY INTERNAL CORRO; Stanley RG, 2011, WI S MAS SP, P3; Tao Qu, 2015, STUDY EFFECT CORROSI; Tong SK, 2019, ARAB J SCI ENG, V44, P10467, DOI 10.1007/s13369-019-03905-8; Van Arnam WD, 2000, SPE ICOTA CT ROUNDTA; Xianning Jiangfang Rongming, 2011, NATURAL GAS IND, V31; Yue BiZong, 2016, WELDED PIPE, V33, P6; Zhu Chenglong, 2013, CORROSION PROTECTION, V34, P232	25	0	0	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244237	10.1371/journal.pone.0244237	http://dx.doi.org/10.1371/journal.pone.0244237			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481831	Green Published, gold			2022-12-26	WOS:000612929300086
J	Michelot, C; Kato, A; Raclot, T; Ropert-Coudert, Y				Michelot, Candice; Kato, Akiko; Raclot, Thierry; Ropert-Coudert, Yan			Adelie penguins foraging consistency and site fidelity are conditioned by breeding status and environmental conditions	PLOS ONE			English	Article							SEA-ICE COVER; INDIVIDUAL-DIFFERENCES; REPRODUCTIVE SUCCESS; MARINE PREDATOR; REPEATABILITY; BEHAVIOR; STRATEGIES; SEABIRDS; ECOSYSTEMS; MOVEMENTS	There is a growing interest in studying consistency and site fidelity of individuals to assess, respectively, how individual behaviour shapes the population response to environmental changes, and to highlight the critical habitats needed by species. In Antarctica, the foraging activity of central place foragers like Adelie penguins (Pygoscelis adeliae) is constrained by the sea-ice cover during the breeding season. We estimated the population-level repeatability in foraging trip parameters and sea-ice conditions encountered by birds across successive trips over several years, and we examined their foraging site fidelity linked to sea-ice concentrations throughout the chick-rearing season. Penguins' foraging activity was repeatable despite varying annual sea-ice conditions. Birds' site fidelity is constrained by both seaice conditions around the colony that limit movements and resources availability, and also behavioural repeatability of individuals driven by phenological constraints. Adelie penguins favoured sea-ice concentrations between 20-30%, as these facilitate access to open water while opening multiple patches for exploration in restricted areas in case of prey depletion. When the sea-ice concentration became greater than 30%, foraging site fidelity decreased and showed higher variability, while it increased again after 60%. Between two trips, the foraging site fidelity remained high when sea-ice concentration changed by +/- 10% but showed greater variability when sea-ice concentrations differed on a larger range. In summary, Adelie penguins specialize their foraging behaviour during chick-rearing according to sea-ice conditions to enhance their reproductive success. The balance between being consistent under favourable environmental conditions vs. being flexible under more challenging conditions may be key to improving foraging efficiency and reproductive success to face fast environmental changes.	[Michelot, Candice; Kato, Akiko; Ropert-Coudert, Yan] La Rochelle Univ, Ctr Etud Biol Chize, CNRS, UMR 7372, Villiers En Bois, France; [Raclot, Thierry] CNRS, Inst Pluridisciplinaire Hubert Curien, UMR 7178, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Michelot, C (corresponding author), La Rochelle Univ, Ctr Etud Biol Chize, CNRS, UMR 7372, Villiers En Bois, France.	candice.michelot@gmail.com		Michelot, Candice/0000-0001-7742-7174	French Polar Institute Paul Emile Victor (IPEV); WWF-UK; Zone Atelier Antarctique et Subantarctique - LTER France of CNRS; PEW Foundation; BNP Paribas Foundation	French Polar Institute Paul Emile Victor (IPEV); WWF-UK; Zone Atelier Antarctique et Subantarctique - LTER France of CNRS; PEW Foundation; BNP Paribas Foundation	The study was financially supported by the French Polar Institute Paul Emile Victor (IPEV), the WWF-UK through R. Downie, the Zone Atelier Antarctique et Subantarctique -LTER France of CNRS, the PEW Foundation, and BNP Paribas Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Aplin LM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1016; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Ballard G, 2010, MAR ECOL PROG SER, V405, P287, DOI 10.3354/meps08514; Barbraud C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140456; Barreau E, 2019, POLAR BIOL, V42, P1405, DOI 10.1007/s00300-019-02531-2; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Boyd C, 2015, J ANIM ECOL, V84, P1575, DOI 10.1111/1365-2656.12409; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Calenge C, 2015, ANAL ANIMAL MOVEMENT, P20; Camprasse ECM, 2017, MAR ECOL PROG SER, V578, P227, DOI 10.3354/meps12151; Camprasse ECM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3193-y; Ceia FR, 2015, MAR BIOL, V162, P1923, DOI 10.1007/s00227-015-2735-4; Cherel Y, 2008, MAR BIOL, V154, P813, DOI 10.1007/s00227-008-0974-3; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; Clarke J, 2006, MAR ECOL PROG SER, V310, P247, DOI 10.3354/meps310247; Comiso JC, 2017, J CLIMATE, V30, P2251, DOI [10.1175/JCLI-D-16-0408.1, 10.1175/jcli-d-16-0408.1]; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Daan S., 1988, P392; Dingemanse NJ, 2002, ANIM BEHAV, V64, P929, DOI 10.1006/anbe.2002.2006; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Elliott KH, 2009, AUK, V126, P613, DOI 10.1525/auk.2009.08245; Emmerson L, 2008, ECOLOGY, V89, P2096, DOI 10.1890/08-0011.1; Fauchald P, 2017, MAR ECOL PROG SER, V568, P203, DOI 10.3354/meps12082; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Freeman R, 2011, BIOL LETTERS, V7, P63, DOI 10.1098/rsbl.2010.0627; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Hinke JT, 2012, MAR ECOL PROG SER, V454, P91, DOI 10.3354/meps09633; Kato A, 2003, POLAR BIOL, V26, P389, DOI 10.1007/s00300-003-0493-0; Koubbi P, 2010, POLAR SCI, V4, P115, DOI 10.1016/j.polar.2010.04.012; Le Guen C, 2018, GLOBAL CHANGE BIOL, V24, P5304, DOI 10.1111/gcb.14377; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lescroel A, 2005, MAR ECOL PROG SER, V302, P245, DOI 10.3354/meps302245; Lescroel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085291; Lindelov JK, 2020, MCP R PACKAGE REGRES; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Michel LN, 2019, SCI REPORTS, V9, P10, DOI [10.1038/s41598-018-36877.0, DOI 10.1038/S41598-018-36877.0]; Michelot C, 2020, MAR ECOL PROG SER, V640, P215, DOI 10.3354/meps13289; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Patrick SC, 2014, OIKOS, V123, P33, DOI 10.1111/j.1600-0706.2013.00406.x; Potier S, 2015, ANIM BEHAV, V103, P83, DOI 10.1016/j.anbehav.2015.02.008; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Rey AR, 2010, J ORNITHOL, V151, P933, DOI 10.1007/s10336-010-0531-y; Reale D, 2009, J EVOLUTION BIOL, V22, P1599, DOI 10.1111/j.1420-9101.2009.01781.x; Ronconi RA, 2008, MAR ECOL PROG SER, V366, P245, DOI 10.3354/meps07529; Ropert-Coudert Y, 2004, BEHAV ECOL, V15, P824, DOI 10.1093/beheco/arh086; Ropert-Coudert Y, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00264; Sato K, 2010, P R SOC B, V277, P707, DOI 10.1098/rspb.2009.1515; Schuster AC, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1430-3; Smith WO, 2007, ELSEV OCEANOGR SERIE, V74, P411, DOI 10.1016/S0422-9894(06)74013-2; Takahashi A, 2003, FUNCT ECOL, V17, P590, DOI 10.1046/j.1365-2435.2003.00772.x; Traisnel G, 2019, MAR ECOL PROG SER, V608, P279, DOI 10.3354/meps12827; Votier SC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1068; Wakefield ED, 2015, ECOLOGY, V96, P3058, DOI 10.1890/14-1300.1; Watanabe YY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba4828; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Widmann M, 2015, MOV ECOL, V3, DOI [10.1186/s40462-015-0052, 10.1186/s40462-015-0052-7]; Wilson RP, 1997, WILDLIFE SOC B, V25, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883; Yoda K, 2007, MAR BIOL, V151, P1951, DOI 10.1007/s00227-007-0631-2; Zuur Alain F., 2009, P1	65	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244298	10.1371/journal.pone.0244298	http://dx.doi.org/10.1371/journal.pone.0244298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481825	Green Published, gold			2022-12-26	WOS:000612929300034
J	Sun, MH; Yan, KL; Wang, CY; Xing, J; Duan, ZJ; Jin, Y; Cardona, CJ; Xing, Z				Sun, Menghuai; Yan, Kunlong; Wang, Chunyang; Xing, Jiao; Duan, Zhaojun; Jin, Yu; Cardona, Carol J.; Xing, Zheng			Intrinsic apoptosis and cytokine induction regulated in human tonsillar epithelial cells infected with enterovirus A71	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MOUTH-DISEASE; CRYPT EPITHELIUM; IMMUNE-RESPONSE; EX-VIVO; HAND; FOOT; ACTIVATION; REPLICATION; EXPRESSION	Enterovirus A71 (EV-A71) has emerged as a clinically important neurotropic virus following poliovirus eradication. Recent studies have shown that human tonsillar epithelial cell lines (UT-SCC-60A and UT-SCC-60B) were susceptible to EV-A71, suggesting that human tonsillar crypt epithelium could be important in EV-A71 pathogenesis. However, the mechanism about how EV-A71 infects the upper oro-digestive tract remains largely unclear. In this study, we demonstrated that the human tonsillar epithelial cells infected with EV-A71 underwent apoptotic, in which cytochrome c was released from the mitochondria to the cytosol and caspase-9 was activated, while caspase-2 and -8 were not cleaved or activated during the infection. A selective inhibitor of caspase-9, Z-LEHD-FMK, inhibited the cleavage of the executioner caspase-3 and -7, indicating that only mitochondria-mediated intrinsic apoptotic pathway was activated in EV-A71-infected tonsillar epithelial cells. No evidence of pyroptosis or necroptosis was involved in the cell death. EV-A71 infection induced interferon, pro-inflammatory cytokines and chemokines, including IFN-beta, IL-6, CCL5, and TNF-alpha in tonsillar epithelial cells, which may play a critical role in EV-A71-caused herpangina. Our data indicated that the induction of the cytokines was partially regulated by the mitogen-activated protein kinases (MAPKs) signaling pathway. The findings unveiled the host response to EV-A71 and its regulation mechanism, and will further our understanding the significance about the tonsillar crypt epithelium as the initial and primary portal in viral pathogenesis for EV-A71 infection.	[Sun, Menghuai; Jin, Yu; Xing, Zheng] Nanjing Univ, Med Sch, Nanjing, Peoples R China; [Sun, Menghuai; Jin, Yu; Xing, Zheng] Nanjing Univ, Jiangsu Prov Key Lab Med, Nanjing, Peoples R China; [Sun, Menghuai; Yan, Kunlong; Xing, Jiao; Jin, Yu] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Peoples R China; [Wang, Chunyang] Xian Med Univ, Clin Med Coll, Xian, Peoples R China; [Duan, Zhaojun] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA	Nanjing University; Nanjing University; Nanjing Medical University; Xi'an Medical University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Minnesota System; University of Minnesota Twin Cities	Jin, Y; Xing, Z (corresponding author), Nanjing Univ, Med Sch, Nanjing, Peoples R China.; Jin, Y; Xing, Z (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Med, Nanjing, Peoples R China.; Jin, Y (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN 55108 USA.	jinyuldyy@163.com; zxing@umn.edu	Xing, Zheng/O-3137-2015	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China (NSFC) [83452147, 81672020, 81702010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported partially by funding grants from the National Natural Science Foundation of China (NSFC) to Z.X. (No. 83452147), Y.J. (81672020), and C.W. (81702010). NSFC plays no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. There was no additional external funding received for this study.	BELZ GT, 1995, ANAT EMBRYOL, V192, P189; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chan Yoke-Fun, 2003, Malays J Pathol, V25, P29; Cheng P, 2009, ONCOL REP, V22, P1101, DOI 10.3892/or_00000542; Cong HL, 2016, J VIROL, V90, P9862, DOI 10.1128/JVI.01499-16; daSilva EE, 1996, EMERG INFECT DIS, V2, P231, DOI 10.3201/eid0203.960312; Du XL, 2015, MOL MED REP, V12, P953, DOI 10.3892/mmr.2015.3482; Ehlin-Henriksson B, 2009, IMMUNOLOGY, V127, P549, DOI 10.1111/j.1365-2567.2008.03029.x; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; GRENMAN R, 1992, ARCH OTOLARYNGOL, V118, P542; Grivel JC, 2000, J VIROL, V74, P8077, DOI 10.1128/JVI.74.17.8077-8084.2000; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; He YX, 2014, AM J PATHOL, V184, P714, DOI 10.1016/j.ajpath.2013.11.009; Ho Monto, 2000, Journal of Microbiology Immunology and Infection, V33, P205; Hu YQ, 2015, PEDIATR INFECT DIS J, V34, P951, DOI 10.1097/INF.0000000000000794; ISHIMARU Y, 1980, ARCH DIS CHILD, V55, P583, DOI 10.1136/adc.55.8.583; Jacotot E, 2000, J EXP MED, V191, P33, DOI 10.1084/jem.191.1.33; Jartti T, 2014, ALLERGY, V69, P658, DOI 10.1111/all.12396; Jiao XY, 2014, VIRUS RES, V190, P40, DOI 10.1016/j.virusres.2014.05.007; Kaneko Y, 2014, J CLIN EXP HEMATOP, V54, P111, DOI 10.3960/jslrt.54.111; Kennedy PGE, 2015, J NEUROVIROL, V21, P1, DOI 10.1007/s13365-014-0306-y; Kong XY, 2004, FEBS LETT, V559, P33, DOI 10.1016/S0014-5793(04)00002-X; Kuo RL, 2002, J GEN VIROL, V83, P1367, DOI 10.1099/0022-1317-83-6-1367; Li J, 2017, J VIROL, V91, DOI 10.1128/JVI.02016-16; Li ML, 2002, VIROLOGY, V293, P386, DOI 10.1006/viro.2001.1310; Liang CC, 2004, J MED VIROL, V74, P597, DOI 10.1002/jmv.20216; Liu BY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135503; Lu JR, 2013, J GEN VIROL, V94, P1477, DOI 10.1099/vir.0.047753-0; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; Ndjomou J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007498; Neumann S, 2015, VIRUS RES, V209, P45, DOI 10.1016/j.virusres.2015.02.026; Ogra PL, 2000, PEDIATR INFECT DIS J, V19, pS4, DOI 10.1097/00006454-200005001-00002; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Ooi MH, 2007, J CLIN MICROBIOL, V45, P1858, DOI 10.1128/JCM.01394-06; Perry M, 1998, IMMUNOL TODAY, V19, P414, DOI 10.1016/S0167-5699(98)01307-3; PERRY ME, 1994, J ANAT, V185, P111; Popik W, 1998, J VIROL, V72, P6406, DOI 10.1128/JVI.72.8.6406-6413.1998; Rao L, 1996, J CELL BIOL, V135, P1441, DOI 10.1083/jcb.135.6.1441; SMINIA T, 1989, CRIT REV IMMUNOL, V9, P119; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Wang CY, 2015, J GEN VIROL, V96, P3010, DOI 10.1099/jgv.0.000235; Xie GC, 2016, VIROLOGY, V494, P108, DOI 10.1016/j.virol.2016.04.016; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09; Yi Ting, 2011, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V27, P142; Zhao CQ, 2004, J IMMUNOL, V172, P3086, DOI 10.4049/jimmunol.172.5.3086	52	0	1	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245529	10.1371/journal.pone.0245529	http://dx.doi.org/10.1371/journal.pone.0245529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481814	gold, Green Published			2022-12-26	WOS:000612929300047
J	Konstantinidis, AO; Adamama-Moraitou, KK; Pardali, D; Dovas, CI; Brellou, GD; Papadopoulos, T; Jergens, AE; Allenspach, K; Rallis, TS				Konstantinidis, Alexandros O.; Adamama-Moraitou, Katerina K.; Pardali, Dimitra; Dovas, Chrysostomos I.; Brellou, Georgia D.; Papadopoulos, Theologos; Jergens, Albert E.; Allenspach, Karin; Rallis, Timoleon S.			Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score	PLOS ONE			English	Article							INTERLEUKIN-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; GERMAN-SHEPHERD DOGS; TOLL-LIKE RECEPTORS; GENE-EXPRESSION; DUODENAL MUCOSA; ULCERATIVE-COLITIS; CHRONIC ENTEROPATHIES; EPITHELIAL-CELLS; CROHNS-DISEASE	Canine inflammatory bowel disease (IBD) is a group of chronic gastrointestinal disorders, the pathogenesis of which remains elusive, but it possibly involves the interaction of the intestinal immune system with luminal microbiota and food-derived antigens. Mucosal cytokines profiles in canine IBD have been investigated mainly in small intestinal disease, while data on cytokine profiles in large intestinal IBD are limited. The objective of this study was to measure colonic mucosal and cytobrush sample messenger (m)RNA expression of interleukin (IL)-1 beta, IL-2, IL-12p40, IL-23p19, tumor necrosis factor-alpha (TNF-alpha) and chemokine C-C motif ligand (CCL28) in dogs with IBD and healthy controls using quantitative real-time polymerase chain reaction (PCR), and assess their correlation with clinical disease activity, endoscopic and histopathologic score. Dogs with IBD had a significantly increased mRNA expression of IL-1 beta, IL-23p19 and CCL28 in the colonic mucosa, compared to healthy controls. None of the selected cytokines had significantly different mRNA expression in the colonic cytobrush samples between the two groups or between the colonic mucosa and cytobrush samples of dogs with IBD. Finally, there was a statistically significant correlation of clinical disease activity with endoscopic activity score and fibrosis and atrophy of the colonic mucosa in dogs with large intestinal IBD. IL-1 beta, IL-23p19 and CCL28 could play a role in the pathogenesis of canine large intestinal IBD. Colonic cytokine expression does not correlate with clinical disease activity and/or endoscopic score. However, clinical signs reflect the severity of endoscopic lesions.	[Konstantinidis, Alexandros O.; Adamama-Moraitou, Katerina K.; Rallis, Timoleon S.] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Compan Anim Clin,Med Unit, Thessaloniki, Greece; [Pardali, Dimitra; Dovas, Chrysostomos I.; Papadopoulos, Theologos] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Diagnost Lab, Thessaloniki, Greece; [Brellou, Georgia D.] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Lab Pathol, Thessaloniki, Greece; [Jergens, Albert E.; Allenspach, Karin] Iowa State Univ, Coll Vet Med, Dept Clin Sci, Ames, IA USA	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Aristotle University of Thessaloniki; Iowa State University	Konstantinidis, AO (corresponding author), Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Vet Med, Compan Anim Clin,Med Unit, Thessaloniki, Greece.	alexandroskonstantinidis@gmail.com		Konstantinidis, Alexandros/0000-0002-0445-2229; Dovas, Chrysostomos/0000-0003-2947-1765; Brellou, Georgia/0000-0003-0588-7256	Hellenic Foundation for Research and Innovation; General Secretariat for Research and Technology [2497/95036]	Hellenic Foundation for Research and Innovation; General Secretariat for Research and Technology(Greek Ministry of Development-GSRT)	The first author (A.O.K.) was supported financially by the Hellenic Foundation for Research and Innovation and the General Secretariat for Research and Technology (grant code number: 2497/95036).	Aksentijevich I, 2009, NEW ENGL J MED, V360, P2426, DOI 10.1056/NEJMoa0807865; Allenspach K, 2007, J VET INTERN MED, V21, P700, DOI 10.1892/0891-6640(2007)21[700:CEIDEO]2.0.CO;2; Allenspach K, 2010, VET MICROBIOL, V146, P326, DOI 10.1016/j.vetmic.2010.05.025; Allenspach K, 2011, VET CLIN N AM-SMALL, V41, P345, DOI 10.1016/j.cvsm.2011.01.004; Allenspach KA, 2019, VET PATHOL, V56, P435, DOI 10.1177/0300985818813090; BATT RM, 1992, AM J VET RES, V53, P1935; Brydges SD, 2009, IMMUNITY, V30, P875, DOI 10.1016/j.immuni.2009.05.005; Burgener IA, 2008, J VET INTERN MED, V22, P553, DOI 10.1111/j.1939-1676.2008.0093.x; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; COMINELLI F, 1990, J CLIN INVEST, V86, P972, DOI 10.1172/JCI114799; Craven M, 2004, J SMALL ANIM PRACT, V45, P336, DOI 10.1111/j.1748-5827.2004.tb00245.x; De Majo M, 2008, VET RES COMMUN, V32, pS275, DOI 10.1007/s11259-008-9127-x; Dignass AU, 1996, EXP CELL RES, V225, P422, DOI 10.1006/excr.1996.0193; Drygiannakis I, 2013, J CROHNS COLITIS, V7, P286, DOI 10.1016/j.crohns.2012.04.008; El-Bassat H, 2016, ADV DIG MED, V3, P88, DOI 10.1016/j.aidm.2015.04.002; Ertugrul AS, 2013, J PERIODONTAL RES, V48, P44, DOI 10.1111/j.1600-0765.2012.01500.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Garcia-Sancho M, 2007, J VET INTERN MED, V21, P11, DOI 10.1892/0891-6640(2007)21[11:EOCMAH]2.0.CO;2; Gaschen FP., 2013, CANINE FELINE GASTRO, V1st ed, P736; German AJ, 2000, DIGEST DIS SCI, V45, P7, DOI 10.1023/A:1005436721798; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gordon IO, 2014, INFLAMM BOWEL DIS, V20, P2198, DOI 10.1097/MIB.0000000000000080; Hasnain SZ, 2013, INT J BIOCHEM CELL B, V45, P364, DOI 10.1016/j.biocel.2012.10.011; Hawes M, 2018, VET REC, V183, P536, DOI 10.1136/vr.104495; Hieshima K, 2003, J IMMUNOL, V170, P1452, DOI 10.4049/jimmunol.170.3.1452; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jergens AE, 2014, VET PATHOL, V51, P946, DOI 10.1177/0300985813511123; JERGENS AE, 1992, J AM VET MED ASSOC, V201, P1603; Jergens AE, 2009, COMPARATIVE MED, V59, P153; Johansson MEV, 2011, CELL MOL LIFE SCI, V68, P3635, DOI 10.1007/s00018-011-0822-3; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Konstantinidis A, 2020, BMC VET RES, V16, DOI 10.1186/s12917-020-02287-6; Lamacchia C, 2010, ARTHRITIS RHEUM-US, V62, P452, DOI 10.1002/art.27235; Latella G, 2015, SCAND J GASTROENTERO, V50, P53, DOI 10.3109/00365521.2014.968863; Latella G, 2014, J CROHNS COLITIS, V8, P1147, DOI 10.1016/j.crohns.2014.03.008; Lee DS, 2021, GUT LIVER, V15, P70, DOI 10.5009/gnl19273; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Maeda S, 2012, VET J, V194, P66, DOI 10.1016/j.tvjl.2012.02.026; Maeda S, 2011, VET IMMUNOL IMMUNOP, V144, P290, DOI 10.1016/j.vetimm.2011.08.020; Mao LM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02566; MCCABE RP, 1993, CLIN IMMUNOL IMMUNOP, V66, P52, DOI 10.1006/clin.1993.1007; MCCALL RD, 1994, GASTROENTEROLOGY, V106, P960, DOI 10.1016/0016-5085(94)90755-2; McCann TM, 2007, J SMALL ANIM PRACT, V48, P619, DOI 10.1111/j.1748-5827.2007.00335.x; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; O'Gorman MT, 2005, CELL IMMUNOL, V238, P87, DOI 10.1016/j.cellimm.2006.02.003; Ogawa H, 2004, AM J PHYSIOL-GASTR L, V287, pG1062, DOI 10.1152/ajpgi.00162.2004; Ogawa M, 2018, J VET INTERN MED, V32, P1019, DOI 10.1111/jvim.15117; Ohta H, 2014, J VET MED SCI, V76, P409, DOI 10.1292/jvms.13-0008; Okanishi H, 2013, J VET INTERN MED, V27, P439, DOI 10.1111/jvim.12082; Okanishi H, 2013, VET IMMUNOL IMMUNOP, V154, P145, DOI 10.1016/j.vetimm.2013.05.013; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Okuno T, 2002, SCAND J GASTROENTERO, V37, P317, DOI 10.1080/003655202317284228; Pan JL, 2000, J IMMUNOL, V165, P2943, DOI 10.4049/jimmunol.165.6.2943; Peters IR, 2007, VET IMMUNOL IMMUNOP, V117, P55, DOI 10.1016/j.vetimm.2007.01.011; Peters IR, 2005, J VET INTERN MED, V19, P644, DOI 10.1892/0891-6640(2005)19[644:CMQIDM]2.0.CO;2; Peters IR, 2005, VET IMMUNOL IMMUNOP, V103, P101, DOI 10.1016/j.vetimm.2004.08.020; Raza A, 2012, EXPERT REV CLIN IMMU, V8, P161, DOI [10.1586/ECI.11.96, 10.1586/eci.11.96]; Reddy S, 2009, NEW ENGL J MED, V360, P2438, DOI 10.1056/NEJMoa0809568; Ridyard AE, 2002, VET IMMUNOL IMMUNOP, V86, P205, DOI 10.1016/S0165-2427(02)00039-9; Rieder F, 2017, GASTROENTEROLOGY, V152, P340, DOI 10.1053/j.gastro.2016.09.047; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Schmitz S, 2014, SCAND J IMMUNOL, V80, P85, DOI 10.1111/sji.12186; Schmitz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120779; Schmitz S, 2012, VET IMMUNOL IMMUNOP, V146, P87, DOI 10.1016/j.vetimm.2012.01.013; Schreiner NMS, 2008, J VET INTERN MED, V22, P1079, DOI 10.1111/j.1939-1676.2008.0153.x; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Slovak JE, 2015, VET J, V203, P290, DOI 10.1016/j.tvjl.2014.12.030; STEVENS C, 1992, DIGEST DIS SCI, V37, P818, DOI 10.1007/BF01300378; Strugnell RA, 2010, NAT REV MICROBIOL, V8, P656, DOI 10.1038/nrmicro2384; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tamura Y, 2014, J VET MED SCI, V76, P1407, DOI 10.1292/jvms.13-0635; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Washabau RJ, 2010, J VET INTERN MED, V24, P10, DOI 10.1111/j.1939-1676.2009.0443.x; Wera O, 2016, J CLIN MED, V5, DOI 10.3390/jcm5120118	83	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2021	16	1							e0245713	10.1371/journal.pone.0245713	http://dx.doi.org/10.1371/journal.pone.0245713			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RM1OE	33471872	Green Published, gold			2022-12-26	WOS:000639428800061
J	Eiyama, A; Aaltonen, MJ; Nolte, H; Tatsuta, T; Langer, T				Eiyama, Akinori; Aaltonen, Mari J.; Nolte, Hendrik; Tatsuta, Takashi; Langer, Thomas			Disturbed intramitochondrial phosphatidic acid transport impairs cellular stress signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN-RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSMEMBRANE PROTEIN; PHOSPHOLIPID TRANSFER; MITOCHONDRIAL FUSION; TRANSCRIPTION FACTOR; SENSOR IRE1; CARDIOLIPIN; YEAST; SCH9	Lipid transfer proteins of the Ups1/PRELID1 family facilitate the transport of phospholipids across the intermembrane space of mitochondria in a lipid-specific manner. Heterodimeric complexes of yeast Ups1/Mdm35 or human PRELID1/TRIAP1 shuttle phosphatidic acid (PA) mainly synthesized in the endoplasmic reticulum (ER) to the inner membrane, where it is converted to cardiolipin (CL), the signature phospholipid of mitochondria. Loss of Ups1/PRELID1 proteins impairs the accumulation of CL and broadly affects mitochondrial structure and function. Unexpectedly and unlike yeast cells lacking the CL synthase Crd1, Ups1-deficient yeast cells exhibit glycolytic growth defects, pointing to functions of Ups1-mediated PA transfer beyond CL synthesis. Here, we show that the disturbed intramitochondrial transport of PA in ups1. cells leads to altered unfolded protein response (UPR) and mTORC1 signaling, independent of disturbances in CL synthesis. The impaired flux of PA into mitochondria is associated with the increased synthesis of phosphatidylcholine and a reduced phosphatidylethanolamine/phosphatidylcholine ratio in the ER of ups1. cells which suppresses the UPR. Moreover, we observed inhibition of target of rapamycin complex 1 (TORC1) signaling in these cells. Activation of either UPR by ER protein stress or of TORC1 signaling by disruption of its negative regulator, the Seh1-associated complex inhibiting TORC1 complex, increased cytosolic protein synthesis, and restored glycolytic growth of ups1. cells. These results demonstrate that PA influx into mitochondria is required to preserve ER membrane homeostasis and that its disturbance is associated with impaired glycolytic growth and cellular stress signaling.	[Eiyama, Akinori; Nolte, Hendrik; Tatsuta, Takashi; Langer, Thomas] Max Planck Inst Biol Ageing, Cologne, Germany; [Aaltonen, Mari J.; Langer, Thomas] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Aaltonen, Mari J.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Max Planck Society; University of Cologne; McGill University	Langer, T (corresponding author), Max Planck Inst Biol Ageing, Cologne, Germany.; Langer, T (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	TLanger@age.mpg.de		Aaltonen, Mari J./0000-0002-7333-9334	JSPS Overseas Research Fellowships; Deutsche Forschungsgemeinschaft [TA1132/2-1, LA918/14-1]	JSPS Overseas Research Fellowships; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by JSPS Overseas Research Fellowships to A. E. and by grants of the Deutsche Forschungsgemeinschaft to T. T. (TA1132/2-1) and T. L. (LA918/14-1).	Aaltonen MJ, 2016, J CELL BIOL, V213, P525, DOI 10.1083/jcb.201602007; Ahmed K, 2019, FEBS LETT, V593, P1957, DOI 10.1002/1873-3468.13463; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Bertero E, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165803; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Bruderer R, 2015, MOL CELL PROTEOMICS, V14, P1400, DOI 10.1074/mcp.M114.044305; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Connerth M, 2012, SCIENCE, V338, P815, DOI 10.1126/science.1225625; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Dokudovskaya S, 2015, J CELL SCI, V128, P2219, DOI 10.1242/jcs.168922; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2013, TRENDS ENDOCRIN MET, V24, P272, DOI 10.1016/j.tem.2013.02.003; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; GAIGG B, 1995, BBA-BIOMEMBRANES, V1234, P214, DOI 10.1016/0005-2736(94)00287-Y; Gao X, 2015, BBA-MOL BASIS DIS, V1852, P2689, DOI 10.1016/j.bbadis.2015.09.006; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Ho N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.199307; Huber A, 2011, EMBO J, V30, P3052, DOI 10.1038/emboj.2011.221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kameoka S, 2018, TRENDS CELL BIOL, V28, P67, DOI 10.1016/j.tcb.2017.08.011; Kannan M, 2017, J LIPID RES, V58, P553, DOI 10.1194/jlr.M072959; Kawai S, 2011, EUKARYOT CELL, V10, P1367, DOI 10.1128/EC.05157-11; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lev S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013300; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; MacVicar T, 2019, NATURE, V575, P361, DOI 10.1038/s41586-019-1738-6; Metge F., 2018, AGEPY PYTHON PACKAGE, DOI [10.1101/450890, DOI 10.1101/450890]; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229; Miyata N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16661-2; Miyata N, 2016, J CELL BIOL, V214, P77, DOI 10.1083/jcb.201601082; MORI K, 1993, CELL, V74, P743; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Musatov A, 2017, BIOCHIMIE, V142, P102, DOI 10.1016/j.biochi.2017.08.013; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Peng KY, 2018, J LIPID RES, V59, P1977, DOI 10.1194/jlr.M085613; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pincus D, 2014, P NATL ACAD SCI USA, V111, P14800, DOI 10.1073/pnas.1409588111; Pizzuto M, 2020, TRENDS CELL BIOL, V30, P892, DOI 10.1016/j.tcb.2020.09.004; Pollard AK, 2017, AGING-US, V9, P986, DOI 10.18632/aging.101204; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Powis K, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2015.49; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Saita S, 2018, EMBO J, V37, DOI 10.15252/embj.201797909; Samluk L, 2018, CURR OPIN PHYSIOL, V3, P41, DOI 10.1016/j.cophys.2018.02.010; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Tamura Y, 2020, BIOL CHEM, V401, P821, DOI 10.1515/hsz-2020-0121; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tatsuta T, 2017, METHODS MOL BIOL, V1567, P79, DOI 10.1007/978-1-4939-6824-4_7; Tatsuta T, 2017, BBA-MOL CELL BIOL L, V1862, P81, DOI 10.1016/j.bbalip.2016.08.006; Thibault G, 2012, MOL CELL, V48, P16, DOI 10.1016/j.molcel.2012.08.016; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Watanabe Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8922; Weidberg H, 2018, SCIENCE, V360, DOI 10.1126/science.aan4146; Yu F, 2015, EMBO REP, V16, P813, DOI 10.15252/embr.201540137	77	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100335	10.1016/j.jbc.2021.100335	http://dx.doi.org/10.1016/j.jbc.2021.100335			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33497623	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400309
J	Baker, JD; Uhrich, RL; Kraemer, GC; Love, JE; Kraemer, BC				Baker, Jeremy D.; Uhrich, Rikki L.; Kraemer, Gerald C.; Love, Jason E.; Kraemer, Brian C.			A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease	PLOS ONE			English	Article							ACCURATE DOCKING; DISCOVERY; NARLAPREVIR; BOCEPREVIR; RESISTANCE; GLIDE; SARS	Effective SARS-CoV-2 antiviral drugs are desperately needed. The SARS-CoV-2 main protease (Mpro) appears as an attractive target for drug development. We show that the existing pharmacopeia contains many drugs with potential for therapeutic repurposing as selective and potent inhibitors of SARS-CoV-2 Mpro. We screened a collection of similar to 6,070 drugs with a previous history of use in humans for compounds that inhibit the activity of Mpro in vitro and found similar to 50 compounds with activity against Mpro. Subsequent dose validation studies demonstrated 8 dose responsive hits with an IC50 <= 50 mu M. Hits from our screen are enriched with hepatitis C NS3/4A protease targeting drugs including boceprevir, ciluprevir. narlaprevir, and telaprevir. This work suggests previous large-scale commercial drug development initiatives targeting hepatitis C NS3/4A viral protease should be revisited because some previous lead compounds may be more potent against SARS-CoV-2 Mpro than boceprevir and suitable for rapid repurposing.	[Baker, Jeremy D.; Kraemer, Brian C.] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Baker, Jeremy D.; Uhrich, Rikki L.; Kraemer, Brian C.] Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Kraemer, Gerald C.] Thomas Jefferson High Sch, Auburn, WA USA; [Love, Jason E.] Western Washington Pathol, Tacoma, WA USA; [Kraemer, Brian C.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Kraemer, Brian C.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kraemer, BC (corresponding author), Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA.; Kraemer, BC (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.; Kraemer, BC (corresponding author), Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA.; Kraemer, BC (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kraemerb@uw.edu		Kraemer, Brian/0000-0002-2252-7634	Department of Veterans Affairs; Seattle Institute for Biomedical and Clinical Research; University of Washington; Washington Research Foundation (WRF)	Department of Veterans Affairs(US Department of Veterans Affairs); Seattle Institute for Biomedical and Clinical Research; University of Washington(University of Washington); Washington Research Foundation (WRF)	Research infrastructure, facilities, and support was provided by the Department of Veterans Affairs, the Seattle Institute for Biomedical and Clinical Research, and the University of Washington. The Washington Research Foundation (WRF) supported this study in the form of a Postdoctoral Fellowship to JDB.	Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254; Arasappan A, 2010, ACS MED CHEM LETT, V1, P64, DOI 10.1021/ml9000276; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541; Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658; Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197; Corsello SM, 2017, NAT MED, V23, P405, DOI 10.1038/nm.4306; Dai WH, 2020, SCIENCE, V368, P1331, DOI 10.1126/science.abb4489; de Bruijne J, 2010, HEPATOLOGY, V52, P1590, DOI 10.1002/hep.23899; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Dvory-Sobol H, 2012, ANTIMICROB AGENTS CH, V56, P5289, DOI 10.1128/AAC.00780-12; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hotho DM, 2013, J VIRAL HEPATITIS, V20, pe78, DOI 10.1111/jvh.12012; Jiang M, 2013, ANTIMICROB AGENTS CH, V57, P6236, DOI 10.1128/AAC.01578-13; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Kuhn B, 2017, J MED CHEM, V60, P2485, DOI 10.1021/acs.jmedchem.6b01881; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lang L, 2007, GASTROENTEROLOGY, V132, P6, DOI 10.1053/j.gastro.2006.12.010; Li Guangdi, 2020, Nat Rev Drug Discov, V19, P149, DOI 10.1038/d41573-020-00016-0; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Mohammad M., 2020, IDENTIFICATION 14 KN; Njoroge FG, 2008, ACCOUNTS CHEM RES, V41, P50, DOI 10.1021/ar700109k; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Piliero PJ, 2002, EXPERT OPIN INV DRUG, V11, P1295, DOI 10.1517/13543784.11.9.1295; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Rotella DP, 2013, EXPERT OPIN DRUG DIS, V8, P1439, DOI 10.1517/17460441.2013.843525; Shamsi A, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201256; Shi ST, 2005, CURR TOP MICROBIOL, V287, P95, DOI 10.1007/3-540-26765-4_4; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Tan SL, 2004, CURR OPIN PHARMACOL, V4, P465, DOI 10.1016/j.coph.2004.07.003; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Tong X, 2010, ANTIMICROB AGENTS CH, V54, P2365, DOI 10.1128/AAC.00135-10; Wang HF, 2016, VIROL SIN, V31, P24, DOI 10.1007/s12250-015-3711-3; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wioletta Rut KG, 2020, SUBSTRATE SPECIFICIT; Wishart D., 2012, DRUG BANK OPEN DATA; You DM, 2013, EXPERT OPIN PHARMACO, V14, P2581, DOI 10.1517/14656566.2013.850074; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405; Zhao Qi, 2013, Recent Pat Antiinfect Drug Discov, V8, P150; Zhao W, 2020, AM J ROENTGENOL, V214, P1072, DOI 10.2214/AJR.20.22976	45	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245962	10.1371/journal.pone.0245962	http://dx.doi.org/10.1371/journal.pone.0245962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524017	Green Submitted, gold, Green Published			2022-12-26	WOS:000616578400002
J	Komissarov, A; Molodtsov, I; Ivanova, O; Maryukhnich, E; Kudryavtseva, S; Mazus, A; Nikonov, E; Vasilieva, E				Komissarov, Alexey; Molodtsov, Ivan; Ivanova, Oxana; Maryukhnich, Elena; Kudryavtseva, Svetlana; Mazus, Alexey; Nikonov, Evgeniy; Vasilieva, Elena			High SARS-CoV-2 load in the nasopharynx of patients with a mild form of COVID-19 is associated with clinical deterioration regardless of the hydroxychloroquine administration	PLOS ONE			English	Article							CHLOROQUINE	Because of the constantly growing numbers of COVID-19 infections and deaths, attempts were undertaken to find drugs with anti-SARS-CoV-2 activity among ones already approved for other pathologies. In the framework of such attempts, in a number of in vitro, as well as in vivo, models it was shown that hydroxychloroquine (HCQ) has an effect against SARS-CoV-2. While there were not enough clinical data to support the use of HCQ, several countries including Russia have included HCQ in treatment protocols for infected patients and for prophylaxis. In the current non-randomized, observational study we evaluated the SARS-CoV-2 RNA in nasopharynx swabs from infected patients 7-10 days post symptoms with clinically mild disease and compared the viral RNA load dynamics between patients receiving HCQ (200 mg twice per day according to the Ministry of Health of Russian Federation treatment instructions, n = 33) and a control group without antiviral pharmacological therapy (n = 12). We found a statistically significant relationship between maximal RNA quantity and deterioration of patients' medical conditions, and as well we confirmed arterial hypertension to be a risk factor for people with COVID-19. However, we showed that at the dose used in the study HCQ therapy neither shortened the viral shedding period nor reduced the virus RNA load.	[Komissarov, Alexey; Molodtsov, Ivan; Ivanova, Oxana; Maryukhnich, Elena; Kudryavtseva, Svetlana; Vasilieva, Elena] Clin City Hosp, Moscow Dept Healthcare, Moscow, Russia; [Komissarov, Alexey; Ivanova, Oxana; Maryukhnich, Elena; Vasilieva, Elena] Moscow State Univ Med & Dent, Cardiol Dept, Lab Atherothrombosis, Moscow, Russia; [Molodtsov, Ivan] NF Gamaleya Fed Natl Res Ctr Epidemiol & Microbio, Moscow, Russia; [Mazus, Alexey] Moscow City Ctr AIDS Prevent & Control, Moscow Dept Healthcare, Moscow, Russia; [Nikonov, Evgeniy] Moscow Dept Healthcare, Moscow, Russia	Moscow State University of Medicine & Dentistry; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Vasilieva, E (corresponding author), Clin City Hosp, Moscow Dept Healthcare, Moscow, Russia.; Vasilieva, E (corresponding author), Moscow State Univ Med & Dent, Cardiol Dept, Lab Atherothrombosis, Moscow, Russia.	vasilievahelena@gmail.com	Vasilieva, Elena/B-2137-2016; Nikonov, Evgeniy/T-9090-2017; Ivanova, Oxana/L-8578-2016	Vasilieva, Elena/0000-0003-4111-0874; Nikonov, Evgeniy/0000-0003-3021-6534; Ivanova, Oxana/0000-0002-8477-9706	Russian Science Foundation [18-15-00420]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was funded by the Russian Science Foundation (https://www.rscf.ru/en/) grant, agreement #18-15-00420 (EV). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Hashem AM, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101735; Huang SJ, 2020, HYPERTENS RES, V43, P824, DOI 10.1038/s41440-020-0485-2; Lammers AJJ, 2020, INT J INFECT DIS, V101, P283, DOI 10.1016/j.ijid.2020.09.1460; Liu K, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-019-0132-8; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Skipper CP, 2020, ANN INTERN MED, V173, P623, DOI 10.7326/M20-4207; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Yu FT, 2020, CLIN INFECT DIS, V71, P793, DOI 10.1093/cid/ciaa345; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246396	10.1371/journal.pone.0246396	http://dx.doi.org/10.1371/journal.pone.0246396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513195	Green Published, gold			2022-12-26	WOS:000613891400036
J	Mennecart, B; Metais, G; Costeur, L; Ginsburg, L; Rossner, GE				Mennecart, Bastien; Metais, Gregoire; Costeur, Loic; Ginsburg, Leonard; Roessner, Gertrud E.			Reassessment of the enigmatic ruminant Miocene genus Amphimoschus Bourgeois, 1873 (Mammalia, Artiodactyla, Pecora)	PLOS ONE			English	Article							LOIR-ET-CHER; MIDDLE MIOCENE; BONY LABYRINTH; FRANCE; OLIGOCENE; NEOGENE; HISTORY; WETLAND; SANDS	Amphimoschus is an extinct Eurasian ruminant genus, mostly recorded in Europe, without a close living relative and, hence, an unknown systematic position. This genus is known from around 50 localities from the late early to the middle Miocene. Two species were described during 180 years, but since their first description during the late 19(th) century and early 20(th) century, hardly any detailed taxonomic work has been done on the genus. Over the years, extensive collecting and excavating activities have enriched collections with more and more complete material of this still rare and enigmatic animal. Most interestingly, a number of skull remains have been unearthed and are promising in terms of providing phylogenetic information. In the present paper, we describe cranial material, the bony labyrinth, the dentition through 780 teeth and five skulls from different ontogenetic stages. We cannot find a clear morphometric distinction between the supposedly smaller and older species Amphimoschus artenensis and the supposedly younger and larger species A. ponteleviensis. Accordingly, we have no reason to retain the two species and propose, following the principle of priority (ICZN chapter 6 article 23), that only A. ponteleviensis Bourgeois, 1873 is valid. Our studies on the ontogenetic variation of Amphimoschus does reveal that the sagittal crest may increase in size and a supraorbital ridge may appear with age. Despite the abundant material, the family affiliation is still uncertain.	[Mennecart, Bastien; Costeur, Loic] Nat Hist Museum Basel, Basel, Switzerland; [Mennecart, Bastien] Nat Hist Museum Wien, Vienna, Austria; [Metais, Gregoire; Ginsburg, Leonard] Sorbonne Univ, CR2P Ctr Rech Paleontol Paris, UMR 7207, MNHN,CNRS,Museum Natl Hist Nat,CP38, Paris, France; [Roessner, Gertrud E.] Staatl Nat Wissensch Sammlungen Bayerns, Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Roessner, Gertrud E.] Ludwig Maximilians Univ Munchen, Dept Geo & Umweltwissensch, Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Munich	Mennecart, B (corresponding author), Nat Hist Museum Basel, Basel, Switzerland.; Mennecart, B (corresponding author), Nat Hist Museum Wien, Vienna, Austria.	mennecartbastien@gmail.com	; Mennecart, Bastien/W-4477-2017	Costeur, Loic/0000-0001-6213-8556; Mennecart, Bastien/0000-0002-9669-2907	Swiss National Science Foundation [P300P2_161065, P3P3P2_161066, 200021_178853, 200021_159854/1, 200021-178853]; German Research Foundation [RO 1197/3-1]; Museum National d'Histoire Naturelle de Paris [Ast-RX-2013051]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Museum National d'Histoire Naturelle de Paris	BM and LC are grateful to the Swiss National Science Foundation for supporting this research through the projects P300P2_161065 and P3P3P2_161066 on the evolution of the early ruminants and 200021_178853, 200021_159854/1, and 200021-178853 on the ear region evolution in ruminants. GER thanks the German Research Foundation project RO 1197/3-1. GM, BM, and LC want to thank the Museum National d'Histoire Naturelle de Paris for financing the Ast-RX-2013051 Project which permitted to scan the Artenay skull. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiglstorfer M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185679; [Anonymous], 2016, CRIT CARE NURSE, V36, pe11; [Anonymous], 2020, CHIN J CRIT CARE INT, V6, P1; Antoine PO, 2000, CR ACAD SCI II A, V330, P571, DOI 10.1016/S1251-8050(00)00174-9; Athanasiou G, 2009, IEEE T MOBILE COMPUT, V8, P65, DOI 10.1109/TMC.2008.75; Azanza Asensio Beatriz, 2000, Memorias del Museo Paleontologico de la Universidad de Zaragoza, V8, P1; Barmann EV, 2011, MAMM BIOL, V76, P762, DOI 10.1016/j.mambio.2011.07.002; Barone R., 1999, ANATOMIE COMPAREE MA, V1; Bibi F, 2009, PALAEONTOL ELECTRON, V12; Bolliger Thomas, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P501; Bourgeois L.-A., 1873, J ZOOLOGIE, V2, P235; BULOT C, 1993, CR ACAD SCI II, V316, P1011; Caroll RL, 1988, VERTEBRATE PALEONTOL; Chen L, 2019, SCIENCE, V364, P1152, DOI 10.1126/science.aav6202; Costeur L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26094-0; Costeur L, 2017, J ANAT, V230, P347, DOI 10.1111/joa.12549; Costeur Loic, 2011, Acta Geologica Slovaca, V3, P105; Costeur L, 2008, PALAEOGEOGR PALAEOCL, V261, P127, DOI 10.1016/j.palaeo.2008.01.011; Eronen JT, 2007, EVOL ECOL RES, V9, P471; Fejfar O, 1993, PAL GESS 63 JAHR 21, P16; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Gagnaison Cyril, 2012, Revue de Paleobiologie, V31, P219; Gentry A.W., 1996, P378; Gentry A.W., 1994, Historical Biology, V7, P115; Gentry Alan W., 2000, P11; Gentry Alan W., 1999, P225; GINSBURG L, 1989, NATO ADV SCI I A-LIF, V180, P157; GINSBURG L, 1959, CR HEBD ACAD SCI, V248, P2891; GINSBURG L, 1982, B SOC GEOL FR, V24, P403; Ginsburg Leonard, 2001, Geodiversitas, V23, P381; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Heckeberg NS, 2020, PEERJ, V8, DOI 10.7717/peerj.8114; Janis CM., 1987, AM MUS NOVIT, V2893, P1; JEHENNE Y, 1988, CR ACAD SCI II, V307, P1991; Kaiser TM, 2007, PALAEOGEOGR PALAEOCL, V252, P424, DOI 10.1016/j.palaeo.2007.04.013; Leinders J, 1983, SCRIPTA GEOL, V70, P1; LI CK, 1983, VERTEBRAT PALASIATIC, V21, P313; Macaire Jean-Jacques, 2020, Bulletin d'Information des Geologues du Bassin de Paris, V57, P34; Mallet C., 2013, PALEO REV DARCHEOLOG, P173; MATTHEWS S C, 1973, Palaeontology (Oxford), V16, P713; Mayet L., 1908, ANN U LYON, V24, P1, DOI DOI 10.5962/BHL.TITLE.52982; Mazza PPA, 2011, ZOOL J LINN SOC-LOND, V163, P1304, DOI 10.1111/j.1096-3642.2011.00737.x; McKenna MC, 1997, CLASSIFICATION MAMMA; Mennecart B, 2010, MESOGEE, V66, P71; Mennecart B, 2012, RUMINANTS ANATOMY BE, P205; Mennecart B, 2019, J SYST PALAEONTOL, V17, P691, DOI 10.1080/14772019.2018.1472145; Mennecart B, 2018, CR PALEVOL, V17, P189, DOI 10.1016/j.crpv.2017.08.004; Mennecart B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12848-9; Mennecart B, 2016, J MORPHOL, V277, P1329, DOI 10.1002/jmor.20579; Mennecart B, 2016, J ANAT, V229, P422, DOI 10.1111/joa.12487; Mennecart B, 2011, SWISS J GEOSCI, V104, pS115, DOI 10.1007/s00015-010-0034-0; Mors Thomas, 2000, Palaeontologische Zeitschrift, V74, P145; Nargolwalla MC, 2009, THESIS; Nowak R.M, 1999, WALKERS MAMMALS WORL, V6th; O'Leary MA, 2010, B AM MUS NAT HIST, P4; Orliac MJ, 2012, J ANAT, V221, P417, DOI 10.1111/j.1469-7580.2012.01562.x; Owen R., 1848, Q J GEOL SOC LOND, V4, P103, DOI DOI 10.1144/GSL.JGS.1848.004.01-02.21; Park T, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1525-x; Raia P, 2010, EVOLUTION, V64, P1489, DOI 10.1111/j.1558-5646.2009.00921.x; Rinnert P., 1956, Palaeontographica, V107A, P1; Rossner GE, 2010, PALAEONTOL Z, V84, P123, DOI 10.1007/s12542-010-0052-2; Rogl F., 1999, HOMINOID EVOLUTION C, V1, P8, DOI DOI 10.1017/CB09780511542329.002; Roman F., 1934, MEM SOC GEOL FRANCE, V9, P1; Rook Lorenzo, 1999, P191; Rossner GE, 2004, COUR FOR SEKENBG, V249, P91; Rossner GE, 2001, J VERTEBR PALEONTOL, V21, P591, DOI 10.1671/0272-4634(2001)021[0591:ANROTE]2.0.CO;2; Rossner Gertrud, 1997, Memoires et Travaux de l'Institut de Montpellier de l'Ecole Pratique des Hautes Etudes, V21, P609; Sach Volker J., 2001, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V310, P1; Sanchez IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143034; Scherler L, 2013, SWISS J GEOSCI, V106, P349, DOI 10.1007/s00015-013-0140-x; Solounias N., 2007, EVOLUTION ARTIODACTY, P287; Stehlin H.G, 1925, B SOC HIST NATURELLE, V18, P77; Studer T., 1895, MEMOIRES SOC PALEONT, VXXII, P1; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; von Meyer H., 1938, NEUES JB MINERALOGIE, P413; Wang Ban-Yue, 2003, Vertebrata Palasiatica, V41, P66; Wang XM, 2004, ZOOL J LINN SOC-LOND, V142, P405, DOI 10.1111/j.1096-3642.2004.00135.x; Wang XM, 2003, EARTH PLANET SC LETT, V208, P253, DOI 10.1016/S0012-821X(03)00047-5; Wang Y, 2019, SCIENCE, V364, P1153, DOI 10.1126/science.aav6335	79	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0244661	10.1371/journal.pone.0244661	http://dx.doi.org/10.1371/journal.pone.0244661			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513144	Green Published, gold			2022-12-26	WOS:000613891400052
J	Bardi, F; Bakker, M; Kenkhuis, MJA; Ranchor, AV; Bakker, MK; Elvan, A; Birniel, E; Bilardo, CM				Bardi, Francesca; Bakker, Merel; Kenkhuis, Monique J. A.; Ranchor, Adelita, V; Bakker, Marian K.; Elvan, Ayten; Birniel, Erwin; Bilardo, Caterina M.			Psychological outcomes, knowledge and preferences of pregnant women on first-trimester screening for fetal structural abnormalities: A prospective cohort study	PLOS ONE			English	Article							DOWNS-SYNDROME; MATERNAL ANXIETY; INFORMED CHOICES; TERMINATION; TRIMESTER; ANOMALIES; ATTITUDES; IMPACT; TRIAL; 1ST	Introduction The primary aim of this study is to investigate the impact of a 13-week anomaly scan on the experienced levels of maternal anxiety and well-being. Secondly, to explore women's knowledge on the possibilities and limitations of the scan and the preferred timing of screening for structural abnormalities. Material and methods In a prospective-cohort study conducted between 2013-2015, pregnant women in the North-Netherlands underwent a 13-week anomaly scan. Four online-questionnaires (Q1, Q2, Q3 and Q4) were completed before and after the 13- and the 20-week anomaly scans. In total, 1512 women consented to participate in the study and 1118 (74%) completed the questionnaires at Q1, 941 (64%) at Q2, 807 (55%) at Q3 and 535 (37%) at Q4. Psychological outcomes were measured by the state-trait inventory-scale (STAI), the patient's positive-negative affect (PANAS) and ad-hoc designed questionnaires. Results Nine-nine percent of women wished to be informed as early as possible in pregnancy about the absence/presence of structural abnormalities. In 87% of women levels of knowledge on the goals and limitations of the 13-week anomaly scan were moderate-to-high. In women with a normal 13-week scan result, anxiety levels decreased (P < .001) and well-being increased over time (P < .001). In women with false-positive results (n = 26), anxiety levels initially increased (STAI-Q1: 39.8 vs. STAI-Q2: 48.6, P= 0.025), but later decreased around the 20-week anomaly scan (STAI-Q3: 36.4 vs. STAI-Q4: 34.2, P= 0.36). Conclusions The 13-week scan did not negatively impact the psychological well-being of pregnant women. The small number of women with screen-positive results temporarily experienced higher anxiety after the scan but, in false-positive cases, anxiety levels normalized again when the abnormality was not confirmed at follow-up scans. Finally, most pregnant women have moderate-to-high levels of knowledge and strongly prefer early screening for fetal structural abnormalities.	[Bardi, Francesca; Bakker, Merel; Kenkhuis, Monique J. A.; Bakker, Marian K.; Elvan, Ayten; Birniel, Erwin; Bilardo, Caterina M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [Ranchor, Adelita, V] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Psychol, Groningen, Netherlands; [Birniel, Erwin] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Bilardo, Caterina M.] Amsterdam Univ Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen	Bardi, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.	f.bardi@umcg.nl						Andermann A, 2008, B WORLD HEALTH ORGAN, V86, P317, DOI 10.2471/BLT.07.050112; [Anonymous], 2002, NED VER OBS GYN; Bardi F, 2019, FETAL DIAGN THER, V46, P12, DOI 10.1159/000490723; Boyd PA, 2008, BJOG-INT J OBSTET GY, V115, P689, DOI 10.1111/j.1471-0528.2008.01700.x; Chueh HY, 2007, ACTA OBSTET GYN SCAN, V86, P1437, DOI 10.1080/00016340701622724; Coupe VMH, 2016, BEST PRACT RES CL RH, V30, P1084, DOI 10.1016/j.berh.2017.07.002; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dennis CL, 2017, BRIT J PSYCHIAT, V210, P315, DOI 10.1192/bjp.bp.116.187179; Gourounti K, 2008, MIDWIFERY, V24, P153, DOI 10.1016/j.midw.2006.09.001; Grande M, 2012, ULTRASOUND OBST GYN, V39, P157, DOI 10.1002/uog.10070; Grant KA, 2008, J AFFECT DISORDERS, V108, P101, DOI 10.1016/j.jad.2007.10.002; Health Council of the Netherlands, 2014, HAG PO SCREEN ACT 1; Kaasen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174412; Karim JN, 2017, ULTRASOUND OBST GYN, V50, P429, DOI 10.1002/uog.17246; Kenkhuis MJA, 2018, ULTRASOUND OBST GYN, V51, P463, DOI 10.1002/uog.17487; Knutzen DM, 2013, J MATERN-FETAL NEO M, V26, P1799, DOI 10.3109/14767058.2013.804504; Korenromp MJ, 2005, PRENATAL DIAG, V25, P253, DOI 10.1002/pd.1127; Kornman LH, 1997, PRENATAL DIAG, V17, P1011, DOI 10.1002/(SICI)1097-0223(199711)17:11<1011::AID-PD193>3.0.CO;2-1; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Lou S, 2015, ACTA OBSTET GYN SCAN, V94, P15, DOI 10.1111/aogs.12482; Maiz N, 2016, PRENATAL DIAG, V36, P449, DOI 10.1002/pd.4802; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Muller MA, 2006, ULTRASOUND OBST GYN, V27, P357, DOI 10.1002/uog.2761; Mulvey S, 2000, BRIT J OBSTET GYNAEC, V107, P1302, DOI 10.1111/j.1471-0528.2000.tb11624.x; Ohman SG, 2004, ACTA OBSTET GYN SCAN, V83, P634; Pop-Tudose ME, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2077-6; Rostant K, 2003, AUST NZ J OBSTET GYN, V43, P134, DOI 10.1046/j.0004-8666.2003.00041.x; Rothwell E, 2019, AM J PERINAT, V36, P322, DOI 10.1055/s-0038-1667371; Souka AP, 2010, PRENATAL DIAG, V30, P977, DOI 10.1002/pd.2600; Spencer K, 2004, ULTRASOUND OBST GYN, V24, P735, DOI 10.1002/uog.1768; Syngelaki A, 2011, PRENATAL DIAG, V31, P90, DOI 10.1002/pd.2642; van den Berg M, 2005, GENET MED, V7, P332, DOI 10.1097/01.GIM.0000162876.65555.AB; Viaux-Savelon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030935; Yee LM, 2014, PRENATAL DIAG, V34, P552, DOI 10.1002/pd.4347	34	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245938	10.1371/journal.pone.0245938	http://dx.doi.org/10.1371/journal.pone.0245938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503072	gold, Green Published			2022-12-26	WOS:000613751800042
J	Packel, L; Reingold, A; Hunter, L; Facente, S; Li, Y; Harte, A; Nicolette, G; Urnov, FD; Lu, M; Petersen, M				Packel, Laura; Reingold, Arthur; Hunter, Lauren; Facente, Shelley; Li, Yi; Harte, Anna; Nicolette, Guy; Urnov, Fyodor D.; Lu, Michael; Petersen, Maya		IGI Testing Consortium	Piloting an integrated SARS-CoV-2 testing and data system for outbreak containment among college students: A prospective cohort study	PLOS ONE			English	Article								Background Colleges and universities across the country are struggling to develop strategies for effective control of COVID-19 transmission as students return to campus. Methods and findings We conducted a prospective cohort study with students living on or near the UC Berkeley campus from June 1st through August 18th, 2020 with the goal of providing guidance for campus reopening in the safest possible manner. In this cohort, we piloted an alternative testing model to provide access to low-barrier, high-touch testing and augment student-driven testing with data-driven adaptive surveillance that targets higher-risk students and triggers testing notifications based on reported symptoms, exposures, or other relevant information. A total of 2,180 students enrolled in the study, 51% of them undergraduates. Overall, 6,247 PCR tests were administered to 2,178 students over the two-month period. Overall test positivity rate was 0.9%; 2.6% of students tested positive. Uptake and acceptability of regular symptom and exposure surveys was high; 98% of students completed at least one survey, and average completion rate was 67% (Median: 74%, IQR: 39%) for daily reporting of symptoms and 68% (Median: 75%, IQR: 40%) for weekly reporting of exposures. Of symptom-triggered tests, 5% were PCR-positive; of exposure-triggered tests, 10% were PCR-positive. The integrated study database augmented traditional contact tracing during an outbreak; 17 potentially exposed students were contacted the following day and sent testing notifications. At study end, 81% of students selected their desire "to contribute to UC Berkeley's response to COVID-19" as a reason for their participation in the Safe Campus study. Conclusions Our results illustrate the synergy created by bringing together a student-friendly, harm reduction approach to COVID-19 testing with an integrated data system and analytics. We recommend the use of a confidential, consequence-free, incentive-based daily symptom and exposure reporting system, coupled with low-barrier, easy access, no stigma testing. Testing should be implemented alongside a system that integrates multiple data sources to effectively trigger testing notifications to those at higher risk of infection and encourages students to come in for low-barrier testing when needed.	[Packel, Laura; Reingold, Arthur; Hunter, Lauren; Facente, Shelley; Li, Yi; Lu, Michael; Petersen, Maya] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA; [Facente, Shelley] Facente Consulting, Richmond, CA USA; [Harte, Anna; Nicolette, Guy] Univ Calif Berkeley, Univ Hlth Serv, Berkeley, CA 94720 USA; [Urnov, Fyodor D.] Univ Calif Berkeley, Innovat Genom Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Packel, L (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.	lpackel@berkeley.edu	Facente, Shelley/M-1147-2019	Li, Yi/0000-0003-4602-5572; Facente, Shelley N./0000-0002-7266-352X; Lin Shiao, Enrique/0000-0001-5396-9614				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; Benkeser D, 2018, STAT MED, V37, P249, DOI 10.1002/sim.7320; Fausset R., 2020, NY TIMES; Gardner B, 2015, HEALTH PSYCHOL REV, V9, P277, DOI 10.1080/17437199.2013.876238; Giuliani-Hoffman F., 2020, CNN; Gold JAW, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa255; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Larsen DA, 2020, NAT BIOTECHNOL, V38, P1151, DOI 10.1038/s41587-020-0690-1; Loewenstein G., 2017, BEHAV PUBLIC POLICY, V1, P26; Maldonado B, 2020, ADDITIONAL INFORM LA; Mantzari E, 2015, PREV MED, V75, P75, DOI 10.1016/j.ypmed.2015.03.001; Office of Student Rights and Responsibilities, COVID 19 INF; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Robles Frances, 2020, NY TIMES; Service Owain Hallsworth Michael Halpern David Algate Felicity Gallagher Rory Nguyen Sam, E 4 SIMPLE WAYS APPL; Sina Booeshaghi A., 2020, MARKEDLY HETEROGENEO; Thomsen I., 2020, NEWS NE; Treisman R., 2020, MORE 200 OHIO STATE; Woodley E., 2020, COVID 19 MESSAGE REG; Xu XY, 2021, INTERNET RES, V31, P699, DOI 10.1108/INTR-10-2019-0397	22	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245765	10.1371/journal.pone.0245765	http://dx.doi.org/10.1371/journal.pone.0245765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497404	Green Published, gold			2022-12-26	WOS:000613707100001
J	Kitaura, A; Nishinaka, T; Hamasaki, S; Hatipoglu, OF; Wake, H; Nishibori, M; Mori, S; Nakao, S; Takahashi, H				Kitaura, Atsuhiro; Nishinaka, Takashi; Hamasaki, Shinichi; Hatipoglu, Omer Faruk; Wake, Hidenori; Nishibori, Masahiro; Mori, Shuji; Nakao, Shinichi; Takahashi, Hideo			Advanced glycation end-products reduce lipopolysaccharide uptake by macrophages	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; TYPE-2 DIABETES-MELLITUS; RECEPTOR 4; CD14; INTERNALIZATION; INFLAMMATION; INVOLVEMENT; INTERFERON; ACTIVATION; MECHANISMS	Hyperglycaemia provides a suitable environment for infections and the mechanisms of glucose toxicity include the formation of advanced glycation end-products (AGEs), which comprise non-enzymatically glycosylated proteins, lipids, and nucleic acid amino groups. Among AGE-associated phenotypes, glycolaldehyde-derived toxic AGE (AGE-3) is involved in the pathogenesis of diabetic complications. Internalisation of endotoxin by various cell types contributes to innate immune responses against bacterial infection. An endotoxin derived from Gram-negative bacteria, lipopolysaccharide (LPS), was reported to enhance its own uptake by RAW264.7 mouse macrophage-like cells, and an LPS binding protein, CD14, was involved in the LPS uptake. The LPS uptake induced the activation of RAW264.7 leading to the production of chemokine CXC motif ligand (CXCL) 10, which promotes T helper cell type 1 responses. Previously, we reported that AGE-3 was internalised into RAW264.7 cells through scavenger receptor-1 Class A. We hypothesized that AGEs uptake interrupt LPS uptake and impair innate immune response to LPS in RAW264.7 cells. In the present study, we found that AGE-3 attenuated CD14 expression, LPS uptake, and CXCL10 production, which was concentration-dependent, whereas LPS did not affect AGE uptake. AGEs were reported to stimulate the receptor for AGEs and Toll-like receptor 4, which cause inflammatory reactions. We found that inhibitors for RAGE, but not Toll-like receptor 4, restored the AGE-induced suppression of CD14 expression, LPS uptake, and CXCL10 production. These results indicate that the receptor for the AGE-initiated pathway partially impairs the immune response in diabetes patients.	[Kitaura, Atsuhiro; Hamasaki, Shinichi; Nakao, Shinichi] Kindai Univ, Dept Anesthesiol, Fac Med, Osakasayama, Osaka, Japan; [Nishinaka, Takashi; Hatipoglu, Omer Faruk; Takahashi, Hideo] Kindai Univ, Dept Pharmacol, Fac Med, Osaka, Osaka, Japan; [Wake, Hidenori; Nishibori, Masahiro] Okayama Univ, Grad Sch Med, Dept Pharmacol Dent & Pharmaceut Sci, Okayama, Japan; [Mori, Shuji] Shujitsu Univ, Dept Pharm, Okayama, Japan	Kindai University (Kinki University); Okayama University	Takahashi, H (corresponding author), Kindai Univ, Dept Pharmacol, Fac Med, Osaka, Osaka, Japan.	hkt@med.kindai.ac.jp	Hatipoglu, Omer Faruk/J-6706-2019; Nishinaka, Takashi/AAR-4332-2020	Hatipoglu, Omer Faruk/0000-0002-1012-001X; Nishinaka, Takashi/0000-0001-7500-7889	Japan Society for the Promotion of Science (JSPS) [17K16766, 18K06905]; Japan Agency for Medical Research and Development (AMED) [15LK0201014h0003]; Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1411037]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Early-Career Scientists (17K16766), Scientific Research (C) (18K06905), by Japan Agency for Medical Research and Development (AMED) (15LK0201014h0003), by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (S1411037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 1999, J ENDOTOXIN RES, V5, P139, DOI 10.1179/096805199101531642; Andreasen AS, 2010, INTENS CARE MED, V36, P1548, DOI 10.1007/s00134-010-1845-1; [Anonymous], 2015, BMJ, V2015, ph1887; Ayelign B, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/6196532; BAZIL V, 1991, J IMMUNOL, V147, P1567; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Borzcka K, 2013, MEDIAT INFLAMM, V2013, P824919, DOI 10.1155/2013/824919; Byun K, 2017, PHARMACOL THERAPEUT, V177, P44, DOI 10.1016/j.pharmthera.2017.02.030; Cantuaria APC, 2018, CYTOKINE, V107, P18, DOI 10.1016/j.cyto.2017.11.008; Chen ZX, 2018, SHOCK, V49, P82, DOI 10.1097/SHK.0000000000000913; Cheng N, 2018, EMBO REP, V19, DOI 10.15252/embr.201745517; Cowan DB, 2001, CIRC RES, V88, P491, DOI 10.1161/01.RES.88.5.491; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Czerkies M, 2013, IMMUNOBIOLOGY, V218, P1217, DOI 10.1016/j.imbio.2013.04.005; Donath MY, 2019, NAT REV IMMUNOL, V19, P734, DOI 10.1038/s41577-019-0213-9; Drake LR, 2020, J PHARM ANAL, V10, P452, DOI 10.1016/j.jpha.2020.07.009; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Frydrych L, 2018, J LEUKOCYTE BIOL, V104, P525, DOI 10.1002/JLB.5VMR0118-021RR; Gomes JMG, 2017, METABOLISM, V68, P133, DOI 10.1016/j.metabol.2016.12.009; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hamasaki S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24325-y; HAZIOT A, 1988, J IMMUNOL, V141, P547; Heming TA, 2001, CLIN SCI, V100, P259, DOI 10.1042/CS20000192; Hodgkinson CP, 2008, ARTERIOSCL THROM VAS, V28, P2275, DOI 10.1161/ATVBAHA.108.175992; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Hudson BI, 2018, ANNU REV MED, V69, P349, DOI 10.1146/annurev-med-041316-085215; Jafar N, 2016, AM J MED SCI, V351, P201, DOI 10.1016/j.amjms.2015.11.011; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Kanterman J, 2012, SEMIN CANCER BIOL, V22, P307, DOI 10.1016/j.semcancer.2012.02.008; Kim S, 2013, MOL MED, V19, P88, DOI 10.2119/molmed.2012.00306; Kovtun O, 2015, J CELL SCI, V128, P1269, DOI 10.1242/jcs.167866; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202; Miki Y, 2014, BIOL PHARM BULL, V37, P588, DOI 10.1248/bpb.b13-00818; Munch G, 1997, EUR J CLIN CHEM CLIN, V35, P669; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Niven J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132688; Qi XF, 2009, J CELL PHYSIOL, V220, P690, DOI 10.1002/jcp.21815; Schuetz P, 2011, DIABETES CARE, V34, P771, DOI 10.2337/dc10-1185; Senft AP, 2005, J IMMUNOL, V174, P4953, DOI 10.4049/jimmunol.174.8.4953; Snell LM, 2017, TRENDS IMMUNOL, V38, P542, DOI 10.1016/j.it.2017.05.005; Takahashi HK, 2009, J PHARMACOL EXP THER, V330, P89, DOI 10.1124/jpet.109.150581; Takeuchi M, 2010, CURR DRUG TARGETS, V11, P1468, DOI 10.2174/1389450111009011468; Tan YH, 2015, IMMUNITY, V43, P909, DOI 10.1016/j.immuni.2015.10.008; Tebo JM, 1998, BLOOD, V92, P4742, DOI 10.1182/blood.V92.12.4742.424k26_4742_4749; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Uhle F, 2017, INFLAMM RES, V66, P961, DOI 10.1007/s00011-017-1076-9; Vasselon T, 1999, J EXP MED, V190, P509, DOI 10.1084/jem.190.4.509; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; Watanabe M, 2020, BIOTECHNOL APPL BIOC, V67, P265, DOI 10.1002/bab.1843; Zanoni I, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00032; Zhang F, 2011, J SURG RES, V171, P871, DOI 10.1016/j.jss.2010.04.027; Zoppini G, 2018, NUTR METAB CARDIOVAS, V28, P444, DOI 10.1016/j.numecd.2017.12.007	55	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245957	10.1371/journal.pone.0245957	http://dx.doi.org/10.1371/journal.pone.0245957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493233	gold, Green Published			2022-12-26	WOS:000613081500059
J	Wu, CL; Wang, CX; Zhai, B; Zhao, YH; Zhao, Z; Yuan, ZY; Fu, XF; Zhang, MX				Wu, Cuiling; Wang, Chunxin; Zhai, Bo; Zhao, Yunhui; Zhao, Zhuo; Yuan, Zhiyu; Fu, Xuefeng; Zhang, Mingxin			Study on the region-specific expression of epididymis mRNA in the rams	PLOS ONE			English	Article							GENE-EXPRESSION; SPERM MATURATION; RAT; FAMILY; IDENTIFICATION; TRANSCRIPTOME; PROTEINS; INSIGHTS; MEMBER; CAPUT	The epididymis is divided into three regions including the caput, corpus and cauda. Gene expression profiles in different regions indicate the different functions of epididymis which are crucial for sperm maturation. In this study, three one-year-old rams was used as the experimental animal. Transcriptome sequencing technology was used to sequence mRNA in the caput, corpus and cauda of the epididymis. Based on the spatiotemporal-specific expression pattern in the epididymis, the mRNA expression profiles of the three parts of the epididymis were analysed. Region-specifically expressed genes were analysed by GO and KEGG analyses to screen the key genes involved in sheep sperm maturation. We obtained 129, 54 and 99 specifically expressed genes in the caput, corpus and cauda, respectively. And twenty specific expressed genes related to sperm maturation were used to construct functional networks. The heatmap showed that 6 genes of LCN protein family were highly expressed in the head of epididymis of sheep. We infer that sperm maturation is gradual in the epididymis and that there are significant differences in epididymal gene expression patterns between different species. This provides a data resource for analysing the regulatory mechanism of epididymis genes related to sperm maturation in rams.	[Wu, Cuiling] Xinjiang Agr Univ, Coll Anim Sci, Urumqi, Peoples R China; [Wu, Cuiling; Wang, Chunxin; Zhai, Bo; Zhao, Yunhui; Zhao, Zhuo; Yuan, Zhiyu; Zhang, Mingxin] Jilin Acad Agr Sci, Branch Anim Husb, Gongzhuling, Peoples R China; [Fu, Xuefeng] Xinjiang Acad Anim Sci, Inst Anim Sci, Key Lab Genet Breeding & Reprod Xinjiang Wool She, Urumqi, Peoples R China	Xinjiang Agricultural University; Jilin Academy of Agricultural Sciences	Zhang, MX (corresponding author), Jilin Acad Agr Sci, Branch Anim Husb, Gongzhuling, Peoples R China.; Fu, XF (corresponding author), Xinjiang Acad Anim Sci, Inst Anim Sci, Key Lab Genet Breeding & Reprod Xinjiang Wool She, Urumqi, Peoples R China.	fuxuefeng@xjaas.net; zmxin@163.com		Wu, Cuiling/0000-0001-5863-5744	Xinjiang Uygur Autonomous Region Science and Technology Department [2020D01A39]; Jilin Provincial Department of Science and Technology [20190301005NY]	Xinjiang Uygur Autonomous Region Science and Technology Department; Jilin Provincial Department of Science and Technology	This work was supported by the Xinjiang Uygur Autonomous Region Science and Technology Department awarded to Xuefeng Fu (Grant Number 2020D01A39) and Jilin Provincial Department of Science and Technology awarded to Chunxin Wang((Grant Number 20190301005NY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2007, ENCY MEASUREMENT STA, V3, P103; AMANN RP, 1993, REPROD FERT DEVELOP, V5, P361, DOI 10.1071/RD9930361; Battistone MA, 2020, MOL HUM REPROD, V26, P14, DOI 10.1093/molehr/gaz059; Belleannee C, 2012, CELL TISSUE RES, V349, P717, DOI 10.1007/s00441-012-1381-0; Bernath G, 2018, CRYOBIOLOGY, V81, P125, DOI 10.1016/j.cryobiol.2018.01.014; Castella S, 2004, BIOL REPROD, V70, P319, DOI 10.1095/biolreprod.103.022459; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Curry MR, 2000, REV REPROD, V5, P46, DOI 10.1530/ror.0.0050046; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Ded L, 2013, REPRODUCTION, V145, P255, DOI 10.1530/REP-12-0472; Devor EJ, 2004, HUM BIOL, V76, P921, DOI 10.1353/hub.2005.0016; Guyonnet B, 2011, J ANDROL, V32, P651, DOI 10.2164/jandrol.111.013086; Guyonnet B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-369; Hall SH, 2007, ASIAN J ANDROL, V9, P453, DOI 10.1111/j.1745-7262.2007.00298.x; Hermo L, 2019, ANDROLOGY-US, V7, P566, DOI 10.1111/andr.12641; Hornshoj H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001203; Inaba K, 2018, MICROSCOPY-JPN, V67, P144, DOI 10.1093/jmicro/dfy021; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jeong J, 2019, GENE EXPR PATTERNS, V31, P18, DOI 10.1016/j.gep.2018.12.001; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Johnston DS, 2007, ASIAN J ANDROL, V9, P522, DOI 10.1111/j.1745-7262.2007.00317.x; Krutskikh A, 2012, FASEB J, V26, P4198, DOI 10.1096/fj.12-205211; Liu FJ, 2012, MOL BIOL REP, V39, P10257, DOI 10.1007/s11033-012-1902-7; Liu J, 2008, BMC Res Notes, V1, P111, DOI 10.1186/1756-0500-1-111; Ma L, 2013, J BIOL CHEM, V288, P10154, DOI 10.1074/jbc.M112.445866; Marchitelli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073020; Narciandi F, 2011, IMMUNOGENETICS, V63, P641, DOI 10.1007/s00251-011-0551-7; Ozbek M, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13387; Park YJ, 2012, J PROTEOME RES, V11, P4162, DOI 10.1021/pr300248s; Peralta-Arias RD, 2015, REPRODUCTION, V149, P475, DOI 10.1530/REP-14-0471; Rahman MS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/841615; Suzuki K, 2007, ASIAN J ANDROL, V9, P515, DOI 10.1111/j.1745-7262.2007.00300.x; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; Thimon V, 2007, MOL HUM REPROD, V13, P691, DOI 10.1093/molehr/gam051; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Westmuckett AD, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116863; Zalazar L, 2020, THERIOGENOLOGY, V144, P45, DOI 10.1016/j.theriogenology.2019.12.019; Zhang ChunXiang, 2015, Acta Veterinaria et Zootechnica Sinica, V46, P1122; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116; Zhao WS, 2019, THERIOGENOLOGY, V139, P132, DOI 10.1016/j.theriogenology.2019.08.006; Zhu CF, 2007, BIOL REPROD, V76, P63, DOI 10.1095/biolreprod.106.054635	42	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245933	10.1371/journal.pone.0245933	http://dx.doi.org/10.1371/journal.pone.0245933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493206	Green Published, gold			2022-12-26	WOS:000613081500018
J	Du, ZZ; Deng, SR; Wu, ZX; Wang, C				Du, Zezhen; Deng, Suren; Wu, Zixuan; Wang, Chuang			Genome-wide analysis of haloacid dehalogenase genes reveals their function in phosphate starvation responses in rice	PLOS ONE			English	Article							PURPLE ACID-PHOSPHATASE; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; SUSPENSION CELLS; SN-2 PREFERENCE; HAD SUPERFAMILY; PROTEIN; PECP1; PHOSPHOCHOLINE	The HAD superfamily is named after the halogenated acid dehalogenase found in bacteria, which hydrolyses a diverse range of organic phosphate substrates. Although certain studies have shown the involvement of HAD genes in Pi starvation responses, systematic classification and bioinformatics analysis of the HAD superfamily in plants is lacking. In this study, 41 and 40 HAD genes were identified by genomic searching in rice and Arabidopsis, respectively. According to sequence similarity, these proteins are divided into three major groups and seven subgroups. Conserved motif analysis indicates that the majority of the identified HAD proteins contain phosphatase domains. A further structural analysis showed that HAD proteins have four conserved motifs and specified cap domains. Fewer HAD genes show collinearity relationships in both rice and Arabidopsis, which is consistent with the large variations in the HAD genes. Among the 41 HAD genes of rice, the promoters of 28 genes contain Pi-responsive cis-elements. Mining of transcriptome data and qRT-PCR results showed that at least the expression of 17 HAD genes was induced by Pi starvation in shoots or roots. These HAD proteins are predicted to be involved in intracellular or extracellular Po recycling under Pi stress conditions in plants.	[Du, Zezhen; Deng, Suren; Wu, Zixuan; Wang, Chuang] Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Peoples R China; [Du, Zezhen; Deng, Suren; Wu, Zixuan; Wang, Chuang] Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, MOA, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, C (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Peoples R China.; Wang, C (corresponding author), Huazhong Agr Univ, Key Lab Arable Land Conservat Middle & Lower Reac, MOA, Wuhan, Peoples R China.	chuang.wang@mail.hzau.edu.cn		Wang, Chuang/0000-0002-7663-7433	National Science Foundation of China [31772378, 32072663]; Fundamental Research Funds for the Central University of China [2662019PY013, 2662017PY012]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University of China	This work was supported by the National Science Foundation of China (31772378, 32072663) and the Fundamental Research Funds for the Central University of China (2662019PY013, 2662017PY012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Angkawijaya AE, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00662; Angkawijaya AE, 2017, BIOCHEM BIOPH RES CO, V494, P397, DOI 10.1016/j.bbrc.2017.09.094; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baldwin JC, 2008, PLANTA, V228, P273, DOI 10.1007/s00425-008-0736-y; Bozzo GG, 2006, PLANT CELL ENVIRON, V29, P303, DOI 10.1111/j.1365-3040.2005.01422.x; Bozzo GG, 2004, BIOCHEM J, V377, P419, DOI 10.1042/BJ20030947; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Cai ZD, 2018, THEOR APPL GENET, V131, P1715, DOI 10.1007/s00122-018-3109-3; Caparros-Martin JA, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8040077; Chen CJ, 2020, MOL PLANT, V13, P1194, DOI 10.1016/j.molp.2020.06.009; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Collet JF, 1999, J BIOL CHEM, V274, P33985, DOI 10.1074/jbc.274.48.33985; Deng SR, 2020, J EXP BOT, V71, P4321, DOI 10.1093/jxb/eraa179; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Hanchi M, 2018, PLANT PHYSIOL, V176, P2943, DOI 10.1104/pp.17.01246; Huang H, 2015, P NATL ACAD SCI USA, V112, pE1974, DOI 10.1073/pnas.1423570112; Puga MI, 2017, CURR OPIN PLANT BIOL, V39, P40, DOI 10.1016/j.pbi.2017.05.007; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuznetsova E, 2006, J BIOL CHEM, V281, P36149, DOI 10.1074/jbc.M605449200; Lahiri SD, 2004, BIOCHEMISTRY-US, V43, P2812, DOI 10.1021/bi0356810; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Liang CY, 2012, J INTEGR PLANT BIOL, V54, P400, DOI 10.1111/j.1744-7909.2012.01126.x; Liang CY, 2010, PLANT PHYSIOL, V152, P854, DOI 10.1104/pp.109.147918; Liu PD, 2018, PLANT CELL ENVIRON, V41, P2821, DOI 10.1111/pce.13412; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LH, 2016, PLANT CELL ENVIRON, V39, P2247, DOI 10.1111/pce.12794; May A, 2012, BBA-PROTEINS PROTEOM, V1824, P319, DOI 10.1016/j.bbapap.2011.10.003; Miller SS, 2001, PLANT PHYSIOL, V127, P594, DOI 10.1104/pp.010097; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; Pandey BK, 2017, PLANT PHYSIOL, V174, P2316, DOI 10.1104/pp.17.00571; Pratt J, 2009, PLANT PHYSIOL, V151, P1646, DOI 10.1104/pp.109.144626; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Seifried A, 2013, FEBS J, V280, P549, DOI 10.1111/j.1742-4658.2012.08633.x; Shen JB, 2011, PLANT PHYSIOL, V156, P997, DOI 10.1104/pp.111.175232; Sun LC, 2018, PLANT SCI, V277, P278, DOI 10.1016/j.plantsci.2018.09.016; Tannert M, 2018, J EXP BOT, V69, P467, DOI 10.1093/jxb/erx408; Tian JL, 2012, J INTEGR PLANT BIOL, V54, P631, DOI 10.1111/j.1744-7909.2012.01143.x; Tran HT, 2010, PLANT SCI, V179, P14, DOI 10.1016/j.plantsci.2010.04.005; Veljanovski V, 2006, PLANT PHYSIOL, V142, P1282, DOI 10.1104/pp.106.087171; Wang H, 2014, PLANT PHYSIOL, V164, P2020, DOI 10.1104/pp.113.235077; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wilkins MR, 1999, METH MOL B, V112, P531; Wu WW, 2018, J EXP BOT, V69, P603, DOI 10.1093/jxb/erx441; Yang WL, 2012, PLANT PHYSIOL, V160, P638, DOI 10.1104/pp.112.201996; Yang WL, 2010, P NATL ACAD SCI USA, V107, P12040, DOI 10.1073/pnas.0914149107; Zhang Q, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2010.00346.x	54	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245600	10.1371/journal.pone.0245600	http://dx.doi.org/10.1371/journal.pone.0245600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481906	Green Published, gold			2022-12-26	WOS:000612929300001
J	Ghaforinejad, H; Mazaheri, H; Joshaghani, AH; Marjani, A				Ghaforinejad, Hamed; Mazaheri, Hossein; Joshaghani, Ali Hassani; Marjani, Azam			Study on novel modified large mesoporous silica FDU-12/polymer matrix nanocomposites for adsorption of Pb(II)	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; FUNCTIONALIZED SBA-15; PERFORMANCE; REMOVAL; FDU-12; MICRO; ACID; NANOPARTICLES; FRUCTOSE; LIQUID	In this study, porous methacrylate-modified FDU-12/poly(methyl methacrylate) and amine-modified FDU-12/Nylon 6 nanocomposites were synthesized via a facile solution casting protocol. The physicochemical properties of the prepared materials were studied using various characterization techniques including Fourier transform-infrared spectroscopy, field emission-scanning electron microscopy, transmission electron microscopy, and nitrogen adsorption/desorption. After characterization of the materials, the prepared nanocomposites were applied as novel adsorbents for the removal of Pb(II) from aqueous media. In this regard, the effect of various parameters including solution pH, adsorbent amount, contact time, and initial concentration of Pb(II) on the adsorption process was investigated. To study the mechanism of adsorption, kinetic studies were conducted. The kinetic models of pseudo-first-order, pseudo-second-order, Elovich, and intraparticle diffusion were employed. The results revealed that the adsorption of Pb(II) onto methacrylate-modified FDU-12/poly(methyl methacrylate) and amine-modified FDU-12/Nylon 6 adsorbents followed the pseudo-second-order kinetic model. Also, different isotherms including Langmuir, Freundlich, and Dubinin-Radushkevich were applied to evaluate the equilibrium adsorption data. Langmuir isotherm provided the best fit with the equilibrium data of both adsorbents with maximum adsorption capacities of 99.0 and 94.3 mg g(-1) for methacrylate-modified FDU-12/poly(methyl methacrylate) and amine-modified FDU-12/Nylon 6, respectively, for the removal of Pb(II).	[Ghaforinejad, Hamed; Mazaheri, Hossein; Joshaghani, Ali Hassani] Islamic Azad Univ, Dept Chem Engn, Arak Branch, Arak, Iran; [Marjani, Azam] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam; [Marjani, Azam] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam	Islamic Azad University; Ton Duc Thang University; Ton Duc Thang University	Marjani, A (corresponding author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Marjani, A (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.	azam.marjani@tdtu.edu.vn	Mazaheri, Hossein/AAN-6827-2021; Marjani, Azam/H-2001-2018	Marjani, Azam/0000-0003-1536-1960				Abu-Danso E, 2020, J HAZARD MATER, V381, DOI 10.1016/j.jhazmat.2019.120871; Awad AM, 2020, J MOL LIQ, V301, DOI 10.1016/j.molliq.2019.112335; Babaei Z, 2019, SUSTAIN ENERG FUELS, V3, P1024, DOI 10.1039/c9se00015a; Babaei Z, 2018, J CLEAN PROD, V198, P381, DOI 10.1016/j.jclepro.2018.06.305; Badruddoza AM, 2013, CARBOHYD POLYM, V91, P322, DOI 10.1016/j.carbpol.2012.08.030; Bajpai VK, 2019, ACS APPL MATER INTER, V11, P43949, DOI 10.1021/acsami.9b16989; Beecroft LL, 1997, CHEM MATER, V9, P1302, DOI 10.1021/cm960441a; Carmona D, 2014, MATER RES BULL, V59, P311, DOI 10.1016/j.materresbull.2014.07.039; Chermahini AN, 2017, RES CHEM INTERMEDIAT, V43, P5507, DOI 10.1007/s11164-017-2943-2; Cui HZ, 2017, MICROPOR MESOPOR MAT, V241, P165, DOI 10.1016/j.micromeso.2016.12.036; Dastkhoon M, 2017, ULTRASON SONOCHEM, V36, P42, DOI 10.1016/j.ultsonch.2016.10.030; Deka JR, 2015, MICROPOR MESOPOR MAT, V213, P150, DOI 10.1016/j.micromeso.2015.04.015; Dinari M, 2016, RSC ADV, V6, P11419, DOI 10.1039/c5ra23500f; Fan J, 2005, J AM CHEM SOC, V127, P10794, DOI 10.1021/ja052619c; Fan J, 2003, ANGEW CHEM INT EDIT, V42, P3146, DOI 10.1002/anie.200351027; Hodgkins RP, 2005, MICROPOR MESOPOR MAT, V79, P241, DOI 10.1016/j.micromeso.2004.10.036; Hosseini SM, 2018, J PHYS CHEM C, V122, P27477, DOI 10.1021/acs.jpcc.8b08788; Huang LA, 2010, LANGMUIR, V26, P14871, DOI 10.1021/la102228u; Hubbell JA, 2012, SCIENCE, V337, P303, DOI 10.1126/science.1219657; Kao HM, 2006, MICROPOR MESOPOR MAT, V97, P9, DOI 10.1016/j.micromeso.2006.08.002; Kegl T, 2020, J HAZARD MATER, V386, DOI 10.1016/j.jhazmat.2019.121632; Lawrence G, 2014, SCI ADV MATER, V6, P1481, DOI 10.1166/sam.2014.1845; Liu Q, 2020, ACS SUSTAINABLE CHEM; Liu Y, 2011, J HAZARD MATER, V186, P197, DOI 10.1016/j.jhazmat.2010.10.105; Meng Q, 2018, RSC ADV, V8, P27565, DOI 10.1039/c8ra05032e; Mohammadnezhad G, 2017, ULTRASON SONOCHEM, V39, P765, DOI 10.1016/j.ultsonch.2017.06.001; Mohammadnezhad G, 2017, J APPL POLYM SCI, V134, DOI 10.1002/app.45383; Molla-Abbasi P, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/10/105012; Moller K, 1998, CHEM MATER, V10, P1841, DOI 10.1021/cm980020o; Morales-Luckie RA, 2013, INT J POLYM SCI, V2013, DOI 10.1155/2013/235850; Nyairo WN, 2018, SEP SCI TECHNOL, V53, P1498, DOI 10.1080/01496395.2018.1424203; Patel JP, 2017, INT J ADHES ADHES, V78, P256, DOI 10.1016/j.ijadhadh.2017.08.006; Patel JP, 2017, J POLYM SCI POL PHYS, V55, P206, DOI 10.1002/polb.24261; Patel JP, 2015, J POLYM SCI POL PHYS, V53, P1519, DOI 10.1002/polb.23789; Rezaei M, 2019, J ENVIRON CHEM ENG, V7, DOI 10.1016/j.jece.2018.102855; Saini D, 2020, ACS APPL BIOMATERIAL; Saraji M, 2017, ANAL CHIM ACTA, V973, P51, DOI 10.1016/j.aca.2017.04.029; Saraji M, 2016, ANAL METHODS-UK, V8, P830, DOI 10.1039/c5ay02036k; Sarvi MN, 2014, CHEM ENG J, V235, P244, DOI 10.1016/j.cej.2013.09.036; Shahvar A, 2018, J CHROMATOGR A, V1565, P48, DOI 10.1016/j.chroma.2018.06.033; Shahzeydi A, 2019, CHEM ENG J, V370, P1310, DOI 10.1016/j.cej.2019.03.227; Soltani R, 2020, DALTON T, V49, P5323, DOI 10.1039/d0dt00680g; Soltani R, 2020, J COLLOID INTERF SCI, V570, P390, DOI 10.1016/j.jcis.2020.03.003; Soltani R, 2020, CHEM ENG TECHNOL, V43, P392, DOI 10.1002/ceat.201900470; Soltani R, 2019, J MOL LIQ, V294, DOI 10.1016/j.molliq.2019.111617; Soltani R, 2019, NEW J CHEM, V43, P13058, DOI 10.1039/c9nj01915d; Soltani R, 2020, CHEMOSPHERE, V239, DOI 10.1016/j.chemosphere.2019.124735; Soltani R, 2018, ULTRASON SONOCHEM, V40, P395, DOI 10.1016/j.ultsonch.2017.07.031; Wei Q, 2005, MATER LETT, V59, P3611, DOI 10.1016/j.matlet.2005.06.034; Wu Q, 2018, FUEL PROCESS TECHNOL, V172, P55, DOI 10.1016/j.fuproc.2017.12.003; Yu T, 2006, J PHYS CHEM B, V110, P21467, DOI 10.1021/jp064534j; Zarei F, 2019, EUR POLYM J, V119, P400, DOI 10.1016/j.eurpolymj.2019.07.043; Zou B, 2013, IND ENG CHEM RES, V52, P2844, DOI 10.1021/ie303363p; Zulfiqar M, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12020430	54	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245583	10.1371/journal.pone.0245583	http://dx.doi.org/10.1371/journal.pone.0245583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481897	Green Published, gold			2022-12-26	WOS:000612929300162
J	Hedley, D; Uljarevic, M; Cai, RY; Bury, SM; Stokes, MA; Evans, DW				Hedley, Darren; Uljarevic, Mirko; Cai, Ru Ying; Bury, Simon M.; Stokes, Mark A.; Evans, David W.			Domains of the autism phenotype, cognitive control, and rumination as transdiagnostic predictors of DSM-5 suicide risk	PLOS ONE			English	Article							AMAZONS MECHANICAL TURK; SPECTRUM DISORDER; DEPRESSIVE-DISORDERS; CRITERIA RDOC; UNITED-STATES; IV DISORDERS; PREVALENCE; IDEATION; FRAMEWORK; DEFICITS	Suicide is a global health problem affecting both normative and clinical populations. Theoretical models that examine mechanisms underlying suicide risk across heterogeneous samples are needed. The present study explored core characteristics associated with autism spectrum disorder (ASD), a sub-population at high risk of suicide, as well as two dimensional cognitive constructs, as potential transdiagnostic predictors of suicidal ideation in a clinically diverse sample. Participants (n = 1851, 62% female) aged 18 to 89 years completed online questionnaires assessing: social communication difficulties; insistence on sameness; cognitive control; and rumination. Forty-three percent of participants reported the presence of at least one neurodevelopmental or neuropsychiatric disorder. One third of the sample reported some suicidal ideation (SI), and 40 percent met the threshold for concern for depression. All hypothesized constructs were associated with SI and depression and, with the exception of rumination, contributed significantly to SI. Participants reporting SI returned significantly higher social communication difficulties and insistence on sameness, and lower levels of cognitive control than those reporting no-SI. The study was limited by the use of a cross-sectional sample assessed with self-report measures. All diagnoses were self-reported and the study was additionally limited by the use of a single item indicator of suicidal ideation. These findings support a role for constructs associated with the ASD phenotype and associated broad cognitive domains as potential risk factors underlying suicidal ideation in a large clinically diverse sample. Our findings suggest directions for future longitudinal research studies, along with specific targets for suicide prevention and clinical practice.	[Hedley, Darren; Bury, Simon M.] La Trobe Univ, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia; [Uljarevic, Mirko] Univ Melbourne, Melbourne, Vic, Australia; [Uljarevic, Mirko] Stanford Univ, Stanford Autism Ctr, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Cai, Ru Ying] Aspect Res Ctr Autism Practice, Melbourne, Vic, Australia; [Stokes, Mark A.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Evans, David W.] Bucknell Univ, Lewisburg, PA 17837 USA	La Trobe University; University of Melbourne; Stanford University; Deakin University; Bucknell University	Hedley, D (corresponding author), La Trobe Univ, Olga Tennison Autism Res Ctr, Melbourne, Vic, Australia.	D.Hedley@latrobe.edu.au	; Hedley, Darren/H-6667-2016	Bury, Simon/0000-0003-1273-9091; Hedley, Darren/0000-0002-6256-7104	Bucknell University; Suicide Prevention Australia National Suicide Prevention Research fellowship; Australian Research Council	Bucknell University; Suicide Prevention Australia National Suicide Prevention Research fellowship; Australian Research Council(Australian Research Council)	Research reported in this study was supported by Bucknell University Scholarly Development Grant awarded to DWE, a Suicide Prevention Australia National Suicide Prevention Research fellowship awarded to DH, and a Discovery Early Career Researcher Award from the Australian Research Council awarded to MU. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit the report for publication. The content is solely the responsibility of the authors and has not been approved or endorsed by Suicide Prevention Australia, Bucknell University, or the Australian Research Council. The funder provided support in the form of salaries for authors DH and MU and research materials for DWE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abu-Akel A, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0275-3; Allison C, 2012, J AM ACAD CHILD PSY, V51, P202, DOI 10.1016/j.jaac.2011.11.003; American Psychiatric Association, DIAGN STAT MAN MENT, DOI DOI 10.1111/J.1467-7687.2012.01178.X; American Psychiatric Association, 2013, DSM 5 SELF RAT LEV 1; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Berle D, 2011, CLIN PSYCHOL PSYCHOT, V18, P339, DOI 10.1002/cpp.724; Bos DJ, 2019, J ABNORM PSYCHOL, V128, P431, DOI 10.1037/abn0000423; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Buhrmester MD, 2018, PERSPECT PSYCHOL SCI, V13, P149, DOI 10.1177/1745691617706516; Cassidy SA, 2020, J AUTISM DEV DISORD, V50, P3638, DOI 10.1007/s10803-019-04323-3; Cassidy S, 2018, MOL AUTISM, V9, DOI 10.1186/s13229-018-0226-4; Cassidy S, 2014, LANCET PSYCHIAT, V1, P142, DOI 10.1016/S2215-0366(14)70248-2; Clarke DE, 2014, WORLD PSYCHIATRY, V13, P314, DOI 10.1002/wps.20154; Cohen J., 2013, APPL MULTIPLE REGRES; Colvert E, 2015, JAMA PSYCHIAT, V72, P415, DOI 10.1001/jamapsychiatry.2014.3028; Constantino JN, 2003, ARCH GEN PSYCHIAT, V60, P524, DOI 10.1001/archpsyc.60.5.524; Crandall A, 2018, J ADOLESCENCE, V65, P167, DOI 10.1016/j.adolescence.2018.03.009; Cuthbert BN, 2014, WORLD PSYCHIATRY, V13, P28, DOI 10.1002/wps.20087; De Crescenzo F, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00078; Demurie E, 2012, DEVELOPMENTAL SCI, V15, P791, DOI 10.1111/j.1467-7687.2012.01178.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Eisner, 2010, TRANSDIAGNOSTIC MODE; Evans DE, 2007, J RES PERS, V41, P868, DOI 10.1016/j.jrp.2006.11.002; Evans DW, 2018, J CHILD PSYCHOL PSYC, V59, P574, DOI 10.1111/jcpp.12827; Evans DW, 2017, J AM ACAD CHILD PSY, V56, P51, DOI 10.1016/j.jaac.2016.10.014; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Fazakas-DeHoog LL, 2017, EUR J PSYCHOL, V13, P178, DOI 10.5964/ejop.v13i2.1238; Gallyer AJ, 2020, J AFFECT DISORDERS, V271, P59, DOI 10.1016/j.jad.2020.03.092; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P836, DOI 10.1111/j.1469-7610.2004.00276.x; Glenn CR, 2018, DEPRESS ANXIETY, V35, P65, DOI 10.1002/da.22686; Glenn CR, 2017, CLIN PSYCHOL SCI, V5, P568, DOI 10.1177/2167702616686854; Hand BN, 2020, J AUTISM DEV DISORD, V50, P3489, DOI 10.1007/s10803-019-04345-x; Hedley D., 2018, CURR DEV DISORD REP, V5, P65, DOI [DOI 10.1007/s40474-018-0133-6, DOI 10.1007/S40474-018-0133-6]; Hedley D, 2018, DEPRESS ANXIETY, V35, P648, DOI 10.1002/da.22759; Hirvikoski T, 2016, BRIT J PSYCHIAT, V208, P232, DOI 10.1192/bjp.bp.114.160192; Hjelmeland H, 2017, DEATH STUD, V41, P481, DOI 10.1080/07481187.2017.1332905; Hom MA, 2016, PSYCHOL ASSESSMENT, V28, P1026, DOI 10.1037/pas0000241; Hudson CC, 2019, J ABNORM CHILD PSYCH, V47, P165, DOI 10.1007/s10802-018-0402-1; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Joiner TE, 2005, ANNU REV PSYCHOL, V56, P287, DOI 10.1146/annurev.psych.56.091103.070320; Karalunas SL, 2018, J ABNORM CHILD PSYCH, V46, P1705, DOI 10.1007/s10802-017-0394-2; Keenan EG, 2018, AUTISM, V22, P814, DOI 10.1177/1362361317709603; Kessler RC, 2005, JAMA-J AM MED ASSOC, V293, P2487, DOI 10.1001/jama.293.20.2487; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knight MJ, 2019, DEPRESS ANXIETY, V36, P54, DOI 10.1002/da.22844; LeMoult J, 2009, J ABNORM PSYCHOL, V118, P828, DOI 10.1037/a0016944; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; Litinsky AM, 1998, J PERS ASSESS, V71, P368, DOI 10.1207/s15327752jpa7103_6; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; McCoy TH, 2019, DEPRESS ANXIETY, V36, P392, DOI 10.1002/da.22882; Millner AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141606; Miranda R, 2007, BEHAV RES THER, V45, P3088, DOI 10.1016/j.brat.2007.07.015; Narrow WE, 2013, AM J PSYCHIAT, V170, P71, DOI 10.1176/appi.ajp.2012.12071000; Narrow WE, 2011, J MENT HEALTH POLICY, V14, P197; National Institute of Mental Health, 2008, MECH UND SUIC RISK I; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Nolen-Hoeksema S, 2000, J ABNORM PSYCHOL, V109, P504, DOI 10.1037/0021-843X.109.3.504; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; O'Connor RC, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02139; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Palan S, 2018, J BEHAV EXP FINANC, V17, P22, DOI 10.1016/j.jbef.2017.12.004; Pelton MK, 2017, AUTISM RES, V10, P1891, DOI 10.1002/aur.1828; Pelton MK, 2020, AUTISM ADULTHOOD, V2, P193, DOI 10.1089/aut.2019.0055; Phillips JM, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0298-9; PU SH, 2017, SCI REP UK, V7; Rai D, 2018, JAMA PSYCHIAT, V75, P835, DOI 10.1001/jamapsychiatry.2018.1323; Robinson EB, 2016, NAT GENET, V48, P552, DOI 10.1038/ng.3529; Rodriguez-Seijas C, 2020, AUTISM RES, V13, P579, DOI 10.1002/aur.2228; Rosbrook A, 2010, RES AUTISM SPECT DIS, V4, P415, DOI 10.1016/j.rasd.2009.10.012; Russo-Ponsaran NM, 2019, AUTISM RES, V12, P1260, DOI 10.1002/aur.2123; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Smith JM, 2006, SUICIDE LIFE-THREAT, V36, P443, DOI 10.1521/suli.2006.36.4.443; Stanley IH, 2021, PSYCHOL SERV, V18, P377, DOI 10.1037/ser0000418; Stergiakouli E, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0131-2; Stewart JG, 2017, J CLIN PSYCHIAT, V78, pE614, DOI 10.4088/JCP.16m10647; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; United States Census Bureau, 2019, STAT COUNT QUICKFACT; Unruh KE, 2020, J AUTISM DEV DISORD, V50, P2336, DOI 10.1007/s10803-018-3627-5; Upthegrove R, 2018, SCHIZOPHR RES, V195, P80, DOI 10.1016/j.schres.2017.08.028; Weiner L, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2122-7; World Health Organization, 2014, PREV SUIC GLOB IMP, V2020; Zahid S, 2017, CRISIS, V38, P237, DOI 10.1027/0227-5910/a000458	85	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245562	10.1371/journal.pone.0245562	http://dx.doi.org/10.1371/journal.pone.0245562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33482664	Green Published, gold			2022-12-26	WOS:000612929300094
J	Henzi, A; Aguzzi, A				Henzi, Anna; Aguzzi, Adriano			The prion protein is not required for peripheral nerve de- and remyelination after crush injury	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; SCHWANN-CELLS; COUPLED RECEPTOR; MYELINATION; MICE; GFAP; REGENERATION; INSIGHTS; REVEALS; GPR126	The cellular prion protein (PrP) is essential to the long-term maintenance of myelin sheaths in peripheral nerves. PrP activates the adhesion G-protein coupled receptor Adgrg6 on Schwann cells and initiates a pro-myelination cascade of molecular signals. Because Adgrg6 is crucial for peripheral myelin development and regeneration after nerve injury, we investigated the role of PrP in peripheral nerve repair. We performed experimental sciatic nerve crush injuries in co-isogenic wild-type and PrP-deficient mice, and examined peripheral nerve repair processes. Generation of repair Schwann cells, macrophage recruitment and remyelination were similar in PrP-deficient and wild-type mice. We conclude that PrP is dispensable for sciatic nerve de- and remyelination after crush injury. Adgrg6 may sustain its function in peripheral nerve repair independently of its activation by PrP.	[Henzi, Anna; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, Zurich, Switzerland	University of Zurich	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708; Henzi, Anna/0000-0002-5712-7059	Swiss National Research Foundation Sinergia grant [CRSII5183563]	Swiss National Research Foundation Sinergia grant	AA is the recipient of a Swiss National Research Foundation Sinergia grant (CRSII5183563). http://www.snf.ch/en/funding/programmes/sinergia/Pages/default.aspx.The funders did not play any role in study design, data collection, analysis, preparation of the manuscript or decision to publish.	Aguzzi A, 2020, SCIENCE, V370, P32, DOI 10.1126/science.abb8577; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079395; Bosse F, 2006, J NEUROCHEM, V96, P1441, DOI 10.1111/j.1471-4159.2005.03635.x; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Chinthaparthi S, 2018, NEUROLOGY, V90; Gerber D, 2019, ELIFE, V8, DOI 10.7554/eLife.42404; Gokbuget D, 2018, GLIA, V66, P2632, DOI 10.1002/glia.23516; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Henzi A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242137; Jablonka-Shariff A, 2020, GLIA, V68, P1182, DOI 10.1002/glia.23769; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 2008, GLIA, V56, P1552, DOI 10.1002/glia.20761; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lutz AB, 2014, DEV CELL, V28, P7, DOI 10.1016/j.devcel.2013.12.002; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Mogha A, 2016, J NEUROSCI, V36, P12351, DOI 10.1523/JNEUROSCI.3854-15.2016; Monk KR, 2015, GLIA, V63, P1376, DOI 10.1002/glia.22852; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Nocera G, 2020, CELL MOL LIFE SCI, V77, P3977, DOI 10.1007/s00018-020-03516-9; Norrmen C, 2018, J NEUROSCI, V38, P4811, DOI 10.1523/JNEUROSCI.3619-17.2018; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Pereira JA, 2020, HUM MOL GENET, V29, P1253, DOI 10.1093/hmg/ddaa034; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raphael AR, 2011, CURR TOP DEV BIOL, V97, P1, DOI 10.1016/B978-0-12-385975-4.00007-3; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Taskinen HS, 1997, ACTA NEUROPATHOL, V93, P252, DOI 10.1007/s004010050611; Toma JS, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0066-20.2020; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Zhang SJ, 2017, NEURAL REGEN RES, V12, P1538, DOI 10.4103/1673-5374.215266	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245944	10.1371/journal.pone.0245944	http://dx.doi.org/10.1371/journal.pone.0245944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481951	Green Published, gold, Green Submitted			2022-12-26	WOS:000612929300031
J	Rodriguez-Rigueiro, FJ; Santiago-Freijanes, JJ; Mosquera-Losada, MR; Castro, M; Silva-Losada, P; Pisanelli, A; Pantera, A; Rigueiro-Rodriguez, A; Ferreiro-Dominguez, N				Javier Rodriguez-Rigueiro, Francisco; Javier Santiago-Freijanes, Jose; Rosa Mosquera-Losada, Maria; Castro, Marina; Silva-Losada, Pablo; Pisanelli, Andrea; Pantera, Anastasia; Rigueiro-Rodriguez, Antonio; Ferreiro-Dominguez, Nuria			Silvopasture policy promotion in European Mediterranean areas	PLOS ONE			English	Article							AGROFORESTRY SYSTEMS; LAND-USE; MANAGEMENT; VEGETATION; FORESTS; CLIMATE	Silvopasture is the deliberate integration of a woody component with grazed pastures as understorey. It is one of the most extended agroforestry practices all over the world. Silvopasture use is key to increase the sustainability of livestock farming systems as silvopasture reduces the use of concentrates since the woody component provides feed for animals. However, it is not an extensively used practice in Europe. This paper aims at evaluating, from Eurostat, LUCAS database and the 118 rural development programs, the current situation of permanent grasslands in the Mediterranean area of Europe as well as the rural development programmes fostering silvopasture to better understand how sustainable land use systems are promoted and provide insights to foster silvopasture across Europe. The results of this study show that most of the policy measures related to silvopasture are adapted to the local necessity. The already existing agroforestry managed land (dehesas/montado) are related to measures supporting regeneration and maintenance while in those areas where agroforestry does not exist the measures are related to forest fire prevention.	[Javier Rodriguez-Rigueiro, Francisco; Javier Santiago-Freijanes, Jose; Rosa Mosquera-Losada, Maria; Silva-Losada, Pablo; Rigueiro-Rodriguez, Antonio; Ferreiro-Dominguez, Nuria] Univ Santiago de Compostela, High Polytech Sch, Dept Crop Prod & Engn Projects, Lugo, Spain; [Castro, Marina] Polytech Inst Braganca, Mt Res Ctr CIMO, Braganca, Portugal; [Pisanelli, Andrea] CNR, Res Inst Terr Ecosyst, Porano, Italy; [Pantera, Anastasia] Agr Univ Athens, Dept Forestry & Nat Environm Management, Karpenissi, Greece	Universidade de Santiago de Compostela; Instituto Politecnico de Braganca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sugli Ecosistemi Terrestri (IRET)	Mosquera-Losada, MR (corresponding author), Univ Santiago de Compostela, High Polytech Sch, Dept Crop Prod & Engn Projects, Lugo, Spain.	mrosa.mosquera.losada@usc.es	Castro, Marina/AAF-4180-2021; Rodríguez-Rigueiro, Francisco Javier/GVT-2697-2022; FERREIRO, NURIA/S-5363-2019; Mosquera-Losada, Maria Rosa/K-8357-2014	Castro, Marina/0000-0002-6368-8098; FERREIRO, NURIA/0000-0001-9459-1128; Mosquera-Losada, Maria Rosa/0000-0003-4254-2329; Rodriguez-Rigueiro, Francisco Javier/0000-0002-6354-3235	European Commission [727872]; European Union [862674]; Interreg Sudoe Programme [SOE2/P5/E0804]; Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional [213]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union(European Commission); Interreg Sudoe Programme; Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional	MRML was supported by the European Commission through the AFINET (grant agreement no 727872) and the Go-Grass projects (grant agreement no 862674) from the European Union's H2020 Research and Innovation Programme (https://ec.europa.eu/programmes/horizon2020/en) and the Open2preserve project (SOE2/P5/E0804) from the Interreg Sudoe Programme (https://interreg-sudoe.eu/gbr/home).ARR was supported by the Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional (https://www.edu.xunta.gal/portal/es) through the Consolidation funds 2019-2022. NFD was also supported by the Xunta de Galicia, Conselleria de Educacion, Universidade e Formacion Profesional (https://www.edu.xunta.gal/portal/es) (Programa de axudas a etapa posdoutoral modalide B DOG no 213, 08/11/2019 p.48018, exp: ED481D 2019/009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFINET, 2018, D22 AFINET EUR COMM; Alexandrian D E, 2010, UNASYLVA, V197, P35; Baudena M, 2020, NEW PHYTOL, V225, P1500, DOI 10.1111/nph.16252; Bengtsson J, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2582; CHAVES MM, 2002, ANN BOT-LONDON, V89, P907, DOI DOI 10.1093/A0B/MCF105; Cullotta S, 2011, LANDSCAPE URBAN PLAN, V100, P98, DOI 10.1016/j.landurbplan.2010.11.012; da Silva LP, 2019, EUR J FOREST RES, V138, P461, DOI 10.1007/s10342-019-01183-5; den Herder M, 2017, AGR ECOSYST ENVIRON, V241, P121, DOI 10.1016/j.agee.2017.03.005; Zuazo VHD, 2014, J AGR SCI TECH-IRAN, V16, P667; EC (European Commission), 2019, RUR DEV PROGR COUNTR; EIP-Agri, 2017, MIX FARM SYST LIV CA; EU (European Union), 2019, KEY POL OBJ FUT CAP; European Environment Agency (EEA), 2017, BIOG REG EUR; EUROSTAT, 2013, C1 EUROSTAT LUCAS; EUROSTAT, 2019, LUCAS LAND US LAND C; EUROSTAT, 2016, YOUR KEY EUR STAT; Fernandez-Habas J, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.109308; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Gassner S, 2020, VEG HIST ARCHAEOBOT, V29, P75, DOI 10.1007/s00334-019-00734-5; Gea-Izquierdo G, 2019, SCI TOTAL ENVIRON, V685, P963, DOI 10.1016/j.scitotenv.2019.05.378; Hellicar MA, 2019, BIRD STUDY, V66, P317, DOI 10.1080/00063657.2019.1684875; Howlett DS, 2011, J ENVIRON MONITOR, V13, P1897, DOI 10.1039/c1em10059a; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Moral FJ, 2014, ECOL INDIC, V46, P253, DOI 10.1016/j.ecolind.2014.06.040; Moreno G, 2018, AGROFOREST SYST, V92, P877, DOI 10.1007/s10457-017-0126-1; Mosquera-Losada MR, 2018, LAND USE POLICY, V78, P603, DOI 10.1016/j.landusepol.2018.06.052; Mosquera-Losada MR, 2019, AGROFORESTRY SUSTAIN; Papachristou T. G., 2000, Cahiers Options Mediterraneennes, V52, P161; PAPANASTASIS V, 1995, FOREST ECOL MANAG, V77, P181, DOI 10.1016/0378-1127(95)03545-L; Pardini A., 2010, REV SOC ESPANOLA EST, V40, P211; Perevolotsky A, 2011, ISR J ECOL EVOL, V57, P111, DOI 10.1560/IJEE.57.1-2.111; Plana E, 2016, 5 MYTHS REALITIES LE; Puddu G, 2012, AGROFOREST SYST, V85, P319, DOI 10.1007/s10457-011-9443-y; Pulla P., 2013, MAPPING DISTRIBUTION; Rolo V, 2012, NUTR CYCL AGROECOSYS, V93, P89, DOI 10.1007/s10705-012-9502-4; Ruhl J, 2011, PLANT BIOSYST, V145, P120, DOI 10.1080/11263504.2010.540383; Santiago-Freijanes JJ, 2018, LAND USE POLICY, V76, P144, DOI 10.1016/j.landusepol.2018.03.014; Vayreda J, 2013, J BIOGEOGR, V40, P1252, DOI 10.1111/jbi.12105; Vella MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226358	39	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245846	10.1371/journal.pone.0245846	http://dx.doi.org/10.1371/journal.pone.0245846			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481940	Green Published, gold			2022-12-26	WOS:000612929300005
J	Martins, VF; Dobson, CR; Begur, M; Parekh, J; Ball, ST; Gonzalez, F; Hughes-Austin, JM; Schenk, S				Martins, Vitor F.; Dobson, Christopher R.; Begur, Maedha; Parekh, Jesal; Ball, Scott T.; Gonzalez, Francis; Hughes-Austin, Jan M.; Schenk, Simon			Surgical site peptidylarginine deaminase 4 (PAD4), a biomarker of NETosis, correlates with insulin resistance in total joint arthroplasty patients: A preliminary report	PLOS ONE			English	Article							CELL-FREE DNA; NEUTROPHIL EXTRACELLULAR TRAPS; TOTAL KNEE ARTHROPLASTY; WOUND CLOSURE; RISK-FACTORS; TOTAL HIP; OBESITY; PREVALENCE; ELASTASE; MUSCLE	While obesity and insulin resistance are known risk factors for wound complications after total joint arthroplasty (TJA), the biologic causes remain to be elucidated. Recently, neutrophil extracellular trap formation (NETosis) was identified as a mediator of delayed wound healing in insulin resistant states. Herein, we explored the relationship between obesity, insulin resistance and biomarkers of NET formation in TJA subjects. We enrolled 14 obese (body mass index [BMI]>= 30 kg/m(2)), and 15 lean (BMI<30 kg/m(2)) subjects undergoing primary knee or hip TJA. On the day of surgery, skeletal muscle proximal to the operated joint and plasma were collected. Protein abundance of NETosis biomarkers, peptidylarginine deaminase 4 (PAD4) and neutrophil elastase (NE) were assessed in skeletal muscle by immunoblotting and metabolic parameters (glucose, insulin, triglycerides, free fatty acids) and cell-free double-stranded DNA (cf-dsDNA) were assessed in plasma and were correlated with obesity and insulin resistance (as measured by the homeostatic model assessment for insulin resistance). When comparing lean and obese subjects, there were no significant differences in plasma cf-dsDNA or skeletal muscle NE or PAD4 abundance. In contrast, skeletal muscle PAD4 abundance, but not NE or plasma cf-dsDNA, was positively correlated with insulin resistance. Compared to insulin sensitive subjects, insulin resistant TJA subjects have higher expression of PAD4 at the surgical site and therefore may have higher rates of NET formation, which may lead to delayed surgical site wound healing.	[Martins, Vitor F.; Dobson, Christopher R.; Begur, Maedha; Parekh, Jesal; Ball, Scott T.; Gonzalez, Francis; Hughes-Austin, Jan M.; Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Martins, Vitor F.; Schenk, Simon] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Schenk, S (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, La Jolla, CA 92093 USA.; Schenk, S (corresponding author), Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA.	sschenk@ucsd.edu		Schenk, Simon/0000-0002-8224-3203	U.S. National Institutes of Health [T32 AR060712, F30 DK115035]; UC San Diego Institute of Engineering in Medicine; Office of Graduate Studies; Orthopaedic Research and Education Foundation; Medical Student Training in Aging Research Grant	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC San Diego Institute of Engineering in Medicine; Office of Graduate Studies; Orthopaedic Research and Education Foundation; Medical Student Training in Aging Research Grant	This work was supported, in part, by U.S. National Institutes of Health grants, T32 AR060712 and F30 DK115035 to V.F.M. (https://www.nih.gov), Graduate Student Research Support from the UC San Diego Institute of Engineering in Medicine and the Office of Graduate Studies (https://iem.ucsd.edu) to V.F.M, a Resident Research Grant from the Orthopaedic Research and Education Foundation (https://www.oref.org) to C.R.D., and a Medical Student Training in Aging Research Grant (https://www.afar.org/grants/mstar) to M.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelal IT, 2016, EGYPT RHEUMATOL, V38, P295, DOI 10.1016/j.ejr.2016.06.005; [Anonymous], 2021, LANG ENV STAT COMP; Breitbach S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087838; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bronkhorst AJ, 2015, CLIN CHIM ACTA, V450, P243, DOI 10.1016/j.cca.2015.08.028; Delgado-Rizo V, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00081; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Edwards JV, 2007, J BIOMED MATER RES A, V83A, P446, DOI 10.1002/jbm.a.31171; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gayoso-Diz P, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-47; GOODSON WH, 1986, DIABETES, V35, P491, DOI 10.2337/diab.35.4.491; GRINNELL F, 1994, J INVEST DERMATOL, V103, P155, DOI 10.1111/1523-1747.ep12392625; Hemmers S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022043; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Inacio MCS, 2014, J ARTHROPLASTY, V29, P458, DOI 10.1016/j.arth.2013.07.030; Jones JE, 2009, CURR OPIN DRUG DISC, V12, P616; Kerkhoffs GMMJ, 2012, J BONE JOINT SURG AM, V94A, P1839, DOI 10.2106/JBJS.K.00820; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lima MHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036974; Markuson M, 2009, ADV SKIN WOUND CARE, V22, P365, DOI 10.1097/01.ASW.0000358639.45784.cd; Martinod K, 2016, J THROMB HAEMOST, V14, P551, DOI 10.1111/jth.13239; Martins VF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00789; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2004, METABOLISM, V53, P495, DOI 10.1016/j.metabol.2003.10.032; Menegazzo L, 2015, ACTA DIABETOL, V52, P497, DOI 10.1007/s00592-014-0676-x; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Moorthy AN, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00289; Namba RS, 2005, J ARTHROPLASTY, V20, P46, DOI 10.1016/j.arth.2005.04.023; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pierpont Yvonne N, 2014, ISRN Obes, V2014, P638936, DOI 10.1155/2014/638936; Sankhla M, 2012, CLIN LAB, V58, P385; Shibata S, 2012, J IMMUNOL, V189, P3231, DOI 10.4049/jimmunol.1101739; Shin EH, 2014, WOUND REPAIR REGEN, V22, P18, DOI 10.1111/wrr.12163; Steiner C, 2012, US AGENCY HEALTHC RE, V110; Szpechcinski A, 2015, BRIT J CANCER, V113, P476, DOI 10.1038/bjc.2015.225; Tidball JG, 2014, DEVELOPMENT, V141, P1184, DOI 10.1242/dev.098285; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Wagner IJ, 2012, WOUND REPAIR REGEN, V20, P512, DOI 10.1111/j.1524-475X.2012.00803.x; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wertheimer E, 2001, ENDOCRINOLOGY, V142, P1234, DOI 10.1210/en.142.3.1234; Wong SL, 2015, NAT MED, V21, P815, DOI 10.1038/nm.3887; Yager Dorne R., 1997, Wound Repair and Regeneration, V5, P23, DOI 10.1046/j.1524-475X.1997.50108.x	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245594	10.1371/journal.pone.0245594	http://dx.doi.org/10.1371/journal.pone.0245594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481860	gold, Green Published			2022-12-26	WOS:000612929300172
J	Moore, GE; Burdick, DM; Routhier, MR; Novak, AB; Payne, AR				Moore, G. E.; Burdick, D. M.; Routhier, M. R.; Novak, A. B.; Payne, A. R.			Effects of a large-scale, natural sediment deposition event on plant cover in a Massachusetts salt marsh	PLOS ONE			English	Article							SEA-LEVEL RISE; TIDAL MARSH; ELEVATION; ACCRETION; RESPONSES; ACCUMULATION; RESILIENCE; MORPHOLOGY; CORDGRASS; SURFACE	In mid-winter 2018, an unprecedented sediment deposition event occurred throughout portions of the Great Marsh in Massachusetts. Evaluation of this event in distinct marsh areas spanning three towns (Essex, Ipswich, and Newbury) revealed deposition covering 29.2 hectares with an average thickness of 30.1 +/- 2.1 mm measured shortly after deposition. While sediment deposition helps marshes survive sea level rise by building elevation, effects of such a large-scale deposition on New England marshes are unknown. This natural event provided an opportunity to study effects of large-scale sediment addition on plant cover and soil chemistry, with implications for marsh resilience. Sediment thickness did not differ significantly between winter and summer, indicating sediment is not eroding or compacting. The deposited sediment at each site had similar characteristics to that of the adjacent mudflat (e.g., texture, bivalve shells), suggesting that deposited materials resulted from ice rafting from adjacent flats, a natural phenomenon noted by other authors. Vegetative cover was significantly lower in plots with rafted sediment (75.6 +/- 2.3%) than sediment-free controls (93.1 +/- 1.6%) after one growing season. When sorted by sediment thickness categories, the low thickness level (1-19 mm) had significantly greater percent cover than medium (20-39 mm) and high (40-90 mm) categories. Given that sediment accretion in the Great Marsh was found to average 2.7 mm per year, the sediment thickness documented herein represents similar to 11 years of sediment accretion with only a 25% reduction in plant cover, suggesting this natural sediment event will likely increase long-term marsh resilience to sea level rise.	[Moore, G. E.; Burdick, D. M.; Payne, A. R.] Univ New Hampshire, Sch Marine Sci & Ocean Engn, Jackson Estuarine Lab, Durham, NH 03824 USA; [Routhier, M. R.] Univ New Hampshire, Inst Study Earth Oceans & Space, Geospatial Sci Ctr, Ctr Earth Syst Res Ctr, Durham, NH 03824 USA; [Novak, A. B.] Boston Univ, Earth & Environm Dept, Boston, MA 02215 USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Boston University	Moore, GE (corresponding author), Univ New Hampshire, Sch Marine Sci & Ocean Engn, Jackson Estuarine Lab, Durham, NH 03824 USA.	gregg.moore@unh.edu		Moore, Gregg/0000-0001-7424-0275	Massachusetts Municipal Vulnerability Preparedness Grant Program (MVP) through the Executive Office of Energy and Environmental Affairs [CT ENV 0628180000000000 3603]; US Fish and Wildlife Service [F15AC01066]	Massachusetts Municipal Vulnerability Preparedness Grant Program (MVP) through the Executive Office of Energy and Environmental Affairs; US Fish and Wildlife Service(US Fish & Wildlife Service)	As stated in the Acknowledgements, GEM received funding from the Massachusetts Municipal Vulnerability Preparedness Grant Program (MVP) through the Executive Office of Energy and Environmental Affairs (CT ENV 0628180000000000 3603). GEM and DMB also received support through the US Fish and Wildlife Service (Cooperative Agreement #F15AC01066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argow BA, 2011, CONT SHELF RES, V31, P1294, DOI 10.1016/j.csr.2011.05.004; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Baustian JJ, 2015, WETLANDS, V35, P795, DOI 10.1007/s13157-015-0670-2; Boldt KV, 2010, MAR GEOL, V275, P127, DOI 10.1016/j.margeo.2010.05.002; BRICKERURSO S, 1989, ESTUARIES, V12, P300, DOI 10.2307/1351908; Burdick DM, 2012, TIDAL MARSH RESTORAT, P371; Cahoon DR, 2019, ESTUAR COAST, V42, P1, DOI 10.1007/s12237-018-0448-x; Cahoon DR, 2015, ESTUAR COAST, V38, P1077, DOI 10.1007/s12237-014-9872-8; Cornu CE, 2002, RESTOR ECOL, V10, P474, DOI 10.1046/j.1526-100X.2002.01035.x; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Croft AL, 2006, ESTUARIES COASTS, V29, P737, DOI 10.1007/BF02786525; DELAUNE RD, 1990, J COASTAL RES, V6, P181; DIONNE JC, 1989, J COASTAL RES, V5, P281; Donnelly JP, 2001, P NATL ACAD SCI USA, V98, P14218, DOI 10.1073/pnas.251209298; Ford MA, 1999, ECOL ENG, V12, P189, DOI 10.1016/S0925-8574(98)00061-5; Knief U, 2018, VIOLATING NORMALITY; Mckee KL, 2009, WETLANDS, V29, P2, DOI 10.1672/08-32.1; MEGONIGAL JP, 1993, SOIL SCI SOC AM J, V57, P140, DOI 10.2136/sssaj1993.03615995005700010027x; Mendelssohn IA, 2003, ECOL ENG, V21, P115, DOI 10.1016/j.ecoleng.2003.09.006; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; Nyman JA, 2006, ESTUAR COAST SHELF S, V69, P370, DOI 10.1016/j.ecss.2006.05.041; Payne AR, 2019, ESTUAR COAST, V42, P1405, DOI 10.1007/s12237-019-00589-z; Pezeshki SR, 1992, WETL ECOL MANAG, V1, P185, DOI DOI 10.1007/BF00244923; Portnoy JW, 1997, ESTUARIES, V20, P569, DOI 10.2307/1352615; Priestas AM, 2011, GEOMORPHOLOGY, V131, P1, DOI 10.1016/j.geomorph.2011.04.004; Raposa KB, 2016, REGIONAL ENV CHANGE, V16, P389, DOI DOI 10.1007/S10113-016-1020-5; Raposa KB, 2016, BIOL CONSERV, V204, P263, DOI 10.1016/j.biocon.2016.10.015; REDFIELD AC, 1972, ECOL MONOGR, V42, P201, DOI 10.2307/1942263; Reimold RR, 1978, EFFECTS SMOTHERING S, P114; Roman CT, 1997, ESTUAR COAST SHELF S, V45, P717, DOI 10.1006/ecss.1997.0236; Slocum MG, 2005, ESTUARIES, V28, P519, DOI 10.1007/BF02696063; Stagg CL, 2010, RESTOR ECOL, V18, P10, DOI 10.1111/j.1526-100X.2010.00718.x; STUMPF RP, 1983, ESTUAR COAST SHELF S, V17, P495, DOI 10.1016/0272-7714(83)90002-1; Tong CF, 2013, ECOL ENG, V51, P151, DOI 10.1016/j.ecoleng.2012.12.010; Walters DC, 2016, ECOL EVOL, V6, P2948, DOI 10.1002/ece3.2024; WARREN RS, 1993, ECOLOGY, V74, P96, DOI 10.2307/1939504; Weston NB, 2014, ESTUAR COAST, V37, P1, DOI 10.1007/s12237-013-9654-8; WIJTE AHBM, 1991, BOT GAZ, V152, P509, DOI 10.1086/337913; Wilson CA, 2014, GEOMORPHOLOGY, V213, P99, DOI 10.1016/j.geomorph.2014.01.002; WOOD ME, 1989, ESTUARIES, V12, P237, DOI 10.2307/1351903	40	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245564	10.1371/journal.pone.0245564	http://dx.doi.org/10.1371/journal.pone.0245564			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481899	Green Published, gold			2022-12-26	WOS:000612929300096
J	Olagunju, KO; Ogunniyi, AI; Oyetunde-Usman, Z; Omotayo, AO; Awotide, BA				Olagunju, Kehinde Oluseyi; Ogunniyi, Adebayo Isaiah; Oyetunde-Usman, Zainab; Omotayo, Abiodun Olusola; Awotide, Bola Amoke			Does agricultural cooperative membership impact technical efficiency of maize production in Nigeria: An analysis correcting for biases from observed and unobserved attributes	PLOS ONE			English	Article							HOUSEHOLD WELFARE EVIDENCE; TECHNOLOGY ADOPTION; APPLE FARMERS; SMALLHOLDER FARMERS; ECONOMIC-IMPACTS; FOOD SECURITY; RICE FARMERS; PERFORMANCE; DETERMINANTS; ORGANIZATIONS	The formation of agricultural cooperatives has been widely promoted as an agricultural development policy initiative to help smallholder farmers cope with multiple production and marketing challenges. Using a nationally representative survey dataset of smallholder maize producers from rural Nigeria, this study assesses the impact of agricultural cooperative membership on technical efficiency (TE). We based our estimation approach on the combination of a newly developed sample selection stochastic production frontier model with propensity score matching to control for possible selectivity biases from both observables and unobservables. We estimate stochastic meta-frontiers to examine TE differences between cooperative members and non-members. Our results reveal that TE levels of members are consistently higher than that of non-members. This calls for continued policy incentives targeted at encouraging farmers to form as well as participate in agricultural cooperatives.	[Olagunju, Kehinde Oluseyi] Agrifood & Biosci Inst, Econ Res Branch, Belfast, Antrim, North Ireland; [Ogunniyi, Adebayo Isaiah] Int Food Policy Res Inst IFPRI, Abuja, Nigeria; [Oyetunde-Usman, Zainab] Univ Greenwich, Nat Resources Inst, Chatham, England; [Omotayo, Abiodun Olusola] North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa; [Awotide, Bola Amoke] Int Inst Trop Agr IITA, Bamako, Mali	Agri-Food & Biosciences Institute; University of Greenwich; North West University - South Africa	Omotayo, AO (corresponding author), North West Univ, Fac Nat & Agr Sci, Food Secur & Safety Niche Area, Mmabatho, South Africa.	omotayoabiodun777@gmail.com	Omotayo, Abiodun Olusola/B-6199-2018	Omotayo, Abiodun Olusola/0000-0002-4423-9983; Olagunju, Kehinde Oluseyi/0000-0002-5619-054X	Bill & Melinda Gates Foundation; Howard G. Buffett Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Howard G. Buffett Foundation	The authors wish to appreciate the International Institute of Tropical Agriculture for providing access to data, and in particular the efforts of Dr Abdoulaye Tahirou for coordinating and supervising the data collection supported by Bill & Melinda Gates Foundation and the Howard G. Buffett Foundation. Authors are also very much grateful to the Editor of this journal and the four anonymous reviewers for constructive comments and suggestions of great benefit to the paper. The usual disclaimer applies.	Abate GT, 2014, ANN PUBLIC COOP ECON, V85, P256, DOI 10.1111/apce.12035; Abdoulaye T, 2018, FOOD SECUR, V10, P369, DOI 10.1007/s12571-018-0772-9; Abdul-Rahaman A, 2018, FOOD POLICY, V81, P95, DOI 10.1016/j.foodpol.2018.10.007; Abebaw D, 2013, FOOD POLICY, V38, P82, DOI 10.1016/j.foodpol.2012.10.003; Adebayo O., 2020, Journal of Developing Areas, V54, P0045; Adebayo O, 2018, AIMS AGRIC FOOD, V3, P154, DOI 10.3934/agrfood.2018.2.154; Adeyemo TA, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124770; Ainembabazi JH, 2017, AGR ECON-BLACKWELL, V48, P241, DOI 10.1111/agec.12329; Ajayi CO, 2018, INT FOOD AGRIBUS MAN, V21, P915, DOI 10.22434/IFAMR2016.0151; [Anonymous], 2013, NIGERIA DATA GLANCE; Archer KJ, 2006, STATA J, V6, P97, DOI 10.1177/1536867X0600600106; Battese GE, 1997, J AGR ECON, V48, P250, DOI 10.1111/j.1477-9552.1997.tb01149.x; Bravo-Ureta BE, 2007, J PROD ANAL, V27, P57, DOI 10.1007/s11123-006-0025-3; Bravo-Ureta BE, 2012, EMPIR ECON, V43, P55, DOI 10.1007/s00181-011-0491-y; Cadoni P, 2019, GATES OPEN RES, P3; Cai R, 2016, BRIT FOOD J, V118, P858, DOI 10.1108/BFJ-11-2015-0456; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cameron C., 2005, MICROECONOMETRICS US, P1056; Coelli T., 2003, PRIMER EFFICIENCY ME; FAO, 2019, ANN STAT PUBL; Gedara KM, 2012, J AGR ECON, V63, P627, DOI 10.1111/j.1477-9552.2012.00343.x; Ghebru H., 2015, Quarterly Journal of International Agriculture, V54, P1; Gonzalez-Flores M, 2014, FOOD POLICY, V44, P237, DOI 10.1016/j.foodpol.2013.09.014; Greene H., 2003, ECONOMETRIC ANAL; Greene W, 2010, J PROD ANAL, V34, P15, DOI 10.1007/s11123-009-0159-1; Hailu G., 2015, RURAL ORG AGR TECHNO; Hoken H, 2018, AGRIBUSINESS, V34, P831, DOI 10.1002/agr.21554; Hossain MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029509; Huang CJ, 2014, J PROD ANAL, V42, P241, DOI 10.1007/s11123-014-0402-2; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Ito J, 2012, FOOD POLICY, V37, P700, DOI 10.1016/j.foodpol.2012.07.009; Jimi NA, 2019, J PROD ANAL, V52, P37, DOI 10.1007/s11123-019-00555-8; Joe-Nkamuke U., 2019, REV AGR FOOD ENV STU, V100, P69, DOI [10.1007/s41130-019-00090-y, DOI 10.1007/S41130-019-00090-Y]; Koch N, 2019, AM J AGR ECON, V101, P919, DOI 10.1093/ajae/aay110; Kolade O., 2014, Development Studies Research, V1, P340, DOI 10.1080/21665095.2014.978981; Kumar A, 2018, FOOD POLICY, V75, P24, DOI 10.1016/j.foodpol.2018.01.005; Kumbhakar SC, 2009, J PROD ANAL, V31, P151, DOI 10.1007/s11123-008-0081-y; Lai H.-P., 2009, ESTIMATION STOCHASTI; Latynskiy E, 2016, WORLD DEV, V78, P572, DOI 10.1016/j.worlddev.2015.10.014; Lawin KG, 2019, J AGR ECON, V70, P116, DOI 10.1111/1477-9552.12275; Liu YY, 2019, INT FOOD AGRIBUS MAN, V22, P265, DOI [10.22434/IFAMR2018.0058, 10.22434/ifamr2018.0058]; Ma WL, 2019, CHINA AGR ECON REV, V11, P218, DOI 10.1108/CAER-12-2017-0251; Ma WL, 2018, FOOD POLICY, V81, P122, DOI 10.1016/j.foodpol.2018.10.009; Ma WL, 2018, AM J AGR ECON, V100, P502, DOI 10.1093/ajae/aax079; Ma WL, 2017, AGRIBUSINESS, V33, P537, DOI 10.1002/agr.21522; Mayen CD, 2010, AM J AGR ECON, V92, P181, DOI 10.1093/ajae/aap018; Michalek J, 2018, FOOD POLICY, V75, P80, DOI 10.1016/j.foodpol.2017.12.009; Mojo D, 2017, J RURAL STUD, V50, P84, DOI 10.1016/j.jrurstud.2016.12.010; Moore FC, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6eb2; Musa Hasen Ahmed, 2017, Agricultural and Food Economics, V5, DOI 10.1186/s40100-017-0075-z; O'Donnell CJ, 2008, EMPIR ECON, V34, P231, DOI 10.1007/s00181-007-0119-4; Ogunniyi A, 2017, AFR DEV REV, V29, P121, DOI 10.1111/1467-8268.12267; Olagunju KO, 2020, CLIM DEV, V12, P865, DOI 10.1080/17565529.2019.1701401; Oyetunde-Usman Z, 2021, INT SOIL WATER CONSE, V9, P241, DOI 10.1016/j.iswcr.2020.10.007; Oyetunde-Usman Z, 2019, ECONOMIES, V7, DOI 10.3390/economies7040103; Shehu BM, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8020018; Sianesi B.., 2001, UK STAT US GROUP 7 M; STOLP C, 1990, COMPUT ENVIRON URBAN, V14, P103, DOI 10.1016/0198-9715(90)90016-M; Verhofstadt E, 2015, APPL ECON PERSPECT P, V37, P86, DOI 10.1093/aepp/ppu021; Verhofstadt E, 2014, AGR ECON-BLACKWELL, V45, P39, DOI 10.1111/agec.12128; Villano R, 2015, J AGR ECON, V66, P129, DOI 10.1111/1477-9552.12081; Wanglin M., 2016, FOOD POLICY, V58, P94, DOI DOI 10.1016/J.F00DP0L.2015.12.002; Wollni M, 2012, FOOD POLICY, V37, P67, DOI 10.1016/j.foodpol.2011.11.004; [World Bank Bank W], 2019, WORLD BANK AFR DEV I; Wossen T, 2017, J RURAL STUD, V54, P223, DOI 10.1016/j.jrurstud.2017.06.022; Wossen T, 2015, AGR ECON-BLACKWELL, V46, P81, DOI 10.1111/agec.12142; Zhang SM, 2020, CHINA ECON REV, V62, DOI 10.1016/j.chieco.2019.101334; Zheng S, 2012, APPL ECON PERSPECT P, V34, P167, DOI 10.1093/aepp/ppr044	68	21	21	6	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245426	10.1371/journal.pone.0245426	http://dx.doi.org/10.1371/journal.pone.0245426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481874	Green Published, gold			2022-12-26	WOS:000612929300106
J	Pereira, E; Tessema, G; Gissler, M; Regan, AK; Pereira, G				Pereira, Elizabeth; Tessema, Gizachew; Gissler, Mika; Regan, Annette K.; Pereira, Gavin			Re-evaluation of gestational age as a predictor for subsequent preterm birth	PLOS ONE			English	Article							RECURRENCE	Background To evaluate gestational age as a predictor of subsequent preterm birth. Materials and methods This was a retrospective birth cohort study to evaluate gestational age as a predictor of subsequent preterm birth. Participants were mothers who gave birth to their first two children in Western Australia, 1980-2015 (N = 255,151 mothers). For each week of final gestational age of the first birth, we calculated relative risks (RR) and absolute risks (AR) of subsequent preterm birth defined as final gestational age before 28, 32, 34 and <37 weeks. Risks were unadjusted to preserve risk factor profiles at each week of gestation. Results The relative risks of second birth before 28, 32, and 34 weeks' gestation were all approximately twenty times higher for mothers whose first birth had a gestational age of 22 to 30 weeks compared to those whose first birth was at 40 weeks' gestation. The absolute risks of second birth before 28, 32, and 34 weeks' gestation for these mothers had upper confidence limits that were all less than 16.74%. The absolute risk of second birth before 37 weeks was highest at 32.11% (95% CI: 30.27, 34.02) for mothers whose first birth was 22 to 30 weeks' gestation. For all gestational ages of the first child, the lowest quartile and median gestational age of the second birth were at least 36 weeks and at least 38 weeks, respectively. Sensitivity and positive predictive values were all below 35%. Conclusion Relative risks of early subsequent birth increased markedly with decreasing gestational age of the first birth. However, absolute risks of clinically significant preterm birth (<28 weeks, <32 weeks, <34 weeks), sensitivity and positive predictive values remained low. Early gestational age is a strong risk factor but a poor predictor of subsequent preterm birth.	[Pereira, Elizabeth; Tessema, Gizachew; Regan, Annette K.; Pereira, Gavin] Curtin Univ, Curtin Sch Populat Hlth, Perth, WA, Australia; [Gissler, Mika] THL Natl Inst Hlth & Welf, Informat Serv Dept, Helsinki, Finland; [Gissler, Mika] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Regan, Annette K.] Univ San Francisco, Sch Nursing & Hlth Profess, San Francisco, CA USA; [Pereira, Gavin] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway	Curtin University; Finland National Institute for Health & Welfare; Karolinska Institutet; University of San Francisco; Norwegian Institute of Public Health (NIPH)	Pereira, G (corresponding author), Curtin Univ, Curtin Sch Populat Hlth, Perth, WA, Australia.; Pereira, G (corresponding author), Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway.	Gavin.f.pereira@curtin.edu.au	Pereira, Gavin/D-7136-2014; Tessema, Gizachew A/J-9235-2018; Regan, Annette/Q-9159-2016	Pereira, Gavin/0000-0003-3740-8117; Tessema, Gizachew A/0000-0002-4784-8151; Regan, Annette/0000-0002-3879-6193	National Health and Medical Research Council [1099655, 1173991]; Research Council of Norway [262700]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Research Council of Norway(Research Council of Norway)	GP was supported with funding from the National Health and Medical Research Council (www.nhmrc.gov.au) Project and Investigator Grants #1099655 and #1173991 and the Research Council of Norway (www.forskningsradet.no) through its Centres of Excellence funding scheme #262700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananth CV, 2006, AM J OBSTET GYNECOL, V195, P643, DOI 10.1016/j.ajog.2006.05.022; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Clark SL, 2012, AM J OBSTET GYNECOL, V206, P387, DOI 10.1016/j.ajog.2011.08.017; Downey F., 2007, VALIDATION STUDY W A, V38, P1; Esplin MS, 2008, OBSTET GYNECOL, V112, P516, DOI 10.1097/AOG.0b013e318184181a; Getahun D, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.010; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Jain V, 2020, J OBSTET GYNAECOL CA, V42, P806, DOI 10.1016/j.jogc.2019.04.012; Koivu A, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-020-00105-9; Malacova E, 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; McManemy J, 2007, AM J OBSTET GYNECOL, V196, P576, DOI 10.1016/j.ajog.2007.01.039; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Obstetricians ACo Gynecologists, 2012, PRACT B; Paling J, 2003, BRIT MED J, V327, P745, DOI 10.1136/bmj.327.7417.745; Purisch SE, 2017, SEMINARS PERINATOLOG; Shmueli G, 2010, STAT SCI, V25, P289, DOI 10.1214/10-STS330; Team. RC, 2020, RA LANG ENV STAT COM; Vogel JP, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0193-1; Watson HA, 2020, ULTRASOUND OBST GYN, V55, P348, DOI 10.1002/uog.20401; Weber A, 2018, ANN EPIDEMIOL, V28, P783, DOI 10.1016/j.annepidem.2018.08.008; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wright CM, 2002, ARCH DIS CHILD, V86, P11, DOI 10.1136/adc.86.1.11	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245935	10.1371/journal.pone.0245935	http://dx.doi.org/10.1371/journal.pone.0245935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481959	Green Published, gold			2022-12-26	WOS:000612929300145
J	Thayer, MB; Parish, T				Thayer, Mai B.; Parish, Tanya			Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis	PLOS ONE			English	Article							PHENOXYALKYLBENZIMIDAZOLES	The phenoxyalkylimidazoles (PAI) are an attractive chemical series with potent anti-tubercular activity targeting Mycobacterium tuberculosis respiration. Our aim was to determine if the PAI compounds are subject to efflux. Two analogs containing an oxadiazole had improved potency in the presence of the efflux inhibitors reserpine and carbonyl cyanide m-chlorophenylhydrazine, whereas the potency of analogs with a diazole was not affected.	[Thayer, Mai B.; Parish, Tanya] Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98109 USA; [Parish, Tanya] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA; [Thayer, Mai B.] Amgen Res, Pharmacokinet & Drug Metab Dept, San Francisco, CA USA	Seattle Children's Hospital	Parish, T (corresponding author), Infect Dis Res Inst, TB Discovery Res, Seattle, WA 98109 USA.; Parish, T (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.	tanya.parish@seattlechilderns.org	Parish, Tanya/A-8912-2014	Parish, Tanya/0000-0001-7507-0423	Bill & Melinda Gates Foundation [OPP1024038]; NIAID of the National Institutes of Health [R01AI099188]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NIAID of the National Institutes of Health	TP -Bill & Melinda Gates Foundation under grant OPP1024038 https://www.gatesfoundation.org/TP -NIAID of the National Institutes of Health under award number R01AI099188 https://www.niaid.nih.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berube BJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01677-17; Bown L, 2018, J MEMBRANE BIOL, V251, P105, DOI 10.1007/s00232-017-9997-3; Chandrasekera NS, 2017, ACS INFECT DIS, V3, P898, DOI 10.1021/acsinfecdis.7b00112; Chandrasekera NS, 2015, J MED CHEM, V58, P7273, DOI 10.1021/acs.jmedchem.5b00546; Gordon SV, 2018, MICROBIOL-SGM, V164, P437, DOI 10.1099/mic.0.000601; Ioerger TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075245; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Mandal S, 2019, MICROBIOL-SGM, V165, P492, DOI 10.1099/mic.0.000760; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Moraski GC, 2013, ACS MED CHEM LETT, V4, P110, DOI 10.1021/ml400088y; O'Malley T, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.02439-17; Ollinger J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060531; Rodrigues L, 2017, DRUG DISCOV TODAY, V22, P592, DOI 10.1016/j.drudis.2017.01.002; WHO, 2020, GLOB TUB REP 2019; Zuniga ES, 2015, FUTURE MICROBIOL, V10, P217, DOI [10.2217/FMB.14.125, 10.2217/fmb.14.125]	15	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0239353	10.1371/journal.pone.0239353	http://dx.doi.org/10.1371/journal.pone.0239353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481781	Green Published, gold, Green Submitted			2022-12-26	WOS:000612929300168
J	Gunn, KH; Gutgsell, AR; Xu, YM; Johnson, CV; Liu, J; Neher, SB				Gunn, Kathryn H.; Gutgsell, Aspen R.; Xu, Yongmei; Johnson, Caitlin, V; Liu, Jian; Neher, Saskia B.			Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; SMALL-ANGLE SCATTERING; ADIPOSE-TISSUE; ANGPTL4; INHIBITION; PLASMA; RISK; SAXS; IDENTIFICATION; CONFORMATIONS	Elevated plasma triglycerides are a risk factor for coronary artery disease, which is the leading cause of death worldwide. Lipoprotein lipase (LPL) reduces triglycerides in the blood by hydrolyzing them from triglyceride-rich lipoproteins to release free fatty acids. LPL activity is regulated in a nutritionally responsive manner by macromolecular inhibitors including angiopoietin-like proteins 3 and 4 (ANGPTL3 and ANGPTL4). However, the mechanism by which ANGPTL3 inhibits LPL is unclear, in part due to challenges in obtaining pure protein for study. We used a new purification protocol for the N-terminal domain of ANGPTL3, removing a DNA contaminant, and found DNA-free ANGPTL3 showed enhanced inhibition of LPL. Structural analysis showed that ANGPTL3 formed elongated, flexible trimers and hexamers that did not interconvert. ANGPTL4 formed only elongated flexible trimers. We compared the inhibition of ANGPTL3 and ANGPTL4 using human very-low-density lipoproteins as a substrate and found both were noncompetitive inhibitors. The inhibition constants for the trimeric ANGPTL3 (7.5 +/- 0.7 nM) and ANGPTL4 (3.6 +/- 1.0 nM) were only 2-fold different. Heparin has previously been reported to interfere with ANGPTL3 binding to LPL, so we questioned if the negatively charged heparin was acting in a similar fashion to the DNA contaminant. We found that ANGPTL3 inhibition is abolished by binding to low-molecular-weight heparin, whereas ANGPTL4 inhibition is not. Our data show new similarities and differences in how ANGPTL3 and ANGPTL4 regulate LPL and opens new avenues of investigating the effect of heparin on LPL inhibition by ANGPTL3.	[Gunn, Kathryn H.; Gutgsell, Aspen R.; Neher, Saskia B.] Univ N Carolina, Eshelman Sch Pharm, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27515 USA; [Johnson, Caitlin, V] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Neher, SB (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	neher@email.unc.edu		Gunn, Kathryn/0000-0003-2078-6947; Johnson, Caitlin/0000-0003-3474-8204	National Institutes of Health [R01-HL12565, R01-HL094463, R01HL144970, 1R42GM128484]; American Heart Association [20POST35210031, 19PRE34370070]; National Cancer Institute of the National Institutes of Health [P30CA016086]; National Institute of General Medical Sciences project ALS-ENABLE [P30 GM124169]; DOE Office of Science by Argonne National Laboratory [DEAC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [9 P41 GM103622]; National Institute of General Medical Sciences [1S10OD018090-01]; High-End Instrumentation Grant [S10OD018483]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences project ALS-ENABLE; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); High-End Instrumentation Grant	The authors acknowledge support from the National Institutes of Health (Grant No. R01-HL12565 to S. B. N., Grant Nos. R01-HL094463 and R01HL144970 to J. L., and Grant No. 1R42GM128484 to Y. X.) and the American Heart Association (Grant No. 20POST35210031 to K. H. G. and 19PRE34370070 to A. R. G.). The authors acknowledge help from the UNC Macromolecular Interactions Facility, which is supported by the National Cancer Institute of the National Institutes of Health under award number P30CA016086. SAXS data were collected at the Advanced Light Source (ALS), SIBYLS beamline on behalf of US DOE-BER, through the Integrated Diffraction Analysis Technologies (IDAT) program. Additional support comes from the National Institute of General Medical Sciences project ALS-ENABLE (P30 GM124169) and a High-End Instrumentation Grant S10OD018483. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DEAC02-06CH11357. "This project was supported by grant 9 P41 GM103622 from the National Institute of General Medical Sciences of the National Institutes of Health." Use of the Pilatus 3 1M detector was provided by grant 1S10OD018090-01 from National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345; Biterova E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25237-7; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chen YQ, 2020, J LIPID RES, V61, P1203, DOI 10.1194/jlr.RA120000781; Chi X, 2017, MOL METAB, V6, P1137, DOI 10.1016/j.molmet.2017.06.014; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Conklin D, 1999, GENOMICS, V62, P477, DOI 10.1006/geno.1999.6041; Dewey FE, 2017, NEW ENGL J MED, V377, P211, DOI 10.1056/NEJMoa1612790; Dewey FF, 2016, NEW ENGL J MED, V374, P1123, DOI 10.1056/NEJMoa1510926; Dijk W, 2016, CURR OPIN LIPIDOL, V27, P249, DOI 10.1097/MOL.0000000000000290; Dominguez-Martin MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72383-y; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Essalmani R, 2013, J BIOL CHEM, V288, P26410, DOI 10.1074/jbc.M113.501304; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Forster S, 2010, J APPL CRYSTALLOGR, V43, P639, DOI 10.1107/S0021889810008289; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FRIED SK, 1983, J NUTR, V113, P1861, DOI 10.1093/jn/113.9.1861; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Gunn KH, 2020, P NATL ACAD SCI USA, V117, P10254, DOI 10.1073/pnas.1916555117; Gutgsell AR, 2019, J BIOL CHEM, V294, P2678, DOI 10.1074/jbc.RA118.005932; Haller JF, 2017, J LIPID RES, V58, P1166, DOI 10.1194/jlr.M075689; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Hura GL, 2013, NAT METHODS, V10, P453, DOI 10.1038/nmeth.2453; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Knott GJ, 2019, ELIFE, V8, DOI 10.7554/eLife.49110; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kovrov O, 2019, J LIPID RES, V60, P783, DOI 10.1194/jlr.M088807; Kristensen KK, 2020, P NATL ACAD SCI USA, V117, P4337, DOI 10.1073/pnas.1920202117; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lei X, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217638; Leiherer A, 2020, ATHEROSCLEROSIS, V293, P62, DOI 10.1016/j.atherosclerosis.2019.11.011; Miller CM, 2018, THROMB RES, V167, P80, DOI 10.1016/j.thromres.2018.05.018; Mysling S, 2016, ELIFE, V5, DOI 10.7554/eLife.20958; Nimonkar AV, 2020, J BIOL CHEM, V295, P2900, DOI 10.1074/jbc.RA119.011079; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; QUIG DW, 1983, J NUTR, V113, P1150, DOI 10.1093/jn/113.6.1150; Reimund M, 2017, J LIPID RES, V58, P279, DOI 10.1194/jlr.D071787; Segel IH, 1975, ENZYME KINETICS BEHA; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimamura M, 2007, ARTERIOSCL THROM VAS, V27, P366, DOI 10.1161/01.ATV.0000252827.51626.89; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Stitziel NO, 2017, J AM COLL CARDIOL, V69, P2054, DOI 10.1016/j.jacc.2017.02.030; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wu MJ, 2018, J LIPID RES, V59, P2456, DOI 10.1194/jlr.D086793; Xu YM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5954; Yau MH, 2009, J BIOL CHEM, V284, P11942, DOI 10.1074/jbc.M809802200; Yin W, 2009, J BIOL CHEM, V284, P13213, DOI 10.1074/jbc.M900553200; YOSHINO M, 1987, BIOCHEM J, V248, P815, DOI 10.1042/bj2480815; Zhang R, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150272; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	61	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100312	10.1016/j.jbc.2021.100312	http://dx.doi.org/10.1016/j.jbc.2021.100312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482195	gold, Green Published			2022-12-26	WOS:000672866400286
J	van der Zande, HJP; Gonzalez, MA; de Ruiter, K; Wilbers, RHP; Garcia-Tardon, N; van Huizen, M; van Noort, K; Pelgrom, LR; Lambooij, JM; Zawistowska-Deniziak, A; Otto, F; Ozir-Fazalalikhan, A; van Willigen, D; Welling, M; Poles, J; van Leeuwen, F; Hokke, CH; Schots, A; Yazdanbakhsh, M; Loke, P; Guigas, B				van der Zande, Hendrik J. P.; Gonzalez, Michael A.; de Ruiter, Karin; Wilbers, Ruud H. P.; Garcia-Tardon, Noemi; van Huizen, Mariska; van Noort, Kim; Pelgrom, Leonard R.; Lambooij, Joost M.; Zawistowska-Deniziak, Anna; Otto, Frank; Ozir-Fazalalikhan, Arifa; van Willigen, Danny; Welling, Mick; Poles, Jordan; van Leeuwen, Fijs; Hokke, Cornelis H.; Schots, Arjen; Yazdanbakhsh, Maria; Loke, P'ng; Guigas, Bruno			The helminth glycoprotein omega-1 improves metabolic homeostasis in obese mice through type 2 immunity-independent inhibition of food intake	FASEB JOURNAL			English	Article						helminths; immunometabolism; insulin sensitivity; macrophages; type 2 immunity	SCHISTOSOMA-MANSONI EGGS; INNATE LYMPHOID-CELLS; INSULIN SENSITIVITY; TH2 POLARIZATION; NEUROMEDIN-U; MACROPHAGES; RESISTANCE; DRIVES; IDENTIFICATION; EOSINOPHILS	Type 2 immunity plays an essential role in the maintenance of metabolic homeostasis and its disruption during obesity promotes meta-inflammation and insulin resistance. Infection with the helminth parasite Schistosoma mansoni and treatment with its soluble egg antigens (SEA) induce a type 2 immune response in metabolic organs and improve insulin sensitivity and glucose tolerance in obese mice, yet, a causal relationship remains unproven. Here, we investigated the effects and underlying mechanisms of the T2 ribonuclease omega-1 (omega 1), one of the major S mansoni immunomodulatory glycoproteins, on metabolic homeostasis. We show that treatment of obese mice with plant-produced recombinant omega 1, harboring similar glycan motifs as present on the native molecule, decreased body fat mass, and improved systemic insulin sensitivity and glucose tolerance in a time- and dose-dependent manner. This effect was associated with an increase in white adipose tissue (WAT) type 2 T helper cells, eosinophils, and alternatively activated macrophages, without affecting type 2 innate lymphoid cells. In contrast to SEA, the metabolic effects of omega 1 were still observed in obese STAT6-deficient mice with impaired type 2 immunity, indicating that its metabolic effects are independent of the type 2 immune response. Instead, we found that omega 1 inhibited food intake, without affecting locomotor activity, WAT thermogenic capacity or whole-body energy expenditure, an effect also occurring in leptin receptor-deficient obese and hyperphagic db/db mice. Altogether, we demonstrate that while the helminth glycoprotein omega 1 can induce type 2 immunity, it improves whole-body metabolic homeostasis in obese mice by inhibiting food intake via a STAT6-independent mechanism.	[van der Zande, Hendrik J. P.; de Ruiter, Karin; Garcia-Tardon, Noemi; van Huizen, Mariska; Pelgrom, Leonard R.; Lambooij, Joost M.; Zawistowska-Deniziak, Anna; Otto, Frank; Ozir-Fazalalikhan, Arifa; Hokke, Cornelis H.; Yazdanbakhsh, Maria; Guigas, Bruno] Leiden Univ, Dept Parasitol, Med Ctr, POB 9600,Postal Zone P4-P, NL-2300 RC Leiden, Netherlands; [Gonzalez, Michael A.; Poles, Jordan; Loke, P'ng] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Wilbers, Ruud H. P.; van Noort, Kim; Schots, Arjen] Wageningen Univ & Res, Dept Lab Nematol, Wageningen, Netherlands; [Zawistowska-Deniziak, Anna] Polish Acad Sci, Witold Stefanski Inst Parasitol, Warsaw, Poland; [van Willigen, Danny; Welling, Mick; van Leeuwen, Fijs] Leiden Univ, Dept Radiol, Intervent Mol Imaging Lab, Med Ctr, Leiden, Netherlands; [Loke, P'ng] NIAID, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; New York University; Wageningen University & Research; Polish Academy of Sciences; Witold Stefanski Institute of Parasitology of the Polish Academy of Sciences; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Guigas, B (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, POB 9600,Postal Zone P4-P, NL-2300 RC Leiden, Netherlands.	b.g.a.guigas@lumc.nl	Guigas, Bruno/M-2515-2015; van leeuwen, Fijs/AAX-2098-2021; Hokke, Cornelis Hendrik/AAQ-4712-2021; Pelgrom, Leonard/GVT-0523-2022; Welling, Mick/A-4582-2012	Guigas, Bruno/0000-0002-8856-5799; van leeuwen, Fijs/0000-0002-6844-4025; Hokke, Cornelis Hendrik/0000-0003-3545-7804; van Huizen, Mariska/0000-0002-0561-0049; Zawistowska-Deniziak, Anna/0000-0001-6990-9165; Pelgrom, Leonard/0000-0002-8422-6810; Gonzalez, Michael A/0000-0003-2042-6255; Lambooij, Joost Maarten/0000-0002-4853-5843; Otto, Frank/0000-0002-8648-2260; Welling, Mick/0000-0002-2249-5601	NHLBI NIH HHS [R01 HL084312] Funding Source: Medline; NIAID NIH HHS [R01 AI130945, R01 AI133977] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001368; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Cai DS, 2011, ANN NY ACAD SCI, V1243, pE1, DOI 10.1111/j.1749-6632.2011.06388.x; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; DERUITER K, 2017, PARASITE IMMUNOL, V39; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DUNNE DW, 1981, T ROY SOC TROP MED H, V75, P54, DOI 10.1016/0035-9203(81)90013-4; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Gieseck RL, 2016, IMMUNITY, V45, P145, DOI 10.1016/j.immuni.2016.06.009; Grogan JL, 1996, EUR J IMMUNOL, V26, P1365, DOI 10.1002/eji.1830260628; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Hadju V, 1996, PARASITOLOGY, V113, P497, DOI 10.1017/S0031182000081579; Hams E, 2016, FASEB J, V30, P824, DOI 10.1096/fj.15-277822; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Hart KM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3694; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hensbergen AW, 2019, ACS OMEGA, V4, P12438, DOI 10.1021/acsomega.9b01484; HORBURY SR, 1995, J NEUROENDOCRINOL, V7, P867, DOI 10.1111/j.1365-2826.1995.tb00728.x; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Hussaarts L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00499; Kaiser MMM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005504; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kolb H, 2010, DIABETOLOGIA, V53, P10, DOI 10.1007/s00125-009-1573-7; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lee CH, 2018, CELL REP, V25, P934, DOI 10.1016/j.celrep.2018.09.070; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Lohmus M, 2012, BIOL LETTERS, V8, P849, DOI 10.1098/rsbl.2012.0385; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Meevissen MHJ, 2010, J PROTEOME RES, V9, P2630, DOI 10.1021/pr100081c; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Okano M, 1999, J IMMUNOL, V163, P6712; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Schneeberger M, 2014, J ENDOCRINOL, V220, pT25, DOI 10.1530/JOE-13-0398; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Spa SJ, 2018, THERANOSTICS, V8, P2377, DOI 10.7150/thno.23567; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Takeda K, 1996, J IMMUNOL, V157, P3220; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Thomas A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24618; Valdearcos M, 2017, CELL METAB, V26, P185, DOI 10.1016/j.cmet.2017.05.015; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; van der Zande HJP, 2019, TRENDS PARASITOL, V35, P795, DOI 10.1016/j.pt.2019.07.014; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wilbers RHP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45910; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zinsou JF, 2020, PLOS NEGLECT TROP D, V14, DOI [10.1371/journal.pntd.0008464, 10.1371/journal.pntd.0008464.r001, 10.1371/journal.pntd.0008464.r002, 10.1371/journal.pntd.0008464.r003, 10.1371/journal.pntd.0008464.r004]	58	13	13	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21331	10.1096/fj.202001973R	http://dx.doi.org/10.1096/fj.202001973R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33476078	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000647789600008
J	Adamkova, J; Benediktova, K; Svoboda, J; Bartos, L; Vynikalova, L; Novakova, P; Hart, V; Painter, MS; Burda, H				Adamkova, Jana; Benediktova, Katerina; Svoboda, Jan; Bartos, Ludek; Vynikalova, Lucie; Novakova, Petra; Hart, Vlastimil; Painter, Michael S.; Burda, Hynek			Turning preference in dogs: North attracts while south repels	PLOS ONE			English	Article							MAGNETIC COMPASS ORIENTATION; MOTOR LATERALITY; MAGNETORECEPTION; CRYPTOCHROME; VERTEBRATES; BEHAVIOR; HUMANS	It was shown earlier that dogs, when selecting between two dishes with snacks placed in front of them, left and right, prefer to turn either clockwise or counterclockwise or randomly in either direction. This preference (or non-preference) is individually consistent in all trials but it is biased in favor of north if they choose between dishes positioned north and east or north and west, a phenomenon denoted as "pull of the north". Here, we replicated these experiments indoors, in magnetic coils, under natural magnetic field and under magnetic field shifted 90 degrees clockwise. We demonstrate that "pull of the north" was present also in an environment without any outdoor cues and that the magnetic (and not topographic) north exerted the effect. The detailed analysis shows that the phenomenon involves also "repulsion of the south". The clockwise turning preference in the right-preferring dogs is more pronounced in the S-W combination, while the counterclockwise turning preference in the left-preferring dogs is pronounced in the S-E combination. In this way, south-placed dishes are less frequently chosen than would be expected, while the north-placed dishes are apparently more preferred. Turning preference did not correlate with the motoric paw laterality (Kong test). Given that the choice of a dish is visually guided, we postulate that the turning preference was determined by the dominant eye, so that a dominant right eye resulted in clockwise, and a dominant left eye in counterclockwise turning. Assuming further that magnetoreception in canines is based on the radical-pair mechanism, a "conflict of interests" may be expected, if the dominant eye guides turning away from north, yet the contralateral eye "sees the north", which generally acts attractive, provoking body alignment along the north-south axis.	[Adamkova, Jana; Benediktova, Katerina; Svoboda, Jan; Novakova, Petra; Hart, Vlastimil; Painter, Michael S.; Burda, Hynek] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic; [Bartos, Ludek] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Bartos, Ludek] Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Ethol & Compan Anim Sci, Prague, Czech Republic; [Vynikalova, Lucie] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Zool & Fisheries, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech Research Institute of Animal Science; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Burda, H (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic.	burda@fld.czu.cz		Hart, Vlastimil/0000-0003-4901-3817; Adamkova, Jana/0000-0002-1655-6906	OP RDE [CZ.02.1.01/0.0/0.0/16_019/0000803]; Grant Agency of the Czech University of Life Sciences in Prague, CIGA [20174319]; Ministry of Agriculture of the Czech Republic [MZE-RO0718]	OP RDE; Grant Agency of the Czech University of Life Sciences in Prague, CIGA(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The grant "EVA4.0", No. CZ.02.1.01/0.0/0.0/16_019/0000803 financed by OP RDE to JA, KB, HB, VH, MSP; the Grant Agency of the Czech University of Life Sciences in Prague, CIGA (Project No. 20174319) to JA, HB, KB, VH, PN, JS, LV; the grant of the Ministry of Agriculture of the Czech Republic MZE-RO0718 to LB.	Adamkova J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185243; Batt LS, 2009, J VET BEHAV, V4, P216, DOI 10.1016/j.jveb.2009.02.001; Batt L, 2007, J VET BEHAV, V2, P47, DOI 10.1016/j.jveb.2007.01.002; Benediktova K, 2020, ELIFE, V9, DOI 10.7554/eLife.55080; Benmerah A, 2013, CURR OPIN CELL BIOL, V25, P78, DOI 10.1016/j.ceb.2012.10.011; Burda H, 2020, SENSES COMPREHENSIVE, V7, P421; Cerveny J, 2011, BIOL LETTERS, V7, P355, DOI 10.1098/rsbl.2010.1145; Cracknell NR, 2011, J VET BEHAV, V6, P21, DOI 10.1016/j.jveb.2010.07.004; Eber A, 2010, CLANDESTINE CURSES H; Gagliardo A, 2011, J EXP BIOL, V214, P593, DOI 10.1242/jeb.049510; Gehring D, 2012, P ROY SOC B-BIOL SCI, V279, P4230, DOI 10.1098/rspb.2012.1654; Hart V, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-80; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Malkemper EP, 2016, J THEOR BIOL, V399, P141, DOI 10.1016/j.jtbi.2016.03.040; Martini S, 2018, PEERJ, V6, DOI 10.7717/peerj.6117; McGreevy PD, 2010, J VET BEHAV, V5, P318, DOI 10.1016/j.jveb.2010.05.001; Niessner C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21848; Nordmann GC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003234; Ocklenburg S, 2019, LATERALITY, V24, P647, DOI 10.1080/1357650X.2019.1578228; Phillips JB, 2010, J R SOC INTERFACE, V7, pS241, DOI 10.1098/rsif.2009.0459.focus; Plueckhahn TC, 2016, J VET BEHAV, V15, P25, DOI 10.1016/j.jveb.2016.08.004; Pongracz P, 2017, BEHAV PROCESS, V140, P53, DOI 10.1016/j.beproc.2017.04.002; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Rogers L.J., 2013, DIVIDED BRAINS BIOL; Rogers Lesley J., 1989, INT J COMP PSYCHOL, V3, P5; Rogers LJ, 2002, ADV STUD BEHAV, V31, P107, DOI 10.1016/S0065-3454(02)80007-9; Schaafsma SM, 2009, PHILOS T R SOC B, V364, P915, DOI 10.1098/rstb.2008.0244; Scharine AA, 2002, HUM FACTORS, V44, P248, DOI 10.1518/0018720024497916; Schneider LA, 2013, J VET BEHAV, V8, P124, DOI 10.1016/j.jveb.2012.06.004; Siniscalchi M, 2018, ANIMALS, V8, DOI 10.3390/ani8080131; Siniscalchi M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18417-4; Siniscalchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31682; Sokal R. R, 1981, BIOMETRY; Solov'yov IA, 2010, BIOPHYS J, V99, P40, DOI 10.1016/j.bpj.2010.03.053; Tavakkoli M.H., 2013, INT J ED DEV, V2, P23; Tomkins LM, 2012, VET J, V192, P359, DOI 10.1016/j.tvjl.2011.09.010; Tomkins LM, 2010, J VET BEHAV, V5, P256, DOI 10.1016/j.jveb.2010.02.005; Tomkins LM, 2010, J VET BEHAV, V5, P247, DOI 10.1016/j.jveb.2010.03.001; WARREN JM, 1980, PHYSIOL PSYCHOL, V8, P351, DOI 10.3758/BF03337470; Wee EGT, 1998, PLANT CELL, V10, P1759, DOI 10.1105/tpc.10.10.1759; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wilzeck C, 2010, ANIM COGN, V13, P443, DOI 10.1007/s10071-009-0294-0; Worster S, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4958624; YORKE ED, 1979, J THEOR BIOL, V77, P101, DOI 10.1016/0022-5193(79)90140-1; Yosef R, 2020, J VET BEHAV, V35, P34, DOI 10.1016/j.jveb.2019.10.003	48	0	0	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245940	10.1371/journal.pone.0245940	http://dx.doi.org/10.1371/journal.pone.0245940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507979	Green Published, gold			2022-12-26	WOS:000635021400066
J	Chunduri, V; Sharma, N; Garg, M				Chunduri, Venkatesh; Sharma, Natasha; Garg, Monika			A null allele of granule bound starch synthase (Wx-B1) may be one of the major genes controlling chapatti softness	PLOS ONE			English	Article							GLUTENIN SUBUNIT COMPOSITION; END-USE QUALITY; BREADMAKING QUALITY; SIZE DISTRIBUTION; WHEAT-VARIETIES; MAKING QUALITY; STEAMED BREAD; WAXY WHEATS; FLOUR; TEXTURE	Chapatti (unleavened flatbread) is a staple food in northern India and neighboring countries but the genetics behind its processing quality are poorly understood. To understand the genes determining chapatti quality, differentially expressed genes were selected from microarray data of contrasting chapatti cultivars. From the gene and trait association studies, a null allele of granule bound starch synthase (GBSS; Wx-B1) was found to be associated with low amylose content and good chapatti quality. For validation, near-isogenic lines (NILs) of this allele were created by marker assisted backcross (MAB) breeding. Background screening indicated 88.2 to 96.7% background recovery in 16 selected BC3F5 NILs. Processing quality and sensory evaluation of selected NILs indicated improvement in chapatti making quality. Traits that showed improvement were mouthfeel, tearing strength and softness indicating that the Wx-B1 may be one of the major genes controlling chapatti softness.	[Chunduri, Venkatesh; Sharma, Natasha; Garg, Monika] Natl Agrifood Biotechnol Inst, Agribiotechnol Div, Mohali, Punjab, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI)	Garg, M (corresponding author), Natl Agrifood Biotechnol Inst, Agribiotechnol Div, Mohali, Punjab, India.	mkajgarg@gmail.com		Venkatesh, Chunduri/0000-0002-1909-8867	NABICore grant	NABICore grant	The research work was funded by NABICore grant.	Anderson OD, 2001, THEOR APPL GENET, V103, P323, DOI 10.1007/s00122-001-0551-3; Anil Panghal, 2019, Journal of the Saudi Society of Agricultural Sciences, V18, P107, DOI 10.1016/j.jssas.2017.02.005; Anjum FM, 2000, J SCI FOOD AGR, V80, P219, DOI 10.1002/(SICI)1097-0010(20000115)80:2&lt;219::AID-JSFA520&gt;3.0.CO;2-M; Bao Z., 2013, PLOS ONE, V8; Blazek J, 2008, CARBOHYD POLYM, V71, P380, DOI 10.1016/j.carbpol.2007.06.010; Carollo V, 2005, PLANT PHYSIOL, V139, P643, DOI 10.1104/pp.105.064485; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Chen F, 2007, J CEREAL SCI, V45, P59, DOI 10.1016/j.jcs.2006.06.006; Chopra R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2268-8; Cohen A, 1999, PLANT CELL ENVIRON, V22, P989, DOI 10.1046/j.1365-3040.1999.00474.x; Dhaliwal YS, 1996, FOOD RES INT, V29, P163, DOI 10.1016/0963-9969(96)00004-X; Ereful NC, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10050621; Garg M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162350; Gibson TS, 1997, J CEREAL SCI, V25, P111, DOI 10.1006/jcrs.1996.0086; Goryunova SV, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-215; Graybosch RA, 1998, TRENDS FOOD SCI TECH, V9, P135, DOI 10.1016/S0924-2244(98)00034-X; Gujral HS, 2002, J FOOD ENG, V55, P173, DOI 10.1016/S0260-8774(02)00061-4; Gujral HS, 2004, J FOOD ENG, V65, P89, DOI 10.1016/j.jfoodeng.2003.12.007; Guo Q, 2014, CEREAL CHEM, V91, P623, DOI 10.1094/CCHEM-01-14-0015-R; Hemalatha M. S., 2013, Food and Nutrition Sciences, V4, P884, DOI 10.4236/fns.2013.49116; Huang Xiu-Qiang, 2010, BMC Res Notes, V3, P140, DOI 10.1186/1756-0500-3-140; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kaur A, 2016, J FOOD SCI TECH MYS, V53, P2127, DOI 10.1007/s13197-016-2202-3; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Kumar A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01593; Kumar R, 2015, BREEDING SCI, V65, P319, DOI 10.1270/jsbbs.65.319; Kumar S, 2018, INDIAN J BIOTECHNOL, V17, P65; Kundu M, 2017, FOOD CHEM, V226, P95, DOI 10.1016/j.foodchem.2016.12.046; Larmond E., 1977, LAB METHODS SENSORY; Lee MR, 2001, CEREAL CHEM, V78, P701, DOI 10.1094/CCHEM.2001.78.6.701; Liao JL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1222-0; Martin JM, 2007, CROP SCI, V47, P497, DOI 10.2135/cropsci2006.05.0342; Morita N., 2003, P 53 AUSTR CER CHEM, P153; Morris CF, 2002, PLANT MOL BIOL, V48, P633, DOI 10.1023/A:1014837431178; Nakamura T, 2002, GENOME, V45, P1150, DOI [10.1139/g02-090, 10.1139/G02-090]; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Peng M, 1999, CEREAL CHEM, V76, P375, DOI 10.1094/CCHEM.1999.76.3.375; Quayson ET, 2016, J CEREAL SCI, V69, P252, DOI 10.1016/j.jcs.2016.03.017; Ram S, 2004, CEREAL CHEM, V81, P128, DOI 10.1094/CCHEM.2004.81.1.128; Ramu VS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157522; Rao HP, 1993, ENCY FOOD SCI FOOD T, V2, P795; Rehman SU, 2007, LWT-FOOD SCI TECHNOL, V40, P775, DOI 10.1016/j.lwt.2006.04.009; Saito M, 2009, MOL BREEDING, V23, P209, DOI 10.1007/s11032-008-9226-y; Shaikh IM, 2007, FOOD CHEM, V101, P113, DOI 10.1016/j.foodchem.2006.01.015; Singh A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-29; Singh S, 2010, J AGR FOOD CHEM, V58, P1180, DOI 10.1021/jf902753f; Sourdille Pierre, 2004, Functional & Integrative Genomics, V4, P12, DOI 10.1007/s10142-004-0106-1; Srivastava AK, 2003, J SCI FOOD AGR, V83, P225, DOI 10.1002/jsfa.1297; Survase A, 2017, CEREAL CHEM, V94, P409, DOI [10.1094/CCHEM-04-16-0090-R, 10.1094/cchem-04-16-0090-r]; Swaminathan MS, 2013, AGR RES, V2, P183, DOI 10.1007/s40003-013-0069-3; Totosaus A, 2013, J TEXTURE STUD, V44, P424, DOI 10.1111/jtxs.12031; Williams PC, 1986, RACHIS, V2, P3; Xiao ZS, 2006, CEREAL CHEM, V83, P465, DOI 10.1094/CC-83-0465; Zhang XF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-243	54	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246095	10.1371/journal.pone.0246095	http://dx.doi.org/10.1371/journal.pone.0246095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508026	Green Published, gold			2022-12-26	WOS:000635021400086
J	Ledon-LLanes, L; Contreras-Yanez, I; Guaracha-Basanez, G; Valverde-Hernandez, SS; Gonzalez-Marin, A; Ballinas-Sanchez, AD; Durand, M; Pascual-Ramos, V				Ledon-LLanes, Loraine; Contreras-Yanez, Irazu; Guaracha-Basanez, Guillermo; Saul Valverde-Hernandez, Salvador; Gonzalez-Marin, Anayanci; de Jesus Ballinas-Sanchez, Angel; Durand, Marta; Pascual-Ramos, Virginia			Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study	PLOS ONE			English	Article							FEMALE-PATIENTS; LATIN-AMERICAN; WOMEN; DYSFUNCTION; DISEASE; DETERMINANTS; FERTILITY; COMMUNICATION; SATISFACTION; PHYSICIANS	Background Rheumatoid arthritis (RA) impacts sexual and reproductive health (SRH), which is a prominent component of a patient ' s quality of life and highly influenced by the cultural background. The aim of the study was to explore the interest of Mexican outpatients with RA in SRH and to examine patient view on SRH. Methods This cross-sectional study surveyed 303 consecutive outpatients with RA on their perceptions of SRH importance, SRH satisfaction, access to SRH information, preferences regarding SRH communication with healthcare professionals, and understanding of SRH (qualitative open-ended descriptions). Descriptive statistics and inferential analysis were used. Patient knowledge of each dimension of SRH was rated based on pre-specified criteria. Two assessors assigned ten major themes to each patient ' s description of both dimensions of SRH. Results Patients perceived their SRH as an important component of their general health and wished to address the topic, although few had access to such communication. Female patients assigned lesser importance to SRH, showed lesser degree of satisfaction with SRH, and expressed preference for a truthful physician. Age showed a linear association with individual survey responses, except for satisfaction with reproductive health dimension. There was a linear association between increased age and decreased years of formal education with a lower level of SRH knowledge. Ten major themes emerged for each of the two dimensions of the SRH construct, although most individual descriptions were assigned to one or two major themes. Conclusions Further education and assessment of SRH in Mexican patients with RA is warranted.	[Ledon-LLanes, Loraine; Durand, Marta] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Biol Reprod, Mexico City, DF, Mexico; [Contreras-Yanez, Irazu; Guaracha-Basanez, Guillermo; Saul Valverde-Hernandez, Salvador; Gonzalez-Marin, Anayanci; de Jesus Ballinas-Sanchez, Angel; Pascual-Ramos, Virginia] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Pascual-Ramos, V (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico.	virtichu@gmail.com		Valverde Hernandez, Salvador Saul/0000-0003-1163-4175				Abdel-Nasser AM, 2006, CLIN RHEUMATOL, V25, P822, DOI 10.1007/s10067-005-0175-0; Ahlmen M, 2005, RHEUMATOLOGY, V44, P105, DOI 10.1093/rheumatology/keh412; Akkus Y, 2010, SEX DISABIL, V28, P223, DOI 10.1007/s11195-010-9162-8; Alvarez-Nemegyei Jose, 2011, Rev Med Inst Mex Seguro Soc, V49, P599; Andreoli L, 2019, JOINT BONE SPINE, V86, P475, DOI 10.1016/j.jbspin.2018.12.002; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; BALDURSSON H, 1979, SCAND J RHEUMATOL, V8, P214, DOI 10.3109/03009747909114625; Bay LT, 2020, SEX MED-UK, V8, P615, DOI 10.1016/j.esxm.2020.07.004; Berrios-Rivera JP, 2006, ARTHRIT RHEUM-ARTHR, V55, P385, DOI 10.1002/art.21988; Berro Pizzarossa L, 2017, HEALTH HUM RIGHTS, V19, P279; Bortz WM, 1999, WESTERN J MED, V170, P167; Brouwer J, 2017, ARTHRIT CARE RES, V69, P1142, DOI 10.1002/acr.23124; Brouwer J, 2015, ANN RHEUM DIS, V74, P1836, DOI 10.1136/annrheumdis-2014-205383; Cardiel MH, 2012, JCR-J CLIN RHEUMATOL, V18, P327, DOI 10.1097/RHU.0b013e31826d6610; Chakravarty E, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004081; Clowse MEB, 2012, ARTHRIT CARE RES, V64, P668, DOI 10.1002/acr.21593; Colmenares-Roa T, 2016, QUAL HEALTH RES, V26, P1674, DOI 10.1177/1049732315588742; Dalati S., 2018, MODERNIZING ACAD TEA, P175; de Castro F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193780; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Donovan H, 2018, SEXUAL REPROD HLTH R; Dorner TE, 2018, RHEUMATOL INT, V38, P1103, DOI 10.1007/s00296-018-4023-3; El Miedany Y, 2012, CLIN RHEUMATOL, V31, P601, DOI 10.1007/s10067-011-1891-2; Fathalla MF, 2017, INT ENCY PUBLIC HLTH, P481; Freburger JK, 2003, ARTHRIT RHEUM-ARTHR, V49, P51, DOI 10.1002/art.10925; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; Gerosa M, 2008, WOMENS HEALTH, V4, P195, DOI 10.2217/17455057.4.2.195; Geuskens GA, 2007, J RHEUMATOL, V34, P1639; Gott M, 2003, SOC SCI MED, V56, P1617, DOI 10.1016/S0277-9536(02)00180-6; Graves H, 2009, J PSYCHOSOM RES, V67, P417, DOI 10.1016/j.jpsychores.2009.01.006; Gutweniger S, 1999, CLIN EXP RHEUMATOL, V17, P413; Hari A, 2015, CLIN RHEUMATOL, V34, P1047, DOI 10.1007/s10067-015-2888-z; Heiman JR, 2002, J SEX RES, V39, P73, DOI 10.1080/00224490209552124; Helland Y, 2008, SCAND J RHEUMATOL, V37, P194, DOI 10.1080/03009740701867349; Henes M, 2015, RHEUMATOLOGY, V54, P1709, DOI 10.1093/rheumatology/kev124; Hill J, 2003, RHEUMATOLOGY, V42, P280, DOI 10.1093/rheumatology/keg079; Ingram E, 2021, JCR-J CLIN RHEUMATOL, V27, P97, DOI 10.1097/RHU.0000000000001184; Irwin R, 1997, J ADV NURS, V25, P170, DOI 10.1046/j.1365-2648.1997.1997025170.x; Jawaheer D, 2011, ARTHRITIS RHEUM-US, V63, P1517, DOI 10.1002/art.30327; Josefsson KA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-240; Josefsson KA, 2012, MUSCULOSKELET CARE, V10, P76, DOI 10.1002/msc.1002; Karlsson Berit, 2006, Scand J Occup Ther, V13, P193; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Kumar K, 2008, RHEUMATOLOGY, V47, P690, DOI 10.1093/rheumatology/ken050; Labrie F, 2016, MENOPAUSE, V23, P243, DOI 10.1097/GME.0000000000000571; Lazcano-Ponce E, 2004, ARCH MED RES, V35, P66, DOI 10.1016/j.arcmed.2003.06.007; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Lin MC, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0363-5; Massone F, 2017, CLIN RHEUMATOL, V36, P2789, DOI 10.1007/s10067-017-3866-4; Merayo-Chalico J, 2019, J RHEUMATOL, V46, P397, DOI 10.3899/jrheum.180292; Mercer CH, 2003, BRIT MED J, V327, P426, DOI 10.1136/bmj.327.7412.426; Skinner-Taylor CM, 2021, RHEUMATOL INT, V41, P409, DOI 10.1007/s00296-020-04679-1; Mody GM, 2008, BEST PRACT RES CL RH, V22, P621, DOI 10.1016/j.berh.2008.04.003; Nielsen-Bohlman L., 2004, HLTH LITERACY PRESCR; NIH. Health Literacy Definition, 2020, NETWORK NATL LIB MED; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ostensen M, 2017, NAT REV RHEUMATOL, V13, P485, DOI 10.1038/nrrheum.2017.102; Palominos PE, 2018, ADV RHEUMATOL, V58, DOI 10.1186/s42358-018-0036-6; Parker R, 2009, CULT HEALTH SEX, V11, P251, DOI 10.1080/13691050701606941; Pascual-Ramos V, 2019, CLIN EXP RHEUMATOL, V37, P608; Pascual-Ramos V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2620; Perez-Garcia LF, 2020, SEMIN ARTHRITIS RHEU, V50, P557, DOI 10.1016/j.semarthrit.2020.02.002; Pieber K, 2012, J REHABIL MED, V44, P658, DOI 10.2340/16501977-1010; Putrik P, 2016, ANN RHEUM DIS, V75, P715, DOI 10.1136/annrheumdis-2015-207738; Ryan S, 2005, MUSCULOSKELET CARE, V3, P44, DOI 10.1002/msc.25; Saadat SH, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.19005; Savel C, 2020, RHEUMATOL INT, V40, P1481, DOI 10.1007/s00296-020-04630-4; Shahar MA, 2012, INT J RHEUM DIS, V15, P468, DOI 10.1111/j.1756-185X.2012.01753.x; Shiferaw KB, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01202-1; Steiner S, 2003, HLTH MEASUREMENT SCA; Talabi MB, 2019, ARTHRIT CARE RES, V71, P1132, DOI 10.1002/acr.23724; Tasiemski Tomasz, 2009, Ortop Traumatol Rehabil, V11, P346; Thompson GA, 2018, QUAL HEALTH RES, V28, P1910, DOI 10.1177/1049732318783696; Tristano AG, 2009, RHEUMATOL INT, V29, P853, DOI 10.1007/s00296-009-0850-6; United Nations, 1995, 4 WIELD C PLAT; United Nations,, 1995, REPORT INT C POPULAT; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; van Berlo WTM, 2007, CLIN RHEUMATOL, V26, P30, DOI 10.1007/s10067-006-0216-3; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Wallenius M, 2012, SCAND J RHEUMATOL, V41, P202, DOI 10.3109/03009742.2011.641582; Wallenius M, 2011, RHEUMATOLOGY, V50, P1162, DOI 10.1093/rheumatology/keq458; World Health Organization, 2002, WHO TRADITIONAL MED, P1; World Medical Association, 2001, Eur J Emerg Med, V8, P221; Yazdany J, 2011, ARTHRIT CARE RES, V63, P358, DOI 10.1002/acr.20402; Yilmaz H, 2012, J SEX MED, V9, P2664, DOI 10.1111/j.1743-6109.2012.02882.x; Zhang QX, 2018, PSYCHOL HEALTH MED, V23, P114, DOI 10.1080/13548506.2017.1338738; Zhao SK, 2018, J RHEUMATOL, V45, P1375, DOI 10.3899/jrheum.170956	87	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245538	10.1371/journal.pone.0245538	http://dx.doi.org/10.1371/journal.pone.0245538			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33507948	Green Published, gold			2022-12-26	WOS:000635021400039
J	Criado-Mesas, L; Ballester, M; Crespo-Piazuelo, D; Passols, M; Castello, A; Sanchez, A; Folch, JM				Criado-Mesas, Lourdes; Ballester, Maria; Crespo-Piazuelo, Daniel; Passols, Magi; Castello, Anna; Sanchez, Armand; Folch, Josep M.			Expression analysis of porcine miR-33a/b in liver, adipose tissue and muscle and its potential role in fatty acid metabolism	PLOS ONE			English	Article							LIPID-METABOLISM; REGULATORS; TRANSCRIPTION; INTRON; PIG	mir-33a and mir-33b are co-transcribed with the SREBF2 and SREBF1 transcription factors, respectively. The main role of SREBF1 is the regulation of genes involved in fatty acid metabolism, while SREBF2 regulates genes participating in cholesterol biosynthesis and uptake. Our objective was to study the expression of both miR-33a and miR-33b, together with their host SREBF genes, in liver, adipose tissue and muscle to better understand the role of miR-33a/b in the lipid metabolism of pigs. In our study, the expression of miR-33a, miR-33b and SREBF2 in liver, adipose tissue, and muscle was studied in 42 BC1_LD (25% Iberian x 75% Landrace backcross) pigs by RT-qPCR. In addition, the expression of in-silico predicted target genes and fatty acid composition traits were correlated with the miR-33a/b expression. We observed different tissue expression patterns for both miRNAs. In adipose tissue and muscle a high correlation between miR-33a and miR-33b expression was found, whereas a lower correlation was observed in liver. The expression analysis of in-silico predicted target-lipid related genes showed negative correlations between miR-33b and CPT1A expression in liver. Conversely, positive correlations between miR-33a and PPARGC1A and USF1 gene expression in liver were observed. Lastly, positive and negative correlations between miR-33a/b expression and saturated fatty acid (SFA) and polyunsaturated fatty acid (PUFA) content, respectively, were identified. Overall, our results suggested that both miRNAs are differentially regulated and have distinct functions in liver, in contrast to muscle and adipose tissue. Furthermore, the correlations between miR-33a/b expression both with the expression of in-silico predicted target-lipid related genes and with fatty acid composition, opens new avenues to explore the role of miR33a/b in the regulation of lipid metabolism.	[Criado-Mesas, Lourdes; Crespo-Piazuelo, Daniel; Passols, Magi; Castello, Anna; Sanchez, Armand; Folch, Josep M.] CSIC IRTA UAB UB, Ctr Res Agr Genom CRAG, Plant & Anim Genom, Campus UAB, Bellaterra, Spain; [Ballester, Maria] Inst Res & Technol Food & Agr IRTA, Anim Breeding & Genet Programme, Torre Marimon, Caldes De Montb, Spain; [Crespo-Piazuelo, Daniel; Castello, Anna; Sanchez, Armand; Folch, Josep M.] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Dels Aliments, Bellaterra, Spain; [Crespo-Piazuelo, Daniel] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; IRTA; Autonomous University of Barcelona; Teagasc	Criado-Mesas, L (corresponding author), CSIC IRTA UAB UB, Ctr Res Agr Genom CRAG, Plant & Anim Genom, Campus UAB, Bellaterra, Spain.	lourdes.criado@cragenomica.es	Ballester, Maria/E-7201-2016; Farré, Anna Castelló/K-9637-2015; Crespo-Piazuelo, Daniel/K-2280-2015; Folch, Josep M/I-4738-2015	Ballester, Maria/0000-0002-5413-4640; Farré, Anna Castelló/0000-0001-8497-6251; Crespo-Piazuelo, Daniel/0000-0001-7896-2507; Criado Mesas, Lourdes/0000-0002-1115-4131; Folch, Josep M/0000-0003-3689-1303	Spanish Ministerio de Economia y Competitividad (MINECO) [AGL2017-82641-R]; Fondo Europeo de Desarrollo Regional (FEDER); FPI [AGL2017-82641-R]; Spanish Ministerio de Economia y Competitividad [RYC-2013-12573, SEV-2015-0533]; "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya [ECO/1788/2014]; FPI grant [AGL2017-82641-R]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); FPI(Spanish Government); Spanish Ministerio de Economia y Competitividad(Spanish Government); "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya; FPI grant	This work was supported by the Spanish Ministerio de Economia y Competitividad (MINECO) with project AGL2017-82641-R (https://portal.mineco.gob.es/es-es/Paginas/default.aspx) and the Fondo Europeo de Desarrollo Regional (FEDER, http://ec.europa.eu/regional_policy/es/funding/erdf/).LCM was financially supported by an FPI grant from the AGL2014-56369-C2 project. MB was funded with a "Ramon y Cajal" contract (RYC-2013-12573) from the Spanish Ministerio de Economia y Competitividad. DCP was funded by a "Formacio i Contractacio de Personal Investigador Novell" (FI-DGR) Ph.D grant from the Generalitat de Catalunya (ECO/1788/2014). MP was funded by an FPI grant from the AGL2017-82641-R project. We acknowledge the support of the Spanish Ministerio de Economia y Competitividad for the "Severo Ochoa Programme for Centres of Excellence in R&D" 2016-2019 (SEV-2015-0533) to the Centre for Research in Agricultural Genomics and the CERCA Programme / Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ballester M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46539; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; DeBose-Boyd RA, 2018, TRENDS BIOCHEM SCI, V43, P358, DOI 10.1016/j.tibs.2018.01.005; Dubitzky W., 2013, ENCY SYSTEMBIOL, P2303; Echeverria F, 2016, PROSTAG LEUKOTR ESS, V114, P28, DOI 10.1016/j.plefa.2016.10.001; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Gondret F, 2001, J LIPID RES, V42, P106; Griffin MJ, 2004, IUBMB LIFE, V56, P595, DOI 10.1080/15216540400022474; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Mentzel CMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131650; Metpally RPR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-11; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; MUNOZ M, 2013, BMC GENOMICS, V14, DOI DOI 10.1186/1471-2164-14-1423324084; Nafikov RA, 2007, J NUTR, V137, P702, DOI 10.1093/jn/137.3.702; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; Price NL, 2016, MOL CELL BIOL, V36, P1180, DOI 10.1128/MCB.00745-15; Puig-Oliveras A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31803; R Core Team, 2018, R LANG ENV STAT COMP; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; RAMAYOCALDAS Y, 2012, BMC GENOMICS, V13, DOI DOI 10.1186/1471-2164-13-1322233093; Ramirez CM, 2013, MOL CELL BIOL, V33, P2891, DOI 10.1128/MCB.00016-13; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Revilla M, 2018, SCI REP, V8, P1; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091236; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Song ZP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2983908; Taniguchi M, 2014, MOL BIOL REP, V41, P1081, DOI 10.1007/s11033-013-2954-z; Timoneda O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044413; Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029; Wood J, 2007, WHITTEMORES SCI PRAC, DOI [DOI 10.1002/9780470995624.CH2, 10.1002/9780470995624.ch2]; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Zhang BH, 2019, BIOMED PHARMACOTHER, V111, P657, DOI 10.1016/j.biopha.2018.12.123	46	0	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245858	10.1371/journal.pone.0245858	http://dx.doi.org/10.1371/journal.pone.0245858			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497399	Green Published, gold			2022-12-26	WOS:000613707100015
J	Park, KH; Sun, S; Lim, YH; Park, HR; Lee, JM; Park, K; Jeon, B; Park, HP; Kim, HC; Paek, SH				Park, Kwang Hyon; Sun, Sukkyu; Lim, Yong Hoon; Park, Hye Ran; Lee, Jae Meen; Park, Kawngwoo; Jeon, Beomseok; Park, Hee-Pyoung; Kim, Hee Chan; Paek, Sun Ha			Clinical outcome prediction from analysis of microelectrode recordings using deep learning in subthalamic deep brain stimulation for Parkinson`s disease	PLOS ONE			English	Article							NUCLEUS STIMULATION; GENERAL-ANESTHESIA; FREQUENCY; SEGMENTATION; SURGERY	Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for improving the motor symptoms of advanced Parkinson's disease (PD). Accurate positioning of the stimulation electrodes is necessary for better clinical outcomes. Objective We applied deep learning techniques to microelectrode recording (MER) signals to better predict motor function improvement, represented by the UPDRS part III scores, after bilateral STN DBS in patients with advanced PD. If we find the optimal stimulation point with MER by deep learning, we can improve the clinical outcome of STN DBS even under restrictions such as general anesthesia or non-cooperation of the patients. Methods In total, 696 4-second left-side MER segments from 34 patients with advanced PD who underwent bilateral STN DBS surgery under general anesthesia were included. We transformed the original signal into three wavelets of 1-50 Hz, 50-500 Hz, and 500-5,000 Hz. The wavelet-transformed MER was used for input data of the deep learning. The patients were divided into two groups, good response and moderate response groups, according to DBS on to off ratio of UPDRS part III score for the off-medication state, 6 months postoperatively. The ratio were used for output data in deep learning. The Visual Geometry Group (VGG)-16 model with a multitask learning algorithm was used to estimate the bilateral effect of DBS. Different ratios of the loss function in the task-specific layer were applied considering that DBS affects both sides differently. Results When we divided the MER signals according to the frequency, the maximal accuracy was higher in the 50-500 Hz group than in the 1-50 Hz and 500-5,000 Hz groups. In addition, when the multitask learning method was applied, the stability of the model was improved in comparison with single task learning. The maximal accuracy (80.21%) occurred when the right-to-left loss ratio was 5:1 or 6:1. The area under the curve (AUC) was 0.88 in the receiver operating characteristic (ROC) curve. Conclusion Clinical improvements in PD patients who underwent bilateral STN DBS could be predicted based on a multitask deep learning-based MER analysis.	[Park, Kwang Hyon; Lim, Yong Hoon; Paek, Sun Ha] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Sun, Sukkyu; Kim, Hee Chan] Seoul Natl Univ, Grad Sch, Interdisciplinary Program Bioengn, Seoul, South Korea; [Park, Hye Ran] Soonchunhyang Univ, Dept Neurosurg, Seoul Hosp, Seoul, South Korea; [Lee, Jae Meen] Pusan Natl Univ Hosp, Dept Neurosurg, Busan, South Korea; [Park, Kawngwoo] Gachon Univ, Dept Neurosurg, Gil Med Ctr, Incheon, South Korea; [Jeon, Beomseok] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Hee-Pyoung] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Hee Chan] Seoul Natl Univ, Inst Med & Biol Engn, Med Res Ctr, Seoul, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Ischemia Hypoxia Dis Inst, Coll Med, Seoul, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Soonchunhyang University; Pusan National University; Pusan National University Hospital; Gachon University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Paek, SH (corresponding author), Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea.; Kim, HC (corresponding author), Seoul Natl Univ, Grad Sch, Interdisciplinary Program Bioengn, Seoul, South Korea.; Kim, HC (corresponding author), Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.; Kim, HC (corresponding author), Seoul Natl Univ, Inst Med & Biol Engn, Med Res Ctr, Seoul, South Korea.; Paek, SH (corresponding author), Seoul Natl Univ, Ischemia Hypoxia Dis Inst, Coll Med, Seoul, South Korea.; Paek, SH (corresponding author), Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea.	paeksh@snu.ac.kr; hckim@snu.ac.kr		Park, Hee-Pyoung/0000-0002-4772-0780; Park, Kwang Hyon/0000-0003-2386-4680; Kim, Hee Chan/0000-0002-2112-426X	Korea Healthcare Technology RD Project [HI11C21100200]; Ministry of Health & Welfare, Republic of Korea; Industrial Strategic Technology Development Program - Ministry of Trade, Industry & Energy (MI, Korea) [10050154]; Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2015M3C7A1028926]; Ministry of Education, Science and Technology [2017M3C7A1047392]; Soonchunhyang University	Korea Healthcare Technology RD Project; Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Industrial Strategic Technology Development Program - Ministry of Trade, Industry & Energy (MI, Korea)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Soonchunhyang University	This study was supported by the Korea Healthcare Technology R&D Project (grant No. HI11C21100200), funded by the Ministry of Health & Welfare, Republic of Korea; the Industrial Strategic Technology Development Program (grant No. 10050154, Business Model Development for Personalized Medicine Based on Integrated Genome and Clinical Information) funded by the Ministry of Trade, Industry & Energy (MI, Korea); the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant No. 2015M3C7A1028926); the Original Technology Research Program for Brain Science through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (grant No. 2017M3C7A1047392); and by Soonchunhyang University research funds.	Baumgarten C, 2017, IEEE T BIO-MED ENG, V64, P2134, DOI 10.1109/TBME.2016.2638018; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Benazzouz A, 2002, MOVEMENT DISORD, V17, pS145, DOI 10.1002/mds.10156; Cernazanu-Glavan C, 2013, ADV ELECTR COMPUT EN, V13, P87, DOI 10.4316/AECE.2013.01015; Chen SY, 2011, STEREOT FUNCT NEUROS, V89, P372, DOI 10.1159/000332058; Cho ZH, 2010, J NEUROSURG, V113, P639, DOI 10.3171/2010.3.JNS091385; Chung SJ, 2006, EUR NEUROL, V56, P127, DOI 10.1159/000095704; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; Duque P, 2008, EUR J NEUROL, V15, P76, DOI 10.1111/j.1468-1331.2008.02166.x; GOUPILLAUD P, 1984, GEOEXPLORATION, V23, P85, DOI 10.1016/0016-7142(84)90025-5; Hutchison WD, 2003, ANN NEUROL, V53, P480, DOI 10.1002/ana.10474; Kim W, 2014, J KOREAN MED SCI, V29, P1278, DOI 10.3346/jkms.2014.29.9.1278; Kristekova M, 2009, GEOPHYS J INT, V178, P813, DOI [10.1111/J.1365-246X.2009.04177.X, 10.1111/j.1365-246X.2009.04177.x]; Li Z, 2016, STEREOT FUNCT NEUROS, V94, P351, DOI 10.1159/000449206; Mansour RF, 2018, BIOMED ENG LETT, V8, P41, DOI 10.1007/s13534-017-0047-y; Novak P, 2007, J NEUROSURG, V106, P175, DOI 10.3171/jns.2007.106.1.175; Pereira S, 2016, IEEE T MED IMAGING, V35, P1240, DOI 10.1109/TMI.2016.2538465; Ren Z, 2018, IEEE-CAA J AUTOMATIC, V5, P662, DOI 10.1109/JAS.2018.7511066; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sobstyl M, 2017, TURK NEUROSURG, V27, P294, DOI 10.5137/1019-5149.JTN.14894-15.0; Vallabhajosula S, 2015, BRAIN STIMUL, V8, P64, DOI 10.1016/j.brs.2014.10.011; Yamada K, 2007, PARKINSONISM RELAT D, V13, P101, DOI 10.1016/j.parkreldis.2006.07.008; Zaidel A, 2010, BRAIN, V133, P2007, DOI 10.1093/brain/awq144; Zuchner, 2006, NEUROSURGERY, V59, pE1138, DOI [DOI 10.1227/01.NEU.0000245603.77075.55, 10.1227/01.NEU.0000245603.77075.55]	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0244133	10.1371/journal.pone.0244133	http://dx.doi.org/10.1371/journal.pone.0244133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497391	gold, Green Published			2022-12-26	WOS:000613707100026
J	Kacerovsky, M; Pliskova, L; Bolehovska, R; Lesko, D; Gerychova, R; Janku, P; Matlak, P; Simetka, O; Stranik, J; Faist, T; Mls, J; Vescicik, P; Jacobsson, B; Musilova, I				Kacerovsky, Marian; Pliskova, Lenka; Bolehovska, Radka; Lesko, Daniel; Gerychova, Romana; Janku, Petr; Matlak, Petr; Simetka, Ondrej; Stranik, Jaroslav; Faist, Tomas; Mls, Jan; Vescicik, Peter; Jacobsson, Bo; Musilova, Ivana			Cervical Gardnerella vaginalis in women with preterm prelabor rupture of membranes	PLOS ONE			English	Article							PREMATURE RUPTURE; BACTERIAL-VAGINOSIS; BIOFILM FORMATION; AMNIOTIC-FLUID; PATHOGENESIS; MICROBIOTA; ETIOLOGY; IDENTIFICATION; INTERLEUKIN-6; INFECTION	Objective To determine the association between microbial invasion of the amniotic cavity (MIAC) and/or intra-amniotic inflammation (IAI) and the cervical prevalence of Gardnerella vaginalis DNA in pregnancies with preterm prelabor rupture of membrane (PPROM). Method In total, 405 women with singleton pregnancies complicated with PPROM were included. Cervical fluid and amniotic fluid samples were collected at the time of admission. Bacterial and G. vaginalis DNA were assessed in the cervical fluid samples using quantitative PCR technique. Concentrations of interleukin-6 and MIAC were evaluated in the amniotic fluid samples. Loads of G. vaginalis DNA. 1% of the total cervical bacterial DNA were used to define the cervical prevalence of G. vaginalis as abundant. Based on the MIAC and IAI, women were categorized into four groups: with intra- amniotic infection (both MIAC and IAI), with sterile IAI (IAI without MIAC), with MIAC without IAI, and without either MIAC or IAI. Results The presence of the abundant cervical G. vaginalis was related to MIAC (with: 65% vs. without: 44%; p = 0.0004) but not IAI (with: 52% vs. without: 48%; p = 0.70). Women with MIAC without IAI had the highest load of the cervical G. vaginalis DNA (median 2.0 x 10(4) copies DNA/mL) and the highest presence of abundant cervical G. vaginalis (73%). Conclusions In women with PPROM, the presence of cervical G. vaginalis was associated with MIAC, mainly without the concurrent presence of IAI.	[Kacerovsky, Marian; Lesko, Daniel; Stranik, Jaroslav; Faist, Tomas; Mls, Jan; Vescicik, Peter; Musilova, Ivana] Charles Univ Prague, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic; [Kacerovsky, Marian] Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Pliskova, Lenka; Bolehovska, Radka] Univ Hosp Hradec Kralove, Inst Clin Biochem & Diagnost, Hradec Kralove, Czech Republic; [Gerychova, Romana; Janku, Petr] Masaryk Univ, Univ Hosp Brno, Dept Obstet & Gynecol, Fac Med, Brno, Czech Republic; [Matlak, Petr; Simetka, Ondrej] Univ Hosp Ostrava, Dept Obstet & Gynecol, Ostrava, Czech Republic; [Jacobsson, Bo] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Jacobsson, Bo] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Reg Vastra Gotaland, Gothenburg, Sweden; [Jacobsson, Bo] Inst Publ Hlth, Dept Genet & Bioinformat, Domain Hlth Data & Digitalisat, Oslo, Norway	Charles University Prague; University Hospital Hradec Kralove; University Hospital Hradec Kralove; University Hospital Hradec Kralove; Masaryk University Brno; University Hospital Brno; University Hospital Ostrava; University of Gothenburg; Sahlgrenska University Hospital	Kacerovsky, M (corresponding author), Charles Univ Prague, Univ Hosp Hradec Kralove, Dept Obstet & Gynecol, Fac Med Hradec Kralove, Hradec Kralove, Czech Republic.; Kacerovsky, M (corresponding author), Univ Hosp Hradec Kralove, Biomed Res Ctr, Hradec Kralove, Czech Republic.	kacermar@fnhk.cz	Janku, Petr/AAC-7947-2022; Kacerovsky, Marian/A-7586-2011	Janku, Petr/0000-0002-6306-8294; Kacerovsky, Marian/0000-0001-9858-7900	Ministry of Health of the Czech Republic [1628587A]; project PERSONMED - Center for the Development of Personalized Medicine in AgeRelated Diseases [CZ.02.1.01/0.0/0.0/17_048/0007441]; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic [PROGRES P40/10]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); project PERSONMED - Center for the Development of Personalized Medicine in AgeRelated Diseases; Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic	MK, OS, PJ received the following grant: the Ministry of Health of the Czech Republic (1628587A) MK received the financial support from the the project PERSONMED - Center for the Development of Personalized Medicine in AgeRelated Diseases [Reg. Nr. CZ.02.1.01/0.0/0.0/17_048/0007441] MK received financial support by the Charles University in Prague, Faculty of Medicine in Hradec Kralove, Czech Republic, project ``PROGRES P40/10". The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Anton L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02181; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; Benjamino J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0469-5; Brown RG, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0999-x; Castro J, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw007; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P349, DOI 10.3109/14767058.2015.1006620; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Fouhy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119355; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Janulaitiene M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200625; Janulaitiene M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2501-y; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Kacerovsky M, 2020, PEDIATR RES, V87, P952, DOI 10.1038/s41390-019-0692-1; Kacerovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126884; Kacerovsky M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.069; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky M, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.028; Kroon SJ, 2018, FERTIL STERIL, V110, P327, DOI 10.1016/j.fertnstert.2018.06.036; Kumar D, 2016, PLACENTA, V42, P59, DOI 10.1016/j.placenta.2016.03.015; Lee T, 2001, CLIN PERINATOL, V28, P721, DOI 10.1016/S0095-5108(03)00073-3; Liu CM, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-56, 10.1186/1471-2180-12-255]; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Machado A, 2015, J INFECT DIS, V212, P1856, DOI 10.1093/infdis/jiv338; Machado D, 2017, PEERJ, V5, DOI 10.7717/peerj.3750; MCGREGOR JA, 1993, AM J OBSTET GYNECOL, V169, P463, DOI 10.1016/0002-9378(93)90342-G; Menon R, 2017, SEMIN PERINATOL, V41, P409, DOI 10.1053/j.semperi.2017.07.012; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Mikamo H, 1999, Infect Dis Obstet Gynecol, V7, P190, DOI 10.1155/S1064744999000320; Musilova I, 2020, J MATERN-FETAL NEO M, V33, P1919, DOI 10.1080/14767058.2018.1533947; Musilova I, 2018, PEDIATR RES, V83, P630, DOI 10.1038/pr.2017.300; Musilova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189394; Musilova I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182731; Musilova I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133929; Nelson DB, 2014, PAEDIATR PERINAT EP, V28, P88, DOI 10.1111/ppe.12106; OKA K, 1987, BIOL RES PREG PERIN, V8, P1; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Pillay Kayla, 2020, Infect Dis Obstet Gynecol, V2020, P3176407, DOI 10.1155/2020/3176407; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Rampersaud R, 2011, J BACTERIOL, V193, P1034, DOI 10.1128/JB.00694-10; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REID G, 1987, REV INFECT DIS, V9, P470; ROMERO R, 1988, SEMIN PERINATOL, V12, P262; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Schwebke JR, 2014, J INFECT DIS, V210, P338, DOI 10.1093/infdis/jiu089; Shang Y, 2017, LIPIDS, V52, P499, DOI 10.1007/s11745-017-4253-2; Shimaoka M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36964-2; Shin DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033238; SHUBERT PJ, 1992, OBSTET GYN CLIN N AM, V19, P251; Sierra LJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191524; SPIEGEL CA, 1983, SCAND J INFECT DIS, P41; Stewart CJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0295-1; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053997; Theis KR, 2020, J PERINAT MED, V48, P115, DOI 10.1515/jpm-2019-0398	61	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245937	10.1371/journal.pone.0245937	http://dx.doi.org/10.1371/journal.pone.0245937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481958	Green Published, gold			2022-12-26	WOS:000612929300038
J	Carmichael, P; Butler, G; Masic, U; Cole, TJ; De Stavola, BL; Davidson, S; Skageberg, EM; Khadr, S; Viner, RM				Carmichael, Polly; Butler, Gary; Masic, Una; Cole, Tim J.; De Stavola, Bianca L.; Davidson, Sarah; Skageberg, Elin M.; Khadr, Sophie; Viner, Russell M.			Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK	PLOS ONE			English	Article							IDENTITY DISORDER; SELF-HARM; TRANSGENDER CHILDREN; ENDOCRINE TREATMENT; SUICIDAL-BEHAVIOR; HORMONE-TREATMENT; BONE MASS; ADOLESCENTS; SEX; PREVALENCE	Background In adolescents with severe and persistent gender dysphoria (GD), gonadotropin releasing hormone analogues (GnRHa) are used from early/middle puberty with the aim of delaying irreversible and unwanted pubertal body changes. Evidence of outcomes of pubertal suppression in GD is limited. Methods We undertook an uncontrolled prospective observational study of GnRHa as monotherapy in 44 12-15 year olds with persistent and severe GD. Prespecified analyses were limited to key outcomes: bone mineral content (BMC) and bone mineral density (BMD); Child Behaviour CheckList (CBCL) total t-score; Youth Self-Report (YSR) total t-score; CBCL and YSR self-harm indices; at 12, 24 and 36 months. Semistructured interviews were conducted on GnRHa. Results 44 patients had data at 12 months follow-up, 24 at 24 months and 14 at 36 months. All had normal karyotype and endocrinology consistent with birth-registered sex. All achieved suppression of gonadotropins by 6 months. At the end of the study one ceased GnRHa and 43 (98%) elected to start cross-sex hormones. There was no change from baseline in spine BMD at 12 months nor in hip BMD at 24 and 36 months, but at 24 months lumbar spine BMC and BMD were higher than at baseline (BMC +6.0 (95% CI: 4.0, 7.9); BMD +0.05 (0.03, 0.07)). There were no changes from baseline to 12 or 24 months in CBCL or YSR total t-scores or for CBCL or YSR self-harm indices, nor for CBCL total t-score or self-harm index at 36 months. Most participants reported positive or a mixture of positive and negative life changes on GnRHa. Anticipated adverse events were common. Conclusions Overall patient experience of changes on GnRHa treatment was positive. We identified no changes in psychological function. Changes in BMD were consistent with suppression of growth. Larger and longer-term prospective studies using a range of designs are needed to more fully quantify the benefits and harms of pubertal suppression in GD.	[Carmichael, Polly; Butler, Gary; Masic, Una; Davidson, Sarah; Skageberg, Elin M.] Tavistock & Portman NHS Fdn Trust, Gender Ident Dev Serv GIDS, London, England; [Butler, Gary] Univ Coll London Hosp NHS Fdn Trust, Paediat Endocrine Serv, London, England; [Butler, Gary; Cole, Tim J.; De Stavola, Bianca L.; Khadr, Sophie; Viner, Russell M.] UCL, UCL Great Ormond St Inst Child Hlth, London, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London	Carmichael, P (corresponding author), Tavistock & Portman NHS Fdn Trust, Gender Ident Dev Serv GIDS, London, England.	PCarmichael@tavi-port.nhs.uk	Cole, Tim J/B-7883-2008; Viner, Russell/A-1441-2009	Cole, Tim J/0000-0001-5711-8200; Viner, Russell/0000-0003-3047-2247; Masic, Una/0000-0002-8287-9471				Achille C, 2020, INT J PEDIATR ENDOCR, V2020, DOI 10.1186/s13633-020-00078-2; Agana MG, 2019, DM-DIS MON, V65, P303, DOI 10.1016/j.disamonth.2019.07.004; Aitken M, 2016, J AM ACAD CHILD PSY, V55, P513, DOI 10.1016/j.jaac.2016.04.001; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 2013, DIAGNOSTIC STAT MANU, V5; Becker I, 2018, ARCH SEX BEHAV, V47, P2335, DOI 10.1007/s10508-018-1278-4; Biggs M, 2020, ARCH SEX BEHAV, V49, P2231, DOI 10.1007/s10508-020-01764-1; Brik T, 2020, ARCH SEX BEHAV, V49, P2611, DOI 10.1007/s10508-020-01660-8; Butler G, 2018, ARCH DIS CHILD, V103, P631, DOI 10.1136/archdischild-2018-314992; Chew D, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3742; Cohen-Kettenis PT, 2011, ARCH SEX BEHAV, V40, P843, DOI 10.1007/s10508-011-9758-9; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Costa R, 2015, J SEX MED, V12, P2206, DOI 10.1111/jsm.13034; Crijnen AAM, 1997, J AM ACAD CHILD PSY, V36, P1269, DOI 10.1097/00004583-199709000-00020; de Graaf NM, 2018, EUR CHILD ADOLES PSY, V27, P909, DOI 10.1007/s00787-017-1098-4; de Vries ALC, 2011, J SEX MED, V8, P2276, DOI 10.1111/j.1743-6109.2010.01943.x; Deutz MHF, 2016, EUR CHILD ADOLES PSY, V25, P431, DOI 10.1007/s00787-015-0745-x; Ghelani R, 2020, J PEDIATR ENDOCR MET, V33, P107, DOI 10.1515/jpem-2019-0045; Goedegebuure WJ, 2018, J CLIN ENDOCR METAB, V103, P3931, DOI 10.1210/jc.2018-01463; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Hembree WC, 2018, J CLIN ENDOCR METAB, V103, P699, DOI [10.1210/jc.2017-02548, 10.1210/jc.2017-01658]; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Hewitt JK, 2012, MED J AUSTRALIA, V196, P578, DOI 10.5694/mja12.10222; Joseph T, 2019, J PEDIATR ENDOCR MET, V32, P1077, DOI 10.1515/jpem-2019-0046; Jung KY, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e191; Kalkwarf HJ, 2007, J CLIN ENDOCR METAB, V92, P2087, DOI 10.1210/jc.2006-2553; Klink D, 2015, J CLIN ENDOCR METAB, V100, pE270, DOI 10.1210/jc.2014-2439; Krogh AB, 2015, CEPHALALGIA, V35, P1181, DOI 10.1177/0333102415573512; Kuper LE, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-3006; Levitan N, 2019, EUR CHILD ADOLES PSY, V28, P1487, DOI 10.1007/s00787-019-01308-6; LINDGREN TW, 1975, ARCH SEX BEHAV, V4, P639, DOI 10.1007/BF01544272; Mahfouda S, 2017, LANCET DIABETES ENDO, V5, P816, DOI 10.1016/S2213-8587(17)30099-2; Meyer WJ, 2012, PEDIATRICS, V129, P571, DOI [10.1542/peds.2011-3696, 10.1542/PEDS.2011-3696]; Morey Y, 2017, J PUBLIC HEALTH-UK, V39, P58, DOI 10.1093/pubmed/fdw010; Nock MK, 2013, JAMA PSYCHIAT, V70, P300, DOI 10.1001/2013.jamapsychiatry.55; Oliphant J, 2018, NEW ZEAL MED J, V131, P86; Olson-Kennedy J, 2019, TRANSGENDER HEALTH, V4, P304, DOI 10.1089/trgh.2019.0024; Olson-Kennedy J, 2019, JMIR RES PROTOC, V8, DOI 10.2196/14434; Panagiotakopoulos L, 2018, REV ENDOCR METAB DIS, V19, P221, DOI 10.1007/s11154-018-9457-0; Rafferty J, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-2162; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Rothman MS, 2019, CLIN REV BONE MINER, V17, P77, DOI 10.1007/s12018-019-09261-3; Schagen SEE, 2016, J SEX MED, V13, P1125, DOI 10.1016/j.jsxm.2016.05.004; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Skagerberg E, 2013, INT J TRANSGENDERISM, V14, P105, DOI 10.1080/15532739.2013.822340; Skordis N, 2018, HORM RES PAEDIAT, V90, P326, DOI 10.1159/000496115; Spack NP, 2012, PEDIATRICS, V129, P418, DOI 10.1542/peds.2011-0907; Stallard P, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-328; Steensma TD, 2013, J AM ACAD CHILD PSY, V52, P582, DOI 10.1016/j.jaac.2013.03.016; Taliaferro LA, 2019, ARCH SUICIDE RES, V23, P203, DOI 10.1080/13811118.2018.1430639; Telfer MM, 2018, MED J AUSTRALIA, V209, P132, DOI 10.5694/mja17.01044; Turban JL, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2019-1725; Turban JL, 2018, J CHILD PSYCHOL PSYC, V59, P1228, DOI 10.1111/jcpp.12833; Van Meter AR, 2018, EUR CHILD ADOLES PSY, V27, P159, DOI 10.1007/s00787-017-1030-y; Vandenbroucke JP, 2006, CAN MED ASSOC J, V174, P645, DOI 10.1503/cmaj.051484; Verhulst FC, 2003, AM J PSYCHIAT, V160, P1479, DOI 10.1176/appi.ajp.160.8.1479; Viner RM, 2006, J ADOLESCENT HEALTH, V38, P113, DOI 10.1016/j.jadohealth.2005.11.080; Vlot MC, 2017, BONE, V95, P11, DOI 10.1016/j.bone.2016.11.008; World Health Organization, 2019, INT STAT CLASS DIS R; Zemel BS, 2010, J CLIN ENDOCR METAB, V95, P1265, DOI 10.1210/jc.2009-2057; Zucker KJ, 2019, ARCH SEX BEHAV, V48, P1983, DOI 10.1007/s10508-019-01518-8; Zucker KJ, 2012, J SEX MARITAL THER, V38, P151, DOI 10.1080/0092623X.2011.611219	62	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0243894	10.1371/journal.pone.0243894	http://dx.doi.org/10.1371/journal.pone.0243894			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529227	gold, Green Submitted, Green Published			2022-12-26	WOS:000616736200052
J	Sawada, M; Kubota, N; Sekine, R; Yakabe, M; Kojima, T; Umeda-Kameyama, Y; Usami, S; Akishita, M; Ogawa, S				Sawada, Mika; Kubota, Naoto; Sekine, Rie; Yakabe, Mitsutaka; Kojima, Taro; Umeda-Kameyama, Yumi; Usami, Satoshi; Akishita, Masahiro; Ogawa, Sumito			Sex-related differences in the effects of nutritional status and body composition on functional disability in the elderly	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; GERIATRIC ASSESSMENT; MULTIMORBIDITY; MORTALITY; DEMENTIA; SARCOPENIA; ANEMIA; RISK; CARE; MEN	Background The aim of our study was to evaluate the influence of changes of nutritional status and body composition on the results of comprehensive geriatric assessment (CGA) in inpatients of a geriatric ward. Sex differences in these relationships were also investigated. Methods A total of 212 elderly patients (>65 years old) admitted to the geriatric ward at the University of Tokyo hospital between 2012 and 2019 were enrolled in this study. CGA (ADL, IADL, MMSE, GDS, Vitality Index) was performed, along with assessment of body compositions (appendicular muscle mass, abdominal muscle mass, body fat mass) and blood malnutrition biomarkers (serum albumin, pre-albumin, 25-hydroxy vitamin D, zinc, hemoglobin concentrations). Results Multiple linear regression analysis showed that upper, lower limbs and abdominal muscle masses were significantly associated with the score on ADL in men. On the other hand, abdominal muscle mass was negatively associated with the scores on GDS. Body fat mass was also negatively associated with the score on IADL. In contrast, in women, multiple linear regression analysis failed to show any significant associations between body composition parameters and scores on any domains of CGA. Unlike in men, however, blood malnutrition biomarkers were significantly associated with ADL, IADL, MMSE, and Vitality Index in women. Conclusions Our study findings revealed that the association of the nutritional status and body composition with the functional status in the elderly differs by sex. These results suggest that intensification of exercise in men and improvement of the nutritional status in women are particularly useful to maintain the functional status.	[Sawada, Mika; Kubota, Naoto; Sekine, Rie] Univ Tokyo, Dept Clin Nutr Therapy, Tokyo, Japan; [Kubota, Naoto] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Yakabe, Mitsutaka; Kojima, Taro; Umeda-Kameyama, Yumi; Akishita, Masahiro; Ogawa, Sumito] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan; [Usami, Satoshi] Univ Tokyo, Grad Sch Educ, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan.	suogawa-tky@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18K07463, 15K08898]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	S.O. Grant-in-Aid for Scientific Research in Priority Areas (C) (18K07463) and (C) (15K08898) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagger YZ, 2004, OBES RES, V12, P1519, DOI 10.1038/oby.2004.189; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Brodaty H, 2016, DEMENT GERIATR COGN, V42, P323, DOI 10.1159/000450992; Brown Kenneth H., 2001, Food and Nutrition Bulletin, V22, P113; Byrn MA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040729; Chung SD, 2014, J NEUROL SCI, V346, P90, DOI 10.1016/j.jns.2014.07.062; Denny SD, 2006, AM J MED, V119, P327, DOI [10.1016/j.amjmed.2005.08.027, 10.1016/j.amjmed.2005.10.042]; Gomez-Gomez ME, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112842; Ellis G, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6553; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gschwind YJ, 2014, GERONTOLOGY, V60, P123, DOI 10.1159/000355667; Guo SS, 1999, AM J CLIN NUTR, V70, P405; He X, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011152; Herrmann N, 1996, INT J GERIATR PSYCH, V11, P457, DOI 10.1002/(SICI)1099-1166(199605)11:5<457::AID-GPS325>3.0.CO;2-2; Huffman FG, 2018, GERIATRICS-BASEL, V3, DOI 10.3390/geriatrics3020024; Ito H, 2001, EUR J CLIN NUTR, V55, P462, DOI 10.1038/sj.ejcn.1601206; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Jeong SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0322-2; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee CG, 2011, J AM GERIATR SOC, V59, P233, DOI 10.1111/j.1532-5415.2010.03245.x; MAHONEY F I, 1965, Md State Med J, V14, P61; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Minn YK, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0433-4; Nathans L. L., 2012, PRACTICAL ASSESSMENT, V17, P9, DOI DOI 10.7275/5FEX-B874; Oliveira A, 2015, CLIN RHEUMATOL, V34, P1673, DOI 10.1007/s10067-015-2943-9; Palmer RM, 1999, MED CLIN N AM, V83, P1503, DOI 10.1016/S0025-7125(05)70177-2; Pasco JA, 2017, J CACHEXIA SARCOPENI, V8, P482, DOI 10.1002/jcsm.12177; Pedhazur EJ., 1997, MULTIPLE REGRESSION, V3rd ed; Portbury SD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122506; RUBENSTEIN LZ, 1991, J AM GERIATR SOC, V39, P926, DOI 10.1111/j.1532-5415.1991.tb04462.x; RUBENSTEIN LZ, 1984, NEW ENGL J MED, V311, P1664, DOI 10.1056/NEJM198412273112604; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Toba K, 2002, GERIATR GERONTOL INT, V2, P23, DOI DOI 10.1046/J.1444-1586.2002.00016.X; Tsoi KKF, 2015, JAMA INTERN MED, V175, P1450, DOI 10.1001/jamainternmed.2015.2152; United Nation United Nation (UN) Department of Economic and Social Affairs, WORLD POP AG 2019 RE; VERBRUGGE LM, 1982, PUBLIC HEALTH REP, V97, P417; Woodrow G, 2009, CURR OPIN CLIN NUTR, V12, P8, DOI 10.1097/MCO.0b013e32831b9c5b; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Zhang ZY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080829	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246276	10.1371/journal.pone.0246276	http://dx.doi.org/10.1371/journal.pone.0246276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529213	gold, Green Published			2022-12-26	WOS:000616736200040
J	Barbieri, DM; Lou, BW; Passavanti, M; Hui, C; Hoff, I; Lessa, DA; Sikka, G; Chang, K; Gupta, A; Fang, K; Banerjee, A; Maharaj, B; Lam, L; Ghasemi, N; Naik, B; Wang, FS; Mirhosseini, AF; Naseri, S; Liu, ZZ; Qiao, YN; Tucker, A; Wijayaratna, K; Peprah, P; Adomako, S; Yu, L; Goswami, S; Chen, H; Shu, BN; Hessami, A; Abbas, M; Agarwal, N; Rashidi, TH				Barbieri, Diego Maria; Lou, Baowen; Passavanti, Marco; Hui, Cang; Hoff, Inge; Lessa, Daniela Antunes; Sikka, Gaurav; Chang, Kevin; Gupta, Akshay; Fang, Kevin; Banerjee, Arunabha; Maharaj, Brij; Lam, Louisa; Ghasemi, Navid; Naik, Bhaven; Wang, Fusong; Mirhosseini, Ali Foroutan; Naseri, Sahra; Liu, Zhuangzhuang; Qiao, Yaning; Tucker, Andrew; Wijayaratna, Kasun; Peprah, Prince; Adomako, Solomon; Yu, Lei; Goswami, Shubham; Chen, Hao; Shu, Benan; Hessami, Amir; Abbas, Montasir; Agarwal, Nithin; Rashidi, Taha Hossein			Impact of COVID-19 pandemic on mobility in ten countries and associated perceived risk for all transport modes	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; INCOME INEQUALITY; RECALLING ATTITUDES; HEALTH; PERCEPTION; BEHAVIOR; TRAVEL; METHODOLOGY; BIOGRAPHIES; QUESTIONS	The restrictive measures implemented in response to the COVID-19 pandemic have triggered sudden massive changes to travel behaviors of people all around the world. This study examines the individual mobility patterns for all transport modes (walk, bicycle, motorcycle, car driven alone, car driven in company, bus, subway, tram, train, airplane) before and during the restrictions adopted in ten countries on six continents: Australia, Brazil, China, Ghana, India, Iran, Italy, Norway, South Africa and the United States. This cross-country study also aims at understanding the predictors of protective behaviors related to the transport sector and COVID-19. Findings hinge upon an online survey conducted in May 2020 (N = 9,394). The empirical results quantify tremendous disruptions for both commuting and non-commuting travels, highlighting substantial reductions in the frequency of all types of trips and use of all modes. In terms of potential virus spread, airplanes and buses are perceived to be the riskiest transport modes, while avoidance of public transport is consistently found across the countries. According to the Protection Motivation Theory, the study sheds new light on the fact that two indicators, namely income inequality, expressed as Gini index, and the reported number of deaths due to COVID-19 per 100,000 inhabitants, aggravate respondents' perceptions. This research indicates that socio-economic inequality and morbidity are not only related to actual health risks, as well documented in the relevant literature, but also to the perceived risks. These findings document the global impact of the COVID-19 crisis as well as provide guidance for transportation practitioners in developing future strategies.	[Barbieri, Diego Maria; Hoff, Inge; Mirhosseini, Ali Foroutan; Chen, Hao] Norwegian Univ Sci & Technol, Dept Civil & Environm Engn, Trondheim, Trondelag, Norway; [Lou, Baowen; Liu, Zhuangzhuang] Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China; [Passavanti, Marco] Italian Soc Cognit Behav Therapy CBT Italy, Florence, Toscana, Italy; [Hui, Cang] Stellenbosch Univ, Ctr Invas Biol, Dept Math Sci, Matieland, South Africa; [Hui, Cang] African Inst Math Sci, Biodivers Informat Unit, Cape Town, South Africa; [Lessa, Daniela Antunes] Univ Fed Ouro Preto, Dept Civil Engn, Ouro Preto, MG, Brazil; [Sikka, Gaurav] Lalit Narayan Mithila Univ, Dept Geog, Darbhanga, Bihar, India; [Chang, Kevin] Univ Idaho, Dept Civil & Environm Engn, Moscow, ID 83843 USA; [Gupta, Akshay] Indian Inst Technol Roorkee, Transportat Engn Grp, Dept Civil Engn, Roorkee, Uttarakhand, India; [Fang, Kevin] Sonoma State Univ, Dept Geog Environm & Planning, Rohnert Pk, CA USA; [Banerjee, Arunabha] Indian Inst Technol Guwahati, Dept Civil Engn, Gauhati, Assam, India; [Maharaj, Brij] Univ KwaZulu Natal, Dept Geog, Durban, KwaZulu, South Africa; [Lam, Louisa] Federat Univ Australia, Sch Hlth, Berwick, Vic, Australia; [Ghasemi, Navid] Univ Bologna, Dept Civil Chem Environm & Mat Engn, Bologna, Emilia Romagna, Italy; [Naik, Bhaven] Ohio Univ, Russ Coll Engn & Technol, Dept Civil Engn, Athens, OH 45701 USA; [Wang, Fusong] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan, Hubei, Peoples R China; [Naseri, Sahra] Bam Univ Med Sci, Sch Med, Kerman, Iran; [Qiao, Yaning] China Univ Min & Technol, Sch Mech & Civil Engn, Xuzhou, Jiangsu, Peoples R China; [Tucker, Andrew] Univ Connecticut, Connecticut Transportat Safety Res Ctr, Storrs, CT USA; [Wijayaratna, Kasun; Rashidi, Taha Hossein] Univ Technol Sydney, Sch Civil & Environm Engn, Ultimo, NSW, Australia; [Peprah, Prince] Univ New South Wales, Dept Social Policy Res Ctr, Sydney, NSW, Australia; [Adomako, Solomon] Univ Agder, Dept Engn & Sci, Grimstad, Agder, Norway; [Yu, Lei] Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Guangdong, Peoples R China; [Goswami, Shubham] Indian Inst Sci Bangalore, Dept Civil Engn, Bangalore, Karnataka, India; [Shu, Benan] Foshan Transportat Sci & Technol Co Ltd, Foshan, Guangdong, Peoples R China; [Hessami, Amir] Texas A&M Univ Kingsville, Dept Civil & Architectural Engn, Kingsville, TX USA; [Abbas, Montasir] Virginia Tech, Dept Civil & Environm Engn, Blacksburg, VA USA; [Agarwal, Nithin] Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL USA	Norwegian University of Science & Technology (NTNU); Chang'an University; Stellenbosch University; Universidade Federal de Ouro Preto; Idaho; University of Idaho; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; California State University System; Sonoma State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; University of Kwazulu Natal; Federation University Australia; University of Bologna; University System of Ohio; Ohio University; Wuhan University of Technology; China University of Mining & Technology; University of Connecticut; University of Technology Sydney; University of New South Wales Sydney; University of Agder; Sun Yat Sen University; Indian Institute of Science (IISC) - Bangalore; Texas A&M University System; Texas A&M University Kingsville; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida	Barbieri, DM (corresponding author), Norwegian Univ Sci & Technol, Dept Civil & Environm Engn, Trondheim, Trondelag, Norway.; Lou, BW (corresponding author), Changan Univ, Sch Highway, Xian, Shaanxi, Peoples R China.	diego.barbieri@ntnu.no; loubaowen@chd.edu.cn	Fang, Kevin/AAV-7165-2021; Barbieri, Diego Maria/AAD-6001-2019; Wijayaratna, Kasun/AAC-8070-2022; Lou, Baowen/ABF-3630-2021; Lam, Louisa/ADA-7185-2022; Lam, Louisa Lok Yi/R-7147-2018; Hui, Cang/A-1781-2008	Fang, Kevin/0000-0003-3765-158X; Barbieri, Diego Maria/0000-0002-5924-9367; Wijayaratna, Kasun/0000-0002-4604-7256; Lou, Baowen/0000-0001-6099-1713; Passavanti, Marco/0000-0003-0744-7051; Hoff, Inge/0000-0002-6784-0333; Lam, Louisa Lok Yi/0000-0002-1439-0893; SIKKA, GAURAV/0000-0002-0861-1194; Qiao, Yaning/0000-0002-9051-8406; Hui, Cang/0000-0002-3660-8160; Gupta, Akshay/0000-0003-3109-9245; ANTUNES LESSA, DANIELA/0000-0002-4856-5671; Goswami, Shubham/0000-0002-8118-2453; Ghasemi, Navid/0000-0003-3703-7352				Abdulkareem SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226483; Acter T, 2020, SCI TOTAL ENVIRON, V730, DOI 10.1016/j.scitotenv.2020.138996; Adekunle IA, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138998; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; [Anonymous], 2020, NYE FYLKER REGJERING; [Anonymous], 2019, CHINA BLANK PROVINCE; [Anonymous], 2011, URBAN PLAN NEWSREP, V11, P2; [Anonymous], 2014, MAP 2009 SO AUSTR HE; [Anonymous], 2007, BLANK MAP IRAN; [Anonymous], 2006, INDIA TER1; [Anonymous], 2006, MAP ITALY BLANK; [Anonymous], 2009, MAP S AFRICA; [Anonymous], 2007, BLANK US MAP BORDERS; [Anonymous], 2014, GLOB AIRP DEV C; [Anonymous], 2020, LANCET, DOI DOI 10.1016/S0140-6736(20)30183-5; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; Apple, 2020, MOB TREND REP; Barbieri DM, 2020, DATA BRIEF, V33, DOI 10.1016/j.dib.2020.106459; Barsky AJ, 2002, ARCH INTERN MED, V162, P981, DOI 10.1001/archinte.162.9.981; Beck MJ, 2020, TRANSPORT POLICY, V96, P76, DOI 10.1016/j.tranpol.2020.07.001; Belot M, 2020, 6 COUNTRY SURVEY COV; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bohte W, 2009, TRANSPORT REV, V29, P325, DOI 10.1080/01441640902808441; Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Borkowski P, 2020, J TRANSP GEOGR, V90; BRISLIN RW, 1976, INT J PSYCHOL, V11, P215, DOI 10.1080/00207597608247359; Brog W, 2015, TRANSP RES PROC, V11, P98, DOI 10.1016/j.trpro.2015.12.009; Browne A, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav002; Budd Lucy, 2020, Transp Res Interdiscip Perspect, V6, P100151, DOI 10.1016/j.trip.2020.100151; Cahyanto I, 2016, TOUR MANAG PERSPECT, V20, P195, DOI 10.1016/j.tmp.2016.09.004; Carteni A, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140489; Conceicao P., 2019, HUMAN DEV REPORT 201; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; De Beuckelaer A, 2009, APPL PSYCHOL-INT REV, V58, P336, DOI 10.1111/j.1464-0597.2008.00350.x; de Haas Mathijs, 2020, Transp Res Interdiscip Perspect, V6, P100150, DOI 10.1016/j.trip.2020.100150; De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; Ferrer RA, 2015, CURR OPIN PSYCHOL, V5, P85, DOI 10.1016/j.copsyc.2015.03.012; Fetzer T., 2020, PERCEPTIONS INSUFFIC; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Ghana government via Wikimedia Commons, 2019, NEW GHAN MAP 2019; Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; HARRISON JA, 1992, HEALTH EDUC RES, V7, P107, DOI 10.1093/her/7.1.107; Hipp L, 2020, SURV RES METHODS-GER, V14, P109, DOI 10.18148/srm/2020.v14i2.7741; Hotle Susan, 2020, Transp Res Interdiscip Perspect, V5, P100127, DOI 10.1016/j.trip.2020.100127; Huang X, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241957; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Jaspers E, 2009, EUR SOCIOL REV, V25, P287, DOI 10.1093/esr/jcn048; Jones S.P., 2020, COVID 19 BEHAV TRACK; Kashfi SA, 2015, J TRANSP GEOGR, V46, P67, DOI 10.1016/j.jtrangeo.2015.05.008; Kramer A, 2020, J VOCAT BEHAV, V119; Kuzemko C, 2020, ENERGY RES SOC SCI, V68, DOI 10.1016/j.erss.2020.101685; Law R., 2006, International Journal of Tourism Research, V8, P289, DOI 10.1002/jtr.576; Lou JH, 2020, J TRANSP GEOGR, V89, DOI 10.1016/j.jtrangeo.2020.102894; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Mcisaac SJ, 1997, EUR J PUBLIC HEALTH, V7, P45, DOI 10.1093/eurpub/7.1.45; McKinsey & Company, 2020, GLOB SURV CONS SENT; Mogaji Emmanuel, 2020, Transp Res Interdiscip Perspect, V6, P100154, DOI 10.1016/j.trip.2020.100154; Muggenburg H, 2015, J TRANSP GEOGR, V46, P151, DOI 10.1016/j.jtrangeo.2015.06.004; Musselwhite C, 2020, J TRANSP HEALTH, V16, DOI 10.1016/j.jth.2020.100853; Nakamura H, 2020, TRANSPORT POLICY, V96, P40, DOI 10.1016/j.tranpol.2020.06.018; Nordgren LF, 2007, J BEHAV DECIS MAKING, V20, P533, DOI 10.1002/bdm.565; Norman P., 2005, PREDICTING HLTH BEHA, P81; Oxford University, 2020, COR GOV RESP TRACK; Oztig LI, 2020, PUBLIC HEALTH, V185, P364, DOI 10.1016/j.puhe.2020.07.002; Peretti-Watel P, 2014, ADDICT BEHAV, V39, P1304, DOI 10.1016/j.addbeh.2014.04.016; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pucher J, 2007, TRANSPORT REV, V27, P379, DOI 10.1080/01441640601089988; Quintal VA, 2010, TOURISM MANAGE, V31, P797, DOI 10.1016/j.tourman.2009.08.006; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Rosenstock I.M., 1990, HLTH BEHAV HLTH ED T, P39; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Schmiege SJ, 2009, J APPL SOC PSYCHOL, V39, P95, DOI 10.1111/j.1559-1816.2008.00431.x; Schoenduwe R, 2015, J TRANSP GEOGR, V42, P98, DOI 10.1016/j.jtrangeo.2014.12.001; Sevilla NL, 2018, TRANSPORT RES REC, V2672, P93, DOI 10.1177/0361198118799709; Shamshiripour Ali, 2020, Transp Res Interdiscip Perspect, V7, P100216, DOI 10.1016/j.trip.2020.100216; Shen J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115291; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; SMITH TW, 1984, PUBLIC OPIN QUART, V48, P639, DOI 10.1086/268865; Solga H, 2001, QUAL QUANT, V35, P291, DOI 10.1023/A:1010387414959; Soobader MJ, 1999, SOC SCI MED, V48, P733, DOI 10.1016/S0277-9536(98)00401-8; Stockemer D., 2019, QUANTITATIVE METHODS, V50; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Verlinghieri E, 2020, J TRANSP GEOGR, V87, DOI 10.1016/j.jtrangeo.2020.102798; Weill JA, 2020, P NATL ACAD SCI USA, V117, P19658, DOI 10.1073/pnas.2009412117; Wells CR, 2020, P NATL ACAD SCI USA, V117, P7504, DOI 10.1073/pnas.2002616117; WHO, 2020, WHO COR DIS COVID 19; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wilder-Smith Annelies, 2006, Travel Med Infect Dis, V4, P53, DOI 10.1016/j.tmaid.2005.04.004; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; WILKINSON RG, 1992, BRIT MED J, V304, P165, DOI 10.1136/bmj.304.6820.165; World Economic Forum, 2018, P WORLD EC FOR GEN S; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Population Review, 2020, GIN COEFF COUNTR 202	100	65	65	24	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245886	10.1371/journal.pone.0245886	http://dx.doi.org/10.1371/journal.pone.0245886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524042	Green Accepted, Green Published, gold			2022-12-26	WOS:000616578400001
J	Saha, J; Dean, DN; Dhakal, S; Stockmal, KA; Morgan, SE; Dillon, KD; Adamo, MF; Levites, Y; Rangachari, V				Saha, Jhinuk; Dean, Dexter N.; Dhakal, Shailendra; Stockmal, Kelli A.; Morgan, Sarah E.; Dillon, Kristy D.; Adamo, Munir F.; Levites, Yona; Rangachari, Vijayaraghavan			Biophysical characteristics of lipid-induced A beta oligomers correlate to distinctive phenotypes in transgenic mice	FASEB JOURNAL			English	Article						amyloid&#8208; &#946; Alzheimer disease; cerebral amyloid angiopathy; membrane lipids; oligomers; phenotypes	ALZHEIMERS-DISEASE; AMYLOID PEPTIDE(1-40); FIBRIL FORMATION; ENDOGENOUS SEED; ALPHA-SYNUCLEIN; MOUSE MODEL; GANGLIOSIDE; PROTEIN; BRAIN; FORM	Alzheimer's disease (AD) is a progressive neurodegenerative disorder that affects cognition and memory. Recent advances have helped identify many clinical sub-types in AD. Mounting evidence point toward structural polymorphism among fibrillar aggregates of amyloid-beta (A beta) to being responsible for the phenotypes and clinical manifestations. In the emerging paradigm of polymorphism and prion-like propagation of aggregates in AD, the role of low molecular weight soluble oligomers, which are long known to be the primary toxic agents, in effecting phenotypes remains inconspicuous. In this study, we present the characterization of three soluble oligomers of A beta 42, namely 14LPOs, 16LPOs, and GM1Os with discreet biophysical and biochemical properties generated using lysophosphatidyl glycerols and GM1 gangliosides. The results indicate that the oligomers share some biophysical similarities but display distinctive differences with GM1Os. Unlike the other two, GM1Os were observed to be complexed with the lipid upon isolation. It also differs mainly in detection by conformation-sensitive dyes and conformation-specific antibodies, temperature and enzymatic stability, and in the ability to propagate morphologically-distinct fibrils. GM1Os also show distinguishable biochemical behavior with pronounced neuronal toxicity. Furthermore, all the oligomers induce cerebral amyloid angiopathy (CAA) and plaque burden in transgenic AD mice, which seems to be a consistent feature among all lipid-derived oligomers, but 16LPOs and GM1Os displayed significantly higher effect than the others. These results establish a correlation between molecular features of A beta 42 oligomers and their distinguishable effects in transgenic AD mice attuned by lipid characteristics, and therefore help bridge the knowledge gap in understanding how oligomer conformers could elicit AD phenotypes.	[Saha, Jhinuk; Dean, Dexter N.; Dhakal, Shailendra; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Stockmal, Kelli A.; Morgan, Sarah E.] Univ Southern Mississippi, Sch Polymer Sci & Engn, Hattiesburg, MS 39406 USA; [Dillon, Kristy D.; Adamo, Munir F.; Levites, Yona] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Rangachari, Vijayaraghavan] Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA; [Dean, Dexter N.] NHLBI, Lab Prot Conformat & Dynam, Biochem & Biophys Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; University of Florida; University of Southern Mississippi; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rangachari, V (corresponding author), Univ Southern Mississippi, Sch Math & Nat Sci, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Dhakal, Shailendra/ABD-2879-2021	Dhakal, Shailendra/0000-0003-0019-803X; Morgan, Sarah/0000-0002-8796-9548; Dean, Dexter N./0000-0002-2279-3393	NCRR NIH HHS [5P20RR01647-11] Funding Source: Medline; NIA NIH HHS [R56 AG062292] Funding Source: Medline; NIGMS NIH HHS [P20 GM103476, 8 P20 GM103476-11, R01 GM120634] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen NH, 1996, FEBS LETT, V399, P47, DOI 10.1016/S0014-5793(96)01279-3; [Anonymous], 2017, PRION; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; BUYUKMIHCI N, 1983, EXP NEUROL, V81, P396, DOI 10.1016/0014-4886(83)90271-6; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chemes Lucia B, 2012, Methods Mol Biol, V895, P387, DOI 10.1007/978-1-61779-927-3_22; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Colin J, 2016, BIOCHIMIE, V130, P178, DOI 10.1016/j.biochi.2016.08.014; Condello C, 2018, P NATL ACAD SCI USA, V115, pE782, DOI 10.1073/pnas.1714966115; Couto D, 2016, J AM SOC MASS SPECTR, V27, P1965, DOI 10.1007/s13361-016-1474-1; Creasey RG, 2012, CURR PROTEIN PEPT SC, V13, P232; Das PK, 2017, BIOMACROMOLECULES, V18, P3359, DOI 10.1021/acs.biomac.7b01007; Dean DN, 2018, BIOPHYS J, V114, P539, DOI 10.1016/j.bpj.2017.11.3778; Dean DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40787; Dean DN, 2016, BIOCHEMISTRY-US, V55, P2238, DOI 10.1021/acs.biochem.6b00161; Downey MA, 2019, J AM SOC MASS SPECTR, V30, P85, DOI 10.1007/s13361-018-1975-1; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gu L, 2014, J BIOL CHEM, V289, P27300, DOI 10.1074/jbc.M114.569004; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hou H., 2020, SCI REP-UK, V10, P1; HOWARD AJ, 1989, J ANTIMICROB CHEMOTH, V24, P963, DOI 10.1093/jac/24.6.963; Huang DT, 2015, J MOL BIOL, V427, P2319, DOI 10.1016/j.jmb.2015.04.004; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Jongbloed W, 2015, J ALZHEIMERS DIS, V45, P35, DOI 10.3233/JAD-142136; Ju DD, 1997, J CHROMATOGR A, V779, P195; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kaspersen JD, 2017, BIOPHYS J, V112, P1609, DOI 10.1016/j.bpj.2017.03.013; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Kiskis J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13489; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111492; Kumar A, 2012, J BIOL CHEM, V287, P21253, DOI 10.1074/jbc.M112.355156; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Liberski PP, 2012, FOLIA NEUROPATHOL, V50, P85; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Morgado I, 2015, ADV EXP MED BIOL, V855, P67, DOI 10.1007/978-3-319-17344-3_3; Naudi A, 2015, INT REV NEUROBIOL, V122, P133, DOI 10.1016/bs.irn.2015.05.008; Noel A, 2017, BIOCHIMIE, V137, P158, DOI 10.1016/j.biochi.2017.03.019; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Planchard MS, 2012, ACS CHEM NEUROSCI, V3, P900, DOI 10.1021/cn300030a; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; Sacino AN, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-38; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; Tettamanti G., 2010, HDB NEUROCHEMISTRY M, P99; VANHOLDE KE, 1978, BIOPOLYMERS, V17, P1387, DOI 10.1002/bip.1978.360170602; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Xi WH, 2019, J CHEM PHYS, V150, DOI 10.1063/1.5082659; Xu GL, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-00911-y; Yanagisawa D, 2011, J ALZHEIMERS DIS, V24, P33, DOI 10.3233/JAD-2011-102100; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yates EA, 2014, BIOCHEMISTRY-US, V53, P7038, DOI 10.1021/bi500792f	74	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21318	10.1096/fj.202002025RR	http://dx.doi.org/10.1096/fj.202002025RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508158	hybrid, Green Published			2022-12-26	WOS:000647789600061
J	Timelli, L; Girardi, E				Timelli, Laura; Girardi, Enrico			Effect of timing of implementation of containment measures on Covid-19 epidemic. The case of the first wave in Italy	PLOS ONE			English	Article								There is evidence that adoption of non-pharmaceutical containment measures (NPMs) may have had a major impact on Covid-19 epidemic dynamics, and mitigated its effect on healthcare system. Optimal timing of implementation of these measures however is not known. In Italy, a national lockdown was decided on March 11(th) 2020 and ended 4(th) of May. At that time, cumulative incidence (CI) was different in Italian regions which ranged from <5 cases/100,000 to >11 cases/100,000 inhabitants. In this paper, we aim to evaluate how level of incidence in different regions at the time of implementation of NPMs affected CI and had an impact on the healthcare system in terms of ICU bed occupancy and mortality rates. We used regional daily new COVID-19 diagnosed cases as well number of people hospitalized in ICU and number of deaths for period February 24-May 11 from all the 19 Italian regions and two autonomous provinces. For each region we calculated: temporal daily trend of cumulative cases of Covid-19/100,000 inhabitants, daily trend of ICU bed occupancy and mortality rate at the end of period. We found that the epidemic curves show similar trends for all regions and all tend to flatten between 11-32 days. However, after 2 months, regions with lower CI at lockdown remained at substantially lower CI (<265 cases/100,000), had a peak of percentage of cases hospitalized in ICU which did not exceed 79.4% and a mortality<0.27/1,000. On the other hand, in regions with higher incidence at lockdown, CI reached 382-921 cases/100,000, the peak of percentage of cases hospitalized in ICU and mortality rate reached 270%, and 1.5/1,000, respectively. Our data suggests that level of CI at the moment of lockdown is important to control the subsequent spread of infection so NPMs should be adopted very early during the course of Covid-19 epidemic, in order to mitigate the impact on the healthcare system and to reduce related mortality.	[Timelli, Laura; Girardi, Enrico] IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy	IRCCS Lazzaro Spallanzani	Timelli, L (corresponding author), IRCCS, L Spallanzani Natl Inst Infect Dis, Rome, Italy.	laura.timelli@inmi.it		Timelli, Laura/0000-0003-2306-0260	Italian Ministry of Health-Ricerca Corrente INMI Spallanzani-IRCCS -Linea 1	Italian Ministry of Health-Ricerca Corrente INMI Spallanzani-IRCCS -Linea 1	This study was funded by the Italian Ministry of Health-Ricerca Corrente INMI Spallanzani-IRCCS -Linea 1, to EG.	Bonaccorsi G, 2020, P NATL ACAD SCI USA, V117, P15530, DOI 10.1073/pnas.2007658117; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Guzzetta G, 2021, EMERG INFECT DIS, V27, P267, DOI 10.3201/eid2701.202114; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Imai N, 2020, REPORT 9 IMPACT NON, DOI 10.25561/77482; Imai Natsuko, 2020, Wellcome Open Res, V5, P59, DOI 10.12688/wellcomeopenres.15808.1; Istituto Nazionale di Statistica (ISTAT), PRIM RIS IND SIER SA; Istituto Superiore di Sanita,, 2020, IMP EP COVID 19 MORT; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Pei Sen, 2020, medRxiv, DOI 10.1101/2020.05.15.20103655; Riccardo F, 2020, MEDRXIV, DOI [10.1101/2020.04.08.20056861, DOI 10.1101/2020.04.08.20056861V1]; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; World Health Organization, 2019, MAP TOP TRAV DEST EU	16	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245656	10.1371/journal.pone.0245656	http://dx.doi.org/10.1371/journal.pone.0245656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HH	33513157	Green Published, gold			2022-12-26	WOS:000613892100003
J	Youssef, D; Hassab-Elnaby, S; El-Ghandoor, H				Youssef, Doaa; Hassab-Elnaby, Salah; El-Ghandoor, Hatem			Nanoscale quantitative surface roughness measurement of articular cartilage using second-order statistical-based biospeckle	PLOS ONE			English	Article							BLOOD-FLOW; SPECKLE; FRICTION	Quantitative measurement of nanoscale surface roughness of articular cartilage tissue is significant to assess the surface topography for early treatment of osteoarthritis, the most common joint disease worldwide. Since it was not established by clinical diagnostic tools, the current studies have been suggesting the use of alternative diagnostic tools using pre-clinical methods. This study aims to measure the nanoscale surface roughness of articular cartilage tissue utilizing biospeckle which is used as a non-destructive and non-contact optical imaging technique. An experimental setup was implemented to capture biospeckle images from twelve cross-section areas of articular cartilage tissue gathered from bovine knee joints at 632 nm wavelength laser radiation. Then, to analyze the biospeckle image, a second-order statistical-based method was proposed through the combination of 308 highly correlated statistical features extracted from implemented gray-level co-occurrence matrices by employing principal component analysis. The result indicated that the measurement of the nanoscale surface roughness based on the first principal component only is able to provide accurate and precise quantitative measurement of early signs of articular cartilage degeneration up to 2500 nm.	[Youssef, Doaa; Hassab-Elnaby, Salah] Cairo Univ, Natl Inst Laser Enhanced Sci, Dept Engn Applicat Laser, Giza, Egypt; [El-Ghandoor, Hatem] Ain Shams Univ, Fac Sci, Dept Phys, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University	Youssef, D (corresponding author), Cairo Univ, Natl Inst Laser Enhanced Sci, Dept Engn Applicat Laser, Giza, Egypt.	doaaysf@niles.edu.eg		Youssef, Doaa/0000-0001-8269-6694				Abdurashitov AS, 2015, FRONT OPTOELECTRON, V8, P187, DOI 10.1007/s12200-015-0493-z; ADLER RS, 1992, ULTRASOUND MED BIOL, V18, P51, DOI 10.1016/0301-5629(92)90008-X; Ahmed AT, 2020, SILICON-NETH, V12, P1603, DOI 10.1007/s12633-019-00255-w; An W., 2002, IND APPL SPECKLE TEC; [Anonymous], 2012, BUHGALTERSKIJ UCHET, V2, P106; [Anonymous], 2013, U VERMONT HIST REV, VXXIV, P1; Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319; Athanasiou K.A., 2009, SYNTH LECT TISSUE EN, V1, P1, DOI DOI 10.2200/S00212ED1V01Y200910TIS003; Basak K, 2012, MED BIOL ENG COMPUT, V50, P547, DOI 10.1007/s11517-012-0902-z; Beddoes CM, 2016, MATERIALS, V9, DOI 10.3390/ma9060443; Carlos Rodriguez-Merchan E., 2012, ARTICULAR CARTILAGE, DOI [10.1007/978-88-470-2727-5, DOI 10.1007/978-88-470-2727-5]; Damiani C, 2020, ANN IG MED PREV COMU, V32, P327, DOI 10.7416/ai.2020.2356; Deana AM, 2013, LASER PHYS, V23, DOI 10.1088/1054-660X/23/7/075607; Dhanasekar B, 2008, PRECIS ENG, V32, P196, DOI 10.1016/j.precisioneng.2007.08.005; Dirksen D, 1999, CELLS TISSUES ORGANS, V164, P212, DOI 10.1159/000016661; DUDA RO, 2001, PATTERN CLASSIFICATI; Ebert DW, 1998, J BIOMED OPT, V3, P326, DOI 10.1117/1.429893; El Ghandoor H, 2012, PHYS SCRIPTA, V86, DOI 10.1088/0031-8949/86/01/015403; El-Ghandoor H., 2012, J MAT SCI ENG B, V2, P7; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Francon M., 1980, OPTICS LASER TECHNOL, DOI [10.1016/0030-3992(80)90039-0, DOI 10.1016/0030-3992(80)90039-0]; FUJII H, 1987, APPL OPTICS, V26, P5321, DOI 10.1364/AO.26.005321; Ghosh S, 2013, MICRON, V44, P179, DOI 10.1016/j.micron.2012.06.007; Goodman J. W., 1975, Laser speckle and related phenomena, P9; Hamdy O, 2018, CAIRO INT BIOM ENG, P53, DOI 10.1109/CIBEC.2018.8641819; Hamed AM, 2004, OPT LASER TECHNOL, V36, P249, DOI 10.1016/j.optlastec.2003.09.005; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hayashi D, 2011, CARTILAGE IMAGING: SIGNIFICANCE, TECHNIQUES, AND NEW DEVELOPMENTS, P27, DOI 10.1007/978-1-4419-8438-8_4; Herrmann JM, 1999, J RHEUMATOL, V26, P627; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Jung CK, 2014, TECHNIQUES CARTILAGE, DOI [10.1007/978-3-642-41921-8, DOI 10.1007/978-3-642-41921-8]; Kaleva E., 2009, OPTIMIZATION QUANTIT; Kayahan E, 2009, ISOT: 2009 INTERNATIONAL SYMPOSIUM ON OPTOMECHATRONIC TECHNOLOGIES, P235, DOI 10.1109/ISOT.2009.5326076; Kayahan E, 2010, TRIBOL INT, V43, P307, DOI 10.1016/j.triboint.2009.06.010; Kuznetsov I, 2013, PROC SPIE, V8699, DOI 10.1117/12.2016963; LYYRA T, 1995, MED ENG PHYS, V17, P395, DOI 10.1016/1350-4533(95)97322-G; Mannicke N, 2014, OSTEOARTHR CARTILAGE, V22, P1577, DOI 10.1016/j.joca.2014.06.019; Martinez O.S., 2014, J MAT SCI ENG, V3, P759; Moa-anderson BJ, 2003, P 2003 SUMM BIOENG C, P0561; Nadkarni SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982529; Nadkarni SK, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2186046; Nadkarni SK, 2005, CIRCULATION, V112, P885, DOI 10.1161/CIRCULATIONAHA.104.520098; Niemz Niemz MH., 2013, LASER TISSUE INTERAC, Vthird, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Niu HJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-34; Peng ZX, 2013, WEAR, V301, P210, DOI 10.1016/j.wear.2012.11.056; Peron MC, 2007, OPT LASER TECHNOL, V39, P40, DOI 10.1016/j.optlastec.2005.05.019; PERSSON U, 1992, OPT LASER ENG, V17, P61, DOI 10.1016/0143-8166(92)90012-V; Pino A, 2009, PROC SPIE, V7432, DOI 10.1117/12.825072; Rabal HJ, 2008, DYNAMIC LASER SPECKL, DOI [10.1201/9781420060164, DOI 10.1201/9781420060164]; Saarakkala S., 2007, PRECLINICAL ULTRASOU; Saarakkala S, 2006, PHYS MED BIOL, V51, P5333, DOI 10.1088/0031-9155/51/20/017; Sampaio AL, 2011, OPT LASER ENG, V49, P32, DOI 10.1016/j.optlaseng.2010.09.005; Santilli V, 2018, EARLY EFFICACY INTRA, V4, P131; Seccia R, 2020, DATA BRIEF, V30, DOI 10.1016/j.dib.2020.105419; Shekhawat VK, 2009, OSTEOARTHR CARTILAGE, V17, P1197, DOI 10.1016/j.joca.2009.03.013; Shulev A, 2016, J THEOR APPL MECH-BU, V46, P27, DOI 10.1515/jtam-2016-0008; Smyth PA, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005934; Sugiyama T, 2009, ARCH OPHTHALMOL-CHIC, V127, P454, DOI 10.1001/archophthalmol.2008.606; Talaat MS, 1997, PURE APPL OPT, V6, P137, DOI 10.1088/0963-9659/6/1/015; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Tearney GJ, 2002, OPT LETT, V27, P533, DOI 10.1364/OL.27.000533; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; Wang J, 2017, BIOMED OPT EXPRESS, V8, P137, DOI 10.1364/BOE.8.000137; Wang M.L., 2015, BIOSURF BIOTRIBOL, V1, P98, DOI [DOI 10.1016/J.BSBT.2015.06.003, 10.1016/j.bsbt.2015.06.003]; Wang ML, 2012, P I MECH ENG H, V226, P899, DOI 10.1177/0954411912460482; Webb A. R., 2003, STAT PATTERN RECOGNI; Youssef D, 2020, P SPIE, V11575, DOI [10.1117/12.2583503, DOI 10.1117/12.2583503]; Youssef D, 2019, OPTIK, V183, P55, DOI 10.1016/j.ijleo.2019.02.026; Youssef D, 2017, MATERIALS, V10, DOI 10.3390/ma10070714; Zhang M, 1997, MED ENG PHYS, V19, P512, DOI 10.1016/S1350-4533(97)00017-9; 2013, WOODH PUB SER ELECT, P1, DOI DOI 10.1533/9780857097545	71	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246395	10.1371/journal.pone.0246395	http://dx.doi.org/10.1371/journal.pone.0246395			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513197	gold, Green Published			2022-12-26	WOS:000613891400034
J	Nief, C; Morhard, R; Chelales, E; Alvarez, DA; Bourla, BSI; Lam, CT; Sag, AA; Crouch, BT; Mueller, JL; Katz, D; Dewhirst, MW; Everitt, JI; Ramanujam, N				Nief, Corrine; Morhard, Robert; Chelales, Erika; Alvarez, Daniel Adrianzen; Bourla, Ioanna B. S.; Lam, Christopher T.; Sag, Alan A.; Crouch, Brian T.; Mueller, Jenna L.; Katz, David; Dewhirst, Mark W.; Everitt, Jeffrey, I; Ramanujam, Nirmala			Polymer-assisted intratumoral delivery of ethanol: Preclinical investigation of safety and efficacy in a murine breast cancer model	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INTRAHEPATIC RECURRENCE; RADIOFREQUENCY ABLATION; INJECTION; METASTASES; EXPERIENCE; OUTCOMES; ALCOHOL	Focal tumor ablation with ethanol could provide benefits in low-resource settings because of its low overall cost, minimal imaging technology requirements, and acceptable clinical outcomes. Unfortunately, ethanol ablation is not commonly utilized because of a lack of predictability of the ablation zone, caused by inefficient retention of ethanol at the injection site. To create a predictable zone of ablation, we have developed a polymer-assisted ablation method using ethyl cellulose (EC) mixed with ethanol. EC is ethanol-soluble and water-insoluble, allowing for EC-ethanol to be injected as a liquid and precipitate into a solid, occluding the leakage of ethanol upon contact with tissue. The aims of this study were to compare the 1) safety, 2) release kinetics, 3) spatial distribution, 4) necrotic volume, and 5) overall survival of EC-ethanol to conventional ethanol ablation in a murine breast tumor model. Non-target tissue damage was monitored through localized adverse events recording, ethanol release kinetics with Raman spectroscopy, injectate distribution with in vivo imaging, target-tissue necrosis with NADH-diaphorase staining, and overall survival by proxy of tumor growth. EC-ethanol exhibited decreased localized adverse events, a slowing of the release rate of ethanol, more compact injection zones, 5-fold increase in target-tissue necrosis, and longer overall survival rates compared to the same volume of pure ethanol. A single 150 mu L dose of 6% EC-ethanol achieved a similar survival probability rates to six daily 50 mu L doses of pure ethanol used to simulate a slow-release of ethanol over 6 days. Taken together, these results demonstrate that EC-ethanol is safer and more effective than ethanol alone for ablating tumors.	[Nief, Corrine; Morhard, Robert; Chelales, Erika; Alvarez, Daniel Adrianzen; Bourla, Ioanna B. S.; Lam, Christopher T.; Crouch, Brian T.; Mueller, Jenna L.; Katz, David; Ramanujam, Nirmala] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Sag, Alan A.] Duke Univ, Dept Intervent Radiol, Sch Med, Durham, NC USA; [Crouch, Brian T.] Duke Univ, Preston Robert Tisch Brain Tumor Ctr, Sch Med, Durham, NC USA; [Katz, David] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA; [Dewhirst, Mark W.] Duke Univ, Dept Radiat Oncol, Sch Med, Durham, NC USA; [Everitt, Jeffrey, I] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Ramanujam, Nirmala] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Ramanujam, Nirmala] Duke Univ, Duke Global Hlth Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Nief, C (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	corrinenief@gmail.com		Nief, Corrine/0000-0003-3870-4786; Chelales, Erika/0000-0002-8860-7143; Everitt, Jeffrey/0000-0003-0273-6284; Crouch, Brian/0000-0002-2310-6110	North Carolina Biotechnology Center Biotechnology Innovation Grant; National Institutes of Health R21 [1R21CA241205-01]; National Institutes of Health R01 [1R01CA23926801]	North Carolina Biotechnology Center Biotechnology Innovation Grant; National Institutes of Health R21(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the North Carolina Biotechnology Center Biotechnology Innovation Grant (N. Ramanujam), the National Institutes of Health R21 (1R21CA241205-01 N. Ramanujam), and the National Institutes of Health R01 (1R01CA23926801 N. Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Bai XM, 2019, INT J HYPERTHER, V35, P183, DOI 10.1080/02656736.2018.1488279; Bellini M, 2015, AM J NEURORADIOL, V36, P600, DOI 10.3174/ajnr.A4166; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruggemann H, 2020, APMIS, V128, P80, DOI 10.1111/apm.13021; Cazzato RL, 2019, INT J HYPERTHER, V35, P493, DOI 10.1080/02656736.2018.1508760; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Chuchuen O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185633; Chuchuen O, 2017, J PHARM SCI-US, V106, P639, DOI 10.1016/j.xphs.2016.09.030; Clark TWI, 2002, J VASC INTERV RADIOL, V13, pS245, DOI 10.1016/S1051-0443(07)61792-8; Dompmartin A, 2011, EUR RADIOL, V21, P2647, DOI 10.1007/s00330-011-2213-4; Facciorusso Antonio, 2016, World J Gastrointest Pharmacol Ther, V7, P477; Filippiadis DK, 2014, RADIOL MED, V119, P462, DOI 10.1007/s11547-014-0418-8; Germani G, 2010, J HEPATOL, V52, P380, DOI 10.1016/j.jhep.2009.12.004; Giorgio A, 2011, ANTICANCER RES, V31, P2291; Hasegawa S, 1999, CANCER-AM CANCER SOC, V86, P1682, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1682::AID-CNCR9>3.0.CO;2-6; Kenny LM, 2017, BREAST, V35, P98, DOI 10.1016/j.breast.2017.06.012; Koda M, 2000, CANCER-AM CANCER SOC, V88, P529; Kurup A Nicholas, 2010, Semin Intervent Radiol, V27, P276, DOI 10.1055/s-0030-1261786; Kurup AN, 2010, J VASC INTERV RADIOL, V21, pS242, DOI 10.1016/j.jvir.2010.05.001; Li FB, 2018, SPECTROCHIM ACTA A, V189, P621, DOI 10.1016/j.saa.2017.08.077; Livraghi T, 1998, CANCER, V83, P48, DOI 10.1002/(SICI)1097-0142(19980701)83:1<48::AID-CNCR7>3.0.CO;2-A; Lomakin SM, 2011, THERMOCHIM ACTA, V521, P66, DOI 10.1016/j.tca.2011.04.005; Maher JR, 2015, BIOMED OPT EXPRESS, V6, P2022, DOI 10.1364/BOE.6.002022; Mauz PS, 2004, ACTA OTO-LARYNGOL, V124, P1226, DOI 10.1080/00016480410020284; McGuire S, 2006, ANN BIOMED ENG, V34, P1173, DOI 10.1007/s10439-006-9136-2; Morhard R, 2020, IEEE T BIO-MED ENG, V67, P2337, DOI 10.1109/TBME.2019.2960049; Morhard R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09371-2; Prager GW, 2018, ESMO OPEN, V3, DOI 10.1136/esmoopen-2017-000285; Sanford CL, 2001, J CHEM EDUC, V78, P1221, DOI 10.1021/ed078p1221; Schumacher M, 2011, EUR J RADIOL, V80, pE366, DOI 10.1016/j.ejrad.2010.12.074; Scorsetti M, 2017, REP PRACT ONCOL RADI, V22, P163, DOI 10.1016/j.rpor.2016.07.008; Sharma R, 2019, BREAST CANCER-TOKYO, V26, P428, DOI 10.1007/s12282-018-00941-4; Slovak R, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0284-8; Takaki H, 2017, DIAGN INTERV IMAG, V98, P651, DOI 10.1016/j.diii.2017.04.008; Torre LA, 2017, CANCER EPIDEM BIOMAR, V26, P444, DOI 10.1158/1055-9965.EPI-16-0858; Tsai HM, 2003, J COMPUT ASSIST TOMO, V27, P590, DOI 10.1097/00004728-200307000-00025; Zhu YQ, 2020, INT J HYPERTHER, V37, P157, DOI 10.1080/02656736.2020.1717647; Zubizarreta EH, 2015, CLIN ONCOL-UK, V27, P107, DOI 10.1016/j.clon.2014.10.006	39	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0234535	10.1371/journal.pone.0234535	http://dx.doi.org/10.1371/journal.pone.0234535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507942	Green Published, Green Submitted, gold			2022-12-26	WOS:000635021400002
J	Ohno, T; Tashiro, S; Amano, Y; Yoshida, N; Yoshida, R; Abe, H				Ohno, Takuya; Tashiro, Shinsuke; Amano, Yuki; Yoshida, Naoki; Yoshida, Ryoichiro; Abe, Hitoshi			Consistent modelling of material weight loss and gas release due to pyrolysis and conducting benchmark tests of the model-A case for glovebox panel materials such as polymethyl methacrylate	PLOS ONE			English	Article							THERMAL-DEGRADATION; BISPHENOL-A; PMMA; POLYCARBONATES; DECOMPOSITION; KINETICS	It is necessary to consider how a glove box's confinement function will be lost when evaluating the amount of radioactive material leaking from a nuclear facility during a fire. In this study, we build a model that consistently explains the weight loss of glove box materials because of heat input from a flame and accompanying generation of the pyrolysis gas. The weight loss suggests thinning of the glove box housing, and the generation of pyrolysis gas suggests the possibility of fire spreading. The target was polymethyl methacrylate (PMMA), used as the glove box panel. Thermal gravimetric tests on PMMA determined the parameters to be substituted in the Arrhenius equation for predicting the weight loss in pyrolysis. The pyrolysis process of PMMA was divided into 3 stages with activation energies of 62 kJ/mol, 250 kJ/mol, and 265 kJ/mol. Furthermore, quantifying the gas composition revealed that the composition of the pyrolysis gas released from PMMA can be approximated as 100% methyl methacrylate. This result suggests that the released amount of methyl methacrylate can be estimated by the Arrhenius equation. To investigate the validity of such estimation, a sealed vessel test was performed. In this test, we observed increase of the number of gas molecules during the pyrolysis as internal pressure change of the vessel. The number of gas molecules was similar to that estimated from the Arrhenius equation, and indicated the validity of our method. Moreover, we also performed the same tests on bisphenol-A-polycarbonate (PC) for comparison. In case of PC, the number of gas molecules obtained in the vessel test was higher than the estimated value.	[Ohno, Takuya; Tashiro, Shinsuke; Amano, Yuki; Yoshida, Naoki; Yoshida, Ryoichiro; Abe, Hitoshi] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan	Japan Atomic Energy Agency	Ohno, T (corresponding author), Japan Atom Energy Agcy, Tokai, Ibaraki, Japan.	ohno.takuya@jaea.go.jp		Yoshida, Naoki/0000-0002-6425-6190				Abe Hitoshi, 2014, Transactions of the Atomic Energy Society of Japan, V13, P136, DOI 10.3327/taesj.J13.024; Becerra V, 2012, ANALYST, V137, P2250, DOI 10.1039/c2an15961a; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Bifulco A, 2020, COMPOSITES PART C OP, V2, DOI [10.1016/j.jcomc.2020.100022, DOI 10.1016/J.JCOMC.2020.100022]; Bifulco A, 2020, MATER DESIGN, V193, DOI 10.1016/j.matdes.2020.108862; Brooks KP, 2013, SEPID130012; Cai HM, 2019, J CLEAN PROD, V239, DOI 10.1016/j.jclepro.2019.118113; Chen RY, 2020, WASTE MANAGE, V113, P51, DOI 10.1016/j.wasman.2020.05.039; Coutin N, 2017, 15 INT POSTC SEM FIR; Delpech MC, 2002, POLYM TEST, V21, P155, DOI 10.1016/S0142-9418(01)00063-0; Ding ZY, 2021, J HAZARD MATER, V402, DOI 10.1016/j.jhazmat.2020.123472; Domning WE, 1970, RFP1557; Factory Mutual Research Corporation, 1967, TID24236 FAC MUT RES; Factory Mutual Research Corporation, 1969, TID24896 FAC MUT RES; FRIEDMAN HL, 1964, J POLYM SCI POL SYM, P183; Han TU, 2017, KOREAN J CHEM ENG, V34, P1214, DOI 10.1007/s11814-016-0354-5; Hart JR, 2010, 201018 FRRF; Hill AJ, 1971, DP1261 AEC; Huang JB, 2018, WASTE MANAGE, V71, P181, DOI 10.1016/j.wasman.2017.10.016; Ishilkawa T, 2004, J MACROMOL SCI PURE, VA41, P523, DOI 10.1081/MA-120030922; Ito M, 2008, POLYM DEGRAD STABIL, V93, P1723, DOI 10.1016/j.polymdegradstab.2008.07.011; Jang BN, 2004, POLYM DEGRAD STABIL, V86, P419, DOI 10.1016/j.polymdegradstab.2004.05.009; Korobeinichev OP, 2019, THERMOCHIM ACTA, V671, P17, DOI 10.1016/j.tca.2018.10.019; MCNEILL IC, 1991, POLYM DEGRAD STABIL, V31, P163, DOI 10.1016/0141-3910(91)90072-Y; Montaudo G., 2001, MASS SPECTROMETRY PO; Navarro-Gonzalez R, 2002, POLYM BULL, V48, P43, DOI 10.1007/s00289-002-0004-4; Nikolaidis AK, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10050491; ONeil MJ, 2013, MERCK INDEX ENCY CHE, V15th; OZAWA T, 1986, J THERM ANAL, V31, P547, DOI 10.1007/BF01914230; POLA J, 1989, TETRAHEDRON, V45, P5065, DOI 10.1016/S0040-4020(01)81086-3; Primpke S, 2020, ANAL BIOANAL CHEM, V412, P8283, DOI 10.1007/s00216-020-02979-w; Rajendran S, 2004, MATER LETT, V58, P641, DOI 10.1016/S0167-577X(03)00585-8; Redjala S, 2019, J FAIL ANAL PREV, V19, P536, DOI 10.1007/s11668-019-00630-0; Rhude HV, 1962, ANLFGF342A; Shin T, 2011, PYROLYSIS-GC/MS DATA BOOK OF SYNTHETIC POLYMERS: PYROGRAMS, THERMOGRAMS AND MS OF PYROLYZATES, P1; Silva GG, 2004, APPL SURF SCI, V238, P64, DOI 10.1016/j.apsusc.2004.05.211; Sivalingam G, 2004, IND ENG CHEM RES, V43, P7716, DOI 10.1021/ie049590q; Smolders K, 2004, WASTE MANAGE, V24, P849, DOI 10.1016/j.wasman.2004.06.002; Steinmetz Z, 2020, J ANAL APPL PYROL, V147, DOI 10.1016/j.jaap.2020.104803; Sunita MAA, 2019, MACROMOL SYMP, V387, DOI 10.1002/masy.201800189; Takahashi T, 2007, PUBL ASTRON SOC JPN, V59, pS35, DOI 10.1093/pasj/59.sp1.S35; Uemura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8473; Cao XT, 2015, MOL CRYST LIQ CRYST, V618, P111, DOI 10.1080/15421406.2015.1076305; Yamane S, 2020, J ANAL APPL PYROL, V151, DOI 10.1016/j.jaap.2020.104923; Zhang JH, 2020, J CLEAN PROD, V253, DOI 10.1016/j.jclepro.2019.119950	45	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245303	10.1371/journal.pone.0245303	http://dx.doi.org/10.1371/journal.pone.0245303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507991	gold, Green Published			2022-12-26	WOS:000635021400032
J	Sole, E; Ros-Freixedes, R; Tor, M; Reixach, J; Pena, RN; Estany, J				Sole, Emma; Ros-Freixedes, Roger; Tor, Marc; Reixach, Josep; Pena, Ramona N.; Estany, Joan			Antagonistic maternal and direct effects of the leptin receptor gene on body weight in pigs	PLOS ONE			English	Article							LACTATING PRIMIPAROUS SOWS; QUANTITATIVE TRAIT LOCI; FATTY-ACID-COMPOSITION; FEEDING LEVEL; MILK-YIELD; INTRAMUSCULAR FAT; DAIRY HEIFERS; GROWTH; POPULATION; COMPONENTS	Maternal effects on offspring growth can impact survival and evolution of natural and domesticated populations. Genetic correlation estimates often support a negative relationship between direct and maternal effects. However, the genetic underpinnings whereby this antagonism operates are unclear. In pigs, sow feeding status and body composition condition piglet development and growth. We hypothesized that variants in genes impacting these traits may be causative of maternal influences that could be antagonistic to the direct effects for piglet growth. A recessive missense mutation (C>T) in the porcine leptin receptor (LEPR) gene (rs709596309) has been identified as the possible causal polymorphism for increased feed intake and fatness. Using data from a Duroc line, we show that the TT sows exerted a negative impact on the body weight of their offspring at the end of the growing period of similar extent to the positive direct effect of the TT genotype over each individual. Thus, TT pigs from TT dams were about as heavy as CC and CT (C-) pigs from C-dams, but TT pigs from C-dams were around 5% heavier than C-pigs from TT dams. In contrast, body composition was only influenced by LEPR direct effects. This antagonism is due to a higher propensity of TT pigs for self-maintenance rather than for offspring investment. We show that TT pigs consumed more feed, favored fatty acid uptake over release, and produced lighter piglets at weaning than their C-counterparts. We conclude that LEPR underlies a transgenerational mechanism for energy distribution that allocates resources to the sow or the offspring according to whether selective pressure is exerted before or after weaning.	[Sole, Emma; Ros-Freixedes, Roger; Tor, Marc; Pena, Ramona N.; Estany, Joan] Univ Lleida, Dept Anim Sci, Agrotecnio Ctr, Lleida, Catalonia, Spain; [Reixach, Josep] Selecc Batalle SA, Riudarenes, Catalonia, Spain	Centre de Recerca en Agrotecnologia (Agrotecnio); Universitat de Lleida	Estany, J (corresponding author), Univ Lleida, Dept Anim Sci, Agrotecnio Ctr, Lleida, Catalonia, Spain.	joan.estany@udl.cat	Ros-Freixedes, Roger/M-5247-2013; Pena, Romi/C-7756-2011; Estany, Joan/D-3228-2013	Ros-Freixedes, Roger/0000-0002-3745-6736; Pena, Romi/0000-0002-3558-7302; Estany, Joan/0000-0002-5660-5709	Spanish Ministry of Science, Innovation and Universities; European Union Regional Development Funds [AGL2015-65846-R, RTI2018-101346-B-I00]; University of Lleida; Seleccion Batalle	Spanish Ministry of Science, Innovation and Universities; European Union Regional Development Funds(European Commission); University of Lleida; Seleccion Batalle	The authors acknowledge the financial support from the Spanish Ministry of Science, Innovation and Universities and European Union Regional Development Funds (grants AGL2015-65846-R and RTI2018-101346-B-I00; https://www.ciencia.gob.es) and Seleccion Batalle (https://www.batalle.com).JR is employed by Seleccion Batalle and ER is a recipient of a PhD scholarship from the University of Lleida (https://www.udl.cat).Seleccion Batalle provided support in the form of salaries for coauthor JR, but the funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alves K, 2018, J ANIM SCI, V96, P2567, DOI 10.1093/jas/sky172; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Bergsma R, 2009, LIVEST SCI, V125, P208, DOI 10.1016/j.livsci.2009.04.011; Beyer M, 2007, ARCH ANIM NUTR, V61, P452, DOI 10.1080/17450390701563433; Bijma P, 2006, J ANIM SCI, V84, P800, DOI 10.2527/2006.844800x; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bosch L, 2009, MEAT SCI, V82, P432, DOI 10.1016/j.meatsci.2009.02.013; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Douglas SL, 2014, J ANIM SCI, V92, P5716, DOI 10.2527/jas.2014-7986; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Edwards DB, 2008, J ANIM SCI, V86, P241, DOI 10.2527/jas.2006-625; Estany J, 2017, J ANIM SCI, V95, P2261, DOI 10.2527/jas.2016.1108; FALCONER D. S., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V3, P763; Feng S, 2004, J DAIRY SCI, V87, P3785, DOI 10.3168/jds.S0022-0302(04)73517-1; French SS, 2009, P ROY SOC B-BIOL SCI, V276, P4003, DOI 10.1098/rspb.2009.1199; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; Henderson C R, 1988, J DAIRY SCI S2, V71, P1; Heydarpour M, 2008, J ANIM BREED GENET, V125, P89, DOI 10.1111/j.1439-0388.2007.00703.x; Houseknecht KL, 1998, J ANIM SCI, V76, P1405; Huting AMS, 2019, J ANIM SCI, V97, P1656, DOI 10.1093/jas/skz062; Jawed K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160035; JENSEN P, 1992, APPL ANIM BEHAV SCI, V33, P227, DOI 10.1016/S0168-1591(05)80010-3; KIRKPATRICK M, 1989, EVOLUTION, V43, P485, DOI 10.1111/j.1558-5646.1989.tb04247.x; Lavery A, 2019, ANIMAL, V13, P622, DOI 10.1017/S1751731118001799; Le Dividich J, 2000, DOMEST ANIM ENDOCRIN, V19, P63, DOI 10.1016/S0739-7240(00)00067-9; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lohakare JD, 2012, ASIAN AUSTRAL J ANIM, V25, P1338, DOI 10.5713/ajas.2012.12282; LONNQVIST F, 1995, NAT MED, V1, P950, DOI 10.1038/nm0995-950; Lopez-Bote CJ, 1998, MEAT SCI, V49, pS17, DOI 10.1016/S0309-1740(98)00072-2; Maestripieri D., 2010, MATERNAL EFFECTS MAM; Marginean C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005551; MEYER K, 1992, GENET SEL EVOL, V24, P487, DOI 10.1051/gse:19920602; Middelkoop A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52530-w; Munoz G, 2009, J ANIM SCI, V87, P459, DOI 10.2527/jas.2008-1127; NOBLET J, 1990, J ANIM SCI, V68, P562; Ovilo C, 2005, GENET RES, V85, P57, DOI 10.1017/S0016672305007330; Perez-Montarelo D, 2015, J APPL GENET, V56, P525, DOI 10.1007/s13353-015-0284-7; Pluske J. R., 1995, P187; Pluske JR, 1998, J ANIM SCI, V76, P1165; ROBISON OW, 1972, J ANIM SCI, V35, P1303; Rodriguez MC, 2010, P 9 WORLD C GEN; Ros-Freixedes R, 2012, J ANIM SCI, V90, P4230, DOI 10.2527/jas.2011-5063; Sejrsen K, 1997, J ANIM SCI, V75, P828; Sulabo RC, 2010, J ANIM SCI, V88, P3145, DOI 10.2527/jas.2009-2131; Tor M, AIDA 16 JORNADAS PRO, V11, P600; Uemoto Y, 2012, ANIM SCI J, V83, P375, DOI 10.1111/j.1740-0929.2011.00963.x; van den Brand H, 2000, J ANIM SCI, V78, P1520; Varro MT, 1934, DE RE RUSTICA, VII; VERSTEGEN MWA, 1985, J ANIM SCI, V60, P731, DOI 10.2527/jas1985.603731x; WILLHAM RL, 1963, BIOMETRICS, V19, P18, DOI 10.2307/2527570; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238	53	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246198	10.1371/journal.pone.0246198	http://dx.doi.org/10.1371/journal.pone.0246198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508034	gold, Green Published			2022-12-26	WOS:000635021400105
J	Spargo, RM; Coetzer, A; Makuvadze, FT; Chikerema, SM; Chiwerere, V; Bhara, E; Nel, LH				Spargo, Reverend M.; Coetzer, Andre; Makuvadze, Francis T.; Chikerema, Sylvester M.; Chiwerere, Vaida; Bhara, Esnath; Nel, Louis H.			Knowledge, attitudes and practices towards rabies: A survey of the general population residing in the Harare Metropolitan Province of Zimbabwe	PLOS ONE			English	Article							PREVENTION	Background Rabies remains endemic to the Harare Metropolitan Province of Zimbabwe, with a lack of public participations potentially contributing to the limited success in eliminating the disease. We hypothesized that rabies intervention campaigns were less successful than they could be as a result of poor understanding of the disease at the community level, and thus aimed to identify the knowledge, attitudes, and practices towards rabies in the province. Methods A cross-sectional survey, using a semi-structured questionnaire, was implemented between January 2017 and June 2018 across the province and data were collected from 798 respondents. Frequency distributions and logistic regressions were undertaken to determine the factors associated with the adequacy of the prevailing rabies knowledge, pet ownership characteristics and the existing preventative practices. Results The results of our study suggested that the majority of the respondents (92%) had heard of rabies. However, the level of rabies knowledge could be classified as "adequate" in only 36% of respondents. The multivariate logistic regression analysis indicated that pet ownership and type of occupation were statistically associated with a better understanding and knowledge of the disease. Off all the respondents, 49% owned at least one dog or cat and suburb density and occupation were statistically associated with owning a pet. Amongst the pet owners, 57% consulted an animal health practitioner at least once a year and 75% were aware of a rabies vaccine for their pets. The multivariate logistic regression analysis indicated that age, education and gender were statistically associated with pet owners taking their pet(s) to an animal clinic. Conclusion This study showed that the majority of the respondents lacked comprehensive knowledge about rabies, with the knowledge pertaining to health seeking behaviour and the importance of rabies vaccination being the most lacking. Additional public education relying on key messages, aimed at the different target audiences, is required in the province.	[Spargo, Reverend M.] Dept Vet Serv, Div Epidemiol & Dis Control, Harare, Zimbabwe; [Coetzer, Andre; Nel, Louis H.] Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa; [Coetzer, Andre; Nel, Louis H.] Global Alliance Rabies Control SA NPC, Pretoria, South Africa; [Makuvadze, Francis T.] Univ Zimbabwe, Dept Paraclin Vet Studies, Harare, Zimbabwe; [Chikerema, Sylvester M.; Chiwerere, Vaida; Bhara, Esnath] Univ Zimbabwe, Dept Clin Vet Studies, Harare, Zimbabwe	University of Pretoria; University of Zimbabwe; University of Zimbabwe	Coetzer, A (corresponding author), Univ Pretoria, Dept Biochem Genet & Microbiol, Pretoria, South Africa.; Coetzer, A (corresponding author), Global Alliance Rabies Control SA NPC, Pretoria, South Africa.	andre.coetzer@rabiesalliance.org	Nel, Louis/F-1001-2012	Nel, Louis/0000-0001-8963-0153; Coetzer, Andre/0000-0003-0581-7207	Faculty of Veterinary Science	Faculty of Veterinary Science	The authors wish to thank Professor D. Pfukenyi, Dr S. Dhliwayo and Dr M. Nyagura from the Faculty of Veterinary Science for their support and guidance during the study.	Ahmadi-Abhari S, 2008, J EVAL CLIN PRACT, V14, P775, DOI 10.1111/j.1365-2753.2008.01073.x; Banyard AC, 2013, ANTIVIR RES, V98, P357, DOI 10.1016/j.antiviral.2013.04.004; BROOKS R, 1990, VET REC, V127, P592; Coetzer A, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030108; Coetzer A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210018; Dabuma T, 2017, J MED MICROB DIAGN, V6, DOI 10.4172/2161-0703.1000263; Edukugho AA, 2018, PAN AFR MED J, V31, DOI 10.11604/pamj.2018.31.21.15120; Ghosh S, 2016, VET MED SCI, V2, P161, DOI 10.1002/vms3.30; Global Alliance for Rabies Control, 2020, 24 MILL SCH CHILDR B; Global Alliance for Rabies Control, 2019, RAB EP B REB; Hagos WG, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8145-7; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI [10.1371/journal.pntd.0003709, 10.1371/journal.pntd.0003786]; Herbert Mrudu, 2012, J Infect Public Health, V5, P374, DOI 10.1016/j.jiph.2012.05.002; Kabeta T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003867; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; Mucheru GM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.255.4745; Ngah Osoe Bouli F., 2018, J AFRICAN SCI VET ME, V3, P176, DOI [10.31248/JASVM2018.114, DOI 10.31248/JASVM2018.114]; Ntampaka P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210044; Omodo M, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4934-y; Rinchen S, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007305; Sambo M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003310; The Gates Foundation, 2014, ASS RISKS DIG PAYM; WHO, 2013, WHO TECH REP SER, V982, P1; World Health Organization, 2018, Weekly Epidemiological Record, V93, P201; Zimbabwe National Statistical Agency, 2012, ZIMB POP CENS 2012	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246103	10.1371/journal.pone.0246103	http://dx.doi.org/10.1371/journal.pone.0246103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508028	gold, Green Published			2022-12-26	WOS:000635021400088
J	Marquez, J; Dong, JP; Dong, C; Tian, CS; Serrero, G				Marquez, Jorge; Dong, Jianping; Dong, Chun; Tian, Changsheng; Serrero, Ginette			Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development	PLOS ONE			English	Article								Antibody-drug conjugates (ADC) are effective antibody-based therapeutics for hematopoietic and lymphoid tumors. However, there is need to identify new targets for ADCs, particularly for solid tumors and cancers with unmet needs. From a hybridoma library developed against cancer cells, we selected the mouse monoclonal antibody 33B7, which was able to bind to, and internalize, cancer cell lines. This antibody was used for identification of the target by immunoprecipitation and mass spectrometric analysis, followed by target validation. After target validation, 33B7 binding and target positivity were tested by flow cytometry and western blot analysis in several cancer cell lines. The ability of 33B7 conjugated to saporin to inhibit in vitro proliferation of PTFRN positive cell lines was investigated, as well as the 33B7 ADC in vivo effect on tumor growth in athymic mice. All flow cytometry and in vitro internalization assays were analyzed for statistical significance using a Welsh's T-test. Animal studies were analyzed using Two-Way Analysis of Variance (ANOVA) utilizing post-hoc Bonferroni analysis, and/or Mixed Effects analysis. The 33B7 cell surface target was identified as Prostaglandin F2 Receptor Negative Regulator (PTGFRN), a transmembrane protein in the Tetraspanin family. This target was confirmed by showing that PTGFRNexpressing cells bound and internalized 33B7, compared to PTGFRN negative cells. Cells able to bind 33B7 were PTGFRN-positive by Western blot analysis. In vitro treatment PTGFRN-positive cancer cell lines with the 33B7-saporin ADC inhibited their proliferation in a dose-dependent fashion. 33B7 conjugated to saporin was also able to block tumor growth in vivo in mouse xenografts when compared to a control ADC. These findings show that screening antibody libraries for internalizing antibodies in cancer cell lines is a good approach to identify new cancer targets for ADC development. These results suggest PTGFRN is a possible therapeutic target via antibody-based approach for certain cancers.	[Marquez, Jorge; Dong, Jianping; Tian, Changsheng; Serrero, Ginette] A&G Pharmaceut Inc, Target Discovery Div, Columbia, MD 21045 USA; [Marquez, Jorge] Univ Maryland, Dept Pharmaceut Sci, Baltimore Sch Pharm, Baltimore, MD USA; [Dong, Chun; Serrero, Ginette] A&G Pharmaceut Inc, Precis Antibody Div, Columbia, MD 21045 USA	University System of Maryland; University of Maryland Baltimore	Serrero, G (corresponding author), A&G Pharmaceut Inc, Target Discovery Div, Columbia, MD 21045 USA.; Serrero, G (corresponding author), A&G Pharmaceut Inc, Precis Antibody Div, Columbia, MD 21045 USA.	gserrero@agpharma.com			National Cancer Institute [CA162629-02-A1]; A&G Pharmaceutical	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); A&G Pharmaceutical	This study was funded in part by grant CA162629-02-A1 from the National Cancer Institute to Ginette Serrero. A&G Pharmaceutical acted as funder by providing support for salary for GS, JD and CD, and in supply purchases. A&G did not have any role in the design, data collections and analysis, decision to publish or preparation of the manuscript.	Aguila B, 2019, CANCER LETT, V462, P33, DOI 10.1016/j.canlet.2019.07.018; Barok M, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3621; Cardillo TM, 2011, CLIN CANCER RES, V17, P3157, DOI 10.1158/1078-0432.CCR-10-2939; Chambrion C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011219; Charrin S, 2003, BIOCHEM BIOPH RES CO, V304, P107, DOI 10.1016/S0006-291X(03)00545-X; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Colin S, 2011, BRIT J CANCER, V105, P1002, DOI 10.1038/bjc.2011.303; Diamantis N, 2016, BRIT J CANCER, V114, P362, DOI 10.1038/bjc.2015.435; Durbin KR, 2018, MOL CANCER THER, V17, P1341, DOI 10.1158/1535-7163.MCT-17-0672; Flavell DJ, 1998, CURR TOP MICROBIOL, V234, P57; Gao CS, 2003, J IMMUNOL METHODS, V274, P185, DOI 10.1016/S0022-1759(02)00522-7; Gerber H, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0660-3; Glazar AI, 2009, REPROD FERT DEVELOP, V21, P293, DOI 10.1071/RD08158; Goenaga AL, 2007, MOL IMMUNOL, V44, P3777, DOI 10.1016/j.molimm.2007.03.023; Goldenberg DM, 2015, ONCOTARGET, V6, P22496, DOI 10.18632/oncotarget.4318; Halford Z, 2021, ANN PHARMACOTHER, V55, P772, DOI 10.1177/1060028020960402; HELLSTROM I, 1990, CANCER RES, V50, P2183; Hotta K, 2018, HEPATOL RES, V48, pE320, DOI 10.1111/hepr.12992; Huang CY, 2012, CANCER TREAT REV, V38, P854, DOI 10.1016/j.ctrv.2011.12.005; Ikeda M, 2010, BIOL PSYCHIAT, V67, P263, DOI 10.1016/j.biopsych.2009.08.030; Jain N, 2015, PHARM RES-DORDR, V32, P3526, DOI 10.1007/s11095-015-1657-7; Kantarjian HM, 2016, NEW ENGL J MED, V375, P740, DOI 10.1056/NEJMoa1509277; Karhemo PR, 2012, J PROTEOMICS, V77, P87, DOI 10.1016/j.jprot.2012.07.009; Kitson SL, 2013, CHEM TODAY, V31, P30; Kuroda K, 2010, PROSTATE, V70, P1286, DOI 10.1002/pros.21164; Mazurov D, 2013, FEBS J, V280, P1200, DOI 10.1111/febs.12110; Mazzocca A, 2014, CANCER LETT, V351, P23, DOI 10.1016/j.canlet.2014.05.016; Modi S, 2020, NEW ENGL J MED, V382, P610, DOI 10.1056/NEJMoa1914510; Nejadmoghaddam Mohammad-Reza, 2019, Avicenna Journal of Medical Biotechnology, V11, P3; Norman RA, 2020, BRIEF BIOINFORM, V21, P1549, DOI 10.1093/bib/bbz095; Orlicky DJ, 1998, J LIPID RES, V39, P1152; Ritchie M, 2013, MABS-AUSTIN, V5, P13, DOI 10.4161/mabs.22854; Swegen A, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600433; Teicher BA, 2012, NEW ENGL J MED, V367, P1847, DOI 10.1056/NEJMe1211736; Tilly H, 2019, J CLIN ONCOL, V37; Tsuchikama K, 2018, PROTEIN CELL, V9, P33, DOI 10.1007/s13238-016-0323-0; Tzogani K, 2020, ONCOLOGIST, V31, P1, DOI [10.1002/onco.13592PMID:33179377, DOI 10.1002/ONCO.13592PMID:33179377]; von Minckwitz G, 2019, NEW ENGL J MED, V380, P617, DOI 10.1056/NEJMoa1814017; Xu JJ, 2019, ELIFE, V8, DOI 10.7554/eLife.48191; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhao PX, 2020, ACTA PHARMACOL SIN B, V10, P1589, DOI 10.1016/j.apsb.2020.04.012	41	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246197	10.1371/journal.pone.0246197	http://dx.doi.org/10.1371/journal.pone.0246197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503070	Green Published, gold			2022-12-26	WOS:000613751800035
J	Surono, IS; Widiyanti, D; Kusumo, PD; Venema, K				Surono, Ingrid S.; Widiyanti, Dian; Kusumo, Pratiwi D.; Venema, Koen			Gut microbiota profile of Indonesian stunted children and children with normal nutritional status	PLOS ONE			English	Article							FATTY-ACIDS	The gut microbiota has been shown to play a role in energy metabolism of the host. Dysbiosis of the gut microbiota may predispose to obesity on the one hand, and stunting on the other. The aim of the study was to study the difference in gut microbiota composition of stunted Indonesian children and children of normal nutritional status between 3 and 5 years. Fecal samples and anthropometric measurements, in addition to economic and hygiene status were collected from 78 stunted children and 53 children with normal nutritional status in two regions in Banten and West Java provinces: Pandeglang and Sumedang, respectively. The gut microbiota composition was determined by sequencing amplicons of the V3-V4 region of the 16S rRNA gene. The composition was correlated to nutritional status and anthropometric parameters. Macronutrient intake was on average lower in stunted children, while energy-loss in the form of short-chain fatty acids (SCFA) and branched-chain fatty acids (BCFA) appeared to be higher in stunted children. In stunted children, at the phylum level the relative abundance of Bacteroidetes (44.4%) was significantly lower than in normal children (51.3%; p-value 2.55*10(-4)), while Firmicutes was significantly higher (45.7% vs. 39.8%; p-value 5.89*10(-4)). At the genus level, overall Prevotella 9 was the most abundant genus (average of 27%), and it was significantly lower in stunted children than in normal children (23.5% vs. 30.5%, respectively; q-value 0.059). Thirteen other genera were significantly different between stunted and normal children (q-value < 0.1), some of which were at low relative abundance and present in only a few children. Prevotella 9 positively correlated with height (in line with its higher relative abundance in normal children) and weight. In conclusion, Prevotella 9, which was the most abundant genus in the children, was significantly lower in stunted children. The abundance of Prevotella has been correlated with dietary fibre intake, which was lower in these stunted children. Since fibres are fermented by the gut microbiota into SCFA, and these SCFA are a source of energy for the host, increasing the proportion of Prevotella in stunted children may be of benefit. Whether this would prevent the occurrence of stunting or even has the potential to revert it, remains to be seen in follow up research.	[Surono, Ingrid S.] Bina Nusantara Univ, Fac Engn, Food Technol Dept, Jakarta, Indonesia; [Widiyanti, Dian] YARSI Univ, Fac Med, Dept Microbiol, Jakarta, Indonesia; [Kusumo, Pratiwi D.] Univ Kristen Indonesia, Fac Med, Dept Biomed, Jakarta, Indonesia; [Venema, Koen] Maastricht Univ, Ctr Hlth Eating & Food Innovat, Campus Venlo, Venlo, Netherlands	Universitas Bina Nusantara; YARSI University; The Christian University of Indonesia; Maastricht University	Venema, K (corresponding author), Maastricht Univ, Ctr Hlth Eating & Food Innovat, Campus Venlo, Venlo, Netherlands.	k.venema@maastrichtuniversity.nl	Widiyanti, Dian/GNP-8391-2022; Surono, Ingrid/AAP-3652-2021	Surono, Ingrid/0000-0002-2222-609X	Research and Technology Transfer Office, Bina Nusantara University as a part of Bina Nusantara University's International Research Grant [026/VR.RTT/IV/2020]; Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University campus Venlo; Dutch Province of Limburg; YARSI University; Binus; HEFI	Research and Technology Transfer Office, Bina Nusantara University as a part of Bina Nusantara University's International Research Grant; Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University campus Venlo; Dutch Province of Limburg; YARSI University; Binus; HEFI	ISS received funding by Research and Technology Transfer Office, Bina Nusantara University as a part of Bina Nusantara University's International Research Grant entitled "Korelasi Profil Mikrobiota, Status Imun dan Inflammasi Anak Balita Normal dan Stunting" (Correlation of Microbiota Profile, Immune Status and Inflammation of Normal and Stunted Toddlers) with contract number: No.026/VR.RTT/IV/2020 and contract date: 6 April 2020. KV received funding by the Centre for Healthy Eating & Food Innovation (HEFI) of Maastricht University campus Venlo, which has been made possible with the support of the Dutch Province of Limburg. DW received funding from YARSI University. PDK received funding from Universitas Kristen Indonesia. Binus, HEFI, YARSI and UKI employees designed the study, collected data and performed the analyses on the data, and prepared the manuscript.	Anderson M.J., 2017, WILEY STATSREF STAT, DOI DOI 10.1002/9781118445112.STAT05999.PUB2; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z; Canfora EE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02546-x; Central Bureau of Statistics-Ministry of Health Indonesia, 2019, REP INT EC SOC SURV; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dinh DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155405; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gehrig JL, 2019, SCIENCE, V365, P139, DOI 10.1126/science.aau4732; Guido S, 2015, J FUNCT FOODS, V14, P407, DOI 10.1016/j.jff.2015.02.014; Gupta VK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18476-8; Herpertz-Dahlmann B, 2017, EUR CHILD ADOLES PSY, V26, P1031, DOI 10.1007/s00787-017-0945-7; Hoffman DJ, 2017, ANN HUM BIOL, V44, P201, DOI 10.1080/03014460.2016.1267261; Kolde R, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0515-8; Kumar M, 2018, METAB ENG, V49, P128, DOI 10.1016/j.ymben.2018.07.018; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Ministry of Healthy Indonesia, 2018, MAIN RES 2018 IND BA; Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; Scheffler C, 2020, EUR J CLIN NUTR, V74, P377, DOI 10.1038/s41430-019-0439-4; Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654; Subramanian S, 2014, NATURE, V510, P417, DOI 10.1038/nature13421; United Nations Children's Fund, 2009, TRACK PROGR CHILD MA; United Nations Children's Fund (UNICEF), 2020, LEVELS TRENDS CHILD; Venema K, 2020, BENEF MICROBES, V11, P191, DOI 10.3920/BM2019.0159; Vonaesch P, 2018, P NATL ACAD SCI USA, V115, pE8489, DOI 10.1073/pnas.1806573115; Vonaesch P, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1189-5; WEAVER LT, 1984, ARCH DIS CHILD, V59, P649, DOI 10.1136/adc.59.7.649; World Health Organization, 2018, GLOB TARG IMPR MAT I; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	38	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245399	10.1371/journal.pone.0245399	http://dx.doi.org/10.1371/journal.pone.0245399			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497390	gold, Green Published			2022-12-26	WOS:000613707100032
J	Han, TA; Pereira, LM; Lenaerts, T; Santos, FC				The Anh Han; Pereira, Luis Moniz; Lenaerts, Tom; Santos, Francisco C.			Mediating artificial intelligence developments through negative and positive incentives	PLOS ONE			English	Article							COOPERATION; INSTITUTIONS; PUNISHMENT; LESSONS; RACES	The field of Artificial Intelligence (AI) is going through a period of great expectations, introducing a certain level of anxiety in research, business and also policy. This anxiety is further energised by an AI race narrative that makes people believe they might be missing out. Whether real or not, a belief in this narrative may be detrimental as some stake-holders will feel obliged to cut corners on safety precautions, or ignore societal consequences just to "win". Starting from a baseline model that describes a broad class of technology races where winners draw a significant benefit compared to others (such as AI advances, patent race, pharmaceutical technologies), we investigate here how positive (rewards) and negative (punishments) incentives may beneficially influence the outcomes. We uncover conditions in which punishment is either capable of reducing the development speed of unsafe participants or has the capacity to reduce innovation through over-regulation. Alternatively, we show that, in several scenarios, rewarding those that follow safety measures may increase the development speed while ensuring safe choices. Moreover, in the latter regimes, rewards do not suffer from the issue of over-regulation as is the case for punishment. Overall, our findings provide valuable insights into the nature and kinds of regulatory actions most suitable to improve safety compliance in the contexts of both smooth and sudden technological shifts.	[The Anh Han] Teesside Univ, Sch Comp & Digital Technol, Middlesbrough, Cleveland, England; [Pereira, Luis Moniz] Univ Nova Lisboa, NOVA Lab Comp Sci & Informat NOVA LINCS, Caparica, Portugal; [Lenaerts, Tom] Univ Libre Bruxelles, Machine Learning Grp, Blvd Triomphe, Brussels, Belgium; [Lenaerts, Tom] Vrije Univ Brussel, Artificial Intelligence Lab, Brussels, Belgium; [Santos, Francisco C.] Univ Lisbon, INESC ID, Porto Salvo, Portugal; [Santos, Francisco C.] Univ Lisbon, Inst Super Tecn, Porto Salvo, Portugal	University of Teesside; Universidade Nova de Lisboa; Universite Libre de Bruxelles; Vrije Universiteit Brussel; INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Han, TA (corresponding author), Teesside Univ, Sch Comp & Digital Technol, Middlesbrough, Cleveland, England.	t.han@tees.ac.uk	Lenaerts, Tom/B-6376-2008; Santos, Francisco C./D-2394-2010; Han, The Anh/G-1674-2011; Pereira, Luis/C-6241-2009	Lenaerts, Tom/0000-0003-3645-1455; Santos, Francisco C./0000-0002-9103-2862; Han, The Anh/0000-0002-3095-7714; Pereira, Luis/0000-0001-7880-4322	Future of Life Institute [RFP2-154]; Leverhulme Research Fellowship [RF-2020-603/9]; NOVA LINCS [UIDB/04516/2020]; FCT-Fundacao para a Ciencia e a Tecnologia, Portugal; FCT Portugal [UIDB/50021/2020, PTDC/MAT-APL/6804/2020, PTDC/CCI-INF/7366/2020]; TAILOR - EU Horizon 2020 research and innovation programme [952215]; FuturICT2.0 project - FLAG-ERA JTC 2016	Future of Life Institute; Leverhulme Research Fellowship(Leverhulme Trust); NOVA LINCS; FCT-Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FCT Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); TAILOR - EU Horizon 2020 research and innovation programme; FuturICT2.0 project - FLAG-ERA JTC 2016	T.A.H., L.M.P. and T.L. have been supported by Future of Life Institute grant RFP2-154. T.A.H. is also supported by a Leverhulme Research Fellowship (RF-2020-603/9). L.M.P. is also supported by NOVA LINCS (UIDB/04516/2020) with the financial support of FCT-Fundacao para a Ciencia e a Tecnologia, Portugal, through national funds. F.C.S. acknowledges support from FCT Portugal (grants UIDB/50021/2020, PTDC/MAT-APL/6804/2020, and PTDC/CCI-INF/7366/2020). T.L. and F.C.S. acknowledge the support by TAILOR, a project funded by EU Horizon 2020 research and innovation programme under GA No 952215. T.L. acknowledges support by the FuturICT2.0 (www.futurict2.eu) project funded by the FLAG-ERA JTC 2016.	Abbott FM, 2009, GLOBAL PHARMACEUTICAL POLICY: ENSURING MEDICINES FOR TOMORROWS WORLD, P1; Abou Chakra M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04968-1; AI-Roadmap-Institute, 2017, AI RAC AV WORKSH TOK; [Anonymous], 2018, NAT CLIM CHANGE, V8, P1, DOI 10.1038/s41558-017-0058-9; Armstrong S, 2016, AI SOC, V31, P201, DOI 10.1007/s00146-015-0590-y; Armstrong S, 2014, J EXP THEOR ARTIF IN, V26, P317, DOI 10.1080/0952813X.2014.895105; Askell A, 2019, ARXIV190704534; Baliga S, 2004, REV ECON STUD, V71, P351, DOI 10.1111/0034-6527.00287; Barrett S, 2016, P NATL ACAD SCI USA, V113, P14515, DOI 10.1073/pnas.1604989113; Baum SD, 2017, AI SOC, V32, P543, DOI 10.1007/s00146-016-0677-0; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brundage M, 2020, ARXIV200407213; Burrell R, 2020, COVID 19 PANDEMIC CH; Burrell R, 2014, MOD LAW REV, V77, P858, DOI 10.1111/1468-2230.12095; Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y; Campart S, 2014, ECON INNOV NEW TECH, V23, P215, DOI 10.1080/10438599.2013.825427; Cave S, 2018, PROCEEDINGS OF THE 2018 AAAI/ACM CONFERENCE ON AI, ETHICS, AND SOCIETY (AIES'18), P36, DOI 10.1145/3278721.3278780; Chen XJ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0935; Cherry TL, 2013, ENVIRON RESOUR ECON, V54, P63, DOI 10.1007/s10640-012-9581-3; Cimpeanu T, 2020, IEEE C EVOL COMPUTAT; Collingridge D, 1980, SOCIAL CONTROL TECHN; d'Onofrio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045653; Denicolo V, 2010, J EUR ECON ASSOC, V8, P1133; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Garcia J, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0127; Geist EM, 2016, B ATOM SCI, V72, P318, DOI 10.1080/00963402.2016.1216672; Gois AR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52524-8; Han TA, 2013, IJCAI 2013, P177; Han TA, 2020, J ARTIF INTELL RES, V69, P881; Han TA, 2019, AIES '19: PROCEEDINGS OF THE 2019 AAAI/ACM CONFERENCE ON AI, ETHICS, AND SOCIETY, P5, DOI 10.1145/3306618.3314265; Han TA, 2012, ARTIF LIFE, V18, P365, DOI [10.1162/artl_a_00072, 10.1162/ARTL_a_00072]; Hilbe C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00458; Hindersin L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43102-z; Imhof LA, 2005, P NATL ACAD SCI USA, V102, P10797, DOI 10.1073/pnas.0502589102; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Kahn J, 2007, IOWA LAW REV, V92, P353; Lemley MA, 2012, MICH LAW REV, V110, P709; Martinez-Vaquero LA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10639; Maynard Smith J., 1982, pi; McCullough M., 2008, REVENGE EVOLUTION FO; Morgan Maxwell R., 2010, COLUM SCI TECH L REV, V11, P93; Nesse RM, 2001, FDN SERIES TRUST; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC, DOI DOI 10.2307/J.CTVJGHW98; Pamlin D, 2015, GLOBAL CHALLENGES 12; Perc M, 2017, PHYS REP, V687, P1, DOI 10.1016/j.physrep.2017.05.004; Pereira LG, 2018, MANAGE IND ENG, P69, DOI 10.1007/978-3-319-73648-8_3; Pereira LM, 2017, AAMAS'17: PROCEEDINGS OF THE 16TH INTERNATIONAL CONFERENCE ON AUTONOMOUS AGENTS AND MULTIAGENT SYSTEMS, P1422; Rosenstock S, 2018, FRONT ROBOT AI, V5, DOI 10.3389/frobt.2018.00009; Santos FP, 2018, AAAI CONF ARTIF INTE, P4727; Santos FP, 2018, NATURE, V555, P242, DOI 10.1038/nature25763; Shulman C, 2009, 7 EUR C COMP PHIL EC, P2; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K., 2010, CALCULUS SELFISHNESS; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sotala K, 2015, PHYS SCRIPTA, V90, DOI 10.1088/0031-8949/90/1/018001; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Taddeo M, 2018, NATURE, V556, P296, DOI 10.1038/d41586-018-04602-6; Han TA, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P289; Han TA, 2016, AAAI CONF ARTIF INTE, P2494; Han TA, 2016, ADAPT BEHAV, V24, P237, DOI 10.1177/1059712316653451; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Van Segbroeck S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.158104; Vasconcelos VV, 2013, NAT CLIM CHANGE, V3, P797, DOI [10.1038/nclimate1927, 10.1038/NCLIMATE1927]; Vinuesa R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14108-y; Wang SX, 2019, COMMUN NONLINEAR SCI, V79, DOI 10.1016/j.cnsns.2019.104914; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006; World Health Organization, 2003, MED DEV REG GLOB OV	69	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0244592	10.1371/journal.pone.0244592	http://dx.doi.org/10.1371/journal.pone.0244592			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA8QK	33497424	gold, Green Published, Green Submitted			2022-12-26	WOS:000613707100006
J	Liu, JZ; Zhang, D; Tang, QJ; Xu, HB; Huang, SH; Shang, D; Liu, RX; Xue, B				Liu, Junzhao; Zhang, Dong; Tang, Qiuju; Xu, Hongbin; Huang, Shanheng; Shang, Dan; Liu, Ruxue; Xue, Bing			Water quality assessment and source identification of the Shuangji River (China) using multivariate statistical methods	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; TEMPORAL VARIATIONS; CLUSTER-ANALYSIS; INFORMATION; GROUNDWATER; EXTRACTION; STREAMFLOW; METAL; MODEL; BASIN	Multivariate statistical techniques, including cluster analysis (CA), discriminant analysis (DA), principal component analysis (PCA) and factor analysis (FA), were used to evaluate temporal and spatial variations in and to interpret large and complex water quality datasets collected from the Shuangji River Basin. The datasets, which contained 19 parameters, were generated during the 2 year (2018-2020) monitoring programme at 14 different sites (3192 observations) along the river. Hierarchical CA was used to divide the twelve months into three periods and the fourteen sampling sites into three groups. Discriminant analysis identified four parameters (CODMn, Cu, As, Se) loading more than 68% correct assignations in temporal analysis, while seven parameters (COD, TP, CODMn, F, LAS, Cu and Cd) to load 93% correct assignations in spatial analysis. The FA/PCA identified six factors that were responsible for explaining the data structure of 68% of the total variance of the dataset, allowing grouping of selected parameters based on common characteristics and assessing the incidence of overall change in each group. This study proposes the necessity and practicality of multivariate statistical techniques for evaluating and interpreting large and complex data sets, with a view to obtaining better information about water quality and the design of monitoring networks to effectively manage water resources.	[Liu, Junzhao; Tang, Qiuju; Xu, Hongbin; Huang, Shanheng; Shang, Dan; Liu, Ruxue; Xue, Bing] Zhengzhou Univ, Sch Ecol & Environm, Zhengzhou, Peoples R China; [Zhang, Dong] Zhengzhou Univ, Sch Architecture, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Zhang, D (corresponding author), Zhengzhou Univ, Sch Architecture, Zhengzhou, Peoples R China.	zdong39@zzu.edu.cn	xu, hong/GSD-8903-2022		Major Science and Technology Program for Water Pollution Control and Treatment of China [2017ZX07602-001-002]	Major Science and Technology Program for Water Pollution Control and Treatment of China	This study was supported by Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2017ZX07602-001-002).	Acar O, 2012, GRASAS ACEITES, V63, P383, DOI 10.3989/gya.047512; Amir M., 2011, FREE RADICAL ANTIOXI, V1, P75, DOI DOI 10.5530/AX.2011.4.12; Aristizabal JP, 2019, SPAT STAT-NETH, V32, DOI 10.1016/j.spasta.2019.100381; Bouza-Deano R, 2008, J HYDROL, V361, P227, DOI 10.1016/j.jhydrol.2008.07.048; Chattopadhyay T, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/2/91; Chow MF, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-015-4922-5; Conaway CH, 2007, ENVIRON RES, V105, P53, DOI 10.1016/j.envres.2006.10.006; Corporal-Lodangco IL, 2014, PROCEDIA COMPUT SCI, V36, P293, DOI 10.1016/j.procs.2014.09.096; Cruz RCD, 2017, USING CLUSTER ANAL M; Ding SF, 2011, NEURAL COMPUT APPL, V20, P297, DOI 10.1007/s00521-010-0416-2; Dominick D, 2012, ATMOS ENVIRON, V60, P172, DOI 10.1016/j.atmosenv.2012.06.021; Duan WL, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8020133; Ebrahimiyan M, 2013, GRASS FORAGE SCI, V68, P59, DOI 10.1111/j.1365-2494.2012.00869.x; El-Ashtoukhy ESZ, 2015, ALEX ENG J, V54, P77, DOI 10.1016/j.aej.2014.11.007; El-Sheikh AH, 2010, TALANTA, V83, P667, DOI 10.1016/j.talanta.2010.10.022; Friedel MJ, 2006, INT J RIVER BASIN MA, V4, P109, DOI 10.1080/15715124.2006.9635281; Gashi S, 2016, IFAC PAPERSONLINE, V49, P129, DOI 10.1016/j.ifacol.2016.11.072; Gonzalez MJ, 2018, QUAEST GEOGR, V37, P43, DOI 10.2478/quageo-2018-0036; Guo L, 2012, FRONT ENV SCI ENG, V6, P238, DOI 10.1007/s11783-011-0382-7; Huang MD, 2005, ANAL BIOANAL CHEM, V382, P1877, DOI 10.1007/s00216-005-3333-y; Jebb AT, 2017, HUM RESOUR MANAGE R, V27, P265, DOI 10.1016/j.hrmr.2016.08.003; Kazi TG, 2009, ECOTOX ENVIRON SAFE, V72, P301, DOI 10.1016/j.ecoenv.2008.02.024; Koutsias N, 2009, ISPRS J PHOTOGRAMM, V64, P37, DOI 10.1016/j.isprsjprs.2008.06.004; LANYongchao DKMZ, 2003, RELATIONSHIP BETWWEN, V13, P105; Li HH, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081792; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; LIU GW, 2019, SUSTAINABILITY-BASEL, V11, DOI DOI 10.3390/SU11123345; Lo FC, 2012, PROCD SOC BEHV, V64, P545, DOI 10.1016/j.sbspro.2012.11.064; Asri MNM, 2020, AUST J FORENSIC SCI, V52, P38, DOI 10.1080/00450618.2018.1466913; Muangthong S, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4774-1; Nowak B, 2018, METEOROLOGY HYDROLOG; Oda R, 2020, J MULTIVARIATE ANAL, V175, DOI 10.1016/j.jmva.2019.104561; Paiga P, 2012, CHEM PAP, V66, P711, DOI 10.2478/s11696-012-0193-8; Pehlivan E, 2007, FUEL PROCESS TECHNOL, V88, P99, DOI 10.1016/j.fuproc.2006.09.004; Rayner J, 2011, J PUBL ADM RES THEOR, V21, P27, DOI 10.1093/jopart/muq016; Rezaee F, 2015, EFFECT MARKETING KNO, P69; Singh CK, 2011, ENVIRON EARTH SCI, V62, P871, DOI 10.1007/s12665-010-0574-7; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; Singh KP, 2004, WATER RES, V38, P3980, DOI 10.1016/j.watres.2004.06.011; Toman R., 2014, American Journal of Animal and Veterinary Sciences, V9, P194; Tri Wahyuni E., 2016, AM J APPL CHEM, V4, P174; Twine TE, 2005, J CLIMATE, V18, P4840, DOI 10.1175/JCLI3566.1; Vargas Fernanda de, 2015, J. bras. psiquiatr., V64, P266, DOI 10.1590/0047-2085000000088; Varol M, 2012, CATENA, V92, P11, DOI 10.1016/j.catena.2011.11.013; Yang JS, 2013, ADV MATER RES-SWITZ, V610-613, P948, DOI 10.4028/www.scientific.net/AMR.610-613.948; Yidana S. M., 2011, Journal of Water Resource and Protection, V3, P695, DOI 10.4236/jwarp.2011.310080; Younis AM, 2015, CATRINA, V10, P45, DOI 10.12816/0010694; Zhang W, 2012, J SOIL SEDIMENT, V12, P354, DOI 10.1007/s11368-011-0460-2; Zhang XA, 2011, ENVIRON MONIT ASSESS, V173, P17, DOI 10.1007/s10661-010-1366-y; Zhao XD, 2014, MICROPOR MESOPOR MAT, V185, P72, DOI 10.1016/j.micromeso.2013.11.002	50	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245525	10.1371/journal.pone.0245525	http://dx.doi.org/10.1371/journal.pone.0245525			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481880	gold, Green Published			2022-12-26	WOS:000612929300044
J	Liu, YF; Gu, K; Shu, YM; Zhang, XL; Liu, XX; Mao, WL				Liu, Yun-Feng; Gu, Ke; Shu, Yi-Ming; Zhang, Xian-Lei; Liu, Xin-Xin; Mao, Wen-long			Shear models and parametric analysis of the PVC geomembrane-cushion interface in a high rock-fill dam	PLOS ONE			English	Article							STABILITY; VARIABILITY; STRENGTH; FAILURE	As a type of flexible impermeable material, a PVC geomembrane must be cooperatively used with cushion materials. The contact interface between a PVC geomembrane and cushion easily loses stability. In this present paper, we analyzed the shear models and parameters of the interface to study the stability. Two different cushion materials were used: the common extrusion sidewall and non-fines concrete. To simulate real working conditions, flexible silicone cushions were added under the loading plates to simulate hydraulic pressure loading, and the loading effect of flexible silicone cushions was demonstrated by measuring the actual contact areas under different normal pressures between the geomembrane and cushion using the thin-film pressure sensor. According to elastomer shear stress, there are two main types of shear stress between the PVC geomembrane and the cushion: viscous shear stress and hysteresis shear stress. The viscous shear stress between the geomembrane and the cement grout was measured using a dry, smooth concrete sample, then the precise formula parameters of the viscous shear stress and viscous friction coefficient were obtained. The hysteresis shear stress between the geomembrane and the cushion was calculated by subtracting the viscous shear stress from the total shear stress. The formula parameters of the hysteresis shear stress and hysteresis friction coefficient were calculated. The three-dimensional box-counting dimensions of the cushion surface were calculated, and the formula parameters of the hysteresis friction were positively correlated with the three-dimensional box dimensions.	[Liu, Yun-Feng; Gu, Ke; Shu, Yi-Ming; Mao, Wen-long] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China; [Zhang, Xian-Lei] North China Univ Water Resources & Elect Power, Sch Water Conservancy, Zhengzhou, Peoples R China; [Liu, Xin-Xin] Nanchang Inst Sci & Technol, Sch Human Habitat & Environm, Nanchang, Jiangxi, Peoples R China	Hohai University; North China University of Water Resources & Electric Power	Gu, K (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China.	356649397@qq.com		Liu, Yunfeng/0000-0001-9410-5759; Liu, Yunfeng/0000-0002-6376-4265	Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX17_0440]; Fundamental Research Funds for the Central Universities [2017B626X14]; National Natural Science Foundation of China [51379069]; Youth Science Foundation of Jiangxi Province [20192BAB216039]; Scientific Research Foundation of Jiangxi Provincial Education Department [GJJ191093]	Postgraduate Research & Practice Innovation Program of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Jiangxi Province; Scientific Research Foundation of Jiangxi Provincial Education Department	The present research was financially funded by the Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX17_0440) to YFL, the Fundamental Research Funds for the Central Universities (No. 2017B626X14) to YFL, the National Natural Science Foundation of China (No. 51379069) to YMS, the Youth Science Foundation of Jiangxi Province (No. 20192BAB216039) to XXL, the Scientific Research Foundation of Jiangxi Provincial Education Department(No. GJJ191093) to XXL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne R. J., 1994, P WAST TECH 94 CHARL; Chui R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S17-A17; Dixon N, 2006, GEOSYNTH INT, V13, P1, DOI 10.1680/gein.2006.13.1.1; Dixon N., 2002, GROUND ENG, V35, P49; Filz GM, 2001, J GEOTECH GEOENVIRON, V127, P841, DOI 10.1061/(ASCE)1090-0241(2001)127:10(841); Ge W, 2021, J WATER RES PLAN MAN, V147, DOI 10.1061/(ASCE)WR.1943-5452.0001311; Ge W, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138139; GIRARD H, 1990, GEOTEXT GEOMEMBRANES, V9, P129, DOI 10.1016/0266-1144(90)90010-A; Giroud JP, 1989, US P GEOSYNTH C, P35; Gomez J. E., 1999, P GEOS 99 IND FABR A, V99, P681; Jones D. R. V., 1998, GEOTEXT GEOMEMBRANES, V16, P45, DOI [10.1016/S0266-1144(97)10022-X, DOI 10.1016/S0266-1144(97)10022-X, DOI 10.1016/S0266-1144(00)00002-9]; KOERNER RM, 1991, GEOTEXT GEOMEMBRANES, V10, P335, DOI 10.1016/0266-1144(91)90010-T; Seed R.B., 1988, UCBGT88O1; Shallenberger WC, 1996, ENVIRONMENTAL GEOTECHNICS, VOL 1, P147; Sia AHI, 2007, GEOTEXT GEOMEMBRANES, V25, P139, DOI 10.1016/j.geotexmem.2006.12.003; Valentin LP, 2018, CONTACT MECH FRICTIO; White J.R., 2009, ENG ELASTOMERS RUBBE, V2, P287; Wu HM, 2012, KSCE J CIV ENG, V16, P1123, DOI 10.1007/s12205-012-1466-z; Wu W, 2008, GEOTEXT GEOMEMBRANES, V26, P363, DOI 10.1016/j.geotexmem.2007.12.001	19	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245245	10.1371/journal.pone.0245245	http://dx.doi.org/10.1371/journal.pone.0245245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481854	Green Published, gold			2022-12-26	WOS:000612929300139
J	Rivas, DRZ; Jaldin, MLL; Canaviri, BN; Escalante, LFP; Fernandez, AMCA; Ticona, JPA				Zeballos Rivas, Diana Reyna; Lopez Jaldin, Marinalda Lidia; Nina Canaviri, Blanca; Portugal Escalante, Luisa Fabiola; Alanes Fernandez, Angela M. C.; Aguilar Ticona, Juan Pablo			Social media exposure, risk perception, preventive behaviors and attitudes during the COVID-19 epidemic in La Paz, Bolivia: A cross sectional study	PLOS ONE			English	Article							EBOLA; SARS	Social media has an important role in diffusion of information, during COVID-19 pandemic it could help to promote preventive behaviors, however its role and the pathway is still unclear. Objective To investigate the association among social media exposure, risk perception, preventive behaviors, and attitudes toward the COVID-19 epidemic in Bolivia. Methods We launched an online survey in La Paz and El Alto, Bolivia, during April and May 2020. The questionnaire examined: Socio-demographic factors, Social media use, Risk Perception, Preventive behaviors, attitudes and the willingness to use a vaccine if it were available in the context of the COVID-19 epidemic. A logistic regression was used to evaluate factors associated with risk perception and a structural equation model (SEM) was performed to explore the pathway of the relationship among social media exposure, risk perception and preventive behaviors and attitudes. Results Among 886 participants, the most were young adults, between 18-25 years old (73.4%) and 577 (65.1%) were female. During the the week before the survey 387 (43.7%) reported be exposure to social media Covid-19 information almost always or always. Moreover 304 (34.3%) were categorized as with a high risk perception. The multivariable analyses show that being female (aOR = 1.5, CI 95% 1.1-2.1) and having high exposure to Covid-19 information on social media (aOR = 2.5, CI 95% 1.3-5.3) were associated with a higher risk perception for Covid-19. Furthermore, SEM results indicated that risk perception is associated with the adoption of preventive behaviors and attitudes (beta = 0.605, p < 0.001) including the acceptance of a vaccine if one were available (beta = 0.388, p < 0.001). Conclusion Social media exposure to COVID-19 information influences the adoption of preventive attitudes and behaviors through shaping risk perception. Understanding the role of social media during the pandemic could help policymakers and communicators to develop better communication strategies that enable the population to adopt appropriate attitudes and behaviors.	[Zeballos Rivas, Diana Reyna; Alanes Fernandez, Angela M. C.; Aguilar Ticona, Juan Pablo] Higher Univ San Andres, Publ Hlth Dept, La Paz, Bolivia; [Zeballos Rivas, Diana Reyna; Aguilar Ticona, Juan Pablo] Univ Fed Bahia, Postgrad Program Collect Hlth, Salvador, BA, Brazil; [Lopez Jaldin, Marinalda Lidia; Nina Canaviri, Blanca] Higher Univ San Andres, Sci Soc Med Students, La Paz, Bolivia; [Portugal Escalante, Luisa Fabiola] Univ Republic, Hosp Clin Dr Manuel Quintela, Montevideo, Uruguay	Universidad Mayor de San Andres; Universidade Federal da Bahia; Universidad Mayor de San Andres; Universidad de la Republica, Uruguay	Ticona, JPA (corresponding author), Higher Univ San Andres, Publ Hlth Dept, La Paz, Bolivia.; Ticona, JPA (corresponding author), Univ Fed Bahia, Postgrad Program Collect Hlth, Salvador, BA, Brazil.	pkjpablo@gmail.com	Aguilar Ticona, Juan Pablo/AAE-3068-2021	Aguilar Ticona, Juan Pablo/0000-0002-6971-2677; Zeballos Rivas, Diana Reyna/0000-0003-2045-765X; Lopez Jaldin, Marinalda Lidia/0000-0002-3899-2207				Ahmed N, 2018, VACCINE, V36, P7556, DOI 10.1016/j.vaccine.2018.10.049; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Depoux A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa031; Detoc Maelle, 2020, Vaccine, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Escalera-Antezana JP, 2020, TRAVEL MED INFECT DI, V35, DOI 10.1016/j.tmaid.2020.101653; Freimuth VS, 2017, RISK ANAL, V37, P2150, DOI 10.1111/risa.12790; GAO JL, 2020, PLOS ONE, V15, DOI [DOI 10.1371/JOURNAL.PONE.0231924, 10.1371/journal.pone.0231924]; Gostin LO, 2020, JAMA-J AM MED ASSOC, V324, P335, DOI 10.1001/jama.2020.10802; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Jang K, 2019, HEALTH COMMUN, V34, P991, DOI 10.1080/10410236.2018.1449552; Kaplan HS, 2020, LANCET, V395, P1727, DOI 10.1016/S0140-6736(20)31104-1; Kuchar E, 2017, ADV EXP MED BIOL, V980, P27, DOI 10.1007/5584_2016_207; Lerner JS, 2007, J CONSUM PSYCHOL, V17, P184; Liu PL, 2020, CYBERPSYCH BEH SOC N, V23, P677, DOI 10.1089/cyber.2020.0250; Lu N, 2020, AM J INFECT CONTROL, V48, P851, DOI 10.1016/j.ajic.2020.04.021; MinSal Bolivia, 2020, SIST NAC INF SALUD S; Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Pakpour AH, 2021, INT J MENT HEALTH AD, V19, P2407, DOI 10.1007/s11469-020-00334-9; Park JE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5484-8; Peeri NC, 2020, INT J EPIDEMIOL, V49, P717, DOI 10.1093/ije/dyaa033; Perez-Lopez FR, 2020, MATURITAS, V141, P59, DOI 10.1016/j.maturitas.2020.06.017; R Core Team, 2021, R LANGUAGE ENV STAT; Rosseel Y., 2017, PACKAGE LAVAAN, V17; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Rozenberg S, 2020, MATURITAS, V138, P62, DOI 10.1016/j.maturitas.2020.05.009; Rubsamen N, 2015, EMERG INFECT DIS, V21, P1012, DOI 10.3201/eid2106.150013; Smith RD, 2006, SOC SCI MED, V63, P3113, DOI 10.1016/j.socscimed.2006.08.004; Huynh TLD, 2020, ECON BULL, V40, P758; Whitworth J, 2020, T ROY SOC TROP MED H, V114, P227, DOI 10.1093/trstmh/traa025; Yoshida K., 2021, TABLEONE CREATETABLE; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X; Zhu MS, 2004, CELL MOL IMMUNOL, V1, P193	35	44	44	17	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245859	10.1371/journal.pone.0245859	http://dx.doi.org/10.1371/journal.pone.0245859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481945	Green Published, gold			2022-12-26	WOS:000612929300023
J	Zhang, YX; Wang, L; Peng, DZ; Zhang, QF; Yang, QC; Li, JY; Li, D; Tang, DF; Chen, MZ; Liang, SP; Liu, Y; Wang, S; Liu, ZH				Zhang, Yunxiao; Wang, Li; Peng, Dezheng; Zhang, Qingfeng; Yang, Qiuchu; Li, Jiayan; Li, Dan; Tang, Dongfang; Chen, Minzhi; Liang, Songping; Liu, Yu; Wang, Sheng; Liu, Zhonghua			Engineering of highly potent and selective HNTX-III mutant against hNa(v)1.7 sodium channel for treatment of pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAIN-OF-FUNCTION; ANALGESIC TARGET; NEUROPATHIC PAIN; VENOM; MUTATION; ANTAGONIST; MODULATORS; NA(V)1.6; SCN8A; MECHANISMS	Human voltage-gated sodium channel Na(v)1.7 (hNa(v)1.7) is involved in the generation and conduction of neuropathic and nociceptive pain signals. Compelling genetic and preclinical studies have validated that hNa(v)1.7 is a therapeutic target for the treatment of pain; however, there is a dearth of currently available compounds capable of targeting hNav1.7 with high potency and specificity. Hainantoxin-III (HNTX-III) is a 33-residue polypeptide from the venom of the spider Ornithoctonus hainana. It is a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels. Here, we report the engineering of improved potency and Na-v selectivity of hNa(v)1.7 inhibition peptides derived from the HNTX-III scaffold. Alanine scanning mutagenesis showed key residues for HNTX-III interacting with hNa(v)1.7. Site-directed mutagenesis analysis indicated key residues on hNa(v)1.7 interacting with HNTX-III. Molecular docking was conducted to clarify the binding interface between HNTX-III and Nav1.7 and guide the molecular engineering process. Ultimately, we obtained H4 [K0G1-P18K-A21L-V] based on molecular docking of HNTX-III and hNa(v)1.7 with a 30-fold improved potency (IC50 0.007 +/- 0.001 mu M) and >1000-fold selectivity against Na(v)1.4 and Na(v)1.5. H4 also showed robust analgesia in the acute and chronic inflammatory pain model and neuropathic pain model. Thus, our results provide further insight into peptide toxins that may prove useful in guiding the development of inhibitors with improved potency and selectivity for Na-v subtypes with robust analgesia.	[Zhang, Yunxiao; Wang, Li; Peng, Dezheng; Zhang, Qingfeng; Yang, Qiuchu; Li, Jiayan; Li, Dan; Tang, Dongfang; Chen, Minzhi; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China; [Zhang, Yunxiao; Peng, Dezheng; Liu, Yu] Hunan Inst Sci & Technol, Sch Chem & Chem Engn, Key Lab Hunan Prov Adv Carbon Based Funct Mat, Yueyang, Hunan, Peoples R China; [Wang, Sheng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China	Hunan Normal University; Hunan Institute of Science & Technology; Huazhong University of Science & Technology	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Hunan, Peoples R China.; Liu, Y (corresponding author), Hunan Inst Sci & Technol, Sch Chem & Chem Engn, Key Lab Hunan Prov Adv Carbon Based Funct Mat, Yueyang, Hunan, Peoples R China.; Wang, S (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan, Hubei, Peoples R China.	hiliu2000@126.com; shengwang@hust.edu.cn; liuzh@hunnu.edu.cn			National Natural Science Foundation of China [31900906, 32071262, 31570782, 31770832]; Science and Technology Innovation Program of Hunan Province [2020RC4023]; Research Foundation of Education Bureau of Hunan Province [16A131, 18A318, 19B240]; Hunan Natural Science Foundation [2018JJ2150]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Program of Hunan Province; Research Foundation of Education Bureau of Hunan Province; Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China (No. 31900906, 32071262, 31570782, 31770832), the Science and Technology Innovation Program of Hunan Province (2020RC4023), the Research Foundation of Education Bureau of Hunan Province (16A131, 18A318, 19B240) and Hunan Natural Science Foundation (No. 2018JJ2150).	Adedeji HA, 2014, PROG NEURO-PSYCHOPH, V48, P245, DOI 10.1016/j.pnpbp.2013.10.014; Ahuja S, 2015, SCIENCE, V350, DOI 10.1126/science.aac5464; Alexandrou AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152405; Bagal SK, 2014, BIOORG MED CHEM LETT, V24, P3690, DOI 10.1016/j.bmcl.2014.06.038; Beard E L Jr, 2001, JONAS Healthc Law Ethics Regul, V3, P78; Blanchard MG, 2015, J MED GENET, V52, P330, DOI 10.1136/jmedgenet-2014-102813; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Bourquin AF, 2006, PAIN, V122, P14, DOI 10.1016/j.pain.2005.10.036; Cardoso FC, 2017, BRIT J PHARMACOL, V174, P2528, DOI 10.1111/bph.13865; Cardoso FC, 2015, MOL PHARMACOL, V88, P291, DOI 10.1124/mol.115.098178; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chen L., 2014, SCI REP-UK, V4; Chow CY, 2015, TOXINS, V7, P2494, DOI 10.3390/toxins7072494; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Deuis JR, 2017, SCI REP-UK, V7, DOI 10.1038/srep40883; Devigili G, 2014, PAIN, V155, P1702, DOI 10.1016/j.pain.2014.05.006; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Estacion M, 2014, NEUROBIOL DIS, V69, P117, DOI 10.1016/j.nbd.2014.05.017; Gingras J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105895; Goldberg DS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-770; Jensen TS, 2002, EUR J PAIN, V6, P61, DOI 10.1053/eujp.2001.0324; Kawamoto Y, 2019, BIOCHEM PHARMACOL, V163, P178, DOI 10.1016/j.bcp.2019.02.015; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Kornecook TJ, 2017, J PHARMACOL EXP THER, V362, P146, DOI 10.1124/jpet.116.239590; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Liu Y, 2014, TOXINS, V6, P2363, DOI 10.3390/toxins6082363; Liu ZH, 2013, J BIOL CHEM, V288, P20392, DOI 10.1074/jbc.M112.426627; Lorenz D, 1998, J GEN PHYSIOL, V112, P577, DOI 10.1085/jgp.112.5.577; Mao JR, 2000, PAIN, V87, P7, DOI 10.1016/S0304-3959(00)00229-3; McKerrall SJ, 2019, J MED CHEM, V62, P4091, DOI 10.1021/acs.jmedchem.9b00141; Moyer BD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196791; Mulcahy JV, 2019, J MED CHEM, V62, P8695, DOI 10.1021/acs.jmedchem.8b01906; Murray JK, 2016, J MED CHEM, V59, P2704, DOI 10.1021/acs.jmedchem.5b01947; Murray JK, 2015, BIOORG MED CHEM LETT, V25, P4866, DOI 10.1016/j.bmcl.2015.06.033; Murray JK, 2015, J MED CHEM, V58, P2299, DOI 10.1021/jm501765v; Osteen JD, 2016, NATURE, V534, P494, DOI 10.1038/nature17976; Owoyele Victor B., 2005, Inflammopharmacology, V13, P479, DOI 10.1163/156856005774649386; Pi JH, 2007, CHIN J CHROMATOGR, V25, P399, DOI 10.1016/S1872-2059(07)60014-5; Rahnama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173551; Redondo A, 2017, J PHARMACOL EXP THER, V363, P293, DOI 10.1124/jpet.117.244376; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Sanna MD, 2017, BRIT J PHARMACOL, V174, P28, DOI 10.1111/bph.13644; Shcherbatko A, 2016, J BIOL CHEM, V291, P13974, DOI 10.1074/jbc.M116.725978; Shen HZ, 2019, SCIENCE, V363, P1303, DOI 10.1126/science.aaw2493; Sugawara T, 2001, P NATL ACAD SCI USA, V98, P6384, DOI 10.1073/pnas.111065098; Suter MR, 2015, ANESTHESIOLOGY, V122, P414, DOI 10.1097/ALN.0000000000000476; Tanaka BS, 2016, MOL MED, V22, P338, DOI 10.2119/molmed.2016.00131; Veeramah KR, 2012, AM J HUM GENET, V90, P502, DOI 10.1016/j.ajhg.2012.01.006; Waxman SG, 2006, NATURE, V444, P831, DOI 10.1038/444831a; Wu B, 2017, CURR MOL MED, V17, P450, DOI 10.2174/1566524017666171009105029; Xie W, 2015, NEUROSCIENCE, V291, P317, DOI 10.1016/j.neuroscience.2015.02.010; Xie WR, 2013, PAIN, V154, P1170, DOI 10.1016/j.pain.2013.02.027; Xu H, 2019, CELL, V176, P702, DOI 10.1016/j.cell.2018.12.018; Yang Y, 2016, J NEUROSCI, V36, P7511, DOI 10.1523/JNEUROSCI.0462-16.2016; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhou X, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00852; Zhu YQ, 2014, BIOCHIMIE, V99, P38, DOI 10.1016/j.biochi.2013.10.017	61	4	4	4	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100326	10.1016/j.jbc.2021.100326	http://dx.doi.org/10.1016/j.jbc.2021.100326			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493520	Green Published, gold			2022-12-26	WOS:000672866400300
J	Buchman, AS; Leurgans, SE; Wang, TH; Schnaider-Beeri, M; Agarwal, P; Dawe, RJ; Delbono, O; Bennett, DA				Buchman, Aron S.; Leurgans, Sue E.; Wang, Tianhao; Schnaider-Beeri, Michal; Agarwal, Puja; Dawe, Robert J.; Delbono, Osvaldo; Bennett, David A.			Motor function is the primary driver of the associations of sarcopenia and physical frailty with adverse health outcomes in community-dwelling older adults	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; FOOD FREQUENCY QUESTIONNAIRE; DECLINE; IMPAIRMENT; MORTALITY; CONSENSUS; COGNITION; DISEASE; PEOPLE; MEMORY	Background This study tested the hypothesis that sarcopenia and its constituent components, reduced lean muscle mass and impaired motor function, are associated with reduced survival and increased risk of incident disabilities. Methods 1466 community-dwelling older adults underwent assessment of muscle mass with bioelectrical impedance analysis (BIA), grip strength, gait speed and other components of physical frailty and annual self-report assessments of disability. We used Cox proportional hazards models that controlled for age, sex, race, education and height to examine the associations of a continuous sarcopenia metric with the hazard of death and incident disabilities. Results Mean baseline age was about 80 years old and follow-up was 5.5 years. In a proportional hazards model controlling for age, sex, race, education and baseline sarcopenia, each 1-SD higher score on a continuous sarcopenia scale was associated with lower hazards of death (HR 0.70, 95%CI [0.62, 0.78]), incident IADL (HR 0.80,95%CI [0.70, 0.93]), incident ADL disability (HR 0.80 95%CI [71, 91]) and incident mobility disability (HR 0.81, 95%CI [0.70, 0.93]). Further analyses suggest that grip strength and gait speed rather than muscle mass drive the associations with all four adverse health outcomes. Similar findings were observed when controlling for additional measures used to assess physical frailty including BMI, fatigue and physical activity. Conclusions Motor function is the primary driver of the associations of sarcopenia and physical frailty with diverse adverse health outcomes. Further work is needed to identify other facets of muscle structure and motor function which together can identify adults at risk for specific adverse health outcomes.	[Buchman, Aron S.; Leurgans, Sue E.; Wang, Tianhao; Dawe, Robert J.; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Buchman, Aron S.; Leurgans, Sue E.; Wang, Tianhao; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Schnaider-Beeri, Michal] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Schnaider-Beeri, Michal] Tel Aviv Univ, Joseph Sagol Sch Neurosci, Tel Aviv, Israel; [Agarwal, Puja] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Dawe, Robert J.] Rush Univ, Dept Diagnost Radiol & Nucl Med, Med Ctr, Chicago, IL 60612 USA; [Delbono, Osvaldo] Wake Forest Sch Med, Sect Gerontol, Winston Salem, NC 27101 USA	Rush University; Rush University; Icahn School of Medicine at Mount Sinai; Tel Aviv University; Rush University; Rush University; Wake Forest University	Buchman, AS (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.; Buchman, AS (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA.	Aron_S_Buchman@rush.edu		, Puja/0000-0002-0274-6653	National Institute of Health [R01AG17917, R01AG47976, R01AG56352, R01AG53446, R01AG57013]; Illinois Department of Public Health; Robert C. Borwell Endowment Fund	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; Robert C. Borwell Endowment Fund	This work was supported by National Institute of Health [R01AG17917 (DAB), R01AG47976 (ASB), R01AG56352 (ASB); R01AG53446 (MB), R01AG57013 (OD), the Illinois Department of Public Health (DAB); and the Robert C. Borwell Endowment Fund (DAB). The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2019, J GERONTOL A-BIOL, V74, P1331, DOI 10.1093/gerona/gly211; [Anonymous], 2002, SAS STAT SOFTW UN VE; [Anonymous], J COMP NEUROLOGY ANT; Bennett DA, 2018, J ALZHEIMERS DIS, V64, pS161, DOI 10.3233/JAD-179939; Bernabeu-Wittel M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040535; Bhasin S, 2020, J AM GERIATR SOC, V68, P1410, DOI 10.1111/jgs.16372; Boyle PA, 2010, J AM GERIATR SOC, V58, P248, DOI 10.1111/j.1532-5415.2009.02671.x; Buchman AS, 2007, MUSCLE NERVE, V35, P354, DOI 10.1002/mus.20702; Buchman AS, 2009, EXP AGING RES, V35, P61, DOI 10.1080/03610730802545051; Buchman AS, 2008, NEUROLOGY, V71, P499, DOI 10.1212/01.wnl.0000324864.81179.6a; Buchman AS, 2007, PSYCHOSOM MED, V69, P483, DOI 10.1097/psy.0b013e318068de1d; Buchman AS, 2007, J AM GERIATR SOC, V55, P11, DOI 10.1111/j.1532-5415.2006.01032.x; Buchman AS, 2020, ACTA NEUROPATHOL, V140, P587, DOI 10.1007/s00401-020-02212-z; Buchman AS, 2021, J GERONTOL A-BIOL, V76, P615, DOI 10.1093/gerona/glaa176; Buchman AS, 2020, J GERONTOL A-BIOL, V75, P1176, DOI 10.1093/gerona/glz160; Buchman AS, 2019, NEUROLOGY, V92, pE1821, DOI 10.1212/WNL.0000000000007315; Buchman AS, 2014, J GERONTOL A-BIOL, V69, P1536, DOI 10.1093/gerona/glu117; Buchman AS, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-42; Cawthon PM, 2020, J AM GERIATR SOC, V68, P1429, DOI 10.1111/jgs.16517; Cederholm T, 2015, NESTLE NUTR WORKS SE, V83, P65, DOI 10.1159/000382063; Cesari M, 2020, J AM GERIATR SOC, V68, P1406, DOI 10.1111/jgs.16575; Cesari M, 2013, EXP GERONTOL, V48, P451, DOI 10.1016/j.exger.2012.10.004; Clark BC, 2012, NUTRITION, V28, P495, DOI 10.1016/j.nut.2011.12.002; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fallaize R, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010049; Ferrucci L, 2004, J AM GERIATR SOC, V52, P625, DOI 10.1111/j.1532-5415.2004.52174.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; KATZ S, 1976, INT J HEALTH SERV, V6, P493, DOI 10.2190/UURL-2RYU-WRYD-EY3K; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Liguori I, 2018, NUTR CLIN PRACT, V33, P879, DOI 10.1002/ncp.10022; Manini TM, 2020, J AM GERIATR SOC, V68, P1419, DOI 10.1111/jgs.16524; Manini TM, 2013, CURR OPIN CLIN NUTR, V16, P21, DOI 10.1097/MCO.0b013e32835b5880; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1007, DOI 10.1016/j.jalz.2014.11.009; Morris MC, 2003, AM J EPIDEMIOL, V158, P1213, DOI 10.1093/aje/kwg290; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Patel SM, 2020, J AM GERIATR SOC, V68, P1438, DOI 10.1111/jgs.16419; Peter S, 2015, NUTRIENTS, V7, P10491, DOI 10.3390/nu7125547; Rebok GW, 2007, J GERONTOL B-PSYCHOL, V62, P53, DOI 10.1093/geronb/62.special_issue_1.53; ROSOW I, 1966, J GERONTOL, V21, P556, DOI 10.1093/geronj/21.4.556; Schaap LA, 2018, J GERONTOL A-BIOL, V73, P1199, DOI 10.1093/gerona/glx245; Subra J, 2012, J NUTR HEALTH AGING, V16, P714, DOI 10.1007/s12603-012-0391-7; Tangney CC, 2004, J NUTR, V134, P927, DOI 10.1093/jn/134.4.927; Team R, 2015, RSTUDIO INT DEV R; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881	48	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245680	10.1371/journal.pone.0245680	http://dx.doi.org/10.1371/journal.pone.0245680			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529220	Green Published, gold			2022-12-26	WOS:000616736200005
J	Mytidou, C; Koutsoulidou, A; Katsioloudi, A; Prokopi, M; Kapnisis, K; Michailidou, K; Anayiotos, A; Phylactou, LA				Mytidou, Chrystalla; Koutsoulidou, Andrie; Katsioloudi, Anna; Prokopi, Marianna; Kapnisis, Konstantinos; Michailidou, Kyriaki; Anayiotos, Andreas; Phylactou, Leonidas A.			Muscle-derived exosomes encapsulate myomiRs and are involved in local skeletal muscle tissue communication	FASEB JOURNAL			English	Article						exosomal cross talk; exosomes; myomiRs; skeletal muscle	HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MEDIATED DELIVERY; FIBER TYPES; IN-VITRO; MICRORNAS; VESICLES; CELLS; IDENTIFICATION; MICROVESICLES; EXPRESSION	Exosomes are extracellular vesicles that are released from most cell types encapsulating specific molecular cargo. Exosomes serve as mediators of cell-to-cell and tissue-to-tissue communications under normal and pathological conditions. It has been shown that exosomes carrying muscle-specific miRNAs, myomiRs, are secreted from skeletal muscle cells in vitro and are elevated in the blood of muscle disease patients. The aim of this study was to investigate the secretion of exosomes encapsulating the four myomiRs from skeletal muscle tissues and to assess their role in inter-tissue communication between neighboring skeletal muscles in vivo. We demonstrate, for the first time, that isolated, intact skeletal muscle tissues secrete exosomes encapsulating the four myomiRs, miR-1, miR-133a, miR-133b, and miR-206. Notably, we show that the sorting of the four myomiRs within exosomes varies between skeletal muscles of different muscle fiber-type composition. miR-133a and miR-133b downregulation in TA muscles caused a reduction of their levels in neighboring skeletal muscles and in serum exosomes. In conclusion, our results reveal that skeletal muscle-derived exosomes encapsulate the four myomiRs, some of which enter the blood, while a portion is used for the local communication between proximal muscle tissues. These findings provide important evidence regarding novel pathways implicated in skeletal muscle function.	[Mytidou, Chrystalla; Koutsoulidou, Andrie; Phylactou, Leonidas A.] Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 23462, CY-1683 Nicosia, Cyprus; [Mytidou, Chrystalla; Koutsoulidou, Andrie; Michailidou, Kyriaki; Phylactou, Leonidas A.] Cyprus Sch Mol Med, Cyprus Inst Neurol & Genet, Nicosia, Cyprus; [Katsioloudi, Anna; Prokopi, Marianna] Theramir Ltd, Limassol, Cyprus; [Prokopi, Marianna; Kapnisis, Konstantinos; Anayiotos, Andreas] Cyprus Univ Technol, Dept Mech Engn & Mat Sci & Engn, Lemesos, Cyprus; [Prokopi, Marianna] German Oncol Ctr, Dept Res & Dev, Limassol, Cyprus; [Michailidou, Kyriaki] Cyprus Inst Neurol & Genet, Biostat Unit, Nicosia, Cyprus	Cyprus University of Technology	Phylactou, LA (corresponding author), Cyprus Inst Neurol & Genet, Dept Mol Genet Funct & Therapy, POB 23462, CY-1683 Nicosia, Cyprus.	laphylac@cing.ac.cy	Kapnisis, Konstantinos/ABG-6186-2020; Anayiotos, Andreas/AFE-8497-2022; Anayiotos, Andreas/AAE-9728-2022	Anayiotos, Andreas/0000-0003-4471-7604; Anayiotos, Andreas/0000-0003-4471-7604; Michailidou, Kyriaki/0000-0001-7065-1237; Phylactou, Leonidas/0000-0002-1377-211X; Kapnisis, Konstantinos/0000-0002-4999-0231				Aoi W, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00039; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Aswad H, 2014, DIABETOLOGIA, V57, P2155, DOI 10.1007/s00125-014-3337-2; Atay S, 2011, EXP CELL RES, V317, P1192, DOI 10.1016/j.yexcr.2011.01.014; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Borges FT, 2013, J AM SOC NEPHROL, V24, P385, DOI 10.1681/ASN.2012101031; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Charoenviriyakul C, 2017, EUR J PHARM SCI, V96, P316, DOI 10.1016/j.ejps.2016.10.009; Chen B, 2017, STEM CELL TRANSL MED, V6, P1753, DOI 10.1002/sctm.16-0477; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Cicchillitti L, 2012, J BIOL CHEM, V287, P44761, DOI 10.1074/jbc.M112.421255; De Gasperi R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13105-9; Delcayre A, 2005, EXPERT REV ANTICANC, V5, P537, DOI 10.1586/14737140.5.3.537; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Favier FB, 2015, CELL MOL LIFE SCI, V72, P4681, DOI 10.1007/s00018-015-2025-9; Forterre A, 2014, CELL CYCLE, V13, P78, DOI 10.4161/cc.26808; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; Horak M, 2016, DEV BIOL, V410, P1, DOI 10.1016/j.ydbio.2015.12.013; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Ji W., 2018, PLOS ONE, V13, P1; JOHNSTONE RM, 1992, BIOCHEM CELL BIOL, V70, P179, DOI 10.1139/o92-028; Kaewpila S, 2008, CANCER RES, V68, P2781, DOI 10.1158/0008-5472.CAN-07-2635; Katayama M, 2019, DIABETES, V68, P515, DOI 10.2337/db18-0470; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; Koutalianos D, 2015, J CELL SCI, V128, P3631, DOI 10.1242/jcs.172288; Koutsoulidou A, 2017, HUM MOL GENET, V26, P3285, DOI 10.1093/hmg/ddx212; Koutsoulidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125341; Koutsoulidou A, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-34; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li SP, 2018, ACTA PHARMACOL SIN, V39, P542, DOI 10.1038/aps.2017.178; Lima LG, 2018, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS OF EXOSOMES IN CANCER, P175, DOI 10.1016/B978-0-12-812774-2.00010-9; Ma GD, 2015, INT J BIOL SCI, V11, P345, DOI 10.7150/ijbs.10921; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Naseri Z, 2018, INT J NANOMED, V13, P7727, DOI 10.2147/IJN.S182384; Nie YH, 2019, EXP PHYSIOL, V104, P1262, DOI 10.1113/EP087396; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Quattrocelli M, 2015, ADV DRUG DELIVER REV, V88, P37, DOI 10.1016/j.addr.2015.04.011; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Rome S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00929; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Ryan MJ, 2008, J GERONTOL A-BIOL, V63, P1015, DOI 10.1093/gerona/63.10.1015; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Steinbichler TB, 2017, SEMIN CANCER BIOL, V44, P170, DOI 10.1016/j.semcancer.2017.02.006; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Zhang D, 2017, AM J PHYSIOL-LUNG C, V312, pL110, DOI 10.1152/ajplung.00423.2016; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	62	16	16	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21279	10.1096/fj.201902468RR	http://dx.doi.org/10.1096/fj.201902468RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484211	hybrid, Green Published			2022-12-26	WOS:000647789600056
J	Seita, A; Nakaoka, H; Okura, R; Wakamoto, Y				Seita, Akihisa; Nakaoka, Hidenori; Okura, Reiko; Wakamoto, Yuichi			Intrinsic growth heterogeneity of mouse leukemia cells underlies differential susceptibility to a growth-inhibiting anticancer drug	PLOS ONE			English	Article							RESISTANCE; PLASTICITY; VARIABILITY; MECHANISMS; NOISE; STATE; RARE; TIME	Cancer cell populations consist of phenotypically heterogeneous cells. Growing evidence suggests that pre-existing phenotypic differences among cancer cells correlate with differential susceptibility to anticancer drugs and eventually lead to a relapse. Such phenotypic differences can arise not only externally driven by the environmental heterogeneity around individual cells but also internally by the intrinsic fluctuation of cells. However, the quantitative characteristics of intrinsic phenotypic heterogeneity emerging even under constant environments and their relevance to drug susceptibility remain elusive. Here we employed a microfluidic device, mammalian mother machine, for studying the intrinsic heterogeneity of growth dynamics of mouse lymphocytic leukemia cells (L1210) across tens of generations. The generation time of this cancer cell line had a distribution with a long tail and a heritability across generations. We determined that a minority of cell lineages exist in a slow-cycling state for multiple generations. These slow-cycling cell lineages had a higher chance of survival than the fast-cycling lineages under continuous exposure to the anticancer drug Mitomycin C. This result suggests that heritable heterogeneity in cancer cells' growth in a population influences their susceptibility to anticancer drugs.	[Seita, Akihisa; Nakaoka, Hidenori; Okura, Reiko; Wakamoto, Yuichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo, Japan; [Wakamoto, Yuichi] Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan; [Wakamoto, Yuichi] Univ Tokyo, Universal Biol Inst, Tokyo, Japan; [Nakaoka, Hidenori] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kyoto University	Nakaoka, H; Wakamoto, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo, Japan.; Wakamoto, Y (corresponding author), Univ Tokyo, Res Ctr Complex Syst Biol, Tokyo, Japan.; Wakamoto, Y (corresponding author), Univ Tokyo, Universal Biol Inst, Tokyo, Japan.; Nakaoka, H (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Kyoto, Japan.	nakaoka.hidenori.6n@kyoto-u.ac.jp; cwaka@mail.ecc.u-tokyo.ac.jp		Nakaoka, Hidenori/0000-0001-8465-5853	JST CREST [JPMJCR1927]; Japan Society for the Promotion of Science KAKENHI [15KT0075, 15H05746, 17H06389, 19H03216]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST CREST Grant Number JPMJCR1927 (to Y.W.); and Japan Society for the Promotion of Science KAKENHI (grant number 15KT0075, 15H05746, 17H06389, and 19H03216 to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn A, 2017, MOL CANCER THER, V16, P1002, DOI 10.1158/1535-7163.MCT-16-0535; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; BROOKS RF, 1980, CELL, V19, P493, DOI 10.1016/0092-8674(80)90524-3; Cipponi A, 2020, SCIENCE, V368, P1127, DOI 10.1126/science.aau8768; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Ebinger S, 2016, CANCER CELL, V30, P849, DOI 10.1016/j.ccell.2016.11.002; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hammerlindl H, 2018, J CELL COMMUN SIGNAL, V12, P133, DOI 10.1007/s12079-017-0435-1; Hashimoto M, 2016, P NATL ACAD SCI USA, V113, P3251, DOI 10.1073/pnas.1519412113; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Kuchen EE, 2020, ELIFE, V9, DOI 10.7554/eLife.51002; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; Liu MW, 2014, APPL SPECTROSC, V68, P577, DOI 10.1366/13-07236; Mizrahi SP, 2016, CELL CYCLE, V15, P3442, DOI 10.1080/15384101.2016.1248006; Moore N, 2012, STEM CELLS DEV, V21, P1822, DOI 10.1089/scd.2011.0477; Mosheiff N, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021035; Nakaoka H, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001109; Nguyen A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11246; Paek AL, 2016, CELL, V165, P631, DOI 10.1016/j.cell.2016.03.025; Perego M, 2018, ONCOGENE, V37, P302, DOI 10.1038/onc.2017.341; Pisco AO, 2015, BRIT J CANCER, V112, P1725, DOI 10.1038/bjc.2015.146; POWELL EO, 1955, BIOMETRIKA, V42, P16, DOI 10.1093/biomet/42.1-2.16; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Redmond KM, 2008, FRONT BIOSCI-LANDMRK, V13, P5138, DOI 10.2741/3070; Reyes J, 2018, CURR OPIN BIOTECH, V51, P109, DOI 10.1016/j.copbio.2017.12.007; Ross DD, 2000, LEUKEMIA, V14, P467, DOI 10.1038/sj.leu.2401694; Russo M, 2019, SCIENCE, V366, P1473, DOI 10.1126/science.aav4474; Sandler O, 2015, NATURE, V519, P468, DOI 10.1038/nature14318; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith EA, 2019, TRENDS CANCER, V5, P411, DOI 10.1016/j.trecan.2019.05.009; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Spivey EC, 2017, ELIFE, V6, DOI [10.7554/eLife.20340.001, 10.7554/eLife.20340]; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Wakamoto Y, 2005, ANALYST, V130, P311, DOI 10.1039/b409860a; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0236534	10.1371/journal.pone.0236534	http://dx.doi.org/10.1371/journal.pone.0236534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524064	gold, Green Submitted, Green Published			2022-12-26	WOS:000616578400016
J	Wang, CY; Dang, T; Baste, J; Joshi, AA; Bhushan, A				Wang, Chengyao; Thao Dang; Baste, Jasmine; Joshi, Advait Anil; Bhushan, Abhinav			A novel standalone microfluidic device for local control of oxygen tension for intestinal-bacteria interactions	FASEB JOURNAL			English	Article						anaerobe; barrier function; colon; hypoxic intestine; intestine&#8208; bacteria interaction; microfluidics; organ&#8208; on&#8208; chip; oxygen sensor; partitioned oxygen environment	IN-VITRO MODEL; HYPOXIA; CELL; CULTURE; METABOLISM; MICROBIOME; EXPRESSION; RESPONSES	The intestinal environment is unique because it supports the intestinal epithelial cells under a normal oxygen environment and the microbiota under an anoxic environment. Due to importance of understanding the interactions between the epithelium and the microbiota, there is a strong need for developing representative and simple experimental models. Current approaches do not capture the partitioned oxygen environment, require external anaerobic chambers, or are complex. Another major limitation is that with the solutions that can mimic this oxygen environment, the oxygenation level of the epithelial cells is not known, raising the question whether the cells are hypoxic or not. We report standalone microfluidic devices that form a partitioned oxygen environment without the use of an external anaerobic chamber or oxygen scavengers to coculture intestinal epithelial and bacterial cells. By changing the thickness of the device cover, the oxygen tension in the chamber was modulated. We verified the oxygen levels using several tests: microscale oxygen sensitive sensors which were integrated within the devices, immunostaining of Caco-2 cells to determine hypoxia levels, and genetically encoded bacteria to visualize the growth. Collectively, these methods monitored oxygen concentrations in the devices more comprehensively than previous reports and allowed for control of oxygen tension to match the requirements of both intestinal cells and anaerobic bacteria. Our experimental model is supported by the mathematical model that considered diffusion of oxygen into the top chamber. This allowed us to experimentally determine the oxygen consumption rate of the intestinal epithelial cells under perfusion.	[Wang, Chengyao; Thao Dang; Baste, Jasmine; Joshi, Advait Anil; Bhushan, Abhinav] IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 224, Chicago, IL 60616 USA	Illinois Institute of Technology	Bhushan, A (corresponding author), IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 224, Chicago, IL 60616 USA.	abhushan@iit.edu	Bhushan, Abhinav/AAR-6996-2020	Bhushan, Abhinav/0000-0002-8861-9005; Wang, Chengyao/0000-0002-0362-4498				Aguilera KY., 2014, BIOPROTOC, V4; Ahluwalia A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42113; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Amao Y, 2001, J FLUORINE CHEM, V107, P101, DOI 10.1016/S0022-1139(00)00352-3; Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014; Bao BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050860; Beaurivage C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225661; Byron Bird R, 2007, TRANSPORT PHENOMENA, V2nd, DOI DOI 10.1002/AIC.690070245; Chung HH, 2018, LAB CHIP, V18, P1671, DOI 10.1039/c7lc01248a; Chung HH, 2014, LAB CHIP, V14, P2456, DOI 10.1039/c4lc00326h; Decleer M, 2018, TOXINS, V10, DOI 10.3390/toxins10070266; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duttal D, 2017, CURR OPIN IMMUNOL, V48, P15, DOI 10.1016/j.coi.2017.07.012; Fang KL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23180-1; Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312; Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14; Gao YD, 2019, LAB CHIP, V19, P306, DOI 10.1039/c8lc00825f; Glover LE, 2011, GASTROENTEROLOGY, V140, P1748, DOI 10.1053/j.gastro.2011.01.056; Grauso M., 2019, SCI REP-UK, V9, P1; Hegde M, 2014, LAB CHIP, V14, P2033, DOI 10.1039/c4lc00071d; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jalili-Firoozinezhad S, 2019, NAT BIOMED ENG, V3, P520, DOI 10.1038/s41551-019-0397-0; Jenkins J, 2015, ACTA BIOMATER, V16, P126, DOI 10.1016/j.actbio.2015.01.032; Jung SR, 2018, P NATL ACAD SCI USA, V115, pE5706, DOI 10.1073/pnas.1717724115; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Karhausen J, 2003, CELL MOL BIOL, V49, P77; Kaska L, 2016, WORLD J GASTROENTERO, V22, P8698, DOI 10.3748/wjg.v22.i39.8698; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kim R, 2020, BIOFABRICATION, V12, DOI 10.1088/1758-5090/ab446e; Lei Qi, 2014, Int J Mol Med, V34, P1629, DOI 10.3892/ijmm.2014.1965; Lizier M, 2010, FEMS MICROBIOL LETT, V308, P8, DOI 10.1111/j.1574-6968.2010.01978.x; Loskill P, 2017, LAB CHIP, V17, P1645, DOI 10.1039/c6lc01590e; Markov DA, 2014, BIOMED MICRODEVICES, V16, P91, DOI 10.1007/s10544-013-9808-2; Melican K, 2008, CELL MICROBIOL, V10, P1987, DOI 10.1111/j.1462-5822.2008.01182.x; Morowitz MJ, 2011, SURG CLIN N AM, V91, P771, DOI 10.1016/j.suc.2011.05.001; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Oz HS, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101085; Page S, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0042-1; Pearce SC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01584; Pickard JM, 2017, IMMUNOL REV, V279, P70, DOI 10.1111/imr.12567; Place TL, 2017, FREE RADICAL BIO MED, V113, P311, DOI 10.1016/j.freeradbiomed.2017.10.003; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Raleigh JA, 1998, CANCER RES, V58, P3765; Sadaghian Sadabad M., 2015, SCI REP-UK, V5, P1; Samy KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46408-0; Schultz M, 2005, J MICROBIOL METH, V61, P389, DOI 10.1016/j.mimet.2005.01.007; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Shin W, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00013; Sonnenborn Ulrich, 2009, Microbial Ecology in Health and Disease, V21, P122, DOI 10.3109/08910600903444267; Sturrock A, 2018, J IMMUNOL, V201, P3411, DOI 10.4049/jimmunol.1701387; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Thomas PC, 2011, ANAL CHEM, V83, P8821, DOI 10.1021/ac202300g; Thomas PC, 2009, ANAL CHEM, V81, P9239, DOI 10.1021/ac9013379; Tirella A, 2015, J BIOMED NANOTECHNOL, V11, P1451, DOI 10.1166/jbn.2015.2085; Ulluwishewa D, 2015, CELL MICROBIOL, V17, P226, DOI 10.1111/cmi.12360; van Kessel SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08294-y; Wang CY, 2018, ACS BIOMATER SCI ENG, V4, P1377, DOI 10.1021/acsbiomaterials.7b00883; Xu DZ, 1999, J TRAUMA, V46, P280, DOI 10.1097/00005373-199902000-00014; Yeh TS, 2006, SENSOR ACTUAT B-CHEM, V119, P701, DOI 10.1016/j.snb.2006.01.051; Zeitouni N. E., 2016, MOL CELL PEDIAT, V3; Zeitouni NE, 2015, HYPOXIA, V3, P53, DOI 10.2147/HP.S85625; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015	65	7	8	7	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21291	10.1096/fj.202001600RR	http://dx.doi.org/10.1096/fj.202001600RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33506497	Bronze, Green Submitted			2022-12-26	WOS:000647789600017
J	Cristiano, E; Farris, S; Deidda, R; Viola, F				Cristiano, Elena; Farris, Stefano; Deidda, Roberto; Viola, Francesco			Comparison of blue-green solutions for urban flood mitigation: A multi-city large-scale analysis	PLOS ONE			English	Article							COST-BENEFIT-ANALYSIS; HYDROLOGICAL PERFORMANCE; ROOF; RETENTION; IMPLEMENTATION; RESOLUTION; RAINFALL; CITIES; SLOPE	Flooding risk in cities has been recently exacerbated by increased urbanization and climate change, often with catastrophic consequences in terms of casualties and economic losses. Rainwater harvesting systems and green roofs are recognized as being among the most effective blue-green mitigation measures. However, performances of these systems have currently been investigated only at laboratory or very-small local scales. In this work, we assess the potential benefit of the extensive installation of these solutions on all the rooftops of 9 cities, with different climatological and geographical characteristics. Both surface discharge reduction and delay between rainfall and runoff peak generation have been investigated. Green roofs ensure a larger average lag time between rainfall and runoff peaks than rainwater harvesting systems, without significant differences between intensive and extensive structures. On the other hand, the cost-efficiency analysis, considering the entire urban area, shows a higher retention capacity with a lower financial investment for rainwater harvesting rather than for green roofs in most cases. For extreme rainfall events, large-scale installation of rainwater harvesting systems coupled with intensive green roofs over the entire city have shown to be the most efficient solution, with a total discharge reduction that can vary from 5% to 15%, depending on the city characteristics and local climate.	[Cristiano, Elena; Farris, Stefano; Deidda, Roberto; Viola, Francesco] Univ Cagliari, Fac Ingn, Sez Idraul, Dipartimento Ingn Civile Ambientale & Architettur, Cagliari, CA, Italy	University of Cagliari	Cristiano, E (corresponding author), Univ Cagliari, Fac Ingn, Sez Idraul, Dipartimento Ingn Civile Ambientale & Architettur, Cagliari, CA, Italy.	elena.cristiano@unica.it	Viola, Francesco/E-9722-2013; Cristiano, Elena/AAJ-5635-2021	Viola, Francesco/0000-0003-1716-192X; Cristiano, Elena/0000-0002-0725-3014	Sardinian Region, project: "HYDROSARD: Un approccio multidisciplinare integrato e multiscala per la valutazione globale delle risorse idriche nella Regione Sardegna, anche in condizioni di cambiamento climatico" [CUP: F76C18000920002]; Fondazione di Sardegna [CUP: F71I17000270002]	Sardinian Region, project: "HYDROSARD: Un approccio multidisciplinare integrato e multiscala per la valutazione globale delle risorse idriche nella Regione Sardegna, anche in condizioni di cambiamento climatico"; Fondazione di Sardegna(Fondazione Banco di Sardegna)	RD was supported by the Sardinian Region with law 7/2007, funding call 2017, project: "HYDROSARD: Un approccio multidisciplinare integrato e multiscala per la valutazione globale delle risorse idriche nella Regione Sardegna, anche in condizioni di cambiamento climatico", CUP: F76C18000920002. FV was partially supported by the Fondazione di Sardegna, funding call 2017, project: Impacts of climate change on water resources and floods, CUP: F71I17000270002.	Adugna D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020336; Akter A, 2015, J HYDROL, V528, P84, DOI 10.1016/j.jhydrol.2015.06.017; Alexandria E, 2008, BUILD ENVIRON, V43, P480, DOI 10.1016/j.buildenv.2006.10.055; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 2016, SCIENCE, V352, P906, DOI 10.1126/science.352.6288.906; Berardi U, 2014, APPL ENERG, V115, P411, DOI 10.1016/j.apenergy.2013.10.047; Bianchini F, 2012, BUILD ENVIRON, V58, P152, DOI 10.1016/j.buildenv.2012.07.005; Black D, 1999, J POLIT ECON, V107, P252, DOI 10.1086/250060; BOERS TM, 1982, AGR WATER MANAGE, V5, P145, DOI 10.1016/0378-3774(82)90003-8; Campisano A, 2017, WATER RES, V115, P195, DOI 10.1016/j.watres.2017.02.056; Chow M.F., 2018, IOP C SERIES EARTH E; Cipolla SS, 2018, ACTA HORTIC, V1215, P295, DOI [10.17660/ActaHortic.2018.1215.54, 10.17660/actahortic.2018.1215.54]; Cristiano E, 2020, BUILD ENVIRON, V183, DOI 10.1016/j.buildenv.2020.107179; Cristiano E, 2019, WATER RESOUR RES, V55, P3375, DOI 10.1029/2018WR024143; Cristiano E, 2018, HYDROL EARTH SYST SC, V22, P2425, DOI 10.5194/hess-22-2425-2018; Depietri Y, 2017, THEOR PRACT URB SUST, P91, DOI 10.1007/978-3-319-56091-5_6; Dvorak B, 2010, LANDSCAPE URBAN PLAN, V96, P197, DOI 10.1016/j.landurbplan.2010.04.009; Feng H., 2018, CHAPTER 45 NATURE BA, P307, DOI [10.1016/B978-0-12-812150-4.00028-8, DOI 10.1016/B978-0-12-812150-4.00028-8]; Freni G, 2019, WATER-SUI, V11, DOI 10.3390/w11071389; Getter KL, 2007, ECOL ENG, V31, P225, DOI 10.1016/j.ecoleng.2007.06.004; Hanzl M., 2020, CITIES HLTH, P1, DOI [10.1080/23748834.2020.1791441, DOI 10.1080/23748834.2020.1791441]; Hellies M, 2018, LAND DEGRAD DEV, V29, P1940, DOI 10.1002/ldr.2947; Jenkins AR, 2020, COPD, V17, P253, DOI 10.1080/15412555.2020.1753669; Karteris M, 2016, RENEW SUST ENERG REV, V58, P510, DOI 10.1016/j.rser.2015.11.098; Kuichling E., 1889, T AM SOC CIV ENG, V20, P1, DOI DOI 10.1061/TACEAT.0000694; Kundzewicz ZW, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P173; Laio F, 2001, ADV WATER RESOUR, V24, P707, DOI 10.1016/S0309-1708(01)00005-7; Liu L, 2019, WATER-SUI, V11, DOI 10.3390/w11102024; Liu MF, 2019, NPJ CLIM ATMOS SCI, V2, DOI 10.1038/s41612-019-0095-3; Locatelli L, 2014, J HYDROL, V519, P3237, DOI 10.1016/j.jhydrol.2014.10.030; Lund NSV, 2019, NAT SUSTAIN, V2, P1003, DOI 10.1038/s41893-019-0392-1; Mahdiyar A, 2016, URBAN FOR URBAN GREE, V20, P317, DOI 10.1016/j.ufug.2016.10.001; Mentens J, 2006, LANDSCAPE URBAN PLAN, V77, P217, DOI 10.1016/j.landurbplan.2005.02.010; Molaei O, 2019, WATER SUPPLY, V19, P1322, DOI 10.2166/ws.2018.193; Myhre G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52277-4; Ochoa-Rodriguez S, 2015, J HYDROL, V531, P389, DOI 10.1016/j.jhydrol.2015.05.035; Parizotto S, 2011, ENERG BUILDINGS, V43, P1712, DOI 10.1016/j.enbuild.2011.03.014; QGIS Development Team, 2018, GEOGR INF SYST; Rademacher A, 2019, SCIENCE, V364, P245, DOI 10.1126/science.aaw9265; Rosasco P, 2019, BUILDINGS-BASEL, V9, DOI 10.3390/buildings9050134; Sahani J, 2019, SCI TOTAL ENVIRON, V696, DOI 10.1016/j.scitotenv.2019.133936; Santos T, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8121247; Stovin V, 2012, J HYDROL, V414, P148, DOI 10.1016/j.jhydrol.2011.10.022; VanWoert ND, 2005, J ENVIRON QUAL, V34, P1036, DOI 10.2134/jeq2004.0364; Vijayaraghavan K, 2016, RENEW SUST ENERG REV, V57, P740, DOI 10.1016/j.rser.2015.12.119; Villarreal EL, 2005, ECOL ENG, V25, P1, DOI 10.1016/j.ecoleng.2004.11.008; Viola F, 2017, J HYDROL, V553, P763, DOI 10.1016/j.jhydrol.2017.08.033; Viola F, 2014, HYDROL PROCESS, V28, P3361, DOI 10.1002/hyp.9876; Xie J, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176751; Zhou DM, 2019, URBAN FOR URBAN GREE, V40, P105, DOI 10.1016/j.ufug.2017.12.010	50	9	9	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246429	10.1371/journal.pone.0246429	http://dx.doi.org/10.1371/journal.pone.0246429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513176	Green Published, gold			2022-12-26	WOS:000613891400018
J	Estrella-Maldonado, H; Ramirez, AG; Ortiz, GF; Peraza-Echeverria, S; Martinez-de La Vega, O; Gongora-Castillo, E; Santamaria, JM				Estrella-Maldonado, Humberto; Giron Ramirez, Amaranta; Fuentes Ortiz, Gabriela; Peraza-Echeverria, Santy; Martinez-de La Vega, Octavio; Gongora-Castillo, Elsa; Santamaria, Jorge M.			Transcriptomic analysis reveals key transcription factors associated to drought tolerance in a wild papaya (Carica papaya) genotype	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; WATER-STRESS; RNA-SEQ; CHLOROPHYLL FLUORESCENCE; NEW-GENERATION; RESPONSES; PLANTS; L.; ANNOTATION; DISCOVERY	Most of the commercial papaya genotypes show susceptibility to water deficit stress and require high volumes of irrigation water to yield properly. To tackle this problem, we have collected wild native genotypes of Carica papaya that have proved to show better physiological performance under water deficit stress than the commercial cultivar grown in Mexico. In the present study, plants from a wild Carica papaya genotype and a commercial genotype were subjected to water deficit stress (WDS), and their response was characterized in physiological and molecular terms. The physiological parameters measured (water potential, photosynthesis, Fv/Fm and electrolyte leakage) confirmed that the papaya wild genotype showed better physiological responses than the commercial one when exposed to WDS. Subsequently, RNA-Seq was performed for 4 cDNA libraries in both genotypes (susceptible and tolerant) under well-watered conditions, and when they were subjected to WDS for 14 days. Consistently, differential expression analysis revealed that after 14 days of WDS, the wild tolerant genotype had a higher number of up-regulated genes, and a higher number of transcription factors (TF) that were differentially expressed in response to WDS, than the commercial genotype. Thus, six TF genes (CpHSF, CpMYB, CpNAC, CpNFY-A, CpERF and CpWRKY) were selected for further qRT-PCR analysis as they were highly expressed in response to WDS in the wild papaya genotype. qRT-PCR results confirmed that the wild genotype had higher expression levels (REL) in all 6 TF genes than the commercial genotype. Our transcriptomic analysis should help to unravel candidate genes that may be useful in the development of new drought-tolerant cultivars of this important tropical crop.	[Estrella-Maldonado, Humberto; Giron Ramirez, Amaranta; Peraza-Echeverria, Santy; Gongora-Castillo, Elsa; Santamaria, Jorge M.] Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico; [Martinez-de La Vega, Octavio] Langebio, Guanajuato, Mexico	Centro de Investigacion Cientifica de Yucatan	Gongora-Castillo, E; Santamaria, JM (corresponding author), Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico.	elsa.gongora@cicy.mx; jorgesm@cicy.mx	; Martinez, Octavio/F-3951-2014	Estrella Maldonado, Humberto Jose/0000-0002-3266-9425; Santamaria, Jorge M./0000-0002-6801-034X; Martinez, Octavio/0000-0002-7590-0041	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [CB-2013-221208-Z, INFR-2014-01, 226260]; SAGARPA-SNICS [18-PFA-IIDTTT-1172-L000-DF]; CONACYT [254647]	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); SAGARPA-SNICS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico (Project No. CB-2013-221208-Z), (Project No. INFR-2014-01; 226260) and SAGARPA-SNICS (Project No. 18-PFA-IIDTTT-1172-L000-DF), granted to JSF. HEM received the scholarship No. 254647 funded by CONACYT.	Al Seesi S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S8-S2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrews S., 2010, FASTQC QUALITY CONTR; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; Bedada G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-995; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Burritt D., 2016, DROUGHT STRESS TOLER, DOI 10.1007/978-3-319-28899-4_1; Cappe O, 2009, J ROY STAT SOC B, V71, P593, DOI 10.1111/j.1467-9868.2009.00698.x; Carr MKV, 2014, EXP AGR, V50, P270, DOI 10.1017/S0014479713000380; Chan-Leon AC, 2017, FOOD RES INT, V100, P45, DOI 10.1016/j.foodres.2017.08.017; Chaves MM, 2004, J EXP BOT, V55, P2365, DOI 10.1093/jxb/erh269; Clarke SM, 2004, PLANT J, V38, P432, DOI 10.1111/j.1365-313X.2004.02054.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui X, 2018, FUNCT INTEGR GENOMIC, V18, P489, DOI 10.1007/s10142-018-0608-x; Gamboa-Tuz SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32904-2; Gomes MDD, 2013, THEOR EXP PLANT PHYS, V25, P186, DOI 10.1590/S2197-00252013000300003; Ding H, 2014, ELECTRON J BIOTECHN, V17, P304, DOI 10.1016/j.ejbt.2014.09.004; Dong B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181835; Elgadir M.A., 2014, INT J PHARM PHARM SC, V6, P868; Erpen L, 2018, PLANT CELL TISS ORG, V132, P1, DOI 10.1007/s11240-017-1320-6; Estrella-Maldonado H, 2016, PLANT CELL TISS ORG, V126, P187, DOI 10.1007/s11240-016-0989-2; Farooq M, 2008, J AGRON CROP SCI, V194, P325, DOI 10.1111/j.1439-037X.2008.00323.x; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183428; Hu HH, 2014, ANNU REV PLANT BIOL, V65, P715, DOI 10.1146/annurev-arplant-050213-040000; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Hussain RM, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1001-y; Jager CE, 2008, PHYSIOL PLANTARUM, V133, P417, DOI 10.1111/j.1399-3054.2008.01057.x; Jaleel CA, 2008, COLLOID SURFACE B, V61, P298, DOI 10.1016/j.colsurfb.2007.09.008; Janiak A, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02212; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Joshi R, 2016, PLANT CELL REP, V35, P27, DOI 10.1007/s00299-015-1864-z; Kogan F, 2019, GEOMAT NAT HAZ RISK, V10, P651, DOI 10.1080/19475705.2018.1541257; Kudo M, 2017, PLANT BIOTECHNOL J, V15, P458, DOI 10.1111/pbi.12644; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; de Sa MEL, 2012, GENET MOL BIOL, V35, P272, DOI 10.1590/S1415-47572012000200008; Lu SY, 2003, J HORTIC SCI BIOTECH, V78, P663, DOI 10.1080/14620316.2003.11511681; Lu X, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00136; Mahouachi J, 2007, PLANT GROWTH REGUL, V53, P43, DOI 10.1007/s10725-007-9202-2; Mahouachi J, 2006, PLANT SOIL, V281, P137, DOI 10.1007/s11104-005-3935-3; Mahouachi J, 2012, J PLANT GROWTH REGUL, V31, P1, DOI 10.1007/s00344-011-9214-z; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Moumeni A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-174; Pape S, 2010, PLANT PHYSIOL, V154, P1805, DOI 10.1104/pp.110.165563; Porter BW, 2008, PLANT SCI, V174, P38, DOI 10.1016/j.plantsci.2007.09.013; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shen YH, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5388-0; Shen YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4072-0; Singh D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3596-7; Singh D, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1834-7; Singh D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00895; SMILLIE RM, 1982, PLANT PHYSIOL, V70, P1049, DOI 10.1104/pp.70.4.1049; Song K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00267; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Urasaki N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040904; Verslues PE, 2011, CURR OPIN PLANT BIOL, V14, P240, DOI 10.1016/j.pbi.2011.04.006; Wang M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072067; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xiong HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092913; Zhao XB, 2018, MOL BIOL REP, V45, P119, DOI 10.1007/s11033-018-4145-4	74	4	4	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245855	10.1371/journal.pone.0245855	http://dx.doi.org/10.1371/journal.pone.0245855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513158	Green Published, gold			2022-12-26	WOS:000613891400015
J	Soria, A; Galimberti, S; Lapadula, G; Visco, F; Ardini, A; Valsecchi, MG; Bonfanti, P				Soria, Alessandro; Galimberti, Stefania; Lapadula, Giuseppe; Visco, Francesca; Ardini, Agata; Valsecchi, Maria Grazia; Bonfanti, Paolo			The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19	PLOS ONE			English	Article							PNEUMONIA	Background During the Coronavirus disease 2019 (COVID-19) pandemic, advanced health systems have come under pressure by the unprecedented high volume of patients needing urgent care. The impact on mortality of this "patients' burden" has not been determined. Methods and findings Through retrieval of administrative data from a large referral hospital of Northern Italy, we determined Aalen-Johansen cumulative incidence curves to describe the in-hospital mortality, stratified by fixed covariates. Age- and sex-adjusted Cox models were used to quantify the effect on mortality of variables deemed to reflect the stress on the hospital system, namely the time-dependent number of daily admissions and of total hospitalized patients, and the calendar period. Of the 1225 subjects hospitalized for COVID-19 between February 20 and May 13, 283 died (30-day mortality rate 24%) after a median follow-up of 14 days (interquartile range 5-19). Hospitalizations increased progressively until a peak of 465 subjects on March 26, then declined. The risk of death, adjusted for age and sex, increased for a higher number of daily admissions (adjusted hazard ratio [AHR] per an incremental daily admission of 10 patients: 1.13, 95% Confidence Intervals [CI] 1.05-1.22, p = 0.0014), and for a higher total number of hospitalized patients (AHR per an increase of 50 patients in the total number of hospitalized subjects: 1.11, 95%CI 1.04-1.17, p = 0.0004), while was lower for the calendar period after the peak (AHR 0.56, 95%CI 0.43-0.72, p<0.0001). A validation was conducted on a dataset from another hospital where 500 subjects were hospitalized for COVID-19 in the same period. Figures were consistent in terms of impact of daily admissions, daily census, and calendar period on in-hospital mortality. Conclusions The pressure of a high volume of severely ill patients suffering from COVID-19 has a measurable independent impact on in-hospital mortality.	[Soria, Alessandro; Lapadula, Giuseppe; Bonfanti, Paolo] Univ Milano Bicocca, San Gerardo Hosp, Sch Med & Surg, Clin Infect Dis, Monza, Italy; [Galimberti, Stefania; Valsecchi, Maria Grazia] Univ Milano Bicocca, Sch Med & Surg, Bicocca Bioinformat Biostat & Bioimaging Ctr B4, Monza, Italy; [Visco, Francesca; Ardini, Agata] Edoardo Bassini Hosp, Med Direct, Cinisello Balsamo, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milano-Bicocca	Soria, A (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Sch Med & Surg, Clin Infect Dis, Monza, Italy.	alessandro.soria@unim.ib.it		GALIMBERTI, STEFANIA/0000-0003-1504-7242; LAPADULA, Giuseppe/0000-0002-9976-8102; SORIA, Alessandro/0000-0002-4447-2574; Bonfanti, Paolo/0000-0001-7289-8823				Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Berg LM, 2019, ANN EMERG MED, V74, P345, DOI 10.1016/j.annemergmed.2019.04.012; Carenzo L, 2020, ANAESTHESIA, V75, P928, DOI 10.1111/anae.15072; Fagiuoli S, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2011599; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Jo S, 2012, J INFECTION, V64, P268, DOI 10.1016/j.jinf.2011.12.007; Meng XM, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102581; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Pan L, 2020, AM J GASTROENTEROL, V115, P766, DOI 10.14309/ajg.0000000000000620; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Remuzzi A, 2020, LANCET, V395, P1225, DOI 10.1016/S0140-6736(20)30627-9; Sun BC, 2013, ANN EMERG MED, V61, P605, DOI 10.1016/j.annemergmed.2012.10.026; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Zangrillo A, 2020, INTENS CARE MED, V46, P1622, DOI 10.1007/s00134-020-06137-9; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	18	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246170	10.1371/journal.pone.0246170	http://dx.doi.org/10.1371/journal.pone.0246170			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507954	gold, Green Published			2022-12-26	WOS:000635021400101
J	Trick, WE; Badri, S; Doshi, K; Zhang, HY; Rezai, K; Hoffman, MJ; Weinstein, RA				Trick, William E.; Badri, Sheila; Doshi, Kruti; Zhang, Huiyuan; Rezai, Katayoun; Hoffman, Michael J.; Weinstein, Robert A.			Epidemiology of COVID-19 vs. influenza: Differential failure of COVID-19 mitigation among Hispanics, Cook County Health, Illinois	PLOS ONE			English	Article							DISPARITIES; CHICAGO; VIRUS	Background During the early phases of the COVID-19 pandemic in the U.S., African-American or Hispanic communities were disproportionately impacted. To better understand the epidemiology and relative effects of COVID-19 among hospitalized Hispanic patients, we compared individual and census-tract level characteristics of patients diagnosed with COVID-19 to those diagnosed with influenza, another viral infection with respiratory transmission. We evaluated temporal changes in epidemiology related to a shelter-in-place mandate. Methods We evaluated patients hospitalized at Cook County Health, the safety-net health system for the Chicago metropolitan area. Among self-identified hospitalized Hispanic patients, we compared those with influenza (2019-2020 season) to COVID-19 infection during March 16, 2020-May 11, 2020. We used multivariable analysis to identify differences in individual and census-tract level characteristics between the two groups. Results Relative to non-Hispanic blacks and whites, COVID-19 rapidly increased among Hispanics during promotion of social-distancing policies. Whereas non-Hispanic blacks were more likely to be hospitalized for influenza, Hispanic patients predominated among COVID-19 infections (40% relative increase compared to influenza). In the comparative analysis of influenza and COVID-19, Hispanic patients with COVID-19 were more likely to reside in census tracts with higher proportions of residents with the following characteristics: Hispanic; no high school diploma; non-US citizen; limited English speaking ability; employed in manufacturing or construction; and overcrowding. By multivariable analysis, Hispanic patients hospitalized with COVID-19 compared to those with influenza were more likely to be male (adjusted OR = 1.8; 95% CI 1.1 to 2.9), obese (aOR = 2.5; 95% CI 1.5 to 4.2), or reside in a census tract with.40% of residents without a high-school diploma (aOR = 2.5; 95% CI 1.3 to 4.8). Conclusions The rapid and disproportionate increase in COVID-19 hospitalizations among Hispanics after the shelter-in-place mandate indicates that public health strategies were inadequate in protecting this population-in particular, for those residing in neighborhoods with lower levels of educational attainment.	[Trick, William E.; Doshi, Kruti; Zhang, Huiyuan] Cook Cty Hlth, Ctr Hlth Equ & Innovat, Hlth Res & Solut, Chicago, IL 60612 USA; [Trick, William E.; Weinstein, Robert A.] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Badri, Sheila; Rezai, Katayoun; Hoffman, Michael J.; Weinstein, Robert A.] Cook Cty Hlth, Dept Med, Chicago, IL USA	Rush University	Trick, WE (corresponding author), Cook Cty Hlth, Ctr Hlth Equ & Innovat, Hlth Res & Solut, Chicago, IL 60612 USA.; Trick, WE (corresponding author), Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA.	wtrick@cookcountyhhs.org		Trick, William/0000-0002-3243-5098				Allard R, 2010, DIABETES CARE, V33, P1491, DOI 10.2337/dc09-2215; Blumenshine P, 2008, EMERG INFECT DIS, V14, P709, DOI 10.3201/eid1405.071301; Centers for Disease Control and Prevention/Agency for Toxic Substances and Diseae Registry/Geos- patial Research Analysis and Services Program, 2018, SOCIAL VULNERABILITY; Cholera R, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1094; Clark E, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008484; Di Castelnuovo A, 2020, NUTR METAB CARDIOVAS, V30, P1899, DOI 10.1016/j.numecd.2020.07.031; Faust JS, 2020, JAMA INTERN MED, V180, P1045, DOI 10.1001/jamainternmed.2020.2306; Fazel S, 2014, LANCET, V384, P1529, DOI 10.1016/S0140-6736(14)61132-6; Gil RM, 2020, J INFECT DIS, V222, P1592, DOI 10.1093/infdis/jiaa474; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Hunter S., 2017, EVALUATION HOUSING H; Institute for Health Metrics and Evaluation, 2020, SOCIAL DISTANCING; Klinenberg E, 1999, THEOR SOC, V28, P239, DOI 10.1023/A:1006995507723; Kossoudji SA, 2002, J LABOR ECON, V20, P598, DOI 10.1086/339611; Quinn SC, 2011, AM J PUBLIC HEALTH, V101, P285, DOI 10.2105/AJPH.2009.188029; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; Teunis PFM, 2010, EPIDEMICS-NETH, V2, P215, DOI 10.1016/j.epidem.2010.10.001; Walter N, 2002, J GEN INTERN MED, V17, P221, DOI 10.1046/j.1525-1497.2002.10501.x; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0240202	10.1371/journal.pone.0240202	http://dx.doi.org/10.1371/journal.pone.0240202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33507941	gold, Green Published			2022-12-26	WOS:000635021400006
J	Arnot, M; Emmott, EH; Mace, R				Arnot, Megan; Emmott, Emily H.; Mace, Ruth			The relationship between social support, stressful events, and menopause symptoms	PLOS ONE			English	Article								Many women going through the menopausal transition experience vasomotor symptoms (VMS), and research has shown that there is a large amount of variation in their frequency and severity. Many lifestyle factors have been found to co-vary with VMS, including the level of social support received by the woman, and how stressed she is. Stress is well documented to worsen menopause symptoms, and there is some evidence that support eases them; however, there is little research into whether support is an effective buffer against the negative effects of stress on VMS. Using nine years of data from the Study of Women's Health Across the Nation (n = 2718), we use multilevel Poisson regression with random effects to test: 1) if more social support is associated with decreased VMS frequency, 2) if increased life stress worsens VMS, and 3) if support acts as a buffer against stress. After adjusting for age, marital status, smoking, self-perceived overall health, ethnicity, and menopausal status, we find that stress increases the frequency of VMS. Contrary to our hypothesis, we did not find strong evidence that emotional support led to lower VMS frequency, or that support buffers against the effects of stress. Experience of a stressful event, but not amount of social support, was included in the best fitting model; with the degree to which the woman was upset by the life stressor having the largest effect on menopause symptoms. Here, women who said they were currently upset by a stressful event experienced 21% more VMS than women who had experienced no life stressor. This research highlights that social factors may impact the menopausal transition.	[Arnot, Megan; Emmott, Emily H.; Mace, Ruth] UCL, Dept Anthropol, London, England	University of London; University College London	Arnot, M (corresponding author), UCL, Dept Anthropol, London, England.	megan.arnot.13@ucl.ac.uk		Emmott, Emily/0000-0003-4862-179X; Mace, Ruth/0000-0002-6137-7739; Arnot, Megan/0000-0002-6293-5202	ESRC-BBSRC Soc-B Centre for Doctoral Training [ES/P000347/1]	ESRC-BBSRC Soc-B Centre for Doctoral Training(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Economic & Social Research Council (ESRC))	MA is funded by the ESRC-BBSRC Soc-B Centre for Doctoral Training (grant no. ES/P000347/1). The funders had no role in study design, data collection and analysis, decision to public, or preparation of the manuscript. https://www.ucl.ac.uk/soc-b-biosocial-doctoral-training/.	Ahmad AH, 2015, MALAYS J MED SCI, V22, P52; Anderson D, 2004, CLIMACTERIC, V7, P165, DOI 10.1080/13697130410001713760; [Anonymous], 2015, J STAT SOFTW, DOI [DOI 10.18637/JSS.V067.I01, DOI 10.18637/jss.v067.i01]; Augoulea A, 2019, MENOPAUSE REV, V18, P191, DOI 10.5114/pm.2019.93117; Avis NE, 2018, OBSTET GYN CLIN N AM, V45, P629, DOI 10.1016/j.ogc.2018.07.005; Avis NE, 2005, AM J MED, V118, P1406, DOI 10.1016/j.amjmed.2005.10.010; Avis NE, 2001, SOC SCI MED, V52, P345, DOI 10.1016/S0277-9536(00)00147-7; Ayers B, 2010, MATURITAS, V65, P28, DOI 10.1016/j.maturitas.2009.10.016; Bauld R, 2009, MATURITAS, V62, P160, DOI 10.1016/j.maturitas.2008.12.004; Boen CE, 2018, CANCER EPIDEM BIOMAR, V27, P541, DOI 10.1158/1055-9965.EPI-17-0836; Bove R, 2016, MULT SCLER RELAT DIS, V9, P56, DOI 10.1016/j.msard.2016.06.015; Bromberger JT, 2003, AM J EPIDEMIOL, V158, P347, DOI 10.1093/aje/kwg155; Brown LL, 2020, J GERONTOL B-PSYCHOL, V75, P650, DOI 10.1093/geronb/gby072; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chyu L, 2011, J WOMENS HEALTH, V20, P575, DOI 10.1089/jwh.2010.2170; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cohen S, 1998, HEALTH PSYCHOL, V17, P214, DOI 10.1037/0278-6133.17.3.214; Dare JS, 2011, HEALTH CARE WOMEN IN, V32, P111, DOI 10.1080/07399332.2010.500753; de Bruin JP, 2001, HUM REPROD, V16, P2014, DOI 10.1093/humrep/16.9.2014; Deeks AA, 2004, QUAL LIFE RES, V13, P389, DOI 10.1023/B:QURE.0000018506.33706.05; Del Sueldo M, 2018, INT J WOMENS HEALTH, V10, P655, DOI 10.2147/IJWH.S173891; Dimkpa DI, 2011, INT MULTIDISCIPLINAR, V5, P288; Duffy O, 2011, CLIMACTERIC, V14, P497, DOI 10.3109/13697137.2010.549974; Dyer AH, 2021, AGING MENT HEALTH, V25, P1923, DOI 10.1080/13607863.2020.1745146; Falconi AM, 2016, MENOPAUSE, V23, P518, DOI 10.1097/GME.0000000000000579; Ford ES, 2000, PREV MED, V30, P83, DOI 10.1006/pmed.1999.0606; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Gallicchio L, 2006, MATURITAS, V53, P133, DOI 10.1016/j.maturitas.2005.03.007; Genazzani AR, 2011, MENOPAUSE, V18, P1265, DOI 10.1097/gme.0b013e31823767b6; Glazer Greer, 2002, Health Care Women Int, V23, P612, DOI 10.1080/07399330290107377; Gold E. B., 2019, Study of Women's Health Across the Nation (SWAN): Visit 01 Dataset, [United States], 1997-1999, DOI 10.3886/ICPSR29221.v3; Gold EB, 2000, AM J EPIDEMIOL, V152, P463, DOI 10.1093/aje/152.5.463; Gold EB, 2004, AM J EPIDEMIOL, V159, P1189, DOI 10.1093/aje/kwh168; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gold EB, 2006, AM J PUBLIC HEALTH, V96, P1226, DOI 10.2105/AJPH.2005.066936; Ikeda A, 2013, CANCER CAUSE CONTROL, V24, P847, DOI 10.1007/s10552-013-0147-7; Jalava-Broman J, 2020, MATURITAS, V133, P7, DOI 10.1016/j.maturitas.2019.12.009; Kiecolt-Glaser JK, 1998, AM PSYCHOL, V53, P1209, DOI 10.1037/0003-066X.53.11.1209; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; KRAUSE N, 1986, J GERONTOL, V41, P512, DOI 10.1093/geronj/41.4.512; Leserman J, 2000, AM J PSYCHIAT, V157, P1221, DOI 10.1176/appi.ajp.157.8.1221; Li L, 2012, MATURITAS, V73, P354, DOI 10.1016/j.maturitas.2012.09.008; Lian H, 2012, ELECTRON J STAT, V6, P1, DOI 10.1214/12-EJS665; Khuong LQ, 2018, SUBST ABUSE TREAT PR, V13, DOI 10.1186/s13011-018-0147-4; Ludecke D., 2018, J OPEN SOURCE SOFTW, V3, P772, DOI [10.21105/joss.00772, DOI 10.21105/JOSS.00772]; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; Mazerolle MJ, 2020, AICcmodavg: model selection and multimodel inference based on (Q)AIC(c); Melby MK, 2005, HUM REPROD UPDATE, V11, P495, DOI 10.1093/humupd/dmi018; Melby MK, 2005, MENOPAUSE, V12, P250, DOI 10.1097/01.GME.0000146108.27840.D9?; Minkin MJ, 2015, MENOPAUSE, V22, P1231, DOI 10.1097/GME.0000000000000464; Nosek M, 2010, J MIDWIFERY WOM HEAL, V55, P328, DOI 10.1016/j.jmwh.2009.09.005; Perrig-Chiello Pasqualina, 2005, Eur J Ageing, V2, P183, DOI 10.1007/s10433-005-0003-z; R Core Team, 2020, R LANG ENV STAT COMP; Randolph JF, 2005, J CLIN ENDOCR METAB, V90, P6106, DOI 10.1210/jc.2005-1374; Robitaille Annie, 2011, Health Rep, V22, P33; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; Saddki N, 2017, J HIV-AIDS SOC SERV, V16, P60, DOI 10.1080/15381501.2015.1107801; Sakraida TJ., 2005, J DIVORCE REMARRIAGE, V43, P69, DOI DOI 10.1300/J087v43n01_04; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Sergeant J, 2017, J PSYCHOSOM OBST GYN, V38, P189, DOI 10.1080/0167482X.2016.1270937; Shaya FT, 2013, J CLIN HYPERTENS, V15, P34, DOI 10.1111/jch.12036; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Sood R, 2019, CLIMACTERIC, V22, P377, DOI 10.1080/13697137.2018.1551344; Steptoe A, 2012, NAT REV CARDIOL, V9, P360, DOI 10.1038/nrcardio.2012.45; Sutton-Tyrell K, 2018, Study of Women's Health Across the Nation (SWAN), 2001-2003: Visit 05 Dataset, DOI 10.3886/ICPSR30501.v2; Sutton-Tyrrell K, 2001, Study of Women's Health Across the Nation (SWAN): Visit 03 Dataset, DOI 10.3886/ICPSR29701.v4; Sutton-Tyrrell K., 2019, Study of Women's Health Across the Nation (SWAN): Visit 02 Dataset, [United States], 1998-2000, DOI 10.3886/ICPSR29401.v4; Sutton-Tyrrell K, 2018, Study of Women's Health Across the Nation (SWAN), 2006-2008: Visit 10 Dataset, DOI 10.3886/ICPSR32961.v2; Sutton-Tyrrell K., 2018, Study of Women's Health Across the Nation (SWAN), 2002-2004: Visit 06 Dataset, DOI 10.3886/ICPSR31181.v2; Sutton-Tyrrell K., 2018, Study of Women's Health Across the Nation (SWAN), 2005-2007: Visit 09 Dataset, DOI 10.3886/ICPSR32721.v2; Sutton-Tyrrell K., 2019, Study of Women's Health Across the Nation (SWAN): Visit 04 Dataset, [United States], 2000-2002, DOI 10.3886/ICPSR30142.v4; Sutton-Tyrrell K., 2018, Study of Women's Health Across the Nation (SWAN), 2004-2006: Visit 08 Dataset, DOI 10.3886/ICPSR32122.v2; Thoits PA, 2011, J HEALTH SOC BEHAV, V52, P145, DOI 10.1177/0022146510395592; Thurston RC, 2008, MENOPAUSE, V15, P841, DOI 10.1097/gme.0b013e318168f09b; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; VERNON SW, 1981, ARCH GEN PSYCHIAT, V38, P1239; Wadsworth G, 2003, GENDER, IDENTITY AND REPRODUCTION: SOCIAL PERSPECTIVES, P205; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams RE, 2008, CLIMACTERIC, V11, P32, DOI 10.1080/13697130701744696; Yang YP, 2019, ECOL EVOL, V9, P12503, DOI 10.1002/ece3.5705; Yazdkhasti M, 2012, IRAN J PUBLIC HEALTH, V41, P78; Yu DSF, 2004, RES NURS HEALTH, V27, P135, DOI 10.1002/nur.20008; Zhao D, 2019, MENOPAUSE, V26, P233, DOI 10.1097/GME.0000000000001208	85	10	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245444	10.1371/journal.pone.0245444	http://dx.doi.org/10.1371/journal.pone.0245444			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503073	Green Published, gold			2022-12-26	WOS:000613751800012
J	Beom, JH; Kim, JH; Seo, J; Lee, JH; Chung, YE; Chung, HS; Chung, SP; Kim, CH; You, JS				Beom, Jin Ho; Kim, Ju Hee; Seo, Jeho; Lee, Jung Ho; Chung, Yong Eun; Chung, Hyun Soo; Chung, Sung Phil; Kim, Chul Hoon; You, Je Sung			Targeted temperature management at 33 degrees C or 36 degrees C induces equivalent myocardial protection by inhibiting HMGB1 release in myocardial ischemia/reperfusion injury	PLOS ONE			English	Article								Acute myocardial infarction (AMI) is lethal and causes myocardial necrosis via time-dependent ischemia due to prolonged occlusion of the infarct-related artery. No effective therapy or potential therapeutic targets can prevent myocardial ischemia/reperfusion (I/R) injury. Targeted temperature management (TTM) may reduce peri-infarct regions by inhibiting the extracellular release of high mobility group box-1 (HMGB1) as a primary mediator of the innate immune response. We used a rat left anterior descending (LAD) coronary artery ligation model to determine if TTM at 33 degrees C and 36 degrees C had similar myocardial protective effects. Rats were divided into sham, LAD I/R+37 degrees C normothermia, LAD I/R+33 degrees C TTM, and LAD I/R+36 degrees C TTM groups (n = 5 per group). To verify the cardioprotective effect of TTM by specifically inhibiting HMGB1, rats were assigned to sham, LAD I/R, and LAD I/R after pre-treatment with glycyrrhizin (known as a pharmacological inhibitor of HMGB1) groups (n = 5 per group). Different target temperatures of 33 degrees C and 36 degrees C caused equivalent reductions in infarct volume after myocardial I/R, inhibited the extracellular release of HMGB1 from infarct tissue, and suppressed the expression of inflammatory cytokines from peri-infarct regions. TTM at 33 degrees C and 36 degrees C significantly attenuated the elevation of cardiac troponin, a sensitive and specific marker of heart muscle damage, after injury. Similarly, glycyrrhizin alleviated myocardial damage by suppressing the extracellular release of HMGB1. TTM at 33 degrees C and 36 degrees C had equivalent myocardial protective effects by similar inhibiting HMGB1 release against myocardial I/R injury. This is the first study to suggest that a target core temperature of 36 degrees C is applicable for cardioprotection.	[Beom, Jin Ho; Kim, Ju Hee; Seo, Jeho; Chung, Hyun Soo; Chung, Sung Phil; You, Je Sung] Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea; [Lee, Jung Ho; Kim, Chul Hoon] Yonsei Univ, Brain Res Inst, Coll Med, Dept Pharmacol,BK21 PLUS Project Med Sci, Seoul, South Korea; [Lee, Jung Ho] Eulji Univ, Dept Pharmacol, Sch Med, Daejeon, South Korea; [Chung, Yong Eun] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Eulji University; Yonsei University; Yonsei University Health System	You, JS (corresponding author), Yonsei Univ, Dept Emergency Med, Coll Med, Seoul, South Korea.; Kim, CH (corresponding author), Yonsei Univ, Brain Res Inst, Coll Med, Dept Pharmacol,BK21 PLUS Project Med Sci, Seoul, South Korea.	kimhoon@yuhs.ac; youjsmd@yuhs.ac	; Chung, Sung Phil/F-8344-2016	You, Je Sung/0000-0002-2074-6745; Chung, Hyun Soo/0000-0001-6110-1495; Chung, Yong Eun/0000-0003-0811-9578; Chung, Sung Phil/0000-0002-3074-011X; Kim, Chul Hoon/0000-0002-7360-429X	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2015R1C1A1A01054641, NRF-2018R1C1B6006159, NRF-2019R1A2C3002354, NRF-2019R1C1C1006332]; Yonsei University College of Medicine [6-2017-0092, 6-2019-0188]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science and ICT; Yonsei University College of Medicine(General Electric)	This work was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (grant numbers NRF-2015R1C1A1A01054641 and NRF-2018R1C1B6006159 to J.S.Y; NRF-2019R1A2C3002354 to C.H.K; and NRF-2019R1C1C1006332 to J.B.) and a faculty research grant from the Yonsei University College of Medicine (grant number 6-2017-0092 to J.B. and 6-2019-0188 to J.S.Y.). The funding bodies had no role in the design, collection, analysis, or interpretation of this study.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2011, J INTERN MED, V270, P245, DOI 10.1111/j.1365-2796.2011.02369.x; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Arvidsson L, 2017, ACTA ANAESTH SCAND, V61, P1176, DOI 10.1111/aas.12957; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Dai WD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002265; Dash R, 2018, JACC-CARDIOVASC INTE, V11, P195, DOI 10.1016/j.jcin.2017.08.056; Ding HS, 2013, GENE, V527, P389, DOI 10.1016/j.gene.2013.05.041; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Greulich S, 2019, J AM HEART ASSOC, V8, DOI [10.1161/JAHA.119.012429, DOI 10.1161/JAHA.119.012429]; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1073, DOI 10.1056/NEJMe1509718; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Herring MJ, 2015, J CARDIOVASC PHARM T, V20, P193, DOI 10.1177/1074248414535664; Herring MJ, 2014, THER HYPOTHERMIA TEM, V4, P159, DOI 10.1089/ther.2014.0016; Heusch G, 2017, EUR HEART J, V38, P774, DOI 10.1093/eurheartj/ehw224; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kelly FE, 2010, ANAESTHESIA, V65, P505, DOI 10.1111/j.1365-2044.2009.06237.x; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Kirkegaard H, 2019, ANESTHESIOLOGY, V131, P186, DOI 10.1097/ALN.0000000000002700; Kohlhauer M, 2016, ARCH CARDIOVASC DIS, V109, P716, DOI 10.1016/j.acvd.2016.05.005; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Lee JH, 2018, SHOCK, V50, P714, DOI 10.1097/SHK.0000000000001106; Lee JH, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0260-0; Li L, 2018, PATHOL RES PRACT, V214, P174, DOI 10.1016/j.prp.2017.11.016; Lin YL, 2015, EXP THER MED, V9, P1537, DOI 10.3892/etm.2015.2290; Liu P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14848-1; Loukili N, 2011, CARDIOVASC RES, V89, P586, DOI 10.1093/cvr/cvq373; Lu HX, 2019, CYTOKINE GROWTH F R, V47, P74, DOI 10.1016/j.cytogfr.2019.05.009; Menees DS, 2013, NEW ENGL J MED, V369, P901, DOI 10.1056/NEJMoa1208200; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Mu SW, 2018, BIOMED REP, V9, P191, DOI 10.3892/br.2018.1127; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Rochitte CE, 2012, HEART, V98, P348, DOI 10.1136/heartjnl-2011-301332; Schwartz BG, 2012, AM J CARDIOL, V110, P461, DOI 10.1016/j.amjcard.2012.03.048; Sorensen MV, 2011, JACC-CARDIOVASC INTE, V4, P281, DOI 10.1016/j.jcin.2010.10.015; Takahashi M, 2008, CARDIOVASC RES, V80, P5, DOI 10.1093/cvr/cvn212; Takahashi M, 2015, J ATHEROSCLER THROMB, V22, P553, DOI 10.5551/jat.ED008; Tian Ming, 2015, Chronic Dis Transl Med, V1, P18, DOI 10.1016/j.cdtm.2015.02.002; Tissier R, 2009, CARDIOVASC RES, V83, P345, DOI 10.1093/cvr/cvp046; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang WE, 2013, CIRC RES, V113, P288, DOI 10.1161/CIRCRESAHA.113.300929; Wang XW, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008024; Xu H, 2011, AM J PHYSIOL-HEART C, V300, pH913, DOI 10.1152/ajpheart.00703.2010; Yan W, 2019, AM J PHYSIOL-HEART C, DOI [10.1152/ajpheart.00065.20192019, DOI 10.1152/AJPHEART.00065.20192019]; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Zhai CL, 2012, ACTA PHARMACOL SIN, V33, P1477, DOI 10.1038/aps.2012.112	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246066	10.1371/journal.pone.0246066	http://dx.doi.org/10.1371/journal.pone.0246066			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503060	Green Published, gold			2022-12-26	WOS:000613751800022
J	Fiorenzato, E; Zabberoni, S; Costa, A; Cona, G				Fiorenzato, Eleonora; Zabberoni, Silvia; Costa, Alberto; Cona, Giorgia			Cognitive and mental health changes and their vulnerability factors related to COVID-19 lockdown in Italy	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION; IMPACT	The COVID-19 pandemic and government imposed social restrictions like lockdown exposed most individuals to an unprecedented stress, increasing mental health disorders worldwide. We explored subjective cognitive functioning and mental health changes and their possible interplay related to COVID-19-lockdown. We also investigated potential risk factors to identify more vulnerable groups. Across Italy, 1215 respondents completed our Qualtrics-based online-survey during the end of a seven to 10-week imposed lockdown and home confinement (from April 29 to May 17, 2020). We found subjective cognitive functioning and mental health severely changed in association with the lockdown. Under government regulations, cognitive complaints were mostly perceived in routine tasks involving attention, temporal orientation and executive functions-with no changes in language abilities. A paradoxical effect was observed for memory, with reduced forgetfulness compared to pre-lockdown. We found higher severity and prevalence of depression, anxiety disorders, abnormal sleep, appetite changes, reduced libido and health anxiety: with mild-to-severe depression and anxiety prevalence climbing to 32 and 36 percent, respectively, under restrictions. Being female, under 45 years, working from home or being underemployed were all identified as relevant risk factors for worsening cognition and mental health. Frequent consumers of COVID-19 mass media information or residents in highly infected communities reported higher depression and anxiety symptoms, particularly hypochondria in the latter. If similar restrictions are reimposed, governments must carefully consider these more vulnerable groups in their decisions, whilst developing effective global and long-term responses to the cognitive and mental health challenges of this type of pandemic; as well as implementing appropriate psychological interventions with specific guidelines: particularly regarding exposure to COVID-19 mass-media reports.	[Fiorenzato, Eleonora; Cona, Giorgia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Zabberoni, Silvia; Costa, Alberto] IRCCS Fdn Santa Lucia, Rome, Italy; [Costa, Alberto] Niccolo Cusano Univ, Rome, Italy; [Cona, Giorgia] Univ Padua, Padova Neurosci Ctr, Padua, Italy	University of Padua; IRCCS Santa Lucia; Niccolo Cusano Online University; University of Padua	Cona, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.; Cona, G (corresponding author), Univ Padua, Padova Neurosci Ctr, Padua, Italy.	giorgia.cona@unipd.it	Fiorenzato, Eleonora/ABF-5939-2021	Fiorenzato, Eleonora/0000-0001-7947-5903; , Giorgia/0000-0003-1844-9327	Ministry of Health, Italy [GR-2018-12366002]	Ministry of Health, Italy(Ministry of Health, Italy)	This work was supported by Grant 'Giovani Ricercatori - Ricerca Finalizzata 2018' code GR-2018-12366002 from Ministry of Health, Italy (SZ). This work was carried out within the scope of the project "use-inspired basic research", for which the Department of General Psychology of the University of Padova has been recognized as "Dipartimento di eccellenza" by the Ministry of University and Research" (GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Albert PR, 2015, J PSYCHIATR NEUROSCI, V40, P219, DOI 10.1503/jpn.150205; Altena E, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13052; Beck A., 1996, BECK DEPRESSION INVE, DOI 10.1037/t00742-000; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Bzdok D, 2020, TRENDS COGN SCI, V24, P717, DOI 10.1016/j.tics.2020.05.016; Casagrande M, 2020, SLEEP MED, V75, P12, DOI 10.1016/j.sleep.2020.05.011; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Damin Antonio Eduardo, 2015, Dement. neuropsychol., V9, P237, DOI [10.1590/1980-57642015DN93000005, 10.1590/1980-57642015dn93000005]; Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02594-4; Di Renzo L, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072152; Fullana MA, 2020, J AFFECT DISORDERS, V275, P80, DOI 10.1016/j.jad.2020.06.027; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Gates NJ, 2015, CURR OPIN PSYCHIATR, V28, P165, DOI 10.1097/YCO.0000000000000141; Giusti EM, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01684; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Gualano MR, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17134779; Hamilton M, 1986, ASSESSMENT DEPRESSIO, P143, DOI [10.1007/9783642704864_14, 10.1007/978-3-642-70486-4_14, DOI 10.1007/978-3-642-70486-4_14]; Hawkley LC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0114; Ho CS, 2020, PARANOIA PANIC, V49, P6; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Ko NY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165822; Landi G, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02195; Lee TMC, 2006, AGING MENT HEALTH, V10, P303, DOI 10.1080/13607860600638545; Lei L, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924609; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Mackin R Scott, 2018, Alzheimers Dement (Amst), V10, P573, DOI 10.1016/j.dadm.2018.05.005; Marcum CS, 2013, RES AGING, V35, P612, DOI 10.1177/0164027512453468; Marelli S, 2021, J NEUROL, V268, P8, DOI 10.1007/s00415-020-10056-6; Marra DE, 2020, CLIN NEUROPSYCHOL, V34, P1411, DOI 10.1080/13854046.2020.1769192; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Power K., 2020, Sustainability: Science, Practice & Policy, V17, P67, DOI 10.1080/15487733.2020.1776561; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Razzoli M, 2017, NEUROSCI BIOBEHAV R, V76, P154, DOI 10.1016/j.neubiorev.2017.01.026; Reisberg B, 2010, ALZHEIMERS DEMENT, V6, P11, DOI 10.1016/j.jalz.2009.10.002; Scarpina F, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02252; Schnitzspahn KM, 2011, INT PSYCHOGERIATR, V23, P583, DOI 10.1017/S1041610210001651; Song MK, 2015, HEMODIAL INT, V19, P90, DOI 10.1111/hdi.12202; Sullivan M.J., 1990, CANADIAN J REHABIL, V4, P99; Taylor MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-347; Thompson RR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3502; Tull MT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113098; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Young E, 2010, MOL PSYCHIATR, V15, P23, DOI 10.1038/mp.2009.94; Yuan S, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923767; Zhang CX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00306; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	56	56	56	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246204	10.1371/journal.pone.0246204	http://dx.doi.org/10.1371/journal.pone.0246204			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503055	gold, Green Published			2022-12-26	WOS:000613751800044
J	Miles, A; Andiappan, M; Upenieks, L; Orfanidis, C				Miles, Andrew; Andiappan, Meena; Upenieks, Laura; Orfanidis, Christos			Using prosocial behavior to safeguard mental health and foster emotional well-being during the COVID-19 pandemic: A registered report protocol for a randomized trial	PLOS ONE			English	Article								The COVID-19 pandemic, the accompanying lockdown measures, and their possible long-term effects have made mental health a pressing public health concern. Acts that focus on benefiting others-known as prosocial behaviors-offer one promising intervention that is both flexible and low cost. However, neither the range of emotional states prosocial acts impact nor the size of those effects is currently clear, both of which directly influence its attractiveness as a treatment option. Using a large online sample from Canada and the United States, we will examine the effect of a three-week prosocial intervention on two indicators of emotional well-being (happiness and the belief that one's life is valuable) and mental health (anxiety and depression). Respondents will be randomly assigned to perform prosocial, self-focused, or neutral behaviors each week. Two weeks after the intervention, a final survey will assess whether the intervention has a lasting effect on mental health and emotional well-being. Our results will illuminate whether prosocial interventions are a viable approach to addressing mental health needs during the current COVID-19 pandemic, as well for those who face emotional challenges during normal times.	[Miles, Andrew; Orfanidis, Christos] Univ Toronto, Dept Sociol, Toronto, ON, Canada; [Andiappan, Meena] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Upenieks, Laura] Baylor Univ, Dept Sociol, Waco, TX USA	University of Toronto; University of Toronto; Baylor University	Miles, A (corresponding author), Univ Toronto, Dept Sociol, Toronto, ON, Canada.	andrew.miles@utoronto.ca		Miles, Andrew/0000-0003-4288-373X	Toronto COVID-19 Action Fund	Toronto COVID-19 Action Fund	This research was funded by a grant from the Toronto COVID-19 Action Fund, with Co-PIs AM and MA (no grant number assigned). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aknin LB, 2020, J PERS SOC PSYCHOL, V119, pE15, DOI 10.1037/pspa0000191; Aknin LB, 2018, SOC PERSONAL PSYCHOL, V12, DOI 10.1111/spc3.12386; Aknin LB, 2018, CURR OPIN PSYCHOL, V20, P55, DOI 10.1016/j.copsyc.2017.08.017; Aknin LB, 2013, J PERS SOC PSYCHOL, V104, P635, DOI 10.1037/a0031578; Aknin LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039211; Alden LE, 2013, EMOTION, V13, P64, DOI 10.1037/a0027761; Baker Edward, 2020, Br J Community Nurs, V25, P231, DOI 10.12968/bjcn.2020.25.5.231; Baumeister R. F., 1991, MEANINGS LIFE; Bierman A, 2020, J HEALTH SOC BEHAV, V61, P398, DOI 10.1177/0022146520970190; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bollen KA, 2010, SOC FORCES, V89, P1, DOI 10.1353/sof.2010.0072; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Callister A, 2019, INT J RELIG SPIRITUA, V9, P9; Carter TJ, 2010, J PERS SOC PSYCHOL, V98, P146, DOI 10.1037/a0017145; Chancellor J, 2018, EMOTION, V18, P507, DOI 10.1037/emo0000321; Crocker J, 2010, J PERS SOC PSYCHOL, V98, P1009, DOI 10.1037/a0019400; Curry OS, 2018, J EXP SOC PSYCHOL, V76, P320, DOI 10.1016/j.jesp.2018.02.014; Donnelly Grant E., 2017, J ASSOC CONSUM RES, V2, P48, DOI [DOI 10.1086/689866, 10.1086/689866]; Duan L, 2020, LANCET PSYCHIAT, V7, P300, DOI 10.1016/S2215-0366(20)30073-0; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Enders C. K., 2010, APPL MISSING DATA AN; FIRESTONE RW, 1987, AM J PSYCHOANAL, V47, P210, DOI 10.1007/BF01250340; Fischer R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.563876; Geenen NYR, 2014, J POSIT PSYCHOL, V9, P204, DOI 10.1080/17439760.2014.891154; Gilbert P, 2000, PERS INDIV DIFFER, V29, P757, DOI 10.1016/S0191-8869(99)00230-5; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Haski-Leventhal D, 2009, J THEOR SOC BEHAV, V39, P271, DOI 10.1111/j.1468-5914.2009.00405.x; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Heintzelman SJ, 2014, AM PSYCHOL, V69, P561, DOI 10.1037/a0035049; Hendriks T, 2020, J HAPPINESS STUD, V21, P357, DOI 10.1007/s10902-019-00082-1; Hofmann W, 2014, SCIENCE, V345, P1340, DOI 10.1126/science.1251560; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Hui BPH, 2020, PSYCHOL BULL, V146, P1084, DOI 10.1037/bul0000298; Jeong HJ, 2015, J PROD BRAND MANAG, V24, P758, DOI 10.1108/JPBM-01-2015-0784; Kasser Tim, 2002, HIGH PRICE MAT, DOI 10.7551/mitpress/3501.001.0001; Kennedy R, 2020, POLIT SCI RES METH, V8, P614, DOI 10.1017/psrm.2020.6; Kerr SL, 2015, J HAPPINESS STUD, V16, P17, DOI 10.1007/s10902-013-9492-1; Klein N, 2017, J POSIT PSYCHOL, V12, P354, DOI 10.1080/17439760.2016.1209541; Kohout F J, 1993, J Aging Health, V5, P179, DOI 10.1177/089826439300500202; Krause N, 2019, ARCH PSYCHOL RELIG, V41, P53, DOI 10.1177/0084672419839797; Krendl AC, 2021, J GERONTOL B-PSYCHOL, V76, pE53, DOI 10.1093/geronb/gbaa110; Lambert NM, 2013, PERS SOC PSYCHOL B, V39, P1418, DOI 10.1177/0146167213499186; Layous K, 2017, J POSIT PSYCHOL, V12, P385, DOI 10.1080/17439760.2016.1198924; Layous K, 2013, J CROSS CULT PSYCHOL, V44, P1294, DOI 10.1177/0022022113487591; Layous K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051380; Lee CM, 2020, J ADOLESCENT HEALTH, V67, P714, DOI 10.1016/j.jadohealth.2020.08.009; Lee KJ, 2018, J POSIT PSYCHOL, V13, P48, DOI 10.1080/17439760.2017.1374437; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lyubomirsky S, 2013, CURR DIR PSYCHOL SCI, V22, P57, DOI 10.1177/0963721412469809; Manthey L, 2016, J HAPPINESS STUD, V17, P319, DOI 10.1007/s10902-014-9596-2; Martela F, 2016, J PERS, V84, P750, DOI 10.1111/jopy.12215; Martela F, 2016, J POSIT PSYCHOL, V11, P531, DOI 10.1080/17439760.2015.1137623; Martela F, 2016, MOTIV EMOTION, V40, P351, DOI 10.1007/s11031-016-9552-z; Miles A, 2019, AM SOCIOL REV, V84, P308, DOI 10.1177/0003122419832497; Mongrain M, 2011, J HAPPINESS STUD, V12, P963, DOI 10.1007/s10902-010-9239-1; Morelli SA, 2015, EMOTION, V15, P484, DOI 10.1037/emo0000084; Morgan J, 2009, J HAPPINESS STUD, V10, P197, DOI 10.1007/s10902-007-9075-0; Moss A., 2018, BOT SCARE UNDERSTAND; Nelson SK, 2016, EMOTION, V16, P850, DOI 10.1037/emo0000178; Newman DB, 2014, J HAPPINESS STUD, V15, P555, DOI 10.1007/s10902-013-9435-x; Otake Keiko, 2006, J Happiness Stud, V7, P361, DOI 10.1007/s10902-005-3650-z; Ouweneel E, 2014, J PSYCHOL, V148, P37, DOI 10.1080/00223980.2012.742854; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Prentice M, 2020, MOTIV EMOTION, DOI [10.1007/s11031-020-09853-3, DOI 10.1007/S11031-020-09853-3]; Proyer RT, 2015, APPL PSYCHOL-HLTH WE, V7, P108, DOI 10.1111/aphw.12039; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raposa EB, 2016, CLIN PSYCHOL SCI, V4, P691, DOI 10.1177/2167702615611073; ROSS CE, 1984, J HEALTH SOC BEHAV, V25, P189, DOI 10.2307/2136668; Rowland L, 2019, J SOC PSYCHOL, V159, P340, DOI 10.1080/00224545.2018.1469461; Stanley TD, 2010, AM STAT, V64, P70, DOI 10.1198/tast.2009.08205; SWANN WB, 1992, J ABNORM PSYCHOL, V101, P293, DOI 10.1037/0021-843X.101.2.293; Taylor CT, 2017, DEPRESS ANXIETY, V34, P267, DOI 10.1002/da.22593; Trew J, 2015, MOTIV EMOTION, V39, P892, DOI 10.1007/s11031-015-9499-5; Twenge JM, 2000, J PERS SOC PSYCHOL, V79, P1007, DOI 10.1037//0022-3514.79.6.1007; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van Tilburg TG, 2021, J GERONTOL B-PSYCHOL, V76, pE249, DOI 10.1093/geronb/gbaa111; Van Tongeren DR, 2016, J POSIT PSYCHOL, V11, P225, DOI 10.1080/17439760.2015.1048814; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; White CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216588; Wiese CW, 2018, J POSIT PSYCHOL, V13, P57, DOI 10.1080/17439760.2017.1374436; Wilhelm K, 2004, J AFFECT DISORDERS, V79, P33, DOI 10.1016/S0165-0327(02)00069-1; Wilson J, 2003, SOCIOL QUART, V44, P433, DOI 10.1525/tsq.2003.44.3.433; Wong P. T. P., 2008, EXISTENTIAL SPIRITUA, P65; Wood D, 2017, SOC PSYCHOL PERS SCI, V8, P454, DOI 10.1177/1948550617703168	87	9	10	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245865	10.1371/journal.pone.0245865	http://dx.doi.org/10.1371/journal.pone.0245865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503045	gold, Green Published			2022-12-26	WOS:000613751800031
J	Son, YB; Yang, JH; Kim, MG; Jo, SK; Cho, WY; Oh, SW				Son, Young-Bin; Yang, Ji Hyun; Kim, Myung-Gyu; Jo, Sang Kyung; Cho, Won Yong; Oh, Se Won			The effect of baseline serum uric acid on chronic kidney disease in normotensive, normoglycemic, and non-obese individuals: A health checkup cohort study	PLOS ONE			English	Article								Introduction The independent role of serum uric acid (SUA) on kidney disease is controversial due to its association with metabolic syndrome. The objective of this study was to investigate the association of baseline SUA with development of chronic kidney disease and eGFR decline in normotensive, normoglycemic and non-obese individuals during follow up period. Materials and methods We included non-hypertensitive, non-diabetic, and non-obese 13,133 adults with estimated glomerular filtration rate (eGFR) >= 60ml/min/1.73m(2) who had a voluntary health check-up during 2004-2017. Results SUA was positively related to adjusted means of systolic blood pressure (SBP), triglyceride, body mass index, and body fat percent. SUA was inversely associated with high density lipoprotein HDL (P for trend <= 0.001). SUA was an independent risk factor for the development of diabetes, hypertension, and obesity. During 45.0 [24.0-76.0] months of median follow up, the highest quartiles of SUA showed significant risks of 30% eGFR decline compared than the lowest quartile (RR:3.701; 95% CI: 1.504-9.108). The highest quartile had a 2.2 fold (95% CI: 1.182-4.177) increase in risk for incident chronic kidney disease (CKD). Conclusions SUA is an independent risk factor for the development of diabetes, hypertension, and obesity in the healthy population. High SUA is associated with increased risk of CKD development and eGFR decline in participants with intact renal function.	[Son, Young-Bin; Yang, Ji Hyun; Kim, Myung-Gyu; Jo, Sang Kyung; Cho, Won Yong; Oh, Se Won] Korea Univ, Coll Med, Anam Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine)	Oh, SW (corresponding author), Korea Univ, Coll Med, Anam Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea.	hisy81@hanmail.net	; Oh, Se Won/G-2632-2017	Kim, Myung Gyu/0000-0001-8807-2452; Yang, Jihyun/0000-0002-8616-238X; Oh, Se Won/0000-0003-3795-9322	Korea University Grant [K2008381]	Korea University Grant	This study is supported by a Korea University Grant (Grant No. K2008381)	Bandaru P, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/604715; Bhole V, 2010, AM J MED, V123, P957, DOI 10.1016/j.amjmed.2010.03.027; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Chino Y, 2014, BIOPHARM DRUG DISPOS, V35, P391, DOI 10.1002/bdd.1909; Cicero AFG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29955-w; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2014, CURR OPIN RHEUMATOL, V26, P176, DOI 10.1097/BOR.0000000000000033; GALVAN AQ, 1995, AM J PHYSIOL-ENDOC M, V268, pE1, DOI 10.1152/ajpendo.1995.268.1.E1; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Grainger R, 2013, RHEUMATOLOGY, V52, P1018, DOI 10.1093/rheumatology/kes326; Haque T, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0446-6; Johnson RJ, 2018, AM J KIDNEY DIS, V71, P851, DOI 10.1053/j.ajkd.2017.12.009; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kawai T, 2012, HYPERTENS RES, V35, P1087, DOI 10.1038/hr.2012.99; Kimura K, 2018, AM J KIDNEY DIS, V72, P798, DOI 10.1053/j.ajkd.2018.06.028; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Momeni A, 2010, IRAN J KIDNEY DIS, V4, P128; Nagano S, 2017, HYPERTENS RES, V40, P620, DOI 10.1038/hr.2017.10; Perez-Ruiz F, 2015, RHEUMATOL INT, V35, P1519, DOI 10.1007/s00296-015-3242-0; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sezai A, 2013, CIRC J, V77, P2043, DOI 10.1253/circj.CJ-13-0082; Shi YJ, 2012, KIDNEY BLOOD PRESS R, V35, P153, DOI 10.1159/000331453; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Srivastava A, 2018, AM J KIDNEY DIS, V71, P362, DOI 10.1053/j.ajkd.2017.08.017; Tanaka K, 2015, CLIN EXP NEPHROL, V19, P1044, DOI 10.1007/s10157-015-1095-1; Tsushima Y, 2013, J BIOL CHEM, V288, P27138, DOI 10.1074/jbc.M113.485094; Wang YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180111; Wasilewska A, 2012, ACTA PAEDIATR, V101, P497, DOI 10.1111/j.1651-2227.2011.02582.x; Zhao YM, 2018, DIABETES OBES METAB, V20, P458, DOI 10.1111/dom.13101; Zhu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100801	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0244106	10.1371/journal.pone.0244106	http://dx.doi.org/10.1371/journal.pone.0244106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503029	Green Published, gold			2022-12-26	WOS:000613751800049
J	van der Merwe, J; van der Veeken, L; Inversetti, A; Galgano, A; Toelen, J; Deprest, J				van der Merwe, Johannes; van der Veeken, Lennart; Inversetti, Analisa; Galgano, Angela; Toelen, Jaan; Deprest, Jan			Earlier preterm birth is associated with a worse neurocognitive outcome in a rabbit model	PLOS ONE			English	Article								Background Preterm birth (PTB) and particularly late preterm PTB has become a research focus for obstetricians, perinatologists, neonatologists, pediatricians and policy makers alike. Translational models are useful tools to expedite and guide clinical but presently no model exists that contextualizes the late PTB scenario. Herein we aimed to develop a rabbit model that echo's the clinical neurocognitive phenotypes of early and late PTB. Methods Time mated rabbit does underwent caesarean delivery at a postconceptional age (PCA) of either 28 (n = 6), 29 (n = 5), 30 (n = 4) or 31 (n = 4) days, term = 31 d. Newborn rabbits were mixed and randomly allocated to be raised by cross fostering and underwent short term neurobehavioral testing on corrected post-natal day 1. Open field (OFT), spontaneous alteration (TMT) and novel object recognition (NORT) tests were subsequently performed at 4 and 8 weeks of age. Results PTB was associated with a significant gradient of short-term mortality and morbidity inversely related to the PCA. On postnatal day 1 PTB was associated with a significant sensory deficit in all groups but a clear motor insult was only noted in the PCA 29d and PCA 28d groups. Furthermore, PCA 29d and PCA 28d rabbits had a persistent neurobehavioral deficit with less exploration and hyperanxious state in the OFT, less alternation in TMT and lower discriminatory index in the NORT. While PCA 30d rabbits had some anxiety behavior and lower spontaneous alteration at 4 weeks, however at 8 weeks only mild anxiety driven behavior was observed in some of these rabbits. Conclusions In this rabbit model, delivery at PCA 29d and PCA 28d mimics the clinical phenotype of early PTB while delivery at PCA 30d resembles that of late PTB. This could serve as a model to investigate perinatal insults during the early and late preterm period.	[van der Merwe, Johannes; van der Veeken, Lennart; Inversetti, Analisa; Galgano, Angela; Toelen, Jaan; Deprest, Jan] KU Leuven Univ Leuven, Grp Biomed Sci, Dept Dev & Regenerat, Cluster Woman & Child, Leuven, Belgium; [van der Merwe, Johannes; van der Veeken, Lennart; Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Woman & Child, Leuven, Belgium; [Toelen, Jaan] Univ Hosp Leuven, Dept Pediat, Div Woman & Child, Leuven, Belgium; [Deprest, Jan] UCL, Inst Womens Hlth, London, England	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; University of London; University College London	Deprest, J (corresponding author), KU Leuven Univ Leuven, Grp Biomed Sci, Dept Dev & Regenerat, Cluster Woman & Child, Leuven, Belgium.; Deprest, J (corresponding author), Univ Hosp Leuven, Dept Obstet & Gynaecol, Div Woman & Child, Leuven, Belgium.; Deprest, J (corresponding author), UCL, Inst Womens Hlth, London, England.	jan.deprest@uzleuven.be	van der Merwe, Hannes/H-7598-2019	van der Merwe, Hannes/0000-0002-1381-4033; Deprest, Jan/0000-0002-4920-945X; Van der Veeken, Lennart/0000-0002-6551-661X	Erasmus + Programme of the European Union [2013-0040]	Erasmus + Programme of the European Union	JvdM and LvdV are funded with support of the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allotey J, 2018, BJOG-INT J OBSTET GY, V125, P16, DOI 10.1111/1471-0528.14832; [Anonymous], 2019, Obstet Gynecol, V133, pe151, DOI 10.1097/AOG.0000000000003083; Baker B, 2015, JOGNN-J OBST GYN NEO, V44, P127, DOI 10.1111/1552-6909.12533; Balakrishnan B, 2013, DEV NEUROSCI-BASEL, V35, P396, DOI 10.1159/000353156; Ballabh P, 2014, PEDIATR RES, V76, P495, DOI 10.1038/pr.2014.111; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Bonney EA, 2013, AM J REPROD IMMUNOL, V69, P567, DOI 10.1111/aji.12102; Buser JR, 2010, J CEREBR BLOOD F MET, V30, P1053, DOI 10.1038/jcbfm.2009.286; Carreno CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.004; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Derrick M, 2007, STROKE, V38, P731, DOI 10.1161/01.STR.0000251445.94697.64; Dixon CL, 2018, AM J PERINAT, V35, P1241, DOI 10.1055/s-0038-1653944; Drobyshevsky A, 2014, ANN NEUROL, V75, P533, DOI 10.1002/ana.24115; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Freeman JH, 1996, BEHAV BRAIN RES, V80, P123, DOI 10.1016/0166-4328(96)00027-7; Gouyon JB, 2010, INT J EPIDEMIOL, V39, P769, DOI 10.1093/ije/dyq037; Gumus HG, 2018, BEHAV BRAIN RES, V353, P236, DOI 10.1016/j.bbr.2018.02.032; HAREL S, 1972, BIOL NEONATE, V21, P381; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Horgan MJ, 2015, PEDIATR CLIN N AM, V62, P439, DOI 10.1016/j.pcl.2014.11.007; Illa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076453; Johnson S, 2018, J PEDIATR-US, V193, P85, DOI 10.1016/j.jpeds.2017.10.002; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Manuel CR, 2017, CURR PHARM DESIGN, V23, P6142, DOI 10.2174/1381612823666171012101114; MEIJSSER FM, 1989, APPL ANIM BEHAV SCI, V24, P147, DOI 10.1016/0168-1591(89)90042-7; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Pietrasanta C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211484; Preterm Labour and Birth, 2015, NAT I HLTH CAR EXC C; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Richter J, 2014, AM J PHYSIOL-LUNG C, V306, pL277, DOI 10.1152/ajplung.00315.2013; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Salaets T, 2017, CURR PHARM DESIGN, V23, P5887, DOI 10.2174/1381612823666170926123550; SCHERLE W, 1970, Mikroskopie, V26, P57; Stahlmann N, 2009, NEUROPEDIATRICS, V40, P112, DOI 10.1055/s-0029-1243166; Talge NM, 2010, PEDIATRICS, V126, P1124, DOI 10.1542/peds.2010-1536; Ustun C, 2001, INT J GYNECOL OBSTET, V72, P109, DOI 10.1016/S0020-7292(00)00280-0; van der Merwe J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39922-8; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246008	10.1371/journal.pone.0246008	http://dx.doi.org/10.1371/journal.pone.0246008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503047	gold, Green Published			2022-12-26	WOS:000613751800050
J	Ross, AB; Barman, M; Hartvigsson, O; Lundell, AC; Savolainen, O; Hesselmar, B; Wold, AE; Sandberg, AS				Ross, Alastair B.; Barman, Malin; Hartvigsson, Olle; Lundell, Anna-Carin; Savolainen, Otto; Hesselmar, Bill; Wold, Agnes E.; Sandberg, Ann-Sofie			Umbilical cord blood metabolome differs in relation to delivery mode, birth order and sex, maternal diet and possibly future allergy development in rural children	PLOS ONE			English	Article							HAY-FEVER; FARM EXPOSURE; ASTHMA; SENSITIZATION; DISEASE; HOMOCYSTEINE; FREQUENCY; HYGIENE; PLASMA; WOMEN	Allergy is one of the most common diseases among young children yet all factors that affect development of allergy remain unclear. In a small cohort of 65 children living in the same rural area of south-west Sweden, we have previously found that maternal factors, including prenatal diet, affect childhood allergy risk, suggesting that in utero conditions may be important for allergy development. Here, we studied if metabolites in the umbilical cord blood of newborns may be related to development of childhood allergy, accounting for key perinatal factors such as mode of delivery, birth order and sex. Available umbilical cord blood plasma samples from 44 of the participants were analysed using gas chromatography-mass spectrometry metabolomics; allergy was diagnosed by specialised paediatricians at ages 18 months, 3 years and 8 years and included eczema, asthma, food allergy and allergic rhinoconjunctivitis. Nineteen cord blood metabolites were related to future allergy diagnosis though there was no clear pattern of up- or downregulation of metabolic pathways. In contrast, perinatal factors birth order, sex and mode of delivery affected several energy and biosynthetic pathways, including glutamate and aspartic acid-histidine metabolism (p = 0.004) and the tricarboxylic acid cycle (p = 0.006) for birth order; branched chain amino acid metabolism (p = 0.0009) and vitamin B-6 metabolism (p = 0.01) for sex; and glyoxylate and dicarboxylic acid metabolism (p = 0.005) for mode of delivery. Maternal diet was also related to some of the metabolites associated with allergy. In conclusion, the cord blood metabolome includes individual metabolites that reflect lifestyle, microbial and other factors that may be associated with future allergy diagnosis, and also reflects temporally close events/factors. Larger studies are required to confirm these associations, and perinatal factors such as birth order or siblings must be considered in future cord-blood metabolome studies.	[Ross, Alastair B.; Barman, Malin; Hartvigsson, Olle; Savolainen, Otto; Sandberg, Ann-Sofie] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Ross, Alastair B.] AgResearch, Food & Biobased Prod Grp, Lincoln, New Zealand; [Lundell, Anna-Carin; Wold, Agnes E.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Hesselmar, Bill] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Paediat, Gothenburg, Sweden; [Wold, Agnes E.] Univ Gothenburg, Dept Infect Dis, Clin Bacteriol Sect, Gothenburg, Sweden	Chalmers University of Technology; AgResearch - New Zealand; University of Gothenburg; University of Gothenburg; University of Gothenburg	Sandberg, AS (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.	Ann-Sofie.Sandberg@chalmers.se	barman, malin/AAF-7933-2019	barman, malin/0000-0002-5317-2768; Ross, Alastair/0000-0002-9585-0141	Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (Formas) [222-2004-1958]; Swedish federal government under the LUA/ALF agreement; Swedish Research Council (VR) [521-2013-3154, 2019-01317]	Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish federal government under the LUA/ALF agreement; Swedish Research Council (VR)(Swedish Research Council)	This work was supported by the Swedish Research Council for Environmental, Agricultural Sciences and Spatial Planning (Formas), Grant number 222-2004-1958; the Swedish federal government under the LUA/ALF agreement; the Swedish Research Council (VR) under Grant number 521-2013-3154 and grant number 2019-01317.	Abalos E, 2018, EUR J OBSTET GYN R B, V223, P123, DOI 10.1016/j.ejogrb.2018.02.026; Agache I, 2019, ALLERGY, V74, P449, DOI 10.1111/all.13690; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Baiz N, 2019, ALLERGY ASTHMA CL IM, V15, DOI 10.1186/s13223-019-0353-2; Barman M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12103000; Barman M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022013; Black PN, 1997, EUR RESPIR J, V10, P6, DOI 10.1183/09031936.97.10010006; Braekke K, 2007, PEDIATR RES, V62, P319, DOI 10.1203/PDR.0b013e318123fba2; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Brekke HK, 2003, J AM DIET ASSOC, V103, P835, DOI 10.1016/S0002-8223(03)00378-X; Chawes BL, 2019, METABOLITES, V9, DOI 10.3390/metabo9090185; Chen Y, 2020, RES SQUARE; Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057; Dessi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981219; Douwes J, 2008, EUR RESPIR J, V32, P603, DOI 10.1183/09031936.00033707; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Gil AM, 2018, REPROD SCI, V25, P967, DOI 10.1177/1933719118756748; Haanpaa L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019281; Hashimoto F, 2013, EARLY HUM DEV, V89, P315, DOI 10.1016/j.earlhumdev.2012.10.010; Johansson I, 2002, PUBLIC HEALTH NUTR, V5, P487, DOI 10.1079/PHN2001315; Jonsson K, 2016, ACTA PAEDIATR, V105, P1462, DOI 10.1111/apa.13592; Jonsson K, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.32721; Jonsson K, 2016, PEDIATR RES, V79, P114, DOI 10.1038/pr.2015.187; LARSSON L, 1995, THORAX, V50, P260, DOI 10.1136/thx.50.3.260; Lau CHE, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1190-8; Lundell AC, 2015, J ALLERGY CLIN IMMUN, V136, P1074, DOI 10.1016/j.jaci.2015.03.022; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Nakada EM, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.98101; Perng W, 2017, METABOLISM, V76, P11, DOI 10.1016/j.metabol.2017.07.001; Ramesh M, 2010, J ALLERGY CLIN IMMUN, V125, pAB32, DOI 10.1016/j.jaci.2009.12.159; Remes ST, 2005, CLIN EXP ALLERGY, V35, P160, DOI 10.1111/j.1365-2222.2005.02172.x; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Robinson O, 2018, J PROTEOME RES, V17, P1235, DOI 10.1021/acs.jproteome.7b00846; Ruoppolo M, 2015, MOL BIOSYST, V11, P2483, DOI 10.1039/c5mb00297d; Savolainen OI, 2016, J PROTEOME RES, V15, P259, DOI 10.1021/acs.jproteome.5b00790; Shokry E, 2019, ARCH GYNECOL OBSTET, V300, P589, DOI 10.1007/s00404-019-05213-w; Sipka S, 2014, INT ARCH ALLERGY IMM, V165, P1, DOI 10.1159/000366100; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Staley C, 2017, APPL MICROBIOL BIOT, V101, P47, DOI 10.1007/s00253-016-8006-6; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strombeck A, 2017, CLIN EXP ALLERGY, V47, P918, DOI 10.1111/cea.12922; Strombeck A, 2014, CLIN EXP ALLERGY, V44, P940, DOI 10.1111/cea.12290; Turi KN, 2018, J ALLERGY CLIN IMMUN, V141, P1191, DOI 10.1016/j.jaci.2017.04.021; Vassallo MF, 2010, ANN ALLERG ASTHMA IM, V104, P307, DOI 10.1016/j.anai.2010.01.019; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; Williams HC, 1996, LANCET, V348, P1391, DOI 10.1016/S0140-6736(05)65466-9; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Zanardo V, 2003, THROMB RES, V112, P33, DOI 10.1016/j.thromres.2003.11.004	49	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0242978	10.1371/journal.pone.0242978	http://dx.doi.org/10.1371/journal.pone.0242978			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493154	Green Published, gold			2022-12-26	WOS:000613081500027
J	Wielema, M; Sijens, PE; Dijkstra, H; De Bock, GH; van Bruggen, IG; Siegersma, JE; Langius, E; Pijnappel, RM; Dorrius, MD; Oudkerk, M				Wielema, M.; Sijens, P. E.; Dijkstra, H.; De Bock, G. H.; van Bruggen, I. G.; Siegersma, J. E.; Langius, E.; Pijnappel, R. M.; Dorrius, M. D.; Oudkerk, M.			Diffusion weighted imaging of the breast: Performance of standardized breast tumor tissue selection methods in clinical decision making	PLOS ONE			English	Article							COEFFICIENT ADC MEASUREMENTS; DIAGNOSTIC PERFORMANCE; LESIONS; QUANTIFICATION; REGION; MRI	Objectives In breast diffusion weighted imaging (DWI) protocol standardization, it is recently shown that no breast tumor tissue selection (BTTS) method outperformed the others. The purpose of this study is to analyze the feasibility of three fixed-size breast tumor tissue selection (BTTS) methods based on the reproducibility, accuracy and time-measurement in comparison to the largest oval and manual delineation in breast diffusion weighted imaging data. Methods This study is performed with a consecutive dataset of 116 breast lesions (98 malignant) of at least 1.0 cm, scanned in accordance with the EUSOBI breast DWI working group recommendations. Reproducibility of the maximum size manual (BTTS1) and of the maximal size round/oval (BTTS2) methods were compared with three smaller fixed-size circular BTTS methods in the middle of each lesion (BTTS3, 0.12 cm(3) volume) and at lowest apparent diffusion coefficient (ADC) (BTTS4, 0.12 cm(3); BTTS5, 0.24 cm(3)). Mean ADC values, intraclass-correlation-coefficients (ICCs), area under the curve (AUC) and measurement times (sec) of the 5 BTTS methods were assessed by two observers. Results Excellent inter- and intra-observer agreement was found for any BTTS (with ICC 0.88-0.92 and 0.92-0.94, respectively). Significant difference in ADCmean between any pair of BTTS methods was shown (p = <0.001-0.009), except for BTTS2 vs. BTTS3 for observer 1 (p = 0.10). AUCs were comparable between BTTS methods, with highest AUC for BTTS2 (0.89-0.91) and lowest for BTTS4 (0.76-0.85). However, as an indicator of clinical feasibility, BTTS2-3 showed shortest measurement times (10-15 sec) compared to BTTS1, 4-5 (19-39 sec). Conclusion The performance of fixed-size BTTS methods, as a potential tool for clinical decision making, shows equal AUC but shorter ADC measurement time compared to manual or oval whole lesion measurements. The advantage of a fixed size BTTS method is the excellent reproducibility. A central fixed breast tumor tissue volume of 0.12 cm(3) is the most feasible method for use in clinical practice.	[Wielema, M.; Sijens, P. E.; Dijkstra, H.; Siegersma, J. E.; Dorrius, M. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Wielema, M.; De Bock, G. H.; Dorrius, M. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Bruggen, I. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiotherapy, Groningen, Netherlands; [Langius, E.] Isala Hosp, Dept Radiol, Zwolle, Netherlands; [Pijnappel, R. M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Oudkerk, M.] Univ Groningen, Fac Med Sci, Groningen, Netherlands; [Oudkerk, M.] Inst Diagnost Accuracy, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Groningen	Wielema, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands.; Wielema, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	m.wielema@umcg.nl	; de Bock, Geertruida H./F-6529-2014	Dijkstra, Hildebrand/0000-0001-6664-902X; de Bock, Geertruida H./0000-0003-3104-4471; Pijnappel, Ruud/0000-0002-6912-9414				Pereira FPA, 2009, AM J ROENTGENOL, V193, P1030, DOI 10.2214/AJR.09.2522; Arponent O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138702; Avendano D, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1208-y; Baltzer P, 2020, EUR RADIOL, V30, P1436, DOI 10.1007/s00330-019-06510-3; Bickel H, 2017, EUR RADIOL, V27, P1883, DOI 10.1007/s00330-016-4564-3; Clauser P, 2016, EUR RADIOL, V26, P2291, DOI 10.1007/s00330-015-4051-2; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dorrius MD, 2012, EUR J RADIOL, V81, P209, DOI 10.1016/j.ejrad.2010.12.046; Dorrius MD, 2014, EUR RADIOL, V24, P2835, DOI 10.1007/s00330-014-3338-z; Giannotti E, 2015, EUR J RADIOL, V84, P1729, DOI 10.1016/j.ejrad.2015.05.032; Hirano M, 2012, AM J ROENTGENOL, V198, P717, DOI 10.2214/AJR.11.7093; Lourenco AP, 2014, J MAGN RESON IMAGING, V39, P535, DOI 10.1002/jmri.24198; Naranjo ID, 2021, EUR RADIOL, V31, P356, DOI 10.1007/s00330-020-07094-z; Nogueira L, 2015, DIAGN INTERV RADIOL, V21, P123, DOI 10.5152/dir.2014.14217; Pinker K, 2018, INVEST RADIOL, V53, P587, DOI 10.1097/RLI.0000000000000465; Shi RY, 2018, CLIN BREAST CANCER, V18, pE305, DOI 10.1016/j.clbc.2017.06.011; Strobel K, 2015, RADIOLOGY, V274, P343, DOI 10.1148/radiol.14140645; Wielema M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232856; Zhang L, 2016, ACTA RADIOL, V57, P651, DOI 10.1177/0284185115597265; Zhang W, 2015, INT J CLIN EXP MED, V8, P12096	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245930	10.1371/journal.pone.0245930	http://dx.doi.org/10.1371/journal.pone.0245930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493230	gold, Green Published			2022-12-26	WOS:000613081500009
J	Caira, JN; Jensen, K				Caira, Janine N.; Jensen, Kirsten			Electron microscopy reveals novel external specialized organs housing bacteria in eagle ray tapeworms	PLOS ONE			English	Article							SYMBIOTIC BACTERIA; MYLIOBATIFORMES MYLIOBATIDAE; TEGUMENT; PLATYHELMINTHES; INVERTEBRATES; PARACATENULA; CESTODA; SURFACE; FISH	Nutritionally-based mutualisms with bacteria are known to occur in a wide array of invertebrate phyla, although less commonly in the Platyhelminthes. Here we report what appears to be a novel example of this type of association in two geographically disparate and phylogenetically distant species of tapeworms of eagle rays-the lecanicephalidean Elicilacunosus dharmadii off the island of Borneo and the tetraphyllidean Caulobothrium multispelaeum off Senegal. Scanning and transmission electron microscopy revealed that the grooves and apertures on the outer surfaces of both tapeworms open into expansive cavities housing concentrations of bacteria. This led us to reject the original hypothesis that these structures, and their associated mucopolysaccharides, aid in attachment to the host mucosa. The cavities were found to be specialized in-foldings of the tapeworm body that were lined with particularly elongate filitriches. Given tapeworms lack a gut and employ filitriches to assist in nutrient absorption, enhanced nutrient uptake likely occurs in the cavities. Each tapeworm species appeared to host different bacterial monocultures; those in E. dharmadii were coccoid-like in form, while those in C. multispelaeum were bacillus-like. The presence of bacteria in a specialized structure of this nature suggests the structure is a symbiotic organ. Tapeworms are fully capable of obtaining their own nutrients, and thus the bacteria likely serve merely to supplement their diet. Given the bacteria were also extracellular, this structure is more consistent with a mycetome than a trophosome. To our knowledge, this is not only the first evidence of an external symbiotic organ of any type in a nutritionally-based mutualism, but also the first description of a mycetome in a group of invertebrates that lacks a digestive system. The factors that might account for the independent evolution of this unique association in these unrelated tapeworms are unclear-especially given that none of their closest relatives exhibit any evidence of the phenomenon.	[Caira, Janine N.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; [Jensen, Kirsten] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Jensen, Kirsten] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	University of Connecticut; University of Kansas; University of Kansas	Caira, JN (corresponding author), Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA.	janine.caira@uconn.edu		, Kirsten/0000-0003-0294-8471	DEB [1921411, 1921404]; National Science Foundation Division of Environmental Biology	DEB; National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	JNC DEB No. 1921404, National Science Foundation Division of Environmental Biology; KJ DEB No. 1921411, National Science Foundation Division of Environmental Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO JM, 1991, J PARASITOL, V77, P784, DOI 10.2307/3282717; Bayer C, 2009, ENV MICROBIOL REP, V1, P136, DOI 10.1111/j.1758-2229.2009.00019.x; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Caira JN, 2021, ZOOTAXA, V4903, P127, DOI 10.11646/zootaxa.4903.1.8; Caira JN, 2014, J PARASITOL, V100, P373, DOI 10.1645/14-516.1; Chaston J, 2010, FEMS MICROBIOL REV, V34, P41, DOI 10.1111/j.1574-6976.2009.00193.x; Chervy L, 2009, FOLIA PARASIT, V56, P199, DOI 10.14411/fp.2009.025; COIL WH, 1991, MICROSCOPIC ANATOMY, V3, P219; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Douglas AE, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0603; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; Gruber-Vodicka HR, 2011, P NATL ACAD SCI USA, V108, P12078, DOI 10.1073/pnas.1105347108; HADDAD A, 1995, APPL ENVIRON MICROB, V61, P1679, DOI 10.1128/AEM.61.5.1679-1687.1995; Hayes SF, 1989, INSECT ENDOCYTOBIOSI, P217; Healy CJ, 2009, INT J PARASITOL, V39, P497, DOI 10.1016/j.ijpara.2008.09.002; Hughes-Stamm SR, 1999, J PARASITOL, V85, P1047, DOI 10.2307/3285667; Jensen K, 2016, INT J PARASITOL, V46, P291, DOI 10.1016/j.ijpara.2016.02.002; Katz S, 2006, MAR ECOL PROG SER, V320, P89, DOI 10.3354/meps320089; Koch KR, 2012, J PARASITOL, V98, P175, DOI 10.1645/GE-2798.1; Korneva J.V., 2006, Parazitologiya (St. Petersburg), V40, P535; Korneva J.V., 2006, Parazitologiya (St. Petersburg), V40, P313; Korneva ZV, 2012, INLAND WATER BIOL, V5, P178, DOI 10.1134/S1995082912020071; Korneva ZV, 2009, INLAND WATER BIOL, V2, P280, DOI 10.1134/S1995082909030146; Leisch N, 2011, ZOOMORPHOLOGY, V130, P261, DOI 10.1007/s00435-011-0135-y; Lundin K, 1998, ACTA ZOOL-STOCKHOLM, V79, P187, DOI 10.1111/j.1463-6395.1998.tb01157.x; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Pappas P.W., 1983, P297; Pinel N, 2008, INT J SYST EVOL MICR, V58, P2147, DOI 10.1099/ijs.0.65174-0; Plotnikov AO, 2008, INLAND WATER BIOL, V1, P25, DOI 10.1007/s12212-008-1005-2; Poddubnaya LG, 2005, HELMINTHOLOGIA, V42, P9; READ C. P., 1955, Intestinal physiology and the host-parasite relationship., P27; Robidart JC, 2008, ENVIRON MICROBIOL, V10, P727, DOI 10.1111/j.1462-2920.2007.01496.x; SAFFO MB, 1992, AM ZOOL, V32, P557; Smith DC, 1987, BIOL SYMBIOSIS; Smyth J.D., 1989, PHYSL BIOCH CESTODES; THREADGOLD LT, 1984, PARASITOLOGY, V89, P523, DOI 10.1017/S0031182000056742; Urakawa H, 2005, ENVIRON MICROBIOL, V7, P750, DOI 10.1111/j.1462-2920.2005.00753.x; WATERBURY JB, 1983, SCIENCE, V221, P1401, DOI 10.1126/science.221.4618.1401; Whittington ID, 2001, ADV PARASIT, V48, P101, DOI 10.1016/S0065-308X(01)48006-7; WOOD AP, 1989, J MAR BIOL ASSOC UK, V69, P165, DOI 10.1017/S0025315400049171	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244586	10.1371/journal.pone.0244586	http://dx.doi.org/10.1371/journal.pone.0244586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481793	Green Published, gold			2022-12-26	WOS:000612929300127
J	De Revere, JL; Clausen, RD; Astorino, TA				De Revere, Jamie L.; Clausen, Rasmus D.; Astorino, Todd A.			Changes in VO(2)max and cardiac output in response to short-term high-intensity interval training in Caucasian and Hispanic young women: A pilot study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; OXYGEN-UPTAKE; SEDENTARY; EXERCISE; IMPROVEMENTS; DOTO(2PEAK); VOLUME; MEN	Data obtained in primarily Caucasian (C) and African American adults show that ethnicity does not mediate responsiveness to exercise training. It is unknown if Hispanics (H), who face elevated health risks and are less active than C, exhibit a similar response to exercise training. This study compared cardiorespiratory and hemodynamic responses to high intensity interval training (HIIT) between C and H women. Twelve C and ten H women ages 1935 yr who were non-obese and inactive completed nine sessions of HIIT over a 3 wk period. Maximal oxygen uptake (VO(2)max) was assessed twice at baseline during which thoracic impedance was used to evaluate heart rate (HR), stroke volume (SV) and cardiac output (CO). Habitual physical activity was assessed using accelerometry. Results showed a significant main effect of training for VO(2)max in C and H (F = 13.97, p = 0.001) and no group by training interaction (p = 0.65). There was a main effect of training for CO and SV in C and H (F = 7.57, p = 0.01; F = 7.16, p = 0.02), yet post hoc analyses revealed significant increases were only exhibited in C. There was a tendency for a group by training interaction for a VO(2)diff (F = 1.32, p = 0.054), and a large effect size was seen in H (d = 1.02). Overall, data show no effect of ethnicity on changes in VO(2)max with low-volume HIIT, yet C and H may achieve this outcome differently. Longer studies in similar populations are needed to verify this result.	[De Revere, Jamie L.; Clausen, Rasmus D.; Astorino, Todd A.] Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92096 USA	California State University System; California State University San Marcos	Astorino, TA (corresponding author), Calif State Univ San Marcos, Dept Kinesiol, San Marcos, CA 92096 USA.	astorino@csusm.edu			California State University San Marcos	California State University San Marcos	This study was funded by a University Professional Development grant from California State University San Marcos to TAA.	Alvarez C, 2019, SCAND J MED SCI SPOR, V29, P886, DOI 10.1111/sms.13409; [Anonymous], 2018, ULTR PRIOR; Astorino TA, 2009, INT J SPORTS MED, V30, P279, DOI 10.1055/s-0028-1104588; Astorino TA, 2017, MED SCI SPORT EXER, V49, P265, DOI 10.1249/MSS.0000000000001099; Astorino TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097638; Astorino TA, 2013, EUR J APPL PHYSIOL, V113, P2361, DOI 10.1007/s00421-013-2672-1; Astorino TA, 2018, EUR J APPL PHYSIOL, V118, P51, DOI 10.1007/s00421-017-3756-0; Blackwell JEM, 2018, MED SCI SPORT EXER, V50, P1740, DOI 10.1249/MSS.0000000000001634; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bowdon M, 2018, MED SCI SPORT EXER, V50, P1350, DOI 10.1249/MSS.0000000000001580; Boyd JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068091; Buford TW, 2013, SPORTS MED, V43, P157, DOI 10.1007/s40279-013-0018-0; Centers for Disease Control and Prevention, 2010, STAT IND REP PHYS AC; Centers for Disease Control and Prevention, 2017, US HLTH REP; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Foulds HJA, 2019, ETHNIC HEALTH, V24, P168, DOI 10.1080/13557858.2017.1315377; Gill JMR, 2014, ATHEROSCLEROSIS, V232, P319, DOI 10.1016/j.atherosclerosis.2013.11.039; Gurd BJ, 2016, APPL PHYSIOL NUTR ME, V41, P229, DOI 10.1139/apnm-2015-0449; Hautala AJ, 2003, AM J PHYSIOL-HEART C, V285, pH1747, DOI 10.1152/ajpheart.00202.2003; Hautala A, 2012, J SPORT SCI, V30, P563, DOI 10.1080/02640414.2012.658080; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Johnson JL, 2004, ATHEROSCLEROSIS, V176, P371, DOI 10.1016/j.atherosclerosis.2004.05.018; Jones S, 2020, DIABETOLOGIA, V63, P624, DOI 10.1007/s00125-019-05055-w; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3; Matsuo T, 2014, EUR J APPL PHYSIOL, V114, P1963, DOI 10.1007/s00421-014-2917-7; Milanovic Z, 2015, SPORTS MED, V45, P1339, DOI 10.1007/s40279-015-0361-4; Poole DC, 2017, J APPL PHYSIOL, V122, P997, DOI 10.1152/japplphysiol.01063.2016; Raleigh JP, 2016, APPL PHYSIOL NUTR ME, V41, P706, DOI 10.1139/apnm-2015-0614; Reichert FF, 2007, AM J PUBLIC HEALTH, V97, P515, DOI 10.2105/AJPH.2005.070144; Skinner JS, 2001, J APPL PHYSIOL, V90, P1770, DOI 10.1152/jappl.2001.90.5.1770; Slentz CA, 2004, ARCH INTERN MED, V164, P31, DOI 10.1001/archinte.164.1.31; Stork MJ, 2017, HEALTH PSYCHOL REV, V11, P324, DOI 10.1080/17437199.2017.1326011; Thum JS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166299; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; U. S. Department of Health and Human Services,, 2019, OFF MIN HLTH; Voisin S, 2019, EXERC SPORT SCI REV, V47, P37, DOI 10.1249/JES.0000000000000176; Warburton DER, 2004, MED SCI SPORT EXER, V36, P991, DOI 10.1249/01.MSS.0000128163.88298.CB; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576	43	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244850	10.1371/journal.pone.0244850	http://dx.doi.org/10.1371/journal.pone.0244850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481836	Green Published, gold			2022-12-26	WOS:000612929300037
J	Levin, MW; Shang, MF; Stern, R				Levin, Michael W.; Shang, Mingfeng; Stern, Raphael			Effects of short-term travel on COVID-19 spread: A novel SEIR model and case study in Minnesota	PLOS ONE			English	Article							EPIDEMIC	The novel coronavirus responsible for COVID-19 was first identified in Hubei Province, China in December, 2019. Within a matter of months the virus had spread and become a global pandemic. In addition to international air travel, local travel (e.g. by passenger car) contributes to the geographic spread of COVID-19. We modify the common susceptible-exposed-infectious-removed (SEIR) virus spread model and investigate the extent to which short-term travel associated with driving influences the spread of the virus. We consider the case study of the US state of Minnesota, and calibrated the proposed model with travel and viral spread data. Using our modified SEIR model that considers local short-term travel, we are able to better explain the virus spread than using the long-term travel SEIR model. Short-term travel associated with driving is predicted to be a significant contributor to the historical and future spread of COVID-19. The calibrated model also predicts the proportion of infections that were detected. We find that if driving trips remain at current levels, a substantial increase in COVID-19 cases may be observed in Minnesota, while decreasing intrastate travel could help contain the virus spread.	[Levin, Michael W.; Shang, Mingfeng; Stern, Raphael] Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Levin, MW (corresponding author), Univ Minnesota, Dept Civil Environm & Geoengn, Minneapolis, MN 55455 USA.	mlevin@umn.edu			National Science Foundation [CMMI-1935541, CNS-2028946]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grants No. CMMI-1935541 (Levin) and CNS-2028946 (Stern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, NAT MED, DOI [10.1038/s41591-020-0897-1, DOI 10.1038/S41591-020-0897-1]; Anzai A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020601; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Etbaigha F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202493; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; He WQ, 2020, J MED VIROL, V92, P2543, DOI 10.1002/jmv.26041; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Hou C, 2020, J MED VIROL, V92, P841, DOI 10.1002/jmv.25827; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lekone PE, 2006, BIOMETRICS, V62, P1170, DOI 10.1111/j.1541-0420.2006.00609.x; Lewnard JA, 2020, LANCET INFECT DIS, V20, P631, DOI 10.1016/S1473-3099(20)30190-0; LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Mathur G, 2020, AM J CLIN PATHOL, V154, P1, DOI 10.1093/ajcp/aqaa082; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Pare PE, 2020, IEEE T CONTR SYST T, V28, P79, DOI 10.1109/TCST.2018.2869369; Phelan AL, 2020, LANCET, V395, P1595, DOI 10.1016/S0140-6736(20)31034-5; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; World Health Organization, 2020, DIR GEN OP REM MED B; Yuan H, 2008, APPL MATH COMPUT, V206, P357, DOI 10.1016/j.amc.2008.09.025	29	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245919	10.1371/journal.pone.0245919	http://dx.doi.org/10.1371/journal.pone.0245919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481956	Green Published			2022-12-26	WOS:000612929300141
J	Morlock, R; Morlock, A; Downen, M; Shah, SN				Morlock, Robert; Morlock, Amy; Downen, Martha; Shah, Sonali N.			COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders	PLOS ONE			English	Article								Background Early recognition of COVID-19 cases is essential for effective public health measures aimed at isolation of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2). The objective of this study was to describe characteristics, self-reported symptoms, and predictors of testing positive for SARS-CoV-2 infection in a community-based sample. Methods and findings This was a cross-sectional nationwide survey of adults in the US conducted between April 24 through May 13, 2020. The survey targeted a representative sample of approximately 5,000 respondents. The rate of COVID-19 cases and testing, most frequently reported symptoms, symptom severity, treatment received, impact of COVID-19 on mental and physical health, and factors predictive of testing positive were assessed. Most of the 5,203 participants (85.6%) reported no COVID-19-like symptoms. Of the 747 (14.5%) participants reporting COVID-19-like symptoms, 367 (49.1%) obtained a diagnostic test. Eighty-nine participants (24.3%) reported a positive COVID-19 test result, representing 1.7% of the total sample. For those testing positive, the most common symptoms were dry cough, fever, and shortness of breath/difficulty breathing. Those who tested positive were more likely to report greater symptom severity versus those who tested negative. Severe dry cough, new loss of taste or smell, trouble waking up, living with someone experiencing symptoms, recent international travel, respiratory issues, and reporting ethnicity of Black or African American were predictive of testing positive. Conclusions This study assessed the impact of COVID-19 using community-level self-reported data across the US during the peak of most stay at home' orders. Self-reported symptoms and risk factors identified in this study are consistent with the clinical profile emerging for COVID-19. In the absence of widespread testing, this study demonstrates the utility of a representative US community-based sample to provide direct-reported symptoms and outcomes to quickly identify high-risk individuals who are likely to test positive and should consider taking greater precautions.	[Morlock, Robert] YourCareChoice, Ann Arbor, MI 48109 USA; [Morlock, Amy] Acumen Hlth Res Inst, Ann Arbor, MI USA; [Downen, Martha] Downen Consulting Grp LLC, Rye, NY USA		Morlock, R (corresponding author), YourCareChoice, Ann Arbor, MI 48109 USA.	rmorloc1@yourcarechoice.com						Bushell W, 2020, J ALTERN COMPLEM MED, V26, P547, DOI 10.1089/acm.2020.0177; Calder PC, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041181; Centers for Disease Control and Prevention, 2020, 03 10 2020 LAB ADV U; Centers for Disease Control and Prevention, 2021, INT INF PREV CONTR G; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Hamer M, 2020, BRAIN BEHAV IMMUN, V87, P184, DOI 10.1016/j.bbi.2020.05.059; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Hays RD, 2017, J PATIENT-REP OUTCOM, V1, DOI 10.1186/s41687-017-0003-8; Iddir M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061562; Kullar R, 2020, J INFECT DIS, V222, P890, DOI 10.1093/infdis/jiaa372; Miguel MG, 2017, INTEGR MED INSIGHTS, V12, DOI 10.1177/1178633717702869; Patient-Reported Outcomes Measurement Information System, 2017, GLOB HLTH BRIEF GUID; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P841, DOI 10.15585/mmwr.mm6926e3; The White House Centers for Disease Control and Prevention, 2020, PRES COR GUID AM 30; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P64; Watanabe K, 2014, ARCH MED RES, V45, P359, DOI 10.1016/j.arcmed.2014.05.006; World Health Organization, 2020, DIR GEN OP REM MED B; Wortham JM, 2020, MMWR-MORBID MORTAL W, V69, P923, DOI 10.15585/mmwr.mm6928e1; Zbinden-Foncea H, 2020, OBESITY, V28, P1378, DOI 10.1002/oby.22849	20	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245586	10.1371/journal.pone.0245586	http://dx.doi.org/10.1371/journal.pone.0245586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481900	Green Published, gold			2022-12-26	WOS:000612929300165
J	Yamazaki, R; Nishiyama, O; Yoshikawa, K; Saeki, S; Sano, H; Iwanaga, T; Tohda, Y				Yamazaki, Ryo; Nishiyama, Osamu; Yoshikawa, Kazuya; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji			HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PRESERVED EJECTION FRACTION; ATRIAL-FIBRILLATION; NONCARDIAC COMORBIDITIES; CLINICAL-COURSE; HYPERTENSION; DIAGNOSIS; DYSFUNCTION; POPULATION; MORTALITY	Background Some patients with idiopathic pulmonary fibrosis (IPF) must be hospitalized because of heart failure (HF), including HF with preserved ejection fraction (HFpEF) and HF with reduced EF (HFrEF). The association between IPF and HF has not been clarified. We retrospectively investigated the clinical features and outcomes of patients with IPF who required nonelective hospitalization because of HF. Methods We examined data from IPF patients who required nonelective hospitalization for HF at the Kindai University Hospital from January 2008 to December 2018. We divided the patients into 3 groups: those with HFpEF without elevated right ventricular systolic pressure (RVSP), those with HFpEF and elevated RVSP, and those with HFrEF. The recurrence rates of HF after discharge and the 30- and 90-day mortality rates of the patients were evaluated. Results During the study period, 37 patients with IPF required hospitalization because of HF. Among the 34 patients included in the study, 17 (50.0%) were diagnosed with HFpEF without elevated RVSP, 11 (32.3%) with HFpEF and elevated RVSP, and 6 (17.6%) with HFrEF. Patients with HFrEF had significantly higher values for B-type natriuretic peptide (BNP) and left ventricular (LV) end-systolic and end-diastolic diameters than patients with the 2 types of HFpEF (BNP: P = 0.01 and P = 0.0004, LV end-systolic diameter: P < 0.0001 and P < 0.0001, and LV end-diastolic diameter: P = 0.01 and P = 0.0004, respectively). Notably, the difference between the LVEFs of the patients with 2 types of HFpEF was not significant. The patients with HFpEF without elevated RVSP had the lowest 30- and 90-day mortality rates (0%, P = 0.02 and 11.7%, P = 0.11, respectively). Conclusions Among patients with IPF, HFpEF without elevated RVSP was the most common type of HF that required hospitalization. Patients with HFpEF without elevated RVSP survived longer than the patients with the other 2 types of HF.	[Yamazaki, Ryo; Nishiyama, Osamu; Yoshikawa, Kazuya; Saeki, Sho; Sano, Hiroyuki; Iwanaga, Takashi; Tohda, Yuji] Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osakasayama, Osaka, Japan; [Yamazaki, Ryo] Kindai Univ, Dept Resp Med & Allergol, Nara Hosp, Ikoma, Nara, Japan		Nishiyama, O (corresponding author), Kindai Univ, Dept Resp Med & Allergol, Fac Med, Osakasayama, Osaka, Japan.	nishiyama_o@yahoo.co.jp						Ahmed MI, 2009, EUR HEART J, V30, P2029, DOI 10.1093/eurheartj/ehp222; Albert N, 2010, AM J CRIT CARE, V19, P443, DOI 10.4037/ajcc2009314; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Carter P, 2019, J AM COLL CARDIOL, V73, P2166, DOI 10.1016/j.jacc.2018.11.063; Cottin V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166462; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Goudie A, 2015, EUR J HEART FAIL, V17, P90, DOI 10.1002/ejhf.199; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Hawkins NM, 2009, EUR J HEART FAIL, V11, P130, DOI 10.1093/eurjhf/hfn013; Koitabashi T, 2005, CIRC J, V69, P823, DOI 10.1253/circj.69.823; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Lam CSP, 2011, EUR J HEART FAIL, V13, P18, DOI 10.1093/eurjhf/hfq121; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; McCullough PA, 2002, CIRCULATION, V106, P416, DOI 10.1161/01.CIR.0000025242.79963.4C; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Mentz RJ, 2014, J AM COLL CARDIOL, V64, P2281, DOI 10.1016/j.jacc.2014.08.036; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; Natsuizaka M, 2014, AM J RESP CRIT CARE, V190, P773, DOI 10.1164/rccm.201403-0566OC; Nishiyama O, 2019, RESPIR INVESTIG, V57, P415, DOI 10.1016/j.resinv.2019.03.005; Obokata M, 2019, EUR HEART J, V40, P689, DOI 10.1093/eurheartj/ehy809; Papadopoulos CE, 2008, EUR RESPIR J, V31, P701, DOI 10.1183/09031936.00102107; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Raghu G, 2015, EUR RESPIR J, V46, P1370, DOI 10.1183/13993003.01537-2014; Reddy YNV, 2018, CIRCULATION, V137, P534, DOI 10.1161/CIRCULATIONAHA.117.030093; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rivera-Lebron BN, 2013, CHEST, V144, P564, DOI 10.1378/chest.12-2298; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Tsutsui H, 2001, AM J CARDIOL, V88, P530, DOI 10.1016/S0002-9149(01)01732-5; van Cleemput J, 2019, ADV THER, V36, P298, DOI 10.1007/s12325-018-0857-z; van Manen MJG, 2016, EUR RESPIR REV, V25, P278, DOI 10.1183/16000617.0090-2015; Yamazaki R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232212	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245778	10.1371/journal.pone.0245778	http://dx.doi.org/10.1371/journal.pone.0245778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481923	gold, Green Published			2022-12-26	WOS:000612929300053
J	Guo, YJ; Kawaguchi, A; Takeshita, M; Sekiya, T; Hirohama, M; Yamashita, A; Siomi, H; Murano, K				Guo, Youjia; Kawaguchi, Atsushi; Takeshita, Masaru; Sekiya, Takeshi; Hirohama, Mikako; Yamashita, Akio; Siomi, Haruhiko; Murano, Kensaku			Potent mouse monoclonal antibodies that block SARS-CoV-2 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; SPIKE; RACE	Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has developed into a global pandemic since its first outbreak in the winter of 2019. An extensive investigation of SARS-CoV-2 is critical for disease control. Various recombinant monoclonal antibodies of human origin that neutralize SARS-CoV-2 infection have been isolated from convalescent patients and will be applied as therapies and prophylaxis. However, the need for dedicated monoclonal antibodies suitable for molecular pathology research is not fully addressed. Here, we produced six mouse anti-SARS-CoV-2 spike monoclonal antibodies that not only exhibit robust performance in immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, but also demonstrate neutralizing activity against SARS-CoV-2 infection to VeroE6/TMPRSS2 cells. Due to their mouse origin, our monoclonal antibodies are compatible with the experimental immunoassay setups commonly used in basic molecular biology research laboratories, providing a useful tool for future research. Furthermore, in the hope of applying the antibodies of clinical setting, we determined the variable regions of the antibodies and used them to produce recombinant human/mouse chimeric antibodies.	[Guo, Youjia; Siomi, Haruhiko; Murano, Kensaku] Keio Univ, Dept Mol Biol, Sch Med, Tokyo, Japan; [Kawaguchi, Atsushi; Sekiya, Takeshi; Hirohama, Mikako] Univ Tsukuba, Dept Infect Biol, Fac Med, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan; [Kawaguchi, Atsushi] Univ Tsukuba, Microbiol Res Ctr Sustainabil, Tsukuba, Ibaraki, Japan; [Takeshita, Masaru] Keio Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo, Japan; [Yamashita, Akio] Yokohama City Univ, Dept Mol Biol, Sch Med, Yokohama, Kanagawa, Japan	Keio University; University of Tsukuba; University of Tsukuba; University of Tsukuba; Keio University; Yokohama City University	Siomi, H; Murano, K (corresponding author), Keio Univ, Dept Mol Biol, Sch Med, Tokyo, Japan.	awa403@keio.jp; kmurano@keio.jp		Takeshita, Masaru/0000-0002-3281-6595; Murano, Kensaku/0000-0001-7269-8119; Guo, Youjia "Zach"/0000-0002-4837-9350	Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant; Keio Donner Project; AMED [JP18fk0108076]; NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency; Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba	Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant; Keio Donner Project; AMED; NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency; Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba	This work was supported by the Keio University Global Research Institute (KGRI) COVID-19 Pandemic Crisis Research Grant (to M. T., H. S., and K. M.) and the Keio Donner Project, which is devoted to Shibasaburo Kitasato, the founder of Keio University School of Medicine. This study was also supported in part by AMED (JP18fk0108076 to A. K.), NOMURA Microbial Community Control Project in ERATO of the Japan Science and Technology Agency (to A. K.), and Research Support Program to Tackle COVID-19 Related Emergency Problems, University of Tsukuba (to A. K.).	Artika I Made, 2020, Heliyon, V6, pe04743, DOI 10.1016/j.heliyon.2020.e04743; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Chen XY, 2020, CELL MOL IMMUNOL, V17, P647, DOI 10.1038/s41423-020-0426-7; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Cohen J, 2020, SCIENCE, V368, P564, DOI 10.1126/science.368.6491.564; Connor E. M, 1999, RADIOLOGY, V210, P295; Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002; Corti D, 2016, J INFECT PUBLIC HEAL, V9, P231, DOI 10.1016/j.jiph.2016.04.003; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227; Dinnon KH, 2020, NATURE, V586, P560, DOI 10.1038/s41586-020-2708-8; Graham BS, 2015, CURR OPIN HIV AIDS, V10, P129, DOI 10.1097/COH.0000000000000154; Hansel TT, 2010, NAT REV DRUG DISCOV, V9, P325, DOI 10.1038/nrd3003; Hassan AO, 2020, CELL, V182, P744, DOI 10.1016/j.cell.2020.06.011; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Israelow B, 2020, J EXP MED, V217, DOI [10.1101/2020.05.27.118893, 10.1084/jem.20201241]; Iwasaki YW, 2016, MOL CELL, V63, P408, DOI 10.1016/j.molcel.2016.06.008; Jawhara S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072272; Jiang RD, 2020, CELL, V182, P50, DOI 10.1016/j.cell.2020.05.027; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Juste M, 2006, ANAL BIOCHEM, V349, P159, DOI 10.1016/j.ab.2005.10.046; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Klasse PJ, 2020, ELIFE, V9, DOI 10.7554/eLife.57877; Li Q., 2020, NEW ENGL J MED, V382, P1199; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; Meyer L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218717; Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329; Murano K, 2019, EMBO J, V38, DOI 10.15252/embj.2019102870; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; OPSTELTEN DJE, 1995, J CELL BIOL, V131, P339, DOI 10.1083/jcb.131.2.339; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Riva L, 2020, NATURE, V586, P113, DOI 10.1038/s41586-020-2577-1; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Sadasivan J, 2017, J BIOSCIENCES, V42, P231, DOI 10.1007/s12038-017-9676-7; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Song WF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007236; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Tai WB, 2020, ANTIVIR RES, V179, DOI 10.1016/j.antiviral.2020.104820; Tse LV, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00658; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wan JK, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107918; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Zeng Xin, 2020, Antib Ther, V3, P95, DOI 10.1093/abt/tbaa008; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	57	7	7	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100346	10.1016/j.jbc.2021.100346	http://dx.doi.org/10.1016/j.jbc.2021.100346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524396	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400320
J	Ecker, N; Kruse, K				Ecker, Nicolas; Kruse, Karsten			Excitable actin dynamics and amoeboid cell migration	PLOS ONE			English	Article							REACTION-DIFFUSION WAVES; MODEL; POLARIZATION; PROPAGATION; POLARITY; CORTEX	Amoeboid cell migration is characterized by frequent changes of the direction of motion and resembles a persistent random walk on long time scales. Although it is well known that cell migration is typically driven by the actin cytoskeleton, the cause of this migratory behavior remains poorly understood. We analyze the spontaneous dynamics of actin assembly due to nucleation promoting factors, where actin filaments lead to an inactivation of these factors. We show that this system exhibits excitable dynamics and can spontaneously generate waves, which we analyze in detail. By using a phase-field approach, we show that these waves can generate cellular random walks. We explore how the characteristics of these persistent random walks depend on the parameters governing the actin-nucleator dynamics. In particular, we find that the effective diffusion constant and the persistence time depend strongly on the speed of filament assembly and the rate of nucleator inactivation. Our findings point to a deterministic origin of the random walk behavior and suggest that cells could adapt their migration pattern by modifying the pool of available actin.	[Ecker, Nicolas; Kruse, Karsten] Univ Geneva, Dept Biochem, Geneva, Switzerland; [Ecker, Nicolas; Kruse, Karsten] Univ Geneva, Dept Theoret Phys, Geneva, Switzerland; [Kruse, Karsten] Univ Geneva, NCCR Chem Biol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Kruse, K (corresponding author), Univ Geneva, Dept Biochem, Geneva, Switzerland.; Kruse, K (corresponding author), Univ Geneva, Dept Theoret Phys, Geneva, Switzerland.; Kruse, K (corresponding author), Univ Geneva, NCCR Chem Biol, Geneva, Switzerland.	karsten.kruse@unige.ch	Kruse, Karsten/GOG-8298-2022	Kruse, Karsten/0000-0001-8665-2349	Swiss National Science Foundation [205321-175996]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research work has been supported by the Swiss National Science Foundation (http://www.snf.ch, grant 205321-175996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Alonso S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201977; Asano Y, 2008, CELL MOTIL CYTOSKEL, V65, P923, DOI 10.1002/cm.20314; Bement WM, 2015, NAT CELL BIOL, V17, P1471, DOI 10.1038/ncb3251; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Chandran PL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.031920; Chandran PL, 2009, CELL MOL BIOENG, V2, P13, DOI 10.1007/s12195-009-0044-z; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; Clark AG, 2013, BIOPHYS J, V105, P570, DOI 10.1016/j.bpj.2013.05.057; Clausen MP, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa52a1; Doubrovinski K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.258103; Doubrovinski K, 2002, EPL-EUROPHYS LETT, V83, P18003; Dreher A, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/5/055007; Edelstein-Keshet L, 2005, MATH MODELS BIOL; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Graessl M, 2017, J CELL BIOL, V216, P4271, DOI 10.1083/jcb.201706052; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Jasnin M, 2019, STRUCTURE, V27, P1211, DOI 10.1016/j.str.2019.05.009; Kamps D, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108467; Lober J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09172; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Moreno E, 2020, PHYSICA D, V412, DOI 10.1016/j.physd.2020.132591; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Najem S, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.052405; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Raynaud F, 2016, NAT PHYS, V12, P367, DOI 10.1038/NPHYS3615; Rinzel J, 1981, NONLINEAR PHENOMENA, V75, P345; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Shao DY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.108104; Sohrmann M, 2003, TRENDS CELL BIOL, V13, P526, DOI 10.1016/j.tcb.2003.08.006; Stankevicins L, 2020, P NATL ACAD SCI USA, V117, P826, DOI 10.1073/pnas.1907845117; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Vicker MG, 2000, BIOPHYS CHEM, V84, P87, DOI 10.1016/S0301-4622(99)00146-5; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Winkler B, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0185-x; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433	40	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246311	10.1371/journal.pone.0246311	http://dx.doi.org/10.1371/journal.pone.0246311			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524055	Green Submitted, gold, Green Published			2022-12-26	WOS:000616578400012
J	Gan, YL; Yang, LY; Yang, LC; Li, WL; Liang, XL; Jiang, W; Jiang, GF; Hang, XH; Yang, M; Tang, JL; Jiang, BL				Gan, Yong-Liang; Yang, Li-Yan; Yang, Li-Chao; Li, Wan-Lian; Liang, Xue-Lian; Jiang, Wei; Jiang, Guo-Feng; Hang, Xiao-Hong; Yang, Mei; Tang, Ji-Liang; Jiang, Bo-Le			The C-terminal domain of the type III secretion chaperone HpaB contributes to dissociation of chaperone-effector complex in Xanthomonas campestris pv. campestris	PLOS ONE			English	Article							YERSINIA-ENTEROCOLITICA; PROTEIN; PLANT; VESICATORIA; SIGNALS; ATPASE; IDENTIFICATION; PATHOGENICITY; TRANSLOCATION; REGULATOR	Many animal and plant pathogenic bacteria employ a type three secretion system (T3SS) to deliver type three effector proteins (T3Es) into host cells. Efficient secretion of many T3Es in the plant pathogen Xanthomonas campestris pv. campestris (Xcc) relies on the global chaperone HpaB. However, how the domain of HpaB itself affects effector translocation/secretion is poorly understood. Here, we used genetic and biochemical approaches to identify a novel domain at the C-terminal end of HpaB (amino acid residues 137-160) that contributes to virulence and hypersensitive response (HR). Both in vitro secretion assay and in planta translocation assay showed that the secretion and translocation of T3E proteins depend on the C-terminal region of HpaB. Deletion of the C-terminal region of HpaB did not affect binding to T3Es, self-association or interaction with T3SS components. However, the deletion of C-terminal region sharply reduced the mounts of free T3Es liberated from the complex of HpaB with the T3Es, a reaction catalyzed in an ATP-dependent manner by the T3SS-associated ATPase HrcN. Our findings demonstrate the C-terminal domain of HpaB contributes to disassembly of chaperone-effector complex and reveal a potential molecular mechanism underpinning the involvement of HpaB in secretion of T3Es in Xcc.	[Gan, Yong-Liang; Yang, Li-Yan; Yang, Li-Chao; Li, Wan-Lian; Liang, Xue-Lian; Jiang, Wei; Hang, Xiao-Hong; Tang, Ji-Liang; Jiang, Bo-Le] Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China; [Jiang, Guo-Feng] Guangxi Univ, Coll Forest, Nanning, Peoples R China; [Yang, Mei] Guangxi Univ, Sch Chem & Chem Engn, Nanning, Peoples R China	Guangxi University; Guangxi University; Guangxi University	Tang, JL; Jiang, BL (corresponding author), Guangxi Univ, Coll Life Sci & Technol, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning, Peoples R China.	jltang@gxu.edu.cn; jbl1971@gxu.edu.cn	Yang, Lichao/HDM-6210-2022		Natural Science Foundation of Guangxi Province [2014GXNSFFA118005]; Ba Gui Scholar Program of Guangxi Zhuang Autonomous Region of China [2014A002]; Natural Science Foundation of China [31860033, 31860195]	Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Ba Gui Scholar Program of Guangxi Zhuang Autonomous Region of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the research grants of the Natural Science Foundation of Guangxi Province (2014GXNSFFA118005), the Ba Gui Scholar Program of Guangxi Zhuang Autonomous Region of China (2014A002), and the Natural Science Foundation of China (31860033, 31860195).	Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Andrade A, 2007, ARCH BIOCHEM BIOPHYS, V468, P121, DOI 10.1016/j.abb.2007.09.020; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006; Buttner D, 2016, FEMS MICROBIOL REV, V40, P894, DOI 10.1093/femsre/fuw026; Buttner D, 2012, MICROBIOL MOL BIOL R, V76, P262, DOI 10.1128/MMBR.05017-11; Burgess JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228227; Burgess JL, 2016, PROTEIN SCI, V25, P1037, DOI 10.1002/pro.2917; Buttner D, 2004, MOL MICROBIOL, V54, P755, DOI 10.1111/j.1365-2958.2004.04302.x; Castaneda A, 2005, MOL PLANT MICROBE IN, V18, P1306, DOI 10.1094/MPMI-18-1306; DANIELS MJ, 1984, J GEN MICROBIOL, V130, P2447; Delahay RM, 2002, MOL MICROBIOL, V43, P61, DOI 10.1046/j.1365-2958.2002.02740.x; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Drehkopf S, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13160; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Furutani A, 2009, MOL PLANT MICROBE IN, V22, P96, DOI 10.1094/MPMI-22-1-0096; Galan JE, 2008, NAT STRUCT MOL BIOL, V15, P127, DOI 10.1038/nsmb0208-127; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Guo YP, 2011, MOL PLANT MICROBE IN, V24, P649, DOI 10.1094/MPMI-09-10-0209; Hartmann N, 2013, MOL PLANT MICROBE IN, V26, P1176, DOI 10.1094/MPMI-01-13-0019-R; Hausner J, 2013, APPL ENVIRON MICROB, V79, P6312, DOI 10.1128/AEM.01226-13; He YQ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r218; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Ignatov A. N., 2002, Genetika, V38, P1656; Izore T, 2011, STRUCTURE, V19, P603, DOI 10.1016/j.str.2011.03.015; Jensen JL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008923; Jiang BL, 2008, RES MICROBIOL, V159, P216, DOI 10.1016/j.resmic.2007.12.004; Jiang W, 2009, MOL PLANT MICROBE IN, V22, P1401, DOI 10.1094/MPMI-22-11-1401; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koebnik R, 2006, J BACTERIOL, V188, P7652, DOI 10.1128/JB.00795-06; Li RF, 2014, ENVIRON MICROBIOL, V16, P2053, DOI 10.1111/1462-2920.12207; Lonjon F, 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Lonjon F, 2016, MOL CELL PROTEOMICS, V15, P598, DOI 10.1074/mcp.M115.051078; Lorenz C, 2008, MOL MICROBIOL, V69, P344, DOI 10.1111/j.1365-2958.2008.06280.x; Lorenz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051063; Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094; Lorenz C, 2009, J BACTERIOL, V191, P1414, DOI 10.1128/JB.01446-08; Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717; Majewski DD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08477-7; Miller J.H., 1972, EXPT MOL GENETICS; Mudgett MB, 2000, P NATL ACAD SCI USA, V97, P13324, DOI 10.1073/pnas.230450797; Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200; Prochaska H, 2018, MOL PLANT PATHOL, V19, P2473, DOI 10.1111/mpp.12725; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Ramu T, 2013, J BACTERIOL, V195, P740, DOI 10.1128/JB.01967-12; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Scheibner F, 2018, MOL PLANT MICROBE IN, V31, P61, DOI 10.1094/MPMI-06-17-0138-R; Scheibner F, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02180; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Wang L, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz073; Weber E, 2005, J BACTERIOL, V187, P2458, DOI 10.1128/JB.187.7.2458-2468.2005; Wengelnik K, 1996, MOL PLANT MICROBE IN, V9, P704, DOI 10.1094/MPMI-9-0704; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yang LC, 2018, MOL PLANT PATHOL, V19, P1705, DOI 10.1111/mpp.12653	63	1	2	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246033	10.1371/journal.pone.0246033	http://dx.doi.org/10.1371/journal.pone.0246033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507993	Green Published, gold			2022-12-26	WOS:000635021400076
J	Ibrahim, MR; Haworth, J; Lipani, A; Aslam, N; Cheng, T; Christie, N				Ibrahim, Mohamed R.; Haworth, James; Lipani, Aldo; Aslam, Nilufer; Cheng, Tao; Christie, Nicola			Variational-LSTM autoencoder to forecast the spread of coronavirus across the globe	PLOS ONE			English	Article								Modelling the spread of coronavirus globally while learning trends at global and country levels remains crucial for tackling the pandemic. We introduce a novel variational-LSTM Autoencoder model to predict the spread of coronavirus for each country across the globe. This deep Spatio-temporal model does not only rely on historical data of the virus spread but also includes factors related to urban characteristics represented in locational and demographic data (such as population density, urban population, and fertility rate), an index that represents the governmental measures and response amid toward mitigating the outbreak (includes 13 measures such as: 1) school closing, 2) workplace closing, 3) cancelling public events, 4) close public transport, 5) public information campaigns, 6) restrictions on internal movements, 7) international travel controls, 8) fiscal measures, 9) monetary measures, 10) emergency investment in health care, 11) investment in vaccines, 12) virus testing framework, and 13) contact tracing). In addition, the introduced method learns to generate a graph to adjust the spatial dependences among different countries while forecasting the spread. We trained two models for short and long-term forecasts. The first one is trained to output one step in future with three previous timestamps of all features across the globe, whereas the second model is trained to output 10 steps in future. Overall, the trained models show high validation for forecasting the spread for each country for short and long-term forecasts, which makes the introduce method a useful tool to assist decision and policymaking for the different corners of the globe.	[Ibrahim, Mohamed R.; Haworth, James; Lipani, Aldo; Aslam, Nilufer; Cheng, Tao] Univ Coll London UCL, Dept Civil Environm & Geomat Engn, SpaceTimeLab, London, England; [Christie, Nicola] Univ Coll London UCL, Ctr Transport Studies CTS, Dept Civil Environm & Geomat Engn, London, England	University of London; University College London; University of London; University College London	Ibrahim, MR (corresponding author), Univ Coll London UCL, Dept Civil Environm & Geomat Engn, SpaceTimeLab, London, England.	mohamed.ibrahim.17@ucl.ac.uk	Sari Aslam, Nilufer/ABG-1719-2021; Lipani, Aldo/H-6258-2019	Sari Aslam, Nilufer/0000-0001-8858-5514; Lipani, Aldo/0000-0002-3643-6493; Cheng, Tao/0000-0002-5503-9813; Ibrahim, Mohamed/0000-0001-7733-7777; Christie, Nicola/0000-0001-7152-5240	EPSRC [EP/J004197/1, EP/G023212/1] Funding Source: UKRI; ESRC [ES/L011840/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Al-qaness MAA, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030674; Botha E., 2020, SIMPLE ITERATIVE MAP; Castro C.A. De., 2020, SIR MODEL COVID 19 C, P1; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Crokidakis N, 2020, DATA ANAL MODELING E, DOI [10.1016/j.chaos.2020.109930, DOI 10.1016/J.CHAOS.2020.109930]; Deb S, 2020, ARXIV; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Ha David, 2018, NEURIPS, DOI [10.5281/zenodo.1207631, DOI 10.5281/ZENODO.1207631]; Hale T., 2020, OXFORD COVID 19 GOVT; Hu Z., 2020, FORECASTING EVALUATI; JHU CSSE, 2020, 2019 NOVEL CORONAVIR; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kingma DP., 2014, ADAM METHOD STOCHAST; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Pham K.H., 2020, M APPING L ANDSCAPE, P1; Sameni R, 2020, MATHEMATICAL MODELIN, P1; Simha A., 2020, SIMPLE STOCHASTIC SI; Singer H.M, 2020, ARXIV200311997, P1; Toda A.A, 2020, SUSCEPTIBLE INFECTED; Vaswani A, 2017, ADV NEUR IN, V30; Wordometer, 2020, COVID 19 CORONOVIRUS; World Population Review, 2021, COUNTRIES WORLD POPU	24	12	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246120	10.1371/journal.pone.0246120	http://dx.doi.org/10.1371/journal.pone.0246120			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507932	gold, Green Submitted, Green Published			2022-12-26	WOS:000635021400094
J	Ulianova, O; Ulyanov, S; Zaytsev, S; Saltykov, Y; Ulyanov, A; Feodorova, V				Ulianova, Onega; Ulyanov, Sergey; Zaytsev, Sergey; Saltykov, Yuriy; Ulyanov, Alexander; Feodorova, Valentina			Could LASCA-imaging of GB-speckles be applied for a high discrimination and typing of pathogenic bacteria?	PLOS ONE			English	Article							BLOOD-FLOW	In this article, the method of analysis of GB-speckles (gene-based speckles) has been adapted to the problem of detecting the differences in a group of genes (usually 5-7), used in Multi Locus Sequence Typing (MLST). This method is based on s-LASCA imaging (spatial Laser Speckle Contrast Analysis) of virtual GB-speckle and on the technique of RGB coordinates for GB-speckles, processed by the s-LASCA method. A very high sensitivity and accuracy of the new method for detecting gene polymorphism as a great alternative to classical MLST has been demonstrated. The analysis of GB-speckles, obtained for the concatenated sequences of seven genes (gatA, gidA, enoA, fumC, hemN, hflX, oppA) of three different Chlamydia trachomatis strains (E/Bour, ST94; G/9301, ST95; G/11222, ST94) has been applied as the model. The high efficiency of usage of s-LASCA-imaging of GB-speckles has been shown. The data obtained represent a significant progress in digital biology as a whole and improvements in the bio-digitalization of bacterial DNA.	[Ulianova, Onega; Ulyanov, Sergey; Ulyanov, Alexander] Saratov NG Chernyshevskii State Univ, Dept Med Phys, Saratov, Russia; [Ulyanov, Sergey; Zaytsev, Sergey; Saltykov, Yuriy; Feodorova, Valentina] Fed Res Ctr Virol & Microbiol, Branch Saratov, Saratov, Russia	Saratov State University	Ulyanov, S (corresponding author), Saratov NG Chernyshevskii State Univ, Dept Med Phys, Saratov, Russia.; Ulyanov, S (corresponding author), Fed Res Ctr Virol & Microbiol, Branch Saratov, Saratov, Russia.	prof.sergey.ulyanov@yandex.ru	Saltykov, Yury/O-6816-2017	Saltykov, Yury/0000-0001-8163-1979	Russian Science Foundation [17-16-01099]	Russian Science Foundation(Russian Science Foundation (RSF))	This research has been supported by Russian Science Foundation, grant #17-16-01099.	Aizu Y, 1997, P SOC PHOTO-OPT INS, V2982, P91, DOI 10.1117/12.273603; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Dainty JC, 1975, TOPICS APPL PHYS, V9, DOI [10.1111/j.1365-2672.1975.tb00547.x, DOI 10.1111/J.1365-2672.1975.TB00547.X]; Feodorova VA, 2017, P SPIE; Feodorova VA, 2018, PROC SPIE, V10716, DOI 10.1117/12.2314640; Freddolino PL, 2012, CELL, V150, P248, DOI 10.1016/j.cell.2012.07.001; Goodman J.W, 1988, INTRO FOURIER OPTICS; Lesk A. M., 2002, INTRO BIOINFORMATICS; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Perez-Losada M, 2017, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, 2ND EDITION, P383, DOI 10.1016/B978-0-12-799942-5.00016-0; Sini M. S., 2011, Proceedings 2011 International Conference on Signal Processing, Communication, Computing and Networking Technologies (ICSCCN 2011), P207, DOI 10.1109/ICSCCN.2011.6024545; Sleator RD, 2012, BIOENGINEERED, V3, P311, DOI 10.4161/bioe.22367; Ulianova OV, 2011, QUANTUM ELECTRON+, V41, P340, DOI 10.1070/QE2011v041n04ABEH014598; Ulianova OV, 2019, FRONT BIOSCI-LANDMRK, V24, P700, DOI 10.2741/4744; Ulianova OV, 2016, OPT SPECTROSC+, V120, P88; Ulyanov S, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/18005; Ulyanov SS, 1998, J BIOMED OPT, V3, P237, DOI 10.1117/1.429879; Ulyanov SS, 2018, LASER PHYS LETT, V15, DOI 10.1088/1612-202X/aaa11c; Ulyanov SS., 2018, IZV SARATOV U P, V18, P123, DOI [10.18500/1817-3020-2018-18-2-123-137, DOI 10.18500/1817-3020-2018-18-2-123-137]; Ulyanov SS, 2017, P SPIE	21	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245657	10.1371/journal.pone.0245657	http://dx.doi.org/10.1371/journal.pone.0245657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507914	Green Published, gold			2022-12-26	WOS:000635021400042
J	Boba, A; Kostyn, K; Kozak, B; Zalewski, I; Szopa, J; Kulma, A				Boba, Aleksandra; Kostyn, Kamil; Kozak, Bartosz; Zalewski, Iwan; Szopa, Jan; Kulma, Anna			Transcriptomic profiling of susceptible and resistant flax seedlings after Fusarium oxysporum lini infection	PLOS ONE			English	Article							SALICYLIC-ACID GLUCOSYLTRANSFERASE; RESPIRATORY PATHWAY; HOMEOSTASIS; EXPRESSION; STRESS	In this study transcriptome was analyzed on two fibrous varieties of flax: the susceptible Regina and the resistant Nike. The experiment was carried out on 2-week-old seedlings, because in this phase of development flax is the most susceptible to infection. We analyzed the whole seedlings, which allowed us to recognize the systemic response of the plants to the infection. We decided to analyze two time points: 24h and 48h, because our goal was to learn the mechanisms activated in the initial stages of infection, these points were selected based on the previous analysis of chitinase gene expression, whose increase in time of Fusarium oxysporum lini infection has been repeatedly confirmed both in the case of flax and other plant species. The results show that although qualitatively the responses of the two varieties are similar, it is the degree of the response that plays the role in the differences of their resistance to F. oxysporum.	[Boba, Aleksandra; Zalewski, Iwan; Szopa, Jan; Kulma, Anna] Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland; [Kostyn, Kamil; Kozak, Bartosz] Wroclaw Univ Environm & Plant Sci, Fac Life Sci & Technol, Dept Genet Plant Breeding & Seed Prod, Wroclaw, Poland	University of Wroclaw; Wroclaw University of Environmental & Life Sciences	Boba, A (corresponding author), Univ Wroclaw, Fac Biotechnol, Wroclaw, Poland.	aleksandra.boba@uwr.edu.pl	Boba, Aleksandra/AAO-1636-2021; Kulma, Anna/T-8640-2018	Kulma, Anna/0000-0002-5073-901X; Boba, Aleksandra/0000-0003-1298-8100; Kozak, Bartosz/0000-0001-6472-3273	National Science Centre [AK 2014/15/B/NZ9/00470, 2018/29/B/NZ9/00288]	National Science Centre(National Science Centre, Poland)	AK 2014/15/B/NZ9/00470 National Science Centre 2018/29/B/NZ9/00288 National Science Centre https://www.ncn.gov.pl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruszewska A., 2002, Plant Protection Science, V38, P565; [Anonymous], 2013, NUCLEIC ACIDS RES, V41, pD43; [Anonymous], 2017, INSOLVENCY INTELLIGE, V30, P5; BOBA A, 2020, PLANTA, V251, DOI DOI 10.1007/S00425-020-03339-931950395; Boba A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01951; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen Emily A, 2014, BMC Res Notes, V7, P753, DOI 10.1186/1756-0500-7-753; Di XT, 2017, MOL PLANT PATHOL, V18, P1024, DOI 10.1111/mpp.12559; Dmitriev AA, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1192-2; Dong OX, 2019, PLANT PHYSIOL, V180, P26, DOI 10.1104/pp.18.01224; Ferniah RS, 2018, TROP LIFE SCI RES, V29, P29, DOI 10.21315/tlsr2018.29.2.3; Galindo-Gonzalezi L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01766; Gouveia BC, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02139; Hadley W., 2009, GGPLOT2; Huang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02233-5; Kanapin A, 2020, MOL PLANT MICROBE IN, V33, P1112, DOI 10.1094/MPMI-05-20-0130-SC; KIMMEL C, 2011, HDB BIOL AGING, P177; Klopfenstein DV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28948-z; Kroes GMLW, 1998, EUR J PLANT PATHOL, V104, P725, DOI 10.1023/A:1008604417614; Krol P, 2015, J PLANT PHYSIOL, V179, P122, DOI 10.1016/j.jplph.2015.01.018; Li YB, 2016, PLANT PHYSIOL, V170, P2392, DOI 10.1104/pp.15.01930; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; Mendoza M., 2011, Biotecnologia Vegetal, V11, P67; Moore JW, 2011, PLANT CELL, V23, P2809, DOI 10.1105/tpc.111.087346; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Planchon A, PLANT CELL ENVIRON, DOI [10.1111/pce.13882 32890441, DOI 10.1111/PCE.1388232890441]; Preisner M, 2018, J PLANT PHYSIOL, V221, P132, DOI 10.1016/j.jplph.2017.11.015; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Ratzinger A, 2009, J PLANT RES, V122, P571, DOI 10.1007/s10265-009-0237-5; Song JT, 2008, PHYTOCHEMISTRY, V69, P1128, DOI 10.1016/j.phytochem.2007.12.010; Sun LJ, 2010, MOL PLANT MICROBE IN, V23, P1470, DOI 10.1094/MPMI-01-10-0029; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tyagi S, 2021, GM CROPS FOOD, V12, P125, DOI 10.1080/21645698.2020.1831729; Umemura K, 2009, PLANT J, V57, P463, DOI 10.1111/j.1365-313X.2008.03697.x; Vadassery J, 2009, PLANT SIGNAL BEHAV, V4, P1024, DOI 10.4161/psb.4.11.9800; Vanlerberghe GC, 2013, INT J MOL SCI, V14, P6805, DOI 10.3390/ijms14046805; Wang HH, 2010, PLANT SIGNAL BEHAV, V5, P1636, DOI 10.4161/psb.5.12.13775; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; Wojtasik W, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0762-z; Wojtasik W, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0261-z; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wrobel-Kwiatkowska M, 2004, PHYSIOL MOL PLANT P, V65, P245, DOI 10.1016/j.pmpp.2005.02.008; Yerzhebayeva R, 2018, PEERJ, V6, DOI 10.7717/peerj.5127; Young M. D., 2012, GOSEQ GENE ONTOLOGY; Zhang J, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-26; 2008, NEUROSURG FOCUS, V25	48	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246052	10.1371/journal.pone.0246052	http://dx.doi.org/10.1371/journal.pone.0246052			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497403	gold, Green Published			2022-12-26	WOS:000613707100008
J	Poncet, F; Soussignan, R; Jaffiol, M; Gaudelus, B; Leleu, A; Demily, C; Franck, N; Baudouin, JY				Poncet, Fanny; Soussignan, Robert; Jaffiol, Margaux; Gaudelus, Baptiste; Leleu, Arnaud; Demily, Caroline; Franck, Nicolas; Baudouin, Jean-Yves			The spatial distribution of eye movements predicts the (false) recognition of emotional facial expressions	PLOS ONE			English	Article							CONFIGURAL INFORMATION; PERCEPTION; FACE; DISGUST; DISORDERS; FIXATIONS; ATTENTION; CHILDREN; GENDER	Recognizing facial expressions of emotions is a fundamental ability for adaptation to the social environment. To date, it remains unclear whether the spatial distribution of eye movements predicts accurate recognition or, on the contrary, confusion in the recognition of facial emotions. In the present study, we asked participants to recognize facial emotions while monitoring their gaze behavior using eye-tracking technology. In Experiment 1a, 40 participants (20 women) performed a classic facial emotion recognition task with a 5-choice procedure (anger, disgust, fear, happiness, sadness). In Experiment 1b, a second group of 40 participants (20 women) was exposed to the same materials and procedure except that they were instructed to say whether (i.e., Yes/No response) the face expressed a specific emotion (e.g., anger), with the five emotion categories tested in distinct blocks. In Experiment 2, two groups of 32 participants performed the same task as in Experiment 1a while exposed to partial facial expressions composed of actions units (AUs) present or absent in some parts of the face (top, middle, or bottom). The coding of the AUs produced by the models showed complex facial configurations for most emotional expressions, with several AUs in common. Eye-tracking data indicated that relevant facial actions were actively gazed at by the decoders during both accurate recognition and errors. False recognition was mainly associated with the additional visual exploration of less relevant facial actions in regions containing ambiguous AUs or AUs relevant to other emotional expressions. Finally, the recognition of facial emotions from partial expressions showed that no single facial actions were necessary to effectively communicate an emotional state. In contrast, the recognition of facial emotions relied on the integration of a complex set of facial cues.	[Poncet, Fanny; Soussignan, Robert; Jaffiol, Margaux; Leleu, Arnaud] Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, Dev Ethol & Cognit Psychol Lab, AgroSup Dijon,CNRS,Inrae, Dijon, France; [Gaudelus, Baptiste; Franck, Nicolas] Ctr Hosp Le Vinatier, Ctr Ressource Rehabil Psychosociale & Remediat Co, Lyon, France; [Gaudelus, Baptiste; Franck, Nicolas] Univ Lyon 1, Univ Lyon, CNRS UMR 5229, Lyon, France; [Demily, Caroline] Ctr Hosp le Vinatier, Marc Jeannerod Inst CNRS, Reference Ctr Rare Dis Psychiat Phenotype GenoPsy, Bron, France; [Demily, Caroline] Claude Bernard Lyon 1 Univ, Bron, France; [Baudouin, Jean-Yves] Univ Lyon Lumiere Lyon 2, Inst Psychol, Dept Psychol Dev Educ & Vulnerabilites PsyDEV, Lab Dev Individu Proc Handicap Educ DIPHE, Lyon, France	INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Poncet, F (corresponding author), Univ Bourgogne Franche Comte, Ctr Sci Gout & Alimentat, Dev Ethol & Cognit Psychol Lab, AgroSup Dijon,CNRS,Inrae, Dijon, France.; Baudouin, JY (corresponding author), Univ Lyon Lumiere Lyon 2, Inst Psychol, Dept Psychol Dev Educ & Vulnerabilites PsyDEV, Lab Dev Individu Proc Handicap Educ DIPHE, Lyon, France.	Fanny.Poncet@u-bourgogne.fr; j.baudouin@univ-lyon2.fr	Franck, Nicolas/GWZ-4383-2022; Leleu, Arnaud/J-7883-2019	Franck, Nicolas/0000-0002-2894-5108; Leleu, Arnaud/0000-0002-2943-8183; Poncet, Fanny/0000-0001-9355-9556; Baudouin, Jean-Yves/0000-0002-4405-7987	French "Investissements d'Avenir" program, project ISITE-BFC [ANR-15-IDEX-003]; UBFC (Universite Bourgogne-Franche-Comte)	French "Investissements d'Avenir" program, project ISITE-BFC(French National Research Agency (ANR)); UBFC (Universite Bourgogne-Franche-Comte)	This work received support from the French "Investissements d'Avenir" program, project ISITE-BFC (contract ANR-15-IDEX-003), obtained by JYB: https://anr.fr/ProjetIA-15-IDEX0003. FP was support by a doctoral grant from UBFC (Universite Bourgogne-Franche-Comte): https://www.ubfc.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Beaudry O, 2014, COGNITION EMOTION, V28, P416, DOI 10.1080/02699931.2013.833500; BEEBE SA, 1974, SPEECH TEACH, V23, P21; Buchan JN, 2007, SOC NEUROSCI-UK, V2, P1, DOI 10.1080/17470910601043644; Bundesarztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Busin Y, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02332; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calvo MG, 2008, J EXP PSYCHOL GEN, V137, P471, DOI 10.1037/a0012771; Calvo MG, 2014, PSYCHOL RES-PSYCH FO, V78, P180, DOI 10.1007/s00426-013-0492-x; Calvo MG, 2009, COGNITION EMOTION, V23, P782, DOI 10.1080/02699930802151654; Campbell L, 2010, PSYCHIAT RES, V177, P211, DOI 10.1016/j.psychres.2009.06.007; Chambon V, 2006, NEUROPSYCHOLOGIA, V44, P2437, DOI 10.1016/j.neuropsychologia.2006.04.008; Crivelli C, 2016, P NATL ACAD SCI USA, V113, P12403, DOI 10.1073/pnas.1611622113; Darwin C., 1872, EXPRESS EMOT MAN, DOI DOI 10.1037/10001-000; Dickson H, 2014, SCHIZOPHRENIA BULL, V40, P460, DOI 10.1093/schbul/sbs193; Durand K, 2007, J EXP CHILD PSYCHOL, V97, P14, DOI 10.1016/j.jecp.2006.12.001; Eack SM, 2015, AUTISM, V19, P308, DOI 10.1177/1362361314520755; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman P., 2002, FACIAL ACTION CODING; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; ETCOFF NL, 1992, COGNITION, V44, P227, DOI 10.1016/0010-0277(92)90002-Y; Fernandez-Martin A, 2013, SPAN J PSYCHOL, V16, DOI 10.1017/sjp.2013.68; Gendron M, 2018, EMOT REV, V10, P101, DOI 10.1177/1754073917705717; Gendron M, 2014, EMOTION, V14, P251, DOI 10.1037/a0036052; Hall J. A., 1984, NONVERBAL SEX DIFFER; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; Hsiao JHW, 2008, PSYCHOL SCI, V19, P998, DOI 10.1111/j.1467-9280.2008.02191.x; Jack RE, 2014, CURR BIOL, V24, P187, DOI 10.1016/j.cub.2013.11.064; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jarros RB, 2012, J PSYCHIATR RES, V46, P147, DOI 10.1016/j.jpsychires.2011.09.023; Jhung K, 2010, PSYCHIAT RES, V178, P126, DOI 10.1016/j.psychres.2009.11.023; Jongerius C, 2020, J NONVERBAL BEHAV, V44, P363, DOI 10.1007/s10919-020-00333-3; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Kohler CG, 2004, PSYCHIAT RES, V128, P235, DOI 10.1016/j.psychres.2004.07.003; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Laeng B, 2010, EMOTION, V10, P573, DOI 10.1037/a0018689; Leleu A, 2018, NEUROIMAGE, V179, P235, DOI 10.1016/j.neuroimage.2018.06.048; Leleu A, 2016, EUR CHILD ADOLES PSY, V25, P297, DOI 10.1007/s00787-015-0741-1; Lindell A, 2018, PROG BRAIN RES, V238, P249, DOI 10.1016/bs.pbr.2018.06.005; Luke CJ, 2016, PEERJ, V4, DOI 10.7717/peerj.2241; Lundqvist D., 1998, KAROLINSKA DIRECTED; Nicholls MER, 2002, BRAIN COGNITION, V48, P480, DOI 10.1006/brcg.2001.1402; Nusseck M, 2008, J VISION, V8, DOI 10.1167/8.8.1; Peterson MF, 2012, P NATL ACAD SCI USA, V109, pE3314, DOI 10.1073/pnas.1214269109; Pochedly JT, 2012, EMOTION, V12, P1315, DOI 10.1037/a0027998; Prete G, 2018, PSYCHOL RES-PSYCH FO, V82, P310, DOI 10.1007/s00426-016-0830-x; Prete G, 2015, EUR J NEUROSCI, V42, P2952, DOI 10.1111/ejn.13078; Prete G, 2015, NEUROPSYCHOLOGIA, V68, P94, DOI 10.1016/j.neuropsychologia.2015.01.002; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Widen SC, 2008, COGNITIVE DEV, V23, P291, DOI 10.1016/j.cogdev.2008.01.002; Widen SC, 2013, PSYCHOL BULL, V139, P271, DOI 10.1037/a0031640; Wolf RC, 2014, BRAIN, V137, P1772, DOI 10.1093/brain/awu063; Wyczesany M, 2018, NEUROPSYCHOLOGIA, V121, P98, DOI 10.1016/j.neuropsychologia.2018.10.007	60	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245777	10.1371/journal.pone.0245777	http://dx.doi.org/10.1371/journal.pone.0245777			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA8QK	33497409	Green Published, gold			2022-12-26	WOS:000613707100012
J	Maekawa, R; Muto, H; Hatayama, M; Aruga, J				Maekawa, Ryuta; Muto, Hideki; Hatayama, Minoru; Aruga, Jun			Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice	PLOS ONE			English	Article							ADHESION-LIKE MOLECULES; D-ASPARTATE RECEPTOR; ERYTHROID-DIFFERENTIATION; EXPRESSION; CELLS; MODULATION; CHANNELS; MURINE; FAMILY	LRFN2 encodes a synaptic adhesion-like molecule that physically interacts with N-methyl-D-aspartate (NMDA) receptor 1 and its scaffold proteins. Previous studies in humans and mice have demonstrated its genetic association with neurodevelopmental disorders such as learning deficiency and autism. In this study, we showed that Lrfn2-deficient (KO) mice exhibit abnormalities of erythropoietic systems due to altered NMDA receptor function. In mature Lrfn2 KO male mice, peripheral blood tests showed multilineage abnormalities, including normocytic erythrocythemia, and reduced platelet volume. Colony forming unit assay using bone marrow cells revealed decreases in the counts of erythrocyte progenitors (CFU-E) as well as granulocytes and monocyte progenitors (CFU-GM). Whole bone marrow cell staining showed that serum erythropoietin (EPO) level was decreased and EPO receptor-like immunoreactivity was increased. Flow cytometry analysis of bone marrow cells revealed increased early erythroblast count and increased transferrin receptor expression in late erythroblasts. Further, we found that late erythroblasts in Lrfn2 KO exhibited defective NMDA receptor-mediated calcium influx, which was inhibited by the NMDA receptor antagonist MK801. These results indicate that Lrfn2 has biphasic roles in hematopoiesis and is associated with the functional integrity of NMDA receptors in hematopoietic cells. Furthermore, taken together with previous studies that showed the involvement of NMDA receptors in hematopoiesis, the results of this study indicate that Lrfn2 may regulate erythropoiesis through its regulatory activity on NMDA receptors.	[Maekawa, Ryuta; Hatayama, Minoru; Aruga, Jun] Nagasaki Univ, Dept Med Pharmacol, Inst Biomed Sci, Nagasaki, Japan; [Muto, Hideki] Nagasaki Univ, Biomed Res Support Ctr, Sch Med, Nagasaki, Japan	Nagasaki University; Nagasaki University	Aruga, J (corresponding author), Nagasaki Univ, Dept Med Pharmacol, Inst Biomed Sci, Nagasaki, Japan.	aruga@nagasaki-u.ac.jp		tian shan, shi/0000-0001-7510-4769	MEXT KAKENHI [16H04666, 19H03327, 20K21605]; Uehara Memorial Foundation; Smoking Research Foundation	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation(Uehara Memorial Foundation); Smoking Research Foundation	MEXT KAKENHI 16H04666, 19H03327, 20K21605 Smoking Research Foundation The Uehara Memorial Foundation.	Castellanos A, 2007, EXP HEMATOL, V35, P724, DOI 10.1016/j.exphem.2007.02.004; Caulier A, 2020, HAEMATOLOGICA, V105, P610, DOI 10.3324/haematol.2019.218503; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; CHEUNG JY, 1992, J CLIN INVEST, V90, P1850, DOI 10.1172/JCI116061; Chu HC, 2014, FEBS LETT, V588, P58, DOI 10.1016/j.febslet.2013.11.002; Festing MFW, 2018, LAB ANIM-UK, V52, P341, DOI 10.1177/0023677217738268; Genever PG, 1999, BLOOD, V93, P2876; GILLO B, 1993, BLOOD, V81, P783; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Hanggi P, 2015, AM J PHYSIOL-CELL PH, V308, pC993, DOI 10.1152/ajpcell.00395.2014; Hearn JI, 2020, THROMB HAEMOSTASIS, V120, P671, DOI 10.1055/s-0040-1708483; Hiroyama T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001544; Hitchcock IS, 2003, BLOOD, V102, P1254, DOI 10.1182/blood-2002-11-3553; Kalev-Zylinska ML, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00577; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Li Y, 2018, J NEUROSCI, V38, P5872, DOI 10.1523/JNEUROSCI.3321-17.2018; Makhro A, 2013, AM J PHYSIOL-CELL PH, V305, pC1123, DOI 10.1152/ajpcell.00031.2013; Makhro A, 2010, AM J PHYSIOL-CELL PH, V298, pC1315, DOI 10.1152/ajpcell.00407.2009; Malik J, 2013, HAEMATOLOGICA, V98, P1778, DOI 10.3324/haematol.2013.087361; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Morimura N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15800; Paredes-Gamero Edgar Julian, 2012, Front Biosci (Elite Ed), V4, P1375; Rautiainen MR, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.155; Spivak JL, 2001, ADV EXP MED BIOL, V502, P207; Tefferi A, 2015, AM J HEMATOL, V90, P163, DOI 10.1002/ajh.23895; Thevenon J, 2016, EUR J HUM GENET, V24, P911, DOI 10.1038/ejhg.2015.221; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wolwer CB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146201	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245624	10.1371/journal.pone.0245624	http://dx.doi.org/10.1371/journal.pone.0245624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481887	Green Published, gold			2022-12-26	WOS:000612929300067
J	Nakamura, M; Kawada, H; Uchida, H; Takagi, Y; Obata, S; Eda, R; Hanaki, H; Kitasato, H				Nakamura, Masaki; Kawada, Hayato; Uchida, Hiroki; Takagi, Yusuke; Obata, Shuichi; Eda, Ryotaro; Hanaki, Hideaki; Kitasato, Hidero			Single nucleotide polymorphism leads to daptomycin resistance causing amino acid substitution-T345I in MprF of clinically isolated MRSA strains	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS STRAIN; VANCOMYCIN-INTERMEDIATE; CELL-WALL; BACTERICIDAL ACTIVITY; CROSS-RESISTANCE; IN-VITRO; SUSCEPTIBILITY; JAPAN	Daptomycin (DAP) is one of the most potent antibiotics used for the treatment of methicillinresistant Staphylococcus aureus (MRSA) infections. Due to an increase in its administration for combating MRSA infections, DAP non-susceptible (DAP-NS) MRSA strains have recently been reported in clinical settings. The presence of single nucleotide polymorphisms (SNPs) in the multiple peptide resistance factor (mprF) gene is the most frequently reported cause for the evolution of DAP-NS MRSA strains; however, there are some variations of SNPs that could lead to DAP-NS. In this study, we used two clinical MRSA strains, including DAP susceptible (DAP-S) and DAP-NS, isolated from the same patient at different time points. We introduced T345I SNP to mprF of the DAP-S MRSA strain using the gene exchange method with pIMAY vector. Further, we investigated the phenotype of the mutant strain, including drug susceptibility, cell surface positive charge, and growth speed. The mutant strain exhibited (i) resistance to DAP, (ii) up-regulation of positive surface charge, (iii) slower growth speed, and (iv) thickened cell walls. Hence, the SNP in mprF may have caused an up-regulation in MprF function, with a subsequent increase in positive surface charge. Cumulatively, these results demonstrated that the T345I amino acid substitution in mprF represents one of the primary causes of DAP-NS in MRSA strains.	[Nakamura, Masaki; Uchida, Hiroki; Takagi, Yusuke; Kitasato, Hidero] Kitasato Univ, Dept Microbiol, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Nakamura, Masaki; Kawada, Hayato; Eda, Ryotaro; Kitasato, Hidero] Kitasato Univ, Dept Environm Microbiol, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan; [Nakamura, Masaki; Hanaki, Hideaki] Kitasato Univ, Res Ctr Infect Control, Kitasato Inst Life Sci, Tokyo, Japan; [Obata, Shuichi] Kitasato Univ, Dept Anat Sci, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Obata, Shuichi] Yokohama City Univ, Dept Histol & Cell Biol, Sch Med, Yokohama, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University; Yokohama City University	Nakamura, M (corresponding author), Kitasato Univ, Dept Microbiol, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan.; Nakamura, M (corresponding author), Kitasato Univ, Dept Environm Microbiol, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan.; Nakamura, M (corresponding author), Kitasato Univ, Res Ctr Infect Control, Kitasato Inst Life Sci, Tokyo, Japan.	m-nakamu@kitasato-u.ac.jp		Eda, Ryotaro/0000-0002-6713-9256	Kitasato University School of Allied Health Sciences [2016-1052]	Kitasato University School of Allied Health Sciences	This study was supported by a grant from Kitasato University School of Allied Health Sciences (Grant-in-Aid for Research Project, No. 2016-1052).	Bayer AS, 2014, ANTIMICROB AGENTS CH, V58, P7462, DOI 10.1128/AAC.03422-14; Bertsche U, 2011, ANTIMICROB AGENTS CH, V55, P3922, DOI 10.1128/AAC.01226-10; Chen FJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01086; CLSI, 2019, 15 INF SUPPL CLIN LA, V29th; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Ernst CM, 2011, MOL MICROBIOL, V80, P290, DOI 10.1111/j.1365-2958.2011.07576.x; Ernst CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000660; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Geriak M, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.02483-18, 10.1128/aac.02483-18]; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; Hanaki H, 2014, J INFECT CHEMOTHER, V20, P527, DOI 10.1016/j.jiac.2014.06.012; Haraga Isao, 2002, International Journal of Infectious Diseases, V6, P302, DOI 10.1016/S1201-9712(02)90165-7; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Huang YT, 2008, J CLIN MICROBIOL, V46, P1132, DOI 10.1128/JCM.01844-07; Julian K, 2007, ANTIMICROB AGENTS CH, V51, P3445, DOI 10.1128/AAC.00559-07; Li SG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02199; Ma Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198366; Mammina C, 2010, SCAND J INFECT DIS, V42, P955, DOI 10.3109/00365548.2010.524662; Matsuo M, 2011, MICROBIOL-SGM, V157, P1786, DOI 10.1099/mic.0.044727-0; Mishra NN, 2011, ANTIMICROB AGENTS CH, V55, P4012, DOI 10.1128/AAC.00223-11; Mishra NN, 2009, ANTIMICROB AGENTS CH, V53, P2312, DOI 10.1128/AAC.01682-08; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Murthy MH, 2008, J MED MICROBIOL, V57, P1036, DOI 10.1099/jmm.0.2008/000588-0; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Shafiq I, 2017, INFECT DIS-NOR, V49, P410, DOI 10.1080/23744235.2016.1277587; STRATTON CW, 1987, ANTIMICROB AGENTS CH, V31, P1014, DOI 10.1128/AAC.31.7.1014; Suzuki M, 2006, J APPL MICROBIOL, V101, P938, DOI 10.1111/j.1365-2672.2006.02932.x; Tsukimori A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-459; Yu R, 2012, CAN J INFECT DIS MED, V23, pE48, DOI 10.1155/2012/138470	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245732	10.1371/journal.pone.0245732	http://dx.doi.org/10.1371/journal.pone.0245732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481910	gold, Green Published			2022-12-26	WOS:000612929300018
J	Nichols, JC; Schiffer, CA; Royer, WE				Nichols, Jeffry C.; Schiffer, Celia A.; Royer, William E., Jr.			NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COREPRESSOR CTBP; CELLULAR PHOSPHOPROTEIN; NEGATIVE MODULATION; DROSOPHILA CTBP; ADENOVIRUS E1A; CANCER; EXPRESSION; REPRESSOR; ACTIVATION; INHIBITOR	C-terminal binding proteins (CtBPs) are cotranscriptional factors that play key roles in cell fate. We have previously shown that NAD(H) promotes the assembly of similar tetramers from either human CtBP1 and CtBP2 and that CtBP2 tetramer destabilizing mutants are defective for oncogenic activity. To assist structure-based design efforts for compounds that disrupt CtBP tetramerization, it is essential to understand how NAD(H) triggers tetramer assembly. Here, we investigate the moieties within NAD(H) that are responsible for triggering tetramer formation. Using multiangle light scattering (MALS), we show that ADP is able to promote tetramer formation of both CtBP1 and CtBP2, whereas AMP promotes tetramer assembly of CtBP1, but not CtBP2. Other NAD(H) moieties that lack the adenosine phosphate, including adenosine and those incorporating nicotinamide, all fail to promote tetramer assembly. Our crystal structures of CtBP1 with AMP reveal participation of the adenosine phosphate in the tetrameric interface, pinpointing its central role in NAD(H)-linked assembly. CtBP1 and CtBP2 have overlapping but unique roles, suggesting that a detailed understanding of their unique structural properties might have utility in the design of paralog-specific inhibitors. We investigated the different responses to AMP through a series of site-directed mutants at 13 positions. These mutations reveal a central role for a hinge segment, which we term the 120s hinge that connects the substrate with coenzyme-binding domains and influences nucleotide binding and tetramer assembly. Our results provide insight into suitable pockets to explore in structure-based drug design to interfere with cotranscriptional activity of CtBP in cancer.	[Nichols, Jeffry C.; Schiffer, Celia A.; Royer, William E., Jr.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA; [Nichols, Jeffry C.] Worcester State Univ, Chem Dept, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Massachusetts System of Public Higher Education; Worcester State University	Royer, WE (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01655 USA.	William.Royer@umassmed.edu		Schiffer, Celia/0000-0003-2270-6613	National Institutes of Health (NIH) [R01 GM119014, S10 OD012028]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) grant R01 GM119014 to W. E. R. The Rigaku CCD system used for X-ray diffraction data collection was obtained through NIH shared instrumentation grant S10 OD012028 to C. A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balasubramanian P, 2003, FEBS LETT, V537, P157, DOI 10.1016/S0014-5793(03)00119-4; Barroilhet L, 2013, ONCOGENE, V32, P3896, DOI 10.1038/onc.2012.380; Bellesis AG, 2018, J BIOL CHEM, V293, P9101, DOI 10.1074/jbc.RA118.002514; Bergman LM, 2006, APOPTOSIS, V11, P879, DOI 10.1007/s10495-006-6651-4; Bhambhani C, 2011, EMBO J, V30, P2031, DOI 10.1038/emboj.2011.100; Bi CL, 2018, BIOCHEM BIOPH RES CO, V495, P1980, DOI 10.1016/j.bbrc.2017.12.018; Birts CN, 2011, BIOL CELL, V103, P1, DOI 10.1042/BC20100067; BOYD JM, 1993, EMBO J, V12, P469, DOI 10.1002/j.1460-2075.1993.tb05679.x; Chawla AT, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-019-0163-x; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chinnadurai G, 2007, INT J BIOCHEM CELL B, V39, P1593, DOI 10.1016/j.biocel.2007.01.025; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Cubillos-Rojas M, 2017, ONCOTARGET, V8, P61824, DOI 10.18632/oncotarget.18699; Dcona MM, 2017, CANCER BIOL THER, V18, P379, DOI 10.1080/15384047.2017.1323586; Deng H, 2013, J INVEST DERMATOL, V133, P1294, DOI 10.1038/jid.2012.487; Deng Y, 2012, MOL CARCINOGEN, V51, P500, DOI 10.1002/mc.20813; Di LJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2438; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang M, 2006, EMBO J, V25, P2735, DOI 10.1038/sj.emboj.7601153; Grooteclaes M, 2003, P NATL ACAD SCI USA, V100, P4568, DOI 10.1073/pnas.0830998100; Guan CQ, 2013, J CELL BIOCHEM, V114, P1343, DOI 10.1002/jcb.24475; Hilbert BJ, 2015, ACS CHEM BIOL, V10, P1118, DOI 10.1021/cb500820b; Hilbert BJ, 2014, FEBS LETT, V588, P1743, DOI 10.1016/j.febslet.2014.03.026; Hildebrand JD, 2002, MOL CELL BIOL, V22, P5296, DOI 10.1128/MCB.22.15.5296-5307.2002; Jecrois AM, 2021, STRUCTURE, V29, P310, DOI 10.1016/j.str.2020.11.008; Jin W, 2007, BIOCHEM PHARMACOL, V74, P851, DOI 10.1016/j.bcp.2007.06.017; Kumar V, 2002, MOL CELL, V10, P857, DOI 10.1016/S1097-2765(02)00650-0; Kuppuswamy M, 2008, MOL CELL BIOL, V28, P269, DOI 10.1128/MCB.01077-07; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Madison DL, 2013, J BIOL CHEM, V288, P27836, DOI 10.1074/jbc.M113.493569; Mani-Telang P, 2007, FEBS LETT, V581, P5241, DOI 10.1016/j.febslet.2007.10.011; Mannervik M, 2014, EXP CELL RES, V321, P47, DOI 10.1016/j.yexcr.2013.10.010; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Nardini M, 2006, PROTEIN SCI, V15, P1042, DOI 10.1110/ps.062115406; Nibu Y, 1998, SCIENCE, V280, P101, DOI 10.1126/science.280.5360.101; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paliwal Seema, 2012, Genes Cancer, V3, P481, DOI 10.1177/1947601912463695; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Ray SK, 2017, FEBS LETT, V591, P205, DOI 10.1002/1873-3468.12501; SCHAEPER U, 1995, P NATL ACAD SCI USA, V92, P10467, DOI 10.1073/pnas.92.23.10467; Sumner ET, 2017, ONCOGENE, V36, P4810, DOI 10.1038/onc.2017.106; Thio SSC, 2004, NUCLEIC ACIDS RES, V32, P1836, DOI 10.1093/nar/gkh344; Van Holde K. E., 1971, PHYS BIOCH; Wang C, 2019, ONCOTARGETS THER, V12, P5189, DOI 10.2147/OTT.S203479; Wang R, 2012, NEOPLASIA, V14, P905, DOI 10.1593/neo.121192; Zhang YW, 2011, MOL CELL BIOL, V31, P375, DOI 10.1128/MCB.00772-10; Zheng X, 2015, ONCOTARGET, V6, P3752, DOI 10.18632/oncotarget.2915	49	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100351	10.1016/j.jbc.2021.100351	http://dx.doi.org/10.1016/j.jbc.2021.100351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524397	Green Published, gold			2022-12-26	WOS:000672866400325
J	Pinto, PR; Yoshinaga, MY; Del Bianco, V; Bochi, AP; Ferreira, GS; Pinto, IFD; Rodrigues, LG; Nakandakare, ER; Okamoto, MM; Machado, UF; Miyamoto, S; Catanozi, S; Passarelli, M				Pinto, Paula Ramos; Yoshinaga, Marcos Y.; Del Bianco, Vanessa; Bochi, Ana Paula; Ferreira, Guilherme S.; Pinto, Isabella F. D.; Rodrigues, Leticia G.; Nakandakare, Edna R.; Okamoto, Maristela M.; Machado, Ubiratan F.; Miyamoto, Sayuri; Catanozi, Sergio; Passarelli, Marisa			Dietary sodium restriction alters muscle lipidomics that relates to insulin resistance in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-SALT DIET; SKELETAL-MUSCLE; ANGIOTENSIN-II; CHLORIDE RESTRICTION; GLUCOSE-TRANSPORT; GENE-EXPRESSION; FATTY-ACIDS; ACCUMULATION; SENSITIVITY; LIPOPROTEIN	A low-sodium (LS) diet has been shown to reduce blood pressure (BP) and the incidence of cardiovascular diseases. However, severe dietary sodium restriction promotes insulin resistance (IR) and dyslipidemia in animal models and humans. Thus, further clarification of the long-term consequences of LS is needed. Here, we investigated the effects of chronic LS on gastrocnemius gene and protein expression and lipidomics and its association with IR and plasma lipids in LDL receptor knockout mice. Three-month-old male mice were fed a normal sodium diet (NS; 0.5% Na; n = 12-19) or LS (0.06% Na; n = 14-20) over 90 days. Body mass (BM), BP, plasma total cholesterol, triacylglycerol (TG), glucose, hematocrit, and IR were evaluated. LS increased BM (9%), plasma TG (51%), blood glucose (19%), and IR (46%) when compared with the NS. RT-qPCR analysis revealed that genes involved in lipid uptake and oxidation were increased by the LS: Fabp3 (106%), Prkaa1 (46%), and Cpt1 (74%). Genes and proteins (assessed by Western blotting) involved in insulin signaling were not changed by the LS. Similarly, lipid species classically involved in muscle IR, such as diacylglycerols and ceramides detected by ultra-high-performance liquid chromatography coupled to mass spectrometry, were also unchanged by LS. Species of phosphatidylcholines (68%), phosphatidylinositol (90%), and free fatty acids (59%) increased while cardiolipins (41%) and acylcarnitines (9%) decreased in gastrocnemius in response to LS and were associated with glucose disposal rate. Together these results suggest that chronic LS alters glycerophospholipid and fatty acids species in gastrocnemius that may contribute to glucose and lipid homeostasis derangements in mice.	[Pinto, Paula Ramos; Del Bianco, Vanessa; Bochi, Ana Paula; Ferreira, Guilherme S.; Rodrigues, Leticia G.; Nakandakare, Edna R.; Catanozi, Sergio; Passarelli, Marisa] Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Lipides LIM 10, Sao Paulo, Brazil; [Yoshinaga, Marcos Y.; Pinto, Isabella F. D.; Miyamoto, Sayuri] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil; [Okamoto, Maristela M.; Machado, Ubiratan F.] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Sao Paulo, Brazil; [Passarelli, Marisa] Univ Nove Julho, Programa Posgrad Med, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nove de Julho	Passarelli, M (corresponding author), Univ Sao Paulo, Hosp Clin HCFMUSP, Fac Med, Lab Lipides LIM 10, Sao Paulo, Brazil.; Passarelli, M (corresponding author), Univ Nove Julho, Programa Posgrad Med, Sao Paulo, Brazil.	m.passarelli@fm.usp.br	Nakandakare, Edna R/D-6625-2012; Passarelli, Marisa/C-8129-2012; Miyamoto, Sayuri/A-2144-2008; Yoshinaga, Marcos Y/J-4715-2012; Ferreira, Guilherme da Silva/I-6532-2015	Miyamoto, Sayuri/0000-0002-5714-8984; Yoshinaga, Marcos Y/0000-0002-5533-5348; Ferreira, Guilherme da Silva/0000-0001-7125-441X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [15/21072-5, 2016/15603-0, 2013/07937-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the financial support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (grants #15/21072-5 toM. P. and 2016/15603-0 toM. P. and U. F. M. and 2013/07937-8 to S. M.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES)Finance Code 001 to P. R. P. and G. S. F. M. P., U. F. M., and S. M. are recipients of a research award from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil.	Aguer C., 2008, CELL METAB, V7, P45; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Brink M, 2001, ENDOCRINOLOGY, V142, P1489, DOI 10.1210/en.142.4.1489; Catanozi S, 2003, J LIPID RES, V44, P727, DOI 10.1194/jlr.M200330-JLR200; Catanozi S, 2001, ATHEROSCLEROSIS, V158, P81, DOI 10.1016/S0021-9150(01)00415-4; Chaves AB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48059-7; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Coelho MS, 2006, NUTR METAB CARDIOVAS, V16, P148, DOI 10.1016/j.numecd.2005.09.001; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; Csibi A., 2013, AM J PHYSIOL-RENAL, V304, pF505; Daniele G, 2014, DIABETES, V63, P2812, DOI 10.2337/db13-1130; Das S., 2016, TRENDS BIOCHEM SCI, V41, P261; Daum G, 1997, PROG LIPID RES, V36, P103, DOI 10.1016/S0163-7827(97)00006-4; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Diamond-Stanic Maggie K., 2010, Archives of Physiology and Biochemistry, V116, P88, DOI 10.3109/13813451003758703; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Eum JY, 2020, J CHROMATOGR B, V1141, DOI 10.1016/j.jchromb.2020.122022; Fusco FB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177086; Garg R., 2010, PLOS ONE, V5; Goto-Inoue N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03267; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He JA, 1999, JAMA-J AM MED ASSOC, V282, P2027, DOI 10.1001/jama.282.21.2027; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24976-x; Levin MC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1772, DOI 10.1152/ajpendo.00158.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mejia E. M., 2015, CELL METAB, V21, P868; Nagata S., 2017, J ENDOCRINOL, V232, P547; Nakandakare ER, 2008, ATHEROSCLEROSIS, V200, P410, DOI 10.1016/j.atherosclerosis.2007.12.034; Newsom SA, 2016, J APPL PHYSIOL, V120, P1355, DOI 10.1152/japplphysiol.00664.2015; Okamoto MM, 2004, AM J PHYSIOL-REG I, V286, pR779, DOI 10.1152/ajpregu.00396.2003; Paran C. W., 2018, NAT REV MOL CELL BIO, V19, P654; Prada PD, 2000, HYPERTENSION, V35, P424, DOI 10.1161/01.HYP.35.1.424; Prada PO, 2005, J ENDOCRINOL, V185, P429, DOI 10.1677/joe.1.06028; Sabio G, 2010, MOL CELL BIOL, V30, P106, DOI 10.1128/MCB.01162-09; Sanders PW, 2009, AM J PHYSIOL-RENAL, V297, pF237, DOI 10.1152/ajprenal.00027.2009; Shaikh SR, 2014, BIOCHEMISTRY-US, V53, P5589, DOI 10.1021/bi500868g; Shao W., 2010, PEPTIDES, V31, P889; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; STAMLER J, 1991, HYPERTENSION, V17, pI9, DOI 10.1161/01.HYP.17.1_Suppl.I9; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yang Q, 2018, NAT REV MOL CELL BIO, V19, P654, DOI 10.1038/s41580-018-0044-8; Zabielski P, 2014, AM J PHYSIOL-ENDOC M, V306, pE529, DOI 10.1152/ajpendo.00610.2012	51	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100344	10.1016/j.jbc.2021.100344	http://dx.doi.org/10.1016/j.jbc.2021.100344			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524391	Green Published, gold			2022-12-26	WOS:000672866400318
J	Toure, AA; Camara, LM; Magassouba, AS; Doumbouya, A; Camara, G; Camara, AY; Loua, G; Cisse, D; Sylla, M; Berete, AO; Beavogui, AH				Toure, Almamy Amara; Camara, Lansana Mady; Magassouba, Aboubacar Sidiki; Doumbouya, Abdoulaye; Camara, Gnoume; Camara, Alseny Yarie; Loua, Gaspard; Cisse, Diao; Sylla, Mohamed; Berete, Alpha Oumar; Beavogui, Abdoul Habib			Psychosocial impacts of COVID-19 in the Guinean population. An online cross-sectional survey	PLOS ONE			English	Article							STATE WORRY QUESTIONNAIRE; VALIDATION	Guinea, like many other African countries, has been facing an unprecedented COVID-19 outbreak, since March 2020. In April 2020, Guinean National agency for health security recorded 1351 confirmed cases of COVID-19, including 313 recoveries and 07 deaths. To address this health crisis, some drastic measures were implemented to prevent the spread of COVID-19. Those measures might potentially cause some psychological problems among Guineans. Thus, we conducted this study to assess the psychosocial impacts of COVID-19 in the Guinean population. We carried out an online cross-sectional survey among internet users in Guinea. A free e-survey platform was used, and questionnaires were sent to internet users. The study ran from May 1 through May 10 2020. Participation in the study was voluntary. Data collection was based on sociodemographic information and self-reported questionnaires: Impact of Event Scale-Revised (IES-R) for stress evaluation, Penn state worry questionnaire (PSWQ), and an adapted Social Psychological Measurements of COVID-19. A total of 280 participants took part in the study; responses from 5 participants were deleted because of incompleteness. The average age of participants was 28.9 [95% CI: 28.1;29.6]. Most of participants were male 65.5% [95% CI: 59.5%;71.1%]. Unemployed participants stood for 48.7% [95% CI: 42.7%;54.8%]. IES-R scale for stress evaluation yielded the following findings: 19.6% (mild), 5.23% (moderate) and 9.15% (severe); 82.8% and 17.2% of participants had respectively reported low and moderate worry. No significant statistical association was found between sociodemographic variables and traumatic events (IES-R and PSWQ). However, 82% of our participants had to cope with the negative impacts of COVID-19. Although there were few cases of traumatic events, negative impacts of COVID-19 on study participants deserve to be underlined. So, further investigations are necessary to identify and disentangle specific psychosocial problems in different Guinean socio-cultural contexts.	[Toure, Almamy Amara; Doumbouya, Abdoulaye; Camara, Alseny Yarie; Sylla, Mohamed; Berete, Alpha Oumar; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Toure, Almamy Amara; Camara, Lansana Mady] Univ Koffi Annan Guinee, Conakry, Guinea; [Magassouba, Aboubacar Sidiki; Camara, Gnoume; Cisse, Diao] Gamal Abdel Nasser Univ, Fac Hlth Sci & Tech, Dept Publ Hlth, Conakry, Guinea; [Loua, Gaspard] Johns Hopkins Program Int Educ Gynaecol & Obstet, Conakry, Guinea; [Beavogui, Abdoul Habib] Univ Gamal Abdel Nasser Conakry, Fac Sci & Tech Sante, Dept Parasitol Mycol, Conakry, Guinea		Toure, AA (corresponding author), Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea.; Toure, AA (corresponding author), Univ Koffi Annan Guinee, Conakry, Guinea.	almamy@maferinyah.org	TOURE, Almamy Amara/GQP-0176-2022	TOURE, Almamy Amara/0000-0001-8859-5667	Maferinyah training and research centre in rural health	Maferinyah training and research centre in rural health	This study was self-funded and also supported in the form of administrative support from Maferinyah training and research centre in rural health and the Koffi Annan University of Guinea.	[Anonymous], 2019, NAT ELECTRON, V2, P1, DOI 10.1038/s41928-019-0203-8; [Anonymous], 2002, Bull World Health Organ, V80, P983; Batawi S, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1165-2; Behar E, 2003, J BEHAV THER EXP PSY, V34, P25, DOI 10.1016/S0005-7916(03)00004-1; Bitan DT, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113100; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown TA, 2003, BEHAV RES THER, V41, P1411, DOI 10.1016/S0005-7967(03)00059-7; Brunet A, 2003, CAN J PSYCHIAT, V48, P56, DOI 10.1177/070674370304800111; Conway L.G., 2020, SOCIAL PSYCHOL MEASU, DOI [DOI 10.31234/OSF.IO/Z2X9A, 10.31234/osf.io/z2x9aDe]; Guinee AN de SS, 2020, RAPPORT JOURNALIER; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Jehel L, 2005, CAN J PSYCHIAT, V50, P67, DOI 10.1177/070674370505000112; Keita MM, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1280-8; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee SA, 2020, DEATH STUD, DOI [10.1080/07481187.2020.1748481, 10.1080/07481187.2020.1853885]; Liu D, 2020, SSRN ELECT J, V2019; Liu X, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00678-3; McIntyre RS, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113104; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mukhtar S, 2020, INT J SOC PSYCHIATR, V66, P512, DOI 10.1177/0020764020925835; Pakpour A.H., 2020, J CONCURR DISORD, V2, P58, DOI [10.54127/WCIC8036, DOI 10.54127/WCIC8036]; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Satici B, 2021, INT J MENT HEALTH AD, V19, P1980, DOI 10.1007/s11469-020-00294-0; Sterling M, 2008, AUST J PHYSIOTHER, V54, P78, DOI 10.1016/S0004-9514(08)70074-6; Varshney M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233874; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang J, 2020, YONSEI MED J, V61, P438, DOI 10.3349/ymj.2020.61.5.438; WHO, 2020, DIS CONS COVID 19 OU; Xie XY, 2020, JAMA PEDIATR, V174, P898, DOI 10.1001/jamapediatrics.2020.1619	29	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245751	10.1371/journal.pone.0245751	http://dx.doi.org/10.1371/journal.pone.0245751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529216	gold, Green Published			2022-12-26	WOS:000616736200067
J	Nguyen, NT; Rakow, T; Gardner, B; Dommett, EJ				Ngoc Trai Nguyen; Rakow, Tim; Gardner, Benjamin; Dommett, Eleanor J.			Understanding the relationship between safety beliefs and knowledge for cognitive enhancers in UK university students	PLOS ONE			English	Article							PRESCRIPTION STIMULANTS; ATTITUDES; NEUROENHANCEMENT; METHYLPHENIDATE; MOTIVES; MISUSE; RISK	Background Cognitive enhancers (CE) are prescription drugs taken, either without a prescription or at a dose exceeding that which is prescribed, to improve cognitive functions such as concentration, vigilance or memory. Previous research suggests that users believe the drugs to be safer than non-users and that they have sufficient knowledge to judge safety. However, to date no research has compared the information sources used and safety knowledge of users and non-users. Objectives This study compared users and non-users of CE in terms of i) their sources of knowledge about the safety of CE and ii) the accuracy of their knowledge of possible adverse effects of a typical cognitive enhancer (modafinil); and iii) how the accuracy of knowledge relates to their safety beliefs. Methods Students (N = 148) from King's College London (UK) completed an anonymous online survey assessing safety beliefs, sources of knowledge and knowledge of the safety of modafinil; and indicated whether they used CE, and, if so, which drug(s). Results The belief that the drugs are safe was greater in users than non-users. However, both groups used comparable information sources and have similar, relatively poor drug safety knowledge. Furthermore, despite users more strongly believing in the safety of CE there was no relationship between their beliefs and knowledge, in contrast to non-users who did show correlations between beliefs and knowledge. Conclusion These data suggest that the differences in safety beliefs about CE between users and non-users do not stem from use of different information sources or more accurate safety knowledge.	[Ngoc Trai Nguyen; Rakow, Tim; Gardner, Benjamin; Dommett, Eleanor J.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England	University of London; King's College London	Dommett, EJ (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England.	Eleanor.dommett@kcl.ac.uk		Dommett, Eleanor/0000-0002-6973-8762; Gardner, Benjamin/0000-0003-1223-5934				Adamopoulos P, 2020, J PSYCHOACTIVE DRUGS, V52, P248, DOI 10.1080/02791072.2020.1742949; Banjo OC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014322; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; BORGIDA E, 1977, J APPL SOC PSYCHOL, V7, P258, DOI 10.1111/j.1559-1816.1977.tb00750.x; Bright George M, 2008, Medscape J Med, V10, P111; Cadwalla C., 2018, GUARDIAN; Castaldi S, 2012, J ADDICT MED, V6, P112, DOI 10.1097/ADM.0b013e3182479584; Champagne J, 2019, TRENDS NEUROSCI EDUC, V14, P33, DOI 10.1016/j.tine.2019.02.001; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Eickenhorst P, 2012, J PSYCHOACTIVE DRUGS, V44, P418, DOI 10.1080/02791072.2012.736845; Fagerlin A, 2005, MED DECIS MAKING, V25, P398, DOI 10.1177/0272989X05278931; FESTINGER L, 1962, SCI AM, V207, P93, DOI 10.1038/scientificamerican1062-93; Finger G, 2013, REV ASSOC MED BRAS, V59, P285, DOI 10.1016/j.ramb.2012.10.007; Forlini C, 2009, NEUROETHICS-NETH, V2, P163, DOI 10.1007/s12152-009-9043-y; Forlini Cynthia., 2012, AJOB PRIMARY RES, V3, P33, DOI [DOI 10.1080/21507716.2011.645116, 10.1080/21507716.2011.645116]; Franke AG, 2011, PHARMACOPSYCHIATRY, V44, P60, DOI 10.1055/s-0030-1268417; Franke AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040047; Gamma A, 2005, DRUG ALCOHOL DEPEN, V77, P185, DOI 10.1016/j.drugalcdep.2004.08.014; Giles J, 2005, NATURE, V436, P1076, DOI 10.1038/4361076b; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Heard CL, 2018, MED DECIS MAKING, V38, P646, DOI 10.1177/0272989X18785356; Hildt E., 2013, COGNITIVE ENHANCEMEN; Holloway K, 2012, DRUG-EDUC PREV POLIC, V19, P137, DOI 10.3109/09687637.2011.594114; Ilieva I, 2013, NEUROPHARMACOLOGY, V64, P496, DOI 10.1016/j.neuropharm.2012.07.021; Jenni KE, 1997, J RISK UNCERTAINTY, V14, P235, DOI 10.1023/A:1007740225484; Knapton S, 2015, TELEGRAPH; Kuh G.D., 2001, NATL SURVEY STUDENT; KUNDA Z, 1990, PSYCHOL BULL, V108, P480, DOI 10.1037/0033-2909.108.3.480; Lenk C, 2014, THER CLIN RISK MANAG, V10, P537, DOI 10.2147/TCRM.S40232; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Marsh S., 2017, GUARDIAN; McCabe SE, 2005, ADDICTION, V100, P96, DOI 10.1111/j.1360-0443.2005.00944.x; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Owston R, 2011, LECT CAPTURE LARGE U; Partridge B, 2013, DRUG ALCOHOL REV, V32, P295, DOI 10.1111/dar.12005; Ram S, 2017, SUBST USE MISUSE, V52, P1387, DOI 10.1080/10826084.2017.1281313; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sahakian BJ, 2015, LANCET PSYCHIAT, V2, P357, DOI 10.1016/S2215-0366(15)00004-8; Santoni de Sio F, 2016, MOVING RESPONSIBILIT, DOI [10.1007/s11948-015-9715-4, DOI 10.1007/S11948-015-9715-4]; Sattler S, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-8; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071452; Sattler S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068821; Sattler S, 2013, SUBST USE MISUSE, V48, P220, DOI 10.3109/10826084.2012.751426; Schelle KJ, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00010; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Singh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105969; Smith ME, 2011, PSYCHOL BULL, V137, P717, DOI 10.1037/a0023825; Sweeney S, 2010, SOCIAL WORK STUDENT, P48; Wertz JM, 2001, EXP CLIN PSYCHOPHARM, V9, P3, DOI 10.1037//1064-1297.9.1.3; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1	53	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0244865	10.1371/journal.pone.0244865	http://dx.doi.org/10.1371/journal.pone.0244865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33508011	Green Submitted, gold, Green Published			2022-12-26	WOS:000635021400023
J	Ogawa, K; Pak, K; Yamamoto-Hanada, K; Ishitsuka, K; Sasaki, H; Mezawa, H; Saito-Abe, M; Sato, M; Yang, LM; Nishizato, M; Konishi, M; Sago, H; Ohya, Y				Ogawa, Kohei; Pak, Kyongsun; Yamamoto-Hanada, Kiwako; Ishitsuka, Kazue; Sasaki, Hatoko; Mezawa, Hidetoshi; Saito-Abe, Mayako; Sato, Miori; Yang, Limin; Nishizato, Minaho; Konishi, Mizuho; Sago, Haruhiko; Ohya, Yukihiro		Japan Environm Childrens Study JEC	Association between maternal vegetable intake during pregnancy and allergy in offspring: Japan Environment and Children's Study	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; FOLLOW-UP SURVEY; RESPIRATORY SYMPTOMS; MEDITERRANEAN DIET; CHILDHOOD ASTHMA; FOOD-CONSUMPTION; COHORT-I; RISK; PREVALENCE; ECZEMA	The association between maternal diet during pregnancy and allergy in offspring remains contentious. Here, we examined the association between maternal intake of vegetables and related nutrients during pregnancy and allergic diseases in offspring at one year of age. A cohort of 80,270 pregnant women enrolled in the Japan Environment and Children's Study were asked to respond to a food frequency questionnaire during pregnancy and the International Study of Asthma and Allergies in Childhood questionnaire at one year postpartum. The women were categorized into quintiles according to the energy-adjusted maternal intake of vegetables and related nutrients. Using the categorizations as exposure variables, the adjusted odds ratios (aORs) with 95% confidence intervals (CIs) were determined for the allergic outcomes, including asthma, wheeze, atopic dermatitis, eczema, and food allergy, in the offspring per quintile at one year of age. Of the 80,270 participants, 2,027 (2.5%), 15,617 (19.6%), 3,477 (4.3%), 14,929 (18.7%), 13,801 (17.2%), and 25,028 (31.3%) children experienced asthma, wheeze, atopic dermatitis, eczema, food allergy, and some form of allergic disease, respectively. The aORs of each quintile of maternal vegetable intake for all allergic outcomes were close to 1.0 compared to the lowest quintile. The lowest aOR was found in the association of maternal cruciferous vegetable intake with asthma (aOR: 0.82, 95% CI: 0.70-0.96) and highest was found in the association of maternal total vegetable intake with atopic dermatitis (aOR: 1.17, 95% CI: 1.04-1.31). The risk of allergic outcomes for the various nutrients related to vegetable consumption was close to 1.0. The maternal intake of vegetables and various related nutrients during pregnancy had little or no association with any of the allergic outcomes, including asthma, wheezing, atopic dermatitis, eczema, and food allergy, in offspring at one year.	[Ogawa, Kohei; Sago, Haruhiko] Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan; [Ogawa, Kohei] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Ogawa, Kohei; Yamamoto-Hanada, Kiwako; Ishitsuka, Kazue; Sasaki, Hatoko; Mezawa, Hidetoshi; Saito-Abe, Mayako; Sato, Miori; Yang, Limin; Nishizato, Minaho; Konishi, Mizuho; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo, Japan; [Pak, Kyongsun] Natl Ctr Child Hlth & Dev, Ctr Clin Res, Dept Data Management, Div Biostat, Tokyo, Japan; [Yamamoto-Hanada, Kiwako; Saito-Abe, Mayako; Sato, Miori; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan	Ogawa, K (corresponding author), Natl Ctr Child Hlth & Dev, Ctr Maternal Fetal Neonatal & Reprod Med, Tokyo, Japan.; Ogawa, K (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.; Ogawa, K; Ohya, Y (corresponding author), Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo, Japan.; Ohya, Y (corresponding author), Natl Ctr Child Hlth & Dev, Allergy Ctr, Tokyo, Japan.	ogawa-k@ncchd.go.jp; ohya-y@ncchd.go.jp	Yamamoto-Hanada, Kiwako/GQH-6445-2022; Yamamoto-Hanada, Kiwako/AAR-3094-2020	Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620	Ministry of the Environment, Japan	Ministry of the Environment, Japan(Ministry of the Environment, Japan)	The JECS was funded by the Ministry of the Environment, Japan. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the Japanese government.	Abuabara K, 2018, ALLERGY, V73, P696, DOI 10.1111/all.13320; Allan K, 2011, J AM DIET ASSOC, V111, P258, DOI 10.1016/j.jada.2010.10.048; Beckhaus AA, 2015, ALLERGY, V70, P1588, DOI 10.1111/all.12729; Bekkers MBM, 2012, EUR RESPIR J, V39, P1468, DOI 10.1183/09031936.00094511; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Chatzi L, 2008, THORAX, V63, P507, DOI 10.1136/thx.2007.081745; Chatzi L, 2013, BRIT J NUTR, V110, P2058, DOI 10.1017/S0007114513001426; Chu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140443; Devereux G, 2006, NAT REV IMMUNOL, V6, P869, DOI 10.1038/nri1958; Erkkola M, 2012, PEDIAT ALLERG IMM-UK, V23, P186, DOI 10.1111/j.1399-3038.2012.01272.x; Fitzsimon N, 2007, Ir Med J, V100, P27; Fuxench ZCC, 2017, ADV EXP MED BIOL, V1027, P11, DOI 10.1007/978-3-319-64804-0_2; Granell R, 2008, CLIN EXP ALLERGY, V38, P320, DOI 10.1111/j.1365-2222.2007.02902.x; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; Harasym J, 2014, NUTRITION, V30, P511, DOI 10.1016/j.nut.2013.08.019; Ishitsuka K, 2020, MATERN CHILD HLTH J, V24, P389, DOI 10.1007/s10995-019-02835-z; Jenkins MA, 1996, INT J EPIDEMIOL, V25, P609, DOI 10.1093/ije/25.3.609; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Litonjua AA, 2006, AM J CLIN NUTR, V84, P903, DOI 10.1093/ajcn/84.4.903; Magdelijns FJH, 2011, PEDIATRICS, V128, pE135, DOI 10.1542/peds.2010-1690; Martinez FD, 2002, PEDIATRICS, V109, P362; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Ministry of Education Culture S Science & Technology in Japan, 2010, STAND TABL FOOD COMP; Ministry of Health Law, 2015, ETH GUID MED HLTH RE; Miyake Y, 2010, ALLERGY, V65, P758, DOI 10.1111/j.1398-9995.2009.02267.x; Nurmatov U, 2012, ALLERGY, V67, P1041, DOI 10.1111/j.1398-9995.2012.02858.x; Ogawa K, 2018, EUR J CLIN NUTR, V72, P761, DOI 10.1038/s41430-018-0102-5; Oien T, 2010, J EPIDEMIOL COMMUN H, V64, P124, DOI 10.1136/jech.2008.084921; Raanan R, 2015, ENVIRON HEALTH PERSP, V123, P179, DOI 10.1289/ehp.1408235; Saito M, 2018, ALLERGY, V73, P1908, DOI 10.1111/all.13490; Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662; Salameh PR, 2003, EUR RESPIR J, V22, P507, DOI 10.1183/09031936.03.00107403a; Sasaki S, 2003, J EPIDEMIOL, V13, pS115; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Tsugane S, 2003, J EPIDEMIOL, V13, pS51; Varraso R, 2012, CURR ALLERGY ASTHM R, V12, P201, DOI 10.1007/s11882-012-0253-8; Veeranki SP, 2015, EPIDEMIOLOGY, V26, P934, DOI 10.1097/EDE.0000000000000380; Veeranki SP, 2014, AM J EPIDEMIOL, V179, P938, DOI 10.1093/aje/kwu019; Willers SM, 2008, AM J RESP CRIT CARE, V178, P124, DOI 10.1164/rccm.200710-1544OC; Willet W, 1998, NUTR EPIDEMIOLOGY; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Yamamoto-Hanada K, 2020, ENVIRON HEALTH PREV, V25, DOI 10.1186/s12199-020-00864-7; Yamamoto-Hanada K, 2018, J ALLER CL IMM-PRACT, V6, P1421, DOI 10.1016/j.jaip.2017.12.006; Yamamoto-Hanada K, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0157-0; Yokoyama Y, 2016, J EPIDEMIOL, V26, P420, DOI 10.2188/jea.JE20150064; Zhu F, 2018, CRIT REV FOOD SCI, V58, P1260, DOI DOI 10.1080/10408398.2016.1251390	48	3	3	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245782	10.1371/journal.pone.0245782	http://dx.doi.org/10.1371/journal.pone.0245782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507986	gold, Green Published			2022-12-26	WOS:000635021400052
J	Yamazaki, A; Edamura, K; Tomo, Y; Seki, M; Asano, K				Yamazaki, Atsushi; Edamura, Kazuya; Tomo, Yuma; Seki, Mamiko; Asano, Kazushi			Variations in gene expression levels with severity of synovitis in dogs with naturally occurring stifle osteoarthritis	PLOS ONE			English	Article							GROWTH-FACTOR; JOINT; INTERLEUKIN-1-BETA; CYTOKINES; CARTILAGE; STAGE	Osteoarthritis (OA) is one of the major causes of chronic pain in dogs. However, the pathogenesis of OA has not been fully understood in dogs. The objective of this study was to comprehensively investigate the mRNA expression levels of proinflammatory cytokines, inflammatory mediators, nerve growth factor and its receptor, and matrix metalloproteinases in the synovium of dogs with spontaneous OA as well as to elucidate their relationships with the severity of synovitis. Dogs that were diagnosed with stifle OA on the basis of radiographic findings were included, and the degree of synovitis was observed using stifle arthroscopy. The dogs were assigned to two different groups depending on their synovitis scores: the low-grade group (score of 1 or 2; n = 8) and high-grade group (score of 3 to 5; n = 18). The dogs showing no evidence of orthopedic disease were included in the control group (n = 6). Synovial tissue samples were collected from the sites at which synovitis scores were assessed using arthroscopy. Total RNA was extracted from the collected synovial tissue, and cDNA was synthesized. Subsequently, RT-qPCR were performed using canine-specific primer sets for IL1B, IL6, CXCL8, TNF, TGFB1, PTGS2, PTGES, MMP3, MMP13, NGF, NTRK1, and PTGER4. Expression levels of IL1B, IL6, CXCL8, and MMP13 were significantly higher in the high-grade group than in the control group. In addition, expression levels of IL1B, CXCL8, TNF, and PTGS2 were significantly higher in the high-grade group than in the low-grade group. Expression levels of IL1B, IL6, CXCL8, TNF, PTGS2, and PTGER4 showed significant positive correlation with synovitis score. In conclusion, all mRNA expression levels in the synovial membrane varied according to the degree of synovitis in dogs with spontaneous OA. Thus, this study may partially elucidate the pathogenesis of synovitis in dogs with spontaneous OA.	[Yamazaki, Atsushi; Edamura, Kazuya; Tomo, Yuma; Seki, Mamiko; Asano, Kazushi] Nihon Univ, Coll Bioresource & Sci, Dept Vet Med, Lab Vet Surg, Fujisawa, Kanagawa, Japan	Nihon University	Edamura, K (corresponding author), Nihon Univ, Coll Bioresource & Sci, Dept Vet Med, Lab Vet Surg, Fujisawa, Kanagawa, Japan.	edamura.kazuya@nihon-u.ac.jp		Asano, Kazushi/0000-0003-0099-7974; Edamura, Kazuya/0000-0002-2123-0716				Allen PI, 2019, VET SURG, V48, P770, DOI 10.1111/vsu.13212; Bar-Or D, 2015, CURR RHEUMATOL REV, V11, P50, DOI 10.2174/1573397111666150522094131; Bombardier C, 2013, ANN RHEUM DIS, V72, P7; Chen JJ, 2014, ASIAN PAC J TROP MED, V7, P297, DOI 10.1016/S1995-7645(14)60042-0; Cook JL, 2010, OSTEOARTHR CARTILAGE, V18, pS66, DOI 10.1016/j.joca.2010.04.017; Davidson RK, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2013; Enomoto M, 2019, VET REC, V184, DOI 10.1136/vr.104590; Fan HW, 2015, GENET MOL RES, V14, P12872, DOI 10.4238/2015.October.21.7; Fernandes JC, 1998, J RHEUMATOL, V25, P951; Innes J., 1995, In Practice, V17, P102; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; Lascelles BDX, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0413-x; Liu LZ, 2010, CLIN RHEUMATOL, V29, P1185, DOI 10.1007/s10067-010-1522-3; Maccoux LJ, 2007, VET IMMUNOL IMMUNOP, V118, P59, DOI 10.1016/j.vetimm.2007.04.006; Manni L, 2003, CLIN EXP RHEUMATOL, V21, P617; Mathiessen A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1229-9; Ning L, 2011, INT ORTHOP, V35, P831, DOI 10.1007/s00264-010-1045-1; Pelletier JP, 2013, ANN RHEUM DIS, V72, P250, DOI 10.1136/annrheumdis-2012-201710; Rose BJ, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/4895050; Sellam J, 2010, NAT REV RHEUMATOL, V6, P625, DOI 10.1038/nrrheum.2010.159; Shaw KK, 2016, VET MED SCI, V2, P3, DOI 10.1002/vms3.13; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stoppiello LA, 2014, ARTHRITIS RHEUMATOL, V66, P3018, DOI 10.1002/art.38778; Tu ML, 2019, BONE RES, V7, DOI 10.1038/s41413-019-0071-x; Wang CT, 2006, OSTEOARTHR CARTILAGE, V14, P1237, DOI 10.1016/j.joca.2006.05.009; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459; WOLFE GC, 1993, ARTHRITIS RHEUM-US, V36, P1540, DOI 10.1002/art.1780361108	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246188	10.1371/journal.pone.0246188	http://dx.doi.org/10.1371/journal.pone.0246188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507995	Green Published, gold			2022-12-26	WOS:000635021400103
J	Chambergo-Michilot, D; Rebatta-Acuna, A; Delgado-Flores, CJ; Toro-Huamanchumo, CJ				Chambergo-Michilot, Diego; Rebatta-Acuna, Alexis; Delgado-Flores, Carolina J.; Toro-Huamanchumo, Carlos J.			Socioeconomic determinants of hypertension and prehypertension in Peru: Evidence from the Peruvian Demographic and Health Survey	PLOS ONE			English	Article							OLDER-ADULTS; URBAN; PREVALENCE; RISK	Background Peru is a Latin American country with a significant burden of hypertension that presents worrying rates of disparities in socioeconomic determinants. However, there is a lack of studies exploring the association between those determinants, hypertension and prehypertension in Peruvian population. Objective We aimed to assess the association betwgeen socioeconomic determinants, hypertension and prehypertension using a nationally representative survey of Peruvians. Methods We performed a cross-sectional analysis of the Peruvian Demographic and Health Survey (2018), which is a two-staged regional-level representative survey. We used data from 33,336 people aged 15 and older. The dependent variable was blood pressure classification (normal, prehypertension and hypertension) following the Seventh Report of the Joint National Committee (JNC-7) on hypertension management. Independent variables were socioeconomic: age, sex, marital status, wealth index, health insurance, education, region and area of residence. Due to the nature of the dependent variable (more than two categories), we opted to use the multinomial regression model, adjusting the effect of the multistage sample using the svy command. We tested interactions with the adjusted Wald test. Results The prevalence of prehypertension and hypertension was 33.68% and 19.77%, respectively. Awareness was higher in urban than in rural areas (9.61% vs. 8.31%, p = 0.008). Factors associated with a higher prevalence ratio of both prehypertension and hypertension were age (ratios rose with each age group), male sex (prehypertension aRPR 5.15, 95%CI 4.63-5.73; hypertension aRPR 3.85, 95% CI 3.37-4.40) and abdominal obesity (prehypertension aRPR 2.11, 95%CI 1.92-2.31; hypertension aRPR 3.04, 95% CI 2.69-3.43). Factors with a lower prevalence ratio of both diseases were secondary education (prehypertension aRPR 0.76, 95%CI 0.60-0.95; hypertension aRPR 0.75, 95% CI 0.58-0.97), higher education (prehypertension aRPR 0.78, 95%CI 0.61-0.99; hypertension aRPR 0.62, 95% CI 0.46-0.82), being married/cohabiting (prehypertension aRPR 0.87, 95%CI 0.79-0.95; hypertension aRPR 0.77, 95% CI 0.68-0.87), richest wealth index (only prehypertension aRPR 0.76, 95%CI 0.63-0.92) and living in cities different to Lima (rest of the Coastline, Highlands and Jungle). Having health insurance (only hypertension aRPR 1.26, 95%CI 1.03-1.53) and current drinking (only prehypertension aRPR 1.15, 95%CI 1.01-1.32) became significant factors in rural areas. Conclusions We evidenced socioeconomic disparities among people with hypertension and prehypertension. Better health policies on reducing the burden of risk factors are needed, besides, policy decision makers should focus on hypertension preventive strategies in Peru.	[Chambergo-Michilot, Diego] Univ Cient Sur, Lima, Peru; [Chambergo-Michilot, Diego] Red Latinoamer Cardiol, Lima, Peru; [Rebatta-Acuna, Alexis] Univ Nacl San Luis Gonzaga, Soc Cient Estudiantes Med Ica, Ica, Peru; [Delgado-Flores, Carolina J.] Univ Nacl Jorge Basadre Grohmann, Tacna, Peru; [Toro-Huamanchumo, Carlos J.] Univ Catolica Los Angeles Chimbote, Inst Invest, Chimbote, Peru; [Toro-Huamanchumo, Carlos J.] Clin Avendano, Unidad Invest Multidisciplinaria, Lima, Peru	Universidad Cientifica del Sur (CIENTIFICA); Universidad Nacional San Luis Gonzaga; Universidad Nacional Jorge Basadre Grohmann; Universidad Catolica Los Angeles De Chimbote	Toro-Huamanchumo, CJ (corresponding author), Univ Catolica Los Angeles Chimbote, Inst Invest, Chimbote, Peru.; Toro-Huamanchumo, CJ (corresponding author), Clin Avendano, Unidad Invest Multidisciplinaria, Lima, Peru.	toro2993@hotmail.com	Toro-Huamanchumo, Carlos/E-6693-2017	Toro-Huamanchumo, Carlos/0000-0002-4664-2856; Delgado Flores, Carolina Jaqueline/0000-0001-9291-9652; Chambergo-Michilot, Diego/0000-0002-3904-7514; Rebatta-Acuna, Alexis/0000-0002-5898-4554				Ali N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029364; Bernabe-Ortiz A, 2017, J HUM HYPERTENS, V31, P22, DOI 10.1038/jhh.2015.124; Bernabe-Ortiz A, 2016, J EPIDEMIOL COMMUN H, V70, P49, DOI 10.1136/jech-2015-205988; Bhise MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191948; Bric mag. Roman, 2010, REVIJA SLOVENSKA VOJ, V18, P25; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi YJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56413-y; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Girish N, 2010, Indian J Community Med, V35, P238, DOI 10.4103/0970-0218.66875; Gwatkin DR, 2003, COUNTRY REPORTS HNP; Hernandez-Vasquez A, 2019, REV MED CHILE, V147, P545, DOI 10.4067/S0034-98872019000500545; Hernandez-Vasquez A, 2019, EUR J PREV CARDIOL, V26, P668, DOI 10.1177/2047487318799489; Instituto Nacional de Estadistica e Informatica, 2019, EV POBR MON 2007 201; Instituto Nacional de Estadistica e Informatica, 2019, IND ED DEP 2008 2018; Instituto Nacional de Estadistica e Informatica, 2018, PER ENF NO RANSM TRA; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Lamelas P, 2019, J HYPERTENS, V37, P1813, DOI 10.1097/HJH.0000000000002108; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Li LW, 2016, J AGING HEALTH, V28, P341, DOI 10.1177/0898264315591003; Medina-Lezama J, 2008, REV PANAM SALUD PUBL, V24, P169, DOI 10.1590/S1020-49892008000900003; Ministerio de Salud y Desarrollo Social, 2019, PLAN NAC PREV CONTR; Mishra N, 2018, J OBSTET GYN INDIA, V68, P20, DOI 10.1007/s13224-017-0991-6; Naidu BM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207472; Naranjo-Morales AG, PERUVIAN MIGRATION P; Pereira M, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-114; Piano MR, 2017, ALCOHOL RES-CURR REV, V38, P219; Pourmoghddas Ali, 2019, Acta Biomed, V89, P498, DOI 10.23750/abm.v89i4.5169; Ramezankhani A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215593; Reckelhoff JF, 2018, CURR OPIN NEPHROL HY, V27, P176, DOI 10.1097/MNH.0000000000000404; Rivera-Hernandez M, 2015, J AGING HEALTH, V27, P962, DOI 10.1177/0898264315569457; Rosengren A, 2019, LANCET GLOB HEALTH, V7, pE748, DOI 10.1016/S2214-109X(19)30045-2; Rutstein S.O., 2004, DHS COMP REPORTS; Singh JN, 2020, PHYSL BLOOD PRESSURE; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Tabrizi JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165264; Valladares-Garrido MJ, 2020, DIABETES METAB SYND, V14, P141, DOI 10.1016/j.dsx.2020.02.001; Wolniczak I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186379; Yang LH, 2015, SOC PSYCH PSYCH EPID, V50, P1501, DOI 10.1007/s00127-015-1080-8	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245730	10.1371/journal.pone.0245730	http://dx.doi.org/10.1371/journal.pone.0245730			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA8QK	33497389	Green Published, gold			2022-12-26	WOS:000613707100017
J	Bantle, CM; French, CT; Cummings, JE; Sadasivan, S; Tran, K; Slayden, RA; Smeyne, RJ; Tjalkens, RB				Bantle, Collin M.; French, C. Tenley; Cummings, Jason E.; Sadasivan, Shankar; Tran, Kevin; Slayden, Richard A.; Smeyne, Richard J.; Tjalkens, Ronald B.			Manganese exposure in juvenile C57BL/6 mice increases glial inflammatory responses in the substantia nigra following infection with H1N1 influenza virus	PLOS ONE			English	Article							DEMETHYLASE JMJD3 CONTRIBUTES; HISTONE ACETYLATION; PARKINSONS-DISEASE; INK4A-ARF LOCUS; PROTEIN; ACTIVATION; EXPRESSION; KINASE; TRANSCRIPTION; CELLS	Infection with Influenza A virus can lead to the development of encephalitis and subsequent neurological deficits ranging from headaches to neurodegeneration. Post-encephalitic parkinsonism has been reported in surviving patients of H1N1 infections, but not all cases of encephalitic H1N1 infection present with these neurological symptoms, suggesting that interactions with an environmental neurotoxin could promote more severe neurological damage. The heavy metal, manganese (Mn), is a potential interacting factor with H1N1 because excessive exposure early in life can induce long-lasting effects on neurological function through inflammatory activation of glial cells. In the current study, we used a two-hit model of neurotoxin-pathogen exposure to examine whether exposure to Mn during juvenile development would induce a more severe neuropathological response following infection with H1N1 in adulthood. To test this hypothesis, C57BL/6 mice were exposed to MnCl2 in drinking water (50 mg/kg/day) for 30 days from days 21-51 postnatal, then infected intranasally with H1N1 three weeks later. Analyses of dopaminergic neurons, microglia and astrocytes in basal ganglia indicated that although there was no significant loss of dopaminergic neurons within the substantia nigra pars compacta, there was more pronounced activation of microglia and astrocytes in animals sequentially exposed to Mn and H1N1, as well as altered patterns of histone acetylation. Whole transcriptome Next Generation Sequencing (RNASeq) analysis was performed on the substantia nigra and revealed unique patterns of gene expression in the dual-exposed group, including genes involved in antioxidant activation, mitophagy and neurodegeneration. Taken together, these results suggest that exposure to elevated levels of Mn during juvenile development could sensitize glial cells to more severe neuro-immune responses to influenza infection later in life through persistent epigenetic changes.	[Bantle, Collin M.; French, C. Tenley; Tran, Kevin; Tjalkens, Ronald B.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Cummings, Jason E.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO USA; [Sadasivan, Shankar; Smeyne, Richard J.] Thomas Jefferson Univ, Dept Neurosci, Vickie & Jack Farber Inst Neurosci, Philadelphia, PA USA	Colorado State University; Colorado State University; Jefferson University	Tjalkens, RB (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	ron.tjalkens@colostate.edu	Slayden, Richard/O-8626-2016	Slayden, Richard/0000-0001-6857-7277; Cummings, Jason/0000-0001-6137-9163	National Institutes of Health [ES030937]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	RBT - ES030937 National Institutes of Health nih.gov No role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; [Anonymous], 1852, DAILY SO CROSS 0102, VVII, P3; [Anonymous], 2018, BIG DATA RES, V11, piii, DOI 10.1016/S2214-5796(18)30058-3; [Anonymous], 2019, JUVENILE EXPOSURE MA; [Anonymous], 2016, THE TOTAL AUDIENCE R; Antipova D, 2017, ADV EXP MED BIOL, V1037, P25, DOI 10.1007/978-981-10-6583-5_3; Bantle Collin M., 2019, NATURE PARKINSONS DI; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Barcia C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/357805; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Beal MF, 2010, NATURE, V466, pS8, DOI 10.1038/466S8a; Bonin RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058679; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Butler KM, 2018, BRAIN, V141, P2392, DOI 10.1093/brain/awy171; Caggiu E, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00122; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Civiero L, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00417; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13; Cummings JE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005209; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Delay C, 2014, MOVEMENT DISORD, V29, P1637, DOI 10.1002/mds.25819; Dourmashkin RR, 1997, J ROY SOC MED, V90, P515, DOI 10.1177/014107689709000916; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; ELIZAN TS, 1991, J NEUROL SCI, V105, P131, DOI 10.1016/0022-510X(91)90135-T; ELIZAN TS, 1978, ARCH NEUROL-CHICAGO, V35, P257, DOI 10.1001/archneur.1978.00500290003001; Fan J, 2008, FEBS LETT, V582, P1151, DOI 10.1016/j.febslet.2008.03.003; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Forstner P, 2018, J NEUROTRAUM, V35, P2317, DOI 10.1089/neu.2017.5593; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Guo ZK, 2018, NEUROTOXICOLOGY, V65, P255, DOI 10.1016/j.neuro.2017.11.003; HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997; Harrison IF, 2018, NEUROSCI LETT, V666, P48, DOI 10.1016/j.neulet.2017.12.037; Hecht I, 2018, J IMMUNOL, V200, P2025, DOI 10.4049/jimmunol.1700325; Henry J, 2010, PARKINSONISM RELAT D, V16, P566, DOI 10.1016/j.parkreldis.2010.06.012; Hernandez CC, 2019, BRAIN, V142, P1938, DOI 10.1093/brain/awz123; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jang H, 2012, J NEUROSCI, V32, P1545, DOI 10.1523/JNEUROSCI.5123-11.2012; Jang H, 2009, BBA-MOL BASIS DIS, V1792, P714, DOI 10.1016/j.bbadis.2008.08.001; Kim J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210248; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kirkley KS, 2019, NEUROBIOL DIS, V127, P193, DOI 10.1016/j.nbd.2019.02.020; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kormish JD, 2010, DEV DYNAM, V239, P56, DOI 10.1002/dvdy.22046; Kostuk EW, 2019, GLIA, V67, P1542, DOI 10.1002/glia.23627; Kotake Y, 2007, NEUROTOXICOLOGY, V28, P27, DOI 10.1016/j.neuro.2006.06.002; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kukic I, 2013, BIOCHEM J, V451, P155, DOI 10.1042/BJ20121506; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3; Luo X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28414-w; Mattson MP, 2004, AGEING RES REV, V3, P105, DOI 10.1016/j.arr.2003.08.005; McCarthy MM, 2017, NAT REV NEUROSCI, V18, P471, DOI 10.1038/nrn.2017.61; Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moreno JA, 2008, J NEUROSCI RES, V86, P2028, DOI 10.1002/jnr.21640; Moreno JA, 2011, TOXICOL SCI, V122, P121, DOI 10.1093/toxsci/kfr091; Moreno JA, 2009, TOXICOL SCI, V112, P405, DOI 10.1093/toxsci/kfp221; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Podojil JR, 2018, J IMMUNOL, V200, P2013, DOI 10.4049/jimmunol.1700326; Popichak KA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1349-4; Popichak KA, 2018, MOL PHARMACOL, V94, P1174, DOI 10.1124/mol.118.112631; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Ranger A, 2018, NEUROL-NEUROIMMUNOL, V5, DOI 10.1212/NXI.0000000000000417; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reid AH, 2001, J NEUROPATH EXP NEUR, V60, P663, DOI 10.1093/jnen/60.7.663; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Ronca SE, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00188; Rosensweig C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03503-6; Sadasivan S, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0019-z; Sadasivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124047; Sadasivan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033693; Santiago AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33043-4; Schraivogel D, 2014, TRENDS BIOCHEM SCI, V39, P420, DOI 10.1016/j.tibs.2014.07.004; Schrantz N, 2004, J BIOL CHEM, V279, P1922, DOI 10.1074/jbc.M311145200; Seth P, 2003, BIOMETALS, V16, P359, DOI 10.1023/A:1020682716212; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Streifel KM, 2012, TOXICOL SCI, V126, P183, DOI 10.1093/toxsci/kfr335; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun YW, 2007, CHEM-BIOL INTERACT, V170, P31, DOI 10.1016/j.cbi.2007.06.039; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Takahashi H, 2001, NEUROPATHOLOGY, V21, P315, DOI 10.1046/j.1440-1789.2001.00403.x; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Tjalkens Ronald B, 2017, Adv Neurobiol, V18, P159, DOI 10.1007/978-3-319-60189-2_8; Topol LL, 2009, J BIOL CHEM, V284, P3323, DOI 10.1074/jbc.M808048200; Vignesh KS, 2016, CELL REP, V16, P3232, DOI 10.1016/j.celrep.2016.08.057; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006; Vilarino-Guell C, 2010, NEUROGENETICS, V11, P401, DOI 10.1007/s10048-010-0241-x; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Watanabe K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067234; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wendeln AC, 2018, NATURE, V556, P332, DOI 10.1038/s41586-018-0023-4; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Wu YW, 2011, HUM GENET, V129, P611, DOI 10.1007/s00439-011-0955-3; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoshida K, 2013, SCAND J RHEUMATOL, V42, P276, DOI 10.3109/03009742.2013.765031; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang SR, 2003, ENVIRON RES, V93, P149, DOI 10.1016/S0013-9351(03)00109-9	121	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245171	10.1371/journal.pone.0245171	http://dx.doi.org/10.1371/journal.pone.0245171			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493177	gold, Green Published			2022-12-26	WOS:000613081500025
J	Wilke, ABB; Vasquez, C; Carvajal, A; Ramirez, M; Cardenas, G; Petrie, WD; Beier, JC				Wilke, Andre B. B.; Vasquez, Chalmers; Carvajal, Augusto; Ramirez, Monica; Cardenas, Gabriel; Petrie, William D.; Beier, John C.			Effectiveness of adulticide and larvicide in controlling high densities of Aedes aegypti in urban environments	PLOS ONE			English	Article							ULTRALOW-VOLUME FORMULATION; ZIKA VIRUS; DIPTERA-CULICIDAE; VECTOR; DENGUE; TRANSMISSION; MOSQUITOS; EFFICACY; URBANIZATION; TERRITORIES	Current management and control of Aedes aegypti populations in urban areas are based on the spraying of insecticides. Here, we evaluated the effectiveness of spraying larvicide (Bacillus thuringiensis israelensis) using a truck-mounted Buffalo Turbine and adulticide (Deltamethrin) using a Grizzly ULV Sprayer in an urban area with high densities of Ae. aegypti and many cryptic and difficult to reach aquatic breeding habitats. Experiments were conducted in a tire shop located in Miami-Dade County, Florida with approximately 100,000 used airplane tires. Insecticide interventions were performed after a baseline survey consisting of 3 weeks of collections, followed by two insecticide interventions: (i) application of the adulticide followed by the application of larvicide on the subsequent week; and (ii) application of both adulticide and larvicide on two consecutive weeks. The first insecticide intervention resulted in a non-significant decrease in the relative abundance of Ae. aegypti. On the other hand, the second insecticide intervention significantly reduced the Ae. aegypti relative abundance (P < 0.002). Our results demonstrated that the combined insecticide interventions on two consecutive weeks significantly reduced the relative abundance of Ae. aegypti. This result indicated that the larvicide was successfully propelled reaching cryptical and difficult to reach aquatic habitats. However, even though the number of mosquitoes was greatly reduced, it was still greatly above the 10-mosquito threshold by trap night used by the Miami-Dade Mosquito Control Division to deploy an inspector to survey the area. Considering the lack of new and effective mosquito control tools, efficient and mobile insecticide propellers such as Buffalo Turbine can be of great help to manage mosquito populations in urban areas.	[Wilke, Andre B. B.; Cardenas, Gabriel; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Vasquez, Chalmers; Carvajal, Augusto; Ramirez, Monica; Petrie, William D.] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	Miami-Dade County; CDC grant: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program [1U01CK000510-04]	Miami-Dade County; CDC grant: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program	This research was supported by the Miami-Dade County (http://www.miamidade.gov/global/home.page) and the CDC (https://www.cdc.gov/) grant 1U01CK000510-04: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851; Aldemir A, 2009, J AM MOSQUITO CONTR, V25, P113, DOI 10.2987/08-5836.1; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992; Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150; Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022; Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x; Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013; Clavel J, 2011, FRONT ECOL ENVIRON, V9, P222, DOI 10.1890/080216; Collins John J., 2000, ENCY APOCALYPTICISM, V1, pvii; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Juri MJD, 2013, PARASITOL RES, V112, P1237, DOI 10.1007/s00436-012-3256-4; Darriet F, 2006, J MED ENTOMOL, V43, P1190, DOI 10.1603/0022-2585(2006)43[1190:LEOPAS]2.0.CO;2; Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2; Delannay C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199615; DEMAIO JD, 1981, MOSQ NEWS, V41, P765; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; Fernandes MES, 2016, CHEMOSPHERE, V156, P45, DOI 10.1016/j.chemosphere.2016.04.115; Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x; Harburguer L, 2012, PEST MANAG SCI, V68, P137, DOI 10.1002/ps.2237; Ibanez-Justicia A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2555-0; Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2; Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001; Lucia A, 2009, PARASITOL RES, V104, P1101, DOI 10.1007/s00436-008-1294-8; MAC ARTHUR ROBERT H., 1967; Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; Mundis SJ, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04112-3; Oizumi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157715; Pagel J, 2012, GLOBAL ECOL BIOGEOGR, V21, P293, DOI 10.1111/j.1466-8238.2011.00663.x; PAHO/WHO, ZIK CAS CONG SYNDR A; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369; Reba M, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.34; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Richardson B, 2011, T ASABE, V54, P1245, DOI 10.13031/2013.39020; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; Silver MK, 2017, ENVIRON INT, V106, P248, DOI 10.1016/j.envint.2017.05.015; Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031; TIDWELL MA, 1994, J AM MOSQUITO CONTR, V10, P403; Turrini T, 2015, GLOBAL CHANGE BIOL, V21, P1652, DOI 10.1111/gcb.12825; Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008; WHO, 2013, OUTLOOKS PEST MANAGE, V24, P142; Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7; Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217177; Wilke ABB, 2019, TRENDS PARASITOL, V35, P607, DOI 10.1016/j.pt.2019.05.009; Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688; Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Wilke ABB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69759-5; Williams G. R., 2014, PLOS ONE, V9, P1; Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2; Zannoli S, 2018, CHIKUNGUNYA ZIKA VIR, P193, DOI DOI 10.1016/B978-0-12-811865-8.00006-4	66	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0246046	10.1371/journal.pone.0246046	http://dx.doi.org/10.1371/journal.pone.0246046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493238	Green Published, gold			2022-12-26	WOS:000613081500063
J	Esmaeili-Fard, SM; Gholizadeh, M; Hafezian, SH; Abdollahi-Arpanahi, R				Esmaeili-Fard, Seyed Mehdi; Gholizadeh, Mohsen; Hafezian, Seyed Hasan; Abdollahi-Arpanahi, Rostam			Genome-wide association study and pathway analysis identify NTRK2 as a novel candidate gene for litter size in sheep	PLOS ONE			English	Article							OVULATION RATE; PHOSPHOLIPASE-D; X-CHROMOSOME; BIRTH-WEIGHT; FOLIC-ACID; GROWTH; RECEPTORS; EXPRESSION; OOCYTES; PROTEIN	Litter size is one of the most important economic traits in sheep. Identification of gene variants that are associated with the prolificacy rate is an important step in breeding program success and profitability of the farm. So, to identify genetic mechanisms underlying the variation in litter size in Iranian Baluchi sheep, a two-step genome-wide association study (GWAS) was performed. GWAS was conducted using genotype data from 91 Baluchi sheep. Estimated breeding values (EBVs) for litter size calculated for 3848 ewes and then used as the response variable. Besides, a pathway analysis using GO and KEGG data-bases were applied as a complementary approach. A total of three single nucleotide polymorphisms (SNPs) associated with litter size were identified, one each on OAR2, OAR10, and OAR25. The SNP on OAR2 is located within a novel putative candidate gene, Neurotrophic receptor tyrosine kinase 2. This gene product works as a receptor which is essential for follicular assembly, early follicular growth, and oocyte survival. The SNP on OAR25 is located within RAB4A which is involved in blood vessel formation and proliferation through angiogenesis. The SNP on OAR10 was not associated with any gene in the 1Mb span. Moreover, gene-set analysis using the KEGG database identified several pathways, such as Ovarian steroidogenesis, Steroid hormone biosynthesis, Calcium signaling pathway, and Chemokine signaling. Also, pathway analysis using the GO database revealed several functional terms, such as cellular carbohydrate metabolic, biological adhesion, cell adhesion, cell junction, and cell-cell adherens junction, among others. This is the first study that reports the NTRK2 gene affecting litter size in sheep and our study of this gene functions showed that this gene could be a good candidate for further analysis.	[Esmaeili-Fard, Seyed Mehdi; Gholizadeh, Mohsen; Hafezian, Seyed Hasan] Sari Agr Sci & Nat Resources Univ SANRU, Dept Anim Sci & Fisheries, Sari, Iran; [Abdollahi-Arpanahi, Rostam] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA	Sari Agricultural Sciences & Natural Resources University (SANRU); University System of Georgia; University of Georgia	Esmaeili-Fard, SM (corresponding author), Sari Agr Sci & Nat Resources Univ SANRU, Dept Anim Sci & Fisheries, Sari, Iran.	mehdi.esmaeilifard@gmail.com	Gholizadeh, Mohsen/ABH-1152-2021; Esmaeili-Fard, Seyed Mehdi/AAL-1786-2021	Gholizadeh, Mohsen/0000-0003-4544-1566; Esmaeili-Fard, Seyed Mehdi/0000-0001-7509-5030				Abbasi MA, 2012, SMALL RUMINANT RES, V104, P62, DOI 10.1016/j.smallrumres.2011.10.003; Abdalla EA, 2016, ANIM GENET, V47, P395, DOI 10.1111/age.12438; Abdoli R, 2018, ANIM GENET, V49, P488, DOI 10.1111/age.12700; Abdoli R, 2013, GENE, V524, P296, DOI 10.1016/j.gene.2013.03.133; Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Angst BD, 2001, J CELL SCI, V114, P629; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Banno Y, 2003, BIOCHEM J, V369, P363, DOI 10.1042/BJ20021368; Bindon B M, 1986, Basic Life Sci, V37, P67; Chasman DI, 2008, GENET EPIDEMIOL, V32, P658, DOI 10.1002/gepi.20334; Chen L, 2012, J GENET GENOMICS, V39, P181, DOI 10.1016/j.jgg.2012.03.002; Dadousis C, 2017, J DAIRY SCI, V100, P1223, DOI 10.3168/jds.2016-11587; Davis GH, 2001, BIOL REPROD, V64, P216, DOI 10.1095/biolreprod64.1.216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; Dissen GA, 2009, SEMIN REPROD MED, V27, P24, DOI 10.1055/s-0028-1108007; Dorfman MD, 2014, ENDOCRINOLOGY, V155, P3098, DOI 10.1210/en.2014-1111; Drouilhet L, 2009, ANIM GENET, V40, P804, DOI 10.1111/j.1365-2052.2009.01919.x; Drouilhet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003809; Dundas IS, 2006, NEW ZEAL J AGR RES, V49, P55, DOI 10.1080/00288233.2006.9513693; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fraser HM, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-18; Gao LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148671; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gao YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3636-3; Hernandez DG, 2018, ANIMAL, V12, P915, DOI 10.1017/S1751731117002488; Gholizadeh M, 2014, J GENET, V93, P489, DOI 10.1007/s12041-014-0372-1; Girard CL, 1996, J ANIM SCI, V74, P1711; Gmyrek GB, 2005, EUR J OBSTET GYN R B, V122, P199, DOI 10.1016/j.ejogrb.2005.03.019; Goueli BS, 2012, P NATL ACAD SCI USA, V109, P15787, DOI 10.1073/pnas.1204540109; Han Y, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0454-6; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Harris SE, 2007, REPRODUCTION, V134, P415, DOI 10.1530/REP-07-0061; Hernandez-Montiel W, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030434; Hernandez-Montiel W, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050358; Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001; Jafaroghli M, 2019, IRAN J APPL ANIM SCI, V9, P651; Janssens S, 2004, GENET SEL EVOL, V36, P543, DOI 10.1051/gse:2004016; Jopling HM, 2014, CELLS-BASEL, V3, P363, DOI 10.3390/cells3020363; Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514; Kaler AS, 2020, SCI REP, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Kaler AS, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5992-7; Kang DW, 2014, J BIOL CHEM, V289, P22575, DOI 10.1074/jbc.R114.569822; Kawamura K, 2005, P NATL ACAD SCI USA, V102, P9206, DOI 10.1073/pnas.0502442102; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kerr B, 2009, REPRODUCTION, V138, P131, DOI 10.1530/REP-08-0474; Khodabakhshzadeh R, 2015, ANIM PROD RES, V4; Kirkpatrick BW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129025; Lucock M, 2000, MOL GENET METAB, V71, P121, DOI 10.1006/mgme.2000.3027; Ma L, 2018, ANIM GENET, V49, P483, DOI 10.1111/age.12699; Masuda Y., 2019, INTRO BLUPF90 SUITE; Methot H, 2008, CAN J ANIM SCI, V88, P489, DOI 10.4141/CJAS07086; Metrustry SJ, 2014, TWIN RES HUM GENET, V17, P254, DOI 10.1017/thg.2014.34; Miao XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep25774; Mirshokraei P, 2013, RES VET SCI, V95, P164, DOI 10.1016/j.rvsc.2013.03.009; Misztal I., 2018, MANUAL BLUPF90 FAMIL; Moradband F, 2011, ASIAN AUSTRAL J ANIM, V24, P1179, DOI 10.5713/ajas.2011.10453; Paredes A, 2004, DEV BIOL, V267, P430, DOI 10.1016/j.ydbio.2003.12.001; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pokharel K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4400-4; R Development Core Team, 2019, R DEV COIR TEAM R LA; Richards JS, 2008, TRENDS ENDOCRIN MET, V19, P191, DOI 10.1016/j.tem.2008.03.001; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; Shiboski CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131001; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Spears N, 2003, DEVELOPMENT, V130, P5481, DOI 10.1242/dev.00707; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Szymanski Wieslaw, 2003, Ginekol Pol, V74, P1392; Tahmoorespur M, 2011, SMALL RUMINANT RES, V99, P1, DOI 10.1016/j.smallrumres.2011.01.017; Tang JS, 2019, J PROTEOMICS, V204, DOI 10.1016/j.jprot.2019.103394; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winterhager E, 2015, HUM REPROD UPDATE, V21, P340, DOI 10.1093/humupd/dmv007; XIA Q, 2020, BMC GENET, V21, DOI DOI 10.1186/S12863-019-0803-3; Xu SS, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00118; Yang F, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0577-7; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Yazdi MH, 1999, J ANIM SCI, V77, P533; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zheng WJ, 2012, MOL CELL ENDOCRINOL, V356, P24, DOI 10.1016/j.mce.2011.05.027	83	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244408	10.1371/journal.pone.0244408	http://dx.doi.org/10.1371/journal.pone.0244408			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481819	Green Published, gold			2022-12-26	WOS:000612929300076
J	Khalid, A; Lundqvist, K; Yates, A; Ghzanfar, MA				Khalid, Asra; Lundqvist, Karsten; Yates, Anne; Ghzanfar, Mustansar Ali			Novel online Recommendation algorithm for Massive Open Online Courses (NoR-MOOCs)	PLOS ONE			English	Article								Massive Open Online Courses (MOOCs) have gained in popularity over the last few years. The space of online learning resources has been increasing exponentially and has created a problem of information overload. To overcome this problem, recommender systems that can recommend learning resources to users according to their interests have been proposed. MOOCs contain a huge amount of data with the quantity of data increasing as new learners register. Traditional recommendation techniques suffer from scalability, sparsity and cold start problems resulting in poor quality recommendations. Furthermore, they cannot accommodate the incremental update of the model with the arrival of new data making them unsuitable for MOOCs dynamic environment. From this line of research, we propose a novel online recommender system, namely NoR-MOOCs, that is accurate, scales well with the data and moreover overcomes previously recorded problems with recommender systems. Through extensive experiments conducted over the COCO data-set, we have shown empirically that NoR-MOOCs significantly outperforms traditional KMeans and Collaborative Filtering algorithms in terms of predictive and classification accuracy metrics.	[Khalid, Asra; Lundqvist, Karsten] Victoria Univ Wellington, Sch Engn & Comp Sci, Wellington, New Zealand; [Yates, Anne] Victoria Univ Wellington, Sch Educ, Wellington, New Zealand; [Ghzanfar, Mustansar Ali] Univ East London, Sch Architecture Comp & Engn, Dept Comp Sci, London, England	Victoria University Wellington; Victoria University Wellington; University of East London	Khalid, A (corresponding author), Victoria Univ Wellington, Sch Engn & Comp Sci, Wellington, New Zealand.	khalidasra@myvuw.ac.nz		Yates, Anne/0000-0003-1814-9797; Khalid, Asra/0000-0003-1055-4173; Lundqvist, Karsten/0000-0002-5514-1519				Aher SB, 2013, KNOWL-BASED SYST, V51, P1, DOI 10.1016/j.knosys.2013.04.015; Apaza RG, INT C INF MAN BIG DA, V1318, P42; Berthold M. R., 2016, CLUSTERING TIME SERI, DOI DOI 10.48550/ARXIV.1601.02213; Boratto L, 2019, EFFECT ALGORITHMIC B, P457; BOTTOU L, 1992, NEURAL COMPUT, V4, P888, DOI 10.1162/neco.1992.4.6.888; Dandouh K, 2019, J BIG DATA-GER, V6, DOI 10.1186/s40537-019-0169-4; Downes S., 2008, INNOVATE, V5, P1; Farran B, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS WORKSHOPS: WAINA, VOLS 1 AND 2, P744, DOI 10.1109/WAINA.2009.79; Garg U, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-319-22207-3_1; Ghazanfar MA, 2014, EXPERT SYST APPL, V41, P3261, DOI 10.1016/j.eswa.2013.11.010; Hou Y, IEEE C COMP COMM WOR, P106; Hou Y, 2016, ABS161003147 CORR; Kang Y., 2014, TSINGHUA J ED, V35, P85; Khalid A, 2017, INTELL DATA ANAL, V21, P279, DOI 10.3233/IDA-150316; Kopeinik S, EUR C TECHN ENH LEAR, P124; Legault K, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-77; Li Y, IEEE 2 ADV INF TECHN, P1481; Lundqvist KO, 2019, PROCEEDINGS OF 2019 IEEE LEARNING WITH MOOCS (IEEE LWMOOCS VI 2019), P185; Mi F, 10 INT C ED DAT MIN; Mi F, P 25 INT JOINT C ART, P4018; Obeidat R, 2019 INT C DEEP LEAR, P49; Onah DFO, 9 INT TECHN ED DEV C, P1258; Platt J, 1991, NEURAL COMPUT, V3, P213, DOI 10.1162/neco.1991.3.2.213; Raval UR, 2016, IMPLEMENTING IMPROVI; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Sabnis V, 2018 3 INT C COMP SY, P59; Shah D., 2020, ONLINE DEGREES SLOWD; Symeonidis P, 2019, EXPERT SYST APPL, V118, P261, DOI 10.1016/j.eswa.2018.09.053; Xiao J, 2018, J AMB INTEL HUM COMP, V9, P667, DOI 10.1007/s12652-017-0466-8; Yanhui D, 7 INT C INF TECHN ME, P318; Zahra S, 2015, INFORM SCIENCES, V320, P156, DOI 10.1016/j.ins.2015.03.062; Zhang H, INT S ED TECHN, P106; Zhang H, 2018, MULTIMED TOOLS APPL, V77, P7051, DOI 10.1007/s11042-017-4620-2; Zhang SM, 2018, PROCEEDINGS OF THE FIFTH ANNUAL ACM CONFERENCE ON LEARNING AT SCALE (L@S'18), DOI 10.1145/3231644.3231701	34	3	3	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245485	10.1371/journal.pone.0245485	http://dx.doi.org/10.1371/journal.pone.0245485			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481886	Green Published, gold			2022-12-26	WOS:000612929300137
J	Barklis, E; Alfadhli, A; Kyle, JE; Bramer, LM; Bloodsworth, KJ; Barklis, RL; Leier, HC; Petty, RM; Zelnik, ID; Metz, TO; Futerman, AH; Tafesse, FG				Barklis, Eric; Alfadhli, Ayna; Kyle, Jennifer E.; Bramer, Lisa M.; Bloodsworth, Kent J.; Barklis, Robin Lid; Leier, Hans C.; Petty, R. Max; Zelnik, Iris D.; Metz, Thomas O.; Futerman, Anthony H.; Tafesse, Fikadu G.			Ceramide synthase 2 deletion decreases the infectivity of HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEINS; OMICS ANALYSIS; CELL-LINES; TYPE-1; MEMBRANE; CHOLESTEROL; INHIBITION; CD4; REPLICATION	The lipid composition of HIV-1 virions is enriched in sphingomyelin (SM), but the roles that SM or other sphingolipids (SLs) might play in the HIV-1 replication pathway have not been elucidated. In human cells, SL levels are regulated by ceramide synthase (CerS) enzymes that produce ceramides, which can be converted to SMs, hexosylceramides, and other SLs. In many cell types, CerS2, which catalyzes the synthesis of very long chain ceramides, is the major CerS. We have examined how CerS2 deficiency affects the assembly and infectivity of HIV-1. As expected, we observed that very long chain ceramide, hexosylceramide, and SM were reduced in CerS2 knockout cells. CerS2 deficiency did not affect HIV-1 assembly or the incorporation of the HIV-1 envelope (Env) protein into virus particles, but it reduced the infectivites of viruses produced in the CerS2-deficient cells. The reduced viral infection levels were dependent on HIV-1 Env, since HIV-1 particles that were pseudotyped with the vesicular stomatitis virus glycoprotein did not exhibit reductions in infectivity. Moreover, cell-cell fusion assays demonstrated that the functional defect of HIV-1 Env in CerS2-deficient cells was independent of other viral proteins. Overall, our results indicate that the altered lipid composition of CerS2-deficient cells specifically inhibit the HIV-1 Env receptor binding and/or fusion processes.	[Barklis, Eric; Alfadhli, Ayna; Barklis, Robin Lid; Leier, Hans C.; Petty, R. Max; Tafesse, Fikadu G.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Kyle, Jennifer E.; Bloodsworth, Kent J.; Metz, Thomas O.] Pacific Northwest Natl Lab, Biol Sci Div, Earth & Biol Sci Directorate, Richland, WA 99352 USA; [Bramer, Lisa M.] Natl Secur Directorate PNNL, Comp & Analyt Div, Richland, WA USA; [Zelnik, Iris D.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel	Oregon Health & Science University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Weizmann Institute of Science	Barklis, E; Tafesse, FG (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	barklis@ohsu.edu; tafesse@ohsu.edu	Bramer, Lisa/L-9184-2016; Leier, Hans Christian/CAJ-3082-2022; Leier, Hans Christian/ABI-4923-2020	Bramer, Lisa/0000-0002-8384-1926; Leier, Hans Christian/0000-0002-0363-1444; Tafesse, Fikadu/0000-0002-8575-4164; Metz, Tom/0000-0001-6049-3968	Medial Research Foundation of Oregon; National Institutes of Health (NIH) [R01 AI152579]; Collins Medical Trust; NIH [R21AI133631, 1R01 AI141549]; Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant; NIH, National Institute of Environmental Health Sciences [U2CES030170]; US Department of Energy; Department of Energy [DE-AC05 76RLO 1830]	Medial Research Foundation of Oregon; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collins Medical Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant; NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); US Department of Energy(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE))	E. B. gratefully acknowledges support from the Medial Research Foundation of Oregon and from the National Institutes of Health (NIH; R01 AI152579). F. T. was supported by the Collins Medical Trust and NIH grants R21AI133631 and 1R01 AI141549. E. B. and F. T. also are grateful for an Oregon Health & Sciences University Department of Molecular Microbiology and Immunology seed grant to initiate this work. Additional support was provided by the NIH, National Institute of Environmental Health Sciences grant U2CES030170. The content in this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Lipidomics analyses were performed in the Environmental Molecular Sciences Laboratory, a national scientific user facility sponsored by the US Department of Energy and located at the Pacific Northwest National Laboratory in Richmond, WA. Pacific Northwest National Laboratory is a multiprogram national laboratory operated by Battelle for the Department of Energy under contract DE-AC05 76RLO 1830.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Alfadhli A, 2013, J BIOL CHEM, V288, P666, DOI 10.1074/jbc.M112.399865; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; Barklis E, 2018, VIROLOGY, V518, P264, DOI 10.1016/j.virol.2018.03.004; Bhattacharya J, 2006, J VIROL, V80, P5292, DOI 10.1128/JVI.01469-05; Bowden JA, 2017, J LIPID RES, V58, P2275, DOI 10.1194/jlr.M079012; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brovkovych V, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800370; Brown EL, 2003, VIROLOGY, V310, P343, DOI 10.1016/S0042-6822(03)00165-X; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Brun S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-57; Burnum-Johnson KE, 2017, ANALYST, V142, P442, DOI [10.1039/C6AN02486F, 10.1039/c6an02486f]; Callister SJ, 2006, J PROTEOME RES, V5, P277, DOI 10.1021/pr050300l; Campbell SM, 2002, AIDS, V16, P2253, DOI 10.1097/00002030-200211220-00004; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Chauhan G, 2017, BIOTECHNOL PROGR, V33, P795, DOI 10.1002/btpr.2441; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHEN JK, 1986, EXP CELL RES, V163, P117, DOI 10.1016/0014-4827(86)90563-X; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dautel SE, 2017, SCI REP-UK, V7, DOI 10.1038/srep40555; De Livera AM, 2012, ANAL CHEM, V84, P10768, DOI 10.1021/ac302748b; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eisfeld AJ, 2017, CELL HOST MICROBE, V22, P817, DOI 10.1016/j.chom.2017.10.011; Feng SH, 2019, CHEM SCI, V10, P2253, DOI 10.1039/c8sc03614d; Finnegan CM, 2007, J VIROL, V81, P5294, DOI 10.1128/JVI.02553-06; Finnegan CM, 2004, P NATL ACAD SCI USA, V101, P15452, DOI 10.1073/pnas.0402874101; Frank JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8118; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Harayama T., 2020, ESTABLISHMENT HIGHLY, DOI [10.1101/2020.11.24, DOI 10.1101/2020.11.24]; Hug P, 2000, J VIROL, V74, P6377, DOI 10.1128/JVI.74.14.6377-6385.2000; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001315; Joglekar AV, 2017, HUM GENE THER METHOD, V28, P291, DOI 10.1089/hgtb.2017.084; Johnson MC, 2011, AIDS RES HUM RETROV, V27, P239, DOI 10.1089/AID.2010.0350; JONES TA, 1990, J VIROL, V64, P2265, DOI 10.1128/JVI.64.5.2265-2279.1990; Kim IS, 2017, P NATL ACAD SCI USA, V114, pE28, DOI 10.1073/pnas.1618883114; Kyle JE, 2019, P NATL ACAD SCI USA, V116, P3919, DOI 10.1073/pnas.1815356116; Kyle JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31640-x; Kyle JE, 2017, BIOINFORMATICS, V33, P1744, DOI 10.1093/bioinformatics/btx046; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leier HC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17433-9; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lopez CS, 2014, VIROLOGY, V462, P126, DOI 10.1016/j.virol.2014.05.019; Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256; Lyles D, 2007, FIELDS VIROLOGY, P1364; Ma XC, 2018, ELIFE, V7, DOI 10.7554/eLife.34271; Matzke MM, 2011, BIOINFORMATICS, V27, P2866, DOI 10.1093/bioinformatics/btr479; Mucksch F, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53939-z; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Nieto-Garai JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01983; Noviello CM, 2011, J VIROL, V85, P4730, DOI 10.1128/JVI.00099-11; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Patil A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-3; Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Riley RT, 2019, J LIPID RES, V60, P1183, DOI 10.1194/jlr.S093815; Ritchie C, 2017, CANCER GENOM PROTEOM, V14, P225, DOI 10.21873/cgp.20034; Ritchie C, 2015, J VIROL, V89, P3988, DOI 10.1128/JVI.03584-14; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Salimi H, 2020, J BIOL CHEM, V295, P348, DOI 10.1074/jbc.RA119.009481; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sorensen CM, 2010, CLIN BIOCHEM, V43, P948, DOI 10.1016/j.clinbiochem.2010.04.075; Staubus AO, 2019, VIROLOGY, V538, P1, DOI 10.1016/j.virol.2019.09.008; SULLIVAN N, 1995, J VIROL, V69, P4413, DOI 10.1128/JVI.69.7.4413-4422.1995; Swanstrom R., 1997, P263; t'kindt R, 2015, ANAL CHEM, V87, P4957, DOI 10.1021/acs.analchem.5b00732; Telenga ED, 2014, AM J RESP CRIT CARE, V190, P155, DOI 10.1164/rccm.201312-2210OC; Tidhar R, 2018, J BIOL CHEM, V293, P9912, DOI 10.1074/jbc.RA118.001936; Tisoncik-Go J, 2016, CELL HOST MICROBE, V19, P254, DOI 10.1016/j.chom.2016.01.002; Valsecchi M, 2007, J LIPID RES, V48, P417, DOI 10.1194/jlr.M600344-JLR200; Verlekar D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0964-4; Waheed AA, 2007, P NATL ACAD SCI USA, V104, P8467, DOI 10.1073/pnas.0701443104; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Waheed AA, 2010, J VIROL, V84, P3121, DOI 10.1128/JVI.02002-09; Wang Pei, 2006, Pac Symp Biocomput, P315; Wattenberg BW, 2018, J BIOL CHEM, V293, P9922, DOI 10.1074/jbc.H118.003522; Webb-Robertson BJM, 2011, PROTEOMICS, V11, P4736, DOI 10.1002/pmic.201100078; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	94	4	4	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100340	10.1016/j.jbc.2021.100340	http://dx.doi.org/10.1016/j.jbc.2021.100340			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515546	gold, Green Published			2022-12-26	WOS:000672866400314
J	Chen, K; Gunay-Esiyok, O; Klingeberg, M; Marquardt, S; Pomorski, TG; Gupta, N				Chen, Kai; Gunay-Esiyok, Ozlem; Klingeberg, Melissa; Marquardt, Stephan; Pomorski, Thomas Guenther; Gupta, Nishith			Aminoglycerophospholipid flipping and P4-ATPases in Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASES; PHOSPHOLIPID FLIPPASE; SACCHAROMYCES-CEREVISIAE; PARASITOPHOROUS VACUOLE; PARASITE MITOCHONDRION; PLASMA-MEMBRANE; TRANSPORT; PROTEIN; PHOSPHATIDYLSERINE; BIOGENESIS	Lipid flipping in the membrane bilayers is a widespread eukaryotic phenomenon that is catalyzed by assorted P4-ATPases. Its occurrence, mechanism, and importance in apicomplexan parasites have remained elusive, however. Here we show that Toxoplasma gondii, an obligate intracellular parasite with high clinical relevance, can salvage phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) but not phosphatidylcholine (PtdCho) probes from its milieu. Consistently, the drug analogs of PtdCho are broadly ineffective in the parasite culture. NBD-PtdSer imported to the parasite interior is decarboxylated to NBD-PtdEtn, while the latter is not methylated to yield PtdCho, which confirms the expression of PtdSer decarboxylase but a lack of PtdEtn methyltransferase activity and suggests a role of exogenous lipids in membrane biogenesis of T. gondii. Flow cytometric quantitation of NBD-probes endorsed the selectivity of phospholipid transport and revealed a dependence of the process on energy and protein. Accordingly, our further work identified five P4-ATPases (TgP4-ATPase1-5), all of which harbor the signature residues and motifs required for phospholipid flipping. Of the four proteins expressed during the lytic cycle, TgP4-ATPase1 is present in the apical plasmalemma; TgP4-ATPase3 resides in the Golgi network along with its noncatalytic partner Ligand Effector Module 3 (TgLem3), whereas TgP4-ATPase2 and TgP4-ATPase5 localize in the plasmalemma as well as endo/cytomembranes. Last but not least, auxin-induced degradation of TgP4-ATPase1-3 impaired the parasite growth in human host cells, disclosing their crucial roles during acute infection. In conclusion, we show selective translocation of PtdEtn and PtdSer at the parasite surface and provide the underlying mechanistic and physiological insights in a model eukaryotic pathogen.	[Chen, Kai; Gunay-Esiyok, Ozlem; Klingeberg, Melissa; Marquardt, Stephan; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, Fac Life Sci, Berlin, Germany; [Marquardt, Stephan; Pomorski, Thomas Guenther] Humboldt Univ, Fac Life Sci, Dept Expt Biophys, Berlin, Germany; [Gupta, Nishith] Birla Inst Technol & Sci Pilani BITS P, Dept Biol Sci, Hyderabad, India; [Pomorski, Thomas Guenther] Ruhr Univ, Fac Chem & Biochem, Dept Mol Biochem, Bochum, Germany	Humboldt University of Berlin; Humboldt University of Berlin; Birla Institute of Technology & Science Pilani (BITS Pilani); Ruhr University Bochum	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Fac Life Sci, Berlin, Germany.; Gupta, N (corresponding author), Birla Inst Technol & Sci Pilani BITS P, Dept Biol Sci, Hyderabad, India.	Gupta.Nishith@hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126; Gunay-Esiyok, Ozlem/0000-0003-1245-9030	German Research Foundation (DFG) [GU1100/4-3, GU1100/16]; China Scholarship Council (CSC); DFG via a Heisenberg program [PO 748/9-1]; Open-Access Fund of Humboldt University, Berlin	German Research Foundation (DFG)(German Research Foundation (DFG)); China Scholarship Council (CSC)(China Scholarship Council); DFG via a Heisenberg program(German Research Foundation (DFG)); Open-Access Fund of Humboldt University, Berlin	The work was sponsored by a standard research grant (GU1100/4-3) and a Heisenberg program grant (GU1100/16) awarded to N. G. by the German Research Foundation (DFG). Financial support to K. C. was endowed through the China Scholarship Council (CSC). T. G. P. acknowledges funding by DFG via a Heisenberg program grant (PO 748/9-1). The cost of this publication was defrayed through Open-Access Fund of Humboldt University, Berlin. The funders had no role in the design of this study, data collection and analysis, the decision to publish, or preparation of this manuscript.	Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arroyo-Olarte RD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002288; Bai L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12191-9; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Beitz E, 2000, BIOINFORMATICS, V16, P1050, DOI 10.1093/bioinformatics/16.11.1050; Best JT, 2019, CURR OPIN CELL BIOL, V59, P8, DOI 10.1016/j.ceb.2019.02.004; Bisanz C, 2006, BIOCHEM J, V394, P197, DOI 10.1042/BJ20050609; Bisio H, 2019, NAT MICROBIOL, V4, P420, DOI 10.1038/s41564-018-0339-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blume M, 2009, P NATL ACAD SCI USA, V106, P12998, DOI 10.1073/pnas.0903831106; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Brown K. M., 2018, BIOPROTOC, V8; Brown KM, 2018, CELL HOST MICROBE, V24, P804, DOI 10.1016/j.chom.2018.10.015; Caffaro CE, 2011, EUKARYOT CELL, V10, P1095, DOI 10.1128/EC.00002-11; CARSON MA, 1984, J BIOL CHEM, V259, P6267; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Eissa MM, 2015, EXP PARASITOL, V157, P12, DOI 10.1016/j.exppara.2015.06.005; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Frenal K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15710; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Garcia-Sanchez S, 2014, BIOCHEM J, V459, P83, DOI 10.1042/BJ20131318; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gunay-Esiyok O, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900402; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Hager KM, 1999, J CELL SCI, V112, P2631; Hamai C, 2006, BIOPHYS J, V90, P1241, DOI 10.1529/biophysj.105.069435; Hartmann A, 2014, J BIOL CHEM, V289, P6809, DOI 10.1074/jbc.M113.509406; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Huang BX, 2011, J CELL BIOL, V192, P979, DOI 10.1083/jcb.201005100; Huang YN, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.158581; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Keranen LM, 1997, J BIOL CHEM, V272, P25959, DOI 10.1074/jbc.272.41.25959; Kong PF, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0023-4; Kong PF, 2017, J BIOL CHEM, V292, P7145, DOI 10.1074/jbc.M116.765487; Kuchipudi A, 2016, MICROB CELL, V3, P215, DOI 10.15698/mic2016.05.500; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liang XH, 2020, J BIOL CHEM, V295, P7743, DOI 10.1074/jbc.RA120.013004; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Lyons RE, 2002, TRENDS PARASITOL, V18, P198, DOI 10.1016/S1471-4922(02)02248-1; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Miyoshi N, 2010, ONCOL REP, V23, P505, DOI 10.3892/or_00000662; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Muthusamy BP, 2009, MOL BIOL CELL, V20, P2920, DOI 10.1091/mbc.E08-10-1036; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Nitzsche R, 2017, J BIOL CHEM, V292, P15225, DOI 10.1074/jbc.M117.802702; Nolan SJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006362; Palmgren M, 2019, BBA-BIOMEMBRANES, V1861, P1135, DOI 10.1016/j.bbamem.2019.02.006; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Pernas L, 2018, CELL METAB, V27, P886, DOI 10.1016/j.cmet.2018.02.018; Pittman KJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-806; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Ren BJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01480-5; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Roland BP, 2016, P NATL ACAD SCI USA, V113, pE4460, DOI 10.1073/pnas.1525730113; Sampels V, 2012, J BIOL CHEM, V287, P16289, DOI 10.1074/jbc.M112.347138; Segawa K, 2018, P NATL ACAD SCI USA, V115, P12212, DOI 10.1073/pnas.1814323115; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Shin HW, 2019, FASEB J, V33, P3087, DOI 10.1096/fj.201801873R; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Sinai AP, 1997, J CELL SCI, V110, P2117; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Timcenko M, 2019, NATURE, V571, P366, DOI 10.1038/s41586-019-1344-7; Tomavo S, 2014, INT J PARASITOL, V44, P133, DOI 10.1016/j.ijpara.2013.10.003; Triana MAH, 2018, J EUKARYOT MICROBIOL, V65, P709, DOI 10.1111/jeu.12626; van der Velden LM, 2010, BIOCHEM J, V431, P1, DOI 10.1042/BJ20100644; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Weingartner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012443; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; Yabas M, 2014, J BIOL CHEM, V289, P19531, DOI 10.1074/jbc.C114.570267; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yang LN, 2019, J BIOL CHEM, V294, P8959, DOI 10.1074/jbc.RA118.005491; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986	96	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100315	10.1016/j.jbc.2021.100315	http://dx.doi.org/10.1016/j.jbc.2021.100315			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485966	Green Published, gold			2022-12-26	WOS:000672866400289
J	de Mendonca, EB; Schmaltz, CA; Sant'Anna, FM; Vizzoni, AG; Mendes-de-Almeida, DP; de Oliveira, RDC; Rolla, VC				de Mendonca, Edson Beyker; Schmaltz, Carolina AranaStanis; Sant'Anna, Flavia Marinho; Vizzoni, Alexandre Gomes; Mendes-de-Almeida, Daniela Palheiro; Carvalhaes de Oliveira, Raquel de Vasconcellos; Rolla, Valeria Cavalcanti			Anemia in tuberculosis cases: A biomarker of severity?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; IRON-DEFICIENCY; RISK-FACTORS; HIV; ADULTS; MORTALITY; DEATH	Introduction Anemia is a common condition at tuberculosis diagnosis, and there is evidence that its prevalence is higher in patients with tuberculosis than in those infected with Mycobacterium tuberculosis and healthy controls. Information about anemia during tuberculosis diagnosis is still scarce in the Brazilian population. The aim of this study was to describe the prevalence of anemia in patients with tuberculosis cared for at a referral center and its association with clinical forms of tuberculosis and other characteristics of these patients. Materials and methods This was a retrospective cross-sectional study of tuberculosis patients diagnosed from January 2015 to December 2018 at the Clinical Research Laboratory on Mycobacteria (LAPCLIN-TB) of Evandro Chagas National Institute of Infectious Diseases (INI)/Oswaldo Cruz Foundation (Fiocruz). A database of an ongoing cohort study underway at this service since 2000 provided the baseline information on tuberculosis cases extracted from a visit template. Exploratory and logistic regression analyses were performed to verify associations between anemia and demographic characteristics, socioeconomic status, clinical conditions, and laboratory results. Results Of the 328 cases reviewed, 70 were excluded, with258 retained. The prevalence of anemia was 61.2% (27.5% mild, 27.5% moderate and 6.2% severe). Among patients with anemia, 60.8% had normochromic normocytic anemia, and 27.8% showed hypochromic microcytic anemia. In logistic regression analysis, anemia was associated with a history of weight loss >10%, hospitalizations, coinfection with HIV, increased platelet count and microcytosis. Anemia was more frequent in the most severe clinical forms, such as meningeal and disseminated tuberculosis. Conclusions Anemia was highly prevalent in tuberculosis patients at diagnosis, predominantly as normochromic normocytic anemia and in mild and moderate forms. It was associated with baseline characteristics and conditions indicative of severe disease, suggesting that anemia could be a biomarker of tuberculosis severity.	[de Mendonca, Edson Beyker] Fiocruz MS, Hematol Sect, Clin Anal Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Schmaltz, Carolina AranaStanis; Sant'Anna, Flavia Marinho; Rolla, Valeria Cavalcanti] Fiocruz MS, Clin Res Lab Mycobacteria, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Vizzoni, Alexandre Gomes; Mendes-de-Almeida, Daniela Palheiro] Fiocruz MS, Hemotherapy Sect, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Carvalhaes de Oliveira, Raquel de Vasconcellos] Fiocruz MS, Clin Epidemiol Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	de Mendonca, EB (corresponding author), Fiocruz MS, Hematol Sect, Clin Anal Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil.	edson.beyker@ini.fiocruz.br	Mendonça, Edson Beyker/ABE-1139-2021; Vizzoni, Alexandre Gomes/W-8718-2019; Rolla, Valeria Cavalcanti/AAI-6078-2021; Oliveira, Raquel de V C de/S-7443-2016	Mendonça, Edson Beyker/0000-0003-0486-9603; Vizzoni, Alexandre Gomes/0000-0003-0004-5084; Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Oliveira, Raquel de V C de/0000-0001-9387-8645; Mendes de Almeida, Daniela Palheiro/0000-0002-1936-4774				Abay Feven, 2018, Tuberc Res Treat, V2018, P5740951, DOI 10.1155/2018/5740951; Agrawal Y, 2017, J CLIN DIAGN RES, V11, pBC01, DOI 10.7860/JCDR/2017/23734.9975; Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 2018, CLIN LAB, DOI DOI 10.7754/CLIN.LAB.2017.170824; Bacelo AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140737; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Barzegari Saeed, 2019, Indian J Tuberc, V66, P299, DOI 10.1016/j.ijtb.2019.04.002; Gaiter Z, 2017, INT J MYCOBACT, V6, P162, DOI 10.4103/ijmy.ijmy_31_17; Gil-Santana L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37860-5; Hella J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195985; Holden IK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49439-9; Isanaka S, 2012, J NUTR, V142, P350, DOI 10.3945/jn.111.144287; Kerkhoff AD, 2016, INT J TUBERC LUNG D, V20, P193, DOI 10.5588/ijtld.15.0558; Kirenga BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090614; Kwon YS, 2014, J KOREAN MED SCI, V29, P1226, DOI 10.3346/jkms.2014.29.9.1226; Lee SW, 2006, J KOREAN MED SCI, V21, P1028, DOI 10.3346/jkms.2006.21.6.1028; Minchella PA, 2015, CLIN INFECT DIS, V60, P764, DOI 10.1093/cid/ciu945; Mulenga CM, 2017, J TUBERC RES, V5, P243, DOI [10.4236/jtr.2017.54026, DOI 10.4236/JTR.2017.54026]; Nagu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091229; Oliveira MG, 2014, J BRAS PNEUMOL, V40, P403, DOI 10.1590/S1806-37132014000400008; Orofino RD, 2012, J BRAS PNEUMOL, V38, P88, DOI 10.1590/S1806-37132012000100013; Palmer L, 2015, INT J LAB HEMATOL, V37, P287, DOI 10.1111/ijlh.12327; Romanelli F, 2002, AIDS PATIENT CARE ST, V16, P405, DOI 10.1089/108729102760330245; Saathoff E, 2011, INT J TUBERC LUNG D, V15, P925, DOI 10.5588/ijtld.10.0477; Sahiratmadja E, 2007, BRIT J NUTR, V98, P684, DOI 10.1017/S0007114507742691; Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOL, V50, P19; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127; van Lettow M, 2005, EUR J CLIN NUTR, V59, P526, DOI 10.1038/sj.ejcn.1602116; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; WHO, 2011, WHO TECH REP SER, V959, P1; Woldeamanuel YW, 2014, J NEUROL, V261, P851, DOI 10.1007/s00415-013-7060-6; World Health Organization, 2020, GLOBAL TUBERCULOSIS	34	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245458	10.1371/journal.pone.0245458	http://dx.doi.org/10.1371/journal.pone.0245458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529195	gold, Green Published			2022-12-26	WOS:000616736200022
J	Kimball, E; Schaub, J; Quillen, S; Keuthan, C; Pease, ME; Korneva, A; Quigley, H				Kimball, Elizabeth; Schaub, Julie; Quillen, Sarah; Keuthan, Casey; Pease, Mary Ellen; Korneva, Arina; Quigley, Harry			The role of aquaporin-4 in optic nerve head astrocytes in experimental glaucoma	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; GENE-EXPRESSION; MOUSE MODEL; RAT; BRAIN; CELLS; PROLIFERATION; DYSTROGLYCAN; REACTIVITY; TRANSPORT	Purpose To study aquaporin channel expression in astrocytes of the mouse optic nerve (ON) and the response to IOP elevation in mice lacking aquaporin 4 (AQP4 null). Methods C57BL/6 (B6) and AQP4 null mice were exposed to bead-induced IOP elevation for 3 days (3D-IOP), 1 and 6 weeks. Mouse ocular tissue sections were immunolabeled against aquaporins 1(AQP1), 4(AQP4), and 9(AQP9). Ocular tissue was imaged to identify normal AQP distribution, ON changes, and axon loss after IOP elevation. Ultrastructure examination, cell proliferation, gene expression, and transport block were also analyzed. Results B6 mice had abundant AQP4 expression in Muller cells, astrocytes of retina and myelinated ON (MON), but minimal AQP4in prelaminar and unmyelinated ON (UON). MON of AQP4 nulls had smaller ON area, smaller axon diameter, higher axon density, and larger proportionate axon area than B6 (all p <= 0.05). Bead-injection led to comparable 3D-IOP elevation (p = 0.42) and axonal transport blockade in both strains. In B6, AQP4 distribution was unchanged after 3D-IOP. At baseline, AQP1 and AQP9 were present in retina, but not in UON and this was unaffected after IOP elevation in both strains. In 3D-IOP mice, ON astrocytes and microglia proliferated, more in B6 than AQP4 null. After 6 week IOP elevation, axon loss occurred equally in the two mouse types (24.6%, AQP4 null vs. 23.3%, B6). Conclusion Lack of AQP4 was neither protective nor detrimental to the effects of IOP elevation. The minimal presence of AQP4 in UON may be a vital aspect of the regionally specific phenotype of astrocytes in the mouse optic nerve head.	[Kimball, Elizabeth; Schaub, Julie; Quillen, Sarah; Keuthan, Casey; Pease, Mary Ellen; Korneva, Arina; Quigley, Harry] Johns Hopkins Univ, Wilmer Eye Inst, Glaucoma Ctr Excellence, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Kimball, E (corresponding author), Johns Hopkins Univ, Wilmer Eye Inst, Glaucoma Ctr Excellence, Baltimore, MD 21218 USA.	fcone1@jhmi.edu		Pease, Mary/0000-0002-1368-1234; Keuthan, Casey/0000-0001-9422-490X	National Eye Institute [EY 02120]; Wilmer Eye Institute [EY 0 1765]	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wilmer Eye Institute(Johns Hopkins University)	This work was supported in part by National Eye Institute in the form of PHS research grants awarded to HQ (EY 02120) and Wilmer Eye Institute (EY 0 1765) and by unrestricted support from Saranne and Livingston Kosberg and from William T. Forrester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaratnasingam C, 2014, EXP EYE RES, V121, P11, DOI 10.1016/j.exer.2014.02.008; Binder DK, 2004, J NEUROSCI, V24, P8049, DOI 10.1523/JNEUROSCI.2294-04.2004; Cone-Kimball E, 2013, MOL VIS, V19, P2023; Derouiche A, 2012, NEUROCHEM RES, V37, P2513, DOI 10.1007/s11064-012-0824-z; Dibas A, 2008, MOL VIS, V14, P1770; El-Danaf RN, 2015, J NEUROSCI, V35, P2329, DOI 10.1523/JNEUROSCI.1419-14.2015; Furuyoshi N, 2000, OPHTHALMOLOGICA, V214, P24, DOI 10.1159/000027470; Gondo A, 2014, J BIOL CHEM, V289, P30279, DOI 10.1074/jbc.M114.588384; Haj-Yasein NN, 2011, P NATL ACAD SCI USA, V108, P17815, DOI 10.1073/pnas.1110655108; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Carreras FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128516; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Johnson EC, 2011, INVEST OPHTH VIS SCI, V52, P504, DOI 10.1167/iovs.10-5317; Kalsi AS, 2004, J ANAT, V204, P475, DOI 10.1111/j.0021-8782.2004.00288.x; Karasawa Kaoru, 2011, Vet J, V190, pe72, DOI 10.1016/j.tvjl.2010.12.027; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Ling YTT, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.11.14; Lozano DC, 2019, INVEST OPHTH VIS SCI, V60, P921, DOI 10.1167/iovs.18-25700; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mathieu E, 2018, INVEST OPHTH VIS SCI, V59, P5876, DOI 10.1167/iovs.18-24521; Mathieu E, 2017, INVEST OPHTH VIS SCI, V58, P4784, DOI 10.1167/iovs.17-22290; Mathiisen TM, 2010, GLIA, V58, P1094, DOI 10.1002/glia.20990; Mestre H, 2018, ELIFE, V7, DOI 10.7554/eLife.40070; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nielsen S, 1997, J NEUROSCI, V17, P171; Patil RV, 1997, EXP EYE RES, V64, P203, DOI 10.1006/exer.1996.0196; Peng H, 2008, DEV NEUROBIOL, V68, P559, DOI 10.1002/dneu.20593; Potokar M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071121; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; QUIGLEY HA, 1980, INVEST OPHTH VIS SCI, V19, P137; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quillen S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238104; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Schaub JA, 2017, INVEST OPHTH VIS SCI, V58, P2765, DOI 10.1167/iovs.17-21761; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Smith AJ, 2019, J PHYSIOL-LONDON, V597, P4421, DOI 10.1113/JP277636; Smith AJ, 2017, ELIFE, V6, DOI [10.7554/elife.27679, 10.7554/eLife.27679]; Stamer WD, 2003, INVEST OPHTH VIS SCI, V44, P2803, DOI 10.1167/iovs.03-0001; Sun D, 2017, J EXP MED, V214, P1411, DOI 10.1084/jem.20160412; Sun D, 2013, GLIA, V61, P1218, DOI 10.1002/glia.22507; Suzuki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114694; Tehrani S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167364; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Tenckhoff S, 2005, NEUROREPORT, V16, P53, DOI 10.1097/00001756-200501190-00013; Tezel G, 2005, EXP EYE RES, V81, P207, DOI 10.1016/j.exer.2005.01.022; Tham DKL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165439; Tran TL, 2014, APMIS, V122, P772, DOI 10.1111/apm.12225; TSO MOM, 1975, ARCH OPHTHALMOL-CHIC, V93, P815; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Verkman AS, 2002, J ANAT, V200, P617, DOI 10.1046/j.1469-7580.2002.00058.x; Wang XW, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw3210; Williams PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0091-6; Wostyn P, 2017, BIOMED RES INT, V5, P123; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; 2013, GLJ, V14, P1	64	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0244123	10.1371/journal.pone.0244123	http://dx.doi.org/10.1371/journal.pone.0244123			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529207	Green Published, Green Submitted, gold			2022-12-26	WOS:000616736200032
J	Dou, LL; Sun, YR; Li, SY; Ge, CW; Shen, Q; Li, HZ; Wang, WB; Mao, JY; Xiao, GH; Pang, CY				Dou, Lingling; Sun, Yaru; Li, Shuye; Ge, Changwei; Shen, Qian; Li, Huaizhu; Wang, Wenbo; Mao, Jiayi; Xiao, Guanghui; Pang, Chaoyou			Transcriptomic analyses show that 24-epibrassinolide (EBR) promotes cold tolerance in cotton seedlings	PLOS ONE			English	Article							RNA-SEQ; PLASMA-MEMBRANE; STRESS; ACCUMULATION; EXPRESSION; DROUGHT; PLANTS; L.; BRASSINOSTEROIDS; OVEREXPRESSION	In plants, brassinosteroids (BRs) are a class of steroidal hormones that are involved in numerous physiological responses. However, the function of BRs in cold tolerance in cotton has not been explored. In this study, cotton seedlings were treated with five concentrations (0, 0.05, 0.1, 0.2, 0.5 and 1.0 mg/L) of 24-Epibrassinolide (EBR) at 4 degrees C. We measured the electrolyte leakage, malondialdehyde (MDA) content, proline content, and net photosynthesis rate (Pn) of the seedlings, which showed that EBR treatment increased cold tolerance in cotton in a dose-dependent manner, and that 0.2 mg/L is an optimum concentration for enhancing cold tolerance. The function of EBR in cotton cotyledons was investigated in the control 0 mg/L (Cold+water) and 0.2 mg/L (Cold+EBR) treatments using RNA-Seq. A total of 4,001 differentially expressed genes (DEGs), including 2,591 up-regulated genes and 1,409 down-regulated genes were identified. Gene Ontology (GO) and biochemical pathway enrichment analyses showed that EBR is involved in the genetic information process, secondary metabolism, and also inhibits abscisic acid (ABA) and ethylene (ETH) signal transduction. In this study, physiological experiments showed that EBR can increase cold tolerance in cotton seedlings, and the comprehensive RNA-seq data shed light on the mechanisms through which EBR increases cold tolerance in cotton seedlings.	[Dou, Lingling; Li, Huaizhu; Wang, Wenbo] Xianyang Normal Univ, Sch Chem & Chem Engn, Xianyang, Shaanxi, Peoples R China; [Sun, Yaru] Henan Univ, Sch Life Sci, State Key Lab Crop Stress Adaptat & Improvement, Kaifeng, Henan, Peoples R China; [Li, Shuye; Ge, Changwei; Shen, Qian; Pang, Chaoyou] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China; [Mao, Jiayi; Xiao, Guanghui] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xianyang Normal University; Henan University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shaanxi Normal University	Pang, CY (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.; Xiao, GH (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China.	guanghuix@snnu.edu.cn; chpang@163.com	Li, Huaizhu/AAE-1585-2022; Li, Huaizhu/GWN-4445-2022	Li, Huaizhu/0000-0003-0212-822X; 	Comprehensive Scientific Research fund project of Xianyang Normal University [XSYK20002]; Shaanxi University students Innovation and Entrepreneurship training project [S202010718320]; State Key Laboratory of Cotton Biology Open Fund [CB2019A03, 2019A09]; National Natural Science Foundation of China [31872175]	Comprehensive Scientific Research fund project of Xianyang Normal University; Shaanxi University students Innovation and Entrepreneurship training project; State Key Laboratory of Cotton Biology Open Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the following grants: Comprehensive Scientific Research fund project of Xianyang Normal University (XSYK20002, awarded to LD); Shaanxi University students Innovation and Entrepreneurship training project (S202010718320, awarded to GX); the State Key Laboratory of Cotton Biology Open Fund (CB2019A03 and 2019A09, awarded to LD); and the National Natural Science Foundation of China (31872175, awarded to LD).	Albert A, 2009, OECOLOGIA, V160, P1, DOI 10.1007/s00442-009-1277-1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bibi N, 2014, PLANT GROWTH REGUL, V73, P155, DOI 10.1007/s10725-013-9877-5; Brunakova K, 2017, J BIOTECHNOL, V251, P59, DOI 10.1016/j.jbiotec.2017.04.012; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; Cui F, 2012, PLANT CELL, V24, P233, DOI 10.1105/tpc.111.093062; de Groot GJJB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32692-9; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Divi UK, 2009, NEW BIOTECHNOL, V26, P131, DOI 10.1016/j.nbt.2009.07.006; Dobrikova AG, 2014, PLANT PHYSIOL BIOCH, V80, P75, DOI 10.1016/j.plaphy.2014.03.022; Eremina M, 2016, P NATL ACAD SCI USA, V113, pE5982, DOI 10.1073/pnas.1611477113; Eremina M, 2016, CELL MOL LIFE SCI, V73, P797, DOI 10.1007/s00018-015-2089-6; Feng YN, 2014, PLANT PHYSIOL BIOCH, V75, P138, DOI 10.1016/j.plaphy.2013.11.003; Filova A., 2013, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V61, P623, DOI 10.11118/actaun201361030623; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; George D., 2008, SPSS WINDOWS STEP ST, Veighth; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; Gupta Sanjay Mohan, 2012, Physiology and Molecular Biology of Plants, V18, P377, DOI 10.1007/s12298-012-0133-7; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Huang J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192367; Huang QS, 2012, AQUAT TOXICOL, V120, P54, DOI 10.1016/j.aquatox.2012.04.013; Huang ZA, 2012, J GENET GENOMICS, V39, P149, DOI 10.1016/j.jgg.2012.01.007; Ifuku K, 2004, EMBO REP, V5, P362, DOI 10.1038/sj.embor.7400113; Ito Y, 2012, P JPN ACAD B-PHYS, V88, P31, DOI 10.2183/pjab.88.31; Jiang QH, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S3-S2; Kayum MA, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020084; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; [李保珠 Li Baozhu], 2012, [植物生理学报, Plant Physiology Journal], V48, P11; Li J, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01281; Li JJ, 2014, GENOME RES, V24, P1086, DOI 10.1101/gr.170100.113; Li QF, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194908; Li RW, 2012, FUNCT INTEGR GENOMIC, V12, P35, DOI 10.1007/s10142-011-0259-7; Liu JY, 2018, J APPL PHYCOL, V30, P253, DOI 10.1007/s10811-017-1223-2; Luo HH, 2016, PHOTOSYNTHETICA, V54, P65, DOI 10.1007/s11099-015-0165-7; LYONS JM, 1973, ANNU REV PLANT PHYS, V24, P445, DOI 10.1146/annurev.pp.24.060173.002305; Ma J, 2016, NEW PHYTOL, V212, P282, DOI 10.1111/nph.14014; Ma LF, 2014, MOL BIOL REP, V41, P4369, DOI 10.1007/s11033-014-3308-1; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Montoya T, 2005, PLANT J, V42, P262, DOI 10.1111/j.1365-313X.2005.02376.x; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Pei YK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68943-x; PLATTALOIA KA, 1987, PROTOPLASMA, V136, P71, DOI 10.1007/BF01276356; Pociecha E, 2015, PROCEDIA ENVIRON SCI, V29, P234, DOI 10.1016/j.proenv.2015.07.289; Rivero RM, 2001, PLANT SCI, V160, P315, DOI 10.1016/S0168-9452(00)00395-2; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Su Y, 2017, J PLANT PHYSIOL, V218, P222, DOI 10.1016/j.jplph.2017.07.017; Talaat NB, 2015, ENVIRON EXP BOT, V113, P47, DOI 10.1016/j.envexpbot.2015.01.006; Talkish J, 2016, RNA, V22, P852, DOI 10.1261/rna.055780.115; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Tian X, 2018, P NATL ACAD SCI USA, V115, pE5410, DOI 10.1073/pnas.1805085115; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; Wallaart TE, 2000, PLANTA MED, V66, P57, DOI 10.1055/s-2000-11115; Wang MJ, 2015, NEW PHYTOL, V207, P1181, DOI 10.1111/nph.13429; Wang YanLing, 2006, Journal of Fruit Science, V23, P375; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036940; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang ZE, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00033; Zhang L, 2012, EUR J AGRON, V41, P103, DOI 10.1016/j.eja.2012.04.003; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhao YC, 2013, PLANT PHYSIOL, V163, P555, DOI 10.1104/pp.112.213371	66	3	3	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245070	10.1371/journal.pone.0245070	http://dx.doi.org/10.1371/journal.pone.0245070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524020	Green Published, gold			2022-12-26	WOS:000616578400029
J	Cheng, K; Liu, W; You, JY; Shah, SS; Cai, YQ; Wang, X; Peng, B				Cheng, Ke; Liu, Wei; You, Jiaying; Shah, Shashi; Cai, Yunqiang; Wang, Xin; Peng, Bing			Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching	PLOS ONE			English	Article							LONG-TERM; OUTCOMES; SURGERY; SURVIVAL; IMPACT; TRANSPLANTATION; NATIONWIDE; MORTALITY; CANCER	Currently, safety of laparoscopic pancreaticoduodenectomy (LPD) in patients with liver cirrhosis is unknown. The aim of this study was to explore postoperative morbidity and mortality and long-term outcomes of cirrhotic patients after LPD. The study was a one-center retrospective study comprising 353 patients who underwent LPD between October 2010 and December 2019. A total of 28 patients had liver cirrhosis and were paired with 56 non-cirrhotic counterparts through propensity score matching (PSM). Baseline data, intra-operative data, postoperative data, and survival data were collected. Postoperative morbidity was considered as primary outcome whereas postoperative mortality, surgical parameters (operative durations, intraoperative blood loss), and long-term overall survival were secondary outcomes. Cirrhotic patients showed postoperative complication rates of 82% compared with rates of patients in the control group (48%) (P = 0.003). Further, Clavien-Dindo >= III complication rates of 14% and 11% (P = 0.634), Clavien-Dindo I-II complication rates of 68% and 38% (P = 0.009), hospital mortality of 4% and 2% (P = 0.613) were observed for cirrhotic patients and non-cirrhotic patients, respectively. In addition, an overall survival rate of 32 months and 34.5 months (P = 0.991), intraoperative blood loss of 300 (200-400) ml and 150 (100-250) ml (P<0.0001), drain amount of 2572.5 (1023.8-5275) ml and 1617.5 (907.5-2700) ml (P = 0.048) were observed in the cirrhotic group and control group, respectively. In conclusion, LPD is associated with increased risk of postoperative morbidity in patients with liver cirrhosis. However, the incidence of Clavien-Dindo >= III complications and post-operative mortality showed no significant increase. In addition, liver cirrhosis showed no correlation with poor overall survival in patients who underwent LPD. These findings imply that liver cirrhosis patients can routinely be considered for LPD at high volume centers with rigorous selection and management.	[Cheng, Ke; Liu, Wei; You, Jiaying; Shah, Shashi; Cai, Yunqiang; Wang, Xin; Peng, Bing] Sichuan Univ, West China Hosp, Pancreat Dept, Chengdu, Sichuan, Peoples R China	Sichuan University	Peng, B (corresponding author), Sichuan Univ, West China Hosp, Pancreat Dept, Chengdu, Sichuan, Peoples R China.	drpengbing123@163.com		Cheng, Ke/0000-0002-9272-7615	1.3.5 project for disciplines of excellence clinical Research Incubation Project, West China Hospital, Sichuan University [2018HXFH015]	1.3.5 project for disciplines of excellence clinical Research Incubation Project, West China Hospital, Sichuan University	This work was supported by grants from the 1.3.5 project for disciplines of excellence clinical Research Incubation Project, West China Hospital, Sichuan University (No.2018HXFH015).	Alshahrani AS, 2017, GASTRIC CANCER, V20, P744, DOI 10.1007/s10120-016-0675-4; [Anonymous], 2017, INT J MOL SCI, V18, pE961; Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Befeler AS, 2005, ARCH SURG-CHICAGO, V140, P650, DOI 10.1001/archsurg.140.7.650; Befeler AS, 2005, ARCH SURG-CHICAGO, V140, P5, DOI DOI 10.1001/ARCHSURG.140.7.65016027329.; Benedetto U, 2018, EUR J CARDIO-THORAC, V53, P1112, DOI 10.1093/ejcts/ezy167; Lira RPC, 2020, ARQ BRAS OFTALMOL, V83, pV, DOI 10.5935/0004-2749.20200036; Cheung TT, 2016, ANN SURG, V264, P612, DOI 10.1097/SLA.0000000000001848; Csikesz NG, 2009, J AM COLL SURGEONS, V208, P96, DOI 10.1016/j.jamcollsurg.2008.09.006; Delitto D, 2016, J GASTROINTEST SURG, V20, P1343, DOI 10.1007/s11605-016-3136-9; El Nakeeb A, 2013, WORLD J GASTROENTERO, V19, P7129, DOI 10.3748/wjg.v19.i41.7129; Feng S, 2017, LIVER TRANSPLANT, V23, pS9, DOI 10.1002/lt.24819; Futagawa Y, 2019, J HEPATO-BIL-PAN SCI, V26, P310, DOI 10.1002/jhbp.630; Futagawa Y, 2017, J HEPATO-BIL-PAN SCI, V24, P466, DOI 10.1002/jhbp.482; Goralczyk AD, 2011, TRANSPL INT, V24, P1068, DOI 10.1111/j.1432-2277.2011.01310.x; Hurwitz EE, 2017, ANESTHESIOLOGY, V126, P614, DOI 10.1097/ALN.0000000000001541; Kantor O, 2017, AM J SURG, V213, P512, DOI 10.1016/j.amjsurg.2016.10.030; Kim DJ, 2017, SURG ENDOSC, V31, P3898, DOI 10.1007/s00464-017-5420-5; Liao CH, 2016, WORLD J SURG, V40, P1218, DOI 10.1007/s00268-016-3433-1; Liu MQ, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-019-1624-6; Lopez-Delgado JC, 2016, WORLD J GASTROENTERO, V22, P2657, DOI 10.3748/wjg.v22.i9.2657; Nguyen GC, 2009, DIS COLON RECTUM, V52, P1367, DOI 10.1007/DCR.0b013e3181a80dca; Piano S, 2019, GASTROENTEROLOGY, V156, P1368, DOI 10.1053/j.gastro.2018.12.005; Regimbeau JM, 2015, J SURG ONCOL, V111, P776, DOI 10.1002/jso.23856; SCHWARTZ A, 1981, J LEGAL STUD, V10, P1, DOI 10.1086/467669; Senda Y, 2018, BRIT J SURG, V105, P48, DOI 10.1002/bjs.10727; Sola E, 2016, LIVER INT, V36, P109, DOI 10.1111/liv.13015; Speicher PJ, 2014, ANN SURG ONCOL, V21, P4014, DOI 10.1245/s10434-014-3839-7; Su CH, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-98; Subhas G, 2011, HPB, V13, P149, DOI 10.1111/j.1477-2574.2010.00248.x; Teoule P, 2019, J INVEST SURG, V32, P314, DOI 10.1080/08941939.2017.1420837; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; van Oosten AF, 2019, HPB, V21, P953, DOI 10.1016/j.hpb.2019.02.011; Wang MJ, 2015, SURG ENDOSC, V29, P3783, DOI 10.1007/s00464-015-4154-5; Wang X, 2020, ANN SURG ONCOL, V27, P4562, DOI 10.1245/s10434-020-08533-3; Warnick P, 2011, PANCREATOLOGY, V11, P24, DOI 10.1159/000323961; Xu LC, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0934-5; Yamamoto N, 2015, SURGERY, V158, P1539, DOI 10.1016/j.surg.2015.05.008; Zhou SJ, 2018, INT J SURG, V55, P110, DOI 10.1016/j.ijsu.2018.05.730	39	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246364	10.1371/journal.pone.0246364	http://dx.doi.org/10.1371/journal.pone.0246364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513179	gold, Green Published			2022-12-26	WOS:000613891400050
J	Han, X; Kubota, R; Tanaka, KI; Hayashi, H; Seki, M; Sakai, N; Kawaguchi-Ihara, N; Arakawa, K; Murohashi, I				Han, Xiao; Kubota, Ryo; Tanaka, Ken-Ichi; Hayashi, Hiroyuki; Seki, Miyuki; Sakai, Nobue; Kawaguchi-Ihara, Noriko; Arakawa, Kyoko; Murohashi, Ikuo			The correlation of salivary telomere length and single nucleotide polymorphisms of the ADIPOQ, SIRT1 and FOXO3A genes with lifestyle-related diseases in a Japanese population	PLOS ONE			English	Article							COMMON VARIANTS; ISCHEMIC-STROKE; BLOOD-PRESSURE; ASSOCIATION; HERITABILITY; ADIPONECTIN; LONGEVITY; BIOLOGY; STRESS; IMPACT	Background It has been reported that genetic factors are associated with risk factors and onset of lifestyle-related diseases, but this finding is still the subject of much debate. Objective The aim of the present study was to investigate the correlation of genetic factors, including salivary telomere length and three single nucleotide polymorphisms (SNPs) that may influence lifestyle-related diseases, with lifestyle-related diseases themselves. Methods In one year at a single facility, relative telomere length and SNPs were determined by using monochrome multiplex quantitative polymerase chain reaction and TaqMan SNP Genotyping Assays, respectively, and were compared with lifestyle-related diseases in 120 Japanese individuals near our university. Results In men and all participants, age was inversely correlated with relative telomere length with respective p values of 0.049 and 0.034. In men, the frequency of hypertension was significantly higher in the short relative telomere length group than in the long group with unadjusted p value of 0.039, and the difference in the frequency of hypertension between the two groups was of borderline statistical significance after adjustment for age (p = 0.057). Furthermore, in men and all participants, the sum of the number of affected lifestyle-related diseases, including hypertension, was significantly higher in the short relative telomere length group than in the long group, with p values of 0.004 and 0.029, respectively. For ADIPOQ rs1501299, men's ankle brachial index was higher in the T/T genotype than in the G/G and G/T genotypes, with p values of 0.001 and 0.000, respectively. For SIRT1 rs7895833, men's body mass index and waist circumference and all participants' brachial-ankle pulse wave velocity were higher in the A/G genotype than in the G/G genotype, with respective p values of 0.048, 0.032 and 0.035. For FOXO3A rs2802292, women's body temperature and all participants' saturation of peripheral oxygen were lower in the G/T genotype than in the T/T genotype, with respective p values of 0.039 and 0.032. However, relative telomere length was not associated with physiological or anthropometric measurements except for height in men (p = 0.016). ADIPOQ rs1501299 in men, but not the other two SNPs, was significantly associated with the sum of the number of affected lifestyle-related diseases (p = 0.013), by genotype. For each SNPs, there was no significant difference in the frequency of hypertension or relative telomere length by genotype. Conclusion Relative telomere length and the three types of SNPs determined using saliva have been shown to be differentially associated with onset of and measured risk factors for lifestyle-related diseases consisting mainly of cardiovascular diseases and cancer.	[Han, Xiao; Tanaka, Ken-Ichi; Hayashi, Hiroyuki; Murohashi, Ikuo] Saitama Prefectural Univ, Ctr Univ Wide Educ, Sch Hlth & Social Serv, Koshigaya, Saitama, Japan; [Kubota, Ryo; Sakai, Nobue; Kawaguchi-Ihara, Noriko; Arakawa, Kyoko] Saitama Prefectural Univ, Sch Hlth & Social Serv, Dept Hlth Sci, Koshigaya, Saitama, Japan; [Seki, Miyuki] Saitama Prefectural Univ, Sch Hlth & Social Serv, Dept Nursing, Koshigaya, Saitama, Japan; [Murohashi, Ikuo] Seibu Iruma Hosp, Internal Med, Iruma, Saitama, Japan		Murohashi, I (corresponding author), Saitama Prefectural Univ, Ctr Univ Wide Educ, Sch Hlth & Social Serv, Koshigaya, Saitama, Japan.; Murohashi, I (corresponding author), Seibu Iruma Hosp, Internal Med, Iruma, Saitama, Japan.	murohashi-ikuo@spu.ac.jp			2015 Graduate Student Exchange, Saitama Prefectural University; Saitama Prefectural University	2015 Graduate Student Exchange, Saitama Prefectural University; Saitama Prefectural University	This work was supported by 2015 Graduate Student Exchange (XH) and Grant-in-Aid for Encouragement of Scientists Research Funds (IM), Saitama Prefectural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano H, 2019, CELL METAB, V29, P1274, DOI 10.1016/j.cmet.2019.03.001; Arakawa K, 2018, RINSHO BYORI, V66, P371; Bao Y, 2017, GUT, V66, P1116, DOI 10.1136/gutjnl-2016-312510; Bekaert S, 2005, MECH AGEING DEV, V126, P1115, DOI 10.1016/j.mad.2005.04.007; Beltran-Sanchez H, 2015, P NATL ACAD SCI USA, V112, P8993, DOI 10.1073/pnas.1421942112; Blackburn EH, 2015, SCIENCE, V350, P1193, DOI 10.1126/science.aab3389; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cao WJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020159; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Davy PMC, 2018, J GERONTOL A-BIOL, V73, P1448, DOI 10.1093/gerona/gly071; Fasching CL, 2018, CRIT REV CL LAB SCI, V55, P443, DOI 10.1080/10408363.2018.1504274; FERRANTE A, 1980, CLIN EXP IMMUNOL, V39, P532; Gao X, 2018, EPIGENETICS-US, V13, P846, DOI 10.1080/15592294.2018.1514853; Giampaoli S, 2013, NEW BIOTECHNOL, V30, P475, DOI 10.1016/j.nbt.2012.11.015; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heerspink HJL, 2013, BRIT J CLIN PHARMACO, V76, P536, DOI 10.1111/bcp.12195; Hemminki Kari, 2005, J Carcinog, V4, P2, DOI 10.1186/1477-3163-4-2; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Huang J, 2013, EUR J HUM GENET, V21, P471, DOI 10.1038/ejhg.2012.187; Hui Lester, 2008, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0210s56; Insel KC, 2012, BIOL RES NURS, V14, P124, DOI 10.1177/1099800411406433; Jang Y, 2005, AM J CLIN NUTR, V82, P760, DOI 10.1093/ajcn/82.4.760; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jin X, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000012489, 10.1097/md.0000000000012489]; Kanazawa I, 2008, ENDOCR J, V55, P667, DOI 10.1507/endocrj.K07E-130; Ladd-Acosta Christine, 2015, Curr Environ Health Rep, V2, P117, DOI 10.1007/s40572-015-0051-2; Lee JH, 2014, FRONT GENET, V4, DOI 10.3389/fgene.2013.00310; Lin J, 2019, PSYCHONEUROENDOCRINO, V99, P271, DOI 10.1016/j.psyneuen.2018.10.005; Luu HN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221697; Mirabello L, 2010, HUM MUTAT, V31, P1050, DOI 10.1002/humu.21314; Moon IK, 2007, FRONT BIOSCI, V12, P4595, DOI 10.2741/2412; Morris BJ, 2015, GERONTOLOGY, V61, P515, DOI 10.1159/000375235; Neuner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139308; Osaki R, 2011, EXP THER MED, V2, P783, DOI 10.3892/etm.2011.287; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Ridout KK, 2019, BIOL PSYCHIAT, V86, P725, DOI 10.1016/j.biopsych.2019.04.030; Schurks M, 2013, EUR J NEUROL, V20, P1068, DOI 10.1111/ene.12135; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Sun Q, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02347-3; Takahashi PY, 2004, MAYO CLIN PROC, V79, P416, DOI 10.4065/79.3.416; Tellechea ML, 2017, J HUM HYPERTENS, V31, P99, DOI 10.1038/jhh.2016.45; Wang HS, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00695; Willcox BJ, 2017, J GERONTOL A-BIOL, V72, P724, DOI 10.1093/gerona/glw196; Zhang CA, 2016, AM J EPIDEMIOL, V184, P922, DOI 10.1093/aje/kww102; Zhou YL, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0372-6; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536; Zou YR, 2017, ONCOTARGET, V8, P10836, DOI 10.18632/oncotarget.14793; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0243745	10.1371/journal.pone.0243745	http://dx.doi.org/10.1371/journal.pone.0243745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507936	Green Published, gold			2022-12-26	WOS:000635021400013
J	Skender, K; Singh, V; Stalsby-Lundborg, C; Sharma, M				Skender, Kristina; Singh, Vivek; Stalsby-Lundborg, Cecilia; Sharma, Megha			Trends and patterns of antibiotic prescribing at orthopedic inpatient departments of two private-sector hospitals in Central India: A 10-year observational study	PLOS ONE			English	Article								Background Frequent antibiotic prescribing in departments with high infection risk like orthopedics prominently contributes to the global increase of antibiotic resistance. However, few studies present antibiotic prescribing patterns and trends among orthopedic inpatients. Aim To compare and present the patterns and trends of antibiotic prescription over 10 years for orthopedic inpatients in a teaching (TH) and a non-teaching hospital (NTH) in Central India. Methods Data from orthopedic inpatients (TH-6446; NTH-4397) were collected using a prospective cross-sectional study design. Patterns were compared based on the indications and corresponding antibiotic treatments, mean Defined Daily Doses (DDD)/1000 patient-days, adherence to the National List of Essential Medicines India (NLEMI) and the World Health Organization Model List of Essential Medicines (WHOMLEM). Antibiotic prescriptions were analyzed separately for the operated and the non-operated inpatients. Linear regression was used to analyze the time trends of antibiotic prescribing; in total through DDD/1000 patient-days and by antibiotic groups. Results Third generation cephalosporins were the most prescribed antibiotic class (TH-39%; NTH-65%) and fractures were the most common indications (TH-48%; NTH-48%). Majority of the operated inpatients (TH-99%; NTH-97%) were prescribed pre-operative prophylactic antibiotics. The non-operated inpatients were also prescribed antibiotics (TH-40%; NTH-75%), although few of them had infectious diagnoses (TH-8%; NTH-14%). Adherence to the NLEMI was lower (TH-31%; NTH-34%) than adherence to the WHOMLEM (TH-65%; NTH-62%) in both hospitals. Mean DDD/1000 patient-days was 16 times higher in the TH (2658) compared to the NTH (162). Total antibiotic prescribing increased over 10 years (TH-beta= 3.23; NTH-beta = 1.02). Conclusion Substantial number of inpatients were prescribed antibiotics without clear infectious indications. Adherence to the NLEMI and the WHOMLEM was low in both hospitals. Antibiotic use increased in both hospitals over 10 years and was higher in the TH than in the NTH. The need for developing and implementing local antibiotic prescribing guidelines is emphasized.	[Skender, Kristina; Stalsby-Lundborg, Cecilia; Sharma, Megha] Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy, Stockholm, Sweden; [Singh, Vivek] Ruxmaniben Deepchand Med Coll, Dept Orthoped, Ujjain, Madhya Pradesh, India; [Sharma, Megha] Ruxmaniben Deepchand Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India	Karolinska Institutet	Sharma, M (corresponding author), Karolinska Inst, Dept Global Publ Hlth Hlth Syst & Policy, Stockholm, Sweden.; Sharma, M (corresponding author), Ruxmaniben Deepchand Gardi Med Coll, Dept Pharmacol, Ujjain, Madhya Pradesh, India.	meghasharma27@rediffmail.com	Sharma, Megha/AAJ-1119-2021	Sharma, Megha/0000-0001-9165-9393; Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Skender, Kristina/0000-0003-3511-0202	Swedish Research Council (Vetenskapsradet) [K2007-70X-20514-01-3, K2010-396-70X-20514-04-3, 201701327]; Asia Link [348-2006-6633]; Karolinska Institutet Foundation [2019-01843]; Elisabeth and Alfred Ahlqvist's Foundation 2019 from Apotekarsocieteten, Sweden	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Asia Link; Karolinska Institutet Foundation(Karolinska Institutet); Elisabeth and Alfred Ahlqvist's Foundation 2019 from Apotekarsocieteten, Sweden	The study was funded by the Swedish Research Council (Vetenskapsradet; K2007-70X-20514-01-3, K2010-396-70X-20514-04-3, 201701327) and Asia Link (348-2006-6633). KS is the recipient of scholarships by Karolinska Institutet Foundation 2019-01843 and Elisabeth and Alfred Ahlqvist's Foundation 2019 from Apotekarsocieteten, Sweden. MS is the recipient of Erasmus Mundus Lot-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar FM., 2017, CAMPBELLS OPERATIVE, P3526; Bryson DJ, 2016, BONE JOINT J, V98B, P1014, DOI 10.1302/0301-620X.98B8.37359; Chandy SJ, 2014, J INFECT DEV COUNTR, V8, P1096, DOI 10.3855/jidc.4745; Cohen ME, 2017, J AM COLL SURGEONS, V225, P631, DOI 10.1016/j.jamcollsurg.2017.08.010; Dhammi IK, 2015, INDIAN J ORTHOP, V49, P373, DOI 10.4103/0019-5413.159556; Dixit A, 2019, INDIAN J COMMUN MED, V44, P4, DOI 10.4103/ijcm.IJCM_217_18; Gandra S, 2019, CLIN INFECT DIS, V69, P563, DOI 10.1093/cid/ciy955; Hickson CJ, 2015, BONE JOINT RES, V4, P181, DOI 10.1302/2046-3758.411.2000432; Holloway Kathleen Anne, 2011, Expert Rev Clin Pharmacol, V4, P335, DOI 10.1586/ecp.11.14; Hyndman R. J., 2018, FORECASTING PRINCIPL; Juno AA, 2019, LAT AM J PHARM, V38, P1366; Kim B, 2020, KOREAN J INTERN MED, V35, P703, DOI 10.3904/kjim.2017.332; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Li BY, 2018, J ORTHOP RES, V36, P22, DOI 10.1002/jor.23656; Lundborg CS, 2017, BMJ-BRIT MED J, V358, P42, DOI 10.1136/bmj.j2440; Rodriguez-Merchan E-C, COMPLEX FRACTURES LI; Shallcross LJ, 2014, BRIT J GEN PRACT, V64, P604, DOI 10.3399/bjgp14X682561; Sharma M, PLOS ONE; Sharma M, 2015, INFECT DIS-NOR, V47, P302, DOI 10.3109/00365548.2014.988747; Sharma M, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-155; Solanki N, 2019, ARCH PHARM PRACT, V10, P114; The Core-Committee, 2015, NAT LIST ESS MED 201; Uckay I, 2013, J HOSP INFECT, V84, P5, DOI 10.1016/j.jhin.2012.12.014; World Health Organisation, 2018, WHO REP SURV ANT CON; World Health Organization, 2019, WHO MOD LIST ESS MED; World Health Organization, 2003, INTRO DRUG UTILIZATI; World Health Organization Collaborating Centre for Drug Statistics Methodology, 2020, ATC CLASS IND DDDS	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245902	10.1371/journal.pone.0245902	http://dx.doi.org/10.1371/journal.pone.0245902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503028	Green Published, gold			2022-12-26	WOS:000613751800034
J	Deng, C; Gillette, JC; Derrick, TR				Deng, Chen; Gillette, Jason C.; Derrick, Timothy R.			Measuring femoral neck loads in healthy young and older adults during stair ascent and descent	PLOS ONE			English	Article							BONE-MINERAL DENSITY; HIP FRACTURE; LOWER-LIMB; SKELETAL-MUSCLE; CONTACT FORCES; RISK-FACTORS; WALKING; MORTALITY; COSTS; AGE	Understanding the hip loading environment for daily activities is useful for hip fracture prevention, rehabilitation, and the design of osteogenic exercises. Seventeen older adults (50-70 yrs) and twenty young adults (18-30 yrs) were recruited. A rigid body model combined with a musculoskeletal model was used to estimate lower extremity loading. An elliptical cross-section model of the femoral neck was used to estimate femoral neck stress during stair ascent and descent. Two peaks were identified in the stress curves, corresponding to the peaks in the vertical ground reaction force. During stair ascent, significantly higher tension on the superior femoral neck was found for the young group at peak 1 (young: 13.5 +/- 6.1 MPa, older: 4.2 +/- 6.5 MPa, p<0.001). Also during stair ascent, significantly higher compression on the posterior femoral neck was found for the older group at peak 2 (young: -11.4 +/- 4.9 MPa, old: -18.1 +/- 8.6 MPa, p = 0.006). No significant difference was found for stair descent. Components of stress (muscle vs. reaction forces; axial forces vs. bending moments) were also examined for each trial of stair ascent and descent. The stresses and their components provided loading magnitude and locations of higher stress on the femoral neck during stair ascent and descent. Understanding femoral neck stresses may be used to help prevent hip fractures, reduce pain, improve rehabilitation, and design osteogenic exercises.	[Deng, Chen] Beijing Sport Univ, Sch Sport Sci, Div Sport Biomech, Beijing, Peoples R China; [Gillette, Jason C.; Derrick, Timothy R.] Iowa State Univ, Dept Kinesiol, Ames, IA USA	Beijing Sport University; Iowa State University	Deng, C (corresponding author), Beijing Sport Univ, Sch Sport Sci, Div Sport Biomech, Beijing, Peoples R China.	dengchen@bsu.edu.cn		Deng, Chen/0000-0002-0541-2069; Gillette, Jason/0000-0003-4358-4731	Chinese Universities Scientific Fund [2019QD023]	Chinese Universities Scientific Fund	This work was supported by the Chinese Universities Scientific Fund in the form of a grant (No. 2019QD023) awarded to CD.	Alexander N, 2016, GAIT POSTURE, V45, P137, DOI 10.1016/j.gaitpost.2016.01.022; Anderson DE, 2013, J APPL BIOMECH, V29, P505, DOI 10.1123/jab.29.5.505; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Beck TJ, 2000, J BONE MINER RES, V15, P2297, DOI 10.1359/jbmr.2000.15.12.2297; Bell KL, 1999, J BONE MINER RES, V14, P111, DOI 10.1359/jbmr.1999.14.1.111; BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; BERGMANN G, 1995, J BIOMECH, V28, P817, DOI 10.1016/0021-9290(94)00129-R; BERGMANN G, 1988, J BIOMECH, V21, P169, DOI 10.1016/0021-9290(88)90009-7; BERGMANN G, 1995, J BIOMECH, V28, P535, DOI 10.1016/0021-9290(94)00105-D; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; BROOKS SV, 1994, MED SCI SPORT EXER, V26, P432; Costigan PA, 2002, GAIT POSTURE, V16, P31, DOI 10.1016/S0966-6362(01)00201-6; Deng C, 2018, J APPL BIOMECH, V34, P191, DOI 10.1123/jab.2017-0122; Derrick TR, 2016, J BIOMECH, V49, P429, DOI 10.1016/j.jbiomech.2016.01.003; Dhanwal DK, 2011, INDIAN J ORTHOP, V45, P15, DOI 10.4103/0019-5413.73656; Duday GN, 2005, THEOR ISS ERGON SCI, V6, P287, DOI 10.1080/14639220412331329609; Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Glitsch U, 1997, J BIOMECH, V30, P1123, DOI 10.1016/S0021-9290(97)00089-4; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Hall M, 2015, J ELECTROMYOGR KINES, V25, P298, DOI 10.1016/j.jelekin.2015.01.007; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; Lawrence TM, 2005, INJURY, V36, P88, DOI 10.1016/j.injury.2004.06.015; Nikkel LE, 2012, J BONE JOINT SURG AM, V94A, P9, DOI [10.2106/JBJS.J.01077, 10.2106/JBJS.K.01214]; Novak AC, 2011, GAIT POSTURE, V33, P54, DOI 10.1016/j.gaitpost.2010.09.024; Pesce V, 2009, CLIN CASES MINER BON, V6, P131; Protopapadaki A, 2007, CLIN BIOMECH, V22, P203, DOI 10.1016/j.clinbiomech.2006.09.010; Stansfield BW, 2002, CLIN BIOMECH, V17, P130, DOI 10.1016/S0268-0033(01)00119-X; Stevens JA, 2013, OSTEOPOROSIS INT, V24, P2725, DOI 10.1007/s00198-013-2375-9; Vaughan C. L, 2001, DYNAMICS HUMAN GAIT; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; WHITE BL, 1987, J BONE JOINT SURG AM, V69A, P1335; Yu B, 1999, J APPL BIOMECH, V15, P318, DOI 10.1123/jab.15.3.318; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	35	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245658	10.1371/journal.pone.0245658	http://dx.doi.org/10.1371/journal.pone.0245658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497416	Green Published, gold			2022-12-26	WOS:000613707100014
J	Kmush, BL; Lu, AM; Spillane, T; Hruska, B; Gump, BB; Bendinskas, KG				Kmush, Brittany L.; Lu, Amelia M.; Spillane, Taylor; Hruska, Bryce; Gump, Brooks B.; Bendinskas, Kestutis G.			Seroprevalence of hepatitis E virus antibodies in adults and children from upstate New York: A cross-sectional study	PLOS ONE			English	Article							UNITED-STATES; NATIONAL-HEALTH; INFECTION; EPIDEMIOLOGY; PREVALENCE	Hepatitis E virus (HEV) is a major cause of viral hepatitis around the world, especially in developing countries. Recently, HEV has also been recognized as important cause of hepatitis in Europe and Japan, however, there is a paucity of clinical data from the United States. The overall seroprevalence of HEV antibodies is around 10% in the United States, but considerable variation is seen based on geographic location, year, and assay used. In this study, 63 adults and 417 children from New York State were tested for anti-HEV IgG antibodies using the commercially available Wantai IgG assay. The overall seroprevalence of HEV antibodies among adult participants was 9.52% (95% CI: 3.58-19.59%). Positive adults tended to be older than HEV negative adults, all positive adults were female. Only 3 (0.7%, 95% CI:: 0.15-2.09%) of the children were positive, all positive children were male. These results are consistent with global and United States trends in HEV seroprevalence.	[Kmush, Brittany L.; Lu, Amelia M.; Spillane, Taylor; Hruska, Bryce; Gump, Brooks B.] Syracuse Univ, Dept Publ Hlth, Falk Coll Sport & Human Dynam, Syracuse, NY 13244 USA; [Bendinskas, Kestutis G.] SYUNY Oswego, Dept Chem, Oswego, NY USA	Syracuse University	Kmush, BL (corresponding author), Syracuse Univ, Dept Publ Hlth, Falk Coll Sport & Human Dynam, Syracuse, NY 13244 USA.	blkmush@syr.edu		Hruska, Bryce/0000-0002-8651-5827; Kmush, Brittany/0000-0003-2143-7554; Bendinskas, Kestutis/0000-0002-0275-520X	Project: Time Off [28570]; National Institutes of Health (NIH) [ES023252]; David B. Falk College of Sport and Human Dynamics, Syracuse University	Project: Time Off; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David B. Falk College of Sport and Human Dynamics, Syracuse University	This work was supported by Project: Time Off (funding agreement 28570, BBG), National Institutes of Health (NIH) (grant number ES023252, BBG), and funds provided by the David B. Falk College of Sport and Human Dynamics, Syracuse University (BLK). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, DIABETES CARE S1, V35, pS12; Barbre KA, 2017, AM J TROP MED HYG, V96, P929, DOI 10.4269/ajtmh.16-0727; Cangin C, 2019, J MED VIROL, V91, P124, DOI 10.1002/jmv.25299; Dalton HR, 2014, FUTURE MICROBIOL, V9, P1361, DOI 10.2217/fmb.14.89; Diehl TM, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/7980413; Ditah I, 2014, HEPATOLOGY, V60, P815, DOI 10.1002/hep.27219; Drobeniuc J, 2013, EMERG INFECT DIS, V19, P218, DOI 10.3201/eid1902.120961; Fontana RJ, 2016, HEPATOLOGY, V64, P1870, DOI 10.1002/hep.28649; Gump BB, 2017, ENVIRON RES, V158, P576, DOI 10.1016/j.envres.2017.06.033; Hruska B, 2020, PSYCHOL HEALTH, V35, P984, DOI 10.1080/08870446.2019.1687699; Hruska B, 2020, PSYCHOL HEALTH, V35, P1, DOI 10.1080/08870446.2019.1628962; Huang F, 2016, HEPATOLOGY, V64, P350, DOI 10.1002/hep.28668; Kodani M, 2017, J MED VIROL, V89, P1055, DOI 10.1002/jmv.24741; Kuniholm MH, 2009, J INFECT DIS, V200, P48, DOI 10.1086/599319; Meng XJ, 2002, J CLIN MICROBIOL, V40, P117, DOI 10.1128/JCM.40.1.117-122.2002; Rein DB, 2012, HEPATOLOGY, V55, P988, DOI 10.1002/hep.25505; Sanford BJ, 2013, TRANSBOUND EMERG DIS, V60, P538, DOI 10.1111/tbed.12001; Stramer SL, 2016, TRANSFUSION, V56, P481, DOI 10.1111/trf.13355; Teshale EH, 2015, J INFECT DIS, V211, P366, DOI 10.1093/infdis/jiu466; Verghese VP, 2014, CLIN INFECT DIS, V59, P689, DOI 10.1093/cid/ciu371	20	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0245850	10.1371/journal.pone.0245850	http://dx.doi.org/10.1371/journal.pone.0245850			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497387	gold, Green Published			2022-12-26	WOS:000613707100019
J	Oulas, A; Zanti, M; Tomazou, M; Zachariou, M; Minadakis, G; Bourdakou, MM; Pavlidis, P; Spyrou, GM				Oulas, Anastasis; Zanti, Maria; Tomazou, Marios; Zachariou, Margarita; Minadakis, George; Bourdakou, Marilena M.; Pavlidis, Pavlos; Spyrou, George M.			Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains	PLOS ONE			English	Article							WEB SERVER; SARS	This study aims to highlight SARS-COV-2 mutations which are associated with increased or decreased viral virulence. We utilize genetic data from all strains available from GISAID and countries' regional information, such as deaths and cases per million, as well as COVID-19-related public health austerity measure response times. Initial indications of selective advantage of specific mutations can be obtained from calculating their frequencies across viral strains. By applying modelling approaches, we provide additional information that is not evident from standard statistics or mutation frequencies alone. We therefore, propose a more precise way of selecting informative mutations. We highlight two interesting mutations found in genes N (P13L) and ORF3a (Q57H). The former appears to be significantly associated with decreased deaths and cases per million according to our models, while the latter shows an opposing association with decreased deaths and increased cases per million. Moreover, protein structure prediction tools show that the mutations infer conformational changes to the protein that significantly alter its structure when compared to the reference protein.	[Oulas, Anastasis; Zanti, Maria; Tomazou, Marios; Zachariou, Margarita; Minadakis, George; Bourdakou, Marilena M.; Spyrou, George M.] Cyprus Inst Neurol & Genet, Bioinformat Dept, Nicosia, Cyprus; [Oulas, Anastasis; Zanti, Maria; Tomazou, Marios; Zachariou, Margarita; Spyrou, George M.] Cyprus Sch Mol Med, Nicosia, Cyprus; [Pavlidis, Pavlos] Fdn Res & Technol Hellas, Inst Comp Sci, Iraklion, Greece	Foundation for Research & Technology - Hellas (FORTH)	Oulas, A (corresponding author), Cyprus Inst Neurol & Genet, Bioinformat Dept, Nicosia, Cyprus.; Oulas, A (corresponding author), Cyprus Sch Mol Med, Nicosia, Cyprus.	anastasiso@cing.ac.cy		Zanti, Maria/0000-0002-0136-9921; Zachariou, Margarita/0000-0001-8950-4077; Oulas, Anastasis/0000-0002-9350-7577; Tomazou, Marios/0000-0002-0836-5579; Minadakis, George/0000-0002-7752-2208; Bourdakou, Marilena/0000-0001-8075-0634	European Commission Research Executive Agency Grant BIORISE [669026]	European Commission Research Executive Agency Grant BIORISE	This work was supported by the European Commission Research Executive Agency Grant BIORISE (No. 669026), under the Spreading Excellence, Widening Participation, Science with and for Society Framework.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Dinesh DC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009100; Fehr AR, 2017, ANNU REV MED, V68, P387, DOI 10.1146/annurev-med-051215-031152; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; Guzenko D, 2019, PROTEINS, V87, P1190, DOI 10.1002/prot.25795; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Hale T, 2020, OXFORD COVID19 GOVT; He JH, 2019, BIOINFORMATICS, V35, P4994, DOI 10.1093/bioinformatics/btz388; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Issa E, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00266-20; Ittisoponpisan S, 2019, J MOL BIOL, V431, P2197, DOI 10.1016/j.jmb.2019.04.009; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khafaie Morteza Abdullatif, 2020, Osong Public Health Res Perspect, V11, P74, DOI 10.24171/j.phrp.2020.11.2.03; Korber B, 2020, SPIKE MUTATION PIPEL; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Lv M, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.15.2000125; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000056; Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9; Petrosillo N, 2020, CLIN MICROBIOL INFEC, V26, P729, DOI 10.1016/j.cmi.2020.03.026; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Wang CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16256-y; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xue LC, 2016, BIOINFORMATICS, V32, P3676, DOI 10.1093/bioinformatics/btw514; Yan YM, 2020, NAT PROTOC, V15, P1829, DOI 10.1038/s41596-020-0312-x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	38	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0238665	10.1371/journal.pone.0238665	http://dx.doi.org/10.1371/journal.pone.0238665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497392	Green Submitted, Green Published, gold			2022-12-26	WOS:000613707100035
J	Simelane, MS; Vermaak, K; Zwane, E; Masango, S				Simelane, Maswati S.; Vermaak, Kerry; Zwane, Eugene; Masango, Sdumo			Individual and community-level factors associated with lifetime number of sexual partners among women aged 15-49 in Eswatini	PLOS ONE			English	Article							TRANSMITTED INFECTIONS; MARITAL TRANSITIONS; HIV-INFECTION; 1ST SEX; OVERDISPERSION; HEALTH; NEIGHBORHOOD; ADOLESCENTS; BEHAVIOR; DEBUT	Introduction Understanding the risk factors for behavioral patterns in sexual relationships play a significant role in the reduction of the transmission of HIV/AIDS and other sexually transmitted infections. Objective To investigate individual and community level factors on the lifetime number of sexual partners of women in Eswatini Material and methods The study was a secondary cross-sectional analysis of the 2014 Eswatini Multiple Indicator Cluster Survey (MICS). A total of 2,832 women aged 15-49 years were asked in total, how many different people have you had sexual intercourse in your lifetime. The multilevel negative binomial regression model was used to analyze the data. Results The overall mean number of lifetime sexual partners was 2.78 (95% CI: 2.66, 2.91) in 2014. Compared to women aged 15-19, those aged 20 years and older, formerly married or never married reported more lifetime sexual partners compared to currently married women. Those that were aged 15 years and older at sexual debut reported fewer lifetime sexual partners compared to those that were aged less than 15 years. Compared to women that used a condom at last sexual intercourse, those that did not use a condom at last sexual encounter reported fewer lifetime sexual partners. Relative to women that lived with their sons and daughters, those that did not live with their sons and daughters reported more lifetime sexual partners. Women that lived in the Shiselweni and Lubombo regions reported fewer lifetime sexual partners compared to those residents in the Hhohho region. Conclusion Overall, lifetime sexual partners in Eswatini was significantly associated with individual characteristics and is unique across regions. Programs that aim to elucidate the factors associated with incident HIV infections among women in Eswatini should focus on individual and community-level factors that are associated with multiple sexual partnerships, which in turn might increase the risk of HIV exposure.	[Simelane, Maswati S.; Zwane, Eugene; Masango, Sdumo] Univ Eswatini, Fac Social Sci, Dept Stat & Demog, Kwaluseni, Eswatini; [Vermaak, Kerry] Univ KwaZulu Natal, Sch Built Environm & Dev Studies, Durban, South Africa	University of Kwazulu Natal	Simelane, MS (corresponding author), Univ Eswatini, Fac Social Sci, Dept Stat & Demog, Kwaluseni, Eswatini.	smasimelane@uniswa.sz		Simelane, Maswati/0000-0002-4931-9026				Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adedimeji AA, 2015, AIDS BEHAV, V19, P1366, DOI 10.1007/s10461-014-0964-z; Adedini SA, 2015, J BIOSOC SCI, V47, P165, DOI 10.1017/S0021932013000734; Adeyemi EO, 2011, INFECT DIS REP, V3, P30, DOI [10.4081/i6:2011.e7, 10.4081/idr.2011.e7]; [Anonymous], 2019, SWAZ HIV INC MEAS SU; [Anonymous], 2017, 9 INT AIDS SOC C HIV; Belle JA, 2019, AFR HEALTH SCI, V19, P2302, DOI 10.4314/ahs.v19i3.2; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Carlos S, 2017, AIDS CARE, V29, P772, DOI 10.1080/09540121.2016.1258450; Central Statistical Office and Macro International Inc, 2008, SWAZ DEM HLTH SURV 2; Central Statistical Office and UNFPA, 2010, 2007 POP HOUS CENS; Central Statistics Office, 2019, ESW HOUS INC EXP SUR; Central Statistics office, POV DEC SLOW EC GROW; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; De Cock KM, 2016, LANCET INFECT DIS, V16, P13, DOI 10.1016/S1473-3099(15)00477-6; de Visser R, 2001, AIDS EDUC PREV, V13, P413, DOI 10.1521/aeap.13.5.413.24146; DEAN C, 1989, J AM STAT ASSOC, V84, P467, DOI 10.2307/2289931; Dimbuene ZT, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23103; Son DT, 2016, GLOBAL HEALTH ACTION, V9, P87, DOI 10.3402/gha.v9.29575; Eswatini Central Statistical Office and UNICEF, 2016, ESW MULT IND CLUST S; Exavery A, 2015, HIV AIDS-RES PALLIAT, V7, P105, DOI 10.2147/HIV.S76694; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Gorgens M., 2016, SCALE UP ANTIRETROVI; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; Jackson SE, 2019, BMJ SEX REPROD HEAL, V45, P138, DOI 10.1136/bmjsrh-2018-200230; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, PROGR 90 90 90 TARG; Justman J, 2017, LANCET HIV, V4, pE83, DOI 10.1016/S2352-3018(16)30190-4; Kongnyuy E., 2006, BMC INT HEALTH HUM R, V6, P1; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Lee S, 2005, INT J EPIDEMIOL, V34, P69, DOI 10.1093/ije/dyh258; Lema L A, 2008, Tanzan J Health Res, V10, P79; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Madise Nyovani, 2007, Afr J Reprod Health, V11, P83, DOI 10.2307/25549733; Maonga B., 2018, 141 DHS ICF; Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213; McCree D.H., 2007, BEHAV INTERVENT, DOI 10.1007/978-0-387-48740-3_13; Minnery M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235664; Mutinta G, 2014, AJAR-AFR J AIDS RES, V13, P321, DOI 10.2989/16085906.2014.961938; Nketiah-Amponsah E., 2018, CORRELATES EARLY SEX, V39, P9; Onoya D, 2015, J PUBLIC HEALTH-UK, V37, P97, DOI 10.1093/pubmed/fdu010; Panchanadeswaran S, 2006, SEX TRANSM INFECT, V82, P491, DOI 10.1136/sti.2006.020768; Peltzer K, 2015, W INDIAN MED J, V64, P351, DOI 10.7727/wimj.2014.025; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Rosenman Robert, 2011, Int J Behav Healthc Res, V2, P320; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Silas J., 2013, POVERTY RISKY SEXUAL; The Government of the Kingdom of Eswatini, 2018, NAT MULT HIV AIDS ST; Todd J, 2009, SEX TRANSM INFECT, V85, pI72, DOI 10.1136/sti.2008.033985; Tuoyire DA, 2018, SEX CULT, V22, P651, DOI 10.1007/s12119-017-9488-9; Uthman Olalekan A, 2008, BMC Int Health Hum Rights, V8, P9, DOI 10.1186/1472-698X-8-9; Vernooij E, 2016, AIDS CARE, V28, P7, DOI 10.1080/09540121.2016.1178954; WHO, 2008, CIRC SAT CAS STUD SW; Williams K, 2004, J HEALTH SOC BEHAV, V45, P81, DOI 10.1177/002214650404500106; Yamamoto N, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0078-9; Yaya S, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00171; Yuan TW, 2019, LANCET GLOB HEALTH, V7, pE436, DOI 10.1016/S2214-109X(18)30567-9; Zhu H, 2010, J POPUL AGEING, V3, P161, DOI 10.1007/s12062-011-9034-8; Zuma Khangelani, 2010, Afr J Reprod Health, V14, P47	60	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246100	10.1371/journal.pone.0246100	http://dx.doi.org/10.1371/journal.pone.0246100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA8QK	33497398	Green Published, gold			2022-12-26	WOS:000613707100016
J	Yeh, JS; Hsu, CY; Huang, CY; Chen, WT; Hsieh, YC; Chien, LN				Yeh, Jong-Shiuan; Hsu, Chien-Yi; Huang, Chun-Yao; Chen, Wan-Ting; Hsieh, Yi-Chen; Chien, Li-Nien			The effect of de-escalation of P2Y(12) receptor inhibitor therapy after acute myocardial infarction in patients undergoing percutaneous coronary intervention: A nationwide cohort study	PLOS ONE			English	Article							TICAGRELOR; CLOPIDOGREL; ACS	To examine the effect of de-escalation of P2Y(12) inhibitor in dual antiplatelet therapy (DAPT) on major adverse cardiovascular events (MACE) and bleeding complications after acute myocardial infarction (AMI) in Taiwanese patients undergoing percutaneous coronary intervention (PCI). Patients who had received PCI during hospitalization for AMI (between 2013 and 2016) and were initially treated with aspirin and ticagrelor and without adverse events after 3 months of treatment were retrospectively evaluated. In total, 1,901 and 8,199 patients were identified as "de-escalated DAPT" (switched to aspirin and clopidogrel) and "unchanged DAPT" (continued on aspirin and ticagrelor) cohorts, respectively. With a mean follow-up of 8 months, the incidence rates (per 100 person-year) of death, AMI readmission and MACE were 2.89, 3.68, and 4.91 in the de-escalated cohort and 2.42, 3.28, and 4.72 in the unchanged cohort, respectively, based on an inverse probability of treatment weighted approach that adjusting for baseline characteristics of the patients. Multivariate Cox regression analyses showed the two groups had no significant differences in the hazard risk of death, AMI admission, and MACE. Additionally, there was no observed difference in the risk of bleeding, including major or clinically relevant non-major bleeding. The real-world data revealed that de-escalation of P2Y(12) inhibitor in DAPT was not associated with a higher risk of death or AMI readmission in Taiwanese patients with AMI undergoing successful PCI.	[Yeh, Jong-Shiuan] Taipei Municipal Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan; [Yeh, Jong-Shiuan; Hsu, Chien-Yi; Huang, Chun-Yao] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Hsu, Chien-Yi; Huang, Chun-Yao] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Hsu, Chien-Yi; Huang, Chun-Yao] Taipei Med Univ Hosp, Dept Internal Med, Cardiovasc Res Ctr, Taipei, Taiwan; [Chen, Wan-Ting; Chien, Li-Nien] Taipei Med Univ, Off Data Sci, Hlth & Clin Res Data Ctr, Taipei, Taiwan; [Hsieh, Yi-Chen] Taipei Med Univ, Coll Med Sci & Technol, PHD Program Neural Regenerat Med, Taipei, Taiwan; [Hsieh, Yi-Chen] Taipei Med Univ, Coll Pharm, PHD Program Biotechnol Res & Dev, Taipei, Taiwan; [Hsieh, Yi-Chen] Taipei Med Univ, Coll Publ Hlth, Master Program Appl Mol Epidemiol, Taipei, Taiwan; [Chien, Li-Nien] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan	Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University	Chien, LN (corresponding author), Taipei Med Univ, Off Data Sci, Hlth & Clin Res Data Ctr, Taipei, Taiwan.; Chien, LN (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.	lnchien@tmu.edu.tw	chen, want/GRX-0662-2022	Hsu, Chien-Yi/0000-0002-9493-7325	Health and Clinical Research Data Center, Office of Data Science, Taipei Medical University	Health and Clinical Research Data Center, Office of Data Science, Taipei Medical University	This study was supported by Health and Clinical Research Data Center, Office of Data Science, Taipei Medical University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2017, CIRCULATION, V136, P1955, DOI 10.1161/CIRCULATIONAHA.117.031164; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cuisset T, 2017, EUR HEART J, V38, P3070, DOI 10.1093/eurheartj/ehx175; De Luca L, 2017, EUROINTERVENTION, V13, P459, DOI 10.4244/EIJ-D-17-00092; Fosbol EL, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003602; Franchi F, 2018, CIRCULATION, V137, P2450, DOI 10.1161/CIRCULATIONAHA.118.033983; Granger CB, 2016, JAMA CARDIOL, V1, P381, DOI 10.1001/jamacardio.2016.1018; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Koh L, 2020, ACTA CARDIOL SIN, V36, P8, DOI 10.6515/ACS.202001_36(1).20190627A; Levine GN, 2016, J THORAC CARDIOV SUR, V152, P1243, DOI 10.1016/j.jtcvs.2016.07.044; Li XY, 2018, CLIN CARDIOL, V41, P1446, DOI 10.1002/clc.23074; Limdi NA, 2020, PHARMACOGENOMICS J, V20, P724, DOI 10.1038/s41397-020-0162-5; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Motovska Z, 2016, CIRCULATION, V134, P1603, DOI 10.1161/CIRCULATIONAHA.116.024823; Park J, 2019, INT J ARRHYTHM, V20, P5; Rollini F, 2016, NAT REV CARDIOL, V13, P11, DOI 10.1038/nrcardio.2015.113; Sasikumar P. G. N., 2011, AUNP 12, Patent No. 20110318373; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Sibbing D, 2017, THROMB HAEMOSTASIS, V117, P1240, DOI 10.1160/TH16-12-0963; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wang C, 2019, PLATELETS, P1; Zanchin T, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.117.006132; Zettler ME, 2017, AM HEART J, V183, P62, DOI 10.1016/j.ahj.2016.10.006	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0246029	10.1371/journal.pone.0246029	http://dx.doi.org/10.1371/journal.pone.0246029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493236	gold, Green Published			2022-12-26	WOS:000613081500008
J	Kovalenko, TF; Morozova, KV; Pavlyukov, MS; Anufrieva, KS; Bobrov, MY; Gamisoniya, AM; Ozolinya, LA; Dobrokhotova, YE; Shakhparonov, MI; Patrushev, LI				Kovalenko, Tatyana F.; Morozova, Ksenia, V; Pavlyukov, Marat S.; Anufrieva, Ksenia S.; Bobrov, Mikhail Yu; Gamisoniya, Alina M.; Ozolinya, Lyudmila A.; Dobrokhotova, Yulia E.; Shakhparonov, Mikhail, I; Patrushev, Lev, I			Methylation of the PTENP1 pseudogene as potential epigenetic marker of age-related changes in human endometrium	PLOS ONE			English	Article							DYNAMIC DNA METHYLATION; GENE; HYPERMETHYLATION; EXPRESSION; RNA; CARCINOMA; SURVIVAL	The processed pseudogene PTENP1 is involved in the regulation of the expression of the PTEN and acts as a tumor suppressor in many types of malignances. In our previous study we showed that PTENP1 methylation is present not only in tumor, but also in normal endometrium tissues of women over 45 years old. Here we used methylation-specific PCR to analyze methylation status of CpG island located near promoter region of PTENP1 in malignant and non-malignant endometrium tissues collected from 236 women of different age groups. To confirm our results, we also analyzed RNA sequencing and microarray data from 431 women with endometrial cancer from TCGA database. We demonstrated that methylation of PTENP1 is significantly increased in older patients. We also found an age-dependent increase in the level of PTENP1 expression in endometrial tissue. According to our data, PTENP1 methylation elevates the level of the pseudogene sense transcript. In turn, a high level of this transcript correlates with a more favorable prognosis in endometrial cancer. The data obtained suggested that PTENP1 methylation is associated with age-related changes in normal and hyperplastic endometrial tissues. We assumed that age-related increase in PTENP1 methylation and subsequent elevation of its expression may serve as a protective mechanism aimed to prevent malignant transformation of endometrial tissue in women during the perimenopause, menopause, and postmenopause periods.	[Kovalenko, Tatyana F.; Pavlyukov, Marat S.; Shakhparonov, Mikhail, I] Russian Acad Sci, Lab Membrane Bioenerget, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Morozova, Ksenia, V; Ozolinya, Lyudmila A.; Dobrokhotova, Yulia E.] Pirogov Russian Natl Res Med Univ, Dept Obstet & Gynecol, Moscow, Russia; [Anufrieva, Ksenia S.] Fed Med Biol Agcy, Ctr Precis Genome Editing & Genet Technol Biomed, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Anufrieva, Ksenia S.] Fed Med Biol Agcy, Lab Cell Biol, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Anufrieva, Ksenia S.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Bobrov, Mikhail Yu; Gamisoniya, Alina M.] Minist Healthcare Russian Federat, Lab Mol Pathophysiol, Kulakov Res Ctr Obstet Gynecol & Perinatol, Moscow, Russia; [Gamisoniya, Alina M.] Russian Acad Sci, Lab Oxylipins, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Patrushev, Lev, I] Russian Acad Sci, Educ & Sci Ctr, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Russian Academy of Medical Sciences; Research Center for Obstetrics, Gynecology & Perinatology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Kovalenko, TF (corresponding author), Russian Acad Sci, Lab Membrane Bioenerget, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	t_kov@mail.ru	Ozolinya, Lyudmila/HHM-4657-2022; Bobrov, Mikhail Y/C-2993-2014; Pavlyukov, Marat S/ABB-6791-2021; Shakhparonov, Mikhail I/E-8377-2014	Bobrov, Mikhail Y/0000-0002-5837-473X; Kovalenko, Tatiana/0000-0001-6091-892X; Gamisonia, Alina/0000-0001-8532-4714	Russian Science Foundation [19-44-02027]; Russian Foundation for Basic Research [19-34-90193]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The Russian Science Foundation grant 19-44-02027 (MSP). The Russian Foundation for Basic Research grant 19-34-90193 (KSA; for analysis of RNAseq data). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; Ashapkin VV, 2019, ADV EXP MED BIOL, V1178, P175, DOI 10.1007/978-3-030-25650-0_10; Bell CG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1824-y; Brighton P, 2020, GENOME WIDE EXPRESSI; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Field AE, 2018, MOL CELL, V71, P882, DOI 10.1016/j.molcel.2018.08.008; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hu S, 2019, ONCOTARGETS THER, V12, P147, DOI 10.2147/OTT.S182537; Johansson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067378; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kovalenko TF, 2018, ACTA NATURAE, V10, P43, DOI 10.32607/20758251-2018-10-1-43-50; Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113; LINDBLOM B, 1988, GENE ANAL TECH, V5, P97, DOI 10.1016/0735-0651(88)90003-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo CY, 2018, SCIENCE, V361, P1336, DOI 10.1126/science.aat6806; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Modhukur V, 2018, EPIGENOMICS-UK, V10, P277, DOI 10.2217/epi-2017-0118; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Nabilsi NH, 2009, ONCOGENE, V28, P2046, DOI 10.1038/onc.2009.62; Nijkang NP, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119848247; Pallares J, 2008, MODERN PATHOL, V21, P691, DOI 10.1038/modpathol.2008.38; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Qian YY, 2017, ONCOTARGET, V8, P107859, DOI 10.18632/oncotarget.22305; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Schmitz RJ, 2019, TRENDS GENET, V35, P818, DOI 10.1016/j.tig.2019.07.007; Sproul D, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R84, 10.1186/gb-2012-13-10-r84]; Trimarchi MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173242; Wu CP, 2022, GENE THER, V29, P464, DOI 10.1038/s41434-020-00189-8; Yndestad S, 2018, MOL CANCER RES, V16, P78, DOI 10.1158/1541-7786.MCR-17-0207; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Zhang B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-868; Zhang HM, 2019, BIOCHEM SOC T, V47, P997, DOI 10.1042/BST20180218; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0243093	10.1371/journal.pone.0243093	http://dx.doi.org/10.1371/journal.pone.0243093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481830	Green Published, gold			2022-12-26	WOS:000612929300042
J	Ni, YN; Wang, T; Liang, BM; Liang, ZA				Ni, Yue-Nan; Wang, Ting; Liang, Bin-miao; Liang, Zong-An			The independent factors associated with oxygen therapy in COVID-19 patients under 65 years old	PLOS ONE			English	Article							OUTCOMES	Background The number of hospitalized young coronavirus disease 2019 (COVID-19) patients has increased significantly. However, specific data about COVID-19 patients under 65 years old who are admitted to the hospital are scarce. Methods The COVID-19 patients under 65 years old who were admitted to the hospital in Sichuan Province, Renmin Hospital of Wuhan University, and Wuhan Red Cross Hospital were included in this study. Demographic information, laboratory data and clinical treatment courses were extracted from electronic medical records. Risk factors associated with oxygen therapy were explored. Results Eight hundred thirty-three COVID-19 patients under 65 years old were included. Of the included patients, 29.4% had one or more comorbidities. Oxygen therapy was required in 63.1% of these patients, and the mortality was 2.9% among the oxygen therapy patients. Fever (odds ratio [OR] 2.072, 95% confidence interval [CI] 1.312-3.271, p = 0.002), dys-pnea (OR 2.522, 95% CI 1.213-5.243, p = 0.013), chest distress (OR 2.278, 95% CI 1.160-4.473, p = 0.017), elevated respiratory rate (OR 1.114, 95% CI 1.010-1.228, p = 0.031), and decreased albumin (OR 0.932, 95% CI 0.880-0.987, p = 0.016) and globulin levels (OR 0.929, 95% 0.881-0.980, p = 0.007) were independent factors related to oxygen therapy. Conclusions Oxygen therapy is highly required in COVID-19 patients under 65 years old who are admitted to the hospital, but the success rate is high. Respiratory failure-related symptoms, elevated respiratory rate, low albumin and globulin levels, and fever at admission are independent risk factors related to the requirement of oxygen.	[Ni, Yue-Nan; Wang, Ting; Liang, Bin-miao; Liang, Zong-An] Sichuan Univ, Dept Resp & Crit Care, West China Sch Med, Chengdu, Peoples R China; [Ni, Yue-Nan; Wang, Ting; Liang, Bin-miao; Liang, Zong-An] Sichuan Univ, West China Hosp, Chengdu, Peoples R China	Sichuan University; Sichuan University	Liang, BM; Liang, ZA (corresponding author), Sichuan Univ, Dept Resp & Crit Care, West China Sch Med, Chengdu, Peoples R China.	liangbinmiao@163.com; liangzatg@126.com			National Key Research and Development Program of China [2016YFC1304303]; Sichuan Science and Technology Agency Grant [2019YFS0033]; Sichuan Science and Technology Project [2020YFS0005]	National Key Research and Development Program of China; Sichuan Science and Technology Agency Grant; Sichuan Science and Technology Project	This study was partly supported by the National Key Research and Development Program of China (2016YFC1304303), awarded to Zong-An Liang, and the Sichuan Science and Technology Agency Grant (2019YFS0033), awarded to BinMiao Liang and Sichuan Science and Technology Project (2020YFS0005), awarded to Ting Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwarawrah Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01055; [Anonymous], 2020, RECENT INCREASE COVI; Barlow A, 2020, PHARMACOTHERAPY, V40, P416, DOI 10.1002/phar.2398; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; Catteau L, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106144; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; De Vito A, 2020, EUR REV MED PHARMACO, V24, P7861, DOI 10.26355/eurrev_202007_22291; Duan K, 2020, P NATL ACAD SCI USA, V117, P9490, DOI 10.1073/pnas.2004168117; Edalatifard M, 2020, INTRAVENOUS METHYLPR; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Griffin DE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100282; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00597-2020; Guarneri C, 2021, LANCET INFECT DIS, V21, P24, DOI 10.1016/S1473-3099(20)30402-3; Hasday JD, 2000, CELL STRESS CHAPERON, V5, P471, DOI 10.1379/1466-1268(2000)005<0471:FATHSR>2.0.CO;2; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kim S, 2017, AM SURGEON, V83, P1220; Li Y, 2021, HISTOPATHOLOGY, V78, P542, DOI 10.1111/his.14249; Lu GG, 2020, CLIN CHIM ACTA, V508, P98, DOI 10.1016/j.cca.2020.04.034; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Nakvasina M.A., 2016, Vestn. Voronezh. Gos. Univ., Ser.: Khim., Biol., Farm., P67, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Neuraz A, 2015, CRIT CARE MED, V43, P1587, DOI 10.1097/CCM.0000000000001015; Paliogiannis P, 2020, J INFECT DEV COUNTR, V14, P685, DOI 10.3855/jidc.12879; Richardson S, 2020, JAMA; Saad M, 2014, INT J INFECT DIS, V29, P301, DOI 10.1016/j.ijid.2014.09.003; Shi YF, 2020, CELL DEATH DIFFER, V27, P1451, DOI 10.1038/s41418-020-0530-3; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1560, DOI 10.1002/hed.26269; Vaira LA, 2020, HEAD NECK-J SCI SPEC, V42, P1252, DOI 10.1002/hed.26204; Wang C, 2018, LANCET, V391, P1706, DOI [10.1016/s0140-6736(18)30841-9, 10.1016/S0140-6736(18)30841-9]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie J, 2020, MAYO CLIN PROC, V95, P1138, DOI 10.1016/j.mayocp.2020.04.006; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zinellu A, 2020, RITIS RATIO PROGNOST	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245690	10.1371/journal.pone.0245690	http://dx.doi.org/10.1371/journal.pone.0245690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481912	gold, Green Published			2022-12-26	WOS:000612929300100
J	Saleem, S; Hussain, MZ; Aziz, I				Saleem, Sidra; Hussain, Malik Zawwar; Aziz, Imran			A reliable algorithm to compute the approximate solution of KdV-type partial differential equations of order seven	PLOS ONE			English	Article							HAAR WAVELET METHOD; NUMERICAL-SOLUTION; FINITE-DIFFERENCE; 7TH-ORDER; SYSTEMS	The approximate solution of KdV-type partial differential equations of order seven is presented. The algorithm based on one-dimensional Haar wavelet collocation method is adapted for this purpose. One-dimensional Haar wavelet collocation method is verified on Lax equation, Sawada-Kotera-Ito equation and Kaup-Kuperschmidt equation of order seven. The approximated results are displayed by means of tables (consisting point wise errors and maximum absolute errors) to measure the accuracy and proficiency of the scheme in a few number of grid points. Moreover, the approximate solutions and exact solutions are compared graphically, that represent a close match between the two solutions and confirm the adequate behavior of the proposed method.	[Saleem, Sidra; Hussain, Malik Zawwar] Univ Punjab, Dept Math, Lahore, Pakistan; [Aziz, Imran] Univ Peshawar, Dept Math, Peshawar, Pakistan	University of Punjab; University of Peshawar	Saleem, S (corresponding author), Univ Punjab, Dept Math, Lahore, Pakistan.	sidra.saleem@lcwu.edu.pk						Akinyemi L, 2019, COMPUT APPL MATH, V38, DOI 10.1007/s40314-019-0977-3; Aljahdaly NH, 2019, RESULTS PHYS, V14, DOI 10.1016/j.rinp.2019.102372; Arora R, 2018, INT J SYST ASSUR ENG, V9, P131, DOI 10.1007/s13198-016-0490-7; Aziz I, 2013, APPL MATH MODEL, V37, P676, DOI 10.1016/j.apm.2012.02.046; Aziz I, 2011, COMPUT MATH APPL, V61, P2770, DOI 10.1016/j.camwa.2011.03.043; Cattani C, 2010, APPL MATH COMPUT, V215, P4164, DOI 10.1016/j.amc.2009.12.037; Cattani C., 2018, J ADV ENG COMPUT, V2, P224, DOI [10.25073/jaec.201824.225, DOI 10.25073/jaec.201824.225, DOI 10.25073/JAEC.201824.225]; Chen CF, 1997, IEE P-CONTR THEOR AP, V144, P87, DOI 10.1049/ip-cta:19970702; Darvishi M.T., 2007, INT J CONT MATH SCI, V2, P1097, DOI DOI 10.12988/IJCMS.2007.07111; El-Sayed SM, 2004, APPL MATH COMPUT, V157, P93, DOI 10.1016/j.amc.2003.08.104; Feng LL, 2020, B MALAYS MATH SCI SO, V43, P141, DOI 10.1007/s40840-018-0668-z; Fermo L, 2020, APPL NUMER MATH, V149, P3, DOI 10.1016/j.apnum.2019.07.001; Ganji DD, 2008, APPL MATH COMPUT, V206, P438, DOI 10.1016/j.amc.2008.09.033; GROSSMANN A, 1984, SIAM J MATH ANAL, V15, P723, DOI 10.1137/0515056; Haar A, 1910, MATH ANN, V69, P331, DOI 10.1007/BF01456326; Hsiao CH, 1997, MATH COMPUT SIMULAT, V44, P457, DOI 10.1016/S0378-4754(97)00075-X; Kaya D, 2018, THERM SCI, V22, pS153, DOI 10.2298/TSCI170613281K; Kaya D, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1531-0; Kong DS, 2019, APPL MATH COMPUT, V355, P61, DOI 10.1016/j.amc.2019.02.031; Lepik U, 2006, APPL MATH COMPUT, V176, P324, DOI 10.1016/j.amc.2005.09.021; Lepik U, 2005, MATH COMPUT SIMULAT, V68, P127, DOI 10.1016/j.matcom.2004.10.005; Majak J, 2018, COMPOS STRUCT, V201, P72, DOI 10.1016/j.compstruct.2018.06.013; Majak J, 2015, COMPOS PART B-ENG, V80, P321, DOI 10.1016/j.compositesb.2015.06.008; Majak J, 2015, COMPOS STRUCT, V126, P227, DOI 10.1016/j.compstruct.2015.02.050; Majak J, 2009, APPL MATH COMPUT, V211, P488, DOI 10.1016/j.amc.2009.01.089; MALLAT SG, 1989, T AM MATH SOC, V315, P69, DOI 10.2307/2001373; Mao JJ, 2020, NONLINEAR ANAL-MODEL, V25, P358, DOI 10.15388/namc.2020.25.16653; Meyer Y., 1989, ANAL URBANA, V1; Mohanty R., 1995, NUMER METHODS PART D, V11, P187, DOI DOI 10.1002/NUM.1690110303; Mohanty R.K., 2011, J ADV RES SCI COMPUT, V3, P53; Mohanty RK, 2000, J COMPUT APPL MATH, V114, P275, DOI 10.1016/S0377-0427(99)00202-2; Peng WQ, 2020, COMPLEX ANAL OPER TH, V14, DOI 10.1007/s11785-020-00997-1; Peng WQ, 2019, PHYS FLUIDS, V31, DOI 10.1063/1.5116231; Peng WQ, 2019, J GEOM PHYS, V146, DOI 10.1016/j.geomphys.2019.103508; Peng WQ, 2019, MATH METHOD APPL SCI, V42, P6865, DOI 10.1002/mma.5792; POMEAU Y, 1988, PHYSICA D, V31, P127, DOI 10.1016/0167-2789(88)90018-8; Salas AH, 2010, APPL MATH COMPUT, V216, P2333, DOI 10.1016/j.amc.2010.03.078; Saleem S, 2020, THESIS U PUNJAB LAHO, P1; Saravi M, 2013, J MATH COMPUT SCI-JM, V6, P230; Sharma A, 2017, INT J APPL COMPUT MA, V3, P3857, DOI [10.1007/s40819-017-0332-6, DOI 10.1007/S40819-017-0332-6]; Siraj-ul-Islam, 2010, MATH COMPUT MODEL, V52, P1577, DOI 10.1016/j.mcm.2010.06.023; Tian SF, 2020, APPL MATH LETT, V106, DOI 10.1016/j.aml.2020.106378; Tian SF, 2020, APPL MATH LETT, V100, DOI 10.1016/j.aml.2019.106056; Wazwaz AM, 2006, APPL MATH COMPUT, V182, P771, DOI 10.1016/j.amc.2006.04.040; Wu X, 2020, E ASIAN J APPL MATH, V10, P717, DOI 10.4208/eajam.170120.080420; Xu TY, 2020, MATH METHOD APPL SCI, V43, P865, DOI 10.1002/mma.5964; Yokus A, 2019, COMMUN FAC SCI UNIV, V68, P353, DOI 10.31801/cfsuasmas.420771; Yokus A, 2018, ALEX ENG J, V57, P2085, DOI 10.1016/j.aej.2017.05.028; Zhang LD, 2020, E ASIAN J APPL MATH, V10, P243, DOI 10.4208/eajam.130219.290819	49	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244027	10.1371/journal.pone.0244027	http://dx.doi.org/10.1371/journal.pone.0244027			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481786	gold, Green Published			2022-12-26	WOS:000612929300167
J	Choi, BH; Kou, ZY; Colon, TM; Chen, CH; Chen, Y; Dai, W				Choi, Byeong Hyeok; Kou, Ziyue; Colon, Tania Marlyn; Chen, Chih-Hong; Chen, Yuan; Dai, Wei			Identification of Radil as a Ras binding partner and putative activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-RAS; ACTIN CYTOSKELETON; CELL-MIGRATION; ONCOGENIC RAS; E-CADHERIN; MOTILITY; ADHESION; INVASION; EMT	Ras genes are among the most frequently mutated oncogenes in human malignancies. To date, there are no successful anticancer drugs in the clinic that target Ras proteins or their pathways. Therefore, it is imperative to identify and characterize new components that regulate Ras activity or mediate its downstream signaling. To this end, we used a combination of affinity-pulldown and mass spectrometry to search for proteins that are physically associated with KRas. One of the top hits was Radil, a gene product with a Ras-association domain. Radil is known to be a downstream effector of Rap1, inhibiting RhoA signaling to regulate cell adhesion and migration. We demonstrate that Radil interacted with all three isoforms of Ras including HRas, NRas, and KRas, although it exhibited the strongest interaction with KRas. Moreover, Radil interacts with GTP-bound Ras more efficiently, suggesting a possibility that Radil may be involved in Ras activation. Supporting this, ectopic expression of Radil led to transient activation of mitogen-activated protein kinase kinase and extracellular signal-regulated kinase; Radil knockdown resulted in weakened activation of Ras downstream signaling components, which was coupled with decreased cell proliferation and invasion, and reduced expression of mesenchymal cell markers. Moreover, Radil knockdown greatly reduced the number of adhesion foci and depolymerized actin filaments, molecular processes that facilitate cancer cell migration. Taken together, our present studies strongly suggest that Radil is an important player for regulating Ras signaling, cell adhesion, and the epithelial-mesenchymal transition and may provide new directions for Ras-related anticancer drug development.	[Choi, Byeong Hyeok; Kou, Ziyue; Colon, Tania Marlyn; Dai, Wei] NYU, Dept Environm Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Chen, Chih-Hong; Chen, Yuan] UC San Diego Hlth, Dept Surg, La Jolla, CA USA; [Chen, Chih-Hong; Chen, Yuan] UC San Diego Hlth, Moores Canc Ctr, La Jolla, CA USA; [Dai, Wei] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10003 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Dai, W (corresponding author), NYU, Dept Environm Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.; Dai, W (corresponding author), NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, New York, NY 10003 USA.	wei.dai@nyumc.org	Kou, Ziyue/GQB-5681-2022	Choi, Byeong Hyeok/0000-0002-8866-1131; Dai, Wei/0000-0003-0169-8327	US Public Service Awards [CA213159, CA216987]; NIEHS Center grant [ES000260]	US Public Service Awards; NIEHS Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by US Public Service Awards to W.D. (CA213159 and CA216987) and Y.C. (CA216987), and NIEHS Center grant (ES000260).	Ahmed SM, 2012, J CELL BIOL, V199, P951, DOI 10.1083/jcb.201206051; Bezdekova M, 2012, INT J MOL SCI, V13, P1632, DOI 10.3390/ijms13021632; Campbell K, 2016, DEVELOPMENT, V143, P4291, DOI 10.1242/dev.139071; Campbell K, 2010, MECH DEVELOP, V127, P345, DOI 10.1016/j.mod.2010.04.002; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Choi BH, 2018, J BIOL CHEM, V293, P17574, DOI 10.1074/jbc.RA118.003723; Chrzanowska-Wodnicka M, 2017, CURR OPIN HEMATOL, V24, P248, DOI 10.1097/MOH.0000000000000332; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Giehl K, 2005, BIOL CHEM, V386, P193, DOI 10.1515/BC.2005.025; Gingras AR, 2016, STRUCTURE, V24, P2152, DOI 10.1016/j.str.2016.10.001; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kidd ME, 2014, AM J RESP CELL MOL, V50, P1, DOI 10.1165/rcmb.2013-0314TR; Konig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057996; Liu LH, 2012, MOL BIOL CELL, V23, P4751, DOI 10.1091/mbc.E12-05-0408; Lynch SJ, 2015, J CELL PHYSIOL, V230, P610, DOI 10.1002/jcp.24779; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nakhaeizadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167145; Peled M, 2018, P NATL ACAD SCI USA, V115, pE468, DOI 10.1073/pnas.1710437115; Pollock CB, 2005, CANCER RES, V65, P1244, DOI 10.1158/0008-5472.CAN-04-1911; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Rodriguez-Viciana P, 2004, MOL CELL BIOL, V24, P4943, DOI 10.1128/MCB.24.11.4943-4954.2004; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Shah S, 2019, SEMIN CANCER BIOL, V54, P29, DOI 10.1016/j.semcancer.2018.03.005; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Smolen GA, 2007, GENE DEV, V21, P2131, DOI 10.1101/gad.1561507; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zhang Haibo, 2016, Small GTPases, V7, P39, DOI 10.1080/21541248.2016.1161698	34	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100314	10.1016/j.jbc.2021.100314	http://dx.doi.org/10.1016/j.jbc.2021.100314			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482197	gold, Green Published			2022-12-26	WOS:000672866400288
J	Cook, I; Cacace, M; Wang, T; Darrah, K; Deiters, A; Leyh, TS				Cook, Ian; Cacace, Mary; Wang, Ting; Darrah, Kristie; Deiters, Alexander; Leyh, Thomas S.			Small-molecule control of neurotransmitter sulfonation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-DISORDERS; SULFOTRANSFERASE; DOPAMINE; LOCALIZATION; EXPRESSION; PARALLEL; GOVERNS; COMPLEX; SULT1A3; 1A1	Controlling unmodified serotonin levels in brain synapses is a primary objective when treating major depressive disorder-a disease that afflicts similar to 20% of the world's population. Roughly 60% of patients respond poorly to first-line treatments and thus new therapeutic strategies are sought. To this end, we have constructed isoform-specific inhibitors of the human cytosolic sulfotransferase 1A3 (SULT1A3)-the isoform responsible for sulfonating similar to 80% of the serotonin in the extracellular brain fluid. The inhibitor design includes a core ring structure, which anchors the inhibitor into a SULT1A3-specific binding pocket located outside the active site, and a side chain crafted to act as a latch to inhibit turnover by fastening down the SULT1A3 activesite cap. The inhibitors are allosteric, they bind with nanomolar affinity and are highly specific for the 1A3 isoform. The capstabilizing effects of the latch can be accurately calculated and are predicted to extend throughout the cap and into the surrounding protein. A free-energy correlation demonstrates that the percent inhibition at saturating inhibitor varies linearly with cap stabilization - the correlation is linear because the rate-limiting step of the catalytic cycle, nucleotide release, scales linearly with the fraction of enzyme in the cap-open form. Inhibitor efficacy in cultured cells was studied using a human mammary epithelial cell line that expresses SULT1A3 at levels comparable with those found in neurons. The inhibitors perform similarly in ex vivo and in vitro studies; consequently, SULT1A3 turnover can now be potently suppressed in an isoform-specific manner in human cells.	[Cook, Ian; Wang, Ting; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Cacace, Mary; Darrah, Kristie; Deiters, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Wang, Ting] Boehringer Ingelheim GmbH & Co KG, Drug Metab & Pharmacokinet Dept, Danbury, CT USA	Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boehringer Ingelheim	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	tom.leyh@einsteinmed.org			National Institutes of Health [GM112728, GM121849, GM127144]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research supported by the National Institutes of Health Grants GM112728 (to A. D.), GM121849 (to T. S. L.), and GM127144 (to T. S. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Case DA, 2012, AMBER 12; Chesney E, 2014, WORLD PSYCHIATRY, V13, P153, DOI 10.1002/wps.20128; Cook I, 2019, BIOCHEM PHARMACOL, V159, P25, DOI 10.1016/j.bcp.2018.11.010; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, BIOCHEMISTRY-US, V54, P6114, DOI 10.1021/acs.biochem.5b00406; Cook I, 2015, DRUG METAB DISPOS, V43, P418, DOI 10.1124/dmd.114.061887; Cook I, 2013, J BIOL CHEM, V288, P8619, DOI 10.1074/jbc.M112.445015; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook I, 2012, BIOCHEMISTRY-US, V51, P5674, DOI 10.1021/bi300631g; Cook IT, 2009, DRUG METAB DISPOS, V37, P2069, DOI 10.1124/dmd.108.025759; Dajani R, 1998, MOL PHARMACOL, V54, P942, DOI 10.1124/mol.54.6.942; Darrah K, 2019, J BIOL CHEM, V294, P2293, DOI 10.1074/jbc.RA118.006511; EBERHARDT ES, 1994, J AM CHEM SOC, V116, P2149, DOI 10.1021/ja00084a067; Eisenhofer G, 1999, CLIN EXP PHARMACOL P, V26, pS41; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; Falany JL, 1996, CANCER RES, V56, P1551; Falany JL, 2006, DRUG METAB DISPOS, V34, P361, DOI 10.1124/dmd.105.006551; Grant GA, 2018, ARCH BIOCHEM BIOPHYS, V653, P10, DOI 10.1016/j.abb.2018.06.009; Lu JH, 2005, BIOCHEM BIOPH RES CO, V335, P417, DOI 10.1016/j.bbrc.2005.07.091; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Merikangas KR, 2010, J AM ACAD CHILD PSY, V49, P980, DOI 10.1016/j.jaac.2010.05.017; Nowell S, 2006, ONCOGENE, V25, P1673, DOI 10.1038/sj.onc.1209376; Nurisso A, 2012, J CHEM INF MODEL, V52, P1319, DOI 10.1021/ci200515g; Olgiati P, 2018, J AFFECT DISORDERS, V227, P777, DOI 10.1016/j.jad.2017.11.004; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; Salman ED, 2009, DRUG METAB DISPOS, V37, P706, DOI 10.1124/dmd.108.025767; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; STEWART MJ, 1983, BRIT J CLIN PHARMACO, V16, P3, DOI 10.1111/j.1365-2125.1983.tb02136.x; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; Thomas SJ, 2015, PHARMACOTHERAPY, V35, P433, DOI 10.1002/phar.1576; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Wang T, 2016, BIOCHEMISTRY-US, V55, P4036, DOI 10.1021/acs.biochem.6b00401; Wang T, 2014, BIOCHEMISTRY-US, V53, P6893, DOI 10.1021/bi501120p; Wang T, 2014, J BIOL CHEM, V289, P26474, DOI 10.1074/jbc.M114.573501; Weisz J, 2000, AM J PATHOL, V156, P1841, DOI 10.1016/S0002-9440(10)65057-2; Whiteley CG, 1999, BIOCHEM EDUC, V27, P15, DOI 10.1016/S0307-4412(98)00265-9; Zhu W, 2010, AAPS J, V12, P525, DOI 10.1208/s12248-010-9209-x	44	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100094	10.1074/jbc.RA120.015177	http://dx.doi.org/10.1074/jbc.RA120.015177			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33485192	gold, Green Published			2022-12-26	WOS:000672866400074
J	Liang, L; Wang, ZY; Qu, LH; Huang, W; Guo, S; Guan, XC; Zhang, W; Sun, FP; Yuan, HR; Zou, HR; Liu, HT; Yu, ZB				Liang, Lin; Wang, Zeyu; Qu, Lihua; Huang, Wei; Guo, Shuang; Guan, Xiangchen; Zhang, Wei; Sun, Fuping; Yuan, Hongrui; Zou, Huiru; Liu, Haitao; Yu, Zhongbo			Single-molecule multiplexed profiling of protein-DNA complexes using magnetic tweezers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN-STRUCTURE; CXXC DOMAIN; BINDING; TET1; METHYLATION; GENE; FORK	Epigenetics, such as the dynamic interplay between DNA methylation and demethylation, play diverse roles in critical cellular events. Enzymatic activity at CpG sites, where cytosines are methylated or demethylated, is known to be influenced by the density of CpGs, methylation states, and the flanking sequences of a CpG site. However, how the relevant enzymes are recruited to and recognize their target DNA is less clear. Moreover, although DNA-binding epigenetic enzymes are ideal targets for therapeutic intervention, these targets have been rarely exploited. Single-molecule techniques offer excellent capabilities to probe site-specific protein-DNA interactions and unravel the dynamics. Here, we develop a single-molecule approach that allows multiplexed profiling of protein-DNA complexes using magnetic tweezers. When a DNA hairpin with multiple binding sites is unzipping, strand separation pauses at the positions bound by a protein. We can thus measure site-specific binding probabilities and dissociation time directly. Taking the TET1 CXXC domain as an example, we show that TET1 CXXC binds multiple CpG motifs with various flanking nucleotides or different methylation patterns in an AT-rich DNA. We are able to establish for the first time, at nanometer resolution, that TET1 CXXC prefers G/C flanked CpG motif over C/G, A/T, or T/A flanked ones. CpG methylation strengthens TET1 CXXC recruitment but has little effect on dissociation time. Finally, we demonstrate that TET1 CXXC can distinguish five CpG clusters in a CpG island with crowded binding motifs. We anticipate that the feasibility of single-molecule multiplexed profiling assays will contribute to the understanding of protein-DNA interactions.	[Liang, Lin; Wang, Zeyu; Qu, Lihua; Huang, Wei; Guo, Shuang; Guan, Xiangchen; Yu, Zhongbo] Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Zhang, Wei; Sun, Fuping; Yuan, Hongrui; Liu, Haitao] Nankai Univ, Coll Elect Informat & Opt Engn, Inst Modern Opt, Tianjin Key Lab Optoelect Sensor & Sensing Networ, Tianjin, Peoples R China; [Zou, Huiru] Nankai Univ, Tianjin Stomatol Hosp, Affiliated Stomatol Hosp, Cent Lab, Tianjin, Peoples R China	Nankai University; Nankai University; Nankai University; Tianjin Medical University	Yu, ZB (corresponding author), Nankai Univ, Coll Pharm, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	zyu@nankai.edu.cn	Liang, Lin/AAH-9280-2021		Fundamental Research Funds for the Central Universities, Nankai University [035-63161138, 035-63191141, 035-63191735]; National Natural Science Foundation of China [31670763, 32071227]; National Natural Science Foundation of China	Fundamental Research Funds for the Central Universities, Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities, Nankai University [035-63161138, 035-63191141 and 035-63191735 to Z. Y.]. We also acknowledge support from the National Natural Science Foundation of China [Grants 31670763 and 32071227 to Z. Y.]. Funding for open access charge: National Natural Science Foundation of China.	Aguilar CA, 2013, NAT NANOTECHNOL, V8, P709, DOI 10.1038/nnano.2013.195; Berghuis BA, 2015, NAT CHEM BIOL, V11, P579, DOI [10.1038/NCHEMBIO.1857, 10.1038/nchembio.1857]; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Blackledge NP, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a018648; Bosco A, 2014, NUCLEIC ACIDS RES, V42, P2064, DOI 10.1093/nar/gkt1089; Camunas-Soler J, 2017, SCIENCE, V355, P412, DOI 10.1126/science.aah4077; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Cierpicki T, 2010, NAT STRUCT MOL BIOL, V17, P62, DOI 10.1038/nsmb.1714; Cnossen JP, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898178; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Good CR, 2017, NUCLEIC ACIDS RES, V45, P8269, DOI 10.1093/nar/gkx435; Gulvady R, 2018, NUCLEIC ACIDS RES, V46, P10216, DOI 10.1093/nar/gky826; Guo SW, 2018, CHEM SCI, V9, P5871, DOI 10.1039/c8sc01319e; Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Huang H, 2013, P NATL ACAD SCI USA, V110, P11994, DOI 10.1073/pnas.1310656110; Jiang X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02290-w; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; Koch SJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.028103; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Li N, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz464; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Lovkvist C, 2016, NUCLEIC ACIDS RES, V44, P5123, DOI 10.1093/nar/gkw124; Mandal S, 2015, ANGEW CHEM INT EDIT, V54, P7607, DOI 10.1002/anie.201502580; Manosas M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00379-w; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Ngo TTM, 2015, CELL, V160, P1135, DOI 10.1016/j.cell.2015.02.001; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Schmutz I, 2017, NAT STRUCT MOL BIOL, V24, P734, DOI 10.1038/nsmb.3451; Sun M, 2013, P NATL ACAD SCI USA, V110, P9920, DOI 10.1073/pnas.1305172110; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Velthuis AJWT, 2010, BIOPHYS J, V99, P1292, DOI 10.1016/j.bpj.2010.06.008; Visacka K, 2012, J BIOL CHEM, V287, P32206, DOI 10.1074/jbc.M112.385591; Wang YN, 2019, BIOCHEMISTRY-US, V58, P4696, DOI 10.1021/acs.biochem.9b00453; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wu H, 2014, NAT BIOTECHNOL, V32, P1231, DOI 10.1038/nbt.3073; Xu C, 2018, STRUCTURE, V26, P85, DOI 10.1016/j.str.2017.11.022; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yan J, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011905; Yu ZB, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4904148; Zhang Q, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw9807; Zhao XD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09104-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	45	5	5	2	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100327	10.1016/j.jbc.2021.100327	http://dx.doi.org/10.1016/j.jbc.2021.100327			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493518	gold, Green Published			2022-12-26	WOS:000672866400301
J	Castillo, LS; Fujiwara, M				Castillo, Liliana Sierra; Fujiwara, Masami			Assessment of a small-scale fishery: Lane Snapper (Lutjanus synagris) using a length metric method	PLOS ONE			English	Article							GILL-NET SELECTIVITY; REFERENCE POINTS; MANAGEMENT; INDICATORS; PARAMETERS; MORTALITY; RECRUIT; YIELD	Small-scale fisheries are hard to assess because of the limited availability of data. Therefore, a method requiring easy-to-obtain catch-data is important for the assessment and management of small-scale fisheries. The objective of this study was to assess the effect of fishing gear selectivity on a length-based metric method proposed by Froese by estimating three indicators using catch-data from Lane Snapper (Lutjanus synagris) collected in Honduras. These indicators are (1) the percentage of mature individuals in the catch, (2) the percentage of fish within the range of estimated optimal lengths to be captured, and (3) the percentage of fish larger than the optimal length. These indicators determine the level of overfishing. The indicators were estimated separately for catch-data corresponding to gill nets, and each indicator was estimated with and without selectivity correction. Selectivity and mesh sizes of the fishing gear had a major impact on the estimation of indicators 1 and 2. As for indicator 3, it consistently showed a high level of exploitation. The three estimated indicators suggested that the Lane Snapper fishery in Honduras is experiencing overfishing. Overall, the method appears to be promising for the assessment of small-scale fisheries, but it should be used cautiously.	[Castillo, Liliana Sierra] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Fujiwara, Masami] Texas A&M Univ, Dept Ecol & Conservat Biol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Castillo, LS (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lilianap.sierra@gmail.com			World Wildlife Fund (WWF); NSF [OCE 1656923]; Coral Reef Alliance	World Wildlife Fund (WWF); NSF(National Science Foundation (NSF)); Coral Reef Alliance	We would like to acknowledge the Coral Reef Alliance and the World Wildlife Fund (WWF) for providing the funding that made this study possible. MF was supported, in part, by NSF OCE 1656923.	ACOSTA A, 1992, B MAR SCI, V50, P282; ACOSTA AR, 1994, FISH RES, V19, P105, DOI 10.1016/0165-7836(94)90017-5; Andrew NL, 2007, FISH FISH, V8, P227, DOI 10.1111/j.1467-2679.2007.00252.x; Aschenbrenner A, 2017, FISH RES, V194, P155, DOI 10.1016/j.fishres.2017.06.004; Ault JS, 2008, ENVIRON CONSERV, V35, P221, DOI 10.1017/S0376892908005043; Babcock EA, 2018, FISH RES, V208, P70, DOI 10.1016/j.fishres.2018.07.003; Babcock EA, 2013, FISH RES, V147, P434, DOI 10.1016/j.fishres.2013.03.011; Berthou P., 2001, DIAGNOSTICO PESCA AR; BEVERTON RJH, 1992, J FISH BIOL, V41, P137, DOI 10.1111/j.1095-8649.1992.tb03875.x; Busilacchi S, 2012, FISHERIES MANAG ECOL, V19, P233, DOI 10.1111/j.1365-2400.2011.00826.x; Carbajal E., 2017, PORTAL CIENC, V12, P36, DOI DOI 10.5377/PC.V12I0.5516; Carruthers TR, 2014, FISH RES, V153, P48, DOI 10.1016/j.fishres.2013.12.014; Castillo LS, 2020, FISH RES, V231, DOI 10.1016/j.fishres.2020.105709; Cope JM, 2009, MAR COAST FISH, V1, P169, DOI 10.1577/C08-025.1; Cury PA, 2005, ICES J MAR SCI, V62, P307, DOI 10.1016/j.icesjms.2005.02.003; Doll JC, 2014, J FRESHWATER ECOL, V29, P279, DOI 10.1080/02705060.2014.891084; Francis RC, 2007, FISHERIES, V32, P217, DOI 10.1577/1548-8446(2007)32[217:TCFBFS]2.0.CO;2; Freitas MO, 2014, J MAR BIOL ASSOC UK, V94, P1711, DOI 10.1017/S0025315414001088; Froese R, 2004, FISH FISH, V5, P86, DOI 10.1111/j.1467-2979.2004.00144.x; Froese R, 2000, J FISH BIOL, V56, P758, DOI 10.1111/j.1095-8649.2000.tb00870.x; Froese R., 2018, ICES J MAR SCI, DOI [10.1093/icesjms/fsx22529881244, DOI 10.1093/ICESJMS/FSX22529881244]; Froese R, 2012, MAR BIOL, V159, P1283, DOI 10.1007/s00227-012-1909-6; GULLAND JA, 1987, MAR ECOL PROG SER, V39, P197, DOI 10.3354/meps039197; Gwinn DC, 2015, FISH FISH, V16, P259, DOI 10.1111/faf.12053; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Hilborn R, 2003, ANNU REV ENV RESOUR, V28, P359, DOI 10.1146/annurev.energy.28.050302.105509; Hilborn R, 2011, OVERFISHING WHAT EVE; Levin PS, 2006, CONSERV BIOL, V20, P1181, DOI 10.1111/j.1523-1739.2006.00400.x; Lobyrev F, 2018, REV FISH BIOL FISHER, V28, P909, DOI 10.1007/s11160-018-9534-1; McClanahan TR, 2004, FISHERIES MANAG ECOL, V11, P51, DOI 10.1111/j.1365-2400.2004.00358.x; Orensanz JM, 2005, B MAR SCI, V76, P527; Pauly D, 1997, AM FISH S S, V20, P40; Punt AE, 2001, MAR FRESHWATER RES, V52, P819, DOI 10.1071/MF00095; REIS EG, 1992, FISH RES, V13, P173, DOI 10.1016/0165-7836(92)90025-O; Shoup DE, 2016, N AM J FISH MANAGE, V36, P485, DOI 10.1080/02755947.2016.1141809; SISSENWINE MP, 1987, CAN J FISH AQUAT SCI, V44, P913, DOI 10.1139/f87-110; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	37	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0233479	10.1371/journal.pone.0233479	http://dx.doi.org/10.1371/journal.pone.0233479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524063	Green Submitted, Green Published, gold			2022-12-26	WOS:000616578400028
J	Zong, GN; Jork, N; Hostachy, S; Fiedler, D; Jessen, HJ; Shears, SB; Wang, HC				Zong, Guangning; Jork, Nikolaus; Hostachy, Sarah; Fiedler, Dorothea; Jessen, Henning J.; Shears, Stephen B.; Wang, Huanchen			New structural insights reveal an expanded reaction cycle for inositol pyrophosphate hydrolysis by human DIPP1	FASEB JOURNAL			English	Article						cell&#8208; signaling; Nudix; phosphatase; reaction mechanism	DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; ADP-RIBOSE PYROPHOSPHATASE; PHOSPHATE; ENZYME; SPECIFICITY; HYDROLASE; MECHANISM; PROTEINS; CAPTURE; ANALOGS	Nudix hydrolases attract considerable attention for their wide range of specialized activities in all domains of life. One particular group of Nudix phosphohydrolases (DIPPs), through their metabolism of diphosphoinositol polyphosphates (PP-InsPs), regulates the actions of these polyphosphates upon bioenergetic homeostasis. In the current study, we describe, at an atomic level, hitherto unknown properties of human DIPP1.We provide X-ray analysis of the catalytic core of DIPP1 in crystals complexed with either natural PP-InsPs, alternative PP-InsP stereoisomers, or non-hydrolysable methylene bisphosphonate analogs ("PCP-InsPs"). The conclusions that we draw from these data are interrogated by studying the impact upon catalytic activity upon mutagenesis of certain key residues. We present a picture of a V-shaped catalytic furrow with overhanging ridges constructed from flexible positively charged side chains; within this cavity, the labile phosphoanhydride bond is appropriately positioned at the catalytic site by an extensive series of interlocking polar contacts which we analogize as "suspension cables." We demonstrate functionality for a triglycine peptide within a beta-strand which represents a non-canonical addition to the standard Nudix catalytic core structure. We describe pre-reaction enzyme/substrate states which we posit to reflect a role for electrostatic steering in substrate capture. Finally, through time-resolved analysis, we uncover a chronological sequence of DIPP1/product post-reaction states, one of which may rationalize a role for InsP(6) as an inhibitor of catalytic activity.	[Zong, Guangning; Shears, Stephen B.; Wang, Huanchen] NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Jork, Nikolaus; Jessen, Henning J.] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Inst Organ Chem, Freiburg, Germany; [Hostachy, Sarah; Fiedler, Dorothea] Leibniz Forschungsinst Mol Pharmakol, Berlin, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Freiburg; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Wang, HC (corresponding author), NIEHS, Signal Transduct Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	Huanchen.wang@nih.gov	; Jessen, Henning/F-5108-2014	Zong, Guangning/0000-0001-6019-5741; Jessen, Henning/0000-0002-1025-9484; Jork, Nikolaus/0000-0002-3717-443X; Wang, Huanchen/0000-0003-2701-7155	Intramural NIH HHS [Z99 ES999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; Capolicchio S, 2014, ANGEW CHEM INT EDIT, V53, P9508, DOI 10.1002/anie.201404398; Capolicchio S, 2013, ANGEW CHEM INT EDIT, V52, P6912, DOI 10.1002/anie.201301092; Dollins DE, 2020, P NATL ACAD SCI USA, V117, P9356, DOI 10.1073/pnas.1908875117; Elliott TS, 2012, MEDCHEMCOMM, V3, P735, DOI 10.1039/c2md20079a; ENGEL R, 1977, CHEM REV, V77, P349, DOI 10.1021/cr60307a003; Flohr A, 1999, J MED CHEM, V42, P2633, DOI 10.1021/jm991008q; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Gao Y, 2016, SCIENCE, V352, P1334, DOI 10.1126/science.aad9633; Gerasimaite R, 2017, ACS CHEM BIOL, V12, P648, DOI 10.1021/acschembio.7b00026; Hua LV, 2003, BIOCHEM J, V373, P81, DOI 10.1042/BJ20030142; Kilari RS, 2013, FEBS LETT, V587, P3464, DOI 10.1016/j.febslet.2013.08.035; Kramer S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1511; Laussmann T, 2000, EUR J BIOCHEM, V267, P2447, DOI 10.1046/j.1432-1327.2000.01264.x; Leslie NR, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-20; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlovic I, 2016, ORG BIOMOL CHEM, V14, P5559, DOI 10.1039/c6ob00094k; Randall Thomas A., 2020, Advances in Biological Regulation, V75, P100674, DOI 10.1016/j.jbior.2019.100674; Riley AM, 2018, MEDCHEMCOMM, V9, DOI [10.1039/c8md00149a, 10.1039/C8MD00149A]; Safrany ST, 1998, EMBO J, V17, P6599, DOI 10.1093/emboj/17.22.6599; Saiardi A, 2005, P NATL ACAD SCI USA, V102, P1911, DOI 10.1073/pnas.0409322102; Shears SB, 2018, J CELL PHYSIOL, V233, P1897, DOI 10.1002/jcp.26017; Singh AN, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-0977-6; Srouji JR, 2017, PROTEINS, V85, P775, DOI 10.1002/prot.25223; Steidle EA, 2016, J BIOL CHEM, V291, P6772, DOI 10.1074/jbc.M116.714907; Thomas MP, 2014, FEBS J, V281, P14, DOI 10.1111/febs.12575; Thorsell AG, 2009, PROTEINS, V77, P242, DOI 10.1002/prot.22489; Tong J, 2015, PROTEINS, V83, P411, DOI 10.1002/prot.24746; Wade RC, 1998, P NATL ACAD SCI USA, V95, P5942, DOI 10.1073/pnas.95.11.5942; Wang HC, 2018, J BIOL CHEM, V293, P6905, DOI 10.1074/jbc.RA117.001670; Wang HC, 2014, CHEM BIOL, V21, P689, DOI 10.1016/j.chembiol.2014.03.009; Wang HC, 2012, NAT CHEM BIOL, V8, P111, DOI 10.1038/nchembio.733; WILCOX RA, 1994, EUR J BIOCHEM, V223, P115, DOI 10.1111/j.1432-1033.1994.tb18972.x; Williams MJ, 2015, MOL ENDOCRINOL, V29, P1303, DOI 10.1210/ME.2015-1077; Wilson MS, 2019, J BIOL CHEM, V294, P11597, DOI 10.1074/jbc.RA119.007848; Winward L, 2020, METHODS MOL BIOL, V2091, P75, DOI 10.1007/978-1-0716-0167-9_6; Winward L, 2010, INT J BIOCHEM CELL B, V42, P1174, DOI 10.1016/j.biocel.2010.04.003; Wu MX, 2014, ANGEW CHEM INT EDIT, V53, P7192, DOI 10.1002/anie.201402905; Yang XN, 1999, J BIOL CHEM, V274, P35434, DOI 10.1074/jbc.274.50.35434; York SJ, 2005, J BIOL CHEM, V280, P4264, DOI 10.1074/jbc.M412070200	44	5	5	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21275	10.1096/fj.202001489R	http://dx.doi.org/10.1096/fj.202001489R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475202	Green Accepted			2022-12-26	WOS:000647789600052
J	Balfanz, P; Hartmann, B; Muller-Wieland, D; Kleines, M; Hackl, D; Kossack, N; Kersten, A; Cornelissen, C; Muller, T; Daher, A; Stohr, R; Bickenbach, J; Marx, G; Marx, N; Dreher, M				Balfanz, Paul; Hartmann, Bojan; Mueller-Wieland, Dirk; Kleines, Michael; Haeckl, Dennis; Kossack, Nils; Kersten, Alexander; Cornelissen, Christian; Mueller, Tobias; Daher, Ayham; Stoehr, Robert; Bickenbach, Johannes; Marx, Gernot; Marx, Nikolaus; Dreher, Michael			Early risk markers for severe clinical course and fatal outcome in German patients with COVID-19	PLOS ONE			English	Article								Background Some patients with Corona Virus Disease 2019 (COVID-19) develop a severe clinical course with acute respiratory distress syndrome (ARDS) and fatal outcome. Clinical manifestations and biomarkers in early stages of disease with relevant predictive impact for outcomes remain largely unexplored. We aimed to identify parameters which are significantly different between subgroups. Design 125 patients with COVID-19 were analysed. Patients with ARDS (N = 59) or non-ARDS (N = 66) were compared, as well as fatal outcome versus survival in the two groups. Key results ARDS and non-ARDS patients did not differ with respect to comorbidities or medication on developing a fatal outcome versus survival. Body mass index was higher in patients with ARDS versus non-ARDS (p = 0.01), but not different within the groups in survivors versus non-survivors. Interleukin-6 levels on admission were higher in patients with ARDS compared to non-ARDS as well as in patients with fatal outcome versus survivors, whereas lymphocyte levels were lower in the different subgroups (all p<0.05). There was a highly significant 3.5-fold difference in fever load in non-survivors compared to survivors (p<0.0001). Extrapulmonary viral spread was detected more often in patients with fatal outcome compared to survivors (P = 0.01). Further the detection of SARS-CoV-2 in serum showed a significantly more severe course and an increased risk of death (both p<0.05). Conclusions We have identified early risk markers for a severe clinical course, like ARDS or fatal outcome. This data might help develop a strategy to address new therapeutic options early in patients with COVID-19 and at high risk for fatal outcome.	[Balfanz, Paul; Hartmann, Bojan; Mueller-Wieland, Dirk; Kersten, Alexander; Stoehr, Robert; Marx, Nikolaus] Univ Hosp Aachen, Dept Cardiol Angiol & Intens Care Med, Aachen, Germany; [Kleines, Michael] Univ Hosp Aachen, Dept Med Microbiol, Aachen, Germany; [Haeckl, Dennis; Kossack, Nils] WIG2 Sci Inst Hlth Econ & Hlth Syst Res, Leipzig, Germany; [Cornelissen, Christian; Mueller, Tobias; Daher, Ayham; Dreher, Michael] Univ Hosp Aachen, Dept Pneumol & Intens Care Med, Aachen, Germany; [Bickenbach, Johannes; Marx, Gernot] Univ Hosp Aachen, Dept Surg Intens Med & Intermediate Care, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Dreher, M (corresponding author), Univ Hosp Aachen, Dept Pneumol & Intens Care Med, Aachen, Germany.	mdreher@ukaachen.de	Müller, Tobias/ABH-7263-2020; Hartmann, Bojan/CAG-7460-2022; Kleines, Michael/C-8801-2009	Müller, Tobias/0000-0002-9801-3496; Hartmann, Bojan/0000-0003-4802-3458; Daher, Ayham/0000-0002-2088-8129; Balfanz, Paul/0000-0001-9539-4804	University Hospital and Medical Faculty of the RWTH Aachen	University Hospital and Medical Faculty of the RWTH Aachen	This analysis was funded by the University Hospital and Medical Faculty of the RWTH Aachen.	Bornstein SR, 2020, LANCET DIABETES ENDO, V8, P546, DOI 10.1016/S2213-8587(20)30152-2; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Dietz W, OBESITY, DOI [10.1002/oby.22818 32237206, DOI 10.1002/OBY.22818 32237206]; Dreher M, 2020, DTSCH ARZTEBL INT, V117, P271, DOI 10.3238/arztebl.2020.0271; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Kass DA, 2020, LANCET, V395, P1544, DOI 10.1016/S0140-6736(20)31024-2; Ma RCW, 2020, DIABETIC MED, V37, P723, DOI 10.1111/dme.14300; Mancia G, 2020, NEW ENGL J MED, V382, P2431, DOI 10.1056/NEJMoa2006923; Mehra MR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMoa2007621; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Patel AB, 2020, JAMA-J AM MED ASSOC, V323, P1769, DOI 10.1001/jama.2020.4812; Richardson S, 2020, JAMA; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yang X, J THROMBOSIS HAEMOST, DOI [10.1111/jth.14848 32302435, DOI 10.1111/JTH.14848 32302435]; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	24	5	5	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246182	10.1371/journal.pone.0246182	http://dx.doi.org/10.1371/journal.pone.0246182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513168	Green Published, gold			2022-12-26	WOS:000613891400028
J	Yoseph, A; Tamiso, A; Ejeso, A				Yoseph, Amanuel; Tamiso, Alemu; Ejeso, Amanuel			Knowledge, attitudes, and practices related to COVID-19 pandemic among adult population in Sidama Regional State, Southern Ethiopia: A community based cross-sectional study	PLOS ONE			English	Article								Introduction COVID-19 incidence is increasing and different measures have been adopted to control the spread of the pandemic in Ethiopia. Among these measures, enhancing the knowledge, positive attitudes, and proper practices of prevention measures about the disease is a basic strategy to control it. However, community compliance to control measures is largely dependent on their knowledge, attitudes, and practices (KAP) towards COVID-19. Objective To assess the current level of KAP towards COVID-19 pandemic and predictors among the rural dwellers in Sidama regional state, Southern Ethiopia; 2020. Methods This community-based prospective cross-sectional study was carried out from May 1-30, 2020 on a sample of 1,278 adult populations in Sidama regional state, Southern Ethiopia. A multi-stage sampling technique was used to choice the study participants. The data were collected using a structured interviewer-administered questionnaire. We have entered data using Epi data version 3.1 and all analyses were done using SPSS version 25. KAPs scores of study participants based on their independent variables were compared using Chi-square test, t-test or one-way analysis of variance (ANOVA) as required. Bi-variable and multivariable logistic regression analyses were used to identify factors associated with KAP. The important assumptions of the logistic regression model were checked to be satisfied. Adjusted odds ratios (AOR) with a 95% confidence interval (CI) were calculated to assess the existence and strength of associations. Results From a total of 1,214 study participants, the overall attained knowledge, attitude and practice score about COVID-19 were 90%, 82.4% and 65%, respectively. Among these, 43.9%, 37.5%, and 24.4% of the study participants had demonstrated good knowledge, high attitude and proper practice, respectively. The mean knowledge scores were significantly different between sex, categories of marital status, educational levels, main occupation, and the monthly income quintiles of the study participants (p<0.05). Similarly, the mean attitude scores significantly varied across educational levels, main occupations and marital status (p<0.05). Based on multivariable logistic regression analysis, main occupation of the government employees, education level of diploma and above, highest and second highest wealth rank were positively associated with COVID-19 prevention and control practice. Conclusions The majority of study participants had showed good knowledge and optimistic attitude toward COVID-19. But, the level of practice lower than that expected to maximize effective control measures. Further public education interventions and community sensitization campaigns are required for rural adult population in the Sidama regional state, Ethiopia.	[Yoseph, Amanuel; Tamiso, Alemu] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia; [Ejeso, Amanuel] Hawassa Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Hawassa, Ethiopia	Hawassa University; Hawassa University	Yoseph, A (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Hawassa, Ethiopia.	amanuelyoseph45@gmail.com	Debiso, Amanuel/AEY-8658-2022	Debiso, Amanuel/0000-0002-2447-5620; Yoseph, Amanuel/0000-0002-7708-6370	Hawassa University [HU/234/12]	Hawassa University	The financial aid of this thesis was obtained from Hawassa University with specific grant numbers HU/234/12. Alemu Tamiso Debiso is an author who received an award. The funded agency did not take part in thesis design, data collection and manuscript preparation process.	ALdowyan Nouf M., 2017, GHARABAWY REHAB M KN; [Anonymous], 2005, CANC BIOL THERAPY, V4, pv; Bernheim A, 2020, RADIOLOGY, V295, P685, DOI 10.1148/radiol.2020200463; CDC, 2020, COR DIS 2019 COVID 1; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; EFMO, 2020, COVID 19 PREV CONTR; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Erfani A, 2020, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.20.256651, DOI 10.2471/BLT.20.256651]; Ethiopia Federal Democratic Republic government, 2020, AN LEG STAT ETH COVI; Ethiopia Federal Democratic Republic government, 2020, ETH SUSP SCH SPORT E; Ethiopia Public Health Institute, 2020, PROT PUBL HLTH COVID; Gil M.R., 2020, Q A COR COVID 19; Hawassa City Administration, 2020, WEEKL COVID 19 REP C; News from the Earth Institute, 2020, HLTH CAR CRIS COVID; Sidama Administration, 2020, HLTH AGR REL ANN REP; Srichan P., 2020, KNOWLEDGE ATTITUDE P; WHO, 2019, REP WHO CHIN JOINT M; World Health Organization, COR DIS COVID 2019 S; World Health Organization, 2020, 64 WHO; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246283	10.1371/journal.pone.0246283	http://dx.doi.org/10.1371/journal.pone.0246283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513211	Green Published, gold			2022-12-26	WOS:000613891400056
J	Krayem, A; Yeretzian, A; Faour, G; Najem, S				Krayem, Alaa; Yeretzian, Aram; Faour, Ghaleb; Najem, Sara			Machine learning for buildings' characterization and power-law recovery of urban metrics	PLOS ONE			English	Article							STOCK; CLASSIFICATION; GENERATION; ALGORITHM; ENGLAND; MODELS; CITY	In this paper we focus on a critical component of the city: its building stock, which holds much of its socio-economic activities. In our case, the lack of a comprehensive database about their features and its limitation to a surveyed subset lead us to adopt data-driven techniques to extend our knowledge to the near-city-scale. Neural networks and random forests are applied to identify the buildings' number of floors and construction periods' dependencies on a set of shape features: area, perimeter, and height along with the annual electricity consumption, relying a surveyed data in the city of Beirut. The predicted results are then compared with established scaling laws of urban forms, which constitutes a further consistency check and validation of our workflow.	[Krayem, Alaa; Najem, Sara] Amer Univ Beirut, Phys Dept, Beirut, Lebanon; [Yeretzian, Aram] Amer Univ Beirut, Architecture & Design, Beirut, Lebanon; [Faour, Ghaleb] CNRS L, Natl Ctr Remote Sensing, Beirut, Lebanon	American University of Beirut; American University of Beirut; Centre National de la Recherche Scientifique (CNRS) - Lebanon; National Center for Remote Sensing (CNRSL)	Najem, S (corresponding author), Amer Univ Beirut, Phys Dept, Beirut, Lebanon.	sn62@aub.edu.lb	Krayem, Alaa/AAW-2755-2021	Yeretzian, Aram/0000-0001-5787-2334; Krayem, Alaa/0000-0003-1428-7826; Najem, Sara/0000-0002-1171-870X				Aksoezen M, 2015, ENERG BUILDINGS, V87, P74, DOI 10.1016/j.enbuild.2014.10.074; Arbid GJ, 2002, PRACTICING MODERNISM; Batty M, 2008, EUR PHYS J B, V63, P303, DOI 10.1140/epjb/e2008-00251-5; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2015, NEXUS NETW J, V17, P831, DOI 10.1007/s00004-015-0268-2; Belgiu M, 2014, REMOTE SENS-BASEL, V6, P1347, DOI 10.3390/rs6021347; Bettencourt L.M.A., 2015, ARXIV PREPRINT ARXIV; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bruhns H, 2000, ENVIRON PLANN B, V27, P33, DOI 10.1068/bst6; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Chen YX, 2019, ENERG BUILDINGS, V183, P252, DOI 10.1016/j.enbuild.2018.11.008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Costanzo V, 2019, CITIES, V95, DOI 10.1016/j.cities.2019.102467; Davila CC, 2013, BUILDING SIMULATION 2013: 13TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL BUILDING PERFORMANCE SIMULATION ASSOCIATION, P1280; Davila CC, 2016, ENERGY, V117, P237, DOI 10.1016/j.energy.2016.10.057; Dogan T, 2017, ENERG BUILDINGS, V140, P140, DOI 10.1016/j.enbuild.2017.01.030; Evans S, 2017, ENVIRON PLAN B-URBAN, V44, P227, DOI 10.1177/0265813516652898; Greger K, 2015, T GIS, V19, P129, DOI 10.1111/tgis.12086; Heinrich MA, 2019, IOP C SERIES EARTH E, V225; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hu SG, 2013, INT J REMOTE SENS, V34, P790, DOI 10.1080/01431161.2012.714510; Hudson P, 2018, HIST ENVIRON POLICY, V9, P306, DOI 10.1080/17567505.2018.1542776; Kohler N, 2009, BUILD RES INF, V37, P449, DOI 10.1080/09613210903189384; Krayem A, 2019, ENERG BUILDINGS, V199, P223, DOI 10.1016/j.enbuild.2019.06.050; Liu FT, 2008, IEEE DATA MINING, P413, DOI 10.1109/ICDM.2008.17; McPhearson T, 2016, BIOSCIENCE, V66, P198, DOI 10.1093/biosci/biw002; Meinel G, 2009, BUILD RES INF, V37, P468, DOI 10.1080/09613210903159833; Ng ST, 2014, PROCEDIA ENGINEER, V85, P385, DOI 10.1016/j.proeng.2014.10.564; Nguyen Hien M., 2011, International Journal of Knowledge Engineering and Soft Data Paradigms, V3, P4, DOI 10.1504/IJKESDP.2011.039875; Piette MA., 2016, 5 INT URB COMP WORKS; Ravetz J, 2008, ENERG POLICY, V36, P4462, DOI 10.1016/j.enpol.2008.09.026; Saliba R., 1998, BEIRUT 1920 1940 DOM; Smith D., 2019, COLOURING LONDON A C; Steadman P, 2009, BUILD RES INF, V37, P455, DOI 10.1080/09613210903152531; Svozil D, 1997, CHEMOMETR INTELL LAB, V39, P43, DOI 10.1016/S0169-7439(97)00061-0; Tanikawa H, 2009, BUILD RES INF, V37, P483, DOI 10.1080/09613210903169394; Zaki MJ, 2001, MACH LEARN, V42, P31, DOI 10.1023/A:1007652502315	37	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246096	10.1371/journal.pone.0246096	http://dx.doi.org/10.1371/journal.pone.0246096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33508036	Green Published, Green Submitted, gold			2022-12-26	WOS:000635021400087
J	Sudatip, D; Chasiri, K; Kritiyakan, A; Phanprasit, W; Thinphovong, C; Tiengrim, S; Thamlikitkul, V; Abdallah, R; Baron, SA; Rolain, JM; Morand, S; Hilty, M; Oppliger, A				Sudatip, Duangdao; Chasiri, Kittipong; Kritiyakan, Anamika; Phanprasit, Wantanee; Thinphovong, Chuanphot; Tiengrim, Surapee; Thamlikitkul, Visanu; Abdallah, Rim; Baron, Sophie Alexandra; Rolain, Jean-Marc; Morand, Serge; Hilty, Markus; Oppliger, Anne			A One Health approach to assessing occupational exposure to antimicrobial resistance in Thailand: The FarmResist project	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; EXTENDED-SPECTRUM; ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; PIG FARMERS; PREVALENCE; CARRIAGE; BACTERIA; PEOPLE	This Southeast Asia-Europe research project will use a One Health approach to identify the major parameters responsible for the presence of animal-associated antimicrobial resistant bacteria in animal production facilities in Thailand and the risk of their transmission from animals to humans. We will focus on traditional, small, extensive pig and poultry farms where information on antibiotic use is scarce and animals live in close contact with humans. This cross-sectional study will be based on the epidemiological analysis of the antimicrobial resistance (AMR) present in fecal samples from animals and humans. Extended spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) and Enterobacteriaceae resistant to colistin will be actively searched in the feces of farm animals (pigs and poultry), small wild rodents and farmers. Phenotypic (selective plating) and genotypic ( multilocus seuquence typing and sequencing) methods will be used for the detection of AMR, the identification of antibiotic resistance genes (ARGs) and the characterization of strains carrying resistance genes. Questionnaires will be administered to investigate the effects of antibiotic use, farm characteristics and biosecurity measures on the occurrence of AMR in animals. Subsequently, the fecal carriage of AMR and ARGs in farmers will be compared to a control population with no occupational contacts with animals, thus enabling an estimation of the risk of transmission of AMR/ARGs from animals to farmers.	[Sudatip, Duangdao; Phanprasit, Wantanee] Mahidol Univ, Fac Publ Hlth, Dept Occupat Hlth & Safety, Bangkok, Thailand; [Sudatip, Duangdao; Hilty, Markus] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Sudatip, Duangdao; Oppliger, Anne] Univ Lausanne, Dept Occupat Hlth & Environm, Unisante, Lausanne, Switzerland; [Chasiri, Kittipong; Thinphovong, Chuanphot] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Kritiyakan, Anamika; Morand, Serge] Kasetsart Univ, Fac Vet Technol, Bangkok, Thailand; [Tiengrim, Surapee] Mahidol Univ, Fac Med Technol, Dept Clin Microbiol & Appl Technol, Salaya, Nakhon Pathom, Thailand; [Thamlikitkul, Visanu] Mahidol Univ, Siriraj Hosp, Fac Med, Div Infect Dis & Trop Med,Dept Med, Bangkok, Thailand; [Abdallah, Rim; Baron, Sophie Alexandra; Rolain, Jean-Marc] Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, Marseille, France; [Morand, Serge] Univ Montpellier, Inst Sci Evolut, CNRS, Montpellier, France	Mahidol University; University of Bern; University of Lausanne; Mahidol University; Kasetsart University; Mahidol University; Mahidol University; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Oppliger, A (corresponding author), Univ Lausanne, Dept Occupat Hlth & Environm, Unisante, Lausanne, Switzerland.	anne.oppliger@unisante.ch	Rolain, Jean-Marc/Y-3788-2019; Morand, Serge/M-5433-2018; Baron, Sophie Alexandra/AAE-4512-2021	Rolain, Jean-Marc/0000-0002-2402-4467; Morand, Serge/0000-0003-3986-7659; Phanprasit, Wantanee/0000-0002-3928-3111	Southeast Asia - Europe Joint Funding Scheme for Research and Innovation [IZJFZ3-177614]; Thailand Center of Excellence for Life Sciences (TCELS); French ANR FutureHealthSEA [ANR-17-CE35-0003-02]	Southeast Asia - Europe Joint Funding Scheme for Research and Innovation; Thailand Center of Excellence for Life Sciences (TCELS); French ANR FutureHealthSEA(French National Research Agency (ANR))	This project is supported by the Southeast Asia - Europe Joint Funding Scheme for Research and Innovation, grant IZJFZ3-177614 to AO, MH, VT, JMR and SM; Thailand Center of Excellence for Life Sciences (TCELS) to VT; AK and KC are supported by the French ANR FutureHealthSEA (ANR-17-CE35-0003-02).	Boonyasiri A, 2014, PATHOG GLOB HEALTH, V108, P235, DOI 10.1179/2047773214Y.0000000148; Dohmen W, 2015, CLIN MICROBIOL INFEC, V21, P917, DOI 10.1016/j.cmi.2015.05.032; Fautsch Maci, 2014, ATTITUDES PRACTICES; Furuya-Kanamori L, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taz083; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Huijbers PMC, 2014, J ANTIMICROB CHEMOTH, V69, P2669, DOI 10.1093/jac/dku178; Kiratisin P, 2008, T ROY SOC TROP MED H, V102, P460, DOI 10.1016/j.trstmh.2008.02.005; Kraemer JG, 2017, SCI TOTAL ENVIRON, V603, P401, DOI 10.1016/j.scitotenv.2017.06.110; Liu WD, 2015, AM J INFECT CONTROL, V43, P469, DOI 10.1016/j.ajic.2014.12.009; Luvsansharav UO, 2012, J ANTIMICROB CHEMOTH, V67, P1769, DOI 10.1093/jac/dks118; Luvsansharav UO, 2011, J INFECT CHEMOTHER, V17, P722, DOI 10.1007/s10156-011-0225-2; Masclaux FG, 2013, ANN OCCUP HYG, V57, P550, DOI 10.1093/annhyg/mes098; Nang SC, 2019, CRIT REV MICROBIOL, V45, P131, DOI 10.1080/1040841X.2018.1492902; NaRanong V., 2007, PUBLICATION COMMISSI, P37; Nguyen NT, 2016, APPL ENVIRON MICROB, V82, P3727, DOI 10.1128/AEM.00337-16; Cuong NV, 2016, ECOHEALTH, V13, P490, DOI 10.1007/s10393-016-1130-z; Nhung NT, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5040037; Olaitan AO, 2015, J ANTIMICROB CHEMOTH, V70, P3402, DOI 10.1093/jac/dkv252; Olaitan AO, 2014, INT J ANTIMICROB AG, V44, P500, DOI 10.1016/j.ijantimicag.2014.07.020; Oppliger A, 2012, APPL ENVIRON MICROB, V78, P8010, DOI 10.1128/AEM.01902-12; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Ricardo T, 2018, PLOS NEGLECT TROP D, V12, DOI [10.1371/journal.pntd.0006470, DOI 10.1371/journal.pntd.0006470]; Sasaki T, 2010, J ANTIMICROB CHEMOTH, V65, P666, DOI 10.1093/jac/dkq008; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Tangcharoensathien V, 2017, B WORLD HEALTH ORGAN, V95, P599, DOI 10.2471/BLT.16.179648; Thanapongtharm W, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0849-7	26	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245250	10.1371/journal.pone.0245250	http://dx.doi.org/10.1371/journal.pone.0245250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507909	gold, Green Published			2022-12-26	WOS:000635021400030
J	Boujemaa, M; Hamdi, Y; Mejri, N; Romdhane, L; Ghedira, K; Bouaziz, H; El Benna, H; Labidi, S; Dallali, H; Jaidane, O; Ben Nasr, S; Haddaoui, A; Rahal, K; Abdelhak, S; Boussen, H; Boubaker, MS				Boujemaa, Maroua; Hamdi, Yosr; Mejri, Nesrine; Romdhane, Lilia; Ghedira, Kais; Bouaziz, Hanen; El Benna, Houda; Labidi, Soumaya; Dallali, Hamza; Jaidane, Olfa; Ben Nasr, Sonia; Haddaoui, Abderrazek; Rahal, Khaled; Abdelhak, Sonia; Boussen, Hamouda; Boubaker, Mohamed Samir			Germline copy number variations in BRCA1/2 negative families: Role in the molecular etiology of hereditary breast cancer in Tunisia	PLOS ONE			English	Article								Hereditary breast cancer accounts for 5-10% of all breast cancer cases. So far, known genetic risk factors account for only 50% of the breast cancer genetic component and almost a quarter of hereditary cases are carriers of pathogenic mutations in BRCA1/2 genes. Hence, the genetic basis for a significant fraction of familial cases remains unsolved. This missing heritability may be explained in part by Copy Number Variations (CNVs). We herein aimed to evaluate the contribution of CNVs to hereditary breast cancer in Tunisia. Whole exome sequencing was performed for 9 BRCA negative cases with a strong family history of breast cancer and 10 matched controls. CNVs were called using the ExomeDepth R-package and investigated by pathway analysis and web-based bioinformatic tools. Overall, 483 CNVs have been identified in breast cancer patients. Rare CNVs affecting cancer genes were detected, of special interest were those disrupting APC2, POU5F1, DOCK8, KANSL1, TMTC3 and the mismatch repair gene PMS2. In addition, common CNVs known to be associated with breast cancer risk have also been identified including CNVs on APO-BECA/B, UGT2B17 and GSTT1 genes. Whereas those disrupting SULT1A1 and UGT2B15 seem to correlate with good clinical response to tamoxifen. Our study revealed new insights regarding CNVs and breast cancer risk in the Tunisian population. These findings suggest that rare and common CNVs may contribute to disease susceptibility. Those affecting mismatch repair genes are of interest and require additional attention since it may help to select candidates for immunotherapy leading to better outcomes.	[Boujemaa, Maroua; Hamdi, Yosr; Mejri, Nesrine; Romdhane, Lilia; Bouaziz, Hanen; El Benna, Houda; Labidi, Soumaya; Dallali, Hamza; Abdelhak, Sonia; Boussen, Hamouda; Boubaker, Mohamed Samir] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, LR16IPT05, Tunis, Tunisia; [Hamdi, Yosr; Boubaker, Mohamed Samir] Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia; [Mejri, Nesrine; El Benna, Houda; Labidi, Soumaya; Boussen, Hamouda] Univ Tunis El Manar, Abderrahman Mami Hosp, Fac Med Tunis, Med Oncol Dept, Tunis, Tunisia; [Romdhane, Lilia] Univ Carthage, Fac Sci Bizerte, Dept Biol, Jarzouna, Tunisia; [Ghedira, Kais] Univ Tunis El Manar, Lab Bioinformat Biomath & Biostat, Inst Pasteur Tunis, LR16IPT09, Tunis, Tunisia; [Bouaziz, Hanen; Jaidane, Olfa; Rahal, Khaled] Salah Azaiez Inst Canc, Surg Oncol Dept, Tunis, Tunisia; [Ben Nasr, Sonia; Haddaoui, Abderrazek] Mil Hosp Tunis, Dept Med Oncol, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Hopital Abderrahmene Mami; Universite de Carthage; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Institut Salah Azaiez; Universite de Tunis-El-Manar; Hopital Militaire de Tunis	Hamdi, Y (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, LR16IPT05, Tunis, Tunisia.; Hamdi, Y (corresponding author), Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia.	yosr.hamdi@pasteur.tn	Bouaziz, Hanen/AAK-8308-2021; Hamdi, Yosr/GLT-7117-2022	Bouaziz, Hanen/0000-0001-5885-1252; Hamdi, Yosr/0000-0002-2815-1834; Boujemaa, Maroua/0000-0001-7409-9240	Tunisian Ministry of Health [PEC-4-TUN]; Tunisian Ministry of Higher Education and Scientific Research [LR11IPT05, LR16IPT05]; MOBIDOC fellowship - EU through the EMORI program	Tunisian Ministry of Health; Tunisian Ministry of Higher Education and Scientific Research; MOBIDOC fellowship - EU through the EMORI program	This study was supported by the Tunisian Ministry of Health (PEC-4-TUN) and the Tunisian Ministry of Higher Education and Scientific Research (LR11IPT05 and LR16IPT05). MB is a recipient of a MOBIDOC fellowship, funded by the EU through the EMORI program and managed by the ANPR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel HJ, 2020, NATURE, V583, P83, DOI 10.1038/s41586-020-2371-0; An O, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau015; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Curran JE, 2000, CANCER LETT, V153, P113, DOI 10.1016/S0304-3835(00)00361-X; Daly CS, 2017, ONCOGENE, V36, P1793, DOI 10.1038/onc.2016.342; Desvignes JP, 2018, NUCLEIC ACIDS RES, V46, pW545, DOI 10.1093/nar/gky471; Disciglio V, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0115-1; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; Economopoulou P, 2015, CANCER TREAT REV, V41, P1, DOI 10.1016/j.ctrv.2014.10.008; Ellingford JM, 2017, EUR J HUM GENET, V25, P719, DOI 10.1038/ejhg.2017.42; Eskandari-Nasab E, 2012, MOL BIOL REP, V39, P10531, DOI 10.1007/s11033-012-1938-8; Geoffroy V, 2018, BIOINFORMATICS, V34, P3572, DOI 10.1093/bioinformatics/bty304; Germani Aldo, 2018, Oncotarget, V9, P33648, DOI 10.18632/oncotarget.26000; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hamdi Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1504-9; Han YL, 2016, ONCOTARGET, V7, P74979, DOI 10.18632/oncotarget.11792; Hu XY, 2016, TUMOUR BIOL, V37; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jones DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044294; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Khedhaier A, 2003, BRIT J CANCER, V89, P1502, DOI 10.1038/sj.bjc.6601292; Klonowska K, 2017, ONCOTARGET, V8, P76357, DOI 10.18632/oncotarget.19400; Koolen DA, 2016, EUR J HUM GENET, V24, P652, DOI 10.1038/ejhg.2015.178; Krepischi ACV, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3109; Krishnamurthy N, 2018, CANCER TREAT REV, V62, P50, DOI 10.1016/j.ctrv.2017.11.002; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumaran M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14799-7; Kuusisto KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071802; Kwong A, 2015, CANCER GENET-NY, V208, P448, DOI 10.1016/j.cancergen.2015.05.031; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Masson AL, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-15; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moreno-Cabrera JM, 2019, BIORXIV, P850958; Moyer AM, 2011, PHARMACOGENOMICS, V12, P1535, DOI [10.2217/PGS.11.97, 10.2217/pgs.11.97]; Nowakowska B, 2017, J APPL GENET, V58, P449, DOI 10.1007/s13353-017-0407-4; Nunziato M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112487; Pan J-W, 2020, BIORXIV; Permuth-Wey J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2613; Pfundt R, 2017, GENET MED, V19, P667, DOI 10.1038/gim.2016.163; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Plagnol V, 2012, BIOINFORMATICS, V28, P2747, DOI 10.1093/bioinformatics/bts526; Pylkas K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002734; Reinholz MM, 2009, LANCET ONCOL, V10, P267, DOI 10.1016/S1470-2045(09)70063-4; Rezaei M, 2015, INT J MOL CELL MED, V4, P103; Riahi A, 2017, CANCER GENET-NY, V210, P22, DOI 10.1016/j.cancergen.2016.11.002; Roberts ME, 2018, GENET MED, V20, P1167, DOI 10.1038/gim.2017.254; Robertson A.G., 2017, CELL, V171, P540, DOI [10.1016/j.cell.2017.09.007, DOI 10.1016/J.CELL.2017.09.007]; Rotunno M, 2012, MOL CARCINOGEN, V51, pE142, DOI 10.1002/mc.21890; Saladores PH, 2013, EXPERT REV MOL DIAGN, V13, P349, DOI [10.1586/ERM.13.26, 10.1586/erm.13.26]; Schmidt AY, 2017, J MOL DIAGN, V19, P809, DOI 10.1016/j.jmoldx.2017.07.003; Schramm A, 2015, NAT GENET, V47, P872, DOI 10.1038/ng.3349; Sergentanis TN, 2010, BREAST CANCER RES TR, V121, P195, DOI 10.1007/s10549-009-0520-0; Shlien A, 2009, GENOME MED, V1, DOI 10.1186/gm62; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Surekha D., 2010, Biology and Medicine, V2, P49; Suszynska M, 2019, GYNECOL ONCOL, V153, P452, DOI 10.1016/j.ygyno.2019.01.027; Tan RJ, 2014, HUM MUTAT, V35, P899, DOI 10.1002/humu.22537; Tchatchou S, 2008, CYTOGENET GENOME RES, V123, P183, DOI 10.1159/000184707; Tengstrom M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-257; Vaughn CP, 2011, HUM MUTAT, V32, P1063, DOI 10.1002/humu.21540; Krepischi ACV, 2012, FUTURE ONCOL, V8, P441, DOI [10.2217/FON.12.34, 10.2217/fon.12.34]; Vos CBJ, 1999, BRIT J CANCER, V81, P1410, DOI 10.1038/sj.bjc.6693372; Walker LC, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0825-6; Wang LH, 2012, GENOME RES, V22, P208, DOI 10.1101/gr.123109.111; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089302; Yang JQ, 2017, INT J CLIN EXP MED, V10, P6273; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhan T, 2017, ONCOGENE, V36, P1461, DOI 10.1038/onc.2016.304; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506; Zhao FQ, 2018, INT J ONCOL, V52, P2069, DOI 10.3892/ijo.2018.4341	78	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245362	10.1371/journal.pone.0245362	http://dx.doi.org/10.1371/journal.pone.0245362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503040	gold, Green Published			2022-12-26	WOS:000613751800010
J	Giummarra, MJ; Ben Beck; Gabbe, BJ				Giummarra, Melita J.; Ben Beck; Gabbe, Belinda J.			Classification of road traffic injury collision characteristics using text mining analysis: Implications for road injury prevention	PLOS ONE			English	Article								Road traffic injuries are a leading cause of morbidity and mortality globally. Understanding circumstances leading to road traffic injury is crucial to improve road safety, and implement countermeasures to reduce the incidence and severity of road trauma. We aimed to characterise crash characteristics of road traffic collisions in Victoria, Australia, and to examine the relationship between crash characteristics and fault attribution. Data were extracted from the Victorian State Trauma Registry for motor vehicle drivers, motorcyclists, pedal cyclists and pedestrians with a no-fault compensation claim, aged > = 16 years and injured 2010-2016. People with intentional injury, serious head injury, no compensation claim/missing injury event description or who died < = 12-months post-injury were excluded, resulting in a sample of 2,486. Text mining of the injury event using QDA Miner and Wordstat was used to classify crash circumstances for each road user group. Crashes in which no other was at fault included circumstances involving lost control or avoiding a hazard, mechanical failure or medical conditions. Collisions in which another was predominantly at fault occurred at intersections with another vehicle entering from an adjacent direction, and head-on collisions. Crashes with higher prevalence of unknown fault included multi-vehicle collisions, pedal cyclists injured in rear-end collisions, and pedestrians hit while crossing the road or navigating slow traffic areas. We discuss several methods to promote road safety and to reduce the incidence and severity of road traffic injuries. Our recommendations take into consideration the incidence and impact of road trauma for different types of road users, and include engineering and infrastructure controls through to interventions targeting or accommodating human behaviour.	[Giummarra, Melita J.; Ben Beck; Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Giummarra, Melita J.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia; [Gabbe, Belinda J.] Swansea Univ, Swansea Univ Med Sch, Hlth Data Res UK, Swansea, W Glam, Wales	Monash University; Swansea University	Giummarra, MJ (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Giummarra, MJ (corresponding author), Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia.	melita.guimmarra@monash.edu	; Giummarra, Melita/H-8387-2012	Gabbe, Belinda/0000-0001-7096-7688; Beck, Ben/0000-0003-3262-5956; Giummarra, Melita/0000-0001-7839-6058	Australian Research Council (ARC) [DE170100726, DE180100825]; ARC Future Fellowship [FT170100048]; Transport Accident Commission (TAC); Department of Health and Human Services (State Government of Victoria)	Australian Research Council (ARC)(Australian Research Council); ARC Future Fellowship(Australian Research Council); Transport Accident Commission (TAC); Department of Health and Human Services (State Government of Victoria)	This project was funded by an Australian Research Council (ARC) Discovery Early Career Research Awards to MJG (DE170100726) and BB (DE180100825), and ARC Future Fellowship to BJG (FT170100048). The Victorian State Trauma Registry is funded by the Transport Accident Commission (TAC) and the Department of Health and Human Services (State Government of Victoria).	AGENT KR, 1980, TRANSPORT ENG-J ASCE, V106, P283; Allen T, 2017, TRANSPORT RES F-TRAF, V45, P157, DOI 10.1016/j.trf.2016.11.003; Ang JY, 2019, EMERG MED AUSTRALAS, V31, P851, DOI 10.1111/1742-6723.13361; [Anonymous], 2017, COST ROAD CRASHES AU; Asgarzadeh M, 2018, AM J IND MED, V61, P556, DOI 10.1002/ajim.22849; Ashley WS, 2015, B AM METEOROL SOC, V96, P755, DOI 10.1175/BAMS-D-14-00026.1; Assale M, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00066; Australian Bureau of Statistics, 1997, AUSTR STAND CLASS OC; Australian Bureau of Statistics, 2001, AUSTR STAND CALSS ED; Australian Bureau of Statistics, 2019, 9309 0 MOTOR VEH CEN; Australian Treasury Department, 2019, CONTRIBUTORY NEGLIGE; Beck B, 2019, ACCIDENT ANAL PREV, V128, P253, DOI 10.1016/j.aap.2019.03.007; Beck B, 2019, INJURY PREV, V25, P448, DOI 10.1136/injuryprev-2018-043014; Beck B, 2016, ACCIDENT ANAL PREV, V96, P219, DOI 10.1016/j.aap.2016.08.012; Brooks B, 2008, SAFETY SCI, V46, P1, DOI 10.1016/j.ssci.2006.09.006; Cameron PA, 2005, J TRAUMA, V59, P1469, DOI 10.1097/01.ta.0000198350.15936.a1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chekijian S, 2014, EMERG MED INT, V2014, DOI 10.1155/2014/139219; Cherry CC, 2019, TRAFFIC INJ PREV, V20, P58, DOI 10.1080/15389588.2018.1508835; Devlin A, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.105279; Ewing R, 2009, J PLAN LIT, V23, P347, DOI 10.1177/0885412209335553; Federal Chamber of Automotive Industries, FCAI RESP VICROADS R; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009907; Gabbe BJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-30; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Gabbe BJ, 2020, INJURY PREV; Giummarra MJ, 2020, ACCIDENT ANAL PREV, V135, DOI 10.1016/j.aap.2019.105333; Hasselberg M, 2009, ACCIDENT ANAL PREV, V41, P734, DOI 10.1016/j.aap.2009.03.012; Hedlund James H, 2004, Traffic Inj Prev, V5, P122, DOI 10.1080/15389580490435079; Hu W, 2018, J SAFETY RES, V67, P37, DOI 10.1016/j.jsr.2018.09.009; Ioannou LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178894; Ivan JN, 1999, ACCIDENT ANAL PREV, V31, P695, DOI 10.1016/S0001-4575(99)00030-5; Johnson M, 2013, SAFETY SCI, V59, P135, DOI 10.1016/j.ssci.2013.04.010; Johnson M, 2010, ROAD TRANSP RES, V19, P32; Karsligil ME, 2011 18 IEEE INT C I; Koppel S, 2018, TRAFFIC INJ PREV, V19, pS181, DOI 10.1080/15389588.2018.1426911; Lemieux CE, 2008, J FORENSIC SCI, V53, P709, DOI 10.1111/j.1556-4029.2008.00723.x; New Zealand Government, 2012, EMB SAF SYST APPR RO; Nguyen TQ, 2017, AUST HEALTH REV, V41, P283, DOI 10.1071/AH16050; NISBETT RE, 1973, J PERS SOC PSYCHOL, V27, P154, DOI 10.1037/h0034779; Ogden KW, 1994, AN CRASH PATT VICT S; Pennelly C, 2018, ATMOS OCEAN, V56, P362, DOI 10.1080/07055900.2018.1548344; Pink B., 2008, INFORM PAPER INTRO S; Rowden P, 2008, ACCIDENT ANAL PREV, V40, P1865, DOI 10.1016/j.aap.2008.08.002; Stephan KL, 2014, TRAFFIC INJ PREV, V15, pS74, DOI 10.1080/15389588.2014.930450; Stewart AE, 2005, ACCIDENT ANAL PREV, V37, P681, DOI 10.1016/j.aap.2005.03.010; Teschke K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1205; Theofilatos A, 2014, ACCIDENT ANAL PREV, V72, P244, DOI 10.1016/j.aap.2014.06.017; Thompson JP, 2013, ACCIDENT ANAL PREV, V50, P768, DOI 10.1016/j.aap.2012.06.028; Towards Zero Foundation, SAFE SYSTEM 2020; Tseng WS, 2005, IND MANAGE DATA SYST, V105, P1188, DOI 10.1108/02635570510633257; Vic Roads, 2013, APP C DEF CLASS ACC; Vic Roads, 2020, TYP HOURL TRAFF VOL; Williamson OD, 2013, INJURY PREV, V19, P238, DOI 10.1136/injuryprev-2012-040457; Zeng Q, 2016, J SAFETY RES, V59, P105, DOI 10.1016/j.jsr.2016.10.005	56	7	7	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245636	10.1371/journal.pone.0245636	http://dx.doi.org/10.1371/journal.pone.0245636			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503030	Green Published, gold			2022-12-26	WOS:000613751800052
J	Hollenbach, M; Sonnenberg, S; Sommerer, I; Lorenz, J; Hoffmeister, A				Hollenbach, Marcus; Sonnenberg, Sebastian; Sommerer, Ines; Lorenz, Jana; Hoffmeister, Albrecht			Pitfalls in AR42J-model of cerulein-induced acute pancreatitis	PLOS ONE			English	Article							ACINAR-CELLS; INFLAMMATORY RESPONSE; IL-6 EXPRESSION; AR42J CELLS; ACTIVATION; PATHWAY; PROTEIN; GROWTH; INJURY; GLUCOCORTICOIDS	Background AR42J are immortalized pancreatic adenocarcinoma cells that share similarities with pancreatic acinar cells. AR42J are often used as a cell-culture model of cerulein (CN)-induced acute pancreatitis (AP). Nevertheless, it is controversial how to treat AR42J for reliable induction of AP-like processes. Gene knockout and/or overexpression often remain challenging, as well. In this study, we demonstrate conditions for a reliable induction of proinflammatory markers upon CN treatment in AR42J and high transfection efficacy using Glyoxalase-I (Glo-I) as a target of interest. Methods Effects of dexamethasone (dexa) and CN on cell morphology and amylase secretion were analyzed via ELISA of supernatant. IL-6, TNF-alpha and NF-kappa B-p65 were measured via qRT-PCR, ELISA and Western Blot (WB). Transfection efficacy was determined by WB, qRT-PCR and immune fluorescence of pEGFP-N1-Glo-I-Vector and Glo-I-siRNA. Results Treatment of AR42J with 100 nm dexa is mandatory for differentiation to an acinar-cell-like phenotype and amylase production. CN resulted in secretion of amylase but did not influence amylase production. High levels of CN-induced amylase secretion were detected between 3 and 24 hours of incubation. Treatment with LPS alone or in combination with CN did not influence amylase release compared to control or CN. CN treatment resulted in increased TNF-alpha production but not secretion and did not influence IL-6 mRNA. CN-induced stimulation of NF-kappa B was found to be highest on protein levels after 6h of incubation. Transient transfection was able to induce overexpression on protein and mRNA levels, with highest effect after 12 to 24 hours. Gene-knockdown was achieved by using 30 pmol of siRNA leading to effective reduction of protein levels after 72 hours. CN did not induce amylase secretion in AR42J cell passages beyond 35. Conclusion AR42J cells demonstrate a reliable in-vitro model of CN-induced AP but specific conditions are mandatory to obtain reproducible data.	[Hollenbach, Marcus; Sonnenberg, Sebastian; Sommerer, Ines; Lorenz, Jana; Hoffmeister, Albrecht] Univ Leipzig, Med Ctr, Med Dept Oncol Gastroenterol Hepatol Pulmonol Inf, D-04103 Leipzig, Germany	Leipzig University	Hollenbach, M (corresponding author), Univ Leipzig, Med Ctr, Med Dept Oncol Gastroenterol Hepatol Pulmonol Inf, D-04103 Leipzig, Germany.	marcus.hollenbach@medizin.uni-leipzig.de	Hollenbach, Marcus/ABF-7452-2021		German Research Foundation (DFG); Universitat Leipzig	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig	We acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing (to MH).	[Anonymous], 2013, LANCET, V382, P1, DOI 10.1016/S0140-6736(13)61509-3; [Anonymous], 2015, GUT LIVER, V9, P267; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Bhatia V, 2012, REGUL PEPTIDES, V175, P49, DOI 10.1016/j.regpep.2012.01.006; BLACKMORE M, 1992, BRIT J CANCER, V66, P32, DOI 10.1038/bjc.1992.212; Cai YX, 2016, IN VITRO CELL DEV-AN, V52, P530, DOI 10.1007/s11626-016-0011-7; Cai YX, 2016, DIGEST DIS SCI, V61, P747, DOI 10.1007/s10620-015-3948-6; Chan YC, 2011, REGUL PEPTIDES, V166, P128, DOI 10.1016/j.regpep.2010.10.006; Chen P, 2011, INT J MOL MED, V27, P731, DOI 10.3892/ijmm.2011.632; Chen P, 2010, INT J MOL MED, V26, P619, DOI 10.3892/ijmm_00000507; Chen X, 2018, MED SCI MONITOR, V24, P3204, DOI 10.12659/MSM.906968; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; De Lisle RC, 2005, AM J PHYSIOL-CELL PH, V289, pC1169, DOI 10.1152/ajpcell.00099.2005; DICKINSON CJ, 1993, AM J PHYSIOL, V264, pG553, DOI 10.1152/ajpgi.1993.264.3.G553; Eum WS, 2003, EXP MOL MED, V35, P379, DOI 10.1038/emm.2003.50; Gu LG, 2018, BIOCHEM BIOPH RES CO, V503, P1563, DOI 10.1016/j.bbrc.2018.07.080; GUTHRIE J, 1991, PANCREAS, V6, P506, DOI 10.1097/00006676-199109000-00002; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Hollenbach M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112466; Hollenbach M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171260; Huang LY, 2012, INFLAMMATION, V35, P1023, DOI 10.1007/s10753-011-9406-5; Huang LY, 2012, INT J MOL MED, V30, P514, DOI 10.3892/ijmm.2012.1050; Jia D, 2008, GASTROENTEROLOGY, V135, P1687, DOI 10.1053/j.gastro.2008.07.026; Jiang CY, 2017, MOL MED REP, V15, P502, DOI 10.3892/mmr.2016.6027; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Johnson JR, 2017, NEW ENGL J MED, V376, P598, DOI 10.1056/NEJMc1616177; Ju KD, 2017, J CANCER PREV, V22, P189, DOI 10.15430/JCP.2017.22.3.189; Ju KD, 2011, INFLAMM RES, V60, P791, DOI 10.1007/s00011-011-0335-4; Kandil E, 2006, WORLD J GASTROENTERO, V12, P6806, DOI 10.3748/wjg.v12.i42.6806; Kimura K, 1998, GASTROENTEROLOGY, V114, P372, DOI 10.1016/S0016-5085(98)70490-1; Kullman J, 1996, AM J PHYSIOL-GASTR L, V270, pG746, DOI 10.1152/ajpgi.1996.270.5.G746; Lee J, 2003, ANN NY ACAD SCI, V1010, P104, DOI 10.1196/annals.1299.017; Lee J, 2007, ANN NY ACAD SCI, V1095, P129, DOI 10.1196/annals.1397.016; LERCH MM, 1994, INT J PANCREATOL, V15, P159; Lim JW, 2008, INT J BIOCHEM CELL B, V40, P2065, DOI 10.1016/j.biocel.2008.02.015; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; LOGSDON CD, 1987, J BIOL CHEM, V262, P15765; Mayerle J, 2019, GASTROENTEROLOGY, V156, P1951, DOI 10.1053/j.gastro.2018.11.081; Michel M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00785; Nakamura Y, 2010, AM J PHYSIOL-GASTR L, V298, pG92, DOI 10.1152/ajpgi.00324.2009; RAJASEKARAN AK, 1993, J CELL SCI, V105, P333; Santel T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003508; Sledzinski M, 2013, PANCREAS, V42, P1070, DOI 10.1097/MPA.0b013e318287d097; Song EA, 2017, INT J BIOCHEM CELL B, V88, P60, DOI 10.1016/j.biocel.2017.05.011; SWAROVSKY B, 1988, EUR J CELL BIOL, V47, P101; Tang XP, 2017, PANCREAS, V46, P1305, DOI 10.1097/MPA.0000000000000946; Wan HY, 2008, BIOMED PHARMACOTHER, V62, P466, DOI 10.1016/j.biopha.2007.10.012; Wang GL, 2018, SHOCK, V50, P465, DOI 10.1097/SHK.0000000000001071; Wang J, 2015, PANCREAS, V44, P266, DOI 10.1097/MPA.0000000000000247; Wang Y, 2018, MOL MED REP, V17, P3511, DOI 10.3892/mmr.2017.8354; Xie HL, 2017, MED SCI MONITOR, V23, P5650, DOI 10.12659/MSM.904398; Xue DB, 2009, PANCREAS, V38, pE183, DOI 10.1097/MPA.0b013e3181b65dec; Yu JH, 2005, FREE RADICAL BIO MED, V39, P590, DOI 10.1016/j.freeradbiomed.2005.04.019; Yu JH, 2003, ANN NY ACAD SCI, V1010, P66, DOI 10.1196/annals.1299.009; Yu JH, 2005, INT J BIOCHEM CELL B, V37, P1458, DOI 10.1016/j.biocel.2005.02.004; Yu JH, 2007, INT J BIOCHEM CELL B, V39, P2063, DOI 10.1016/j.biocel.2007.05.021; Yu JH, 2006, BIOCHEM PHARMACOL, V72, P1555, DOI 10.1016/j.bcp.2006.07.008; Yuan JZ, 2008, AM J PHYSIOL-GASTR L, V295, pG1190, DOI 10.1152/ajpgi.90452.2008; Zhang J, 2015, DIGEST DIS SCI, V60, P127, DOI 10.1007/s10620-014-3261-9; Zhao JL, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/7321352; Zhao Q, 2018, PANCREAS, V47, P884, DOI 10.1097/MPA.0000000000001082; Zhou HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154483; 2014, REG ANESTH PAIN MED, V9	64	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0242706	10.1371/journal.pone.0242706	http://dx.doi.org/10.1371/journal.pone.0242706			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493150	Green Published, gold			2022-12-26	WOS:000613081500046
J	Kloucek, P; von Gunten, A				Kloucek, Petr; von Gunten, Armin			The geometric approach to human stress based on stress-related surrogate measures	PLOS ONE			English	Article							TRANSPORT; BLOOD	We present a predictive Geometric Stress Index (pGSI) and its relation to behavioural Entropy (b E). b E is a measure of the complexity of an organism's reactivity to stressors yielding patterns based on different behavioural and physiological variables selected as Surrogate Markers of Stress (SMS). We present a relationship between pGSI and b E in terms of a power law model. This nonlinear relationship describes congruences in complexity derived from analyses of observable and measurable SMS based patterns interpreted as stress. The adjective geometric refers to subdivision(s) of the domain derived from two SMS (heart rate variability and steps frequency) with respect to a positive/negative binary perceptron based on a third SMS (blood oxygenation). The presented power law allows for both quantitative and qualitative evaluations of the consequences of stress measured by pGSI. In particular, we show that elevated stress levels in terms of pGSI leads to a decrease of the b E of the blood oxygenation, measured by peripheral blood oxygenation SpO2 as a model of SMS.	[Kloucek, Petr; von Gunten, Armin] Lausanne Univ Hosp, Dept Psychiat, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Kloucek, P (corresponding author), Lausanne Univ Hosp, Dept Psychiat, Lausanne, Switzerland.	petr.kloucek@iCloud.com		von Gunten, Armin/0000-0001-7852-3803				Alberdi A, 2016, J BIOMED INFORM, V59, P49, DOI 10.1016/j.jbi.2015.11.007; [Anonymous], 2016, ARS IURIS SALMANTICE, V4, P261; Bolstad WM, 2010, WILEY SERIES COMPUTA; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Cain G, 2017, COMPUTER SCI TECHNOL; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cantrell C. D., 2000, MODERN MATH METHODS; CHIEN S, 1970, SCIENCE, V168, P977, DOI 10.1126/science.168.3934.977; Cutsem Bv, 1994, LECT NOTES STAT; Everitt B, 2009, STAT SOCIAL BEHAV SC, V1st; FIELD DA, 1988, COMMUN APPL NUMER M, V4, P709, DOI 10.1002/cnm.1630040603; Greenacre M, 2017, ECOLOGY, V98, P2293, DOI 10.1002/ecy.1937; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Health Executive Agency Work-related stress, 2017, WORK REL STRESS DEPR; Hosmer DW, 2013, WILEY SER PROBAB ST, P1, DOI 10.1002/9781118548387; Howell D. C., 2013, STAT METHODS PSYCHOL; Kloucek P, 2018, J APPL MATH, V9, P1378, DOI [10.4236/am.2018.912090, DOI 10.4236/AM.2018.912090]; Kloucek P, 2016, J APPL MATH, V7, P2212, DOI [10.4236/am.2016.717176, DOI 10.4236/AM.2016.717176]; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Kruse R., 2013, TEXTS COMPUTER SCI; LEE DT, 1980, INT J COMPUT INF SCI, V9, P219, DOI 10.1007/BF00977785; MacKay D. J. C., 2003, INFORM THEORY INFERE; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Morters P., 2010, CAMBRIDGE SERIES STA; NIKINMAA M, 1992, J COMP PHYSIOL B, V162, P424; NIKINMAA M, 1992, PHYSIOL REV, V72, P301, DOI 10.1152/physrev.1992.72.2.301; NIKINMAA M, 1992, RESP PHYSIOL, V87, P219, DOI 10.1016/0034-5687(92)90061-Z; Pearson K., 1895, P R SOC LOND, V58, P240, DOI [10.1098/rspl.1895.0041, DOI 10.1098/RSPL.1895.0041]; Peitgen H., 1992, CHAOS FRACTALS, DOI [10.1007/978-1-4757-4740-9, DOI 10.1007/978-1-4757-4740-9]; Point Carbon, 2011, POINT CARBON, V6, P1; RIGGS AF, 1988, ANNU REV PHYSIOL, V50, P181, DOI 10.1146/annurev.ph.50.030188.001145; Ripley B. D., 1996, PATTERN RECOGNITION; Rossi RJ, 2010, APPL BIOSTATISTICS H; Schalkoff RJ, 1997, MCGRAW HILL SERIES C; Schrodinger E, 1944, WHAT IS LIFE; Shi Yuan, 2010, SANTOSH PERSONALIZED; SNYDER GK, 1977, J APPL PHYSIOL, V42, P673, DOI 10.1152/jappl.1977.42.5.673	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0219414	10.1371/journal.pone.0219414	http://dx.doi.org/10.1371/journal.pone.0219414			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493209	Green Published, Green Submitted, gold			2022-12-26	WOS:000613081500034
J	Satoh, D; Nakayama, H; Furuta, T; Yoshihiro, T; Sakamoto, K				Satoh, Daiki; Nakayama, Hiromasa; Furuta, Takuya; Yoshihiro, Tamotsu; Sakamoto, Kensaku			Simulation code for estimating external gamma-ray doses from a radioactive plume and contaminated ground using a local-scale atmospheric dispersion model	PLOS ONE			English	Article							LARGE-EDDY SIMULATION; TURBULENT-FLOW; TRANSPORT; SYSTEM; EXPOSURE; PARTICLE; VERSION; SCHEME; CESIUM	In this study, we developed a simulation code powered by lattice dose-response functions (hereinafter SIBYL), which helps in the quick and accurate estimation of external gamma-ray doses emitted from a radioactive plume and contaminated ground. SIBYL couples with atmospheric dispersion models and calculates gamma-ray dose distributions inside a target area based on a map of activity concentrations using pre-evaluated dose-response functions. Moreover, SIBYL considers radiation shielding due to obstructions such as buildings. To examine the reliability of SIBYL, we investigated five typical cases for steady-state and unsteady-state plume dispersions by coupling the Gaussian plume model and the local-scale high-resolution atmospheric dispersion model using large eddy simulation. The results of this coupled model were compared with those of full Monte Carlo simulations using the particle and heavy-ion transport code system (PHITS). The dose-distribution maps calculated using SIBYL differed by up to 10% from those calculated using PHITS in most target locations. The exceptions were locations far from the radioactive contamination and those behind the intricate structures of building arrays. In addition, SIBYL's computation time using 96 parallel processing elements was several tens of minutes even for the most computationally expensive tasks of this study. The computation using SIBYL was approximately 100 times faster than the same calculation using PHITS under the same computation conditions. From the results of the case studies, we concluded that SIBYL can estimate a ground-level dose-distribution map within one hour with accuracy that is comparable to that of the full Monte Carlo simulation.	[Satoh, Daiki; Nakayama, Hiromasa; Furuta, Takuya] Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Ibaraki, Japan; [Yoshihiro, Tamotsu] Hewlett Packard Japan Ltd, Tech Serv, East Tech Consultant, Koto Ku, Tokyo, Japan; [Sakamoto, Kensaku] Japan Atom Energy Agcy, Ctr Computat Sci & E Syst, Ibaraki, Japan	Japan Atomic Energy Agency; Hewlett-Packard; Japan Atomic Energy Agency	Satoh, D (corresponding author), Japan Atom Energy Agcy, Nucl Sci & Engn Ctr, Ibaraki, Japan.	satoh.daiki@jaea.go.jp	Satoh, Daiki/GON-4416-2022	Satoh, Daiki/0000-0001-6639-8208	Japan Society for the Promotion of Science KAKENHI Grant [JP17K07017]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) KAKENHI Grant Number JP17K07017. In addition, one of the authors (TY) is affiliated with HewlettPackard Japan, Ltd. (HPE, https://www.hpe.com), which is a commercial company, and HPE provided support in the form of salaries for the author. The specific roles of the author are articulated in the "author contributions" section. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahrens James, 2005, VISUALIZATION HDB, V717, DOI [10.1016/B978-012387582-2/50038-1, DOI 10.1016/B978-012387582-2/50038-1]; Allwine J, 2004, OVERVIEW JOINT URBAN; Andronopoulos S, 2010, J RADIOL PROT, V30, P747, DOI 10.1088/0952-4746/30/4/008; Armand P, 2015, COST ES1006 BEST PRA; FACKRELL JE, 1982, J FLUID MECH, V117, P1, DOI 10.1017/S0022112082001499; Gifford F.A., 1960, NUCL SAFETY, V2, P67; Gifford Jr. F.A., 1961, NUCL SAFETY, V2, P47; Hirayama H, 2005, SLACR730; ICRP, 1996, CONV COEFF US RAD PR, P74; Iwamoto Y, 2017, J NUCL SCI TECHNOL, V54, P617, DOI 10.1080/00223131.2017.1297742; Nakayama H, 2016, J NUCL SCI TECHNOL, V53, P887, DOI 10.1080/00223131.2015.1078262; Nakayama H, 2014, J NUCL SCI TECHNOL, V51, P626, DOI 10.1080/00223131.2014.885400; Nakayama H, 2013, J NUCL SCI TECHNOL, V50, P503, DOI 10.1080/00223131.2013.785267; Nakayama H, 2011, J NUCL SCI TECHNOL, V48, P374, DOI 10.3327/jnst.48.374; Nakayama H, 2009, J NUCL SCI TECHNOL, V46, P1170, DOI 10.3327/jnst.46.1170; Namito Y, 2012, J NUCL SCI TECHNOL, V49, P167, DOI 10.1080/00223131.2011.649079; Pecha P, 2014, ATMOS ENVIRON, V89, P298, DOI 10.1016/j.atmosenv.2014.01.007; Rakesh PT, 2015, J ENVIRON RADIOACTIV, V145, P30, DOI 10.1016/j.jenvrad.2015.03.021; Sada K, 2002, ATMOS ENVIRON, V36, P5527, DOI 10.1016/S1352-2310(02)00668-4; Sato T, 2018, J NUCL SCI TECHNOL, V55, P684, DOI 10.1080/00223131.2017.1419890; Satoh D, 2017, J NUCL SCI TECHNOL, V54, P1018, DOI 10.1080/00223131.2017.1344157; Satoh D, 2016, J NUCL SCI TECHNOL, V53, P69, DOI 10.1080/00223131.2015.1021286; Satoh D, 2014, J NUCL SCI TECHNOL, V51, P656, DOI 10.1080/00223131.2014.886534; Simsek V, 2014, SCI TOTAL ENVIRON, V499, P74, DOI 10.1016/j.scitotenv.2014.08.038; Stocki TJ, 2009, RADIOPROTECTION, V44, P735, DOI DOI 10.1051/RADIOPRO/20095134; Sutton OG, 1932, P R SOC LOND A-CONTA, V135, P143, DOI 10.1098/rspa.1932.0025; Vervecken L, 2015, J RADIOL PROT, V35, P165, DOI 10.1088/0952-4746/35/1/165; Zhang XL, 2018, J ENVIRON RADIOACTIV, V184, P32, DOI 10.1016/j.jenvrad.2018.01.002	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245932	10.1371/journal.pone.0245932	http://dx.doi.org/10.1371/journal.pone.0245932			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493217	gold, Green Published			2022-12-26	WOS:000613081500011
J	Crnogorac, A; Panno, S; Mandic, A; Gaspar, M; Caruso, AG; Noris, E; Davino, S; Matic, S				Crnogorac, Ana; Panno, Stefano; Mandic, Ana; Gaspar, Mladen; Caruso, Andrea Giovanni; Noris, Emanuela; Davino, Salvatore; Matic, Slavica			Survey of five major grapevine viruses infecting Blatina and Zilavka cultivars in Bosnia and Herzegovina	PLOS ONE			English	Article							HEMIPTERA PSEUDOCOCCIDAE; RECOMBINATION EVENTS; GENETIC-VARIABILITY; PLANOCOCCUS-FICUS; XIPHINEMA-INDEX; FANLEAF-VIRUS; GRAPEVINE-LEAFROLL-ASSOCIATED-VIRUS-3; LEAFROLL; TRANSMISSION; DIVERSITY	The sanitary status of grapevines has not yet been considered sufficiently in vineyards throughout Bosnia and Herzegovina (BiH). An extensive survey of five major grapevine viruses in the country was carried out in 2019. A total of 630 samples from the two dominant autochthonous cultivars, named Zilavka and Blatina, were tested by DAS-ELISA for the presence of grapevine leafroll-associated viruses (GLRaV-1 and 3), grapevine fleck virus (GFkV), grapevine fanleaf virus (GFLV) and Arabis mosaic virus (ArMV). Eighty-eight % of the samples were positive for at least one virus, and all five viruses were detected, thought with different incidence, i.e. GLRaV-3 (84%), GFLV (43%), GLRaV-1 (14%), GFkV (10%) and ArMV (0.2%). The majority of infected plants (about 75%) were asymptomatic. Specific virus symptoms were observed in the remaining infected plants, together with the reported GLRaV vectors, Planococcus ficus and Parthenolecanium corni, while nematodes of the Xiphinema genus were not found in the GFLV- or ArMV-infected vineyards. The GLRaV-3 CP phylogenetic analyses showed 75-100% nucleotide identity between the BiH and reference isolates, and the BiH isolates clustered into the major group. The dNS/dS ratio indicated a negative selection of the virus population, and the lack of geographical structuring within the population was observed. In addition, putative GLRaV-3 recombinants with breakpoints in the 5' of the CP gene were detected, while no recombinant strains were identified for the other four viruses. The obtained results indicate a deteriorated sanitary status of the cultivated grapevines, the prevalence and intraspecies genetic diversity of GLRaV-3 throughout the country. The establishment of certified grapevine material and adequate virus vector control is therefore of primary importance to prevent further spread of these viruses. This study presents the results of the first molecular characterisation of grapevine viruses in Bosnia and Herzegovina.	[Crnogorac, Ana; Gaspar, Mladen] Fed Agromediterranean Inst Mostar, Mostar, Bosnia & Herceg; [Panno, Stefano; Caruso, Andrea Giovanni; Davino, Salvatore] Univ Palermo, Dept Agr Food & Forest Sci, Palermo, Italy; [Panno, Stefano] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol, Palermo, Italy; [Mandic, Ana] Univ Mostar, Fac Agr & Food Technol, Mostar, Bosnia & Herceg; [Noris, Emanuela; Davino, Salvatore; Matic, Slavica] Natl Res Council Italy IPSP CNR, Inst Sustainable Plant Protect, Turin, Italy	University of Palermo; University of Palermo; University of Mostar; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR)	Davino, S (corresponding author), Univ Palermo, Dept Agr Food & Forest Sci, Palermo, Italy.; Davino, S; Matic, S (corresponding author), Natl Res Council Italy IPSP CNR, Inst Sustainable Plant Protect, Turin, Italy.	salvatore.davino@unipa.it; slavica.matic@ipsp.cnr.it	Noris, Emanuela/ABF-7030-2021; Noris, Emanuela/B-9419-2015; Caruso, Andrea Giovanni/ABG-8698-2020; Matić, Slavica/L-6810-2017	Noris, Emanuela/0000-0001-8656-8841; Noris, Emanuela/0000-0001-8656-8841; Matić, Slavica/0000-0002-0885-8744; Mandic, Ana/0000-0002-2648-7879				Al Rwahnih M, 2015, PHYTOPATHOLOGY, V105, P758, DOI 10.1094/PHYTO-06-14-0165-R; Alabi OJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149666; Alabi OJ, 2011, PHYTOPATHOLOGY, V101, P1446, DOI 10.1094/PHYTO-04-11-0114; Andret-Link P, 2004, J PLANT PATHOL, V86, P183; [Anonymous], 1999, SAMPLING TECHNIQUES; [Anonymous], 2013, PRAVILNIK STAVLJANJU, V50, P68; Bahder BW, 2013, ENVIRON ENTOMOL, V42, P1292, DOI 10.1603/EN13060; Barsi L., 1996, Nematologia Mediterranea, V24, P195; Basso MF, 2017, REV BRAS FRUTIC, V39, DOI 10.1590/0100-29452017411; Burger J.T., 2017, GRAPEVINE VIRUSES MO, P167; Cabaleiro C, 1997, PLANT DIS, V81, P283, DOI 10.1094/PDIS.1997.81.3.283; Cabaleiro C, 2006, EUR J PLANT PATHOL, V114, P441, DOI 10.1007/s10658-006-0006-4; Cid M, 2007, EUR J PLANT PATHOL, V118, P23, DOI 10.1007/s10658-006-9090-8; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Credi R, 1997, AM J ENOL VITICULT, V48, P7; Crnogorac A, 2020, J PLANT PATHOL, V102, P1299, DOI 10.1007/s42161-020-00580-9; Cseh E, 2009, CEREAL RES COMMUN, V37, P153; Czotter N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00122; Davino S., 2018, CHEM ENG TRANS, V58, P619, DOI DOI 10.3303/CET1758104; Delic D., 2016, Agroznanje - Agro-knowledge Journal, V17, P143; Delic D., 2007, Pesticidi i Fitomedicina, V22, P45; Demian E, 2020, EUR J PLANT PATHOL, V156, P897, DOI 10.1007/s10658-020-01942-w; Diaz-Lara A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208862; Digiaro M., 1999, OPT MEDITERRRANEEN B, V29, P83; DIMITRIJEVIC B, 1973, Rivista di Patologia Vegetale, V9, P114; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Elena SF, 2014, ADV VIRUS RES, V88, P161, DOI 10.1016/B978-0-12-800098-4.00003-9; Esteves F, 2013, J VIROL METHODS, V194, P258, DOI 10.1016/j.jviromet.2013.09.004; Fan XD, 2015, ARCH VIROL, V160, P1669, DOI 10.1007/s00705-015-2437-8; Farooq AU, 2013, VIRUS RES, V171, P15, DOI 10.1016/j.virusres.2012.10.014; FLEGG JJM, 1967, ANN APPL BIOL, V60, P429, DOI 10.1111/j.1744-7348.1967.tb04497.x; Fuchs M, 2009, PHYTOPATHOLOGY, V99, P1177, DOI 10.1094/PHYTO-99-10-1177; Fuchs M, 2020, J PLANT PATHOL, V102, P643, DOI 10.1007/s42161-020-00579-2; Gambino G, 2006, PHYTOPATHOLOGY, V96, P1223, DOI 10.1094/PHYTO-96-1223; Glasa M, 2012, J PLANT PATHOL, V94, P675; Golino DA, 2008, CALIF AGR, V62, P156, DOI 10.3733/ca.v062n04p156; Gouveia P, 2011, ARCH VIROL, V156, P413, DOI 10.1007/s00705-010-0878-7; Herrbach E., 2016, VECTOR MEDIATED TRAN, P147; Hodgson C.J., 1994, SCALE INSECT FAMILY; Karacic A, 2014, ZBORNIK SAZ B; Kostadinovska E, 2014, PLANT DIS, V98, DOI 10.1094/PDIS-05-14-0518-PDN; Kosztarab M., 1988, Scale insects of Central Europe.; Kruger K, 2015, S AFR J ENOL VITIC, V36, P223; Krueger K, 2013, AFR ENTOMOL, V21, P1, DOI 10.4001/003.021.0115; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuzmanovic S, 2003, 14 M ICVG SEPT 12 17, P180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasic V, 2010, 21 SCI EXP C AGR FOO, P130; Leopold S, 2007, VITIS, V46, P49; Madden L.V., 2007, STUDY PLANT DIS EPID; Mahfoudhi N, 2009, PLANT DIS, V93, P999, DOI 10.1094/PDIS-93-10-0999; Maree HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126819; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Marmonier A, 2010, J PLANT PATHOL, V92, P275; Martelli G.P., 2017, GRAPEVINE VIRUSES MO, P31, DOI DOI 10.1007/978-3-319-57706-7_2; Martelli GP, 2014, J PLANT PATHOL, V96, P1; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Martin RR, 2005, PLANT DIS, V89, P763, DOI 10.1094/PD-89-0763; de Moura CJM, 2018, SCI AGR, V75, P43, DOI [10.1590/1678-992X-2016-0328, 10.1590/1678-992x-2016-0328]; Matic S, 2006, PLANT PATHOL, V55, P11, DOI 10.1111/j.1365-3059.2005.01309.x; Mekuria TA, 2009, PHYTOPATHOLOGY, V99, P1394, DOI 10.1094/PHYTO-99-12-1394; Naidu R, 2014, PLANT DIS, V98, P1172, DOI 10.1094/PDIS-08-13-0880-FE; Nei M, 2000, MOL EVOLUTION PHYLOG, P147; Oliver JE, 2012, PSYCHOSIS, V4, P6, DOI 10.1080/17522439.2011.637117; Olmos A, 2016, PHYTOPATHOLOGY, V106, P510, DOI 10.1094/PHYTO-10-15-0246-R; Ostojic I, 2014, S ZAST BILJ BOSN HER, P38; Panno S, 2019, PLANT PATHOL, V68, P601, DOI 10.1111/ppa.12978; Panno S, 2018, ARCH VIROL, V163, P795, DOI 10.1007/s00705-017-3674-9; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Pesqueira AM, 2016, PLANT PATHOL, V65, P310, DOI 10.1111/ppa.12413; Pompe-Novak M, 2007, EUR J PLANT PATHOL, V117, P307, DOI 10.1007/s10658-006-9096-2; Poojari S, 2016, PLANT DIS, V100, P1028, DOI 10.1094/PDIS-10-15-1212-PDN; RASKI DJ, 1983, PLANT DIS, V67, P335, DOI 10.1094/PD-67-335; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Sabella E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200875; Tsai CW, 2008, PHYTOPATHOLOGY, V98, P1093, DOI 10.1094/PHYTO-98-10-1093; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; van Zyl S, 2012, S AFR J ENOL VITIC, V33, P21; Williams D., 1992, MEALYBUGS CENTRAL S; Xiao HG, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1036-1	80	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245959	10.1371/journal.pone.0245959	http://dx.doi.org/10.1371/journal.pone.0245959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481949	Green Published, gold			2022-12-26	WOS:000612929300016
J	El-Turk, N; Chou, MSH; Ting, NCH; Girgis, A; Vinod, SK; Bray, V; Dobler, CC				El-Turk, Nicole; Chou, Michael S. H.; Ting, Natasha C. H.; Girgis, Afaf; Vinod, Shalini K.; Bray, Victoria; Dobler, Claudia C.			Treatment burden experienced by patients with lung cancer	PLOS ONE			English	Article								Introduction Patients' burden from lung cancer treatment is not well researched, but this understanding can facilitate a patient-centred treatment approach. Current models of treatment burden suggest it is influenced by a patient's perception of their disease and treatment and their capacity to do the work required to treat their disease. Methods Sixteen patients and 1 carer who were undergoing or had completed conventional or stereotactic ablative radiotherapy, chemotherapy or immunotherapy for lung cancer in the last 6 months participated in a semi-structured interview. A treatment burden framework was used with three main themes: a) treatment work, b) consequences of treatment and c) psychosocial factors affecting treatment burden. Results The majority of patients did not feel unduly burdened by treatment tasks, despite having a large treatment-associated workload. Many saw treatment as a priority, causing them to restructure their life to accommodate for it. Patients wished that they would have been better informed about the lifestyle changes that they would have to make before treatment for lung cancer commenced and that the health service would provide services to assist them with this task. Discussion While there was a large burden associated with lung cancer treatment, patients felt motivated and equipped to manage the workload because the disease was considered severe and life-threatening, and the treatment was seen as beneficial. Before initiating treatment for lung cancer, patients should be informed about lifestyle changes they likely have to make and should be offered assistance.	[El-Turk, Nicole; Chou, Michael S. H.; Ting, Natasha C. H.; Dobler, Claudia C.] Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia; [El-Turk, Nicole; Chou, Michael S. H.; Ting, Natasha C. H.; Girgis, Afaf; Vinod, Shalini K.; Dobler, Claudia C.] Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Girgis, Afaf; Vinod, Shalini K.; Bray, Victoria] Ingham Inst Appl Med Res, Ctr Oncol Educ & Res Translat CONCERT, Sydney, NSW, Australia; [Vinod, Shalini K.; Bray, Victoria] Liverpool Hosp, Canc Therapy Ctr, Sydney, NSW, Australia; [Dobler, Claudia C.] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld, Australia; [Dobler, Claudia C.] Gold Coast Univ Hosp, Gold Coast, Qld, Australia	Liverpool Hospital; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Liverpool Hospital; Bond University; Gold Coast University Hospital	El-Turk, N (corresponding author), Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia.; El-Turk, N (corresponding author), Univ New South Wales, South Western Sydney Clin Sch, Sydney, NSW, Australia.	nicole_elturk@hotmail.com		El-Turk, Nicole/0000-0003-1112-9670; Dobler, Claudia/0000-0002-5460-0189; Vinod, Shalini/0000-0001-8075-6219	South Western Sydney Local Health District (SWSLHD); Australian National Health and Medical Research Council [APP1123733]; Cancer Institute NSW	South Western Sydney Local Health District (SWSLHD); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW	C.C.D. was supported by an award from the South Western Sydney Local Health District (SWSLHD, https://www.swslhd.health.nsw.gov.au/) and a fellowship of the Australian National Health and Medical Research Council (grant#APP1123733, https://www.nhmrc.gov.au/).A.G.is funded through Cancer Institute NSW grants (https://www.cancer.nsw.gov.au/).The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Boehmer KR, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0525-9; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Demain S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125457; Dobler CC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4065; Eisfeld H, 2019, J CANC ED OFFICIAL J; Eton DT, 2013, PATIENT-RELAT OUTCOM, V4, P7, DOI 10.2147/PROM.S44694; Lehto RH, 2017, LUNG CANCER-TARGETS, V8, P79, DOI 10.2147/LCTT.S120215; Lippiett KA, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2017-020515; May CR, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-281; Mazieres J, 2015, J THORAC ONCOL, V10, P420, DOI 10.1097/JTO.0000000000000433; Midthun DE, 2020, OVERVIEW RISK FACTOR; Petri S, 2015, INT J QUAL STUD HEAL, V10, DOI 10.3402/qhw.v10.29397; Presley CJ, 2017, J ONCOL PRACT, V13, pE98, DOI 10.1200/JOP.2016.014100; Pujol JL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197605; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Srivastava P., 2009, INT J QUAL METH, V8, P76, DOI [10.1177/160940690900800107, DOI 10.1177/160940690900800107]; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245492	10.1371/journal.pone.0245492	http://dx.doi.org/10.1371/journal.pone.0245492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481895	gold, Green Published			2022-12-26	WOS:000612929300147
J	Thabet, P; Joshi, A; MacDonald, E; Hutton, B; Cheng, W; Stevens, A; Kanji, S				Thabet, Pierre; Joshi, Anchal; MacDonald, Erika; Hutton, Brian; Cheng, Wei; Stevens, Adrienne; Kanji, Salmaan			Clinical and pharmacokinetic/dynamic outcomes of prolonged infusions of beta-lactam antimicrobials: An overview of systematic reviews	PLOS ONE			English	Review							ALTERNATIVE DOSING STRATEGIES; TERM INTRAVENOUS-INFUSION; CRITICALLY-ILL PATIENTS; PIPERACILLIN-TAZOBACTAM; EXTENDED-INFUSION; SEPTIC SHOCK; INTERMITTENT INFUSION; EVALUATING OUTCOMES; REDUCING WASTE; SEVERE SEPSIS	Objective This overview of reviews aims to map and compare of objectives, methods, and findings of existing systematic reviews to develop a greater understanding of the information available about prolonged beta-lactam infusions in hospitalized patients with infection. Design Overview of systematic reviews. Data sources Medline, Embase, PROSPERO and the Cochrane Library were systematically searched from January, 1990 to June, 2019 using a peer reviewed search strategy. Grey literature was also searched for relevant reviews. Eligibility criteria for selecting reviews Systematic reviews were sought that compared two or more infusion strategies for intravenous beta-lactam antimicrobials and report clinical cure or mortality. Populations of included reviews were restricted to hospitalized patients with infection, without restrictions on age, infection type, or disease. Data extraction and analysis Abstract screening, data extraction, quality and risk of bias assessment were conducted by two independent reviewers. Overlap between reviews was assessed using a modified corrected covered area. Overview findings are reported in accordance with Cochrane's recommendation for overview conduct. Clinical outcomes extracted included survival, clinical cure, treatment failure, microbiological cure, length of stay, adverse events, cost, and emergence of resistance. Results The search strategy identified 3327 unique citations from which 21 eligible reviews were included. Reviews varied by population, intervention and outcomes studied. Between reviews, overlap of primary studies was generally high, methodologic quality generally low and risk of bias variable. Nine of 14 reviews that quantitatively evaluated mortality and clinical cure identified a benefit with prolonged infusions of beta lactams when compared with intermittent infusions. Evidence of mortality and clinical cure benefit was greater among critically ill patients when compared to less sick patients and lower in randomized controlled trials when compared with observational studies. Conclusions Findings from our review demonstrate a consistent and reproducible lack of harm with prolonged infusions of beta-lactam antibiotics with variability in effect size and significance of benefits. Despite 21 systematic reviews addressing prolonged infusions of beta-lactams, this overview supports the continued need for a definitive systematic review given variability in populations, interventions and outcomes in the current systematic reviews. Subsequent systematic reviews should have more rigorous and transparent methods, only include RCTs and evaluate the proposed benefits found in various subgroup-analyses-i.e. high risk of mortality.	[Thabet, Pierre; MacDonald, Erika; Kanji, Salmaan] Ottawa Hosp, Ottawa, ON, Canada; [Joshi, Anchal] Univ Waterloo, Waterloo, ON, Canada; [Hutton, Brian; Cheng, Wei; Kanji, Salmaan] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Hutton, Brian; Kanji, Salmaan] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Stevens, Adrienne] McMaster Univ, Hamilton, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Waterloo; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McMaster University	Kanji, S (corresponding author), Ottawa Hosp, Ottawa, ON, Canada.; Kanji, S (corresponding author), Ottawa Hosp Res Inst, Ottawa, ON, Canada.; Kanji, S (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.	skanji@toh.ca	Thabet, Pierre/GRS-0558-2022; Cheng, Wei/AAE-4605-2022	Cheng, Wei/0000-0002-1475-4079; Kanji, Salmaan/0000-0003-0594-0360				Acosta Garcia H, 2012, Farm Hosp, V36, P424, DOI 10.1016/j.farma.2011.06.013; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauer KA, 2013, ANTIMICROB AGENTS CH, V57, P2907, DOI 10.1128/AAC.02365-12; Bougioukas KI, 2018, J CLIN EPIDEMIOL, V93, P9, DOI 10.1016/j.jclinepi.2017.10.002; Burgess SV, 2015, ANN PHARMACOTHER, V49, P311, DOI 10.1177/1060028014564179; CADTH, 2014, GREY MATT PRACT TOOL, DOI [10.1016/j.jclinepi.2015.06.005, DOI 10.1016/J.JCLINEPI.2015.06.005]; Centre for Reviews and D, 2015, DATABASE ABSTRACTS R; Chant C, 2013, CRIT CARE, V17, DOI 10.1186/cc13134; Chytra I, 2012, CRIT CARE, V16, DOI 10.1186/cc11405; De Waele JJ, 2014, INTENS CARE MED, V40, P1340, DOI 10.1007/s00134-014-3403-8; Falagas ME, 2013, CLIN INFECT DIS, V56, P272, DOI 10.1093/cid/cis857; Feher C, 2014, J ANTIMICROB CHEMOTH, V69, P2556, DOI 10.1093/jac/dku150; Felton TW, 2013, ANTIMICROB AGENTS CH, V57, P5811, DOI 10.1128/AAC.00867-13; Gao H, 2008, CRIT CARE, V12, DOI 10.1186/cc6862; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Grant EM, 2002, PHARMACOTHERAPY, V22, P471, DOI 10.1592/phco.22.7.471.33665; Guilhaumou R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2378-9; Hassan F, 2013, INT J PHARM SCI REV, V23, P356; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Korbila IP, 2013, EXPERT REV ANTI-INFE, V11, P585, DOI [10.1586/eri.13.44, 10.1586/ERI.13.44]; Kumar A, 2009, CRIT CARE CLIN, V25, P733, DOI 10.1016/j.ccc.2009.08.004; Kuti J. L., 2016, REV M DICA 150 NICA, V27, P615; LAGAST H, 1983, EUR J CLIN MICROBIOL, V2, P554, DOI 10.1007/BF02016564; Lal A, 2016, INFECT CHEMOTHER, V48, P81, DOI 10.3947/ic.2016.48.2.81; Lau WK, 2006, ANTIMICROB AGENTS CH, V50, P3556, DOI 10.1128/AAC.00329-06; Lee YR, 2018, EUR J DRUG METAB PH, V43, P171, DOI 10.1007/s13318-017-0446-6; Lee YR, 2018, EUR J DRUG METAB PH, V43, P155, DOI 10.1007/s13318-017-0439-5; Lodise TP, 2007, CLIN INFECT DIS, V44, P357, DOI 10.1086/510590; Lux L.J., 2014, PHARMACOKINETIC PHAR; Mah GT, 2012, ANN PHARMACOTHER, V46, P265, DOI 10.1345/aph.1Q378; Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Muller AE, 2013, J ANTIMICROB CHEMOTH, V68, P900, DOI 10.1093/jac/dks468; Nicolau DP, 2008, CRIT CARE, V12, DOI 10.1186/cc6818; Perez-Bracchiglione, 2019, COCHR SANT C 2019 SA; Perrott J, 2010, ANN PHARMACOTHER, V44, P557, DOI 10.1345/aph.1M339; Pieper D, 2014, J CLIN EPIDEMIOL, V67, P368, DOI 10.1016/j.jclinepi.2013.11.007; Polat G, 2017, EURASIAN J MED, V49, P53, DOI 10.5152/eurasianjmed.2017.17062; Pollock M, 2020, COCHRANE HDB SYSTEMA, P2020; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rhodes NJ, 2018, CRIT CARE MED, V46, P236, DOI 10.1097/CCM.0000000000002836; Roberts JA, 2007, INT J ANTIMICROB AG, V30, P11, DOI 10.1016/j.ijantimicag.2007.02.002; Roberts JA, 2016, AM J RESP CRIT CARE, V194, P681, DOI 10.1164/rccm.201601-0024OC; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027; Roberts JA, 2009, CRIT CARE MED, V37, P2071, DOI 10.1097/CCM.0b013e3181a0054d; Seyler L, 2011, CRIT CARE, V15, DOI 10.1186/cc10257; Shabaan AE, 2017, PEDIATR INFECT DIS J, V36, P358, DOI [10.1097/INF.0000000000001445, 10.1097/inf.0000000000001445]; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Taccone FS, 2010, CRIT CARE, V14, DOI 10.1186/cc9091; Tamma PD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-181; Teo J, 2014, INT J ANTIMICROB AG, V43, P403, DOI 10.1016/j.ijantimicag.2014.01.027; Thalhammer F, 1999, J ANTIMICROB CHEMOTH, V43, P523, DOI 10.1093/jac/43.4.523; Vardakas KZ, 2018, LANCET INFECT DIS, V18, P108, DOI [10.1016/S1473-3099(17)30615-1, 10.1016/s1473-3099(17)30615-1]; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; Walker MC, 2012, ANN PHARMACOTHER, V46, P1537, DOI 10.1345/aph.1R216; Wang Zhenhong, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P644, DOI 10.3760/cma.j.issn.2095-4352.2014.09.008; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Yang H, 2016, J PHARM PHARM SCI, V19, P274, DOI 10.18433/jpps.v19i2.27517; Yang H, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116769, 10.1155/2015/985351]; Yu ZW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201667; Yusuf E, 2014, J CRIT CARE, V29, P1089, DOI 10.1016/j.jcrc.2014.07.033; Zhao HY, 2017, CHINESE MED J-PEKING, V130, P1139, DOI 10.4103/0366-6999.205859	63	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244966	10.1371/journal.pone.0244966	http://dx.doi.org/10.1371/journal.pone.0244966			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481817	gold, Green Published			2022-12-26	WOS:000612929300144
J	Isidoro-Garcia, L; Villalpando, DM; Ferrer, M				Isidoro-Garcia, Lucia; Villalpando, Diva M.; Ferrer, Mercedes			Vasomotor action of androgens in the mesenteric artery of hypertensive rats. Role of perivascular innervation	PLOS ONE			English	Article							NEURONAL NITRIC-OXIDE; GENE-RELATED PEPTIDE; PROTEIN-KINASE-C; ORCHIECTOMY INCREASES; VASCULAR REACTIVITY; NORADRENALINE RELEASE; CONTRACTILE RESPONSES; TESTOSTERONE THERAPY; CORONARY-ARTERIES; NERVE STIMULATION	Androgens may exert cardiovascular protective actions by regulating the release and function of different vascular factors. In addition, testosterone (TES) and its 5-reduced metabolites, 5 alpha- and 5 beta-dihydrotestosterone (5 alpha- and 5 beta-DHT) induce vasorelaxant and hypotensive effects. Furthermore, hypertension has been reported to alter the release and function of the neurotransmitters nitric oxide (NO), calcitonin gene-related peptide (CGRP) and noradrenaline (NA). Since the mesenteric arteries possess a dense perivascular innervation and significantly regulate total peripheral vascular resistance, the objective of this study was to analyze the effect of TES, 5 alpha- and 5 beta-DHT on the neurogenic release and vasomotor function of NO, CGRP and NA. For this purpose, the superior mesenteric artery from male spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) rats was used to analyze: (i) the effect of androgens (10 nM, incubated for 30 min) on the neurogenic release of NO, CGRP and NA and (ii) the vasoconstrictor-response to NA and the vasodilator responses to the NO donor, sodium nitroprusside (SNP) and exogenous CGRP. The results showed that TES, 5 alpha- or 5 beta-DHT did not modify the release of NO, CGRP or NA induced by electrical field stimulation (EFS) in the arteries of SHR; however, in the arteries of WKY rats androgens only caused an increase in EFS-induced NO release. Moreover, TES, and especially 5 beta-DHT, increased the vasodilator response induced by SNP and CGRP in the arteries of SHR. These findings could be contributing to the hypotensive/antihypertensive efficacy of 5 beta-DHT previously described in conscious SHR and WKY rats, pointing to 5 beta- DHT as a potential drug for the treatment of hypertension.	[Isidoro-Garcia, Lucia; Villalpando, Diva M.; Ferrer, Mercedes] Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain; [Ferrer, Mercedes] Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain	Autonomous University of Madrid; Hospital Universitario La Paz	Ferrer, M (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Fisiol, Madrid, Spain.; Ferrer, M (corresponding author), Inst Invest Hosp Univ La Paz IdiPAZ, Madrid, Spain.	mercedes.ferrer@uam.es	Isidoro, Lucia/ABF-5225-2021	Isidoro, Lucia/0000-0003-0369-8582	Instituto de Salud Carlos III [PI11/00406, PI19/01282]; Comunidad de Madrid (INSPIRA1-CM) [S2013/ABI-2783]; Fondo Europeo de Desarrollo Regional	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid (INSPIRA1-CM)(Comunidad de Madrid); Fondo Europeo de Desarrollo Regional(European Commission)	This study was supported by grants to MF from the Instituto de Salud Carlos III (PI11/00406 and PI19/01282), Comunidad de Madrid (S2013/ABI-2783, "INSPIRA1-CM") and Fondo Europeo de Desarrollo Regional. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETTCONNOR E, 1988, CIRCULATION, V78, P539, DOI 10.1161/01.CIR.78.3.539; Bekesi G, 2000, STEROIDS, V65, P889, DOI 10.1016/S0039-128X(00)00183-5; Bencze M, 2016, LIFE SCI, V166, P46, DOI 10.1016/j.lfs.2016.10.005; Blanco-Rivero J, 2006, NEUROENDOCRINOLOGY, V84, P378, DOI 10.1159/000098820; Blanco-Rivero J, 2005, J VASC RES, V42, P526, DOI 10.1159/000088342; Blanco-Rivero J, 2007, J ENDOCRINOL, V192, P189, DOI 10.1677/joe.1.07079; Blanco-Rivero J, 2013, J HYPERTENS, V31, P916, DOI 10.1097/HJH.0b013e32835f749c; Byku M, 2010, AM J PHYSIOL-HEART C, V298, pH457, DOI 10.1152/ajpheart.00400.2009; Cameron AC, 2016, DRUGS, V76, P1529, DOI 10.1007/s40265-016-0642-8; CHRISTENSEN KL, 1993, J VASC RES, V30, P73, DOI 10.1159/000158978; Cignarella A, 2000, N-S ARCH PHARMACOL, V361, P166, DOI 10.1007/s002109900173; Deenadayalu VUP, 2001, AM J PHYSIOL-HEART C, V281, pH1720, DOI 10.1152/ajpheart.2001.281.4.H1720; del Campo L, 2008, J ENDOCRINOL, V197, P371, DOI 10.1677/JOE-07-0647; del Campo L, 2009, J HYPERTENS, V27, P791, DOI 10.1097/HJH.0b013e32832531e6; del Campo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102523; EKAS RD, 1981, AM J PHYSIOL, V241, pR379, DOI 10.1152/ajpregu.1981.241.5.R379; Ferrer M, 2004, EUR J PHARMACOL, V506, P151, DOI 10.1016/j.ejphar.2004.11.001; Ferrer M, 2004, EUR J PHARMACOL, V487, P167, DOI 10.1016/j.ejphar.2004.01.030; Ferrer M., 2011, BASIC CLIN ENDOCRINO, P91; Gangula PRR, 2004, BIOL REPROD, V71, P1739, DOI 10.1095/biolreprod.104.031369; Gangula PRR, 2000, HYPERTENSION, V35, P470, DOI 10.1161/01.HYP.35.1.470; Gendron G, 2004, CLIN EXP HYPERTENS, V26, P511, DOI 10.1081/CEH-200031826; Girouard H, 2001, J HYPERTENS, V19, P1369, DOI 10.1097/00004872-200108000-00004; Gonzalez-Hernandez A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2056786; Haider A, 2016, VASC HEALTH RISK MAN, V12, P251, DOI 10.2147/VHRM.S108947; Hatanaka Y, 2015, BRAIN RES, V1621, P121, DOI 10.1016/j.brainres.2014.12.011; HIRST GDS, 1989, PHYSIOL REV, V69, P546, DOI 10.1152/physrev.1989.69.2.546; Hsu SJ, 2017, BIOSCIENCE REP, V37, DOI [10.1042/BSR20171015, 10.1042/bsr20171015]; Isidoro L, 2018, ENDOCR RES, V43, P166, DOI 10.1080/07435800.2018.1448868; Jones RD, 2003, EUR J ENDOCRINOL, V148, P111, DOI 10.1530/eje.0.1480111; Jones TJ, 1998, HYPERTENSION, V32, P880, DOI 10.1161/01.HYP.32.5.880; KAWASAKI H, 1990, BRAIN RES, V518, P303, DOI 10.1016/0006-8993(90)90987-M; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Kelly DM, 2013, J ENDOCRINOL, V217, pR47, DOI 10.1530/JOE-12-0582; KUMAI T, 1994, JPN J PHARMACOL, V66, P439, DOI 10.1254/jjp.66.439; LEI S, 1994, PHARMACOL TOXICOL, V74, P130, DOI 10.1111/j.1600-0773.1994.tb01087.x; Maranon RO, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12669; Marin J, 2000, CLIN SCI, V99, P277, DOI 10.1042/CS20000009; Marquez-Rodas L, 2006, REGUL PEPTIDES, V134, P61, DOI 10.1016/j.regpep.2005.12.003; Martin MD, 2005, NITRIC OXIDE-BIOL CH, V12, P163, DOI 10.1016/j.niox.2005.02.003; Martorell A, 2008, CARDIOVASC RES, V77, P590, DOI 10.1093/cvr/cvm059; Montano LM, 2008, ENDOCRINOLOGY, V149, P2517, DOI 10.1210/en.2007-1288; Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008; Morgentaler A, 2015, MAYO CLIN PROC, V90, P224, DOI 10.1016/j.mayocp.2014.10.011; MUIR TC, 1989, J AUTON PHARMACOL, V9, P23, DOI 10.1111/j.1474-8673.1989.tb00193.x; Perusquia M, 2002, STEROIDS, V67, P1021, DOI 10.1016/S0039-128X(02)00061-2; Perusquia M, 2019, ENDOCRINE, V65, P416, DOI 10.1007/s12020-019-01978-x; Perusquia M, 2018, J STEROID BIOCHEM, V178, P65, DOI 10.1016/j.jsbmb.2017.11.001; Perusquia M, 2017, J STEROID BIOCHEM, V167, P106, DOI 10.1016/j.jsbmb.2016.11.016; Perusquia M, 2015, AM J PHYSIOL-REG I, V309, pR189, DOI 10.1152/ajpregu.00110.2015; Perusquia M, 2010, AM J PHYSIOL-HEART C, V298, pH1301, DOI 10.1152/ajpheart.00753.2009; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; RAYCHAUDHURI K, 1993, BRIT J CLIN PHARMACO, V35, P517, DOI 10.1111/j.1365-2125.1993.tb04178.x; Ruige JB, 2013, J CLIN ENDOCR METAB, V98, P4300, DOI 10.1210/jc.2013-1970; Sagredo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073474; Sastre E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31076; Sastre E, 2012, CLIN SCI, V122, P337, DOI 10.1042/CS20110303; Sharma R, 2015, EUR HEART J, V36, P2706, DOI 10.1093/eurheartj/ehv346; STEPHENS N, 1991, HYPERTENSION, V18, P674, DOI 10.1161/01.HYP.18.5.674; Sun C, 2001, NEUROREPORT, V12, P3497, DOI 10.1097/00001756-200111160-00025; Svartberg J, 2004, EUR J ENDOCRINOL, V150, P65, DOI 10.1530/eje.0.1500065; Tanaka Naoko, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS60, DOI 10.1111/j.1440-1681.2004.04109.x; TSUDA K, 1984, JPN CIRC J, V48, P1263, DOI 10.1253/jcj.48.1263; Villalpando DM, 2020, PROSTAG OTH LIPID M, V148, DOI 10.1016/j.prostaglandins.2019.106406; Wang XF, 2012, J HUAZHONG U SCI-MED, V32, P42, DOI 10.1007/s11596-012-0007-9; Watanabe S, 2016, PFLUG ARCH EUR J PHY, V468, P1271, DOI 10.1007/s00424-016-1834-5; WESTFALL TC, 1987, BLOOD VESSELS, V24, P94; Yallampalli C, 2004, BIOL REPROD, V70, P1055, DOI 10.1095/biolreprod.103.022467; Yorek MA, 2002, AM J PHYSIOL-ENDOC M, V283, pE1067, DOI 10.1152/ajpendo.00173.2002; YUE P, 1995, CIRCULATION, V91, P1154, DOI 10.1161/01.CIR.91.4.1154	70	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246254	10.1371/journal.pone.0246254	http://dx.doi.org/10.1371/journal.pone.0246254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529222	gold, Green Published			2022-12-26	WOS:000616736200009
J	Khan, MS; Rego, S; Rajal, JB; Bond, V; Fatima, RK; Isani, AK; Sutherland, J; Kranzer, K				Khan, Mishal S.; Rego, Sonia; Rajal, Joaquin Benitez; Bond, Virginia; Fatima, Razia Kaneez; Isani, Afshan Khurshid; Sutherland, Jayne; Kranzer, Katharina			Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries	PLOS ONE			English	Article								Objective The experiences of frontline healthcare professionals are essential in identifying strategies to mitigate the disruption to healthcare services caused by the COVID-19 pandemic. Methods We conducted a cross-sectional study of TB and HIV professionals in low and middle-income countries (LMIC). Between May 12 and August 6, 2020, we collected qualitative and quantitative data using an online survey in 11 languages. We used descriptive statistics and thematic analysis to analyse responses. Findings 669 respondents from 64 countries completed the survey. Over 40% stated that it was either impossible or much harder for TB and HIV patients to reach healthcare facilities since COVID-19. The most common barriers reported to affect patients were: fear of getting infected with SARS-CoV-2, transport disruptions and movement restrictions. 37% and 28% of responses about TB and HIV stated that healthcare provider access to facilities was also severely impacted. Strategies to address reduced transport needs and costs-including proactive coordination between the health and transport sector and cards that facilitate lower cost or easier travel-were presented in qualitative responses. Access to non-medical support for patients, such as food supplementation or counselling, was severely disrupted according to 36% and 31% of HIV and TB respondents respectively; qualitative data suggested that the need for such services was exacerbated. Conclusion Patients and healthcare providers across numerous LMIC faced substantial challenges in accessing healthcare facilities, and non-medical support for patients was particularly impacted. Synthesising recommendations of frontline professionals should be prioritised for informing policymakers and healthcare service delivery organisations.	[Khan, Mishal S.; Rego, Sonia; Bond, Virginia; Kranzer, Katharina] London Sch Hyg & Trop Med, London, England; [Bond, Virginia] Univ Zambia, Sch Publ Hlth, Zambart, Lusaka, Zambia; [Fatima, Razia Kaneez] Common Management Unit HIV AIDS TB & Malaria, Islamabad, Pakistan; [Isani, Afshan Khurshid] Stop TB Partnership, Natl Core Res Grp, Islamabad, Pakistan; [Sutherland, Jayne] London Sch Hyg & Trop Med, MRC Unit Gambia, Fajara, Gambia; [Kranzer, Katharina] Univ Munich, Div Infect & Trop Med, Med Ctr, Munich, Germany	University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of Munich	Khan, MS (corresponding author), London Sch Hyg & Trop Med, London, England.	mishal.khan@lshtm.ac.uk	; Kranzer, Katharina/O-8845-2014	Rego, Sonia/0000-0002-8837-8029; Sutherland, Jayne/0000-0002-7083-4997; Kranzer, Katharina/0000-0001-5691-7270	Wellcome/LSHTM Institutional Strategic Support Fund (ISSF); MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI	Wellcome/LSHTM Institutional Strategic Support Fund (ISSF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MSK received funding from the Wellcome/LSHTM Institutional Strategic Support Fund (ISSF) partnership grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasa EW, 2017, HEALTH POLICY PLANN, V32, P91, DOI 10.1093/heapol/czx118; Boudarene L, 2017, HEALTH POLICY PLANN, V32, P3, DOI 10.1093/heapol/czx041; Bradley JE, 2002, SOC SCI MED, V55, P269, DOI 10.1016/S0277-9536(01)00170-8; Buyum AM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003394; Dalglish SL, 2020, LANCET, V395, P1189, DOI 10.1016/S0140-6736(20)30739-X; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Fallah MP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004260; Hellmann F, 2020, ARCH MED RES, V51, P572, DOI 10.1016/j.arcmed.2020.04.017; Keene C, 2020, LANCET RESP MED, V8, P844, DOI 10.1016/S2213-2600(20)30311-8; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Konwloh P K, 2017, Public Health Action, V7, pS62, DOI 10.5588/pha.16.0097; McQuaid CF, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01718-2020; Semaan A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002967; Sheikh K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001073; Soreide K, 2020, BRIT J SURG, V107, P1250, DOI 10.1002/bjs.11670; van Griensven F, 2006, JAMA-J AM MED ASSOC, V296, P537, DOI 10.1001/jama.296.5.537; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; Welsh T., 2020, DEVEX INSIDE DEV AID; WHO, 2020, TUBERCULOSIS; World Health Organization, NUMB DEATHS DUE HIV	21	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0244936	10.1371/journal.pone.0244936	http://dx.doi.org/10.1371/journal.pone.0244936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529206	Green Submitted, gold, Green Published			2022-12-26	WOS:000616736200072
J	Park, L; Luth, ES; Jones, K; Hofer, J; Nguyen, I; Watters, KE; Juo, P				Park, Lidia; Luth, Eric S.; Jones, Kelsey; Hofer, Julia; Nguyen, Irene; Watters, Katherine E.; Juo, Peter			The Snail transcription factor CES-1 regulates glutamatergic behavior in C. elegans	PLOS ONE			English	Article							VENTRAL NERVE CORD; DEUBIQUITINATING ENZYME USP-46; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; CELL-CYCLE; RECEPTOR; GLR-1; PROTEIN; ABUNDANCE; EXPRESSION	Regulation of AMPA-type glutamate receptor (AMPAR) expression and function alters synaptic strength and is a major mechanism underlying synaptic plasticity. Although transcription is required for some forms of synaptic plasticity, the transcription factors that regulate AMPA receptor expression and signaling are incompletely understood. Here, we identify the Snail family transcription factor ces-1 in an RNAi screen for conserved transcription factors that regulate glutamatergic behavior in C. elegans. ces-1 was originally discovered as a selective cell death regulator of neuro-secretory motor neuron (NSM) and I2 interneuron sister cells in C. elegans, and has almost exclusively been studied in the NSM cell lineage. We found that ces-1 loss-of-function mutants have defects in two glutamatergic behaviors dependent on the C. elegans AMPA receptor GLR-1, the mechanosensory nose-touch response and spontaneous locomotion reversals. In contrast, ces-1 gain-of-function mutants exhibit increased spontaneous reversals, and these are dependent on glr-1 consistent with these genes acting in the same pathway. ces-1 mutants have wild type cholinergic neuromuscular junction function, suggesting that they do not have a general defect in synaptic transmission or muscle function. The effect of ces-1 mutation on glutamatergic behaviors is not due to ectopic cell death of ASH sensory neurons or GLR-1-expressing neurons that mediate one or both of these behaviors, nor due to an indirect effect on NSM sister cell deaths. Rescue experiments suggest that ces-1 may act, in part, in GLR-1-expressing neurons to regulate glutamatergic behaviors. Interestingly, ces-1 mutants suppress the increased reversal frequencies stimulated by a constitutively-active form of GLR-1. However, expression of glr-1 mRNA or GFP-tagged GLR-1 was not decreased in ces-1 mutants suggesting that ces-1 likely promotes GLR-1 function. This study identifies a novel role for ces-1 in regulating glutamatergic behavior that appears to be independent of its canonical role in regulating cell death in the NSM cell lineage.	[Park, Lidia; Jones, Kelsey; Hofer, Julia; Juo, Peter] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Park, Lidia] Tufts Univ, Grad Sch Biomed Sci, Grad Program Cell Dev & Mol Biol, Sch Med, Boston, MA USA; [Luth, Eric S.; Nguyen, Irene] Simmons Univ, Dept Biol, Boston, MA USA; [Watters, Katherine E.] Tufts Univ, Grad Sch Biomed Sci, Grad Program Neurosci, Sch Med, Boston, MA USA	Tufts University; Tufts University; Simmons University; Tufts University	Juo, P (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA.	peter.juo@tufts.edu	Juo, Peter/CJY-3695-2022	Juo, Peter/0000-0002-3039-2266	National Institutes of Health [R21NS101534]; Tufts Center for Neuroscience Research [P30NS047243]; Caenorhabditis Genetics Center - NIH Office of Research Infrastructure Programs [P40 OD010440]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; Caenorhabditis Genetics Center - NIH Office of Research Infrastructure Programs	This research was supported by a National Institutes of Health grant (R21NS101534) to P.J., the Tufts Center for Neuroscience Research (P30NS047243) and the Caenorhabditis Genetics Center which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Anggono V, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8256196; Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Ashraf SI, 2001, DEVELOPMENT, V128, P4757; Baran R, 1999, DEVELOPMENT, V126, P2241; Barger AJ, 1998, J NEUROSCI, V18, P2871; Barrallo-Gimeno A, 2009, TRENDS GENET, V25, P248, DOI 10.1016/j.tig.2009.04.001; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, NEURON, V31, P617, DOI 10.1016/S0896-6273(01)00394-4; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chatzigeorgiou M, 2011, NEURON, V70, P299, DOI 10.1016/j.neuron.2011.02.046; Dahlberg CL, 2014, J BIOL CHEM, V289, P3444, DOI 10.1074/jbc.M113.507541; ELLIS RE, 1991, DEVELOPMENT, V112, P591; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Ezcurra M, 2011, EMBO J, V30, P1110, DOI 10.1038/emboj.2011.22; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Garafalo SD, 2015, MOL BIOL CELL, V26, P1887, DOI 10.1091/mbc.E14-06-1048; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Goold CP, 2010, NEURON, V68, P512, DOI 10.1016/j.neuron.2010.09.020; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Itoh Y, 2013, NAT NEUROSCI, V16, P416, DOI 10.1038/nn.3336; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Juo P, 2007, MOL BIOL CELL, V18, P3883, DOI 10.1091/mbc.E06-09-0818; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Korb E, 2013, NAT NEUROSCI, V16, P874, DOI 10.1038/nn.3429; Kowalski JR, 2011, J NEUROSCI, V31, P1341, DOI 10.1523/JNEUROSCI.4765-10.2011; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McNamara James O, 2006, Sci STKE, V2006, pre12, DOI 10.1126/stke.3562006re12; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Metzstein MM, 1999, MOL CELL, V4, P309, DOI 10.1016/S1097-2765(00)80333-0; Metzstein MM, 1996, NATURE, V382, P545, DOI 10.1038/382545a0; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Moss BJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006180; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nakakura EK, 2001, P NATL ACAD SCI USA, V98, P4010, DOI 10.1073/pnas.051014098; NGUYEN M, 1995, GENETICS, V140, P527; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Packer JS, 2019, SCIENCE, V365, P1265, DOI 10.1126/science.aax1971; Park EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004284; Paul V, 2014, CEREB CORTEX, V24, P754, DOI 10.1093/cercor/bhs356; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Piggott BJ, 2011, CELL, V147, P922, DOI 10.1016/j.cell.2011.08.053; Priya A, 2014, BBA-MOL CELL RES, V1843, P3018, DOI 10.1016/j.bbamcr.2014.09.006; Priya A, 2014, BBA-MOL CELL RES, V1843, P1196, DOI 10.1016/j.bbamcr.2014.02.008; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Ramat A, 2016, DEVELOPMENT, V143, P3024, DOI 10.1242/dev.134387; Reece-Hoyes JS, 2009, NUCLEIC ACIDS RES, V37, P3689, DOI 10.1093/nar/gkp232; Rodriguez-Aznar E, 2013, J NEUROSCI, V33, P5095, DOI 10.1523/JNEUROSCI.4459-12.2013; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Schaefer H, 2006, MOL BIOL CELL, V17, P1250, DOI 10.1091/mbc.E05-08-0794; Schaukowitch K, 2017, CELL REP, V18, P1512, DOI 10.1016/j.celrep.2017.01.033; Shaye DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020085; Shi AB, 2010, MOL BIOL CELL, V21, P2930, DOI 10.1091/mbc.E10-02-0149; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Volk L, 2015, ANNU REV NEUROSCI, V38, P127, DOI 10.1146/annurev-neuro-071714-033821; Wang R, 2008, NEURON, V59, P997, DOI 10.1016/j.neuron.2008.07.023; Wei H, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008912; Wei H, 2017, GENETICS, V206, P2069, DOI 10.1534/genetics.117.202754; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yan B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003884; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	79	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245587	10.1371/journal.pone.0245587	http://dx.doi.org/10.1371/journal.pone.0245587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529210	Green Published, gold			2022-12-26	WOS:000616736200045
J	Parker, B; Ward, T; Hayward, O; Jacob, I; Arthurs, E; Becker, D; Anderson, SJ; Chounta, V; Van de Velde, N				Parker, Ben; Ward, Tom; Hayward, Olivia; Jacob, Ian; Arthurs, Erin; Becker, Debbie; Anderson, Sarah-Jane; Chounta, Vasiliki; Van de Velde, Nicolas			Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; INFECTION; METAANALYSIS; PREDICTORS; BURDEN; NAIVE; LOAD	Introduction Combination antiretroviral therapy (cART) improves outcomes for people living with HIV (PLWH) but requires adherence to daily dosing. Suboptimal adherence results in reduced treatment effectiveness, increased costs, and greater risk of resistance and onwards transmission. Treatment with long-acting (LA), injection-based ART administered by healthcare professionals (directly observed therapy (DOT)) eliminates the need for adherence to daily dosing and may improve clinical outcomes. This study reports the cost-effectiveness of the cabotegravir plus rilpivirine LA regimen (CAB+RPV LA) and models the potential impact of LA DOT therapies. Methods Parameterisation was performed using pooled data from recent CAB+RPV LA Phase III trials. The analysis was conducted using a cohort-level hybrid decision-tree and state-transition model, with states defined by viral load and CD4 cell count. The efficacy of oral cART was adjusted to reflect adherence to daily regimens from published data. A Canadian health service perspective was adopted. Results CAB+RPV LA is predicted to be the dominant intervention when compared to oral cART, generating, per 1,000 patients treated, lifetime cost-savings of $1.5 million, QALY and life-year gains of 107 and 138 respectively with three new HIV cases averted. Conclusions Economic evaluations of LA DOTs need to account for the impact of adherence and HIV transmission. This study adds to the existing literature by incorporating transmission and using clinical data from the first LA DOT regimen. Providing PLWH and healthcare providers with novel modes of ART administration, enhancing individualisation of treatment, may facilitate the achievement of UNAIDS 95-95-95 objectives.	[Parker, Ben; Ward, Tom; Hayward, Olivia; Jacob, Ian] Hlth Econ & Outcomes Res Ltd, Cardiff, Wales; [Arthurs, Erin] GlaxoSmithKline, Hlth Econ & Outcomes Res, Toronto, ON, Canada; [Becker, Debbie] Quadrant Hlth Econ Inc, Cambridge, ON, Canada; [Anderson, Sarah-Jane] GlaxoSmithKline, Value Evidence & Outcomes, Brentford, Middx, England; [Chounta, Vasiliki; Van de Velde, Nicolas] ViiV Healthcare Ltd, Global Hlth Outcomes, Brentford, Middx, England	Health Economics & Outcomes Research Ltd; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Jacob, I (corresponding author), Hlth Econ & Outcomes Res Ltd, Cardiff, Wales.; Van de Velde, N (corresponding author), ViiV Healthcare Ltd, Global Hlth Outcomes, Brentford, Middx, England.	ian.jacob@heor.co.uk; nicolas.x.van-de-velde@gsk.com			ViiV Healthcare	ViiV Healthcare	This work was supported by ViiV Healthcare who provided support for model development and analysis for this study. The funding agreement ensured the authors' independence in designing the study, interpreting the data, and preparing the manuscript for publication. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the `author contributions' section.	Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bank of Canada, 2017, INFL CALC; Benitez-Gutierrez L, 2018, EXPERT REV CLIN PHAR, V11, P507, DOI 10.1080/17512433.2018.1453805; Brazier R., 2017, HLTH RELATED QUALITY; Clay PG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001677; Darlington O, 2018, ISPOR US 2018 BALT U; Despiegel N, 2015, INFECT DIS THER, V4, P337, DOI 10.1007/s40121-015-0071-0; Drugs CAf Health Ti, GUID EC EV HLTH TECH; Fernandez C, 2019, HIV AIDS-RES PALLIAT, V11, P179, DOI 10.2147/HIV.S184642; Ford N, 2009, LANCET, V374, P2064, DOI 10.1016/S0140-6736(09)61671-8; Hall HI, 2012, AIDS, V26, P893, DOI 10.1097/QAD.0b013e328351f73f; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Harripersaud K, 2017, MAJOR INFECT DIS HIV; Iacob SA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00831; Kalichman SC, 2010, AIDS PATIENT CARE ST, V24, P271, DOI 10.1089/apc.2009.0309; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Margolis DA, 2017, LANCET, V390, P1499, DOI 10.1016/S0140-6736(17)31917-7; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; McEwan P, 2017, ISPOR EUR 2017 GLASG; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Needle RH, 2004, EVIDENCE ACTION EFFE; Orkin C, 2020, NEW ENGL J MED, V382, P1124, DOI 10.1056/NEJMoa1909512; Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67; Ouellet E, 2015, CAN J INFECT DIS MED, V26, P23, DOI 10.1155/2015/964512; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pitman R, 2012, MED DECIS MAKING, V32, P712, DOI 10.1177/0272989X12454578; Rizzardini Giuliano, 2020, JAIDS J ACQUIRED IMM; Ross EL, 2015, CLIN INFECT DIS, V60, P1102, DOI 10.1093/cid/ciu1159; Samji H, 2015, HIV MED, V16, P76, DOI 10.1111/hiv.12173; Sansom SL, 2008, AIDS PATIENT CARE ST, V22, P131, DOI 10.1089/apc.2006.0216; Swindells S, 2020, NEW ENGL J MED, V382, P1112, DOI 10.1056/NEJMoa1904398; UNAIDS, 2020, US; UNAIDS JUNPoHAJG, 2014, FAST TRACK END AIDS; Ward T, 2018, ISPOR EUR 2018 BARC; Wood E, 2004, JAIDS-J ACQ IMM DEF, V35, P261, DOI 10.1097/00126334-200403010-00006; World Health Organization (WHO), 2020, GLOB HLTH OBS GHO DA; Yu Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5731-z	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245955	10.1371/journal.pone.0245955	http://dx.doi.org/10.1371/journal.pone.0245955			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529201	Green Published, gold			2022-12-26	WOS:000616736200058
J	Hara, T; Saeki, K; Jinnouchi, H; Kazuno, S; Miura, Y; Yokomizo, T				Hara, Takuya; Saeki, Kazuko; Jinnouchi, Hiromi; Kazuno, Saiko; Miura, Yoshiki; Yokomizo, Takehiko			The c-terminal region of BLT2 restricts its localization to the lateral membrane in a LIN7C-dependent manner	FASEB JOURNAL			English	Article						APEX2; barrier; GPCR; LIN7C; trafficking	DARBY CANINE KIDNEY; LEUKOTRIENE B-4 RECEPTOR; PROTEIN-COUPLED RECEPTORS; GROWTH-FACTOR RECEPTOR; BASOLATERAL LOCALIZATION; APICAL SECRETION; BARRIER FUNCTION; DILEUCINE MOTIF; COMPLEX; LIN-7	Leukotriene B-4 receptor type 2 (BLT2) is a G protein-coupled receptor (GPCR) mainly expressed in epithelial cells, where it enhances barrier function. A unique characteristic of BLT2 is its restricted localization to the lateral membrane. However, the molecular mechanism underlying the localization of BLT2 to the lateral membrane and the physiological roles of laterally localized BLT2 are unknown. BLT1 is the most homologous GPCR to BLT2 and localizes to both the apical and lateral membranes. In this study, we generated chimeric receptors of BLT2 and BLT1 as well as deletion mutants of BLT2 to determine the region(s) of BLT2 responsible for its localization. Chimeric receptors containing the C-terminal domain of BLT2 localized only to the lateral membrane, and the C-terminal deletion mutant of BLT2 accumulated at the Golgi apparatus. Furthermore, the middle and C-terminal regions of BLT2 were important for maintaining epithelial barrier function. Proteomics analysis using the chimeric BLT-ascorbate peroxidase 2 biotinylation method showed that some proteins involved in intracellular protein transport, cell-cell junctions, and actin filament binding were located very close to the C-terminal domain of BLT2. Knockdown of lin-7 homolog C (LIN7C), a membrane trafficking protein, led to accumulation of BLT2 in the Golgi apparatus, resulting in diminished epithelial barrier function. These results suggest that the C-terminal region of BLT2 plays an important role in the transport of BLT2 from the Golgi apparatus to the plasma membrane in a LIN7C-dependent manner.	[Hara, Takuya; Saeki, Kazuko; Jinnouchi, Hiromi; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Hara, Takuya] Kowa Co Ltd, Fuji Res Labs, Shizuoka, Japan; [Kazuno, Saiko; Miura, Yoshiki] Juntendo Univ, Res Support Ctr, Lab Prote & Biomol Sci, Grad Sch Med, Tokyo, Japan	Juntendo University; Kowa Company, Ltd.; Juntendo University	Saeki, K (corresponding author), Juntendo Univ, Dept Biochem, Sch Med, Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksaeki@juntendo.ac.jp	Miura, Yoshiki/U-8875-2019; Yokomizo, Takehiko/P-5673-2016	Miura, Yoshiki/0000-0002-7596-0482; Yokomizo, Takehiko/0000-0002-5219-1553				Alewine C, 2007, AM J PHYSIOL-CELL PH, V293, pC1733, DOI 10.1152/ajpcell.00323.2007; Bachmann A, 2008, EUR J CELL BIOL, V87, P123, DOI 10.1016/j.ejcb.2007.11.002; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chiba T, 2016, EXP DERMATOL, V25, P532, DOI 10.1111/exd.12976; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Denker BM, 1996, J BIOL CHEM, V271, P25750, DOI 10.1074/jbc.271.42.25750; DENNING GM, 1992, J CELL BIOL, V118, P551, DOI 10.1083/jcb.118.3.551; Dhitavat J, 2003, J INVEST DERMATOL, V121, P1349, DOI 10.1046/j.1523-1747.2003.12557.x; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Hayase J, 2013, J CELL BIOL, V200, P635, DOI 10.1083/jcb.201208150; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; HUNZIKER W, 1994, EMBO J, V13, P2963, DOI 10.1002/j.1460-2075.1994.tb06594.x; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Ishii Y, 2016, FASEB J, V30, P933, DOI 10.1096/fj.15-279653; KITAGAWA Y, 1994, EXP CELL RES, V213, P449, DOI 10.1006/excr.1994.1222; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; Liu M, 2014, J EXP MED, V211, P1063, DOI 10.1084/jem.20132063; Lozovatsky L, 2009, MOL BIOL CELL, V20, P4489, DOI 10.1091/mbc.E09-04-0280; Mandai K, 1997, J CELL BIOL, V139, P517, DOI 10.1083/jcb.139.2.517; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Massari S, 2009, TRAFFIC, V10, P246, DOI 10.1111/j.1600-0854.2008.00854.x; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; MONLAUZEUR L, 1995, J BIOL CHEM, V270, P12219, DOI 10.1074/jbc.270.20.12219; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Perego C, 1999, EMBO J, V18, P2384, DOI 10.1093/emboj/18.9.2384; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Saeki K, 2017, SEMIN IMMUNOL, V33, P30, DOI 10.1016/j.smim.2017.07.010; Sandvig K, 2018, HISTOCHEM CELL BIOL, V150, P107, DOI 10.1007/s00418-018-1678-5; Sasaki F, 2012, ANAL BIOCHEM, V425, P157, DOI 10.1016/j.ab.2012.03.014; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shelly M, 2003, DEV CELL, V5, P475, DOI 10.1016/j.devcel.2003.08.001; Shigematsu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34560; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; SORKIN A, 1995, J BIOL CHEM, V270, P619, DOI 10.1074/jbc.270.2.619; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Straight SW, 2006, J BIOL CHEM, V281, P37738, DOI 10.1074/jbc.M607059200; URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735; Wang JL, 2018, CIRC RES, V123, P716, DOI 10.1161/CIRCRESAHA.118.311403; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; WILSON PD, 1991, AM J PHYSIOL, V260, pF420, DOI 10.1152/ajprenal.1991.260.3.F420; Wozniak M, 1996, J BIOL CHEM, V271, P5017; Yokomizo T, 2000, J EXP MED, V192, P421, DOI 10.1084/jem.192.3.421	50	2	2	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21364	10.1096/fj.202002640R	http://dx.doi.org/10.1096/fj.202002640R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481310	Bronze, Green Submitted			2022-12-26	WOS:000647789600109
J	Janke, N; Coe, JB; Bernardo, TM; Dewey, CE; Stone, EA				Janke, Natasha; Coe, Jason B.; Bernardo, Theresa M.; Dewey, Cate E.; Stone, Elizabeth A.			Pet owners' and veterinarians' perceptions of information exchange and clinical decision-making in companion animal practice	PLOS ONE			English	Article							CLIENT-PATIENT COMMUNICATION; TERTIARY REFERRAL CENTER; ACCESSING ONCOLOGY CARE; SKILLS; APPOINTMENTS; EXPECTATIONS; ADHERENCE; DOGS	One of the most complex aspects of the veterinarian-client-patient interaction is the clinical decision-making process. Research suggests that the approach to communication used by veterinarians can impact veterinary clients' involvement in the decision-making process and their ultimate satisfaction. Using different approaches to the decision-making process may affect how information is exchanged and consequently how decisions are made. The objective of this study was to determine pet owners' expectations with respect to information exchange and decision-making during veterinarian-client-patient interactions and to compare veterinarians' perceptions of those expectations and the challenges they face in meeting them. Five pet owner focus groups (27 owners) and three veterinarian focus groups (24 veterinarians) were conducted with standardized open-ended questions and follow-up probes. Thematic analysis of the transcribed data was conducted to identify trends and patterns that emerged during the focus groups. Three pet owner-based themes were identified: 1) understanding the client; 2) providing information suitable for the client; and 3) decision-making. In addition, three barriers for veterinarians affecting information exchange and decision-making were identified: 1) time constraints; 2) involvement of multiple clients; and 3) language barriers. Results suggest that pet owners expect to be supported by their veterinarian to make informed decisions by understanding the client's current knowledge, tailoring information and educating clients about their options. Breakdowns in the information exchange process can impact pet owners' perceptions of veterinarians' motivations. Pet owners' emphasis on partnership suggests that a collaborative approach between veterinarians and clients may improve client satisfaction.	[Janke, Natasha; Coe, Jason B.; Bernardo, Theresa M.; Dewey, Cate E.] Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada; [Stone, Elizabeth A.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON, Canada	University of Guelph; University of Guelph	Janke, N (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Populat Med, Guelph, ON, Canada.	njanke@uoguelph.ca	Janke, Natasha/AAE-4874-2021	Janke, Natasha/0000-0002-2999-8287	OVC Pet Trust [054060]; Ontario Veterinary College Scholarship	OVC Pet Trust; Ontario Veterinary College Scholarship	The project was funded by the OVC Pet Trust (grant number: 054060) to JBC, EAS, and NJ (https://ovc.uoguelph.ca/pettrust/help-pets-welove-live-longer-healthier-lives).This publication is part of NJ's PhD dissertation, the stipend for which was provided by the Ontario Veterinary College Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C., 2017, SKILLS COMMUNICATING, V1st ed.; American Animal Hospital Association, 2015, AAHA STAT IND FACT S; Bard AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171380; Belshaw Z, 2018, VET SCI, V5, DOI 10.3390/vetsci5010007; Belshaw Z, 2018, VET SCI, V5, DOI 10.3390/vetsci5010020; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Borden LJN, 2010, JAVMA-J AM VET MED A, V237, P1275, DOI 10.2460/javma.237.11.1275; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Christiansen SB, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0211-x; Coe J, 2008, COMMUNICATION VETERI; Coe JB, 2010, PREV VET MED, V93, P201, DOI 10.1016/j.prevetmed.2009.10.005; Coe JB, 2008, JAVMA-J AM VET MED A, V233, P1072, DOI 10.2460/javma.233.7.1072; Coe JB, 2007, JAVMA-J AM VET MED A, V231, P1510, DOI 10.2460/javma.231.10.1510; Cornell KK, 2007, VET CLIN N AM-SMALL, V37, P37, DOI 10.1016/j.cvsm.2006.10.005; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Dysart LMA, 2011, JAVMA-J AM VET MED A, V238, P1609, DOI 10.2460/javma.238.12.1609; Englar RE., 2020, GUIDE ORAL COMMUNICA; Futures Vet, 2015, TAK CHARG OUR FUT VI; Glaser B.G., 1968, DISCOV GROUNDED THEO; Guest G, 2017, FIELD METHOD, V29, P3, DOI 10.1177/1525822X16639015; Kamleh MK, 2020, J VET MED ED, DOI [10.3138/jvme.0918-113r132412363, DOI 10.3138/JVME.0918-113R132412363]; Kanji N, 2012, JAVMA-J AM VET MED A, V240, P427, DOI 10.2460/javma.240.4.427; Kogan L, 2018, VET REC, V182, DOI 10.1136/vr.104716; Kogan LR, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00180; Latham CE, 2007, VET REC, V160, P181, DOI 10.1136/vr.160.6.181; Loftus L., 2012, Veterinary Nursing Journal, V27, P294, DOI 10.1111/j.2045-0648.2012.00201.x; MacMartin C, 2018, J VET MED EDUC, V45, P514, DOI 10.3138/jvme.0317-034r; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McArthur ML, 2013, AUST VET J, V91, P374, DOI 10.1111/avj.12083; Michel KE, 2009, COMPENDIUM, V31, P22; Patton M, 2015, UTILIZATION FOCUSED, VFourth; Quinn Patton M., 2007, MED SANS FRONT, V8, P1; Ritter C, 2019, J DAIRY SCI, V102, P4280, DOI 10.3168/jds.2018-15825; Shaw JR, 2008, JAVMA-J AM VET MED A, V233, P1576, DOI 10.2460/javma.233.10.1576; Shaw JR, 2019, JAVMA-J AM VET MED A, V255, P722, DOI 10.2460/javma.255.6.722; Shaw JR, 2012, JAVMA-J AM VET MED A, V240, P832, DOI 10.2460/javma.240.7.832; Shaw JR, 2006, JAVMA-J AM VET MED A, V228, P714, DOI 10.2460/javma.228.5.714; Stoewen DL, 2014, JAVMA-J AM VET MED A, V245, P785, DOI 10.2460/javma.245.7.785; Stoewen DL, 2014, JAVMA-J AM VET MED A, V245, P773, DOI 10.2460/javma.245.7.773; Svensson C, 2019, J DAIRY SCI, V102, P10173, DOI 10.3168/jds.2018-15731; Tuckett D, 1985, M EXP APPR SHAR ID M; Vijfhuizen M, 2017, PATIENT EDUC COUNS, V100, P682, DOI 10.1016/j.pec.2016.11.001	43	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245632	10.1371/journal.pone.0245632	http://dx.doi.org/10.1371/journal.pone.0245632			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524061	Green Published, gold			2022-12-26	WOS:000616578400019
J	Sarder, A; Islam, SMS; Maniruzzaman; Talukder, A; Ahammed, B				Sarder, Alamgir; Islam, Sheikh Mohammed Shariful; Maniruzzaman; Talukder, Ashis; Ahammed, Benojir			Prevalence of unintended pregnancy and its associated factors: Evidence from six south Asian countries	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; MODERN CONTRACEPTIVE USE; FEMALE SEX WORKERS; UNWANTED PREGNANCY; DOMESTIC VIOLENCE; WOMEN; ABORTION; HEALTH; CHILDBEARING; ATTITUDES	Aim Unintended pregnancy is a significant public health concern in South Asian countries because of its negative association with the socioeconomic and health outcomes for both children and mothers. The present study aimed to explore the prevalence of unintended pregnancy and explore its determinants among women of reproductive age in six South Asian countries. Methods Nationwide latest demography and health survey data from six South Asian countries, including Bangladesh (2014), Pakistan (2017-2018), Nepal (2016), Afghanistan (2015), Maldives (2016-2017) and India (2015-2016) were pooled for the present study. Multivariate analysis was performed to explore the association between unintended pregnancy and its associated factors. Results Amongst the total women (n = 41,689), overall, 19.1% pregnancies were reported as unintended (ranging from 11.9% in India to 28.4% in Bangladesh). The logistic regression model showed that younger women (15-19 years) had 1.42 times higher chance of unintended pregnancies. The odds of unintended pregnancies was 1.24 times higher for poorest women and 1.19 times higher for poorer women. Further, urban women (aOR = 0.70, 95% CI = 0.50-0.80), women having no children (aOR = 0.10, 95% CI = 0.09-0.12), smaller (<= 4) family (aOR = 0.72, 95% CI = 0.67-0.78), those who intent to use contraceptive (aOR = 0.72, 95% CI = 0.60-0.86), currently living with partner (aOR = 0.90, 95% CI = 0.81-0.99), first cohabitation in teenage (<= 19 years) (aOR = 0.85, 95% CI = 0.78-0.92) were less likely to report unintended pregnancies. Conclusions This study has showed that women's age, wealth index, place of residence, number of children, family size, the intention of contraceptive use, living with a partner, and first cohabitation age are essential determinants of unintended pregnancy. These factors should be considered when trying to reduce unintended pregnancy in six South Asian countries. However, there is a need to improve health education, counselling, skills-building, sex education, modern contraceptive use and its access in this region. Intervention programs regarding reproductive health and policies are warranted to reduce rates of unintended pregnancy in South Asian countries.	[Sarder, Alamgir; Maniruzzaman; Talukder, Ashis; Ahammed, Benojir] Khulna Univ, Stat Discipline, Khulna, Bangladesh; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr IPAN, Melbourne, Vic, Australia	Khulna University; Deakin University	Ahammed, B (corresponding author), Khulna Univ, Stat Discipline, Khulna, Bangladesh.	benojirstat@ku.ac.bd	Maniruzzaman, Md/R-2123-2019; Talukder, Ashis/AAW-4512-2021; Islam, Mohammed Shariful/B-1219-2011	Maniruzzaman, Md/0000-0001-6151-8071; Talukder, Ashis/0000-0002-2205-0696; Islam, Mohammed Shariful/0000-0001-7926-9368				Ameyaw ID, 2020, PLOS ONE, V24, P187, DOI [10.29063/ajrh2020/v24i2.18, DOI 10.29063/AJRH2020/V24I2.18]; Amin SF, 2009, EUR J SCI RES, V26, P108; [Anonymous], 2017, AM J TRANSPLANT, V17, P1; [Anonymous], 2015, PHILOS SOCIAL CRITIS, V40, P1; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Baschieri A, 2017, MATERN CHILD HLTH J, V21, P467, DOI 10.1007/s10995-016-2124-8; Bearak J, 2018, LANCET GLOB HEALTH, V6, pE380, DOI 10.1016/S2214-109X(18)30029-9; Begum S, 2010, NATL MED J INDIA, V23, P198; Bishwajit G, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1379-4; *CENTR STAT AG, 2006, ETH DEM HLTH SURV 20; Central Statistics Organization (CSO) Ministry of Public Health (MoPH) and ICF, 2017, AFGH DEM HLTH SURV; Chanda MM, 2017, CONTRACEPTION, V96, P196, DOI 10.1016/j.contraception.2017.07.003; Christofides NJ, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23719; Claridge AM, 2013, WOMEN HEALTH, V53, P777, DOI 10.1080/03630242.2013.831018; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Croft Trevor N., 2018, GUIDE DHS STAT, P22; Darroch J.E., 2011, CONTRACEPTIVE TECHNO, V201, P1; Exavery A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-63; Geda NR, 2011, GEOGRAPHY REGIONAL P, V4, P417; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Huda A, 2013, UNDERSTANDING UNINTE, P76; Indian Institute of Population Science, 2000, NAT FAM HLTH SURV NF, P539; Kamal M, 2011, SALUD PUBLICA MEXICO, V53, P108, DOI 10.1590/S0036-36342011000200003; Kassahun EA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4419-5; Khademi S, 2003, MATURITAS, V46, P113, DOI 10.1016/S0378-5122(03)00182-8; Kuhn R, 2010, POPUL DEV REV, V36, P655, DOI 10.1111/j.1728-4457.2010.00353.x; Mahmud S, 2012, WORLD DEV, V40, P610, DOI 10.1016/j.worlddev.2011.08.003; Maxwell L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118234; Miller E, 2010, CONTRACEPTION, V81, P316, DOI 10.1016/j.contraception.2009.12.004; Ministry of Health (MOH) [Maldives] and ICF, 2018, MALD DEM HLTH SURV 2; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Muanda MF, 2017, CULT HEALTH SEX, V19, P1011, DOI 10.1080/13691058.2017.1286690; Nagase T, 2003, CONTRACEPTION, V68, P125, DOI 10.1016/S0010-7824(03)00113-6; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National Institute of Population Studies (NIPS) [Pakistan] and ICF,, 2019, PAK DEM HLTH SURV 20; Noor FR, 2012, INT Q COMMUNITY HEAL, V32, P101, DOI 10.2190/IQ.32.2.b; Nyarko SH, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/2920491; PJ M, 2006, CURR OPIN RHEUMAT S1, V18, pS11, DOI 10.1097/01.bor.0000229522.89546.7b; Puri M, 2016, INT PERSPECT SEX R H, V42, P197, DOI 10.1363/42e2116; Raj A, 2015, CONTRACEPTION, V91, P456, DOI 10.1016/j.contraception.2015.03.008; Rashid M, 2007, PAA ANN M; Roy TK, 2003, INT FAM PLAN PERSPEC, V29, P25, DOI 10.2307/3180998; Sathar Z, 2014, STUD FAMILY PLANN, V45, P471, DOI 10.1111/j.1728-4465.2014.00004.x; Sedgh G, 2006, INT FAM PLAN PERSPEC, V32, P175, DOI 10.1363/3217506; Singh S., 2018, ABORTION UNINTENDED; Singh S, 2018, LANCET GLOB HEALTH, V6, pE111, DOI [10.1016/S2214-109X(17)30453-9, 10.1016/s2214-109x(17)30453-9]; Stephenson R, 2008, STUD FAMILY PLANN, V39, P177, DOI 10.1111/j.1728-4465.2008.165.x; Tabassum A, 2016, J PAK MED ASSOC, V66, P1577; Todd CS, 2010, J WOMENS HEALTH, V19, P2057, DOI 10.1089/jwh.2010.1947; Williams L, 2007, J MARRIAGE FAM, V69, P1244, DOI 10.1111/j.1741-3737.2007.00444.x	50	13	13	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245923	10.1371/journal.pone.0245923	http://dx.doi.org/10.1371/journal.pone.0245923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524018	Green Published, gold			2022-12-26	WOS:000616578400004
J	Agrafiotis, DK; Yang, E; Littman, GS; Byttebier, G; Dipietro, L; DiBernardo, A; Chavez, JC; Rykman, A; McArthur, K; Hajjar, K; Lees, KR; Volpe, BT; Krams, M; Krebs, HI				Agrafiotis, Dimitris K.; Yang, Eric; Littman, Gary S.; Byttebier, Geert; Dipietro, Laura; DiBernardo, Allitia; Chavez, Juan C.; Rykman, Avrielle; McArthur, Kate; Hajjar, Karim; Lees, Kennedy R.; Volpe, Bruce T.; Krams, Michael; Krebs, Hermano, I			Accurate prediction of clinical stroke scales and improved biomarkers of motor impairment from robotic measurements	PLOS ONE			English	Article							ARM MOVEMENTS; QSAR; TRIALS	Objective One of the greatest challenges in clinical trial design is dealing with the subjectivity and variability introduced by human raters when measuring clinical end-points. We hypothesized that robotic measures that capture the kinematics of human movements collected longitudinally in patients after stroke would bear a significant relationship to the ordinal clinical scales and potentially lead to the development of more sensitive motor biomarkers that could improve the efficiency and cost of clinical trials. Materials and methods We used clinical scales and a robotic assay to measure arm movement in 208 patients 7, 14, 21, 30 and 90 days after acute ischemic stroke at two separate clinical sites. The robots are low impedance and low friction interactive devices that precisely measure speed, position and force, so that even a hemiparetic patient can generate a complete measurement profile. These profiles were used to develop predictive models of the clinical assessments employing a combination of artificial ant colonies and neural network ensembles. Results The resulting models replicated commonly used clinical scales to a cross-validated R-2 of 0.73, 0.75, 0.63 and 0.60 for the Fugl-Meyer, Motor Power, NIH stroke and modified Rankin scales, respectively. Moreover, when suitably scaled and combined, the robotic measures demonstrated a significant increase in effect size from day 7 to 90 over historical data (1.47 versus 0.67). Discussion and conclusion These results suggest that it is possible to derive surrogate biomarkers that can significantly reduce the sample size required to power future stroke clinical trials.	[Agrafiotis, Dimitris K.; Yang, Eric; DiBernardo, Allitia; Krams, Michael] Janssen Res & Dev, Titusville, NJ 08560 USA; [Agrafiotis, Dimitris K.; Yang, Eric] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Littman, Gary S.] GSL Stat Consulting, Ardmore, PA USA; [Byttebier, Geert] Bioconstat Bvba, Ghent, Belgium; [Dipietro, Laura; Krebs, Hermano, I] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Chavez, Juan C.] Biogen Idec Inc, Cambridge, MA USA; [Rykman, Avrielle] Burke Med Res Inst, New York, NY USA; [McArthur, Kate; Hajjar, Karim; Lees, Kennedy R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Hajjar, Karim] Univ Duisburg Essen, Dept Neurol, Essen, Germany; [Volpe, Bruce T.] Feinstein Inst Med Res, Manhasset, NY USA	Johnson & Johnson; Janssen Pharmaceuticals; Novartis; Massachusetts Institute of Technology (MIT); Biogen; University of Glasgow; University of Duisburg Essen; Northwell Health	Agrafiotis, DK (corresponding author), Janssen Res & Dev, Titusville, NJ 08560 USA.; Agrafiotis, DK (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.; Krebs, HI (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	dimitris.agrafiotis@gmail.com; hikrebs@mit.edu		Agrafiotis, Dimitris/0000-0002-5604-5692	Wyeth [6917860]	Wyeth(Wyeth)	This study was funded by a grant from Wyeth to HIK (Grant No. 6917860). Support for this study in the form of salaries was provided by the following: Janssen Research & Development (DA, EY, AD and MK), GSL Statistical Consulting (GL), Bioconstat Bvba (GB), and Biogen-Idec (JC). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrafiotis DK, 2007, J CHEM INF MODEL, V47, P1999, DOI 10.1021/ci700267w; Agrafiotis DK, 2002, NAT REV DRUG DISCOV, V1, P337, DOI 10.1038/nrd791; Agrafiotis DK, 2002, P NATL ACAD SCI USA, V99, P15869, DOI 10.1073/pnas.242424399; Agrafiotis DK, 2003, J COMPUT CHEM, V24, P1215, DOI 10.1002/jcc.10234; Agrafiotis DK, 2003, J CHEM INF COMP SCI, V43, P475, DOI 10.1021/ci025631m; Agrafiotis DK, 2002, J CHEM INF COMP SCI, V42, P903, DOI 10.1021/ci0203702; Ali M, 2007, STROKE, V38, P1905, DOI 10.1161/STROKEAHA.106.473579; Alt Murphy M, 2011, NEUROREHAB NEURAL RE, V25, P71, DOI 10.1177/1545968310370748; [Anonymous], 2014, AIDS EX PER NERV SYS; Balasubramanian Sivakumar, 2012, Am J Phys Med Rehabil, V91, pS255, DOI 10.1097/PHM.0b013e31826bcdc1; Bosecker C, 2010, NEUROREHAB NEURAL RE, V24, P62, DOI 10.1177/1545968309343214; Breiman L, 1996, MACH LEARN, V24, P49; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Colombo R, 2005, IEEE T NEUR SYS REH, V13, P311, DOI 10.1109/TNSRE.2005.848352; Dipietro L, 2007, J NEUROPHYSIOL, V98, P757, DOI 10.1152/jn.01295.2006; Dorigo M., 1997, IEEE Transactions on Evolutionary Computation, V1, P53, DOI 10.1109/4235.585892; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Ferraro M, 2003, NEUROLOGY, V61, P1604, DOI 10.1212/01.WNL.0000095963.00970.68; Ferraro M, 2002, NEUROREHAB NEURAL RE, V16, P283, DOI 10.1177/154596830201600306; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Gassert R, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0383-x; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Glantz SA, 2012, PRIMER BIOSTATISTICS; Goffredo M, 2019, APPL BIONICS BIOMECH, V2019, DOI 10.1155/2019/4251089; Gregson JM, 2000, AGE AGEING, V29, P223, DOI 10.1093/ageing/29.3.223; Haykin S., 1994, NEURAL NETWORKS, DOI 10.5555/521706; Health NI of others. National Institute of Neurological Disorders and Stroke, 2010, STROK SCAL; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Hogan N, 2011, PROG BRAIN RES, V192, P59, DOI 10.1016/B978-0-444-53355-5.00004-X; Izrailev S, 2002, SAR QSAR ENVIRON RES, V13, P417, DOI 10.1080/10629360290014296; Izrailev S, 2001, J CHEM INF COMP SCI, V41, P176, DOI 10.1021/ci000036s; Kanzler CM, 2020, NPJ DIGIT MED, V3, DOI 10.1038/s41746-020-0286-7; Kerr DM, 2012, STROKE, V43, P1401, DOI 10.1161/STROKEAHA.111.644484; Kohavi J., 1994, P 11 INT C MACH LEAR, P121, DOI [DOI 10.1016/B978-1-55860-335-6.50023-4, 10.1016/B978-1-55860-335-6.50023-4]; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Krabben T, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-15; Krebs H I, 2002, Top Stroke Rehabil, V8, P54; Krebs HI, 2014, STROKE, V45, P200, DOI 10.1161/STROKEAHA.113.002296; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; Marsh EB, 2016, NEUROHOSPITALIST, V6, P97, DOI 10.1177/1941874415619964; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; Novak KE, 2002, EXP BRAIN RES, V144, P351, DOI 10.1007/s00221-002-1060-6; Ona ED, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/9758939; R Core Team, 2013, R LANG ENV STAT COMP; RANKIN J, 1957, Scott Med J, V2, P200; Rohrer B, 2002, J NEUROSCI, V22, P8297; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tikhonov A. N, 1977, SCRIPTA SERIES MATH; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245874	10.1371/journal.pone.0245874	http://dx.doi.org/10.1371/journal.pone.0245874			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513170	Green Published, gold, Green Accepted			2022-12-26	WOS:000613891400044
J	Monteys, VSI; Ribes, AC; Savin, I				Sarto i Monteys, Victor; Costa Ribes, Adria; Savin, Ivan			The invasive longhorn beetle Xylotrechus chinensis, pest of mulberries, in Europe: Study on its local spread and efficacy of abamectin control	PLOS ONE			English	Article							COLEOPTERA; CERAMBYCIDAE	The invasive wasp-mimicking Tiger Longicorn Beetle, Xylotrechus chinensis, a potentially lethal pest of mulberry trees (Moraceae: Morus sp.), was first reported in Europe in 2018, although its colonization and establishment were estimated to have occurred during the year 2012 or earlier. In Catalonia the infestation spread from four towns and 44.1 km(2) in 2018 to 12 towns and 378.1 km(2) in 2020; in the studied town of Barbera del Valles, infested trees rose from 16.21% in February 2016 to 59.29% in December 2018. Human safety in public parks and avenues is a concern, as beetle infestation increases the risk of falling branches. The main objective of this study was to evaluate how the infestation progresses over time, with and without abamectin treatment, and provide insights into female egg-laying preferences. Such knowledge helps contribute to management efforts to reduce expansion of the range of beetle infestation. Our statistical analysis shows that females prefer laying eggs on larger trees, on the highest part of trunks and on the crown base (this being more preferred than the trunk), and they do so on warmer, SW orientations rather than those facing N, NW and E. Emergence holes and gallery slits predict the spreading of infestations to new trees. An abamectin treatment (trunk injection) carried out at the end of April significantly reduced the number of new infestation. However, for maximum insecticide efficiency, the best time for treating with abamectin would be from mid-July to mid-August, when newly hatched larvae begin feeding on the phloem.	[Sarto i Monteys, Victor; Costa Ribes, Adria; Savin, Ivan] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals ICTA, Entomol Plants & Hlth, Edif ICTA ICP Campus Bellaterra, Bellaterra, Spain; [Sarto i Monteys, Victor] Gen Catalunya, Serv Sanitat Vegetal, DARP, Barcelona, Spain; [Savin, Ivan] Ural Fed Univ, Grad Sch Econ & Management, Ekaterinburg, Russia	Autonomous University of Barcelona; Ural Federal University	Monteys, VSI (corresponding author), Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals ICTA, Entomol Plants & Hlth, Edif ICTA ICP Campus Bellaterra, Bellaterra, Spain.; Monteys, VSI (corresponding author), Gen Catalunya, Serv Sanitat Vegetal, DARP, Barcelona, Spain.	victor.sarto@uab.cat	Savin, Ivan/P-9035-2016	Savin, Ivan/0000-0002-9469-0510; SARTO I MONTEYS, VICTOR/0000-0003-2701-6558	grant from the President of the Russian Federation for young doctors of science [MD-3196.2019.6]	grant from the President of the Russian Federation for young doctors of science	Ivan Savin acknowledges financial support from the grant from the President of the Russian Federation for young doctors of science MD-3196.2019.6. The City Hall of Barbera del Valles (Barcelona) contributed to the costs of organizing and running this Project. The Departament d'Agricultura, Ramaderia, Pesca i Alimentacio ' of the Generalitat of Catalonia contributed 50% of the publication costs.	Aruga H., 1994, PRINCIPLES SERICULTU; Benker Ullrich, 2008, Forstschutz Aktuell, V44, P30; Cocquempot Christian, 2019, Bulletin de la Societe Entomologique de France, V124, P27, DOI 10.32475/bsef_2064; EPPO, 2018, EPPO REP SERV, V157, P7; Fettig CJ, 2013, J ENTOMOL SCI, V48, P270; Han Youngeun, 2010, Korean Journal of Applied Entomology, V49, P69; Huang C., 2000, NEWSLETTER SERICULTU; Leivadara E., 2018, Bulletin OEPP, V48, P277, DOI 10.1111/epp.12468; Lim Jongok, 2014, Korean Journal of Applied Entomology, V53, P111, DOI 10.5656/KSAE.2013.11.1.061; Marson M, 2015, WORLD DEV, V76, P26, DOI 10.1016/j.worlddev.2015.06.002; Murakami M., 1960, TECHNICAL B SERICULT, V77, P1; Pelegrin M., 2013, THESIS; Perez Canavate JG, 1992, HORTICULTURA, V76, P13; Philadelphia U.S. Customs and Border Protection, 2011, PHILLY CBP INTERCEPT; Sarto I, 2018, ADELANTOS DIGITAL; Monteys VSI, 2018, INSECTS, V9, DOI 10.3390/insects9020052; Schrader G., 2017, JULIUS KUHN I NATL I; Sun YJ, 2011, HUBEI AGR SCI; Valladares L, 2019, XYLOTRECHUS CHINENSI	19	5	5	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245527	10.1371/journal.pone.0245527	http://dx.doi.org/10.1371/journal.pone.0245527			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513188	Green Published, gold			2022-12-26	WOS:000613891400004
J	Hameed, SS; Hassan, R; Hassan, WH; Muhammadsharif, FF; Latiff, LA				Hameed, Shilan S.; Hassan, Rohayanti; Hassan, Wan Haslina; Muhammadsharif, Fahmi F.; Latiff, Liza Abdul			HDG-select: A novel GUI based application for gene selection and classification in high dimensional datasets	PLOS ONE			English	Article							CANCER CLASSIFICATION; T-TEST; MICROARRAY; ALGORITHM; AUTISM; OPTIMIZATION	The selection and classification of genes is essential for the identification of related genes to a specific disease. Developing a user-friendly application with combined statistical rigor and machine learning functionality to help the biomedical researchers and end users is of great importance. In this work, a novel stand-alone application, which is based on graphical user interface (GUI), is developed to perform the full functionality of gene selection and classification in high dimensional datasets. The so-called HDG-select application is validated on eleven high dimensional datasets of the format CSV and GEO soft. The proposed tool uses the efficient algorithm of combined filter-GBPSO-SVM and it was made freely available to users. It was found that the proposed HDG-select outperformed other tools reported in literature and presented a competitive performance, accessibility, and functionality.	[Hameed, Shilan S.; Hassan, Wan Haslina] Univ Teknol Malaysia, Malaysia Japan Int Inst Technol MJIIT, Comp Syst & Networks CSN, Kuala Lumpur, Malaysia; [Hameed, Shilan S.] Koya Univ, Directorate Informat Technol, Koya, Kurdistan Regio, Iraq; [Hassan, Rohayanti] Univ Teknol Malaysia, Fac Engn, Sch Comp, Johor Baharu, Johor, Malaysia; [Muhammadsharif, Fahmi F.] Koya Univ, Fac Sci & Hlth, Dept Phys, Koya, Kurdistan Regio, Iraq; [Latiff, Liza Abdul] Univ Teknol Malaysia, Razak Fac Technol & Informat, U BAN Res Grp, Kuala Lumpur, Malaysia	Universiti Teknologi Malaysia; Koya University; Universiti Teknologi Malaysia; Koya University; Universiti Teknologi Malaysia	Hameed, SS (corresponding author), Univ Teknol Malaysia, Malaysia Japan Int Inst Technol MJIIT, Comp Syst & Networks CSN, Kuala Lumpur, Malaysia.; Hameed, SS (corresponding author), Koya Univ, Directorate Informat Technol, Koya, Kurdistan Regio, Iraq.	shilan.sameen@koyauniversity.org	Latiff, Liza Abdul/G-3329-2017; Abdul Latiff, Liza/GQP-2971-2022; Muhammadsharif, Fahmi F./B-3802-2010	Latiff, Liza Abdul/0000-0002-5652-5477; Muhammadsharif, Fahmi F./0000-0002-4563-9671	Fundamental Research Grant Scheme (FRGS), Ministry of Education and Universiti Teknologi Malaysia [RJ130000.7851.5F037]	Fundamental Research Grant Scheme (FRGS), Ministry of Education and Universiti Teknologi Malaysia	RH received a financial support from the Fundamental Research Grant Scheme (FRGS), Ministry of Education and Universiti Teknologi Malaysia under Vote No: RJ130000.7851.5F037.	Alba E, 2007, IEEE C EVOL COMPUTAT, P284, DOI 10.1109/CEC.2007.4424483; Algamal ZY, 2019, ADV DATA ANAL CLASSI, V13, P753, DOI 10.1007/s11634-018-0334-1; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Annavarapu CSR, 2016, EXCLI J, V15, P460, DOI 10.17179/excli2016-481; Ardjani F, 2010, 2010 2ND INTERNATIONAL WORKSHOP ON DATABASE TECHNOLOGY AND APPLICATIONS PROCEEDINGS (DBTA); Barash E, 2019, BIOINFORMATICS, V35, P2001, DOI 10.1093/bioinformatics/bty928; Bolon-Canedo V, 2014, INFORM SCIENCES, V282, P111, DOI 10.1016/j.ins.2014.05.042; Bommert A, 2020, COMPUT STAT DATA AN, V143, DOI 10.1016/j.csda.2019.106839; Bridge PD, 1999, J CLIN EPIDEMIOL, V52, P229, DOI 10.1016/S0895-4356(98)00168-1; Bruyneel AAN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226694; Chen LF, 2012, NEURAL COMPUT APPL, V21, P2087, DOI 10.1007/s00521-011-0632-4; Chen WH, 2020, IEEE ACCESS, V8, P40138, DOI 10.1109/ACCESS.2020.2975905; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cosma G, 2017, EXPERT SYST APPL, V70, P1, DOI 10.1016/j.eswa.2016.11.006; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; Duez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166126; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Garcia-Nieto J, 2009, INFORM PROCESS LETT, V109, P887, DOI 10.1016/j.ipl.2009.03.029; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Govindarajan R, 2012, J PHARM BIOALLIED SC, V4, pS310, DOI 10.4103/0975-7406.100283; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hameed SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187371; Hameed SS, 2018, J COMPOS SCI, V14, P868; Han J, 2012, MOR KAUF D, P1; Hassanien AE, 2013, COMPUT BIOL CHEM, V47, P37, DOI 10.1016/j.compbiolchem.2013.04.007; Haury AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028210; Hira Zena M., 2015, Advances in Bioinformatics, V2015, P198363, DOI 10.1155/2015/198363; Huertas C Jua, 2014, INFORM FUSION FUSION; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Karizaki AA, 2019, 2019 9TH INTERNATIONAL CONFERENCE ON COMPUTER AND KNOWLEDGE ENGINEERING (ICCKE 2019), P300, DOI 10.1109/ICCKE48569.2019.8965106; Kaya H, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00612-17; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104, DOI 10.1109/ICSMC.1997.637339; Khoshgoftaar T, 2012, 2012 11TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA 2012), VOL 2, P151, DOI 10.1109/ICMLA.2012.192; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lai C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-235; Latkowski T, 2015, COMPUT BIOL MED, V56, P82, DOI 10.1016/j.compbiomed.2014.11.004; Latkowski T, 2015, EXPERT SYST APPL, V42, P864, DOI 10.1016/j.eswa.2014.08.043; Lazar C, 2012, IEEE ACM T COMPUT BI, V9, P1106, DOI 10.1109/TCBB.2012.33; Li ST, 2008, SOFT COMPUT, V12, P1039, DOI 10.1007/s00500-007-0272-x; Moraglio Alberto, 2008, Journal of Artificial Evolution & Applications, DOI 10.1155/2008/143624; Osowski S., 2015, C ART NEUR NET A; Patil AR, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8010110; Pirooznia M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S25; Rejani Y.IA., 2009, INT J COMPUTER SCI E, V1, P127, DOI DOI 10.1007/S00330-009-1616-Y.; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Saha S, 2016, INT J BIOINFORMATICS, V12, P263; Sayed S, 2019, EXPERT SYST APPL, V121, P233, DOI 10.1016/j.eswa.2018.12.022; Singh RK, 2015, PROCEDIA COMPUT SCI, V50, P52, DOI 10.1016/j.procs.2015.04.060; Song XF, 2020, IEEE T EVOLUT COMPUT, V24, P882, DOI 10.1109/TEVC.2020.2968743; Sprent P., 2016, APPL NONPARAMETRIC S; Tamazian G, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0141-6; Thaher T, 2020, ALGO INTELL SY, P251, DOI 10.1007/978-981-32-9990-0_12; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wild C, 2011, WILCOXON RANK SUM TE; Yan CK, 2019, CHEMOMETR INTELL LAB, V184, P102, DOI 10.1016/j.chemolab.2018.11.010; Zhang YD, 2014, KNOWL-BASED SYST, V64, P22, DOI 10.1016/j.knosys.2014.03.015; Zhu ZX, 2007, PATTERN RECOGN, V40, P3236, DOI 10.1016/j.patcog.2007.02.007	63	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246039	10.1371/journal.pone.0246039	http://dx.doi.org/10.1371/journal.pone.0246039			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507983	Green Published, gold			2022-12-26	WOS:000635021400077
J	Forns, J; Layton, JB; Bartsch, J; Turner, ME; Dempsey, C; Anthony, M; Ritchey, ME; Demos, G				Forns, Joan; Layton, J. Bradley; Bartsch, Jennifer; Turner, Mary Ellen; Dempsey, Colleen; Anthony, Mary; Ritchey, Mary E.; Demos, George			Increased risk of falls and fractures in patients with psychosis and Parkinson disease	PLOS ONE			English	Article								Objective Evaluate whether the risk of falls and fractures differs between patients with Parkinson disease with psychosis (PDP) and patients with Parkinson disease (PD) without psychosis at similar disease stages. Methods Patients with PD without psychosis were identified in the Medicare claims databases (2008-2018) and followed from the first PD diagnosis date during the study period. Patients with a subsequent diagnosis of psychosis were included in the PDP group. Patients with PDP and PD without psychosis were propensity score-matched based on characteristics within blocks of time since cohort entry. The incidence rates (IRs), expressed per 100 person-years, and 95% confidence intervals (CIs) of falls and fractures were evaluated as composite and separate outcomes. Incidence rate ratios (IRRs) were used to compare patients with PDP and PD without psychosis in the matched cohort. Results 154,306 patients had PD without psychosis and no falls or fractures before cohort entry; the IR for falls and fractures was 11.41 events (95% CI, 11.29-11.53). 12,127 patients (7.8%) had a subsequent PDP diagnosis. PDP patients had a higher prevalence of most comorbidities and risk factors for falls and fractures than those without psychosis. The crude IR for falls and fractures among PDP patients was 29.03 events (95% CI, 28.27-29.81). PD without psychosis and PDP groups had more falls than fractures. After matching, 24,144 PD patients without psychosis (15.6%) and 12,077 PDP patients (99.6%) were retained. Matched PDP patients had a higher incidence of falls and fractures than PD patients without psychosis (IRR = 1.44; 95% CI, 1.39-1.49). The higher increased rate was noted separately for falls (IRR = 1.48; 95% CI, 1.43-1.54) and any fractures (IRR = 1.17; 95% CI, 1.08-1.27) as well as within specific types of fracture, including pelvis and hip fractures. Conclusions Our findings suggest a modest but consistently higher increased risk of falls and fractures in PDP patients compared with PD patients without psychosis.	[Forns, Joan] RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Barcelona, Spain; [Layton, J. Bradley; Anthony, Mary; Ritchey, Mary E.] RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Res Triangle Pk, NC USA; [Bartsch, Jennifer] RTI Hlth Solut, Biometr, Res Triangle Pk, NC USA; [Turner, Mary Ellen; Dempsey, Colleen; Demos, George] ACADIA Pharmaceut Inc, San Diego, CA USA	Research Triangle Institute; Research Triangle Institute; Research Triangle Institute	Forns, J (corresponding author), RTI Hlth Solut, Pharmacoepidemiol & Risk Management, Barcelona, Spain.	jforns@rti.org	Layton, J. Bradley/B-4950-2018	Layton, J. Bradley/0000-0003-0994-5820; Anthony, Mary/0000-0002-5201-1794; Bartsch, Jennifer/0000-0003-1506-5715; Forns, Joan/0000-0002-1066-0358	ACADIA Pharmaceuticals Inc.	ACADIA Pharmaceuticals Inc.	This study was funded by ACADIA Pharmaceuticals Inc. The authors JF, JBL, JB, MEB, and MA are full-time salaried employees of RTI Health Solutions. MET, CD, and GD are fulltime salaried employees of ACADIA. The specific roles of these authors are articulated in the "author contributions" section. Except as disclosed above, the funders otherwise had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/906274; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Cuthbertson CC, 2018, EPIDEMIOLOGY, V29, P556, DOI 10.1097/EDE.0000000000000833; DOBSON AJ, 1991, STAT MED, V10, P457, DOI 10.1002/sim.4780100317; Faurot KR, 2015, PHARMACOEPIDEM DR S, V24, P59, DOI 10.1002/pds.3719; Fredericks D, 2017, AM J MANAG CARE, V23, pS83; Kalilani L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161689; Kianirad Y, 2017, EXPERT REV CLIN PHAR, V10, P1161, DOI 10.1080/17512433.2017.1369405; Leslie DL, 2012, AM J MANAG CARE, V18, pE109; Levin J, 2016, J NEURAL TRANSM, V123, P45, DOI 10.1007/s00702-015-1400-x; Mansbach WE, 2016, RES GERONTOL NURS, V9, P257, DOI 10.3928/19404921-20160920-03; Parsons L, 2004, 29 ANN SAS R US GROU; Phillips LJ, 2018, J PSYCHIATR MENT HLT, V25, P463, DOI 10.1111/jpm.12488; Sahai H, 1996, STAT EPIDEMIOLOGY ME; Taddei RN, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/3256542; Torsney KM, 2014, J NEUROL NEUROSUR PS, V85, P1159, DOI 10.1136/jnnp-2013-307307; Vestergaard P, 2007, CALCIFIED TISSUE INT, V81, P153, DOI 10.1007/s00223-007-9065-6	18	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246121	10.1371/journal.pone.0246121	http://dx.doi.org/10.1371/journal.pone.0246121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503061	gold, Green Published			2022-12-26	WOS:000613751800054
J	Ausems, ANMA; Skrzypek, G; Wojczulanis-Jakubas, K; Jakubas, D				Ausems, Anne N. M. A.; Skrzypek, Grzegorz; Wojczulanis-Jakubas, Katarzyna; Jakubas, Dariusz			Birds of a feather moult together: Differences in moulting distribution of four species of storm-petrels	PLOS ONE			English	Article							STABLE-ISOTOPE ANALYSIS; KING-GEORGE-ISLAND; OCEANITES-OCEANICUS; BREEDING SUCCESS; HYDROBATES-PELAGICUS; FEEDING ECOLOGY; OCEANODROMA-LEUCORHOA; FORAGING BEHAVIOR; TROPHIC POSITION; SOUTHERN-OCEAN	The non-breeding period of pelagic seabirds, and particularly the moulting stage, is an important, but understudied part of their annual cycle as they are hardly accessible outside of the breeding period. Knowledge about the moulting ecology of seabirds is important to understand the challenges they face outside and within the breeding season. Here, we combined stable carbon (delta C-13) and oxygen (delta O-18) signatures of rectrices grown during the non-breeding period of two pairs of storm-petrel species breeding in the northern (European storm-petrel, Hydrobates pelagicus, ESP; Leach's storm-petrel, Hydrobates leucorhous, LSP) and southern (black-bellied storm-petrel, Fregetta tropica, BBSP; Wilson's storm-petrel, Oceanites oceanicus, WSP) hemispheres to determine differences in moulting ranges within and between species. To understand clustering patterns in delta C-13 and delta O-18 moulting signatures, we examined various variables: species, sexes, years, morphologies (feather growth rate, body mass, tarsus length, wing length) and delta N-15. We found that different factors could explain the differences within and between the four species. We additionally employed a geographical distribution prediction model based on oceanic delta C-13 and delta O-18 isoscapes, combined with chlorophyll-a concentrations and observational data to predict potential moulting areas of the sampled feather type. The northern species were predicted to moult in temperate and tropical Atlantic zones. BBSP was predicted to moult on the southern hemisphere north of the Southern Ocean, while WSP was predicted to moult further North, including in the Arctic and northern Pacific. While moulting distribution can only be estimated on large geographical scales using delta C-13 and delta O-18, validating predictive outcomes with food availability proxies and observational data may provide valuable insights into important moulting grounds. Establishing those, in turn, is important for conservation management of elusive pelagic seabirds.	[Ausems, Anne N. M. A.; Wojczulanis-Jakubas, Katarzyna; Jakubas, Dariusz] Univ Gdansk, Fac Biol, Dept Vertebrate Ecol & Zool, Gdansk, Poland; [Skrzypek, Grzegorz] Univ Western Australia, West Australian Biogeochem Ctr, Crawley, WA, Australia	Fahrenheit Universities; University of Gdansk; University of Western Australia	Ausems, ANMA (corresponding author), Univ Gdansk, Fac Biol, Dept Vertebrate Ecol & Zool, Gdansk, Poland.	anne.ausems@gmail.com	Ausems, Anne/AAP-6725-2021; Jakubas, Dariusz/N-3680-2019; Wojczulanis-Jakubas, Katarzyna/AAO-4126-2021	Jakubas, Dariusz/0000-0002-1879-4342; Wojczulanis-Jakubas, Katarzyna/0000-0001-6230-0509; Ausems, Anne/0000-0002-6683-6674; Skrzypek, Grzegorz/0000-0002-5686-2393	National Science Centre, Poland [2015/19/B/NZ8/01981]	National Science Centre, Poland(National Science Centre, Poland)	The study was funded by a grant of the National Science Centre, Poland to Dr. Dariusz Jakubas (2015/19/B/NZ8/01981; https://www.ncn.gov.pl/?language=en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D.G., 1984, ORNITHOL MONOGR, V32, P1, DOI 10.2307/40166773; AINLEY DG, 1976, WILSON BULL, V88, P76; Ainslie JA, 1936, BRIT BIRDS, P234; Amengual J. F., 1999, Ringing and Migration, V19, P181; Arroyo B, 2004, ARDEOLA, V51, P365; Ausems ANMA, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138768; Ausems ANMA, 2019, PEERJ, V7, DOI 10.7717/peerj.7807; Beck JR, 1972, BRIT ANTARCTIC SURV, V69, P1; Bogdanova MI, 2017, MAR ECOL PROG SER, V578, P167, DOI 10.3354/meps12096; Bolton M., 2001, Ringing and Migration, V20, P193; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Busser C, 2004, POLAR BIOL, V27, P613, DOI 10.1007/s00300-004-0627-z; Busser C., 2003, THESIS; Cadiou Bernard, 2001, Atlantic Seabirds, V3, P149; Campbell Caitlin J., 2020, Animal Migration, V7, P27, DOI 10.1515/ami-2020-0004; Carboneras C, 2017, HDB BIRDS WORLD ALIV, P197; Carreiro AR, 2020, MAR BIOL, V167, DOI 10.1007/s00227-019-3626-x; Carroll MJ, 2017, AQUAT CONSERV, V27, P1164, DOI 10.1002/aqc.2780; Ceia FR, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00377; Ceia FR, 2014, MAR ECOL PROG SER, V497, P273, DOI 10.3354/meps10586; Cherel Y, 2000, OECOLOGIA, V122, P155, DOI 10.1007/PL00008843; Cherel Y, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00003; Coplen T.B., 1996, GEOCHIM COSMOCHIM AC, V60, P3359, DOI [10.1016/0016-7037(96)00263-3, DOI 10.1016/0016-7037(96)00263-3]; Coplen TB, 2012, FORENSIC SCI INT, V214, P135, DOI 10.1016/j.forsciint.2011.07.035; Cramp S, 1977, HDB BIRDS EUROPE MID, VI, P155; CROXALL JP, 1988, J ZOOL, V216, P83, DOI 10.1111/j.1469-7998.1988.tb02417.x; CROXALL JP, 1980, BIOL J LINN SOC, V14, P103, DOI 10.1111/j.1095-8312.1980.tb00101.x; D'Elbee J, 1998, ARDEA, V86, P1; Edwards AE, 2008, J AVIAN BIOL, V39, P144, DOI 10.1111/j.2007.0908-8857.04139.x; Elorriaga Javier, 2010, British Birds, V103, P396; Enfield DB, 1997, J GEOPHYS RES-OCEANS, V102, P929, DOI 10.1029/96JC03296; ESRI, 2014, ARCMAP 10 3 1; Flood Robert L., 2007, British Birds, V100, P407; Frith R, 2020, NORTHEAST NAT, V27, P612, DOI 10.1656/045.027.0402; Furness RW, 1997, ICES J MAR SCI, V54, P726, DOI 10.1006/jmsc.1997.0243; Gladbach A, 2007, POLAR BIOL, V30, P1005, DOI 10.1007/s00300-007-0258-2; Gladbach A, 2009, POLAR BIOL, V32, P1315, DOI 10.1007/s00300-009-0628-z; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Griffiths A.M., 1981, Cormorant, V9, P47; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; GRUBB TC, 1989, AUK, V106, P314; Hahn S, 1998, POLAR BIOL, V19, P354, DOI 10.1007/s003000050258; Hahn Steffen, 1998, Marine Ornithology, V26, P80; Halpin LR, 2018, J F ORNITHOL, P1; Hattori A., 1990, NITROGEN SEA FORMS A; Hedd A, 2009, CAN J ZOOL, V87, P787, DOI 10.1139/Z09-060; Hedd A, 2006, MAR ECOL PROG SER, V322, P291, DOI 10.3354/meps322291; Hedd A, 2012, MAR ECOL PROG SER, V449, P277, DOI 10.3354/meps09538; Hedenstrom A, 1999, J EXP BIOL, V202, P67; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn T, 2015, J MACH LEARN RES, V16, P3905; Hovinen JEH, 2019, MAR ECOL PROG SER, V613, P183, DOI 10.3354/meps12886; Jakubas D, 2014, ACTA ORNITHOL, V49, P71, DOI 10.3161/000164514X682904; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; LEOPOLD MF, 1993, HYDROBIOLOGIA, V258, P197, DOI 10.1007/BF00006197; Magozzi S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1763; Magozzi S, 2019, OECOLOGIA, V191, P777, DOI 10.1007/s00442-019-04532-8; Martinez C, 2019, ARDEOLA, V66, P13, DOI 10.13157/arla.66.1.2019.ra2; Mayaud N., 1949, ALAUDA, V17, P222; McMahon KW, 2013, OCEANOGR MAR BIOL, V51, P327; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Medeiros RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046330; Meier RE, 2017, DIVERS DISTRIB, V23, P130, DOI 10.1111/ddi.12509; Michener R.H., 1994, P138; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; MIZUTANI H, 1992, ECOLOGY, V73, P1391, DOI 10.2307/1940684; Orben RA, 2015, J ANIM ECOL, V84, P1589, DOI 10.1111/1365-2656.12410; Pacyna AD, 2019, SCI TOTAL ENVIRON, V692, P382, DOI 10.1016/j.scitotenv.2019.07.137; Pacyna-Kuchta AD, 2020, SCI TOTAL ENVIRON, V732, DOI 10.1016/j.scitotenv.2020.139103; Paiva VH, 2018, ZOOLOGY, V126, P29, DOI 10.1016/j.zool.2017.12.006; Penhallurick J, 2004, EMU, V104, P125, DOI 10.1071/MU01060; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; Pollet IL, 2019, MAR ORNITHOL, V47, P55; Pollet IL, 2014, J FIELD ORNITHOL, V85, P321, DOI 10.1111/jofo.12071; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Quillfeldt P, 2006, POLAR BIOL, V29, P372, DOI 10.1007/s00300-005-0066-5; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2002, POLAR BIOL, V25, P216, DOI 10.1007/s00300-001-0332-0; Quillfeldt P, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3224-8; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; Reiertsen TK, 2014, MAR ECOL PROG SER, V509, P289, DOI 10.3354/meps10825; Ridoux Vincent, 1994, Marine Ornithology, V22, P1; Rodriguez A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00094; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Sausner J, 2016, AUK, V133, P397, DOI 10.1642/AUK-15-158.1; Skrzypek G, 2013, ANAL BIOANAL CHEM, V405, P2815, DOI 10.1007/s00216-012-6517-2; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Spear LB, 1998, AUK, V115, P1017, DOI 10.2307/4089519; Suryan RM, 2012, MAR ECOL PROG SER, V451, P213, DOI 10.3354/meps09597; Visser GH, 1993, PHYSIOL ZOOL, V66, P490; WASILEWSKI A, 1986, Polish Polar Research, V7, P173; Weiss F, 2009, POLAR BIOL, V32, P1753, DOI 10.1007/s00300-009-0674-6	98	1	1	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245756	10.1371/journal.pone.0245756	http://dx.doi.org/10.1371/journal.pone.0245756			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481938	gold, Green Published			2022-12-26	WOS:000612929300079
J	Buser, JM; Munro-Kramer, ML; Veliz, PT; Zhang, XY; Lockhart, N; Biemba, G; Ngoma, T; Scott, N; Lori, JR				Buser, Julie M.; Munro-Kramer, Michelle L.; Veliz, Philip T.; Zhang, Xingyu; Lockhart, Nancy; Biemba, Godfrey; Ngoma, Thandiwe; Scott, Nancy; Lori, Jody R.			How maternity waiting home use influences attendance of antenatal and postnatal care	PLOS ONE			English	Article							MORTALITY	As highlighted in the International Year of the Nurse and the Midwife, access to quality nursing and midwifery care is essential to promote maternal-newborn health and improve survival. One intervention aimed at improving maternal-newborn health and reducing underutilization of pregnancy services is the construction of maternity waiting homes (MWHs). The purpose of this study was to assess whether there was a significant change in antenatal care (ANC) and postnatal care (PNC) attendance, family planning use, and vaccination rates before and after implementation of the Core MWH Model in rural Zambia. A quasi-experimental controlled before-and-after design was used to evaluate the impact of the Core MWH Model by assessing associations between ANC and PNC attendance, family planning use, and vaccination rates for mothers who gave birth to a child in the past 13 months. Twenty health care facilities received the Core MWH Model and 20 were identified as comparison facilities. Before-and-after community surveys were carried out. Multivariable logistic regression were used to assess the association between Core MWH Model use and ANC and PNC attendance. The total sample includes 4711 mothers. Mothers who used the Core MWH Model had better ANC and PNC attendance, family planning use, and vaccination rates than mothers who did not use a MWH. All mothers appeared to fare better across these outcomes at endline. We found an association between Core MWH Model use and better ANC and PNC attendance, family planning use, and newborn vaccination outcomes. Maternity waiting homes may serve as a catalyst to improve use of facility services for vulnerable mothers.	[Buser, Julie M.] Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA; [Munro-Kramer, Michelle L.; Lockhart, Nancy; Lori, Jody R.] Univ Michigan, Sch Nursing, Dept Hlth Behav & Biol Sci, Ann Arbor, MI 48109 USA; [Veliz, Philip T.; Zhang, Xingyu] Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Appl Biostat Lab, Ann Arbor, MI 48109 USA; [Biemba, Godfrey] Natl Hlth Res Author, Lusaka, Zambia; [Biemba, Godfrey; Scott, Nancy] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Biemba, Godfrey; Ngoma, Thandiwe] Zambian Ctr Appl Hlth Res & Dev ZCAHRD Ltd, Lusaka, Zambia; [Ngoma, Thandiwe] Right Care Zambia, Lusaka, Zambia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Boston University	Buser, JM (corresponding author), Univ Michigan, Michigan Med, Ann Arbor, MI 48109 USA.	jbuser@umich.edu		Zhang, Xingyu/0000-0001-8108-1997; Scott, Nancy/0000-0002-4713-4642	Bill & Melinda Gates Foundation [OPP1130334]; ELMA Foundation [ELMA-15-F0010]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); ELMA Foundation	The study program was developed and is being implemented in collaboration with Merck for Mothers, Merck's 10-year, $500 million initiative to help create a world where no woman dies giving life. Merck for Mothers is known as MSD for Mothers outside the United States and Canada (MRK 1846-06500.COL). The development of the study article was additionally supported in part by the Bill & Melinda Gates Foundation (OPP1130334) https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2015/06/OPP1130334 and The ELMA Foundation (ELMA-15-F0010) http://www.elmaphilanthropies.org/the-elma-foundation/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily reflect positions or policies of Merck, the Bill & Melinda Gates Foundation, or The ELMA Foundation.	Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Bekele BB, MATERNITY WAITING HO; Bonawitz R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225523; Chama-Chiliba CM, 2015, HEALTH POLICY PLANN, V30, P78, DOI 10.1093/heapol/czt099; Chungu C, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00094; Conlon CM, 2019, GLOB HEALTH-SCI PRAC, V7, pS6, DOI 10.9745/GHSP-D-18-00427; DHS, ZAMBIA DHS 2013 14 F; DHS, 2018, ZAMB STAND DHS; FigaTalamanca I, 1996, SOC SCI MED, V42, P1381, DOI 10.1016/0277-9536(95)00286-3; Fogliati P, 2017, HEALTH POLICY PLANN, V32, P1354, DOI 10.1093/heapol/czx100; Henry EG, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-4989-x; Henry EG, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0328-z; Jacobs C, 2018, BMC HEALTH SERV RES, V18, P1, DOI [10.1186/s12913-017-2770-6, DOI 10.1186/S12913-017-2770-6]; Jacobs C, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00011; Lori JR, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2384-6; Lori JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209815; Lori JR, 2016, MIDWIFERY, V41, P89, DOI 10.1016/j.midw.2016.08.005; Lori JR, 2013, INT J GYNECOL OBSTET, V123, P114, DOI 10.1016/j.ijgo.2013.05.024; Lori JR, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-134; Mutale W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4187-x; Nganjo Phiri S, RURAL URBAN INEQUITY; Nuamah GB, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-018-2159-5; Okedo-Alex IN, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031890; Renfrew MJ, 2019, BIRTH-ISS PERINAT C, V46, P396, DOI 10.1111/birt.12442; Scott NA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022224; Sialubanje C, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1317-5; SMGL, ZAMB OUR PROGR; UN IGME, ZAMB; van Lonkhuijzen L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006759.pub3; WHO, 1996, MAT WAIT HOM REV EXP; WHO, WHO REC ANT CAR SCH; WHO, ZAMB COUNTR PROF; World Health Organization, WHO REC POSTN CAR MO; World Health Organization, OPPORTUNITIES AFRICA; World Health Organization, YEAR NURS MIDW 2020	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245893	10.1371/journal.pone.0245893	http://dx.doi.org/10.1371/journal.pone.0245893			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481942	gold, Green Published			2022-12-26	WOS:000612929300059
J	Demkovich, MR; Calla, B; Ngumbi, E; Higbee, BS; Siegel, JP; Berenbaum, MR				Demkovich, Mark R.; Calla, Bernarda; Ngumbi, Esther; Higbee, Bradley S.; Siegel, Joel P.; Berenbaum, May R.			Differential regulation of cytochrome P450 genes associated with biosynthesis and detoxification in bifenthrin-resistant populations of navel orangewom (Amyelois transitella)	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; HELICOVERPA-ARMIGERA; RNA INTERFERENCE; LEPIDOPTERA; TOXICITY; CHLORANTRANILIPROLE; IDENTIFICATION; EXPRESSION; PATTERNS; EVALUATE	Pyrethroid resistance was first reported in 2013 for the navel orangeworm, Amyelois transitella, but the genetic underpinnings of pyrethroid resistance are unknown. We investigated the role of cytochrome P450 monooxygenases (P450s) belonging to the CYP3 and CYP4 clans using colonies derived from individuals collected in 2016 from almond orchards in two counties. One colony (ALM) originated from an almond orchard in Madera County with no reported pyrethroid resistance and the second colony (R347) originated from the same Kern County orchard where pyrethroid resistance was first reported. We used high-throughput quantitative real-time PCR (qRT-PCR) analyses of 65 P450s in the CYP3 and CYP4 clans of A. transitella to identify P450s induced by bifenthrin and associated with pyrethroid resistance. Nine P450s were constitutively overexpressed in R347 compared to ALM, including CYP6AE54 (11.7-fold), belonging to a subfamily associated with metabolic pesticide detoxification in Lepidoptera and CYP4G89 (33-fold) belonging to a subfamily associated with cuticular hydrocarbon (CHC) synthesis and resistance via reduced pesticide penetrance. Cuticular hydrocarbons analysis revealed that R347 produced twice as many total CHCs in the egg and adult stages as ALM. Topical toxicity bioassays for R347 determined that egg mortality was reduced at low bifenthrin concentrations and larval mortality was reduced at high concentrations of bifenthrin compared to ALM. Our discovery of both changes in metabolism and production of CHCs for R347 have implications for the possible decreased efficacy of other classes of insecticide used to control this insect. The threat of widespread pyrethroid resistance combined with the potential for cross-resistance to develop through the mechanism of reduced penetrance warrants developing management strategies that facilitate insecticide passage across the cuticle.	[Demkovich, Mark R.; Calla, Bernarda; Ngumbi, Esther; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Higbee, Bradley S.] Trece Inc, Adair, OK USA; [Siegel, Joel P.] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA	University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA)	Calla, B (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	calla2@illinois.edu	Higbee, Bradley S./AAX-6662-2020	Higbee, Bradley S./0000-0002-2093-8309	Almond Board of California (ABC) [ABC15.ENT01]	Almond Board of California (ABC)	This work was funded by the Almond Board of California (ABC grant#ABC15.ENT01). The company Trece Incorporated provided some resources for sampling but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this authors are articulated in the 'author contributions' section.	Achaleke J, 2009, PEST MANAG SCI, V65, P1147, DOI 10.1002/ps.1807; Administrative Committee for Pistachios in California, 2018, PIST BEAR ACR PROD Y; Balabanidou V, 2016, P NATL ACAD SCI USA, V113, P9268, DOI 10.1073/pnas.1608295113; Berenbaum MR, 2002, J CHEM ECOL, V28, P873, DOI 10.1023/A:1015260931034; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Bush DS, 2017, ENVIRON ENTOMOL, V46, P602, DOI 10.1093/ee/nvx068; California Department of Pesticide Regulation, 1990, PEST US ANN SUMM REP; Calla B, 2020, GEN BIOL EVOL; Calla B, 2017, MOL ECOL, V26, P6021, DOI 10.1111/mec.14348; Campbell BE, 2016, INSECTICIDES RESISTANCE, P83, DOI 10.5772/61848; Carvalho RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062268; Chen N, 2020, PEST MANAG SCI, V76, P215, DOI 10.1002/ps.5499; Davies L, 2006, INSECT BIOCHEM MOLEC, V36, P801, DOI 10.1016/j.ibmb.2006.08.001; Demkovich M, 2015, J ECON ENTOMOL, V108, P2753, DOI 10.1093/jee/tov237; Demkovich M, 2015, ENVIRON ENTOMOL, V44, P855, DOI 10.1093/ee/nvv047; Demkovich MR, 2018, J PEST SCI, V91, P1127, DOI 10.1007/s10340-018-0959-z; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FINNEY GL, 1967, J ECON ENTOMOL, V60, P1109, DOI 10.1093/jee/60.4.1109; Gao X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030274; Hu Z, 2014, B ENTOMOL RES, V104, P716, DOI 10.1017/S0007485314000510; Ishak IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005302; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kefi M, 2019, INSECT BIOCHEM MOLEC, V110, P52, DOI 10.1016/j.ibmb.2019.04.018; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu NN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023403; Maibeche-Coisne M, 2000, BIOCHEM BIOPH RES CO, V273, P1132, DOI 10.1006/bbrc.2000.3058; NELSON DR, 1995, COMP BIOCHEM PHYS B, V111, P681, DOI 10.1016/0305-0491(94)00240-U; Ngumbi EN, 2020, J CHEM ECOL, V46, P40, DOI 10.1007/s10886-019-01129-6; Niu GD, 2012, J ECON ENTOMOL, V105, P410, DOI 10.1603/EC10194; Niu GD, 2011, INSECT BIOCHEM MOLEC, V41, P244, DOI 10.1016/j.ibmb.2010.12.009; Noble KG, 2013, THESIS; Palumbo JD, 2014, PLANT DIS, V98, P1194, DOI 10.1094/PDIS-09-13-1015-RE; Pittendrigh B, 1997, INSECT BIOCHEM MOLEC, V27, P507, DOI 10.1016/S0965-1748(97)00025-8; Qiu Y, 2012, P NATL ACAD SCI USA, V109, P14858, DOI 10.1073/pnas.1208650109; Rodriguez MA, 2011, PESTIC BIOCHEM PHYS, V100, P151, DOI 10.1016/j.pestbp.2011.03.003; Rozen S, 2000, Methods Mol Biol, V132, P365; Rupasinghe SG, 2007, PROTEIN ENG DES SEL, V20, P615, DOI 10.1093/protein/gzm063; Sasabe M, 2004, GENE, V338, P163, DOI 10.1016/j.gene.2004.04.028; Schuler MA, 2013, J CHEM ECOL, V39, P1232, DOI 10.1007/s10886-013-0335-7; Siegel JP, 2019, PEST MANAG SCI, V75, P2989, DOI 10.1002/ps.5413; Siegel JP, 2019, PEST MANAG SCI, V75, P1435, DOI 10.1002/ps.5265; Toloza AC, 2008, J MED ENTOMOL, V45, P421, DOI 10.1603/0022-2585(2008)45[421:DPOIRI]2.0.CO;2; United States Department of Agriculture National Agricultural Statistics Service, 2019, CAL ALM OBJ MEAS REP; WADE WILLIAM H., 1961, HILGARDIA, V31, P129; WALDBAUER GP, 1984, GREAT LAKES ENTOMOL, V17, P113; Wang RL, 2017, INSECT SCI, V24, P235, DOI 10.1111/1744-7917.12315; Wang SY, 2019, INSECT MOL BIOL, V28, P637, DOI 10.1111/imb.12581; Wang SY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00913; Yahouedo GA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11357-z; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Yang YH, 2006, J ECON ENTOMOL, V99, P1784, DOI 10.1603/0022-0493-99.5.1784; Yu LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16221; Zhen CG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198671	54	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245803	10.1371/journal.pone.0245803	http://dx.doi.org/10.1371/journal.pone.0245803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481873	Green Published, gold			2022-12-26	WOS:000612929300132
J	Ihssen, J; Jovanovic, N; Sirec, T; Spitz, U				Ihssen, Julian; Jovanovic, Nina; Sirec, Teja; Spitz, Urs			Real-time monitoring of extracellular ATP in bacterial cultures using thermostable luciferase	PLOS ONE			English	Article							FIREFLY LUCIFERASE; BIOLUMINESCENCE ASSAY; CELLS	Adenosine triphosphate (ATP) is one of the most important indicators of cell viability. Extracellular ATP (eATP) is commonly detected in cultures of both eukaryotic and prokaryotic cells but is not the focus of current scientific research. Although ATP release has traditionally been considered to mainly occur as a consequence of cell destruction, current evidence indicates that ATP leakage also occurs during the growth phase of diverse bacterial species and may play an important role in bacterial physiology. ATP can be conveniently measured with high sensitivity in luciferase-based bioluminescence assays. However, wild-type luciferases suffer from low stability, which limit their use. Here we demonstrate that an engineered, thermostable luciferase is suitable for real-time monitoring of ATP release by bacteria, both in broth culture and on agar surfaces. Different bacterial species show distinct patterns of eATP accumulation and decline. Real-time monitoring of eATP allows for the estimation of viable cell number by relating luminescence onset time to initial cell concentration. Furthermore, the method is able to rapidly detect the effect of antibiotics on bacterial cultures as Ampicillin sensitive strains challenged with beta lactam antibiotics showed strongly increased accumulation of eATP even in the absence of growth, as determined by optical density. Patterns of eATP determined by real-time luminescence measurement could be used to infer the minimal inhibitory concentration of Ampicillin. Compared to conventional antibiotic susceptibility testing, the method presented here is faster and more sensitive, which is essential for better treatment outcomes and reducing the risk of inducing antibiotic resistance. Real-time eATP bioluminescence assays are suitable for different cell types, either prokaryotic or eukaryotic, thus, permitting their application in diverse fields of research. It can be used for example in the study of the role of eATP in physiology and pathophysiology, for monitoring microbial contamination or for antimicrobial susceptibility testing in clinical diagnostics.	[Ihssen, Julian; Spitz, Urs] Biosynth AG, Staad, Switzerland; [Jovanovic, Nina] Univ Belgrade, Fac Biol, Inst Physiol & Biochem, Dept Biochem & Mol Biol, Belgrade, Serbia; [Sirec, Teja] Carbosynth Ltd, Axis House, Compton, Berks, England	University of Belgrade	Sirec, T (corresponding author), Carbosynth Ltd, Axis House, Compton, Berks, England.	teja.sirec@biosynth-carbosynth.com		Jovanovic, Nina/0000-0001-6300-9705	Biosynth Carbosynth group	Biosynth Carbosynth group	The funding organisation Biosynth Carbosynth group has provided financial support in the form of authors' salaries and research materials. The funder provided support in the form of salaries for authors T.S., N.J., J.I. and U.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasian B, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00439-19; Alt V, 2004, ANTIMICROB AGENTS CH, V48, P4084, DOI 10.1128/AAC.48.11.4084-4088.2004; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Branchini BR, 2007, ANAL BIOCHEM, V361, P253, DOI 10.1016/j.ab.2006.10.043; Cai YY, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00183-18, 10.1128/aac.00183-18]; Corriden R, 2007, AM J PHYSIOL-CELL PH, V293, pC1420, DOI 10.1152/ajpcell.00271.2007; Coutinho-Silva R, 2012, MICROBES INFECT, V14, P1271, DOI 10.1016/j.micinf.2012.05.009; Ding QF, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00155; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Hattori N, 1998, ANTIMICROB AGENTS CH, V42, P1406, DOI 10.1128/AAC.42.6.1406; Heller AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210534; Hironaka I, 2013, APPL ENVIRON MICROB, V79, P2328, DOI 10.1128/AEM.03871-12; Inami A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082371; Ivancic V, 2008, J CLIN MICROBIOL, V46, P1213, DOI 10.1128/JCM.02036-07; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kapoor R, 2010, J CLIN MICROBIOL, V48, P3725, DOI 10.1128/JCM.01482-10; Khan ZA, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020049; Koksharov MI, 2011, PROTEIN ENG DES SEL, V24, P835, DOI 10.1093/protein/gzr044; Liang J, 2016, CELL REP, V17, P1330, DOI 10.1016/j.celrep.2016.09.091; Lomakina GY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P701, DOI 10.1134/S0006297915060061; Lundin A, 2014, ADV BIOCHEM ENG BIOT, V145, P31, DOI 10.1007/978-3-662-43619-6_2; Malanovic N, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9030059; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; NILSSON L, 1978, ANTIMICROB AGENTS CH, V14, P812, DOI 10.1128/AAC.14.6.812; Nolan LM, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0392-x; Otto Michael, 2010, Expert Rev Dermatol, V5, P183, DOI 10.1586/edm.10.6; Pelentir GF, 2019, PHOTOCH PHOTOBIO SCI, V18, P2061, DOI 10.1039/c9pp00174c; Perruzza L, 2017, CELL REP, V18, P2566, DOI 10.1016/j.celrep.2017.02.061; Raheem N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02866; Rajendran M, 2016, BIOL BULL-US, V231, P73, DOI 10.1086/689592; Rayah A, 2012, MICROBES INFECT, V14, P1254, DOI 10.1016/j.micinf.2012.07.006; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Santajit S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2475067; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Shama G, 2013, INT J HYG ENVIR HEAL, V216, P115, DOI 10.1016/j.ijheh.2012.03.009; Squirrell DJ, 2011, Patent No US, Patent No. [7,906,298 B1, 7906298]; Tanaka K, 2010, TRENDS CELL BIOL, V20, P601, DOI 10.1016/j.tcb.2010.07.005; Ugarova NN, 2016, J MICROBIOL METH, V130, P48, DOI 10.1016/j.mimet.2016.08.027; Valat C, 2003, LUMINESCENCE, V18, P254, DOI 10.1002/bio.735; Wang LM, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01064; Wood KV, 1999, PCT Patent Appl. WO, Patent No. [014336, 1999014336]; Wu SM, 2016, NANOSCALE, V8, P2620, DOI 10.1039/c5nr06157a; Xi CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013355; Xu HQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221665; Zimmermann H, 2016, PURINERG SIGNAL, V12, P25, DOI 10.1007/s11302-015-9483-2	46	8	9	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244200	10.1371/journal.pone.0244200	http://dx.doi.org/10.1371/journal.pone.0244200			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481792	gold, Green Published			2022-12-26	WOS:000612929300061
J	Liu, Y; Su, WJ; Wang, LJ; Lei, J; Chai, SS; Zhang, WY; Yang, XS				Liu, Yi; Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Zhang, Wenying; Yang, Xinsun			Integrated transcriptome, small RNA and degradome sequencing approaches proffer insights into chlorogenic acid biosynthesis in leafy sweet potato	PLOS ONE			English	Article							QUINATE HYDROXYCINNAMOYL TRANSFERASE; IPOMOEA-BATATAS; TARAXACUM-ANTUNGENSE; ARABIDOPSIS; EXPRESSION; IDENTIFICATION; PURIFICATION; SHIKIMATE; GENE; COA	Leafy sweet potato is rich in total phenolics (TP) which play key roles in health protection, the chlorogenic acid (CGA) constitutes the major components of phenolic compounds in leafy sweet potato. Unfortunately, the mechanism of CGA biosynthesis in leafy sweet potato is unclear. To dissect the mechanisms of CGA biosynthesis, we performed transcriptome, small RNA (sRNA) and degradome sequencing of one low-CGA content and one high-CGA content genotype at two stages. A total of 2,333 common differentially expressed genes (DEGs) were identified, and the enriched DEGs were related to photosynthesis, starch and sucrose metabolism and phenylpropanoid biosynthesis. The functional genes, such as CCR, CCoAOMT and HCT in the CGA biosynthetic pathway were down-regulated, indicating that the way to lignin was altered, and two possible CGA biosynthetic routes were hypothesized. A total of 38 DE miRNAs were identified, and 1,799 targets were predicated for 38 DE miRNAs by using in silico approaches. The target genes were enriched in lignin and phenylpropanoid catabolic processes. Transcription factors (TFs) such as apetala2/ethylene response factor (AP2/ERF) and Squamosa promoter binding protein-like (SPL) predicated in silico were validated by degradome sequencing. Association analysis of the DE miRNAs and transcriptome datasets identified that miR156 family negatively targeted AP2/ERF and SPL. Six mRNAs and six miRNAs were validated by qRT-PCR, and the results showed that the expression levels of the mRNAs and miRNAs were consistent with the sequencing data. This study established comprehensive functional genomic resources for the CGA biosynthesis, and provided insights into the molecular mechanisms involving in this process. The results also enabled the first perceptions of the regulatory roles of mRNAs and miRNAs, and offered candidate genes for leafy sweet potato improvements.	[Liu, Yi; Zhang, Wenying] Yangtze Univ, Engn Res Ctr Ecol & Agr Use Wetland, Minist Educ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China; [Liu, Yi; Su, Wenjin; Wang, Lianjun; Lei, Jian; Chai, Shasha; Yang, Xinsun] Hubei Acad Agr Sci, Food Crops Inst, Hubei Engn & Technol Res Ctr Sweet Potato, Hubei Key Lab Food Crop Germplasm & Genet Improve, Wuhan, Peoples R China	Yangtze University; Hubei Academy of Agricultural Sciences	Zhang, WY (corresponding author), Yangtze Univ, Engn Res Ctr Ecol & Agr Use Wetland, Minist Educ, Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Peoples R China.; Yang, XS (corresponding author), Hubei Acad Agr Sci, Food Crops Inst, Hubei Engn & Technol Res Ctr Sweet Potato, Hubei Key Lab Food Crop Germplasm & Genet Improve, Wuhan, Peoples R China.	wyzhang@yangtzeu.edu.cn; yangxins013@163.com	Wang, Lianjun/H-6490-2011; Zhang, Wenying/P-2509-2018	Wang, Lianjun/0000-0003-3709-9801; Zhang, Wenying/0000-0002-9926-4115	National Key R&D Program of China [2018YFD1000700, 2018YFD1000705]; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences [2007-620-001-03]; China Agriculture Research System [CARS-11-C-15]; Characteristic Discipline of Hubei Academy of Agricultural Sciences [2015TSXK06]	National Key R&D Program of China; Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences; China Agriculture Research System; Characteristic Discipline of Hubei Academy of Agricultural Sciences	This work was supported by the National Key R&D Program of China (2018YFD1000700, 2018YFD1000705);the Science and Technology Innovation Center of Hubei Academy of Agricultural Sciences (2007-620-001-03); China Agriculture Research System (CARS-11-C-15); the Characteristic Discipline of Hubei Academy of Agricultural Sciences (2015TSXK06).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartley G.E.A., 2016, PLANT GENE, V7, P1, DOI [DOI 10.1016/J.PLGENE.2016.07.001, 10.1016/j.plgene.2016.07.001]; Bian X, 2016, RUSS J PLANT PHYSL+, V63, P283, DOI 10.1134/S1021443716020060; Cadena-Zamudio JD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207572; Cheevarungnapakul K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00968; Chen ZX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137212; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Douglas CJ, 1996, TRENDS PLANT SCI, V1, P171, DOI 10.1016/1360-1385(96)10019-4; Fang YN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2882-0; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; de Carvalho JTG, 2020, J NUTR BIOCHEM, V85, DOI 10.1016/j.jnutbio.2020.108428; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; He LH, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1790-2; Herrmann KM, 1999, ANNU REV PLANT PHYS, V50, P473, DOI 10.1146/annurev.arplant.50.1.473; HERRMANN KM, 1995, PLANT PHYSIOL, V107, P7, DOI 10.1104/pp.107.1.7; Hoffmann L, 2004, PLANT CELL, V16, P1446, DOI 10.1105/tpc.020297; Hoffmann L, 2003, J BIOL CHEM, V278, P95, DOI 10.1074/jbc.M209362200; Huang Q, 2019, FOOD CHEM, V274, P368, DOI 10.1016/j.foodchem.2018.08.119; Ishida H, 2000, FOOD CHEM, V68, P359, DOI 10.1016/S0308-8146(99)00206-X; Islam MS, 2002, J AGR FOOD CHEM, V50, P3718, DOI 10.1021/jf020120l; Jia XY, 2015, PLANTA, V242, P283, DOI 10.1007/s00425-015-2305-5; Johnson M, 2010, NUTR REV, V68, P604, DOI 10.1111/j.1753-4887.2010.00320.x; Jung JK, 2011, J FOOD COMPOS ANAL, V24, P29, DOI 10.1016/j.jfca.2010.03.025; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KOJIMA M, 1972, PLANT CELL PHYSIOL, V13, P311, DOI 10.1093/oxfordjournals.pcp.a074741; Ku YS, 2015, INT J MOL SCI, V16, P24532, DOI 10.3390/ijms161024532; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YQ, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0154-2; Lin JS, 2012, NEW PHYTOL, V196, P427, DOI 10.1111/j.1469-8137.2012.04277.x; Liu Q, 2019, PHYTOCHEMISTRY, V162, P148, DOI 10.1016/j.phytochem.2019.02.014; Liu Q, 2018, PHYTOCHEM LETT, V28, P116, DOI 10.1016/j.phytol.2018.10.003; Liu R, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02059; Liu XY, 2020, PLANT PHYSIOL BIOCH, V154, P379, DOI 10.1016/j.plaphy.2020.06.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mei Xin, 2016, Plant Science Journal, V34, P614; Mudau SP, 2018, PLANT PHYSIOL BIOCH, V127, P287, DOI 10.1016/j.plaphy.2018.04.005; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Ojong PB, 2008, J AM SOC HORTIC SCI, V133, P819, DOI 10.21273/JASHS.133.6.819; Pu GB, 2017, BIOLOGIA, V72, P608, DOI 10.1515/biolog-2017-0069; RHODES MJC, 1976, PHYTOCHEMISTRY, V15, P947, DOI 10.1016/S0031-9422(00)84376-9; Robards K, 1999, FOOD CHEM, V66, P401, DOI 10.1016/S0308-8146(99)00093-X; Rodriguez-Bonilla L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116184; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; STRACK D, 1990, PLANT PHYSIOL, V92, P41, DOI 10.1104/pp.92.1.41; Sun HN, 2014, FOOD CHEM, V156, P380, DOI 10.1016/j.foodchem.2014.01.079; Sun P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171173; Tang C, 2020, J PLANT PHYSIOL, V251, DOI 10.1016/j.jplph.2020.153224; Tang JY, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.77; ULBRICH B, 1979, PHYTOCHEMISTRY, V18, P929, DOI 10.1016/S0031-9422(00)91451-1; VILLEGAS RJA, 1986, J BIOL CHEM, V261, P8729; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06983-8; Xie ZY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16871-8; Xu WQ, 2010, J FOOD COMPOS ANAL, V23, P599, DOI 10.1016/j.jfca.2009.12.008; Yang ZM, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6567-3; Yu JJ, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00687; Zhang J, 2018, NEW PHYTOL, V220, P502, DOI 10.1111/nph.15297; Zhang JR, 2017, PLANT PHYSIOL BIOCH, V121, P74, DOI 10.1016/j.plaphy.2017.10.017; Zheng W, 2008, FOOD CHEM, V106, P147, DOI 10.1016/j.foodchem.2007.05.053	68	5	5	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245266	10.1371/journal.pone.0245266	http://dx.doi.org/10.1371/journal.pone.0245266			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481815	gold, Green Published			2022-12-26	WOS:000612929300032
J	Sandie, SM; Sumbele, IUN; Tasah, MM; Kimbi, HK				Sandie, Sorelle Mekachie; Sumbele, Irene Ule Ngole; Tasah, Martin Mih; Kimbi, Helen Kuokuo			Malaria and intestinal parasite co-infection and its association with anaemia among people living with HIV in Buea, Southwest Cameroon: A community-based retrospective cohort study	PLOS ONE			English	Article							EPIDEMIOLOGY; PREVALENCE; INFECTION	Background Both malaria and intestinal parasites are endemic in Cameroon, and their co-infection can be of great impact on anaemia among people living with HIV (PLWH). This community-based retrospective cohort study determined the prevalence and association of infections with anaemia in PLWH and HIV-negative individuals in Buea, Cameroon from March to August 2019. Methods The study population comprised of 190 PLWH and 216 consenting HIV-negative individuals from the Buea community. Participants were examined clinically, the collected blood sample was used for malaria parasite (MP) detection, HIV diagnosis and haemoglobin (Hb) measurement while stool samples were examined for the detection of intestinal parasites (IPs). Proportions were compared using Pearson's Chi-square test and association of anaemia with independent variables was evaluated using logistic regression analysis. Results Out of the 406 participants, MP, IPs and MP/IP co-infection prevalences were 15.5%, 13.0% and 3.0% respectively. PLWH had a higher prevalence of MP (16.3%, P = 0.17), IPs (23.7%, P < 0.001) and MP/IPs co-infection (3.7%, P = 0.04) when compared with HIV-negative participants. Similarly, PLWH had significantly lower mean haemoglobin value (11.10 +/- 1.54 g/dL) than their HIV-negative counterparts (12.45 +/- 2.06 g/dL). Also, PLWH co-infected with MP and IPs were observed to have a significantly lower mean haemoglobin value (10.6 +/- 1.21 g/dL). PLWH had a significantly (P < 0.001) higher prevalence of mild (56.8%), moderate (18.4%) and severe (1.6%) anaemia when compared with HIV-negative counterparts. The significant risk factors associated with anaemia included being febrile (P = 0.03), MP-infected only (P = 0.001), HIV-infected only (P < 0.001), having dual (P < 0.001) or triple-infections (P = 0.03). Conclusion Malaria and intestinal parasites remain public health concerns among PLWH and anaemia as a serious haematological abnormality gets exacerbated even with the viral load suppression. Hence, routine medical check-ups among PLWH are recommended.	[Sandie, Sorelle Mekachie; Sumbele, Irene Ule Ngole; Tasah, Martin Mih; Kimbi, Helen Kuokuo] Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon; [Sumbele, Irene Ule Ngole] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Kimbi, Helen Kuokuo] Univ Bamenda, Dept Med Lab Sci, Bambili, Cameroon	Cornell University	Sandie, SM (corresponding author), Univ Buea, Dept Zool & Anim Physiol, Buea, Cameroon.	sandiesorelle2@gmail.com		Sandie Mekachie, Sorelle/0000-0003-3396-0983				Adeleke OA, 2015, AFR J PRIM HEALTH CA, V7, DOI 10.4102/phcfm.v7i1.910; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; Ako S., 2018, J HIV RETROVIRUS, V4, P5, DOI 10.21767/2471-9676.100037; Alemu G, 2018, ETHIOP J HEALTH SCI, V28, P147, DOI 10.4314/ejhs.v28i2.6; Angora KE, 2019, J INFECT DIS EPIDEMI, V5; [Anonymous], 2019, MALARIA OPERATIONAL; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Bangert M, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0288-0; Bate A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1853-z; Blake M, 2000, CLIN INFECT DIS, V30, pS96, DOI 10.1086/313859; Bouyou-Akotet MK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/351281; Breymann C, 2015, SEMIN HEMATOL, V52, P339, DOI 10.1053/j.seminhematol.2015.07.003; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; CAMPHIA (Cameroon Population-based HIV Impact Assessment), 2017, SUMM SHEET PREL FIND; Chanyalew MD, 2010, SCI J PUBLIC HLTH, V2, P546, DOI [10.11648/j.sjph.20140206.18, DOI 10.11648/J.SJPH.20140206.18]; Charan Jaykaran, 2013, Indian J Psychol Med, V35, P121, DOI 10.4103/0253-7176.116232; Cheesbrough M., 2014, DISTRICT LAB PRACTIC; Country Operational Plan (COP) Cameroon, 2019, STRAT DIR SUMM; Erhabor O, 2006, Niger J Med, V15, P52; Etusim P., 2013, J SCI MULTIDISCIP RE, V5, P100; Fonjong L, 2017, SOC NATUR RESOUR, V30, P488, DOI 10.1080/08941920.2016.1273414; Gebremedhin Ketema Bizuwork, 2019, Adv Hematol, V2019, P9614205, DOI 10.1155/2019/9614205; Kimbi HK., 2013, J BACTERIOL PARASITO, V4, P164, DOI DOI 10.4172/2155-9597.1000164; Kwenti TE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004673; Lai JL, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818003618; Lehman LG, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P48; Njunda AL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3647-z; Mabbott NA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02579; Mbah-Mbole FG., 2019, INT J ADV MED HLTH R, V6, P46, DOI [10.4103/IJAMR.IJAMR_24_19, DOI 10.4103/IJAMR.IJAMR_24_19]; Nacher M, 2002, J PARASITOL, V88, P55, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2; Njua-Yafi C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1111-2; Njunda AL, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0078-5; Njunda LA., 2012, J MICROBIOL RES, V2, P56, DOI [10.5923/j.microbiology.20120203.03, DOI 10.5923/J.MICROBIOLOGY.20120203.03, DOI 10.5923/j.microbiology.20120203.03]; Nkenfou CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057914; NKUOAKENJI T, 2011, AFR J HLTH SCI, V18, P105; Nsagha DS, 2015, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1337-1; Ojurongbe O, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/161284; Rattanapunya S, 2015, ACTA TROP, V145, P55, DOI 10.1016/j.actatropica.2015.02.001; Sandie SM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4629-4; Sanyaolu AO, 2013, AFR HEALTH SCI, V13, P295, DOI 10.4314/ahs.v13i2.14; Saracino A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-241; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Sumbele IUN, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0266-6; Sumbele IUN, 2016, ANEMIA, V2016, DOI 10.1155/2016/5725634; Tay SCK, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0064-6; UNAIDS, 2018, UND UNTR; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; Vouking MZ, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.136.3052; Wagnew F, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4656-1; Webb EL, 2012, CURR OPIN HIV AIDS, V7, P245, DOI 10.1097/COH.0b013e32835210cd; WHO, 2017, NUTR AN TOOLS EFF PR; World Health Organization, MAL REP 2018; World Health Organization, WORLD MAL REP 2019; World Health Organization, MAL FACTSH 2020	55	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245743	10.1371/journal.pone.0245743	http://dx.doi.org/10.1371/journal.pone.0245743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481933	Green Published, gold			2022-12-26	WOS:000612929300064
J	Furze, CM; Delso, I; Casal, E; Guy, CS; Seddon, C; Brown, CM; Parker, HL; Radhakrishnan, A; Pacheco-Gomez, R; Stansfeld, PJ; Angulo, J; Cameron, AD; Fullam, E				Furze, Christopher M.; Delso, Ignacio; Casal, Enriqueta; Guy, Collette S.; Seddon, Chloe; Brown, Chelsea M.; Parker, Hadyn L.; Radhakrishnan, Anjana; Pacheco-Gomez, Raul; Stansfeld, Phillip J.; Angulo, Jesus; Cameron, Alexander D.; Fullam, Elizabeth			Structural basis of trehalose recognition by the mycobacterial LpqY-SugABC transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; BINDING PROTEIN; TUBERCULOSIS; SMEGMATIS; ANALOGS; GROWTH	The Mycobacterium tuberculosis (Mtb) LpqY-SugABC ATP-binding cassette transporter is a recycling system that imports trehalose released during remodeling of the Mtb cell-envelope. As this process is essential for the virulence of the Mtb pathogen, it may represent an important target for tuberculosis drug and diagnostic development, but the transporter specificity and molecular determinants of substrate recognition are unknown. To address this, we have determined the structural and biochemical basis of how mycobacteria transport trehalose using a combination of crystallography, saturation transfer difference NMR, molecular dynamics, site-directed mutagenesis, biochemical/biophysical assays, and the synthesis of trehalose analogs. This analysis pinpoints key residues of the LpqY substrate binding lipoprotein that dictate substrate-specific recognition and has revealed which disaccharide modifications are tolerated. These findings provide critical insights into how the essential Mtb LpqY-SugABC transporter reuses trehalose and modified analogs and specifies a framework that can be exploited for the design of new antitubercular agents and/or diagnostic tools.	[Furze, Christopher M.; Guy, Collette S.; Seddon, Chloe; Brown, Chelsea M.; Parker, Hadyn L.; Radhakrishnan, Anjana; Stansfeld, Phillip J.; Cameron, Alexander D.; Fullam, Elizabeth] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Delso, Ignacio] Univ Zaragoza, Inst Sintesis Quim & Catalisis Homogenea ISQCH, CSIC, Zaragoza, Spain; [Delso, Ignacio; Casal, Enriqueta; Angulo, Jesus] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England; [Pacheco-Gomez, Raul] Malvern Panalyt Ltd, Malvern, Worcs, England; [Stansfeld, Phillip J.] Univ Warwick, Dept Chem, Coventry, W Midlands, England; [Angulo, Jesus] Univ Seville, Dept Quim Organ, Seville, Spain; [Angulo, Jesus] Inst Invest Quim CSIC Us, Seville, Spain	University of Warwick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC-UZA - Instituto de Sintesis Quimica y Catalisis Homogenea (ISQCH); University of Zaragoza; University of East Anglia; Malvern Panalytical; University of Warwick; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ)	Fullam, E (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	e.fullam@warwick.ac.uk	Delso, Ignacio/AAW-2250-2021	Delso, Ignacio/0000-0001-8355-2289; Guy, Collette/0000-0002-5153-0613; Parker, Hadyn L./0000-0001-8779-4541; Brown, Chelsea/0000-0003-2006-5015; Cumley, Anjana/0000-0002-5785-546X	Sir Henry Dale Fellowship; Wellcome Trust; Royal Society [104193/Z/14/Z, 104193/Z/14/B, RG120405]; Leverhulme Trust [RPG-2019-087]; BBSRC [BB/M01116X/1, BB/M017982/1, BB/P010660/1]; MRC [MR/N014294/1]; EPSRC [EP/R029407/1, EP/P020232/1]; Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); University of Warwick Scientific Computing Research Technology Platform; BBSRC [1786898] Funding Source: UKRI	Sir Henry Dale Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia); University of Warwick Scientific Computing Research Technology Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Sir Henry Dale Fellowship to E. F. jointly funded by the Wellcome Trust and Royal Society (104193/Z/14/Z and 104193/Z/14/B), a research grant from the Royal Society (RG120405), a research grant from the Leverhulme Trust (RPG-2019-087), the BBSRC for a studentship to H. P. and A. R. (BB/M01116X/1) and the MRC for a studentship for CMB (MR/N014294/1). We acknowledge equipment access, training, and support made available by the Research Technology Facility (managed by Dr Sarah Bennett) of the Warwick Integrative Synthetic Biology center (WISB), which received funding from EPSRC and BBSRC (BB/M017982/1). J. A. acknowledges support from the BBSRC through a New Investigator grant (BB/P010660/1) and the Universidad de Sevilla (Acciones Especiales del VI Plan Propio de Investigacion y Transferencia). We are also grateful for the use of the University of East Anglia (UEA) Faculty of Science NMR facility. This project made use of time on ARCHER and JADE granted via the UK High-End Computing Consortium for Biomolecular Simulation, HECBioSim (http://hecbiosim.ac.uk), supported by the EPSRC (EP/R029407/1), Athena, at HPC Midlands+ funded by the EPSRC (EP/P020232/1) and used the University of Warwick Scientific Computing Research Technology Platform for computational access.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Backus KM, 2011, NAT CHEM BIOL, V7, P228, DOI 10.1038/NCHEMBIO.539; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belisle John T., 2008, V465, P1, DOI 10.1007/978-1-59745-207-6_1; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; Bell A, 2019, NAT MICROBIOL, V4, P2393, DOI 10.1038/s41564-019-0590-7; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandravanshi M, 2020, FEBS J, V287, P1576, DOI 10.1111/febs.15093; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203; ELBEIN AD, 1973, J BACTERIOL, V113, P863, DOI 10.1128/JB.113.2.863-873.1973; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenn JS, 2019, ACS CHEM BIOL, V14, P1879, DOI 10.1021/acschembio.9b00204; Fullam E, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160105; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Jackson M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021105; JEFFREY GA, 1985, CARBOHYD RES, V137, P21, DOI 10.1016/0008-6215(85)85146-6; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Lowery R, 2015, CHEM COMMUN, V51, P4838, DOI 10.1039/c4cc09588j; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; Mayer M, 2004, J AM CHEM SOC, V126, P4453, DOI 10.1021/ja0398870; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Monaco S, 2017, ANGEW CHEM INT EDIT, V56, P15289, DOI 10.1002/anie.201707682; Moriarty NW, 2017, ACTA CRYSTALLOGR D, V73, P123, DOI 10.1107/S2059798316016570; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Ojha AK, 2010, J BIOL CHEM, V285, P17380, DOI 10.1074/jbc.M110.112813; Parker HL, 2020, ORG BIOMOL CHEM, V18, P3607, DOI 10.1039/d0ob00253d; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Sikharulidze I, 2016, ACTA CRYSTALLOGR A, V72, pS193, DOI 10.1107/S2053273316097114; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Swarts BM, 2012, J AM CHEM SOC, V134, P16123, DOI 10.1021/ja3062419; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Titgemeyer F, 2007, J BACTERIOL, V189, P5903, DOI 10.1128/JB.00257-07; Yamagami H, 2001, INFECT IMMUN, V69, P810, DOI 10.1128/IAI.69.2.810-815.2001; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008	49	4	4	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100307	10.1016/j.jbc.2021.100307	http://dx.doi.org/10.1016/j.jbc.2021.100307			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33476646	gold, Green Published, Green Accepted			2022-12-26	WOS:000672866400281
J	Martin-Sanchez, C; Ales, E; Balseiro-Gomez, S; Atienza, G; Arnalich, F; Bordas, A; Cedillo, JL; Extremera, M; Chavez-Reyes, A; Montiel, C				Martin-Sanchez, Carolina; Ales, Eva; Balseiro-Gomez, Santiago; Atienza, Gema; Arnalich, Francisco; Bordas, Anna; Cedillo, Jose L.; Extremera, Maria; Chavez-Reyes, Arturo; Montiel, Carmen			The human-specific duplicated alpha 7 gene inhibits the ancestral alpha 7, negatively regulating nicotinic acetylcholine receptor-mediated transmitter release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL EXPRESSION REGULATION; POSITIVE ALLOSTERIC MODULATOR; ACH RECEPTORS; PREFRONTAL CORTEX; IN-VITRO; CHRFAM7A; SUBUNIT; DOPAMINE; CHRNA7; AGONIST	Gene duplication generates new functions and traits, enabling evolution. Human-specific duplicated genes in particular are primary sources of innovation during our evolution although they have very few known functions. Here we examine the brain function of one of these genes (CHRFAM7A) and its product (dup alpha 7 subunit). This gene results from a partial duplication of the ancestral CHRNA7 gene encoding the alpha 7 subunit that forms the homopentameric alpha 7 nicotinic acetylcholine receptor (alpha 7-nAChR). The functions of alpha 7-nAChR in the brain are well defined, including the modulation of synaptic transmission and plasticity underlying normal attention, cognition, learning, and memory processes. However, the role of the dup alpha 7 subunit remains unexplored at the neuronal level. Here, we characterize that role by combining immunoblotting, quantitative RT-PCR and FRET techniques with functional assays of alpha 7-nAChR activity using human neuroblastoma SH-SY5Y cell variants with different dup alpha 7 expression levels. Our findings reveal a physical interaction between dup alpha 7 and alpha 7 subunits in fluorescent protein-tagged dup alpha 7/alpha 7 transfected cells that negatively affects normal alpha 7-nAChR activity. Specifically, in both single cells and cell populations, the [Ca2+] i signal and the exocytotic response induced by selective stimulation of alpha 7-nAChR were either significantly inhibited by stable dup alpha 7 overexpression or augmented after silencing dup alpha 7 gene expression with specific siRNAs. These findings identify a new role for the dup alpha 7 subunit as a negative regulator of alpha 7-nAChR-mediated control of exocytotic neurotransmitter release. If this effect is excessive, it would result in an impaired synaptic transmission that could underlie the neurocognitive and neuropsychiatric disorders associated with alpha 7-nAChR dysfunction.	[Martin-Sanchez, Carolina; Atienza, Gema; Bordas, Anna; Cedillo, Jose L.; Extremera, Maria; Montiel, Carmen] Univ Autonoma Madrid, Med Sch, Dept Pharmacol & Therapeut, Madrid, Spain; [Ales, Eva; Balseiro-Gomez, Santiago] Univ Seville, Med Sch, Dept Med Physiol & Biophys, Seville, Spain; [Arnalich, Francisco] Univ Hosp La Paz IdiPAZ, Internal Med Serv, Madrid, Spain; [Chavez-Reyes, Arturo] Univ Finis Terrae, Med Sch, Santiago, Chile	Autonomous University of Madrid; University of Sevilla; Universidad Finis Terrae	Montiel, C (corresponding author), Univ Autonoma Madrid, Med Sch, Dept Pharmacol & Therapeut, Madrid, Spain.	carmen.montiel@uam.es		Chavez-Reyes, Arturo/0000-0002-6655-815X	Ministry of Economy, Industry and Competitiveness, Government of Spain [SAF2017-82689-R]; FPI fellowship (Ministry of Economy, Industry and Competitiveness); FPI fellowship (Autonomous University of Madrid); FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain)	Ministry of Economy, Industry and Competitiveness, Government of Spain(Spanish Government); FPI fellowship (Ministry of Economy, Industry and Competitiveness); FPI fellowship (Autonomous University of Madrid); FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain)	This work was supported by a Grant from the Ministry of Economy, Industry and Competitiveness, Government of Spain (SAF2017-82689-R) to C. M. and F. A. C. M. -S. was recipient of an FPI fellowship (Ministry of Economy, Industry and Competitiveness). A. B. was recipient of an FPI fellowship (Autonomous University of Madrid). J. L. C. was recipient of an FPU fellowship (Ministry of Education, Culture and Sports, Government of Spain). M. E. and G. A. were hired with funds from the above Grant.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Beilharz Traude H., 2004, Briefings in Functional Genomics & Proteomics, V3, P103, DOI 10.1093/bfgp/3.2.103; Bertrand D, 2015, PHARMACOL REV, V67, P1025, DOI 10.1124/pr.113.008581; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; Bordas A, 2017, ONCOTARGET, V8, P67878, DOI 10.18632/oncotarget.18948; Brockmann R, 2007, PLOS COMPUT BIOL, V3, P531, DOI 10.1371/journal.pcbi.0030057; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Cedillo JL, 2019, LUNG CANCER, V128, P134, DOI 10.1016/j.lungcan.2018.12.029; Chan T, 2019, NEUROSCI LETT, V690, P126, DOI 10.1016/j.neulet.2018.10.010; Cheng Q, 2015, BIOCHEM PHARMACOL, V97, P439, DOI 10.1016/j.bcp.2015.07.015; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Dickinson JA, 2008, MOL PHARMACOL, V74, P348, DOI 10.1124/mol.108.046623; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Faro LRF, 2019, TOXICOLOGY, V426, DOI 10.1016/j.tox.2019.152285; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Freedman R, 2010, PROG NEUROBIOL, V90, P263, DOI 10.1016/j.pneurobio.2009.10.008; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hajos M, 2005, J PHARMACOL EXP THER, V312, P1213, DOI 10.1124/jpet.104.076968; Hashemi A, 2012, Tsitol Genet, V46, P19; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P4541, DOI 10.1007/s00213-014-3596-0; Huang M, 2014, PSYCHOPHARMACOLOGY, V231, P2199, DOI 10.1007/s00213-013-3373-5; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jones IW, 2004, J NEUROSCI, V24, P11244, DOI 10.1523/JNEUROSCI.3009-04.2004; Kabbani N, 2018, TRENDS PHARMACOL SCI, V39, P354, DOI 10.1016/j.tips.2018.01.002; Kalmady SV, 2018, J NEURAL TRANSM, V125, P741, DOI 10.1007/s00702-017-1833-5; Koranda JL, 2014, J NEUROPHYSIOL, V111, P103, DOI 10.1152/jn.00269.2013; Kunii Y, 2015, AM J PSYCHIAT, V172, P1122, DOI 10.1176/appi.ajp.2015.14080978; Lasala M, 2018, J BIOL CHEM, V293, P10707, DOI 10.1074/jbc.RA117.001698; Livingstone PD, 2009, EUR J NEUROSCI, V29, P539, DOI 10.1111/j.1460-9568.2009.06613.x; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Lozada AF, 2012, J NEUROSCI, V32, P7651, DOI 10.1523/JNEUROSCI.6246-11.2012; Ly T, 2014, ELIFE, V3, DOI 10.7554/eLife.01630; Magin S, 2013, DNA REPAIR, V12, P148, DOI 10.1016/j.dnarep.2012.11.008; Maldifassi MC, 2018, J BIOL CHEM, V293, P13874, DOI 10.1074/jbc.RA118.003443; Maldifassi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108397; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rossi S, 2005, NEUROCHEM RES, V30, P541, DOI 10.1007/s11064-005-2689-x; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Sadigh-Eteghad S, 2015, EUR J PHARMACOL, V755, P34, DOI 10.1016/j.ejphar.2015.02.047; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Sydserff S, 2009, BIOCHEM PHARMACOL, V78, P880, DOI 10.1016/j.bcp.2009.07.005; Tabar MS, 2015, CELL J, V17, P438; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Yakel JL, 2013, PFLUG ARCH EUR J PHY, V465, P441, DOI 10.1007/s00424-012-1200-1; Zhu PJ, 2005, J NEUROPHYSIOL, V94, P3081, DOI 10.1152/jn.00974.2004	61	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100341	10.1016/j.jbc.2021.100341	http://dx.doi.org/10.1016/j.jbc.2021.100341			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33515545	gold, Green Published			2022-12-26	WOS:000672866400315
J	Takaishi, T				Takaishi, Tetsuya			Time-varying properties of asymmetric volatility and multifractality in Bitcoin	PLOS ONE			English	Article							PRICE FLUCTUATIONS; STYLIZED FACTS; ASSET RETURNS; STOCK; INEFFICIENCY; EFFICIENCY; MARKETS	This study investigates the volatility of daily Bitcoin returns and multifractal properties of the Bitcoin market by employing the rolling window method and examines relationships between the volatility asymmetry and market efficiency. Whilst we find an inverted asymmetry in the volatility of Bitcoin, its magnitude changes over time, and recently, it has become small. This asymmetric pattern of volatility also exists in higher frequency returns. Other measurements, such as kurtosis, skewness, average, serial correlation, and multifractal degree, also change over time. Thus, we argue that properties of the Bitcoin market are mostly time dependent. We examine efficiency-related measures: the Hurst exponent, multifractal degree, and kurtosis. We find that when these measures represent that the market is more efficient, the volatility asymmetry weakens. For the recent Bitcoin market, both efficiency-related measures and the volatility asymmetry prove that the market becomes more efficient.	[Takaishi, Tetsuya] Hiroshima Univ Econ, Hiroshima, Japan	Hiroshima University	Takaishi, T (corresponding author), Hiroshima Univ Econ, Hiroshima, Japan.	tt-taka@hue.ac.jp			Japan Society for the Promotion of Science [JP18K01556]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by the Japan Society for the Promotion of Science (Grand #JP18K01556;https://www.jsps.go.jp/english/index.html).	Alvarez-Ramirez J, 2018, PHYSICA A, V492, P948, DOI 10.1016/j.physa.2017.11.025; Amihud Y, 2002, J FINANC MARK, V5, P31, DOI 10.1016/S1386-4181(01)00024-6; Ardia D, 2019, FINANC RES LETT, V29, P266, DOI 10.1016/j.frl.2018.08.009; Asai M, 2006, ECONOMET REV, V25, P145, DOI 10.1080/07474930600713564; Avramov D, 2006, REV FINANC STUD, V19, P1241, DOI 10.1093/rfs/hhj027; Bariviera AF, 2017, ECON LETT, V161, P1, DOI 10.1016/j.econlet.2017.09.013; Bariviera AF, 2017, PHYSICA A, V484, P82, DOI 10.1016/j.physa.2017.04.159; Baur DG, 2018, ECON LETT, V173, P148, DOI 10.1016/j.econlet.2018.10.008; Begusic S, 2018, PHYSICA A, V510, P400, DOI 10.1016/j.physa.2018.06.131; Bennedsen M, 2016, ARXIV161000332; Black F., 1976, P AM STAT ASS BUS EC, P177; BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307, DOI 10.1016/0304-4076(86)90063-1; BOLLERSLEV T, 1992, J ECONOMETRICS, V52, P5, DOI 10.1016/0304-4076(92)90064-X; Bouchaud JP, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228701; Bouoiyour J, 2016, ECON BULL, V36, P1430; Bouri E, 2017, ECONOMICS-KIEL, V11, DOI 10.5018/economics-ejournal.ja.2017-2; Cheah ET, 2015, ECON LETT, V130, P32, DOI 10.1016/j.econlet.2015.02.029; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079531; CHRISTIE AA, 1982, J FINANC ECON, V10, P407, DOI 10.1016/0304-405X(82)90018-6; Chu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133678; Cont R, 2001, QUANT FINANC, V1, P223, DOI [10.1080/713665670, 10.1088/1469-7688/1/2/304]; da Silva AC, 2018, PHYSICA A, V512, P954, DOI 10.1016/j.physa.2018.08.076; Dimitrova V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219243; Drozdz S, 2020, ENTROPY-SWITZ, V22, DOI 10.3390/e22091043; Drozdz S, 2019, FUTURE INTERNET, V11, DOI 10.3390/fi11070154; Drozdz S, 2018, CHAOS, V28, DOI 10.1063/1.5036517; Dyhrberg AH, 2016, FINANC RES LETT, V16, P139, DOI 10.1016/j.frl.2015.10.025; Dyhrberg AH, 2016, FINANC RES LETT, V16, P85, DOI 10.1016/j.frl.2015.10.008; Easwaran S, 2015, ECONOPHYSICS DATA DR, P121; ENGLE RF, 1982, ECONOMETRICA, V50, P987, DOI 10.2307/1912773; Fakhfekh M, 2020, RES INT BUS FINANC, V51, DOI 10.1016/j.ribaf.2019.101075; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Fang W, 2018, PHYSICA A, V512, P109, DOI 10.1016/j.physa.2018.08.051; Gatheral J, 2018, QUANT FINANC, V18, P933, DOI 10.1080/14697688.2017.1393551; GLOSTEN LR, 1993, J FINANC, V48, P1779, DOI 10.2307/2329067; Gopikrishnan P, 1998, EUR PHYS J B, V3, P139, DOI 10.1007/s100510050292; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Heston SL, 2000, REV FINANC STUD, V13, P585, DOI 10.1093/rfs/13.3.585; Ihlen EAF, 2013, HUM MOVEMENT SCI, V32, P633, DOI 10.1016/j.humov.2013.01.008; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Jafari GR, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/04/P04012; Jiang ZQ, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/ab42fb; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Katsiampa P, 2017, ECON LETT, V158, P3, DOI 10.1016/j.econlet.2017.06.023; Koutmos D, 2018, ECON LETT, V167, P81, DOI 10.1016/j.econlet.2018.03.021; Kristoufek L, 2018, PHYSICA A, V503, P257, DOI 10.1016/j.physa.2018.02.161; Kwapien J, 2012, PHYS REP, V515, P115, DOI 10.1016/j.physrep.2012.01.007; Kyriazis NA, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02239; Lennartz S, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/69001; Livieri G, 2018, IISE TRANS, V50, P767, DOI 10.1080/24725854.2018.1444297; Nakamoto S., 2009, WORKING PAPER; NELSON DB, 1991, ECONOMETRICA, V59, P347, DOI 10.2307/2938260; Nikolova V, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8081216; Pan RK, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/58004; Phillip A, 2019, FINANC RES LETT, V28, P95, DOI 10.1016/j.frl.2018.04.003; Plerou V, 1999, PHYS REV E, V60, P6519, DOI 10.1103/PhysRevE.60.6519; Qiu T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065103; ROLL R, 1977, J FINANC ECON, V4, P129, DOI 10.1016/0304-405X(77)90009-5; SENTANA E, 1995, REV ECON STUD, V62, P639, DOI 10.2307/2298081; STANLEY HE, 1988, NATURE, V335, P405, DOI 10.1038/335405a0; Stavroyiannis S, 2017, DYNAMIC PROPERTIES B; Takaishi T, 2020, EPL-EUROPHYS LETT, V129, DOI 10.1209/0295-5075/129/28001; Takaishi T., 2020, ARXIV200906874; Takaishi T, 2020, ASIA-PAC FINANC MARK, V27, P145, DOI 10.1007/s10690-019-09286-0; Takaishi T, 2020, FINANC RES LETT, V32, DOI 10.1016/j.frl.2019.101379; Takaishi T, 2018, ECON LETT, V172, P5, DOI 10.1016/j.econlet.2018.07.046; Takaishi T, 2018, PHYSICA A, V506, P507, DOI 10.1016/j.physa.2018.04.046; Takaishi T, 2017, PHYSICA A, V473, P451, DOI 10.1016/j.physa.2017.01.011; Taylor S., 1986, MODELLING FINANCIAL; Taylor SJ, 1982, FINANCIAL RETURNS MO; Thies S, 2018, FINANC RES LETT, V27, P223, DOI 10.1016/j.frl.2018.03.018; Segovia JET, 2019, PHYSICA A, V535, DOI 10.1016/j.physa.2019.122452; Urquhart A, 2017, ECON LETT, V159, P145, DOI 10.1016/j.econlet.2017.07.035; Urquhart A, 2016, ECON LETT, V148, P80, DOI 10.1016/j.econlet.2016.09.019; Wei WC, 2018, ECON LETT, V168, P21, DOI 10.1016/j.econlet.2018.04.003; Wu GJ, 2001, REV FINANC STUD, V14, P837, DOI 10.1093/rfs/14.3.837; Zhang W, 2018, PHYSICA A, V510, P658, DOI 10.1016/j.physa.2018.07.032; Zunino L, 2008, PHYSICA A, V387, P6558, DOI 10.1016/j.physa.2008.08.028; Zunino L, 2012, PHYSICA A, V391, P4342, DOI 10.1016/j.physa.2012.04.009	79	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246209	10.1371/journal.pone.0246209	http://dx.doi.org/10.1371/journal.pone.0246209			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524019	Green Submitted, gold, Green Published			2022-12-26	WOS:000616578400021
J	Tedeschi, V; Sisalli, MJ; Petrozziello, T; Canzoniero, LMT; Secondo, A				Tedeschi, Valentina; Sisalli, Maria Jose; Petrozziello, Tiziana; Canzoniero, Lorella Maria Teresa; Secondo, Agnese			Lysosomal calcium is modulated by STIM1/TRPML1 interaction which participates to neuronal survival during ischemic preconditioning	FASEB JOURNAL			English	Article						oxygen and glucose deprivation followed by reoxygenation; ischemic preconditioning; lysosome; ER interplay; neuronal survival; organellar Ca2+ homeostasis; primary cortical neurons; TRPML1	ENDOPLASMIC-RETICULUM; TRP CHANNEL; MOTOR-NEURONS; CA2+ RELEASE; AUTOPHAGY; ACTIVATION; TOXICITY; NCX3; EXOCYTOSIS; CLEARANCE	A robust activity of the lysosomal Ca2+ channel TRPML1 is sufficient to correct cellular defects in neurodegeneration. Importantly, lysosomes are refilled by the endoplasmic reticulum (ER). However, it is unclear how TRPML1 function could be modulated by the ER. Here, we deal with this issue in rat primary cortical neurons exposed to different oxygen conditions affecting neuronal survival. Under normoxic conditions, TRPML1: (1) showed a wide distribution within soma and along neuronal processes; (2) was stimulated by the synthetic agonist ML-SA1 and the analog of its endogenous modulator, PI(3,5)P-2 diC8; (3) its knockdown by siRNA strategy produced an ER Ca2+ accumulation; (4) co-localized and co-immunoprecipitated with the ER-located Ca2+ sensor stromal interacting molecule 1 (STIM1). In cortical neurons lacking STIM1, ML-SA1 and PI(3,5)P-2 diC8 failed to induce Ca2+ release and, more deeply, they induced a negligible Ca2+ passage through the channel in neurons transfected with the genetically encoded Ca2+ indicator GCaMP3-ML1. Moreover, TRPML1/STIM1 interplay changed at low-oxygen conditions: both proteins were downregulated during the ischemic preconditioning (IPC) while during IPC followed by 1 hour of normoxia, at which STIM1 is upregulated, TRPML1 protein was reduced. However, during oxygen and glucose deprivation (OGD) followed by reoxygenation, TRPML1 and STIM1 proteins peaked at 8 hours of reoxygenation, when the proteins were co-immunoprecipitated and reactive oxygen species (ROS) hyperproduction was measured in cortical neurons. This may lead to a persistent TRPML1 Ca2+ release and lysosomal Ca2+ loss. Collectively, we showed a new modulation exerted by STIM1 on TRPML1 activity that may differently intervene during hypoxia to regulate organellar Ca2+ homeostasis.	[Tedeschi, Valentina; Sisalli, Maria Jose; Petrozziello, Tiziana; Secondo, Agnese] Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Via S Pansini 5, I-80131 Naples, Italy; [Canzoniero, Lorella Maria Teresa] Univ Sannio, Dept Sci & Technol DST, Div Pharmacol, Benevento, Italy	University of Naples Federico II; University of Sannio	Secondo, A (corresponding author), Federico II Univ Naples, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Div Pharmacol, Via S Pansini 5, I-80131 Naples, Italy.	secondo@unina.it	Secondo, Agnese/AAA-3407-2022; Petrozziello, Tiziana/GNM-6238-2022; Sisalli, Maria Josè Sisalli/AAB-8255-2022; Tedeschi, Valentina/GZL-0164-2022	Petrozziello, Tiziana/0000-0002-5487-1667; CANZONIERO, Lorella Maria Teresa/0000-0003-2255-5341; Tedeschi, Valentina/0000-0002-6540-4730				Atakpa P, 2018, CELL REP, V25, P3180, DOI 10.1016/j.celrep.2018.11.064; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Cao Q, 2017, J BIOL CHEM, V292, P8424, DOI 10.1074/jbc.M116.772160; Christensen KA, 2002, J CELL SCI, V115, P599; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Garrity AG, 2016, ELIFE, V5, DOI 10.7554/eLife.15887; Gomez NM, 2018, FASEB J, V32, P782, DOI 10.1096/fj.201700220RR; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hollerhage M, 2019, NEUROPHARMACOLOGY, V149, P13, DOI 10.1016/j.neuropharm.2019.01.023; Hui L, 2015, CELL CALCIUM, V58, P617, DOI 10.1016/j.ceca.2015.10.001; Jiang T, 2014, PHARMACOL RES, V81, P54, DOI 10.1016/j.phrs.2014.02.008; Kahlert S, 2004, CELL CALCIUM, V36, P295, DOI 10.1016/j.ceca.2004.02.009; Kilpatrick Bethan S, 2016, Messenger (Los Angel), V5, P76, DOI 10.1166/msr.2016.1059; La Rovere RML, 2016, CELL CALCIUM, V60, P74, DOI 10.1016/j.ceca.2016.04.005; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; Lee JH, 2015, CELL REP, V12, P1430, DOI 10.1016/j.celrep.2015.07.050; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lopez-Sanjurjo CI, 2013, J CELL SCI, V126, P289, DOI 10.1242/jcs.116103; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; McLeod IX, 2012, IMMUNOL REV, V249, P195, DOI 10.1111/j.1600-065X.2012.01143.x; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Morgan AJ, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2019.102139; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Petrozziello T, 2017, CELL DEATH DIFFER, V24, P511, DOI 10.1038/cdd.2016.154; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rosato AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13572-w; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scorziello A, 2013, J CELL SCI, V126, P5566, DOI 10.1242/jcs.129668; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Secondo A, 2019, STROKE, V50, P1240, DOI 10.1161/STROKEAHA.118.024115; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Sirabella R, 2009, STROKE, V40, P922, DOI 10.1161/STROKEAHA.108.531962; Sisalli MJ, 2014, CELL DEATH DIFFER, V21, P1142, DOI 10.1038/cdd.2014.32; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Tedeschi V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46708-5; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Tsunemi T, 2019, J NEUROSCI, V39, P5760, DOI 10.1523/JNEUROSCI.3085-18.2019; Urbanczyk J, 2006, J PHYSIOL-LONDON, V575, P693, DOI 10.1113/jphysiol.2006.113910; Wang P, 2018, PROG NEUROBIOL, V163, P98, DOI 10.1016/j.pneurobio.2018.01.001; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12109	45	6	6	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21277	10.1096/fj.202001886R	http://dx.doi.org/10.1096/fj.202001886R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484198	Bronze			2022-12-26	WOS:000647789600049
J	Yeh, TL; Hsu, HY; Tsai, MC; Hsu, LY; Hwang, LC; Chien, KL				Yeh, Tzu-Lin; Hsu, Hsin-Yin; Tsai, Ming-Chieh; Hsu, Le-Yin; Hwang, Lee-Ching; Chien, Kuo-Liong			Association between metabolically healthy obesity/overweight and cardiovascular disease risk: A representative cohort study in Taiwan	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; OBESITY; PREVALENCE	Objectives To investigate the relationship between metabolically healthy obesity and cardiovascular disease risk in Taiwanese individuals. Methods Taiwanese individuals were recruited from a nationwide, representative community-based prospective cohort study and classified according to body mass index as follows: normal weight (18.5-23.9 kilogram (kg)/meter(m)(2)) and obesity/overweight (>= 24 kg/m(2)). Participants without diabetes, hypertension, and hyperlipidemia and who did not meet the metabolic syndrome without waist circumference criteria were considered metabolically healthy. The study end points were cardiovascular disease morbidity and mortality. Multivariable adjusted hazard ratios and 95% confidence intervals were obtained from a Cox regression analysis. Results Among 5 358 subjects (mean [standard deviation] age, 44.5 [15.3] years; women, 48.2%), 1 479 were metabolically healthy with normal weight and 491 were metabolically healthy with obesity. The prevalence of metabolically healthy obesity/overweight was 8.6% in the Taiwanese general population, which included individuals who were >20 years old, not pregnant, and did not have CVD (n = 5,719). In the median follow-up period of 13.7 years, 439 cardiovascular disease events occurred overall and 24 in the metabolically healthy obesity group. Compared with the reference group, the metabolically healthy obesity group had a significantly higher cardiovascular disease risk (adjusted hazard ratio: 1.74, 95% confidence interval: 1.02, 2.99). Conclusions Individuals with metabolically healthy obesity have a higher risk of cardiovascular disease and require aggressive body weight control for cardiovascular disease control.	[Yeh, Tzu-Lin] Hsinchu MacKay Mem Hosp, Dept Family Med, Hsinchu, Taiwan; [Yeh, Tzu-Lin; Hsu, Hsin-Yin; Tsai, Ming-Chieh; Hsu, Le-Yin; Chien, Kuo-Liong] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Hsu, Hsin-Yin; Hwang, Lee-Ching] Taipei MacKay Mem Hosp, Dept Family Med, Taipei, Taiwan; [Tsai, Ming-Chieh] MacKay Mem Hosp, Dept Internal Med, Div Endocrinol, Tamsui Branch, New Taipei, Taiwan; [Tsai, Ming-Chieh; Hwang, Lee-Ching] MacKay Mem Hosp, Dept Med Res, New Taipei, Taiwan; [Chien, Kuo-Liong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan	Mackay Memorial Hospital; National Taiwan University; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chien, KL (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan.; Chien, KL (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan.	klchien@ntu.edu.tw						Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Brandao I, 2020, METABOLITES, V10, DOI 10.3390/metabo10020048; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Clegg D, 2017, ENDOCRINOLOGY, V158, P1095, DOI 10.1210/en.2016-1677; De Lorenzo A, 2018, CURR DIABETES REV, V14, P405, DOI 10.2174/1573399813666170502105859; Dhana K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154273; Eckel N, 2018, LANCET DIABETES ENDO, V6, P714, DOI 10.1016/S2213-8587(18)30137-2; Eckel N, 2016, EUR J PREV CARDIOL, V23, P956, DOI 10.1177/2047487315623884; Health Promotion Administration Ministry of Health and Welfare, 2018, CHECK YOUR BOD WEIGH; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Huang MY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17041320; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Hwang LC, 2012, ASIA PAC J CLIN NUTR, V21, P227; Jung CH, 2017, KOREAN J INTERN MED, V32, P611, DOI 10.3904/kjim.2016.259; Kabootari M, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0340-0; Lassale C, 2018, EUR HEART J, V39, P397, DOI 10.1093/eurheartj/ehx448; Morkedal B, 2014, J AM COLL CARDIOL, V63, P1071, DOI 10.1016/j.jacc.2013.11.035; Munoz-Garach A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060320; Nilsson PM, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-1027-7; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Sims EAH, 2001, METABOLISM, V50, P1499, DOI 10.1053/meta.2001.27213; Smith GI, 2019, J CLIN INVEST, V129, P3978, DOI 10.1172/JCI129186; Stefan N, 2018, LANCET DIABETES ENDO, V6, P249, DOI 10.1016/S2213-8587(17)30292-9; Thomsen M, 2014, JAMA INTERN MED, V174, P15, DOI 10.1001/jamainternmed.2013.10522; Twig G, 2015, EUR J ENDOCRINOL, V173, P305, DOI 10.1530/EJE-15-0284; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Westerterp KR, 2018, OBES REV, V19, P8, DOI 10.1111/obr.12781; Xu YJ, 2018, EUR J ENDOCRINOL, V179, P343, DOI [10.1530/eje-18-0356, 10.1530/EJE-18-0356]; Yeh TL, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081228; Zhang R, 2018, J GERIATR CARDIOL, V15, P422, DOI 10.11909/j.issn.1671-5411.2018.06.004	34	8	9	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246378	10.1371/journal.pone.0246378	http://dx.doi.org/10.1371/journal.pone.0246378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524067	Green Published, gold			2022-12-26	WOS:000616578400014
J	Ziani, W; Shao, JS; Fang, A; Connolly, PJ; Wang, XL; Veazey, RS; Xu, HB				Ziani, Widade; Shao, Jiasheng; Fang, Angela; Connolly, Patrick J.; Wang, Xiaolei; Veazey, Ronald S.; Xu, Huanbin			Mucosal integrin alpha 4 beta 7 blockade fails to reduce the seeding and size of viral reservoirs in SIV-infected rhesus macaques	FASEB JOURNAL			English	Article						&#945; 4&#946; 7; &#945; 4&#946; 1; HIV&#8208; 1; SIV; integrin; viral reservoir	SIMIAN IMMUNODEFICIENCY VIRUS; CD4(+) T-CELLS; HIV-1 ENVELOPE; LYMPHOCYTE SUBSETS; DUAL ANTAGONIST; ALPHA(4)BETA(7); DNA; ANTIBODY; ACTIVATION; EXPRESSION	Cellular viral reservoirs are rapidly established in tissues upon HIV-1/SIV infection, which persist throughout viral infection, even under long-term antiretroviral therapy (ART). Specific integrins are involved in the homing of cells to gut-associated lymphoid tissues (GALT) and inflamed tissues, which may promote the seeding and dissemination of HIV-1/SIV to these tissue sites. In this study, we investigated the efficacy of prophylactic integrin blockade (alpha 4 beta 7 antibody or alpha 4 beta 7/alpha 4 beta 1 dual antagonist TR-14035) on viral infection, as well as dissemination and seeding of viral reservoirs in systemic and lymphoid compartments post-SIV inoculation. The results showed that blockade of alpha 4 beta 7/alpha 4 beta 1 did not decrease viral infection, replication, or reduce viral reservoir size in tissues of rhesus macaques after SIV infection, as indicated by equivalent levels of plasma viremia and cell-associated SIV RNA/DNA to controls. Surprisingly, TR-14035 administration in acute SIV infection resulted in consistently higher viremia and more rapid disease progression. These findings suggest that integrin blockade alone fails to effectively control viral infection, replication, dissemination, and reservoir establishment in HIV-1/SIV infection. The use of integrin blockade for prevention or/and therapeutic strategies requires further investigation.	[Ziani, Widade; Shao, Jiasheng; Fang, Angela; Connolly, Patrick J.; Wang, Xiaolei; Veazey, Ronald S.; Xu, Huanbin] Tulane Univ, Tulane Natl Primate Res Ctr, Sch Med, Covington, LA USA	Tulane University	Xu, HB (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, 18703 Three Rivers Rd, Covington, LA 70433 USA.	hxu@tulane.edu		Veazey, Ronald/0000-0002-6298-2391	NIAID NIH HHS [R01 AI099795, R01 AI147372] Funding Source: Medline; NICHD NIH HHS [R01 HD099857] Funding Source: Medline; NIDCR NIH HHS [R01 DE025432] Funding Source: Medline; NIH HHS [P51 OD011104] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abbink P, 2019, SCIENCE, V365, P1029, DOI 10.1126/science.aaw8562; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Arrode-Bruses G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005720; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Bachmann N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10884-9; Baiula M, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00489; Baxter AE, 2016, CELL HOST MICROBE, V20, P368, DOI 10.1016/j.chom.2016.07.015; Brodin J, 2016, ELIFE, V5, DOI 10.7554/eLife.18889; Byrareddy SN, 2016, SCIENCE, V354, P197, DOI 10.1126/science.aag1276; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Calenda G, 2018, J IMMUNOL, V200, P810, DOI 10.4049/jimmunol.1701150; Chan JR, 2001, J EXP MED, V193, P1149, DOI 10.1084/jem.193.10.1149; Chand S, 2017, VIROLOGY, V508, P199, DOI 10.1016/j.virol.2017.05.016; Cicala C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S2; Cillo AR, 2018, AIDS, V32, P699, DOI [10.1097/QAD.0000000000001748, 10.1097/qad.0000000000001748]; Cimbro R, 2012, BLOOD, V120, P2610, DOI 10.1182/blood-2012-06-434779; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Cortijo J, 2006, BRIT J PHARMACOL, V147, P661, DOI 10.1038/sj.bjp.0706658; De Spiegelaere W, 2014, CLIN CHEM, V60, P886, DOI 10.1373/clinchem.2013.219378; DEAN DC, 1993, AM REV RESPIR DIS, V148, pS43, DOI 10.1164/ajrccm/148.6_Pt_2.S43; Deleage C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7116; DeNucci CC, 2010, J IMMUNOL, V184, P2458, DOI 10.4049/jimmunol.0902407; Di Mascio M, 2019, SCIENCE, V365, P1025, DOI 10.1126/science.aav6695; Dubois N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00527; Gorfu G, 2009, CURR MOL MED, V9, P836, DOI 10.2174/156652409789105525; Guzzo C, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam7341; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hong FY, 2016, J CLIN MICROBIOL, V54, P902, DOI 10.1128/JCM.02904-15; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Iwamoto N, 2019, SCIENCE, V365, P1033, DOI 10.1126/science.aaw7765; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Kiselinova M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005472; Kostrikis LG, 2002, J VIROL, V76, P10099, DOI 10.1128/JVI.76.20.10099-10108.2002; Lee M, 2016, J MED PRIMATOL, V45, P215, DOI 10.1111/jmp.12244; Lertjuthaporn S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007278; Li H, 2018, EXPERT OPIN THER PAT, V28, P903, DOI 10.1080/13543776.2018.1549227; Li W, 2008, GLYCOBIOLOGY, V18, P114, DOI 10.1093/glycob/cwm107; Ling LJ, 2019, AIDS, V33, pF1, DOI 10.1097/QAD.0000000000002149; Lord JD, 2018, CLIN IMMUNOL, V193, P24, DOI 10.1016/j.clim.2018.05.006; Lu CL, 2018, P NATL ACAD SCI USA, V115, pE11341, DOI 10.1073/pnas.1813512115; Martin-Blondel G, 2015, EUR J IMMUNOL, V45, P3302, DOI 10.1002/eji.201545632; Martinelli E, 2013, JAIDS-J ACQ IMM DEF, V64, P325, DOI 10.1097/QAI.0b013e31829f6e1a; Mavigner M, 2016, J VIRUS ERAD, V2, P219; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Mittelbrunn M, 2004, P NATL ACAD SCI USA, V101, P11058, DOI 10.1073/pnas.0307927101; Nawaz F, 2018, MUCOSAL IMMUNOL, V11, P1342, DOI 10.1038/s41385-018-0044-1; Nawaz F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001301; Nishimura Y, 2009, P NATL ACAD SCI USA, V106, P8015, DOI 10.1073/pnas.0903022106; Nolte MA, 2020, BLOOD, V135, P7, DOI 10.1182/blood.2019003336; O'Doherty U, 2002, J VIROL, V76, P10942, DOI 10.1128/JVI.76.21.10942-10950.2002; Okoye AA, 2018, NAT MED, V24, P1430, DOI 10.1038/s41591-018-0130-7; Pardons M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007619; Pasternak AO, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0397-2; Pasternak AO, 2016, J VIROL, V90, P1148, DOI 10.1128/JVI.02597-15; Pasternak AO, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-41; Pauls E, 2009, AIDS, V23, P266, DOI 10.1097/QAD.0b013e328320a7f8; Pereira LE, 2009, CELL IMMUNOL, V259, P165, DOI 10.1016/j.cellimm.2009.06.012; Policicchio BB, 2018, J VIROL, V92, DOI 10.1128/JVI.02100-17; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Rouzioux C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0412-7; Sandborn WJ, 2019, GASTROENTEROLOGY; Santangelo PJ, 2018, MUCOSAL IMMUNOL, V11, P932, DOI 10.1038/mi.2017.112; Sivro A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6354; Sneller MC, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax3447; Tsuda-Tsukimoto M, 2006, PHARM RES-DORDR, V23, P2646, DOI 10.1007/s11095-006-9102-6; Uzzan M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau4711; Vandergeeten C, 2013, BLOOD, V121, P4321, DOI 10.1182/blood-2012-11-465625; Wagner N, 1996, NATURE, V382, P366, DOI 10.1038/382366a0; Wang X, 2009, MUCOSAL IMMUNOL, V2, P518, DOI 10.1038/mi.2009.104; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wibmer CK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06794-x; Williams MB, 1997, J IMMUNOL, V159, P1746; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Woyciechowski S, 2017, EUR J IMMUNOL, V47, P244, DOI 10.1002/eji.201646722; Xu H, 2012, MUCOSAL IMMUNOL, V5, P658, DOI 10.1038/mi.2012.39; Xu HB, 2016, J VIROL, V90, P1578, DOI 10.1128/JVI.02471-15; Yukl SA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap9927; Zundler S, 2017, INFLAMM BOWEL DIS, V23, P379, DOI 10.1097/MIB.0000000000001029	79	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21282	10.1096/fj.202002235R	http://dx.doi.org/10.1096/fj.202002235R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484474	Green Published, hybrid			2022-12-26	WOS:000647789600082
J	D'Acunto, LE; Pearlstine, L; Romanach, SS				D'Acunto, Laura E.; Pearlstine, Leonard; Romanach, Stephanie S.			Joint species distribution models of Everglades wading birds to inform restoration planning	PLOS ONE			English	Article							HABITAT SELECTION; FORAGING HABITAT; OCCUPANCY MODELS; WHITE IBISES; FLORIDA; VEGETATION; COMMUNITIES; CONSERVATION; INDICATORS; MANAGEMENT	Restoration of the Florida Everglades, a substantial wetland ecosystem within the United States, is one of the largest ongoing restoration projects in the world. Decision-makers and managers within the Everglades ecosystem rely on ecological models forecasting indicator wildlife response to changes in the management of water flows within the system. One such indicator of ecosystem health, the presence of wading bird communities on the landscape, is currently assessed using three species distribution models that assume perfect detection and report output on different scales that are challenging to compare against one another. We sought to use current advancements in species distribution modeling to improve models of Everglades wading bird distribution. Using a joint species distribution model that accounted for imperfect detection, we modeled the presence of nine species of wading bird simultaneously in response to annual hydrologic conditions and landscape characteristics within the Everglades system. Our resulting model improved upon the previous model in three key ways: 1) the model predicts probability of occupancy for the nine species on a scale of 0-1, making the output more intuitive and easily comparable for managers and decision-makers that must consider the responses of several species simultaneously; 2) through joint species modeling, we were able to consider rarer species within the modeling that otherwise are detected in too few numbers to fit as individual models; and 3) the model explicitly allows detection probability of species to be less than 1 which can reduce bias in the site occupancy estimates. These improvements are essential as Everglades restoration continues and managers require models that consider the impacts of water management on key indicator wildlife such as the wading bird community.	[D'Acunto, Laura E.; Romanach, Stephanie S.] US Geol Survey, Wetland & Aquat Res Ctr, Ft Lauderdale, FL 33314 USA; [Pearlstine, Leonard] Natl Pk Serv, Everglades Natl Pk, Homestead, FL USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior	D'Acunto, LE (corresponding author), US Geol Survey, Wetland & Aquat Res Ctr, Ft Lauderdale, FL 33314 USA.	ldacunto@usgs.gov		D'Acunto, Laura/0000-0001-6227-0143	U.S. Department of the Interior's Everglades National Park, Critical Ecosystem Studies Initiative (CESI), Interagency Agreement [P16PG00252]; U.S. Geological Survey Greater Everglades Priority Ecosystems Science	U.S. Department of the Interior's Everglades National Park, Critical Ecosystem Studies Initiative (CESI), Interagency Agreement; U.S. Geological Survey Greater Everglades Priority Ecosystems Science	Funding was provided by the U.S. Department of the Interior's Everglades National Park, Critical Ecosystem Studies Initiative (CESI), Interagency Agreement #P16PG00252 (https://www.nps.gov/ever/learn/nature/cesi.htm) and the U.S. Geological Survey Greater Everglades Priority Ecosystems Science (https://www.usgs.gov/ecosystems/environments-program/science/everglades). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 1996, COLON WATERBIRD, V19, P65, DOI 10.2307/1521808; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; Bancroft GT, 2002, WATERBIRDS, V25, P265, DOI 10.1675/1524-4695(2002)025[0265:DOWBRT]2.0.CO;2; Bansal S, 2019, WETLANDS, V39, P645, DOI 10.1007/s13157-019-01174-7; Beerens JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128182; Beerens JM, 2011, AUK, V128, P651, DOI 10.1525/auk.2011.10165; Blanchet FG, 2020, ECOL LETT, V23, P1050, DOI 10.1111/ele.13525; Botson BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158864; Boyle RA, 2012, WATERBIRDS, V35, P154, DOI 10.1675/063.035.0116; Burtner BF, 2017, WETLANDS, V37, P697, DOI 10.1007/s13157-017-0900-x; Catano CP, 2015, ENVIRON MANAGE, V55, P807, DOI 10.1007/s00267-014-0397-5; Chastant JE, 2017, HYDROBIOLOGIA, V788, P371, DOI 10.1007/s10750-016-3015-0; Conroy MJ, 2008, AUK, V125, P731, DOI 10.1525/auk.2008.07134; Cook MI, 2014, FRESHWATER BIOL, V59, P1608, DOI 10.1111/fwb.12367; Crozier GE, 2003, WATERBIRDS, V26, P303, DOI 10.1675/1524-4695(2003)026[0303:WBNEAA]2.0.CO;2; DeAngelis DL, 1998, ECOSYSTEMS, V1, P64, DOI 10.1007/s100219900006; Devarajan K, 2020, ECOGRAPHY, V43, P1612, DOI 10.1111/ecog.04957; Dorazio RM, 2005, J AM STAT ASSOC, V100, P389, DOI 10.1198/016214505000000015; Dunn PK., 1996, J COMPUTATIONAL GRAP, V5, P236, DOI DOI 10.2307/1390802; Frederick P, 2009, ECOL INDIC, V9, pS83, DOI 10.1016/j.ecolind.2008.10.012; Frederick Peter C., 1994, P659; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gawlik DE, 2002, ECOL MONOGR, V72, P329, DOI 10.1890/0012-9615(2002)072[0329:TEOPAO]2.0.CO;2; Gelman A., 2013, CHAPMAN HALL CRC TEX, DOI [10.1201/b16018, DOI 10.1201/B16018]; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guillera-Arroita G, 2017, ECOGRAPHY, V40, DOI 10.1111/ecog.02445; Herring G, 2010, AUK, V127, P660, DOI 10.1525/auk.2010.09144; Jeffreys H., 1961, THEORY OF PROBABILIT; Jimenez-Valverde A, 2012, GLOBAL ECOL BIOGEOGR, V21, P498, DOI 10.1111/j.1466-8238.2011.00683.x; Lahoz-Monfort JJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P504, DOI 10.1111/geb.12138; Lantz SM, 2010, CONDOR, V112, P460, DOI 10.1525/cond.2010.090167; Lodge TE, 2016, EVERGLADES HDB UNDER; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; National Academies of Sciences Engineering and Medicine., 2019, EXPL MED PUBL HLTH P; Ogden John C., 1994, P533; Pearlstine LG, 2020, ENVIRON MODELL SOFTW, V132, DOI 10.1016/j.envsoft.2020.104783; Pierce RL, 2010, WATERBIRDS, V33, P494, DOI 10.1675/063.033.0408; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; R Core Team, 2020, R LANG ENV STAT COMP; Ross MS, 2003, WETL ECOL MANAG, V11, P291, DOI 10.1023/B:WETL.0000005541.30283.11; Rota CT, 2016, METHODS ECOL EVOL, V7, P1164, DOI 10.1111/2041-210X.12587; Ruiz-Gutierrez V, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00207.1; Sah JP, 2018, FOREST ECOL MANAG, V421, P16, DOI 10.1016/j.foreco.2018.03.022; Sklar FH, 2005, FRONT ECOL ENVIRON, V3, P161, DOI 10.2307/3868544; Strong AM, 1997, CONDOR, V99, P894, DOI 10.2307/1370140; Su YS., 2015, R2JAGS USING R RUN J; Telis PA, 20145209 US GEOL SUR; Tobler MW, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2754; Todd MJ, 2010, ADV WATER RESOUR, V33, P1279, DOI 10.1016/j.advwatres.2010.04.003; Trexler JC, 2009, ECOL INDIC, V9, pS108, DOI 10.1016/j.ecolind.2008.11.001; USDA Forest Service, 2019, NRM FIELD SAMPLED VE; VERDINELLI I, 1995, J AM STAT ASSOC, V90, P614, DOI 10.2307/2291073; Warton DI, 2017, METHODS ECOL EVOL, V8, P408, DOI 10.1111/2041-210X.12761; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zipkin EF, 2010, BIOL CONSERV, V143, P479, DOI 10.1016/j.biocon.2009.11.016	59	2	2	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245973	10.1371/journal.pone.0245973	http://dx.doi.org/10.1371/journal.pone.0245973			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508032	Green Published, gold			2022-12-26	WOS:000635021400068
J	Xie, J; Peng, Y; Chen, XY; Li, QG; Jian, B; Wen, ZL; Liu, SC				Xie, Jian; Peng, Yang; Chen, Xiaoyu; Li, Qigang; Jian, Bin; Wen, Zelin; Liu, Shengchun			LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis	PLOS ONE			English	Article							END-POINTS; CANCER; DEFINITIONS; DIVERSITY; TRIALS	This study aimed to find the prognostic value of Beta-lactamase-like (LACTB) in pancreatic adenocarcinoma (PAAD) patients. The mRNA expression of LACTB was upregulated in PAAD and was correlated with vital status (P = 0.0199). The immunoreactive scores of LACTB protein in human PAAD tissues were significantly higher than those in adjacent noncancerous pancreatic tissues. Receiver operating characteristic (ROC) curve assessment showed that LACTB mRNA expression has high diagnostic value in PAAD. Kaplan-Meier curve and Cox analyses suggested that patients with high LACTB mRNA expression have a poor prognosis, indicating that LACTB mRNA is an independent prognostic factor for overall survival [hazard ratio (HR) = 1.72, P = 0.015, 95% confidence interval (CI) = 1.106-2.253] and disease-specific survival (HR = 1.97, P = 0.004, 95% CI = 1.238-3.152) of PAAD patients. Gene set enrichment analysis (GSEA) revealed that hallmark_g2m_checkpoint, hallmark_myc_targets_v1, hallmark_e2f_targets, and kegg_cell_cycle were differentially enriched in phenotypes with high LACTB expression. In addition, CDC20, CDK4, MCM6, MAD2L1, MCM2 and MCM5 were leading genes intersecting in these four pathways, and a positive correlation between mRNA expression and LACTB was observed in most normal and cancer tissues. Finally, elevated LACTB mRNA expression was significantly related to multiple immune marker sets. Our results elucidate that LACTB is involved in the development of cancer, and that high LACTB expression in patients with PAAD can predict a poor prognosis. High LACTB expression was significantly correlated with cell cycle-related genes and multiple immune marker sets.	[Xie, Jian; Li, Qigang; Jian, Bin; Wen, Zelin] Chongqing Med Univ, Dept Gen Surg, Yong Chuan Hosp, Chongqing, Peoples R China; [Peng, Yang; Liu, Shengchun] Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China; [Chen, Xiaoyu] Chongqing Med Univ, Dept Prevent & Hlth Protect, Yong Chuan Hosp, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, SC (corresponding author), Chongqing Med Univ, Dept Endocrine & Breast Surg, Affiliated Hosp 1, Chongqing, Peoples R China.	liushengchun1968@163.com	Peng, Yang/ABH-1961-2021	liu, shengchun/0000-0002-9933-3643	National Natural Science Foundation of China [81772979, 81472658]; Natural Sciences Foundation project proposals of YongChuan [2019nb0203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation project proposals of YongChuan	The present study was supported by grants from the National Natural Science Foundation of China (nos. 81772979 and 81472658) and Natural Sciences Foundation project proposals of YongChuan (Ycstc, 2019nb0203).	Bains RK, 2004, ENDOCRINOLOGY, V145, P2666, DOI 10.1210/en.2003-1608; Chang DZ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-15; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Daniel P, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.21; Eriksson O, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00396; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; Li HT, 2019, ONCOL RES, V27, P423, DOI 10.3727/096504017X15030178624579; Liao XW, 2018, CANCER MANAG RES, V10, P3255, DOI 10.2147/CMAR.S171293; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Peitsaro N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-26; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Retzer-Lidl M, 2007, INT J CANCER, V121, P66, DOI 10.1002/ijc.22619; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Xue C, 2018, AM J TRANSL RES, V10, P4152; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zeng KX, 2018, ONCOGENE, V37, P5534, DOI 10.1038/s41388-018-0352-7	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245908	10.1371/journal.pone.0245908	http://dx.doi.org/10.1371/journal.pone.0245908			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507917	gold, Green Published			2022-12-26	WOS:000635021400062
J	Kato, S; Demura, S; Shinmura, K; Yokogawa, N; Kabata, T; Matsubara, H; Kajino, Y; Igarashi, K; Inoue, D; Kurokawa, Y; Oku, N; Tsuchiya, H				Kato, Satoshi; Demura, Satoru; Shinmura, Kazuya; Yokogawa, Noriaki; Kabata, Tamon; Matsubara, Hidenori; Kajino, Yoshitomo; Igarashi, Kentaro; Inoue, Daisuke; Kurokawa, Yuki; Oku, Norihiro; Tsuchiya, Hiroyuki			Association of low back pain with muscle weakness, decreased mobility function, and malnutrition in older women: A cross-sectional study	PLOS ONE			English	Article							LOCOMOTIVE SYNDROME; RISK-FACTOR; STRENGTH; EXERCISE; DISABILITY; OUTCOMES; ADULTS	Background Low back pain (LBP) and decreased mobility function are common problem among older people. Muscle weakness has been reported as a risk factor for these conditions, and exercise therapy can improve them. We created a novel exercise device that also measures abdominal trunk muscle strength. Malnutrition has also emerged as a major problem among older people. Muscle is a direct key linking decreased mobility function and malnutrition. This study aimed to examine the associations of LBP with not only decreased physical function and muscle weakness but also nutritional status of older people. Methods We examined the associations of LBP with muscle weakness, decreased mobility function (locomotive syndrome [LS]), and malnutrition among older women. The study included 101 female patients aged 60 years or older scheduled to undergo surgery for degenerative lower extremity diseases. Preoperatively, physical tests including abdominal trunk muscle strength assessment using the device and laboratory tests were conducted. Subjects with LBP (numerical rating scale >= 2; range, 0-4) during the preceding month were allocated to the LBP group (n = 36). Other subjects were allocated to the non-LBP group (n = 65). Results The LBP group had lower abdominal trunk and knee extensor muscle strength, lower serum albumin, and hemoglobin levels as blood biomarkers associated with malnutrition risk, and higher LS test scores than the non-LBP group. A multivariate analysis showed that abdominal trunk muscle weakness and advanced LS were associated with LBP. LBP intensity was negatively correlated with abdominal trunk and knee extensor muscle strength and positively correlated with the LS test score. The serum hemoglobin level was negatively correlated with the LS test score. Conclusion Abdominal trunk muscle weakness and decreased mobility function were associated with LBP among older women.	[Kato, Satoshi; Demura, Satoru; Shinmura, Kazuya; Yokogawa, Noriaki; Kabata, Tamon; Matsubara, Hidenori; Kajino, Yoshitomo; Igarashi, Kentaro; Inoue, Daisuke; Kurokawa, Yuki; Oku, Norihiro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Kanazawa University	Kato, S (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	skato323@gmail.com		Kato, Satoshi/0000-0003-4762-5932	Japanese Society for Musculoskeletal Medicine	Japanese Society for Musculoskeletal Medicine	This research was supported by a research grant from the Japanese Society for Musculoskeletal Medicine. S.K. (the corresponding author) received the grant. The grand did not have a grant number. URL: http://www.jsmr.org/The funder did not play any role in the study design,	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Cascio BL, 2018, GERIATR NURS, V39, P95, DOI 10.1016/j.gerinurse.2017.07.006; Chen CCH, 2001, J ADV NURS, V36, P131, DOI 10.1046/j.1365-2648.2001.01950.x; Cho KH, 2014, ANN REHABIL MED-ARM, V38, P234, DOI 10.5535/arm.2014.38.2.234; Coyle PC, 2017, PAIN MED, V18, P161, DOI 10.1093/pm/pnw136; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Garcia William J, 2019, J Allied Health, V48, P302; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; Hayden JA, 2005, ANN INTERN MED, V142, P776, DOI 10.7326/0003-4819-142-9-200505030-00014; HELEWA A, 1990, J RHEUMATOL, V17, P965; Ishibashi Hideaki, 2018, Osteoporos Sarcopenia, V4, P86, DOI 10.1016/j.afos.2018.09.004; Jensen GL, 2019, JPEN-PARENTER ENTER, V43, P32, DOI [10.1002/jpen.1440, 10.1016/j.clnu.2018.08.002]; Jimenez-Redondo S, 2014, J NUTR HEALTH AGING, V18, P359, DOI 10.1007/s12603-013-0416-x; Kadono Y, 2010, J ORTHOP SCI, V15, P162, DOI 10.1007/s00776-009-1448-2; Kasukawa Y, 2010, J BONE MINER METAB, V28, P82, DOI 10.1007/s00774-009-0107-1; Kato S, 2020, ANN REHABIL MED-ARM, V44, P246, DOI 10.5535/arm.19100; Kato S, 2020, J BACK MUSCULOSKELET, V33, P677, DOI 10.3233/BMR-181419; Kato S, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2655-4; Kato S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172934; Kimachi K, 2019, PAIN MED, V20, P2377, DOI 10.1093/pm/pny313; Kong YS, 2015, J PHYS THER SCI, V27, P2749, DOI 10.1589/jpts.27.2749; Kudo D, 2020, J BACK MUSCULOSKELET, V33, P263, DOI 10.3233/BMR-160618; Lee JH, 1999, SPINE, V24, P54, DOI 10.1097/00007632-199901010-00013; Morris P, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-3154-3; Nakamura K, 2008, J ORTHOP SCI, V13, P1, DOI 10.1007/s00776-007-1202-6; Nakamura K, 2016, CLIN REV BONE MINER, V14, P56, DOI 10.1007/s12018-016-9208-2; Nourbakhsh MR, 2002, J ORTHOP SPORT PHYS, V32, P447, DOI 10.2519/jospt.2002.32.9.447; Pereira Costa Aline Barbara, 2016, Journal of Nutrition in Gerontology and Geriatrics, V35, P43, DOI 10.1080/21551197.2015.1125325; Phillips EM, 2004, ARCH PHYS MED REHAB, V85, pS52, DOI 10.1016/j.apmr.2004.03.012; Ramsey KA, 2020, AGING CLIN EXP RES, V32, P1085, DOI 10.1007/s40520-019-01295-3; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Rudy TE, 2007, PAIN, V131, P293, DOI 10.1016/j.pain.2007.01.012; Saka B, 2010, CLIN NUTR, V29, P745, DOI 10.1016/j.clnu.2010.04.006; Sarafadeen R, 2020, J EXERC REHABIL, V16, P293, DOI 10.12965/jer.2040380.190; Schwan Josianna, 2019, Anesthesiol Clin, V37, P547, DOI 10.1016/j.anclin.2019.04.012; Seichi A, 2012, J ORTHOP SCI, V17, P163, DOI 10.1007/s00776-011-0193-5; Suh JH, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016173; Suzuki T, 2015, J PHYS THER SCI, V27, P967, DOI 10.1589/jpts.27.967; Vadala G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041023; van den Berg R, 2018, SPINE J, V18, P2140, DOI 10.1016/j.spinee.2018.06.349; Visvanathan R, 2003, J Postgrad Med, V49, P352; Wu AM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.02.175; Yoshimura N, 2019, J BONE MINER METAB, V37, P1058, DOI 10.1007/s00774-019-01012-0; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Zhang ZY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080829	46	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245879	10.1371/journal.pone.0245879	http://dx.doi.org/10.1371/journal.pone.0245879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493191	Green Published, gold			2022-12-26	WOS:000613081500054
J	Oguntade, AS; Ajayi, IO				Oguntade, Ayodipupo S.; Ajayi, IkeOluwapo O.			Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; MEDICATION ADHERENCE; ALCOHOL-CONSUMPTION; ALBUMINURIA; PREVALENCE; GUIDELINES; OBESITY; MEN	Aim Hypertension is the leading cause of heart failure (HF) in sub-Saharan Africa. Preventive public health approach to reduce the scourge of HF must seek to understand the risk factors of HF in at-risk populations. The aim of this study was to characterize the risk factors of HF among patients with hypertension attending a cardiology clinic. Methods and results One hundred and one (101) case-control age- and sex-matched pairs were recruited. The study population were adults with a clinical diagnosis of hypertensive HF (cases) and individuals with systemic hypertension without HF. They were interviewed and evaluated for cardiovascular risk factors. Associations between variables were tested with chi square test, Fisher's exact test and independent sample t test as appropriate. Logistic regression modelling was used to determine the independent risk factors of hypertensive HF (HHF) in the study population while 'punafcc' package in stata12 was used to calculate the population attributable fraction (PAF) of the risk factors. Suboptimal medication adherence was the strongest adverse risk factor of HHF (medium adherence aOR: 3.53, 95%CI: 1.35-9.25; low adherence aOR: 9.44, 95%CI: 3.41-26.10) with a PAF of 67% followed by dipstick proteinuria (aOR: 4.22, 95%CI: 1.62-11.02; PAF: 34%) and alcohol consumption/day per 10grams (aOR: 1.23, 95%CI: 1.02-1.49; PAF: 22%). The protective risk factors of HHF were use of calcium channel blockers (aOR 0.25, 95%CI: 0.11-0.59; PAF: 59%), then daily fruits and vegetable consumption (aOR 0.41, 95%CI: 0.17-1.01; PAF: 46%), and eGFR (aOR 0.98, 95%CI: 0.96-0.99; PAF: 5.3%). Conclusions The risk factors of HHF are amenable to lifestyle and dietary changes. Public health interventions and preventive cardiovascular care to improve medication adherence, promote fruit and vegetable consumption and reduce alcohol consumption among patients with hypertension are recommended. Renoprotection has utility in the prevention of HF among hypertensives.	[Oguntade, Ayodipupo S.] Univ Coll Hosp, Dept Med, Ibadan, Oyo State, Nigeria; [Oguntade, Ayodipupo S.; Ajayi, IkeOluwapo O.] Univ Ibadan, Dept Epidemiol & Med Stat, Ibadan, Oyo State, Nigeria	University of Ibadan; University College Hospital, Ibadan; University of Ibadan	Oguntade, AS (corresponding author), Univ Coll Hosp, Dept Med, Ibadan, Oyo State, Nigeria.; Oguntade, AS (corresponding author), Univ Ibadan, Dept Epidemiol & Med Stat, Ibadan, Oyo State, Nigeria.	ayodipupooguntade@gmail.com	Oguntade, Ayodipupo/AAZ-5266-2020	ajayi, Ikeoluwapo/0000-0001-7719-8746				Abegaz TM, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005641; Abramson JL, 2001, JAMA-J AM MED ASSOC, V285, P1971, DOI 10.1001/jama.285.15.1971; Adeloye D, 2015, J HYPERTENS, V33, P230, DOI 10.1097/HJH.0000000000000413; Adeoye AM, 2019, NIGER POSTGRAD MED J, V26, P18, DOI 10.4103/npmj.npmj_147_18; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ajayi I.O., 2016, NIGERIAN J CARDIOLOG, V13, P67, DOI 10.4103/0189-7969.165168; Akinlua JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140021; Akintunde Adeseye A, 2012, J Cardiovasc Dis Res, V3, P290, DOI 10.4103/0975-3583.102705; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; [Anonymous], 1992, AM J HYPERTENS, V5, P207; [Anonymous], 1996, BRIT MED J, V313, P1448; [Anonymous], 2013, N 1, V17, DOI DOI 10.1093/NDT/GFV100; [Anonymous], 2015, PETROLEUM VERTICAL, V5, P22; [Anonymous], 2019, PREV TREAT CARDIO CE, V19, P1, DOI [DOI 10.5230/jgc.2019.19.e8, DOI 10.1186/s12877-019-1185-0]; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Arena R, 2010, FUTUR CARDIOL, V6, P1, DOI 10.2217/FCA.09.158; Bahrami H, 2008, J AM COLL CARDIOL, V51, P1775, DOI 10.1016/j.jacc.2007.12.048; Basile G, 2012, GERONTOLOGY, V58, P216, DOI 10.1159/000330801; Burton R, 2018, LANCET, V392, P987, DOI 10.1016/S0140-6736(18)31571-X; Carnethon MR, 2009, AM J LIFESTYLE MED, V3, p44S, DOI 10.1177/1559827609332737; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chijioke C, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/5628453; Corrao G, 2015, HYPERTENSION, V66, P742, DOI 10.1161/HYPERTENSIONAHA.115.05463; Djousse L, 2008, CURR ATHEROSCLER REP, V10, P117, DOI 10.1007/s11883-008-0017-z; Dzudie A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001217; FRIEDMAN GD, 1982, HYPERTENSION, V4, P143; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Karppi J, 2013, INT J CARDIOL, V168, P1841, DOI 10.1016/j.ijcard.2012.12.072; Katz DH, 2014, JACC-HEART FAIL, V2, P586, DOI 10.1016/j.jchf.2014.05.016; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Kotchen TA, 2015, HARRISONS PRINCIPLES, P1611; Kurt O, 2013, INT J CARDIOL, V168, P2985, DOI 10.1016/j.ijcard.2013.04.098; Laabes EP, 2008, ACTA CARDIOL, V63, P437, DOI 10.2143/AC.63.4.2033041; Lachman S, 2018, EUR J PREV CARDIOL, V25, P200, DOI 10.1177/2047487317737628; Lam CSP, 2015, ESC HEART FAIL, V2, P46, DOI 10.1002/ehf2.12036; Lwanga S., 1991, SAMPLE SIZE DETERMIN, DOI [10.2307/2290547, DOI 10.2307/2290547]; Mene-Afejuku TO, 2017, VASC HEALTH RISK MAN, V13, P71, DOI 10.2147/VHRM.S124477; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Niizeki T, 2013, AM J CARDIOL, V111, P1180, DOI 10.1016/j.amjcard.2012.12.050; Odeyinka O.T., 2017, NIG J CARDIOL, V14, P75, DOI DOI 10.4103/NJC.NJC_11_17; Ogah OS, 2015, J CLIN HYPERTENS, V17, P263, DOI 10.1111/jch.12496; Oguntade A, 2016, NIG CARD SOC 45 ANN; Oguntade AS, 2020, J SAUDI HEART ASSOC, V32, P383, DOI 10.37616/2212-5043.1156; Oguntola S, 2018, NIGER TRIB 0623; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Ojji DB, 2019, NEW ENGL J MED, V380, P2429, DOI 10.1056/NEJMoa1901113; Omotoye FE, 2018, ASIAN PAC J HLTH SCI, V5, P53; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Prineas RJ, 2010, MINNESOTA CODE MANUA, DOI [10.1007/978-1-84882-778-3, DOI 10.1007/978-1-84882-778-3]; Rahman I, 2015, JACC-HEART FAIL, V3, P681, DOI 10.1016/j.jchf.2015.05.006; Raji Yemi Raheem, 2017, Pan Afr Med J, V27, P190, DOI 10.11604/pamj.2017.27.190.11682; Saguner AM, 2010, AM J HYPERTENS, V23, P775, DOI 10.1038/ajh.2010.71; Sanchez GP, 2017, QUAL PRIM CARE, V25, P217; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Sliwa K, 2014, CLIN RES CARDIOL, V103, P515, DOI 10.1007/s00392-014-0660-z; Thangavel K, 2009, APPL SOFT COMPUT, V9, P1, DOI 10.1016/j.asoc.2008.05.006; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wahid A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002495; WHO, 2012, GUID SOD INT AD CHIL; World Health Organization, 2003, FRAM SURV WHO STEPW; Yang H, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000222; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	63	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245734	10.1371/journal.pone.0245734	http://dx.doi.org/10.1371/journal.pone.0245734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493215	Green Published, gold, Green Submitted			2022-12-26	WOS:000613081500012
J	Qanche, Q; Asefa, A; Nigussie, T; Hailemariam, S; Duguma, T				Qanche, Qaro; Asefa, Adane; Nigussie, Tadesse; Hailemariam, Shewangizaw; Duguma, Tadesse			Knowledge of COVID-19 and preventive behaviors among waiters working in food and drinking establishments in Southwest Ethiopia	PLOS ONE			English	Article								Background Waiters working in different food and drinking establishments have a higher risk of contracting COVID-19 and transmitting the infection to others because they interact with many people. Most COVID-19 related studies in Ethiopia mainly focused on the general population, whereas, this study aimed to assess the knowledge of COVID-19 and preventive behaviors among waiters in Southwest Ethiopia. Methods A cross-sectional study was conducted from June 1 to June 15, 2020, among waiters working in food and drinking establishments found in Mizan-Aman, Jemu, and Masha towns in Southwest Ethiopia. A total of 422 waiters were selected using a simple random sampling technique, and the data were collected through face-to-face interviews using a structured questionnaire. The data were entered into Epi-data manager version 4.0.2 and analyzed using SPSS version 22. Multivariable binary logistic regression analysis was carried out to identify predictors of good preventive behaviors at a p-value of less than 0.05. Results Four hundred and sixteen respondents participated in this study, with a response rate of 98.6%. A significant proportion of participants know the cause, route of transmission, symptoms, and prevention methods of COVID-19 virus. However, very few (21.2%) had good preventive behaviors. The study showed that good preventive behavior was positively associated with female sex (AOR = 2.33, 95% CI: 1.38-3.94), higher schooling (AOR = 0.39, 95% CI: 0.17-0.88), high-risk perception (AOR = 2.26, 95% CI: 1.51-4.32), and high perceived self-efficacy (AOR = 1.1.75, 95% CI: 1.05-2.90). Conclusions A significant proportion of waiters know common symptoms of COVID 19, route of transmission, and its prevention methods. However, the preventive behavior was very low. Thus, all concerned bodies working on the prevention and control of COVID-19 should give attention to this population group to enhance compliance with recommended preventive behaviors.	[Qanche, Qaro; Asefa, Adane; Nigussie, Tadesse] Mizan Tepi Univ, Coll Hlth Sci, Dept Publ Hlth, Mizan Aman, Ethiopia; [Hailemariam, Shewangizaw] Mizan Tepi Univ, Coll Hlth Sci, Dept Midwifery, Mizan Aman, Ethiopia; [Duguma, Tadesse] Mizan Tepi Univ, Coll Hlth Sci, Dept Med Lab, Mizan Aman, Ethiopia		Asefa, A (corresponding author), Mizan Tepi Univ, Coll Hlth Sci, Dept Publ Hlth, Mizan Aman, Ethiopia.	adane779@gmail.com	Duguma, Tadesse/AIE-5692-2022; Qanche, Qaro/ABE-7172-2021	Duguma, Tadesse/0000-0001-7372-7145; Qanche, Qaro/0000-0002-8051-2529; Asefa, Adane/0000-0001-9374-978X				Ahmed N, J HEAL RES, V22, P33; [Anonymous], 2020, FMOH INFECT PREVENTI; Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; CDC, 2020, GUID MAN PAT CONF CO; Christopher R, 2020, J COMMUNITY HLTH; DC T, 2020, NAT PROD COMMUN, V15, P1, DOI DOI 10.1080/15567249.2020.1729900; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gil M.R., 2020, Q A COR COVID 19; Hauck G, 2020, CORONAVIRUS UPDATES; Holmes EA, 2018, LANCET PSYCHIAT, V5, P237, DOI 10.1016/S2215-0366(17)30513-8; Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2; Hospital AZ, 2020, KNOWLEDGE ATTITUDE P, P1949; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Jemal B, 2020, KNOWLEDGE ATTITUDE P; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Luszczynska A., 2005, PREDICTING HLTH BEHA, P127; Marfleet P, 2007, REFUG SURV Q, V26, P136, DOI 10.1093/rsq/hdi0248; Municipal Public Health Service Rotterdam-Rijnmond, 2015, STAND QUEST RISK PER; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Saqlain M, 2020, J HOSP INFECT, V105, P419, DOI 10.1016/j.jhin.2020.05.007; Singla R, 2020, VET RES COMMUN, V44, P119, DOI 10.1007/s11259-020-09781-0; Tadesse AW, KNOWLEDGE ATTITUDE P; Vandeweerd V, 2020, COVID 19 OVERVIEW IN, P1; WHO, 2020, 1 CAS COVID 19 CONF; WHO,, 2020, COVID 19 MAN HOT OTH; Wolff K, 2019, ANN TOURISM RES, V79, DOI 10.1016/j.annals.2019.102759; World Health Organization, 2020, SURV GUID RAP SIMPL; World Health Organization ( WHO), 2020, WHO REC RED RISK TRA; Zettler I., 2020, INDIVIDUAL DIFFERENC, DOI [DOI 10.31234/OSF.IO/PKM2A, 10.31234/osf.io/pkm2a]	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245753	10.1371/journal.pone.0245753	http://dx.doi.org/10.1371/journal.pone.0245753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493226	gold, Green Published			2022-12-26	WOS:000613081500052
J	Niu, H; Pang, ZQ; Fallah, N; Zhou, YM; Zhang, CF; Hu, CH; Lin, WX; Yuan, ZN				Niu, Huan; Pang, Ziqin; Fallah, Nyumah; Zhou, Yongmei; Zhang, Caifang; Hu, Chaohua; Lin, Wenxiong; Yuan, Zhaonian			Diversity of microbial communities and soil nutrients in sugarcane rhizosphere soil under water soluble fertilizer	PLOS ONE			English	Article							PLANT-GROWTH; ORGANIC FERTILIZER; BACTERIAL; MICROORGANISMS; ENHANCEMENT; COMPOST; CARBON; CROPS; YIELD	The dynamics of soil microbial communities are important for plant health and productivity. Soil microbial communities respond differently to fertilization. Organic water soluble fertilizer is an effective soil improver, which can effectively improve soil nutrient status and adjust soil pH value. However, little is known about the effects of water soluble fertilizers on soil microbial community, and the combined effects on soil nutrients and sugarcane productivity. Therefore, this study sought to assess the effects of water soluble fertilizer (1,050 kg/hm(2) (WS1), 1,650 kg/hm(2) (WS2)) and mineral fertilizer (1,500 kg/hm(2) (CK)) on the soil microbial community, soil nutrients and crop yield of sugarcane. The results showed that compared with CK, the application of water soluble fertilizers (WS1 and WS2) alleviated soil acidity, increased the OM, DOC, and AK contents in the soil, and further improved agronomic parameters and sugarcane yield. Both WS1 and WS2 treatments significantly increased the species richness of microorganisms, especially the enrichment of beneficial symbiotic bacteria such as Acidobacteria and Planctomycetes, which are more conducive to the healthy growth of plants. Furthermore, we found that soil nutrient contents were associated with soil microbial enrichment. These results indicate that water soluble fertilizer affects the enrichment of microorganisms by improving the nutrient content of the soil, thereby affecting the growth and yield of sugarcane. These findings therefore suggest that the utilization of water soluble fertilizer is an effective agriculture approach to improve soil fertility.	[Niu, Huan; Pang, Ziqin; Fallah, Nyumah; Zhou, Yongmei; Zhang, Caifang; Lin, Wenxiong; Yuan, Zhaonian] Fujian Agr & Forestry Univ, Coll Agr, Fuzhou, Peoples R China; [Pang, Ziqin; Zhang, Caifang; Hu, Chaohua; Yuan, Zhaonian] Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China; [Pang, Ziqin; Yuan, Zhaonian] Guangxi Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr, Nanning, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; Guangxi University	Yuan, ZN (corresponding author), Fujian Agr & Forestry Univ, Coll Agr, Fuzhou, Peoples R China.; Yuan, ZN (corresponding author), Fujian Agr & Forestry Univ, Key Lab Sugarcane Biol & Genet Breeding, Minist Agr, Fuzhou, Peoples R China.; Yuan, ZN (corresponding author), Guangxi Univ, Prov & Minist Cosponsored Collaborat Innovat Ctr, Nanning, Peoples R China.	yuanzn05@163.com	Pang, Ziqin/AFW-3395-2022	Pang, Ziqin/0000-0002-0943-1224	Modern Agricultural Industry Technology System of China [CARS-170208]; Nature Science Foundation of Fujian Province [2017J01456]; Special Foundation for Scientific and Technological Innovation of Fujian Agriculture and Forestry University [CXZX2016172]	Modern Agricultural Industry Technology System of China; Nature Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province); Special Foundation for Scientific and Technological Innovation of Fujian Agriculture and Forestry University	This research was funded by the Modern Agricultural Industry Technology System of China (CARS-170208), the Nature Science Foundation of Fujian Province (2017J01456), and the Special Foundation for Scientific and Technological Innovation of Fujian Agriculture and Forestry University (CXZX2016172).	Abegaz A, 2020, AGR ECOSYST ENVIRON, V300, DOI 10.1016/j.agee.2020.106997; Badagliacca G, 2020, AGR ECOSYST ENVIRON, V300, DOI 10.1016/j.agee.2020.107010; Barka EA, 2000, FEMS MICROBIOL LETT, V186, P91, DOI 10.1111/j.1574-6968.2000.tb09087.x; Bokhtiar SM, 2008, J PLANT NUTR, V31, P1832, DOI 10.1080/01904160802325545; Champely S, 2002, ENVIRON ECOL STAT, V9, P167, DOI 10.1023/A:1015170104476; Chen RK, 2010, INT SUGAR J, V112, P452; Delgado-Baquerizo M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10541; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Failaka MF, 2017, AIP CONF PROC, V1840, DOI 10.1063/1.4982294; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FROMMEL MI, 1991, PLANT PHYSIOL, V96, P928, DOI 10.1104/pp.96.3.928; Fu MM, 2015, PEDOSPHERE, V25, P343, DOI 10.1016/S1002-0160(15)30002-3; Glymenaki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08732-1; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Guo ZB, 2020, APPL SOIL ECOL, V149, DOI 10.1016/j.apsoil.2020.103510; Gyaneshwar P, 2002, PLANT SOIL, V245, P83, DOI 10.1023/A:1020663916259; Hao TX, 2020, J ENVIRON MANAGE, V270, DOI 10.1016/j.jenvman.2020.110888; Ihara Y, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00360-19; Jannoura R, 2014, EUR J AGRON, V52, P259, DOI 10.1016/j.eja.2013.09.001; Karlidag NE, 2020, FOOD CHEM, V329, DOI 10.1016/j.foodchem.2020.127210; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; Kwon HY, 2009, SOIL SCI SOC AM J, V73, P1033, DOI 10.2136/sssaj2008.0233; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lin WX, 2013, BMC MICROBIOL, V13, DOI [10.1186/1471-2180-13-135, 10.1186/1472-6882-13-144]; Luo J, 2015, SCI REP-UK, V5, DOI 10.1038/srep15721; Ma TS, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139667; Manghabati H, 2018, J PLANT NUTR SOIL SC, V181, P547, DOI 10.1002/jpln.201700536; Mora-Cantallops M, 2020, J SOFTW-EVOL PROC, V32, DOI 10.1002/smr.2270; Mori K, 2014, MICROBES ENVIRON, V29, P335, DOI 10.1264/jsme2.ME2904rh; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462; Pang Z, 2019, APPL ECOL ENV RES, V17, P6151, DOI 10.15666/aeer/1703_61516170; Pang ZQ, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120808; Panke-Buisse K, 2015, ISME J, V9, P980, DOI 10.1038/ismej.2014.196; Rhoads A, 2015, GENOM PROTEOM BIOINF, V13, P278, DOI 10.1016/j.gpb.2015.08.002; Nogueira TAR, 2013, J ENVIRON MANAGE, V114, P168, DOI 10.1016/j.jenvman.2012.09.012; Rodriguez-Echeverria S, 2016, FUNCT ECOL, V30, P30, DOI 10.1111/1365-2435.12594; SAKAKI T, 1994, J NEUROSURG, V80, P58, DOI 10.3171/jns.1994.80.1.0058; Sakthiselvi T, 2020, FOOD CHEM, V328, DOI 10.1016/j.foodchem.2020.127134; Schloss PD, 2016, PEERJ, V4, DOI 10.7717/peerj.1869; Sharma A, 2017, HORTIC PLANT J, V3, P67, DOI 10.1016/j.hpj.2017.07.003; Shen ZZ, 2015, PLANT SOIL, V393, P21, DOI 10.1007/s11104-015-2474-9; Shi LM, 2017, SCI TOTAL ENVIRON, V598, P77, DOI 10.1016/j.scitotenv.2017.04.115; Siles JA, 2016, MICROB ECOL, V72, P207, DOI 10.1007/s00248-016-0748-2; Smith BR, 2004, J PLANT NUTR, V27, P497, DOI 10.1081/PLN-120028875; Soumare M, 2003, BIORESOURCE TECHNOL, V86, P15, DOI 10.1016/S0960-8524(02)00133-5; Tedersoo L, 2019, ENV MICROBIOL REP, V11, P659, DOI 10.1111/1758-2229.12776; Tian Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep45289; Pham TG, 2018, INT SOIL WATER CONSE, V6, P280, DOI 10.1016/j.iswcr.2018.08.001; Wang J, 2016, BIORESOURCE TECHNOL, V218, P892, DOI 10.1016/j.biortech.2016.06.130; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Yang H, 2003, ATMOS ENVIRON, V37, P865, DOI 10.1016/S1352-2310(02)00953-6; Yang JH, 2017, ENVIRON SCI TECHNOL, V51, P3057, DOI 10.1021/acs.est.6b05606; Zhang JY, 2019, NAT BIOTECHNOL, V37, P676, DOI 10.1038/s41587-019-0104-4; Zhang XN, 2020, CHEM REV, V120, P5308, DOI 10.1021/acs.chemrev.9b00613; Zheng YF, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8020207; Zhu HH, 2012, EUR J SOIL BIOL, V51, P1, DOI 10.1016/j.ejsobi.2012.03.003	59	12	12	16	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245626	10.1371/journal.pone.0245626	http://dx.doi.org/10.1371/journal.pone.0245626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481857	gold, Green Published			2022-12-26	WOS:000612929300068
J	Sakanaka, TE; Lakie, M; Reynolds, RF				Sakanaka, Tania E.; Lakie, Martin; Reynolds, Raymond F.			Individual differences in intrinsic ankle stiffness and their relationship to body sway and ankle torque	PLOS ONE			English	Article							HUMAN CALF MUSCLES; POSTURAL SWAY; SHORT-RANGE; BALANCE; DYNAMICS; STANCE; JOINT	When standing, intrinsic ankle stiffness is smaller when measured using large perturbations, when sway size is large, and when background torque is low. However, there is a large variation in individual intrinsic ankle stiffness. Here we determine if individual variation has consequences for postural control. We examined the relationship between ankle stiffness, ankle torque and body sway across different individuals. Ankle stiffness was estimated in 19 standing participants by measuring torque responses to small, brief perturbations. Perturbation sizes of 0.2 & 0.9 degrees (both lasting 140 ms) measured short- and long-range stiffness respectively, while participants either stood quietly on a fixed platform or were imperceptibly tilted to reduce stability (0.1 Hz sinusoid; 0.2 & 0.4 deg). The spontaneous body sway component (natural random relatively rapid postural adjustments) and background ankle torque were averaged from sections immediately before perturbations. The results show that, first, intrinsic ankle stiffness is positively associated with ankle torque, and that this relationship is stronger for long-range stiffness. Second, intrinsic ankle stiffness is negatively associated with body sway, but, in contrast to the relationship with torque, this relationship is stronger for short-range stiffness. We conclude that high short-range intrinsic ankle stiffness is associated with reduced spontaneous sway, although the causal relationship between these two parameters is unknown. These results suggest that, in normal quiet standing where sway is very small, the most important determinant of intrinsic ankle stiffness may be stillness. In less stable conditions, intrinsic ankle stiffness may be more dependent on ankle torque.	[Sakanaka, Tania E.] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Sakanaka, Tania E.; Lakie, Martin; Reynolds, Raymond F.] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	Universidade Estadual de Campinas; University of Birmingham	Reynolds, RF (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	R.F.Reynolds@bham.ac.uk	; Sakanaka, Tania Emi/E-1587-2017	Reynolds, Raymond/0000-0002-5031-3473; Sakanaka, Tania Emi/0000-0003-3518-0198	FAPESP (Sao Paulo Research Foundation, Brazil) [2018/16103-7]; University of Birmingham Scholarship for Research Excellence, Brazil - University of Birmingham, UK; BBSRC (Biotechnology and Biological Sciences Research Council, UK) [BB/L02103X/1]; BBSRC [BB/L02103X/1] Funding Source: UKRI	FAPESP (Sao Paulo Research Foundation, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Birmingham Scholarship for Research Excellence, Brazil - University of Birmingham, UK; BBSRC (Biotechnology and Biological Sciences Research Council, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by FAPESP (Sao Paulo Research Foundation, Brazil, http://www.fapesp.br/) grant 2018/16103-7 (TES), the University of Birmingham Scholarship for Research Excellence, Brazil - University of Birmingham, UK (TES), and BBSRC (Biotechnology and Biological Sciences Research Council, UK, https://bbsrc.ukri.org/) grant BB/L02103X/1 (RFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamova D, 2008, PHYSIOL RES, V57, P957, DOI 10.33549/physiolres.931238; Agarwal G. C., 1977, Transactions of the ASME. Series K, Journal of Biomechanical Engineering, V99, P166, DOI 10.1115/1.3426285; Amiri P, 2019, J BIOMECH, V85, P50, DOI 10.1016/j.jbiomech.2019.01.009; Aramaki Y, 2001, EXP BRAIN RES, V136, P463, DOI 10.1007/s002210000603; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; DIENER HC, 1982, EXP BRAIN RES, V45, P126; DIENER HC, 1984, ELECTROEN CLIN NEURO, V57, P134, DOI 10.1016/0013-4694(84)90172-X; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; FITZPATRICK RC, 1992, J PHYSIOL-LONDON, V454, P533, DOI 10.1113/jphysiol.1992.sp019278; Gatev P, 1999, J PHYSIOL-LONDON, V514, P915, DOI 10.1111/j.1469-7793.1999.915ad.x; GURFINKEL V S, 1972, BIOPHYSICS (ENGL TRANSL BIOFIZ), V17, P496; GURFINKEL VS, 1994, PHYSIOL RES, V43, P371; GURFINKEL VS, 1995, NEUROSCIENCE, V68, P229, DOI 10.1016/0306-4522(95)00136-7; Hellebrandt FA, 1939, AM J PHYS ANTHROPOL, V24, P347, DOI 10.1002/ajpa.1330240318; HUNTER IW, 1982, J BIOMECH, V15, P747, DOI 10.1016/0021-9290(82)90089-6; KEARNEY RE, 1982, J BIOMECH, V15, P753, DOI 10.1016/0021-9290(82)90090-2; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Lakie M, 2019, J APPL PHYSIOL, V126, P1790, DOI 10.1152/japplphysiol.00788.2018; Loram ID, 2007, J PHYSIOL-LONDON, V584, P677, DOI 10.1113/jphysiol.2007.140053; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; MCCOLLUM G, 1989, J MOTOR BEHAV, V21, P225; Morasso PG, 1999, J NEUROPHYSIOL, V82, P1622, DOI 10.1152/jn.1999.82.3.1622; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Nomura T, 2013, MATH BIOSCI, V245, P86, DOI 10.1016/j.mbs.2013.02.002; Ozkaya N., 1999, FUNDAMENTALS BIOMECH, P195, DOI DOI 10.1007/978-1-4757-3067-8_9; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Sakanaka TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193850; Sakanaka TE, 2016, J PHYSIOL-LONDON, V594, P781, DOI 10.1113/JP271137; Sakanaka TE, 2016, CAUSES VARIATION INT; Schmid M, 2004, HUM MOVEMENT SCI, V23, P105, DOI 10.1016/j.humov.2004.06.001; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; SMITH JW, 1957, J ANAT, V91, P545; Vlutters M, 2015, J BIOMECH, V48, P1258, DOI 10.1016/j.jbiomech.2015.03.004; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Zhang HB, 2015, J ELECTROMYOGR KINES, V25, P937, DOI 10.1016/j.jelekin.2015.10.011	45	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244993	10.1371/journal.pone.0244993	http://dx.doi.org/10.1371/journal.pone.0244993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481823	Green Published, gold			2022-12-26	WOS:000612929300013
J	Susic, AP; Klemenc-Ketis, Z; Blagus, R; Gorenjec, NR				Susic, Antonija Poplas; Klemenc-Ketis, Zalika; Blagus, Rok; Gorenjec, Nina Ruzic			Factors that determine dependence in daily activities: A cross-sectional study of family practice non-attenders from Slovenia	PLOS ONE			English	Article							UNITED-STATES; OLDER-ADULTS; HEALTH-CARE; DISABILITY; RISK; COMMUNITY; PREVALENCE; VALIDITY; MALNUTRITION; RELIABILITY	Background Independence in daily activities is defined as the ability to perform functions related to daily living, i.e. the capacity of living independently in the community with little or no help from others. Objective We focused on non-attenders as a subgroup of patients whose health status is not well known to family practice teams. Our goal was to estimate the prevalence of dependence and its severity level in the daily activities of patients, and to determine the factors that are associated with the occurrence of dependence. Design Cross-sectional observational study. Settings and participants Data was obtained in family medicine settings. Participants in the study were adults living in the community (aged 18 or over) who had not visited their chosen family physician in the last 5 years (non-attenders) and who were able to participate in the study. Through the electronic system, we identified 2,025 non-attenders. Community nurses collected data in the participants' homes. The outcome measure was dependence in daily activities, assessed through eight items: personal hygiene; eating and drinking; mobility; dressing and undressing; urination and defecation; continence; avoiding hazards in the environment; and communication. Results The final sample consisted of 1,999 patients (98.7% response rate). The mean age was 59.9 (range 20 to 99). Dependence in daily activities was determined in 466 or 23.3% (95% CI: [21.5, 25.2]) of the patients. Older patients (over 60 years), with at least one chronic disease, increased risk of falling, moderate feelings of loneliness and a lower self-assessment of health were statistically significantly more likely to be dependent in their daily activities, according to our multivariate model. Conclusions A considerable proportion of family practice non-attenders were found to be dependent in daily activities, though at a low level. We identified several factors associated with this dependence. This could help to identify people at risk of being dependent in daily activities in the general adult population, and enable specific interventions that would improve their health status.	[Susic, Antonija Poplas; Klemenc-Ketis, Zalika; Gorenjec, Nina Ruzic] Ljubljana Community Hlth Ctr, Ljubljana, Slovenia; [Susic, Antonija Poplas; Klemenc-Ketis, Zalika] Univ Ljubljana, Fac Med, Dept Family Med, Ljubljana, Slovenia; [Klemenc-Ketis, Zalika] Univ Maribor, Fac Med, Dept Family Med, Maribor, Slovenia; [Blagus, Rok; Gorenjec, Nina Ruzic] Univ Ljubljana, Fac Med, Inst Biostat & Med Informat, Ljubljana, Slovenia	University of Ljubljana; University of Maribor; University of Ljubljana	Klemenc-Ketis, Z (corresponding author), Ljubljana Community Hlth Ctr, Ljubljana, Slovenia.; Klemenc-Ketis, Z (corresponding author), Univ Ljubljana, Fac Med, Dept Family Med, Ljubljana, Slovenia.; Klemenc-Ketis, Z (corresponding author), Univ Maribor, Fac Med, Dept Family Med, Maribor, Slovenia.	zalika.klemenc@um.si		Klemenc-Ketis, Zalika/0000-0002-0270-1754; Ruzic Gorenjec, Nina/0000-0001-8505-1437; Poplas Susic, Antonija/0000-0002-4328-3333	Norway Grants; Government Office for Development and European Cohesian Policy in Slovenia [4300-367/2014]; Slovenian Research Agency (Methodology for Data Analysis in Medical Sciences) [P3-0154]; Slovenian Research Agency [P3-0339]	Norway Grants; Government Office for Development and European Cohesian Policy in Slovenia; Slovenian Research Agency (Methodology for Data Analysis in Medical Sciences); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by the Norway Grants and the Government Office for Development and European Cohesian Policy in Slovenia (No. 4300-367/2014). RB was partly supported by the Slovenian Research Agency (Methodology for Data Analysis in Medical Sciences, P3-0154). ZKK was partly supported by the Slovenian Research Agency (Research in the field of Public Health, P3-0339).	[Anonymous], 2002, ACTIVE AGEING POLICY; Beach SR, 2017, J AM GERIATR SOC, V65, P560, DOI 10.1111/jgs.14547; Buchman AS, 2014, ARCH GERONTOL GERIAT, V58, P74, DOI 10.1016/j.archger.2013.08.001; Buchman AS, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-77; Cinarli T, 2017, NURS RES, V66, P330, DOI 10.1097/NNR.0000000000000227; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Daniels R, 2010, EUR J AGEING, V7, P37, DOI 10.1007/s10433-010-0141-9; Dryden R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-723; Durovich CJ, 2018, POPUL HEALTH MANAG, V21, P13, DOI 10.1089/pop.2017.0015; Feinglass J, 2018, POPUL HEALTH MANAG, V21, P96, DOI 10.1089/pop.2017.0026; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gierach Marcin, 2014, ISRN Endocrinol, V2014, P514589, DOI 10.1155/2014/514589; Graf Carla, 2009, Medsurg Nurs, V18, P315; Hardy S. E., 2014, CURRENT DIAGNOSIS TR, P3; Holmgren M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-381; Holst KK, 2014, GOF PACKAGE MODEL DI; Klemenc-Ketis Z, 2020, NUTRITION, V72, DOI 10.1016/j.nut.2019.110657; Klemenc-Ketis Z, 2019, J COMMUN HEALTH NURS, V36, P139, DOI 10.1080/07370016.2019.1630996; Laan W, 2013, MATURITAS, V75, P276, DOI 10.1016/j.maturitas.2013.04.005; Leikauf J, 2009, J AM GERIATR SOC, V57, P1219, DOI 10.1111/j.1532-5415.2009.02313.x; Li XJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019901; Litwin H, 2009, EUR J AGEING, V6, P167, DOI 10.1007/s10433-009-0126-8; Mlinac ME, 2016, ARCH CLIN NEUROPSYCH, V31, P506, DOI 10.1093/arclin/acw049; Morse J. M., 1997, PREVENTING PATIENT F; Nagarkar A, 2017, ARCH GERONTOL GERIAT, V69, P151, DOI 10.1016/j.archger.2016.11.015; Okoro CA, 2018, MMWR-MORBID MORTAL W, V67, P882, DOI 10.15585/mmwr.mm6732a3; Perenboom RJM, 2012, DISABIL REHABIL, V34, P1556, DOI 10.3109/09638288.2011.647233; Pharr Jennifer R, 2012, Glob J Health Sci, V4, P99, DOI 10.5539/gjhs.v4n6p99; R Core Team, 2021, R LANG ENV STAT; Ramadass S, 2018, J Family Med Prim Care, V7, P1177, DOI 10.4103/jfmpc.jfmpc_10_18; REBOUCAS M, 2017, REV SAUDE PUBL, V51, P65220, DOI DOI 10.11606/51518-8787.2017051006959; Reboucas M, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051006959, 10.11606/s1518-8787.2017051006959]; Rubio Encarnacion, 2009, BMC Geriatr, V9, P26, DOI 10.1186/1471-2318-9-26; Sekaran NK, 2013, J AM GERIATR SOC, V61, P96, DOI 10.1111/jgs.12071; SMILKSTEIN G, 1982, J FAM PRACTICE, V15, P303; Stevens AC, 2016, MMWR-MORBID MORTAL W, V65, P1021, DOI 10.15585/mmwr.mm6538a1; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; TUSEKBUNC K, 2018, ACTA MEDICOBIOTECHNI, V11, P45; Van der Heyden J, 2014, J PUBLIC HEALTH-HEID, V22, P371, DOI 10.1007/s10389-014-0624-9; van der Vorst A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165127; Wang YF, 2005, AM J CLIN NUTR, V81, P555; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245465	10.1371/journal.pone.0245465	http://dx.doi.org/10.1371/journal.pone.0245465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481824	gold, Green Published			2022-12-26	WOS:000612929300164
J	Zurlo, E; Kumar, P; Meisl, G; Dear, AJ; Mondal, D; Claessens, MMAE; Knowles, TPJ; Huber, M				Zurlo, Enrico; Kumar, Pravin; Meisl, Georg; Dear, Alexander J.; Mondal, Dipro; Claessens, Mireille M. A. E.; Knowles, Tuomas P. J.; Huber, Martina			In situ kinetic measurements of alpha-synuclein aggregation reveal large population of short-lived oligomers	PLOS ONE			English	Article							BINDING-AFFINITY; AMYLOID FIBRILS; NUCLEATION; DIVERSITY; TOXICITY; PEPTIDE	Knowledge of the mechanisms of assembly of amyloid proteins into aggregates is of central importance in building an understanding of neurodegenerative disease. Given that oligomeric intermediates formed during the aggregation reaction are believed to be the major toxic species, methods to track such intermediates are clearly needed. Here we present a method, electron paramagnetic resonance (EPR), by which the amount of intermediates can be measured over the course of the aggregation, directly in the reacting solution, without the need for separation. We use this approach to investigate the aggregation of alpha-synuclein (alpha S), a synaptic protein implicated in Parkinson's disease and find a large population of oligomeric species. Our results show that these are primary oligomers, formed directly from monomeric species, rather than oligomers formed by secondary nucleation processes, and that they are short-lived, the majority of them dissociates rather than converts to fibrils. As demonstrated here, EPR offers the means to detect such short-lived intermediate species directly in situ. As it relies only on the change in size of the detected species, it will be applicable to a wide range of self-assembling systems, making accessible the kinetics of intermediates and thus allowing the determination of their rates of formation and conversion, key processes in the self-assembly reaction.	[Zurlo, Enrico; Kumar, Pravin; Mondal, Dipro; Huber, Martina] Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands; [Meisl, Georg; Dear, Alexander J.; Knowles, Tuomas P. J.] Univ Cambridge, Ctr Misfolding Dis, Dept Chem, Lensfield Rd, Cambridge, England; [Claessens, Mireille M. A. E.] Univ Twente, Dept Sci & Technol, Nanobiophys Grp, Enschede, Netherlands; [Knowles, Tuomas P. J.] Univ Cambridge, Cavendish Lab, Cambridge, England	Leiden University; Leiden University - Excl LUMC; University of Cambridge; University of Twente; University of Cambridge	Huber, M (corresponding author), Leiden Univ, Dept Phys, Huygens Kamerlingh Onnes Lab, Leiden, Netherlands.	huber@physics.leidenuniv.nl	Meisl, Georg/GLR-2659-2022; Knowles, Tuomas/C-6663-2009	Meisl, Georg/0000-0002-6562-7715; Knowles, Tuomas/0000-0002-7879-0140; Mondal, Dipro/0000-0002-4356-0011; Kumar, Pravin/0000-0002-7966-578X	Netherlands Organisation for Scientific Research (NWO), research program of the Foundation for Fundamental Research on Matter (FOM), NWO [700.58.014, 10SMPA04]; Lindemann Trust Fellowship, English-Speaking Union	Netherlands Organisation for Scientific Research (NWO), research program of the Foundation for Fundamental Research on Matter (FOM), NWO; Lindemann Trust Fellowship, English-Speaking Union	M.H. Netherlands Organisation for Scientific Research (NWO), grant 700.58.014 and grant number 10SMPA04 in the context of the program entitled "A Single Molecule View on Protein Aggregation'', part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of NWO; Lindemann Trust Fellowship, English-Speaking Union (to A.D.).	Afitska K, 2019, BBA-PROTEINS PROTEOM, V1867, P701, DOI 10.1016/j.bbapap.2019.05.003; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Braun AR, 2014, J AM CHEM SOC, V136, P9962, DOI 10.1021/ja5016958; Braun AR, 2012, J AM CHEM SOC, V134, P2613, DOI 10.1021/ja208316h; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cascella R, 2019, ACS CHEM BIOL, V14, P1352, DOI 10.1021/acschembio.9b00312; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dear AJ, 2020, CHEM SCI, V11, P6236, DOI 10.1039/c9sc06501f; Dear AJ, 2020, P NATL ACAD SCI USA, V117, P12087, DOI 10.1073/pnas.1922267117; Drescher M, 2008, CHEMBIOCHEM, V9, P2411, DOI 10.1002/cbic.200800238; Drescher M, 2012, CHEMBIOCHEM, V13, P761, DOI 10.1002/cbic.201200059; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Fakhree MAA, 2019, BIOMACROMOLECULES, V20, P1217, DOI 10.1021/acs.biomac.8b01606; Fakhree MAA, 2018, J PHYS CHEM LETT, V9, P1249, DOI 10.1021/acs.jpclett.8b00092; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; GASPAR R, 2017, Q REV BIOPHYS, V50, DOI DOI 10.1017/80033583516000172; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Ilie IM, 2019, CHEM REV, V119, P6956, DOI 10.1021/acs.chemrev.8b00731; Iljina M, 2018, ACS NANO, V12, P10855, DOI 10.1021/acsnano.8b03575; Iljina M, 2016, P NATL ACAD SCI USA, V113, pE1206, DOI 10.1073/pnas.1524128113; Iyer A, 2019, BBA-PROTEINS PROTEOM, V1867, P468, DOI 10.1016/j.bbapap.2018.10.006; Jao CC, 2004, P NATL ACAD SCI USA, V101, P8331, DOI 10.1073/pnas.0400553101; Ke PC, 2017, CHEM SOC REV, V46, P6492, DOI 10.1039/c7cs00372b; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Michaels TCT, 2020, NAT CHEM, V12, P445, DOI 10.1038/s41557-020-0452-1; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Perez-Pi I, ASYN CONA NOVEL BEAD; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reyes JF, 2019, ACTA NEUROPATHOL, V138, P23, DOI 10.1007/s00401-019-02007-x; Shabestari MH, 2016, J BIOL PHYS, V42, P299, DOI 10.1007/s10867-016-9408-5; Shvadchak V V, 2015, FIBRIL BREAKING ACCE; Snead David, 2014, Exp Neurobiol, V23, P292, DOI 10.5607/en.2014.23.4.292; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; van Diggelen F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213663; van Diggelen F, 2017, ISR J CHEM, V57, P699, DOI 10.1002/ijch.201600116; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Villar-Pique A, 2016, J NEUROCHEM, V139, P240, DOI 10.1111/jnc.13249; Xu M, 2019, ACS CHEM NEUROSCI, DOI [10.1021/anschemneuro.9b00092, DOI 10.1021/ANSCHEMNEURO.9B00092]	45	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245548	10.1371/journal.pone.0245548	http://dx.doi.org/10.1371/journal.pone.0245548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481908	gold, Green Published			2022-12-26	WOS:000612929300110
J	Gagnon, M; Savard, M; Jacques, JF; Bkaily, G; Geha, S; Roucou, X; Gobeil, F				Gagnon, Maxime; Savard, Martin; Jacques, Jean-Francois; Bkaily, Ghassan; Geha, Sameh; Roucou, Xavier; Gobeil, Fernand			Potentiation of B2 receptor signaling by AltB2R, a newly identified alternative protein encoded in the human bradykinin B2 receptor gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KININ RECEPTORS; READING FRAMES; CANCER; CLASSIFICATION; AGONISTS; TARGETS	Recent functional and proteomic studies in eukaryotes (www.openprot.org) predict the translation of alternative open reading frames (AltORFs) in mature G-protein-coupled receptor (GPCR) mRNAs, including that of bradykinin B2 receptor (B2R). Our main objective was to determine the implication of a newly discovered AltORF resulting protein, termed AltB2R, in the known signaling properties of B2R using complementary methodological approaches. When ectopically expressed in HeLa cells, AltB2R presented predominant punctate cytoplasmic/perinuclear distribution and apparent cointeraction with B2R at plasma and endosomal/vesicular membranes. The presence of AltB2R increases intracellular [Ca2+] and ERK1/2-MAPK activation (via phosphorylation) following B2R stimulation. Moreover, HEK293A cells expressing mutant B2R lacking concomitant expression of AltB2R displayed significantly decreased maximal responses in agonist-stimulated G alpha(q)-G alpha(i2/3)-protein coupling, IP3 generation, and ERK1/2-MAPK activation as compared with wild-type controls. Conversely, there was no difference in cell-surface density as well as ligand-binding properties of B2R and in efficiencies of cognate agonists at promoting B2R internalization and beta-arrestin 2 recruitment. Importantly, both AltB2R and B2R proteins were overexpressed in prostate and breast cancers, compared with their normal counterparts suggesting new associative roles of AltB2R in these diseases. Our study shows that BDKRB2 is a dual-coding gene and identifies AltB2R as a novel positive modulator of some B2R signaling pathways. More broadly, it also supports a new, unexpected alternative proteome for GPCRs, which opens new frontiers in fields of GPCR biology, diseases, and drug discovery.	[Gagnon, Maxime; Roucou, Xavier] Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada; [Gagnon, Maxime; Savard, Martin; Roucou, Xavier; Gobeil, Fernand] Univ Sherbrooke, Inst Pharmacol, Sherbrooke, PQ, Canada; [Savard, Martin; Jacques, Jean-Francois; Gobeil, Fernand] Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada; [Bkaily, Ghassan] Univ Sherbrooke, Dept Immunol & Cellular Biol, Sherbrooke, PQ, Canada; [Geha, Sameh] Ctr Hosp Univ Sherbrooke, Dept Pathol, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Dept Biochem, Sherbrooke, PQ, Canada.; Roucou, X; Gobeil, F (corresponding author), Univ Sherbrooke, Inst Pharmacol, Sherbrooke, PQ, Canada.; Gobeil, F (corresponding author), Univ Sherbrooke, Dept Pharmacol & Physiol, Sherbrooke, PQ, Canada.	Xavier.Roucou@USherbrooke.ca; Fernand.Gobeil@USherbrooke.ca		GEHA, Sameh/0000-0002-4851-9034	Canadian Institutes of Health Research [MOP-136962]; Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins; PROTEO, Quebec Network; Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins; PROTEO, Quebec Network; Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke	This work was supported by the Canadian Institutes of Health Research Grant MOP-136962 (to F. G. and X. R.) and the Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins (X. R.). M. G. is a former graduate scholarship recipient of the PROTEO, Quebec Network. G. B., S. G., X. R., and F. G. are members of the Fonds de Recherche du Quebec Sante (FRQS)-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke.	Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Akimoto C, 2013, BBA-GEN SUBJECTS, V1830, P2728, DOI 10.1016/j.bbagen.2012.12.010; Alla SA, 1996, J BIOL CHEM, V271, P1748, DOI 10.1074/jbc.271.3.1748; Anderson DM, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaj1460; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Autio KJ, 2008, FASEB J, V22, P569, DOI 10.1096/fj.07-8986; Bausch-Fluck D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121314; Belanger S, 2009, PEPTIDES, V30, P777, DOI 10.1016/j.peptides.2008.12.003; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; Bkaily G, 1997, MOL CELL BIOCHEM, V172, P171, DOI 10.1023/A:1006840228104; Bkaily G, 2017, METHODS MOL BIOL, V1527, P177, DOI 10.1007/978-1-4939-6625-7_14; Blaukat A, 2003, ANDROLOGIA, V35, P17, DOI 10.1046/j.1439-0272.2003.00533.x; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Brunet MA, 2019, NUCLEIC ACIDS RES, V47, pD403, DOI 10.1093/nar/gky936; Brunet MA, 2018, GENOME RES, V28, P609, DOI 10.1101/gr.230938.117; Cabrera-Quio LE, 2016, RNA BIOL, V13, P1051, DOI 10.1080/15476286.2016.1218589; Campbell DJ, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00257; Cardon T, 2020, ANAL CHEM, V92, P1122, DOI 10.1021/acs.analchem.9b04188; Chalick M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165031; Chu Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12816-z; Cote J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037485; Cote J, 2009, PEPTIDES, V30, P788, DOI 10.1016/j.peptides.2008.12.018; Couso JP, 2017, NAT REV MOL CELL BIO, V18, P575, DOI 10.1038/nrm.2017.58; Couture R, 2014, CURR VASC PHARMACOL, V12, P223, DOI 10.2174/1570161112666140226121627; D'Lima NG, 2017, NAT CHEM BIOL, V13, P174, DOI [10.1038/NCHEMBIO.2249, 10.1038/nchembio.2249]; da Costa PLN, 2014, CANCER LETT, V345, P27, DOI 10.1016/j.canlet.2013.12.009; Delcourt V, 2017, EBIOMEDICINE, V21, P55, DOI 10.1016/j.ebiom.2017.06.001; Dubuc Celena, 2018, Oncotarget, V9, P9885, DOI 10.18632/oncotarget.24009; Figueroa CD, 2012, EXPERT OPIN THER TAR, V16, P299, DOI 10.1517/14728222.2012.662957; Furuno M, 2003, GENOME RES, V13, P1478, DOI 10.1101/gr.1060303; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hellens RP, 2016, TRENDS PLANT SCI, V21, P317, DOI 10.1016/j.tplants.2015.11.005; Khoury E, 2014, J BIOL CHEM, V289, P23302, DOI 10.1074/jbc.M114.568147; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Lee CF, 2014, J BIOL CHEM, V289, P1257, DOI 10.1074/jbc.M113.509059; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leschner J, 2013, J PHARMACOL EXP THER, V344, P85, DOI 10.1124/jpet.112.199190; Liu J, 2014, AM J PHYSIOL-REG I, V306, pR619, DOI 10.1152/ajpregu.00562.2013; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nesvizhskii AI, 2014, NAT METHODS, V11, P1114, DOI [10.1038/NMETH.3144, 10.1038/nmeth.3144]; Olexiouk V, 2018, NUCLEIC ACIDS RES, V46, pD497, DOI 10.1093/nar/gkx1130; Orr MW, 2020, NUCLEIC ACIDS RES, V48, P1029, DOI 10.1093/nar/gkz734; QUELLE DE, 1995, CELL, V83, P993; Rathore A, 2018, BIOCHEMISTRY-US, V57, P5564, DOI 10.1021/acs.biochem.8b00726; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; Regoli D, 2012, PHARMACOL THERAPEUT, V135, P94, DOI 10.1016/j.pharmthera.2012.04.002; Samandi S, 2017, ELIFE, V6, DOI [10.7754/eLife.27860, 10.7554/eLife.27860]; Savard M, 2016, BIOL CHEM, V397, P365, DOI 10.1515/hsz-2015-0246; Shenoy SK, 2005, NAT CELL BIOL, V7, P1159, DOI 10.1038/ncb1205-1159; Vanderperre B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070698; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Wang GJ, 2017, J CELL BIOCHEM, V118, P4444, DOI 10.1002/jcb.26100; Yeasmin F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00144; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	59	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100329	10.1016/j.jbc.2021.100329	http://dx.doi.org/10.1016/j.jbc.2021.100329			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33497625	Green Published, gold			2022-12-26	WOS:000672866400303
J	Hocky, GM; Sindelar, CV; Cao, WX; Voth, GA; De La Cruz, EM				Hocky, Glen M.; Sindelar, Charles, V; Cao, Wenxiang; Voth, Gregory A.; De La Cruz, Enrique M.			Structural basis of fast- and slow-severing actin-cofilactin boundaries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COFILIN-LINKED CHANGES; F-ACTIN; FILAMENTS; DYNAMICS; FLEXIBILITY; TWIST; DEPOLYMERIZATION; INCREASES; MECHANISM; KINETICS	Members of the ADF/cofilin family of regulatory proteins bind actin filaments cooperatively, locally change actin subunit conformation and orientation, and sever filaments at "boundaries" between bare and cofilin-occupied segments. A cluster of bound cofilin introduces two distinct classes of boundaries due to the intrinsic polarity of actin filaments, one at the "pointed" end side and the other at the "barbed" end-side of the cluster; severing occurs more readily at the pointed end side of the cluster ("fast-severing" boundary) than the barbed end side ("slow-severing" boundary). A recent electron-cryomicroscopy (cryo-EM) model of the slow-severing boundary revealed structural "defects" at the interface that potentially contribute to severing. However, the structure of the fast-severing boundary remains uncertain. Here, we use extensive molecular dynamics simulations to produce atomic resolution models of both severing boundaries. Our equilibrated simulation model of the slow-severing boundary is consistent with the cryo-EM structural model. Simulations indicate that actin subunits at both boundaries adopt structures intermediate between those of bare and cofilin-bound actin subunits. These "intermediate" states have compromised intersubunit contacts, but those at the slow-severing boundary are stabilized by cofilin bridging interactions, accounting for its lower fragmentation probability. Simulations where cofilin proteins are removed from cofilactin filaments favor a mechanism in which a cluster of two contiguously bound cofilins is needed to fully stabilize the cofilactin conformation, promote cooperative binding interactions, and accelerate filament severing. Together, these studies provide a molecular-scale foundation for developing coarse-grained and theoretical descriptions of cofilin-mediated actin filament severing.	[Hocky, Glen M.] NYU, Dept Chem, New York, NY 10003 USA; [Sindelar, Charles, V; Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA; [Voth, Gregory A.] Univ Chicago, Dept Chem, Chicago Ctr Theoret Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Voth, Gregory A.] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA	New York University; Yale University; University of Chicago; University of Chicago	Hocky, GM (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.; De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06511 USA.	hockyg@nyu.edu; enrique.delacruz@yale.edu	Hocky, Glen M/E-9412-2012; Hocky, Glen M/AAD-7662-2019	Hocky, Glen M/0000-0002-5637-0698; De La Cruz, Enrique/0000-0003-4798-2892; Sindelar, Charles/0000-0002-6646-7776	DOD ARO MURI [W911NF1410403]; NIH [R01-GM-110530, R35-GM136656, R35-GM138312]	DOD ARO MURI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by DOD ARO MURI W911NF1410403, on which G. A. V. and E. M. D. L. C. are coinvestigators, and by NIH R35-GM136656 (awarded to E. M. D. L. C.). Support for G. M. H. was provided by NIH R35-GM138312. C. V. S. was supported by NIH R01-GM-110530.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bibeau JP, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166833; Bobkov AA, 2006, J MOL BIOL, V356, P325, DOI 10.1016/j.jmb.2005.11.072; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Chou SZ, 2019, P NATL ACAD SCI USA, V116, P4265, DOI 10.1073/pnas.1807028115; De La Cruz EM, 2005, J MOL BIOL, V346, P557, DOI 10.1016/j.jmb.2004.11.065; De La Cruz EM, 2015, J BIOL CHEM, V290, P17137, DOI 10.1074/jbc.R115.636472; De la Cruz EM, 2015, BIOPHYS J, V108, P2270, DOI 10.1016/j.bpj.2015.03.058; De La Cruz EM, 2010, BIOPHYS J, V98, P1893, DOI 10.1016/j.bpj.2010.01.023; De La Cruz Enrique M, 2009, Biophys Rev, V1, P51, DOI 10.1007/s12551-009-0008-5; Dedova IV, 2004, BIOPHYS CHEM, V110, P119, DOI 10.1016/j.bpc.2004.01.009; Elam WA, 2017, J BIOL CHEM, V292, P19565, DOI 10.1074/jbc.M117.808378; Elam WA, 2013, FEBS LETT, V587, P1215, DOI 10.1016/j.febslet.2013.01.062; Fan J, 2013, J MOL BIOL, V425, P1225, DOI 10.1016/j.jmb.2013.01.020; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Hocky GM, 2016, J PHYS CHEM B, V120, P4558, DOI 10.1021/acs.jpcb.6b02741; Huehn A, 2018, J BIOL CHEM, V293, P5377, DOI 10.1074/jbc.AC118.001843; Huehn AR, 2020, P NATL ACAD SCI USA, V117, P1478, DOI 10.1073/pnas.1915987117; Huehn AR, 2018, BIOPHYS J, V114, p145A, DOI 10.1016/j.bpj.2017.11.812; Jermyn AS, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.032409; Kang HR, 2014, P NATL ACAD SCI USA, V111, P17821, DOI 10.1073/pnas.1413397111; Lorenzo AMM, 2020, SOFT MATTER, V16, P2017, DOI 10.1039/c9sm01637f; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Pavlov D, 2007, J MOL BIOL, V365, P1350, DOI 10.1016/j.jmb.2006.10.102; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaendtner J, 2010, P NATL ACAD SCI USA, V107, P7299, DOI 10.1073/pnas.0911675107; Pollard T.D., 2016, CELL BIOL; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Saunders MG, 2014, BIOPHYS J, V106, P1710, DOI 10.1016/j.bpj.2014.03.012; Saunders MG, 2012, STRUCTURE, V20, P641, DOI 10.1016/j.str.2012.02.008; Schramm AC, 2019, BIOPHYS J, V117, P453, DOI 10.1016/j.bpj.2019.06.018; Schramm AC, 2017, BIOPHYS J, V112, P2624, DOI 10.1016/j.bpj.2017.05.016; Suarez C, 2011, CURR BIOL, V21, P862, DOI 10.1016/j.cub.2011.03.064; Tanaka K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04290-w; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wioland H, 2017, CURR BIOL, V27, P1956, DOI 10.1016/j.cub.2017.05.048; Wong DY, 2011, J MOL BIOL, V413, P97, DOI 10.1016/j.jmb.2011.08.039	44	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100337	10.1016/j.jbc.2021.100337	http://dx.doi.org/10.1016/j.jbc.2021.100337			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508320	Green Published, gold			2022-12-26	WOS:000672866400311
J	Minnow, YVT; Harijan, RK; Schramm, VL				Minnow, Yacoba V. T.; Harijan, Rajesh K.; Schramm, Vern L.			A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSITION-STATE ANALOG; DRUG-RESISTANCE; MALARIA; INHIBITORS; PIPERAQUINE; MUTATIONS; PATHWAYS; TARGETS; SALVAGE; BIOLOGY	Plasmodium falciparum purine nucleoside phosphorylase (PfPNP) catalyzes an essential step in purine salvage for parasite growth. 4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-G (DADMe-ImmG) is a transition state analog inhibitor of this enzyme, and P. falciparum infections in an Aotus primate malaria model can be cleared by oral administration of DADMe-ImmG. P. falciparum cultured under increasing DADMe-ImmG drug pressure exhibited PfPNP gene amplification, increased protein expression, and point mutations involved in DADMe-ImmG binding. However, the weak catalytic properties of the M183L resistance mutation (similar to 17,000-fold decrease in catalytic efficiency) are inconsistent with the essential function of PfPNP. We hypothesized that M183L subunits may form mixed oligomers of native and mutant PfPNP monomers to give hybrid hexameric enzymes with properties conferring DADMe-ImmG resistance. To test this hypothesis, we designed PfPNP constructs that covalently linked native and the catalytically weak M183L mutant subunits. Engineered hybrid PfPNP yielded trimer-of-dimer hexameric protein with alternating native and catalytically weak M183L subunits. This hybrid PfPNP gave near-native K-m values for substrate, but the affinity for DADMe-ImmG and catalytic efficiency were both reduced approximately ninefold relative to a similar construct of native subunits. Contact between the relatively inactive M183L and native subunits is responsible for altered properties of the hybrid protein. Thus, gene amplification of PfPNP provides adequate catalytic activity while resistance to DADMe-ImmGoccurs in the hybrid oligomer to promote parasite survival. Coupled with the slow development of drug resistance, this resistance mechanism highlights the potential for DADMe-ImmG use in antimalarial combination therapies.	[Minnow, Yacoba V. T.; Harijan, Rajesh K.; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.	vern.schramm@einsteinmed.org	Harijan, Rajesh K./AAY-3277-2021		NIH [T32 AI070117, AI127807, GM041916]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH research grants (AI127807 and GM041916) and NIH training grant (T32 AI070117) for geographic medicine and emerging infectious disease. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adam I, 2012, AM J TROP MED HYG, V87, P35, DOI 10.4269/ajtmh.2012.11-0410; Bayih AG, 2016, AM J TROP MED HYG, V94, P132, DOI 10.4269/ajtmh.15-0477; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Cassera MB, 2011, CURR TOP MED CHEM, V11, P2103; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Chaudhary K, 2006, J BIOL CHEM, V281, P25652, DOI 10.1074/jbc.M602624200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cowell AN, 2018, SCIENCE, V359, P191, DOI 10.1126/science.aan4472; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Ducati RG, 2018, P NATL ACAD SCI USA, V115, P2114, DOI 10.1073/pnas.1525670115; Ducati RG, 2013, FUTURE MED CHEM, V5, P1341, DOI 10.4155/fmc.13.51; Dziekan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3174; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/S1473-3099(17)30048-8, 10.1016/s1473-3099(17)30048-8]; Jagannathan P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002606; Kakuru A, 2016, NEW ENGL J MED, V374, P928, DOI 10.1056/NEJMoa1509150; Khammanee T, 2019, KOREAN J PARASITOL, V57, P369, DOI 10.3347/kjp.2019.57.4.369; Kicska GA, 2002, J BIOL CHEM, V277, P3226, DOI 10.1074/jbc.M105906200; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Li CM, 1999, NAT STRUCT BIOL, V6, P582, DOI 10.1038/9367; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Madrid DC, 2008, J BIOL CHEM, V283, P35899, DOI 10.1074/jbc.M807218200; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Preechapornkul P, 2009, ANTIMICROB AGENTS CH, V53, P1509, DOI 10.1128/AAC.00241-08; Schramm VL, 2018, CHEM REV, V118, P11194, DOI 10.1021/acs.chemrev.8b00369; Schramm VL, 2015, ACCOUNTS CHEM RES, V48, P1032, DOI 10.1021/acs.accounts.5b00002; Schramm VL, 2013, ACS CHEM BIOL, V8, P71, DOI 10.1021/cb300631k; Shi WX, 2004, J BIOL CHEM, V279, P18103, DOI 10.1074/jbc.C400068200; Stokes BH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007722; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI 10.1016/j.pt.2016.05.010; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; van der Pluijm RW, 2020, LANCET, V395, P1345, DOI 10.1016/S0140-6736(20)30552-3; Wang SZ, 2014, BIOCHEMISTRY-US, V53, P1527, DOI 10.1021/bi401589n; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yagnik K, 2019, CASE REP INFECT DIS, V2019, DOI 10.1155/2019/2630825	40	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100342	10.1016/j.jbc.2021.100342	http://dx.doi.org/10.1016/j.jbc.2021.100342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524395	gold, Green Published			2022-12-26	WOS:000672866400316
J	Wang, T; Cook, I; Leyh, TS				Wang, Ting; Cook, Ian; Leyh, Thomas S.			The molecular basis of OH-PCB estrogen receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFURYL-TRANSFER; POLYCHLORINATED-BIPHENYLS; GENETIC ALGORITHM; SULFOTRANSFERASE; SULFATION; LIGAND; PARALLEL; GROMACS; SITE; NMR	Polychlorinated bisphenols (PCBs) continue to contaminate food chains globally where they concentrate in tissues and disrupt the endocrine systems of species throughout the ecosphere. Hydroxylated PCBs (OH-PCBs) are major PCB metabolites and high-affinity inhibitors of human estrogen sulfotransferase (SULT1E1), which sulfonates estrogens and thus prevents them from binding to and activating their receptors. OH-PCB inhibition of SULT1E1 is believed to contribute significantly to PCB-based endocrine disruption. Here, for the first time, the molecular basis of OH-PCB inhibition of SULT1E1 is revealed in a structure of SULT1E1 in complex with OH-PCB1 (4'-OH-2,6-dichlorobiphenol) and its substrates, estradiol (E2), and PAP (3'-phosphoadenosine-5-phosphosulfate). OH-PCB1 prevents catalysis by intercalating between E2 and catalytic residues and establishes a new E2-binding site whose E2 affinity and positioning are greater than and competitive with those of the reactive-binding pocket. Such complexes have not been observed previously and offer a novel template for the design of high-affinity inhibitors. Mutating residues in direct contact with OH-PCB weaken its affinity without compromising the enzyme's catalytic parameters. These OH-PCB resistant mutants were used in stable transfectant studies to demonstrate that OH-PCBs regulate estrogen receptors in cultured human cell lines by binding the OH-PCB binding pocket of SULT1E1.	[Wang, Ting; Cook, Ian; Leyh, Thomas S.] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA; [Wang, Ting] Boehringer Ingelheim GmbH & Co KG, Drug Metab & Pharmacokinet Dept, Danbury, CT USA	Yeshiva University; Boehringer Ingelheim	Leyh, TS (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY 10461 USA.	tom.leyh@einsteinmed.org			National Institutes of Health [GM121849, GM127144]; NIH [1S10OD016305]; Albert Einstein College of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine	Research supported by the National Institutes of Health Grants GM121849 (T. S. L.) and GM127144 (T. S. L.). The Bruker 600 MHz NMR instrument in the Einstein Structural NMR Resource was purchased using funds from NIH award 1S10OD016305 and is supported by the Albert Einstein College of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JAM, 2001, J BIOL CHEM, V276, P9755, DOI 10.1074/jbc.M010048200; [Anonymous], 2019, NATL SPREADSHEET FAC; Bai QM, 2011, ATHEROSCLEROSIS, V214, P350, DOI 10.1016/j.atherosclerosis.2010.11.021; Baker J, 2009, J COMPUT CHEM, V30, P317, DOI 10.1002/jcc.21052; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bertini I, 2001, METHOD ENZYMOL, V339, P314, DOI 10.1016/S0076-6879(01)39320-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cleland W W, 1979, Methods Enzymol, V63, P103; CLELAND WW, 1963, NATURE, V198, P463, DOI 10.1038/198463a0; Cook I, 2017, P NATL ACAD SCI USA, V114, pE5317, DOI 10.1073/pnas.1704500114; Cook I, 2016, P NATL ACAD SCI USA, V113, P14312, DOI 10.1073/pnas.1613913113; Cook I, 2016, CELL CHEM BIOL, V23, P579, DOI 10.1016/j.chembiol.2016.04.009; Cook I, 2015, BIOCHEMISTRY-US, V54, P6114, DOI 10.1021/acs.biochem.5b00406; Cook I, 2013, J BIOL CHEM, V288, P34494, DOI 10.1074/jbc.M113.510974; Cook I, 2013, BIOCHEMISTRY-US, V52, P415, DOI 10.1021/bi301492j; Cook IT, 2010, HORM MOL BIOL CLIN I, V1, P81, DOI 10.1515/HMBCI.2010.012; Darrah K, 2019, J BIOL CHEM, V294, P2293, DOI 10.1074/jbc.RA118.006511; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103; Falany JL, 2006, STEROIDS, V71, P880, DOI 10.1016/j.steroids.2006.05.018; Faroon O. M., 2003, CONCISE INT CHEM ASS, P12; FAYZ S, 1984, DRUG METAB DISPOS, V12, P323; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GIRVIN ME, 1995, BIOCHEMISTRY-US, V34, P1635, DOI 10.1021/bi00005a020; Gochin M, 2011, ACS CHEM BIOL, V6, P267, DOI 10.1021/cb100368d; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; Gosavi RA, 2013, ENVIRON HEALTH PERSP, V121, P1194, DOI 10.1289/ehp.1306902; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Ihunnah CA, 2014, MOL CELL BIOL, V34, P1682, DOI 10.1128/MCB.01147-13; Jackson EN, 2019, ENVIRON HEALTH PERSP, V127, DOI [10.1289/EHP4133, 10.1289/ehp4133]; JENSEN S, 1972, Ambio, V1, P123; John M, 2006, J AM CHEM SOC, V128, P12910, DOI 10.1021/ja063584z; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kester MHA, 2000, ENDOCRINOLOGY, V141, P1897, DOI 10.1210/en.141.5.1897; KORACH KS, 1988, MOL PHARMACOL, V33, P120; KOSEN PA, 1989, METHOD ENZYMOL, V177, P86; Kotov A, 1999, J STEROID BIOCHEM, V68, P137, DOI 10.1016/S0960-0760(99)00022-9; Koziara KB, 2014, J COMPUT AID MOL DES, V28, P221, DOI 10.1007/s10822-014-9713-7; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Lauby-Secretan B, 2013, LANCET ONCOL, V14, P287, DOI 10.1016/S1470-2045(13)70104-9; LITTLEFIELD BA, 1990, ENDOCRINOLOGY, V127, P2757, DOI 10.1210/endo-127-6-2757; Ma B, 2003, DRUG METAB DISPOS, V31, P1300, DOI 10.1124/dmd.31.11.1300; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MAN M, 1974, ANAL BIOCHEM, V57, P429, DOI 10.1016/0003-2697(74)90098-0; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mauvais-Jarvis F, 2012, DIABETES, V61, P1353, DOI 10.2337/db12-0357; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Otake Y, 2000, J STEROID BIOCHEM, V73, P265, DOI 10.1016/S0960-0760(00)00073-X; Parker CR, 1999, STEROIDS, V64, P640, DOI 10.1016/S0039-128X(99)00046-X; Pedersen LC, 2002, J BIOL CHEM, V277, P17928, DOI 10.1074/jbc.M111651200; Porta M, 2002, OCCUP ENVIRON MED, V59, P651, DOI 10.1136/oem.59.10.651; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quinete N, 2017, TOXICOL LETT, V276, P100, DOI 10.1016/j.toxlet.2017.05.025; Quintaneiro C, 2019, J ENVIRON SCI HEAL A, V54, P478, DOI 10.1080/10934529.2019.1568793; Satake A, 2008, KIDNEY INT, V73, P308, DOI 10.1038/sj.ki.5002690; SCHMITZ U, 1993, J MOL BIOL, V234, P373, DOI 10.1006/jmbi.1993.1593; Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014; Sechman A, 2016, TOXICOL LETT, V264, P29, DOI 10.1016/j.toxlet.2016.11.001; Selvan RS, 1996, ANN NY ACAD SCI, V797, P127, DOI 10.1111/j.1749-6632.1996.tb52955.x; Shen L, 2006, ENVIRON POLLUT, V144, P434, DOI 10.1016/j.envpol.2005.12.054; Silva MS, 2017, MOLECULES, V22, DOI 10.3390/molecules22020247; SOLOMON I, 1955, PHYS REV, V99, P559, DOI 10.1103/PhysRev.99.559; Stowers L, 2010, CURR OPIN NEUROBIOL, V20, P770, DOI 10.1016/j.conb.2010.08.015; Sun MH, 2010, BIOCHEMISTRY-US, V49, P4779, DOI 10.1021/bi902190r; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; Tangemann K, 1999, J EXP MED, V190, P935, DOI 10.1084/jem.190.7.935; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; VISSER TJ, 1994, CHEM-BIOL INTERACT, V92, P293, DOI 10.1016/0009-2797(94)90071-X; Wang T, 2017, J BIOL CHEM, V292, P20305, DOI 10.1074/jbc.M117.817387; Yu DZ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16122178; Zhang HJ, 2007, CLIN PHARMACOKINET, V46, P133, DOI 10.2165/00003088-200746020-00003; Zhang HP, 1998, J BIOL CHEM, V273, P10888, DOI 10.1074/jbc.273.18.10888	76	2	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100353	10.1016/j.jbc.2021.100353	http://dx.doi.org/10.1016/j.jbc.2021.100353			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524392	Green Published, gold			2022-12-26	WOS:000672866400327
J	Nichol, AA; Antierens, A				Nichol, Ariadne A.; Antierens, Annick			Ethics of emerging infectious disease outbreak responses: Using Ebola virus disease as a case study of limited resource allocation	PLOS ONE			English	Article							HEALTH; CHALLENGES	Emerging infectious diseases such as Ebola Virus Disease (EVD), Nipah Virus Encephalitis and Lassa fever pose significant epidemic threats. Responses to emerging infectious disease outbreaks frequently occur in resource-constrained regions and under high pressure to quickly contain the outbreak prior to potential spread. As seen in the 2020 EVD outbreaks in the Democratic Republic of Congo and the current COVID-19 pandemic, there is a continued need to evaluate and address the ethical challenges that arise in the high stakes environment of an emerging infectious disease outbreak response. The research presented here provides analysis of the ethical challenges with regard to allocation of limited resources, particularly experimental therapeutics, using the 2013-2016 EVD outbreak in West Africa as a case study. In-depth semi-structured interviews were conducted with senior healthcare personnel (n = 16) from international humanitarian aid organizations intimately engaged in the 2013-2016 EVD outbreak response in West Africa. Interviews were recorded in private setting, transcribed, and iteratively coded using grounded theory methodology. A majority of respondents indicated a clear propensity to adopt an ethical framework of guiding principles for international responses to emerging infectious disease outbreaks. Respondents agreed that prioritization of frontline workers' access to experimental therapeutics was warranted based on a principle of reciprocity. There was widespread acceptance of adaptive trial designs and greater trial transparency in providing access to experimental therapeutics. Many respondents also emphasized the importance of community engagement in limited resource allocation scheme design and culturally appropriate informed consent procedures. The study results inform a potential ethical framework of guiding principles based on the interview participants' insights to be adopted by international response organizations and their healthcare workers in the face of allocating limited resources such as experimental therapeutics in future emerging infectious disease outbreaks to ease the moral burden of individual healthcare providers.	[Nichol, Ariadne A.] Stanford Univ, Ctr Biomed Eth, Sch Med, Stanford, CA 94305 USA; [Antierens, Annick] Medecins Sans Frontieres, Brussels, Belgium	Stanford University; Doctors Without Borders	Nichol, AA (corresponding author), Stanford Univ, Ctr Biomed Eth, Sch Med, Stanford, CA 94305 USA.	ariadnen@stanford.edu		Nichol, Ariadne/0000-0001-9174-9671				Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; Ambe JR, 2019, CONTEXT ETHICAL CHAL, P191, DOI [10.1007/978-3-030-17474-3_14, DOI 10.1007/978-3-030-17474-3_14]; Royo-Bordonada MA, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0135-z; Bausch DG, 2017, CURR TOP MICROBIOL, V411, P63, DOI 10.1007/82_2017_69; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; Calain P, 2018, J MED ETHICS, V44, P3, DOI 10.1136/medethics-2016-103474; Caluwaerts S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0429-8; Claude KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223104; Clinical Trials.gov, 2018, INV THER TREATM PEOP; Dawson A, 2020, PUBLIC HEALTH ETH-UK, V13, P127, DOI 10.1093/phe/phaa017; ELLIS C, 1992, CONTEMP SOCIOL, V21, P138, DOI 10.2307/2074814; Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0; Folayan MO, 2015, PAN AFR MED J, V22, DOI 10.11694/pamj.supp.2015.22.1.6176; Iversen PL, 2020, LANCET INFECT DIS, V20, pE231, DOI 10.1016/S1473-3099(20)30282-6; Keusch G, 2017, INTEGRATING CLIN RES, DOI [10.17226/2473928696651, DOI 10.17226/2473928696651]; Klitzman R, 2015, AM J PUBLIC HEALTH, V105, P1513, DOI 10.2105/AJPH.2015.302757; Maduka O, 2015, J MED ETHICS, V41, P917, DOI 10.1136/medethics-2014-102561; Mastroleo I, 2020, AM J BIOETHICS, V20, P41, DOI 10.1080/15265161.2020.1795539; Maxwell J.A., 2013, QUALITATIVE RES DESI, V3rd; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Onishi N., 2014, NY TIMES; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Raven J, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3072-3; Richardson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168975; Schmidt-Sane MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230683; Singh JA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001793; Upshur REG, 2014, J BIOETHIC INQ, V11, P421, DOI 10.1007/s11673-014-9580-x; US Food and Drug Administration, 2016, EXP ACC INV DRUGS TR; Walker A, 2020, CRIT PUBLIC HEALTH, V30, P577, DOI 10.1080/09581596.2019.1648763; Wallace RG, 2015, SOC SCI MED, V129, P68, DOI 10.1016/j.socscimed.2014.09.047; Weiss RS, 1994, LEARNING STRANGERS A; WHO, 2014, ETH CONS US UNR INT; WHO, 2015, BLUEPR R D PREP RESP; WHO, 2018, RES DEV BLUEPR ACT P; WHO, 2018, WHO R D BLUEPR AD HO; WHO Ethics Working Group, 2014, WHO ETH WORK GROUP M; World Health Organization, 2016, SIT REP EB VIR DIS 1; World Health Organization, 2016, GUID MAN ETH ISS INF	42	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246320	10.1371/journal.pone.0246320	http://dx.doi.org/10.1371/journal.pone.0246320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF2NJ	33529237	Green Published, gold			2022-12-26	WOS:000616736200062
J	Swenson, SJ; Gemeinholzer, B				Swenson, Stephanie J.; Gemeinholzer, Birgit			Testing the effect of pollen exine rupture on metabarcoding with Illumina sequencing	PLOS ONE			English	Article							DNA; IDENTIFICATION; BIODIVERSITY; EXTRACTION; SAMPLES	Pollen metabarcoding has received much attention recently for its potential to increase taxonomic resolution of the identifications of pollen grains necessary for various public health, ecological and environmental inquiry. However, methodologies implemented are widely varied across studies confounding comparisons and casting uncertainty on the reliability of results. In this study, we investigated part of the methodology, the effects of level of exine rupture and lysis incubation time, on the performance of DNA extraction and Illumina sequencing. We examined 15 species of plants from 12 families with pollen that varies in size, shape, and aperture number to evaluate effort necessary for exine rupture. Then created mock communities of 14 of the species from DNA extractions at 4 levels of exine rupture (0, 33, 67, and 100%) and two levels of increased lysis incubation time without exine rupture (2 or 24 hours). Quantities of these DNA extractions displayed a positive correlation between increased rupture and DNA yield, however increasing time of lysis incubation was associated with decreased DNA yield. Illumina sequencing was performed with these artificial community treatments with three common plant DNA barcode regions (rbcL, ITS1, ITS2) with two different primer pairings for ITS2 and rbcL. We found decreased performance in treatments with 0% or 100% exine rupture compared to 33% and 67% rupture, based on deviation from expected proportions and species retrieval, and increased lysis incubation was found to be detrimental to results.	[Swenson, Stephanie J.; Gemeinholzer, Birgit] Justus Liebig Univ Giessen, Systemat Bot, Giessen, Germany	Justus Liebig University Giessen	Swenson, SJ (corresponding author), Justus Liebig Univ Giessen, Systemat Bot, Giessen, Germany.	stephanie.swenson-friedrich@bot1.bio.uni-giessen.de		Swenson, Stephanie/0000-0002-7550-6693	Federal Ministry of Education and Research Germany, BMBF as part of The German Barcode of Life (GBOL) Phase II projects [FKZ: 01LI1501H]	Federal Ministry of Education and Research Germany, BMBF as part of The German Barcode of Life (GBOL) Phase II projects(Federal Ministry of Education & Research (BMBF))	This research was funded by the Federal Ministry of Education and Research Germany, BMBF, FKZ: 01LI1501H as part of The German Barcode of Life (GBOL) Phase II projects, received by BG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Banchi E, 2020, DATABASE-OXFORD, DOI 10.1093/database/baz155; Bell KL, 2019, MOL ECOL, V28, P431, DOI 10.1111/mec.14840; Bell KL, 2017, APPL PLANT SCI, V5, DOI 10.3732/apps.1600110; Bruni I, 2015, FOOD CHEM, V170, P308, DOI 10.1016/j.foodchem.2014.08.060; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cornman RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145365; Danner N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183716; de Vere N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42838; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Edgar RC, 2016, SINTAX SIMPLE NONBAY, P074161; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Flores-Juarez CR, 2016, BIOTECHNIQUES, V61, P175, DOI 10.2144/000114457; Folloni S, 2012, MOL ECOL RESOUR, V12, P810, DOI 10.1111/j.1755-0998.2012.03168.x; Galimberti A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109363; Galliot JN, 2017, J INSECT CONSERV, V21, P827, DOI 10.1007/s10841-017-0022-z; Gibbons LE, 2014, RAN PRIMERS, V12, P1; Gous A, 2019, EVOL APPL, V12, P187, DOI 10.1111/eva.12707; Guertler P, 2014, FOOD CHEM, V149, P302, DOI 10.1016/j.foodchem.2013.10.129; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Ivanova NV, 2007, CCDB PROTOCOLS COI A; KAPYLA M, 1981, Grana, V20, P131; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Korpelainen H, 2017, NORD J BOT, V35, P602, DOI 10.1111/njb.01623; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Laha RC, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0429-7; Lalhmangaihi Ralte, 2014, J Biomol Tech, V25, P92, DOI 10.7171/jbt.14-2504-001; Lang DD, 2019, MOL ECOL RESOUR, V19, P1433, DOI 10.1111/1755-0998.13061; Leontidou K, 2018, AEROBIOLOGIA, V34, P63, DOI 10.1007/s10453-017-9497-z; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Longhi S, 2009, ANN ALLERG ASTHMA IM, V103, P508, DOI 10.1016/S1081-1206(10)60268-2; Mcfrederick QS, 2016, MOL ECOL, V25, P2302, DOI 10.1111/mec.13608; Nurnberger F, 2019, MOL ECOL, V28, P3602, DOI 10.1111/mec.15156; Nunez A, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00472-17; Palmieri L, 2009, NUTRIENTS, V1, P316, DOI 10.3390/nu1020316; PAYNE WW, 1981, REV PALAEOBOT PALYNO, V35, P39, DOI 10.1016/0034-6667(81)90013-0; Peel N, 2019, METHODS ECOL EVOL, V10, P1690, DOI 10.1111/2041-210X.13265; Pornon A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27282; Potter C, 2019, PEERJ, V7, DOI 10.7717/peerj.5999; Prosser SWJ, 2017, FOOD CHEM, V214, P183, DOI 10.1016/j.foodchem.2016.07.077; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500043; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Schnell IB, 2010, ARTHROPOD-PLANT INTE, V4, P107, DOI 10.1007/s11829-010-9089-0; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Simel EJ, 1997, BIOTECHNIQUES, V22, P390, DOI 10.2144/97223bm02; Valentini A., 2010, Diversity, V2, P610; Wang R, 2018, ANN PLANT REV ONLINE, V1, P589, DOI 10.1002/9781119312994.apr0625; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wodehouse RP, 1935, POLLEN GRAINS THEIR	53	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245611	10.1371/journal.pone.0245611	http://dx.doi.org/10.1371/journal.pone.0245611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529182	gold, Green Published			2022-12-26	WOS:000616736200016
J	Altai, Z; Montefiori, E; van Veen, B; Paggiosi, MA; McCloskey, EV; Viceconti, M; Mazza, C; Li, XS				Altai, Zainab; Montefiori, Erica; van Veen, Bart; Paggiosi, Margaret A.; McCloskey, Eugene, V; Viceconti, Marco; Mazza, Claudia; Li, Xinshan			Femoral neck strain prediction during level walking using a combined musculoskeletal and finite element model approach	PLOS ONE			English	Article							HIP-JOINT LOAD; PROXIMAL FEMUR; MUSCLE FORCES; CONTACT FORCES; LOWER-LIMB; FRACTURE; GEOMETRY; STRENGTH; FAILURE; AGE	Recently, coupled musculoskeletal-finite element modelling approaches have emerged as a way to investigate femoral neck loading during various daily activities. Combining personalised gait data with finite element models will not only allow us to study changes in motion/movement, but also their effects on critical internal structures, such as the femur. However, previous studies have been hampered by the small sample size and the lack of fully personalised data in order to construct the coupled model. Therefore, the aim of this study was to build a pipeline for a fully personalised multiscale (body-organ level) model to investigate the strain levels at the femoral neck during a normal gait cycle. Five postmenopausal women were included in this study. The CT and MRI scans of the lower limb, and gait data were collected for all participants. Muscle forces derived from the body level musculoskeletal models were used as boundary constraints on the finite element femur models. Principal strains were estimated at the femoral neck region during a full gait cycle. Considerable variation was found in the predicted peak strain among individuals with mean peak first principal strain of 0.24% +/- 0.11% and mean third principal strain of -0.29% +/- 0.24%. For four individuals, two overall peaks of the maximum strains were found to occur when both feet were in contact with the floor, while one individual had one peak at the toe-off phase. Both the joint contact forces and the muscular forces were found to substantially influence the loading at the femoral neck. A higher correlation was found between the predicted peak strains and the gluteus medius (R-2 ranged between 0.95 and 0.99) than the hip joint contact forces (R-2 ranged between 0.63 and 0.96). Therefore, the current findings suggest that personal variations are substantial, and hence it is important to consider multiple subjects before deriving general conclusions for a target population.	[Altai, Zainab; Montefiori, Erica; van Veen, Bart; Mazza, Claudia; Li, Xinshan] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Altai, Zainab; Montefiori, Erica; van Veen, Bart; Paggiosi, Margaret A.; McCloskey, Eugene, V; Mazza, Claudia; Li, Xinshan] Univ Sheffield, Insigneo Inst Silico Med, Sheffield, S Yorkshire, England; [Paggiosi, Margaret A.; McCloskey, Eugene, V; Li, Xinshan] Univ Sheffield, Mellanby Ctr Bone Res, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Viceconti, Marco] Univ Bologna, Dept Ind Engn, Alma Mater Studiorum, Bologna, Italy; [Viceconti, Marco] IRCCS, Lab Tecnol Med, Ist Ortoped Rizzoli, Bologna, Italy	University of Sheffield; University of Sheffield; University of Sheffield; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Li, XS (corresponding author), Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England.; Li, XS (corresponding author), Univ Sheffield, Insigneo Inst Silico Med, Sheffield, S Yorkshire, England.; Li, XS (corresponding author), Univ Sheffield, Mellanby Ctr Bone Res, Dept Oncol & Metab, Sheffield, S Yorkshire, England.	xinshan.li@sheffield.ac.uk	Viceconti, Marco/ABG-5546-2020; Altai, Zainab/ABB-4552-2020	Viceconti, Marco/0000-0002-2293-1530; Li, Xinshan/0000-0003-2012-5831; Mazza, Claudia/0000-0002-5215-1746	EPSRC [EP/K03877X/1, EP/S032940/1]; European Commission H2020 programme through the CompBioMed and CompBioMed2 Centres of Excellence; SANO European Centre for Computational Medicine [H2020-EINFRA-2015-1/675451, H2020-INFRAEDI-2018-1/823712, H2020-WIDESPREAD-2018-01/857533]; NIHR Sheffield Biomedical Research Centre (BRC)	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission H2020 programme through the CompBioMed and CompBioMed2 Centres of Excellence; SANO European Centre for Computational Medicine; NIHR Sheffield Biomedical Research Centre (BRC)	This study was funded, in part, by the EPSRC Frontier Engineering Awards, MultiSim and MultiSim2 projects (received by all the authors, Grant Reference Numbers: EP/K03877X/1 and EP/S032940/1, https://epsrc.ukri.org).MV and XL recieved funding from the European Commission H2020 programme through the CompBioMed and CompBioMed2 Centres of Excellence and the SANO European Centre for Computational Medicine (Grants N. H2020-EINFRA-2015-1/675451, H2020-INFRAEDI-2018-1/823712 and H2020-WIDESPREAD-2018-01/857533, https://www.compbiomed.eu/).CM is supported by the NIHR Sheffield Biomedical Research Centre (BRC). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altai Z, 2019, CLIN BIOMECH, V68, P137, DOI 10.1016/j.clinbiomech.2019.06.004; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bosmans L, 2015, J BIOMECH, V48, P2116, DOI 10.1016/j.jbiomech.2015.02.052; Cody DD, 1999, J BIOMECH, V32, P1013, DOI 10.1016/S0021-9290(99)00099-8; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Dall'Ara E, 2013, BONE, V52, P27, DOI 10.1016/j.bone.2012.09.006; Dartmouth Medical School, 2008, BASIC HUMAN ANATOMY; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Duda GN, 1998, J BIOMECH, V31, P841, DOI 10.1016/S0021-9290(98)00080-3; Edwards WB, 2016, J BIOMECH, V49, P1206, DOI 10.1016/j.jbiomech.2016.03.007; FAULKNER KG, 1993, J BONE MINER RES, V8, P1211, DOI 10.1002/jbmr.5650081008; Fick R., 2012, HDB ANATOMIE MECH GE; Giarmatzis G, 2015, J BONE MINER RES, V30, P1431, DOI 10.1002/jbmr.2483; Gnudi S, 2002, OSTEOPOROSIS INT, V13, P69, DOI 10.1007/s198-002-8340-2; Gnudi S, 1999, BRIT J RADIOL, V72, P729, DOI 10.1259/bjr.72.860.10624337; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Helgason B, 2008, MED ENG PHYS, V30, P444, DOI 10.1016/j.medengphy.2007.05.006; Hicks JL, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029304; Kainz H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235966; Kersh ME, 2018, J BONE MINER RES, V33, P1999, DOI 10.1002/jbmr.3529; Keyak JH, 2001, J ORTHOPAED RES, V19, P539, DOI 10.1016/S0736-0266(00)00046-2; Kjer HM., 2010, EVALUATION SURFACE R; Liu MQ, 2008, J BIOMECH, V41, P3243, DOI 10.1016/j.jbiomech.2008.07.031; Martelli S, 2015, COMPUT METHOD BIOMEC, V18, P1555, DOI 10.1080/10255842.2014.930134; Martelli S, 2014, CLIN BIOMECH, V29, P869, DOI 10.1016/j.clinbiomech.2014.08.001; Martelli S, 2014, J BIOMECH, V47, P1784, DOI 10.1016/j.jbiomech.2014.03.036; Martelli S, 2011, J BIOMECH, V44, P1716, DOI 10.1016/j.jbiomech.2011.03.039; Maruyama M, 2001, CLIN ORTHOP RELAT R, P52; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Modenese L, 2011, J BIOMECH, V44, P2185, DOI 10.1016/j.jbiomech.2011.06.019; Modenese L, 2018, J BIOMECH, V73, P108, DOI 10.1016/j.jbiomech.2018.03.039; Montefiori E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242973; Montefiori E, 2019, J BIOMECH, V85, P27, DOI 10.1016/j.jbiomech.2018.12.041; Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X; Polgar K, 2003, Proc Inst Mech Eng H, V217, P173, DOI 10.1243/095441103765212677; Pottecher P, 2016, RADIOLOGY, V280, P837, DOI 10.1148/radiol.2016142796; Qasim M, 2016, OSTEOPOROSIS INT, V27, P2815, DOI 10.1007/s00198-016-3597-4; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2008, GAIT POSTURE, V28, P358, DOI 10.1016/j.gaitpost.2008.05.002; Schileo E, 2008, J BIOMECH, V41, P2483, DOI 10.1016/j.jbiomech.2008.05.017; Schileo E, 2008, J BIOMECH, V41, P356, DOI 10.1016/j.jbiomech.2007.09.009; Schileo E, 2007, J BIOMECH, V40, P2982, DOI 10.1016/j.jbiomech.2007.02.010; Schileo E, 2014, J BIOMECH, V47, P3531, DOI 10.1016/j.jbiomech.2014.08.024; Soodmand E, 2019, ORTHOP SURG, V11, P135, DOI 10.1111/os.12416; Speirs AD, 2007, J BIOMECH, V40, P2318, DOI 10.1016/j.jbiomech.2006.10.038; Stansfield BW, 2003, J BIOMECH, V36, P929, DOI 10.1016/S0021-9290(03)00072-1; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Steele KM, 2010, J BIOMECH, V43, P2099, DOI 10.1016/j.jbiomech.2010.04.003; Taddei F, 2004, MED ENG PHYS, V26, P61, DOI 10.1016/S1350-4533(03)00138-3; Thompson BJ, 2014, AGE, V36, P839, DOI 10.1007/s11357-013-9605-0; Toda H, 2015, J PHYS THER SCI, V27, P1833, DOI 10.1589/jpts.27.1833; Toogood PA, 2009, CLIN ORTHOP RELAT R, V467, P876, DOI 10.1007/s11999-008-0473-3; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; van Veen BC, 2020, IEEE T NEUR SYS REH, V28, P1800, DOI 10.1109/TNSRE.2020.3003559; Viceconti M, 2012, J BIOMECH, V45, P421, DOI 10.1016/j.jbiomech.2011.11.048; WHITE DR, 1987, BRIT J RADIOL, V60, P907, DOI 10.1259/0007-1285-60-717-907; Wright D, 2011, CLIN ORTHOP RELAT R, V469, P2583, DOI 10.1007/s11999-010-1754-1; Zhang X, 2015, P I MECH ENG H, V229, P477, DOI 10.1177/0954411915589115	63	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245121	10.1371/journal.pone.0245121	http://dx.doi.org/10.1371/journal.pone.0245121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524024	Green Published, gold, Green Accepted			2022-12-26	WOS:000616578400008
J	Luo, XH; Yin, JY; Miao, SH; Feng, WQ; Ning, TT; Xu, SM; Huang, SJ; Zhang, S; Liao, YJ; Hao, CB; Wu, BL; Ma, DD				Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Ning, Tingting; Xu, Shuaimei; Huang, Shijiang; Zhang, Sheng; Liao, Yunjun; Hao, Chunbo; Wu, Buling; Ma, Dandan			mTORC1 promotes mineralization via p53 pathway	FASEB JOURNAL			English	Article						cell signaling; dentinogenesis; molecular biology; mTORC1; odontoblast; tooth development	PULP STEM-CELLS; ODONTOGENIC DIFFERENTIATION; ODONTOBLAST DIFFERENTIATION; EXPRESSION; GROWTH; SUPPRESSES; PROTEINS; TARGET; TOOTH; MDM2	The objectives of our study were to investigate the roles of mTORC1 in odontoblast proliferation and mineralization and to determine the mechanism by which mTORC1 regulates odontoblast mineralization. In vitro, MDPC23 cells were treated with rapamycin (10 nmol/L) and transfected with a lentivirus for short hairpin (shRNA)-mediated silencing of the tuberous sclerosis complex (shTSC1) to inhibit and activate mTORC1, respectively. CCK8 assays, flow cytometry, Alizarin red S staining, ALP staining, qRT-PCR, and western blot analysis were performed. TSC1-conditional knockout (DMP1-Cre(+); TSC1(f/f), hereafter CKO) mice and littermate control (DMP1-Cre(-); TSC1(f/f), hereafter WT) mice were generated. H&E staining, immunofluorescence, and micro-CT analysis were performed. Transcriptome sequencing analysis was used to screen the mechanism of this process. mTORC1 inactivation decreased the cell proliferation. The qRT-PCR and western blot results showed that mineralization-related genes and proteins were downregulated in mTORC1-inactivated cells. Moreover, mTORC1 overactivation promoted cell proliferation and mineralization-related gene and protein expression. In vivo, the micro-CT results showed that DV/TV and dentin thickness were higher in CKO mice than in controls and H&E staining showed the same results. Mineralization-related proteins expression was upregulated. Transcriptome sequencing analysis revealed that p53 pathway-associated genes were differentially expressed in TSC1-deficient cells. By inhibiting p53 alone or both mTORC1 and p53 with rapamycin and a p53 inhibitor, we elucidated that p53 acts downstream of mTORC1 and that mTORC1 thereby promotes odontoblast mineralization. Taken together, our findings demonstrate that the role of mTORC1 in odontoblast proliferation and mineralization, and confirm that mTORC1 upregulates odontoblast mineralization via the p53 pathway.	[Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Wu, Buling] Southern Med Univ, Nanfang Hosp, Dept Stomatol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China; [Luo, Xinghong; Yin, Jingyao; Miao, Shenghong; Feng, Weiqing; Ning, Tingting; Xu, Shuaimei; Wu, Buling] Southern Med Univ, Coll Stomatol, Guangzhou, Peoples R China; [Ning, Tingting; Xu, Shuaimei; Ma, Dandan] Southern Med Univ, Stomatol Hosp, Dept Endodont, Guangzhou, Peoples R China; [Huang, Shijiang; Zhang, Sheng] Southern Med Univ, Sch Basic Med Sci, Dept Cell Biol, Guangzhou, Peoples R China; [Hao, Chunbo] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Dept Stomatol, Haikou, Hainan, Peoples R China; [Liao, Yunjun] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Peoples R China; [Ma, Dandan] Univ Maryland, Sch Dent, Dept Adv Oral Sci & Therapeut, Baltimore, MD 21201 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Hainan Medical University; Southern Medical University - China; University System of Maryland; University of Maryland Baltimore	Ma, DD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Stomatol, 1838 North Guangzhou Ave, Guangzhou 510515, Peoples R China.	mdd@smu.edu.cn						Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Chen M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00703; Chen P, 2009, EXP MOL PATHOL, V86, P101, DOI 10.1016/j.yexmp.2009.01.013; Chen Z, 2016, CELL TISSUE RES, V363, P385, DOI 10.1007/s00441-015-2260-2; Choi H, 2016, CELL TISSUE RES, V364, P95, DOI 10.1007/s00441-015-2310-9; Da Pozzo E, 2014, ACS CHEM NEUROSCI, V5, P390, DOI 10.1021/cn4002208; Garg A, 2020, BIOPHYS J, V118, P720, DOI 10.1016/j.bpj.2019.12.015; Hanks CT, 1998, EUR J ORAL SCI, V106, P260, DOI 10.1111/j.1600-0722.1998.tb02185.x; Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442; Hasty P, 2013, CELL CYCLE, V12, P20, DOI 10.4161/cc.22912; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13911-x; Huang B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005426; Huang DL, 2020, STEM CELL REV REP, V16, P41, DOI 10.1007/s12015-019-09940-0; Hur SW, 2015, J DENT RES, V94, P1135, DOI 10.1177/0022034515585125; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kaufman MH, 1997, J ANAT, V191, P57, DOI 10.1046/j.1469-7580.1997.19110057.x; Kim JK, 2011, J ENDODONT, V37, P1081, DOI 10.1016/j.joen.2011.03.034; Lai KP, 2010, EMBO J, V29, P2994, DOI 10.1038/emboj.2010.166; Li C, 2018, INT ENDOD J, V51, pe115, DOI 10.1111/iej.12771; Li N, 2019, DENT MATER J, V38, P534, DOI 10.4012/dmj.2018-155; Liao CF, 2019, J CELL PHYSIOL, V234, P20779, DOI 10.1002/jcp.28684; Liu W, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Fernandez-Cruz ML, 2011, LIFE SCI, V88, P774, DOI 10.1016/j.lfs.2011.02.019; Ma DD, 2018, J CELL MOL MED, V22, P3442, DOI 10.1111/jcmm.13621; MATSUYAMA T, 1990, CALCIFIED TISSUE INT, V47, P276, DOI 10.1007/BF02555909; Alvarez MMP, 2019, DENT MATER, V35, P606, DOI 10.1016/j.dental.2019.02.008; Shaikh MF, 2016, ANN CLIN LAB SCI, V46, P627; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Tanaka Y, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1077-9; Tao ZH, 2010, BIOCHEMISTRY-US, V49, P8488, DOI 10.1021/bi100673c; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; Wang HY, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00075; Wang H, 2019, J CELL PHYSIOL, V234, P12897, DOI 10.1002/jcp.27954; Xie FR, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00250; Yu D, 2019, J CELL PHYSIOL, V234, P1442, DOI 10.1002/jcp.26950; Zhang XY, 2019, J PROTEOMICS, V202, DOI 10.1016/j.jprot.2019.04.014; Zhang YD, 2005, CELL RES, V15, P301, DOI 10.1038/sj.cr.7290299; Zhang Y, 2017, J BONE MINER RES, V32, P1829, DOI 10.1002/jbmr.3172; Zheng H, 2020, J DENT RES, V99, P320, DOI 10.1177/0022034519893672	43	2	2	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21325	10.1096/fj.202002016R	http://dx.doi.org/10.1096/fj.202002016R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33508145	Bronze			2022-12-26	WOS:000647789600073
J	Warner, DR; Warner, JB; Hardesty, JE; Song, YL; Chen, CY; Chen, Z; Kang, JX; McClain, CJ; Kirpich, IA				Warner, Dennis R.; Warner, Jeffrey B.; Hardesty, Josiah E.; Song, Ying L.; Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.; McClain, Craig J.; Kirpich, Irina A.			Beneficial effects of an endogenous enrichment in n3-PUFAs on Wnt signaling are associated with attenuation of alcohol-mediated liver disease in mice	FASEB JOURNAL			English	Article						alcohol&#8208; associated liver disease; n3&#8208; PUFAs; n6; n3&#8208; PUFA ratio; Wnt signaling	TRANSGENIC MICE; NEGATIVE REGULATOR; BETA-CATENIN; CELL-DEATH; INJURY; PROMOTES; ETHANOL; INFLAMMATION; ACID; JNK	Alcohol-associated liver disease (ALD) is a major human health issue for which there are limited treatment options. Experimental evidence suggests that nutrition plays an important role in ALD pathogenesis, and specific dietary fatty acids, for example, n6 or n3-PUFAs, may exacerbate or attenuate ALD, respectively. The purpose of the current study was to determine whether the beneficial effects of n3-PUFA enrichment in ALD were mediated, in part, by improvement in Wnt signaling. Wild-type (WT) and fat-1 transgenic mice (that endogenously convert n6-PUFAs to n3) were fed ethanol (EtOH) for 6 weeks followed by a single LPS challenge. fat-1 mice had less severe liver damage than WT littermates as evidenced by reduced plasma alanine aminotransferase, hepatic steatosis, liver tissue neutrophil infiltration, and pro-inflammatory cytokine expression. WT mice had a greater downregulation of Axin2, a key gene in the Wnt pathway, than fat-1 mice in response to EtOH and LPS. Further, there were significant differences between WT and fat-1 EtOH+LPS-challenged mice in the expression of five additional genes linked to the Wnt signaling pathway, including Apc, Fosl1/Fra-1, Mapk8/Jnk-1, Porcn, and Nkd1. Compared to WT, primary hepatocytes isolated from fat-1 mice exhibited more effective Wnt signaling and were more resistant to EtOH-, palmitic acid-, or TNF alpha-induced cell death. Further, we demonstrated that the n3-PUFA-derived lipid mediators, resolvins D1 and E1, can regulate hepatocyte expression of several Wnt-related genes that were differentially expressed between WT and fat-1 mice. These data demonstrate a novel mechanism by which n3-PUFAs can ameliorate ALD.	[Warner, Dennis R.; Warner, Jeffrey B.; Hardesty, Josiah E.; Song, Ying L.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, 505 South Hancock St, Louisville, KY 40202 USA; [Warner, Jeffrey B.; Hardesty, Josiah E.; McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Dept Pharmacol & Toxicol, Sch Med, Louisville, KY 40202 USA; [Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Chen, Chi-Yu; Chen, Zoe; Kang, Jing X.] Harvard Med Sch, Boston, MA 02115 USA; [McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Alcohol Ctr, Sch Med, Louisville, KY 40202 USA; [McClain, Craig J.; Kirpich, Irina A.] Univ Louisville, Sch Med, Hepatobiol & Toxicol Ctr, Louisville, KY 40202 USA; [McClain, Craig J.] Robley Rex Vet Med Ctr, Louisville, KY USA	University of Louisville; University of Louisville; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Louisville	Kirpich, IA (corresponding author), Univ Louisville, Dept Med, Div Gastroenterol Hepatol & Nutr, 505 South Hancock St, Louisville, KY 40202 USA.	i0kirp01@louisville.edu			NIAAA NIH HHS [R01 AA024102, L30 AA027913, U01 AA026936, P50 AA024337, U01 AA026934, R01 AA023681, U01 AA026980, P50AA024337, F31 AA028423, F32 AA027950] Funding Source: Medline; NIEHS NIH HHS [T32 ES011564] Funding Source: Medline; NIGMS NIH HHS [P20 GM113226, P20GM113226] Funding Source: Medline; NIH HHS [1U01AA026926-01] Funding Source: Medline; BLRD VA [I01 BX002996] Funding Source: Medline	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BLRD VA		Asai S, 2004, J IMMUNOL, V173, P4669, DOI 10.4049/jimmunol.173.7.4669; Bellentani S, 2001, J HEPATOL, V35, P531, DOI 10.1016/S0168-8278(01)00151-9; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Dara L, 2011, HEPATOLOGY, V53, P1752, DOI 10.1002/hep.24279; Diehl AM, 2004, ALCOHOL, V34, P81, DOI 10.1016/j.alcohol.2004.07.010; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gustot T, 2017, J HEPATOL, V67, P1031, DOI 10.1016/j.jhep.2017.06.013; Han MS, 2016, CELL REP, V15, P19, DOI 10.1016/j.celrep.2016.03.008; HERMAN B, 1988, FASEB J, V2, P146, DOI 10.1096/fasebj.2.2.3342967; Huang CK, 2015, J HEPATOL, V63, P191, DOI 10.1016/j.jhep.2015.02.030; Huang LL, 2013, PROSTAG LEUKOTR ESS, V88, P347, DOI 10.1016/j.plefa.2013.02.002; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Innes JK, 2018, PROSTAG LEUKOTR ESS, V132, P41, DOI 10.1016/j.plefa.2018.03.004; Isayama F, 2016, AM J PATHOL, V186, P1524, DOI 10.1016/j.ajpath.2016.02.006; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kang Jing X., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-5; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Khadge S, 2018, J NUTR BIOCHEM, V52, P92, DOI 10.1016/j.jnutbio.2017.09.017; Kireva T, 2011, HEPATOLOGY, V53, P1259, DOI 10.1002/hep.24175; Kirpich IA, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010001; Liebig M, 2019, HEPATOBIL SURG NUTR, V8, P447, DOI 10.21037/hbsn.2019.04.03; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockwood WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063610; Lopez MF, 2018, AM J PHYSIOL-ENDOC M, V315, pE735, DOI 10.1152/ajpendo.00048.2018; Ma J, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.136496; Nile AH, 2017, P NATL ACAD SCI USA, V114, P4147, DOI 10.1073/pnas.1618293114; Perugorria MJ, 2019, NAT REV GASTRO HEPAT, V16, P121, DOI 10.1038/s41575-018-0075-9; Praetner M, 2018, ARTERIOSCL THROM VAS, V38, P829, DOI 10.1161/ATVBAHA.117.309760; Preziosi M, 2018, HEPATOL COMMUN, V2, P845, DOI 10.1002/hep4.1196; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Schulien I, 2019, CELL DEATH DIFFER, V26, P1688, DOI 10.1038/s41418-018-0239-8; Seitz HK, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0014-7; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shim YR, 2020, EXP MOL MED, V52, P772, DOI 10.1038/s12276-020-0438-5; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Steinhart Z, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.146589; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Wang K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.499; Warner DR, 2019, J LIPID RES, V60, P2034, DOI 10.1194/jlr.RA119000200; Warner DR, 2017, AM J PATHOL, V187, P2232, DOI 10.1016/j.ajpath.2017.06.008; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Zhao LD, 2019, HEPATOLOGY, V69, P2623, DOI 10.1002/hep.30563; Zirnheld K.H., 2019, LIVER RES, V3, P206, DOI [10.1016/j.livres.2019.10.001, DOI 10.1016/J.LIVRES.2019.10.001]	48	5	5	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21377	10.1096/fj.202001202R	http://dx.doi.org/10.1096/fj.202001202R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33481293	Green Accepted, Bronze			2022-12-26	WOS:000647789600083
J	Chen, HY; Hsu, BWY; Yin, YK; Lin, FH; Yang, TH; Yang, RS; Lee, CK; Tseng, VS				Chen, Hsuan-Yu; Hsu, Benny Wei-Yun; Yin, Yu-Kai; Lin, Feng-Huei; Yang, Tsung-Han; Yang, Rong-Sen; Lee, Chih-Kuo; Tseng, Vincent S.			Application of deep learning algorithm to detect and visualize vertebral fractures on plain frontal radiographs	PLOS ONE			English	Article								Background Identification of vertebral fractures (VFs) is critical for effective secondary fracture prevention owing to their association with the increasing risks of future fractures. Plain abdominal frontal radiographs (PARs) are a common investigation method performed for a variety of clinical indications and provide an ideal platform for the opportunistic identification of VF. This study uses a deep convolutional neural network (DCNN) to identify the feasibility for the screening, detection, and localization of VFs using PARs. Methods A DCNN was pretrained using ImageNet and retrained with 1306 images from the PARs database obtained between August 2015 and December 2018. The accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were evaluated. The visualization algorithm gradient-weighted class activation mapping (Grad-CAM) was used for model interpretation. Results Only 46.6% (204/438) of the VFs were diagnosed in the original PARs reports. The algorithm achieved 73.59% accuracy, 73.81% sensitivity, 73.02% specificity, and an AUC of 0.72 in the VF identification. Conclusion Computer driven solutions integrated with the DCNN have the potential to identify VFs with good accuracy when used opportunistically on PARs taken for a variety of clinical purposes. The proposed model can help clinicians become more efficient and economical in the current clinical pathway of fragile fracture treatment.	[Chen, Hsuan-Yu; Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan; [Chen, Hsuan-Yu; Yang, Tsung-Han; Yang, Rong-Sen] Natl Taiwan Univ, Coll Med, Dept Orthoped, Taipei, Taiwan; [Chen, Hsuan-Yu; Yang, Tsung-Han; Yang, Rong-Sen] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chen, Hsuan-Yu; Yang, Tsung-Han] Natl Taiwan Univ, HsinChu Hosp, Dept Orthoped, Hsinchu, Taiwan; [Hsu, Benny Wei-Yun; Yin, Yu-Kai; Tseng, Vincent S.] Natl Chiao Tung Univ, Inst Comp Sci & Engn, Hsinchu, Taiwan; [Lee, Chih-Kuo] Natl Taiwan Univ, HsinChu Hosp, Dept Internal Med, Hsinchu, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Taiwan University	Tseng, VS (corresponding author), Natl Chiao Tung Univ, Inst Comp Sci & Engn, Hsinchu, Taiwan.	vtseng@cs.nctu.edu.tw	Chen, Hsuan-Yu/AAT-5581-2021	Chen, Hsuan-Yu/0000-0003-4998-7566; Tseng, Vincent/0000-0002-4853-1594; Hsu, Benny/0000-0003-2101-704X				Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Bogoni L, 2012, J DIGIT IMAGING, V25, P771, DOI 10.1007/s10278-012-9496-0; Caliskan A, 2018, TEH VJESN, V25, P679, DOI 10.17559/TV-20171220221947; Chung SW, 2018, ACTA ORTHOP, V89, P468, DOI 10.1080/17453674.2018.1453714; Delmas PD, 2005, J BONE MINER RES, V20, P557, DOI 10.1359/JBMR.041214; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Khan A, 2020, ARTIF INTELL REV, V53, P5455, DOI 10.1007/s10462-020-09825-6; Kim DH, 2018, CLIN RADIOL, V73, P439, DOI 10.1016/j.crad.2017.11.015; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Rhee PM, 2002, J TRAUMA, V53, P663, DOI 10.1097/00005373-200210000-00007; Roth H.R., 2018, MED IMAGING TECHNOL, V36, P63; Roth S., 2018, LNCS, V11134; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shen YC, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1909, DOI 10.1145/3292500.3330657; Svedbom A, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0137-0; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634	22	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245992	10.1371/journal.pone.0245992	http://dx.doi.org/10.1371/journal.pone.0245992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507982	Green Published, gold			2022-12-26	WOS:000635021400070
J	Kinnby, A; White, JCB; Toth, GB; Pavia, H				Kinnby, Alexandra; White, Joel C. B.; Toth, Gunilla B.; Pavia, Henrik			Ocean acidification decreases grazing pressure but alters morphological structure in a dominant coastal seaweed	PLOS ONE			English	Article							NUTRITIONAL QUALITY; CARBON-DIOXIDE; CLIMATE-CHANGE; ELEVATED CO2; BROWN ALGA; RESPONSES; GROWTH; FOOD; PHOTOSYNTHESIS; ENRICHMENT	Ocean acidification driven by anthropogenic climate change is causing a global decrease in pH, which is projected to be 0.4 units lower in coastal shallow waters by the year 2100. Previous studies have shown that seaweeds grown under such conditions may alter their growth and photosynthetic capacity. It is not clear how such alterations might impact interactions between seaweed and herbivores, e.g. through changes in feeding rates, nutritional value, or defense levels. Changes in seaweeds are particularly important for coastal food webs, as they are key primary producers and often habitat-forming species. We cultured the habitat-forming brown seaweed Fucus vesiculosus for 30 days in projected future pCO(2) (1100 mu atm) with genetically identical controls in ambient pCO(2) (400 mu atm). Thereafter the macroalgae were exposed to grazing by Littorina littorea, acclimated to the relevant pCO(2)-treatment. We found increased growth (measured as surface area increase), decreased tissue strength in a tensile strength test, and decreased chemical defense (phlorotannins) levels in seaweeds exposed to high pCO(2)-levels. The herbivores exposed to elevated pCO(2)-levels showed improved condition index, decreased consumption, but no significant change in feeding preference. Fucoid seaweeds such as F. vesiculosus play important ecological roles in coastal habitats and are often foundation species, with a key role for ecosystem structure and function. The change in surface area and associated decrease in breaking force, as demonstrated by our results, indicate that F. vesiculosus grown under elevated levels of pCO(2) may acquire an altered morphology and reduced tissue strength. This, together with increased wave energy in coastal ecosystems due to climate change, could have detrimental effects by reducing both habitat and food availability for herbivores.	[Kinnby, Alexandra; White, Joel C. B.; Toth, Gunilla B.; Pavia, Henrik] Univ Gothenburg, Dept Marine Sci, Tjarno Marine Lab, Stromstad, Sweden	University of Gothenburg	Kinnby, A (corresponding author), Univ Gothenburg, Dept Marine Sci, Tjarno Marine Lab, Stromstad, Sweden.	alexandra.kinnby@marine.gu.se		Kinnby, Alexandra/0000-0002-0977-0648	Swedish Research Council VR; Swedish Research Council Formas through a Linnaeus grant [217-2008-1719]; Radman och Fru Ernst Collianders stiftelse for valgorande andamal	Swedish Research Council VR(Swedish Research Council); Swedish Research Council Formas through a Linnaeus grant; Radman och Fru Ernst Collianders stiftelse for valgorande andamal	This work was funded by the Swedish Research Council VR and Formas through a Linnaeus grant to the Centre for Marine Evolutionary Biology (CeMEB; http://cemeb.science.gu.se 217-2008-1719 awarded to Henrik Pavia, and by Radman och Fru Ernst Collianders stiftelse for valgorande andamal awarded to Alexandra Kinnby. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152948; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Borell EM, 2013, CORAL REEFS, V32, P937, DOI 10.1007/s00338-013-1066-5; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cardoso PG, 2017, ESTUAR COAST SHELF S, V197, P35, DOI 10.1016/j.ecss.2017.08.007; Chen BB, 2019, AQUACULT INT, V27, P721, DOI 10.1007/s10499-019-00360-y; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Cruz-Rivera E, 2001, MAR ECOL PROG SER, V218, P249, DOI 10.3354/meps218249; Duarte C, 2016, OECOLOGIA, V180, P453, DOI 10.1007/s00442-015-3459-3; Eriander L, 2016, ICES J MAR SCI, V73, P596, DOI 10.1093/icesjms/fsv214; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fernandez PA, 2015, PHOTOSYNTH RES, V124, P293, DOI 10.1007/s11120-015-0138-5; Gao G, 2018, FOOD CHEM, V258, P71, DOI 10.1016/j.foodchem.2018.03.040; Gao G, 2018, GCB BIOENERGY, V10, P39, DOI 10.1111/gcbb.12465; Graiff A, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00112; Guenther R, 2018, J PHYCOL, V54, P153, DOI 10.1111/jpy.12614; Gutow L, 2014, J EXP MAR BIOL ECOL, V453, P84, DOI 10.1016/j.jembe.2014.01.005; Hammill E, 2018, GLOBAL CHANGE BIOL, V24, pE128, DOI 10.1111/gcb.13849; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Hepburn CD, 2011, GLOBAL CHANGE BIOL, V17, P2488, DOI 10.1111/j.1365-2486.2011.02411.x; HICKMAN RW, 1980, MAR BIOL, V60, P27, DOI 10.1007/BF00395603; Kawamitsu Y, 1999, MAR BIOL, V133, P361, DOI 10.1007/s002270050475; Kinnby A, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00470; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Leung JYS, 2018, SCI TOTAL ENVIRON, V639, P360, DOI 10.1016/j.scitotenv.2018.05.161; Liu CX, 2015, MAR BIOL RES, V11, P1043, DOI 10.1080/17451000.2015.1062520; Ober GT, 2017, MAR ENVIRON RES, V131, P69, DOI 10.1016/j.marenvres.2017.09.003; Olischlager M, 2012, BOT MAR, V55, P511, DOI 10.1515/bot-2012-0163; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pavia H, 2000, ECOLOGY, V81, P3212; Pavia H, 1997, MAR ECOL PROG SER, V157, P139, DOI 10.3354/meps157139; PETERSON CH, 1989, OECOLOGIA, V80, P82, DOI 10.1007/BF00789935; Poore AGB, 2013, OECOLOGIA, V173, P1113, DOI 10.1007/s00442-013-2683-y; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Pretzsch H, 2018, FOREST ECOL MANAG, V429, P589, DOI 10.1016/j.foreco.2018.07.045; Pretzsch H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5967; Robbins L., 2010, CO2CALCA USER FRIEND; Robinson EA, 2012, NEW PHYTOL, V194, P321, DOI 10.1111/j.1469-8137.2012.04074.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; SURIF MB, 1989, OECOLOGIA, V78, P97, DOI 10.1007/BF00377203; Swanson AK, 2007, GLOBAL CHANGE BIOL, V13, P1696, DOI 10.1111/j.1365-2486.2007.01384.x; Takolander A, 2019, EUR J PHYCOL, V54, P380, DOI 10.1080/09670262.2019.1572226; Toth GB, 2005, ECOLOGY, V86, P612, DOI 10.1890/04-0484; Urabe J, 2003, GLOBAL CHANGE BIOL, V9, P818, DOI 10.1046/j.1365-2486.2003.00634.x; van de Waal DB, 2010, FRONT ECOL ENVIRON, V8, P145, DOI 10.1890/080178; van der Loos LM, 2019, ECOL EVOL, V9, P125, DOI 10.1002/ece3.4679; VANALSTYNE KL, 1995, J CHEM ECOL, V21, P45, DOI 10.1007/BF02033661; Watt CA, 2013, MAR ECOL PROG SER, V491, P91, DOI 10.3354/meps10521; Wernberg T, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL III: ECOLOGICAL ISSUES AND ENVIRONMENTAL IMPACTS, 2ND EDITION, P57, DOI 10.1016/B978-0-12-805052-1.00003-6; Werner FJ, 2016, OECOLOGIA, V180, P889, DOI 10.1007/s00442-015-3489-x; Young CS, 2019, MAR ECOL PROG SER, V627, P83, DOI 10.3354/meps13087; Young CS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155152	59	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245017	10.1371/journal.pone.0245017	http://dx.doi.org/10.1371/journal.pone.0245017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508019	Green Published, gold, Green Submitted			2022-12-26	WOS:000635021400028
J	Li, QY; Chen, GM				Li, Qiaoyang; Chen, Guiming			Recognition of industrial machine parts based on transfer learning with convolutional neural network	PLOS ONE			English	Article							GRADIENT DESCENT; CLASSIFICATION	As the industry gradually enters the stage of unmanned and intelligent, factories in the future need to realize intelligent monitoring and diagnosis and maintenance of parts and components. In order to achieve this goal, it is first necessary to accurately identify and classify the parts in the factory. However, the existing literature rarely studies the classification and identification of parts of the entire factory. Due to the lack of existing data samples, this paper studies the identification and classification of small samples of industrial machine parts. In order to solve this problem, this paper establishes a convolutional neural network model based on the InceptionNet-V3 pretrained model through migration learning. Through experimental design, the influence of data expansion, learning rate and optimizer algorithm on the model effectiveness is studied, and the optimal model was finally determined, and the test accuracy rate reaches 99.74%. By comparing with the accuracy of other classifiers, the experimental results prove that the convolutional neural network model based on transfer learning can effectively solve the problem of recognition and classification of industrial machine parts with small samples and the idea of transfer learning can also be further promoted.	[Li, Qiaoyang; Chen, Guiming] Xian Res Inst High Tech, Xian, Peoples R China		Li, QY (corresponding author), Xian Res Inst High Tech, Xian, Peoples R China.	liqiaoyang2019@163.com		Li, Qiaoyang/0000-0001-7942-9982	National Natural Science Foundation of China [71601180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (71601180).	Arab A, 2015, INFORM SCIENCES, V299, P117, DOI 10.1016/j.ins.2014.11.051; Bernardoni F, 2018, BIOL PSYCHIAT, V83, P235, DOI 10.1016/j.biopsych.2017.07.024; Castelluccio BC, 2020, J INT NEUROPSYCH SOC, V26, P19, DOI 10.1017/S1355617719001243; de Bruijne M, 2016, MED IMAGE ANAL, V33, P94, DOI 10.1016/j.media.2016.06.032; Efendioglu HS, 2009, SENSORS-BASEL, V9, P7167, DOI 10.3390/s90907167; Ghate VN, 2010, EXPERT SYST APPL, V37, P3468, DOI 10.1016/j.eswa.2009.10.041; Govindarajan R, 1996, IEEE T PARALL DISTR, V7, P1133, DOI 10.1109/71.544355; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang Q, 2020, IEEE J BIOMED HEALTH, V24, P160, DOI 10.1109/JBHI.2019.2905623; Jin KH, 2017, IEEE T IMAGE PROCESS, V26, P4509, DOI 10.1109/TIP.2017.2713099; Kim DH, 2018, CLIN RADIOL, V73, P439, DOI 10.1016/j.crad.2017.11.015; Kitamura G, 2019, J DIGIT IMAGING, V32, P672, DOI 10.1007/s10278-018-0167-7; Krizhevsky A., 2012, NIPS, P1097; Li B, 2018, EURASIP J IMAGE VIDE, DOI 10.1186/s13640-018-0339-x; Matsugu M, 2003, NEURAL NETWORKS, V16, P555, DOI 10.1016/S0893-6080(03)00115-1; Minhas RA, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9030483; Parikh D., HIERARCHICAL QUESTIO; Peng YQ, 2020, IEEE ACCESS, V8, P3987, DOI 10.1109/ACCESS.2019.2961767; Raghu S, 2020, NEURAL NETWORKS, V124, P202, DOI 10.1016/j.neunet.2020.01.017; Rani R, 2018, PATTERN ANAL APPL, V21, P1, DOI 10.1007/s10044-017-0641-8; Rastegari M, 2016, LECT NOTES COMPUT SC, V9908, P525, DOI 10.1007/978-3-319-46493-0_32; Saikia AR, 2019, TISSUE CELL, V57, P8, DOI 10.1016/j.tice.2019.02.001; Samala RK, 2016, MED PHYS, V43, P6654, DOI 10.1118/1.4967345; Soriano JB, 2020, LANCET RESP MED, V8, P585, DOI 10.1016/S2213-2600(20)30105-3; Sun ZY, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.5.056003; Tan J, 2019, INT J MOD PHYS D, V28, DOI 10.1142/S0218271819501530; Tian WC, 2019, ENVIRON SCI POLLUT R, V26, P29857, DOI 10.1007/s11356-019-06156-0; Vabalas A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224365; Wei W, 2020, MON NOT R ASTRON SOC, V493, P3178, DOI 10.1093/mnras/staa325; Yang JF, 2020, IEEE T PATTERN ANAL, V42, P1537, DOI 10.1109/TPAMI.2019.2913863; Ying ZL, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20061724; Zhang C, 2019, J NEUROSCI METH, V325, DOI 10.1016/j.jneumeth.2019.108318; Zhu XL, 2020, CONNECT SCI, V32, P1, DOI 10.1080/09540091.2019.1609420	36	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245735	10.1371/journal.pone.0245735	http://dx.doi.org/10.1371/journal.pone.0245735			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507901	gold, Green Published			2022-12-26	WOS:000635021400050
J	Queinnec, M; Tompalski, P; Bolton, DK; Coops, NC				Queinnec, Martin; Tompalski, Piotr; Bolton, Douglas K.; Coops, Nicholas C.			FOSTER-An R package for forest structure extrapolation	PLOS ONE			English	Article							LANDSAT TIME-SERIES; NEAREST-NEIGHBOR IMPUTATION; ABOVEGROUND BIOMASS; LIDAR PLOTS; FIELD PLOTS; INVENTORY; ATTRIBUTES; COMPOSITES; MODEL; DISTURBANCE	The uptake of technologies such as airborne laser scanning (ALS) and more recently digital aerial photogrammetry (DAP) enable the characterization of 3-dimensional (3D) forest structure. These forest structural attributes are widely applied in the development of modern enhanced forest inventories. As an alternative to extensive ALS or DAP based forest inventories, regional forest attribute maps can be built from relationships between ALS or DAP and wall-to-wall satellite data products. To date, a number of different approaches exist, with varying code implementations using different programming environments and tailored to specific needs. With the motivation for open, simple and modern software, we present FOSTER (Forest Structure Extrapolation in R), a versatile and computationally efficient framework for modeling and imputation of 3D forest attributes. FOSTER derives spectral trends in remote sensing time series, implements a structurally guided sampling approach to sample these often spatially auto correlated datasets, to then allow a modelling approach (currently k-NN imputation) to extrapolate these 3D forest structure measures. The k-NN imputation approach that FOSTER implements has a number of benefits over conventional regression based approaches including lower bias and reduced over fitting. This paper provides an overview of the general framework followed by a demonstration of the performance and outputs of FOSTER. Two ALS-derived variables, the 95th percentile of first returns height (elev_p95) and canopy cover above mean height (cover), were imputed over a research forest in British Columbia, Canada with relative RMSE of 18.5% and 11.4% and relative bias of -0.6% and 1.4% respectively. The processing sequence developed within FOSTER represents an innovative and versatile framework that should be useful to researchers and managers alike looking to make forest management decisions over entire forest estates.	[Queinnec, Martin; Tompalski, Piotr; Coops, Nicholas C.] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Bolton, Douglas K.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA	University of British Columbia; Boston University	Queinnec, M (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC, Canada.	queinnec@mail.ubc.ca	Coops, Nicholas C/J-1543-2012	Coops, Nicholas C/0000-0002-0151-9037; Queinnec, Martin/0000-0002-2741-1032	AWARE (Assessment of Wood Attributes using Remote Sensing) Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development grant [RDPJ 462973 14]	AWARE (Assessment of Wood Attributes using Remote Sensing) Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development grant	This research was funded by the AWARE (Assessment of Wood Attributes using Remote Sensing) Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development grant (RDPJ 462973 14) to a team led by Dr. Nicholas Coops.	Andersen HE, 2011, CAN J REMOTE SENS, V37, P596, DOI 10.5589/m12-003; Beaudoin A, 2014, CAN J FOREST RES, V44, P521, DOI 10.1139/cjfr-2013-0401; Bolton DK, 2020, REMOTE SENS ENVIRON, V239, DOI 10.1016/j.rse.2020.111645; Bolton DK, 2018, INT J APPL EARTH OBS, V66, P174, DOI 10.1016/j.jag.2017.11.016; Breiman L., 2001, MACH LEARN, V45, P5; BUCKLAND ST, 1993, J APPL ECOL, V30, P478, DOI 10.2307/2404188; Carabajal C, 2011, ASTER GLOBAL DIGITAL; Chi H, 2015, REMOTE SENS-BASEL, V7, P5534, DOI 10.3390/rs70505534; Coops NC, 2016, ECOL INDIC, V67, P346, DOI 10.1016/j.ecolind.2016.02.057; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Crookston NL, 2008, J STAT SOFTW, V23, P1, DOI DOI 10.18637/jss.v023.i10; Deo RK, 2017, CAN J REMOTE SENS, V43, P28, DOI 10.1080/07038992.2017.1259556; Dubayah R., 2020, SCI REMOTE SENS, V1, DOI DOI 10.1016/J.SRS.2020.100002; Engelhardt A, 2015, caret: Classification and Regression Training, V6, P81; Eskelson BNI, 2009, SCAND J FOREST RES, V24, P235, DOI 10.1080/02827580902870490; Falkowski MJ, 2010, CAN J FOREST RES, V40, P184, DOI 10.1139/X09-183; Goodbody TRH., 2019, CURR FOR REP; Hermosilla T., 2018, CAN J REMOTE SENS, V44, P67, DOI [10.1080/07038992.2018.1437719, DOI 10.1080/07038992.2018.1437719]; Hermosilla T, 2017, INT J APPL EARTH OBS, V63, P104, DOI 10.1016/j.jag.2017.07.013; Hermosilla T, 2016, INT J DIGIT EARTH, V9, P1035, DOI 10.1080/17538947.2016.1187673; Hermosilla T, 2015, REMOTE SENS ENVIRON, V170, P121, DOI 10.1016/j.rse.2015.09.004; Hermosilla T, 2015, REMOTE SENS ENVIRON, V158, P220, DOI 10.1016/j.rse.2014.11.005; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hudak AT, 2008, REMOTE SENS ENVIRON, V112, P2232, DOI 10.1016/j.rse.2007.10.009; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Kim AM, 2015, PROC SPIE, V9465, DOI 10.1117/12.2177431; Leutner B., 2018, RSTOOLBOX TOOLS REMO; Lim K, 2003, PROG PHYS GEOG, V27, P88, DOI 10.1191/0309133303pp360ra; Makela H, 2004, FOREST ECOL MANAG, V196, P245, DOI 10.1016/j.foreco.2004.02.049; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Matasci G, 2018, REMOTE SENS ENVIRON, V216, P697, DOI 10.1016/j.rse.2018.07.024; Matasci G, 2018, REMOTE SENS ENVIRON, V209, P90, DOI 10.1016/j.rse.2017.12.020; Mersmann O, 2015, MICROBENCHMARK ACCUR; Ministry of Forests Lands and Natural Resource Operations, 2018, GROUND SAMPL PROC; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Natural Resources Canada, 2018, STAT CAN FOR; Neumann TA, 2019, REMOTE SENS ENVIRON, V233, DOI 10.1016/j.rse.2019.111325; Nguyen TH, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111825; Penner M, 2013, CAN J REMOTE SENS, V39, P426, DOI 10.5589/m13-049; Pflugmacher D, 2014, REMOTE SENS ENVIRON, V151, P124, DOI 10.1016/j.rse.2013.05.033; Ploton P, 2020, SPATIAL VALIDATION R; Puliti S, 2018, REMOTE SENS ENVIRON, V204, P485, DOI 10.1016/j.rse.2017.10.007; R Core Team, 2013, R LANG ENV STAT COMP; Roussel JR, 2020, REMOTE SENS ENVIRON, V251, DOI 10.1016/j.rse.2020.112061; Saarela S, 2016, ANN FOREST SCI, V73, P895, DOI 10.1007/s13595-016-0590-1; Strunk JL, 2014, PHOTOGRAMM ENG REM S, V80, P143, DOI 10.14358/PERS.80.2.143-150; Sun GQ, 2011, REMOTE SENS ENVIRON, V115, P2906, DOI 10.1016/j.rse.2011.03.021; THOMSON K S, 1976, Postilla, P1; Tomppo E, 2008, REMOTE SENS ENVIRON, V112, P1982, DOI 10.1016/j.rse.2007.03.032; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; White JC, 2013, FOREST CHRON, V89, P722, DOI 10.5558/tfc2013-132; Wilkes P, 2015, REMOTE SENS-BASEL, V7, P12563, DOI 10.3390/rs70912563; Wulder MA, 2014, NATURE, V513, P30, DOI 10.1038/513030a; Wulder MA, 2012, CAN J REMOTE SENS, V38, P600, DOI 10.5589/m12-049; Wulder MA, 2008, FOREST CHRON, V84, P807, DOI 10.5558/tfc84807-6; Zald HSJ, 2016, REMOTE SENS ENVIRON, V176, P188, DOI 10.1016/j.rse.2016.01.015; Zhang HB, 2002, PATTERN RECOGN, V35, P1481, DOI 10.1016/S0031-3203(01)00137-6; Zhu Z, 2014, REMOTE SENS ENVIRON, V152, P217, DOI 10.1016/j.rse.2014.06.012	58	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0244846	10.1371/journal.pone.0244846	http://dx.doi.org/10.1371/journal.pone.0244846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507959	gold, Green Published			2022-12-26	WOS:000635021400021
J	Tanigawa, T; Watanabe, T; Higashimori, A; Shimada, S; Kitamura, H; Kuzumoto, T; Nadatani, Y; Otani, K; Fukunaga, S; Hosomi, S; Tanaka, F; Kamata, N; Nagami, Y; Taira, K; Shiba, M; Suda, W; Hattori, M; Fujiwara, Y				Tanigawa, Tetsuya; Watanabe, Toshio; Higashimori, Akira; Shimada, Sunao; Kitamura, Hiroyuki; Kuzumoto, Takuya; Nadatani, Yuji; Otani, Koji; Fukunaga, Shusei; Hosomi, Shuhei; Tanaka, Fumio; Kamata, Noriko; Nagami, Yasuaki; Taira, Koichi; Shiba, Masatsugu; Suda, Wataru; Hattori, Masahira; Fujiwara, Yasuhiro			Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiota	PLOS ONE			English	Article							SMALL-BOWEL INJURY; SALIVARY MICROBIOTA; GUT MICROBIOTA; MUCOSAL INJURY; RISK-FACTORS; NSAID; DYSBIOSIS; DIVERSITY; DISEASE; TRIAL	Non-steroidal anti-inflammatory drugs (NSAIDs) induce small intestinal damage. It has been reported that rebamipide, a mucoprotective drug, exerts a protective effect against NSAID-induced small intestinal damage; however, the underlying mechanism remains unknown. In this study, we investigated the significance of the small intestinal microbiota in the protective effect of rebamipide against indomethacin-induced small intestinal damage in mice. A comprehensive analysis of the 16S rRNA gene sequencing revealed an alteration in the composition of the small intestinal microbiota at the species level, modulated by the administration of rebamipide and omeprazole. The transplantation of the small intestinal microbiota of the mice treated with rebamipide suppressed the indomethacin-induced small intestinal damage. Omeprazole, a proton pump inhibitor, exacerbated the indomethacin-induced small intestinal damage, which was accompanied by the alteration of the small intestinal microbiota. We found that the transplantation of the small intestinal microbiota of the rebamipide-treated mice ameliorated indomethacin-induced small intestinal damage and the omeprazole-induced exacerbation of the damage. These results suggest that rebamipide exerts a protective effect against NSAID-induced small intestinal damage via the modulation of the small intestinal microbiota, and that its ameliorating effect extends also to the exacerbation of NSAID-induced small intestinal damage by proton pump inhibitors.	[Tanigawa, Tetsuya; Watanabe, Toshio; Higashimori, Akira; Shimada, Sunao; Kitamura, Hiroyuki; Kuzumoto, Takuya; Nadatani, Yuji; Otani, Koji; Fukunaga, Shusei; Hosomi, Shuhei; Tanaka, Fumio; Kamata, Noriko; Nagami, Yasuaki; Taira, Koichi; Shiba, Masatsugu; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Tanigawa, Tetsuya; Shimada, Sunao] Osaka City Juso Hosp, Dept Gastroenterol, Osaka, Japan; [Suda, Wataru; Hattori, Masahira] RIKEN, Ctr Integrat Med Sci, Lab Microbiome Sci, Yokohama, Kanagawa, Japan	Osaka Metropolitan University; RIKEN	Tanigawa, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan.; Tanigawa, T (corresponding author), Osaka City Juso Hosp, Dept Gastroenterol, Osaka, Japan.	ttanigawa@med.osaka-cu.ac.jp	Suda, Wataru/AAF-4469-2019; Tanaka, Fumio/HCI-5442-2022	Tanaka, Fumio/0000-0002-9186-1249; Tanigawa, Tetsuya/0000-0002-9305-1637				Alipour M, 2016, J CROHNS COLITIS, V10, P462, DOI 10.1093/ecco-jcc/jjv223; Blackler RW, 2015, AM J PHYSIOL-GASTR L, V308, pG994, DOI 10.1152/ajpgi.00066.2015; Cosorich I, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700492; DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Fujimori S, 2011, J GASTROENTEROL, V46, P57, DOI 10.1007/s00535-010-0332-3; Goldstein JL, 2007, ALIMENT PHARM THER, V25, P1211, DOI 10.1111/j.1365-2036.2007.03312.x; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Holler E, 2014, BIOL BLOOD MARROW TR, V20, P640, DOI 10.1016/j.bbmt.2014.01.030; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Imaeda H, 2012, DIGESTION, V86, P250, DOI 10.1159/000341508; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Isani M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196710; Iwasawa K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23870-w; Kim SW, 2020, TOXINS, V12, DOI 10.3390/toxins12070432; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kumari R, 2019, DIGEST DIS SCI, V64, P669, DOI 10.1007/s10620-018-5369-9; Kurata S, 2015, J CLIN BIOCHEM NUTR, V56, P20, DOI 10.3164/jcbn.14-67; Kurokawa S, 2014, J GASTROENTEROL, V49, P239, DOI 10.1007/s00535-013-0805-2; Lanza FL, 2009, AM J GASTROENTEROL, V104, P728, DOI 10.1038/ajg.2009.115; Liu P, 2020, J ETHNOPHARMACOL, V259, DOI 10.1016/j.jep.2020.112944; Lo Presti A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01655; Lopetuso LR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010183; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Mizukami K, 2011, WORLD J GASTROENTERO, V17, P5117, DOI 10.3748/wjg.v17.i46.5117; Mosca A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00455; Nadatani Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53559-7; Nilsen T, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01594-20; Pan FW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0440-5; Peled JU, 2020, NEW ENGL J MED, V382, P822, DOI 10.1056/NEJMoa1900623; Pellegrini S, 2017, J CLIN ENDOCR METAB, V102, P1468, DOI 10.1210/jc.2016-3222; Raj AS, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000068; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Satoh H, 2012, J PHARMACOL EXP THER, V343, P270, DOI 10.1124/jpet.112.197475; Shimada S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211436; Shimada S, 2017, SCAND J GASTROENTERO, V52, P1219, DOI 10.1080/00365521.2017.1349174; Staffas A, 2017, BLOOD, V129, P927, DOI 10.1182/blood-2016-09-691394; Sugimori S, 2008, DIGESTION, V78, P208, DOI 10.1159/000190403; Suzuki Y, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0737-z; Takashima S, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13841; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Todorov SD, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.581778; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Washio E, 2016, CLIN GASTROENTEROL H, V14, P809, DOI 10.1016/j.cgh.2015.10.022; Watanabe T, 2020, J GASTROENTEROL, V55, P481, DOI 10.1007/s00535-019-01657-8; Watanabe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122330; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Zhang SH, 2013, DIGEST DIS SCI, V58, P1991, DOI 10.1007/s10620-013-2606-0	51	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245995	10.1371/journal.pone.0245995	http://dx.doi.org/10.1371/journal.pone.0245995			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507971	Green Published, gold			2022-12-26	WOS:000635021400071
J	Hao, Z; Li, Z; Huo, JJ; Li, JD; Liu, FH; Yin, P				Hao, Zhuang; Li, Zhen; Huo, Jinjin; Li, Jiandong; Liu, Fenghua; Yin, Peng			Effects of Chinese wolfberry and Astragalus extract on the antioxidant capacity of Tibetan pig liver	PLOS ONE			English	Article							PEROXISOMES	The objective of this study is to determine the effect of Chinese wolfberry (Lycium barbarum) and Astragalus (Astragalus membranaceus) extract (WAE) on the antioxidant capacity of Tibetan pig liver, and discussed the regulatory effect of WAE on the liver antioxidant mechanism. Twelve healthy 120-day-old Tibetan black pigs (35 +/- 2 kg) were divided randomly into two groups. The WAE group was fed a basal diet supplemented with 1% WAE for 90 days. The control group was fed the same diet, but without the WAE. We found that liver superoxide dismutase 1 (SOD1) activity (P<0.05), total antioxidative capacity (T-AOC) (P<0.05), and catalase (CAT) activity (P<0.01) significantly increased in the WAE group compared with the control group; malondialdehyde (MDA) content decreased, but this was not significant (P >0.05). Transcriptome sequencing analysis detected 106 differentially expressed genes (DEGs) related to oxidative stress. GO enrichment analysis showed these DEGs were involved in the positive regulation of reactive oxygen metabolism and biosynthesis, process regulation, and regulation of the oxidative stress response. KEGG Pathway enrichment analysis showed they were enriched in the PI3K-Akt, AMPK, Rap1, and peroxisome signaling pathways. The expression levels of key peroxisome biosynthesis genes (e.g., PEX3 and PEX11B) and key antioxidant genes (e.g., CAT and SOD1) were significantly higher in the WAE group than in the control group. The PRDX1 and PRDX5 content also was significantly higher in the WAE group. This study showed that the WAE regulated the antioxidant and anti-stress ability of Tibetan pig liver through a "peroxisome antioxidant-oxidant stress" signaling pathway.	[Hao, Zhuang; Li, Zhen; Huo, Jinjin; Li, Jiandong; Liu, Fenghua] Beijing Univ Agr, Coll Anim Sci & Technol, Beijing, Peoples R China; [Yin, Peng] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Beijing University of Agriculture; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, FH (corresponding author), Beijing Univ Agr, Coll Anim Sci & Technol, Beijing, Peoples R China.; Yin, P (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	liufenghua1209@126.com; leilaileila@126.com			Beijing Municipal Science and Technology Project [D171100002117002]	Beijing Municipal Science and Technology Project	This work was supported by a grant from Beijing Municipal Science and Technology Project (No. D171100002117002).	Abdelaziz AR, 2019, J INVEST DERMATOL, V139, pB3, DOI 10.1016/j.jid.2019.06.012; Alagawany M, 2018, POULTRY SCI; Amagase H, 2011, FOOD RES INT, V44, P1702, DOI 10.1016/j.foodres.2011.03.027; Aranovich A, 2014, J CELL SCI, V127, P3675, DOI 10.1242/jcs.146282; Bajor M, 2018, BRIT J CANCER, V119, P873, DOI 10.1038/s41416-018-0263-y; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonekamp NA, 2010, BIOFACTORS OXFORD EN, V35, P345; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chen JS, 2020, J ANIM PHYSIOL AN N, V104, P1106, DOI 10.1111/jpn.13247; Delille HK, 2009, HISTOCHEM CELL BIOL, V131, P441, DOI 10.1007/s00418-009-0561-9; DHAUNSI GS, 1992, J BIOL CHEM, V267, P6870; Ding CB, 2017, J CELL MOL MED, V21, P193, DOI 10.1111/jcmm.12955; ECONOMOU KD, 1991, J AM OIL CHEM SOC, V68, P109, DOI 10.1007/BF02662329; Ellah MRA, 2010, COMP CLIN PATHOL, V19, P615; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Fagarasanu A, 2007, ANNU REV CELL DEV BI, V23, P321, DOI 10.1146/annurev.cellbio.23.090506.123456; Farag MR, 2018, ECOTOX ENVIRON SAFE, V156, P311, DOI 10.1016/j.ecoenv.2018.03.010; Feng Y, 2018, J FORESTRY RES, V29, P851, DOI 10.1007/s11676-017-0472-x; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Gueant JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03054-w; Gulcin I, 2004, FOOD CHEM, V87, P393, DOI 10.1016/j.foodchem.2003.12.008; Gunawan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072298; Guo WW, 2018, INT J BIOL MACROMOL, V112, P608, DOI 10.1016/j.ijbiomac.2018.02.009; Han R, 2017, MOL MED REP, V15; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Huang YF, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9573291; Jia L, 2016, SCI REP-UK, V6, DOI 10.1038/srep36209; Jia N, 2019, INT J BIOL MACROMOL, V132, P213, DOI 10.1016/j.ijbiomac.2019.03.196; Jiang JB, 2010, INT J RHEUM DIS, V13, P396, DOI 10.1111/j.1756-185X.2010.01555.x; Kim W, 2015, J TRADITIONAL COMPLE, V6, P294, DOI [10.1016/j.jtcme.2015.10.002PMID:27419096, DOI 10.1016/J.JTCME.2015.10.002PMID:27419096]; Kinoshita N, 1998, J BIOL CHEM, V273, P24122, DOI 10.1074/jbc.273.37.24122; Knoops B, 2011, ANTIOXID REDOX SIGN, V15, P817, DOI 10.1089/ars.2010.3584; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAZAROW PB, 1985, ANNU REV CELL BIOL, V1, P489, DOI 10.1146/annurev.cb.01.110185.002421; Li MH, 2011, LWT-FOOD SCI TECHNOL, V44, P1745, DOI 10.1016/j.lwt.2011.02.017; Li XM, 2007, INT J BIOL MACROMOL, V40, P461, DOI 10.1016/j.ijbiomac.2006.11.002; Liu YH, 2018, ANIM NUTR, V4, P113, DOI 10.1016/j.aninu.2018.01.007; Lopez-Lluch G, 2008, EXP GERONTOL, V43, P813, DOI 10.1016/j.exger.2008.06.014; Matsuzaki T, 2008, J CELL BIOL, V183, P1275, DOI 10.1083/jcb.200806062; Matsuzono Y, 1999, P NATL ACAD SCI USA, V96, P2116, DOI 10.1073/pnas.96.5.2116; McAlpine K. E., 2020, INT J MOL SCI, V101; Oboh G, 2007, FOOD CHEM, V102, P178, DOI 10.1016/j.foodchem.2006.05.048; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Samborski A, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107870; Sanchez-Valle V, 2012, CURR MED CHEM, V19, P4850, DOI 10.2174/092986712803341520; Schrader M, 2007, BIOESSAYS, V29, P1105, DOI 10.1002/bies.20659; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Slamenova D, 2008, NEOPLASMA, V55, P394; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stolz DB, 2002, HEPATOLOGY, V36, P81, DOI 10.1053/jhep.2002.33716; Tiippana E, 2016, SCAND J PAIN, V12, P19, DOI 10.1016/j.sjpain.2016.02.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner-Ivey B, 2013, ONCOGENE, V32, P5302, DOI 10.1038/onc.2012.624; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wu JD, 2010, J HEPATOL, V53, P73, DOI 10.1016/j.jhep.2010.01.032; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Yang RF, 2015, J FUNCT FOODS, V17, P903, DOI 10.1016/j.jff.2015.06.045; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yong JW, 2012, PLOS ONE, V7; Zhang Q, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28696; Zhou Y, 2015, J MOL NEUROSCI, V55, P941, DOI 10.1007/s12031-014-0449-6; Zhu J, 2013, CARBOHYD POLYM, V98, P8, DOI 10.1016/j.carbpol.2013.04.057	67	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245749	10.1371/journal.pone.0245749	http://dx.doi.org/10.1371/journal.pone.0245749			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503027	gold, Green Published			2022-12-26	WOS:000613751800033
J	Ben Lagha, A; Pellerin, G; Vaillancourt, K; Grenier, D				Ben Lagha, Amel; Pellerin, Genevieve; Vaillancourt, Katy; Grenier, Daniel			Effects of a tart cherry (Prunus cerasus L.) phenolic extract on Porphyromonas gingivalis and its ability to impair the oral epithelial barrier	PLOS ONE			English	Article							POLYPHENOLS; IRON; PATHOGENESIS; PERIODONTITIS; GINGIPAINS; MECHANISMS; EXPRESSION; CLAUDIN-4; VIRULENCE; OCCLUDIN	Periodontal diseases, including gingivitis and periodontitis, are a global oral health problem. Porphyromonas gingivalis, a key pathogen involved in the onset of periodontitis, is able to colonize the subgingival epithelium and invade the underlying connective tissue due to the contribution of cysteine proteases known as gingipains. In this study, we investigated the effects of a phenolic extract prepared from tart cherry (Prunus cerasus L.) juice on the growth, adherence, and protease activity of P. gingivalis. We also assessed the protective effect of the tart cherry extract on the disruption of the oral epithelial barrier induced by P. gingivalis. The tart cherry extract that contains procyanidins and quercetin and its derivatives (rutinoside, glucoside) as the most important phenolic compounds attenuated P. gingivalis growth, reduced adherence to an experimental basement membrane matrix model, and decreased the protease activities of P. gingivalis. The tart cherry extract also exerted a protective effect on the integrity of the oral epithelial barrier in an in vitro model infected with P. gingivalis. More specifically, the extract prevented a decrease in transepithelial electrical resistance as well as the destruction of tight junction proteins (zonula occludens-1 and occludin). These results suggest that the tart cherry phenolic extract may be a promising natural product for the treatment of periodontitis through its ability to attenuate the virulence properties of P. gingivalis and curtail the ability of this pathogen to impair the oral epithelial barrier.	[Ben Lagha, Amel; Pellerin, Genevieve; Vaillancourt, Katy; Grenier, Daniel] Univ Laval, Oral Ecol Res Grp, Fac Dent, Quebec City, PQ, Canada	Laval University	Grenier, D (corresponding author), Univ Laval, Oral Ecol Res Grp, Fac Dent, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Grenier, Daniel/E-5557-2015	Grenier, Daniel/0000-0003-0878-4674	Laboratoire de Contro le Microbiologique de l'Universite Laval [2020-11]	Laboratoire de Contro le Microbiologique de l'Universite Laval	DG; 2020-11; Laboratoire de Contro le Microbiologique de l'Universite Laval; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba CMA, 2019, CRIT REV FOOD SCI, V59, P626, DOI 10.1080/10408398.2017.1384918; Allaker RP, 2015, VIRULENCE, V6, P196, DOI 10.4161/21505594.2014.983783; Amano A, 2003, J PERIODONTOL, V74, P90, DOI 10.1902/jop.2003.74.1.90; Amasheh M, 2008, J NUTR, V138, P1067, DOI 10.1093/jn/138.6.1067; Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; [Anonymous], 2018, AM J TRANSPLANT S1, V18, P10, DOI DOI 10.1109/JSEN.2018.2870228; Ben Lagha A, 2020, ANAEROBE, V65, DOI 10.1016/j.anaerobe.2020.102266; Ben Lagha A, 2020, PHYTOTHER RES, V34, P886, DOI 10.1002/ptr.6574; Ben Lagha A, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty030; Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525; Bodet C, 2006, J DENT RES, V85, P235, DOI 10.1177/154405910608500306; Carrasco-Pozo C, 2013, J AGR FOOD CHEM, V61, P5291, DOI 10.1021/jf400150p; Cekici A, 2014, PERIODONTOL 2000, V64, P57, DOI 10.1111/prd.12002; Chai SC, 2018, FOOD FUNCT, V9, P3185, DOI [10.1039/C8FO00468D, 10.1039/c8fo00468d]; Checchi V, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17144923; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Feghali K, 2012, J AGR FOOD CHEM, V60, P5728, DOI 10.1021/jf203304v; Fitzpatrick RE, 2009, FUTURE MICROBIOL, V4, P471, DOI 10.2217/FMB.09.18; Frencken JE, 2017, J CLIN PERIODONTOL, V44, pS94, DOI 10.1111/jcpe.12677; Grenier D, 2003, INFECT IMMUN, V71, P4742, DOI 10.1128/IAI.71.8.4742-4748.2003; Grenier D, 2011, CURR DRUG TARGETS, V12, P322, DOI 10.2174/138945011794815310; Groger S, 2008, J PERIODONTAL RES, V43, P604, DOI 10.1111/j.1600-0765.2007.01019.x; Groeger S, 2010, EUR J ORAL SCI, V118, P582, DOI 10.1111/j.1600-0722.2010.00782.x; Hajishengallis G, 2014, TRENDS IMMUNOL, V35, P3, DOI 10.1016/j.it.2013.09.001; Hajishengallis G, 2012, ADV EXP MED BIOL, V946, P69, DOI 10.1007/978-1-4614-0106-3_5; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kelley DS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030368; Khokhar S, 2003, FOOD CHEM, V81, P133, DOI 10.1016/S0308-8146(02)00394-1; Kirakosyan A, 2018, FOOD CHEM, V252, P142, DOI 10.1016/j.foodchem.2018.01.084; Konkel JE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01403; Lamont RJ, 2018, NAT REV MICROBIOL, V16, P745, DOI 10.1038/s41579-018-0089-x; Lemanceau P, 2009, ADV BOT RES, V51, P491, DOI 10.1016/S0065-2296(09)51012-9; Lopez NJ, 2000, J PERIODONTOL, V71, P948, DOI 10.1902/jop.2000.71.6.948; McCune LM, 2011, CRIT REV FOOD SCI, V51, P1, DOI 10.1080/10408390903001719; Mila I, 1996, PHYTOCHEMISTRY, V42, P1551, DOI 10.1016/0031-9422(96)00174-4; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nakayama M, 2017, JPN DENT SCI REV, V53, P134, DOI 10.1016/j.jdsr.2017.06.001; Nigri F, 2016, SURG NEUROL INT S31, V7, pS785; Ohya M, 2016, MICROB PATHOGENESIS, V94, P54, DOI 10.1016/j.micpath.2015.10.016; Pan WY, 2019, INT J ORAL SCI, V11, DOI 10.1038/s41368-019-0064-z; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Vitale KC, 2017, CURR SPORT MED REP, V16, P230, DOI 10.1249/JSR.0000000000000385; Wang SS, 2019, LIFE SCI, V227, P129, DOI 10.1016/j.lfs.2019.04.029; Wilensky A, 2015, J INNATE IMMUN, V7, P127, DOI 10.1159/000365970; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	49	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246194	10.1371/journal.pone.0246194	http://dx.doi.org/10.1371/journal.pone.0246194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497417	Green Published, gold			2022-12-26	WOS:000613707100027
J	Heikkila, AR; Elovainio, M; Raaska, H; Matomaki, J; Sinkkonen, J; Lapinleimu, H				Heikkila, Anna-Riitta; Elovainio, Marko; Raaska, Hanna; Matomaki, Jaakko; Sinkkonen, Jari; Lapinleimu, Helena			Intestinal parasites may be associated with later behavioral problems in internationally adopted children	PLOS ONE			English	Article							INFECTIOUS-DISEASES; IRON-DEFICIENCY; GUT MICROBIOTA; HEALTH; DISORDER; GROWTH	Aim At arrival in new home country, internationally adopted children often have intestinal parasites. International adoptees also exhibit more behavioral problems than their biological peers. We examined whether intestinal parasite infections in international adoptees on arrival in Finland are associated with their later behavioral and emotional problems. Methods Data for this study were sourced from the Finnish Adoption Study (FinAdo) based on parental questionnaires for all internationally adopted children under 18 years (n = 1450) who arrived in Finland from 1985 to 2007. A total of 1293 families provided sufficient information on the adoptee's background, parasitic status on arrival, and behavioral symptoms at the median time of 5 years after arrival (mean age = 7.8 years). Behavioral and emotional disorders were evaluated with the Child Behavior Checklist (CBCL). Statistical analyses were conducted using linear regression. Results Of the 1293 families, parents of 206 adoptive children reported intestinal parasites in their adopted children on arrival. Parasite-infected children had subsequently higher CBCL problem scores than the children without parasites (p < 0.001). The association between intestinal parasites and later behavioral problems was stronger than that between intestinal parasites and any other factors measured in this study, except disability. Limitations The control group was naturally provided by the adopted children without parasite infections, but we could not compare the adopted children to non-adopted children without a defined parasite infection. We were unable to specify the effects associated with a specific parasite type. It was not possible either to include multiple environmental factors that could have been associated with behavioral problems in the models, which indicated only modest explanatory values. Conclusions In this study, intestinal parasite infections in early childhood may be associated with children's later psychological wellbeing, even in children who move to a country with a low prevalence of parasites. Our findings may support further developments pertaining to the gut-brain theory.	[Heikkila, Anna-Riitta] Univ Helsinki, Dept Pediat, Helsinki, Finland; [Heikkila, Anna-Riitta] Helsinki Univ Hosp, Helsinki, Finland; [Elovainio, Marko] Univ Helsinki, Fac Med, Res Program Unit, Helsinki, Finland; [Elovainio, Marko] Finnish Inst Hlth & Welf, Helsinki, Finland; [Raaska, Hanna] Helsinki Univ Hosp, Dept Child Psychiat, Helsinki, Finland; [Matomaki, Jaakko] Turku Univ Hosp, Clin Res Ctr, Turku, Finland; [Sinkkonen, Jari] Univ Turku, Dept Child Psychiat, Turku, Finland; [Lapinleimu, Helena] Univ Turku, Dept Pediat & Adolescent Med, Turku, Finland; [Lapinleimu, Helena] Turku Univ Hosp, Turku, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku	Heikkila, AR (corresponding author), Univ Helsinki, Dept Pediat, Helsinki, Finland.; Heikkila, AR (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	anna-riitta.heikkila@helsinki.fi	Lapinleimu, Helena/AAT-8415-2021	Elovainio, Marko/0000-0002-1401-1910	The Foundation of Pediatric Research, Finland; Finland's Slot Machine Association (RAY); Gyllenberg Association; Foundation for Pediatric Research, Finland; EVO Grant from Turku University Hospital; Tiukula foundation; Yrjo Jahnsson Association; Finnish Cultural Foundation; VarsinaisSuomi Regional fund; The Tiukula Foundation	The Foundation of Pediatric Research, Finland; Finland's Slot Machine Association (RAY); Gyllenberg Association; Foundation for Pediatric Research, Finland; EVO Grant from Turku University Hospital; Tiukula foundation; Yrjo Jahnsson Association; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); VarsinaisSuomi Regional fund; The Tiukula Foundation	AH: The Foundation of Pediatric Research, Finland (personal grant, no specific grant number), https://www.lastentautientutkimussaatio.fi HL: Finland's Slot Machine Association (RAY) (personal grant, no specific grant number), https://www.stea.fi/web/en/frontpage; The Gyllenberg Association (personal grant, no specific grant number), https://gyllenbergs.fi; the Foundation for Pediatric Research, Finland (personal grant, no specific grant number), www.lastentautientutkimussaatio.fi; EVO Grant from Turku University Hospital (personal grant, no specific grant number), https://www.utu.fi/fi/tutkimus/tutkimusrahoituksen-tuki; The Tiukula foundation (personal grant, no specific grant number); the Yrjo Jahnsson Association (personal grant, no specific grant number) https://www.yjs.fi; Finnish Cultural Foundation, VarsinaisSuomi Regional fund (personal grant, no specific grant number) https://skr.fi/en received consultation fees from the following national adoption organizations in Finland: Interpedia, Save the Children Association Finland., and the international adoption service of the City of Helsinki. JS: The Tiukula Foundation (personal grant, no specific grant number); Finland's Slot Machine Association (RAY) (personal grant, no specific grant number), https://www.stea.fi/web/en/frontpage The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Afrin T, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00217; Beatty JK, 2017, INT J PARASITOL, V47, P311, DOI 10.1016/j.ijpara.2016.11.010; Bruch JD, 2016, BRAIN BEHAV IMMUN, V57, P222, DOI 10.1016/j.bbi.2016.05.014; Buonsenso D, 2019, PEDIATR INFECT DIS J, V38, P983, DOI 10.1097/INF.0000000000002399; Cenit MC, 2017, WORLD J GASTROENTERO, V23, P5486, DOI 10.3748/wjg.v23.i30.5486; Chiappini E, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00448; Chiappini E, 2018, ACTA PAEDIATR, V107, P1581, DOI 10.1111/apa.14237; Cohen NJ, 2008, J CHILD PSYCHOL PSYC, V49, P458, DOI 10.1111/j.1469-7610.2007.01853.x; Dekker MC, 2002, J CHILD PSYCHOL PSYC, V43, P1087, DOI 10.1111/1469-7610.00235; Doenyas C, 2018, NEUROSCIENCE, V374, P271, DOI 10.1016/j.neuroscience.2018.01.060; Doom JR, 2015, DEVELOPMENTAL SCI, V18, P484, DOI 10.1111/desc.12223; Doom JR, 2014, CHILD DEV, V85, P1805, DOI 10.1111/cdev.12231; Fuglestad AJ, 2008, J PEDIATR-US, V153, P272, DOI 10.1016/j.jpeds.2008.02.048; Fuglestad AJ, 2016, ACTA PAEDIATR, V105, pE67, DOI 10.1111/apa.13234; Fuglestad AJ, 2013, MATERN CHILD HLTH J, V17, P1080, DOI 10.1007/s10995-012-1090-z; Ganci M, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1408; Gilliam W, 2000, EARLY CHILD DEV CARE, V162, P9, DOI DOI 10.1080/0300443001620102; Hawk B, 2010, CLIN CHILD FAM PSYCH, V13, P199, DOI 10.1007/s10567-010-0068-x; Henaff F, 2015, J TRAVEL MED, V22, P179, DOI 10.1111/jtm.12196; Iizumi T, 2017, ARCH MED RES, V48, P727, DOI 10.1016/j.arcmed.2017.11.004; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016; Juffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501, DOI 10.1001/jama.293.20.2501; Kim HN, 2018, BRAIN BEHAV IMMUN, V69, P374, DOI 10.1016/j.bbi.2017.12.012; Loughman A, 2020, EBIOMEDICINE, V52, DOI 10.1016/j.ebiom.2020.102640; Miller L, 2005, PEDIATRICS, V115, pE710, DOI 10.1542/peds.2004-2359; Miller LC, 2008, MATERN CHILD HLTH J, V12, P599, DOI 10.1007/s10995-007-0274-4; Miller LC, 2007, ACTA PAEDIATR, V96, P1765, DOI 10.1111/j.1651-2227.2007.00537.x; Miller LC, 2005, CLIN INFECT DIS, V40, P286, DOI 10.1086/427109; Miller LC, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e76; Murray J, 2010, CAN J PSYCHIAT, V55, P633, DOI 10.1177/070674371005501003; Neuman H, 2018, FEMS MICROBIOL REV, V42, P489, DOI 10.1093/femsre/fuy018; Nielsen AV, 2020, ACTA PAEDIATR, V109, P1004, DOI 10.1111/apa.15045; Oliveira D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137327; Partida-Rodriguez O, 2017, ARCH MED RES, V48, P690, DOI 10.1016/j.arcmed.2017.11.015; Raaska H, 2012, CHILD CARE HLTH DEV, V38, P697, DOI 10.1111/j.1365-2214.2011.01289.x; Saiman L, 2001, PEDIATRICS, V108, P608, DOI 10.1542/peds.108.3.608; Serra D, 2019, MOL NEUROBIOL, V56, P6941, DOI 10.1007/s12035-019-1572-8; Simsek Z, 2004, J TROP PEDIATRICS, V50, P90, DOI 10.1093/tropej/50.2.90; Slykerman RF, 2017, ACTA PAEDIATR, V106, P87, DOI 10.1111/apa.13613; Staat MA, 2011, PEDIATRICS, V128, pE613, DOI 10.1542/peds.2010-3032; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Toro-Londono MA, 2019, PEERJ, V7, DOI 10.7717/peerj.6200; Totaro C, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay036; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; Van Kesteren L, 2017, ACTA CLIN BELG, V72, P300, DOI 10.1080/17843286.2016.1258178; van Schaik R, 2009, EUR J PEDIATR, V168, P1101, DOI 10.1007/s00431-008-0895-7; Weitzman C, 2005, PEDIATR CLIN N AM, V52, P1395, DOI 10.1016/j.pcl.2005.06.009; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Ximenez C, 2017, ARCH MED RES, V48, P666, DOI 10.1016/j.arcmed.2017.11.007; Zaiss MM, 2016, PARASITE IMMUNOL, V38, P5, DOI 10.1111/pim.12274; Zavala GA, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12518	53	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245786	10.1371/journal.pone.0245786	http://dx.doi.org/10.1371/journal.pone.0245786			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ9QF	33493225	gold, Green Published			2022-12-26	WOS:000613081500031
J	Narzi, D; van Keulen, SC; Rothlisberger, U				Narzi, Daniele; van Keulen, Siri C.; Rothlisberger, Ursula			G alpha(i1) inhibition mechanism of ATP-bound adenylyl cyclase type 5	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; COINCIDENCE DETECTOR; CATALYTIC MECHANISM; PROTEIN-KINASE; DOMAIN MOTIONS; ION CHANNELS; DYNAMICS; EXPRESSION; PARAMETERS; SIGNALS	Conversion of adenosine triphosphate (ATP) to the second messenger cyclic adenosine monophosphate (cAMP) is an essential reaction mechanism that takes place in eukaryotes, triggering a variety of signal transduction pathways. ATP conversion is catalyzed by the enzyme adenylyl cyclase (AC), which can be regulated by binding inhibitory, G alpha(i), and stimulatory, G alpha(s) subunits. In the past twenty years, several crystal structures of AC in isolated form and complexed to G alpha(s) subunits have been resolved. Nevertheless, the molecular basis of the inhibition mechanism of AC, induced by G alpha(i), is still far from being fully understood. Here, classical molecular dynamics simulations of the isolated holo AC protein type 5 and the holo binary complex AC5:G alpha(i) have been analyzed to investigate the conformational impact of G alpha(i) association on ATP-bound AC5. The results show that G alpha(i) appears to inhibit the activity of AC5 by preventing the formation of a reactive ATP conformation.	[Narzi, Daniele; van Keulen, Siri C.; Rothlisberger, Ursula] Ecole Polytech Fed Lausanne EPFL, Inst Sci & Ingn Chim, Lausanne, Switzerland; [Narzi, Daniele] Univ Aquila, Dipartimento Sci Fis & Chim, Laquila, Italy; [van Keulen, Siri C.] Univ Utrecht, Bijvoet Ctr Biomol Res, Computat Struct Biol Grp, Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of L'Aquila; Utrecht University	Rothlisberger, U (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Sci & Ingn Chim, Lausanne, Switzerland.	ursula.roethlisberger@epfl.ch		Narzi, Daniele/0000-0003-2731-6286	Swiss National Science Foundation; European Union [720270]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	This work was supported by the Swiss National Science Foundation and computer time on the CSCS Piz Daint cluster. This project/research has received funding from the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement 720270 (Human Brain Project SGA1).	Allner O, 2012, J CHEM THEORY COMPUT, V8, P1493, DOI 10.1021/ct3000734; ANHOLT RRH, 1994, TRENDS NEUROSCI, V17, P37, DOI 10.1016/0166-2236(94)90033-7; BEKKER H, 1993, PHYSICS COMPUTING '92, P252; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Bruce NJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007382; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen-Goodspeed M, 2005, J BIOL CHEM, V280, P1808, DOI 10.1074/jbc.M409172200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; Dessauer CW, 1998, J BIOL CHEM, V273, P25831, DOI 10.1074/jbc.273.40.25831; Frezza E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196207; GLATT CE, 1993, NATURE, V361, P536, DOI 10.1038/361536a0; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Hahn DK, 2015, BIOCHEMISTRY-US, V54, P6252, DOI 10.1021/acs.biochem.5b00655; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; LUSTIG KD, 1993, J BIOL CHEM, V268, P13900; McVey M, 1999, J BIOL CHEM, V274, P18887, DOI 10.1074/jbc.274.27.18887; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; Mons N, 1999, CELL MOL LIFE SCI, V55, P525, DOI 10.1007/s000180050311; Nair AG, 2015, J NEUROSCI, V35, P14017, DOI 10.1523/JNEUROSCI.0730-15.2015; Nakamura T, 2012, NATURE, V487, P196, DOI 10.1038/nature11181; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PEDARZANI P, 1995, P NATL ACAD SCI USA, V92, P11716, DOI 10.1073/pnas.92.25.11716; Preininger AM, 2003, BIOCHEMISTRY-US, V42, P7931, DOI 10.1021/bi0345438; Qi C, 2019, SCIENCE, V364, P389, DOI 10.1126/science.aav0778; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; STEITZ TA, 1993, CURR OPIN STRUC BIOL, V3, P31, DOI 10.1016/0959-440X(93)90198-T; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; van Keulen SC, 2017, BIOCHEMISTRY-US, V56, P271, DOI 10.1021/acs.biochem.6b00388; van Keulen SC, 2019, BIOCHEMISTRY-US, V58, P4317, DOI 10.1021/acs.biochem.9b00662; van Keulen SC, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005673; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621	51	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245197	10.1371/journal.pone.0245197	http://dx.doi.org/10.1371/journal.pone.0245197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493164	Green Published, gold			2022-12-26	WOS:000613081500062
J	Zhang, SJ; Hu, BB; Zhang, XF				Zhang, Shujing; Hu, Beibei; Zhang, Xiufeng			Have FDI quantity and quality promoted the low-carbon development of science and technology parks (STPs)? The threshold effect of knowledge accumulation	PLOS ONE			English	Article							FOREIGN DIRECT-INVESTMENT; ECONOMIC-GROWTH; ENERGY-CONSUMPTION; CHINA; SPILLOVERS; IMPACT; INNOVATION; EMISSIONS; POLLUTION; TRADE	In recent times, China has emphasized five major development concepts to promote high-quality development: coordination, green, innovation, openness, and sharing. As a metamorphosis of these ideas, Chinese science and technology parks (STPs) are gathering areas of high-tech industries and represent advanced productive forces. Their greenness, openness, and innovative developments herald the future development trends of China. Based on the data of 52 STPs in China from 2011 to 2018, this study analyzes the impact of foreign direct investment (FDI) quantity and quality on the low-carbon development of the STPs. We use Hansen's nonlinear panel threshold regression model with knowledge accumulation as the threshold variable. The results show the following: First, there are complex nonlinear relationships between FDI quantity, FDI quality, and the low-carbon development of the STPs. Second, FDI quantity has a significant positive impact on the low-carbon development of the STPs only when the level of knowledge accumulation is below a certain threshold. Beyond this threshold the effect is no longer significant. Third, FDI quality has a significant positive impact on the low-carbon development of STPs only when the level of knowledge accumulation is lower than a certain threshold; beyond which, the impact is no longer significant. These results can serve as a reference for China to effectively promote economic low-carbon growth of STPs and achieve green, open, and innovative development.	[Zhang, Shujing] North China Univ Water Resources & Elect Power, Sch Management & Econ, Zhengzhou, Peoples R China; [Hu, Beibei] Chinese Acad Sci, Inst Sci & Dev, Beijing, Peoples R China; [Zhang, Xiufeng] Henan Normal Univ, Business Sch, Xinxiang, Henan, Peoples R China	North China University of Water Resources & Electric Power; Chinese Academy of Sciences; Henan Normal University	Hu, BB (corresponding author), Chinese Acad Sci, Inst Sci & Dev, Beijing, Peoples R China.	hubeibei@casisd.cn	García, Francisco/AAJ-5004-2021	zhang, xiufeng/0000-0002-5401-4665				Ahmad M, 2021, ECON INNOV NEW TECH, V30, P89, DOI 10.1080/10438599.2019.1684643; Alfaro L, 2004, J INT ECON, V64, P89, DOI 10.1016/S0022-1996(03)00081-3; [Anonymous], 2008, PSYCHOONCOLOGY, V17, pS1, DOI 10. 1002/pon. 1389; [Anonymous], 2002, IND OWNERSHIP ENV PE; Antweiler W, 2001, AM ECON REV, V91, P877, DOI 10.1257/aer.91.4.877; Baumol WJ., 1988, THEORY ENV POLICY, V2, DOI 10.1017/CBO9781139173513; Birdsall N, 1993, J ENVIRON DEV, V2, P137, DOI [DOI 10.1177/107049659300200107, 10.1177/107049659300200107]; Blackman A, 1999, ENERG POLICY, V27, P695, DOI 10.1016/S0301-4215(99)00063-4; Borensztein E, 1998, J INT ECON, V45, P115, DOI 10.1016/S0022-1996(97)00033-0; Bu ML, 2019, ENERG ECON, V80, P366, DOI 10.1016/j.eneco.2019.01.003; Cheng ZH, 2020, J ENVIRON MANAGE, V265, DOI 10.1016/j.jenvman.2020.110532; Crosby M, 2000, ECON REC, V76, P255, DOI 10.1111/j.1475-4932.2000.tb00021.x; Fan WY, 2020, RENEW ENERG, V146, P598, DOI 10.1016/j.renene.2019.06.170; Feng YC, 2019, J CLEAN PROD, V235, P210, DOI 10.1016/j.jclepro.2019.06.184; FINDLAY R, 1978, Q J ECON, V92, P1, DOI 10.2307/1885996; Gilbert BA, 2008, J BUS VENTURING, V23, P405, DOI 10.1016/j.jbusvent.2007.04.003; Glass AJ, 1998, J DEV ECON, V55, P369, DOI 10.1016/S0304-3878(98)00041-8; GRILICHES Z, 1990, J ECON LIT, V28, P1661, DOI 10.3386/w3301; Hansen BE, 1999, J ECONOMETRICS, V93, P345, DOI 10.1016/S0304-4076(99)00025-1; He J, 2006, ECOLOGICAL EC, V60; Hedong Liu, EMPIRICAL RES TECHNO; Hu AGZ, 2007, RES POLICY, V36, P76, DOI 10.1016/j.respol.2006.08.003; Hubler M, 2010, ENVIRON DEV ECON, V15, P59, DOI 10.1017/S1355770X09990088; Jiang D, 2005, WORLD ECON, P5; Jiang D., 2006, WORLD ECON, V10, P21; Keller W, 2002, REV ECON STAT, V84, P691, DOI 10.1162/003465302760556503; KOKKO A, 1994, J DEV ECON, V43, P279, DOI 10.1016/0304-3878(94)90008-6; Li L., 2016, MANAG REV, V28, P11; Li Wenwen, 2018, J CLEANER PRODUCTION, V170; List JA, 2000, J ENVIRON ECON MANAG, V40, P1, DOI 10.1006/jeem.1999.1095; Liu QQ, 2018, SCI TOTAL ENVIRON, V613, P521, DOI 10.1016/j.scitotenv.2017.09.110; Liu XH, 2008, J WORLD BUS, V43, P352, DOI 10.1016/j.jwb.2007.11.004; Marques Antonio Cardoso, STRUCTURAL CHANGE EC, V20; Mielnik O, 2002, ENERG POLICY, V30, P87, DOI 10.1016/S0301-4215(01)00080-5; Nieto M, 2005, TECHNOVATION, V25, P1141, DOI 10.1016/j.technovation.2004.05.001; Qi S, 2011, WORLD EC RES, V11, P69; Rahman ZU, 2019, CARBON MANAG, V10, P227, DOI 10.1080/17583004.2019.1577179; Rahman Zia Ur, 2019, SINGAP ECON REV, V66, P1, DOI [10.1142/S0217590819500176, DOI 10.1142/S0217590819500176]; Ren SG, 2014, ENERG POLICY, V69, P624, DOI 10.1016/j.enpol.2014.02.032; Salim R, 2017, ENERG ECON, V66, P43, DOI 10.1016/j.eneco.2017.05.026; Su YQ, 2016, CHINA ECON REV, V37, P97, DOI 10.1016/j.chieco.2015.12.007; Sung B, 2018, ECON SYST, V42, P320, DOI 10.1016/j.ecosys.2017.06.002; Suyanto M, 2009, WORLD DEV, V37, P1861, DOI 10.1016/j.worlddev.2009.05.009; Todo Y, 2006, J ASIAN ECON, V17, P996, DOI 10.1016/j.asieco.2006.09.002; Tong Yun, EXPLORING TRANSITION; WALTER I, 1979, AMBIO, V8, P102; Wang X., 2020, J CLEANER PRODUCTION; Xie QC, 2020, J CLEAN PROD, V249, DOI 10.1016/j.jclepro.2019.119422; Xu S.-C., REGIONAL DIFFERENCES; Yu Y, 2019, ATMOS POLLUT RES, V10, P1627, DOI 10.1016/j.apr.2019.06.003; 2010, SLUZBENI GLASNIK RS, V5, P1	51	5	5	10	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245891	10.1371/journal.pone.0245891	http://dx.doi.org/10.1371/journal.pone.0245891			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ9QF	33493180	Green Published, gold			2022-12-26	WOS:000613081500021
J	Almarzooqi, F; Souid, AK; Vijayan, R; Al-Hammadi, S				Almarzooqi, Farida; Souid, Abdul-Kader; Vijayan, Ranjit; Al-Hammadi, Suleiman			Novel genetic variants of inborn errors of immunity	PLOS ONE			English	Article							MUTATIONS	Objectives Inborn errors of immunity (IEI) are prevalent in tribal cultures due to frequent consanguineous marriages. Many of these disorders are autosomal recessive, resulting from founder mutations; hence they are amenable to prevention. The primary objective of this study was to evaluate the pathogenicity of novel variants of IEI found among Emiratis. Methods This retrospective data collection study reports novel variants of IEI detected by diagnostic exome sequencing. Pathogenicity prediction was based on scoring tools, amino acid alignment, and Jensen-Shannon divergence values. Results Twenty-one novel variants were identified; nine were frameshift, three nonsense, four intronic (one pathogenic), and five missense (two pathogenic). Fifteen variants were likely pathogenic, of which 13 were autosomal recessive and two uncertain inheritance. Their clinical spectra included combined immunodeficiency, antibody deficiency, immune dysregulation, defects in intrinsic/innate immunity, and bone marrow failure. Conclusion The described novel pathogenic variants are core to a planned national screening program that aims toward IEI prevention. Future studies, however, are needed to confirm their natural history in individual patients and estimate their prevalence in the community.	[Almarzooqi, Farida; Souid, Abdul-Kader; Al-Hammadi, Suleiman] UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; [Vijayan, Ranjit] UAE Univ, Coll Sci, Dept Biol, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Almarzooqi, F (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates.	famarzooqi@uaeu.ac.ae	Vijayan, Ranjit/GXF-4345-2022	Vijayan, Ranjit/0000-0002-3830-7409; Almarzooqi, Farida/0000-0003-4531-6570				Abdelrahman HA, 2018, AM J MED GENET A, V176, P1996, DOI 10.1002/ajmg.a.40424; Al-Herz W, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01754; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Bucciol G, 2017, CURR OPIN ALLERGY CL, V17, P421, DOI 10.1097/ACI.0000000000000398; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Casanova JL, 2014, J EXP MED, V211, P2137, DOI 10.1084/jem.20140520; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; Fujimi A, 2002, BRIT J HAEMATOL, V119, P858, DOI 10.1046/j.1365-2141.2002.03914.x; Gadola SD, 2000, CLIN EXP IMMUNOL, V121, P173, DOI 10.1046/j.1365-2249.2000.01264.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Itan Y, 2016, NAT METHODS, V13, P109, DOI 10.1038/nmeth.3739; Leuzzi V, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000228; Lo B, 2015, SCIENCE, V349, P436, DOI 10.1126/science.aaa1663; Lopez-Llano J, 2006, PROTEINS, V64, P769, DOI 10.1002/prot.21041; Prodosmo A, 2013, J CLIN INVEST, V123, P1335, DOI 10.1172/JCI67289; Sandoval N, 1999, HUM MOL GENET, V8, P69, DOI 10.1093/hmg/8.1.69; Shirts BH, 2016, GENET MED, V18, P974, DOI 10.1038/gim.2015.212; Simon AJ, 2020, CLIN IMMUNOL, V214, DOI 10.1016/j.clim.2020.108376; Wang XX, 2016, MATER TODAY CHEM, V1-2, P7, DOI 10.1016/j.mtchem.2016.10.005; Xiao JX, 2019, CELL RES, V29, P683, DOI 10.1038/s41422-019-0205-0; Zweier C, 2007, AM J HUM GENET, V80, P510, DOI 10.1086/511993	22	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245888	10.1371/journal.pone.0245888	http://dx.doi.org/10.1371/journal.pone.0245888			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481921	Green Published, gold			2022-12-26	WOS:000612929300043
J	Greyling, T; Rossouw, S; Adhikari, T				Greyling, Talita; Rossouw, Stephanie; Adhikari, Tamanna			The good, the bad and the ugly of lockdowns during Covid-19	PLOS ONE			English	Article							HAPPINESS; MONEY	Amidst the rapid global spread of Covid-19, many governments enforced country-wide lockdowns, with likely severe well-being consequences. In this regard, South Africa is an extreme case suffering from low levels of well-being, but at the same time enforcing very strict lockdown regulations. In this study, we analyse the causal effect of a lockdown and consequently, the determinants of happiness during the aforementioned. A difference-in-difference approach is used to make causal inferences on the lockdown effect on happiness, and an OLS estimation investigates the determinants of happiness after lockdown. The results show that the lockdown had a significant and negative impact on happiness. In analysing the determinants of happiness after lockdown, we found that stay-at-home orders have positively impacted happiness during this period. On the other hand, other lockdown regulations such as a ban on alcohol sales, a fear of becoming unemployed and a greater reliance on social media have negative effects, culminating in a net loss in happiness. Interestingly, Covid-19, proxied by new deaths per day, had an inverted U-shape relationship with happiness. Seemingly people were, at the onset of Covid-19 positive and optimistic about the low fatality rates and the high recovery rates. However, as the pandemic progressed, they became more concerned, and this relationship changed and became negative, with peoples' happiness decreasing as the number of new deaths increased.	[Greyling, Talita; Adhikari, Tamanna] Univ Johannesburg, Sch Econ, Johannesburg, South Africa; [Rossouw, Stephanie] Auckland Univ Technol, Sch Econ, Auckland, New Zealand	University of Johannesburg; Auckland University of Technology	Rossouw, S (corresponding author), Auckland Univ Technol, Sch Econ, Auckland, New Zealand.	stephanie.rossouw@aut.ac.nz	Greyling, Talita/AAC-7567-2022	Greyling, Talita/0000-0002-3777-7003; Rossouw, Stephanie/0000-0003-3538-9215	University of Johannesburg; Auckland University of Technology via the Faculty of Business, Economics and Law	University of Johannesburg; Auckland University of Technology via the Faculty of Business, Economics and Law	The following authors received salaries from their institutions, whom were also the funders of the research. 1. Prof T Greyling: University of Johannesburg via the University Research Fund. 2. Dr Stephanie Rossouw: Auckland University of Technology via the Faculty of Business, Economics and Law. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, HAPPINESS LESSONS NE; Brodeur A., 2020, ARXIV200412129; Bryson A, 2016, LABOUR ECON, V42, P151, DOI 10.1016/j.labeco.2016.09.002; Chae J., 2018, TELEMAT INFORM, P35; de Pedraza P., 2020, LIFE DISSATISFACTION; Diener E, 2009, SOC INDIC RES SER, V37, P201, DOI 10.1007/978-90-481-2350-6_9; Dunn EW, 2014, CURR DIR PSYCHOL SCI, V23, P41, DOI 10.1177/0963721413512503; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Greyling T, 2019, GROSS NATL HAPPINESS; Greyling T., 2020, TALE 3 COUNTRIES HOW; Hale T., 2020, VARIATION GOVT RESPO; Hamermesh DS, 2020, REV ECON HOUSEHOLD, V18, P983, DOI 10.1007/s11150-020-09495-x; Helliwell JF, 2015, REPORTER, V2, P14; Krosnick, 2018, PALGRAVE HDB SURVEY, P175, DOI [10.1007/978-3-319-54395-6_23, DOI 10.1007/978-3-319-54395-6_23]; Layard R, 2006, ECON J, V116, pC24, DOI 10.1111/j.1468-0297.2006.01073.x; Layard R., 2020, SSRN ELECT J; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Malesevic-Perovic L., 2008, FINANCIAL THEORY PRA, V32, P519; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; OFS, 2020, GLOB BEH PERC COVID; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Piekalkiewicz M, 2017, ECON LABOUR RELAT RE, V28, P361, DOI 10.1177/1035304617717130; Reddy P, 2015, SAMJ S AFR MED J, V105, P648, DOI [10.7196/SAMJnew.7932, 10.7196/SAMJNEW.7932]; Rolland B, 2020, JMIR PUBLIC HLTH SUR; Roser M., 2020, DAILY NEW CONFIRMED; Rossouw S, 2020, MARKOV SWITCHING MOD; Rossouw S., 2020, HDB LABOR HUMAN RESO; Sacks DW, 2013, ANN WORLD BANK C DEV, P283; Sibley CG, 2020, SHORT TERM EFFECTS C; Simionescu M, 2017, J RENMIN U CHINA; Sommer T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44201; Statistics South Africa, 2017, BEER IS MOR POP VEG; Statistics South Africa, 2020, BEH HLTH IMP COVID 1; Stevenson B., 2008, EC GROWTH SUBJECTIVE; Stiglitz E., 2009, REPORT COMMISSION ME; Veenhoven R, 2009, HAPPINESS, ECONOMICS AND POLITICS: TOWARDS A MULTI-DISCIPLINARY APPROACH, P45; Wilson RE, 2012, PERSPECT PSYCHOL SCI, V7, P203, DOI 10.1177/1745691612442904	37	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245546	10.1371/journal.pone.0245546	http://dx.doi.org/10.1371/journal.pone.0245546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481848	gold, Green Published			2022-12-26	WOS:000612929300108
J	Oofuvong, M; Tanasansuttiporn, J; Wasinwong, W; Chittithavorn, V; Duangpakdee, P; Jarutach, J; Yunuswangsa, Q				Oofuvong, Maliwan; Tanasansuttiporn, Jutarat; Wasinwong, Wirat; Chittithavorn, Voravit; Duangpakdee, Pongsanae; Jarutach, Jirayut; Yunuswangsa, Qistina			Predictors of death after receiving a modified Blalock-Taussig shunt in cyanotic heart children: A competing risk analysis	PLOS ONE			English	Article							PULMONARY-ATRESIA; VENTRICULAR SEPTUM; PALLIATION; MANAGEMENT; MORTALITY; OUTCOMES; INFANTS; TIME	Objective To determine risk factors affecting time-to-death <= 90 and >90 days in children who underwent a modified Blalock-Taussig shunt (MBTS). Methods Data from a retrospective cohort study were obtained from children aged 0-3 years who experienced MBTS between 2005 and 2016. Time-to-death (prior to Glenn/repair), time-to-alive up until December 2017 without repair, and time-to-progression to Glenn/repair following MBTS were presented using competing risks survival analysis. Demographic, surgical and anesthesia-related factors were recorded. Time-to-death <= 90 days and >90 days was analyzed using multivariate time-dependent Cox regression models to identify independent predictors and presented by adjusted hazard ratios (HR) and 95% confidence intervals (CI). Results Of 380 children, 119 died, 122 survived and 139 progressed to Glenn/repair. Time-to-death probability (95% CI) within 90 days was 0.18 (0.14-0.22). Predictors of time-to-death <= 90 days (n = 63) were low weight (<3 kg) (HR 7.6, 95% CI:2.8-20.4), preoperative ventilator support (HR 2.7, 95% CI:1.3-5.6), postoperative shunt thrombosis (HR 5.0, 95% CI:2.4-10.4), bleeding (HR 4.5, 95% CI:2.1-9.4) and renal failure (HR 4.1, 95% CI:1.5-10.9). Predictors of time-to-death >90 days (n = 56) were children diagnosed with pulmonary atresia with ventricular septal defect and single ventricle (compared to tetralogy of fallot) (HR 3.2, 95% CI:1.2-7.7 and HR 3.1, 95% CI:1.3-7.6, respectively), shunt size/weight ratio >1.1 vs <0.65 (HR 6.8, 95% CI:1.4-32.6) and longer duration of mechanical ventilator (HR 1.002, 95% CI:1.001-1.004). Shunt size/weight ratio >= 1.0 (vs <1.0) and >= 0.65 (vs <0.65) were predictors for overall time-to-death in neonates and toddlers, respectively (HR 13.1, 95% CI:2.8-61.4 and HR 7.8, 95% CI:1.7-34.8, respectively). Conclusions Perioperative factors were associated with time-to-death <= 90 days, whereas particular cardiac defect, larger shunt size/weight ratio, and longer mechanical ventilation were associated with time-to-death > 90 days after receiving MBTS. Larger shunt size/weight ratio should be reevaluated within 90 days to minimize the risk of shunt over flow.	[Oofuvong, Maliwan; Tanasansuttiporn, Jutarat; Wasinwong, Wirat; Yunuswangsa, Qistina] Prince Songkla Univ, Fac Med, Dept Anesthesiol, Hat Yai, Thailand; [Chittithavorn, Voravit; Duangpakdee, Pongsanae] Prince Songkla Univ, Fac Med, Dept Surg, Div Cardiothorac Surg, Hat Yai, Thailand; [Jarutach, Jirayut] Prince Songkla Univ, Fac Med, Dept Pediat, Div Cardiol, Hat Yai, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Oofuvong, M (corresponding author), Prince Songkla Univ, Fac Med, Dept Anesthesiol, Hat Yai, Thailand.	oomaliwa@gmail.com		jarutach, jirayut/0000-0002-6086-2054; Oofuvong, Maliwan/0000-0001-5840-5965	Faculty of Medicine, Prince of Songkla University	Faculty of Medicine, Prince of Songkla University	MO received award funding No.59-30108-01 from the Faculty of Medicine, Prince of Songkla University. URL: medinfo.psu.ac.th The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad U, 2008, HEART LUNG CIRC, V17, P54, DOI 10.1016/j.hlc.2007.06.003; Alkhulaifi AM, 2000, ANN THORAC SURG, V69, P1499, DOI 10.1016/S0003-4975(00)01078-X; Alsoufi B, 2016, EUR J CARDIO-THORAC, V50, P169, DOI 10.1093/ejcts/ezw017; Alsoufi B, 2015, ANN THORAC SURG, V99, P1639, DOI 10.1016/j.athoracsur.2014.12.082; Alwi M, 2006, CATHETER CARDIO INTE, V67, P679, DOI 10.1002/ccd.20672; Bove T, 2015, WORLD J PEDIATR CONG, V6, P67, DOI 10.1177/2150135114558690; Cain MT, 2014, WORLD J PEDIATR CONG, V5, P241, DOI 10.1177/2150135113520559; Cheung EW, 2014, ANN THORAC SURG, V98, P1371, DOI 10.1016/j.athoracsur.2014.06.039; Chittithavorn V, 2017, INTERACT CARDIOV TH, V25, P407, DOI 10.1093/icvts/ivx147; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Fenton KN, 2004, ANN THORAC SURG, V78, P1994, DOI 10.1016/j.athoracsur.2004.06.015; Gedicke M, 2010, HEART VESSELS, V25, P405, DOI 10.1007/s00380-009-1219-1; HANLEY FL, 1993, J THORAC CARDIOV SUR, V105, P406; Hanley FL, 1993, J THORAC CARDIOVASC, V105, P424; Hanley FL, 1993, J THORAC CARDIOVASC, V105, P423; HENNEIN HA, 1994, J PEDIATR SURG, V29, P866, DOI 10.1016/0022-3468(94)90004-3; Hopkins TJ, 2016, PERIOPER MED, V5, DOI 10.1186/s13741-016-0054-z; Ingaramo OA, 2012, PEDIATR CRIT CARE ME, V13, P174, DOI 10.1097/PCC.0b013e3182231862; Jo Tae Kyoung, 2018, Korean J Pediatr, V61, P210, DOI 10.3345/kjp.2018.61.7.210; Kucuk M, 2016, ACTA CARDIOL SIN, V32, P337, DOI 10.6515/ACS20150731A; Lertsakulpiriya K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61879-2; Maghur HA, 2002, PEDIATR CARDIOL, V23, P49, DOI 10.1007/s00246-001-0012-4; McKenzie ED, 2013, J AM COLL SURGEONS, V216, P699, DOI 10.1016/j.jamcollsurg.2012.12.027; Mirzaei Maryam, 2015, Glob J Health Sci, V8, P33, DOI 10.5539/gjhs.v8n5p33; Murthy KS, 2010, ANN PEDIAT CARDIOL, V3, P127, DOI 10.4103/0974-2069.74040; Oofuvong M, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-13; Petrucci O, 2011, ANN THORAC SURG, V92, P642, DOI 10.1016/j.athoracsur.2011.02.030; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; SCHOENFELD DA, 1982, BIOMETRICS, V38, P163, DOI 10.2307/2530299; Singh SP, 2014, ANN CARD ANAESTH, V17, P191, DOI 10.4103/0971-9784.135847; Williams JA, 2007, ANN THORAC SURG, V84, P2070, DOI 10.1016/j.athoracsur.2007.06.067; Woldu KL, 2014, ANN THORAC SURG, V98, P1399, DOI 10.1016/j.athoracsur.2014.05.034	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245754	10.1371/journal.pone.0245754	http://dx.doi.org/10.1371/journal.pone.0245754			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481924	Green Published, gold			2022-12-26	WOS:000612929300077
J	Tsai, CM; Chu, CH; Liu, X; Weng, KP; Liu, SF; Huang, YH; Kuo, HC				Tsai, Chih-Min; Chu, Chi-Hsiang; Liu, Xi; Weng, Ken-Pen; Liu, Shih-Feng; Huang, Ying-Hsien; Kuo, Ho-Chang			A novel score system of blood tests for differentiating Kawasaki disease from febrile children	PLOS ONE			English	Article							IMMUNOGLOBULIN TREATMENT FAILURE; CORONARY-ARTERY LESIONS; LONG-TERM MANAGEMENT; HEALTH-PROFESSIONALS; DIAGNOSIS; UNRESPONSIVENESS; METAANALYSIS; STATEMENT; HEPCIDIN	Background Kawasaki disease is the most common cause of acquired heart disease among febrile children under the age of 5 years old. It is also a clinically diagnosed disease. In this study, we developed and assessed a novel score system using objective parameters to differentiate Kawasaki disease from febrile children. Methods We analyzed 6,310 febrile children and 485 Kawasaki disease subjects in this study. We collected biological parameters of a routine blood test, including complete blood count with differential, C-reactive protein, aspartate aminotransferase, and alanine aminotransferase. Receiver operating characteristic curve, logistic regression, and Youden's index were all used to develop the prediction model. Two other independent cohorts from different hospitals were used for verification. Results We obtained eight independent predictors (platelets, eosinophil, alanine aminotransferase, C-reactive protein, hemoglobin, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and monocyte) and found the top three scores to be eosinophil >1.5% (score: 7), alanine aminotransferase >30 U/L (score: 6), and C-reactive protein>25 mg/L (score: 6). A score of 14 represents the best sensitivity value plus specificity prediction rate for Kawasaki disease. The sensitivity, specificity, and accuracy for our cohort were 0.824, 0.839, and 0.838, respectively. The verification test of two independent cohorts of Kawasaki disease patients (N = 103 and 170) from two different institutes had a sensitivity of 0.780 (213/273). Conclusion Our findings demonstrate a novel score system with good discriminatory ability for differentiating between children with Kawasaki disease and other febrile children, as well as highlight the importance of eosinophil in Kawasaki disease. Using this novel score system can help first-line physicians diagnose and then treat Kawasaki disease early.	[Tsai, Chih-Min; Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan; [Tsai, Chih-Min; Liu, Shih-Feng; Huang, Ying-Hsien; Kuo, Ho-Chang] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Chu, Chi-Hsiang] Natl Cheng Kung Univ, Dept Stat, Tainan, Taiwan; [Liu, Xi] Jinan Univ, Baoan Womens & Childrens Hosp, Dept Pediat, Shenzhen, Peoples R China; [Weng, Ken-Pen] Kaohsiung Vet Gen Hosp, Dept Pediat, Kaohsiung, Taiwan; [Weng, Ken-Pen] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Liu, Shih-Feng; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan; [Liu, Shih-Feng] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung, Taiwan; [Huang, Ying-Hsien; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University; Jinan University; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Huang, YH; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan.; Huang, YH; Kuo, HC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Resp Therapy, Kaohsiung, Taiwan.; Huang, YH; Kuo, HC (corresponding author), Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan.	yhhuang123@yahoo.com.tw; erickuo48@yahoo.com.tw		Liu, Shih-Feng/0000-0003-1394-5401; Tsai, Chih Min/0000-0001-5267-9594; Chu, Chi-Hsiang/0000-0002-7883-377X	Ministry of Science and Technology of Taiwan [MOST 108-2314-B-182 -037 MY3, MOST 103-2410-H-264-004]; Chang Gung Memorial Hospital, Taiwan [8E0212]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study received funding from the following grants: MOST 108-2314-B-182 -037 MY3 and MOST 103-2410-H-264-004 from the Ministry of Science and Technology of Taiwan and 8E0212 from Chang Gung Memorial Hospital, Taiwan. Although these institutes provided financial support, they had no influence on the way in which we collected, analyzed, or interpreted the data or wrote this manuscript.	Alves NRD, 2011, REV ASSOC MED BRAS, V57, P295; Armaroli G, 2019, ARTHRITIS RHEUMATOL, V71, P792, DOI 10.1002/art.40784; Baek Jin-Young, 2016, Korean J Pediatr, V59, P80, DOI 10.3345/kjp.2016.59.2.80; Chiu I-Min, 2019, Pediatr Neonatol, V60, P197, DOI 10.1016/j.pedneo.2018.06.004; DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057; ElAdawy M, 2011, PEDIATR INFECT DIS J, V30, P141, DOI 10.1097/INF.0b013e3181f6fe2a; Excellence NIfHaC, 2013, FEV ILLN CHILDR ASS; Girelli D, 2016, BLOOD, V127, P2809, DOI 10.1182/blood-2015-12-639112; Hao SY, 2016, J PEDIATR-US, V176, P114, DOI 10.1016/j.jpeds.2016.05.060; Huang LH, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0557-1; Huang YS, 2017, ONCOTARGET, V8, P111631, DOI 10.18632/oncotarget.22881; Huang YH, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00121; Huang YH, 2018, J MOL CELL CARDIOL, V117, P82, DOI 10.1016/j.yjmcc.2018.02.017; Huang YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050715; Huang YH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003501; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2018, J ALLERGY CLIN IMMUN, V142, P710, DOI 10.1016/j.jaci.2018.04.018; Kuo HC, 2018, MOL CELL PROTEOMICS, V17, P472, DOI 10.1074/mcp.RA117.000198; Kuo HC, 2012, J CLIN IMMUNOL, V32, P746, DOI 10.1007/s10875-012-9668-1; Kuo HC, 2010, ACTA PAEDIATR, V99, P1578, DOI 10.1111/j.1651-2227.2010.01875.x; Kuo HC, 2009, PEDIAT ALLERG IMM-UK, V20, P266, DOI 10.1111/j.1399-3038.2008.00779.x; Kuo Ho-Chang, 2007, Journal of Microbiology Immunology and Infection, V40, P395; Kwak JH, 2019, KOREAN CIRC J, V49, P755, DOI 10.4070/kcj.2018.0434; Li X, 2018, EUR J PEDIATR, V177, P1279, DOI 10.1007/s00431-018-3182-2; Liang CD, 2009, AM HEART J, V157, P584, DOI 10.1016/j.ahj.2008.11.020; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin LY, 2012, PEDIATR CARDIOL, V33, P1269, DOI 10.1007/s00246-012-0293-9; Lin YJ, 2015, PEDIATR INFECT DIS J, V34, P1163, DOI 10.1097/INF.0000000000000852; Ling XFB, 2013, J PEDIATR-US, V162, P183, DOI 10.1016/j.jpeds.2012.06.012; Ling XB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-130; Liu LT, 2018, CHEMELECTROCHEM, V5, P6, DOI 10.1002/celc.201700931; Liu L, 2016, INFLAMM RES, V65, P161, DOI 10.1007/s00011-015-0900-3; Massin MM, 2006, ACTA CLIN BELG, V61, P161, DOI 10.1179/acb.2006.027; McCrindle BW, 2017, CIRCULATION, V135, pE927, DOI 10.1161/CIR.0000000000000484; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Oates-Whitehead R M, 2003, Cochrane Database Syst Rev, pCD004000, DOI 10.1002/14651858.CD003511; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa; Yang BG, 2017, IMMUNE NETW, V17, P41, DOI 10.4110/in.2017.17.1.41; Yilmazer MM, 2015, TURKISH J PEDIATR, V57, P248	44	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244721	10.1371/journal.pone.0244721	http://dx.doi.org/10.1371/journal.pone.0244721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481812	Green Published, gold			2022-12-26	WOS:000612929300143
J	Xu, RL; Adam, L; Chapados, J; Soliman, A; Daayf, F; Tambong, JT				Xu, Renlin; Adam, Lorne; Chapados, Julie; Soliman, Atta; Daayf, Fouad; Tambong, James T.			MinION Nanopore-based detection of Clavibacter nebraskensis, the corn Goss's wilt pathogen, and bacteriomic profiling of necrotic lesions of naturally-infected leaf samples	PLOS ONE			English	Article							REAL-TIME PCR; MICHIGANENSIS SUBSP NEBRASKENSIS; 1ST REPORT; DIVERSITY; STRAINS; IDENTIFICATION; GENOME; QUANTIFICATION; ALIGNMENT; PRIMERS	The Goss's bacterial wilt pathogen, Clavibacter nebraskensis, of corn is a candidate A1 quarantine organism; and its recent re-emergence and spread in the USA and Canada is a potential biothreat to the crop. We developed and tested an amplicon-based Nanopore detection system for C. nebraskensis (Cn), targeting a purine permease gene. The sensitivity (1 pg) of this system in mock bacterial communities (MBCs) spiked with serially diluted DNA of C. nebraskensis NCPPB 2581(T) is comparable to that of real-time PCR. Average Nanopore reads increased exponentially from 125 (1pg) to about 6000 reads (1000 pg) after a 3-hr run-time, with 99.0% of the reads accurately assigned to C. nebraskensis. Three run-times were used to process control MBCs, Cn-spiked MBCs, diseased and healthy leaf samples. The mean Nanopore reads doubled as the run-time is increased from 3 to 6 hrs while from 6 to 12 hrs, a 20% increment was recorded in all treatments. Cn-spiked MBCs and diseased corn leaf samples averaged read counts of 5,100, 11,000 and 14,000 for the respective run-times, with 99.8% of the reads taxonomically identified as C. nebraskensis. The control MBCs and healthy leaf samples had 47 and 14 Nanopore reads, respectively. 16S rRNA bacteriomic profiles showed that Sphingomonas (22.7%) and Clavibacter (21.2%) were dominant in diseased samples while Pseudomonas had only 3.5% relative abundance. In non-symptomatic leaf samples, however, Pseudomonas (20.0%) was dominant with Clavibacter at 0.08% relative abundance. This discrepancy in Pseudomonas abundance in the samples was corroborated by qPCR using EvaGreen chemistry. Our work outlines a new useful tool for diagnosis of the Goss's bacterial wilt disease; and provides the first insight on Pseudomonas community dynamics in necrotic leaf lesions.	[Xu, Renlin; Chapados, Julie; Tambong, James T.] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Adam, Lorne; Soliman, Atta; Daayf, Fouad; Tambong, James T.] Univ Manitoba, Dept Plant Sci, Winnipeg, MB, Canada	Agriculture & Agri Food Canada; University of Manitoba	Tambong, JT (corresponding author), Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada.; Tambong, JT (corresponding author), Univ Manitoba, Dept Plant Sci, Winnipeg, MB, Canada.	james.tambong@canada.ca		Tambong, James Tabi/0000-0001-5325-8038	Agriculture and Agri-Food Canada [J-000409]; Manitoba Corn Growers Association [CRADA AGR-10755, J-22272, J-001557]	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Manitoba Corn Growers Association	This study was funded by Agriculture and Agri-Food Canada through the following projects: J-000409, Manitoba Corn Growers Association project number CRADA AGR-10755, J-22272 and J-001557.	Agarkova IV, 2011, CAN J MICROBIOL, V57, P366, DOI [10.1139/W11-016, 10.1139/w11-016]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bach HJ, 2003, J MICROBIOL METH, V52, P85, DOI 10.1016/S0167-7012(02)00152-5; Baek KY, 2018, PLANT PATHOLOGY J, V34, P104, DOI 10.5423/PPJ.OA.11.2017.0250; Benitez-Paez A, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix043; Boykin L, 2018, F1000 RES, V7, P1101, DOI DOI 10.12688/F1000RESEARCH.15507.1; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chalupowicz L, 2019, PLANT PATHOL, V68, P229, DOI 10.1111/ppa.12957; Charalampous T, 2019, NAT BIOTECHNOL, V37, P783, DOI 10.1038/s41587-019-0156-5; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; DAVIS MJ, 1984, INT J SYST BACTERIOL, V34, P107, DOI 10.1099/00207713-34-2-107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng LiPing, 2014, Journal of Food Safety and Quality, V5, P3933; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Ghequire MGK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02706; Ghequire MGK, 2012, BIOCHEM SOC T, V40, P1553, DOI 10.1042/BST20120170; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796; Holtsmark I, 2008, FEMS MICROBIOL LETT, V280, P1, DOI 10.1111/j.1574-6968.2007.01010.x; Hu YH, 2019, PHYTOBIOMES J, V3, P92, DOI 10.1094/PBIOMES-01-19-0004-R; Jacques MA, 2012, APPL ENVIRON MICROB, V78, P8388, DOI 10.1128/AEM.02158-12; Jain M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1103-0; Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Koskella B, 2017, NAT ECOL EVOL, V1, P1606, DOI 10.1038/s41559-017-0340-2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leggett RM, 2017, J EXP BOT, V68, P5419, DOI 10.1093/jxb/erx289; Li X, 2018, INT J SYST EVOL MICR, V68, P234, DOI 10.1099/ijsem.0.002492; McNally RR, 2016, PHYTOPATHOLOGY, V106, P1465, DOI 10.1094/PHYTO-05-16-0190-R; Menendez E, 2015, INT J SYST EVOL MICR, V65, P2852, DOI 10.1099/ijs.0.000344; Milling A, 2004, PLANT SOIL, V266, P23; Mitsuhashi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05772-5; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Osdaghi E, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02873-19; Panicker G, 2005, APPL ENVIRON MICROB, V71, P5702, DOI 10.1128/AEM.71.10.5702-5709.2005; Paul V. H., 1989, OEPP EPPO B, P33; Paulin MM, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00073-17, 10.1128/aem.00073-17]; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; RCore Team, 2020, R LANG ENV STAT COMP; Riley MA, 2002, BIOCHIMIE, V84, P357, DOI 10.1016/S0300-9084(02)01421-9; Ruhl G, 2009, PLANT DIS, V93, P841, DOI 10.1094/PDIS-93-8-0841B; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sakai J, 2019, J MED MICROBIOL, V68, P1219, DOI 10.1099/jmm.0.001024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Shen W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163962; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Singh R, 2015, PLANT DIS, V99, P1268, DOI 10.1094/PDIS-08-14-0807-PDN; SMIDT ML, 1987, PHYTOPATHOLOGY, V77, P388, DOI 10.1094/Phyto-77-388; Tambong JT, 2008, J APPL MICROBIOL, V104, P1525, DOI 10.1111/j.1365-2672.2007.03674.x; Tambong JT, 2009, MICROBIOL-SGM, V155, P2630, DOI 10.1099/mic.0.028274-0; Tambong JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172295; Tambong JT, 2016, PHYTOPATHOLOGY, V106, P1473, DOI 10.1094/PHYTO-05-16-0188-R; Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5; VIDAVER AK, 1981, PLANT DIS, V65, P480, DOI 10.1094/PD-65-480; VIDAVER AK, 1972, CAN J MICROBIOL, V18, P705, DOI 10.1139/m72-113; Waleron M, 2011, EUR J PLANT PATHOL, V131, P341, DOI 10.1007/s10658-011-9812-4; Xu R, 2011, CAN J PLANT PATHOL, V33, P318, DOI 10.1080/07060661.2011.600335; Yasuhara-Bell J, 2016, PHYTOPATHOLOGY, V106, P226, DOI 10.1094/PHYTO-10-15-0249-R; Yip CCY, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02127-19	68	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245333	10.1371/journal.pone.0245333	http://dx.doi.org/10.1371/journal.pone.0245333			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481876	Green Published, gold			2022-12-26	WOS:000612929300104
J	Lan, QY; Li, YC; Wang, FQ; Li, ZD; Gao, Y; Lu, H; Wang, YH; Zhao, ZW; Deng, ZX; He, FC; Wu, JZ; Xu, P				Lan, Qiuyan; Li, Yanchang; Wang, Fuqiang; Li, Zhaodi; Gao, Yuan; Lu, Hui; Wang, Yihao; Zhao, Zhenwen; Deng, Zixin; He, Fuchu; Wu, Junzhu; Xu, Ping			Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; TERBINAFINE RESISTANCE; GENE-EXPRESSION; 26S PROTEASOME; UBIQUITIN; PROTEIN; MECHANISMS; REDUCTASE; BRE5; RPN4	Sterol homeostasis is tightly controlled by molecules that are highly conserved from yeast to humans, the dysregulation of which plays critical roles in the development of antifungal resistance and various cardiovascular diseases. Previous studies have shown that sterol homeostasis is regulated by the ubiquitin-proteasome system. Two E3 ubiquitin ligases, Hrd1 and Doa10, are known to mediate the proteasomal degradation of 3-hydroxy-3-methylglutaryl-CoA reductase Hmg2 and squalene epoxidase Erg1 with accumulation of the toxic sterols in cells, but the deubiquitinases (DUBs) involved are unclear. Here, we screened for DUBs responsible for sterol homeostasis using yeast strains from a DUB-deletion library. The defective growth observed in ubp3-deleted (ubp3.) yeast upon fluconazole treatment suggests that lack of Ubp3 disrupts sterol homeostasis. Deep-coverage quantitative proteomics reveals that ergosterol biosynthesis is rerouted into a sterol pathway that generates toxic products in the absence of Ubp3. Further genetic and biochemical analysis indicated that Ubp3 enhances the proteasome's ability to degrade the ergosterol biosynthetic enzymes Erg1 and Erg3. The retardation of ergosterol enzyme degradation in the ubp3. strain resulted in the severe accumulation of the intermediate lanosterol and a branched toxic sterol, and ultimately disrupted sterol homeostasis and led to the fluconazole susceptibility. Our findings uncover a role for Ubp3 in sterol homeostasis and highlight its potential as a new antifungal target.	[Lan, Qiuyan; Deng, Zixin; Wu, Junzhu; Xu, Ping] Wuhan Univ, Sch Pharmaceut Sci, Sch Basic Med Sci, Minist Educ,Key Lab Combinatorial Biosynth & Drug, Wuhan, Peoples R China; [Lan, Qiuyan; Li, Yanchang; Wang, Fuqiang; Gao, Yuan; Lu, Hui; Wang, Yihao; He, Fuchu; Xu, Ping] Chinese Acad Med Sci, Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote,Beijing Proteome Res Ctr,Res, Beijing, Peoples R China; [Li, Zhaodi] Chongqing Med Univ, Mol Med & Canc Res Ctr, Dept Cell Biol & Genet, Chongqing, Peoples R China; [Zhao, Zhenwen] Chinese Acad Sci, CAS Res Educ Ctr Excellence Mol Sci, Inst Chem, Beijing Natl Lab Mol Sci,Key Lab Analyt Chem Livi, Beijing, Peoples R China; [Xu, Ping] Guizhou Univ, Med Sch, Guiyang, Peoples R China	Wuhan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chongqing Medical University; Chinese Academy of Sciences; Institute of Chemistry, CAS; Guizhou University	Wu, JZ; Xu, P (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Sch Basic Med Sci, Minist Educ,Key Lab Combinatorial Biosynth & Drug, Wuhan, Peoples R China.; Li, YC; Xu, P (corresponding author), Chinese Acad Med Sci, Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote,Beijing Proteome Res Ctr,Res, Beijing, Peoples R China.; Xu, P (corresponding author), Guizhou Univ, Med Sch, Guiyang, Peoples R China.	liyanchang1017@163.com; wujunzhu@whu.edu.cn; xuping@ncpsb.org.cn			Ministry of Science and Technology [2017YFA0505002, 2017YFA0505100, 2016YFA0501300]; National Natural Science Foundation of China [32071431, 31700723, 31670834, 31870824, 91839302]; Innovation Foundation of Medicine [BWS17J032, AWS17J008, 20SWAQX34, 19SWAQ17]; National Megaprojects for Key Infectious Diseases [2018ZX10302302]; Guangzhou Science and Technology Innovation & Development Project [201802020016]; Unilevel 21th Century Toxicity Program [MA-2018-02170N]; Foundation of State Key Lab of Proteomics [SKLP-K201704, SKLP-Y201901]; China Postdoctoral Science Foundation [2019M664016]; CAMS Innovation Fund for Medical Sciences [2019-I2M-5-017]; Beijing-Tianjin-Hebei Basic Research Cooperation Project [J200001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Foundation of Medicine; National Megaprojects for Key Infectious Diseases; Guangzhou Science and Technology Innovation & Development Project; Unilevel 21th Century Toxicity Program; Foundation of State Key Lab of Proteomics; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); CAMS Innovation Fund for Medical Sciences; Beijing-Tianjin-Hebei Basic Research Cooperation Project	We thank Drs Guanghua Huang, Lilin Du, and Cong Xu for gracious gifts of their reagents and strains. We thank Drs Guangwei Du and Hua Mo for the kindness advice for our article. This study was funded by the Ministry of Science and Technology (2017YFA0505002, 2017YFA0505100, and 2016YFA0501300), the National Natural Science Foundation of China (32071431, 31700723, 31670834, 31870824, and 91839302), the Innovation Foundation of Medicine (BWS17J032, AWS17J008, 20SWAQX34, and 19SWAQ17), National Megaprojects for Key Infectious Diseases (2018ZX10302302), Guangzhou Science and Technology Innovation & Development Project (201802020016), the Unilevel 21th Century Toxicity Program (MA-2018-02170N), the Foundation of State Key Lab of Proteomics (SKLP-K201704 and SKLP-Y201901), the China Postdoctoral Science Foundation (2019M664016), CAMS Innovation Fund for Medical Sciences (2019-I2M-5-017), and the Beijing-Tianjin-Hebei Basic Research Cooperation Project (J200001).	Agarwal-Mawal A, 2003, J BIOL CHEM, V278, P12722, DOI 10.1074/jbc.M211491200; Bhattacharya S, 2018, MBIO, V9, DOI 10.1128/mBio.01291-18; Bilsland E, 2007, DNA REPAIR, V6, P1471, DOI 10.1016/j.dnarep.2007.04.010; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; Chew BS, 2010, BIOCHEM J, V431, P391, DOI 10.1042/BJ20101152; Christiano R, 2014, CELL REP, V9, P1959, DOI 10.1016/j.celrep.2014.10.065; Cohen M, 2003, NAT CELL BIOL, V5, P661, DOI 10.1038/ncb1003; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Della Corte A, 2015, TALANTA, V140, P52, DOI 10.1016/j.talanta.2015.03.003; EDWARDS PA, 1972, J BIOL CHEM, V247, P1520; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gao Y, 2016, MOL CELL PROTEOMICS, V15, P1381, DOI [10.1074/mcp.O115.051839, 10.1074/mcp.O115.051839 ]; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Isasa M, 2015, J PROTEOME RES, V14, P5306, DOI 10.1021/acs.jproteome.5b00802; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Klobucnikova V, 2003, BIOCHEM BIOPH RES CO, V309, P666, DOI 10.1016/j.bbrc.2003.08.051; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Kvint K, 2008, MOL CELL, V30, P498, DOI 10.1016/j.molcel.2008.04.018; Leber R, 2003, ANTIMICROB AGENTS CH, V47, P3890, DOI 10.1128/AAC.47.12.3890-3900.2003; Li KQ, 2007, J MOL BIOL, V372, P194, DOI 10.1016/j.jmb.2007.06.052; Li KQ, 2005, J BIOL CHEM, V280, P29176, DOI 10.1074/jbc.M502975200; Li YC, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100984; Li YC, 2019, MOL CELL, V76, P126, DOI 10.1016/j.molcel.2019.07.001; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; MERCER EI, 1984, PESTIC SCI, V15, P133, DOI 10.1002/ps.2780150206; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mor V, 2015, MBIO, V6, DOI 10.1128/mBio.00647-15; Nakatsukasa K, 2015, CRIT REV BIOCHEM MOL, V50, P489, DOI 10.3109/10409238.2015.1081869; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; Ossareh-Nazari B, 2010, EMBO REP, V11, P548, DOI 10.1038/embor.2010.74; Poulsen JW, 2012, J PROTEOMICS, V75, P3886, DOI 10.1016/j.jprot.2012.04.055; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; South PF, 2013, P NATL ACAD SCI USA, V110, pE1016, DOI 10.1073/pnas.1215768110; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Vik A, 2001, MOL CELL BIOL, V21, P6395, DOI 10.1128/MCB.21.19.6395-6405.2001; Wang L, 2004, J BIOL CHEM, V279, P55218, DOI 10.1074/jbc.M410085200; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Xiao WD, 2019, ANAL CHEM, V91, P15890, DOI 10.1021/acs.analchem.9b04340; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan L, 2008, ACTA BIOCH BIOPH SIN, V40, P1048, DOI 10.1111/j.1745-7270.2008.00483.x; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129; Zhang Xibo, 2015, Kobe J Med Sci, V61, pE54	56	3	3	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100348	10.1016/j.jbc.2021.100348	http://dx.doi.org/10.1016/j.jbc.2021.100348			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524398	Green Published, gold			2022-12-26	WOS:000672866400322
J	Papke, CM; Smolen, KA; Swingle, MR; Cressey, L; Heng, RA; Toporsian, M; Deng, L; Hagen, J; Shen, YF; Chung, WK; Kettenbach, AN; Honkanen, RE				Papke, Cinta M.; Smolen, Kali A.; Swingle, Mark R.; Cressey, Lauren; Heng, Richard A.; Toporsian, Mourad; Deng, Liyong; Hagen, Jacob; Shen, Yufeng; Chung, Wendy K.; Kettenbach, Arminja N.; Honkanen, Richard E.			A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; OKADAIC-ACID; BETA-CATENIN; CONSENSUS SEQUENCES; B56 FAMILY; PP2A; INHIBITION; PHOSPHORYLATION; KINASE	Functional genomic approaches have facilitated the discovery of rare genetic disorders and improved efforts to decipher their underlying etiology. PPP2R5D-related disorder is an early childhood onset condition characterized by intellectual disability, hypotonia, autism-spectrum disorder, macrocephaly, and dysmorphic features. The disorder is caused by de novo single nucleotide changes in PPP2R5D, which generate heterozygous dominant missense variants. PPP2R5D is known to encode a B'-type (B'56d) regulatory subunit of a PP2A-serine/threonine phosphatase. To help elucidate the molecular mechanisms altered in PPP2R5D-related disorder, we used a CRISPR-single-base editor to generate HEK-293 cells in which a single transition (c.1258G>A) was introduced into one allele, precisely recapitulating a clinically relevant E420K variant. Unbiased quantitative proteomic and phosphoproteomic analyses of endogenously expressed proteins revealed heterozygous-dominant changes in kinase/phosphatase signaling. These data combined with orthogonal validation studies revealed a previously unrecognized interaction of PPP2R5D with AKT in human cells, leading to constitutively active AKT-mTOR signaling, increased cell size, and uncoordinated cellular growth in E420K-variant cells. Rapamycin reduced cell size and dose-dependently reduced RPS6 phosphorylation in E420K-variant cells, suggesting that inhibition of mTOR1 can suppress both the observed RPS6 hyperphosphorylation and increased cell size. Together, our findings provide a deeper understanding of PPP2R5D and insight into how the E420K-variant alters signaling networks influenced by PPP2R5D. Our comprehensive approach, which combines precise genome editing, isobaric tandem mass tag labeling of peptides generated from endogenously expressed proteins, and concurrent liquid chromatography-mass spectrometry (LC-MS3), also provides a roadmap that can be used to rapidly explore the etiologies of additional genetic disorders.	[Papke, Cinta M.; Swingle, Mark R.; Heng, Richard A.; Toporsian, Mourad; Honkanen, Richard E.] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Smolen, Kali A.; Cressey, Lauren; Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA; [Smolen, Kali A.; Cressey, Lauren; Kettenbach, Arminja N.] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03755 USA; [Deng, Liyong; Hagen, Jacob; Chung, Wendy K.] Columbia Univ, Dept Pediat, Irving Med Ctr, New York, NY 10027 USA; [Shen, Yufeng] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Chung, Wendy K.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	University of South Alabama; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; Columbia University	Honkanen, RE (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.; Kettenbach, AN (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem & Cell Biol, Hanover, NH 03755 USA.; Kettenbach, AN (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03755 USA.	Arminja.N.Kettenbach@dartmouth.edu; rhonkanen@southalabama.edu		Papke, Cinta Maria/0000-0003-0719-2642	Jordan's Guardians Angels (JGA); National Institutes of Health/National Institute of General Medical Sciences, United States [R35GM119455]	Jordan's Guardians Angels (JGA); National Institutes of Health/National Institute of General Medical Sciences, United States	The research was supported by the Jordan's Guardians Angels (JGA) and National Institutes of Health/National Institute of General Medical Sciences, United States, R35GM119455 to A. N. K.	Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Alcantara D, 2017, BRAIN, V140, P2610, DOI 10.1093/brain/awx203; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Buck SB, 2003, J AM CHEM SOC, V125, P15694, DOI 10.1021/ja038672n; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chattopadhyay D, 2016, BIOCHEM PHARMACOL, V109, P14, DOI 10.1016/j.bcp.2016.03.011; Chong ZZ, 2016, DRUG DISCOV TODAY, V21, P1222, DOI 10.1016/j.drudis.2016.04.005; Choy MS, 2017, J AM CHEM SOC, V139, P17703, DOI 10.1021/jacs.7b09368; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Dean DA, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-6; Edelstein J, 2012, NEUROSCI LETT, V531, P74, DOI 10.1016/j.neulet.2012.10.052; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Galbo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027424; Grassetti AV, 2017, ANAL BIOANAL CHEM, V409, P4615, DOI 10.1007/s00216-017-0407-6; Gu XD, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20175920, 10.1590/1414-431x20175920]; Hastie CJ, 1998, FEBS LETT, V431, P357, DOI 10.1016/S0014-5793(98)00775-3; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Houge G, 2015, J CLIN INVEST, V125, P3051, DOI 10.1172/JCI79860; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jong CJ, 2020, J BIOL CHEM, V295, P5654, DOI 10.1074/jbc.RA119.011270; Jordens J, 2006, J BIOL CHEM, V281, P6349, DOI 10.1074/jbc.M507760200; Kaplanis J, 2019, GENOME RES, V29, P1047, DOI 10.1101/gr.239756.118; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kruse T, 2020, EMBO J, V39, DOI 10.15252/embj.2019103695; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee TY, 2010, J BIOL CHEM, V285, P21567, DOI 10.1074/jbc.M109.094953; Leontieva OV, 2014, P NATL ACAD SCI USA, V111, P8832, DOI 10.1073/pnas.1405723111; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2019, MOL METAB, V28, P26, DOI 10.1016/j.molmet.2019.07.009; Li W, 2010, CANCER SCI, V101, P1226, DOI 10.1111/j.1349-7006.2010.01523.x; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Loveday C, 2015, HUM MOL GENET, V24, P4775, DOI 10.1093/hmg/ddv182; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; McCright B, 1996, GENOMICS, V36, P168, DOI 10.1006/geno.1996.0438; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mirzaa G, 2019, GENEREVIEWS, P1193; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; NOVAKHOFER I, 1984, J BIOL CHEM, V259, P5995; Onore C, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00043; Pei JJ, 2003, AM J PATHOL, V163, P845, DOI 10.1016/S0002-9440(10)63445-1; Prickett TD, 2006, J BIOL CHEM, V281, P30503, DOI 10.1074/jbc.M601054200; Qi HJ, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007822; Ray RM, 2005, J BIOL CHEM, V280, P31091, DOI 10.1074/jbc.M503041200; Reece KM, 2009, BIOCHEM BIOPH RES CO, V386, P582, DOI 10.1016/j.bbrc.2009.06.062; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; RUEDIGER R, 1991, MOL CELL BIOL, V11, P4282, DOI 10.1128/MCB.11.8.4282; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Schmidt T, 2018, NUCLEIC ACIDS RES, V46, pD1271, DOI 10.1093/nar/gkx1029; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shang LS, 2016, NEUROGENETICS, V17, P43, DOI 10.1007/s10048-015-0466-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Slupe A. M, 2011, ENZYME RES, V2011; Smith RJ, 2019, CELL REP, V28, P2206, DOI 10.1016/j.celrep.2019.07.067; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; Swingle Mark, 2007, V365, P23; Swingle MR, 2019, CURR MED CHEM, V26, P2634, DOI 10.2174/0929867325666180508095242; Swingle MR, 2014, ASSAY DRUG DEV TECHN, V12, P481, DOI 10.1089/adt.2014.603; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Ueda K, 2018, DIABETES, V67, P1524, DOI 10.2337/db17-1342; Vignoli A, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0371-1; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wegner Adam M., 2007, V365, P61; Weinbrenner C, 1998, CIRCULATION, V98, P899, DOI 10.1161/01.CIR.98.9.899; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wu CG, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02405-3; Xu P, 2013, BIOL OPEN, V2, P479, DOI 10.1242/bio.20134051; Yan Y, 2010, ONCOGENE, V29, P4317, DOI 10.1038/onc.2010.187; Yan Y, 1999, J BIOL CHEM, V274, P31917, DOI 10.1074/jbc.274.45.31917; Yeung KS, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0182-4; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698; Zhou H, 2017, ONCOTARGET, V8, P80770, DOI 10.18632/oncotarget.20415; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	93	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100313	10.1016/j.jbc.2021.100313	http://dx.doi.org/10.1016/j.jbc.2021.100313			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482199	Green Published, gold			2022-12-26	WOS:000672866400287
J	Rottenaicher, GJ; Weber, B; Ruhrnossl, F; Kazman, P; Absmeier, RM; Hitzenberger, M; Zacharias, M; Buchner, J				Rottenaicher, Georg J.; Weber, Benedikt; Ruehrnoessl, Florian; Kazman, Pamine; Absmeier, Ramona M.; Hitzenberger, Manuel; Zacharias, Martin; Buchner, Johannes			Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANONICAL STRUCTURES; FIBRIL FORMATION; LAMBDA-III; STABILITY; SEQUENCE; PROTEINS; DOMAIN; CONFORMATIONS; DETERMINANTS; EVOLUTIONARY	Systemic light chain (AL) amyloidosis is a fatal protein misfolding disease in which excessive secretion, misfolding, and subsequent aggregation of free antibody light chains eventually lead to deposition of amyloid plaques in various organs. Patient-specific mutations in the antibody V-L domain are closely linked to the disease, but the molecular mechanisms by which certain mutations induce misfolding and amyloid aggregation of antibody domains are still poorly understood. Here, we compare a patient V-L domain with its non-amyloidogenic germline counterpart and show that, out of the five mutations present, two of them strongly destabilize the protein and induce amyloid fibril formation. Surprisingly, the decisive, disease-causing mutations are located in the highly variable complementarity determining regions (CDRs) but exhibit a strong impact on the dynamics of conserved core regions of the patient V-L domain. This effect seems to be based on a deviation from the canonical CDR structures of CDR2 and CDR3 induced by the substitutions. The amyloid-driving mutations are not necessarily involved in propagating fibril formation by providing specific side chain interactions within the fibril structure. Rather, they destabilize the V-L domain in a specific way, increasing the dynamics of framework regions, which can then change their conformation to form the fibril core. These findings reveal unexpected influences of CDR-framework interactions on antibody architecture, stability, and amyloid propensity.	[Rottenaicher, Georg J.; Weber, Benedikt; Ruehrnoessl, Florian; Kazman, Pamine; Absmeier, Ramona M.; Buchner, Johannes] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Garching, Germany; [Hitzenberger, Manuel; Zacharias, Martin] Tech Univ Munich, Ctr Integrated Prot Sci Munich, Phys Dept, Garching, Germany; [Weber, Benedikt] Roche Diagnost GmbH, Nonnenwald 2, D-82377 Penzberg, Germany	Technical University of Munich; Technical University of Munich; Roche Holding	Buchner, J (corresponding author), Tech Univ Munich, Ctr Integrated Prot Sci Munich, Dept Chem, Garching, Germany.	johannes.buchner@tum.de	Buchner, Johannes/A-2651-2010		German Research Foundation DFG [FOR2969]	German Research Foundation DFG(German Research Foundation (DFG))	This study was performed in the framework of the research unit FOR2969 on systemic light chain amyloidosis (German Research Foundation DFG; Project SP03). We thank Prof. Dr Sevil Weinkauf and Dr Carsten Peters for help with TEM data acquisition. We also thank Sonja Engler and Jacqueline Bambach for help with protein purification and biophysical experiments.	Abraham RS, 2004, J CLIN IMMUNOL, V24, P340, DOI 10.1023/B:JOCI.0000029113.68758.9f; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Annamalai K, 2017, ANGEW CHEM INT EDIT, V56, P7510, DOI 10.1002/anie.201701761; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Baden EM, 2008, J BIOL CHEM, V283, P30950, DOI 10.1074/jbc.M804822200; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; Blancas-Mejia LM, 2018, CHEM COMMUN, V54, P10664, DOI 10.1039/c8cc04396e; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Brumshtein B, 2018, J BIOL CHEM, V293, P19659, DOI 10.1074/jbc.RA118.004142; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Buxbaum Joel N., 2004, Current Opinion in Rheumatology, V16, P67, DOI 10.1097/00002281-200401000-00013; Case DA, AMBER 18; Chang HJ, 2014, STRUCTURE, V22, P9, DOI 10.1016/j.str.2013.10.005; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Creighton T. E., 1993, PROTEINS STRUCTURES; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; del Pozo-Yauner L, 2014, BIOCHEM BIOPH RES CO, V443, P495, DOI 10.1016/j.bbrc.2013.11.123; DiCostanzo AC, 2012, J BIOL CHEM, V287, P27997, DOI 10.1074/jbc.M112.362921; Dondelinger M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02278; ELHAWRANI AS, 1994, TRENDS BIOTECHNOL, V12, P207, DOI 10.1016/0167-7799(94)90084-1; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; Enqvist S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000981; Feige MJ, 2008, P NATL ACAD SCI USA, V105, P13373, DOI 10.1073/pnas.0802809105; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Fontana A., 1999, PROTEOLYTIC ENZYMES, P253; Gaciarz A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189964; Gertz MA, 2018, AM J HEMATOL, V93, P1169, DOI 10.1002/ajh.25149; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gonzalez-Andrade M, 2013, FEBS J, V280, P6173, DOI 10.1111/febs.12538; HELMS LR, 1995, PROTEIN SCI, V4, P2073, DOI 10.1002/pro.5560041012; Hernandez-Santoyo A, 2010, J MOL BIOL, V396, P280, DOI 10.1016/j.jmb.2009.11.038; Herold EM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12519-9; Hora M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181799; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazman P, 2020, ELIFE, V9, DOI 10.7554/eLife.52300; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Le Marchand T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04078-y; Lecoq L, 2019, CHEMBIOCHEM, V20, P1027, DOI 10.1002/cbic.201800732; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Luna-Martinez OD, 2017, FEBS J, V284, P3702, DOI [10.1111/febs.14265, 10.1111/febs.14266]; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Maritan M, 2020, J MOL BIOL, V432, P845, DOI 10.1016/j.jmb.2019.12.015; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Morgan GJ, 2016, J MOL BIOL, V428, P4280, DOI 10.1016/j.jmb.2016.08.021; Murphy KM., 2016, JANEWAYS IMMUNOBIOLO, V9, DOI DOI 10.1201/9781315533247; Nokwe CN, 2016, J MOL BIOL, V428, P1315, DOI 10.1016/j.jmb.2016.01.015; Nokwe CN, 2015, J MOL BIOL, V427, P3572, DOI 10.1016/j.jmb.2015.09.012; Nokwe CN, 2014, J BIOL CHEM, V289, P26829, DOI 10.1074/jbc.M114.582247; Oberti L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16953-7; Perfetti V, 2002, BLOOD, V100, P948, DOI 10.1182/blood-2002-01-0114; Poshusta TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005169; Pradhan T, 2020, J BIOL CHEM, V295, P18474, DOI 10.1074/jbc.RA120.016006; Radamaker L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21126-2; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Rennella E, 2019, J AM CHEM SOC, V141, P13562, DOI 10.1021/jacs.9b05499; Rennella E, 2019, P NATL ACAD SCI USA, V116, P854, DOI 10.1073/pnas.1817538116; Rouet R, 2014, FEBS LETT, V588, P269, DOI 10.1016/j.febslet.2013.11.029; Ruiz-Zamora RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39781-3; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Swindells MB, 2017, J MOL BIOL, V429, P356, DOI 10.1016/j.jmb.2016.08.019; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; Thies MJW, 2000, J CHROMATOGR B, V737, P63, DOI 10.1016/S0378-4347(99)00377-1; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; van der Kant R, 2019, PROTEIN ENG DES SEL, V32, P109, DOI 10.1093/protein/gzz012; Villalba MI, 2015, J BIOL CHEM, V290, P2577, DOI 10.1074/jbc.M114.629550; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber B, 2018, J MOL BIOL, V430, P4925, DOI 10.1016/j.jmb.2018.10.024; Weber B, 2018, J BIOL CHEM, V293, P17107, DOI 10.1074/jbc.RA118.005475; Weiss BM, 2014, J CLIN ONCOL, V32, P2699, DOI 10.1200/JCO.2013.50.0892; Woody R. W., 1995, 4 CIRCULAR DICHROISM; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Yauner LD, 2006, PROTEINS, V62, P122, DOI 10.1002/prot.20779; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang CL, 2017, BLOOD REV, V31, P261, DOI 10.1016/j.blre.2017.03.002	92	12	12	2	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100334	10.1016/j.jbc.2021.100334	http://dx.doi.org/10.1016/j.jbc.2021.100334			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508322	gold, Green Published			2022-12-26	WOS:000672866400308
J	Klopfstein, M; Leyer, A; Berchtold, B; Torgerson, PR; Meylan, M				Klopfstein, Myriam; Leyer, Alexandra; Berchtold, Beat; Torgerson, Paul Robert; Meylan, Mireille			Limitations in the implementation of control measures for bovine paratuberculosis in infected Swiss dairy and beef herds	PLOS ONE			English	Article							AVIUM SUBSP PARATUBERCULOSIS; JOHNES-DISEASE; CONTROL PROGRAM; VOLUNTARY; PERCEPTIONS; MANAGEMENT; FARMERS; CATTLE; TRANSMISSION; PRODUCERS	Various measures have been advocated for the control of Johne's disease (caused by Mycobacterium avium subsp. paratuberculosis, MAP) in different countries. Farmers' compliance has been reported to be variable depending on disease prevalence and incentives to participate in control programs. After the prevalence of MAP shedding and risk factors for within-herd spread of MAP were assessed in 17 Swiss cattle herds (10 dairy and 7 beef), general and herd-specific recommendations were given to the farmers to reduce MAP transmission within the herd. Participation in the study and implementation of control measures were voluntary, no financial incentives were provided for the realization of control measures. After a 3-year period of monitored observation including biannual farm visits and discussion of the situation, the implementation of the recommended control measures and their effect on prevalence of MAP shedding were evaluated. Implementation of recommended general and farm-specific control measures was only partially realized. Neither the number of animals tested positive (before or during the study) nor the farmers' knowledge about paratuberculosis were significantly associated with their compliance for the implementation of management changes. The apparent within-herd prevalence remained constant despite limited implementation of control measures, and no particular group of control measures was found to be associated with changes in prevalence. Farmers' compliance for the implementation of control measures to reduce the impact of Johne's disease in infected farms was very limited under Swiss farming conditions in the frame of voluntary participation in a research project. These results indicate that the losses associated with paratuberculosis in Swiss dairy and beef operations are not estimated to be high enough by the farmers to justify important efforts for control measures, and that incentives may be necessary to achieve efficient implementation of such measures.	[Klopfstein, Myriam; Berchtold, Beat; Meylan, Mireille] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Leyer, Alexandra] Univ Zurich, Vetsuisse Fac, Inst Food Safety & Hyg, Sect Vet Bacteriol, Zurich, Switzerland; [Torgerson, Paul Robert] Univ Zurich, Vetsuisse Fac, Sect Vet Epidemiol, Zurich, Switzerland	University of Bern; University of Zurich; University of Zurich	Meylan, M (corresponding author), Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland.	mireille.meylan@vetsuisse.unibe.ch	Torgerson, Paul/M-4447-2013	Torgerson, Paul/0000-0003-4277-9983	Swiss Federal Food Safety and Veterinary Office [1.11.05]	Swiss Federal Food Safety and Veterinary Office	The study was funded by a grant of the Swiss Federal Food Safety and Veterinary Office (www.blv.admin.ch; grant number 1.11.05, MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango-Sabogal JC, 2017, PREV VET MED, V148, P94, DOI 10.1016/j.prevetmed.2017.10.006; Bhattarai B, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-27; Bhattarai B, 2013, PREV VET MED, V112, P330, DOI 10.1016/j.prevetmed.2013.08.009; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; Donat K, 2016, J DAIRY SCI, V99, P3744, DOI 10.3168/jds.2015-10625; Dore E, 2012, J VET INTERN MED, V26, P32, DOI 10.1111/j.1939-1676.2011.00854.x; Ellis-Iversen J, 2010, PREV VET MED, V93, P276, DOI 10.1016/j.prevetmed.2009.11.005; Espejo LA, 2012, J DAIRY SCI, V95, P4141, DOI 10.3168/jds.2011-4550; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Garry F, 2011, VET CLIN N AM-FOOD A, V27, P599, DOI 10.1016/j.cvfa.2011.07.006; Geraghty T, 2014, PREV VET MED, V116, P1, DOI 10.1016/j.prevetmed.2014.06.003; Keller SM, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0068-9; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; Kunzler R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-132; McAloon CG, 2016, J DAIRY SCI, V99, P1449, DOI 10.3168/jds.2015-10156; Mortier RAR, 2015, PREV VET MED, V121, P189, DOI 10.1016/j.prevetmed.2015.08.011; Puerto-Parada M, 2018, PREV VET MED, V152, P74, DOI 10.1016/j.prevetmed.2018.02.010; RCore Team, 2020, R LANG ENV STAT COMP; Ritter C, 2016, J DAIRY SCI, V99, P9114, DOI 10.3168/jds.2016-10896; Ritter C, 2015, J DAIRY SCI, V98, P7831, DOI 10.3168/jds.2015-9789; Roche SM, 2019, J DAIRY SCI, V102, P4476, DOI 10.3168/jds.2018-15944; Roche SM, 2015, J DAIRY SCI, V98, P5222, DOI 10.3168/jds.2014-8765; Scharrer S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0468-8; Sorge U, 2010, J DAIRY SCI, V93, P1491, DOI 10.3168/jds.2009-2447; Sweeney RW, 2012, J VET INTERN MED, V26, P1239, DOI 10.1111/j.1939-1676.2012.01019.x; Sweeney RW, 1996, VET CLIN N AM-FOOD A, V12, P305, DOI 10.1016/S0749-0720(15)30408-4; Vidondo B, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1406-3; Whittington R, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1943-4; Wolf R, 2016, J DAIRY SCI, V99, P4526, DOI 10.3168/jds.2015-10478; Wolf R, 2015, J DAIRY SCI, V98, P7784, DOI 10.3168/jds.2015-9610	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245836	10.1371/journal.pone.0245836	http://dx.doi.org/10.1371/journal.pone.0245836			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529202	Green Published, gold			2022-12-26	WOS:000616736200061
J	Nkosi-Gondwe, T; Calis, J; van Hensbroek, MB; Bates, I; Blomberg, B; Phiri, KS				Nkosi-Gondwe, Thandile; Calis, Job; van Hensbroek, Michael Boele; Bates, Imelda; Blomberg, Bjorn; Phiri, Kamija S.			A cohort analysis of survival and outcomes in severely anaemic children with moderate to severe acute malnutrition in Malawi	PLOS ONE			English	Article							MORTALITY; MALARIA	Introduction Moderate to severe acute malnutrition (SAM/MAM) and severe anaemia are important and associated co-morbidities in children aged less than five years. Independently, these two morbidities are responsible for high risk of in-hospital and post-discharge deaths and hospital readmissions. The primary objective of this study is to investigate the risk of death among severely anaemic children with moderate to severe acute malnutrition compared to children with severe anaemia alone. Methods This was a retrospective analysis of data collected from a large prospective study that was investigating severe anaemia in children aged less than 5 years old. The study was conducted at Queen Elizabeth Central Hospital in Blantyre and Chikhwawa district hospital in southern Malawi. Children aged less than five years old; with severe anaemia were screened and enrolled. Each child was followed up for eighteen months at one, three, six, twelve and eighteen months after enrolment. Data were analysed using STATA 15. Results Between July 2002 and July 2004, 382 severely anaemic children were enrolled in the main study. A total of 52 children were excluded due to missing anthropometric data. Out of the 330 included, 53 children were moderately to severely malnourished and 277 were not. At the end of the 18-month follow period, 28.3% of children with MAM/SAM died compared to 13% of children without MAM/SAM (RR 2.1, CI 0.9-4.2, p = 0.03). Similarly, children with moderate to severe malnutrition reported a significantly higher number of malaria infection cases (33.9%) compared to children with severe anaemia alone (27.9%, p = 0.02). However, the number of hospitalizations and recurrence of severe anaemia was similar and not statistically significant between the two groups (RR 0.8 (0.4-1.4), p = 0.6 and RR 1.1 (0.3-2.8), p = 0.8). Conclusion Among children with severe anaemia, those who also had moderate to severe malnutrition had a twofold higher risk of dying compared to those who did not. It is therefore crucial to investigate acute malnutrition among severely anaemic children, as this might be treatable factor associated with high mortality.	[Nkosi-Gondwe, Thandile] Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Nkosi-Gondwe, Thandile; Calis, Job; van Hensbroek, Michael Boele; Phiri, Kamija S.] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Calis, Job; van Hensbroek, Michael Boele] Coll Med, Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi; [Calis, Job; van Hensbroek, Michael Boele] Univ Amsterdam, Emma Childrens Hosp, Acad Med Ctr, Global Child Hlth Grp, Amsterdam, Netherlands; [van Hensbroek, Michael Boele; Bates, Imelda] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Blomberg, Bjorn] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Blomberg, Bjorn] Haukeland Hosp, Norwegian Natl Advisory Unit Trop Infect Dis, Bergen, Norway	University of Bergen; University of Malawi; University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Liverpool School of Tropical Medicine; University of Bergen; University of Bergen; Haukeland University Hospital	Nkosi-Gondwe, T (corresponding author), Univ Bergen, Ctr Int Hlth, Dept Global Publ Hlth & Primary Care, Bergen, Norway.; Nkosi-Gondwe, T (corresponding author), Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi.	thandile_nkosi@yahoo.com	Blomberg, Bjorn/B-9605-2015	Blomberg, Bjorn/0000-0001-5647-4297; bates, imelda/0000-0002-0862-8199; Boele van Hensbroek, Michael/0000-0003-1907-5427				Akiyama T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1548-3; [Anonymous], 2008, Ment Health Fam Med, V5, P9; [Anonymous], 2013, GUIDELINE UPDATES MA; [Anonymous], 2020 GLOBAL NUTR REP; [Anonymous], 2014, NEAR E ARCHAEOLOGICA; Bahwere P, 2012, J PUBLIC HLTH EPIDEM, V4, P11; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Das D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1177-5; Desalegn M., 2016, INT J NUTR METAB, V8, P12, DOI [10.5897/IJNAM2015.0193, DOI 10.5897/IJNAM2015.0193]; Desyibelew HD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171020; Dhabangi A, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1398-6; Ding LY, 2017, FRONT ENG MANAG, V4, P4, DOI 10.15302/J-FEM-2017015; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Guesh Gebremicael, 2018, BMC Res Notes, V11, P832, DOI 10.1186/s13104-018-3937-x; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kerac M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096030; Lackritz EM, 1997, AIDS, V11, P1487, DOI 10.1097/00002030-199712000-00013; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Mengesha MM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.30704; Moraleda C, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0816-x; National Statistical Office (NSO) [Malawi] and ICF International, 2016, MALAWI DEMOGRAPHIC H; Phiri KS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002903; Rahman MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219170; Sumbele IUN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2462-2; Thakur N, 2014, NUTRITION, V30, P440, DOI 10.1016/j.nut.2013.09.011; Thorne CJ, 2013, PAEDIATR INT CHILD H, V33, P151, DOI 10.1179/2046905513Y.0000000060; United Nations Children's Fund (UNICEF) WHO International Bank for Reconstruction and Development/The World Bank, LEVELS TRENDS CHILD; van Hensbroek MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012589; Wondim A, 2020, INT J PEDIAT, V2020, DOI 10.1155/2020/8406597; World Health Organization, 2015, GLOBAL PREVALENCE AN; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization/ United Nations Children's Fund (UNICEF), 2020, INT BANK RECONSTRUCT; Yang W, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-1127, 10.1186/1471-2458-12-804]	38	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246267	10.1371/journal.pone.0246267	http://dx.doi.org/10.1371/journal.pone.0246267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529189	gold, Green Accepted, Green Published			2022-12-26	WOS:000616736200028
J	Daryadel, A; Ruiz, PA; Gehring, N; Stojanovic, D; Ugrica, M; Bettoni, C; Sabrautzki, S; Pastor-Arroyo, EM; Frey-Wagner, I; Lorenz-Depiereux, B; Strom, TM; de Angelis, MH; Rogler, G; Wagner, CA; Rubio-Aliaga, I				Daryadel, Arezoo; Ruiz, Pedro A.; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Sabrautzki, Sibylle; Pastor-Arroyo, Eva-Maria; Frey-Wagner, Isabelle; Lorenz-Depiereux, Bettina; Strom, Tim M.; de Angelis, Martin Hrabe; Rogler, Gerhard; Wagner, Carsten A.; Rubio-Aliaga, Isabel			Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage	FASEB JOURNAL			English	Article						FGF23; Jak; Stat signaling; inflammation; calcitriol; PTH	GROWTH-FACTOR 23; ELEVATED FGF23; EXPRESSION; PHOSPHATE; KIDNEY; TRANSPORT; HYPOPHOSPHATEMIA; MECHANISMS; RESISTANCE; MUTATIONS	Fibroblast growth factor 23 (FGF23) is a main regulator of mineral homeostasis. Low and high circulating FGF23 levels are associated with bone, renal, cardiovascular diseases, and increased mortality. Understanding the factors and signaling pathways affecting FGF23 levels is crucial for the management of these diseases and their complications. Here, we show that activation of the Jak1/Stat3 signaling pathway leads to inflammation in liver and to an increase in hepatic FGF23 synthesis, a key hormone in mineral metabolism. This increased synthesis leads to massive C-terminal FGF23 circulating levels, the inactive C-terminal fragment, and increased intact FGF23 levels, the active form, resulting in imbalanced production and cleavage. Liver inflammation does not lead to activation of the calcineurin-NFAT pathway, and no signs of systemic inflammation could be observed. Despite the increase of active intact FGF23, excessive C-terminal FGF23 levels block the phosphaturic activity of FGF23. Therefore, kidney function and renal alpha Klotho expression are normal and no activation of the MAPK pathway was detected. In addition, activation of the Jak1/Stat3 signaling pathway leads to high calcitriol levels and low parathyroid hormone production. Thus, JAK1 is a central regulator of mineral homeostasis. Moreover, this study also shows that in order to assess the impact of high FGF23 levels on disease and kidney function, the source and the balance in FGF23 production and cleavage are critical.	[Daryadel, Arezoo; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Pastor-Arroyo, Eva-Maria; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Univ Zurich UZH, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Daryadel, Arezoo; Gehring, Nicole; Stojanovic, Dragana; Ugrica, Marko; Bettoni, Carla; Pastor-Arroyo, Eva-Maria; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Natl Ctr Competence Res NCCR Kidney CH, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Ruiz, Pedro A.; Frey-Wagner, Isabelle; Rogler, Gerhard] Univ Zurich, Univ Hosp Zurich, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Sabrautzki, Sibylle; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Mouse Clin, Inst Expt Genet, German Res Ctr Environm Hlth GmbH, D-85764 Neuherberg, Germany; [Lorenz-Depiereux, Bettina] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Human Genet, Neuherberg, Germany; [Strom, Tim M.] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, Munich, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany	University of Zurich; University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Wagner, CA; Rubio-Aliaga, I (corresponding author), Univ Zurich UZH, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Wagner, CA; Rubio-Aliaga, I (corresponding author), Natl Ctr Competence Res NCCR Kidney CH, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch; isabel.rubioaliaga@uzh.ch	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Rubio-Aliaga, Isabel/0000-0003-1051-9511				Bar L, 2019, FEBS LETT, V593, P1879, DOI 10.1002/1873-3468.13494; Bao JF, 2020, J AM SOC NEPHROL, V31, P1423, DOI 10.1681/ASN.2020010081; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; BIBER J, 1983, PFLUG ARCH EUR J PHY, V396, P335, DOI 10.1007/BF01063939; Bienaime F, 2018, J CLIN ENDOCR METAB, V103, P2319, DOI 10.1210/jc.2018-00123; Bon N, 2018, MOL METAB, V11, P197, DOI 10.1016/j.molmet.2018.02.007; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Daryadel A, 2018, PFLUG ARCH EUR J PHY, V470, P1569, DOI 10.1007/s00424-018-2171-7; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Durlacher-Betzer K, 2018, KIDNEY INT, V94, P315, DOI 10.1016/j.kint.2018.02.026; Edmonston D, 2020, NAT REV NEPHROL, V16, P7, DOI 10.1038/s41581-019-0189-5; Egli-Spichtig D, 2019, KIDNEY INT, V96, P890, DOI 10.1016/j.kint.2019.04.009; Flamme I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186979; Gallo LH, 2015, CYTOKINE GROWTH F R, V26, P425, DOI 10.1016/j.cytogfr.2015.03.003; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; HOFFMANN N, 1976, PFLUG ARCH EUR J PHY, V362, P147, DOI 10.1007/BF00583641; Holecki M, 2015, CLIN ENDOCRINOL, V82, P900, DOI 10.1111/cen.12759; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Ito N, 2015, MOL CELL ENDOCRINOL, V399, P208, DOI 10.1016/j.mce.2014.10.007; Johnson K, 2017, J BONE MINER RES, V32, P2062, DOI 10.1002/jbmr.3197; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kuro-o M, 2017, BONE, V100, P4, DOI 10.1016/j.bone.2016.11.013; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Levi M, 2019, NAT REV NEPHROL, V15, P482, DOI 10.1038/s41581-019-0159-y; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; Li Q, 2017, ONCOTARGET, V8, P34687, DOI 10.18632/oncotarget.16670; Masuda Y, 2015, BIOL PHARM BULL, V38, P687, DOI 10.1248/bpb.b14-00276; Mendoza FA, 2012, CLIN J AM SOC NEPHRO, V7, P1155, DOI 10.2215/CJN.13281211; NasrAllah MM, 2013, NEPHRON EXTRA, V3, P106, DOI 10.1159/000356118; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Pastor-Arroyo EM, 2018, KIDNEY INT, V94, P49, DOI 10.1016/j.kint.2018.02.017; Pathak JL, 2016, CALCIFIED TISSUE INT, V98, P596, DOI 10.1007/s00223-016-0116-8; Pathare G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22041-1; Prie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066182; Rabadi S, 2018, AM J PHYSIOL-RENAL, V314, pF132, DOI 10.1152/ajprenal.00081.2017; Richter B, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00189; Roberts MS, 2018, J CLIN INVEST, V128, P5368, DOI 10.1172/JCI122004; Sabrautzki S, 2013, AM J PATHOL, V183, P352, DOI 10.1016/j.ajpath.2013.04.027; Sato H, 2016, INTERNAL MED, V55, P121, DOI 10.2169/internalmedicine.55.5507; Shikida Y, 2018, CALCIFIED TISSUE INT, V103, P455, DOI 10.1007/s00223-018-0440-2; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Silver J, 1999, KIDNEY INT, V56, pS2, DOI 10.1046/j.1523-1755.1999.07310.x; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Toro L, 2018, KIDNEY INT, V93, P1131, DOI 10.1016/j.kint.2017.11.018; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; Vervloet M, 2019, NAT REV NEPHROL, V15, P109, DOI 10.1038/s41581-018-0087-2; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xu LJ, 2018, J CELL BIOCHEM, V119, P3819, DOI 10.1002/jcb.26332; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670	55	6	6	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21302	10.1096/fj.202002113R	http://dx.doi.org/10.1096/fj.202002113R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475190	Bronze			2022-12-26	WOS:000647789600092
J	Ghaffarzadegan, N				Ghaffarzadegan, Navid			Simulation-based what-if analysis for controlling the spread of Covid-19 in universities	PLOS ONE			English	Article								A simulation model is developed to analyze the spread of covid-19 in universities. The model can be used to conduct a what-if analysis and estimate infection cases under different policies. For proof-of-concept, the model is simulated for a hypothetical university of 25,000 students and 3,000 faculty/staff in a U.S. college town. Simulation results show that early outbreaks are very likely, and there is no silver bullet to avoid them. Instead, a combination of policies should be carefully implemented. The results suggest (almost) full remote university operations from the beginning of the semester. In a less-preferred alternative, if universities decide to have students attend in person, they should encourage remote operations for high-risk individuals, conduct frequent rapid tests, enforce mask use, communicate with students and employees about the risks, and promote social distancing. Universities should be willing to move to remote operations if cases rise. Under this scenario, and considering implementation challenges, many universities are still likely to experience an early outbreak, and the likelihood of having a case of death is worrisome. In the long run, students and faculty react to the risks, and even if universities decide to continue operations, classes are likely to have very low in-person attendance. Overall, our analysis depicts several sources of system complexities, negative unintended consequences of relying on a single policy, non-linear incremental effects, and positive synergies of implementing multiple policies. A simulation platform for a what-if analysis is offered so marginal effectiveness of different policies and different decision-making thresholds for closure can be tested for universities of varying populations.	[Ghaffarzadegan, Navid] Virginia Tech, Dept Ind & Syst Engn, Falls Church, VA 22043 USA	Virginia Polytechnic Institute & State University	Ghaffarzadegan, N (corresponding author), Virginia Tech, Dept Ind & Syst Engn, Falls Church, VA 22043 USA.	navidg@vt.edu		Ghaffarzadegan, Navid/0000-0003-3632-8588				Abouk R, 2021, PUBLIC HEALTH REP, V136, P245, DOI 10.1177/0033354920976575; Aizenman N., 2020, CAN MASKS SAVE US MO; Amini H, 2020, MODEST IMPACT WEATHE, V3, P1, DOI [10.1101/2020.05.05.20092627, DOI 10.1101/2020.05.05.20092627V3]; Anderson KB, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00002; Azadeh-Fard N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162976; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Cai W., 2020, NY TIMES; CDC, 2020, COVID 19 IS PREC AD; CDC, 2020, COVID 19 PAND PLANN; Chang JST, 2021, HEALTH CARE MANAG SC, V24, P305, DOI 10.1007/s10729-020-09526-0; Daniels M, 2020, WASHINGTON POST; Darabi N, 2020, SYST DYNAM REV, V36, P29, DOI 10.1002/sdr.1646; Diep F., 2020, CHRONICLE HIGHER ED; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Fausset R., 2020, NY TIMES; Ferguson N. M., 2020, REPORT 9 IMPACT NONP; Gendreau H., 2020, THE ROANOKE TIMES; Ghaffarzadegan N, 2021, BIOSCIENCE, V71, P113, DOI 10.1093/biosci/biaa122; Ghaffarzadegan N, 2020, SYST DYNAM REV, V36, P101, DOI 10.1002/sdr.1655; Ghaffarzadegan N, 2018, SYST DYNAM REV, V34, P327, DOI 10.1002/sdr.1598; Ghaffarzadegan N, 2011, SYST DYNAM REV, V27, P22, DOI 10.1002/sdr.442; Ivory D, 2020, NY TIMES; Jalali MS, 2020, LANCET GLOB HEALTH, V8, pE1459, DOI 10.1016/S2214-109X(20)30447-2; Jenkins JI, 2020, NY TIMES; Karanfil O, 2020, SYST DYNAM REV, V36, P294, DOI 10.1002/sdr.1661; Larson RC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240007; Li J, 2020, IDENTIFYING SYNERGIS, DOI 10.1101/2020.12.11.20247825v1; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Nourinejad M, 2020, SSRN, DOI [10.2139/ssrn.3744179, DOI 10.2139/SSRN.3744179]; Pei S, 2020, INITIAL SIMULATION S, DOI [10.1101/2020.03.21.20040303v2, DOI 10.1101/2020.03.21.20040303V2]; Rahmandad H., 2020, BEHAV DYNAMICS COVID, DOI [10.2139/ssrn.3635047, DOI 10.2139/SSRN.3635047]; Robles F., 2020, NEW YORK TIME 0818; Senge P.M., 1980, SYSTEM DYNAMICS TIMS, V14, P209; Struben J, 2020, SYST DYNAM REV, V36, P247, DOI 10.1002/sdr.1660; Torres JP, 2019, SYST DYNAM REV, V35, P160, DOI 10.1002/sdr.1628	37	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246323	10.1371/journal.pone.0246323	http://dx.doi.org/10.1371/journal.pone.0246323			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QF0FZ	33524045	Green Published, gold			2022-12-26	WOS:000616578400027
J	Hirata, H; Xu, XH; Nishioka, K; Matsuhisa, F; Kitajima, S; Kukita, T; Murayama, M; Urano, Y; Miyamoto, H; Mawatari, M; Kukita, A				Hirata, Hirohito; Xu, Xianghe; Nishioka, Kenichi; Matsuhisa, Fumikazu; Kitajima, Shuji; Kukita, Toshio; Murayama, Masatoshi; Urano, Yasuteru; Miyamoto, Hiroshi; Mawatari, Masaaki; Kukita, Akiko			PMEPA1 and NEDD4 control the proton production of osteoclasts by regulating vesicular trafficking	FASEB JOURNAL			English	Article						lysosomal secretion; NEDD4; osteoclast; proton production; V&#8208; ATPase	UBIQUITIN LIGASE NEDD4; VACUOLAR H+-ATPASE; RUFFLED BORDER; MEMBRANE TRAFFICKING; BONE HOMEOSTASIS; OSTEOPETROSIS; EXPRESSION; SECRETION; AUTOPHAGY; TRANSPORT	Osteoclast bone resorption activity is critically regulated to maintain bone homeostasis. Osteoclasts resorb bone by producing protons and acid hydrolase via lysosomal secretion, however, a detailed mechanism remains elusive. PMEPA1 is a vesicular membrane protein, which binds to the NEDD4 family member of ubiquitin ligases. We have previously reported that Pmepa1 is highly expressed in bone resorbing osteoclasts, and regulates bone resorption. Here, we investigated the mechanism of bone resorption regulated by PMEPA1. Mutant mice lacking NEDD4-binding domains of PMEPA1 displayed enhanced bone volume, and reduced bone resorption activity in comparison with those of WT mice. Analysis with pH-sensitive fluorescence probe revealed that proton secretion from osteoclasts significantly decreased in Pmepa1 mutant osteoclasts. Immunofluorescence analysis revealed that PMEPA1 was colocalized with NEDD4, V0A3, and V0D2 subunits of vacuolar ATPase, which regulate the proton production of osteoclasts. In addition, Nedd4 knockdown reduced bone resorption and proton secretion of osteoclasts. Furthermore, Pmepa1 mutation and Nedd4 knockdown altered the cytoplasmic distribution of components of V-ATPase and expression of autophagy-related proteins, suggesting that lysosomal secretion is affected. Collectively, these findings indicate that PMEPA1 controls proton secretion from osteoclasts via NEDD4 by regulating vesicular trafficking, and NEDD4 is an important regulator of bone resorption.	[Hirata, Hirohito; Xu, Xianghe; Murayama, Masatoshi; Miyamoto, Hiroshi; Kukita, Akiko] Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan; [Hirata, Hirohito; Murayama, Masatoshi; Mawatari, Masaaki] Saga Univ, Fac Med, Dept Orthoped Surg, Saga, Japan; [Xu, Xianghe; Kukita, Toshio] Kyushu Univ, Dept Mol Cell Biol & Oral Anat, Fukuoka, Japan; [Nishioka, Kenichi] Musashimurayama Hosp, Dept Internal Med, Tokyo, Japan; [Matsuhisa, Fumikazu; Kitajima, Shuji] Saga Univ, Analyt Res Ctr Expt Sci, Div Biol Resources & Dev, Saga, Japan; [Urano, Yasuteru] Univ Tokyo, Grad Sch Med, Dept Chem Biol & Mol Imaging, Tokyo, Japan; [Urano, Yasuteru] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Chem & Biol, Tokyo, Japan; [Xu, Xianghe] Sun Yat Sen Univ, Dept Orthopaed, Affiliated Hosp 5, Zhuhai, Peoples R China	Saga University; Saga University; Kyushu University; Saga University; University of Tokyo; University of Tokyo; Sun Yat Sen University	Kukita, A (corresponding author), Saga Univ, Fac Med, Dept Pathol & Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan.	kukita@cc.saga-u.ac.jp						Bai XL, 2014, CELL SIGNAL, V26, P2030, DOI 10.1016/j.cellsig.2014.06.001; Chen SH, 2004, J BIOL CHEM, V279, P7988, DOI 10.1074/jbc.M305351200; Cremasco V, 2012, J BONE MINER RES, V27, P2452, DOI 10.1002/jbmr.1701; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Oyarzun JE, 2019, BBA-MOL BASIS DIS, V1865, P1076, DOI 10.1016/j.bbadis.2019.03.009; Ferron M, 2013, GENE DEV, V27, P955, DOI 10.1101/gad.213827.113; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Fujiwara T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86330; Funakubo N, 2018, J CELL PHYSIOL, V233, P3105, DOI 10.1002/jcp.26147; Hirvonen Mirkka J, 2013, Bonekey Rep, V2, P306, DOI 10.1038/bonekey.2013.40; Huang X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2142-8; Itoh S, 2018, J BIOCHEM, V164, P195, DOI 10.1093/jb/mvy059; Jeon SA, 2018, BONE, V116, P248, DOI 10.1016/j.bone.2018.08.012; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kukita A, 2011, ARTHRITIS RHEUM-US, V63, P2744, DOI 10.1002/art.30455; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Lin Q, 2017, J CELL SCI, V130, P3839, DOI 10.1242/jcs.207068; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Luo SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42668; Luo SH, 2016, INT J BIOCHEM CELL B, V76, P98, DOI 10.1016/j.biocel.2016.05.004; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Matsumoto N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24918-7; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mulari M, 2003, MICROSC RES TECHNIQ, V61, P496, DOI 10.1002/jemt.10371; Mulari MTK, 2003, TRAFFIC, V4, P113, DOI 10.1034/j.1600-0854.2003.40206.x; Ohmae S, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep41710; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palokangas H, 1997, J CELL SCI, V110, P1767; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pei G, 2017, AUTOPHAGY, V13, P2041, DOI 10.1080/15548627.2017.1376160; Pu J, 2016, J CELL SCI, V129, P4329, DOI 10.1242/jcs.196287; Salo J, 1997, SCIENCE, V276, P270, DOI 10.1126/science.276.5310.270; Sharma SM, 2007, J BIOL CHEM, V282, P15921, DOI 10.1074/jbc.M609723200; Shiratori T, 2018, J IMMUNOL, V200, P218, DOI 10.4049/jimmunol.1602035; Stenbeck G, 2004, J CELL SCI, V117, P827, DOI 10.1242/jcs.00935; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; Urano Y, 2009, NAT MED, V15, P104, DOI 10.1038/nm.1854; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Van Wesenbeeck L, 2007, J CLIN INVEST, V117, P919, DOI 10.1172/JCI30328; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Willett R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01871-z; Wiszniak S, 2016, DEV BIOL, V410, P98, DOI 10.1016/j.ydbio.2015.12.001; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/JBMR.081239, 10.1359/jbmr.081239]; Xu XH, 2019, FASEB J, V33, P4365, DOI 10.1096/fj.201801573R; Xu Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14570; Yu J, 2019, BONE, V127, P376, DOI 10.1016/j.bone.2019.07.009; Zhao HB, 2012, TRAFFIC, V13, P1307, DOI 10.1111/j.1600-0854.2012.01395.x; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200; Zou X, 2015, BBA-REV CANCER, V1856, P91, DOI 10.1016/j.bbcan.2015.06.005; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	51	3	3	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21281	10.1096/fj.202001795R	http://dx.doi.org/10.1096/fj.202001795R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484199	Bronze			2022-12-26	WOS:000647789600079
J	Nishinaka, A; Nakamura, S; Tanaka, M; Masuda, T; Inoue, Y; Yamamoto, T; Imai, T; Hidaka, Y; Shimazawa, M; Hara, H				Nishinaka, Anri; Nakamura, Shinsuke; Tanaka, Miruto; Masuda, Tomomi; Inoue, Yuki; Yamamoto, Takumi; Imai, Takahiko; Hidaka, Yae; Shimazawa, Masamitsu; Hara, Hideaki			Excess adiponectin in eyes with progressive ocular vascular diseases	FASEB JOURNAL			English	Article						adiponectin; edema; ischemia; retina; vascular disease	RETINAL VEIN OCCLUSION; ENDOTHELIAL GROWTH-FACTOR; DIABETIC MACULAR EDEMA; INSULIN-RESISTANCE; PROTEIN-KINASE; RETINOPATHY; VEGF; ADIPOSE; RANIBIZUMAB; ASSOCIATION	Anti-vascular endothelial growth factor (VEGF) therapies are now the first-line treatment for many ocular diseases, but some patients are non-responders to these therapies. The purpose of this study was to determine whether the level of adiponectin increased the pathogenesis of retinal edema and neovascularization in the retina of progressive ocular vascular diseases. We examined the role played by adiponectin in two types of cells and animal models which are retinal vein occlusion (RVO) and oxygen-induced retinopathy (OIR) mice. Our results showed that an injection of anti-adiponectin antibody ameliorated the retinal edema and ischemia through the depression of the expression level of VEGF-related factors and tight junction-related proteins in the retina of RVO mice. The intravitreal injection of anti-adiponectin antibody also decreased the degree of retinal neovascularization in an OIR mice. In addition, exposure of human retinal microvascular endothelial cells and human brain microvascular pericytes in culture to adiponectin increased both the vascular permeability and neovascularization through the increase of inflammatory factor and the dropout of the pericytes. These findings indicate that adiponectin plays a critical role in retinal edema and neovascularization, and adiponectin is a potential therapeutic target for the treatment of diabetic macular edema, proliferative diabetic retinopathy, and RVO.	[Nishinaka, Anri; Nakamura, Shinsuke; Tanaka, Miruto; Masuda, Tomomi; Inoue, Yuki; Yamamoto, Takumi; Imai, Takahiko; Hidaka, Yae; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan	Gifu Pharmaceutical University	Hara, H (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Mol Pharmacol, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	hidehara@gifu-pu.ac.jp	Imai, Takahiko/ABF-6143-2020	Imai, Takahiko/0000-0002-4422-2946; Hara, Hideaki/0000-0003-2046-9001				Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Adamis AP, 2005, RETINA-J RET VIT DIS, V25, P111, DOI 10.1097/00006982-200502000-00001; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; Brakenhielm E, 2004, P NATL ACAD SCI USA, V101, P2476, DOI 10.1073/pnas.0308671100; Bunce C, 2010, EYE, V24, P1692, DOI 10.1038/eye.2010.122; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Campochiaro PA, 2011, OPHTHALMOLOGY, V118, P2041, DOI 10.1016/j.ophtha.2011.02.038; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Dai Y, 2013, J GERONTOL A-BIOL, V68, P117, DOI 10.1093/gerona/gls131; Ebneter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119046; Ebrahimi-Mamaeghani M, 2015, VASC HEALTH RISK MAN, V11, P55, DOI 10.2147/VHRM.S48753; Fu ZJ, 2017, INVEST OPHTH VIS SCI, V58, P3862, DOI 10.1167/iovs.17-21796; Fu ZJ, 2015, AM J CLIN NUTR, V101, P879, DOI 10.3945/ajcn.114.099291; Fuma S, 2017, SCI REP-UK, V7, DOI 10.1038/srep43509; Guenther M, 2014, TRANSL RES, V164, P270, DOI 10.1016/j.trsl.2014.04.008; Gupta A, 2015, OMICS, V19, P733, DOI 10.1089/omi.2015.0128; Higuchi A, 2010, ARTERIOSCL THROM VAS, V30, P46, DOI 10.1161/ATVBAHA.109.198465; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Hood JD, 1998, AM J PHYSIOL-HEART C, V274, pH1054; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hu XM, 2017, CIRC RES, V120, P449, DOI 10.1161/CIRCRESAHA.116.308427; Inoue Y, 2018, ARTERIOSCL THROM VAS, V38, P174, DOI 10.1161/ATVBAHA.117.310337; Isola V, 2013, CLIN OPHTHALMOL, V7, P455, DOI 10.2147/OPTH.S30156; Kato K, 2008, CLIN ENDOCRINOL, V68, P442, DOI 10.1111/j.1365-2265.2007.03063.x; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Khayat M, 2017, INVEST OPHTH VIS SCI, V58, P6175, DOI 10.1167/iovs.17-22788; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kuo JZ, 2015, J CLIN ENDOCR METAB, V100, P3348, DOI 10.1210/jc.2015-1221; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mao DN, 2012, CURR EYE RES, V37, P803, DOI 10.3109/02713683.2012.676700; Masuda T, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-20539; Mouquet F, 2009, EUR HEART J, V30, P840, DOI 10.1093/eurheartj/ehn569; Nagelhus EA, 2013, PHYSIOL REV, V93, P1543, DOI 10.1152/physrev.00011.2013; Nakamura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060517; Nakanishi K, 2011, AM J RESP CRIT CARE, V183, P1164, DOI 10.1164/rccm.201007-1091OC; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Nishiguchi KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013493; Nishinaka A, 2018, INVEST OPHTH VIS SCI, V59, P4701, DOI 10.1167/iovs.18-23994; Ogura S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90905; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Osaadon P, 2014, EYE, V28, P510, DOI 10.1038/eye.2014.13; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; PEER J, 1995, LAB INVEST, V72, P638; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rodriguez AJ, 2016, J DIABETES COMPLICAT, V30, P357, DOI 10.1016/j.jdiacomp.2015.11.004; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Simo R, 2014, DIABETES CARE, V37, P893, DOI 10.2337/dc13-2002; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Spyridopoulos I, 2002, ARTERIOSCL THROM VAS, V22, P901, DOI 10.1161/01.ATV.0000020006.89055.11; Srinivasan V., 2013, INT J PHARM BIO SCI, V4, pB993; Stefanini FR, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/632307; Takagi T, 2017, J CEREBR BLOOD F MET, V37, P123, DOI 10.1177/0271678X15621499; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Thach AB, 2014, OPHTHALMOLOGY, V121, P1059, DOI 10.1016/j.ophtha.2013.11.022; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Tsurumi Y, 1997, NAT MED, V3, P879, DOI 10.1038/nm0897-879; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Xie J, 2017, JAMA OPHTHALMOL, V135, P586, DOI 10.1001/jamaophthalmol.2017.0988; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhao Yue, 2018, Drugs Context, V7, P212532, DOI 10.7573/dic.212532	69	8	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21313	10.1096/fj.202001740RR	http://dx.doi.org/10.1096/fj.202001740RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484194	Bronze			2022-12-26	WOS:000647789600055
J	Yu, VY; Nguyen, D; O'Connor, D; Ruan, D; Kaprealian, T; Chin, R; Sheng, K				Yu, Victoria Y.; Nguyen, Dan; O'Connor, Daniel; Ruan, Dan; Kaprealian, Tania; Chin, Robert; Sheng, Ke			Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; MALIGNANT GLIOMAS; IN-VITRO; RADIOTHERAPY; SENSITIVITY; SURVIVAL; PATTERNS; BRAIN; TIME	Purpose A previously developed ordinary differential equation (ODE) that models the dynamic interaction and distinct radiosensitivity between cancer stem cells (CSC) and differentiated cancer cells (DCC) was used to explain the definitive treatment failure in Glioblastoma Multiforme (GBM) for conventionally and hypo-fractionated treatments. In this study, optimization of temporal dose modulation based on the ODE equation is performed to explore the feasibility of improving GBM treatment outcome. Methods A non-convex optimization problem with the objective of minimizing the total cancer cell number while maintaining the normal tissue biological effective dose (BEDnormal) at 100 Gy, equivalent to the conventional 2 Gy x 30 dosing scheme was formulated. With specified total number of dose fractions and treatment duration, the optimization was performed using a paired simulated annealing algorithm with fractional doses delivered to the CSC and DCC compartments and time intervals between fractions as variables. The recurrence time, defined as the time point at which the total tumor cell number regrows to 2.8x10(9) cells, was used to evaluate optimization outcome. Optimization was performed for conventional treatment time frames equivalent to currently and historically utilized fractionation schemes, in which limited improvement in recurrence time delay was observed. The efficacy of a super hyperfractionated approach with a prolonged treatment duration of one year was therefore tested, with both fixed regular and optimized variable time intervals between dose fractions corresponding to total number of fractions equivalent to weekly, bi-weekly, and monthly deliveries (n = 53, 27, 13). Optimization corresponding to BEDnormal of 150 Gy was also obtained to evaluate the possibility in further recurrence delay with dose escalation. Results For the super hyperfractionated schedules with dose fraction number equivalent to weekly, bi-weekly, and monthly deliveries, the recurrence time points were found to be 430.5, 423.9, and 413.3 days, respectively, significantly delayed compared with the recurrence time of 250.3 days from conventional fractionation. Results show that optimal outcome was achieved by first delivering infrequent fractions followed by dense once per day fractions in the middle and end of the treatment course, with sparse and low dose treatments in the between. The dose to the CSC compartment was held relatively constant throughout while larger dose fractions to the DCC compartment were observed in the beginning and final fractions that preceded large time intervals. Dose escalation to BEDnormal of 150 Gy was shown capable of further delaying recurrence time to 452 days. Conclusion The development and utilization of a temporal dose fractionation optimization framework in the context of CSC dynamics have demonstrated that substantial delay in GBM local tumor recurrence could be achieved with a super hyperfractionated treatment approach. Preclinical and clinical studies are needed to validate the efficacy of this novel treatment delivery method.	[Yu, Victoria Y.; Nguyen, Dan; O'Connor, Daniel; Ruan, Dan; Kaprealian, Tania; Chin, Robert; Sheng, Ke] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sheng, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA.	ksheng@mednet.ucia.edu		Sheng, Ke/0000-0002-6696-5409				Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Bachman JWN, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00052; BAUMAN GS, 1994, INT J RADIAT ONCOL, V29, P835, DOI 10.1016/0360-3016(94)90573-8; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bortfeld T, 2015, INFORMS J COMPUT, V27, P788, DOI 10.1287/ijoc.2015.0659; Brada M, 1999, INT J RADIAT ONCOL, V43, P287, DOI 10.1016/S0360-3016(98)00390-3; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; De Bonis P, 2013, CLIN NEUROL NEUROSUR, V115, P37, DOI 10.1016/j.clineuro.2012.04.005; DEUTSCH M, 1989, INT J RADIAT ONCOL, V16, P1389, DOI 10.1016/0360-3016(89)90939-5; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Floyd NS, 2004, INT J RADIAT ONCOL, V58, P721, DOI 10.1016/S0360-3016(03)01623-7; Ford J M, 1997, Clin Oncol (R Coll Radiol), V9, P20, DOI 10.1016/S0936-6555(97)80053-2; Garcia LM, 2007, INT J RADIAT ONCOL, V67, P587, DOI 10.1016/j.ijrobp.2006.10.017; GLINSKI B, 1993, J NEURO-ONCOL, V16, P167, DOI 10.1007/BF01324704; GUTIN PH, 1991, INT J RADIAT ONCOL, V21, P601, DOI 10.1016/0360-3016(91)90676-U; Hillen T, 2013, B MATH BIOL, V75, P161, DOI 10.1007/s11538-012-9798-x; Horiot J C, 1988, Front Radiat Ther Oncol, V22, P149; KEIM H, 1987, RADIOTHER ONCOL, V9, P21, DOI 10.1016/S0167-8140(87)80215-3; Kim M, 2015, MED PHYS, V42, P6671, DOI 10.1118/1.4934369; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; Laperriere N, 2002, RADIOTHER ONCOL, V64, P259, DOI 10.1016/S0167-8140(02)00078-6; Leder K, 2014, CELL, V156, P603, DOI 10.1016/j.cell.2013.12.029; Lee I, 2008, SEMIN RADIAT ONCOL, V18, P7, DOI 10.1016/j.semradonc.2007.09.002; Lindblom E, 2015, ACTA ONCOL, V54, P1592, DOI 10.3109/0284186X.2015.1061207; LUDGATE CM, 1988, INT J RADIAT ONCOL, V15, P1091, DOI 10.1016/0360-3016(88)90189-7; Marko NF, 2014, J CLIN ONCOL, V32, P774, DOI 10.1200/JCO.2013.51.8886; Nieder C, 1999, RADIAT ONCOL INVESTI, V7, P36, DOI 10.1002/(SICI)1520-6823(1999)7:1<36::AID-ROI5>3.0.CO;2-O; Nieder C, 2000, CANCER TREAT REV, V26, P397, DOI 10.1053/ctrv.2000.0191; PAYNE DG, 1982, CANCER-AM CANCER SOC, V50, P2301, DOI 10.1002/1097-0142(19821201)50:11<2301::AID-CNCR2820501114>3.0.CO;2-J; SHRIEVE DC, 1992, INT J RADIAT ONCOL, V24, P599, DOI 10.1016/0360-3016(92)90704-L; Struikmans H, 1997, Radiat Oncol Investig, V5, P170, DOI 10.1002/(SICI)1520-6823(1997)5:4<170::AID-ROI2>3.3.CO;2-2; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Taghian A, 1998, INT J RADIAT ONCOL, V42, P464; TAGHIAN A, 1995, INT J RADIAT ONCOL, V32, P99, DOI 10.1016/0360-3016(94)00494-6; Taghian A, 1996, INT J RADIAT ONCOL, V35, P1124, DOI 10.1016/0360-3016(96)85888-3; WALLNER KE, 1989, INT J RADIAT ONCOL, V16, P1405, DOI 10.1016/0360-3016(89)90941-3; Wein LM, 2000, INT J RADIAT ONCOL, V47, P1073, DOI 10.1016/S0360-3016(00)00534-4; Yang Y, 2005, MED PHYS, V32, P3666, DOI 10.1118/1.2126167; Yu VY, 2015, INT J RADIAT ONCOL, V91, P866, DOI 10.1016/j.ijrobp.2014.12.004	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0245676	10.1371/journal.pone.0245676	http://dx.doi.org/10.1371/journal.pone.0245676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524046	gold, Green Published			2022-12-26	WOS:000616578400020
J	Abebe, S; Gebru, G; Amenu, D; Mekonnen, Z; Dube, L				Abebe, Soressa; Gebru, Girmai; Amenu, Demisew; Mekonnen, Zeleke; Dube, Lemessa			Risk factors associated with congenital anomalies among newborns in southwestern Ethiopia: A case-control study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; MATERNAL SMOKING; BIRTH-DEFECTS; GENE	Introduction Human embryo is well protected in the uterus by the embryonic membrane, although teratogens may cause developmental disruptions after maternal exposure to them during early pregnancy. Most of the risk factors contributing to the development of congenital anomalies are uncertain; however, genetic factors, environmental factors and multifactorial inheritance are found to be risk factors. Regardless of their clinical importance, there are little/no studies conducted directly related to predisposing risk factors in southwestern Ethiopia. Objective The study aimed to determine the associated risk factors with congenital anomalies among newborns in southwestern Ethiopia. Methods Case-control study was conducted on newborns and their mothers in six purposively selected hospitals in southwestern Ethiopia from May 2016 to May 2018. Data was collected after evaluation of the neonates for the presence of congenital anomalies using the standard pretested checklist. The data was analyzed using SPSS version 25.0. P <0.01 was set as statistically significant. Results Risk factors such as unidentified medicinal usage in the first three months of pregnancy (AOR = 3.435; 99% CI: 2.012-5.863), exposure to pesticide (AOR = 3.926; 99% CI: 1.266-12.176), passive smoking (AOR = 4.104; 99% CI: 1.892-8.901), surface water as sources of drinking (AOR = 2.073; 99% CI: 1.221-3.519), folic acid supplementation during the early pregnancy (AOR = 0.428; 99% CI: 0.247-0.740) were significantly associated with the congenital anomalies. Conclusions In this study, risk factors such as passive smoking, exposure to pesticides, chemicals and use of surface water as a source of drinking during early pregnancy had a significant association with congenital anomalies. There is a need to continuously provide health information for the community on how to prevent and control predisposing risk factors.	[Abebe, Soressa; Gebru, Girmai] Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Anat, Addis Ababa, Ethiopia; [Amenu, Demisew] Jimma Univ, Inst Hlth, Dept Gynecol & Obstet, Jimma, Oromia, Ethiopia; [Mekonnen, Zeleke] Jimma Univ, Sch Med Lab Sci, Inst Hlth, Jimma, Oromia, Ethiopia; [Dube, Lemessa] Jimma Univ, Inst Hlth, Dept Epidemiol, Jimma, Oromia, Ethiopia	Addis Ababa University; Jimma University; Jimma University; Jimma University	Abebe, S (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Med, Dept Anat, Addis Ababa, Ethiopia.	abebe.soressa@gmail.com	Sori, Demisew Amenu/AAX-1571-2020	Sori, Demisew Amenu/0000-0003-2715-4440; Mekonnen, Zeleke/0000-0003-3418-7291	Addis Ababa University	Addis Ababa University	This study obtained fund from Addis Ababa University and Jimma University for data collection only. The funders had no role in the study design, data analysis and decision to publish for preparation of the manuscript. No additional external funding was received for this study.	Adane F, 2018, ETHIOP J HEALTH DEV, V32, P156; Ahmed A. M., 2011, The Journal of American Science, V7, P899; Allen VM, 2007, J OBSTET GYNAECOL CA, V29, P927, DOI 10.1016/S1701-2163(16)32653-6; Alverson CJ, 2011, PEDIATRICS, V127, pE647, DOI 10.1542/peds.2010-1399; Ameen SK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-2141-2; Butt F., 2013, BIOMEDICA, V29, P234; Correa A, 2016, CIRCULATION, V133, P2219, DOI 10.1161/CIRCULATIONAHA.116.022960; Croen LA, 2001, AM J EPIDEMIOL, V153, P325, DOI 10.1093/aje/153.4.325; Ehrhardt J, 2014, STILLBIRTHS BIRTH DE, P1; El Koumi MA, 2013, PEDIATRIC REP, V5, P20, DOI 10.4081/pr.2013.e5; Evers IM, 2009, DIABETES CARE, V32, P1194, DOI 10.2337/dc09-0367; Faal G, 2018, MODERN CARE J, V15, P1; Gebremichael TG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227090; Godwin KA, 2008, CAN J PUBLIC HEALTH, V99, P271, DOI 10.1007/BF03403753; Graham TP, 2005, J AM COLL CARDIOL, V45, P1326, DOI 10.1016/j.jacc.2005.02.009; Grewal J, 2008, BIRTH DEFECTS RES A, V82, P519, DOI 10.1002/bdra.20461; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Heinke D, 2020, OBSTET GYNECOL, V135, P133, DOI 10.1097/AOG.0000000000003614; Honein MA, 2000, AM J EPIDEMIOL, V152, P658, DOI 10.1093/aje/152.7.658; Kelsey Et, 2012, STATCALC CALCULATING, P1; Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070; Little J, 2004, CLEFT PALATE-CRAN J, V41, P381, DOI 10.1597/02-142.1; McNeese ML, 2015, BIRTH DEFECTS RES A, V103, P144, DOI 10.1002/bdra.23360; Mekonen HK, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0507-2; Mekonnen AG, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2827-0; NEUMANN PE, 1994, NAT GENET, V6, P357, DOI 10.1038/ng0494-357; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Reece EA, 2012, CURR DIABETES REP, V12, P24, DOI 10.1007/s11892-011-0251-6; Rizk F., 2014, U J PUBLIC HLTH, V2, P58; Shaw GM, 2003, AM J CLIN NUTR, V78, P972, DOI 10.1093/ajcn/78.5.972; Shawky RM, 2018, EGYPTIAN J MED HUMAN, V12, P69; Taboo ZA., 2012, IRAQI POSTGRADUATE M, V22, P140; Taye M, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1096-9; Tayebi Naeimeh, 2010, Oman Med J, V25, P37, DOI 10.5001/omj.2010.9; Vinceti M, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-8	35	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245915	10.1371/journal.pone.0245915	http://dx.doi.org/10.1371/journal.pone.0245915			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508017	gold, Green Published			2022-12-26	WOS:000635021400064
J	Graversen, SB; Pedersen, HS; Sandbaek, A; Foss, CH; Palmer, VJ; Ribe, AR				Graversen, Susanne Boel; Pedersen, Henrik Schou; Sandbaek, Annelli; Foss, Catherine Hauerslev; Palmer, Victoria Jane; Ribe, Anette Riisgaard			Dementia and the risk of short-term readmission and mortality after a pneumonia admission	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; PROSPECTIVE COHORT; DANISH; CARE; BENZODIAZEPINES; HOSPITALIZATION; ASSOCIATION; PEOPLE	Background At time of discharge after a pneumonia admission, care planning for older persons with dementia is essential. However, care planning is limited by lack of knowledge on the short-term prognosis. Aim To investigate 30-day mortality and readmission after hospital discharge for pneumonia in persons with versus without dementia, and to investigate how these associations vary with age, time since discharge, and medication use. Methods Using the Danish registries, we investigated 30-day mortality and readmission in persons (+65 years) discharged after pneumonia in 2000-2016 (N = 298,872). Adjusted mortality rate ratios (aMRRs) and incidence rate ratios (aIRRs) were calculated for persons with versus without dementia, and we investigated if these associations varied with use of benzodiazepines, opioids, and antipsychotics, and with age and time since discharge. Results Among 25,948 persons with dementia, 4,524 died and 5,694 were readmitted within 30 days. The risk of 30-day mortality was 129% higher (95% CI 2.21-2.37) in persons with versus without dementia after adjustment for sociodemographic characteristics, admission-related factors, and comorbidities. Further, the highest mortality risk was found in persons with both dementia and use of antipsychotics (aMRR: 3.39, 95% CI 3.19-3.59); 16% of deaths in this group could not be explained by the independent effect of each exposure. In those with dementia, the highest aMRRs were found for the youngest and for the first days after discharge. The risk of 30-day readmission was 7% higher (95% CI 1.04-1.10) in persons with versus without dementia. In those with dementia, the highest aIRRs were found for the first days after discharge. Conclusions Dementia was associated with higher short-term mortality after pneumonia, especially in users of antipsychotics, and with slightly higher readmission, especially in the first days after discharge. This is essential knowledge in the care planning for persons with dementia who are discharged after a pneumonia admission.	[Graversen, Susanne Boel; Pedersen, Henrik Schou; Ribe, Anette Riisgaard] Res Unit Gen Practice, Aarhus, Denmark; [Graversen, Susanne Boel; Sandbaek, Annelli] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Sandbaek, Annelli] Steno Diabet Ctr Aarhus, Aarhus, Denmark; [Foss, Catherine Hauerslev] Aarhus Univ Hosp, Dept Geriatr, Aarhus, Denmark; [Palmer, Victoria Jane] Univ Melbourne, Melbourne Med Sch, Dept Gen Practice, Melbourne, Vic, Australia	Aarhus University; Aarhus University; University of Melbourne	Graversen, SB (corresponding author), Res Unit Gen Practice, Aarhus, Denmark.; Graversen, SB (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.	sugrav@ph.au.dk		Graversen, Susanne Boel/0000-0002-3731-2521; Palmer, Victoria/0000-0001-7212-932X	General Practice Research Foundation of the Central Denmark Region (Region Midtjyllands Praksisforskningsfond); Danish General Practice Fund (Fonden for Almen Praksis); Public Health in Central Denmark Region; (Danish) Health Foundation (Helsefonden); Danish Foundation for Physicians (Laegefonden) under the A.P. Moeller Foundations; Beckett Foundation (Beckett-fonden); Knud Hoejgaards Fond; Graduate School of Health Aarhus University; Korning Foundation; Novo Nordisk Foundation	General Practice Research Foundation of the Central Denmark Region (Region Midtjyllands Praksisforskningsfond); Danish General Practice Fund (Fonden for Almen Praksis); Public Health in Central Denmark Region; (Danish) Health Foundation (Helsefonden); Danish Foundation for Physicians (Laegefonden) under the A.P. Moeller Foundations; Beckett Foundation (Beckett-fonden); Knud Hoejgaards Fond; Graduate School of Health Aarhus University; Korning Foundation(National Research Foundation of Korea); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	SG was funded by unrestricted grants from the General Practice Research Foundation of the Central Denmark Region (Region Midtjyllands Praksisforskningsfond), the Danish General Practice Fund (Fonden for Almen Praksis), Public Health in Central Denmark Region - a collaboration between municipalities and the Central Denmark Region (Folkesundhed i Midten), the (Danish) Health Foundation (Helsefonden), the Danish Foundation for Physicians (Laegefonden) under the A.P. Moeller Foundations, the Beckett Foundation (Beckett-fonden), the Knud Hoejgaards Fond, the Graduate School of Health Aarhus University, and the Korning Foundation. ARR was funded by an unrestricted grant from the Novo Nordisk Foundation. The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report.	Ahmedani BK, 2015, PSYCHIAT SERV, V66, P134, DOI 10.1176/appi.ps.201300518; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Bickel H, 2018, DTSCH ARZTEBL INT, V115, P733, DOI 10.3238/arztebl.2018.0733; Brown R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009705.pub2; Dang TT, 2014, CLIN INFECT DIS, V59, P74, DOI 10.1093/cid/ciu247; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Fogg C, 2018, INT J GERIATR PSYCH, V33, P1177, DOI 10.1002/gps.4919; Graham KL, 2015, ANN INTERN MED, V162, P741, DOI 10.7326/M14-2159; Graversen SB, 2020, J AM MED DIR ASSOC, V21, P1869, DOI 10.1016/j.jamda.2020.08.025; Hamina A, 2019, J ALZHEIMERS DIS, V69, P807, DOI 10.3233/JAD-181295; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Jo T, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0473-8; Jordan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140203; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knox S, 2019, MED CARE, V57, P766, DOI 10.1097/MLR.0000000000001195; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Maeda K, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010070; Mahoney JE, 1998, CLIN GERIATR MED, V14, P699; Manabe T, 2017, INTERNAL MED, V56, P907, DOI 10.2169/internalmedicine.56.7879; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Muench J, 2010, AM FAM PHYSICIAN, V81, P617; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Pedone C, 2005, J GERONTOL A-BIOL, V60, P1576, DOI 10.1093/gerona/60.12.1576; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Phung TKT, 2007, DEMENT GERIATR COGN, V24, P220, DOI 10.1159/000107084; Phung TKT, 2010, DEMENT GERIATR COGN, V29, P146, DOI 10.1159/000269933; Prior A, 2016, AM J EPIDEMIOL, V184, P199, DOI 10.1093/aje/kwv324; Ribe AR, 2015, JAMA PSYCHIAT, V72, P1095, DOI 10.1001/jamapsychiatry.2015.1546; Rochon PA, 2017, CAN MED ASSOC J, V189, pE517, DOI 10.1503/cmaj.170193; Ryan DJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001772; Salem LC, 2012, DEMENT GERIATR COGN, V34, P292, DOI 10.1159/000345485; Sampson EL, 2009, BRIT J PSYCHIAT, V195, P61, DOI 10.1192/bjp.bp.108.055335; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Spaniolas K, 2010, J TRAUMA, V69, P821, DOI 10.1097/TA.0b013e3181efc6c6; Statistics Denmark, 1991, IDA INT DAT LONG LAN; Sundhedsstyrelsen, 2015, PREV IN ADM OV MUN P; Taudorf L, 2019, ALZHEIMERS DEMENT, V15, P1383, DOI 10.1016/j.jalz.2019.07.006; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Trifiro G, 2010, ANN INTERN MED, V152, P418, DOI 10.7326/0003-4819-152-7-201004060-00006; VanderWeele TJ, 2014, EPIDEMIOL METHODS, V3, P33, DOI [DOI 10.1515/EM-2013-0005, 10.1515/em-2013-0005]; Vergis EN, 2001, ARCH INTERN MED, V161, P2378, DOI 10.1001/archinte.161.19.2378; Vozoris NT, 2014, EXPERT REV RESP MED, V8, P661, DOI 10.1586/17476348.2014.957186; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Xie J, 2008, BMJ-BRIT MED J, V336, P258, DOI 10.1136/bmj.39433.616678.25; Yeh KP, 2014, J CLIN GERONTOL GERI, V5, P13, DOI 10.1016/j.jcgg.2013.08.001	51	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246153	10.1371/journal.pone.0246153	http://dx.doi.org/10.1371/journal.pone.0246153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507947	Green Published, gold			2022-12-26	WOS:000635021400099
J	Lewin, NL; Karlsson, JE; Robinsson, D; Fagerberg, M; Kentsson, M; Sayardoust, S; Nilsson, M; Shamoun, L; Andersson, BA; Lofgren, S; Rutqvist, LE; Lewin, F				Lewin, Nongnit Laytragoon; Karlsson, Jan-Erik; Robinsson, David; Fagerberg, Matida; Kentsson, Magnus; Sayardoust, Shariel; Nilsson, Mats; Shamoun, Levar; Andersson, Bengt-Ake; Lofgren, Sture; Rutqvist, Lars Erik; Lewin, Freddi			Influence of single nucleotide polymorphisms among cigarette smoking and non-smoking patients with coronary artery disease, urinary bladder cancer and lung cancer	PLOS ONE			English	Article							DNA-REPAIR GENES; TOBACCO-SMOKE; P53 MUTATIONS; RISK; XRCC1; INFLAMMATION; ASSOCIATIONS; EXPOSURE; EFFICACY; DAMAGE	Introduction Cigarette smoke is suggested to be a risk factor for coronary artery disease (CAD), urinary bladder cancer (UBCa) or lung cancer (LCa). However, not all heavy smokers develop these diseases and elevated cancer risk among first-degree relatives suggests an important role of genetic factor. Methods Three hundred and ten healthy blood donors (controls), 98 CAD, 74 UBCa and 38 LCa patients were included in this pilot study. The influence of 92 single nucleotide polymorphisms (SNPs) and impact of cigarette smoking were analysed. Results Out of 92 SNPs tested, differences in distribution of 14 SNPs were detected between controls and patient groups. Only CTLA4 rs3087243 showed difference in both CAD and UBCa patient group compared to control group. Stratified by smoking status, the impact of smoking was associated to frequencies of 8, 3 and 4 SNPs in CAD, UBCa, LCa patients, respectively. None of these 92 SNPs showed a statistically significant difference to more than one type of disease among smoking patients. In non-smoking patients, 7, 3 and 6 SNPs were associated to CAD, UBCa, LCa, respectively. Out of these 92 SNPs, CTLA4 rs3087243 was associated to both non-smoking CAD and UBCa. The XRCC1 rs25487 was associated to both non-smoking UBCa and LCa. Conclusion SNPs might be important risk factors for CAD, UBCa and LCa. Distribution of the SNPs was specific for each patient group, not a random event. Impact of cigarette smoking on the disease was associated to the specific SNP sequences. Thus, smoking individuals with SNPs associated to risk of these serious diseases is an important target group for smoking cessation programs.	[Lewin, Nongnit Laytragoon; Shamoun, Levar; Andersson, Bengt-Ake; Lofgren, Sture] Ryhov Hosp, Dept Lab Med, Jonkoping, Sweden; [Karlsson, Jan-Erik; Kentsson, Magnus] Ryhov Hosp, Dept Internal Med, Jonkoping, Sweden; [Karlsson, Jan-Erik] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden; [Robinsson, David; Fagerberg, Matida] Ryhov Hosp, Dept Urol, Jonkoping, Sweden; [Sayardoust, Shariel] Ryhov Hosp, Dept Periodontol, Jonkoping, Sweden; [Nilsson, Mats] Acad Hlth & Care, Futurum, Jonkoping, Sweden; [Nilsson, Mats] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Rutqvist, Lars Erik] Swedish Match AB, Sci Affairs Grp, Stockholm, Sweden; [Lewin, Freddi] Ryhov Hosp, Dept Oncol, Jonkoping, Sweden	Linkoping University; Futurum; Linkoping University	Lewin, NL (corresponding author), Ryhov Hosp, Dept Lab Med, Jonkoping, Sweden.	nongnit.lewin@rjl.se		Laytragoon-Lewin, Nongnit/0000-0001-6815-4530; Robinson, David/0000-0002-3433-8873	Jonko ping Clinical Cancer Research Foundation [110426-1]; Futurum the Academy for health and care [144631]; Medical Research Council of Southeast Sweden (FORSS) [567001]; Internal research Laboratory Medicine; Swedish Match AB	Jonko ping Clinical Cancer Research Foundation; Futurum the Academy for health and care; Medical Research Council of Southeast Sweden (FORSS); Internal research Laboratory Medicine; Swedish Match AB	Grants were received from Jonko ping Clinical Cancer Research Foundation (Grant 110426-1), Futurum the Academy for health and care (Grant 144631), Medical Research Council of Southeast Sweden (FORSS, Grant 567001), Internal research Laboratory Medicine (Grant and Swedish Match AB. The funders had no role in the study design, data collection, analysis, decision to publish or the preparation of the manuscript.	Andersson BA, 2020, ONCOLOGY-BASEL, V98, P42, DOI 10.1159/000502651; Andersson BA, 2019, BIOMARKERS, V24, P180, DOI 10.1080/1354750X.2018.1539764; Atramont A, 2016, J OCCUP ENVIRON MED, V58, P610, DOI 10.1097/JOM.0000000000000722; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bennett WP, 1999, JNCI-J NATL CANCER I, V91, P2009, DOI 10.1093/jnci/91.23.2009; Canova C, 2009, CANCER RES, V69, P2956, DOI 10.1158/0008-5472.CAN-08-2604; Cederblad L, 2013, NICOTINE TOB RES, V15, P890, DOI 10.1093/ntr/nts207; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cummings KJ, 2018, AM J RESP CRIT CARE, V197, P1099, DOI 10.1164/rccm.201801-0138ED; Frisancho-Kiss S, 2006, J IMMUNOL, V176, P6411, DOI 10.4049/jimmunol.176.11.6411; Gao WM, 2006, MOL CARCINOGEN, V45, P828, DOI 10.1002/mc.20208; Gao YY, 2014, J CANCER RES THER, V10, P799, DOI 10.4103/0973-1482.146054; Goodchild M, 2018, TOB CONTROL, V27, P58, DOI 10.1136/tobaccocontrol-2016-053305; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Haug U, 2018, BRIT J CANCER, V118, P1255, DOI 10.1038/s41416-018-0057-2; Hu SW, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019433; Khariwala SS, 2017, CANCER PREV RES, V10, P507, DOI 10.1158/1940-6207.CAPR-17-0140; Laytragoon-Lewin N, 2017, ONCOLOGY-BASEL, V92, P161, DOI 10.1159/000452278; Libby P, 2005, CIRCULATION, V111, P3481, DOI 10.1161/CIRCULATIONAHA.105.537878; Liu LJ, 2018, PATHOL RES PRACT, V214, P1873, DOI 10.1016/j.prp.2018.09.004; London RE, 2015, DNA REPAIR, V30, P90, DOI 10.1016/j.dnarep.2015.02.005; Luetragoon T, 2018, IMMUNOLOGY, V154, P98, DOI 10.1111/imm.12864; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao YQ, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-58; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Qureshi KM, 2011, CELL TRANSPLANT, V20, P523, DOI 10.3727/096368910X528111; Ratnasinghe D, 2001, CANCER EPIDEM BIOMAR, V10, P119; Rom O, 2013, RESP PHYSIOL NEUROBI, V187, P5, DOI 10.1016/j.resp.2013.01.013; Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086; Shen MR, 1998, CANCER RES, V58, P604; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shore RE, 2018, J RADIOL PROT, V38, P1217, DOI 10.1088/1361-6498/aad348; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Sun YQ, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00824-2017; Svanes O, 2018, AM J RESP CRIT CARE, V197, P1157, DOI 10.1164/rccm.201706-1311OC; Syn NL, 2017, LANCET ONCOL, V18, pE731, DOI 10.1016/S1470-2045(17)30607-1; van Osch FHM, 2016, INT J EPIDEMIOL, V45, P857, DOI 10.1093/ije/dyw044; Wagner MJ, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0013-2; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Zou C, 2018, ONCOTARGETS THER, V11, P4609, DOI 10.2147/OTT.S173421	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0243084	10.1371/journal.pone.0243084	http://dx.doi.org/10.1371/journal.pone.0243084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507988	gold, Green Published			2022-12-26	WOS:000635021400009
J	Villar, FMD; Pinto, FDD; Santos, FL; de Queiroz, DM; Pereira, MR; Valente, DSM				Villar, Flora Maria de Melo; Pinto, Francisco de Assis de Carvalho; Santos, Fabio Lucio; de Queiroz, Daniel Marcal; Pereira, Mariana Ribeiro; Magalhaes Valente, Domingos Sarvio			Modal properties of fruit-rachilla system of the macaw palm	PLOS ONE			English	Article							CANOPY-SHAKER; DETACHMENT; EFFICIENCY; FREQUENCY	The macaw palm has been domesticated due to its potential use in the production of biofuel, in addition to several co-products that can be generated from its oil and pulp. One of the current challenges in this area is the harvesting, as there are no specific machines for this operation. Therefore, it is necessary to determine the appropriate information regarding the physical properties of the plant, so that it is feasible to develop the technologies necessary for the commercial scale application of macaw palm, allowing it to contribute to the sustainable production of raw material for the biofuel industry and other co-products. The principle of mechanical vibration can be used to shed fruit from trees when ripe, and it can be a method used for harvesting. Thus, as proposed in this study, it was necessary to study the dynamic behavior of the fruit-rachilla system during vibration. Hence, the modal properties of the system were determined. A study on the dynamic behaviors was carried out using a deterministic finite element model, and the natural frequencies were obtained through a frequency-scanning test to evaluate the model. The mean relative error (MRE) between the measured and simulated natural frequencies was also used to evaluate the model. The natural frequencies, determined experimentally, varied from 26.21 to 33.45 Hz on average, whereas the simulated frequencies varied from 24.81 to 39.27 Hz. The overall MRE was 9.08%. Once the model was validated, a sensibility test was carried out, which showed that the density of fruit and the elasticity modulus are the parameters that most influence the natural frequencies of the fruit-rachilla system.	[Villar, Flora Maria de Melo; Pinto, Francisco de Assis de Carvalho; de Queiroz, Daniel Marcal; Magalhaes Valente, Domingos Sarvio] Univ Fed Vicosa, Dept Engn Agr, Mecanizacao Agr, Vicosa, MG, Brazil; [Santos, Fabio Lucio; Pereira, Mariana Ribeiro] Univ Fed Lavras, Dept Engn, Engn Mecan, Lavras, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Lavras	Villar, FMD (corresponding author), Univ Fed Vicosa, Dept Engn Agr, Mecanizacao Agr, Vicosa, MG, Brazil.	flora.villar@ufv.br	Santos, Fábio Lúcio/GSD-7326-2022; Queiroz, Daniel M/G-4063-2011	Santos, Fábio Lúcio/0000-0003-1197-7338; Queiroz, Daniel M/0000-0003-0987-3855; Villar, Flora/0000-0001-7022-4219	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR)) [001]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR))(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The author (s) received specific funding for this work from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR) - 001) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico).	[Anonymous], 1987, ESTATISTICA MODERNA; [Anonymous], 2017, PEDIAT RADIOL S2, V47, pS303; ANSYS Inc, 1996, ANSYS THEORY REFEREN; da Silva E.P., 2014, ENGINEERING, V2014, DOI [10.4236/eng.2014.63017, DOI 10.4236/ENG.2014.63017]; Coelho Andre Luiz de Freitas, 2015, Pesqui. Agropecu. Trop., V45, P406, DOI 10.1590/1983-40632015v4536227; Grupioni CMD, 2020, IND CROP PROD, V151, DOI 10.1016/j.indcrop.2020.112444; Domiciano GP, 2015, CIENC RURAL, V45, P1599, DOI 10.1590/0103-8478cr20140909; Evaristo AB, 2016, IND CROP PROD, V85, P63, DOI 10.1016/j.indcrop.2016.02.052; Gharaghani BN, 2020, SCI HORTIC-AMSTERDAM, V261, DOI 10.1016/j.scienta.2019.108958; Hoshyarmanesh H, 2017, COMPUT ELECTRON AGR, V132, P34, DOI 10.1016/j.compag.2016.11.014; Liu TH, 2018, COMPUT ELECTRON AGR, V148, P54, DOI 10.1016/j.compag.2018.03.004; Mota CS., 2011, INFORM AGROPECUARIO, V32, P41; Pu YJ, 2018, INT J AGR BIOL ENG, V11, P77, DOI 10.25165/j.ijabe.20181105.4445; Rao S., 2008, VIBRACOES MECANICAS, V4; Santos FL, 2008, SIMULACAO AVALIACAO; Velloso NS, 2020, COMPUT ELECTRON AGR, V175, DOI 10.1016/j.compag.2020.105552; Villar FMM, 2016, THESIS	17	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0237291	10.1371/journal.pone.0237291	http://dx.doi.org/10.1371/journal.pone.0237291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493152	gold, Green Published, Green Submitted			2022-12-26	WOS:000613081500058
J	Clarke, B; Kwon, J; Swinburn, B; Sacks, G				Clarke, Brydie; Kwon, Janelle; Swinburn, Boyd; Sacks, Gary			Understanding the dynamics of obesity prevention policy decision-making using a systems perspective: A case study of Healthy Together Victoria	PLOS ONE			English	Article							CORPORATE POLITICAL ACTIVITY; NONCOMMUNICABLE DISEASES; NUTRITION POLICY; INTERVENTIONS; GOVERNMENT; SCIENCE; COMPLEXITY; CHALLENGES; FRAMEWORK; BARRIERS	Introduction Despite global recommendations for governments to implement a comprehensive suite of policies to address obesity, policy adoption has been deficient globally. This paper utilised political science theory and systems thinking methods to examine the dynamics underlying decisions regarding obesity prevention policy adoption within the context of the Australian state government initiative, Healthy Together Victoria (HTV) (2011-2016). The aim was to understand key influences on policy processes, and to identify potential opportunities to increase the adoption of recommended policies. Methods Data describing government processes in relation to the adoption of six policy interventions considered as part of HTV were collected using interviews (n = 57), document analyses (n = 568) and field note observations. The data were analysed using multiple political science theories. A systematic method was then used to develop a Causal Loop Diagram (CLD) for each policy intervention. A simplified meta-CLD was generated from synthesis of common elements across each of the six policy interventions. Results The dynamics of policy change could be explained using a series of feedback loops. Five interconnected balancing loops served to reduce the propensity for policy change. These pertained to an organisational norm of risk aversion, and the complexity resulting from a whole-of-government policy approach and in-depth stakeholder consultation. However, seven virtuous reinforcing loops helped overcome policy resistance through policy actor capabilities that were improved over time as policy actors gained experience in advocating for change. Conclusion Policy processes for obesity prevention are complex and resistant to change. In order to increase adoption of recommended policies, several capabilities of policy actors, including policy skills, political astuteness, negotiation skills and consensus building, should be fostered and strengthened. Strategies to facilitate effective and broad-based consultation, both across and external to government, need to be implemented in ways that do not result in substantial delays in the policy process.	[Clarke, Brydie; Kwon, Janelle; Sacks, Gary] Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia; [Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand	Deakin University; University of Auckland	Sacks, G (corresponding author), Deakin Univ, Global Obes Ctr, Sch Hlth & Social Dev, Inst Hlth Transformat, Geelong, Vic, Australia.	gary.sacks@deakin.edu.au	Sacks, Gary/I-5731-2014	Sacks, Gary/0000-0001-9736-1539	Heart Foundation Future Leader Fellowship from the National Heart Foundation of Australia [102035]; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Food Retail Environments for Health (RE-FRESH) (Australia) [APP1152968]	Heart Foundation Future Leader Fellowship from the National Heart Foundation of Australia; National Health and Medical Research Council (NHMRC) Centre of Research Excellence in Food Retail Environments for Health (RE-FRESH) (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	GS was supported by a Heart Foundation Future Leader Fellowship (102035) from the National Heart Foundation of Australia (https://www.heartfoundation.org.au/). GS and BS are researchers within a National Health and Medical Research Council (NHMRC) (https://www.nhmrc.gov.au/) Centre of Research Excellence in Food Retail Environments for Health (RE-FRESH) (APP1152968) (Australia). GS and BS are also researchers within a NHMRC Centre for Research Excellence entitled Reducing Salt Intake Using Food Policy Interventions (APP1117300). The authors are solely responsible for the opinions, hypotheses and conclusions or recommendations expressed in this publication, and they do not necessarily reflect their funders' vision. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackrill R, 2011, J EUR PUBLIC POLICY, V18, P72, DOI 10.1080/13501763.2011.520879; Advisory Group on Reform of Australian Government Administration, 2010, GAM BULEPR REF AUSTR, P73, DOI [10.1111/j.1467-789X.2011.00937.x, DOI 10.1111/J.1467-789X.2011.00937.X]; Allender S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129683; Anderson V, 1997, SYSTEMS THINKING CON; Angrosino M., 2005, SAGE HDB QUALITATIVE, P745; Arnold RD, 2015 C SYST ENG RES, P669; Baker P, 2019, OBES REV, V20, P30, DOI 10.1111/obr.12871; Baker P, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000485; Baker P, 2017, SOC SCI MED, V177, P141, DOI 10.1016/j.socscimed.2017.01.047; Bensberg M., 2020, APPL INFLUENCE SYSTE; Bowen S., 2008, AUSTRALASIAN EPIDEMI, V15, P10; Brennan LK, 2015, J PUBLIC HEALTH MAN, P21; Bures V, 2017, SYSTEMS, V5, DOI 10.3390/systems5030046; Cairney P., 2020, UNDERSTANDING PUBLIC, V2nd; Cairney P., 2015, OXFORD HDB CLASSICS; Cairney P., 2015, HDB COMPLEXITY PUBLI; Cairney P, 2017, POLICY SCI, V50, P619, DOI 10.1007/s11077-017-9304-2; Cairney P, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0192-x; Cairney P, 2013, POLICY STUD J, V41, P1, DOI 10.1111/psj.12000; Cairney P, 2012, POLIT STUD REV, V10, P346, DOI 10.1111/j.1478-9302.2012.00270.x; Carey G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1087; Christopoulos D, 2011, PROCD SOC BEHV, V10, DOI 10.1016/j.sbspro.2011.01.006; Christopoulos D, 2015, EUR POLIT SCI REV, V7, P475, DOI 10.1017/S1755773914000277; Clarke B., 2018, THESIS; Clarke B, 2020, SOC SCI MED, V246, DOI 10.1016/j.socscimed.2019.112757; Clarke B, 2019, FOOD POLICY, V89, DOI 10.1016/j.foodpol.2019.101784; Clarke B, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112393; Clarke B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3639-z; Cook D, 2002, SOC POLICY ADMIN, V36, P516, DOI 10.1111/1467-9515.00300; Pereira MMCE, 2019, INT J OBESITY, V43, P1883, DOI 10.1038/s41366-019-0411-3; Crammond B, 2013, OBES REV, V14, P213, DOI 10.1111/obr.12004; Cullerton K, 2016, OBES REV, V17, P1218, DOI 10.1111/obr.12459; Cullerton K, 2016, PUBLIC HEALTH NUTR, V19, P2643, DOI 10.1017/S1368980016000677; Department of Health and Human Services, 2015, HEALTH VICT CREAT HE; Edmonds B, 2015, HDB COMPLEXITY PUBLI; Evans M., 2004, POLICY TRANSFER GLOB; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Fraussen B, 2020, POLICY SCI, V53, P473, DOI 10.1007/s11077-020-09382-3; Freudenberg N., 2014, LETHAL LEGAL CORPORA; Frood S, 2013, CURR OBES REP, V2, P320, DOI 10.1007/s13679-013-0072-9; Ghaffarzadegan N, 2011, SYST DYNAM REV, V27, P22, DOI 10.1002/sdr.442; Hawe P, 2015, ANNU REV PUBL HEALTH, V36, P307, DOI 10.1146/annurev-publhealth-031912-114421; Hawkes C, 2013, OBES REV, V14, P159, DOI 10.1111/obr.12098; Head BW, 2014, ASIA PAC J PUBLIC AM, V36, P48, DOI 10.1080/23276665.2014.892273; Hennessy E, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150414; Holt DH, 2018, SCAND J PUBLIC HEALT, V46, P48, DOI 10.1177/1403494818765705; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; Ingold K, 2012, J PUBL ADM RES THEOR, V22, P319, DOI 10.1093/jopart/mur035; Jackson H, 2017, MUCH DOES AUSTR SPEN; Johnson DB, 2013, J HUNGER ENVIRON NUT, V8, P171, DOI 10.1080/19320248.2012.761575; Kim D.H., 1992, SYSTTHINK, V3, P5; Kim H, 2012, SYST DYNAM REV, V28, P311, DOI 10.1002/sdr.1480; Kingdon JohnW., 1995, AGENDAS ALTERNATIVES, V2nd ed.; Kumar M, 2018, NUTR DIET, V75, P193, DOI 10.1111/1747-0080.12393; Lachat C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001465; Lang T, 2007, OBES REV, V8, P165, DOI 10.1111/j.1467-789X.2007.00338.x; Lang T., 2015, FOOD RES COLLABORATI, DOI [10.13140/RG.2.1.4874.7287, DOI 10.13140/RG.2.1.4874.7287]; Lannon C., 2012, SYSTEMS THINKER, V23; Lindquist E, 2011, AUST J PUBL ADMIN, V70, P437, DOI 10.1111/j.1467-8500.2011.00743.x; Machell G, 2015, J POLICY PRACT, V14, P14, DOI 10.1080/15588742.2014.956968; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; McGlashan J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165459; Meadows D.H., 2008, THINKING SYSTEMS PRI; Mialon M, 2015, OBES REV, V16, P519, DOI 10.1111/obr.12289; Mialon M, 2017, AUST NZ J PUBL HEAL, V41, P165, DOI 10.1111/1753-6405.12639; MINTROM M, 2017, ENVIRON PLANN C, V35, P1, DOI DOI 10.1177/; Monat J.P., 2015, AM J SYSTEMS SCI, V4, P11, DOI [10.5923/j.ajss.20150401.02, DOI 10.5923/J.AJSS.20150401.02, https://doi.org/10.5923/j.ajss.20150401.02]; Monterrosa EC, 2015, HEALTH POLICY PLANN, V30, P28, DOI 10.1093/heapol/czt094; Nestle M., 2007, FOOD POLITICS FOOD I; Olstad DL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1669-6; Organisation for Economic Co-operation and Development, 2012, REC COUNC REG POL GO; Owen B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195141; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Peters DH, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-51; PricewaterhouseCoopers Canada, 2015, AG GOV RESP CIT CHAN; Raine KD, 2013, J PUBLIC HEALTH POL, V34, P239, DOI 10.1057/jphp.2013.9; RICHARDSON GP, 1995, SYST DYNAM REV, V11, P67, DOI 10.1002/sdr.4260110106; Ridder H-G., 2017, BUSINESS RES, V10, P281, DOI [https://doi.org/10.1007/s40685-017-0045-z, DOI 10.1007/S40685-017-0045-Z, 10.1007/s40685-017-0045-z]; Roberto CA, 2015, LANCET, V385, P2400, DOI 10.1016/S0140-6736(14)61744-X; Root HL, 2017, UNDERST COMPLEX SYST, P97, DOI 10.1007/978-3-319-42424-8_7; Sabatier P, 2005, INNOVATIONS ADVOCACY; Sabatier P., 2014, THEORIES POLICY PROC, V3; Sacks G, 2009, OBES REV, V10, P76, DOI 10.1111/j.1467-789X.2008.00524.x; Schilling J, 2008, J HEALTH POLIT POLIC, V33, P455, DOI 10.1215/03616878-2008-005; SCHLAGER E, 1995, POLICY SCI, V28, P243, DOI 10.1007/BF01000289; Shill J, 2012, OBES REV, V13, P162, DOI 10.1111/j.1467-789X.2011.00937.x; Sisnowski J, 2016, FOOD POLICY, V58, P24, DOI 10.1016/j.foodpol.2015.10.007; Stake R.E., 1994, HDB QUALITATIVE RES; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Sterman JD, 2001, CALIF MANAGE REV, V43, P8, DOI 10.2307/41166098; Strugnell C, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0127-y; Swinburn Boyd A, 2008, Aust New Zealand Health Policy, V5, P12, DOI 10.1186/1743-8462-5-12; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Taylor-Robinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029536; Thow AM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-249; Torfing J, 2017, PUBLIC MANAG REV, V19, P37, DOI 10.1080/14719037.2016.1200662; Unwin N, 2017, INT J HEALTH POLICY, V6, P71, DOI 10.15171/ijhpm.2016.74; Waqa G, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0240-6; Waqa G, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-74; WHO, 2016, REP COMM END CHILDH; World Cancer Research Fund, 2020, NOUR POL DAT WORLD C; World Health Organization, 2013, GLOB NUTR POL REV WH; Yin R, 2003, CASE STUDY RES; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed	104	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245535	10.1371/journal.pone.0245535	http://dx.doi.org/10.1371/journal.pone.0245535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481898	Green Published, gold			2022-12-26	WOS:000612929300054
J	Pereira, HV; Palmeira, AL; Carraca, EV; Santos, I; Marques, MM; Teixeira, PJ				Pereira, Hugo, V; Palmeira, Antonio L.; Carraca, Eliana, V; Santos, Ines; Marques, Marta M.; Teixeira, Pedro J.			Running prevalence in Portugal: Socio-demographic, behavioral and psychosocial characteristics	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SUBJECTIVE VITALITY; ALL-CAUSE; EXERCISE; FLOW; PARTICIPATION; VALIDATION; PREDICTORS	The purpose of this study was to cross-sectionally estimate the prevalence of recreational running in Portugal and describe characteristics of adult recreational runners. A random representative sample of 1068 Portuguese adults was selected. Socio-demographic information, physical activity habits and running behavior were assessed. Recreational runners' training habits, motivations, barriers, vitality and flow were also assessed. The prevalence of recreational running in Portugal was 10.6%. It was higher in men (14.6% vs. 6.6%, p = .024) and in younger runners (13.6% vs. 7.7%, p = .026). Participants ran on average 3 times, 20 kilometers and 3 hours per week. General health orientation (88%), self-esteem (63%), and life meaning (57%) were the most predominant motives for running, while time was the most prevalent barrier (43%). This first Portuguese running prevalence representative study, indicates that almost 11% of adults ran regularly, and describes correlates of running, which can inform future running promotion interventions.	[Pereira, Hugo, V; Palmeira, Antonio L.; Carraca, Eliana, V; Santos, Ines; Teixeira, Pedro J.] Univ Lisbon, Fac Motricidade Humana, Ctr Interdisciplinar Estudo Performance Humana CI, Cruz Quebrada Dafundo, Portugal; [Pereira, Hugo, V; Palmeira, Antonio L.; Carraca, Eliana, V] Univ Lusofona, Fac Educ Fis & Desporto, Lisbon, Portugal; [Santos, Ines] Univ Lisbon, Fac Med, Lab Nutr, Lisbon, Portugal; [Marques, Marta M.] Trinity Coll Dublin, ADAPT SFI Res Ctr, Dublin, Ireland; [Marques, Marta M.] Trinity Coll Dublin, Trinity Ctr Practice & Hlth Care Innovat, Dublin, Ireland	Universidade de Lisboa; Lusofona University; Universidade de Lisboa; Trinity College Dublin; Trinity College Dublin	Pereira, HV (corresponding author), Univ Lisbon, Fac Motricidade Humana, Ctr Interdisciplinar Estudo Performance Humana CI, Cruz Quebrada Dafundo, Portugal.; Pereira, HV (corresponding author), Univ Lusofona, Fac Educ Fis & Desporto, Lisbon, Portugal.	hugopereira@fmh.ulisboa.pt	Pereira, Hugo Vieira/ABC-1205-2021; Teixeira, Pedro J./AAA-9438-2021; Carraça, Eliana V/M-8843-2013; Santos, Ines/N-1856-2016	Pereira, Hugo Vieira/0000-0001-5710-524X; Teixeira, Pedro J./0000-0001-7202-0527; Carraça, Eliana V/0000-0002-5789-811X; Santos, Ines/0000-0002-1638-8551; Palmeira, Antonio/0000-0001-6508-0599	Fundacao para a Ciencia e Tecnologia [UIDB/00447/2020]; Universidade de Lisboa; Marie-Sklodowska-Curie Fellowship; EDGE programme [713567]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Universidade de Lisboa; Marie-Sklodowska-Curie Fellowship; EDGE programme	This study was partly supported by the Fundacao para a Ciencia e Tecnologia, under Grant UIDB/00447/2020 to CIPER - Centro Interdisciplinar para o Estudo da Performance Humana (unit 447) and Universidade de Lisboa under PhD. grant conceded to Hugo V. Pereira. Marta M. Marques is funded by a Marie-Sklodowska-Curie Fellowship (Co-fund EDGE programme, grant agreement no. 713567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amireault S, 2013, HEALTH PSYCHOL REV, V7, P55, DOI 10.1080/17437199.2012.701060; [Anonymous], 2017, RUNN JOGG US; ASC, 2016, PART DAT SPORT SECT; Cid L, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01940; CLOUGH P, 1989, J LEISURE RES, V21, P297, DOI 10.1080/00222216.1989.11969806; Ding D, 2020, BRIT J SPORT MED, V54, P462, DOI 10.1136/bjsports-2019-101001; EU, 2018, SPEC EUR 472 SPORT P; Evenson KR, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200118; Gouveia MJ, 2012, REV PSICOL DEPORTE, V21, P81; Hanson N, 2015, J SPORT BEHAV, V38; Hespanhol LC, 2013, J PHYSIOTHER, V59, P263, DOI 10.1016/S1836-9553(13)70203-0; Hoare E, 2017, SPORTS, V5, DOI 10.3390/sports5030047; Jordalen G., 2015, INT J SPORT EXERC SC, V7, P1; Justine M, 2013, SINGAP MED J, V54, P581, DOI 10.11622/smedj.2013203; Kahlert Daniela, 2015, Prev Med Rep, V2, P178, DOI 10.1016/j.pmedr.2015.02.013; Krouse R, 2011, J STRENGTH COND RES, V25, pS53; Lavie CJ, 2015, MAYO CLIN PROC, V90, P1541, DOI 10.1016/j.mayocp.2015.08.001; Lee DC, 2014, J AM COLL CARDIOL, V64, P472, DOI 10.1016/j.jacc.2014.04.058; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Loyen A, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0398-2; Luan X, 2019, J SPORT HEALTH SCI, V8, P422, DOI 10.1016/j.jshs.2019.04.002; Luszczynska A, 2007, PSYCHOL SPORT EXERC, V8, P247, DOI 10.1016/j.psychsport.2006.03.010; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Masters K. S., 1995, Journal of Sport Behavior, V18, P69; MASTERS KS, 1993, RES Q EXERCISE SPORT, V64, P134, DOI 10.1080/02701367.1993.10608790; Moutao JM, 2013, REV LAT AM PSICOL, V45, P223, DOI 10.14349/rlp.v45i2.842; Mullen SP, 2016, RES Q EXERCISE SPORT, V87, P174, DOI 10.1080/02701367.2016.1152349; Nigg CR, 2008, APPL PSYCHOL-INT REV, V57, P544, DOI 10.1111/j.1464-0597.2008.00343.x; Ntoumanis N, 2021, HEALTH PSYCHOL REV, V15, P214, DOI 10.1080/17437199.2020.1718529; Ogles B.M., 2000, J SPORT BEHAV, V23, P130; Omura JD, 2020, CIRCULATION, V142, pE160, DOI 10.1161/CIR.0000000000000884; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Pedisic Z, 2019, BR J SPORTS MED; Petosa RL, 2013, AM J HEALTH EDUC, V44, P273, DOI 10.1080/19325037.2013.811364; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Santos M., 2017, PREVALENCIA CARACTER; Scheerder J, 2015, RUNNING ACROSS EUROPE: THE RISE AND SIZE OF ONE OF THE LARGEST SPORT MARKETS, P1, DOI 10.1057/9781137446374; Schuler J, 2009, PSYCHOL SPORT EXERC, V10, P168, DOI 10.1016/j.psychsport.2008.07.001; Szabo A, 2013, PSYCHOL HEALTH MED, V18, P251, DOI 10.1080/13548506.2012.701755; Teixeira D, 2018, REV IBEROAMERICANA P, V13; Teixeira PJ, 2019, J PHYS ACT HEALTH, V16, P251, DOI 10.1123/jpah.2018-0340; Teixeira PJ, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-78; Titze S, 2005, PSYCHOL SPORT EXERC, V6, P363, DOI 10.1016/j.psychsport.2004.06.001; Tjelta L.I., 2017, ACTA KINESIOLOGIAE U, V23, P42, DOI [DOI 10.12697/AKUT.2017.23.04, 10.12697/akut.2017.23.04]	44	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245242	10.1371/journal.pone.0245242	http://dx.doi.org/10.1371/journal.pone.0245242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481801	Green Published, gold			2022-12-26	WOS:000612929300135
J	Safi, N; Saunders, C; Hayen, A; Anazodo, A; Lui, K; Li, ZY; Remond, M; Nicholl, M; Wang, AY; Sullivan, E				Safi, Nadom; Saunders, Christobel; Hayen, Andrew; Anazodo, Antoinette; Lui, Kei; Li, Zhuoyang; Remond, Marc; Nicholl, Michael; Wang, Alex Y.; Sullivan, Elizabeth			Gestational breast cancer in New South Wales: A population-based linkage study of incidence, management, and outcomes	PLOS ONE			English	Article							PREGNANCY; FATIGUE; WOMEN	Background The incidence of gestational breast cancer (GBC) is increasing in high-income countries. Our study aimed to examine the epidemiology, management and outcomes of women with GBC in New South Wales (NSW), Australia. Methods A retrospective cohort study using linked data from three NSW datasets. The study group comprised women giving birth with a first-time diagnosis of GBC while the comparison group comprised women giving birth without any type of cancer. Outcome measures included incidence of GBC, maternal morbidities, obstetric management, neonatal mortality, and preterm birth. Results Between 1994 and 2013, 122 women with GBC gave birth in NSW (crude incidence 6.8/100,000, 95%CI: 5.6-8.0). Women aged >= 35 years had higher odds of GBC (adjusted odds ratio (AOR) 6.09, 95%CI 4.02-9.2) than younger women. Women with GBC were more likely to give birth by labour induction or pre-labour CS compared to women with no cancer (AOR 4.8, 95%CI: 2.96-7.79). Among women who gave birth by labour induction or prelabour CS, the preterm birth rate was higher for women with GBC than for women with no cancer (52% vs 7%; AOR 17.5, 95%CI: 11.3-27.3). However, among women with GBC, preterm birth rate did not differ significantly by timing of diagnosis or cancer stage. Babies born to women with GBC were more likely to be preterm (AOR 12.93, 95%CI 8.97-18.64), low birthweight (AOR 8.88, 95%CI 5.87-13.43) or admitted to higher care (AOR 3.99, 95% CI 2.76-5.76) than babies born to women with no cancer. Conclusion Women aged >= 35 years are at increased risk of GBC. There is a high rate of preterm birth among women with GBC, which is not associated with timing of diagnosis or cancer stage. Most births followed induction of labour or pre-labour CS, with no major short term neonatal morbidity.	[Safi, Nadom; Hayen, Andrew; Wang, Alex Y.; Sullivan, Elizabeth] Univ Technol Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Safi, Nadom; Li, Zhuoyang; Remond, Marc; Sullivan, Elizabeth] Univ Newcastle, Fac Hlth & Med, Callaghan, NSW, Australia; [Saunders, Christobel] Univ Western Australia, Fac Hlth & Med Sci, Crawley, WA, Australia; [Anazodo, Antoinette; Lui, Kei] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Anazodo, Antoinette] Prince Wales Hosp, Nelune Comprehens Canc Ctr, Randwick, NSW, Australia; [Nicholl, Michael] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia	University of Technology Sydney; University of Newcastle; University of Western Australia; University of New South Wales Sydney; University of Sydney	Sullivan, E (corresponding author), Univ Technol Sydney, Sch Publ Hlth, Sydney, NSW, Australia.; Sullivan, E (corresponding author), Univ Newcastle, Fac Hlth & Med, Callaghan, NSW, Australia.	e.sullivan@newcastle.edu.au	Safi, Nadom Hikmet/AAD-3660-2020; Safi, Nadom/ABC-2183-2021; Saunders, Christobel/H-5779-2014	Safi, Nadom Hikmet/0000-0001-8473-0980; Safi, Nadom/0000-0001-8473-0980; Remond, Marc/0000-0001-7796-4447; Saunders, Christobel/0000-0003-2281-9829; Hayen, Andrew/0000-0003-4046-8030	Cancer Council NSW [RG 18-02]; University of Technology Sydney (UTS), Faculty of Health; UTS Doctoral Scholarship; Australian Government Research Training Program	Cancer Council NSW(Cancer Council New South Wales); University of Technology Sydney (UTS), Faculty of Health; UTS Doctoral Scholarship; Australian Government Research Training Program(Australian Government)	This study received funding from the following sources: Cancer Council NSW grant (reference RG 18-02, awarded to ES); University of Technology Sydney (UTS), Faculty of Health (awarded to ES); UTS Doctoral Scholarship (awarded to NS); and Australian Government Research Training Program (awarded to NS).	Amant F, 2015, NEW ENGL J MED, V373, P1824, DOI 10.1056/NEJMoa1508913; Ancoli-Israel S, 2014, SUPPORT CARE CANCER, V22, P2535, DOI 10.1007/s00520-014-2204-5; Andersson TML, 2009, OBSTET GYNECOL, V114, P568, DOI 10.1097/AOG.0b013e3181b19154; Bardwell WA, 2008, SLEEP MED CLIN, V3, P61, DOI 10.1016/j.jsmc.2007.10.011; Centre for Epidemiology and Evidence, 2018, NSW MOTH BAB 2017; CHeReL, 2019, DAT DICT; CHeReL, 2019, REC LINK WORKS; Dalberg K, 2006, PLOS MED, V3, P1597, DOI 10.1371/journal.pmed.0030336; Durrani S, 2018, CUREUS, V10, DOI 10.7759/cureus.2941; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Goldstein D, 2012, J CLIN ONCOL, V30, P1805, DOI 10.1200/JCO.2011.34.6148; Ionio C, 2016, EUR J PSYCHOL, V12, P604, DOI 10.5964/ejop.v12i4.1093; Kuo K, 2019, J MATERN-FETAL NEO M, V32, P419, DOI 10.1080/14767058.2017.1381900; Lee YY, 2012, BJOG-INT J OBSTET GY, V119, P1572, DOI 10.1111/j.1471-0528.2012.03475.x; Li ZY, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0464-y; Loibl S, 2012, LANCET ONCOL, V13, P887, DOI 10.1016/S1470-2045(12)70261-9; Maor GS, 2019, BREAST J, V25, P86, DOI 10.1111/tbj.13156; Maxwell CV, 2019, GYNECOL OBSTET INVES, V84, P79, DOI 10.1159/000493128; Momen NC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022946; Papiernik E, 2010, HUM REPROD, V25, P1035, DOI 10.1093/humrep/dep430; Paules C, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.10.022; Platt MJ, 2014, PUBLIC HEALTH, V128, P399, DOI 10.1016/j.puhe.2014.03.010; Royal College of Pathologists of Australasia, 2012, INV BREAST CANC STRU; Simoes E, 2018, ARCH GYNECOL OBSTET, V298, P363, DOI 10.1007/s00404-018-4822-5; Van Calsteren K, 2010, J CLIN ONCOL, V28, P683, DOI 10.1200/JCO.2009.23.2801; Yeo KT, 2017, BMJ PAEDIATR OPEN, V1, DOI 10.1136/bmjpo-2017-000205	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245493	10.1371/journal.pone.0245493	http://dx.doi.org/10.1371/journal.pone.0245493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481842	gold, Green Published			2022-12-26	WOS:000612929300146
J	Tokunaga, S; Kawata, T				Tokunaga, Shin; Kawata, Takehisa			The effect of evocalcet on vagus nerve activity of the gastrointestinal tract in miniature pigs	PLOS ONE			English	Article							SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; ANIMAL-MODEL; VITAMIN-D; CINACALCET; CALCIUM; PTH	Evocalcet is a novel calcimimetic agent with fewer gastrointestinal (GI) adverse effects compared to cinacalcet. Although it is thought that cinacalcet induces GI side effects through the direct stimulation of the calcium receptor (CaR) expressed in the GI tract, the differences in the direct stimulatory effects of these two drugs on the GI tract have not been reported. In this study, we analyzed the difference in the GI effects of these two calcimimetic agents using miniature pigs by detecting vagus nerve stimulation after oral administration of the agents. Although cinacalcet induced vomiting in miniature pigs, evocalcet never induced emetic symptoms. A significant increase in the vagus nerve action potentials was observed after the administration of cinacalcet. Although the increase of that after the administration of evocalcet was mild and not significant in comparison to that in the vehicle group, it was not significantly different from the vagus nerve action potentials after cinacalcet treatment.	[Tokunaga, Shin; Kawata, Takehisa] Kyowa Kirin Co Ltd, Nephrol R&D Unit, R&D Div, Nephrol Res Labs, Shizuoka, Japan	Kyowa Kirin Ltd	Kawata, T (corresponding author), Kyowa Kirin Co Ltd, Nephrol R&D Unit, R&D Div, Nephrol Res Labs, Shizuoka, Japan.	takehisa.kawata.kk@kyowakirin.com			Kyowa Kirin Co., Ltd.; Nihon Bioresearch Inc.	Kyowa Kirin Co., Ltd.; Nihon Bioresearch Inc.	Mitsubishi Tanabe Pharma Corporation provided evocalcet. All studies were performed and the cost of them were supported by Kyowa Kirin Co., Ltd. The conduct of studies was supported by Masami Kato (Nihon Bioresearch Inc.). Shin Tokunaga and Takehisa Kawata are employees of Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd provided support in the form of salaries for authors, ST and TK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aresta C, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/7617254; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Chertow GM, 2006, CLIN J AM SOC NEPHRO, V1, P305, DOI 10.2215/CJN.00870805; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Cunningham J, 2011, CLIN J AM SOC NEPHRO, V6, P913, DOI 10.2215/CJN.06040710; Eto S, 1994, Rinsho Byori, V42, P943; Fukagawa M, 2018, KIDNEY INT, V94, P818, DOI 10.1016/j.kint.2018.05.013; FUKUI H, 1992, JPN J PHARMACOL, V59, P221, DOI 10.1254/jjp.59.221; Gincherman Y, 2010, HEMODIAL INT, V14, P68, DOI 10.1111/j.1542-4758.2009.00397.x; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kasperk C, 2017, INTERNIST, V58, P1029, DOI 10.1007/s00108-017-0311-3; Kawata T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195316; MILANO S, 1995, J PHARMACOL EXP THER, V274, P951; Miyazaki H, 2018, BIOORG MED CHEM LETT, V28, P2055, DOI 10.1016/j.bmcl.2018.04.055; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Sakai M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232428; Taylor DM, 2020, EMERG MED AUSTRALAS, V32, P303, DOI 10.1111/1742-6723.13411; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tokunaga Shin, 2019, Folia Pharmacologica Japonica, V154, P35, DOI 10.1254/fpj.154.35; Vodicka P, 2005, ANN NY ACAD SCI, V1049, P161, DOI 10.1196/annals.1334.015	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245785	10.1371/journal.pone.0245785	http://dx.doi.org/10.1371/journal.pone.0245785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481922	Green Published, gold			2022-12-26	WOS:000612929300119
J	Khayyat, NH; Zaika, O; Tomilin, VN; Pyrshev, K; Pochynyuk, O				Khayyat, Naghmeh Hassanzadeh; Zaika, Oleg; Tomilin, Viktor N.; Pyrshev, Kyrylo; Pochynyuk, Oleh			Angiotensin II increases activity of the ClC-K2 Cl- channel in collecting duct intercalated cells by stimulating production of reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-PRESSURE; CHLORIDE CHANNEL; DISTAL NEPHRON; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; PARACELLULAR PATHWAY; CONNECTING TUBULE; BARTTER-SYNDROME; PRINCIPAL CELLS; MICE LACKING	The renal collecting duct plays a critical role in setting urinary volume and composition, with principal cells transporting Na+ and K+ and intercalated cells mediating Cl- reabsorption. Published evidence implies Angiotensin II (Ang II) is a potent regulator of the collecting duct apical transport systems in response to systemic volume depletion. However, virtually nothing is known about Ang II actions on the basolateral conductance of principal and intercalated cells. Here, we combined macroscopic and single channel patch clamp recordings from freshly isolated mouse collecting ducts with biochemical and fluorescence methods to demonstrate an acute stimulation of the basolateral Cl- conductance and specifically the ClC-K2 Cl- channel by nanomolar Ang II concentrations in intercalated cells. In contrast, Ang II did not exhibit measurable effects on the basolateral conductance and on K(ir)4.1/5.1 potassium channel activity in principal cells. Although both Ang II receptors AT(1) and AT(2) are expressed in collecting duct cells, we show that AT(1) receptors were essential for stimulatory actions of Ang II on ClC-K2. Moreover, AT(1)R(-/-) mice had decreased renal ClC-K2 expression. We further demonstrated that activation of NADPH oxidases is the major signaling pathway downstream of Ang II-AT(1)R that leads to stimulation of ClC-K2. Treatment of freshly isolated collecting ducts with Ang II led to production of reactive oxygen species on the same timescale as single channel ClC-K2 activation. Overall, we propose that Ang II-dependent regulation of ClC-K2 in intercalated cells is instrumental for stimulation of Cl- reabsorption by the collecting duct, particularly during hypovolemic states.	[Khayyat, Naghmeh Hassanzadeh; Zaika, Oleg; Tomilin, Viktor N.; Pyrshev, Kyrylo; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Pyrshev, Kyrylo/P-3003-2018	Pyrshev, Kyrylo/0000-0001-5722-0707	NIH-NIDDK [DK095029, DK117865]; AHA [EIA35260097];  [AHA-19CDA34660148]	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); 	This research was supported by NIH-NIDDK DK095029, DK117865, AHA EIA35260097 (to O. P.) and AHA-19CDA34660148 (to V. N. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; Berry C, 2001, AM J PHYSIOL-HEART C, V281, pH2337, DOI 10.1152/ajpheart.2001.281.6.H2337; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; Carey RM, 2000, HYPERTENSION, V35, P155, DOI 10.1161/01.HYP.35.1.155; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Cuevas CA, 2017, J AM SOC NEPHROL, V28, P1814, DOI 10.1681/ASN.2016090935; Dilauro M, 2009, THESCIENTIFICWORLDJO, V9, P522, DOI 10.1100/tsw.2009.70; Gonzalez-Villalobos RA, 2008, AM J PHYSIOL-RENAL, V295, pF772, DOI 10.1152/ajprenal.00019.2008; Gonzalez-Villalobos RA, 2010, AM J PHYSIOL-RENAL, V298, pF150, DOI 10.1152/ajprenal.00477.2009; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Gray DA, 2005, AM J PHYSIOL-RENAL, V288, pF493, DOI 10.1152/ajprenal.00301.2004; Hennings JC, 2017, J AM SOC NEPHROL, V28, P209, DOI 10.1681/ASN.2016010085; Hilliard LM, 2011, HYPERTENSION, V57, P275, DOI 10.1161/HYPERTENSIONAHA.110.166827; Hu QH, 1998, CIRC RES, V83, P644, DOI 10.1161/01.RES.83.6.644; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; IKEBUCHI Y, 1991, J BIOL CHEM, V266, P13233; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; KOTCHEN TA, 1983, ANN INTERN MED, V98, P817, DOI 10.7326/0003-4819-98-5-817; KOTCHEN TA, 1976, AM J PHYSIOL, V231, P1050, DOI 10.1152/ajplegacy.1976.231.4.1050; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Lachheb S, 2008, AM J PHYSIOL-RENAL, V294, pF1398, DOI 10.1152/ajprenal.00288.2007; Lara LS, 2012, AM J PHYSIOL-RENAL, V302, pF85, DOI 10.1152/ajprenal.00351.2011; Lourdel S, 2003, J GEN PHYSIOL, V121, P287, DOI 10.1085/jgp.200208737; LUFT FC, 1988, CLIN SCI, V74, P577, DOI 10.1042/cs0740577; Mamenko M, 2018, J CELL PHYSIOL, V233, P7217, DOI 10.1002/jcp.26552; Mamenko M, 2013, HYPERTENSION, V62, P1111, DOI 10.1161/HYPERTENSIONAHA.113.01797; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; McCallum L, 2015, PFLUG ARCH EUR J PHY, V467, P595, DOI 10.1007/s00424-015-1690-8; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; Monzon CM, 2015, HYPERTENSION, V65, P1245, DOI 10.1161/HYPERTENSIONAHA.115.05356; MUTO S, 1990, J CLIN INVEST, V86, P1829, DOI 10.1172/JCI114913; MUTO S, 1988, J CLIN INVEST, V81, P376, DOI 10.1172/JCI113329; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; NAVAR LG, 1994, J AM SOC NEPHROL, V5, P1153; Nissant A, 2006, AM J PHYSIOL-RENAL, V290, pF1421, DOI 10.1152/ajprenal.00274.2005; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF139, DOI 10.1152/ajprenal.00504.2006; Ozono R, 1997, HYPERTENSION, V30, P1238, DOI 10.1161/01.HYP.30.5.1238; Palygin O, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92331; Paulais M, 2011, P NATL ACAD SCI USA, V108, P10361, DOI 10.1073/pnas.1101400108; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pech V, 2007, AM J PHYSIOL-RENAL, V292, pF914, DOI 10.1152/ajprenal.00361.2006; Pessoa BS, 2013, NAT REV NEPHROL, V9, P26, DOI 10.1038/nrneph.2012.249; Peti-Peterdi J, 2002, J AM SOC NEPHROL, V13, P1131, DOI 10.1097/01.ASN.0000013292.78621.FD; Pinelli L, 2016, J GEN PHYSIOL, V148, P213, DOI 10.1085/jgp.201611623; Pratt JH, 2005, J AM SOC NEPHROL, V16, P3154, DOI 10.1681/ASN.2005050460; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; SCHUSTER VL, 1987, AM J PHYSIOL, V253, pF203, DOI 10.1152/ajprenal.1987.253.2.F203; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; SIRAGY HM, 1995, HYPERTENSION, V25, P1021, DOI 10.1161/01.HYP.25.5.1021; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Tomilin VN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226381; Tomilin VN, 2018, PFLUG ARCH EUR J PHY, V470, P339, DOI 10.1007/s00424-017-2084-x; Wall SM, 2013, AM J PHYSIOL-RENAL, V305, pF427, DOI 10.1152/ajprenal.00022.2013; WARDEN DH, 1988, AM J PHYSIOL, V255, pF720, DOI 10.1152/ajprenal.1988.255.4.F720; Wei YA, 2007, J BIOL CHEM, V282, P6455, DOI 10.1074/jbc.M607477200; Whelton PK, 2018, CIRCULATION, V138, pE426, DOI 10.1161/CIR.0000000000000597; Zaika O, 2020, AM J PHYSIOL-RENAL, V318, pF870, DOI 10.1152/ajprenal.00572.2019; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pF311, DOI 10.1152/ajprenal.00436.2015; Zaika O, 2015, AM J PHYSIOL-RENAL, V308, pF39, DOI 10.1152/ajprenal.00545.2014; Zaika OL, 2013, AM J PHYSIOL-RENAL, V305, pF1277, DOI 10.1152/ajprenal.00363.2013; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	71	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100347	10.1016/j.jbc.2021.100347	http://dx.doi.org/10.1016/j.jbc.2021.100347			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524393	Green Published, gold			2022-12-26	WOS:000672866400321
J	Tewari, R; Shayahati, B; Fan, Y; Akimzhanov, AM				Tewari, Ritika; Shayahati, Bieerkehazhi; Fan, Ying; Akimzhanov, Askar M.			T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOLIPID-ENRICHED MICRODOMAINS; TYROSINE KINASE; PROTEIN PALMITOYLATION; LCK; LOCALIZATION; LAT; FAMILY; ZAP70; SITES	ZAP-70 is a tyrosine kinase essential for T cell immune responses. Upon engagement of the T cell receptor (TCR), ZAP-70 is recruited to the specialized plasma membrane domains, becomes activated, and is released to phosphorylate its laterally segregated targets. A shift in ZAP-70 distribution at the plasma membrane is recognized as a critical step in TCR signal transduction and amplification. However, the molecular mechanism supporting stimulation-dependent plasma membrane compartmentalization of ZAP-70 remains poorly understood. In this study, we identified previously uncharacterized lipidation (S-acylation) of ZAP-70 using Acyl-Biotin Exchange assay, a technique that selectively captures S-acylated proteins. We found that this posttranslational modification of ZAP-70 is dispensable for its enzymatic activity. However, the lipidation-deficient mutant of ZAP-70 failed to propagate the TCR pathway suggesting that S-acylation is essential for ZAP-70 interaction with its protein substrates. The kinetics of ZAP-70 S-acylation were consistent with TCR signaling events indicating that agonist-induced S-acylation is a part of the signaling mechanism controlling T cell activation and function. Taken together, our results suggest that TCR-induced S-acylation of ZAP-70 can serve as a critical regulator of T cell-mediated immunity.	[Tewari, Ritika; Shayahati, Bieerkehazhi; Fan, Ying; Akimzhanov, Askar M.] Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA; [Fan, Ying] Rowan Univ, Dept Biomed Sci, Cooper Med Sch, Camden, NJ USA	University of Texas System; University of Texas Health Science Center Houston; Rowan University; Cooper Medical School of Rowan University	Akimzhanov, AM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Biochem & Mol Biol, McGovern Med Sch, Houston, TX 77030 USA.	Askar.M.Akimzhanov@uth.tmc.edu	Bieerkehazhi, Shayahati/ABG-2791-2021	Akimzhanov, Askar/0000-0002-5592-8215	National Institutes of Health [1R01GM115446]; University of Texas Health Science Center at Houston	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center at Houston	This work was supported by National Institutes of Health Grant 1R01GM115446 (to A.M.A) and startup funds provided by the University of Texas Health Science Center at Houston (to A.M.A.).	Akimzhanov AM, 2015, P NATL ACAD SCI USA, V112, P11876, DOI 10.1073/pnas.1509929112; Akimzhanov AM, 2010, P NATL ACAD SCI USA, V107, P15105, DOI 10.1073/pnas.1005419107; Au-Yeung BB, 2018, ANNU REV IMMUNOL, V36, P127, DOI 10.1146/annurev-immunol-042617-053335; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Duncan JA, 1998, J BIOL CHEM, V273, P15830, DOI 10.1074/jbc.273.25.15830; Fan Y, 2020, MOL BIOL REP, V47, P6471, DOI 10.1007/s11033-020-05691-1; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Hsu LY, 2017, J EXP MED, V214, P833, DOI 10.1084/jem.20161575; Hundt M, 2006, IMMUNITY, V24, P513, DOI 10.1016/j.immuni.2006.03.011; Hundt M, 2009, J IMMUNOL, V183, P1685, DOI 10.4049/jimmunol.0803921; Irvin BJ, 2000, MOL CELL BIOL, V20, P9149, DOI 10.1128/MCB.20.24.9149-9161.2000; Kabouridis PS, 1997, EMBO J, V16, P4983, DOI 10.1093/emboj/16.16.4983; Katz ZB, 2017, NAT IMMUNOL, V18, P86, DOI 10.1038/ni.3631; Kosugi A, 2001, IMMUNOL LETT, V76, P133, DOI 10.1016/S0165-2478(01)00174-2; Ladygina N, 2011, ADV IMMUNOL, V109, P1, DOI 10.1016/B978-0-12-387664-5.00001-7; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lin DTS, 2015, ELIFE, V4, DOI 10.7554/eLife.11306; Lin J, 1999, J BIOL CHEM, V274, P28861, DOI 10.1074/jbc.274.41.28861; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; Tewari R, 2020, JOVE-J VIS EXP, DOI 10.3791/61016; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Torchia MLG, 2018, P NATL ACAD SCI USA, V115, P2174, DOI 10.1073/pnas.1713301115; Turul T, 2009, EUR J PEDIATR, V168, P87, DOI 10.1007/s00431-008-0718-x; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Yokoi N, 2016, J NEUROSCI, V36, P6431, DOI 10.1523/JNEUROSCI.0419-16.2016; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; YURCHAK LK, 1995, MOL CELL BIOL, V15, P6914, DOI 10.1128/mcb.15.12.6914	41	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100311	10.1016/j.jbc.2021.100311	http://dx.doi.org/10.1016/j.jbc.2021.100311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482200	gold, Green Submitted, Green Published			2022-12-26	WOS:000672866400285
J	Lee, Y; Lee, JA; Park, HE; Han, H; Kim, Y; Bae, JM; Kim, JH; Cho, NY; Kim, HP; Kim, TY; Kang, GH				Lee, Yunbeom; Lee, Ji Ae; Park, Hye Eun; Han, Hyojun; Kim, Yuhnam; Bae, Jeong Mo; Kim, Jung Ho; Cho, Nam-Yun; Kim, Hwang-Phill; Kim, Tae-You; Kang, Gyeong Hoon			Targeted next-generation sequencing-based detection of microsatellite instability in colorectal carcinomas	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; MUTATION; GENES; LYNCH	In the present study, we developed a computational method and panel markers to assess microsatellite instability (MSI) using a targeted next-generation sequencing (NGS) platform and compared the performance of our computational method, mSILICO, with that of mSINGS to detect MSI in CRCs. We evaluated 13 CRC cell lines, 84 fresh and 119 formalin-fixed CRC tissues (including 61 MSI-high CRCs and 155 microsatellite-stable CRCs) and tested the classification performance of the two methods on 23, 230, and 3,154 microsatellite markers. For the fresh tissue and cell line samples, mSILICO showed a sensitivity of 100% and a specificity of 100%, regardless of the number of panel markers, whereas for the formalin-fixed tissue samples, mSILICO exhibited a sensitivity of up to 100% and a specificity of up to 100% with three differently sized panels ranging from 23 to 3154. These results were similar to those of mSINGS. With the application of mSILICO, the small panel of 23 markers had a sensitivity of >= 95% and a specificity of 100% in cell lines/fresh tissues and formalin-fixed tissues of CRC. In conclusion, we developed a new computational method and microsatellite marker panels for the determination of MSI that does not require paired normal tissues. A small panel could be integrated into the targeted NGS panel for the concurrent analysis of single nucleotide variations and MSI.	[Lee, Yunbeom; Han, Hyojun; Kim, Yuhnam] Celemics Inc, Seoul, South Korea; [Lee, Ji Ae; Park, Hye Eun; Bae, Jeong Mo; Cho, Nam-Yun; Kang, Gyeong Hoon] Seoul Natl Univ, Canc Res Inst, Lab Epigenet, Coll Med, Seoul, South Korea; [Lee, Ji Ae; Kang, Gyeong Hoon] Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Bae, Jeong Mo; Kim, Jung Ho] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Kim, Hwang-Phill; Kim, Tae-You] Seoul Natl Univ, Canc Res Inst, Lab Canc Epigenet, Coll Med, Seoul, South Korea; [Kim, Tae-You] Seoul Natl Univ, Dept Internal Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ, Canc Res Inst, Lab Epigenet, Coll Med, Seoul, South Korea.; Kang, GH (corresponding author), Seoul Natl Univ, Dept Pathol, Coll Med, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea, in the form of a grant awarded to GHK (HI14C1277) and Celemics, Inc. in the form of salaries for YL, HH, and YK. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 1997, CANCER RES, V57, P3920; Bacher JW, 2004, DIS MARKERS, V20, P237, DOI 10.1155/2004/136734; Baudrin LG, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00621; Cortes-Ciriano I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15180; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Ellegren H, 2000, NAT GENET, V24, P400, DOI 10.1038/74249; Haile S, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gky1142; Hosein AN, 2013, LAB INVEST, V93, P701, DOI 10.1038/labinvest.2013.54; Kim JH, 2016, BRIT J CANCER, V115, P490, DOI 10.1038/bjc.2016.211; Kim JH, 2014, WORLD J GASTROENTERO, V20, P4230, DOI 10.3748/wjg.v20.i15.4230; Kim TM, 2013, CELL, V155, P858, DOI 10.1016/j.cell.2013.10.015; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee DW, 2017, CANCER-AM CANCER SOC, V123, P3513, DOI 10.1002/cncr.30760; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Middha S, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00084; Nowak JA, 2017, J MOL DIAGN, V19, P84, DOI 10.1016/j.jmoldx.2016.07.010; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Pritchard CC, 2012, J MOL DIAGN, V14, P357, DOI 10.1016/j.jmoldx.2012.03.002; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Stadler ZK, 2016, J CLIN ONCOL, V34, P2141, DOI 10.1200/JCO.2015.65.1067; Suraweera N, 2002, GASTROENTEROLOGY, V123, P1804, DOI 10.1053/gast.2002.37070; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Zhao H, 2014, ELIFE, V3, DOI 10.7554/eLife.02725	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246356	10.1371/journal.pone.0246356	http://dx.doi.org/10.1371/journal.pone.0246356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524032	gold, Green Published			2022-12-26	WOS:000616578400013
J	Petkevicius, K; Bidault, G; Virtue, S; Jenkins, B; van Dierendonck, XAMH; Dugourd, A; Saez-Rodriguez, J; Stienstra, R; Koulman, A; Vidal-Puig, A				Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; van Dierendonck, Xanthe A. M. H.; Dugourd, Aurelien; Saez-Rodriguez, Julio; Stienstra, Rinke; Koulman, Albert; Vidal-Puig, Antonio			Norepinephrine promotes triglyceride storage in macrophages via beta2-adrenergic receptor activation	FASEB JOURNAL			English	Article						adrb2; dgat1; hilpda; immunometabolism; lipid	ADIPOSE-TISSUE MACROPHAGES; FATTY-ACID OXIDATION; LIPID-ACCUMULATION; BETA(2)-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; METABOLISM; EXPRESSION; PROTEIN; HEART; INFLAMMATION	Tissue-resident macrophages are required for homeostasis, but also contribute to tissue dysfunction in pathophysiological states. The sympathetic neurotransmitter norepinephrine (NE) induces an anti-inflammatory and tissue-reparative phenotype in macrophages. As NE has a well-established role in promoting triglyceride lipolysis in adipocytes, and macrophages accumulate triglyceride droplets in various physiological and disease states, we investigated the effect of NE on primary mouse bone marrow-derived macrophage triglyceride metabolism. Surprisingly, our data show that in contrast to the canonical role of NE in stimulating lipolysis, NE acting via beta2-adrenergic receptors (B2ARs) in macrophages promotes extracellular fatty acid uptake and their storage as triglycerides and reduces free fatty acid release from triglyceride-laden macrophages. We demonstrate that these responses are mediated by a B2AR activation-dependent increase in Hilpda and Dgat1 gene expression and activity. We further show that B2AR activation favors the storage of extracellular polyunsaturated fatty acids. Finally, we present evidence that macrophages isolated from hearts after myocardial injury, for which survival critically depends on leukocyte B2ARs, have a transcriptional signature indicative of a transient triglyceride accumulation. Overall, we describe a novel and unexpected role of NE in promoting triglyceride storage in macrophages that could have potential implications in multiple diseases.	[Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; Koulman, Albert; Vidal-Puig, Antonio] Univ Cambridge, MDU MRC, Inst Metab Sci, Metab Res Labs, Cambridge, England; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [van Dierendonck, Xanthe A. M. H.; Stienstra, Rinke] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Rhein Westfal TH Aachen, Fac Med, Joint Res Ctr Computat Biomed, Aachen, Germany; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Heidelberg Univ, Fac Med, Inst Computat Biomed, Heidelberg, Germany; [Dugourd, Aurelien; Saez-Rodriguez, Julio] Heidelberg Univ, Heidelberg Univ Hosp, Heidelberg, Germany; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Hinxton, England; [Petkevicius, Kasparas; Bidault, Guillaume; Virtue, Sam; Jenkins, Benjamin; Koulman, Albert; Vidal-Puig, Antonio] AstraZeneca BioPharmaceut R&D, IMED Biotech Unit, Metab Biosci Cardiovasc Renal & Metab, Gothenburg, Sweden	University of Cambridge; Wageningen University & Research; Radboud University Nijmegen; RWTH Aachen University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Wellcome Trust Sanger Institute	Petkevicius, K; Vidal-Puig, A (corresponding author), Univ Cambridge, MDU MRC, Inst Metab Sci, Metab Res Labs, Cambridge, England.	kasparas.petkevicius@gmail.com; ajv22@medschl.cam.ac.uk	Koulman, Albert/B-2967-2009; Saez-Rodriguez, Julio/H-7114-2019; Dugourd, Aurelien/AGI-0197-2022	Koulman, Albert/0000-0001-9998-051X; Saez-Rodriguez, Julio/0000-0002-8552-8976; van Dierendonck, Xanthe/0000-0002-9855-8701	Biotechnology and Biological Sciences Research Council [BB/P028195/1, BB/M027252/2] Funding Source: Medline; British Heart Foundation [RG/18/7/33636, RG/12/13/29853] Funding Source: Medline; Medical Research Council [G0400192, MC_UU_12012/5, G0802051, MC_UU_00014/5, MC_UU_00014/2, MC_UU_12012/2] Funding Source: Medline; Wellcome Trust [102354/Z/13/Z] Funding Source: Medline; BBSRC [BB/P028195/1, BB/M027252/2] Funding Source: UKRI; MRC [MC_UU_00014/2, MC_UU_00014/5, MC_UU_12012/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Batista-Gonzalez A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02993; Biswas S.K., 2014, MACROPHAGES BIOL ROL; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Caspar-Bauguil S., 2015, DIABETOLOGIA, V58, P1; Castoldi A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17881-3; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Das KMP, 2018, J LIPID RES, V59, P531, DOI 10.1194/jlr.M082388; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Esler M, 2002, AM J PHYSIOL-REG I, V282, pR909, DOI 10.1152/ajpregu.00335.2001; Feingold KR, 2012, J LEUKOCYTE BIOL, V92, P829, DOI 10.1189/jlb.1111537; FUNK JL, 1993, ATHEROSCLEROSIS, V98, P67, DOI 10.1016/0021-9150(93)90224-I; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Ghosh PM, 2012, J ENDOCRINOL, V213, P251, DOI 10.1530/JOE-11-0406; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Grailer JJ, 2014, J INNATE IMMUN, V6, P607, DOI 10.1159/000358524; Greer MS, 2014, LIPIDS, V49, P831, DOI 10.1007/s11745-014-3921-8; Grisanti LA, 2016, P NATL ACAD SCI USA, V113, P15126, DOI 10.1073/pnas.1611023114; Grisanti LA, 2016, CIRCULATION, V134, P153, DOI 10.1161/CIRCULATIONAHA.116.022304; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Huang YL, 2014, J BIOL CHEM, V289, P3001, DOI 10.1074/jbc.M113.524587; Huynh FK, 2014, METHOD ENZYMOL, V542, P391, DOI 10.1016/B978-0-12-416618-9.00020-0; Jain M, 2014, AM J PHYSIOL-ENDOC M, V306, pE854, DOI 10.1152/ajpendo.00371.2013; Jaisinghani N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01490; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Kintscher U, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100001; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Kurian GA, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1656450; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu C, 2019, IMMUNITY, V51, P381, DOI 10.1016/j.immuni.2019.06.017; Lu MF, 2014, J IMMUNOL, V193, P1392, DOI 10.4049/jimmunol.1400886; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Maier A, 2017, FASEB J, V31, P4971, DOI 10.1096/fj.201700235R; Mak KM, 2008, ALCOHOL CLIN EXP RES, V32, P683, DOI 10.1111/j.1530-0277.2008.00624.x; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Medina CB, 2020, NATURE, V580, P130, DOI 10.1038/s41586-020-2121-3; Nomura M, 2016, NAT IMMUNOL, V17, P216, DOI 10.1038/ni.3366; Odegaard JI, 2013, CELL METAB, V18, P767, DOI 10.1016/j.cmet.2013.11.011; Parajuli N, 2018, AM J PHYSIOL-HEART C, V315, pH879, DOI 10.1152/ajpheart.00308.2018; Petkevicius K, 2019, ROLE MACROPHAGE INTR, DOI [10.17863/CAM.32789, DOI 10.17863/CAM.32789]; Prieur X, 2011, DIABETES, V60, P797, DOI 10.2337/db10-0705; Rader DJ, 2005, CELL METAB, V1, P223, DOI 10.1016/j.cmet.2005.03.005; Rizzo G., 2020, SINGLE CELL TRANSCRI; Rosas-Ballina M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00131; Schulze RJ, 2017, BBA-MOL CELL BIOL L, V1862, P1178, DOI 10.1016/j.bbalip.2017.06.008; Shi Y, 2016, EXP GERONTOL, V78, P32, DOI 10.1016/j.exger.2016.03.005; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Tang LJ, 2015, ENDOCRINOLOGY, V156, P3680, DOI 10.1210/EN.2015-1096; van Dierendonck XAMH, 2020, CELL REP, V30, P1811, DOI 10.1016/j.celrep.2020.01.046; Walter W, 2018, CELL REP, V23, P622, DOI 10.1016/j.celrep.2018.03.029; Willemze RA, 2019, MOL MED, V25, DOI 10.1186/s10020-018-0068-8; Wu H, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910698; Wu L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01313; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	62	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21266	10.1096/fj.202001101R	http://dx.doi.org/10.1096/fj.202001101R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484195	Green Published, hybrid			2022-12-26	WOS:000647789600088
J	McCarthy, JE; Dewitt, BD; Dumas, BA; McCarthy, MT				McCarthy, John E.; Dewitt, Barry D.; Dumas, Bob A.; McCarthy, Myles T.			Modeling the relative risk of SARS-CoV-2 infection to inform risk-cost-benefit analyses of activities during the SARS-CoV-2 pandemic	PLOS ONE			English	Article								Risk-cost-benefit analysis requires the enumeration of decision alternatives, their associated outcomes, and the quantification of uncertainty. Public and private decision-making surrounding the COVID-19 pandemic must contend with uncertainty about the probability of infection during activities involving groups of people, in order to decide whether that activity is worth undertaking. We propose a model of SARS-CoV-2 infection probability that can produce estimates of relative risk of infection for diverse activities, so long as those activities meet a list of assumptions, including that they do not last longer than one day (e.g., sporting events, flights, concerts), and that the probability of infection among possible routes of infection (i.e., droplet, aerosol, fomite, and direct contact) are independent. We show how the model can be used to inform decisions facing governments and industry, such as opening stadiums or flying on airplanes; in particular, it allows for estimating the ranking of the constituent components of activities (e.g., going through a turnstile, sitting in one's seat) by their relative risk of infection, even when the probability of infection is unknown or uncertain. We prove that the model is a good approximation of a more refined model in which we assume infections come from a series of independent risks. A linearity assumption governing several potentially modifiable risks factors-such as duration of the activity, density of participants, and infectiousness of the attendees-makes interpreting and using the model straightforward, and we argue that it does so without significantly diminishing the reliability of the model.	[McCarthy, John E.] Washington Univ, Dept Math & Stat, St Louis, MO 63110 USA; [Dewitt, Barry D.] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA; [Dumas, Bob A.] Omnium LLC, St Joseph, MO USA; [McCarthy, Myles T.] Univ Illinois, Champaign, IL USA	Washington University (WUSTL); Carnegie Mellon University; University of Illinois System; University of Illinois Urbana-Champaign	McCarthy, JE (corresponding author), Washington Univ, Dept Math & Stat, St Louis, MO 63110 USA.	mccarthy@wustl.edu		McCarthy, John/0000-0003-0036-7606; Dewitt, Barry/0000-0003-1622-6736	National Institutes of Health [R01 AG052550-01A1]; National Science Foundation [DMS 1565243]; Riksbanken Jubileumsfond program on Science and Proven Experience [M14-0138:1]; Omnium LLC	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Riksbanken Jubileumsfond program on Science and Proven Experience; Omnium LLC	JEM was partially supported by National Institutes of Health Grant R01 AG052550-01A1 and National Science Foundation Grant DMS 1565243. BDD was supported by the Riksbanken Jubileumsfond program on Science and Proven Experience (M14-0138:1). JEM, BAD, and MTM received funding through Omnium LLC in Omnium's capacity as a consultant for Delaware North, a company that may be affected by the research reported in the paper. The funders provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2020, BBC NEWS; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; Buonanno G, 2020, ENVIRON INT, V145, DOI 10.1016/j.envint.2020.106112; Center for Systems Science and Engineering at Johns Hopkins University, COVID 19 DASHB; Chen WZ, 2020, BUILD ENVIRON, V176, DOI 10.1016/j.buildenv.2020.106859; Cheng VCC, 2020, J INFECTION, V81, P107, DOI 10.1016/j.jinf.2020.04.024; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; David Berger, 2020, SEIR INFECT DIS MODE; DGA SAG-AFTRA IATSE and Teamsters' Committees for COVID-19 Safety Guidelines, 2020, TEAM COMM COVID 19 S; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dumas Bob A., LONG RANGE VERSUS SH; EDWARDS W, 1954, PSYCHOL BULL, V51, P380, DOI 10.1037/h0053870; Erland S, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.062313; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FISCHHOFF B, 1978, POLICY SCI, V9, P127, DOI 10.1007/BF00143739; Fischhoff B, 2015, SCIENCE, V350, DOI 10.1126/science.aaa6516; Fox-Glassman KT, 2016, J MATH PSYCHOL, V75, P157, DOI 10.1016/j.jmp.2016.05.003; Glusac Elaine, 2020, WORRIED CROWDED PLAN; Grice Patrick, NEW METHOD CALCULATI; Gu Youyang, COVID 19 INFECT TRAC; Haroon S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3181; Harries AD, 2021, T ROY SOC TROP MED H, V115, P117, DOI 10.1093/trstmh/traa106; Hoehl S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18044; Jimenez Jose-Luis, COVID AIRBORNE TRANS; John Kadvany, 2011, RISK VERY SHORT INTR; KAHNEMAN D, 1986, PSYCHOL REV, V93, P136, DOI 10.1037/0033-295X.93.2.136; Karako K, 2020, BIOSCI TRENDS, V14, P134, DOI 10.5582/bst.2020.01482; Krishnamurti T., 2018, PSYCHOL PERSPECTIVES, P299, DOI [DOI 10.1007/978-3-319-92478-6_13, 10.1007/978-3-319-92478-6_13]; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; La Maestra S, 2020, J MED VIROL, V92, P1956, DOI 10.1002/jmv.25908; Lei H, 2020, J INFECTION, V81, P993, DOI 10.1016/j.jinf.2020.08.033; Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morgan G., 2009, HORIZONS, V10, P40; Morgan M. G., 2002, RISK COMMUNICATION M; Muniz-Rodriguez K, 2020, EMERG INFECT DIS, V26, P1912, DOI 10.3201/eid2608.200219; Peeples L, 2020, NATURE, V586, P186, DOI 10.1038/d41586-020-02801-8; Slovic P, 2004, RISK ANAL, V24, P311, DOI 10.1111/j.0272-4332.2004.00433.x; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Stern P. C., 1996, UNDERSTANDING RISK I; The Lancet Respiratory Medicine, 2020, Lancet Respir Med, V8, P1159, DOI 10.1016/S2213-2600(20)30514-2	44	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245381	10.1371/journal.pone.0245381	http://dx.doi.org/10.1371/journal.pone.0245381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33507962	gold, Green Published			2022-12-26	WOS:000635021400033
J	Hikage, F; Furuhashi, M; Ida, Y; Ohguro, H; Watanabe, M; Suzuki, S; Itoh, K				Hikage, Fumihito; Furuhashi, Masato; Ida, Yosuke; Ohguro, Hiroshi; Watanabe, Megumi; Suzuki, Soma; Itoh, Kaku			Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion	PLOS ONE			English	Article								The main objective of current study was to identify the fatty acid-binding protein 4 (FABP4) expressed in both adipocytes and macrophages in vitreous fluid from patients with retinal vein occlusion (RVO). Patients with RVO (n = 14, CRVO; central RVO n = 5, BRVO; branch RVO n = 9) and non-RVO (macular hole or epiretinal membrane, n = 18) were surgically treated by a 25 or 27G vitrectomy. Undiluted vitreous fluid samples obtained as the result of surgery were subjected to enzyme-linked immunosorbent assays to measure the levels of FABP4 and vascular endothelial growth factor A (VEGFA).Data including ocular blood flow by laser speckle flow graphy (LSFG), height and weight, systemic blood pressures and several blood biochemistry values were collected. Among the LSFG mean blur rate (MBR) values of the optic nerve head (ONH) at baseline, MA (MBR of all area), MV (MBR of the vascular area), and MV-MT (MBR of the tissue area) were significantly decreased in patients with CRVO. The levels of V-FABP4 and V-VEGFA were relatively or significantly (P< 0.05) higher in the BRVO or CRVO patients compared to the non-RVO patients, respectively. A positive correlation (r = 0.36, P = 0.045) or a negative correlation (r = -0.51, P = 0.006) was observed between Log V-FABP4 and Log V-VEGF, or Log V-FABP4 and MV-MT at post-operative 1-week, respectively. Furthermore, neither of these factors were affected with respect to sex, body mass index and several clinical parameters that were collected, except that a positive correlation was observed for Log V-FABP4 with blood urea nitrogen. Stepwise multivariable regression analyses indicated that MV-MT at post-operative 1 week was independently associated with Log V-FABP4 after adjustment for age and gender, and gender and Log V-FABP4 were independently associated with Log V-VEGFA after adjustment for age. The findings reported herein suggest that an independent factor, FABP4 may be synergistically involved in the pathogenesis of RVO with VEGFA.	[Hikage, Fumihito; Ida, Yosuke; Ohguro, Hiroshi; Watanabe, Megumi; Suzuki, Soma; Itoh, Kaku] Sapporo Med Univ, Dept Ophthalmol, Sch Med, Sapporo, Hokkaido, Japan; [Furuhashi, Masato] Sapporo Med Univ, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; [Furuhashi, Masato] Sapporo Med Univ, Dept Renal Med, Sapporo, Hokkaido, Japan; [Furuhashi, Masato] Sapporo Med Univ, Dept Metab Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Ida, Y (corresponding author), Sapporo Med Univ, Dept Ophthalmol, Sch Med, Sapporo, Hokkaido, Japan.	funky.sonic@gmail.com	Furuhashi, Masato/AAT-5518-2021	Furuhashi, Masato/0000-0002-0145-3541; Hikage, Fumihito/0000-0002-0124-5494				Achiron A, 2015, ACTA OPHTHALMOL, V93, pE649, DOI 10.1111/aos.12735; ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; AIELLO LP, 1995, ARCH OPHTHALMOL-CHIC, V113, P1538, DOI 10.1001/archopht.1995.01100120068012; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Avila CP, 1998, AM J OPHTHALMOL, V126, P683, DOI 10.1016/S0002-9394(98)00114-7; Bertelsen M, 2014, OPHTHALMOLOGY, V121, P637, DOI 10.1016/j.ophtha.2013.07.025; Bianchi E, 2013, INT J MOL MED, V31, P232, DOI 10.3892/ijmm.2012.1164; Cabre A, 2008, J LIPID RES, V49, P1746, DOI 10.1194/jlr.M800102-JLR200; Campochiaro PA, 2010, OPHTHALMOLOGY, V117, P1102, DOI 10.1016/j.ophtha.2010.02.021; Clark WL, 2016, OPHTHALMOLOGY, V123, P330, DOI 10.1016/j.ophtha.2015.09.035; DODSON PM, 1982, BRIT J OPHTHALMOL, V66, P161, DOI 10.1136/bjo.66.3.161; DVORAK HF, 1995, AM J PATHOL, V146, P1029; ELMAN MJ, 1990, OPHTHALMOLOGY, V97, P1543; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elmasri H, 2009, FASEB J, V23, P3865, DOI 10.1096/fj.09-134882; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2019, J ATHEROSCLER THROMB, V26, P216, DOI 10.5551/jat.48710; Furuhashi M, 2019, J DIABETES INVEST, V10, P1059, DOI 10.1111/jdi.12982; Furuhashi M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0177-8; Furuhashi M, 2015, J LIPID RES, V56, P2372, DOI 10.1194/jlr.M059469; Furuhashi M, 2015, HYPERTENS RES, V38, P252, DOI 10.1038/hr.2015.2; GlacetBernard A, 1996, OPHTHALMOLOGY, V103, P551, DOI 10.1016/S0161-6420(96)30653-2; Green W R, 1981, Retina, V1, P27; Horio N, 2005, AM J OPHTHALMOL, V139, P739, DOI 10.1016/j.ajo.2004.10.026; Hotamisligil GS, 2015, NAT REV ENDOCRINOL, V11, P592, DOI 10.1038/nrendo.2015.122; Ishimura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081318; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Jonas JB, 2017, DEV OPHTHALMOL, V58, P139, DOI 10.1159/000455278; Kingma PB, 1998, BIOCHEMISTRY-US, V37, P3250, DOI 10.1021/bi972520l; Koizumi H, 2007, AM J OPHTHALMOL, V144, P858, DOI 10.1016/j.ajo.2007.07.036; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Manabe K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153817; Noma H, 2006, GRAEF ARCH CLIN EXP, V244, P309, DOI 10.1007/s00417-004-1087-4; Noma H, 2005, AM J OPHTHALMOL, V140, P256, DOI 10.1016/j.ajo.2005.03.003; Noma H, 2009, BRIT J OPHTHALMOL, V93, P630, DOI 10.1136/bjo.2008.146597; Noma H, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01486-x; Noma H, 2009, ACTA OPHTHALMOL, V87, P638, DOI 10.1111/j.1755-3768.2008.01318.x; Osaka R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204015; Ota H, 2012, AM J HYPERTENS, V25, P1124, DOI 10.1038/ajh.2012.88; Pacella E, 2012, CLIN TER, V163, pE413; Pacella F, 2020, CLIN TER, V171, pE534, DOI 10.7417/CT.2020.2269; Pacella F, 2017, CUTAN OCUL TOXICOL, V36, P224, DOI 10.1080/15569527.2016.1254648; Rodriguez-Calvo R, 2017, J ENDOCRINOL, V233, pR173, DOI 10.1530/JOE-17-0031; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Romiti GF, 2020, J THROMB HAEMOST, V18, P3249, DOI 10.1111/jth.15068; Shi M, 2020, CURR MED CHEM, V27, P3657, DOI 10.2174/0929867325666181008154622; Song PG, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010427; Stefanutti C, 2019, ATHEROSCLEROSIS SUPP, V40, P49, DOI 10.1016/j.atherosclerosissup.2019.08.031; Sugiura Y, 2018, RETINA-J RET VIT DIS, V38, P1581, DOI 10.1097/IAE.0000000000001740; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Tadayoni R, 2017, OPHTHALMOLOGY, V124, P1778, DOI 10.1016/j.ophtha.2017.06.027; Wang S, 2009, OPHTHALMOLOGY, V116, P2373, DOI 10.1016/j.ophtha.2009.05.041; Wang YX, 2014, ACTA OPHTHALMOL, V92, pE424, DOI 10.1111/aos.12370; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Yamada Y, 2015, RETINA-J RET VIT DIS, V35, P2037, DOI 10.1097/IAE.0000000000000595; Yamaji H, 2004, AM J OPHTHALMOL, V137, P834, DOI 10.1016/j.ajo.2003.11.071; Yeung DCY, 2007, ARTERIOSCL THROM VAS, V27, P1796, DOI 10.1161/ATVBAHA.107.146274	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245763	10.1371/journal.pone.0245763	http://dx.doi.org/10.1371/journal.pone.0245763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503066	gold, Green Published			2022-12-26	WOS:000613751800011
J	Ijaz, M; Zaidi, SAA; Rashid, A				Ijaz, Muhammad; Zaidi, Syed Azhar Ali; Rashid, Aamir			Uniform patterns based area-efficient and accurate stochastic computing finite impulse response filter	PLOS ONE			English	Article								Stochastic computing has recently gained attention due to its low hardware complexity and better fault tolerance against soft errors. However, stochastic computing based circuits suffer from different errors which affect the output accuracy of these circuits. In this paper, an accurate and area-efficient stochastic computing based digital finite impulse response filter is designed. In the proposed work, constant uniform patterns are used as stochastic numbers for the select lines of different MUXes in the filter and the error performance of filter is analysed. Based on the error performance, the combinations of these patterns are proposed for reducing the output error of stochastic computing based filters. The architectures for generating these uniform patterns are also proposed. Results show that the proposed design methodology has better error performance and comparable hardware complexity as compared to the state-of-the-art implementations.	[Ijaz, Muhammad; Zaidi, Syed Azhar Ali; Rashid, Aamir] Univ Engn & Technol, Elect Engn Dept, Taxila, Pakistan	University of Engineering & Technology Taxila	Ijaz, M (corresponding author), Univ Engn & Technol, Elect Engn Dept, Taxila, Pakistan.	muhammadijaz898@gmail.com		Ijaz, Muhammad/0000-0001-8610-2785				Alaghi A., 2013, P DAC; Alaghi A., 2015, P GREAT LAK S VLSI, P331, DOI [10.1145/2742060.2743758, DOI 10.1145/2742060.2743758]; Alaghi A, 2013, ACM T EMBED COMPUT S, V12, DOI 10.1145/2465787.2465794; Alaghi A, 2013, 2013 IEEE 31ST INTERNATIONAL CONFERENCE ON COMPUTER DESIGN (ICCD), P39, DOI 10.1109/ICCD.2013.6657023; Ardakani A, 2017, IEEE T VLSI SYST, V25, P2688, DOI 10.1109/TVLSI.2017.2654298; Chang YN, 2013, INT CONF ACOUST SPEE, P2697, DOI 10.1109/ICASSP.2013.6638146; Gaines B.R., 1969, ADV INFORM SYSTEMS S, P37, DOI [10.1007/978-1-4899-5841-9_2, DOI 10.1007/978-1-4899-5841-9_2]; Gross WJ, 2005, 2005 39TH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS AND COMPUTERS, VOLS 1 AND 2, P713; Ichihara H, 2019, IEEE T EMERG TOP COM, V7, P31, DOI 10.1109/TETC.2016.2608825; Liang JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-113; Liu Y, 2016, 2016 IEEE INTERNATIONAL WORKSHOP ON SIGNAL PROCESSING SYSTEMS (SIPS), P327, DOI 10.1109/SiPS.2016.64; Liu Y, 2016, PR IEEE COMP DESIGN, P408, DOI 10.1109/ICCD.2016.7753315; Parhi KK, 2019, IEEE T EMERG TOP COM, V7, P44, DOI 10.1109/TETC.2016.2618750; Salehi SA, 2020, IEEE T VLSI SYST, V28, P992, DOI 10.1109/TVLSI.2019.2963678; Seva Ramu, 2017, Journal of Low Power Electronics and Applications, V7, DOI 10.3390/jlpea7040029; Wang R, 2016, MICROELECTRON RELIAB, V57, P111, DOI 10.1016/j.microrel.2015.11.017; Yuan B, 2016, IEEE COMP SOC ANN, P128, DOI 10.1109/ISVLSI.2016.63; Yuan B, 2016, IEEE INT SYMP CIRC S, P157, DOI 10.1109/ISCAS.2016.7527194	18	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245943	10.1371/journal.pone.0245943	http://dx.doi.org/10.1371/journal.pone.0245943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503067	Green Published, gold			2022-12-26	WOS:000613751800030
J	Miyazaki, Y; Nakamura, T; Takenouchi, S; Hayashi, A; Omori, K; Murata, T				Miyazaki, Yusuke; Nakamura, Tatsuro; Takenouchi, Shinya; Hayashi, Akane; Omori, Keisuke; Murata, Takahisa			Urinary 8-iso PGF(2 alpha) and 2,3-dinor-8-iso PGF(2 alpha) can be indexes of colitis-associated colorectal cancer in mice	PLOS ONE			English	Article							MOUSE COLON CARCINOGENESIS; ULCERATIVE-COLITIS; PROSTAGLANDIN D-2; PGE-M; QUANTIFICATION; INFLAMMATION; METABOLITE; EXPRESSION; BIOMARKER; SUPPRESSION	Early diagnosis of colorectal cancer is needed to reduce the mortal consequence by cancer. Lipid mediators play critical role in progression of colitis and colitis-associated colon cancer (CAC) and some of their metabolites are excreted in urine. Here, we attempted to find novel biomarkers in urinary lipid metabolite of a murine model of CAC. Mice were received single administration of azoxymethane (AOM) and repeated administration of dextran sulfate sodium (DSS). Lipid metabolites in their urine was measured by liquid chromatography mass spectrometry and their colon was collected to perform morphological study. AOM and DSS caused inflammation and tumor formation in mouse colon. Liquid chromatography mass spectrometry-based comprehensive analysis of lipid metabolites showed that cyclooxygenase-mediated arachidonic acid (AA) metabolites, prostaglandins, and reactive oxygen species (ROS)-mediated AA metabolites, isoprostanes, were predominantly increased in the urine of tumor-bearing mice. Among that, urinary prostaglandin (PG)E-2 metabolite tetranor-PGEM and PGD(2) metabolite tetranor-PGDM were significantly increased in both of urine collected at the acute phase of colitis and the carcinogenesis phase. On the other hand, two F-2 isoprostanes (F-2-lsoPs), 8-iso PGF(2 alpha) and 2,3-dinor-8-iso PGF(2 alpha), were significantly increased only in the carcinogenesis phase. Morphological study showed that infiltrated monocytes into tumor mass strongly expressed ROS generator NADPH (p22(phox)). These observations suggest that urinary 8-iso PGF(2 alpha) and 2,3-dinor-8-iso PGF(2 alpha) can be indexes of CAC.	[Miyazaki, Yusuke; Nakamura, Tatsuro; Takenouchi, Shinya; Hayashi, Akane; Omori, Keisuke; Murata, Takahisa] Univ Tokyo, Dept Anim Radiol, Tokyo, Japan; [Miyazaki, Yusuke; Nakamura, Tatsuro; Takenouchi, Shinya; Hayashi, Akane; Omori, Keisuke; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796; Takenouchi, Shinya/0000-0003-2327-1789	Japan Society for the Promotion of Science [19H03569, 17H01509, 18K08809, 18K14603]; Shimadzu Science Foundation; Kobayashi Foundation; Morinaga Foundation for Health Nutrition; Takeda Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Shimadzu Science Foundation; Kobayashi Foundation; Morinaga Foundation for Health Nutrition; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (19H03569, 17H01509, 18K08809 to TM, 18K14603 to TN); Shimadzu Science Foundation (to TM); Kobayashi Foundation (to TM); The Morinaga Foundation for Health & Nutrition (to TM); Takeda Science Foundation (to TM).	Agrawal D, 2002, J NATL CANCER I, V94, P513; Arai Y, 2016, DIGESTION, V93, P32, DOI 10.1159/000441665; Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Burt RW, 2010, CURR OPIN GASTROEN, V26, P466, DOI 10.1097/MOG.0b013e32833d1733; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Cianchi F, 2006, MOL CANCER THER, V5, P2716, DOI 10.1158/1535-7163.MCT-06-0318; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hokari R, 2011, AM J PHYSIOL-GASTR L, V300, pG401, DOI 10.1152/ajpgi.00351.2010; Idborg H, 2014, PROSTAG LEUKOTR ESS, V91, P269, DOI 10.1016/j.plefa.2014.09.006; Inagaki S, 2018, J ALLERGY CLIN IMMUN, V142, P1634, DOI 10.1016/j.jaci.2018.06.032; Iwanaga K, 2014, CANCER RES, V74, P3011, DOI 10.1158/0008-5472.CAN-13-2792; Jabr S, 2013, PROSTAG LEUKOTR ESS, V89, P121, DOI 10.1016/j.plefa.2013.06.001; Johnson JC, 2006, CLIN GASTROENTEROL H, V4, P1358, DOI 10.1016/j.cgh.2006.07.015; Karlen P, 1998, GASTROENTEROLOGY, V115, P1395, DOI 10.1016/S0016-5085(98)70018-6; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Ketwaroo GA, 2015, CURR OPIN GASTROEN, V31, P56, DOI 10.1097/MOG.0000000000000140; Kohno H, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-46; Lin LJ, 2016, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00320; Ma N, 2017, INT J IMMUNOPATH PH, V30, P152, DOI 10.1177/0394632017711055; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Milne GL, 2011, CHEM REV, V111, P5973, DOI 10.1021/cr200160h; Morales CR, 2001, CLIN CHIM ACTA, V314, P93, DOI 10.1016/S0009-8981(01)00637-4; Morris PG, 2013, CANCER PREV RES, V6, P428, DOI 10.1158/1940-6207.CAPR-12-0431; Nakanishi M, 2011, CANCER PREV RES, V4, P1198, DOI 10.1158/1940-6207.CAPR-11-0188; Nakatsuji M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005542; Shang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051848; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Song WL, 2008, J BIOL CHEM, V283, P1179, DOI 10.1074/jbc.M706839200; SUZUKI H, 1994, CANCER RES, V54, P4841; Szanto I, 2005, J PATHOL, V207, P164, DOI 10.1002/path.1824; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Tanaka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23920; van Dam L, 2014, BEST PRACT RES CL GA, V28, P315, DOI 10.1016/j.bpg.2014.03.002; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhang HY, 2010, ANAL BIOCHEM, V399, P302, DOI 10.1016/j.ab.2009.12.024	39	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245292	10.1371/journal.pone.0245292	http://dx.doi.org/10.1371/journal.pone.0245292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503019	gold, Green Published			2022-12-26	WOS:000613751800028
J	Lyu, TS; Ahn, Y; Im, YJ; Kim, SS; Lee, KH; Kim, J; Choi, Y; Lee, D; Kang, E; Jin, G; Hwang, J; Lee, SI; Cho, JA				Lyu, Tae Seong; Ahn, Yoojin; Im, Young-Jun; Kim, Seong-Soo; Lee, Ki-Heon; Kim, Jinyoung; Choi, Yujin; Lee, Dongwoo; Kang, EunSeok; Jin, Gayeon; Hwang, Jiwon; Lee, Sang-im; Cho, Jung-Ah			The characterization of exosomes from fibrosarcoma cell and the useful usage of Dynamic Light Scattering (DLS) for their evaluation	PLOS ONE			English	Article							BREAST; VESICLES; TARGETS	Exosomes are a type of extracellular vesicles containing mRNA, miRNA, and proteins of origin cells, which can control the characteristics of other cells or surroundings. Despite increasing evidence on oncogenic properties of tumor-derived exosomes, fibrosarcoma-derived exosomes remain largely unrevealed. While the proper extraction and characterization of exosomes is critical in exosomes research, there are various limitations in techniques to measure the size and homogeneity of exosomes. Here, we analyzed exosomes from a fibrosarcoma cell line WEHI-164 compared with a breast cancer cell line MDA-MD-231 as a control. Results from dot blot and western blot analysis demonstrated that GM1 ganglioside, and TSG101, HSC70 and GAPDH proteins were contained in exosomes from the WEHI-164 fibrosarcoma cell line. The existence of tetraspanins such as CD81, CD63 and CD9 was confirmed in the exosomes by ExoView analysis. The results obtained from TEM showed their sphere-like shapes of around 50 to 70 nm in radius. Through DLS, we found out that the mean radius of the exosomes derived from WEHI-164 and MDA-MB-231 cell lines was 94.4 nm and 107.8 nm, respectively, with high homogeneity. When comparing the radius measured by TEM with the radius measured by DLS, it was revealed that the difference between the two methods was about 40 nm. This study has significance in characterizing the molecular properties of exosomes from a fibrosarcoma, which has not been researched much before, and in providing clear evidence that DLS can be used as an efficient, convenient and noninvasive technique to simply check the homogeneity and size of exosomes.	[Lyu, Tae Seong; Ahn, Yoojin; Im, Young-Jun; Kim, Seong-Soo; Lee, Ki-Heon; Kim, Jinyoung; Choi, Yujin; Lee, Dongwoo; Kang, EunSeok; Jin, Gayeon; Hwang, Jiwon; Lee, Sang-im; Cho, Jung-Ah] DGIST, Sch Undergrad Studies, Coll Transdisciplinary Studies, Daegu, South Korea; [Lee, Sang-im] DGIST, Dept New Biol, Grad Sch, Daegu, South Korea	Daegu Gyeongbuk Institute of Science & Technology (DGIST); Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Cho, JA (corresponding author), DGIST, Sch Undergrad Studies, Coll Transdisciplinary Studies, Daegu, South Korea.	jungahcho@dgist.ac.kr			DGIST Undergraduate Group Research Program (UGRP) grant; Korea Foundation for the Advancement of Science & Creativity (KOFAC); Korean Government (MOE)	DGIST Undergraduate Group Research Program (UGRP) grant; Korea Foundation for the Advancement of Science & Creativity (KOFAC)(Korea Foundation for the Advancement of Science & Creativity (KOFAC)); Korean Government (MOE)	This work was supported by the DGIST Undergraduate Group Research Program (UGRP) grant. This work was supported by the Korea Foundation for the Advancement of Science & Creativity (KOFAC), and funded by the Korean Government (MOE).	Akagi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123603; [Anonymous], 2013, CLIN DIABETOLOGY, V2, pA12; Augsburger D, 2017, ONCOTARGET, V8, P104638, DOI 10.18632/oncotarget.20136; Brenner AW, 2019, METHODS MOL BIOL, V1882, P229, DOI 10.1007/978-1-4939-8879-2_21; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Cho JA, 2012, INT J ONCOL, V40, P130, DOI 10.3892/ijo.2011.1193; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Dinkins MB, 2017, J ALZHEIMERS DIS, V60, P757, DOI 10.3233/JAD-160567; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; El-Saghir J, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0307-4; Erdbrugger U, 2016, CYTOM PART A, V89A, P123, DOI 10.1002/cyto.a.22795; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Gercel-Taylor C, 2012, ANAL BIOCHEM, V428, P44, DOI 10.1016/j.ab.2012.06.004; Gurunathan S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040307; Kesimer M, 2015, METHODS, V87, P59, DOI 10.1016/j.ymeth.2015.03.013; Kibria G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36502; Kruger S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-44; Lawrie AS, 2009, VOX SANG, V96, P206, DOI 10.1111/j.1423-0410.2008.01151.x; Li XJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1741, DOI 10.1159/000485780; Linares R, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29509; Lucien F, 2019, BIOCHEM SOC T, V47, P273, DOI 10.1042/BST20180253; MA Di B, 2018, EXOSOME INVESTIGATIO, P39; Osteikoetxea X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121184; Palazzolo G, 2012, ANTICANCER RES, V32, P847; Palmieri V, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2583-z; ROLLINGHOFF M, 1973, P SOC EXP BIOL MED, V144, P813; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zhou M, 2020, EXOSOMES: A CLINICAL COMPENDIUM, P23, DOI 10.1016/B978-0-12-816053-4.00002-X	32	11	11	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0231994	10.1371/journal.pone.0231994	http://dx.doi.org/10.1371/journal.pone.0231994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497388	Green Published, gold			2022-12-26	WOS:000613707100033
J	Cao, YB; Wei, XS; Fan, W; Nan, YL; Xiong, W; Zhang, SL				Cao, Yanbo; Wei, Xinsheng; Fan, Wen; Nan, Yalin; Xiong, Wei; Zhang, Shilin			Landslide susceptibility assessment using the Weight of Evidence method: A case study in Xunyang area, China	PLOS ONE			English	Article							HAZARD; HIMALAYA; LESSER	The aim of this study is to provide a landslide susceptibility map of the Xunyang District of a mountainous terrain, at the southern part of the Qin-Ba Mountain Region, which has been highly exposed to widely distributed shallow landslides over the past few decades. The Weight of Evidence (WoE) method was adopted in this research considering both the presence of a certain landslide causative factor class and the absence of remaining classes, which was used for determining a clearly spatial correlation between a landslide occurrence and the causative factors. Intrinsic factors, including geomorphological factors, geological factors, and river flow networks, and external factors of anthropogenic engineering activities in terms of density of road network were all considered and involved in the Geological Information System (GIS) environment for reconstructing the thematic layers of factor dataset. Significant assumptions prior to the analysis were emphasized to ensure conditional independence between each pair of factors for this bivariate statistical approach. In addition, a detailed landslide inventory map was constructed through field investigation and a remote sensing interpretation process at a scale of 1:50000. The thematic layers and landslide map were overlapped to obtain a spatial statistical relationship by using the frequency ratio method. At last, the validation process for the derived susceptibility map was conducted by applying the ROC curve, indicating that more than 90% of the landslides were in categories of high and moderate susceptibility zones. The causative factor classes, including the slope angles ranging from 20 to 40 degrees, strong weathered and fractured strata, and road network density were identified to considerably influence the landslide distribution in the study area. The results have proven to be significantly meaningful for landslide hazard risk mitigation and land use management for the local authorities responsible for these fields.	[Cao, Yanbo; Wei, Xinsheng; Fan, Wen; Xiong, Wei; Zhang, Shilin] Changan Univ, Dept Geol Engn, Xian, Peoples R China; [Cao, Yanbo; Fan, Wen; Xiong, Wei] Key Lab Western China Mineral Resources & Geol En, Xian, Peoples R China; [Cao, Yanbo; Fan, Wen; Nan, Yalin] China Elect Res Inst Engn Invest & Design, Xian, Peoples R China	Chang'an University	Fan, W (corresponding author), Changan Univ, Dept Geol Engn, Xian, Peoples R China.; Fan, W (corresponding author), Key Lab Western China Mineral Resources & Geol En, Xian, Peoples R China.; Fan, W (corresponding author), China Elect Res Inst Engn Invest & Design, Xian, Peoples R China.	fanwen@chd.edu.cn		Cao, Yanbo/0000-0002-9713-4341	National Natural Science Foundation of China [41402254, 41272282]; Department of Science and Technology of Shaanxi Province [2019ZDLSF07-0701, 2019ZDSL05-07]; China Geology Survey [1212011220135, DDW2016-01, DDW2017-03, DDW2018-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Shaanxi Province; China Geology Survey(China Geological Survey)	Yanbo Cao Grant No. 41402254, Wen Fan Grant No. 41272282, National Natural Science Foundation of China http://www.nsfc.gov.cn/Yanbo Cao Grant No. 2019ZDLSF07-0701, Yalin Nan Grant No. 2019ZDSL05-07, Department of Science and Technology of Shaanxi Province http://kjt.shaanxi.gov.cn/Wen Fan Grant No. 1212011220135, DDW2016-01, DDW2017-03, DDW2018-04, China Geology Survey http://www.cgs.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour Y, 2020, GEOSCI FRONT, V11, P871, DOI 10.1016/j.gsf.2019.10.001; Agterberg FP., 2002, NAT RESOUR RES, V11, P249, DOI [10.1023/A:, DOI 10.1023/A:1021193827501, https://doi.org/10.1023/A:1021193827501]; Arabameri A, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11090999; Arca D, 2018, ENVIRON MONIT ASSESS, V190, DOI 10.1007/s10661-018-7085-5; Armas I, 2012, NAT HAZARDS, V60, P937, DOI 10.1007/s11069-011-9879-4; Bonham-Carter GF, 2002, COMPUTER METHODS GEO, V13, P302; Bordoni M, 2019, WATER-SUI, V11, DOI 10.3390/w11122653; Chung CJF, 2003, NAT HAZARDS, V30, P451, DOI 10.1023/B:NHAZ.0000007172.62651.2b; Crosta G, 1998, ENVIRON GEOL, V35, P131, DOI 10.1007/s002540050300; Dahal RK, 2008, ENVIRON GEOL, V54, P311, DOI 10.1007/s00254-007-0818-3; Dahal RK, 2008, GEOMORPHOLOGY, V102, P496, DOI 10.1016/j.geomorph.2008.05.041; Gokceoglu C, 1996, ENG GEOL, V44, P147, DOI 10.1016/S0013-7952(97)81260-4; Huang FM, 2020, CATENA, V191, DOI 10.1016/j.catena.2020.104580; Huang FM, 2020, LANDSLIDES, V17, P217, DOI 10.1007/s10346-019-01274-9; Iverson RM, 2000, WATER RESOUR RES, V36, P1897, DOI 10.1029/2000WR900090; Marin RJ, 2020, GEOMORPHOLOGY, V351, DOI 10.1016/j.geomorph.2019.106976; Neuhauser B, 2007, GEOMORPHOLOGY, V86, P12, DOI 10.1016/j.geomorph.2006.08.002; Roering J, 2012, NAT GEOSCI, V5, P446, DOI 10.1038/ngeo1511; Sharma M, 2008, B ENG GEOL ENVIRON, V67, P129, DOI 10.1007/s10064-007-0113-2; Teerarungsigul S, 2016, LANDSLIDES, V13, P1151, DOI 10.1007/s10346-015-0659-1; Varnes David J, 1984, NATURAL HAZARDS, P3; Wang LJ, 2015, CATENA, V135, P271, DOI 10.1016/j.catena.2015.08.007; Wen FAN, 2013, XUNYANG COUNTY SHAAN; Yilmaz I, 2009, COMPUT GEOSCI-UK, V35, P1125, DOI 10.1016/j.cageo.2008.08.007	24	8	8	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245668	10.1371/journal.pone.0245668	http://dx.doi.org/10.1371/journal.pone.0245668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493200	Green Published, gold			2022-12-26	WOS:000613081500032
J	Deng, L; Chen, L; Zhao, JJ; Wang, RM				Deng, Lei; Chen, Lei; Zhao, Jingjie; Wang, Ruimei			Comparative analysis on environmental and economic performance of agricultural cooperatives and smallholder farmers: The case of grape production in Hebei, China	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; DATA ENVELOPMENT ANALYSIS; IMPACT ASSESSMENT; ANAEROBIC-DIGESTION; ENERGY EFFICIENCY; WASTE MANAGEMENT; MAIZE PRODUCTION; WINE PRODUCTION; FERTILIZER USE; LCA	Agricultural modernization and intensification have been regarded as a significant way to support agricultural development and improve farm income in China. Agricultural cooperatives have played an important role in promoting the modernization and intensification of Chinese agricultural sector. Given the increasing concerns about environmental harm, however, it still remains unclear whether and the extent to which agricultural cooperatives contributes to reducing environmental impacts of agricultural production. Hence, this study performed an environmental evaluation using life cycle assessment for three different organization forms of grape production in Changli County, Hebei Province, China: smallholder farmers, farmer-owned cooperatives and investor-owned firm-led cooperatives. Then the results of life cycle assessment were monetarized and cost benefit analysis was used to evaluate the economic performance of these three organization forms of grape production. The results demonstrate that investor-owned firm-led cooperatives present an overall improvement in environmental and economic performance with the lowest weighted environmental index (integrating all impact categories into a single score), the highest net profit and the highest total net benefit. The results also show a difference in potential improvement in environmental impacts and economic returns between cooperatives and smallholder farmers. Additionally, the production and application of organic and chemical fertilizer and pesticide have been identified as major contributors to total environmental damage.	[Deng, Lei; Chen, Lei] Beijing Wuzi Univ, Sch Informat, Beijing, Peoples R China; [Zhao, Jingjie] State Taxat Adm, Beijing Municipal Tax Serv, Beijing, Peoples R China; [Zhao, Jingjie] Chinese Acad Fiscal Sci, Beijing, Peoples R China; [Wang, Ruimei] China Agr Univ, Coll Econ & Management, Beijing, Peoples R China	Beijing Wuzi University; China Agricultural University	Deng, L (corresponding author), Beijing Wuzi Univ, Sch Informat, Beijing, Peoples R China.	dengleibwu@126.com		Lei, Deng/0000-0001-8695-534X	Beijing Social Science Foundation [19GLC043]; Beijing Intelligent Logistics System Collaborative Innovation Center [BILSCIC-2018KF-05]; Beijing Key Laboratory [BZ0211]; Chinese National Funding of Social Sciences [16AJY013]; Beijing Wuzi University [03519012010309]	Beijing Social Science Foundation; Beijing Intelligent Logistics System Collaborative Innovation Center; Beijing Key Laboratory; Chinese National Funding of Social Sciences; Beijing Wuzi University	This work was supported by Beijing Social Science Foundation (No. 19GLC043); the Beijing Intelligent Logistics System Collaborative Innovation Center (No. BILSCIC-2018KF-05); the Beijing Key Laboratory (No. BZ0211); the Chinese National Funding of Social Sciences (No. 16AJY013); Beijing Wuzi University (No. 03519012010309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atabaki MS, 2018, ENERGY, V161, P493, DOI 10.1016/j.energy.2018.07.149; Boone L, 2016, SCI TOTAL ENVIRON, V553, P551, DOI 10.1016/j.scitotenv.2016.02.089; Brentrup F, 2004, EUR J AGRON, V20, P265, DOI 10.1016/S1161-0301(03)00039-X; Cai Z, 2019, RES SER CHIN DREAM, P51, DOI 10.1007/978-981-13-5752-7_3; Deng L, 2016, BRIT FOOD J, V118, P1129, DOI 10.1108/BFJ-09-2015-0310; Elhami B, 2019, RENEW ENERG, V141, P507, DOI 10.1016/j.renene.2019.04.034; Fantin V, 2017, J CLEAN PROD, V140, P631, DOI 10.1016/j.jclepro.2016.06.136; Ferrari AM, 2018, J CLEAN PROD, V172, P3760, DOI 10.1016/j.jclepro.2017.06.241; Grecu E, 2018, RENEW SUST ENERG REV, V93, P691, DOI 10.1016/j.rser.2018.05.026; Hamedani SR, 2011, ENERGY, V36, P6345, DOI 10.1016/j.energy.2011.09.041; He XQ, 2016, J CLEAN PROD, V134, P251, DOI 10.1016/j.jclepro.2015.12.004; Hedayati M, 2019, J CLEAN PROD, V212, P974, DOI 10.1016/j.jclepro.2018.11.190; Hiloidhari M, 2017, BIORESOURCE TECHNOL, V242, P218, DOI 10.1016/j.biortech.2017.03.079; Hong JM, 2015, INT J LIFE CYCLE ASS, V20, P623, DOI 10.1007/s11367-015-0854-2; Hoogmartens R, 2014, ENVIRON IMPACT ASSES, V48, P27, DOI 10.1016/j.eiar.2014.05.001; Hu ZhiYuan, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P141; Huijbregts MAJ, 2017, INT J LIFE CYCLE ASS, V22, P138, DOI 10.1007/s11367-016-1246-y; Ji C, 2019, FOOD POLICY, V83, P231, DOI 10.1016/j.foodpol.2019.01.007; Jiang H., 2018, ISSUES AGR EC, V8, P51; Kaab A, 2019, SCI TOTAL ENVIRON, V664, P1005, DOI 10.1016/j.scitotenv.2019.02.004; Lam CM, 2018, J CLEAN PROD, V187, P751, DOI 10.1016/j.jclepro.2018.03.160; Laso J, 2018, ENERGIES, V11, DOI 10.3390/en11123395; Leng R, 2008, J CLEAN PROD, V16, P374, DOI 10.1016/j.jclepro.2006.12.003; Li H, 2018, J CLEAN PROD, V195, P476, DOI 10.1016/j.jclepro.2018.05.259; Li H, 2017, ENERGY, V126, P649, DOI 10.1016/j.energy.2017.03.068; Liang L, 2009, THESIS; Liang L, 2019, ECOL INDIC, V96, P351, DOI 10.1016/j.ecolind.2018.09.017; Litskas VD, 2013, ECOL INDIC, V27, P1, DOI 10.1016/j.ecolind.2012.11.016; Lu H, 2019, LAND USE POLICY, V81, P160, DOI 10.1016/j.landusepol.2018.10.052; Ma WL, 2018, AM J AGR ECON, V100, P502, DOI 10.1093/ajae/aax079; Ma WL, 2016, FOOD POLICY, V58, P94, DOI 10.1016/j.foodpol.2015.12.002; Meier MS, 2015, J ENVIRON MANAGE, V149, P193, DOI 10.1016/j.jenvman.2014.10.006; Meneses M, 2016, SCI TOTAL ENVIRON, V562, P571, DOI 10.1016/j.scitotenv.2016.04.083; Mohseni P, 2018, J CLEAN PROD, V197, P937, DOI 10.1016/j.jclepro.2018.06.243; Mojo D, 2017, J RURAL STUD, V50, P84, DOI 10.1016/j.jrurstud.2016.12.010; Moller F, 2014, BIOMASS BIOENERG, V60, P41, DOI 10.1016/j.biombioe.2013.11.001; Mousavi-Avval SH, 2017, J CLEAN PROD, V140, P804, DOI 10.1016/j.jclepro.2016.03.075; Nabavi-Pelesaraei A, 2018, SCI TOTAL ENVIRON, V631-632, P1279, DOI 10.1016/j.scitotenv.2018.03.088; National Bureau of Statistics of China, 2019, CHIN RUR STAT YB 201; Nguyen TLT, 2012, APPL ENERG, V89, P254, DOI 10.1016/j.apenergy.2011.07.023; Niero M, 2015, AGR SYST, V136, P46, DOI 10.1016/j.agsy.2015.02.007; Pan D, 2017, J ENVIRON MANAGE, V197, P130, DOI 10.1016/j.jenvman.2017.03.069; Parajuli R, 2018, SCI TOTAL ENVIRON, V619, P127, DOI 10.1016/j.scitotenv.2017.11.082; Point E, 2012, J CLEAN PROD, V27, P11, DOI 10.1016/j.jclepro.2011.12.035; Ruben R, 2007, SUPPLY CHAIN MANAG, V12, P60, DOI 10.1108/13598540710724365; Shang Jie, 2015, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V23, P354; Skunca D, 2018, J CLEAN PROD, V184, P440, DOI 10.1016/j.jclepro.2018.02.274; Sleeswijk AW, 2008, SCI TOTAL ENVIRON, V390, P227, DOI 10.1016/j.scitotenv.2007.09.040; Vazquez-Rowe I, 2012, J CLEAN PROD, V27, P92, DOI 10.1016/j.jclepro.2011.12.039; Villanueva-Rey P, 2014, J CLEAN PROD, V65, P330, DOI 10.1016/j.jclepro.2013.08.026; Wang C, 2014, J CLEAN PROD, V68, P56, DOI 10.1016/j.jclepro.2014.01.018; Wang JM, 2018, ENERG POLICY, V115, P374, DOI 10.1016/j.enpol.2018.01.040; Wang WY, 2017, SCI TOTAL ENVIRON, V590, P22, DOI 10.1016/j.scitotenv.2017.03.053; Wang Y, 2018, J CLEAN PROD, V199, P882, DOI 10.1016/j.jclepro.2018.07.222; Woon KS, 2016, RESOUR CONSERV RECY, V107, P104, DOI 10.1016/j.resconrec.2015.11.020; Zhang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180685; Zhang LG, 2018, J CLEAN PROD, V184, P550, DOI 10.1016/j.jclepro.2018.02.272; Zhang YS, 2011, J ENVIRON MANAGE, V92, P480, DOI 10.1016/j.jenvman.2010.09.018; Zhong Z, 2018, J CLEAN PROD, V172, P2266, DOI 10.1016/j.jclepro.2017.11.184	59	9	9	13	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245981	10.1371/journal.pone.0245981	http://dx.doi.org/10.1371/journal.pone.0245981			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ9QF	33493239	Green Published, gold			2022-12-26	WOS:000613081500041
J	Hasan, A; Luo, L; Baba, S; Li, TS				Hasan, Al Shaimaa; Luo, Lan; Baba, Satoko; Li, Tao-Sheng			Estrogen is required for maintaining the quality of cardiac stem cells	PLOS ONE			English	Article							CARDIOSPHERE-DERIVED CELLS; ENDOTHELIAL PROGENITOR CELLS; RECEPTOR-BETA; MYOCARDIAL-INFARCTION; HEART-FAILURE; TELOMERASE ACTIVITY; 17-BETA-ESTRADIOL; EXPRESSION; RECOVERY; ALPHA	Compared to the age-matched men, the incidence of cardiovascular diseases is lower in premenopausal but higher in postmenopausal women, suggesting the cardio-protective role of estrogen in females. Although cardiac stem cells (CSCs) express estrogen receptors, yet the effects of estrogen on CSCs remain unclear. In this study, we investigated the potential role of estrogen in maintaining the quality of CSCs by in vivo and in vitro experiments. For the in vivo study, estrogen deficiency was induced by ovariectomy in 6-weeks-old C57BL/6 female mice, and then randomly given 17 beta-estradiol (E-2) replacements at a low dose (0.01 mg/60 days) and high dose (0.18 mg/60 days), or vehicle treatment. All mice were killed 2 months after treatments, and heart tissues were collected for ex vivo expansion of CSCs. Compared to age-matched healthy controls, estrogen deficiency slightly decreased the yield of CSCs with significantly lower telomerase activity and more DNA damage. Interestingly, E-2 replacements at low and high doses significantly increased the yield of CSCs and reversed the quality impairment of CSCs following estrogen deficiency. For the in vitro study, twice-passaged CSCs from the hearts of adult healthy female mice were cultured with the supplement of 0.01, 0.1, and 1 mu M E-2 in the medium for 3 days. We found that E-2 supplement increased c-kit expression, increased proliferative activity, improved telomerase activity, and reduced DNA damage of CSCs in a dose-dependent manner. Our data suggested the potential role of estrogen in maintaining the quality of CSCs, providing new insight into the cardio-protective effects of estrogen.	[Hasan, Al Shaimaa; Luo, Lan; Baba, Satoko; Li, Tao-Sheng] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki, Japan; [Hasan, Al Shaimaa] South Valley Univ, Qena Fac Med, Dept Med Pharmacol, Qena, Egypt; [Luo, Lan] Xuzhou Med Univ, Sch Med Technol, Xuzhou, Jiangsu, Peoples R China	Nagasaki University; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Xuzhou Medical University	Li, TS (corresponding author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki, Japan.	litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873; Luo, Lan/0000-0003-4839-104X	Ministry of Education, Science, Sports, Culture and Technology, Japan	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding acquisition: TL This study was supported by a Grant-in-Aid from the Ministry of Education, Science, Sports, Culture and Technology, Japan. The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiker FA, 2006, ARTERIOSCL THROM VAS, V26, P1524, DOI 10.1161/01.ATV.0000223344.11128.23; Bar C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6863; Bayne S, 2011, PROTEIN CELL, V2, P333, DOI 10.1007/s13238-011-1033-2; Bayne S, 2008, CELL RES, V18, P1141, DOI 10.1038/cr.2008.291; Beer S, 2007, BASIC RES CARDIOL, V102, P9, DOI 10.1007/s00395-006-0608-1; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Booth EA, 2003, J PHARMACOL EXP THER, V307, P395, DOI 10.1124/jpet.103.054205; Brinckmann M, 2009, J MOL CELL CARDIOL, V47, P66, DOI 10.1016/j.yjmcc.2009.03.014; Cesselli D, 2018, PHARMACOL RES, V127, P26, DOI 10.1016/j.phrs.2017.01.013; Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cignarella A, 2010, TRENDS PHARMACOL SCI, V31, P183, DOI 10.1016/j.tips.2010.01.001; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Deschamps AM, 2010, TRENDS CARDIOVAS MED, V20, P73, DOI 10.1016/j.tcm.2010.05.001; dos Santos RL, 2014, HORM MOL BIOL CLIN I, V18, P89, DOI 10.1515/hmbci-2013-0048; Drevensek G., 2012, SEX HORMONES, P31; Erwin GS, 2009, J SURG RES, V152, P319, DOI 10.1016/j.jss.2008.02.006; Estrogen Mauvais-Jarvis F., 2011, TRENDS ENDOCRIN MET, V22, P24, DOI [10.1016/j.tem.2010.10.002, DOI 10.1016/J.TEM.2010.10.002]; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; Hasan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165255; Hiyama E, 2007, BRIT J CANCER, V96, P1020, DOI 10.1038/sj.bjc.6603671; Hong SH, 2004, MOL CELLS, V18, P320; Ingberg E, 2012, GEN COMP ENDOCR, V175, P188, DOI 10.1016/j.ygcen.2011.11.014; Iorga A, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-017-0152-8; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Kitajima Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep12861; Kyo S, 1999, CANCER RES, V59, P5917; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Luo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152179; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Marjoribanks J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004143.pub5; Mendelsohn ME, 2002, AM J CARDIOL, V89, p12E; Meng XM, 2011, LIFE SCI, V88, P178, DOI 10.1016/j.lfs.2010.11.008; Misiti S, 2000, MOL CELL BIOL, V20, P3764, DOI 10.1128/MCB.20.11.3764-3771.2000; Nakada D, 2014, NATURE, V505, P555, DOI 10.1038/nature12932; Nalobin D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020503; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Sun HY, 2010, SCI CHINA LIFE SCI, V53, P542, DOI 10.1007/s11427-010-0102-8; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Trenti A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030859; van Eickels M, 2003, J AM COLL CARDIOL, V41, P2084, DOI 10.1016/S0735-1097(03)00423-6; Wang LN, 2014, SURGERY, V156, P243, DOI 10.1016/j.surg.2014.04.002; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279; Zhan E, 2008, EXP PHYSIOL, V93, P982, DOI 10.1113/expphysiol.2008.042788; Zhou S, 2001, J CELL BIOCHEM, P144; Zhu XL, 1996, P NATL ACAD SCI USA, V93, P6091, DOI 10.1073/pnas.93.12.6091	52	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245166	10.1371/journal.pone.0245166	http://dx.doi.org/10.1371/journal.pone.0245166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481861	gold, Green Published			2022-12-26	WOS:000612929300009
J	Hasani, WSR; Saminathan, TA; Ab Majid, NL; Yn, JLM; Rifin, HM; Abd Hamid, HA; Lourdes, TGR; Ahmad, A; Lsmail, H; Abd Rashid, R; Yusoff, MFM				Rodzlan Hasani, Wan Shakira; Saminathan, Thamil Arasu; Ab Majid, Nur Liana; Miaw Yn, Jane Ling; Mat Rifin, Halizah; Abd Hamid, Hamizatul Akmal; Robert Lourdes, Tania Gayle; Ahmad, Ahzairin; Lsmail, Hasimah; Abd Rashid, Rusdi; Mohd Yusoff, Muhammad Fadhli			Polysubstance use among adolescents in Malaysia: Findings from the National Health and Morbidity Survey 2017	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; SUBSTANCE USE; TOBACCO USE; DRUG-USE; CONCURRENT ALCOHOL; GENDER-DIFFERENCES; PATTERNS; SMOKING; COMORBIDITY; TRUANCY	Background Polysubstance use is defined as the use of more than one non-prescribed licit or illicit substance either concurrently or simultaneously. This study aimed to determine the prevalence of single substance users and polysubstance users and 'their associated factors among adolescents in Malaysia. Methods This study was a secondary data analysis from the National Health and Morbidity Survey (NHMS) 2017, a cross-sectional survey conducted among Malaysian school-going adolescents aged 13 to 17. The NHMS utilised a two-stage stratified cluster sampling. Multivariate Multinomial Logistic Regression analysis was applied. Results The overall prevalence of single substance use and polysubstance use among adolescents were 17.2% and 5.1% respectively. The multinomial model showed a higher likelihood of being single or polysubstance user among male (single user OR = 3.0, poly user OR = 4.6), others Bumiputeras vs Malay (single user OR = 1.7, poly user OR = 5.3), those who live with a single parent (single user OR = 1.2, poly user OR = 1.4), involved in truancy (single user OR = 1.7, poly user OR = 3.6) and being bullied (single user OR = 1.3, poly user OR = 3.4), those who had lack of peer support (single user OR = 1.3, poly user OR = 1.4), poor parental bonding (single user OR = 1.4, poly user OR = 1.8), depression (single user OR = 1.4, poly user OR = 3.2) and those who had no close friend (single user OR = 1.3, poly user OR = 2.7). Conclusion Our study highlighted multiple significant associated factors of single and polysubstance use among adolescents in Malaysia. This result can assist in the development of specific intervention and prevention programs targeting high-risk groups.	[Rodzlan Hasani, Wan Shakira; Saminathan, Thamil Arasu; Ab Majid, Nur Liana; Miaw Yn, Jane Ling; Mat Rifin, Halizah; Abd Hamid, Hamizatul Akmal; Robert Lourdes, Tania Gayle; Ahmad, Ahzairin; Lsmail, Hasimah; Mohd Yusoff, Muhammad Fadhli] Minist Hlth Malaysia, Inst Publ Hlth, Natl Inst Hlth, Setia Alam, Selangor, Malaysia; [Abd Rashid, Rusdi] Univ Malaya, Dept Psychol Med, Ctr Addict Sci Studies UMCAS, Fac Med, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Universiti Malaya	Hasani, WSR (corresponding author), Minist Hlth Malaysia, Inst Publ Hlth, Natl Inst Hlth, Setia Alam, Selangor, Malaysia.	shaki_iera@yahoo.com	Saminathan, Thamil Arasu/AAS-1508-2021; Rodzlan Hasani, Wan Shakira Shakira Rodzlan/AAW-5845-2021	Saminathan, Thamil Arasu/0000-0002-8342-0777; 	National Institute of Health, Ministry of Health Malaysia	National Institute of Health, Ministry of Health Malaysia(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded studies National Institute of Health, Ministry of Health Malaysia.	[Anonymous], 2018, DEV COGN NEUROSCI, V21, DOI 10.1016/S1878-9293(18)30129-4; Arkes J, 2013, SUBST USE MISUSE, V48, P290, DOI 10.3109/10826084.2012.755703; Awaluddin SM, 2019, ASIA-PAC J PUBLIC HE, V31, p8S, DOI 10.1177/1010539519854884; Chen XG, 2002, ADDICT BEHAV, V27, P799, DOI 10.1016/S0306-4603(01)00211-8; Chou LC, 2006, ADDICT BEHAV, V31, P149, DOI 10.1016/j.addbeh.2005.04.011; Chun J, 2013, NICOTINE TOB RES, V15, P542, DOI 10.1093/ntr/nts181; Connell CM, 2009, J STUD ALCOHOL DRUGS, V70, P943, DOI 10.15288/jsad.2009.70.943; Connor JP, 2014, CURR OPIN PSYCHIATR, V27, P269, DOI 10.1097/YCO.0000000000000069; Conway KP, 2013, J ADOLESCENT HEALTH, V52, P716, DOI 10.1016/j.jadohealth.2012.12.006; Cranford JA, 2013, ADDICT BEHAV, V38, P2768, DOI 10.1016/j.addbeh.2013.06.015; Crawford LA, 2008, J FAM ISSUES, V29, P155, DOI 10.1177/0192513X07304461; Dierker LC, 2007, DRUG ALCOHOL DEPEN, V87, P83, DOI 10.1016/j.drugalcdep.2006.08.001; Durand V., 2013, J ADDICTION RES THER, V4, P158, DOI DOI 10.4172/2155-6105.1000158; Evans EA, 2017, DRUG ALCOHOL DEPEN, V174, P128, DOI 10.1016/j.drugalcdep.2017.01.021; Fleischman GM, 2017, J MANAG ACCOUNT RES, V29, P11, DOI 10.2308/jmar-51614; Hammond D, 2008, ASIA-PAC J PUBLIC HE, V20, P193, DOI 10.1177/1010539508317572; Hasani WSR, 2019, ASIA-PAC J PUBLIC HE, V31, p48S, DOI 10.1177/1010539519865053; Heath Douglas, 1995, INT HDB ALCOHOL CULT; Henry KL, 2010, J STUD ALCOHOL DRUGS, V71, P115, DOI 10.15288/jsad.2010.71.115; Henry KL, 2009, J STUD ALCOHOL DRUGS, V70, P5, DOI 10.15288/jsad.2009.70.5; Hong SA, 2019, SUBST USE MISUSE, V54, P288, DOI 10.1080/10826084.2018.1517797; Institute for Public Health (IPH), 2017, NAT HLTH MORB SURV N; Institute for Public Health (IPH), 2012, NAT HLTH MORB SURV M; IT Systems, 2001, IT SYSTEMS, V2, P29; Johnson PB, 2000, J ADDICT DIS, V19, P75, DOI 10.1300/J069v19n02_06; Johnston L. D., 2008, NIH PUBLICATION, V08 6418; Kandel DB, 2001, DRUG ALCOHOL DEPEN, V64, P233, DOI 10.1016/S0376-8716(01)00126-0; Kassa A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1044; Kedia S, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-33; Kelder SH, 2001, AM J PUBLIC HEALTH, V91, P761, DOI 10.2105/AJPH.91.5.761; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Lim KH, 2017, TOB INDUC DIS, V15, DOI 10.1186/s12971-016-0108-5; Lotrean LM, 2009, EUR J PUBLIC HEALTH, V19, P285, DOI 10.1093/eurpub/ckp011; Marmorstein NR, 2010, DRUG ALCOHOL DEPEN, V107, P154, DOI 10.1016/j.drugalcdep.2009.10.002; Maslowsky Julie, 2013, Ment Health Subst Use, V7, P157; Matuszka B, 2017, INT J MENT HEALTH AD, V15, P90, DOI 10.1007/s11469-015-9630-6; Midanik LT, 2007, DRUG ALCOHOL DEPEN, V90, P72, DOI 10.1016/j.drugalcdep.2007.02.024; Moss HB, 2014, DRUG ALCOHOL DEPEN, V136, P51, DOI 10.1016/j.drugalcdep.2013.12.011; Musa R, 2007, ASEAN J PSYCHIATR, V8, P82; Musher-Eizenman DR, 2003, J DRUG EDUC, V33, P1, DOI 10.2190/YED0-BQA8-5RVX-95JB; Patrick ME, 2011, J STUD ALCOHOL DRUGS, V72, P106, DOI 10.15288/jsad.2011.72.106; Patten CA, 2001, ADDICT BEHAV, V26, P129, DOI 10.1016/S0306-4603(00)00079-4; Radliff KM, 2012, ADDICT BEHAV, V37, P569, DOI 10.1016/j.addbeh.2012.01.001; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Riley SCE, 2001, ADDICTION, V96, P1035, DOI 10.1046/j.1360-0443.2001.967103513.x; Sangalang CC, 2016, CHILD YOUTH SERV REV, V61, P216, DOI 10.1016/j.childyouth.2015.12.019; Schmid B, 2007, ALCOHOL ALCOHOLISM, V42, P219, DOI 10.1093/alcalc/agm024; Shin SH, 2010, DRUG ALCOHOL DEPEN, V109, P226, DOI 10.1016/j.drugalcdep.2010.01.013; Smith GW, 2011, DRUG ALCOHOL DEPEN, V113, P222, DOI 10.1016/j.drugalcdep.2010.08.010; Tomczyk S, 2016, DRUG ALCOHOL DEPEN, V160, P12, DOI 10.1016/j.drugalcdep.2015.11.035; van Tubergen F, 2010, ETHNIC HEALTH, V15, P1, DOI 10.1080/13557850903373908; Weltzels JJL, 2003, ADDICTION, V98, P1755, DOI 10.1111/j.1360-0443.2003.00553.x; White A, 2013, ADDICT BEHAV, V38, P2068, DOI 10.1016/j.addbeh.2013.01.001; Whitesell NR, 2006, J STUD ALCOHOL, V67, P32, DOI 10.15288/jsa.2006.67.32; World Health Organization, 2013, GLOB SCH BAS STUD HL	55	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2021	16	1							e0245593	10.1371/journal.pone.0245593	http://dx.doi.org/10.1371/journal.pone.0245593			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7NX	33476329	Green Published, gold			2022-12-26	WOS:000612928900002
J	Westendorp, F; Karpus, ON; Koelink, PJ; Vermeulen, JLM; Meisner, S; Koster, J; Buller, NVJA; Wildenberg, ME; Muncan, V; van den Brink, GR				Westendorp, Florien; Karpus, Olga N.; Koelink, Pim J.; Vermeulen, Jacqueline L. M.; Meisner, Sander; Koster, Jan; Buller, Nike V. J. A.; Wildenberg, Manon E.; Muncan, Vanesa; van den Brink, Gijs R.			Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation	ONCOGENE			English	Article							INTESTINAL EPITHELIUM; HOMEOSTASIS; GROWTH; ACTIVATION; RECEPTORS; POLYPOSIS; ADENOMA; GENE	Indian Hedgehog (Ihh) is a morphogen expressed by epithelial cells in the small intestine and colon that signals in a paracrine manner to gp38+ stromal cells. The loss of Ihh signaling results in increased epithelial proliferation, lengthening and multiplication of intestinal crypts and the activation of a stromal cell immune response. How Ihh controls epithelial proliferation through the stroma and how it affects colorectal cancer development remains poorly defined. To study the influence of Ihh signaling on the earliest stage of colorectal carcinogenesis, we used a well characterized mouse model in which both alleles of the Adenoma Polyposis Coli (Apc) gene could be inducibly deleted, leading to instant transformation of the colonic epithelium to an adenomatous phenotype. Concurrent deletion of Ihh from the adenomatous colonic epithelium of Apc inducible double mutant mice resulted in a remarkable increase in the hyperproliferative epithelial phenotype and increased accumulation of Lgr5+ stem cells. Transcriptional profiling of sorted colonic gp38+ fibroblasts showed upregulation of three ErbB pathway ligands (EREG, BTC, and NRG1) in Apc(-/-)Ihh(-/-) double mutant mice. We found that recombinant EREG, BTC, and NRG1 but not Lgr5 ligand R-Spondin promoted growth and proliferation of Apc double mutant colonic organoids. Thus, the loss of Ihh enhances Apc-driven colonic adenomagenesis via upregulation of ErbB pathway family members in colonic stromal cells. Our findings highlight the critical role of epithelium-derived Indian Hedgehog as a stromal tumor suppressor in the intestine.	[Westendorp, Florien; Karpus, Olga N.; Koelink, Pim J.; Vermeulen, Jacqueline L. M.; Meisner, Sander; Buller, Nike V. J. A.; Wildenberg, Manon E.; Muncan, Vanesa; van den Brink, Gijs R.] Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam Gastroenterol & Metab, Amsterdam UMC, Amsterdam, Netherlands; [Westendorp, Florien; Karpus, Olga N.; Koelink, Pim J.; Vermeulen, Jacqueline L. M.; Meisner, Sander; Buller, Nike V. J. A.; Wildenberg, Manon E.; Muncan, Vanesa; van den Brink, Gijs R.] Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam Gastroenterol & Metab, Amsterdam UMC, Amsterdam, Netherlands; [Koster, Jan] Univ Amsterdam, Dept Oncogen, Amsterdam UMC, Amsterdam, Netherlands; [van den Brink, Gijs R.] F Hoffmann La Roche & Cie AG, Roche Innovat Ctr Basel, Basel, Switzerland	University of Amsterdam; University of Amsterdam; University of Amsterdam; Roche Holding	Westendorp, F (corresponding author), Univ Amsterdam, Tytgat Inst Liver & Intestinal Res, Amsterdam Gastroenterol & Metab, Amsterdam UMC, Amsterdam, Netherlands.; Westendorp, F (corresponding author), Univ Amsterdam, Dept Gastroenterol & Hepatol, Amsterdam Gastroenterol & Metab, Amsterdam UMC, Amsterdam, Netherlands.	b.f.westendorp@amsterdamumc.nl		Koster, Jan/0000-0002-0890-7585; Wildenberg, Manon Elisabeth/0000-0003-0671-818X	Netherlands Organization for Scientific Research (NWO) [016140605]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank our colleagues Berend Hooibrink and Toni van Capel from the Department of Experimental Immunology at the Amsterdam UMC, location AMC, for support with cell sorting, and the AMC Animal Research Facility (ARIA) for help with mouse experiments. We thank S.M. van Neerven and prof. dr. L. Vermeulen for providing Lgr5-EGFR-IRES-cre<SUP>ERT2</SUP>-Apc<SUP>fl/fl</SUP> colon organoids. This work was financially supported by a VICI grant (016140605) from the Netherlands Organization for Scientific Research (NWO) to GRB.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Berlin J, 2013, CLIN CANCER RES, V19, P258, DOI 10.1158/1078-0432.CCR-12-1800; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Buller NVJA, 2015, GASTROENTEROLOGY, V148, P170, DOI 10.1053/j.gastro.2014.10.006; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Cai XY, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S71034; Dunker N, 2002, GASTROENTEROLOGY, V122, P1364, DOI 10.1053/gast.2002.32991; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frampton JE, 2018, DRUGS, V78, P1145, DOI 10.1007/s40265-018-0948-9; Gerling M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12321; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Hanna A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0509-3; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Hogan BLM, 1999, CELL, V96, P225, DOI 10.1016/S0092-8674(00)80562-0; International Agency for Research on Cancer, GLOBAL CANC OBSERVAT; Jackstadt R, 2016, J PATHOL, V238, P141, DOI 10.1002/path.4645; Karpus ON, 2019, CELL REP, V26, P3698, DOI 10.1016/j.celrep.2019.02.101; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; NAKAMURA Y, 1992, TOHOKU J EXP MED, V168, P141, DOI 10.1620/tjem.168.141; Preston SL, 2003, CANCER RES, V63, P3819; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Shi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013054; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; van Dop WA, 2009, GASTROENTEROLOGY, V136, P2195, DOI 10.1053/j.gastro.2009.02.068; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Westendorp BF, 2018, CELL MOL GASTROENTER, V5, P67, DOI 10.1016/j.jcmgh.2017.08.004; Xie H, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050394; Xie PX, 2018, J AM ACAD DERMATOL, V79, P1089, DOI 10.1016/j.jaad.2018.07.004; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; You SH, 2010, UPSALA J MED SCI, V115, P169, DOI 10.3109/03009731003668316; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025	47	2	2	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 4	2021	40	9					1628	1643		10.1038/s41388-020-01633-0	http://dx.doi.org/10.1038/s41388-020-01633-0		JAN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	QR9UA	33479497				2022-12-26	WOS:000609352300003
J	Abedrabboh, K; Pilz, M; Al-Fagih, Z; Al-Fagih, OS; Nebel, JC; Al-Fagih, L				Abedrabboh, Khaled; Pilz, Matthias; Al-Fagih, Zaid; Al-Fagih, Othman S.; Nebel, Jean-Christophe; Al-Fagih, Luluwah			Game theory to enhance stock management of Personal Protective Equipment (PPE) during the COVID-19 outbreak	PLOS ONE			English	Article								Since the outbreak of the COVID-19 pandemic, many healthcare facilities have suffered from shortages in medical resources, particularly in Personal Protective Equipment (PPE). In this paper, we propose a game-theoretic approach to schedule PPE orders among healthcare facilities. In this PPE game, each independent healthcare facility optimises its own storage utilisation in order to keep its PPE cost at a minimum. Such a model can reduce peak demand considerably when applied to a variable PPE consumption profile. Experiments conducted for NHS England regions using actual data confirm that the challenge of securing PPE supply during disasters such as COVID-19 can be eased if proper stock management procedures are adopted. These procedures can include early stockpiling, increasing storage capacities and implementing measures that can prolong the time period between successive infection waves, such as social distancing measures. Simulation results suggest that the provision of PPE dedicated storage space can be a viable solution to avoid straining PPE supply chains in case a second wave of COVID-19 infections occurs.	[Abedrabboh, Khaled] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Sci & Engn, Div Sustainable Dev, Doha, Qatar; [Al-Fagih, Othman S.] NHS Hlth Educ East England, Cambridge, England; [Nebel, Jean-Christophe; Al-Fagih, Luluwah] Kingston Univ, Sch Comp Sci & Math, London, England; [Al-Fagih, Luluwah] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Sci & Engn, Div Engn Management & Decis Sci, Doha, Qatar	Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Kingston University; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Al-Fagih, L (corresponding author), Kingston Univ, Sch Comp Sci & Math, London, England.; Al-Fagih, L (corresponding author), Hamad Bin Khalifa Univ, Qatar Fdn, Coll Sci & Engn, Div Engn Management & Decis Sci, Doha, Qatar.	lalfagih@hbku.edu.qa	; Nebel, Jean-Christophe/B-5655-2009	Al-Fagih, Luluwah/0000-0002-0449-1324; Nebel, Jean-Christophe/0000-0003-1812-5269; Abedrabboh, Khaled/0000-0001-7572-0158; Al-Fagih, Zaid/0000-0001-7624-8334				Adida E, 2011, IIE TRANS, V43, P348, DOI 10.1080/0740817X.2010.540639; Amazon.com, BRAND DISP NONST SUR; Amazon.com, PPE VIS FAC SHIELD; Amazon.com, INTCO 100PCS DISP NI; Amazon.com, 100X DISP WHIT POL A; [Anonymous], 2020, REUTERS; [Anonymous], 2020, WEEKLY BULETIN; Boffey D, 2020, UK MISSED 3 CHANCES; Bowden E., 2020, CORONAVIRUS UK TIMEL; Brainard J, 2020, PREPRINT, DOI [10.1101/2020.06.17.20133629, DOI 10.1101/2020.06.17.20133629]; Brandeau ML, 2005, INT SER OPER RES MAN, V70, P443, DOI 10.1007/1-4020-8066-2_17; Cournot A., 1838, RES MATH PRINCIPLES; DeLaurentis Po -Ching, 2008, HOSPITAL, V101, P1; Department of Health & Social Care (DHSC), 2020, COVID 19 PERS PROT E; EpiCentro, 2020, SORV INT COVID 19 IT; European Centre for Disease Prevention and Control (ECDC), 2020, US; Hammerstein P., 1994, HDB GAME THEOR EC AP, V2, P929; Hardy J., 2020, PROTECTIVE EQUIPMENT; Keeling MJ, 2020, PREDICTIONS COVID 19, DOI [10.1101/2020.05.10.2008368332817970, DOI 10.1101/2020.05.10.2008368332817970]; Leon D. A., 2020, WHAT CAN TRENDS HOSP, DOI [10.1101/2020.04.21.20073049, DOI 10.1101/2020.04.21.20073049]; Liu JZ, 2012, J R SOC INTERFACE, V9, P68, DOI 10.1098/rsif.2011.0001; Lofgren E, 2016, AAAI CONF ARTIF INTE, P35; Madabhavi I, 2020, MONALDI ARCH CHEST D, V90, P248, DOI 10.4081/monaldi.2020.1298; Mantyselka P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7377-x; Milmo C, 2020, PPE CHAOS DESPERATE; Nagurney A., 2020, NONLINEAR ANAL GLOBA; NASH J, 1951, ANN MATH, V54, P286, DOI 10.2307/1969529; National Audit Office (NAO), 2020, READ NHS AD SOC CAR; National Health Service (NHS) England, 2014, UND NEW NHS NHS ENGL; National Health Service (NHS) Improvement, QUAL SERV IMPR RED T; National Health Service (NHS) Improvement, WHAT WE DO; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Panovska-Griffiths J, 2020, LANCET CHILD ADOLESC, V4, P817, DOI 10.1016/S2352-4642(20)30250-9; PHE, 2020, COVID 19 INF PREV CO; Pilz M, 2020, INT J INF SECUR, V19, P427, DOI 10.1007/s10207-019-00460-z; Pilz M, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CONTROL, AND COMPUTING TECHNOLOGIES FOR SMART GRIDS (SMARTGRIDCOMM); Pilz M, 2020, DYN GAMES APPL, V10, P897, DOI 10.1007/s13235-019-00309-z; Pilz M, 2019, IEEE T SMART GRID, V10, P1363, DOI 10.1109/TSG.2017.2764275; Public Health England (PHE), 2020, COR COVID 19 UK HEAL; Shoham Y., 2008, MULTIAGENT SYSTEMS A, DOI DOI 10.1017/CBO9780511811654; Shoham Y, 2008, COMMUN ACM, V51, P74, DOI 10.1145/1378704.1378721; Sun P, 2009, OPER RES, V57, P1320, DOI 10.1287/opre.1090.0762; Supply Chain Coordination Limited (SCCL), NHS SUPPL CHAIN SUPP; Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tuzun S, 2018, INT SER OPER RES MAN, V262, P3, DOI 10.1007/978-3-319-65455-3_1; UK Office of National Statistics, 2019, OP GOV LIC V3 0; Vasnani Neelesh N., 2019, International Journal of Applied Decision Sciences, V12, P56; Wang SQ, 2009, MATH BIOSCI, V222, P1, DOI 10.1016/j.mbs.2009.08.002; WHO, 2020, RAT US PERS PROT EQ; WHO, 2020, 7 WHO; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; Wise J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2294; World Health Organization, 2020, ARCH WHO TIM COVID 1; World Health Organization (WHO), 2020, WHO ANNOUNCES COVID; Worldometer, 2022, COR CAS, DOI DOI 10.1101/2020.01.23.20018549V2	57	4	4	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2021	16	2							e0246110	10.1371/journal.pone.0246110	http://dx.doi.org/10.1371/journal.pone.0246110			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF0FZ	33524057	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000616578400011
J	Geleta, B; Park, KC; Jansson, PJ; Sahni, S; Maleki, S; Xu, ZH; Murakami, T; Pajic, M; Apte, MV; Richardson, D; Kovacevic, Z				Geleta, Bekesho; Park, Kyung Chan; Jansson, Patric J.; Sahni, Sumit; Maleki, Sanaz; Xu, Zhihong; Murakami, Takashi; Pajic, Marina; Apte, Minoti, V; Richardson, Des R.; Kovacevic, Zaklina			Breaking the cycle: Targeting of NDRG1 to inhibit bi-directional oncogenic cross-talk between pancreatic cancer and stroma	FASEB JOURNAL			English	Article						DpC; NDRG1; pancreatic cancer; stellate cells; stroma	HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS SUPPRESSOR NDRG1; C-MET EXPRESSION; IRON CHELATORS; REGULATED GENE-1; STELLATE CELLS; ANTIPROLIFERATIVE ACTIVITY; FACTOR RECEPTOR; UP-REGULATION	Pancreatic cancer (PaCa) is characterized by dense stroma that hinders treatment efficacy, with pancreatic stellate cells (PSCs) being a major contributor to this stromal barrier and PaCa progression. Activated PSCs release hepatocyte growth factor (HGF) and insulin-like growth factor (IGF-1) that induce PaCa proliferation, metastasis and resistance to chemotherapy. We demonstrate for the first time that the metastasis suppressor, N-myc downstream regulated gene 1 (NDRG1), is a potent inhibitor of the PaCa-PSC cross-talk, leading to inhibition of HGF and IGF-1 signaling. NDRG1 also potently reduced the key driver of PaCa metastasis, namely GLI1, leading to reduced PSC-mediated cell migration. The novel clinically trialed anticancer agent, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), which upregulates NDRG1, potently de-sensitized PaCa cells to ligands secreted by activated PSCs. DpC and NDRG1 also inhibited the PaCa-mediated activation of PSCs via inhibition of sonic hedgehog (SHH) signaling. In vivo, DpC markedly reduced PaCa tumor growth and metastasis more avidly than the standard chemotherapy for this disease, gemcitabine. Uniquely, DpC was selectively cytotoxic against PaCa cells, while "re-programming" PSCs to an inactive state, decreasing collagen deposition and desmoplasia. Thus, targeting NDRG1 can effectively break the oncogenic cycle of PaCa-PSC bi-directional cross-talk to overcome PaCa desmoplasia and improve therapeutic outcomes.	[Geleta, Bekesho; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW 2006, Australia; [Geleta, Bekesho; Park, Kyung Chan; Jansson, Patric J.; Sahni, Sumit; Richardson, Des R.; Kovacevic, Zaklina] Univ Sydney, Dept Pathol, Mol Pharmacol & Pathol Program, Sydney, NSW, Australia; [Jansson, Patric J.] Univ Sydney, Dept Pathol, Canc Drug Resistance Program, Sydney, NSW, Australia; [Sahni, Sumit] Univ Sydney, Kolling Inst Med Res, Bill Walsh Translat Canc Res Lab, Sydney, NSW, Australia; [Maleki, Sanaz] Univ Sydney, Sch Med Sci, Dept Pathol, Histopathol Lab, Sydney, NSW, Australia; [Xu, Zhihong; Apte, Minoti, V] UNSW Sydney, South Western Sydney Clin Sch, Pancreat Res Grp, Sydney, NSW, Australia; [Xu, Zhihong; Apte, Minoti, V] Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Murakami, Takashi] Saitama Med Univ, Fac Med, Moroyama, Saitama, Japan; [Pajic, Marina] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Pajic, Marina] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Richardson, Des R.] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi, Japan; [Richardson, Des R.] Griffith Univ, Ctr Canc Cell Biol & Drug Discovery, Griffith Inst Drug Discovery, Nathan, Qld, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Kolling Institute of Medical Research; University of Sydney; University of New South Wales Sydney; Ingham Institute for Applied Medical Research; Saitama Medical University; Garvan Institute of Medical Research; University of New South Wales Sydney; Nagoya University; Griffith University	Kovacevic, Z (corresponding author), Univ Sydney, Dept Pathol, Canc Metastasis & Tumour Microenvironm Program, Sydney, NSW 2006, Australia.; Richardson, D (corresponding author), Griffith Univ, Ctr Canc Cell Biol & Drug Discovery, Griffith Inst Drug Discovery, Brisbane, Qld 4611, Australia.	d.richardson@griffith.edu.au; zaklina.kovacevic@sydney.edu.au	Kovacevic, Zaklina/ABD-9581-2021; Geleta, Bekesho/AAC-5785-2022; Jansson, Patric/AAC-4221-2022	Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Wendimu, Bekesho Geleta/0000-0002-4546-9692; Pajic, Marina/0000-0002-3871-3829; Richardson, Des/0000-0002-5506-3274; Xu, Zhihong/0000-0001-8445-1076				Apte MV, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00344; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bai YY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002996; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; Chou A, 2018, GUT, V67, P2142, DOI 10.1136/gutjnl-2017-315144; Cros J., 2016, PANCREATOLOGY, V16, pS27; Cuneo KC, 2018, INT J RADIAT ONCOL, V100, P490, DOI 10.1016/j.ijrobp.2017.10.030; DIRENZO MF, 1995, CANCER RES, V55, P1129; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Fafalios A, 2011, NAT MED, V17, P1577, DOI 10.1038/nm.2531; Fan SJ, 2001, MOL CELL BIOL, V21, P4968, DOI 10.1128/MCB.21.15.4968-4984.2001; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Gual P, 2000, ONCOGENE, V19, P1509, DOI 10.1038/sj.onc.1203514; Haqq J, 2014, EUR J CANCER, V50, P2570, DOI 10.1016/j.ejca.2014.06.021; Hirakawa T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159912; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Ireland L, 2016, CANCER RES, V76, P6851, DOI 10.1158/0008-5472.CAN-16-1201; Jansson PJ, 2015, PHARMACOL RES, V100, P255, DOI 10.1016/j.phrs.2015.08.013; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jin RS, 2014, J CELL SCI, V127, P3116, DOI 10.1242/jcs.147835; Kalinowski DS, 2007, J MED CHEM, V50, P6212, DOI 10.1021/jm070839q; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kasai K, 2016, PATHOL INT, V66, P653, DOI 10.1111/pin.12476; Kiehne K, 1997, PANCREAS, V15, P35, DOI 10.1097/00006676-199707000-00005; Kim JH, 2017, ONCOTARGET, V8, P73098, DOI 10.18632/oncotarget.20392; Kovacevic Z, 2016, J BIOL CHEM, V291, P1029, DOI 10.1074/jbc.M115.689653; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Lee JE, 2015, GENET MOL BIOL, V38, P527, DOI 10.1590/S1415-475738420150028; Li XQ, 2014, CLIN CANCER RES, V20, P4326, DOI 10.1158/1078-0432.CCR-13-3426; Li YH, 2015, CELL REP, V12, P599, DOI 10.1016/j.celrep.2015.06.054; Lim SC, 2020, FASEB J, V34, P11511, DOI 10.1096/fj.201903167R; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Menezes SV, 2019, CARCINOGENESIS, V40, P805, DOI 10.1093/carcin/bgy178; Nair PN, 2001, ONCOGENE, V20, P8203, DOI 10.1038/sj.onc.1205044; Nakashima H, 2006, CANCER RES, V66, P7041, DOI 10.1158/0008-5472.CAN-05-4588; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Pant S, 2014, ANN ONCOL, V25, P1416, DOI 10.1093/annonc/mdu157; Papaconstantinou J, 2015, ONCOTARGET, V6, P35315, DOI 10.18632/oncotarget.6112; Park KC, 2020, J BIOL CHEM, V295, P481, DOI 10.1074/jbc.RA119.011341; Patel MB, 2014, CARCINOGENESIS, V35, P1891, DOI 10.1093/carcin/bgu122; Pothula SP, 2017, ONCOTARGET, V8, P76722, DOI 10.18632/oncotarget.20822; Pothula SP, 2016, BRIT J CANCER, V114, P269, DOI 10.1038/bjc.2015.478; Procacci P, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7100158; Rajbhandari N, 2017, CELL REP, V18, P2243, DOI 10.1016/j.celrep.2017.02.013; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; RICHARDSON D, 1994, CANCER RES, V54, P685; Rucki AA, 2017, MOL CANCER THER, V16, P2399, DOI 10.1158/1535-7163.MCT-16-0452; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stacy AE, 2016, J MED CHEM, V59, P8601, DOI 10.1021/acs.jmedchem.6b01050; Suarez-Causado A, 2015, BBA-MOL CELL RES, V1853, P2453, DOI 10.1016/j.bbamcr.2015.05.017; Subramani R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097016; Sun J, 2013, CARCINOGENESIS, V34, P1943, DOI 10.1093/carcin/bgt163; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	62	16	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21347	10.1096/fj.202002279R	http://dx.doi.org/10.1096/fj.202002279R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484481				2022-12-26	WOS:000647789600037
J	Eigaard, OR; Herrmann, B; Feekings, JP; Krag, LA; Sparrevohn, CR				Eigaard, Ole R.; Herrmann, Bent; Feekings, Jordan P.; Krag, Ludvig A.; Sparrevohn, Claus R.			A netting-based alternative to rigid sorting grids in the small-meshed Norway pout (Trisopterus esmarkii) trawl fishery	PLOS ONE			English	Article							NORTH-SEA; SELECTIVITY; SIZE; COD; SKAGERRAK; MATURITY; GROWTH; GEAR	A new bycatch reduction device, termed "Excluder", is presented as an alternative to a traditional rigid sorting grid, mandatory in the small-meshed Norway Pout (Trisopterus esmarkii) trawl fishery in the North Sea. The fishery is a high-volume fishery with large vessels, large demersal trawls and catches up to 100 tons per haul of this small forage fish. The Excluder is a 30 m long netting-based sorting system, developed to reduce bycatch (70 mm square meshes) and improving on board gear-handling and safety. The Excluder was tested against a 5.8 m(2) standard sorting grid (35 mm bar spacing) in a twin-trawl experiment from the commercial 70 m trawler "S364 Rockall". Catch data were analysed by species and length using the catch comparison method. For all bycatch species analysed, the Excluder had significantly lower catches relative to the grid: herring (21%), whiting (6%), mackerel (5%), American plaice (70%), witch flounder (15%), and lesser silver smelt (71%). For Norway Pout there was a significant increase in the overall catch efficiency of 32%. These results are explained by a 10 cm smaller L50 (the length of fish with 50% probability of being rejected by the sorting system) of the Excluder and a 15 times larger sorting area, which reduces the risk of clogging and loss of function. With these documented effects of improved sorting and target species catch efficiency, implementation of the Excluder would improve sustainability and address two main barriers of the current Norway pout fishery that limit quota capitalization; a tendency for Norway pout to mix with herring and whiting and lowered catch rates from grid-clogging. Additionally, gear-handling and safety on board would be improved.	[Eigaard, Ole R.] Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Lyngby, Denmark; [Herrmann, Bent] SINTEF Ocean, Trondheim, Norway; [Herrmann, Bent] UiT Arctic Univ Norway, Tromso, Norway; [Feekings, Jordan P.; Krag, Ludvig A.] Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, North Sea Sci Pk, Hirtshals, Denmark; [Sparrevohn, Claus R.] Danish Pelag Producers Org, Copenhagen, Denmark	Technical University of Denmark; SINTEF; UiT The Arctic University of Tromso; Technical University of Denmark	Eigaard, OR (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources DTU AQUA, Lyngby, Denmark.	ore@aqua.dtu.dk		Eigaard, Ole Ritzau/0000-0003-4213-2397; Feekings, Jordan P./0000-0001-9103-7332; Krag, Ludvig Ahm/0000-0002-1531-1499	Ministry of environment and food of Denmark [34009-14-0876]	Ministry of environment and food of Denmark	We wish to thank the Ministry of environment and food of Denmark for funding the work presented here through the GUDP (Green Development and Demonstration Program) (Project title "Udvikling af bifangst Excluder til det Danske og Europaeiske fiskeri" and number "34009-14-0876").	ALBERT OT, 1994, ICES J MAR SCI, V51, P45, DOI 10.1006/jmsc.1994.1005; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chosid DM, 2012, FISH RES, V114, P66, DOI 10.1016/j.fishres.2011.03.007; Eigaard OR, 2014, REV FISH SCI AQUAC, V22, P156, DOI 10.1080/23308249.2014.899557; Eigaard OR, 2012, AQUAT LIVING RESOUR, V25, P15, DOI 10.1051/alr/2011152; Eigaard OR, 2011, FISH RES, V110, P39, DOI 10.1016/j.fishres.2011.03.010; Eigaard OR, 2004, FISH RES, V68, P99, DOI 10.1016/j.fishres.2004.02.002; Fassler SMM, 2007, CAN J FISH AQUAT SCI, V64, P362, DOI 10.1139/F07-013; Herrmann B, 2005, FISH RES, V71, P15, DOI 10.1016/j.fishres.2004.08.021; Herrmann B, 2017, FISH RES, V185, P153, DOI 10.1016/j.fishres.2016.09.013; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2016, MAR COAST FISH, V8, P277, DOI 10.1080/19425120.2016.1161682; Herrmann B, 2009, FISH RES, V97, P59, DOI 10.1016/j.fishres.2009.01.002; ICES, 2016, ICES 900 2016ACOM35; ICES, 1996, ICES 900 1996B1; ICES, 2018, GREATER N SEA ECOREG, DOI [10.17895/ices.pub.4564, DOI 10.17895/ICES.PUB.4564]; Kennelly SJ., 2007, REV METHODS TECHNOLO, P290; Kvalsvik K, 2006, FISH RES, V77, P248, DOI 10.1016/j.fishres.2005.10.002; Lambert G, 2009, ICES J MAR SCI, V66, P1899, DOI 10.1093/icesjms/fsp153; Loaec H, 2006, FISH RES, V79, P210, DOI 10.1016/j.fishres.2006.01.011; Molparia B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196826; Nielsen JR, 2012, ICES J MAR SCI, V69, P197, DOI 10.1093/icesjms/fss001; Nielsen JR, 2003, MAR POLICY, V27, P409, DOI 10.1016/S0308-597X(03)00024-1; Sistiaga M, 2008, FISH RES, V93, P195, DOI 10.1016/j.fishres.2008.04.014; Tokac A, 2018, SCI MAR, V82, P147, DOI 10.3989/scimar.04764.18A; Wardle C.S., 1993, Fish and Fisheries Series, V7, P609; Wileman DA, 1996, ICES COOP RES REP NO, DOI [10.17895/ices.pub.4628, DOI 10.17895/ICES.PUB.4628]	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246076	10.1371/journal.pone.0246076	http://dx.doi.org/10.1371/journal.pone.0246076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507905	Green Published, gold			2022-12-26	WOS:000635021400082
J	Han, R; Wei, TM; Tseng, SC; Lo, CC				Han, Rui; Wei, Tzu-Min; Tseng, Szu-Chiao; Lo, Chung-Chuan			Characterizing approach behavior of Drosophila melanogaster in Buridan's paradigm	PLOS ONE			English	Article							SPATIAL ORIENTATION MEMORY; LANDMARK; FIXATION; DYNAMICS; FLY	The Buridan's paradigm is a behavioral task designed for testing visuomotor responses or phototaxis in fruit fly Drosophila melanogaster. In the task, a wing-shortened fruit fly freely moves on a round platform surrounded by a 360 degrees white screen with two vertical black stripes placed at 0 degrees and 180 degrees. A normal fly will tend to approach the stripes one at a time and move back and forth between them. A variety of tasks developed based on the Buridan's paradigm were designed to test other cognitive functions such as visual spatial memory. Although the movement patterns and the behavioral preferences of the flies in the Buridan's or similar tasks have been extensively studies a few decades ago, the protocol and experimental settings are markedly different from what are used today. We revisited the Buridan's paradigm and systematically investigated the approach behavior of fruit flies under different stimulus settings. While early studies revealed an edge-fixation behavior for a wide stripe in the initial visuomotor responses, we did not discover such tendency in the Buridan's paradigm when observing a longer-term behavior up to minutes, a memory-task relevant time scale. Instead, we observed robust negative photoaxis in which the flies approached the central part of the dark stripes of all sizes. In addition, we found that stripes of 20 degrees-30 degrees width yielded the best performance of approach. We further varied the luminance of the stripes and the background screen, and discovered that the performance depended on the luminance ratio between the stripes and the screen. Our study provided useful information for designing and optimizing the Buridan's paradigm and other behavioral tasks that utilize the approach behavior.	[Han, Rui; Lo, Chung-Chuan] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Wei, Tzu-Min; Lo, Chung-Chuan] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Tseng, Szu-Chiao] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Lo, Chung-Chuan] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu, Taiwan; [Tseng, Szu-Chiao] Osaka Univ, Grad Sch Human Sci, Osaka, Japan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; Osaka University	Lo, CC (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.; Lo, CC (corresponding author), Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan.; Lo, CC (corresponding author), Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu, Taiwan.	cclo@mx.nthu.edu.tw	Lo, Chung-Chuan/C-3951-2008	Lo, Chung-Chuan/0000-0001-7737-7250	Ministry of Science and Technology [109-2634-F-007 -025 -, 109-2218-E-007 -021 -]; Ministry of Science and Technology and Ministry of Education in Taiwan	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Science and Technology and Ministry of Education in Taiwan	The work was supported by the Ministry of Science and Technology grants 109-2634-F-007 -025 -and 109-2218-E-007 -021 -, and by the Higher Education Sprout Project funded by the Ministry of Science and Technology and Ministry of Education in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Givon LE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00102; Gong ZF, 2009, BIOCHEM BIOPH RES CO, V382, P395, DOI 10.1016/j.bbrc.2009.03.033; Gorostiza EA, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160229; Gotz KG, 1971, DROSOPH INF SERV, V46, P62; Green J, 2019, NAT NEUROSCI, V22, P1460, DOI 10.1038/s41593-019-0444-x; Guo C, 2015, LEARN MEMORY, V22, P56, DOI 10.1101/lm.036863.114; Han R, 2019, 819185 BIORXIV, DOI [10.1101/819185, DOI 10.1101/819185]; Heisenberg M, 1984, VISION DROSOPHILA GE, V12, P146, DOI [10.1016/S0006-3495(84)84217-4, DOI 10.1016/S0006-3495(84)84217-4]; HORN E, 1975, J COMP PHYSIOL, V101, P39, DOI 10.1007/BF00660118; Huang YC, 2019, FRONT NEUROINFORM, V12, DOI 10.3389/fninf.2018.00099; Kim SS, 2017, SCIENCE, V356, P849, DOI 10.1126/science.aal4835; Kirszenblat L, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.191429; LISKE E, 1977, J INSECT PHYSIOL, V23, P375, DOI 10.1016/0022-1910(77)90276-1; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Owald D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0211; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; Seelig JD, 2015, NATURE, V521, P186, DOI 10.1038/nature14446; Seelig JD, 2013, NATURE, V503, P262, DOI 10.1038/nature12601; Siddiqi O., 1980, BASIC LIFE SCI, V16, P391, DOI [10.1007/978-1-4684-7968-3_28, DOI 10.1007/978-1-4684-7968-3_28]; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strauss R, 1998, J COMP PHYSIOL A, V182, P411, DOI 10.1007/s003590050190; Su TS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00191-6; WEHNER R, 1972, J INSECT PHYSIOL, V18, P1531, DOI 10.1016/0022-1910(72)90232-6; Wehner R, 1981, COMP PHYS EVOLUTION, VVII/ 6C, P287, DOI DOI 10.1007/978-3642-67868-4; Yen HH, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00215	26	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245990	10.1371/journal.pone.0245990	http://dx.doi.org/10.1371/journal.pone.0245990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507934	Green Published, gold			2022-12-26	WOS:000635021400069
J	Tracy, JD; Donnelly, T; Sommer, EC; Heerman, WJ; Barkin, SL; Buchowski, MS				Tracy, J. Dustin; Donnelly, Thomas; Sommer, Evan C.; Heerman, William J.; Barkin, Shari L.; Buchowski, Maciej S.			Identifying bedrest using waist-worn triaxial accelerometers in preschool children	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; SLEEP; ACTIGRAPHY; AGREEMENT; HIP; VALIDATION; DURATION; VALIDITY; IMPACT; WRIST	Purpose To adapt and validate a previously developed decision tree for youth to identify bedrest for use in preschool children. Methods Parents of healthy preschool (3-6-year-old) children (n = 610; 294 males) were asked to help them to wear an accelerometer for 7 to 10 days and 24 hours/day on their waist. Children with.3 nights of valid recordings were randomly allocated to the development (n = 200) and validation (n = 200) groups. Wear periods from accelerometer recordings were identified minute-by-minute as bedrest or wake using visual identification by two independent raters. To automate visual identification, chosen decision tree (DT) parameters (block length, threshold, bedrest-start trigger, and bedrest-end trigger) were optimized in the development group using a Nelder-Mead simplex optimization method, which maximized the accuracy of DT-identified bedrest in 1-min epochs against synchronized visually identified bedrest (n = 4,730,734). DT's performance with optimized parameters was compared with the visual identification, commonly used Sadeh's sleep detection algorithm, DT for youth (10-18-years-old), and parental survey of sleep duration in the validation group. Results On average, children wore an accelerometer for 8.3 days and 20.8 hours/day. Comparing the DT-identified bedrest with visual identification in the validation group yielded sensitivity = 0.941, specificity = 0.974, and accuracy = 0.956. The optimal block length was 36 min, the threshold 230 counts/min, the bedrest-start trigger 305 counts/min, and the bedrest-end trigger 1,129 counts/min. In the validation group, DT identified bedrest with greater accuracy than Sadeh's algorithm (0.956 and 0.902) and DT for youth (0.956 and 0.861) (both P< 0.001). Both DT (564 +/- 77 min/day) and Sadeh's algorithm (604 +/- 80 min/day) identified significantly less bedrest/sleep than parental survey (650 +/- 81 min/day) (both P< 0.001). Conclusions The DT-based algorithm initially developed for youth was adapted for preschool children to identify time spent in bedrest with high accuracy. The DT is available as a package for the R open-source software environment ("PhysActBedRest").	[Tracy, J. Dustin] Chapman Univ, Econ Sci Inst, Orange, CA 92866 USA; [Donnelly, Thomas; Buchowski, Maciej S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr,Energy Balance L, Nashville, TN 37235 USA; [Sommer, Evan C.; Heerman, William J.; Barkin, Shari L.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Chapman University System; Chapman University; Vanderbilt University; Vanderbilt University	Buchowski, MS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr,Energy Balance L, Nashville, TN 37235 USA.	maciej.buchowski@vanderbilt.edu		Buchowski, Maciej/0000-0002-0566-1743; Sommer, Evan/0000-0003-4546-205X; Tracy, Dustin/0000-0002-9618-4507	National Institutes of Health (NIH) from the National Heart, Lung, and Blood Institute [HL103620, HL103561]; National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health and Development [HL103620, HL103561]; Office of Behavioral and Social Sciences Research; National Institute of Diabetes and Digestive and Kidney Diseases [DK058404, DK20593]; National Center for Advancing Translational Sciences [TR000445]; National Heart Lung and Blood Institute [K23 HL127104]	National Institutes of Health (NIH) from the National Heart, Lung, and Blood Institute; National Institutes of Health (NIH) from the Eunice Kennedy Shriver National Institute of Child Health and Development; Office of Behavioral and Social Sciences Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health (NIH) grants HL103620 and HL103561 from the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Development, and the Office of Behavioral and Social Sciences Research: https://nam04.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.nih.gov %2F&data=04%7C01%7Cmaciej.buchowski% 40vanderbilt.edu%7C876b97453d1f47b15de808d 8b8a53769%7Cba5a7f39e3be4ab3b45067fa80fa ecad%7C0%7C0%7C637462367312593967%7C Unknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAw MDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI 6Mn0%3D%7C1000&sdata=PnXgEOgTcQyoZQ8L VFVd1rAn9y0Y6KL3YnIYBw3yyw%3D&reserved= 0. Additional funds were provided by grants DK058404 and DK20593 from the National Institute of Diabetes and Digestive and Kidney Diseases: https://nam04.safelinks.protection.out look.com/?url=https%3A%2F%2Fwww.nih.gov% 2F&data=04%7C01%7Cmaciej.buchowski%40 vanderbilt.edu%7C876b97453d1f47b15de808d 8b8a53769%7Cba5a7f39e3be4ab3b45067fa80 faecad%7C0%7C0%7C637462367312593967% 7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4w LjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiL CJXVCI6Mn0%3D%7C1000&sdata=PnXgEOgT cQyoZQ8eLVFVd1rAn9y0Y6KL3YnIYBw3yyw% 3D&reserved=0. The REDCap Database was supported by TR000445 from the National Center for Advancing Translational Sciences: https://nam04.safelinks.protection.outlook.com/?url= https%3A%2F%2Fwww.nih.gov%2F&data=04% 7C01%7Cmaciej.buchowski%40vanderbilt.edu% 7C876b97453d1f47b15de808d8b8a53769% 7Cba5a7f39e3be4ab3b45067fa80faecad%7C0% 7C0%7C637462367312593967%7CUnknown% 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJ QIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0% 3D%7C1000&sdata=PnXgEOgTcQyoZQ8eLVFVd 1rAn9y0Y6KL3YnIYBw3yyw%3D&reserved=0. WJH was supported by K23 HL127104 grant from the National Heart Lung and Blood Institute: https://nam04.safelinks.protection.outlook.com/?url= https%3A%2F%2Fwww.nih.gov%2F&data=04% 7C01%7Cmaciej.buchowski%40vanderbilt.edu% 7C876b97453d1f47b15de808d8b8a53769% 7Cba5a7f39e3be4ab3b45067fa80faecad%7C0% 7C0%7C637462367312593967%7CUnknown% 7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJ QIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0% 3D%7C1000&sdata=PnXgEOgTcQyoZQ8eLVFVd1 rAn9y0Y6KL3YnIYBw3yyw%3D&reserved=0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ancoli-Israel S, 2015, BEHAV SLEEP MED, V13, pS4, DOI 10.1080/15402002.2015.1046356; Barkin SL, 2018, JAMA-J AM MED ASSOC, V320, P450, DOI 10.1001/jama.2018.9128; Barreira TV, 2015, MED SCI SPORT EXER, V47, P937, DOI 10.1249/MSS.0000000000000486; Bathory E, 2017, CURR PROB PEDIATR AD, V47, P29, DOI 10.1016/j.cppeds.2016.12.001; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; Borghese MM, 2018, SLEEP HEALTH, V4, P110, DOI 10.1016/j.sleh.2017.09.006; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Clevenger KA, 2019, PHYSIOL MEAS, V40, DOI 10.1088/1361-6579/ab444b; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; de Souza L, 2003, SLEEP, V26, P81, DOI 10.1093/sleep/26.1.81; Freedson PS, 2013, MED SCI SPORT EXER, V45, P962, DOI 10.1249/MSS.0b013e31827f024d; Galland BC, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy017; Gregory AM, 2012, SLEEP MED REV, V16, P129, DOI 10.1016/j.smrv.2011.03.007; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Irwin MR, 2015, BRAIN BEHAV IMMUN, V47, P86, DOI 10.1016/j.bbi.2014.09.017; Kinder JR, 2012, J PEDIATR NURS, V27, P127, DOI 10.1016/j.pedn.2010.11.004; McVeigh JA, 2016, PHYSIOL MEAS, V37, P1636, DOI 10.1088/0967-3334/37/10/1636; Meltzer LJ, 2016, SLEEP, V39, P1219, DOI 10.5665/sleep.5836; Meltzer LJ, 2015, SLEEP, V38, P1323, DOI 10.5665/sleep.4918; Meltzer LJ, 2012, SLEEP MED REV, V16, P463, DOI 10.1016/j.smrv.2011.10.002; Meredith-Jones K, 2016, J SPORT SCI, V34, P679, DOI 10.1080/02640414.2015.1068438; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Po'e EK, 2013, CONTEMP CLIN TRIALS, V36, P436, DOI 10.1016/j.cct.2013.08.013; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Sadeh A, 2011, SLEEP MED REV, V15, P259, DOI 10.1016/j.smrv.2010.10.001; Spruyt K, 2011, J SLEEP RES, V20, P223, DOI 10.1111/j.1365-2869.2010.00857.x; Toon E, 2016, J CLIN SLEEP MED, V12, P343, DOI 10.5664/jcsm.5580; Tracy DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092512; Tracy JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194461; Tudor-Locke C, 2015, Int J Obes Suppl, V5, pS47, DOI 10.1038/ijosup.2015.19; Tudor-Locke Catrine, 2014, Appl Physiol Nutr Metab, V39, P53, DOI 10.1139/apnm-2013-0173; van Hees VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142533; Vriend J, 2015, SLEEP MED CLIN, V10, P107, DOI 10.1016/j.jsmc.2015.02.009; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015	37	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246055	10.1371/journal.pone.0246055	http://dx.doi.org/10.1371/journal.pone.0246055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507967	gold, Green Published			2022-12-26	WOS:000635021400079
J	Alipour, S; Bilska, K; Stolarska, E; Wojciechowska, N; Kalemba, EM				Alipour, Shirin; Bilska, Karolina; Stolarska, Ewelina; Wojciechowska, Natalia; Kalemba, Ewa Marzena			Nicotinamide adenine dinucleotides are associated with distinct redox control of germination in Acer seeds with contrasting physiology	PLOS ONE			English	Article								Seed germination is a complex process enabling plant reproduction. Germination was found to be regulated at the proteome, metabolome and hormonal levels as well as via discrete post-translational modification of proteins including phosphorylation and carbonylation. Redox balance is also involved but less studied. Acer seeds displaying orthodox and recalcitrant characteristics were investigated to determine the levels of redox couples of nicotinamide adenine dinucleotide (NAD) phosphate (NADP) and integrated with the levels of ascorbate and glutathione. NAD and NADP concentrations were higher in Norway maple seeds and exceptionally high at the germinated stage, being the most contrasting parameter between germinating Acer seeds. In contrast, NAD(P)H/NAD(P)(+) ratios were higher in sycamore seeds, thus exhibiting higher reducing power. Despite distinct concentrations of ascorbate and glutathione, both seed types attained in embryonic axes and cotyledons had similar ratios of reduced/oxidized forms of ascorbate and half-cell reduction potential of glutathione at the germinated stage. Both species accomplished germination displaying different strategies to modulate redox status. Sycamore produced higher amounts of ascorbate and maintained pyridine nucleotides in reduced forms. Interestingly, lower NAD(P) concentrations limited the regeneration of ascorbate and glutathione but dynamically drove metabolic reactions, particularly in this species, and contributed to faster germination. We suggest that NAD(P) is an important player in regulating redox status during germination in a distinct manner in Norway maple and sycamore seeds.	[Alipour, Shirin; Bilska, Karolina; Stolarska, Ewelina; Wojciechowska, Natalia; Kalemba, Ewa Marzena] Polish Acad Sci, Inst Dendrol, Kornik, Poland; [Wojciechowska, Natalia] Adam Mickiewicz Univ, Dept Gen Bot, Inst Expt Biol, Fac Biol, Uniwersytetu Poznanskiego 6, Poznan, Poland	Polish Academy of Sciences; Adam Mickiewicz University	Kalemba, EM (corresponding author), Polish Acad Sci, Inst Dendrol, Kornik, Poland.	kalemba@man.poznan.pl	Kalemba, Ewa/M-8301-2019	Kalemba, Ewa/0000-0002-0092-0339; Stolarska, Ewelina/0000-0002-1774-3762; Alipour, Shirin/0000-0001-7780-5411	National Science Center (Poland) [2015/18/E/NZ9/00729]; Institute of Dendrology of the Polish Academy of Sciences	National Science Center (Poland)(National Science Centre, Poland); Institute of Dendrology of the Polish Academy of Sciences	This research was funded by the National Science Center (Poland), grant No. 2015/18/E/NZ9/00729. The Institute of Dendrology of the Polish Academy of Sciences provided support in the form of salary and scholarships for all authors who are affiliated to the Institute. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour S, 2020, PLANT CELL PHYSIOL, V61, P1158, DOI 10.1093/pcp/pcaa044; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Bailly C, 2019, BIOCHEM J, V476, P3019, DOI 10.1042/BCJ20190159; Bewley J., 2013, SEEDS, P299, DOI [DOI 10.1007/978-1-4614-4693-4, 10.1007/978-1-4614-4693-4_7, DOI 10.1007/978-1-4614-4693-4_7]; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Bewley JD, 1994, SEEDS PHYSL DEV GERM, V3rd, P445, DOI 10.1007/978-1-4899-1002-8; Cairns NG, 2006, PLANT PHYSIOL, V141, P446, DOI 10.1104/pp.106.077982; Cardenas L, 2006, PLANT PHYSIOL, V142, P1460, DOI 10.1104/pp.106.087882; Chakrabarty A, 2019, PHYSIOL MOL BIOL PLA, V25, P649, DOI 10.1007/s12298-019-00656-6; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Colville L, 2010, PLANT GROWTH REGUL, V62, P241, DOI 10.1007/s10725-010-9482-9; Considine MJ, 2014, ANTIOXID REDOX SIGN, V21, P1305, DOI 10.1089/ars.2013.5665; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; de Simone A, 2017, ANTIOXID REDOX SIGN, V27, P1505, DOI 10.1089/ars.2016.6959; Dell'Aglio E, 2020, PLANT PHYSIOL, V183, P11, DOI 10.1104/pp.20.00388; Ding HY, 2020, J EXP BOT, V71, P3405, DOI 10.1093/jxb/eraa107; Finch-Savage WE, 1998, ANN BOT-LONDON, V81, P519, DOI 10.1006/anbo.1998.0587; Foyer CH, 2011, PLANT PHYSIOL, V155, P2, DOI 10.1104/pp.110.167569; Gakiere B, 2018, CRIT REV PLANT SCI, V37, P259, DOI 10.1080/07352689.2018.1505591; Gallais S, 1998, J PLANT PHYSIOL, V153, P664, DOI 10.1016/S0176-1617(98)80218-6; Geigenberger P, 2003, CURR OPIN PLANT BIOL, V6, P247, DOI 10.1016/S1369-5266(03)00038-4; Gerna D, 2017, FREE RADICAL RES, V51, P568, DOI 10.1080/10715762.2017.1338344; Greggains V, 2000, SEED SCI RES, V10, P317, DOI 10.1017/S0960258500000362; Gupta H, 1999, PHYSIOL PLANTARUM, V106, P262; Han C, 2015, PROTEOMICS, V15, P1671, DOI 10.1002/pmic.201400375; Hasanuzzaman M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090384; Hashida SN, 2007, PLANT J, V49, P694, DOI 10.1111/j.1365-313X.2006.02989.x; Hashida SN, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23937; Hashida S, 2016, PLANT CELL PHYSIOL, V57, P2427, DOI 10.1093/pcp/pcw155; Hashida SN, 2013, MOL PLANT, V6, P216, DOI 10.1093/mp/sss071; HEWITT EJ, 1961, BIOCHEM J, V78, P384, DOI 10.1042/bj0780384; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; HONG TD, 1990, NEW PHYTOL, V116, P589, DOI 10.1111/j.1469-8137.1990.tb00543.x; Hunt L, 2004, NEW PHYTOL, V163, P31, DOI 10.1111/j.1469-8137.2004.01087.x; Hunt L, 2009, NEW PHYTOL, V181, P62, DOI 10.1111/j.1469-8137.2008.02641.x; Hunt L, 2007, PLANT J, V51, P341, DOI 10.1111/j.1365-313X.2007.03151.x; Kalemba EM, 2018, J PLANT PHYSIOL, V223, P72, DOI 10.1016/j.jplph.2018.02.010; Kalemba EM, 2012, J PLANT GROWTH REGUL, V31, P351, DOI 10.1007/s00344-011-9246-4; Kapoor D., 2019, PLANT GENE, V19, P100182, DOI [DOI 10.1016/J.PLGENE.2019.100182, 10.1016/j.plgene.2019.100182]; Kasimova MR, 2006, PLANT CELL, V18, P688, DOI 10.1105/tpc.105.039354; Kawai S, 2008, BIOSCI BIOTECH BIOCH, V72, P919, DOI 10.1271/bbb.70738; KERK NM, 1995, DEVELOPMENT, V121, P2825; Kermode Allison R., 2002, P149, DOI 10.1079/9780851995342.0149; Kocsy G, 2015, PLANT CELL ENVIRON, V38, P1008, DOI 10.1111/pce.12515; Kramer DM, 2004, TRENDS PLANT SCI, V9, P349, DOI 10.1016/j.tplants.2004.05.001; Kranner I, 2006, FREE RADICAL BIO MED, V40, P2155, DOI 10.1016/j.freeradbiomed.2006.02.013; Lim SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17056-0; Lorenc G, 1994, ACTA SOC BOT POL, V63, P167, DOI 2; Mahalingam R., 2007, PYRIDINE NUCLEOTIDE, V1, P194; Mayer AM., 1989, GERMINATION SEEDS; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; NIEHAUS WG, 1994, ARCH BIOCHEM BIOPHYS, V313, P304, DOI 10.1006/abbi.1994.1392; Nietzel T, 2020, P NATL ACAD SCI USA, V117, P741, DOI 10.1073/pnas.1910501117; Noctor G, 2006, PLANT CELL ENVIRON, V29, P409, DOI 10.1111/j.1365-3040.2005.01476.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Noctor G, 2006, J EXP BOT, V57, P1603, DOI 10.1093/jxb/erj202; Noctor G, 2018, SEMIN CELL DEV BIOL, V80, P3, DOI 10.1016/j.semcdb.2017.07.013; Palsson B, 2011, SYSTEMS BIOL SIMULAT; Pawlowski TA, 2016, J PLANT PHYSIOL, V195, P9, DOI 10.1016/j.jplph.2016.02.017; Pellny TK, 2009, MOL PLANT, V2, P442, DOI 10.1093/mp/ssp008; Petriacq P, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22477; Potters G, 2004, PLANT PHYSIOL, V134, P1479, DOI 10.1104/pp.103.033548; Pukacka S, 2007, FUNCT PLANT BIOL, V34, P601, DOI 10.1071/FP07013; Pukacka S, 2006, J PLANT PHYSIOL, V163, P1259, DOI 10.1016/j.jplph.2005.10.003; QUEBEDEAUX B, 1981, PLANT PHYSIOL, V68, P23, DOI 10.1104/pp.68.1.23; Queval G, 2007, ANAL BIOCHEM, V363, P58, DOI 10.1016/j.ab.2007.01.005; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Ratajczak E, 2019, J PLANT GROWTH REGUL, V38, P298, DOI 10.1007/s00344-018-9841-8; Ratajczak E, 2013, FUNCT PLANT BIOL, V40, P1005, DOI 10.1071/FP13002; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Selinski J, 2019, PLANT BIOLOGY, V21, P21, DOI 10.1111/plb.12869; Staszak AM, 2014, INT J MOL SCI, V15, P10868, DOI 10.3390/ijms150610868; Suszka J, 1994, SEEDS FOREST TREES C; Tommasi F, 1999, PHYSIOL PLANTARUM, V105, P193, DOI 10.1034/j.1399-3054.1999.105202.x; Tommasi F, 2001, J EXP BOT, V52, P1647, DOI 10.1093/jexbot/52.361.1647; Turner WL, 2005, BIOCHEM J, V385, P217, DOI 10.1042/BJ20040292; Waller JC, 2010, PLANTA, V231, P305, DOI 10.1007/s00425-009-1047-7; Wei T, 2017, R PACKAGE CORRPLOT V; WIGGE B, 1993, PHYSIOL PLANTARUM, V88, P10, DOI 10.1111/j.1399-3054.1993.tb01754.x; Wojciechowska N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21239197; Wojciechowska N, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9050391; Xia XJ, 2015, J EXP BOT, V66, P2839, DOI 10.1093/jxb/erv089	84	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245635	10.1371/journal.pone.0245635	http://dx.doi.org/10.1371/journal.pone.0245635			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503034	gold, Green Published			2022-12-26	WOS:000613751800046
J	Huffaker, R; Hartmann, M				Huffaker, Ray; Hartmann, Monika			Reconstructing dynamics of foodborne disease outbreaks in the US cattle market from monitoring data	PLOS ONE			English	Article								Conventional empirical studies of foodborne-disease outbreaks (FDOs) in agricultural markets are linear-stochastic formulations hardwiring a world in which markets self-correct in response to external random shocks including FDOs. These formulations were unequipped to establish whether FDOs cause market reaction, or whether markets endogenously propagate outbreaks. We applied nonlinear time series analysis (NLTS) to reconstruct annual dynamics of FDOs in US cattle markets from CDC outbreak data, live cattle futures market prices, and USDA cattle inventories from 1967-2018, and used reconstructed dynamics to detect causality. Reconstructed deterministic nonlinear market dynamics are endogenously unstable-not self-correcting, and cattle inventories drive futures prices and FDOs attributed to beef in temporal patterns linked to a multi-decadal cattle cycle undetected in daily/weekly price movements investigated previously. Benchmarking real-world dynamics with NLTS offers more informative and credible empirical modeling at the convergence of natural and economic sciences.	[Huffaker, Ray] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Hartmann, Monika] Univ Bonn, Inst Food & Resource Econ, Bonn, Germany	State University System of Florida; University of Florida; University of Bonn	Huffaker, R (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	rhuffaker@ufl.edu		Huffaker, Ray/0000-0003-3434-3709				[Anonymous], 2016, ECONOMIST; Baumgartner J, FARMERS GUIDE FOOD S; Berg E., 2015, International Journal on Food System Dynamics, V6, P64; CHAVAS JP, 1991, AM J AGR ECON, V73, P819, DOI 10.2307/1242834; CHAVAS JP, 1993, AM J AGR ECON, V75, P113, DOI 10.2307/1242959; Crutchfield S, 1995, EC ISSUES ASS FOOD S; Deyle E, 2018, P ROY SOC B-BIOL SCI, V283; Ellenberg J., 2015, NOT BE WRONG; Galtier F, 2013, GLOB FOOD SECUR-AGR, V2, P72, DOI 10.1016/j.gfs.2013.02.001; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Glendinning P, 1994, STABILITY INSTABILIT; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Gorton G, 2006, FINANC ANAL J, V62, P47, DOI 10.2469/faj.v62.n2.4083; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Greco G, 2011, SCI REP-UK, V1, DOI 10.1038/srep00091; Gregson R, 2011, INTRO NONLINEAR DYNA; Hoffman S, 2015, USDA EC INFORM B, V140; Hoover K, 2009, HDB PHILOS EC, P89; Houser M, 2018, APPL EC PERSPECTIVES, P1; Huffaker R, 2018, AGR SYST, V160, P98, DOI 10.1016/j.agsy.2016.09.019; Huffaker R, 2017, NONLINEAR TIME SERIES ANALYSIS WITH R; Huffaker R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221167; Huffaker R, 2016, ENVIRON MODELL SOFTW, V83, P74, DOI 10.1016/j.envsoft.2016.04.024; Huffaker R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115123; JENSEN RV, 1984, ECON LETT, V15, P235, DOI 10.1016/0165-1765(84)90106-X; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN D, 1995, UNDERSTANDING NONLIN; Lusk J L, 2002, AGR RESOURCE EC REV, V31, P47; McKenzie AM, 2001, J AGR RESOUR ECON, V26, P431; McLamore E, 2020, NAT SCI REP, DOI [10.1038/s41598-020-64789-5, DOI 10.1038/S41598-020-64789-5]; Medina M, 2019, WATER RESOUR RES, V55, P11101, DOI 10.1029/2018WR024427; Muir J., 1911, MY 1 SUMMER SIERRA; Nash J., 1970, J HYDROL, V10, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Ollinger M, 2003, AMBER WAVES; Origin, VERSION 2019; Palma M. A., 2010, Journal of Agricultural and Applied Economics, V42, P731; Piggott NE, 2004, AM J AGR ECON, V86, P154, DOI 10.1111/j.0092-5853.2004.00569.x; Ritter A, 2013, J HYDROL, V480, P33, DOI 10.1016/j.jhydrol.2012.12.004; Schreiber T, 1997, PHYS REV LETT, V78, P843, DOI 10.1103/PhysRevLett.78.843; Small M, 2002, PHYSICA D, V164, P187, DOI 10.1016/S0167-2789(02)00382-2; Small M, 2003, IEEE T CIRCUITS-I, V50, P663, DOI 10.1109/TCSI.2003.811020; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Theiler J., 1990, Lincoln Laboratory Journal, V3, P63; University of Connecticut, FOOD SAFETY MEAT; VantagePoint, 2020, LIVE CATTLE FUTURES; Vautard R., 1999, ANAL CLIMATE VARIABI; Vojtko R, 2019, QUANTPEDIA; Wang HH, 2017, AGRIBUSINESS, V33, P493, DOI 10.1002/agr.21501; Ye H, 2015, SCI REP-UK, V5, DOI 10.1038/srep14750	53	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0245867	10.1371/journal.pone.0245867	http://dx.doi.org/10.1371/journal.pone.0245867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	QA9GX	33503063	Green Published, gold			2022-12-26	WOS:000613751800032
J	Blanchette, RA; Held, BW; Jurgens, J; Stear, A; Dupont, C				Blanchette, Robert A.; Held, Benjamin W.; Jurgens, Joel; Stear, Amanda; Dupont, Catherine			Fungi attacking historic wood of Fort Conger and the Peary Huts in the High Arctic	PLOS ONE			English	Article							SOFT-ROT; ARCHAEOLOGICAL WOOD; DETERIORATION; DIVERSITY; PRESERVATION; DEGRADATION; ANTARCTICA; ISLAND	Historic wooden structures in Polar Regions are being adversely affected by decay fungi and a warming climate will likely accelerate degradation. Fort Conger and the Peary Huts at Lady Franklin Bay in northern Ellesmere Island are important international heritage sites associated with early exploration in the High Arctic. Fort Conger, built by Adolphus Greely and expedition members during the First International Polar Year in 1881, was dismantled and used by Robert Peary and his expedition crew in the early 1900's to build several smaller shelters. These historic structures remain at the site but are deteriorating. This investigation examines the fungi associated with wood decay in the historic woods. Soft rot was observed in all 125 wood samples obtained from the site. The major taxa found associated with the decayed wood were Coniochaeta (18%), Phoma (13%) Cadophora (12%), Graphium (9%), and Penicillium (9%) as well as many other Ascomycota that are known to cause soft rot in wood. Micromorphological observations using scanning electron microscopy of historic wooden timbers that were in ground contact revealed advanced stages of type I soft rot. No wood destroying Basidiomycota were found. Identification of the fungi associated with decay in these historic woods is a first step to better understand the unusual decomposition processes underway in this extreme environment and will aid future research to help control decay and preserve this important cultural heritage.	[Blanchette, Robert A.; Held, Benjamin W.; Jurgens, Joel; Stear, Amanda] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA; [Dupont, Catherine] Pk Canada, Nunavut Field Unit, Iqaluit, NU, Canada	University of Minnesota System; University of Minnesota Twin Cities	Blanchette, RA (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.	robertb@umn.edu		Blanchette, Robert A./0000-0003-2819-6511	National Institute for Food and Agriculture; USDA Hatch Project [MIN-22-081]	National Institute for Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA Hatch Project	RAB Funded in part by the National Institute for Food and Agriculture and USDA Hatch Project MIN-22-081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antarctic Heritage Trust, 2004, CONS PLAN SCOTTS HUT; Antarctic Heritage Trust, 2003, CONS REP SHACKL HUT; Arenz B.A., 2008, HIST POLAR BASES PRE, VXVII, P96; Arenz BE, 2011, SOIL BIOL BIOCHEM, V43, P308, DOI 10.1016/j.soilbio.2010.10.016; Arenz BE, 2011, FUNGAL DIVERS, V49, P13, DOI 10.1007/s13225-010-0079-4; Arenz BE, 2009, CAN J MICROBIOL, V55, P46, DOI 10.1139/W08-120; Berthelot C, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw144; Bertulli MM, 2013, ARCTIC, V66, P312; Biskaborn BK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08240-4; Blanchette RA, 2004, APPL ENVIRON MICROB, V70, P1328, DOI 10.1128/AEM.70.3.1328-1335.2004; BLANCHETTE RA, 1992, IAWA BULL, V13, P201, DOI 10.1163/22941932-90001269; Blanchette RA, 2000, INT BIODETER BIODEGR, V46, P189, DOI 10.1016/S0964-8305(00)00077-9; BLANCHETTE RA, 1990, ADV CHEM SER, P141; Blanchette RA, 2008, HIST POLAR BASES PRE, P96; Blanchette RA, 2016, FUNGAL ECOL, V23, P58, DOI 10.1016/j.funeco.2016.06.001; Blanchette RA, 2010, MICROB ECOL, V60, P29, DOI 10.1007/s00248-010-9664-z; CHRISTIE P, 1983, T BRIT MYCOL SOC, V80, P557, DOI 10.1016/S0007-1536(83)80059-X; Cowan, 2014, ANTARCTIC TERRESTRIA, P35, DOI DOI 10.1007/978-3-642-45213-0_3; Dawson P, 2015, SPRINGERBRIEFS ARCHA, DOI [10.1007/978-3-319-096896_11, DOI 10.1007/978-3-319-096896_11]; Dawson PC, 2013, ARCTIC, V66, P147; Dick L, 2001, MUSKOX LAND ELLESMER; Duncan CG, 1965, 48 USDA FPL FOR SERV; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Farrell RL, 2011, POLAR BIOL, V34, P1669, DOI 10.1007/s00300-011-1060-8; Feng JJ, 2020, MICROBIOME, V8, DOI 10.1186/s40168-019-0778-3; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Greely AW, 1888, REPORT P US EXPEDITI, VI, DOI [10.1126/science.ns-11.276.240-b17756896, DOI 10.1126/SCIENCE.NS-11.276.240-B17756896]; Harmsen H, 2018, CONSERV MANAGE ARCHA, V20, P175, DOI 10.1080/13505033.2018.1513303; Held BW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234208; Held BW, 2017, FUNGAL BIOL-UK, V121, P145, DOI 10.1016/j.funbio.2016.11.009; Held BW, 2006, POLAR BIOL, V29, P526, DOI 10.1007/s00300-005-0084-3; Held BW, 2011, POLAR SETTLEMENTS LO, P35; Hollesen J., 2017, PUBLIC ARCHAEOLOGY C, V1st ed., P90, DOI DOI 10.2307/J.CTVH1DP4N.14; Hollesen J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45200-4; Jurgens JA, 2009, POLAR BIOL, V32, P751, DOI 10.1007/s00300-008-0578-x; Karunasekera H, 2015, INT WOOD PROD J, V6, P189, DOI 10.1080/20426445.2015.1104077; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Laursen GA, 1997, ARCTIC ALPINE RES, V29, P483, DOI 10.2307/1551996; Matthiesen H, 2014, ARCHAEOMETRY, V56, P479, DOI 10.1111/arcm.12023; McBean G, 2005, ARCTIC CLIMATE IMPAC, P21; Newsham KK, 2009, FUNGAL ECOL, V2, P10, DOI 10.1016/j.funeco.2008.10.005; Nilsson T., 1973, STUD FOR SUEC, V104, P1; Ormsby A, 2007, CAN J BOT, V85, P599, DOI 10.1139/B07-044; Panshin AJ, 1970, TXB WOOD TECHNOLOGY, V1; PEDERSEN NB, 2020, SCI REP, V10, DOI DOI 10.1038/S41598-020-71245-X32873836; Upson R, 2008, ARCT ANTARCT ALP RES, V40, P592, DOI 10.1657/1523-0430(07-057)[UPSON]2.0.CO;2; ZABEL RA, 1991, WOOD FIBER SCI, V23, P220; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	48	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2021	16	1							e0246049	10.1371/journal.pone.0246049	http://dx.doi.org/10.1371/journal.pone.0246049			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA8QK	33497418	gold, Green Published			2022-12-26	WOS:000613707100031
J	Cheng, MM; Yu, L; Gao, JB; Lei, GL; Zhang, ZW				Cheng, Mingming; Yu, Long; Gao, Jianbo; Lei, Guanglun; Zhang, Zaiwang			Isolating, identifying and evaluating of oil degradation strains for the air-assisted microbial enhanced oil recovery process	PLOS ONE			English	Article							BACILLUS; TEMPERATURE	Due to the inefficient reproduction of microorganisms in oxygen-deprived environments of the reservoir, the applications of microbial enhanced oil recovery (MEOR) are restricted. To overcome this problem, a new type of air-assisted MEOR process was investigated. Three compounding oil degradation strains were screened using biochemical experiments. Their performances in bacterial suspensions with different amounts of dissolved oxygen were evaluated. Water flooding, microbial flooding and air-assisted microbial flooding core flow experiments were carried out. Carbon distribution curve of biodegraded oil with different oxygen concentration was determined by chromatographic analysis. The long-chain alkanes are degraded by microorganisms. A simulation model was established to take into account the change in oxygen concentration in the reservoir. The results showed that the optimal dissolved oxygen concentration for microbial growth was 4.5 similar to 5.5mg/L. The main oxygen consumption in the reservoir happened in the stationary and declining phases of the microbial growth systems. In order to reduce the oxygen concentration to a safe level, the minimum radius of oxygen consumption was found to be about 145m. These results demonstrate that the air-assisted MEOR process can overcome the shortcomings of traditional microbial flooding techniques. The findings of this study can help for better understanding of microbial enhanced oil recovery and improving the efficiency of microbial oil displacement.	[Cheng, Mingming; Zhang, Zaiwang] Binzhou Univ, Inst Chem & Safety Engn, Binzhou, Shandong, Peoples R China; [Yu, Long] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore, Singapore; [Gao, Jianbo] Binzhou Ind & Informat Bur, Binzhou, Peoples R China; [Lei, Guanglun] China Univ Petr East China, Inst Petr Engn, Qingdao, Shandong, Peoples R China	Binzhou University; National University of Singapore; China University of Petroleum	Cheng, MM (corresponding author), Binzhou Univ, Inst Chem & Safety Engn, Binzhou, Shandong, Peoples R China.	Rachel19cheng@163.com			National Natural Science Foundation of China [51604291]; Natural Science Foundation of Shandong Province [ZR2017PEE003, 2016ZRB01A57]; Binzhou university [2016Y31, 16CX02010A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Binzhou university	This research was supported by the National Natural Science Foundation of China (Grant No. 51604291), the Natural Science Foundation of Shandong Province (Grant No. ZR2017PEE003), the Natural Science Foundation of Shandong Province (Grant No. 2016ZRB01A57), the Fundamental Research Project of doctor Funded by Binzhou university (Grant 2016Y31), the Seed Fundamental Research Funded by Binzhou university (Grant No. 16CX02010A)	Anbalagan S, 2020, J CLEAN PROD, P120777; [Anonymous], 2017, RHEUMATOLOGY, V56, pe22; Baker BJ, 2006, SCIENCE, V314, P1933, DOI 10.1126/science.1132690; Banat IM, 2010, APPL MICROBIOL BIOT, V87, P427, DOI 10.1007/s00253-010-2589-0; Bodtker G, 2009, J IND MICROBIOL BIOT, V36, P439, DOI 10.1007/s10295-008-0515-6; Cheng MM, 2014, ENERG FUEL, V28, P6655, DOI 10.1021/ef5014083; Cheng MM, 2014, CHEM ENG 3 P 3 SREE, P135; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Greaves M, 2000, J CANADIAN PETROLEUM, V39, P124; Hassan A, 2020, J MOL LIQ, P113095; Karimi M, 2012, COLLOID SURFACE B, V95, P129, DOI 10.1016/j.colsurfb.2012.02.035; Kaster KM, 2012, TRANSPORT POROUS MED, V91, P59, DOI 10.1007/s11242-011-9833-7; Nazina TN, 2007, MICROBIOLOGY+, V76, P287, DOI 10.1134/S0026261707030058; Nguyen TT, 2008, WATER RES, V42, P1735, DOI 10.1016/j.watres.2007.10.038; Pathak KV, 2014, 3 BIOTECH, V4, P283, DOI 10.1007/s13205-013-0151-3; Rangarajan V, 2015, BIOCHEM ENG J, V99, P147, DOI 10.1016/j.bej.2015.03.016; Santisi S, 2015, BRAZ J MICROBIOL, V46, P377, DOI 10.1590/S1517-838246120131276; Simpson DR, 2011, APPL MICROBIOL BIOT, V91, P1083, DOI 10.1007/s00253-011-3326-z; Sugai Y, 2012, J NAT GAS SCI ENG, V5, P31, DOI 10.1016/j.jngse.2012.01.011; Ugwu CU, 2007, PHOTOSYNTHETICA, V45, P309, DOI 10.1007/s11099-007-0052-y; Walmsley R.M., 2000, BIOTECHNOL BIOPROC E, V5, P387; Wang JJ, 2016, FUEL, V172, P37, DOI 10.1016/j.fuel.2015.12.069; Wang J, 2008, J IND MICROBIOL BIOT, V35, P619, DOI 10.1007/s10295-008-0326-9; Wang T, 2019, ENVIRONMENTS, V6, DOI 10.3390/environments6030034; Yu Hong-min, 2010, Journal of China University of Petroleum, V34, P99, DOI 10.3969/j.issn.1673-5005.2010.06.019; Zhi-Yuan W, 2012, ENVIRONMENT, V18, P123; Zhu HB, 2013, ENVIRON SCI TECHNOL, V47, P8970, DOI 10.1021/es401838b	27	2	2	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0243976	10.1371/journal.pone.0243976	http://dx.doi.org/10.1371/journal.pone.0243976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493159	gold, Green Published			2022-12-26	WOS:000613081500056
J	Kaiser, RA; Carlson, DF; Allen, KL; Webster, DA; VanLith, CJ; Nicolas, CT; Hillin, LG; Yu, Y; Kaiser, CW; Wahoff, WR; Hickey, RD; Watson, AL; Winn, SR; Thony, B; Kern, DR; Harding, CO; Lillegard, JB				Kaiser, Robert A.; Carlson, Daniel F.; Allen, Kari L.; Webster, Dennis A.; VanLith, Caitlin J.; Nicolas, Clara T.; Hillin, Lori G.; Yu, Yue; Kaiser, Catherine W.; Wahoff, William R.; Hickey, Raymond D.; Watson, Adrienne L.; Winn, Shelley R.; Thony, Beat; Kern, Douglas R.; Harding, Cary O.; Lillegard, Joseph B.			Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing	PLOS ONE			English	Article							METABOLIC SYNDROME; PHENYLALANINE; DEFICIENCY; DOPAMINE; CELLS; MICE	Phenylketonuria (PKU) is a metabolic disorder whereby phenylalanine metabolism is deficient due to allelic variations in the gene for phenylalanine hydroxylase (PAH). There is no cure for PKU other than orthotopic liver transplantation, and the standard of care for patients is limited to dietary restrictions and key amino acid supplementation. Therefore, Pah was edited in pig fibroblasts for the generation of PKU clone piglets that harbor a common and severe human mutation, R408W. Additionally, the proximal region to the mutation was further humanized by introducing 5 single nucleotide polymorphisms (SNPs) to allow for development of gene editing machinery that could be translated directly from the pig model to human PKU patients that harbor at least one classic R408W allele. Resulting piglets were hypopigmented (a single Ossabaw piglet) and had low birthweight (all piglets). The piglets had similar levels of PAH expression, but no detectable enzymatic activity, consistent with the human phenotype. The piglets were fragile and required extensive neonatal care to prevent failure to thrive and early demise. Phenylalanine levels rose sharply when dietary Phe was unrestricted but could be rapidly reduced with a low Phe diet. Fibroblasts isolated from R408W piglets show susceptibility to correction using CRISPR or TALEN, with subsequent homology-directed recombination to correct Pah. This pig model of PKU provides a powerful new tool for development of all classes of therapeutic candidates to treat or cure PKU, as well as unique value for proof-of-concept studies for in vivo human gene editing platforms in the context of this humanized PKU allele.	[Kaiser, Robert A.; Allen, Kari L.; VanLith, Caitlin J.; Nicolas, Clara T.; Hillin, Lori G.; Yu, Yue; Kaiser, Catherine W.; Wahoff, William R.; Hickey, Raymond D.; Lillegard, Joseph B.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Kaiser, Robert A.; Lillegard, Joseph B.] Childrens Hosp & Clin Minnesota, Midwest Fetal Care Ctr, Minneapolis, MN 55404 USA; [Carlson, Daniel F.; Webster, Dennis A.; Watson, Adrienne L.; Kern, Douglas R.] Recombinetics Inc, St Paul, MN USA; [Nicolas, Clara T.] Univ Barcelona, Fac Med, Barcelona, Spain; [Hickey, Raymond D.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Winn, Shelley R.; Harding, Cary O.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Thony, Beat] Univ Zurich, Dept Pediat, Zurich, Switzerland; [Lillegard, Joseph B.] Pediat Surg Associates, Minneapolis, MN 55404 USA	Mayo Clinic; Children's Hospitals & Clinics of Minnesota; University of Barcelona; Mayo Clinic; Oregon Health & Science University; University of Zurich	Lillegard, JB (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55905 USA.; Lillegard, JB (corresponding author), Childrens Hosp & Clin Minnesota, Midwest Fetal Care Ctr, Minneapolis, MN 55404 USA.; Lillegard, JB (corresponding author), Pediat Surg Associates, Minneapolis, MN 55404 USA.	jlillegard@msn.com	Watson, Adrienne L/GRO-1978-2022	Watson, Adrienne L/0000-0002-9752-3689; Allen, Kari/0000-0001-8311-6508; Kaiser, Robert/0000-0003-1411-1513	Children's Hospital of Minnesota Foundation; NIH SBIR Phase I [1R43OD021314-01A1]	Children's Hospital of Minnesota Foundation; NIH SBIR Phase I(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Children's Hospital of Minnesota Foundation, the Children's Hospital of Minnesota Foundation, and additional funding was provided by NIH SBIR Phase I; 1R43OD021314-01A1, awarded to Drs. Carlson and Harding. Individual authors in this study are employed by Recombinetics, Inc., which provided support in the form of salaries for authors DRK, DFC, ALW, and DAW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Al Hafid N, 2015, TRANSL PEDIATR, V4, P304, DOI 10.3978/j.issn.2224-4336.2015.10.07; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bayat A, 2016, CLIN GENET, V90, P247, DOI 10.1111/cge.12692; Belanger-Quintana A, 2011, MOL GENET METAB, V104, pS19, DOI 10.1016/j.ymgme.2011.08.009; Blau N, 1999, J INHERIT METAB DIS, V22, P216, DOI 10.1023/A:1005584627797; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Carlson DF, 2011, TRANSGENIC RES, V20, P29, DOI 10.1007/s11248-010-9386-5; Dyson MC, 2006, COMPARATIVE MED, V56, P35; EISENSMITH RC, 1995, AM J HUM GENET, V56, P278; Elzaouk L, 2003, J BIOL CHEM, V278, P28303, DOI 10.1074/jbc.M303986200; Giannattasio S, 1997, HUM HERED, V47, P155, DOI 10.1159/000154403; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hamman K, 2005, MOL THER, V12, P337, DOI 10.1016/j.ymthe.2005.03.025; Harding CO, 2014, J INHERIT METAB DIS, V37, P735, DOI 10.1007/s10545-013-9675-2; Harding CO, 2010, J INHERIT METAB DIS, V33, P681, DOI 10.1007/s10545-010-9099-1; Harding CO, 1998, GENE THER, V5, P677, DOI 10.1038/sj.gt.3300653; Himmelreich N, 2018, MOL GENET METAB, V125, P86, DOI 10.1016/j.ymgme.2018.06.011; Jacobi AM, 2017, METHODS, V121, P16, DOI 10.1016/j.ymeth.2017.03.021; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; LEDLEY FD, 1987, SOMAT CELL MOLEC GEN, V13, P145, DOI 10.1007/BF01534694; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Loeber JG, 2007, J INHERIT METAB DIS, V30, P430, DOI 10.1007/s10545-007-0644-5; MATALON R, 1991, CLIN BIOCHEM, V24, P337, DOI 10.1016/0009-9120(91)80008-Q; ONEILL CA, 1994, ACTA PAEDIATR, V83, P43, DOI 10.1111/j.1651-2227.1994.tb13448.x; Schmidt M, 2015, THERIOGENOLOGY, V84, P1014, DOI 10.1016/j.theriogenology.2015.05.037; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Tighe O, 2003, HUM MUTAT, V21, P387, DOI 10.1002/humu.10195; Winn SR, 2018, MOL GENET METAB, V123, P6, DOI 10.1016/j.ymgme.2017.10.009; Yuan F, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.006207; Zabaleta N, 2019, HUM GENE THER, V30, P1190, DOI 10.1089/hum.2019.140; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x	33	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2021	16	1							e0245831	10.1371/journal.pone.0245831	http://dx.doi.org/10.1371/journal.pone.0245831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ9QF	33493163	Green Published, gold, Green Accepted			2022-12-26	WOS:000613081500049
J	Capistran, MA; Capella, A; Christen, JA				Capistran, Marcos A.; Capella, Antonio; Andres Christen, J.			Forecasting hospital demand in metropolitan areas during the current COVID-19 pandemic and estimates of lockdown-induced 2nd waves	PLOS ONE			English	Article							EPIDEMIC; LESSONS; MODEL; DISTRIBUTIONS; OUTBREAK	We present a forecasting model aim to predict hospital occupancy in metropolitan areas during the current COVID-19 pandemic. Our SEIRD type model features asymptomatic and symptomatic infections with detailed hospital dynamics. We model explicitly branching probabilities and non-exponential residence times in each latent and infected compartments. Using both hospital admittance confirmed cases and deaths, we infer the contact rate and the initial conditions of the dynamical system, considering breakpoints to model lockdown interventions and the increase in effective population size due to lockdown relaxation. The latter features let us model lockdown-induced 2nd waves. Our Bayesian approach allows us to produce timely probabilistic forecasts of hospital demand. We have applied the model to analyze more than 70 metropolitan areas and 32 states in Mexico.	[Capistran, Marcos A.; Andres Christen, J.] CIMAT, Ctr Invest Matemat, Guanajuato, Mexico; [Capella, Antonio] UNAM, Inst Matemat, Cdmx, Mexico	CIMAT - Centro de Investigacion en Matematicas; Universidad Nacional Autonoma de Mexico	Capistran, MA (corresponding author), CIMAT, Ctr Invest Matemat, Guanajuato, Mexico.	marcos@cimat.mx		Capistran, Marcos/0000-0002-7891-6380; Christen, J Andres/0000-0002-5795-4345	CONACYT [CB-2016-01-284451, COVID19 312772]; UNAM [PAPPIT-IN106118]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM(Universidad Nacional Autonoma de Mexico)	The authors are partially funded by CONACYT CB-2016-01-284451 and COVID19 312772 grants. AC was partially supported by UNAM PAPPIT-IN106118 grant.	Ahmed A., 2020, NEW YORK TIMES; Christen JA, 2010, BAYESIAN ANAL, V5, P263, DOI 10.1214/10-BA60; [Anonymous], 2020, PRELIMINARY ESTIMATE, DOI [10.15585/mmwr.mm6919e5, DOI 10.15585/MMWR.MM6919E5]; Bhatia S, 2020, SHORT TERM FORECASTS; Champredon D, 2018, SIAM J APPL MATH, V78, P3258, DOI 10.1137/18M1186411; Cordova-Villalobos JA, 2017, GAC MED MEX, V153, P102; COVID I, 2020, FORECASTING IMPACT 1; Daunizeau J, 2020, MODELLING LOCKDOWN I, DOI [10.1126/science.abb6936, DOI 10.1126/SCIENCE.ABB6936]; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Domenico LD., 2020, EXPECTED IMPACT REOP, DOI [10.1101/2020.05.08.20095521, DOI 10.1101/2020.05.08.20095521]; Eksin C, 2019, EPIDEMICS-NETH, V27, P96, DOI 10.1016/j.epidem.2019.02.004; Emanuel EJ, 2003, ANN INTERN MED, V139, P589, DOI 10.7326/0003-4819-139-7-200310070-00011; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fang YC, 2020, RADIOLOGY, V296, pE115, DOI 10.1148/radiol.2020200432; Ferguson NM, 2020, IMPACT NONPHARMACETI, V16; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Ha KM, 2016, J HOSP INFECT, V92, P232, DOI 10.1016/j.jhin.2015.10.004; Henderson M, 2020, COVID ACT NOW; Hoffman SJ, 2018, AM J PUBLIC HEALTH, V108, P329, DOI [10.2105/ajph.2017.304245, 10.2105/AJPH.2017.304245]; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Karin Omer, 2020, MEDRXIV, DOI [10.1101/2020.04.04.20053579, DOI 10.1101/2020.04.04.20053579]; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Linden A, 2011, ECOLOGY, V92, P1414, DOI 10.1890/10-1831.1; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Oden JT, 2010, SIAM NEWS, V43, P1; Park SW, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2020.0144; Perra N, 2015, COMPUT SOC SCI, P59, DOI 10.1007/978-3-319-14011-7_4; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Silal S, 2020, ESTIMATING CASES COV; Singh V. P., 1986, Advances in Water Resources, V9, P91, DOI 10.1016/0309-1708(86)90015-1; Verity R, 2020, ESTIMATES SEVERITY C, DOI DOI 10.1101/2020.03.09.20033357; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang WD, 2006, MATH BIOSCI ENG, V3, P267; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3; Weitz JS, 2020, MOVING PEAK MENTALIT; Yamana T., 2020, PROJECTION COVID 19, DOI 10.1101/2020.05.04.20090670; Zarebski Alexander E, 2017, Infect Dis Model, V2, P56, DOI 10.1016/j.idm.2016.12.004; Zhou X, 2020, CLIN MICROBIOL INFEC, V26, P957, DOI 10.1016/j.cmi.2020.03.024	45	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245669	10.1371/journal.pone.0245669	http://dx.doi.org/10.1371/journal.pone.0245669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481925	gold, Green Published, Green Submitted			2022-12-26	WOS:000612929300112
J	Coelho, AC; Pires, R; Schutz, G; Santa, C; Manadas, B; Pinto, P				Coelho, Ana Cristina; Pires, Rosa; Schutz, Gabriela; Santa, Catia; Manadas, Bruno; Pinto, Patricia			Disclosing proteins in the leaves of cork oak plants associated with the immune response to Phytophthora cinnamomi inoculation in the roots: A long-term proteomics approach	PLOS ONE			English	Article							ACETOACETYL-COA THIOLASE; QUERCUS-SUBER L.; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; MANAGEMENT OPTIONS; DISEASE RESISTANCE; GLYCOLATE OXIDASE; GENE-EXPRESSION; JASMONIC ACID; CLP PROTEASE	The pathological interaction between oak trees and Phytophthora cinnamomi has implications in the cork oak decline observed over the last decades in the Iberian Peninsula. During host colonization, the phytopathogen secretes effector molecules like elicitins to increase disease effectiveness. The objective of this study was to unravel the proteome changes associated with the cork oak immune response triggered by P. cinnamomi inoculation in a long-term assay, through SWATH-MS quantitative proteomics performed in the oak leaves. Using the Arabidopis proteome database as a reference, 424 proteins were confidently quantified in cork oak leaves, of which 80 proteins showed a p-value below 0.05 or a fold-change greater than 2 or less than 0.5 in their levels between inoculated and control samples being considered as altered. The inoculation of cork oak roots with P. cinnamomi increased the levels of proteins associated with protein-DNA complex assembly, lipid oxidation, response to endoplasmic reticulum stress, and pyridine-containing compound metabolic process in the leaves. In opposition, several proteins associated with cellular metabolic compound salvage and monosaccharide catabolic process had significantly decreased abundances. The most significant abundance variations were observed for the Ribulose 1,5-Bisphosphate Carboxylase small subunit (RBCS1A), Heat Shock protein 90-1 (Hsp90-1), Lipoxygenase 2 (LOX2) and Histone superfamily protein H3.3 (A8MRLO/At4G40030) revealing a pertinent role for these proteins in the host-pathogen interaction mechanism. This work represents the first SWATH-MS analysis performed in cork oak plants inoculated with P. cinnamomi and highlights host proteins that have a relevant action in the homeostatic states that emerge from the interaction between the oomycete and the host in the long term and in a distal organ.	[Coelho, Ana Cristina; Pires, Rosa; Schutz, Gabriela] Univ Algarve, Ctr Elect Optoelect & Telecommun CEOT, Faro, Portugal; [Coelho, Ana Cristina] Univ Algarve, Escola Super Educ & Comunicacao ESEC, Faro, Portugal; [Schutz, Gabriela] Univ Algarve, Inst Super Engn, Faro, Portugal; [Santa, Catia; Manadas, Bruno] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Santa, Catia] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal; [Pinto, Patricia] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal	Universidade do Algarve; Universidade do Algarve; Universidade do Algarve; Universidade de Coimbra; Universidade de Coimbra; Universidade do Algarve	Coelho, AC (corresponding author), Univ Algarve, Ctr Elect Optoelect & Telecommun CEOT, Faro, Portugal.; Coelho, AC (corresponding author), Univ Algarve, Escola Super Educ & Comunicacao ESEC, Faro, Portugal.	acoelho@ualg.pt	Santa, Cátia/AAJ-7151-2021; Coelho, Ana Cristina H. M./E-4606-2012; Pires, Rosa/AAJ-1818-2021; Manadas, Bruno/A-7667-2012; de Castro Schütz, Maria Gabriela Figueiredo/O-5305-2015; Pinto, Patricia IS/M-3817-2013	Santa, Cátia/0000-0002-7854-1670; Pires, Rosa/0000-0002-7456-9414; Manadas, Bruno/0000-0002-2087-4042; de Castro Schütz, Maria Gabriela Figueiredo/0000-0001-5081-3913; Coelho, Ana Cristina/0000-0002-2919-5468; Pinto, Patricia IS/0000-0001-7854-3898	FCT [UID/Multi/00631/2013, UID/Multi/00631/2019, UIDB/00631/2020, UIDB/04326/2020, SFRH/BPD/84033/2012]; University of Algarve [DL57/2016/CP1361/CT0015]; NIBAP [ALG-01-0247-FEDER-037303, POCI-01-0145-FEDER-007440, UIDB/04539/2020, POCI-01-0145-FEDER-016428, SAICTPAC/0010/2015, POCI-01-0145FEDER-029311, PTDC/BTM-TEC/29311/2017, POCI-01-0145-FEDER-30943, PTDC/MECPSQ/30943/2017, PTDC/MED-NEU/27946/2017]; National Mass Spectrometry Network (RNEM) [POCI-01-0145-FEDER-402-022125, ROTEIRO/0028/2013]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Algarve; NIBAP; National Mass Spectrometry Network (RNEM)	This work was financially supported by FCT, integrated in projects UID/Multi/00631/2013, UID/Multi/00631/2019 and UIDB/00631/2020 CEOT BASE to CEOT and ACC, GS and RP; UIDB/04326/2020 to CCMAR; fellowship SFRH/BPD/84033/2012 and researcher contract with the University of Algarve under Norma Transito ' riaDL57/2016/CP1361/CT0015 to PP; contract NIBAP (ALG-01-0247-FEDER-037303) to RP; projects POCI-01-0145-FEDER-007440 (Ref. UIDB/04539/2020), POCI-01-0145-FEDER-016428 (Ref. SAICTPAC/0010/2015), POCI-01-0145FEDER-029311 (Ref. PTDC/BTM-TEC/29311/2017), POCI-01-0145-FEDER-30943 (Ref. PTDC/MECPSQ/30943/2017) and PTDC/MED-NEU/27946/2017 to CNC, BM and CS. The work at CNC was also funded by the National Mass Spectrometry Network (RNEM) under contract POCI-01-0145-FEDER-402-022125 (Ref. ROTEIRO/0028/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada I, 2008, FUNCT PLANT BIOL, V35, P1100, DOI 10.1071/FP08012; Aizat WM, 2018, PEERJ, V6, DOI 10.7717/peerj.5525; Anjo SI, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600278; Anjo SI, 2015, PROTEOMICS, V15, P757, DOI 10.1002/pmic.201400221; Arosa ML, 2017, ECOL MODEL, V343, P68, DOI 10.1016/j.ecolmodel.2016.10.008; Avila JM, 2017, EUR J FOREST RES, V136, P677, DOI 10.1007/s10342-017-1064-1; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camilo-Alves CDEP, 2013, EUR J FOREST RES, V132, P411, DOI 10.1007/s10342-013-0688-z; Camilo-Alves CSP, 2017, NEW FOREST, V48, P753, DOI 10.1007/s11056-017-9595-3; Caplan JL, 2015, DEV CELL, V34, P45, DOI 10.1016/j.devcel.2015.05.011; Carrie C, 2007, PLANT MOL BIOL, V63, P97, DOI 10.1007/s11103-006-9075-1; Cha JY, 2013, PLANT PHYSIOL BIOCH, V70, P368, DOI 10.1016/j.plaphy.2013.05.039; CHEN MX, 2020, TRENDS BIOTECHNOL, DOI DOI 10.1016/J.TIBTECH.2020.09; Clarke AK, 2012, PHYSIOL PLANTARUM, V145, P235, DOI 10.1111/j.1399-3054.2011.01541.x; Coelho AC, 2006, SILVAE GENET, V55, P105, DOI 10.1515/sg-2006-0016; Coelho AC, 1997, MYCOL RES, V101, P1499, DOI 10.1017/S0953756297004711; Coelho AC, 2011, NZ J FORESTRY SCI, P143; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Engelbrecht Juanita, 2013, S. Afr. j. sci., V109, P1; Everard J.., 2017, ENCYCL APPL PLANT SC, V1, P96, DOI [10.1016/B978-0-12-394807-6.00095-2, DOI 10.1016/B978-0-12-394807-6.00095-2]; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Gao QM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00228; Gascuel Q, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01887; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Hardham AR, 2018, MOL PLANT PATHOL, V19, P260, DOI 10.1111/mpp.12568; Hardoim PR, 2016, FOREST PATHOL, V46, P122, DOI 10.1111/efp.12229; Henriques Joana, 2014, Silva Lus., V22, P83; Horta M, 2010, EUR J PLANT PATHOL, V127, P427, DOI 10.1007/s10658-010-9609-x; Horta M, 2008, PHYSIOL MOL PLANT P, V73, P48, DOI 10.1016/j.pmpp.2009.02.003; Huang S, 2014, PLANT J, V79, P427, DOI 10.1111/tpj.12573; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Islam MT, 2019, PHYSIOL MOL PLANT P, V107, P21, DOI 10.1016/j.pmpp.2019.04.003; Isserlin R, 2014, F1000RES, P3; Izumi M, 2012, J EXP BOT, V63, P2159, DOI 10.1093/jxb/err434; Jin HN, 2012, PLANT J, V70, P1015, DOI 10.1111/j.1365-313X.2012.04942.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kim M, 2006, PLANT CELL, V18, P2341, DOI 10.1105/tpc.106.041509; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kong L, 2017, CURR BIOL, V27, P981, DOI 10.1016/j.cub.2017.02.044; Kumar AS, 2018, ELIFE, V7, DOI 10.7554/eLife.23625; Lee JH, 2018, MOL PLANT MICROBE IN, V31, P356, DOI [10.1094/MPMI-07-17-0156-R, 10.1094/mpmi-07-17-0156-r]; Liu J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26666-0; Lu W, 2012, GENE, V503, P65, DOI 10.1016/j.gene.2012.04.042; Maksimov V, 2016, PLANT J, V88, P425, DOI 10.1111/tpj.13263; Marri L, 2005, J EXP BOT, V56, P73, DOI 10.1093/jxb/eri020; Maurino Veronica G, 2015, Arabidopsis Book, V13, pe0182, DOI 10.1199/tab.0182; Mendes MP, 2016, FOREST ECOL MANAG, V378, P122, DOI 10.1016/j.foreco.2016.07.024; Meyer FE, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00191; Mhamdi A, 2010, PLANT CELL ENVIRON, V33, P1112, DOI 10.1111/j.1365-3040.2010.02133.x; Moreno JC, 2018, PLANT PHYSIOL, V176, P1485, DOI 10.1104/pp.17.01635; Moricca S, 2016, PLANT DIS, V100, P2184, DOI 10.1094/PDIS-03-16-0408-FE; Nejat N, 2017, CRIT REV BIOTECHNOL, V37, P229, DOI 10.3109/07388551.2015.1134437; Nie X, 2014, BIOL OPEN, V3, P794, DOI 10.1242/bio.20148680; Pinto PIS, 2019, DATA BRIEF, V27, DOI 10.1016/j.dib.2019.104587; Pinto PIS, 2019, J STEROID BIOCHEM, V195, DOI 10.1016/j.jsbmb.2019.105448; Pollmann S, 2019, J EXP BOT, V70, P1483, DOI 10.1093/jxb/erz015; Ramos AM, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.69; Rojas CM, 2012, PLANT SIGNAL BEHAV, V7, P752, DOI 10.4161/psb.20429; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Sahu PP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27078; Santos C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00515; Serrazina S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0829-7; Sghaier-Hammami B, 2013, PLANT PHYSIOL BIOCH, V71, P191, DOI 10.1016/j.plaphy.2013.06.030; Serrano MS, 2015, PHYTOPATHOL MEDITERR, V54, P461; Sokol A, 2007, PLANTA, V227, P245, DOI 10.1007/s00425-007-0612-1; Song TQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005348; Srivastava R, 2013, PLANT CELL, V25, P1416, DOI 10.1105/tpc.113.110684; Stary T, 2019, PLANTA, V249, P739, DOI 10.1007/s00425-018-3036-1; Suty L, 2003, INT J BIOCHEM CELL B, V35, P637, DOI 10.1016/S1357-2725(02)00386-2; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tanaka S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00349; Tiberi R, 2016, ANN FOREST SCI, V73, P219, DOI 10.1007/s13595-015-0534-1; Trujillo M, 2010, CURR OPIN PLANT BIOL, V13, P402, DOI 10.1016/j.pbi.2010.04.002; van den Berg N, 2018, PLANT PATHOL, V67, P1150, DOI 10.1111/ppa.12819; van den Berg N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205705; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Vessella F, 2017, EUR J FOREST RES, V136, P555, DOI 10.1007/s10342-017-1055-2; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Wang HY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020409; Wollmann H, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1221-3; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Xu YP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27000-4; Zhang H, 2016, PROTEOMICS, V16, P989, DOI 10.1002/pmic.201500248; Zhao ZX, 2011, J EXP BOT, V62, P5179, DOI 10.1093/jxb/err223; Zhou JM, 2000, MOL PLANT MICROBE IN, V13, P191, DOI 10.1094/MPMI.2000.13.2.191; Zhu FY, 2020, TRENDS PLANT SCI, V25, P1171, DOI 10.1016/j.tplants.2020.07.014; Zhu FY, 2018, J PROTEOMICS, V187, P161, DOI 10.1016/j.jprot.2018.07.014; Zhu FY, 2016, J PROTEOME RES, V15, P3528, DOI 10.1021/acs.jproteome.6b00258	96	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245148	10.1371/journal.pone.0245148	http://dx.doi.org/10.1371/journal.pone.0245148			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481834	gold, Green Published			2022-12-26	WOS:000612929300029
J	Hutto, D; Barrett, K				Hutto, David, Jr.; Barrett, Kyle			Do urban open spaces provide refugia for frogs in urban environments?	PLOS ONE			English	Article							SPECIES RICHNESS; HABITAT LOSS; LAND-USE; URBANIZATION; PATTERNS; FRAGMENTATION; CONSERVATION; BIODIVERSITY; COMMUNITIES; AMPHIBIANS	Urbanization is among the largest threats to wildlife populations through factors such as fragmentation, isolation, and habitat destruction. Urban open spaces, such as parks and golf courses, have the potential to provide wildlife with suitable habitat within an urbanized matrix. These refugia may be particularly important for amphibians, which represent one of the most endangered and least vagile vertebrate groups on earth. During the spring and summer of 2018, we conducted surveys to determine the presence of anurans at 51 wetland sites within the Piedmont ecoregion of South Carolina. Nearly one-third of these wetlands were located within urban open spaces, one-third in low development areas, and one-third in highly developed areas. Impervious surface and total road length surrounding the wetlands were measured at two scales, a core habitat scale (300 m) and average maximum migration scale (750 m), and we measured several within-wetland habitat variables. Urban Open Space wetlands had levels of surrounding impervious surface similar to High Urbanization wetlands at the larger scale and were intermediate between Low and High Urbanization wetlands at the smaller scale. The total length of road segments occurring within buffers (at both scales) surrounding our study wetlands was higher for Urban Open Space compared to Low and High Urbanization sites. Among the within-wetland variables measured, Low Urbanization sites had higher canopy cover and were more likely to have a terrestrial buffer zone relative to the other categories. Species richness decreased significantly as total road length increased among all wetlands. Wetland category was not a significant driver explaining species richness, but beta-diversity was more variable among Urban Open Space wetlands than either Low or High Urbanization wetlands. Urban Open Space wetlands did not appear to increase suitability for anurans relative to High Urbanization wetlands. Urban Open Space wetlands had higher variability in species composition, which was perhaps attributable to the diversity among sites represented in the Urban Open Space category.	[Hutto, David, Jr.; Barrett, Kyle] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA		Hutto, D (corresponding author), Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC 29634 USA.	drhutto88@gmail.com			South Carolina Wildlife Federation; Riverbanks Conservation Support Fund; D. L. Scurry Foundation; Margaret H. Lloyd-SmartState Endowment	South Carolina Wildlife Federation; Riverbanks Conservation Support Fund; D. L. Scurry Foundation; Margaret H. Lloyd-SmartState Endowment	A funding scholarship was provided to DH from the South Carolina Wildlife Federation in association with The Riverbanks Conservation Support Fund and The D. L. Scurry Foundation (http://www.scwf.org/scholarships/).The authors also acknowledge the support of Margaret H. Lloyd-SmartState Endowment to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrey C, 2014, URBAN STUD, V51, P1290, DOI 10.1177/0042098013494417; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baillie J.E.M., 2004, IUCN RED LIST THREAT; Barrett K, 2014, FRESHW SCI, V33, P927, DOI 10.1086/677556; Birx-Raybuck Devynn A., 2010, Urban Ecosystems, V13, P181, DOI 10.1007/s11252-009-0116-9; Bock CE, 2002, CONSERV BIOL, V16, P1653, DOI 10.1046/j.1523-1739.2002.01291.x; Boughton RG, 2000, AM MIDL NAT, V144, P168, DOI 10.1674/0003-0031(2000)144[0168:UOPPRA]2.0.CO;2; Brand AB, 2010, CONSERV BIOL, V24, P295, DOI 10.1111/j.1523-1739.2009.01301.x; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; Calhoun Aram J. K., 2005, Wetlands Ecology and Management, V13, P291, DOI 10.1007/s11273-004-7523-8; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Denys C, 1998, OECOLOGIA, V113, P269, DOI 10.1007/s004420050378; Donnelly R., 2002, THESIS; Dorcas M., 2008, FROGS TOADS SE; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Eigenbrod F, 2008, LANDSCAPE ECOL, V23, P159, DOI 10.1007/s10980-007-9174-7; FAHRIG L, 1995, BIOL CONSERV, V73, P177, DOI 10.1016/0006-3207(94)00102-V; Findlay CS, 2001, ECOSCIENCE, V8, P336, DOI 10.1080/11956860.2001.11682661; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Gagne SA, 2010, ENVIRON CONSERV, V37, P128, DOI 10.1017/S0376892910000421; Germaine SS, 1998, ECOL APPL, V8, P680, DOI 10.1890/1051-0761(1998)008[0680:RABBHA]2.0.CO;2; Goddard MA, 2010, TRENDS ECOL EVOL, V25, P90, DOI 10.1016/j.tree.2009.07.016; Hamer AJ, 2008, BIOL CONSERV, V141, P2432, DOI 10.1016/j.biocon.2008.07.020; Hamer AJ, 2012, URBAN ECOSYST, V15, P451, DOI 10.1007/s11252-011-0212-5; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Hecnar SJ, 1998, J BIOGEOGR, V25, P763, DOI 10.1046/j.1365-2699.1998.2540763.x; Jackson DC, 2010, J EXP ZOOL PART A, V313A, P311, DOI 10.1002/jez.603; Jim CY, 2003, LANDSCAPE URBAN PLAN, V65, P95, DOI 10.1016/S0169-2046(02)00244-X; Knutson MG, 1999, CONSERV BIOL, V13, P1437, DOI 10.1046/j.1523-1739.1999.98445.x; Kong FH, 2010, LANDSCAPE URBAN PLAN, V95, P16, DOI 10.1016/j.landurbplan.2009.11.001; Kruger DJD, 2015, URBAN ECOSYST, V18, P1333, DOI 10.1007/s11252-015-0443-y; Larson CL, 2018, LANDSCAPE URBAN PLAN, V175, P62, DOI 10.1016/j.landurbplan.2018.03.009; Larson CL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167259; Lehtinen RM, 1999, WETLANDS, V19, P1, DOI 10.1007/BF03161728; Marsh DM, 2017, DIVERS DISTRIB, V23, P158, DOI 10.1111/ddi.12516; Matich P, 2019, PEERJ, V7, DOI 10.7717/peerj.6956; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Miller DAW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06157-6; Miyashita T, 1998, BIOL CONSERV, V86, P357, DOI 10.1016/S0006-3207(98)00025-1; Nielsen AB, 2014, URBAN ECOSYST, V17, P305, DOI 10.1007/s11252-013-0316-1; Parris KM, 2006, J ANIM ECOL, V75, P757, DOI 10.1111/j.1365-2656.2006.01096.x; Pillsbury FC, 2008, ECOL APPL, V18, P1107, DOI 10.1890/07-1899.1; Pope SE, 2000, ECOLOGY, V81, P2498; Puglis HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039590; Rittenhouse TAG, 2007, WETLANDS, V27, P153, DOI 10.1672/0277-5212(2007)27[153:DOAITH]2.0.CO;2; Rubbo MJ, 2005, CONSERV BIOL, V19, P504, DOI 10.1111/j.1523-1739.2005.000101.x; Rytwinski T, 2015, HANDBOOK OF ROAD ECOLOGY, P237; Scheffers BR, 2012, URBAN ECOSYST, V15, P133, DOI 10.1007/s11252-011-0199-y; Semlitsch RD, 2000, J WILDLIFE MANAGE, V64, P615, DOI 10.2307/3802732; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Sievers M, 2019, CONSERV BIOL, V33, P389, DOI 10.1111/cobi.13210; Smallbone LT, 2011, LANDSCAPE URBAN PLAN, V101, P43, DOI 10.1016/j.landurbplan.2011.01.002; Steelman CK, 2010, J HERPETOL, V44, P61, DOI 10.1670/08-329.1; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; United States Environmental Protection Agency, REG 1 EPA NEW ENGL W; Villasenor NR, 2017, LANDSCAPE URBAN PLAN, V157, P26, DOI 10.1016/j.landurbplan.2016.06.006; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wier LA, 2005, N AM AMPHIBIAN MONIT	61	2	2	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244932	10.1371/journal.pone.0244932	http://dx.doi.org/10.1371/journal.pone.0244932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481837	Green Published, gold			2022-12-26	WOS:000612929300158
J	Jadhav, S; Tripathi, S; Chandrekar, A; Waikar, SS; Hsiao, LL				Jadhav, Shreyas; Tripathi, Sudipta; Chandrekar, Anil; Waikar, Sushrut S.; Hsiao, Li-Li			A novel antibody for the detection of alternatively spliced secreted KLOTHO isoform in human plasma	PLOS ONE			English	Article							GENE; EXPRESSION; PHENOTYPES; CLEAVAGE; RELEASE; PROTEIN; KIDNEY; MICE	alpha Klotho is primarily known to express as a transmembrane protein. Proteolytic cleavage results in shedding of the extracellular domain which enters systemic circulation. A truncated form of alpha Klotho resulting from alternative splicing of the alpha KLOTHO transcript exists and is believed to be secreted, thereby also entering systemic circulation. Existing ELISA methods fail to distinguish between the two circulating isoforms resulting in inconsistencies in assessing circulating alpha Klotho levels. We have exploited a unique 15aa peptide sequence present in the alternatively spliced secreted isoform to generate an antibody and show that it is able to specifically detect only the secreted Klotho isoform in human plasma. This finding will facilitate in distinguishing the levels of different circulating Klotho isoforms in health and disease and enhance their potential to serve as a biomarker for CKD and other conditions.	[Jadhav, Shreyas; Tripathi, Sudipta; Chandrekar, Anil; Hsiao, Li-Li] Harvard Med Sch, Renal Div, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Waikar, Sushrut S.] Boston Univ, Med Ctr, Sect Nephrol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University	Hsiao, LL (corresponding author), Harvard Med Sch, Renal Div, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA.	lhsiao@bwh.harvard.edu	Hsiao, Li-Li/R-8665-2018	Hsiao, Li-Li/0000-0003-0830-3391				Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Davidsohn N, 2019, P NATL ACAD SCI USA, V116, P23505, DOI 10.1073/pnas.1910073116; Di Bona D, 2014, REJUV RES, V17, P212, DOI 10.1089/rej.2013.1523; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2010, J NEPHROL, V23, pS136; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kuro-o M, 2019, NAT REV NEPHROL, V15, P27, DOI 10.1038/s41581-018-0078-3; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lim K, 2015, J CLIN ENDOCR METAB, V100, pE1308, DOI 10.1210/jc.2015-1800; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Liu QH, 2019, J MOL CELL CARDIOL, V136, P113, DOI 10.1016/j.yjmcc.2019.09.004; Masso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143623; Masuda H, 2005, MECH AGEING DEV, V126, P1274, DOI 10.1016/j.mad.2005.07.007; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mencke R, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94375; Negri AL, 2005, J NEPHROL, V18, P654; Neyra JA, 2020, CLIN KIDNEY J, V13, P235, DOI 10.1093/ckj/sfz085; Shiraki-Iida T, 2000, J GENE MED, V2, P233, DOI 10.1002/1521-2254(200007/08)2:4<233::AID-JGM110>3.0.CO;2-5; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245614	10.1371/journal.pone.0245614	http://dx.doi.org/10.1371/journal.pone.0245614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481901	gold, Green Published			2022-12-26	WOS:000612929300021
J	Yehualashet, SS; Asefa, KK; Mekonnen, AG; Gemeda, BN; Shiferaw, WS; Aynalem, YA; Bilchut, AH; Derseh, BT; Mekuria, AD; Mekonnen, WN; Meseret, WA; Tegegnework, SS; Abosetegn, AE				Yehualashet, Sisay Shewasinad; Asefa, Kokebe Kefelegn; Mekonnen, Alemayehu Gonie; Gemeda, Belete Negess; Shiferaw, Wondimenh Shibabaw; Aynalem, Yared Asmare; Bilchut, Awraris Hailu; Derseh, Behailu Tariku; Mekuria, Abinet Dagnaw; Mekonnen, Wassie Negash; Meseret, Wondesen Asegidew; Tegegnework, Sisay Shine; Abosetegn, Akine Eshete			Predictors of adherence to COVID-19 prevention measure among communities in North Shoa Zone, Ethiopia based on health belief model: A cross-sectional study	PLOS ONE			English	Article							BREAST-CANCER; ATTITUDES; KNOWLEDGE; STUDENTS; WOMEN	Introduction Coronavirus disease 2019 (COVID-19) is an emerging respiratory infections and is known to cause illness ranging from the common cold to severe acute respiratory syndrome. At present, the disease has been posing a serious threat to the communities, and it is critical to know the communities' level of adherence on COVID-19 prevention measures. Thus, this study aimed to identify the predictors of adherence to COVID-19 prevention measure among communities in North Shoa zone, Ethiopia by using a health belief model. Methods Community-based cross-sectional study design was employed. A total of 683 respondents were interviewed using a structured and pre-tested questionnaire. The data were collected by using a mobile-based application called "Google form." Logistic regression was performed to analyze the data. Estimates were reported in adjusted odds ratios with 95% confidence intervals (CI) and a significant association was declared at p-value of less than 0.05. Result The overall adherence level of the community towards the recommended safety measures of COVID-19 was 44.1%. Self-efficacy (AOR = 0.23; 95% 0.14, 0.36), perceived benefits (AOR = 0.35; 95% 0.23, 0.56), perceived barriers (AOR = 3.36; 95% 2.23, 5.10), and perceived susceptibility of COVID-19 (AOR = 1.60; 95% 1.06, 2.39) were important predictors that influenced the adherence of the community to COVID-19 preventive behaviors. Conclusions In this study, the overall adherence level of the community towards the recommended safety measures of COVID-19 was relatively low. It is vital to consider the communities' self-efficacy, perceived benefits, perceived barriers and perceived susceptibility of COVID-19 in order to improve the adherence of the community towards the recommended safety measures of COVID-19.	[Yehualashet, Sisay Shewasinad; Asefa, Kokebe Kefelegn; Mekonnen, Alemayehu Gonie; Gemeda, Belete Negess; Shiferaw, Wondimenh Shibabaw; Aynalem, Yared Asmare] Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Amhara Regional, Ethiopia; [Bilchut, Awraris Hailu; Derseh, Behailu Tariku; Mekuria, Abinet Dagnaw; Mekonnen, Wassie Negash; Meseret, Wondesen Asegidew; Tegegnework, Sisay Shine; Abosetegn, Akine Eshete] Debre Berhan Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Berhan, Amhara Regional, Ethiopia		Yehualashet, SS (corresponding author), Debre Berhan Univ, Coll Hlth Sci, Dept Nursing, Debre Berhan, Amhara Regional, Ethiopia.	sisyehu@gmail.com	Bilchut, Awraris/AAT-2833-2021; Negese, Belete/AAG-1887-2021; Tegegnework, Sisay Shine/AGZ-8590-2022; Mekuria, Abinet/AAV-1831-2021; Mekonnen, Wassie/GQZ-7823-2022	Bilchut, Awraris/0000-0003-4425-5403; Negese, Belete/0000-0003-4922-9319; Tegegnework, Sisay Shine/0000-0001-8754-303X; Mekuria, Abinet/0000-0002-3892-1572; Mekonnen, Wassie/0000-0002-0869-9747; Shewasinad, Sisay/0000-0003-0264-5227				Abate GT, 2020, FOOD NUTR SECURITY A, V145; Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; Afzal MS, 2021, J COMMUN HEALTH, V46, P476, DOI 10.1007/s10900-020-00875-z; Ahmed BA, 2010, ASIAN PAC J CANCER P, V11, P101; Ajilore K, 2017, HEALTH EDUC J, V76, P648, DOI 10.1177/0017896917710969; [Anonymous], 2020, RISK COMM COMM ENG R; Assessment RR., 2020, COR DIS 2019 COVID 1; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Banik R, 2020, INVESTIGATING KNOWLE; Baye K, 2020, COVID 19 PREVENTION, V141; Chan EYY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113869; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Costantine MM, 2020, OBSTET GYNECOL, V136, P26, DOI [10.1097/AOG.0000000000003924, 10.1097/A0G.0000000000003924]; Council ADPA, 2013, PEDIAT PREP RES KIT; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Erhabor O, 2020, HUMAN ANTIBODIES, P1, DOI [10.3233/HAB-190387, DOI 10.3233/HAB-190387]; Glanz K., 2008, HLTH BEHAV HLTH ED T; Griffin JL, 2010, OBSTET GYNECOL, V116, P1410, DOI 10.1097/AOG.0b013e3181fe714e; Haftom M, 2020, INFECT DRUG RESIST, V13, P3727, DOI 10.2147/IDR.S275744; Haque, 2020, KNOWLEDGE ATTITUDE P; Harris, 2020, RES REPORT RESULTS 1; Hossain I, COVID 19 CHANGING BE; Ikhlaq A, 2020, PAK J MED SCI, V36, pS32, DOI 10.12669/pjms.36.COVID19-S4.2636; Kassema J, 2020, CASE AFRICAN COUNTIE, P2020; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lee M, 2020, INT J ENV RES PUBLIC, V17; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Mohsen F, 2020, CRISIS CRISIS COVID; Mya K.S., 2020, INT J COMMUNITY MED, V7, P1627, DOI [10.18203/2394-6040.ijcmph20201530, DOI 10.18203/2394-6040.IJCMPH20201530]; Peterman A., 2020, PANDEMICS VIOLENCE W, P528; Peyronnet, 2020, CNGOF GYNECOLOGIE OB; Qeadan F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176295; Singh A, KNOWLEDGE ATTITUDE P; Siordia JA, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104357; Tachfouti N, 2012, PAN AFR MED J, V12; Tekle AL, 2020, J PUBLIC HEAL EPIDEM, V12, P86; Waheed, 2020, BIOMEDICA, V36, P253; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Wolf, 2020, ANN INTERNAL MED; World Health Organization, 2020, SURV TOOL GUID RAP S; World Health Organization, 2020, NOV COR 2019 N COV S; Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; 2020, MMWR MORBID MORTAL W, V69, P343	44	35	36	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0246006	10.1371/journal.pone.0246006	http://dx.doi.org/10.1371/journal.pone.0246006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481962	gold, Green Published			2022-12-26	WOS:000612929300039
J	Zheng, DJ; Sur, PJ; Ariokot, MG; Juillard, C; Ajiko, MM; Dicker, RA				Zheng, Dennis J.; Sur, Patrick J.; Ariokot, Mary Goretty; Juillard, Catherine; Ajiko, Mary Margaret; Dicker, Rochelle A.			Epidemiology of injured patients in rural Uganda: A prospective trauma registry's first 1000 days	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; 195 COUNTRIES; TERRITORIES; MORTALITY; PATTERNS; DISEASE; CARE	Trauma is a leading cause of morbidity and mortality worldwide. Data characterizing the burden of injury in rural Uganda is limited. Hospital-based trauma registries are a critical tool in illustrating injury patterns and clinical outcomes. This study aims to characterize the traumatic injuries presenting to Soroti Regional Referral Hospital (SRRH) in order to identify opportunities for quality improvement and policy development. From October 2016 to July 2019, we prospectively captured data on injured patients using a locally designed, context-relevant trauma registry instrument. Information regarding patient demographics, injury characteristics, clinical information, and treatment outcomes were recorded. Descriptive, bivariate, and multivariate statistical analyses were conducted. A total of 4109 injured patients were treated during the study period. Median age was 26 years and 63% were male. Students (33%) and peasant farmers (31%) were the most affected occupations. Falls (36%) and road traffic injuries (RTIs, 35%) were the leading causes of injury. Nearly two-thirds of RTIs were motorcycle-related and only 16% involved a pedestrian. Over half (53%) of all patients had a fracture or a sprain. Suffering a burn or a head injury were significant predictors of mortality. The number of trauma patients enrolled in the study declined by five-fold when comparing the final six months and initial six months of the study. Implementation of a context-appropriate trauma registry in a resource-constrained setting is feasible. In rural Uganda, there is a significant need for injury prevention efforts to protect vulnerable populations such as children and women from trauma on roads and in the home. Orthopedic and neurosurgical care are important targets for the strengthening of health systems. The comprehensive data provided by a trauma registry will continue to inform such efforts and provide a way to monitor their progress moving forward.	[Zheng, Dennis J.] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA; [Sur, Patrick J.] Univ Calif Riverside, UC Riverside Sch Med, Riverside, CA 92521 USA; [Ariokot, Mary Goretty; Ajiko, Mary Margaret] Soroti Reg Referral Hosp, Dept Surg, Soroti, Uganda; [Juillard, Catherine; Dicker, Rochelle A.] Univ Calif Los Angeles, Dept Surg, Program Adv Surg Equ, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Riverside; University of California System; University of California Los Angeles	Dicker, RA (corresponding author), Univ Calif Los Angeles, Dept Surg, Program Adv Surg Equ, Los Angeles, CA 90024 USA.	rdicker@mednet.ucla.edu			Doris Duke Charitable Foundation	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF))	Dennis J. Zheng received a Doris Duke International Clinical Research Fellowship from the Doris Duke Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeloye D, 2016, B WORLD HEALTH ORGAN, V94, P510, DOI 10.2471/BLT.15.163121; Balikuddembe K. J, 2016, JIVR, V9, P1, DOI DOI 10.5249/JIVR.V9I1.796; Bellamkonda N, 2020, J SURG RES, V245, P587, DOI 10.1016/j.jss.2019.07.037; Bommakanti K, 2018, J SURG RES, V223, P72, DOI 10.1016/j.jss.2017.09.039; Broadis E, 2020, BURNS, V46, P727, DOI 10.1016/j.burns.2019.08.015; Central Intelligence Agency, 2020, CIA WORLD FACTB; Christie SA, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.5171; Demetriou C, 2019, ANZ J SURG, DOI 10.1111/ans.15475; Feldhaus I, 2020, TRAUMA SURG ACUTE CA, V5, DOI 10.1136/tsaco-2019-000424; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Juillard C, 2017, SURGERY, V162, pS24, DOI 10.1016/j.surg.2017.01.025; Kobusingye OC, 2000, J TRAUMA, V48, P498, DOI 10.1097/00005373-200003000-00022; Kotagal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091862; Kuo BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182285; Lin N, 2019, WORLD J SURG, V43, P2666, DOI 10.1007/s00268-019-05095-8; Lozano R, 2018, LANCET, V392, P2091, DOI 10.1016/s0140-6736(18)32281-5; Moore L, 2008, INJURY, V39, P686, DOI 10.1016/j.injury.2008.02.023; Motsumi MJ, 2020, AFR J EMERG MED, V10, pS29, DOI 10.1016/j.afjem.2020.06.011; Mukwaya P., 2012, J AFR DEV, V14, P169; Muni KM, 2021, INJURY PREV, V27, P208, DOI 10.1136/injuryprev-2020-043654; Ndung'u A, 2019, AFR J EMERG MED, V9, pS47, DOI 10.1016/j.afjem.2018.12.004; O'Hara NN, 2018, J BONE JOINT SURG AM, V100, DOI 10.2106/JBJS.17.00439; Purcell L, 2017, MALAWI MED J, V29, P146, DOI 10.4314/mmj.v29i2.13; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Sawe HR, 2020, INJURY, V51, P2938, DOI 10.1016/j.injury.2020.09.032; Schlottmann F, 2017, MALAWI MED J, V29, P301, DOI 10.4314/mmj.v29i4.4; Spiegel DA, 2013, WORLD J SURG, V37, P1462, DOI 10.1007/s00268-012-1831-6; StataCorp, 2019, STATA STAT SOFTWARE, DOI [10.2307/2234838, DOI 10.2307/2234838]; Vaca SD, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062110; Wong EG, 2015, J SURG RES, V193, P217, DOI 10.1016/j.jss.2014.08.055; Zargaran E, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2018.0087	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245779	10.1371/journal.pone.0245779	http://dx.doi.org/10.1371/journal.pone.0245779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481891	gold, Green Published			2022-12-26	WOS:000612929300055
J	Barnawi, H; Woodward, L; Fava, N; Roubakha, M; Shaw, SD; Kubinec, C; Naismith, JH; Creuzenet, C				Barnawi, Heba; Woodward, Laura; Fava, Natalie; Roubakha, Mikhail; Shaw, Steve D.; Kubinec, Chelsea; Naismith, James H.; Creuzenet, Carole			Structure-function studies of the C3/C5 epimerases and C4 reductases of the Campylobacter jejuni capsular heptose modification pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CATALYTIC MECHANISM; ACTIVE-SITE; O-ANTIGENS; BIOSYNTHESIS; COMPLEX; ENZYME; FUCOSE; DIVERSITY; VIRULENCE	Many bacteria produce polysaccharide-based capsules that protect them from environmental insults and play a role in virulence, host invasion, and other functions. Understanding how the polysaccharide components are synthesized could provide new means to combat bacterial infections. We have previously characterized two pairs of homologous enzymes involved in the biosynthesis of capsular sugar precursors GDP-6-deoxy-D-altro-heptose and GDP-6-OMe-L-gluco-heptose in Campylobacter jejuni. However, the substrate specificity and mechanism of action of these enzymes-C3 and/or C5 epimerases DdahB and MlghB and C4 reductases DdahC and MlghC-are unknown. Here, we demonstrate that these enzymes are highly specific for heptose substrates, using mannose substrates inefficiently with the exception of MlghB. We show that DdahB and MlghB feature a jellyroll fold typical of cupins, which possess a range of activities including epimerizations, GDP occupying a similar position as in cupins. DdahC and MlghC contain a Rossman fold, a catalytic triad, and a small C-terminal domain typical of short-chain dehydratase reductase enzymes. Integrating structural information with site-directed mutagenesis allowed us to identify features unique to each enzyme and provide mechanistic insight. In the epimerases, mutagenesis of H67, D173, N121, Y134, and Y132 suggested the presence of alternative catalytic residues. We showed that the reductases could reduce GDP-4-keto-6-deoxy-mannulose without prior epimerization although DdahC preferred the pre-epimerized substrate and identified T110 and H180 as important for substrate specificity and catalytic efficacy. This information can be exploited to identify inhibitors for therapeutic applications or to tailor these enzymes to synthesize novel sugars useful as glycobiology tools.	[Barnawi, Heba; Fava, Natalie; Roubakha, Mikhail; Shaw, Steve D.; Kubinec, Chelsea; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Woodward, Laura; Naismith, James H.] St Andrews Univ, Biomed Sci Res Complex, St Andrews, Fife, Scotland; [Naismith, James H.] Res Complex Harwell, Rosalind Franklin Inst, Harwell Campus, Didcot, Oxon, England; [Naismith, James H.] Univ Oxford, Div Struct Biol, Oxford, England	Western University (University of Western Ontario); University of St Andrews; University of Oxford	Creuzenet, C (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.; Naismith, JH (corresponding author), St Andrews Univ, Biomed Sci Res Complex, St Andrews, Fife, Scotland.; Naismith, JH (corresponding author), Res Complex Harwell, Rosalind Franklin Inst, Harwell Campus, Didcot, Oxon, England.; Naismith, JH (corresponding author), Univ Oxford, Div Struct Biol, Oxford, England.	naismith@strubi.ox.ac.uk; ccreuzen@uwo.ca	Naismith, James Henderson/H-3408-2012; Naismith, James Henderson/AAB-8614-2020	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Shaw, Steve/0000-0002-5556-5629; Kubinec, Chelsea/0000-0002-2814-3287; Creuzenet, Carole/0000-0002-7435-5862; Barnawi, Heba/0000-0001-5156-0647	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 240762-2010, 05717-2015, RGPIN 04765-2016]; Wellcome Trust [100209/Z/12/Z]; King Abdullah scholarship from Saudi Arabia	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Wellcome Trust(Wellcome Trust); King Abdullah scholarship from Saudi Arabia	This work was supported through operating grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 240762-2010, 05717-2015, and RGPIN 04765-2016) to C. C. and Wellcome Trust to J. H. N. (100209/Z/12/Z). H. B. was the recipient of a King Abdullah scholarship from Saudi Arabia.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Blankenfeldt W, 2002, STRUCTURE, V10, P773, DOI 10.1016/S0969-2126(02)00770-0; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Committee to Advise on Tropical Medicine and Travel (CATMAT), 2009, Can Commun Dis Rep, V35 Suppl 1, P1; Creuzenet C, 2002, J BIOL CHEM, V277, P26769, DOI 10.1074/jbc.M202882200; DeLaBarre B, 2000, NAT STRUCT BIOL, V7, P238; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Dong CJ, 2003, STRUCTURE, V11, P715, DOI 10.1016/S0969-2126(03)00098-4; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Giraud MF, 2000, NAT STRUCT BIOL, V7, P398; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Huddleston JP, 2020, BIOCHEMISTRY-US, V59, P1314, DOI 10.1021/acs.biochem.0c00096; Huddleston JP, 2020, BIOCHEMISTRY-US, V59, P1328, DOI 10.1021/acs.biochem.0c00097; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Kondakova AN, 2008, CARBOHYD RES, V343, P1383, DOI 10.1016/j.carres.2008.04.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2011, ACTA CRYSTALLOGR D, V67, P376, DOI 10.1107/S0907444911007232; Kubiak RL, 2012, BIOCHEMISTRY-US, V51, P9375, DOI 10.1021/bi3012737; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Lin J, 2007, ANTIMICROB AGENTS CH, V51, P1678, DOI 10.1128/AAC.01411-06; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; McCallum M, 2013, J BIOL CHEM, V288, P19569, DOI 10.1074/jbc.M113.468066; McCallum M, 2012, J BIOL CHEM, V287, P29776, DOI 10.1074/jbc.M112.390492; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merkel AB, 2004, J BIOL CHEM, V279, P32684, DOI 10.1074/jbc.M404091200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rizzi M, 1998, STRUCTURE, V6, P1453, DOI 10.1016/S0969-2126(98)00144-0; Somers WS, 1998, STRUCTURE, V6, P1601, DOI 10.1016/S0969-2126(98)00157-9; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wong A, 2015, MOL MICROBIOL, V96, P1136, DOI 10.1111/mmi.12995	46	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100352	10.1016/j.jbc.2021.100352	http://dx.doi.org/10.1016/j.jbc.2021.100352			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33524389	Green Published, gold			2022-12-26	WOS:000672866400326
J	Herrmann, GK; Russell, WK; Garg, NJ; Yin, YW				Herrmann, Geoffrey K.; Russell, William K.; Garg, Nisha J.; Yin, Y. Whitney			Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; STRUCTURAL BASIS; CELL-DEATH; DAMAGE; NUCLEAR; DEPLETION; REDOX; HEART; PARP1	Mitochondrial DNA is located in organelle that house essential metabolic reactions and contains high reactive oxygen species. Therefore, mitochondrial DNA suffers more oxidative damage than its nuclear counterpart. Formation of a repair enzyme complex is beneficial to DNA repair. Recent studies have shown that mitochondrial DNA polymerase (Pol gamma) and poly(ADP-ribose) polymerase 1 (PARP1) were found in the same complex along with other mitochondrial DNA repair enzymes, and mitochondrial PARP1 level is correlated with mtDNA integrity. However, the molecular basis for the functional connection between Pol gamma and PARP1 has not yet been elucidated because cellular functions of PARP1 in DNA repair are intertwined with metabolism via NAD(+) (nicotinamide adenosine dinucleotide), the substrate of PARP1, and a metabolic cofactor. To dissect the direct effect of PARP1 on mtDNA from the secondary perturbation of metabolism, we report here biochemical studies that recapitulated Pol gamma PARylation observed in cells and showed that PARP1 regulates Pol gamma activity during DNA repair in a metabolic cofactor NAD(+) (nicotinamide adenosine dinucleotide)-dependent manner. In the absence of NAD(+), PARP1 completely inhibits Pol gamma, while increasing NAD(+) levels to a physiological concentration that enables Pol gamma to resume maximum repair activity. Because cellular NAD(+) levels are linked to metabolism and to ATP production via oxidative phosphorylation, our results suggest that mtDNA damage repair is coupled to cellular metabolic state and the integrity of the respiratory chain.	[Herrmann, Geoffrey K.; Russell, William K.; Yin, Y. Whitney] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Herrmann, Geoffrey K.; Yin, Y. Whitney] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Garg, Nisha J.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Yin, YW (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Yin, YW (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA.; Yin, YW (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.	ywyin@utmb.edu		Herrmann, Geoffrey/0000-0002-0581-616X	National Institutes of Health [GM 110591, AI 134970, AI 136031]; CPRIT grant [RP190682]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT grant	The work is supported by National Institutes of Health grants GM 110591 and AI 134970 to Y. W. Y. and AI 136031 to N. J. G. The UTMB Mass Spectrometry Facility is supported in part by CPRIT grant RP190682 to W. K. R. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312; Bian CJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08530-5; Brautigam CA, 2016, NAT PROTOC, V11, P882, DOI 10.1038/nprot.2016.044; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; BURZIO LO, 1977, ANN NY ACAD SCI, V286, P398, DOI 10.1111/j.1749-6632.1977.tb29432.x; Cambronne XA, 2016, SCIENCE, V352, P1474, DOI 10.1126/science.aad5168; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Copeland WC, 2010, SUBCELL BIOCHEM, V50, P211, DOI 10.1007/978-90-481-3471-7_11; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dantzer F, 2000, BIOCHEMISTRY-US, V39, P7559, DOI 10.1021/bi0003442; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fischer JMF, 2014, FEBS J, V281, P3625, DOI 10.1111/febs.12885; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; FREI B, 1988, BIOCHEMISTRY-US, V27, P529, DOI 10.1021/bi00402a004; He Q, 2013, MITOCHONDRION, V13, P592, DOI 10.1016/j.mito.2013.08.003; Hegedus C, 2020, CANCERS, V12, DOI 10.3390/cancers12010005; Henning RJ, 2018, CARDIOVASC TOXICOL, V18, P493, DOI 10.1007/s12012-018-9462-2; Jarrett SG, 2007, OPHTHALMIC RES, V39, P213, DOI 10.1159/000104683; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Kalesh K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43154-1; Krainz T, 2018, ACS CHEM BIOL, V13, P2868, DOI 10.1021/acschembio.8b00423; KUN E, 1975, P NATL ACAD SCI USA, V72, P1436, DOI 10.1073/pnas.72.4.1436; Langelier MF, 2017, METHODS MOL BIOL, V1608, P431, DOI 10.1007/978-1-4939-6993-7_27; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Lavrik OI, 2001, J BIOL CHEM, V276, P25541, DOI 10.1074/jbc.M102125200; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; LOETSCHER P, 1987, P NATL ACAD SCI USA, V84, P1286, DOI 10.1073/pnas.84.5.1286; Lombardi AA, 2015, AM J PHYSIOL-HEART C, V309, pH393, DOI 10.1152/ajpheart.00475.2015; MASMOUDI A, 1987, BIOCHEMISTRY-US, V26, P1965, DOI 10.1021/bi00381a027; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; MENISSIERDEMURCIA J, 1989, J MOL BIOL, V210, P229, DOI 10.1016/0022-2836(89)90302-1; Mosgoeller W, 1996, J CELL SCI, V109, P409; Nissink J. W., 2012, PLOS ONE, V7, pE5088; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; Picca A, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080647; Prasad R, 2017, DNA REPAIR, V60, P77, DOI 10.1016/j.dnarep.2017.10.011; RICHTER C, 1983, P NATL ACAD SCI-BIOL, V80, P3188, DOI 10.1073/pnas.80.11.3188; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; Sukhanova MV, 2004, BIOCHEMISTRY-MOSCOW+, V69, P558, DOI 10.1023/B:BIRY.0000029855.68502.fa; Sykora P, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00237-17; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Szymanski MR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14959; Szymanski MR, 2015, EMBO J, V34, P1959, DOI 10.15252/embj.201591520; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; Van Houten B, 2016, FRONT BIOSCI-LANDMRK, V21, P42, DOI 10.2741/4375; VEECH RL, 1972, BIOCHEM J, V127, P387, DOI 10.1042/bj1270387; Wen JJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007065; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579; Zhang QH, 2002, SCIENCE, V295, P1895; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	60	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100309	10.1016/j.jbc.2021.100309	http://dx.doi.org/10.1016/j.jbc.2021.100309			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33482196	Green Published, gold			2022-12-26	WOS:000672866400283
J	Kapoor, S; Kodesia, A; Kalidas, N; Ashish; Thakur, KG				Kapoor, Srajan; Kodesia, Akriti; Kalidas, Nidhi; Ashish; Thakur, Krishan Gopal			Structural characterization of Myxococcus xanthus MglC, a component of the polarity control system, and its interactions with its paralog MglB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLIDING MOTILITY; EVOLUTIONARY CONSERVATION; RESPONSE REGULATOR; CELL POLARITY; PROTEIN; CONSURF; REFINEMENT; SCATTERING; ALIGNMENT; MYXOBACTERALES	The delta-proteobacteria Myxococcus xanthus displays social (S) and adventurous (A) motilities, which require pole-to-pole reversal of the motility regulator proteins. Mutual gliding motility protein C (MglC), a paralog of GTPase-activating protein Mutual gliding motility protein B (MglB), is a member of the polarity module involved in regulating motility. However, little is known about the structure and function of MglC. Here, we determined similar to 1.85 angstrom resolution crystal structure of MglC using Selenomethionine Single-wavelength anomalous diffraction. The crystal structure revealed that, despite sharing <9% sequence identity, both MglB and MglC adopt a Regulatory Light Chain 7 family fold. However, MglC has a distinct similar to 30 degrees to 40 degrees shift in the orientation of the functionally important alpha 2 helix compared with other structural homologs. Using isothermal titration calorimetry and size-exclusion chromatography, we show that MglC binds MglB in 2:4 stoichiometry with submicromolar range dissociation constant. Using small-angle X-ray scattering and molecular docking studies, we show that the MglBC complex consists of a MglC homodimer sandwiched between two homodimers of MglB. A combination of size-exclusion chromatography and site-directed mutagenesis studies confirmed the MglBC interacting interface obtained by molecular docking studies. Finally, we show that the C-terminal region of MglB, crucial for binding its established partner MglA, is not required for binding MglC. These studies suggest that the MglB uses distinct interfaces to bind MglA and MglC. Based on these data, we propose a model suggesting a new role for MglC in polarity reversal in M. xanthus.	[Kapoor, Srajan; Kodesia, Akriti; Thakur, Krishan Gopal] GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India; [Kalidas, Nidhi; Ashish] GN Ramachandran Prot Ctr, CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Thakur, KG (corresponding author), GN Ramachandran Prot Ctr, Struct Biol Lab, Chandigarh, India.	krishang@imtech.res.in	Kapoor, Srajan/GRO-5233-2022	Kapoor, Srajan/0000-0003-1347-550X; Kalidas, Nidhi/0000-0001-7956-4009; Thakur, Krishan/0000-0003-4500-2133	Council of Scientific and Industrial Research, India; Department of Biotechnology, India; Department of Science and Technology-INSPIRE, India; BIRAC fellowship, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology-INSPIRE, India; BIRAC fellowship, India	This work was supported by grant to K. G. T. and Ashish by the Council of Scientific and Industrial Research, India. S. K. is a recipient of senior research fellowship from the Department of Biotechnology, India. A. K. is a recipient of junior research fellowship from the Department of Science and Technology-INSPIRE, India. N. K. is a recipient of BIRAC fellowship, India.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Badmalia MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04975-0; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baranwal J, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000459; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BLACKHART BD, 1985, P NATL ACAD SCI USA, V82, P8767, DOI 10.1073/pnas.82.24.8767; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Galicia C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13274-3; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Guzzo M, 2018, NAT MICROBIOL, V3, P948, DOI 10.1038/s41564-018-0203-x; HARTZELL P, 1991, J BACTERIOL, V173, P7615, DOI 10.1128/jb.173.23.7615-7624.1991; Herrou J, 2020, CURR OPIN CELL BIOL, V62, P54, DOI 10.1016/j.ceb.2019.09.001; HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004; HODGKIN J, 1979, MOL GEN GENET, V171, P167, DOI 10.1007/BF00270003; Inclan YF, 2007, MOL MICROBIOL, V65, P90, DOI 10.1111/j.1365-2958.2007.05774.x; Islam ST, 2015, SEMIN CELL DEV BIOL, V46, P143, DOI 10.1016/j.semcdb.2015.10.033; Kaimer C, 2013, MOL MICROBIOL, V88, P740, DOI 10.1111/mmi.12219; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kanade M, 2021, FEBS J, V288, P1565, DOI 10.1111/febs.15513; Keilberg D, 2014, BIOCHEMISTRY-US, V53, P1899, DOI 10.1021/bi500141f; Keilberg D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002951; Konovalova A, 2010, FEMS MICROBIOL REV, V34, P89, DOI 10.1111/j.1574-6976.2009.00194.x; Koonin EV, 2000, CURR BIOL, V10, pR774, DOI 10.1016/S0960-9822(00)00774-0; Kovalevskiy O, 2018, ACTA CRYSTALLOGR D, V74, P215, DOI 10.1107/S2059798318000979; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Leonardy S, 2007, EMBO J, V26, P4433, DOI 10.1038/sj.emboj.7601877; Leonardy S, 2010, EMBO J, V29, P2276, DOI 10.1038/emboj.2010.114; Levine Timothy P, 2013, Small GTPases, V4, P62, DOI 10.4161/sgtp.24262; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mauriello EMF, 2007, CURR OPIN MICROBIOL, V10, P624, DOI 10.1016/j.mib.2007.09.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLoon AL, 2016, J BACTERIOL, V198, P510, DOI 10.1128/JB.00548-15; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicholls RA, 2018, ACTA CRYSTALLOGR D, V74, P492, DOI 10.1107/S2059798318007313; Pandey K, 2014, J PHYS CHEM B, V118, P5059, DOI 10.1021/jp501641r; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Putnam CD, 2016, J APPL CRYSTALLOGR, V49, P1412, DOI 10.1107/S1600576716010906; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schumacher D, 2017, ANNU REV MICROBIOL, V71, P61, DOI 10.1146/annurev-micro-102215-095415; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Shen K, 2019, CELL, V179, P1319, DOI 10.1016/j.cell.2019.10.036; SHI WY, 1993, MOL MICROBIOL, V9, P601, DOI 10.1111/j.1365-2958.1993.tb01720.x; Spormann AM, 1999, J BACTERIOL, V181, P2593, DOI 10.1128/JB.181.8.2593-2601.1999; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szadkowski D, 2019, NAT MICROBIOL, V4, P1344, DOI 10.1038/s41564-019-0451-4; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WU SS, 1995, MOL MICROBIOL, V18, P547, DOI 10.1111/j.1365-2958.1995.mmi_18030547.x; Yang RF, 2004, J BACTERIOL, V186, P6168, DOI 10.1128/jb.186.18.6168-6178.2004; Zhang TL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01567-4; Zhang Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002872; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]; ZUSMAN DR, 1982, J BACTERIOL, V150, P1430, DOI 10.1128/JB.150.3.1430-1437.1982	71	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100308	10.1016/j.jbc.2021.100308	http://dx.doi.org/10.1016/j.jbc.2021.100308			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493516	Green Published, gold			2022-12-26	WOS:000672866400282
J	Khater, M; Wei, Z; Xu, X; Huang, W; Lokeshwar, BL; Lambert, NA; Wu, GY				Khater, Mostafa; Wei, Zhe; Xu, Xin; Huang, Wei; Lokeshwar, Bal L.; Lambert, Nevin A.; Wu, Guangyu			G protein beta gamma translocation to the Golgi apparatus activates MAPK via p110 gamma-p101 heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; COMPLEX TRANSLOCATION; SIGNALING PATHWAY; COUPLED RECEPTORS; ANGIOTENSIN-II; KINASE; ARRESTIN; SUBUNITS; ORGANIZATION; TRAFFICKING	The Golgi apparatus (GA) is a cellular organelle that plays a critical role in the processing of proteins for secretion. Activation of G protein-coupled receptors at the plasma membrane (PM) induces the translocation of G protein beta gamma dimers to the GA. However, the functional significance of this translocation is largely unknown. Here, we study PM-GA translocation of all 12 G gamma subunits in response to chemokine receptor CXCR4 activation and demonstrate that G gamma 9 is a unique Golgi-translocating G gamma subunit. CRISPR-Cas9-mediated knockout of G gamma 9 abolishes activation of extracellular signal-regulated kinase 1 and 2 (ERK1/2), two members of the mitogen-activated protein kinase family, by CXCR4. We show that chemically induced recruitment to the GA of G beta gamma dimers containing different G gamma subunits activates ERK1/2, whereas recruitment to the PM is ineffective. We also demonstrate that pharmacological inhibition of phosphoinositide 3-kinase. (PI3K gamma) and depletion of its subunits p110 gamma and p101 abrogate ERK1/2 activation by CXCR4 and G beta gamma recruitment to the GA. Knockout of either G gamma 9 or PI3K gamma significantly suppresses prostate cancer PC3 cell migration, invasion, and metastasis. Collectively, our data demonstrate a novel function for G beta gamma translocation to the GA, via activating PI3K gamma heterodimers p110 gamma-p101, to spatiotemporally regulate mitogen-activated protein kinase activation by G protein-coupled receptors and ultimately control tumor progression.	[Khater, Mostafa; Wei, Zhe; Xu, Xin; Huang, Wei; Lambert, Nevin A.; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA; [Lokeshwar, Bal L.] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Khater, Mostafa/0000-0001-7080-6534; Lambert, Nevin/0000-0001-7550-0921	National Institutes of Health, United States [R35GM136397, R01GM118915, R01GM130142]; Veterans Affairs Office of Research and Development, United States [BX003862]	National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Office of Research and Development, United States	This work was supported by grants from the National Institutes of Health, United States (R35GM136397 and R01GM118915 to G. W. and R01GM130142 to N. A. L.) and Veterans Affairs Office of Research and Development, United States (BX003862 to B. L. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bilanges B, 2019, NAT REV MOL CELL BIO, V20, P515, DOI 10.1038/s41580-019-0129-z; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Campbell AP, 2018, NAT REV DRUG DISCOV, V17, P789, DOI 10.1038/nrd.2018.135; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Eichel K, 2016, NAT CELL BIOL, V18, P303, DOI 10.1038/ncb3307; Eichel K, 2018, TRENDS PHARMACOL SCI, V39, P200, DOI 10.1016/j.tips.2017.11.009; El-Haibi CP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-64; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gioeli D, 1999, CANCER RES, V59, P279; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Kallifatidis G, 2016, MOL CANCER RES, V14, P493, DOI 10.1158/1541-7786.MCR-15-0498; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; O'Hayre M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3395; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Paudyal P, 2017, ONCOTARGET, V8, P36067, DOI 10.18632/oncotarget.16428; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schutzman JL, 2012, P NATL ACAD SCI USA, V109, P20023, DOI 10.1073/pnas.1217204109; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Smrcka AV, 2019, CELL MOL LIFE SCI, V76, P4447, DOI 10.1007/s00018-019-03275-2; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Taichman RS, 2002, CANCER RES, V62, P1832; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu V, 2019, J BIOL CHEM, V294, P11062, DOI 10.1074/jbc.REV119.005601; Zhou FG, 2015, CELL SIGNAL, V27, P2035, DOI 10.1016/j.cellsig.2015.06.007	58	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100325	10.1016/j.jbc.2021.100325	http://dx.doi.org/10.1016/j.jbc.2021.100325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493514	Green Published, gold			2022-12-26	WOS:000672866400299
J	Alshaheen, TA; Awaad, MHH; Mehaisen, GMK				Alshaheen, Tarek A.; Awaad, Mohamed H. H.; Mehaisen, Gamal M. K.			Leptin improves the in vitro development of preimplantation rabbit embryos under oxidative stress of cryopreservation	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BOVINE BLASTOCYSTS; GENE-EXPRESSION; MOUSE EMBRYOS; VITRIFICATION; APOPTOSIS; RECEPTOR; SURVIVAL; OOCYTES; CULTURE	Vitrification is an economically effective method for embryo cryopreservation in human and livestock animals; however, it carries the risk of damage by the exposure to severe oxidative stress. The present study was conducted to evaluate the effect of leptin at different levels on the in vitro development of fresh and vitrified preimplantation embryos in a rabbit model. Normal embryos at morulae stage were randomly cultured for 2 h with 0, 10, 20 or 100 ng/mL of leptin, then were cultured for further 48 h as freshly or after vitrification. Thereafter, developed blastocysts form the best leptin level in fresh and vitrified embryos along with their controls were allocated to analyze the pro-oxidant (malondialdehyde, MDA; nitric oxide, NO), antioxidant (total antioxidant capacity, TAC; superoxide dismutase, SOD; glutathione peroxidase, GPx), apoptotic (Bcl-2 associated X protein, BAX; heat shock 60kD protein member 1, HSP60; tumor necrosis factor alpha, TNF alpha) and developmental (sex determining region Y box protein 2, SOX2; Nanog homeobox protein, NANOG; Octamer-binding protein 4, OCT4) biomarkers. Results indicate that expanding and hatching rates of embryos were significantly higher at 20 ng/mL leptin than the other levels, while vitrification had an independent suppression effect on the in vitro development rates. The MDA and NO were significantly higher, while TAC, SOD and GPx were significantly lower in the vitrified than fresh embryos. In contrast, leptin treatment significantly decreased the pro-oxidant biomarkers and increased the antioxidant biomarkers in both fresh and vitrified embryos. Vitrification significantly increased the antiapoptotic biomarkers, and decreased the developmental biomarkers in embryos. In contrast, leptin decreased the BAX and TNF alpha, increased the HSP60, and moreover, ameliorated the reduction of developmental biomarkers in the vitrified embryos. These results conclude that leptin could be used as antiapoptotic and antioxidant promotor to support the in vitro embryonic development, particularly under oxidative stress emerged from cryopreservation programs.	[Alshaheen, Tarek A.] King Faisal Univ, Coll Agr & Food Sci, Dept Anim & Fish Prod, Al Hasa, Saudi Arabia; [Awaad, Mohamed H. H.] Cairo Univ, Fac Vet Med, Dept Poultry Dis, Giza, Egypt; [Mehaisen, Gamal M. K.] Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt	King Faisal University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Mehaisen, GMK (corresponding author), Cairo Univ, Fac Agr, Dept Anim Prod, Giza, Egypt.	gamoka@cu.edu.eg	Mehaisen, Gamal/I-5277-2019	Mehaisen, Gamal/0000-0003-2006-4290	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFT20083]	Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia	This research was funded by the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia (Project number: IFT20083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-28; Amin A, 2014, MOL REPROD DEV, V81, P497, DOI [10.1002/mrd.22316, 1]; Arav A, 2019, TRANSFUS MED HEMOTH, V46, P182, DOI 10.1159/000497749; Bajari TM, 2004, CURR OPIN LIPIDOL, V15, P315, DOI 10.1097/00041433-200406000-00012; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Bonior J, 2006, J PHYSIOL PHARMACOL, V57, P135; Burnett L, 2017, INT J OBESITY, V41, P355, DOI 10.1038/ijo.2016.238; Castillo-Martin M, 2014, CRYOBIOLOGY, V68, P451, DOI 10.1016/j.cryobiol.2014.03.001; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chandrakanthan V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-39; Chehab FF, 2014, J ENDOCRINOL, V223, pT37, DOI 10.1530/JOE-14-0413; Combelles CMH, 2009, REPROD BIOMED ONLINE, V18, P864, DOI 10.1016/S1472-6483(10)60038-7; Craig JA, 2005, MOL CELL ENDOCRINOL, V229, P141, DOI 10.1016/j.mce.2004.08.008; Dehghani-Mohammadabadi M, 2014, J ASSIST REPROD GEN, V31, P453, DOI 10.1007/s10815-014-0172-9; Dobrinsky JR, 2001, THERIOGENOLOGY, V56, P1333, DOI 10.1016/S0093-691X(01)00634-3; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Elomda AM, 2018, ZYGOTE, V26, P326, DOI 10.1017/S0967199418000308; Fontoura Paula, 2017, J Reprod Infertil, V18, P172; Ghanem N, 2011, REPRODUCTION, V142, P551, DOI 10.1530/REP-10-0476; Gomez E, 2009, REPROD DOMEST ANIM, V44, P194, DOI 10.1111/j.1439-0531.2007.01026.x; Gomez E, 2009, J REPROD DEVELOP, V55, P607, DOI 10.1262/jrd.09-077M; Gonzalez RR, 2000, J CLIN ENDOCR METAB, V85, P4883, DOI 10.1210/jc.85.12.4883; Gonzalez-Anover P, 2018, INT J REPROD BIOMED, V16, P497; Goto K, 2002, MOL REPROD DEV, V62, P307, DOI 10.1002/mrd.10119; Gupta S, 2005, J CELL MOL MED, V9, P51, DOI 10.1111/j.1582-4934.2005.tb00336.x; Hamzawy MA, 2018, INT J IMMUNOPATH PH, V32, DOI 10.1177/2058738418785514; Herrid M, 2006, REPRODUCTION, V132, P247, DOI 10.1530/rep.1.01083; Kawamura K, 2002, ENDOCRINOLOGY, V143, P1922, DOI 10.1210/en.143.5.1922; Kim HS, 2006, THERIOGENOLOGY, V65, P831, DOI 10.1016/j.theriogenology.2005.06.016; Klikova K, 2016, Klin Onkol, V29, P29; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; Ksinanova M, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00233; Kumar L, 2012, ANIM REPROD SCI, V135, P8, DOI 10.1016/j.anireprosci.2012.08.030; Lavara R, 2005, THERIOGENOLOGY, V64, P1130, DOI 10.1016/j.theriogenology.2005.01.009; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Li Xingsheng, 2003, Acta Theriologica Sinica, V23, P168; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Marco-Jimenez F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148661; Mehaisen GMK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139814; Mehaisen GMK, 2015, ZYGOTE, V23, P111, DOI 10.1017/S0967199413000415; Mehaisen GMK, 2006, THERIOGENOLOGY, V65, P1279, DOI 10.1016/j.theriogenology.2005.08.007; Moschos S, 2002, FERTIL STERIL, V77, P433, DOI 10.1016/S0015-0282(01)03010-2; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Nowotny A., 1979, PROTEIN DETERMINATIO, P168, DOI [10.1007/978-3-642-67356-6_50, DOI 10.1007/978-3-642-67356-6_50]; Panda BSK, 2017, THERIOGENOLOGY, V98, P116, DOI 10.1016/j.theriogenology.2017.05.008; Paula-Lopes FF, 2007, BIOL REPROD, V76, P532, DOI 10.1095/biolreprod.106.054551; Pereira RM, 2008, CELL TISSUE BANK, V9, P267, DOI 10.1007/s10561-008-9075-2; Perez-Perez A, 2016, PLACENTA, V42, P106, DOI 10.1016/j.placenta.2016.03.009; Perez-Perez A, 2015, CLIN CHEM LAB MED, V53, P15, DOI 10.1515/cclm-2014-0387; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Poprac P, 2017, TRENDS PHARMACOL SCI, V38, P592, DOI 10.1016/j.tips.2017.04.005; Prentice Jennifer R, 2010, Vet Med Int, V2011, DOI 10.4061/2011/146405; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Ramos-Ibeas P, 2019, MOL REPROD DEV, V86, P1292, DOI 10.1002/mrd.23119; Toro AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099187; Sarkar M, 2010, MOL REPROD DEV, V77, P174, DOI 10.1002/mrd.21129; Sebert S, 2011, AM J CLIN NUTR, V94, p1953S, DOI 10.3945/ajcn.110.001040; Serbetci K, 2012, MOL BIOL REP, V39, P1173, DOI 10.1007/s11033-011-0847-6; Shaw L, 2012, REPRODUCTION, V144, P569, DOI 10.1530/REP-12-0047; Song NY, 2018, BIOCHEM PHARMACOL, V153, P282, DOI 10.1016/j.bcp.2018.02.001; Tatone C, 2010, GYNECOL ENDOCRINOL, V26, P563, DOI 10.3109/09513591003686395; Vajta G, 2000, ANIM REPROD SCI, V60, P357, DOI 10.1016/S0378-4320(00)00097-X; Vicente JS, 1999, REPROD NUTR DEV, V39, P657, DOI 10.1051/rnd:19990511; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2003, BIOL REPROD, V68, P2073, DOI 10.1095/biolreprod.102.012104; Yagishita Y, 2017, CELL REP, V18, P2030, DOI 10.1016/j.celrep.2017.01.064; Zheng JA, 2010, CLIN EXP PHARMACOL P, V37, P955, DOI 10.1111/j.1440-1681.2010.05415.x	67	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246307	10.1371/journal.pone.0246307	http://dx.doi.org/10.1371/journal.pone.0246307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529203	gold, Green Published			2022-12-26	WOS:000616736200023
J	Mohler, H; Diekotter, T; Bauer, GM; Donath, TW				Moehler, Henrike; Diekoetter, Tim; Bauer, Geeltje Marie; Donath, Tobias W.			Conspecific and heterospecific grass litter effects on seedling emergence and growth in ragwort (Jacobaea vulgaris)	PLOS ONE			English	Article							PLANT-SOIL FEEDBACK; TREE LEAF-LITTER; SENECIO-JACOBAEA; SEMINATURAL GRASSLANDS; GERMINATION; ESTABLISHMENT; DYNAMICS; DECOMPOSITION; FACILITATION; DISTURBANCE	Jacobaea vulgaris Gaertn. or common ragwort is a widespread noxious grassland weed that is subject to different regulation measures worldwide. Seedling emergence and growth are the most crucial stages for most plants during their life cycle. Therefore, heterospecific grass or conspecific ragwort litter as well as soil-mediated effects may be of relevance for ragwort control. Our study examines the effects of conspecific and heterospecific litter as well as ragwort conditioned soil on seedling emergence and growth. We conducted pot experiments to estimate the influence of soil conditioning (with, without ragwort), litter type (grass, ragwort, grass-ragwort-mix) and amount (200 g/m(2), 400 g/m(2)) on J. vulgaris recruitment. As response parameters, we assessed seedling number, biomass, height and number of seedling leaves. We found that 200 g/m(2) grass litter led to higher seedling numbers, while litter composed of J. vulgaris reduced seedling emergence. Litter amounts of 400 g/m(2) had negative effects on the number of seedlings regardless of the litter type. Results for biomass, plant height and leaf number showed opposing patterns to seedling numbers. Seedlings in pots treated with high litter amounts and seedlings in ragwort litter became heavier, grew higher and had more leaves. Significant effects of the soil conditioned by ragwort on seedling emergence and growth were negligible. The study confirms that the amount and composition of litter strongly affect seedling emergence and growth of J. vulgaris. Moreover, while conspecific litter and high litter amounts negatively affected early seedling development in ragwort, those seedlings that survived accumulated more biomass and got taller than seedlings grown in heterospecific or less dense litter. Therefore, ragwort litter has negative effects in ragwort germination, but positive effects in ragwort growth. Thus, leaving ragwort litter on pastures will not reduce ragwort establishment and growth and cannot be used as management tool.	[Moehler, Henrike; Diekoetter, Tim; Bauer, Geeltje Marie; Donath, Tobias W.] Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany	University of Kiel	Mohler, H (corresponding author), Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany.	hmoehler@ecology.uni-kiel.de	Donath, Tobias W./B-2856-2012	Donath, Tobias W./0000-0003-1874-1096	Stiftung Naturschutz Schleswig-Holstein	Stiftung Naturschutz Schleswig-Holstein	This work was supported by the Stiftung Naturschutz Schleswig-Holstein (http://www.stiftungsland.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2018, ECOL LETT, V21, P1319, DOI 10.1111/ele.13098; [Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2015, AOB PLANTS, DOI DOI 10.1093/aobpla/plv029; [Anonymous], 2011, CONTES DISCOURS BIGA, V28, P53; ANTONOVICS J, 1980, ANNU REV ECOL SYST, V11, P411, DOI 10.1146/annurev.es.11.110180.002211; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1; Begon M, 2011, ECOLOGY INDIVIDUALS, V4th; Bezemer TM, 2006, ECOLOGY, V87, P2002, DOI 10.1890/0012-9658(2006)87[2002:IBSJAP]2.0.CO;2; Bonanomi G, 2006, NEW PHYTOL, V169, P571, DOI 10.1111/j.1469-8137.2005.01611.x; Cavieres LA, 2012, PERSPECT PLANT ECOL, V14, P13, DOI 10.1016/j.ppees.2011.09.003; CRAWLEY MJ, 1985, J ECOL, V73, P255, DOI 10.2307/2259781; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; FACELLI JM, 1988, FLORA, V180, P241; FENNER M, 1983, NEW PHYTOL, V95, P697, DOI 10.1111/j.1469-8137.1983.tb03533.x; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; HARPER JL, 1957, J ECOL, V45, P617, DOI 10.2307/2256946; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Huckauf A, 2017, UMGANG JAKOBS KREUZK, V25; ISTA, 2015, INT RULES SEED TEST, V2015, P6; Jacobs J, 2009, ECOLOGY MANAGEMENT T; Kaltner F, 2018, J AGR FOOD CHEM, V66, P5221, DOI 10.1021/acs.jafc.7b06036; Leiss KA, 2011, PHYTOCHEM REV, V10, P153, DOI 10.1007/s11101-010-9173-1; Loydi A, 2015, PLANT BIOLOGY, V17, P667, DOI 10.1111/plb.12287; Loydi A, 2015, BIOL INVASIONS, V17, P581, DOI 10.1007/s10530-014-0750-x; Loydi A, 2014, J PLANT ECOL, V7, P264, DOI 10.1093/jpe/rtt027; Loydi A, 2013, J ECOL, V101, P454, DOI 10.1111/1365-2745.12033; MCEVOY P, 1991, ECOL APPL, V1, P430, DOI 10.2307/1941900; MCEVOY PB, 1987, ECOLOGY, V68, P2006, DOI 10.2307/1939891; MCEVOY PB, 1984, OIKOS, V42, P138, DOI 10.2307/3544785; Milberg P, 2000, SEED SCI RES, V10, P99, DOI 10.1017/S0960258500000118; Mohler H, 2018, PLANT ECOL DIVERS, V11, P539, DOI 10.1080/17550874.2018.1541487; Montesinos D, 2006, INT J PLANT SCI, V167, P103, DOI 10.1086/497843; Myster RW, 2006, ECOSCIENCE, V13, P95, DOI 10.2980/1195-6860(2006)13[95:SEOGLM]2.0.CO;2; Neumann H, 2009, UMGANG JAKOBS KREUZK; Olson BE, 2002, BASIC APPL ECOL, V3, P309, DOI 10.1078/1439-1791-00127; Pardini EA, 2009, ECOL APPL, V19, P387, DOI 10.1890/08-0845.1; Pausas JG, 2003, PLANT ECOL, V169, P205, DOI 10.1023/A:1026019528443; PLEASANTS JM, 1992, AM J BOT, V79, P133, DOI 10.2307/2445099; Quested H, 2006, FUNCT ECOL, V20, P522, DOI 10.1111/j.1365-2435.2006.01131.x; Quintana JR, 2004, J BIOGEOGR, V31, P241, DOI 10.1111/j.1365-2699.2004.00955.x; Reinhart KO, 2006, BIOL INVASIONS, V8, P231, DOI 10.1007/s10530-004-5163-9; Renne IJ, 2006, ECOLOGY, V87, P2264, DOI 10.1890/0012-9658(2006)87[2264:SIGIEO]2.0.CO;2; Roll J, 1997, CONSERV BIOL, V11, P738, DOI 10.1046/j.1523-1739.1997.96013.x; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schuster MJ, 2017, PLANT SOIL, V415, P257, DOI 10.1007/s11104-016-3162-0; Seiwa K, 2000, OECOLOGIA, V123, P208, DOI 10.1007/s004420051007; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; Siegrist-Maag S, 2008, AGRARFORSCHUNG, V15, P338; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Smit HJ, 2008, AGR SYST, V98, P208, DOI 10.1016/j.agsy.2008.07.004; Smith-Ramesh LM, 2017, J VEG SCI, V28, P484, DOI 10.1111/jvs.12519; Suter M, 2011, WEED RES, V51, P601, DOI 10.1111/j.1365-3180.2011.00875.x; Suzuki RO, 2003, J ECOL, V91, P114, DOI 10.1046/j.1365-2745.2003.00745.x; SYDES C, 1981, J ECOL, V69, P249, DOI 10.2307/2259829; van de Voorde TFJ, 2012, BASIC APPL ECOL, V13, P533, DOI 10.1016/j.baae.2012.08.012; van de Voorde TFJ, 2012, OIKOS, V121, P1251, DOI 10.1111/j.1600-0706.2011.19964.x; van de Voorde TFJ, 2011, J ECOL, V99, P945, DOI 10.1111/j.1365-2745.2011.01815.x; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; VANDERMEIJDEN E, 1979, J ECOL, V67, P131, DOI 10.2307/2259341; WARDLE DA, 1991, NEW ZEAL J AGR RES, V34, P185; WARDLE DA, 1987, NEW ZEAL J ECOL, V10, P67	66	3	3	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0246459	10.1371/journal.pone.0246459	http://dx.doi.org/10.1371/journal.pone.0246459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529241	gold, Green Published			2022-12-26	WOS:000616736200003
J	Zhou, Y; Yuan, Y; Li, LY; Wang, XL; Quan, YM; Liu, CY; Yu, MC; Hu, XT; Meng, XF; Zhou, Z; Zhang, CY; Chen, X; Liu, MH; Wang, C				Zhou, Yu; Yuan, Yuan; Li, Liuyi; Wang, Xueliang; Quan, Yimin; Liu, Chunyu; Yu, Mengchao; Hu, Xiuting; Meng, Xiangfeng; Zhou, Zhen; Zhang, Chen-Yu; Chen, Xi; Liu, Minghui; Wang, Chen			HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer	PLOS ONE			English	Article							SURVIVAL; MICRORNAS; GROWTH; ERBB2; TOOL	HER2 amplification greatly contributes to the tumorigenesis of multiple cancers. Intronic miR-4728-5p is transcribed along with its host gene HER2. However, little is known about the role of miR-4728-5p in cancer. This study aims to elucidate the potential role of miR-4728-5p and the underlying mechanism in breast cancer. Kaplan-Meier analysis showed that higher expression of HER2 led to worse survival outcomes in breast cancer patients. The TCGA dataset revealed that compared to normal breast tissues, HER2 and miR-4728-5p levels were significantly upregulated in breast cancer tissues with a positive correlation. In functional assays, miR-4728-5p was confirmed to promote the proliferation and migration in breast cancer cell BT474. EBP1 was identified as a direct target of miR-4728-5p via bioinformatics and luciferase reporter assays. miR-4728-5p was further demonstrated to increase HER2 expression and promote cell proliferation and migration by directly inhibiting EBP1 in breast cancer. Taken together, the HER2-intronic miR-4728-5p/EBP1/HER2 feedback loop plays an important role in promoting breast cancer cell proliferation and migration. Our study provides novel insights for targeted therapies of breast cancer.	[Zhou, Yu; Yuan, Yuan; Li, Liuyi; Wang, Xueliang; Quan, Yimin; Liu, Chunyu; Yu, Mengchao; Hu, Xiuting; Meng, Xiangfeng; Zhou, Zhen; Zhang, Chen-Yu; Chen, Xi; Liu, Minghui; Wang, Chen] Nanjing Univ, Nanjing Drum Tower Hosp,Jiangsu Engn Res Ctr Micr, Ctr Mol Diagnost & Therapy,State Key Lab Pharmace, Sch Life Sci,Chinese Acad Med Sci,Res Unit Extrac, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Nanjing University	Liu, MH; Wang, C (corresponding author), Nanjing Univ, Nanjing Drum Tower Hosp,Jiangsu Engn Res Ctr Micr, Ctr Mol Diagnost & Therapy,State Key Lab Pharmace, Sch Life Sci,Chinese Acad Med Sci,Res Unit Extrac, Nanjing, Jiangsu, Peoples R China.	minghuiliu@nju.edu.cn; chenwang@nju.edu.cn	wang, chen/GWM-9481-2022		Chinese Science and Technology Major Project of China [2015ZX09102023-003]; China Postdoctoral Science Foundation [2018M642211]; National Natural Science Foundation of China [81602697, 31601057]	Chinese Science and Technology Major Project of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the following funders: the Chinese Science and Technology Major Project of China, 2015ZX09102023-003, received by CZ; the China Postdoctoral Science Foundation, No. 2018M642211, received by ML; the National Natural Science Foundation of China, 81602697, received by ZZ; the National Natural Science Foundation of China, 31601057, received by CW.	[Anonymous], 2019, FILOSOFIA POLITICA, V1, P7; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Awasthi S, 2015, MOL CELL BIOCHEM, V405, P177, DOI 10.1007/s11010-015-2409-z; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bobrow LG, 1997, EUR J CANCER, V33, P1846, DOI 10.1016/S0959-8049(97)00244-X; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Floros KV, 2018, P NATL ACAD SCI USA, V115, pE2594, DOI 10.1073/pnas.1717820115; Gao X, 2012, IUBMB LIFE, V64, P835, DOI 10.1002/iub.1079; Gebert LFR, 2019, NAT REV MOL CELL BIO, V20, P21, DOI 10.1038/s41580-018-0045-7; Ghosh A, 2013, ONCOL REP, V29, P1161, DOI 10.3892/or.2012.2186; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Y, 2011, BREAST CANCER RES TR, V126, P27, DOI 10.1007/s10549-010-0873-4; Newie I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35664; Newie I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097200; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Tanner B, 2006, J CLIN ONCOL, V24, P4317, DOI 10.1200/JCO.2005.04.8397; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Ying SY, 2006, J BIOMED SCI, V13, P5, DOI 10.1007/s11373-005-9036-8; Zhang Y, 2008, CANCER LETT, V265, P298, DOI 10.1016/j.canlet.2008.02.024	28	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2021	16	2							e0245832	10.1371/journal.pone.0245832	http://dx.doi.org/10.1371/journal.pone.0245832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QF2NJ	33529238	gold, Green Published			2022-12-26	WOS:000616736200056
J	Duran-Guell, M; Flores-Costa, R; Casulleras, M; Lopez-Vicario, C; Titos, E; Diaz, A; Alcaraz-Quiles, J; Horrillo, R; Costa, M; Fernandez, J; Arroyo, V; Claria, J				Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Titos, Esther; Diaz, Alba; Alcaraz-Quiles, Jose; Horrillo, Raquel; Costa, Montserrat; Fernandez, Javier; Arroyo, Vicente; Claria, Joan			Albumin protects the liver from tumor necrosis factor alpha-induced immunopathology	FASEB JOURNAL			English	Article						albumin; cytokine&#8208; induced tissue injury; liver cells; liver injury; mitochondrial damage	HUMAN SERUM-ALBUMIN; MITOCHONDRIAL RELEASE; HEPATOCYTE APOPTOSIS; RECEPTOR; PATHWAY; MODEL; MICE	Besides its oncotic power, albumin exerts pleiotropic actions, including binding, transport, and detoxification of endogenous and exogenous molecules, antioxidant activity, and modulation of immune and inflammatory responses. In particular, recent studies have demonstrated that albumin reduces leukocyte cytokine production. Here, we investigated whether albumin also has the ability to protect tissues from the damaging actions of these inflammatory mediators. We circumscribed our investigation to tumor necrosis factor (TNF) alpha, which exemplifies the connection between immunity and tissue injury. In vivo experiments in analbuminemic mice showed that these mice exhibit a more pronounced response to a model of TNF alpha-mediated liver injury induced by the administration of lipopolysaccharide (LPS) and D-galactosamine (D-gal). A tissue protective action against LPS/D-gal liver injury was also observed during the administration of human albumin to humanized mice expressing the human genes for albumin and neonatal Fc receptor (hAlb(+/+)/hFcRn(+/+)) with preestablished carbon tetrachloride (CCl4)-induced early cirrhosis. The cytoprotective actions of albumin against TNF alpha-induced injury were confirmed ex vivo, in precision-cut liver slices, and in vitro, in primary hepatocytes in culture. Albumin protective actions were independent of its scavenging properties and were reproduced by recombinant human albumin expressed in Oryza sativa. Albumin cytoprotection against TNF alpha injury was related to inhibition of lysosomal cathepsin B leakage accompanied by reductions in mitochondrial cytochrome c release and caspase-3 activity. These data provide evidence that in addition to reducing cytokines, the albumin molecule also has the ability to protect tissues against inflammatory injury.	[Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Fernandez, Javier; Arroyo, Vicente; Claria, Joan] European Fdn Study Chron Liver Failure EF Clif &, Barcelona, Spain; [Duran-Guell, Marta; Flores-Costa, Roger; Casulleras, Mireia; Lopez-Vicario, Cristina; Titos, Esther; Alcaraz-Quiles, Jose; Claria, Joan] CIBERehd, Biochem & Mol Genet Serv, Hosp Clin IDIBAPS, Barcelona, Spain; [Titos, Esther; Claria, Joan] Univ Barcelona, Dept Biomed Sci, Barcelona, Spain; [Diaz, Alba] Hosp Clin Barcelona, Pathol Serv, Barcelona, Spain; [Horrillo, Raquel; Costa, Montserrat] Grifols, Biosci Res Grp, Barcelona, Spain; [Fernandez, Javier] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Grifols; University of Barcelona; Hospital Clinic de Barcelona	Claria, J (corresponding author), Hosp Clin IDIBAPS, Barcelona 08036, Spain.	jclaria@clinic.cat	Arroyo, Vicente/F-9189-2015	Arroyo, Vicente/0000-0002-2728-1848; Lopez-Vicario, Cristina/0000-0002-6609-8501; TITOS, ESTHER/0000-0002-2543-2243; Duran, Marta/0000-0002-3265-395X; Casulleras, Mireia/0000-0002-2899-5826				Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Barbaro B, 2008, ARTIF CELL BLOOD SUB, V36, P74, DOI 10.1080/10731190701857819; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Carl DE, 2016, LIVER INT, V36, P865, DOI 10.1111/liv.13023; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; Casulleras M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax5135; CORTESE JD, 1993, BIOCHIM BIOPHYS ACTA, V1142, P194, DOI 10.1016/0005-2728(93)90102-L; Ellmerer M, 2000, AM J PHYSIOL-ENDOC M, V278, pE352, DOI 10.1152/ajpendo.2000.278.2.E352; Fajgenbaum DC, 2020, NEW ENGL J MED, V383, P2255, DOI 10.1056/NEJMra2026131; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Gallego-Sandin S, 2005, EUR J PHARMACOL, V520, P1, DOI 10.1016/j.ejphar.2005.06.044; Gatta A, 2012, INTERN EMERG MED, V7, pS193, DOI 10.1007/s11739-012-0802-0; Guicciardi ME, 2013, COMPR PHYSIOL, V3, P977, DOI 10.1002/cphy.c120020; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Jones DT, 2003, BLOOD, V101, P3174, DOI 10.1182/blood-2002-07-2143; Kuwana T, 1998, J BIOL CHEM, V273, P16589, DOI 10.1074/jbc.273.26.16589; LARRICK JW, 1990, FASEB J, V4, P3215, DOI 10.1096/fasebj.4.14.2172061; LEIST M, 1994, J IMMUNOL, V153, P1778; Leist M, 1997, GASTROENTEROLOGY, V112, P923, DOI 10.1053/gast.1997.v112.pm9041255; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Liu SY, 2012, APOPTOSIS, V17, P1156, DOI 10.1007/s10495-012-0758-6; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Marshall JS, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0278-1; Moran-Salvador E, 2013, J HEPATOL, V59, P1045, DOI 10.1016/j.jhep.2013.06.023; Moriyama T, 2017, J CELL PHYSIOL, V232, P3565, DOI 10.1002/jcp.25817; Pyzik M, 2017, P NATL ACAD SCI USA, V114, pE2862, DOI 10.1073/pnas.1618291114; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rius B, 2017, FASEB J, V31, P5384, DOI 10.1096/fj.201700394R; Schmidt EGW, 2017, J BIOL CHEM, V292, P13312, DOI 10.1074/jbc.M117.794248; Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Tabernero A, 2002, J NEUROCHEM, V81, P881, DOI 10.1046/j.1471-4159.2002.00843.x; Zhang WJ, 2002, CARDIOVASC RES, V55, P820, DOI 10.1016/S0008-6363(02)00492-3; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zoellner H, 1996, J CELL SCI, V109, P2571	38	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21365	10.1096/fj.202001615RRR	http://dx.doi.org/10.1096/fj.202001615RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33496031				2022-12-26	WOS:000647789600107
J	Li, EK; Ajuwon, KM				Li, Enkai; Ajuwon, Kolapo M.			Mechanism of endocytic regulation of intestinal tight junction remodeling during nutrient starvation in jejunal IPEC-J2 cells	FASEB JOURNAL			English	Article						endocytosis; lysosome; nutrient starvation; proteasome; tight junction	BARRIER FUNCTION; CLAUDIN-2 PROTEIN; AUTOPHAGY; DEGRADATION; INTERNALIZATION; INHIBITION	Intestinal epithelial cells are tightly bound by tight junction proteins (TJP) which are dynamic and sensitive to environmental stress. However, the role of the endocytic pathway in the regulation of TJP abundance and tight junction integrity during nutrient stress is poorly understood. Therefore, this study was conducted to investigate the regulation of TJP abundance during nutrient starvation and the role of the endocytic mechanism in this process. IPEC-J2 cells were subjected to nutrient starvation in Krebs-Ringer bicarbonate buffer (KRB) and abundance of TJP, an indication of tight junction remodeling, was characterized with RT-PCR, western blotting and immunofluorescence. Abundance of TJP was dynamically regulated by nutrient starvation. The protein levels of claudin-1, 3, and 4 were initially downregulated within the first 6 hours of starvation, and then, increased thereafter (P < .01). However, there was no change in occludin and ZO-1. Lysosome and proteasome inhibitors were used to determine the contribution of these protein degradation pathways to the TJP remodeling. Short-term starvation-induced degradation of claudin-1, 3, and 4 was found to be lysosome dependent. Specifically, the downregulation of claudin-3 and 4 was via a dynamin-dependent, but clathrin and caveolae independent, endocytic pathway and this downregulation was partly reversed by amino acids supplementation. Interestingly, the re-synthesis of TJP with prolonged starvation partly depended on proteasome function. Collectively, this study, for the first time, elucidated a major role for dynamin-dependent endocytosis of claudin-3 and 4 during nutrient stress in intestinal epithelial cells. Therefore, transient endocytosis inhibition may be a potential mechanism for preserving tight junction integrity and function in metabolic or pathological states such as inflammatory bowel disease that involves destruction of intestinal epithelial TJP.	[Li, Enkai; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, 270 S Russell St, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, 270 S Russell St, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu						Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brooks P. H., 2001, The weaner pig: nutrition and management. Proceedings of a British Society of Animal Science Occasional Meeting, University of Nottingham, UK, September 2000, P153, DOI 10.1079/9780851995328.0153; Bruewer M, 2005, FASEB J, V19, P923, DOI 10.1096/fj.04-3260com; Chalmers AD, 2012, ESSAYS BIOCHEM, V53, P41, DOI [10.1042/bse0530041, 10.1042/BSE0530041]; Choi HS, 2009, J MED FOOD, V12, P37, DOI 10.1089/jmf.2007.0613; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Dennis AP, 2005, J STEROID BIOCHEM, V94, P337, DOI 10.1016/j.jsbmb.2004.11.009; Edelblum KL, 2009, CURR OPIN PHARMACOL, V9, P715, DOI 10.1016/j.coph.2009.06.022; Flores-Maldonado C, 2017, LYSOSOMES ASS DIS ME, P93; Hammer AM, 2015, ALCOHOL RES-CURR REV, V37, P209; Ikari A, 2011, J CELL PHYSIOL, V226, P2448, DOI 10.1002/jcp.22590; Ji MM, 2016, BIOCHEM BIOPH RES CO, V479, P690, DOI 10.1016/j.bbrc.2016.09.151; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lang MJ, 2014, J BIOL CHEM, V289, P16736, DOI 10.1074/jbc.M113.525782; Lenaerts K, 2006, J PROTEOME RES, V5, P2113, DOI 10.1021/pr060183+; Liu J, 2016, MOL NEUROBIOL, V53, P5935, DOI 10.1007/s12035-015-9504-8; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Mandel I, 2012, J CELL BIOCHEM, V113, P2415, DOI 10.1002/jcb.24118; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marques C, 2004, FASEB J, V18, P1424, DOI 10.1096/fj.04-1743fje; Mueller M, 2015, ELIFE, V4, DOI 10.7554/eLife.07736; Nighot PK, 2015, J BIOL CHEM, V290, P7234, DOI 10.1074/jbc.M114.597492; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pryor PR, 2009, BBA-MOL CELL RES, V1793, P615, DOI 10.1016/j.bbamcr.2008.12.022; Rhoads JM, 2009, AMINO ACIDS, V37, P111, DOI 10.1007/s00726-008-0225-4; Sandvig K, 2011, CURR OPIN CELL BIOL, V23, P413, DOI 10.1016/j.ceb.2011.03.007; Spreeuwenberg MAM, 2001, J NUTR, V131, P1520, DOI 10.1093/jn/131.5.1520; Takei K, 2005, J BIOCHEM, V137, P243, DOI 10.1093/jb/mvi052; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wang B, 2016, J NUTR, V146, P501, DOI 10.3945/jn.115.224857; Wang H, 2015, J NUTR, V145, P25, DOI 10.3945/jn.114.202515; Wen W, 2017, CANC CELL RES, V14, P346; Wijtten PJA, 2011, BRIT J NUTR, V105, P967, DOI 10.1017/S0007114510005660; Yan H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179586; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	41	5	5	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21356	10.1096/fj.202002098R	http://dx.doi.org/10.1096/fj.202002098R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33484473	Bronze			2022-12-26	WOS:000647789600101
J	Vazquez-Rosas-Landa, M; Sanchez-Rangel, D; Hernandez-Dominguez, EE; Perez-Torres, CA; Lopez-Buenfil, A; Garcia-Avila, CD; Carrillo-Hernandez, ED; Castaneda-Casasola, CC; Rodriguez-Haas, B; Perez-Lira, J; Villafan, E; Alonso-Sanchez, A; Ibarra-Laclette, E				Vazquez-Rosas-Landa, Mirna; Sanchez-Rangel, Diana; Hernandez-Dominguez, Eric E.; Perez-Torres, Claudia-Anahi; Lopez-Buenfil, Abel; de Jesus Garcia-Avila, Clemente; Carrillo-Hernandez, Edgar-David; Castaneda-Casasola, Cynthia-Coccet; Rodriguez-Haas, Benjamin; Perez-Lira, Josue; Villafan, Emanuel; Alonso-Sanchez, Alexandro; Ibarra-Laclette, Enrique			Design of a diagnostic system based on molecular markers derived from the ascomycetes pan-genome analysis: The case of Fusarium dieback disease	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MULTIPLE SEQUENCE ALIGNMENT; INVASIVE AMBROSIA BEETLE; CONVERGENT EVOLUTION; FUMONISIN PRODUCTION; IDENTIFICATION; PATHOGEN; GENE; REVEALS; DISCRIMINATE	A key factor to take actions against phytosanitary problems is the accurate and rapid detection of the causal agent. Here, we develop a molecular diagnostics system based on comparative genomics to easily identify fusariosis and specific pathogenic species as the Fusarium kuroshium, the symbiont of the ambrosia beetle Euwallaceae kuroshio Gomez and Hulcr which is responsible for Fusarium dieback disease in San Diego CA, USA. We performed a pan-genome analysis using sixty-three ascomycetes fungi species including phytopathogens and fungi associated with the ambrosia beetles. Pan-genome analysis revealed that 2,631 orthologue genes are only shared by Fusarium spp., and on average 3,941 (SD +/- 1,418.6) are species-specific genes. These genes were used for PCR primer design and tested on DNA isolated from i) different strains of ascomycete species, ii) artificially infected avocado stems and iii) plant tissue of field-collected samples presumably infected. Our results let us propose a useful set of primers to either identify any species from Fusarium genus or, in a specific manner, species such as F. kuroshium, F. oxysporum, and F. graminearum. The results suggest that the molecular strategy employed in this study can be expanded to design primers against different types of pathogens responsible for provoking critical plant diseases.	[Vazquez-Rosas-Landa, Mirna; Sanchez-Rangel, Diana; Hernandez-Dominguez, Eric E.; Perez-Torres, Claudia-Anahi; Carrillo-Hernandez, Edgar-David; Rodriguez-Haas, Benjamin; Perez-Lira, Josue; Villafan, Emanuel; Alonso-Sanchez, Alexandro; Ibarra-Laclette, Enrique] Inst Ecol AC INECOL, Red Estudios Mol Avanzados REMAv, Xalapa, Veracruz, Mexico; [Sanchez-Rangel, Diana; Hernandez-Dominguez, Eric E.; Perez-Torres, Claudia-Anahi] Catedrat CONACYT INECOL, Xalapa, Veracruz, Mexico; [Lopez-Buenfil, Abel] Colegio Postgrad COLPOS, Montecillo, Mexico; [de Jesus Garcia-Avila, Clemente; Castaneda-Casasola, Cynthia-Coccet] Ctr Nacl Referencia Fitosanitaria CNRF, Serv Nacl Sanidad Inocuidad & Calidad Agroaliment, Tecamac, Estado De Mexic, Mexico	Instituto de Ecologia - Mexico; Colegio de Postgraduados - Mexico	Ibarra-Laclette, E (corresponding author), Inst Ecol AC INECOL, Red Estudios Mol Avanzados REMAv, Xalapa, Veracruz, Mexico.	enrique.ibarra@inecol.mx	García Avila, Clemente de Jesús/GQG-9432-2022; Rodriguez Haas, Jose Benjamin/Q-8117-2018	Ibarra-Laclette, Enrique/0000-0003-1441-1938; Hernandez Dominguez, Eric Edmundo/0000-0002-1153-9592; Rodriguez Haas, Jose Benjamin/0000-0002-6692-8667; Vazquez-Rosas-Landa, Mirna/0000-0002-6928-7930	SAGARPASENASICA; FORDECYT-CONACYT project [292399]	SAGARPASENASICA; FORDECYT-CONACYT project	This work was supported by SAGARPASENASICA through an agreement between INECOL and Mexican phytosanitary authorities (SENASICAINECOL, 2016). This work also was supported by FORDECYT-CONACYT project 292399. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andersson JO, 2006, CURR BIOL, V16, pR804, DOI 10.1016/j.cub.2006.08.042; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Baird R, 2008, INT J MOL SCI, V9, P554, DOI 10.3390/ijms9040554; Biedermann PHW, 2014, MITT DEUT GES ALLGEM, V19, P191; Boland JM, 2016, PEERJ, V4, DOI 10.7717/peerj.2141; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Carrillo JD, 2020, PLANT DIS, V104, P227, DOI 10.1094/PDIS-01-19-0201-RE; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chakraborty S, 2011, PLANT PATHOL, V60, P2, DOI 10.1111/j.1365-3059.2010.02411.x; Cisse OH, 2013, MBIO, V4, DOI 10.1128/mBio.00055-13; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; Condon BJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003233; Contreras-Moreira B, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00184; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; de Biazio GR, 2008, BRAZ J MICROBIOL, V39, P554, DOI [10.1590/S1517-83822008000300028, 10.1590/S1517-838220080003000028]; Garcia-Avila CD, 2016, FLA ENTOMOL, V99, P555, DOI 10.1653/024.099.0335; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Ellwood SR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r109; Eskalen A, 2012, PLANT DIS, V96, P1070, DOI 10.1094/PDIS-03-12-0276-PDN; Eskalen A, 2013, PLANT DIS, V97, P938, DOI 10.1094/PDIS-11-12-1026-RE; Faria CB, 2012, CIENCIA TECNOL ALIME, V32, P201, DOI 10.1590/S0101-20612012005000027; Faria CB, 2012, INT J MOL SCI, V13, P115, DOI 10.3390/ijms13010115; Forgetta Vincenzo, 2013, J Biomol Tech, V24, P39, DOI 10.7171/jbt.12-2401-005; Frantzeskakis L, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4750-6; Freeman S, 2013, MYCOLOGIA, V105, P1595, DOI 10.3852/13-066; Gans JD, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn301; Gardiner DM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002952; Golicz AA, 2016, PLANT BIOTECHNOL J, V14, P1099, DOI 10.1111/pbi.12499; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Hanna SE, 2005, J FOOD SCI, V70, pR49; Haridas S, 2020, STUD MYCOL, P141, DOI 10.1016/j.simyco.2020.01.003; Ibarra-Laclette E, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00881-17, 10.1128/genomea.00881-17]; Inglis PW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206085; Innis MA, 1990, PCR PROTOCOLS GUIDE; Jones L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1081; Karlsson I, 2016, APPL ENVIRON MICROB, V82, P491, DOI 10.1128/AEM.02748-15; Kavroulakis N, 2007, J EXP BOT, V58, P3853, DOI 10.1093/jxb/erm230; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2010, NAT BIOTECHNOL, V28, P57, DOI 10.1038/nbt.1596; Li Y, 2010, J PLANT PATHOL, V92, P525; Lievens B, 2005, PHYTOPATHOLOGY, V95, P1374, DOI 10.1094/PHYTO-95-1374; Lievens B, 2008, PEST MANAG SCI, V64, P781, DOI 10.1002/ps.1564; Lievens B, 2007, ENVIRON MICROBIOL, V9, P2145, DOI 10.1111/j.1462-2920.2007.01329.x; Ling J, 2016, J INTEGR AGR, V15, P822, DOI 10.1016/S2095-3119(15)61237-0; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Maphosa MN, 2016, G3-GENES GENOM GENET, V6, P631, DOI 10.1534/g3.115.025817; Marsberg A, 2017, MOL PLANT PATHOL, V18, P477, DOI 10.1111/mpp.12495; McCartney HA, 2003, PEST MANAG SCI, V59, P129, DOI 10.1002/ps.575; McInerney JO, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.40; Mishra RK, 2013, J MICROBIOL, V51, P405, DOI 10.1007/s12275-013-2638-3; Mondo SJ, 2017, NAT GENET, V49, P964, DOI 10.1038/ng.3859; Moriel DG, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00326-16; Moussa TAA, 2017, ANTON LEEUW INT J G, V110, P819, DOI 10.1007/s10482-017-0855-1; Na F, 2018, PLANT DIS, V102, P1154, DOI [10.1094/PDIS-07-17-1042-RE, 10.1094/pdis-07-17-1042-re]; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; O'Donnell K, 2016, PHYTOPARASITICA, V44, P435, DOI 10.1007/s12600-016-0543-0; Ohm RA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003037; Okagaki LH, 2015, G3-GENES GENOM GENET, V5, P2539, DOI 10.1534/g3.115.020057; Qiu H, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0264-3; Rendon-Anaya M, 2019, P NATL ACAD SCI USA, V116, P17081, DOI 10.1073/pnas.1822129116; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Sanchez-Rangel D, 2005, J AGR FOOD CHEM, V53, P8565, DOI 10.1021/jf0514827; Shang YF, 2016, GENOME BIOL EVOL, V8, P1374, DOI 10.1093/gbe/evw082; Short DPG, 2017, PLANT DIS, V101, P233, DOI 10.1094/PDIS-07-16-1046-RE; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Stouthamer R, 2017, AGR FOREST ENTOMOL, V19, P366, DOI 10.1111/afe.12215; Summerell BA, 2003, PLANT DIS, V87, P117, DOI 10.1094/PDIS.2003.87.2.117; Tapia-Tussell R, 2006, MOL BIOTECHNOL, V33, P67; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Dam P, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01868-17; Vanderpool D, 2018, MOL ECOL, V27, P2077, DOI 10.1111/mec.14394; Vestergard M, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv025; Visentin I, 2009, MYCOL RES, V113, P1137, DOI 10.1016/j.mycres.2009.07.011; Waweru B, 2014, BIOL CONTROL, V74, P82, DOI 10.1016/j.biocontrol.2014.04.002; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wu WH, 2017, APPL MICROBIOL BIOT, V101, P2603, DOI 10.1007/s00253-017-8091-1; Zeiner CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157844	90	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246079	10.1371/journal.pone.0246079	http://dx.doi.org/10.1371/journal.pone.0246079			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507916	gold, Green Published			2022-12-26	WOS:000635021400083
J	Diehl, E; Rieger, S; Letzel, S; Schablon, A; Nienhaus, A; Pinzon, LCE; Dietz, P				Diehl, Elisabeth; Rieger, Sandra; Letzel, Stephan; Schablon, Anja; Nienhaus, Albert; Pinzon, Luis Carlos Escobar; Dietz, Pavel			The relationship between workload and burnout among nurses: The buffering role of personal, social and organisational resources	PLOS ONE			English	Article							PALLIATIVE CARE; COMPASSION FATIGUE; STRESS-BURNOUT; MENTAL-HEALTH; WHITE PAPER; QUESTIONNAIRE; HOSPICE; RECOMMENDATIONS; COMMITMENT; MODERATOR	Workload in the nursing profession is high, which is associated with poor health. Thus, it is important to get a proper understanding of the working situation and to analyse factors which might be able to mitigate the negative effects of such a high workload. In Germany, many people with serious or life-threatening illnesses are treated in non-specialized palliative care settings such as nursing homes, hospitals and outpatient care. The purpose of the present study was to investigate the buffering role of resources on the relationship between workload and burnout among nurses. A nationwide cross-sectional survey was applied. The questionnaire included parts of the Copenhagen Psychosocial Questionnaire (COPSOQ) (scale 'quantitative demands' measuring workload, scale 'burnout', various scales to resources), the resilience questionnaire RS-13 and single self-developed questions. Bivariate and moderator analyses were performed. Palliative care aspects, such as the 'extent of palliative care', were incorporated to the analyses as covariates. 497 nurses participated. Nurses who reported workplace commitment', a 'good working team' and 'recognition from supervisor' conveyed a weaker association between 'quantitative demands' and 'burnout' than those who did not. On average, nurses spend 20% of their working time with palliative care. Spending more time than this was associated with 'burnout'. The results of our study imply a buffering role of different resources on burnout. Additionally, the study reveals that the 'extent of palliative care' may have an impact on nurse burnout, and should be considered in future studies.	[Diehl, Elisabeth; Rieger, Sandra; Letzel, Stephan; Pinzon, Luis Carlos Escobar; Dietz, Pavel] Johannes Gutenberg Univ Mainz, Inst Occupat Social & Environm Med, Univ Med Ctr, Mainz, Germany; [Schablon, Anja; Nienhaus, Albert] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany; [Nienhaus, Albert] Inst Accid Insurance & Prevent Hlth & Welf Serv B, Dept Occupat Med Hazardous Subst & Hlth Sci, Hamburg, Germany; [Pinzon, Luis Carlos Escobar] Fed Inst Occupat Safety & Hlth BAuA, Berlin, Germany	Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dietz, P (corresponding author), Johannes Gutenberg Univ Mainz, Inst Occupat Social & Environm Med, Univ Med Ctr, Mainz, Germany.	pdietz@uni-mainz.de		Dietz, Pavel/0000-0002-8390-0594	BGW Berufsgenossenschaft fur Gesundheitsdienst und Wohlfahrtspflege (Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services)	BGW Berufsgenossenschaft fur Gesundheitsdienst und Wohlfahrtspflege (Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services)	The research was funded by the BGW Berufsgenossenschaft fur Gesundheitsdienst und Wohlfahrtspflege (Institution for Statutory Accident Insurance and Prevention in Health and Welfare Services). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamdan Z., 2017, GLOBAL J HLTH SCI, V10, P111, DOI [10.5539/gjhs.v10n1p111, DOI 10.5539/GJHS.V10N1P111]; Biagioli V, 2018, J HOSP PALLIAT NURS, V20, P377, DOI 10.1097/NJH.0000000000000454; Bianchi R, 2015, CLIN PSYCHOL REV, V36, P28, DOI 10.1016/j.cpr.2015.01.004; Bria M., 2012, COGN BRAIN BEHAV INT, V16, P423; Buzgova R., 2015, CENTRAL EUROPEAN J N, V6, P218, DOI 10.15452/CEJNM.2015.06.0006; Canadian Health Services Research Foundation, 2006, EAMW HEALTHC PROM EF; Centeno C, 2018, J PALLIAT MED, V21, P1389, DOI 10.1089/jpm.2018.0248; Chana N, 2015, J CLIN NURS, V24, P2835, DOI 10.1111/jocn.12891; Deutsche Gesellschaft fur Palliativmedizin, 2016, DEF HOSP PALL; Deutsche Krebsgesellschaft Deutsche Krebshilfe, 2015, PALL PAT NICHT HEILB, V1; Diehl E., 2018, ARBEITSMEDIZIN SOZIA, V53, P33; Diehl E, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00589-y; Diehl E, 2019, PFLEGE, V32, P209, DOI 10.1024/1012-5302/a000680; Diehl E, 2018, Z PALLIATMEDIZIN, V19, P306, DOI 10.1055/a-0666-3588; Donald I, 2001, J ENVIRON PSYCHOL, V21, P353, DOI 10.1006/jevp.2001.0229; Drennan VM, 2019, BRIT MED BULL, V130, P25, DOI 10.1093/bmb/ldz014; du Prel JB, 2009, DTSCH ARZTEBL INT, V106, P335, DOI 10.3238/arztebl.2009.0335; EVANS MG, 1985, ORGAN BEHAV HUM DEC, V36, P305, DOI 10.1016/0749-5978(85)90002-0; Field A., 2016, DISCOVERING STAT USI, V4th; Freiburger Forschungsstelle fur Arbeits-und Sozialmedizin, 2016, BEFR PSYCH FAKT ARB; Freimann T, 2015, SCAND J PUBLIC HEALT, V43, P447, DOI 10.1177/1403494815579477; Gama G, 2014, EUR J ONCOL NURS, V18, P527, DOI 10.1016/j.ejon.2014.04.005; Garcia-Izquierdo M, 2018, J NURS SCHOLARSHIP, V50, P228, DOI 10.1111/jnu.12367; Garcia-Sierra R, 2016, J NURS MANAGE, V24, P780, DOI 10.1111/jonm.12382; Gencer D, 2017, GESUNDHEITSWESEN, V81, P92, DOI 10.1055/s-0043-109429; George W, 2013, STERBEN KRANKENHAUS; George W, 2015, KRANKENHAUS, P131; Gerhard C, 2018, Z PALLIATMEDIZIN, V19, P226; German National Academy of Sciences Leopoldina and Union of German Academies of Sciences, 2015, PALL CAR GERM PERSP; Gillet N, 2020, J CLIN NURS, V29, P583, DOI 10.1111/jocn.15116; Gorgens-Ekermans G, 2012, J CLIN NURS, V21, P2275, DOI 10.1111/j.1365-2702.2012.04171.x; Havaei F, 2016, J NURS MANAGE, V24, P393, DOI 10.1111/jonm.12334; Ilic IM, 2017, MED PR, V68, P167, DOI 10.13075/mp.5893.00516; Jourdain G, 2010, INT J NURS STUD, V47, P709, DOI 10.1016/j.ijnurstu.2009.11.007; Kalisch BJ, 2005, J NURS ADMIN, V35, P550, DOI 10.1097/00005110-200512000-00009; Koh MYH, 2015, PALLIATIVE MED, V29, P633, DOI 10.1177/0269216315575850; Leppert K, 2008, KLIN DIAGNOSTIK EVAL, V2008, P226; Leppert K, 2013, PID PSYCHOTHERAPIE D, V14, P52, DOI DOI 10.1055/S-0033-1337097; Lincke H. J., 2016, Public Health Forum, V24, P161; Marc van Veldhoven, 2014, INTRO CONT WORK PSYC, P117; Caro MM, 2017, ENFERM CLIN, V27, P379, DOI 10.1016/j.enfcli.2017.04.007; Melching H., 2015, PALLIATIVVERSORGUNG; Melvin CS, 2015, J HOSP PALLIAT NURS, V17, P66, DOI 10.1097/NJH.0000000000000126; Jurado MDM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061116; Vargas RM, 2016, PALLIATIVE MED, V30, P161, DOI 10.1177/0269216315583434; Muller M, 2010, Z PALLIATMEDIZIN, V11, P227, DOI 10.1055/s-0030-1248520; Nauck F, 2018, KLINIKARZT, V47, P348, DOI [10.1055/a-0656-9107, DOI 10.1055/A-0656-9107]; Nauck F, 2015, ANASTH INTENSIV NOTF, V50, P36, DOI 10.1055/s-0040-100205; Nesje K, 2017, SCAND J PSYCHOL, V58, P185, DOI 10.1111/sjop.12349; Nubling Matthias, 2006, Psychosoc Med, V3, pDoc05; Nuebling M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-538; Nuebling M, 2010, SCAND J PUBLIC HEALT, V38, P120, DOI 10.1177/1403494809353652; ODaniel M, 2008, PATIENT SAFETY QUALI; Pereira SM, 2011, NURS ETHICS, V18, P317, DOI 10.1177/0969733011398092; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Rudow B., 2014, GESUNDE ARBEIT PSYCH, V3rd; Schmidt K. H., 2007, INT J STRESS MANAGE, V14, P26, DOI DOI 10.1037/1072-5245.14.1.26; Seed S, 2012, J HOSP PALLIAT NURS, V14, pE1, DOI 10.1097/NJH.0b013e31825c1485; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Velando-Soriano A, 2020, JPN J NURS SCI, V17, DOI 10.1111/jjns.12269; Wagnild G M, 1993, J Nurs Meas, V1, P165; Whitebird RR, 2013, J PALLIAT MED, V16, P1534, DOI 10.1089/jpm.2013.0202; Xanthopoulou D, 2007, J MANAGE PSYCHOL, V22, P766	64	17	16	5	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245798	10.1371/journal.pone.0245798	http://dx.doi.org/10.1371/journal.pone.0245798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481918	gold, Green Published			2022-12-26	WOS:000612929300122
J	Karhadkar, TR; Pilling, D; Gomer, RH				Karhadkar, Tejas R.; Pilling, Darrell; Gomer, Richard H.			Serum Amyloid P inhibits single stranded RNA-induced lung inflammation, lung damage, and cytokine storm in mice	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; INNATE LYMPHOID-CELLS; FC-GAMMA RECEPTORS; COMPONENT BINDS; SEX-DIFFERENCES; TGF-BETA; DIFFERENTIATION; MACROPHAGES; MEDIATE	SARS-CoV-2 is a single stranded RNA (ssRNA) virus and contains GU-rich sequences distributed abundantly in the genome. In COVID-19, the infection and immune hyperactivation causes accumulation of inflammatory immune cells, blood clots, and protein aggregates in lung fluid, increased lung alveolar wall thickness, and upregulation of serum cytokine levels. A serum protein called serum amyloid P (SAP) has a calming effect on the innate immune system and shows efficacy as a therapeutic for fibrosis in animal models and clinical trials. Here we show that aspiration of the GU-rich ssRNA oligonucleotide ORN06 into mouse lungs induces all of the above COVID-19-like symptoms. Men tend to have more severe COVID-19 symptoms than women, and in the aspirated ORN06 model, male mice tended to have more severe symptoms than female mice. Intraperitoneal injections of SAP starting from day 1 post ORN06 aspiration attenuated the ORN06-induced increase in the number of inflammatory cells and formation of clot-like aggregates in the mouse lung fluid, reduced ORN06-increased alveolar wall thickness and accumulation of exudates in the alveolar air-space, and attenuated an ORN06-induced upregulation of the inflammatory cytokines IL-1 beta, IL-6, IL-12p70, IL-23, and IL-27 in serum. SAP also reduced D-dimer levels in the lung fluid. In human peripheral blood mononuclear cells, SAP attenuated ORN06-induced extracellular accumulation of IL-6. Together, these results suggest that aspiration of ORN06 is a simple model for both COVID-19 as well as cytokine storm in general, and that SAP is a potential therapeutic for diseases with COVID-19-like symptoms and/or a cytokine storm.	[Karhadkar, Tejas R.; Pilling, Darrell; Gomer, Richard H.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Gomer, RH (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	rgomer@tamu.edu	Karhadkar, Tejas/GMW-6597-2022; Karhadkar, Tejas/AGZ-1410-2022	Karhadkar, Tejas/0000-0002-9241-8003; Pilling, Darrell/0000-0002-7413-2773	National Institute of Health [HL-132919]; NIH [GM11835503S1]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health HL-132919 and NIH GM11835503S1 (Both grants to RHG). www.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen O, 1997, SCAND J IMMUNOL, V46, P331, DOI 10.1046/j.1365-3083.1997.d01-147.x; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Bagri P, 2017, J VIROL, V91, DOI 10.1128/JVI.01234-17; BALTZ ML, 1980, IMMUNOLOGY, V41, P59; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Barlow JL, 2019, ANNU REV PHYSIOL, V81, P429, DOI 10.1146/annurev-physiol-020518-114630; Barnes PJ, 2016, AM J RESP CRIT CARE, V193, P813, DOI 10.1164/rccm.201512-2379ED; Barton LM, 2020, AM J CLIN PATHOL, V153, P725, DOI [10.1093/AJCP/AQAA062, 10.1093/ajcp/aqaa062]; Beigmohammadi MT, 2021, INT J SURG PATHOL, V29, P135, DOI 10.1177/1066896920935195; Bharadwaj D, 2001, J IMMUNOL, V166, P6735, DOI 10.4049/jimmunol.166.11.6735; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Chen WS, 2020, EXP LUNG RES, V46, P75, DOI 10.1080/01902148.2020.1733135; Cong M, 2017, INT J MOL MED, V40, P454, DOI 10.3892/ijmm.2017.3028; Cox N, 2014, J IMMUNOL, V193, P1701, DOI 10.4049/jimmunol.1400281; Crawford JR, 2012, J LEUKOCYTE BIOL, V92, P699, DOI 10.1189/jlb.0112033; Crawford JR, 2010, J IMMUNOL METHODS, V363, P9, DOI 10.1016/j.jim.2010.09.025; Crayne CB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00119; Daubeuf Francois, 2012, Curr Protoc Mouse Biol, V2, P167, DOI 10.1002/9780470942390.mo110201; Donovan John, 2005, Curr Protoc Neurosci, VAppendix 4, p4G, DOI 10.1002/0471142301.nsa04gs33; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Galkina Elena V., 2000, Russ J Immunol, V5, P363; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Grobler C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21145168; HAMAZAKI H, 1995, J BIOL CHEM, V270, P10392, DOI 10.1074/jbc.270.18.10392; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Herlihy SE, 2013, J IMMUNOL, V190, P6468, DOI 10.4049/jimmunol.1202583; Horvath A, 2001, ANTIVIR RES, V52, P43, DOI 10.1016/S0166-3542(01)00158-9; Job ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059623; Karhadkar TR, 2020, AM J PHYSIOL-LUNG C, V318, pL165, DOI 10.1152/ajplung.00275.2019; Karhadkar TR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15198-8; Khalil Nasreen, 2008, V1, P581, DOI 10.1007/978-1-59745-292-2_36; Kirwan G, 2014, CYBERPSYCHOLOGY AND NEW MEDIA: A THEMATIC READER, P3; Klein SL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008570; Kuri-Cervantes L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd7114; LE PT, 1984, J LEUKOCYTE BIOL, V35, P587; Li Y, 2013, MICROBES INFECT, V15, P88, DOI 10.1016/j.micinf.2012.10.008; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Linkins LA, 2017, INT J LAB HEMATOL, V39, P98, DOI 10.1111/ijlh.12665; Luzina IG, 2016, AM J PHYSIOL-LUNG C, V310, pL940, DOI 10.1152/ajplung.00346.2015; Majer O, 2017, CURR OPIN IMMUNOL, V44, P26, DOI 10.1016/j.coi.2016.10.003; McElvaney OJ, 2020, AM J RESP CRIT CARE, V202, P812, DOI 10.1164/rccm.202005-1583OC; Mould KJ, 2017, AM J RESP CELL MOL, V57, P294, DOI 10.1165/rcmb.2017-0061OC; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Murray LA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-11; Murray LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009683; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; Nakagawa N, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87446; Parasuraman S, 2010, J PHARMACOL PHARMACO, V1, P87, DOI 10.4103/0976-500X.72350; PEPYS MB, 1979, CLIN EXP IMMUNOL, V38, P284; Pepys MB, 1997, AMYLOID, V4, P274, DOI 10.3109/13506129709003838; PILLING D, 1989, J IMMUNOL METHODS, V122, P235, DOI 10.1016/0022-1759(89)90269-X; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2014, P NATL ACAD SCI USA, V111, P18291, DOI 10.1073/pnas.1417426112; Pilling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093730; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Reyfman PA, 2019, AM J RESP CRIT CARE, V199, P1517, DOI 10.1164/rccm.201712-2410OC; Sanchez-Cerrillo I, 2020, J CLIN INVEST, V130, P6290, DOI 10.1172/JCI140335; Scharff AZ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122998; Schulert GS, 2020, GENES IMMUN, V21, P169, DOI 10.1038/s41435-020-0098-4; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Schutgens RE, 2020, HEMASPHERE, V4, DOI 10.1097/HS9.0000000000000422; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; Stibenz D, 2006, EUR J IMMUNOL, V36, P446, DOI 10.1002/eji.200425360; Tam A, 2016, AM J RESP CRIT CARE, V193, P825, DOI 10.1164/rccm.201503-0487OC; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Vannella KM, 2017, ANNU REV PHYSIOL, V79, P593, DOI 10.1146/annurev-physiol-022516-034356; Verstovsek S, 2016, J EXP MED, V213, P1723, DOI 10.1084/jem.20160283; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Voltz JW, 2008, AM J RESP CELL MOL, V39, P45, DOI 10.1165/rcmb.2007-0340OC; Walters Dianne M, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0546s40; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1101/2020.04.17.20069930, 10.1038/s41591-020-0944-y]; Willinger T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02010; Yao YM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00466-z; Zhang YM, 2011, CLIN CHIM ACTA, V412, P227, DOI 10.1016/j.cca.2010.09.036; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou XM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020273	85	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245924	10.1371/journal.pone.0245924	http://dx.doi.org/10.1371/journal.pone.0245924			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481950	gold, Green Submitted, Green Published			2022-12-26	WOS:000612929300133
J	Ribeiro, HV; Oehlers, M; Moreno-Monroy, AI; Kropp, JP; Rybski, D				Ribeiro, Haroldo, V; Oehlers, Milena; Moreno-Monroy, Ana, I; Kropp, Jurgen P.; Rybski, Diego			Association between population distribution and urban GDP scaling	PLOS ONE			English	Article							POWER-LAW DISTRIBUTIONS; ZIPFS LAW; CITIES; GROWTH	Urban scaling and Zipf's law are two fundamental paradigms for the science of cities. These laws have mostly been investigated independently and are often perceived as disassociated matters. Here we present a large scale investigation about the connection between these two laws using population and GDP data from almost five thousand consistently-defined cities in 96 countries. We empirically demonstrate that both laws are tied to each other and derive an expression relating the urban scaling and Zipf exponents. This expression captures the average tendency of the empirical relation between both exponents, and simulations yield very similar results to the real data after accounting for random variations. We find that while the vast majority of countries exhibit increasing returns to scale of urban GDP, this effect is less pronounced in countries with fewer small cities and more metropolises (small Zipf exponent) than in countries with a more uneven number of small and large cities (large Zipf exponent). Our research puts forward the idea that urban scaling does not solely emerge from intra-city processes, as population distribution and scaling of urban GDP are correlated to each other.	[Ribeiro, Haroldo, V] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil; [Oehlers, Milena; Kropp, Jurgen P.; Rybski, Diego] Member Leibniz Assoc, Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Moreno-Monroy, Ana, I] OECD, Paris, France; [Moreno-Monroy, Ana, I] Univ Liverpool, Dept Geog & Planning, Chatham St, Liverpool, Merseyside, England; [Kropp, Jurgen P.] Univ Potsdam, Inst Environm Sci & Geog, Potsdam, Germany; [Rybski, Diego] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Universidade Estadual de Maringa; Potsdam Institut fur Klimafolgenforschung; Organisation for Economic Co-operation & Development (OECD); University of Liverpool; University of Potsdam; University of California System; University of California Berkeley	Ribeiro, HV (corresponding author), Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil.; Rybski, D (corresponding author), Member Leibniz Assoc, Potsdam Inst Climate Impact Res PIK, Potsdam, Germany.; Rybski, D (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	hvr@dfi.uem.br; ca-dr@rybski.de	Ribeiro, Haroldo Valentin/C-8614-2012; Kropp, Juergen/D-8220-2012	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Kropp, Juergen/0000-0001-7791-3420; Rybski, Diego/0000-0001-6125-7705	CNPq [440650/2014-3, 303642/2014-9]; Alexander von Humboldt Foundation under the Feodor Lynen Fellowship; Leibniz Association (project IMPETUS)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alexander von Humboldt Foundation under the Feodor Lynen Fellowship(Alexander von Humboldt Foundation); Leibniz Association (project IMPETUS)	HVR acknowledges the support of CNPq (Grants Nos. 440650/2014-3 and 303642/2014-9). DR thanks the Alexander von Humboldt Foundation for financial support under the Feodor Lynen Fellowship. DR is also grateful to the Leibniz Association (project IMPETUS) for financially supporting this research.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Alves LGA, 2014, PHYSICA A, V409, P175, DOI 10.1016/j.physa.2014.04.046; Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Auerbach F, 1913, PETERMANNS MITT, V59, P74; Balland PA, 2020, NAT HUM BEHAV, V4, P248, DOI 10.1038/s41562-019-0803-3; Barthelemy M., 2016, STRUCTURE DYNAMICS C; Barthelemy M, 2019, NAT REV PHYS, V1, P406, DOI 10.1038/s42254-019-0054-2; Batty M., 2013, NEW SCI CITIES; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Berry BJL, 2012, CITIES, V29, pS17, DOI 10.1016/j.cities.2011.11.007; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0846; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bhattacharya A, 2020, ARXIV200206870; Bouchand J.-P., 2001, Quantitative Finance, V1, P105, DOI 10.1088/1469-7688/1/1/307; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Bohorquez JC, 2009, NATURE, V462, P911, DOI 10.1038/nature08631; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Depersin J, 2018, P NATL ACAD SCI USA, V115, P2317, DOI 10.1073/pnas.1718690115; Efron B, 1994, INTRO BOOTSTRAP; Gabaix X, 1999, AM ECON REV, V89, P129, DOI 10.1257/aer.89.2.129; Gabaix X., 2004, HDB REGIONAL URBAN E, P2341, DOI DOI 10.1016/S1574-0080(04)80010-5; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Gomez-Lievano A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0012; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Hsieh CT, 2019, AM ECON J-MACROECON, V11, P1, DOI 10.1257/mac.20170388; Huber P.J., 2009, ROBUST STAT, V2nd; Jiang LW, 2017, GLOBAL ENVIRON CHANG, V42, P193, DOI 10.1016/j.gloenvcha.2015.03.008; Keuschnigg M, 2019, P NATL ACAD SCI USA, V116, P13759, DOI 10.1073/pnas.1906258116; Kummu M, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.4; Li XT, 2015, PALGR COMMUN, V1, DOI 10.1057/palcomms.2015.17; Lobo J., 2020, REPORT SUBMITTED NSF, DOI [10.2139/ssrn.3526940, DOI 10.2139/SSRN.3526940]; Marshall A., 1890, PRINCIPLES EC; MetaZipf Cottineau C., 2017, PLOS ONE, V12, DOI [10.1371/journal.pone.0183919, DOI 10.1371/JOURNAL.PONE.0183919]; Moreno-Monroy AI, 2021, J URBAN ECON, V125, DOI 10.1016/j.jue.2020.103242; Mori T, 2020, P NATL ACAD SCI USA, V117, P6469, DOI 10.1073/pnas.1913014117; Nitsch V, 2005, J URBAN ECON, V57, P86, DOI 10.1016/j.jue.2004.09.002; Pesaresi M, 2016, INT GEOSCI REMOTE SE, P7276, DOI 10.1109/IGARSS.2016.7730897; Pesaresi M., 2015, GHS POPULATION GRID; Pumain D., 1997, GEOJOURNAL, V43, P307, DOI DOI 10.1023/A:1006833025206; Pumain D, 2019, ENVIRON PLAN B-URBAN, V46, P1645, DOI 10.1177/2399808318785633; Ribeiro FL, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160926; Ribeiro HV, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.025503; Rybski D, 2017, ENVIRON PLAN B-URBAN, V44, P425, DOI 10.1177/0265813516638340; Schiavina M, 2019, JRC TECHNICAL REPORT; Schmidheiny K, 2015, ECON LETT, V133, P10, DOI 10.1016/j.econlet.2015.05.013; Seabold S, 2010, P 9 PYTHON SCI C; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; Strano E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159465; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; West G., 2017, SCALE UNIVERSAL LAWS; Zhang JA, 2010, PHYSICA A, V389, P4887, DOI 10.1016/j.physa.2010.06.059; Zhang LM, 2019, P NATL ACAD SCI USA, V116, P8673, DOI 10.1073/pnas.1814982116; Zipf GK, 1950, J CLIN PSYCHOL, V6, P306	56	4	4	8	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245771	10.1371/journal.pone.0245771	http://dx.doi.org/10.1371/journal.pone.0245771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481927	Green Submitted, Green Published, gold			2022-12-26	WOS:000612929300060
J	Quittot, N; Fortier, M; Babych, M; Nguyen, PT; Sebastiao, M; Bourgault, S				Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve			Cell surface glycosaminoglycans exacerbate plasma membrane perturbation induced by the islet amyloid polypeptide	FASEB JOURNAL			English	Article						amyloid; glycosaminoglycans; islet amyloid polypeptide; self&#8208; assembly; membrane perturbation	HEPARAN-SULFATE PROTEOGLYCANS; BETA-CELLS; HUMAN-IAPP; TYPE-2; PEPTIDE; AGGREGATION; PROTEIN; MECHANISM; TOXICITY; INTERNALIZATION	Glycosaminoglycans (GAGs) are long and unbranched anionic heteropolysaccharides that have been associated with virtually all amyloid deposits. Soluble sulfated GAGs are known for their propensity to promote the self-assembly of numerous amyloidogenic proteins and to modulate their cytotoxicity. Nonetheless, although GAGs are prevalent on the outer leaflet of eukaryotic cell plasma membrane as part of proteoglycans, their contributions in the perturbation of lipid bilayer induced by amyloid polypeptides remain unknown. Herein, we investigate the roles of GAGs in the cytotoxicity and plasma membrane perturbation induced by the islet amyloid polypeptide (IAPP), whose deposition in the pancreatic islets is associated with type II diabetes. Cellular assays using GAG-deficient cells reveal that GAGs exacerbate IAPP-induced cytotoxicity and permeabilization of the plasma membrane. Confocal microscopy and flow cytometry analyses show that IAPP sequestration at the cell surface is dependent of GAGs and of the aggregation propensity of the peptide. Using giant plasma membrane vesicles (GPMVs) prepared from GAG-deficient cells, we investigate the direct contributions of membrane-embedded proteoglycans in IAPP-induced membrane disassembly. In sharp contrast to soluble sulfated GAGs, kinetics of amyloid self-assembly expose that the presence of GAGs on GPMVs does not significantly modulate in vitro amyloid formation. Overall, this study indicates that cell surface GAGs increase the local concentration of IAPP in the vicinity of the plasma membrane, promoting lipid bilayer perturbation and cell death.	[Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] Univ Quebec Montreal, Dept Chem, CP 8888, Montreal, PQ H3C 3P8, Canada; [Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] Courtois Fdn, Ctr Excellence Res Orphan Dis, Montreal, PQ, Canada; [Quittot, Noe; Fortier, Mathilde; Babych, Margaryta; Phuong Trang Nguyen; Sebastiao, Mathew; Bourgault, Steve] PROTEO, Quebec Network Res Prot Funct Engn & Applicat, Quebec City, PQ, Canada	University of Quebec; University of Quebec Montreal	Bourgault, S (corresponding author), Univ Quebec Montreal, Dept Chem, CP 8888, Montreal, PQ H3C 3P8, Canada.	bourgault.steve@ugam.ca						Abedini A, 2005, ORG LETT, V7, P693, DOI 10.1021/ol047480+; Abedini A, 2018, J CLIN INVEST, V128, P682, DOI 10.1172/JCI85210; Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; Aston-Mourney K, 2011, DIABETOLOGIA, V54, P1756, DOI 10.1007/s00125-011-2143-3; Bejoy J, 2018, ACS BIOMATER SCI ENG, V4, P2922, DOI 10.1021/acsbiomaterials.8b00021; Bergamaschini L, 2002, NEUROBIOL AGING, V23, P531, DOI 10.1016/S0197-4580(02)00003-9; Birol M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03651-9; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Bradshaw AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001142; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Caillon L, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5639875; CARLES J, 1956, B SOC CHIM BIOL, V38, P255; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; COOPER GJS, 1987, P NATL ACAD SCI USA, V84, P8628, DOI 10.1073/pnas.84.23.8628; De Carufel C. A., 2015, ANGEW CHEM, V127, P14591, DOI DOI 10.1002/ANGE.201507092; De Carufel CA, 2013, BIOPOLYMERS, V100, P645, DOI 10.1002/bip.22243; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Engel MFM, 2009, CHEM PHYS LIPIDS, V160, P1, DOI 10.1016/j.chemphyslip.2009.03.008; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Godin E, 2019, J BIOL CHEM, V294, P8452, DOI 10.1074/jbc.RA118.006454; Green JD, 2004, J MOL BIOL, V342, P877, DOI 10.1016/j.jmb.2004.07.052; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Hong YN, 2012, J AM CHEM SOC, V134, P1680, DOI 10.1021/ja208720a; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hull RL, 2009, DIABETOLOGIA, V52, P1102, DOI 10.1007/s00125-009-1329-4; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Jeong HR, 2015, CLIN INTERV AGING, V10, P1873, DOI 10.2147/CIA.S95297; Jha S, 2011, J BIOL CHEM, V286, P22894, DOI 10.1074/jbc.M110.215814; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim J, 2014, J CLIN INVEST, V124, P3311, DOI 10.1172/JCI69625; Kisilevsky R, 2000, AMYLOID, V7, P23, DOI 10.3109/13506120009146820; Krotee P, 2017, ELIFE, V6, DOI 10.7554/eLife.19273; Last NB, 2013, PROTEIN SCI, V22, P870, DOI 10.1002/pro.2274; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LORENZO A, 1994, NATURE, V368, P756, DOI 10.1038/368756a0; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Madine J, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190327; Madine J, 2010, EUR BIOPHYS J BIOPHY, V39, P1281, DOI 10.1007/s00249-010-0581-3; Magzoub M, 2012, FASEB J, V26, P1228, DOI 10.1096/fj.11-194613; Maiza A, 2018, FEBS LETT, V592, P3806, DOI 10.1002/1873-3468.13082; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; Mukherjee A, 2017, J EXP MED, V214, P2591, DOI 10.1084/jem.20161134; Oskarsson ME, 2015, J BIOL CHEM, V290, P15121, DOI 10.1074/jbc.M114.631697; Papy-Garcia D, 2011, CURR PROTEIN PEPT SC, V12, P258, DOI 10.2174/138920311795860188; Park YJ, 2012, DIABETOLOGIA, V55, P1035, DOI 10.1007/s00125-012-2451-2; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; Nguyen PT, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/515307; Potter KJ, 2015, AM J TRANSPLANT, V15, P1519, DOI 10.1111/ajt.13134; Quittot N, 2018, BIOCONJUGATE CHEM, V29, P517, DOI 10.1021/acs.bioconjchem.7b00827; Quittot N, 2017, BIOCHEM CELL BIOL, V95, P329, DOI 10.1139/bcb-2016-0236; Raleigh D, 2017, J MOL ENDOCRINOL, V59, pR121, DOI 10.1530/JME-17-0105; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Rivera JF, 2011, CELL DEATH DIFFER, V18, P415, DOI 10.1038/cdd.2010.111; Sandwall E, 2010, GLYCOBIOLOGY, V20, P533, DOI 10.1093/glycob/cwp205; Schlamadinger DE, 2014, BIOPHYS J, V107, P2559, DOI 10.1016/j.bpj.2014.09.047; Sebastiao M, 2019, BIOCHEMISTRY-US, V58, P1214, DOI 10.1021/acs.biochem.8b01206; Sebastiao M, 2017, ANAL BIOCHEM, V532, P83, DOI 10.1016/j.ab.2017.06.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shigihara N, 2014, J CLIN INVEST, V124, P3634, DOI 10.1172/JCI69866; Solomon JP, 2011, BIOCHEMISTRY-US, V50, P2486, DOI 10.1021/bi101905n; Templin AT, 2019, PROTEIN ENG DES SEL, V32, P95, DOI 10.1093/protein/gzz041; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Trikha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073080; Vidal J, 2003, DIABETOLOGIA, V46, P71, DOI 10.1007/s00125-002-0984-5; Wang H, 2013, J MOL BIOL, V425, P492, DOI 10.1016/j.jmb.2012.11.003; Wesen E, 2018, BBA-BIOMEMBRANES, V1860, P2204, DOI 10.1016/j.bbamem.2018.08.010; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951	80	3	3	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21306	10.1096/fj.202001845R	http://dx.doi.org/10.1096/fj.202001845R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475205				2022-12-26	WOS:000647789600044
J	Rahimi, R; Malek, I; Lerrer-Goldshtein, T; Elkis, Y; Shoval, I; Jacob, A; Shpungin, S; Nir, U				Rahimi, Roni; Malek, Israel; Lerrer-Goldshtein, Tali; Elkis, Yoav; Shoval, Irit; Jacob, Avi; Shpungin, Sally; Nir, Uri			TMF1 is upregulated by insulin and is required for a sustained glucose homeostasis	FASEB JOURNAL			English	Article						golgi; glucose&#8208; uptake; glucose&#8208; homeostasis; GLUT4; insulin; plasma membrane; TMF1; trafficking; vesicle; VAMP2	GLUT4; TMF/ARA160; PROTEIN; MUSCLE; GOLGI; SUSCEPTIBILITY; ABNORMALITIES; TRANSLOCATION; TRANSPORTERS; COACTIVATOR	Insulin-regulated glucose homeostasis is a critical and intricate physiological process, of which not all regulatory components have been deciphered. One of the key players in modulating glucose uptake by cells is the glucose transporter-GLUT4. In this study, we aimed to explore the regulatory role of the trans-Golgi-associated protein-TATA Element Modulatory Factor (TMF1) in the GLUT4 mediated, insulin-directed glucose uptake. By establishing and using TMF1-/- myoblasts and mice, we examined the effect of TMF1 absence on the insulin driven functioning of GLUT4. We show that TMF1 is upregulated by insulin in myoblasts, and is essential for the formation of insulin responsive, glucose transporter GLUT4-containing vesicles. Absence of TMF1 leads to the retention of GLUT4 in perinuclear compartments, and to severe impairment of insulin-stimulated GLUT4 trafficking throughout the cytoplasm and to the cell plasma membrane. Accordingly, glucose uptake is impaired in TMF1-/- cells, and TMF1-/- mice are hyperglycemic. This is reflected by the mice impaired blood glucose clearance and increased blood glucose level. Correspondingly, TMF1-/- animals are leaner than their normal littermates. Thus, TMF1 is a novel effector of insulin-regulated glucose homeostasis, and dys-functioning of this protein may contribute to the onset of a diabetes-like disorder.	[Rahimi, Roni; Malek, Israel; Lerrer-Goldshtein, Tali; Elkis, Yoav; Shoval, Irit; Jacob, Avi; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	uri.nir@biu.ac.il		Shoval, Irit/0000-0002-3009-3418; Jacob, Avi/0000-0002-0096-9888				Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bel S, 2014, P NATL ACAD SCI USA, V111, P4964, DOI 10.1073/pnas.1319114111; Bel S, 2012, J BIOL CHEM, V287, P25631, DOI 10.1074/jbc.M112.364786; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Elkis Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145277; Elkis Y, 2013, MOL CELL ENDOCRINOL, V365, P52, DOI 10.1016/j.mce.2012.09.003; Feng Y, 2020, J CELL PHYSIOL, V235, P5702, DOI 10.1002/jcp.29502; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Folgmann D., 2016, OPTIMIZED PROTOCOL M; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; George TC, 2006, J IMMUNOL METHODS, V311, P117, DOI 10.1016/j.jim.2006.01.018; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; Hindi L., BIOPROTOC, V7; Hsiao JJ, 2016, J BIOL CHEM, V291, P18818, DOI 10.1074/jbc.M116.732313; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Kandror KV, 2011, TRAFFIC, V12, P665, DOI 10.1111/j.1600-0854.2011.01175.x; KATZ EB, 1995, NATURE, V377, P151, DOI 10.1038/377151a0; KRAEGEN EW, 1993, BIOCHEM J, V295, P287, DOI 10.1042/bj2950287; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; Li HB, 2017, FEBS LETT, V591, P491, DOI 10.1002/1873-3468.12555; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Liu ZQ, 2015, TOXICOL APPL PHARM, V285, P61, DOI 10.1016/j.taap.2015.03.011; MAINS PE, 1990, GENETICS, V125, P351; Matsuzaka T, 2012, J DIABETES INVEST, V3, P130, DOI 10.1111/j.2040-1124.2011.00177.x; Miller VJ, 2013, J BIOL CHEM, V288, P4229, DOI 10.1074/jbc.M112.426767; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; OLEFSKY JM, 1993, ADV EXP MED BIOL, V334, P129; Papadopoulos N, 2018, J CELL BIOL, V217, P1701, DOI 10.1083/jcb.201706118; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Randhawa VK, 2004, MOL BIOL CELL, V15, P5565, DOI 10.1091/mbc.E04-03-0266; Rose AJ, 2009, AM J PHYSIOL-REG I, V297, pR1228, DOI 10.1152/ajpregu.00258.2009; Rudich A, 2003, ACTA PHYSIOL SCAND, V178, P297, DOI 10.1046/j.1365-201X.2003.01163.x; Sun Y, 2014, MOL BIOL CELL, V25, P1159, DOI 10.1091/mbc.E13-08-0493; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010	39	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2							e21295	10.1096/fj.202001995R	http://dx.doi.org/10.1096/fj.202001995R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33475194				2022-12-26	WOS:000647789600021
J	Cho, Y; Lee, S; Park, SJ				Cho, Youngjong; Lee, Sangjoon; Park, Sung-Joon			Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DIAGNOSTIC PERFORMANCE; CT; LIPIODOL	To investigate the effectiveness of intraprocedural dual-phase cone-beam computed tomography (CBCT) in detecting hepatocellular carcinoma (HCC) during conventional transcatheter arterial chemoembolization (TACE) and its effect on improving treatment outcomes. Between November 2018 and November 2019, data from 111 patients with unresectable HCCs (N = 263 lesions) were reviewed retrospectively. All patients had undergone baseline magnetic resonance imaging (MRI) scans within one month prior to the procedure. Both arterial-phase (AP) and delayed-phase CBCT images were acquired during all conventional TACEs. Each HCC detection rate when read by AP-CBCT and when read by dual-phase (DP) CBCT including both AP and delayed phase was compared with that of MRI, and the diagnosis of HCC was based on MRI. Additionally, the follow-up results concerning lipiodol uptake status and tumor response of the lesions detected only by AP-/DP-CBCT were analyzed and compared with MRI-only detected lesions. The overall sensitivity of DP-CBCT (94.7%) was significantly higher than that of AP-CBCT (89.0%) (p = 0.003). In particular, the rate of subcentimeter HCC detection by DP-CBCT was pronounced (91.5% vs. 80.3%) (p = 0.01). Lesions found only by DP-CBCT exhibited positive lipiodol uptake (n = 31/31; 100%) and showed complete or partial responses (n = 24/31; 77.4%) on follow-up CT imaging, while MRI-only detected lesions had less lipiodol uptake (n = 6/14, 42.9%) and complete or partial responses (n = 4/14; 28.6%) (p <= 0.001). DP-CBCT imaging during TACE enabled better detection of HCCs than when using AP-CBCT alone, and AP- and DP-CBCT is superior to MRI in detecting chemoembolization-sensitive lesions. This resulted in increased detectability of HCCs and the achievement of better treatment outcomes.	[Cho, Youngjong] Gangneung Asan Hosp, Dept Radiol, Gangneung Si, Gangwon Do, South Korea; [Lee, Sangjoon] Kangwon Natl Univ Hosp, Dept Radiol, Chuncheon Si, Gangwon Do, South Korea; [Park, Sung-Joon] Korea Univ, Dept Radiol, Ansan Hosp, Ansan, Gyeonggi Do, South Korea	Kangwon National University; Kangwon National University Hospital; Korea University; Korea University Medicine (KU Medicine)	Park, SJ (corresponding author), Korea Univ, Dept Radiol, Ansan Hosp, Ansan, Gyeonggi Do, South Korea.	dpcultintv@korea.ac.kr		Lee, Sangjoon/0000-0001-6492-514X; Park, Sung-Joon/0000-0002-1187-7671				El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Idee JM, 2013, CRIT REV ONCOL HEMAT, V88, P530, DOI 10.1016/j.critrevonc.2013.07.003; Langenbach MC, 2019, EUR RADIOL, V29, P6539, DOI 10.1007/s00330-019-06297-3; Li JJ, 2015, WORLD J GASTROENTERO, V21, P3035, DOI 10.3748/wjg.v21.i10.3035; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Loffroy R, 2012, CARDIOVASC INTER RAD, V35, P97, DOI 10.1007/s00270-011-0118-x; Lucatelli P, 2020, EUR J RADIOL, V124, DOI 10.1016/j.ejrad.2019.108806; Lucatelli P, 2019, RADIOL MED, V124, P1212, DOI 10.1007/s11547-019-01076-y; Lucatelli P, 2017, J VASC INTERV RADIOL, V28, P978, DOI 10.1016/j.jvir.2017.03.008; Miyayama S, 2013, J VASC INTERV RADIOL, V24, P501, DOI 10.1016/j.jvir.2012.12.022; Miyayama S, 2011, CARDIOVASC INTER RAD, V34, P81, DOI 10.1007/s00270-010-9835-9; Miyayama S, 2009, CARDIOVASC INTER RAD, V32, P255, DOI 10.1007/s00270-008-9468-4; Sato Y, 2013, UPSALA J MED SCI, V118, P16, DOI 10.3109/03009734.2012.729104; Tacher V, 2015, RADIOLOGY, V274, P320, DOI 10.1148/radiol.14131925; Tang A, 2018, RADIOLOGY, V286, P29, DOI 10.1148/radiol.2017170554; Wang XD, 2017, J CANCER RES THER, V13, P38, DOI 10.4103/0973-1482.206242; Yao XS, 2018, ACAD RADIOL, V25, P1031, DOI 10.1016/j.acra.2017.12.022; Yoshimitsu K, 2014, HEPATIC MED-EVID RES, V6, P89, DOI 10.2147/HMER.S31440; Yu MH, 2013, AM J ROENTGENOL, V201, P675, DOI 10.2214/AJR.12.10445	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0245911	10.1371/journal.pone.0245911	http://dx.doi.org/10.1371/journal.pone.0245911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513172	Green Published, gold			2022-12-26	WOS:000613891400047
J	Vikram, P; Sehgal, D; Sharma, A; Bhavani, S; Gupta, P; Randhawa, M; Pardo, N; Basandra, D; Srivastava, P; Singh, S; Sood, T; Sansaloni, CP; Rahman, H; Singh, S				Vikram, Prashant; Sehgal, Deepmala; Sharma, Achala; Bhavani, Sridhar; Gupta, Priyanka; Randhawa, Mandeep; Pardo, Neftali; Basandra, Daisy; Srivastava, Puja; Singh, Sanjay; Sood, Tanvi; Sansaloni, Carolina Paola; Rahman, Hifzur; Singh, Sukhwinder			Genome-wide association analysis of Mexican bread wheat landraces for resistance to yellow and stem rust	PLOS ONE			English	Article							F-SP TRITICI; STRIIFORMIS F.SP TRITICI; ADULT-PLANT RESISTANCE; ARRAYS TECHNOLOGY DART; PUCCINIA-STRIIFORMIS; STRIPE RUST; LINKAGE DISEQUILIBRIUM; GENETIC DIVERSITY; WINTER-WHEAT; RACES	Deploying under-utilized landraces in wheat breeding has been advocated to accelerate genetic gains in current era of genomics assisted breeding. Mexican bread wheat landraces (Creole wheats) represent an important resource for the discovery of novel alleles including disease resistance. A core set of 1,098 Mexican landraces was subjected to multi-location testing for rust diseases in India, Mexico and Kenya. The landrace core set showed a continuous variation for yellow (YR) and stem rust (SR) disease severity. Principal component analysis differentiated Mexican landraces into three groups based on their respective collection sites. Linkage disequilibrium (LD) decay varied from 10 to 32 Mb across chromosomes with an averge of 23Mb across whole genome. Genome-wide association analysis revealed marker-trait associations for YR resistance in India and Mexico as well as for SR resistance in Kenya. In addition, significant additive-additive interaction effects were observed for both YR and SR resistance including genomic regions on chromosomes 1BL and 3BS, which co-locate with pleiotropic genes Yr29/Lr46/Sr58/Pm39/Ltn2 and Sr2/Yr30/Lr27, respectively. Study reports novel genomic associations for YR (chromosomes 1AL, 2BS, and 3BL) and SR (chromosomes 2AL, 4DS, and 5DS). The novel findings in Creole wheat landraces can be efficiently utilized for the wheat genetic improvement.	[Vikram, Prashant; Sehgal, Deepmala; Bhavani, Sridhar; Pardo, Neftali; Sansaloni, Carolina Paola; Singh, Sukhwinder] Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico; [Vikram, Prashant; Rahman, Hifzur] Int Ctr Biosaline Agr, Academic Ciy, Dubai, U Arab Emirates; [Sharma, Achala; Srivastava, Puja] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana, Punjab, India; [Gupta, Priyanka] Rabat Inst, Int Ctr Agr Res Dry Areas ICARDA, Rabat, Morocco; [Randhawa, Mandeep] CIMMYT World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Basandra, Daisy; Sood, Tanvi] CSK HPKV Palampur, Dept Plant Breeding & Genet, Palampur, Himachal Prades, India; [Singh, Sanjay] ICAR Natl Inst Plant Biotechnol, New Delhi, India	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Punjab Agricultural University; CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); CGIAR; World Agroforestry (ICRAF); Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Singh, S (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, El Batan, Texcoco, Mexico.	sukhmatola@hotmail.com		Sharma, Achla/0000-0002-7932-3499; bhavani, sridhar/0000-0002-4091-2608	Secretariat of Agriculture and Rural Development (SADER); ICAR (Indian Council for Agriculture Research) funds	Secretariat of Agriculture and Rural Development (SADER); ICAR (Indian Council for Agriculture Research) funds	The authors hereby acknowledge the financial support received from Secretariat of Agriculture and Rural Development (SADER). We are also thankful to Punjab Agriculture University, Ludhiana, India for providing valuable support in conducting phenotyping with support from ICAR (Indian Council for Agriculture Research) funds.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01057; Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; [Anonymous], 2013, CROP BREEDING J; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Bansal UK, 2013, EUPHYTICA, V194, P219, DOI 10.1007/s10681-013-0940-0; Bayles RA, 2000, AGRONOMIE, V20, P805, DOI 10.1051/agro:2000176; Beddow JM, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.132, 10.1038/nplants.2015.132]; Berlin A, 2013, PLANT PATHOL, V62, P32, DOI 10.1111/j.1365-3059.2012.02609.x; Bhat JA, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00221; Bhattacharya S, 2017, NATURE, V542, P145, DOI 10.1038/nature.2017.21424; Bhavani S, 2019, FRONT AGRIC SCI ENG, V6, P210, DOI 10.15302/J-FASE-2019268; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Brinez B, 2012, MOL BREEDING, V30, P181, DOI 10.1007/s11032-011-9609-3; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chen XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044510; Crossa J, 2007, GENETICS, V177, P1889, DOI 10.1534/genetics.107.078659; Crossa J, 2016, G3-GENES GENOM GENET, V6, P1819, DOI 10.1534/g3.116.029637; de Vallavieille-Pope C, 2012, PLANT DIS, V96, P131, DOI 10.1094/PDIS-02-11-0078; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Esposti LD, 2013, CLINICOECONOMIC OUTC, V5, P193, DOI 10.2147/CEOR.S41846; Feng JY, 2018, PHYTOPATHOLOGY, V108, P737, DOI 10.1094/PHYTO-11-17-0375-R; Flath K, 2014, BGRI 2014 TECHN WORK; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grzebelus D, 2014, MOL BREEDING, V33, P625, DOI 10.1007/s11032-013-9979-9; Haile JK, 2012, MOL BREEDING, V30, P1479, DOI 10.1007/s11032-012-9734-7; Hao YF, 2011, THEOR APPL GENET, V123, P1401, DOI 10.1007/s00122-011-1675-8; Hovmoller MS, 2016, PLANT PATHOL, V65, P402, DOI 10.1111/ppa.12433; Hovmoller MS, 2008, EUR J PLANT PATHOL, V121, P377, DOI 10.1007/s10658-008-9303-4; Hovmoller MS, 2007, AUST J AGR RES, V58, P518, DOI 10.1071/AR06146; Hovmoller MS, 2010, SCIENCE, V329, P369, DOI 10.1126/science.1194925; Jamil M, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1754-6; JOHNSON R, 1984, ANNU REV PHYTOPATHOL, V22, P309, DOI 10.1146/annurev.py.22.090184.001521; JOHNSON R, 1992, EUPHYTICA, V63, P3, DOI 10.1007/BF00023908; Justesen AF, 2002, PLANT PATHOL, V51, P13, DOI 10.1046/j.0032-0862.2001.00651.x; Knott DR, 1989, WHEAT RUSTS BREEDING, P58, DOI DOI 10.1007/978-3-642-83641-1_5; Kolmer JA, 2011, CROP SCI, V51, P526, DOI 10.2135/cropsci2010.06.0381; Li JB, 2020, THEOR APPL GENET, V133, P1095, DOI 10.1007/s00122-020-03534-y; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Markell SG, 2008, PHYTOPATHOLOGY, V98, P632, DOI 10.1094/PHYTO-98-6-0632; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McIntosh R.A., 2017, CATALOGUE GENE SYMBO; Mert Z, 2012, TURK J AGRIC FOR, V36, P107, DOI 10.3906/tar-1010-1278; Milus EA, 2015, PHYTOPATHOLOGY, V105, P1114, DOI 10.1094/PHYTO-11-14-0305-R; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; Naruoka Y, 2015, THEOR APPL GENET, V128, P1083, DOI 10.1007/s00122-015-2492-2; Neumann S, 2004, PLANT PATHOL, V53, P725, DOI 10.1111/j.1365-3059.2004.01107.x; Newcomb M, 2013, PLANT DIS, V97, P882, DOI 10.1094/PDIS-02-12-0200-RE; Nsabiyera V, 2018, THEOR APPL GENET, V131, P1459, DOI 10.1007/s00122-018-3090-x; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Pakeerathan K, 2019, THEOR APPL GENET, V132, P3169, DOI 10.1007/s00122-019-03416-y; Parlevliet JE, 2002, EUPHYTICA, V124, P147, DOI 10.1023/A:1015601731446; Patpour M, 2020, PLANT DIS, V104, P973, DOI 10.1094/PDIS-10-19-2133-PDN; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; RAPILLY F, 1979, ANNU REV PHYTOPATHOL, V17, P59, DOI 10.1146/annurev.py.17.090179.000423; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Saint Pierre C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27312; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sehgal D, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00197; Sehgal D, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01189; Sehgal D, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00201; Sehgal D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132112; Singh H, 2020, PHYTOPARASITICA, V48, P383, DOI 10.1007/s12600-020-00809-4; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2016, ANNU REV PHYTOPATHOL, V54, P303, DOI 10.1146/annurev-phyto-080615-095835; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; SINGH RM, 2013, PLEIOTROPIC GENE LR4; Singh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30667-4; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Sorensen CK, 2014, PHYTOPATHOLOGY, V104, P1042, DOI 10.1094/PHYTO-12-13-0337-R; Stubbs RW, 1985, DISEASES DISTRIBUTIO, P61; Thompson AL, 2016, CROP SCI, V56, P654, DOI 10.2135/cropsci2015.07.0438; Valdez VA, 2012, CROP SCI, V52, P676, DOI 10.2135/cropsci2011.06.0331; Vazquez MD, 2015, THEOR APPL GENET, V128, P1307, DOI 10.1007/s00122-015-2507-z; Vikram P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23092; Walter S, 2016, ECOL EVOL, V6, P2790, DOI 10.1002/ece3.2069; Wellings CR, 2007, AUST J AGR RES, V58, P567, DOI 10.1071/AR07130; Wingen LU, 2014, THEOR APPL GENET, V127, P1831, DOI 10.1007/s00122-014-2344-5; Yan YY, 2014, DEV CELL, V30, P437, DOI 10.1016/j.devcel.2014.07.004; Yu LX, 2012, THEOR APPL GENET, V125, P749, DOI 10.1007/s00122-012-1867-x; Yu LX, 2011, THEOR APPL GENET, V123, P1257, DOI 10.1007/s00122-011-1664-y; ZADOKS J. C., 1961, TIJDSCHR PLANTEZIEKTEN, V67, P69, DOI 10.1007/BF01984044; 2018, CURR OPIN TOXICOL, V10	84	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2021	16	1							e0246015	10.1371/journal.pone.0246015	http://dx.doi.org/10.1371/journal.pone.0246015			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QB1HB	33513167	Green Published, gold			2022-12-26	WOS:000613891400011
J	Kido, Y; Motomura, H; Ikeda, Y; Satoh, S; Jinno, M				Kido, Yugo; Motomura, Hideki; Ikeda, Yoshihisa; Satoh, Susumu; Jinno, Masafumi			Clarification of electrical current importance in plasma gene transfection by equivalent circuit analysis	PLOS ONE			English	Article							MOLECULAR DELIVERY; BLOOD-CELLS; ELECTROPORATION; EVOLUTION; BREAKDOWN	We have been developing a method of plasma gene transfection that uses microdischarge plasma (MDP) and is highly efficient, minimally invasive, and safe. Using this technique, electrical factors (such as the electrical current and electric field created through processing discharge plasma) and the chemical factors of active species and other substances focusing on radicals are supplied to the cells and then collectively work to introduce nucleic acids in the cell. In this paper, we focus on the electrical factors to identify whether the electric field or electrical current is the major factor acting on the cells. More specifically, we built a spatial distribution model that uses an electrical network to represent the buffer solution and cells separately, as a substitute for the previously reported uniform medium model (based on the finite element method), calculated the voltage and electrical current acting on cells, and examined their intensity. Although equivalent circuit models of single cells are widely used, this study was a novel attempt to build a model wherein adherent cells distributed in two dimensions were represented as a group of equivalent cell circuits and analyzed as an electrical network that included a buffer solution and a 96-well plate. Using this model, we could demonstrate the feasibility of applying equivalent circuit network analysis to calculate electrical factors using fewer components than those required for the finite element method, with regard to electrical processing systems targeting organisms. The results obtained through this equivalent circuit network analysis revealed for the first time that the distribution of voltage and current applied to a cellular membrane matched the spatial distribution of experimentally determined gene transfection efficiency and that the electrical current is the major factor contributing to introduction.	[Kido, Yugo; Motomura, Hideki; Ikeda, Yoshihisa; Satoh, Susumu; Jinno, Masafumi] Ehime Univ, Dept Elect & Elect Engn, Matsuyama, Ehime, Japan; [Kido, Yugo] Pearl Kogyo Co Ltd, Suminoe, Osaka, Japan; [Satoh, Susumu] Ys Corp, Tama, Tokyo, Japan	Ehime University	Jinno, M (corresponding author), Ehime Univ, Dept Elect & Elect Engn, Matsuyama, Ehime, Japan.	jinno.masafumi.mh@ehime-u.ac.jp		JINNO, Masafumi/0000-0001-6557-7685	Japan Society for the Promotion of Science (JSPS) [19KT0035, 17H01068, 15H00896, 25108509]; Japan Keirin Autorace Foundation (JKA)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Keirin Autorace Foundation (JKA)	This study was partly supported by Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/) in the form of KAKENHI grants awarded to MJ (19KT0035, 17H01068, 15H00896, 25108509), Japan Keirin Autorace Foundation (JKA) (https://www.keirin-autorace.or.jp/) in the form of a grant awarded to MJ, Pearl Kogyo Co., Ltd. in the form of a salary for YK, and Y's Corp. in the form of a salary for SS. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABIDOR IG, 1979, BIOELECTROCH BIOENER, V6, P37; Aycock KN, 2019, BIOELECTRICITY, V1, P214, DOI 10.1089/bioe.2019.0029; Chalberg TW, 2006, INVEST OPHTH VIS SCI, V47, P4083, DOI 10.1167/iovs.06-0092; Connolly RJ, 2010, INT J PHARMACEUT, V389, P53, DOI 10.1016/j.ijpharm.2010.01.016; Darbani B., 2008, Biotechnology, V7, P385; Edelblute CM, 2015, BIOTECHNOL BIOENG, V112, P2583, DOI 10.1002/bit.25660; Ermolina I, 2001, IEEE T DIELECT EL IN, V8, P253, DOI 10.1109/94.919948; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; HIBINO M, 1991, BIOPHYS J, V59, P209, DOI 10.1016/S0006-3495(91)82212-3; Honda R, 2020, JPN J APPL PHYS, V59, DOI 10.35848/1347-4065/ab7d7e; Ikeda Y, 2017, PLASMA MED, V7, P321, DOI 10.1615/PlasmaMed.2018019510; Ikeda Y, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.07LG06; Jinno M, 2017, PLASMA SOURCES SCI T, V26, DOI 10.1088/1361-6595/aa70de; Jinno M, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.07LG09; Jinno M, 2016, ARCH BIOCHEM BIOPHYS, V605, P59, DOI 10.1016/j.abb.2016.04.013; Jinno M, 2014, J PHOTOPOLYM SCI TEC, V27, P399, DOI 10.2494/photopolymer.27.399; Kaneko T, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4921278; KINOSITA K, 1988, BIOPHYS J, V53, P1015, DOI 10.1016/S0006-3495(88)83181-3; Kurita H., 2011, INT J PLASMA ENV SCI, V5, P42, DOI 10.34343/ijpest.2011.05.01.042; Kwon I, 2008, PHARM RES, V25, P489, DOI 10.1007/s11095-007-9431-0; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Leduc M, 2010, PLASMA PROCESS POLYM, V7, P899, DOI 10.1002/ppap.201000032; Melikov KC, 2001, BIOPHYS J, V80, P1829, DOI 10.1016/S0006-3495(01)76153-X; Miyoshi S, 2002, WO, Patent No. [2002/064767, 2002064767]; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nomura N, 2009, IEEE T DIELECT EL IN, V16, P1288, DOI 10.1109/TDEI.2009.5293940; Ogawa Y, 2005, BIOTECHNOL BIOENG, V92, P865, DOI 10.1002/bit.20659; Ramachandran N, 2008, IEEE T NANOBIOSCI, V7, P233, DOI 10.1109/TNB.2008.2002290; RIEMANN F, 1975, BIOCHIM BIOPHYS ACTA, V394, P449, DOI 10.1016/0005-2736(75)90296-5; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; Sasaki S, 2018, PLASMA PROCESS POLYM, V15, DOI 10.1002/ppap.201700077; Sasaki S, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/33/334002; Sasaki S, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.07LG04; Sasaki S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25728; Sasaki S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.026202; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TEISSIE J, 1993, BIOPHYS J, V65, P409, DOI 10.1016/S0006-3495(93)81052-X; Zhang ZY, 2012, ACTA PHARM SIN B, V2, P429, DOI 10.1016/j.apsb.2012.03.006; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4	43	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0245654	10.1371/journal.pone.0245654	http://dx.doi.org/10.1371/journal.pone.0245654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33508006	Green Published, gold			2022-12-26	WOS:000635021400041
J	Matsumoto, H; Mukai, R; Hoshino, J; Oda, M; Matsuzaki, T; Ishizaki, Y; Shibasaki, K; Akiyama, H				Matsumoto, Hidetaka; Mukai, Ryo; Hoshino, Junki; Oda, Mai; Matsuzaki, Toshiyuki; Ishizaki, Yasuki; Shibasaki, Koji; Akiyama, Hideo			Choroidal congestion mouse model: Could it serve as a pachychoroid model?	PLOS ONE			English	Article							INDOCYANINE GREEN ANGIOGRAPHY; PHOTODYNAMIC THERAPY; VORTEX VEINS; NEOVASCULOPATHY; RANIBIZUMAB; ASSOCIATION; AFLIBERCEPT	Pachychoroid spectrum diseases have been described as a new clinical entity within the spectrum of macular disorders. "Pachychoroid" is defined as choroidal thickening associated with dilated outer choroidal vessels often showing retinal pigment epithelium (RPE) degeneration. Although various clinical studies on the pachychoroid spectrum diseases have been conducted, the pathophysiology of pachychoroid has yet to be fully elucidated. In this study, we attempted to establish a mouse model of pachychoroid. We sutured vortex veins in eyes of wild type mice to imitate the vortex vein congestion in pachychoroid spectrum diseases. Fundus photography and ultra-widefield indocyanine green angiography showed dilated vortex veins from the posterior pole to the ampulla in eyes after induction of choroidal congestion. Optical coherence tomography and tissue sections presented choroidal thickening with dilatation of choroidal vessels. The RPE-choroid/retina thickness ratios on the tissue sections in the treated day 1 and day 7 groups were significantly greater than that in the control group (0.19 +/- 0.03 and 0.16 +/- 0.01 vs. 0.12 +/- 0.02, P<0.05 each). Moreover, immunohistochemistry using RPE flatmount revealed focal RPE degeneration in the treated eyes. Furthermore, inflammatory response-related genes were upregulated in eyes with choroidal congestion induction, and macrophages migrated into the thickened choroid. These results indicated that vortex vein congestion triggered some pachychoroid features. Thus, we have established a choroidal congestion mouse model by suturing vortex veins, which would potentially be useful for investigating the pathophysiology of pachychoroid spectrum diseases.	[Matsumoto, Hidetaka; Mukai, Ryo; Hoshino, Junki; Akiyama, Hideo] Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gumma, Japan; [Oda, Mai; Ishizaki, Yasuki] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gumma, Japan; [Matsuzaki, Toshiyuki] Gunma Univ, Dept Anat & Cell Biol, Grad Sch Med, Maebashi, Gumma, Japan; [Shibasaki, Koji] Univ Nagasaki, Grad Sch Human Hlth Sci, Lab Neurochem, Nagasaki, Japan	Gunma University; Gunma University; Gunma University; Nagasaki University	Matsumoto, H (corresponding author), Gunma Univ, Dept Ophthalmol, Grad Sch Med, Maebashi, Gumma, Japan.	hide-m@gunma-u.ac.jp		Matsumoto, Hidetaka/0000-0003-2311-0280				Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Gallego-Pinazo Roberto, 2014, Med Hypothesis Discov Innov Ophthalmol, V3, P111; HAYREH SS, 1973, BRIT J OPHTHALMOL, V57, P217, DOI 10.1136/bjo.57.4.217; Hosoda Y, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0712-z; Hosoda Y, 2018, P NATL ACAD SCI USA, V115, P6261, DOI 10.1073/pnas.1802212115; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Imanaga N, 2021, OPHTHALMOL RETINA, V5, P285, DOI 10.1016/j.oret.2020.07.011; Kishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206646; Koh A, 2017, JAMA OPHTHALMOL, V135, P1206, DOI 10.1001/jamaophthalmol.2017.4030; Lee JH, 2016, RETINA-J RET VIT DIS, V36, P889, DOI 10.1097/IAE.0000000000000809; Lee WK, 2016, RETINA-J RET VIT DIS, V36, pS73, DOI 10.1097/IAE.0000000000001346; Matsumoto H, 2020, JPN J OPHTHALMOL, V64, P203, DOI 10.1007/s10384-020-00722-7; Matsumoto H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51268-9; Matsumoto H, 2019, GRAEF ARCH CLIN EXP, V257, P1127, DOI 10.1007/s00417-019-04284-4; Matsumoto H, 2018, JPN J OPHTHALMOL, V62, P144, DOI 10.1007/s10384-018-0562-0; Matsumoto H, 2013, JOVE-J VIS EXP, DOI 10.3791/50660; Miyake M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16204; Mukai R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208713; Nishikawa M, 2009, OPHTHALMIC RES, V41, P53, DOI 10.1159/000165916; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Pang CE, 2014, AM J OPHTHALMOL, V158, P362, DOI 10.1016/j.ajo.2014.04.021; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Terao N, 2018, INVEST OPHTH VIS SCI, V59, P5924, DOI 10.1167/iovs.18-25517; Terao N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28484-w; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Yanai H., 2015, STATCEL USEFUL ADD I, V4th edn	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246115	10.1371/journal.pone.0246115	http://dx.doi.org/10.1371/journal.pone.0246115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RF7LJ	33507997	Green Published, gold			2022-12-26	WOS:000635021400091
J	Ramandi, D; Salmani, ME; Moghimi, A; Lashkarbolouki, T; Fereidoni, M				Ramandi, Daniel; Salmani, Mahmoud Elahdadi; Moghimi, Ali; Lashkarbolouki, Taghi; Fereidoni, Masoud			Pharmacological upregulation of GLT-1 alleviates the cognitive impairments in the animal model of temporal lobe epilepsy	PLOS ONE			English	Article							GLUTAMATE TRANSPORTER; CEFTRIAXONE TREATMENT; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; EXPRESSION; RATS; EXCITOTOXICITY; TRANSMISSION; INDUCTION; SEIZURES	It is known that hippocampal epileptogenesis is accompanied by hyperexcitability, glutamate-related neuronal dysfunctions and consequently cognitive deficits. However, the neuroprotective role of astrocytic glutamate uptake through the Glutamate Transporter-1 (GLT-1) remains to be unknown in these processes. Therefore, to assess the effect of glutamate uptake, pharmacological upregulation of GLT-1 using ceftriaxone administration (200 mg/kg/day, i.p, 5 days) was utilized in Li-PIL animal models of temporal lobe epilepsy (TLE). Glutamate concentration and glutamine synthetase activity were analyzed using biochemical assays. In addition, GLT-1 gene expression was assessed by RT-qPCR. Finally, cognitive function was studied using Morris water maze (MWM) test and novel object recognition task (NORT). Our results demonstrated that the acute phase of epileptogenesis (first 72 hours after Status Epilepticus) was accompanied by an increase in the hippocampal glutamate and downregulation of GLT-1 mRNA expression compared to controls. Ceftriaxone administration in epileptic animals led to a reduction of glutamate along with elevation of the level of glutamine synthetase activity and GLT-1 expression in the acute phase. In the chronic phase of epileptogenesis (4 weeks after Status Epilepticus), glutamate levels and GLT-1 expression were decreased compared to controls. Ceftriaxone treatment increased the levels of GLT-1 expression. Furthermore, impaired learning and memory ability in the chronic phase of epileptogenesis was rescued by Ceftriaxone administration. This study shows that astrocytic glutamate uptake can profoundly impact the processes of hippocampal epileptogenesis through the reduction of glutamate-induced excitotoxicity and consequently rescuing of cognitive deficits caused by epilepsy.	[Ramandi, Daniel; Moghimi, Ali; Fereidoni, Masoud] Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Razavi Khorasan, Iran; [Salmani, Mahmoud Elahdadi; Lashkarbolouki, Taghi] Damghan Univ, Sch Biol, Damghan, Iran	Ferdowsi University Mashhad	Fereidoni, M (corresponding author), Ferdowsi Univ Mashhad, Fac Sci, Dept Biol, Mashhad, Razavi Khorasan, Iran.	fereidoni@um.ac.ir		Ramandi, Daniel/0000-0003-2995-154X	Ferdowsi University of Mashhad, Mashhad, Iran [3/44083, 22.05]	Ferdowsi University of Mashhad, Mashhad, Iran	This study is supported by Ferdowsi University of Mashhad, Mashhad, Iran (grant No. 3/44083 confirmed on 17.03.1396 (22.05) to M. F.).	Althobaiti YS, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00427; Bak LK, 2006, J NEUROCHEM, V98, P641, DOI 10.1111/j.1471-4159.2006.03913.x; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Borges K, 2012, EPILEPSY RES, V100, P239, DOI 10.1016/j.eplepsyres.2011.05.023; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Chen LL, 2013, NEUROSCI BULL, V29, P295, DOI 10.1007/s12264-013-1310-6; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Clossen BL, 2017, BBA-MOL BASIS DIS, V1863, P1519, DOI 10.1016/j.bbadis.2017.02.003; CORDA MG, 1992, J PHARMACOL EXP THER, V262, P792; Costa Anna Maria, 2020, Cell Physiol Biochem, V54, P493, DOI 10.33594/000000232; Dallerac G, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00159; de Lanerolle NC, 2005, EPILEPSY BEHAV, V7, P190, DOI 10.1016/j.yebeh.2005.06.003; dos Santos PS, 2011, ARQ NEURO-PSIQUIAT, V69, P360, DOI 10.1590/S0004-282X2011000300018; Francois J, 2011, NEUROPHARMACOLOGY, V61, P313, DOI 10.1016/j.neuropharm.2011.04.018; Gomez AM, 2014, ELIFE, V3, DOI 10.7554/eLife.04287; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gos T, 2002, LAB ANIM-UK, V36, P127, DOI 10.1258/0023677021912406; Gulati S, 2014, INDIAN J PEDIATR, V81, P1056, DOI 10.1007/s12098-014-1530-4; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Hota SK, 2008, NEUROBIOL LEARN MEM, V89, P522, DOI 10.1016/j.nlm.2008.01.003; Hubbard JA, 2016, EXP NEUROL, V283, P85, DOI 10.1016/j.expneurol.2016.05.003; Hubbard JA, 2013, NEUROCHEM INT, V63, P638, DOI 10.1016/j.neuint.2013.01.017; Hussein Abdelaziz M, 2016, J Epilepsy Res, V6, P8, DOI 10.14581/jer.16002; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Krzyzanowska W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186243; Lee H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104092; Lee SG, 2008, J BIOL CHEM, V283, P13116, DOI 10.1074/jbc.M707697200; Li JM, 2013, BIOMED RES-TOKYO, V34, P75, DOI 10.2220/biomedres.34.75; Liu JZ, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00428; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meister A., 1970, METHOD ENZYMOL, V17, P900, DOI 10.1016/0076-6879(71)17304-1; Mohammad H, 2019, MOL NEUROBIOL, V56, P2508, DOI 10.1007/s12035-018-1230-6; Nemanic S, 2004, J NEUROSCI, V24, P2013, DOI 10.1523/JNEUROSCI.3763-03.2004; Pascalis O, 2004, NEUROPSYCHOLOGIA, V42, P1293, DOI 10.1016/j.neuropsychologia.2004.03.005; Petr GT, 2015, J NEUROSCI, V35, P5187, DOI 10.1523/JNEUROSCI.4255-14.2015; Petroff OAC, 2002, ANN NEUROL, V52, P635, DOI 10.1002/ana.10360; Prieto GA, 2017, J NEUROSCI, V37, P1197, DOI 10.1523/JNEUROSCI.2774-16.2016; Rao PSS, 2015, PSYCHOPHARMACOLOGY, V232, P2333, DOI 10.1007/s00213-015-3868-3; Rehberg M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8087401; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Sari Y, 2013, J MOL NEUROSCI, V51, P779, DOI 10.1007/s12031-013-0064-y; Scharfman HE, 2003, J NEUROPHYSIOL, V90, P2536, DOI 10.1152/jn.00251.2003; Scott RC, 2014, EPILEPTIC DISORD, V16, pS6, DOI 10.1684/epd.2014.0689; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Stafstrom CE, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a022426; Sun H, 2012, NEUROL SCI, V33, P559, DOI 10.1007/s10072-011-0774-2; Vinet J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082178	51	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2021	16	1							e0246068	10.1371/journal.pone.0246068	http://dx.doi.org/10.1371/journal.pone.0246068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RF7LJ	33507976	gold, Green Published			2022-12-26	WOS:000635021400081
J	Boone, JD; Witt, C; Ammon, EM				Boone, John D.; Witt, Chris; Ammon, Elisabeth M.			Behavior-specific occurrence patterns of Pinyon Jays (Gymnorhinus cyanocephalus) in three Great Basin study areas and significance for pinyon-juniper woodland management	PLOS ONE			English	Article							FOREST INVENTORY; SELECTION	The Pinyon Jay is a highly social, year-round inhabitant of pinyon-juniper and other coniferous woodlands in the western United States. Range-wide, Pinyon Jays have declined similar to 3-4% per year for at least the last half-century. Occurrence patterns and habitat use of Pinyon Jays have not been well characterized across much of the species' range, and obtaining this information is necessary for better understanding the causes of ongoing declines and determining useful conservation strategies. Additionally, it is important to better understand if and how targeted removal of pinyon-juniper woodland, a common and widespread vegetation management practice, affects Pinyon Jays. The goal of this study was to identify the characteristics of areas used by Pinyon Jays for several critical life history components in the Great Basin, which is home to nearly half of the species' global population, and to thereby facilitate the inclusion of Pinyon Jay conservation measures in the design of vegetation management projects. To accomplish this, we studied Pinyon Jays in three widely separated study areas using radio telemetry and direct observation and measured key attributes of their locations and a separate set of randomly-selected control sites using the U. S. Forest Service's Forest Inventory Analysis protocol. Data visualizations, principle components analysis, and logistic regressions of the resulting data indicated that Pinyon Jays used a distinct subset of available pinyon-juniper woodland habitat, and further suggested that Pinyon Jays used different but overlapping habitats for seed caching, foraging, and nesting. Caching was concentrated in low-elevation, relatively flat areas with low tree cover; foraging occurred at slightly higher elevations with generally moderate but variable tree cover; and nesting was concentrated in slightly higher areas with high tree and vegetation cover. All three of these Pinyon Jay behavior types were highly concentrated within the lower-elevation band of pinyon-juniper woodland close to the woodland-shrubland ecotone. Woodland removal projects in the Great Basin are often concentrated in these same areas, so it is potentially important to incorporate conservation measures informed by Pinyon Jay occurrence patterns into existing woodland management paradigms, protocols, and practices.	[Boone, John D.; Ammon, Elisabeth M.] Great Basin Bird Observ, Reno, NV 89502 USA; [Witt, Chris] US Forest Serv Rocky Mt Res Stn, Boise, ID USA	United States Department of Agriculture (USDA); United States Forest Service	Boone, JD (corresponding author), Great Basin Bird Observ, Reno, NV 89502 USA.	boone@gbbo.org		Boone, John/0000-0003-3024-1000	National Fish and Wildlife Foundation [20040171-000]; Great Basin Bird Observatory [20040171-000, 12-JV-11221638-130, FAA080097]; U.S. Forest Service [12-JV-11221638-130]; U.S. Bureau of Land Management [FAA080097]	National Fish and Wildlife Foundation; Great Basin Bird Observatory; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); U.S. Bureau of Land Management	Pinyon Jay studies in Eastern Nevada were funded by cooperative agreement #20040171-000 between National Fish and Wildlife Foundation (www.nfwf.org) and Great Basin Bird Observatory (JB and EA). This funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript. Pinyon Jay work in Southern Idaho was funded by cooperative agreement #12-JV-11221638-130 between U.S. Forest Service (www.fs.usda.gov) and Great Basin Bird Observatory (JB and EA). A representative of this funder is a co-author (CW) who contributed to study design, data collection, data analysis, decision to publish, and preparation of the manuscript. Pinyon Jay work in Central Nevada was funded by cooperative agreement #FAA080097 between U.S. Bureau of Land Management (www.blm.gov) and Great Basin Bird Observatory (JB and EA). This funder had a collaborative role in study design, but no role in data collection, analysis, decision to publish, or preparation of the manuscript. Collection of Forest Inventory Analysis data relevant to all study areas was supported internally by the U.S. Forest Service (see above).	Acevedo, 2012, STATUS AD TRENDS LAN; Alexander, 1988, GEN TECH REPORT RM 1; Amacher MC, 2014, RMRSRB18; BALDA RP, 1971, CONDOR, V73, P287, DOI 10.2307/1365755; Baruch-Mordo S, 2013, BIOL CONSERV, V167, P233, DOI 10.1016/j.biocon.2013.08.017; BATEMAN GC, 1973, AUK, V90, P39; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Betancourt JL., 1987, P PINYON JUNIPER C G, P129; Biondi F, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00149.1; BirdLife International, 2017, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2017-3.RLTS.T103890801A118590020.en; Burleigh TD, 1972, BIRDS IDAHO; Burrill E.A., 2018, FOREST INVENTORY ANA, P946; Carlson, 2017, SCI BASIS APPL; Chambers JC, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00241; Cole KL, 1997, GREAT BASIN NAT, V57, P315; Cole KL, 2007, P 21 ANN PAC CLIM WO, DOI 10.1.1.606.6097; Commons M.L., 1999, USDA FOREST SERVICE, V97, P238; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Cottam W. P., 1940, Journal of Forestry, V38, P613; Donnelly JP, 2017, RANGELAND ECOL MANAG, V70, P95, DOI 10.1016/j.rama.2016.10.009; DRIVAS EP, 1988, FOREST ECOL MANAG, V23, P27, DOI 10.1016/0378-1127(88)90011-4; Evans, 1988, GEN TECH REPORT INT; Gabaldon, 1979, THESIS NO ARIZONA U; Gillespie AJR, 1999, J FOREST, V97, P16; Goeking, 2016, NEVADAS FOREST RESOU, DOI DOI 10.2737/RMRS-RB-22; Goeking SA, 2017, RMRSRB23; Gotelli N. J., 2004, PRIMER ECOLOGICAL ST; Gottfried G. J., 1994, Rangelands, V16, P234; Handel, 2019, STUDIES W BIRDS, V3, P190, DOI [10.21199/SWB3.10, DOI 10.21199/SWB3.10]; Hollander JL, 2004, OECOLOGIA, V138, P57, DOI 10.1007/s00442-003-1393-2; HOSMER DW, 1989, APPL LOGISTIC REGRES; Johnson K, BIRDS WORLD VERSION; Johnson K, 2019, AVIAN CONSERV ECOL, V14, DOI 10.5751/ACE-01467-140217; Johnson K, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00487; Johnson K, 2017, J ARID ENVIRON, V146, P1, DOI 10.1016/j.jaridenv.2017.07.006; Johnson K, 2016, AVIAN CONSERV ECOL, V11, DOI 10.5751/ACE-00890-110206; Keating KA, 2004, J WILDLIFE MANAGE, V68, P774, DOI 10.2193/0022-541X(2004)068[0774:UAIOLR]2.0.CO;2; Ko DW, 2011, FOREST ECOL MANAG, V261, P1283, DOI 10.1016/j.foreco.2011.01.007; Kramer DW, 2015, J ARID ENVIRON, V113, P29, DOI 10.1016/j.jaridenv.2014.09.008; Laudenslayer WF, 1983, CALIF WILDLIFE HABIT, V4; Lewallen S, 1998, Community Eye Health, V11, P57; Little E.L., 1971, MISCELLANEOUS PUBLIC, V1146, P320; Manly B., 2007, RESOURCE SELECTION A; Marzluff J.M., 1988, P255; Marzluff J.M., 1992, PINYON JAY BEHAV ECO; MARZLUFF JM, 1988, AUK, V105, P286, DOI 10.2307/4087492; Meeuwig RO, AGR HDB, V654; Mehringer PJ., 1990, PACKRAT MIDDENS LAST, P294; Miller R.F., 2008, RMRSRP69 USDA FOR SE; MILLER RF, 1994, BIOSCIENCE, V44, P465, DOI 10.2307/1312298; Morris LR, 2014, J MAMMAL, V95, P1144, DOI 10.1644/13-MAMM-S-169; NABCI Bird Conservation Regions, CANADA BIRD STUDIES; Natural Resources Conservation Service, 2015, SAGE GROUS IN SUCC R; Newlon KR, 2011, CONDOR, V113, P183, DOI 10.1525/cond.2011.100056; OMEARA TE, 1981, J WILDLIFE MANAGE, V45, P381, DOI 10.2307/3807919; Patterson, 2011, NATURAL RESOURCES EN, V16; Patterson PL, 2005, SRSGTR80; R Core Team, 2021, R LANGUAGE ENV STAT; Redmond MD, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00306.1; Ricca MA, 2018, ECOL APPL, V28, P878, DOI 10.1002/eap.1690; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; Roundy BA, 2019, RMRSGTR403 USDA; Sauer JR, 2017, N AM BREEDING BIRD S; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Somershoe SG, 2020, CONSERVATION STRATEG; TAUSCH RJ, 1981, J RANGE MANAGE, V34, P259, DOI 10.2307/3897846; TAUSCH RJ, 1977, J RANGE MANAGE, V30, P44, DOI 10.2307/3897334; Thompson, 2016, RMRSRB20; Thompson RS, 1990, PACKRAT MIDDENS LAST, P200; U.S. Bureau of Land Management, 2017, UPDATED BUREAU LAND; U.S. Fish and Wildlife Service, 2019, BIRDS CONSERVATION C; United States Department of Agriculture, 2012, INT W FOR INV AN FIE; United States Department of Agriculture Forest Service, 2010, INTERIOR W FOREST IN; United States Department of Agriculture Forest Service, 2007, INTERIOR W FOREST IN; United States Department of Agriculture Forest Service, 2012, INT W FOR INV AN REG; United States Department of Agriculture Forest Service, 2011, INTERIOR W FOREST IN; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Wenninger EJ, 2008, J ARID ENVIRON, V72, P24, DOI 10.1016/j.jaridenv.2007.04.005; Witt, 2008, P 2008 FOR INV AN S; Witt C, 2010, FOREST ECOL MANAG, V260, P1010, DOI 10.1016/j.foreco.2010.06.024; Young J. A., 1979, Journal of Forest History, V23, P112, DOI 10.2307/4004663; Zarnetske PL, 2007, P 7 ANN FOR INV AN S, P291, DOI DOI 10.1890/06-1312.1; Zielinski WJ, 2006, ECOL APPL, V16, P1010, DOI 10.1890/1051-0761(2006)016[1010:UFIDTA]2.0.CO;2	83	2	2	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0237621	10.1371/journal.pone.0237621	http://dx.doi.org/10.1371/journal.pone.0237621			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503032	Green Published, Green Submitted, gold			2022-12-26	WOS:000613751800014
J	Huete-Perez, JA; Cabezas-Robelo, C; Paiz-Medina, L; Hernandez-Alvarez, CA; Quant-Duran, C; McKerrow, JH				Huete-Perez, Jorge A.; Cabezas-Robelo, Cristiana; Paiz-Medina, Lucia; Hernandez-Alvarez, Carlos A.; Quant-Duran, Carlos; McKerrow, James H.			First report on prevalence of SARS-CoV-2 infection among health-care workers in Nicaragua	PLOS ONE			English	Article								The Nicaraguan COVID-19 situation is exceptional for Central America. The government restricts testing and testing supplies, and the true extent of the coronavirus crisis remains unknown. Dozens of deaths have been reported among health-care workers. However, statistics on the crisis' effect on health-care workers and their risk of being infected with SARSCoV-2 are lacking. We aimed to estimate the prevalence of SARS-CoV-2 infection in healthcare workers and to examine correlations with risk factors such as age, sex and comorbidities. Study participants (N = 402, median age 38.48 years) included physicians, nurses and medical assistants, from public and private hospitals, independent of symptom presentation. SARS-CoV-2 was detected on saliva samples using the loop-mediated isothermal amplification assay. A questionnaire was employed to determine subjects' COVID-19-associated symptoms and their vulnerability to complications from risk factors such as age, sex, professional role and comorbidities. The study was performed five weeks into the exponential growth period in Nicaragua. We discovered that 30.35% of health-care workers participating in our study had been infected with SARS-CoV-2. A large percentage (54.92%) of those who tested positive were asymptomatic and were still treating patients. Nearly 50% of health-care workers who tested positive were under 40, an astonishing 30.33% reported having at least one comorbidity. In our study, sex and age are important risk factors for the probability of testing positive for SARS-CoV-2 with significance being greatest among those between 30 and 40 years of age. In general, being male resulted in higher risk. Our data are the first non-governmental data obtained in Nicaragua. They shed light on several important aspects of COVID-19 in an underdeveloped nation whose government has implemented a herd-immunity strategy, while lacking an adequate healthcare system and sufficient PPE for health-care workers. These data are important for creating policies for containing the spread of SARS-CoV-2.	[Huete-Perez, Jorge A.; Cabezas-Robelo, Cristiana; Paiz-Medina, Lucia] Univ Cent Amer, Mol Biol Ctr, Managua, Nicaragua; [Hernandez-Alvarez, Carlos A.] Nicaraguan Multidisciplinary Sci Comm COVID 19, Managua, Nicaragua; [Quant-Duran, Carlos] Vivian Pellas Hosp, Metab & Infect Dis, Masaya, Nicaragua; [McKerrow, James H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Huete-Perez, JA (corresponding author), Univ Cent Amer, Mol Biol Ctr, Managua, Nicaragua.	JorgeHuete@uca.edu.ni	Huete-Perez, Jorge/AAJ-9840-2021	Huete-Perez, Jorge A./0000-0001-5259-8428				[Anonymous], 2020, CONFIDENCIAL    0325; [Anonymous], 2020, JMIR MHEALTH UHEALTH; [Anonymous], 2020, CONFIDENCIAL    0705; [Anonymous], 2020, WASHINGTON POST; Augustine R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080182; Baltodano I., 2020, PRENSA          0626; Castillo Vado H., 2020, VOA             0111; Chew P, 2020, GAME BASE LEARNING P; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Chow EJ, 2020, JAMA-J AM MED ASSOC, V323, P2087, DOI 10.1001/jama.2020.6637; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; El-Tholoth M, 2020, SINGLE 2 STAGE CLOSE, DOI [10.26434/chemrxiv.11860137, DOI 10.26434/CHEMRXIV.11860137.V1]; Fakheran O, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00728-w; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Food and Drug Administration (US), 2020, EM US AUTH EUA SUMM; Ganguli A, 2020, bioRxiv, DOI [10.1101/2020.05.21.108381, 10.1073/pnas.2014739117]; Kashir J, 2020, MED HYPOTHESES, V141, DOI 10.1016/j.mehy.2020.109786; Keeley AJ, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.14.2000433; Khan M, 2020, J MED MICROBIOL, V69, P1114, DOI 10.1099/jmm.0.001231; Kluytmans-van Den Bergh MFQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9673; Kojima N., 2020, MEDRXIV, DOI [10.1101/2020.04.11.20062372, DOI 10.1101/2020.04.11.20062372]; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Lahner E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124417; Lalli Matthew A, 2020, medRxiv, DOI 10.1101/2020.05.07.20093542; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235460; Lopez L., 2020, PRENSA          0808; Luna Y., 2020, CONFIDENCIAL    0602; Magnavita N, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145218; Martin-Delgado J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242185; Mather TPS, 2020, LANCET GLOB HEALTH, V8, pE773, DOI 10.1016/S2214-109X(20)30131-5; Munguia I., 2020, CONFIDENCIAL    0605; Munguia I., 2020, CONFIDENCIAL    0609; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Pasomsub E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.05.001; Pearson AA, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010371; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Ponchner D., 2020, SCI AM          0617; Porru S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17145104; Rodino KG, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00590-20; Schmidt SB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235417; Self WH, 2020, MMWR-MORBID MORTAL W, V69, P1221, DOI 10.15585/mmwr.mm6935e2; Soneji S, 2020, POPULATION LEVEL MOR; Stubblefield W.B., 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA936, 10.1093/cid/ciaa936]; Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; Thi VLD, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abc7075; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Williams E, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00776-20; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Yan C, 2020, CLIN MICROBIOL INFEC, V26, P773, DOI 10.1016/j.cmi.2020.04.001; Yang Qing, 2021, Elife, V10, DOI [10.1101/2020.07.16.20150250, 10.7554/eLife.65113]; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9; Zhang Y., 2020, RAPID MOL DETECTION, V2, P1, DOI [10.1101/2020.02.26.20028373, DOI 10.1101/2020.02.26.20028373]	54	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246084	10.1371/journal.pone.0246084	http://dx.doi.org/10.1371/journal.pone.0246084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503071	Green Published, gold			2022-12-26	WOS:000613751800056
J	Petry, AL; Patience, JF; Koester, LR; Huntley, NF; Bedford, MR; Schmitz-Esser, S				Petry, Amy L.; Patience, John F.; Koester, Lucas R.; Huntley, Nichole F.; Bedford, Michael R.; Schmitz-Esser, Stephan			Xylanase modulates the microbiota of ileal mucosa and digesta of pigs fed corn-based arabinoxylans likely through both a stimbiotic and prebiotic mechanism	PLOS ONE			English	Article								The experimental objective was to characterize the impact of insoluble corn-based fiber, xylanase, and an arabinoxylan-oligosaccharide on ileal digesta and mucosa microbiome of pigs. Three replicates of 20 gilts were blocked by initial body weight, individually-housed, and assigned to 1 of 4 dietary treatments: a low-fiber control (LF), a 30% corn bran high-fiber control (HF), HF+100 mg/kg xylanase (HF+XY), and HF+50 mg/kg arabinoxylan oligosaccharide (HF+AX). Gilts were fed their respective treatments for 46 days. On day 46, pigs were euthanized and ileal digesta and mucosa were collected. The V4 region of the 16S rRNA was amplified and sequenced, generating a total of 2,413,572 and 1,739,013 high-quality sequences from the digesta and mucosa, respectively. Sequences were classified into 1,538 mucosa and 2,495 digesta operational taxonomic units (OTU). Hidden-state predictions of 25 enzymes were made using Phylogenetic Investigation of Communities by Reconstruction of Unobserved States 2 (PICRUST2). Compared to LF, HF increased Erysipelotrichaceae UCG-002, and Turicibacter in the digesta, Lachnospiraceae_unclassified in the mucosa, and decreased Actinobacillus in both (Q<0.05). Relative to HF, HF+XY increased 19 and 14 of the 100 most abundant OTUs characterized from digesta and mucosa, respectively (0<0.05). Notably, HF+XY increased the OTU_23_Faecalibacterium by nearly 6 log(2)-fold change, compared to HF. Relative to HF, HF+XY increased genera Bifidobacterium, and Lactobacillus, and decreased Streptococcus and Turicibacter in digesta (Q<0.05), and increased Bifidobacterium and decreased Escherichia-Shigella in the mucosa (Q<0.05). Compared to HF, HF+AX increased 5 and 6 of the 100 most abundant OTUs characterized from digesta and mucosa, respectively, (Q<0.05), but HF+AX did not modulate similar taxa as HF+XY. The PICRUST2 predictions revealed HF+XY increased gene-predictions for enzymes associated with arabinoxylan degradation and xylose metabolism in the digesta, and increased enzymes related to short-chain fatty acid production in the mucosa. Collectively, these data suggest xylanase elicits a stimbiotic and prebiotic mechanism.	[Petry, Amy L.; Patience, John F.; Huntley, Nichole F.; Schmitz-Esser, Stephan] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Patience, John F.] Iowa State Univ, Iowa Pork Ind Ctr, Ames, IA USA; [Koester, Lucas R.] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Bedford, Michael R.] AB Vista Feed Ingredients, Marlborough, Wilts, England	Iowa State University; Iowa State University; Iowa State University	Schmitz-Esser, S (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	sse@iastate.edu	Schmitz-Esser, Stephan/AAA-7287-2019; Bedford, Michael/AAV-8204-2020	Schmitz-Esser, Stephan/0000-0002-1907-0709; Bedford, Michael/0000-0002-5308-4290; Patience, John/0000-0002-1672-5116	United States Department of Agriculture National Institute of Food and Agriculture (USDA-AFRI) [2016-38420-25496]; USDA-AFRI; AB Vista	United States Department of Agriculture National Institute of Food and Agriculture (USDA-AFRI); USDA-AFRI(United States Department of Agriculture (USDA)); AB Vista	Amy Petry (AP) is a recipient of a United States Department of Agriculture National Institute of Food and Agriculture (USDA-AFRI; https://nifa.usda.gov) National Needs Fellowship for Ph.D. Studies (Grant #2016-38420-25496). USDA-AFRI provided support in the form of salaries for AP only, but the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported by AB Vista, and they provided the xylanase and AXOS used in this trial. MR Bedford is an employee of AB Vista. As one of the authors, MB had influence over the study design. However, MB had a smaller role in the decision to publish or preparation of the manuscript, and there was no point at which conclusions or interpretations put forward, that were suggested by MB, without full agreement of the other authors. AB Vista was involved in the conceptualization of the project and study design. The specific roles of all authors are articulated in the `author contributions' section.	Acosta JA, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa130; Adeola O, 2011, J ANIM SCI, V89, P3189, DOI 10.2527/jas.2010-3715; Alyassin M, HE VALUE FIBRE ENGAG, P343; [Anonymous], 2019, BIOMED RES INT, V23, P14; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Anson NM, 2009, J CEREAL SCI, V49, P296, DOI 10.1016/j.jcs.2008.12.001; Apprill A, 2015, AQUAT MICROB ECOL, V75, P129, DOI 10.3354/ame01753; Barbera P, 2019, SYST BIOL, V68, P365, DOI 10.1093/sysbio/syy054; Bautil A, 2020, POULTRY SCI, V99, P2555, DOI 10.1016/j.psj.2019.12.041; Bedford A, 2018, ANIM NUTR, V4, P151, DOI 10.1016/j.aninu.2017.08.010; Bedford MR, 2018, BRIT POULTRY SCI, V59, P486, DOI 10.1080/00071668.2018.1484074; Bengtsson-Palme J, TAG HMMER; Caporaso J.G., 2018, PLOS ONE, DOI DOI 10.17504/PROTOCOLS.IO.NUUDEWW; Caspi R, 2020, NUCLEIC ACIDS RES, V48, pD445, DOI 10.1093/nar/gkz862; Chen H., 2020, J ANIM SCI, V98, pSKAA185, DOI [10.1093/jas/skaa185, DOI 10.1093/jas/skaa185]; Chen YF, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-019-0348-3; Czech L, 2020, BIOINFORMATICS, V36, P3263, DOI 10.1093/bioinformatics/btaa070; De Rodas B, 2018, J ANIM SCI, V96, P1778, DOI 10.1093/jas/sky109; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; Duarte ME, 2019, ANIM NUTR, V5, P351, DOI 10.1016/j.aninu.2019.04.005; Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06; FASS, 2010, GUIDE CARE USE AGR A; Feng G, 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fouhse JM, 2016, ANIM FRONT, V6, P30, DOI 10.2527/af.2016-0031; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gonzalez-Ortiz G, 2019, VALUE OF FIBRE: ENGAGING THE SECOND BRAIN FOR ANIMAL NUTRITION, P233, DOI 10.3920/978-90-8686-893-3_14; Gonzalez-Ortiz G, 2020, POULTRY SCI, V99, P2068, DOI 10.1016/j.psj.2019.11.051; Gottschalk M, 2003, VET MICROBIOL, V92, P87, DOI 10.1016/S0378-1135(02)00341-3; Grootaert C, 2007, TRENDS FOOD SCI TECH, V18, P64, DOI 10.1016/j.tifs.2006.08.004; Gutierrez NA, 2014, J ANIM SCI, V92, P4505, DOI 10.2527/jas.2013-7265; Gutierrez NA, 2013, J ANIM SCI, V91, P5314, DOI 10.2527/jas.2013-6328; Holman DB, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00004-17; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Jaworski NW, 2015, J ANIM SCI, V93, P1103, DOI 10.2527/jas.2014-8147; Jha R, 2015, ANIMAL, V9, P1441, DOI 10.1017/S1751731115000919; Jorgensen H, 2007, LIVEST SCI, V109, P111, DOI 10.1016/j.livsci.2007.01.102; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kim BR, 2017, J MICROBIOL BIOTECHN, V27, P2089, DOI 10.4014/jmb.1709.09027; Knudsen KEB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101499; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lam-Himlin D, 2011, AM J SURG PATHOL, V35, P1700, DOI 10.1097/PAS.0b013e31822911e6; Le Sciellour M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206159; Lekagul A, 2019, VET ANIM SCI, V7, DOI 10.1016/j.vas.2019.100058; Li QY, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01110; Louca S, 2018, BIOINFORMATICS, V34, P1053, DOI 10.1093/bioinformatics/btx701; Macia L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7734; Mathew S, 2004, CRIT REV BIOTECHNOL, V24, P59, DOI 10.1080/07388550490491467; McLaughlin HP, 2015, INT J FOOD MICROBIOL, V203, P109, DOI 10.1016/j.ijfoodmicro.2015.03.008; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Miquel S, 2014, GUT MICROBES, V5, P146, DOI 10.4161/gmic.27651; Ogiwara T, 2002, ANTICANCER RES, V22, P2711; Ou JY, 2016, PLANT FOOD HUM NUTR, V71, P123, DOI 10.1007/s11130-016-0547-4; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pedersen MB, 2015, BIOCHEM ENG J, V98, P99, DOI 10.1016/j.bej.2015.02.036; Petry AL, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skaa233; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979; Rombouts JL, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiy233; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Stackebrandt E., 2014, PROKARYOTES FIRMICUT, P197; Tiwari UP, 2019, ANIM NUTR, V5, P217, DOI 10.1016/j.aninu.2019.04.003; Tiwari UP, 2018, ANIM FEED SCI TECH, V245, P77, DOI 10.1016/j.anifeedsci.2018.07.002; Tran THT, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv165; Vahjen W, 1998, J AGR SCI-CAMBRIDGE, V130, P489, DOI 10.1017/S0021859698005498; Van den Abbeele P, 2011, FEMS MICROBIOL REV, V35, P681, DOI 10.1111/j.1574-6976.2011.00270.x; Wang XF, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0721-7; Weber EK, 2015, J ANIM SCI, V93, P1905, DOI 10.2527/jas.2014-8136; Zeybek N, 2020, CARBOHYD POLYM, V236, DOI 10.1016/j.carbpol.2020.116076; Zhang L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00048; Zhang ZX, 2018, ANIM NUTR, V4, P339, DOI 10.1016/j.aninu.2018.06.007; Zier-Rush CE, 2016, J ANIM SCI, V94, P115, DOI 10.2527/msasas2016-244	76	10	10	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2021	16	1							e0246144	10.1371/journal.pone.0246144	http://dx.doi.org/10.1371/journal.pone.0246144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	QA9GX	33503052	gold, Green Published			2022-12-26	WOS:000613751800019
J	Banach, JK; Majewska, K; Zuk-Golaszewska, K				Banach, Joanna Katarzyna; Majewska, Katarzyna; Zuk-Golaszewska, Krystyna			Effect of cultivation system on quality changes in durum wheat grain and flour produced in North-Eastern Europe	PLOS ONE			English	Article							YELLOW PIGMENT CONTENT; TRITICUM-AESTIVUM L.; HARDNESS; NITROGEN; CAROTENOIDS; YIELD; OLD	Grain of the highest hardness was produced from durum wheat grown without the use of growth regulator, at the lowest sowing density (350 seeds m(-2)) and nitrogen fertilization dose of 80 kg ha(-1). The highest values L* and b* were determined in the grain of wheat cultivated without additional agrotechnical measures (growth regulator and nitrogen fertilization). Study results, supported by correlation analysis, indicated that high-quality grain with desired flour quality parameters (level of: FER approximate to 64%; FPS approximate to 98%; L* approximate to 92) can be produced from spring durum wheat grown without the growth regulator and at 80 kg.ha(-1) nitrogen fertilization. Additionally, this variant of applied cultivation system can reduce costs of durum wheat production and contamination of the natural environment.	[Banach, Joanna Katarzyna] Univ Warmia & Mazury, Fac Econ, Inst Management & Qual, Olsztyn, Poland; [Majewska, Katarzyna] Univ Warmia & Mazury, Fac Food Sci, Dept Food Plant Chem & Proc, Olsztyn, Poland; [Zuk-Golaszewska, Krystyna] Univ Warmia & Mazury, Fac Agr & Forestry, Dept Agrotechnol & Agribusiness, Olsztyn, Poland	University of Warmia & Mazury; University of Warmia & Mazury; University of Warmia & Mazury	Banach, JK (corresponding author), Univ Warmia & Mazury, Fac Econ, Inst Management & Qual, Olsztyn, Poland.	katarzyna.banach@uwm.edu.pl		Majewska, Katarzyna/0000-0002-3323-7579; Banach, Joanna Katarzyna/0000-0001-9178-1540	University of Warmia and Mazury in Olsztyn, Poland [22.610.100-110, 17.610.012-110, 20.610.020-300]; program entitled 'Regional Initiative of Excellence' for the years 2019-2022 [010/RID/2018/19]	University of Warmia and Mazury in Olsztyn, Poland; program entitled 'Regional Initiative of Excellence' for the years 2019-2022	The research was financed by the University of Warmia and Mazury in Olsztyn, Poland (projects: No. 22.610.100-110; No. 17.610.012-110; No. 20.610.020-300) and financially supported by Minister of Science and Higher Education in the range of the program entitled 'Regional Initiative of Excellence' for the years 2019-2022, project No. 010/RID/2018/19, amount of funding 12.000.000 PLN.	Abdel-Aal ESM, 2007, J AGR FOOD CHEM, V55, P787, DOI 10.1021/jf062764p; [Anonymous], 2011, CER; [Anonymous], 2012, 7122012 PNEN ISO; Beleggia R, 2010, J CEREAL SCI, V52, P106, DOI 10.1016/j.jcs.2010.03.008; Boehm JD, 2018, J CEREAL SCI, V79, P57, DOI 10.1016/j.jcs.2017.09.015; Campiglia E, 2015, FIELD CROP RES, V176, P34, DOI 10.1016/j.fcr.2015.02.021; Ciolek A., 2004, Annales Universitatis Mariae Curie-Sklodowska. Sectio E, Agricultura, V59, P777; Colasuonno P, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01347; De Santis MA, 2017, EUR J AGRON, V87, P19, DOI 10.1016/j.eja.2017.04.003; De Santis MA, 2018, FOOD CHEM, V244, P304, DOI 10.1016/j.foodchem.2017.09.143; Delcour J.A., 2010, PRINCIPLES CEREAL SC, V3rd ed.; Diacono M, 2013, NJAS-WAGEN J LIFE SC, V64-65, P47, DOI 10.1016/j.njas.2013.03.001; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Girma Fana, 2012, World Applied Sciences Journal, V20, P1322; Giuliani MM, 2011, AGRON J, V103, P1668, DOI 10.2134/agronj2011.0154; Golaszewska K, 2018, J CEREAL SCI, V79, P501, DOI [10.1016/j.jcs.2018.01.002, DOI 10.1016/J.JCS.2018.01.002]; Haber T, 1992, ANALIZA TECHNICZNA P, V2; Hare R, 2017, WOODHEAD PUBL FOOD S, P135, DOI 10.1016/B978-0-08-100719-8.00006-1; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Hruskova M, 2009, CZECH J FOOD SCI, V27, P240, DOI 10.17221/71/2009-CJFS; Jurga R., 2007, MLYNARSKI, V5, P34; Kaur A, 2015, FOOD CHEM, V188, P517, DOI 10.1016/j.foodchem.2015.05.009; Makowska A, 2008, ACTA SCI POLON-TECHN, V7, P29; Marti J, 2014, FIELD CROP RES, V156, P258, DOI 10.1016/j.fcr.2013.10.008; Mefleh M, 2019, J SCI FOOD AGR, V99, P2059, DOI 10.1002/jsfa.9388; Miskelly D, 2017, WOODHEAD PUBL FOOD S, P653, DOI 10.1016/B978-0-08-100719-8.00024-3; Morris CF, 2015, ADV WHEAT GENETICS G; Nagamine T, 2003, J CEREAL SCI, V37, P337, DOI 10.1006/jcrs.2002.0505; Nishino H, 2009, ARCH BIOCHEM BIOPHYS, V483, P165, DOI 10.1016/j.abb.2008.09.011; Owens G., 2001, CEREALS PROCESSING 2, P109; Pasha I, 2010, FOOD SCI TECHNOL INT, V16, P511, DOI 10.1177/1082013210379691; Pauly A, 2013, COMPR REV FOOD SCI F, V12, P427, DOI 10.1111/1541-4337.12018; Rachon L, 2015, J ELEMENTOL, V20, P705, DOI 10.5601/jelem.2014.19.4.640; Ropelewska E, 2019, J CONSUM PROT FOOD S, V14, P131, DOI 10.1007/s00003-018-1196-3; Semenov MA, 2014, J CEREAL SCI, V59, P245, DOI 10.1016/j.jcs.2014.01.006; Su WH, 2017, CRIT REV FOOD SCI, V57, P1039, DOI 10.1080/10408398.2015.1082966; Sulewska H., 2007, Biuletyn Instytutu Hodowli i Aklimatyzacji Roslin, P17; Walia S.S., 2019, INTEGRATED FARMING S, P63, DOI [10.1007/978-3-319-99768-1_5, DOI 10.1007/978-3-319-99768-1_5]; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zarroug Y., 2015, EKIN, Journal of Crop Breeding and Genetics, V1, P69; Zhang W, 2008, THEOR APPL GENET, V116, P635, DOI 10.1007/s00122-007-0697-8	41	5	5	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0236617	10.1371/journal.pone.0236617	http://dx.doi.org/10.1371/journal.pone.0236617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481810	gold, Green Submitted, Green Published			2022-12-26	WOS:000612929300098
J	Bhandari, D; Shibanuma, A; Kiriya, J; Hirachan, S; Ong, KIC; Jimba, M				Bhandari, Divya; Shibanuma, Akira; Kiriya, Junko; Hirachan, Suzita; Ong, Ken Ing Cherng; Jimba, Masamine			Factors associated with breast cancer screening intention in Kathmandu Valley, Nepal	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HEALTH-SEEKING BEHAVIOR; PLANNED BEHAVIOR; MAMMOGRAPHY; FATALISM; SUPPORT; LATINAS; MANAGEMENT; MORTALITY; WOMEN	Background Breast cancer burden is increasing in low-income countries (LICs). Increasing incidence and delayed presentation of breast cancer are mainly responsible for this burden. Many women do not participate in breast cancer screening despite its effectiveness. Moreover, studies are limited on the barriers associated with low utilization of breast cancer screening in LICs. This study identified breast cancer screening behavior and factors associated with breast cancer screening intention among women in Kathmandu Valley, Nepal. Methods A cross-sectional study was conducted among 500 women living in five municipalities of Kathmandu Valley, Nepal. Data were collected from July to September 2018, using a structured questionnaire. Interviews were conducted among women selected through proportionate random household sampling. This study was conceptualized using the theory of planned behavior, fatalism, perceived susceptibility, and perceived severity. The outcome variables included: the intention to have mammography (MMG) biennially, the intention to have clinical breast examination (CBE) annually, and the intention to perform breast self-examination (BSE) monthly. Analysis was conducted separately for each outcome variable using partial proportional odds model. Results Out of 500 women, 3.4% had undergone MMG biennially, 7.2% CBE annually, and 14.4% BSE monthly. Women with a positive attitude, high subjective norms, and high perceived behavioral control were more likely to have the intention to undergo all three screening methods. Similarly, women were more likely to have intention to undergo CBE and MMG when they perceived themselves susceptible to breast cancer. Conversely, women were less likely to have intention to undergo CBE when they had high fatalistic beliefs towards breast cancer. Conclusion Women in this study had poor screening behavior. The practice of breast self-examination was comparatively higher than clinical breast examination and mammography. Multidimensional culturally sensitive interventions are needed to enhance screening intentions. Efforts should be directed to improve attitude, family support, and fatalistic belief towards cancer. Furthermore, the proper availability of screening methods should be ensured while encouraging women to screen before the appearance of symptoms.	[Bhandari, Divya; Shibanuma, Akira; Kiriya, Junko; Ong, Ken Ing Cherng; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo, Japan; [Hirachan, Suzita] Tribhuvan Univ, Teaching Hosp, Kathmandu, Nepal	University of Tokyo; Tribhuvan University; Institute of Medicine (IoM) - Nepal	Ong, KIC (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo, Japan.	kenicong@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016; BHANDARI, DIVYA/AAF-2069-2021	Shibanuma, Akira/0000-0003-2058-1722; BHANDARI, DIVYA/0000-0001-7720-9150; Ong, Ken Ing Cherng/0000-0001-7196-7671	University of Tokyo Fund	University of Tokyo Fund	This study is funded by The University of Tokyo Fund to MJ. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraido-Lanza AF, 2015, HEALTH EDUC BEHAV, V42, P633, DOI 10.1177/1090198115580975; Acharya S C, 2012, Kathmandu Univ Med J (KUMJ), V10, P3; ACTION Study Group, 2017, BMC Med, V15, P10, DOI 10.1186/s12916-016-0768-2; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Alexandraki I, 2010, J NATL MED ASSOC, V102, P206, DOI 10.1016/S0027-9684(15)30527-7; Allendorf K, 2010, STUD FAMILY PLANN, V41, P263, DOI 10.1111/j.1728-4465.2010.00252.x; American Cancer Society, 2017, BREAST CANC EARL DET; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; Attum B, 2018, STATPEARLS; Aujesky D, 2008, ARCH INTERN MED, V168, P706, DOI 10.1001/archinte.168.7.706; Bakari A, 2021, J BIOSOC SCI, V53, P497, DOI 10.1017/S0021932020000322; Basharat S, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4521-3; Bhandari PM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2166-8; Blumen H, 2016, AM HEALTH DRUG BENEF, V9, P23; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bynum JPW, 2005, ARCH INTERN MED, V165, P2083, DOI 10.1001/archinte.165.18.2083; Cullati S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-118; Day AK, 2014, J HEALTH PSYCHOL, V19, P1143, DOI 10.1177/1359105313485483; de los Monteros KE, 2011, INT J BEHAV MED, V18, P310, DOI 10.1007/s12529-010-9119-4; de Sanjose S, 2019, INT J WOMENS HEALTH, V11, P381, DOI 10.2147/IJWH.S197115; Fajdic Josip, 2013, Acta Inform Med, V21, P16, DOI 10.5455/AIM.2013.21.16-19; Godin G, 2001, PSYCHOL HEALTH, V16, P423, DOI 10.1080/08870440108405517; Griva F, 2009, WOMEN HEALTH, V49, P662, DOI 10.1080/03630240903496010; Haber G, 2012, AM J PUBLIC HEALTH, V102, P2322, DOI 10.2105/AJPH.2012.300786; Heidari M, 2015, INDIAN J PALLIAT CAR, V21, P198, DOI 10.4103/0973-1075.156500; Hu JM, 2020, DIS COLON RECTUM, V63, P850, DOI 10.1097/DCR.0000000000001611; Huang JJ, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037619; IDRE, 2015, REGR STAT REGR DIAGN; Kiyang Lawrence-Ndoh, 2015, BMC Res Notes, V8, P663, DOI 10.1186/s13104-015-1608-8; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Latalski M, 2001, Wiad Lek, V54, P391; Lee SY, 2015, ASIAN NURS RES, V9, P81, DOI 10.1016/j.anr.2015.05.003; Lee SH, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0557-5; Lin NQ, 2020, INT J HOSP MANAG, V90, DOI 10.1016/j.ijhm.2020.102612; Mantyselka P, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7377-x; Mayo Rachel M, 2003, Health Care Women Int, V24, P608, DOI 10.1080/07399330390217752; Miller-Graff LE, 2020, CHILD ABUSE NEGLECT, V108, DOI 10.1016/j.chiabu.2020.104639; Ministry of Health and Population New ERA ICF International Inc, 2017, NEP DEM HLTH SURV 20; Nahidi Fatemeh, 2017, Electron Physician, V9, P4577, DOI 10.19082/4577; Ohashi A, 2014, NAGOYA J MED SCI, V76, P17; Oldach BR, 2014, PATIENT EDUC COUNS, V94, P149, DOI 10.1016/j.pec.2013.10.001; Pandey A, 2015, J FAM MED COMMUNITY, V2, P1024; Pant PR, 2009, KATHMANDU VALLEY PRO, P1; Patel K, 2014, J COMMUN HEALTH, V39, P943, DOI 10.1007/s10900-014-9834-x; Perfetti AR, 2018, MED HUMANIT, V44, P59, DOI 10.1136/medhum-2017-011319; Poudel KK, 2017, NEPAL J EPIDEMIOL, V7, P659, DOI 10.3126/nje.v7i1.17759; Provencher L, 2016, CURR ONCOL, V23, pE332, DOI 10.3747/co.23.2881; Ramirez AS, 2014, J CANCER EDUC, V29, P50, DOI 10.1007/s13187-013-0541-6; Rivera MM, 2018, BREAST CANC AUCKL, V12, P117; Rivera-Franco MM, 2018, BREAST CANCER-BASIC, V12, DOI 10.1177/1178223417752677; Robinson CA, 2020, AM J HEALTH PROMOT, V34, P431, DOI 10.1177/0890117119896194; Roncancio AM, 2015, HEALTH EDUC BEHAV, V42, P621, DOI 10.1177/1090198115571364; Roncancio AM, 2013, BEHAV MED, V39, P66, DOI 10.1080/08964289.2013.799452; Satyal K., 2013, THESIS; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Singh YP, 2009, J NEPAL MED ASSOC, V48, P252; Tara S, 2008, KATHMANDU U MED J KU, V6, P89; Tfayli A, 2010, J ONCOL, V2010, DOI 10.1155/2010/490631; Widayanti AW, 2020, J EPIDEMIOL GLOB HEA, V10, P6, DOI 10.2991/jegh.k.200102.001; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; Yip CH, 2012, FUTURE ONCOL, V8, P1575, DOI [10.2217/FON.12.141, 10.2217/fon.12.141]; Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007	64	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245856	10.1371/journal.pone.0245856	http://dx.doi.org/10.1371/journal.pone.0245856			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481894	Green Published, gold			2022-12-26	WOS:000612929300022
J	Euswas, N; Phonnopparat, N; Morasert, K; Thakhampaeng, P; Kaewsanit, A; Mungthin, M; Rangsin, R; Sakboonyarat, B				Euswas, Nathakamol; Phonnopparat, Napat; Morasert, Kantapat; Thakhampaeng, Pongpisut; Kaewsanit, Apisit; Mungthin, Mathirut; Rangsin, Ram; Sakboonyarat, Boonsub			National trends in the prevalence of diabetic retinopathy among Thai patients with type 2 diabetes and its associated factors from 2014 to 2018	PLOS ONE			English	Article							RISK-FACTORS; POPULATION	Introduction Diabetic retinopathy (DR) is one of the most common and serious ocular complications in both developed and developing countries. To date, epidemiological data of DR and their associated factors in Southeast Asian countries especially in Thailand are scarce. We aimed to use the information from the Thailand Diabetes Mellitus/Hypertension (DM/HT) study to determine trends in DR prevalence and also risk factors among Thai patients with type 2 diabetes (T2D). Methods A series of cross-sectional surveys of clinical outcomes was conducted annually in 2014, 2015 and 2018 among patients with T2D aged > 18 years receiving medical care for at least 12 months. A stratified single stage cluster sampling method that was proportional to the size sampling technique was used to select a nationally and provincially representative sample of patients with T2D in Thailand. A standardized case report form was used to obtain the required information from medical records. Results A total of 104,472 Thai patients with T2D were included in the study from 2014 to 2018. The dominant proportion of participants, 70,756 (67.7%), were females. The overall prevalence of DR declined from 6.9% in 2014 to 6.3% in 2015 and 5.0% in 2018 (p for trend < 0.001). The independent associated factors with DR included survey year, greater duration of DM, geographic region, hospital level, social security scheme, dyslipidemia, insulin therapy, high HbA1c level and elevated pulse pressure. Conclusion We reported a decreasing in trend in the prevalence of DR among Thai patients with T2D over one half decade. Patients with T2D should be encouraged to control their underlying diseases and engage in other effective interventions. When these modifiable risk factors can be inhibited, DR and other cardiovascular complications will be alleviated.	[Euswas, Nathakamol; Phonnopparat, Napat; Morasert, Kantapat] Phramongkutklao Coll Med, Bangkok, Thailand; [Thakhampaeng, Pongpisut; Rangsin, Ram; Sakboonyarat, Boonsub] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand; [Kaewsanit, Apisit] Phramongkutklao Coll Med, Dept Anat, Bangkok, Thailand; [Mungthin, Mathirut] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand	Phramongkutklao College of Medicine; Phramongkutklao College of Medicine; Phramongkutklao College of Medicine; Phramongkutklao College of Medicine	Sakboonyarat, B (corresponding author), Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand.	boonsub1991@pcm.ac.th	Rangsin, Ram/AAR-9082-2021	Sakboonyarat, Boonsub/0000-0003-0577-0699	Thai National Health Security Office	Thai National Health Security Office	The authors wish to thank the entire staff members of the Department of Military and Community Medicine, Phramongkutklao College of Medicine, for their support in completing this study. The Thai DM/HT study and the Medical Research Network of the Consortium of Thai Medical Schools (MedResNet) were supported by the Thai National Health Security Office.	Aekplakorn W, 2011, DIABETES CARE, V34, P1980, DOI 10.2337/dc11-0099; Aguiree F., 2013, IDF DIABETES ATLAS; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Centers for Disease Control and Prevention, 2020, AD TOB US INF; Chaisakul J., 2020, Journal of the Medical Association of Thailand, V103, P254; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Cui Y, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023586; Deng Yu, 2014, Chinese Medical Sciences Journal, V29, P1; Hove MN, 2004, ACTA OPHTHALMOL SCAN, V82, P443, DOI 10.1111/j.1600-0420.2004.00270.x; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Jin GM, 2018, INVEST OPHTH VIS SCI, V59, P5067, DOI 10.1167/iovs.18-24280; Jingi AM, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0213-3; Jung CH, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-23; Kaewput Wisit, 2019, World J Nephrol, V8, P33, DOI 10.5527/wjn.v8.i2.33; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Krairittichai Udom, 2011, J Med Assoc Thai, V94 Suppl 2, pS1; Liu Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013199; Meng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048393; Ogawa O, 2005, DIABETES RES CLIN PR, V68, P162, DOI 10.1016/j.diabres.2004.09.008; Papier K, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-014102; Patel V, 2001, BR J DIABETES VASC D, V1, P80; Penman A, 2016, OPHTHAL EPIDEMIOL, V23, P88, DOI 10.3109/09286586.2015.1119287; Pereira DM., 2017, J CLIN DIAGN RES, V11, pNC01; Pugliese G, 2012, DIABETES RES CLIN PR, V98, P329, DOI 10.1016/j.diabres.2012.09.006; Rawdaree Petch, 2006, J Med Assoc Thai, V89 Suppl 1, pS1; Reutrakul S, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0725-7; Romero-Aroca P., 2007, Arch Soc Esp Oftalmol, V82, P209; Romero-Aroca P, 2017, BRIT J OPHTHALMOL, V101, P1346, DOI 10.1136/bjophthalmol-2016-310063; SAEEDI P, 2019, DIABETES RES CLIN PR, V157, DOI DOI 10.1016/J.DIABRES.2019.107843; Sakboonyarat B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4417-7; Sakboonyarat B, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0887-0; Steppan J, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/263585; Tseng ST, 2015, INT J CLIN EXP MED, V8, P21507; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wat N, 2016, HONG KONG MED J, V22, P589, DOI 10.12809/hkmj164869; World Health Organization, 1992, INT STAT CLASS DIS R; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yamamoto M, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010627; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhou Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012283	43	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245801	10.1371/journal.pone.0245801	http://dx.doi.org/10.1371/journal.pone.0245801			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481907	gold, Green Published			2022-12-26	WOS:000612929300130
J	Fryirs, K; Hancock, F; Healey, M; Mould, S; Dobbs, L; Riches, M; Raine, A; Brierley, G				Fryirs, Kirstie; Hancock, Fergus; Healey, Michael; Mould, Simon; Dobbs, Lucy; Riches, Marcus; Raine, Allan; Brierley, Gary			Things we can do now that we could not do before: Developing and using a cross-scalar, state-wide database to support geomorphologically-informed river management	PLOS ONE			English	Article							NEW-SOUTH-WALES; FLUVIAL GEOMORPHOLOGY; STREAM RESTORATION; FREEDOM SPACE; FRAMEWORK; HABITAT; REHABILITATION; PRINCIPLES; QUALITY; STYLES	A fundamental premise of river management is that practitioners understand the resource they are working with. In river management this requires that baseline information is available on the structure, function, health and trajectory of rivers. Such information provides the basis to contextualise, to plan, to be proactive, to prioritise, to set visions, to set goals and to undertake objective, pragmatic, transparent and evidence-based decision making. In this paper we present the State-wide NSW River Styles database, the largest and most comprehensive dataset of geomorphic river type, condition and recovery potential available in Australia. The database is an Open Access product covering over 216,600 km of stream length in an area of 802,000 km(2). The availability of the database presents unprecedented opportunities to systematically consider river management issues at local, catchment, regional and state-wide scales, and appropriately contextualise applications in relation to programs at other scales (e.g. internationally)-something that cannot be achieved independent from, or without, such a database. We present summary findings from the database and demonstrate through use of examples how the database has been used in geomorphologically-informed river management. We also provide a cautionary note on the limitations of the database and expert advice on lessons learnt during its development to aid others who are undertaking similar analyses.	[Fryirs, Kirstie; Mould, Simon; Brierley, Gary] Macquarie Univ, Dept Earth & Environm Sci, N Ryde, NSW, Australia; [Hancock, Fergus; Healey, Michael; Mould, Simon; Dobbs, Lucy; Raine, Allan] NSW Dept Planning Ind & Environm, Water Div, Parramatta, NSW, Australia; [Riches, Marcus] NSW Dept Primary Ind Fisheries, Coastal Syst Unit, Orange, NSW, Australia; [Brierley, Gary] Univ Auckland, Sch Environm, Auckland, New Zealand	Macquarie University; NSW Department of Primary Industries; University of Auckland	Fryirs, K (corresponding author), Macquarie Univ, Dept Earth & Environm Sci, N Ryde, NSW, Australia.	kirstie.fryirs@mq.edu.au		Fryirs, Kirstie/0000-0003-0541-3384; Mould, Simon/0000-0003-0029-8719	Land and Water Australia; Natural Heritage Trust; Australian Research Council; Macquarie University; NSW Departments of Land, Water and Environment; Catchment Management Authorities; Local Land Services; NSW Independent Pricing and Regulatory Tribunal (IPART)	Land and Water Australia; Natural Heritage Trust; Australian Research Council(Australian Research Council); Macquarie University; NSW Departments of Land, Water and Environment; Catchment Management Authorities; Local Land Services; NSW Independent Pricing and Regulatory Tribunal (IPART)	Funding for the development of the River Styles Framework over 20 years has been provided by the former Land and Water Resources Research and Development Corporation (later Land and Water Australia) Riparian Landscapes program, the Natural Heritage Trust, the Australian Research Council and Macquarie University. Applications of the River Styles Framework across NSW have over the years been funded by various NSW Departments of Land, Water and Environment, Catchment Management Authorities, Local Land Services. More recently applications have been funded by the NSW Independent Pricing and Regulatory Tribunal (IPART) to the NSW Department of Planning, Industry and Environment (DPIE).	AETG (Aquatic Ecosystems Task Group), 2012, AQ EC TOOLK MOD 2 IN; Allen GH, 2018, SCIENCE, V361, P585, DOI 10.1126/science.aat0636; [Anonymous], 2000, REHABILITATION MANUA; [Anonymous], 2000, REHABILITATION MANUA; Ashmore P, 2015, GEOMORPHOLOGY, V251, P149, DOI 10.1016/j.geomorph.2015.02.020; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Beier U, 2007, FISHERIES MANAG ECOL, V14, P407, DOI 10.1111/j.1365-2400.2007.00579.x; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Biron PM, 2014, ENVIRON MANAGE, V54, P1056, DOI 10.1007/s00267-014-0366-z; Boitsidis AJ, 2006, WATER ENVIRON J, V20, P130, DOI 10.1111/j.1747-6593.2005.00005.x; Bravard JP, 1999, GEOMORPHOLOGY, V31, P291, DOI 10.1016/S0169-555X(99)00091-4; Brierley G, 2002, APPL GEOGR, V22, P91, DOI 10.1016/S0143-6228(01)00016-9; Brierley G.J, 2012, RIVER FUTURES INTEGR; Brierley G, 2011, APPL GEOGR, V31, P1132, DOI 10.1016/j.apgeog.2011.03.002; Brierley G, 2010, SCI TOTAL ENVIRON, V408, P2025, DOI 10.1016/j.scitotenv.2010.01.038; Brierley G, 2009, ENVIRON MANAGE, V43, P1201, DOI 10.1007/s00267-008-9266-4; Brierley GJ, 2005, GEOMORPHOLOGY AND RIVER MANAGEMENT: APPLICATIONS OF THE RIVER STYLES FRAMEWORK, P1; Brierley GJ, 2000, ENVIRON MANAGE, V25, P661, DOI 10.1007/s002670010052; BROOKES A, 1995, EARTH SURF PROCESSES, V20, P593, DOI 10.1002/esp.3290200704; Buffin-Belanger T, 2015, GEOMORPHOLOGY, V251, P137, DOI 10.1016/j.geomorph.2015.05.013; Casado MR, 2015, SENSORS-BASEL, V15, P27969, DOI 10.3390/s151127969; Castro JM, 2019, RIVER RES APPL, V35, P315, DOI 10.1002/rra.3421; Dallaire CO, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aad8e9; Darby S., 2008, RIVER RESTORATION MA; Eze PN, 2018, PHYS CHEM EARTH, V105, P196, DOI 10.1016/j.pce.2018.01.001; FRISSELL CA, 1986, ENVIRON MANAGE, V10, P199, DOI 10.1007/BF01867358; Fryhs KA, 2019, WIRES WATER, V6, DOI 10.1002/wat2.1372; Fryirs K., 2005, PRACTICAL APPL RIVER, P227; Fryirs K.A., 2012, GEOMORPHIC ANAL RIVE, P1; Fryirs K, 2012, EARTH SURF PROC LAND, V37, P763, DOI 10.1002/esp.3210; Fryirs K, 2009, ECOL SOC, V14; Fryirs KA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12020-z; Fryirs KA, 2018, LAND DEGRAD DEV, V29, P3221, DOI 10.1002/ldr.2984; Fryirs KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201909; Fryirs KA, 2018, GEOGR J, V184, P192, DOI 10.1111/geoj.12250; Fryirs KA, 2016, WIRES WATER, V3, P727, DOI 10.1002/wat2.1158; Fryirs KA, 2015, WIRES WATER, V2, P649, DOI 10.1002/wat2.1100; Gilvear DJ, 1999, GEOMORPHOLOGY, V31, P229, DOI 10.1016/S0169-555X(99)00086-0; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gregory KJ., 2004, RIVER CHANNEL MANAGE; Guillon H, 2020, WATER RESOUR RES, V56, DOI 10.1029/2019WR026691; Gurnell AM, 2016, AQUAT SCI, V78, P1, DOI 10.1007/s00027-015-0424-5; Gurnell AM, 2020, RIVER RES APPL, V36, P1559, DOI 10.1002/rra.3673; Hawley RJ, 2018, BIOSCIENCE, V68, P517, DOI 10.1093/biosci/biy048; Healey M., 2012, RIVER CONDITION INDE; Healey M, 2018, APPL HIGH ECOLOGICAL; Henshaw AJ, 2020, EARTH SURF PROC LAND, V45, P331, DOI 10.1002/esp.4732; Huesker F, 2015, LAND USE POLICY, V42, P38, DOI 10.1016/j.landusepol.2014.07.003; Johnson MF, 2020, RIVER RES APPL, V36, P3, DOI 10.1002/rra.3529; Kasprak A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150293; Kondolf G.M., 2003, TOOLS FLUVIAL GEOMOR; Kondolf GM, 2006, ECOL SOC, V11; Kondolf GM, 2011, GEOPHYS MONOGR SER, V194, P29, DOI 10.1029/2010GM001020; KONDOLF GM, 1995, RESTOR ECOL, V3, P133, DOI 10.1111/j.1526-100X.1995.tb00086.x; Koppes M, J GEOPHYS RES EARTH; Lane SN, 2014, HYDROL EARTH SYST SC, V18, P927, DOI 10.5194/hess-18-927-2014; Martinez-Fernandez V, 2016, GEOMORPHOLOGY, V253, P38, DOI 10.1016/j.geomorph.2015.09.029; McManamay RA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198439; Mould S, 2021, MAR FRESHWATER RES, V72, P481, DOI 10.1071/MF20065; Mould S, 2020, WIRES WATER, V7, DOI 10.1002/wat2.1445; Mould SA, 2020, ECOL SOC, V25, DOI 10.5751/ES-11505-250217; Mould SA, 2018, SOC NATUR RESOUR, V31, P106, DOI [10.1080/08941920.2017.1382627, 10.1080/08941920.2017.13]; Newson M., 2009, LAND WATER DEV SUSTA; Newson MD, 2006, EARTH SURF PROC LAND, V31, P1606, DOI 10.1002/esp.1430; Newson MD, 2000, PROG PHYS GEOG, V24, P195, DOI 10.1177/030913330002400203; O'Brien GR, 2017, J MAPS, V13, P369, DOI 10.1080/17445647.2017.1313787; O'Donnell J, 2016, SCI TOTAL ENVIRON, V542, P591, DOI 10.1016/j.scitotenv.2015.10.118; Park JR, 2009, CAT CLASSIF Q, V47, P213, DOI 10.1080/01639370902737240; Pedersen ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108558; Petts G.E., 1984, P1; Piegay H, 2005, RIVER RES APPL, V21, P773, DOI 10.1002/rra.881; Piegay H, 2020, EARTH SURF PROC LAND, V45, P157, DOI 10.1002/esp.4787; Poeppl RE, 2020, SCI TOTAL ENVIRON, V736, DOI 10.1016/j.scitotenv.2020.139627; Polvi LE, 2020, J ENVIRON MANAGE, V265, DOI 10.1016/j.jenvman.2020.110288; Rhoads B.L., 2020, RIVER DYNAMICS GEOMO, DOI 10.1017/9781108164108; Riches M, 2016, FISH COMMUNITY THREA; Rinaldi M, 2015, GEOMORPHOLOGY, V251, P122, DOI 10.1016/j.geomorph.2015.05.010; Rinaldi M, 2013, GEOMORPHOLOGY, V180, P96, DOI 10.1016/j.geomorph.2012.09.009; Rogers KH, 2006, RIVER RES APPL, V22, P269, DOI 10.1002/rra.910; Roux C, 2015, GEOMORPHOLOGY, V242, P29, DOI 10.1016/j.geomorph.2014.04.018; Rutherfurd I., 1999, P 2 STREAM MANAGEMEN, V2, P527; Sayer J, 2013, P NATL ACAD SCI USA, V110, P8349, DOI 10.1073/pnas.1210595110; Sear D.A., 2010, GUIDEBOOK APPL FLUVI, DOI 10.1680/gafg.34846; SEAR DA, 1994, AQUAT CONSERV, V4, P169, DOI 10.1002/aqc.3270040207; SEARM DA, 1995, EARTH SURF PROCESSES, V20, P629, DOI 10.1002/esp.3290200706; Shuker LJ, 2017, WATER ENVIRON J, V31, P418, DOI 10.1111/wej.12259; Simon A, 2013, STREAM RESTORATION D; Spink A, 2010, GEOFORUM, V41, P399, DOI 10.1016/j.geoforum.2009.12.003; Thomson JR, 2001, AQUAT CONSERV, V11, P373, DOI 10.1002/aqc.467; Thorne C, 2005, APPL FLUVIAL GEOMORP; Thorne C.R., 1998, STREAM RECONNAISSANC; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; Tooth S, 2006, EARTH SURF PROC LAND, V31, P1192, DOI 10.1002/esp.1383; Wheaton J.M., 2019, LOW TECH PROCESS BAS; Wheaton JM, 2018, EARTH SURF PROC LAND, V43, P21, DOI 10.1002/esp.4137; Wheaton JM, 2015, GEOMORPHOLOGY, V248, P273, DOI 10.1016/j.geomorph.2015.07.010; Wilcock D, 2013, PROG PHYS GEOG, V37, P573, DOI 10.1177/0309133313483164; Williams RD, 2020, SCI TOTAL ENVIRON, V715, DOI 10.1016/j.scitotenv.2020.136817; Wohl E, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR003985; Wohl E, 2019, EARTH SURF PROC LAND, V44, P4, DOI 10.1002/esp.4434; Wohl E, 2015, BIOSCIENCE, V65, P358, DOI 10.1093/biosci/biv002; Wohl E, 2015, WATER RESOUR RES, V51, P5974, DOI 10.1002/2014WR016874; Wohl E, 2011, EARTH SURF PROC LAND, V36, P1378, DOI 10.1002/esp.2180	103	12	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0244719	10.1371/journal.pone.0244719	http://dx.doi.org/10.1371/journal.pone.0244719			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7OB	33481832	gold, Green Published			2022-12-26	WOS:000612929300155
J	Muravha, T; Hoffmann, CJ; Botha, C; Maruma, W; Charalambous, S; Chetty-Makkan, CM				Muravha, Tshifhiwa; Hoffmann, Christopher J.; Botha, Claire; Maruma, Wellington; Charalambous, Salome; Chetty-Makkan, Candice M.			Exploring perceptions of low risk behaviour and drivers to test for HIV among South African youth	PLOS ONE			English	Article							ADOLESCENTS; CARE	Human Immunodeficiency Virus (HIV) prevalence among South African youth is high, yet HIV testing remains suboptimal. We explored how perceptions of HIV risk and behaviours informed decisions to test for HIV. This study was conducted from April 2018 to March 2019 in Ekurhuleni district, Gauteng Province with males and females aged between 15-24 years. Twenty-five youth with unknown HIV status participated in in-depth interviews (IDIs); while four focus group discussions (FGDs) were conducted with those that previously tested for HIV. Probes used in the guides included types of incentives that youth would value when testing for HIV or receiving treatment; barriers and motivators to HIV testing; enablers and challenges to using cellphone technology and preferences on type of social media that could be used to create awareness about HIV testing services. IDIs and FGDs were audio-recorded, transcribed, and translated. QSR NVIVO 10 was used for the analysis. The majority of the youth perceived that their risk of HIV infection was low due to factors such as being young, lacking physical signs of HIV, being sexually inactive and parents not being HIV positive. However, youth identified high risk behaviours such as unprotected sex, multiple sexual partners, excessive drinking of alcohol, being victims of sexual abuse, road accidents and violent behaviour as increasing their vulnerability to HIV. Most youth highlighted cues to action that would motivate them to test for HIV such as support of parents, receiving incentives, improved confidentiality during HIV testing and receiving information about HIV via social media (Facebook, Twitter and Whatsapp). Despite perceptions of low risk to HIV, youth remain vulnerable to HIV. Disseminating HIV information via digital platforms; giving youth options to choose between testing locations that they consider to be private; providing incentives and equipping parents/guardians to encourage youth to test could optimise HIV testing.	[Muravha, Tshifhiwa; Botha, Claire; Charalambous, Salome; Chetty-Makkan, Candice M.] Aurum Inst, Johannesburg, South Africa; [Hoffmann, Christopher J.] Johns Hopkins Univ, Baltimore, MD USA; [Maruma, Wellington] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Charalambous, Salome; Chetty-Makkan, Candice M.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Chetty-Makkan, Candice M.] Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa	Johns Hopkins University; National Institute for Communicable Diseases (NICD); University of Witwatersrand	Muravha, T (corresponding author), Aurum Inst, Johannesburg, South Africa.	tmuravha@auruminstitute.org		Muravha, Tshifhiwa/0000-0002-6089-6748; Hoffmann, Christopher/0000-0002-9422-0519; Charalambous, Salome/0000-0001-7143-1009; Chetty-Makkan, Candice/0000-0001-9292-9586	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government	Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afriyie James, 2019, Ghana Med J, V53, P29, DOI 10.4314/gmj.v53i1.5; Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; Belle JA, 2019, AFR HEALTH SCI, V19, P2302, DOI 10.4314/ahs.v19i3.2; Chetty-Makkan CM, 2021, AIDS BEHAV, V25, P182, DOI 10.1007/s10461-020-02960-9; Chikwari CD, 2018, CURR OPIN HIV AIDS, V13, P257, DOI [10.1097/COH.0000000000000452, 10.1097/coh.0000000000000452]; Cornelius JB, 2019, ADOLESC HEALTH MED T, V10, P29, DOI 10.2147/AHMT.S185041; Gonzalez RP, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6809-y; Govender Kaymarlin, 2018, Open AIDS J, V12, P53, DOI 10.2174/1874613601812010053; Idele P, 2014, EPIDEMIOLOGY HIV AID; Johnson TL, 2019, REV ASSET PRICING ST, V9, P1, DOI 10.1093/rapstu/ray010; Kranzer K, 2018, LANCET HIV, V5, pE79, DOI 10.1016/S2352-3018(17)30176-5; Madiba S, 2015, BMC PUBLIC HEALTH, V15, P1; Madiba S, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/4842814; Mathews A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08582-z; Matseke Gladys, 2016, Afr. j. prim. health care fam. med. (Online), V8, P1, DOI 10.4102/phcfm.v8i1.1173; Maughan-Brown B, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4593-0; McGovern ME, 2016, INT J EPIDEMIOL, V45, P2100, DOI 10.1093/ije/dyw122; Miller AL, 2017, INT J EDUC ARTS, V18, P1; Moser A, 2017, EUR J GEN PRACT, V24, DOI [10.1080/13814788.2017.1375091, 10.1080/13814788.2017.1375092]; Mwaba K, 2020, AIDS CARE, V32, pS183, DOI 10.1080/09540121.2020.1739214; Ndyabakira A, 2019, BMC PUBLIC HEALTH, V19, P1; Nel JA, 2013, AIDS BEHAV, V17, pS51, DOI 10.1007/s10461-012-0329-4; Nglazi MD, 2012, JAIDS-J ACQ IMM DEF, V59, pE28, DOI 10.1097/QAI.0b013e31824445f0; Ntsepe Y, 2014, SAHARA J-J SOC ASP H, V11, P138, DOI 10.1080/17290376.2014.937355; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Saul J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208167; Schaefer R, 2019, AIDS BEHAV, V23, P2199, DOI 10.1007/s10461-018-2374-0; Shah P, 2019, AIDS BEHAV, V23, P908, DOI 10.1007/s10461-018-2276-1; Sibanda EL, 2019, SERVICES RURAL ZIMBA, V5; Simbayi LC, 2019, BEHAV COMMUNICATION; Smith P, 2018, SAMJ S AFR MED J, V108, P677, DOI [10.7196/SAMJ.2018.v108i8.13013, 10.7196/samj.2018.v108i8.13013]; Soon CN, 2013, SAHARA J-J SOC ASP H, V10, P163, DOI 10.1080/17290376.2014.902769; Strauss M, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0922-0; Tonen-Wolyec S, 2019, PAN AFR MED J, V33, DOI 10.11604/pamj.2019.33.83.18586; United Nations Children's Fund (UNICEF), HIV AIDS AD; United Nations Joint Programme on HIV/AIDS (UNAIDS), 2019, UNAIDS DAT 2019, P476; Zanoni BC, 2018, ADOLESC HEALTH MED T, V9, P211, DOI 10.2147/AHMT.S153204; Zungu NP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3024-y	38	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245542	10.1371/journal.pone.0245542	http://dx.doi.org/10.1371/journal.pone.0245542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481878	Green Published, gold			2022-12-26	WOS:000612929300120
J	Traore, S; Yapi, RB; Coulibaly, K; Mathew, C; Fokou, G; Kazwala, RR; Bonfoh, B; Alambedji, RB				Traore, Souleymane; Yapi, Richard B.; Coulibaly, Kadiatou; Mathew, Coletha; Fokou, Gilbert; Kazwala, Rudovick R.; Bonfoh, Bassirou; Alambedji, Rianatou Bada			Seroprevalence of brucellosis in small ruminants and related risk behaviours among humans in different husbandry systems in Mali	PLOS ONE			English	Article							CAPRINE BRUCELLOSIS; EPIDEMIOLOGY; ANTIBODIES; AFRICA; CATTLE; STATE	Mali has a high pastoral potential with diverse coexisting production systems ranging from traditional (nomadic, transhumant, sedentary) to commercial (fattening and dairy production) production systems. Each of those systems is characterised by close interactions between animals and humans, increasing the potential risk of transmission of zoonotic diseases. The nature of contact network suggests that the risks may vary according to species, production systems and behaviors. However, the study of the link between small ruminants and zoonotic diseases has received limited attention in Mali. The objective of this study was to assess brucellosis seroprevalence and determine how the husbandry systems and human behaviour expose animal and human to infection risk. A cross-sectional study using cluster sampling was conducted in three regions in Mali. Blood was collected from 860 small ruminants. The sera obtained were analysed using both Rose Bengal and cELISA tests. In addition, 119 farmers were interviewed using a structured questionnaire in order to identify the characteristics of farms as well as the risk behaviors of respondents. Husbandry systems were dominated by agro-pastoral systems followed by pastoral systems. The commercial farms (peri-urban and urban) represent a small proportion. Small ruminant individual seroprevalence was 4.1% [2.8-5.6% (95% CI)]. Herd seroprevalence was estimated at 25.2% [17.7-33.9% (95% CI)]. Peri-urban farming system was more affected with seroprevalence of 38.1% [18.1-61.5 (95% CI)], followed by pastoral farming system (24.3% [11.7-41.2 (95% CI)]). Identified risk behaviors of brucellosis transmission to animals were: exchange of reproductive males (30.2%); improper disposal of placentas in the farms (31.1%); and keeping aborted females in the herd (69.7%). For humans, risk factors were: close and prolonged contact with animals (51.2%); consumption of unpasteurized dairy products ( 26.9%); and assisting female animals during delivery without any protection (40.3%). This study observed a high seroprevalence of brucellosis in small ruminants and also identified risky practices that allow cross transmission between the two populations. This calls for control strategy using a multi-sectoral and multidimensional approach.	[Traore, Souleymane; Alambedji, Rianatou Bada] Ecole Interetats Sci & Med Vet Dakar, Dakar, Senegal; [Yapi, Richard B.; Fokou, Gilbert; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote dIvoire, Abidjan, Cote Ivoire; [Yapi, Richard B.] Univ Alassane Ouattara, Ctr Entomol Med & Vet, Bouake, Cote Ivoire; [Coulibaly, Kadiatou] Lab Cent Vet Bamako, Bamako, Mali; [Mathew, Coletha; Kazwala, Rudovick R.] Sokoine Univ Agr, Morogoro, Tanzania	Sokoine University of Agriculture	Traore, S (corresponding author), Ecole Interetats Sci & Med Vet Dakar, Dakar, Senegal.	souleymanet@yahoo.fr		Yapi, Richard Brou/0000-0002-5167-2961; TRAORE, Souleymane/0000-0002-5468-4781; Fokou, Gilbert/0000-0002-4989-299X	DELTAS Africa Initiative [Afrique] [One-ASPIRE/DEL-15-008]; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	DELTAS Africa Initiative [Afrique]; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome TrustEuropean Commission); UK government	The authors acknowledge support from the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008, http://afriqueoneaspire.org/)].Afrique One-ASPIRE is funded by a consortium of donor including the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamou Harouna H., 2014, THESIS; Akakpo A J, 1987, Rev Elev Med Vet Pays Trop, V40, P307; Almoustapha Coulibaly, 2003, PROFIL FOURRAGER MAL; Anne PRAUD, 2012, THESIS; Benkirane A, 2006, SMALL RUMINANT RES, V62, P19, DOI 10.1016/j.smallrumres.2005.07.032; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bonfoh B., 2002, HYGIENE QUALITE LAIT, P51; Bonfoh B, 2005, SYNTHESE BIBLIOGRAPH; Bonfoh B, 2012, ECOHEALTH, V9, P132, DOI 10.1007/s10393-011-0722-x; Centres J -M, 1996, LELEVAGE AGR ZONES U, V5, P373; Dao S., 2009, REV TUNISIENNE DINFE, V2, P24; Dean AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071501; Dicko Maimouna Salah, 2006, Secheresse (Montrouge), V17, P83; DOMENECH J, 1983, REV ELEV MED VET PAY, V36, P19; Kadiatou Coulibaly, 2016, CONTRIBUTION LETUDE; Kanoute YB, 2017, ACTA TROP, V165, P66, DOI 10.1016/j.actatropica.2016.02.012; Mai HM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-144; Mali D., 2018, RAPPORT ANNUEL 2017, P88; Mali D., 2016, RAPPORT ANNUEL 2015, P113; Mangen M., 2002, BOVINE BRUCELLOSIS S; Marianelli C, 2007, J CLIN MICROBIOL, V45, P2923, DOI 10.1128/JCM.00822-07; Megersa B, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-24; Mitchell Becky, BLOOD SAMPLING SHEEP, V3, P5; Mohamed EMA, 2018, VET WORLD, V11, P511, DOI 10.14202/vetworld.2018.511-518; Newcombe RG, 2001, AM STAT, V55, P200, DOI 10.1198/000313001317098167; Omer MK, 2000, EPIDEMIOL INFECT, V125, P447, DOI 10.1017/S0950268899004501; Osoro EM, 2015, AM J TROP MED HYG, V93, P224, DOI 10.4269/ajtmh.15-0113; Ouattara S., 2001, ETUDE CAPITALISATION; Pappas G, 2005, INT J ANTIMICROB AG, V26, P101, DOI 10.1016/j.ijantimicag.2005.06.001; Razac Boukary Abdou, 2013, PLOS ONE, V8, DOI [10.1371/10URNAL.P0NE.0083175, DOI 10.1371/10URNAL.P0NE.0083175]; Saegerman C, 2004, VET MICROBIOL, V100, P91, DOI 10.1016/j.vetmic.2004.02.003; Schelling E, 2004, MED TROP, P474; Sice A, 1939, B SOC PATHOL EXOT, V32, P409; Sow I, 2015, FOOD SAFETY AND INFORMAL MARKETS: ANIMAL PRODUCTS IN SUB-SAHARAN AFRICA, P171; Steinmann P, 2006, BRUCELLOSIS SEROPREV, V6; Tialla D., 2014, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V67, P67; TOUNKARA K, 1994, REV SCI TECH OIE, V13, P777, DOI 10.20506/rst.13.3.795	37	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2021	16	1							e0245283	10.1371/journal.pone.0245283	http://dx.doi.org/10.1371/journal.pone.0245283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PZ7OB	33481859	Green Published, gold			2022-12-26	WOS:000612929300006
J	Mariani, N; Borsini, A; Cecil, CAM; Felix, JF; Sebert, S; Cattaneo, A; Walton, E; Milaneschi, Y; Cochrane, G; Amid, C; Rajan, J; Giacobbe, J; Sanz, Y; Agusti, A; Sorg, T; Herault, Y; Miettunen, J; Parmar, P; Cattane, N; Jaddoe, V; Lotjonen, J; Buisan, C; Ballester, MGA; Piella, G; Gelpi, JL; Lamers, F; Penninx, BWJH; Tiemeier, H; von Tottleben, M; Thiel, R; Heil, KF; Jarvelin, MR; Pariante, C; Mansuy, IM; Lekadir, K				Mariani, Nicole; Borsini, Alessandra; Cecil, Charlotte A. M.; Felix, Janine F.; Sebert, Sylvain; Cattaneo, Annamaria; Walton, Esther; Milaneschi, Yuri; Cochrane, Guy; Amid, Clara; Rajan, Jeena; Giacobbe, Juliette; Sanz, Yolanda; Agusti, Ana; Sorg, Tania; Herault, Yann; Miettunen, Jouko; Parmar, Priyanka; Cattane, Nadia; Jaddoe, Vincent; Lotjonen, Jyrki; Buisan, Carme; Gonzalez Ballester, Miguel A.; Piella, Gemma; Gelpi, Josep L.; Lamers, Femke; Penninx, Brenda W. J. H.; Tiemeier, Henning; von Tottleben, Malte; Thiel, Rainer; Heil, Katharina F.; Jarvelin, Marjo-Riitta; Pariante, Carmine; Mansuy, Isabelle M.; Lekadir, Karim			Identifying causative mechanisms linking early-life stress to psycho-cardio-metabolic multi-morbidity: The EarlyCause project	PLOS ONE			English	Article							DEVELOPMENTAL ORIGINS; DEPRESSION; ENVIRONMENT	Introduction Depression, cardiovascular diseases and diabetes are among the major non-communicable diseases, leading to significant disability and mortality worldwide. These diseases may share environmental and genetic determinants associated with multimorbid patterns. Stressful early-life events are among the primary factors associated with the development of mental and physical diseases. However, possible causative mechanisms linking early life stress (ELS) with psycho-cardio-metabolic (PCM) multi-morbidity are not well understood. This prevents a full understanding of causal pathways towards the shared risk of these diseases and the development of coordinated preventive and therapeutic interventions. Methods and analysis This paper describes the study protocol for EarlyCause, a large-scale and inter-disciplinary research project funded by the European Union's Horizon 2020 research and innovation programme. The project takes advantage of human longitudinal birth cohort data, animal studies and cellular models to test the hypothesis of shared mechanisms and molecular pathways by which ELS shapes an individual's physical and mental health in adulthood. The study will research in detail how ELS converts into biological signals embedded simultaneously or sequentially in the brain, the cardiovascular and metabolic systems. The research will mainly focus on four biological processes including possible alterations of the epigenome, neuroendocrine system, inflammatome, and the gut microbiome. Life-course models will integrate the role of modifying factors as sex, socioeconomics, and lifestyle with the goal to better identify groups at risk as well as inform promising strategies to reverse the possible mechanisms and/or reduce the impact of ELS on multi-morbidity development in high-risk individuals. These strategies will help better manage the impact of multi-morbidity on human health and the associated risk.	[Mariani, Nicole; Borsini, Alessandra; Giacobbe, Juliette; Pariante, Carmine] Kings Coll London, Inst Psychiat Psychol & Neurosci, Stress Psychiat & Immunol Lab, Dept Psychol Med, London, England; [Cecil, Charlotte A. M.] Univ Med Ctr Rotterdam, Dept Epidemiol, Erasmus MC, Rotterdam, Netherlands; [Cecil, Charlotte A. M.] Univ Med Ctr Rotterdam, Dept Child & Adolescent Psychiat, Erasmus MC, Rotterdam, Netherlands; [Felix, Janine F.; Jaddoe, Vincent] Univ Med Ctr Rotterdam, Generat R Study Grp, Erasmus MC, Rotterdam, Netherlands; [Felix, Janine F.; Jaddoe, Vincent] Univ Med Ctr Rotterdam, Dept Pediat, Erasmus MC, Rotterdam, Netherlands; [Sebert, Sylvain; Miettunen, Jouko; Parmar, Priyanka; Jarvelin, Marjo-Riitta] Univ Oulu, Ctr Life Course Hlth Res, Fac Med, Oulu, Finland; [Sebert, Sylvain] Univ Bristol, Bristol Med Sch, Integrat Epidemiol Unit, Med Res Council, Bristol, Avon, England; [Sebert, Sylvain] Imperial Coll London, Dept Metab Digest & Reprod Genom Med, Fac Med, London, England; [Cattaneo, Annamaria; Cattane, Nadia] IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Biol Psychiat Lab, Brescia, Italy; [Cattaneo, Annamaria] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Walton, Esther; Lamers, Femke; Penninx, Brenda W. J. H.] Univ Bath, Dept Psychol, Bath, Avon, England; [Milaneschi, Yuri] Vrije Univ, Amsterdam UMC, Dept Psychiat, Amsterdam, Netherlands; [Milaneschi, Yuri] Amsterdam Publ Hlth, GGZinGeest, Amsterdam, Netherlands; [Milaneschi, Yuri] Amsterdam Neurosci Res Inst, Amsterdam, Netherlands; [Cochrane, Guy; Amid, Clara; Rajan, Jeena] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Cambridge, England; [Amid, Clara] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Sanz, Yolanda; Agusti, Ana] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain; [Sorg, Tania; Herault, Yann] Univ Strasbourg, Ctr Europeen Rech Biol & Med, Inst Genet & Biol Mol & Cellulaire, PHENOMIN ICS,CNRS,INSERM, Strasbourg, France; [Miettunen, Jouko] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Miettunen, Jouko] Univ Oulu, Oulu, Finland; [Lotjonen, Jyrki; Buisan, Carme; Gonzalez Ballester, Miguel A.; Piella, Gemma] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [Gonzalez Ballester, Miguel A.] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Gelpi, Josep L.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain; [Tiemeier, Henning] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [von Tottleben, Malte; Thiel, Rainer] Empir Commun & Technol Res, Bonn, Germany; [Heil, Katharina F.; Lekadir, Karim] Univ Barcelona, Dept Matemat & Informat, Barcelona, Spain; [Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Hlth Care, OYS, Oulu, Finland; [Jarvelin, Marjo-Riitta] Brunel Univ London, Dept Life Sci, Coll Hlth & Life Sci, London, England; [Mansuy, Isabelle M.] Univ Zurich, Med Fac, Zurich, Switzerland; [Mansuy, Isabelle M.] Univ Zurich, Dept Hlth Sci & Technol, Lab Neuroepigenet, Brain Res Inst,Zurich Neurosci Ctr, Zurich, Switzerland	University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oulu; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; Imperial College London; IRCCS Fatebenefratelli; University of Milan; University of Bath; University of Amsterdam; Vrije Universiteit Amsterdam; European Molecular Biology Laboratory (EMBL); Erasmus University Rotterdam; Erasmus MC; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oulu; University of Oulu; Pompeu Fabra University; ICREA; University of Barcelona; Harvard University; Harvard T.H. Chan School of Public Health; University of Barcelona; Imperial College London; University of Oulu; Brunel University; University of Zurich; University of Zurich	Mariani, N (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Stress Psychiat & Immunol Lab, Dept Psychol Med, London, England.	nicole.mariani@kcl.ac.uk	Cattane, Nadia/K-5906-2016; Sanz, Yolanda/H-5498-2012; Choudhary, Priyanka/ABD-7169-2021; Lamers, Femke/G-5161-2012; Tiemeier, Henning/H-6534-2019; Walton, Esther/GSN-8429-2022; Cattane, Nadia/AAE-4316-2022; Walton, Esther/P-9832-2019; Miettunen, Jouko/AAC-4334-2019; Borsini, Alessandra/P-5180-2017; Cecil, Charlotte/I-7388-2015; Pariante, Carmine Maria/B-1297-2011	Cattane, Nadia/0000-0002-6532-583X; Sanz, Yolanda/0000-0002-1615-1976; Tiemeier, Henning/0000-0002-4395-1397; Cattane, Nadia/0000-0002-6532-583X; Walton, Esther/0000-0002-0935-2200; Miettunen, Jouko/0000-0003-0575-2669; Amid, Clara/0000-0001-6534-7425; Borsini, Alessandra/0000-0003-4410-7865; Herault, Yann/0000-0001-7049-6900; Cochrane, Guy/0000-0001-7954-7057; Heil, Katharina F/0000-0003-3341-3736; Cecil, Charlotte/0000-0002-2389-5922; von Tottleben, Malte/0000-0002-2012-9376; Pariante, Carmine Maria/0000-0002-9132-5091; Mariani, Nicole/0000-0001-7918-3492; Rajan, Jeena/0000-0002-3613-0013; Choudhary, Priyanka/0000-0002-2420-4118	European Union's Horizon 2020 research and innovation programme [848158]; MRC [G108/603, MR/N029488/1] Funding Source: UKRI	European Union's Horizon 2020 research and innovation programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the European Union's Horizon 2020 research and innovation programme (grant no 848158). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker C, 2013, P NATL ACAD SCI USA, V110, P8708, DOI 10.1073/pnas.1300886110; Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Baumeister D, 2016, MOL PSYCHIATR, V21, P642, DOI 10.1038/mp.2015.67; Berge LI, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/164760; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Carr CP, 2013, J NERV MENT DIS, V201, P1007, DOI 10.1097/NMD.0000000000000049; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; den Dekker HT, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01795-2018; Ellis B.J., 2018, BIOL EARLY LIFE STRE, P31, DOI [10.1007/978-3-319-72589-5_3, DOI 10.1007/978-3-319-72589-5_3]; Engin AB, 2017, ADV EXP MED BIOL, V960, pV, DOI 10.1007/978-3-319-48382-5_1; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Glover V, 2010, NEUROSCI BIOBEHAV R, V35, P17, DOI 10.1016/j.neubiorev.2009.11.008; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Jiang XL, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/485082; Johnston MC, 2019, EUR J PUBLIC HEALTH, V29, P182, DOI 10.1093/eurpub/cky098; Leeb RebeccaT., 2008, CHILD MALTREATMENT; Lowry E, 2019, INT J OBESITY, V43, P1181, DOI 10.1038/s41366-018-0175-1; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Moya-Perez A, 2017, BRAIN BEHAV IMMUN, V65, P43, DOI 10.1016/j.bbi.2017.05.011; Munoz-Ruiz MA, 2016, DEMENT GER COGN D EX, V6, P313, DOI 10.1159/000447122; Murphy MO, 2017, NEUROSCI BIOBEHAV R, V74, P453, DOI 10.1016/j.neubiorev.2016.07.018; Nathan DM, 1997, LANCET S1, V350, pSI4, DOI DOI 10.1016/S0140-6736(97)90021-0; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Parmar P, 2018, EBIOMEDICINE, V38, P206, DOI 10.1016/j.ebiom.2018.10.066; Penninx BWJH, 2017, NEUROSCI BIOBEHAV R, V74, P277, DOI 10.1016/j.neubiorev.2016.07.003; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Santarelli S, 2017, PSYCHONEUROENDOCRINO, V78, P213, DOI 10.1016/j.psyneuen.2017.01.021; Sharp GC, 2017, HUM MOL GENET, V26, P4067, DOI 10.1093/hmg/ddx290; Smith GD, 2008, BIOSOCIAL SURVEYS	30	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2021	16	1							e0245475	10.1371/journal.pone.0245475	http://dx.doi.org/10.1371/journal.pone.0245475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PZ7NX	33476328	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000612928900004
J	Kmiecik, SW; Drzewicka, K; Melchior, F; Mayer, MP				Kmiecik, Szymon W.; Drzewicka, Katarzyna; Melchior, Frauke; Mayer, Matthias P.			Heat shock transcription factor 1 is SUMOylated in the activated trimeric state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO MODIFICATION; DNA-BINDING; PROTEIN; PHOSPHORYLATION; CONJUGATION; REPRESSION; TEMPERATURE; KINASE; ALPHA	The heat shock response is a transcriptional program of organisms to counteract an imbalance in protein homeostasis. It is orchestrated in all eukaryotic cells by heat shock transcription factor 1 (Hsf1). Despite very intensive research, the intricacies of the Hsf1 activation-attenuation cycle remain elusive at a molecular level. Post-translational modifications belong to one of the key mechanisms proposed to adapt the Hsf1 activity to the needs of individual cells, and phosphorylation of Hsf1 at multiple sites has attracted much attention. According to cell biological and proteomics data, Hsf1 is also modified by small ubiquitin-like modifier (SUMO) at several sites. How SUMOylation affects Hsf1 activity at a molecular level is still unclear. Here, we analyzed Hsf1 SUMOylation in vitro with purified components to address questions that could not be answered in cell culture models. In vitro Hsf1 is primarily conjugated at lysine 298 with a single SUMO, though we did detect low-level SUMOylation at other sites. Different SUMO E3 ligases such as protein inhibitor of activated STAT 4 enhanced the efficiency of in vitro modification but did not alter SUMO site preferences. We provide evidence that Hsf1 trimerization and phosphorylation at serines 303 and 307 increases SUMOylation efficiency, suggesting that Hsf1 is SUMOylated in its activated state. Hsf1 can be SUMOylated when DNA bound, and SUMOylation of Hsf1 does neither alter DNA-binding affinity nor affects heat shock cognate 71kDa protein (HSPA8)+DnaJ homolog subfamily B member 1-mediated monomerization of Hsf1 trimers and concomitant dislocation from DNA. We propose that SUMOylation acts at the transcription level of the heat shock response.	[Kmiecik, Szymon W.; Drzewicka, Katarzyna; Melchior, Frauke; Mayer, Matthias P.] Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Drzewicka, Katarzyna] Oncoarendi Therapeut SA, Warsaw, Poland	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Mayer, MP (corresponding author), Heidelberg Univ ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	m.mayer@zmbh.uni-heidelberg.de	Melchior, Frauke/E-2014-2014	Melchior, Frauke/0000-0001-9546-8797; Kmiecik, Szymon/0000-0001-6139-1680; Mayer, Matthias/0000-0002-7859-3112	Deutsche Forschungsgemeinschaft (German Research Foundation) [201348542-SFB 1036 TP9, SFB1036 TP15]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (German Research Foundation)-project ID: 201348542-SFB 1036 TP9 to M. P. M. and SFB1036 TP15 to F. M.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Anderson DD, 2012, J BIOL CHEM, V287, P4790, DOI 10.1074/jbc.M111.302174; Bekhbat M, 2017, FRONT NEUROENDOCRIN, V46, P15, DOI 10.1016/j.yfrne.2017.05.001; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Chu BY, 1998, J BIOL CHEM, V273, P18640, DOI 10.1074/jbc.273.29.18640; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Chymkowitch P, 2015, BIOESSAYS, V37, P1095, DOI 10.1002/bies.201500065; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Flotho A, 2012, METHODS MOL BIOL, V832, P93, DOI 10.1007/978-1-61779-474-2_5; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Goodson ML, 2001, J BIOL CHEM, V276, P18513, DOI 10.1074/jbc.M008066200; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2017, NAT STRUCT MOL BIOL, V24, P325, DOI 10.1038/nsmb.3366; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hentze N, 2016, ELIFE, V5, DOI 10.7554/eLife.11576; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Holmberg CI, 2001, EMBO J, V20, P3800, DOI 10.1093/emboj/20.14.3800; Hong YL, 2001, J BIOL CHEM, V276, P40263, DOI 10.1074/jbc.M104714200; Kline MP, 1997, MOL CELL BIOL, V17, P2107, DOI 10.1128/MCB.17.4.2107; Kmiecik SW, 2020, EMBO J, V39, DOI 10.15252/embj.2019104096; Knauf U, 1996, GENE DEV, V10, P2782, DOI 10.1101/gad.10.21.2782; LARSON JS, 1988, NATURE, V335, P372, DOI 10.1038/335372a0; Liebelt F, 2019, CELL REP, V26, P236, DOI 10.1016/j.celrep.2018.12.027; Liu YQ, 2019, J MOL CELL BIOL, V11, P564, DOI 10.1093/jmcb/mjz060; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Martin N, 2009, EMBO J, V28, P3534, DOI 10.1038/emboj.2009.279; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Niskanen EA, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600263; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Park-Sarge Ok-Kyong, 2008, V464, P255; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Pichler A, 2004, NAT STRUCT MOL BIOL, V11, P984, DOI 10.1038/nsmb834; Pichler Andrea, 2017, BioMolecular Concepts, V8, P13, DOI 10.1515/bmc-2016-0030; Ptak C, 2017, ADV EXP MED BIOL, V963, P111, DOI 10.1007/978-3-319-50044-7_7; Raychaudhuri S, 2014, CELL, V156, P975, DOI 10.1016/j.cell.2014.01.055; Rosonina E, 2019, CURR GENET, V65, P1307, DOI 10.1007/s00294-019-00992-w; Rosonina E, 2017, TRANSCR-AUSTIN, V8, P220, DOI 10.1080/21541264.2017.1311829; Rosonina E, 2012, GENE DEV, V26, P350, DOI 10.1101/gad.184689.111; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Seifert A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa2213; Simioni MB, 2009, ONCOGENE, V28, P3332, DOI 10.1038/onc.2009.188; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Ulrich HD, 2005, TRENDS CELL BIOL, V15, P525, DOI 10.1016/j.tcb.2005.08.002; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wu SY, 2009, EMBO J, V28, P1246, DOI 10.1038/emboj.2009.83; Zilio N, 2013, DNA REPAIR, V12, P761, DOI 10.1016/j.dnarep.2013.07.001	51	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100324	10.1016/j.jbc.2021.100324	http://dx.doi.org/10.1016/j.jbc.2021.100324			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33493517	gold, Green Published			2022-12-26	WOS:000672866400298
J	Sakurai, K; Tomiyama, R				Sakurai, Kazumasa; Tomiyama, Ryosuke			Enhanced accessibility and hydrophobicity of amyloidogenic intermediates of the beta 2-microglobulin D76N mutant revealed by high-pressure experiments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYSIOLOGICAL CONDITIONS; BETA(2)-MICROGLOBULIN; PROTEIN; FIBRIL; MODEL; CORE	beta 2-Microglobulin (beta 2m) is the causative protein of dialysisrelated amyloidosis. Its unfolding mainly proceeds along the pathway of N-C -> U-C (sic) U-T, whereas refolding follows the U-T. I-T (-> N-T) -> N-C pathway, in which N, I, and U are the native, intermediate, and unfolded states, respectively, with the Pro32 peptidyl-prolyl bond in cis or trans conformation as indicated by the subscript. It is noted that the IT state is a putative amyloidogenic precursor state. Several aggregation-prone variants of beta 2m have been reported to date. One of these variants is D76N beta 2m, which is a naturally occurring amyloidogenic mutant. To elucidate the molecular mechanisms contributing to the enhanced amyloidogenicity of the mutant, we investigated the equilibrium and kinetic transitions of pressure-induced folding/unfolding equilibria in the wild type and D76N mutant by monitoring intrinsic tryptophan and 1-anilino-8-naphthalene sulfonate fluorescence. An analysis of kinetic data revealed that the different folding/unfolding behaviors of the wild type and D76N mutant were due to differences in the activation energy between the unfolded and the intermediate states as well as stability of the native state, leading to more rapid accumulation of IT state for D76N in the refolding process. In addition, the IT state was found to assume more hydrophobic nature. These changes induced the enhanced amyloidogenicity of the D76N mutant and the distinct pathogenic symptoms of patients. Our results suggest that the stabilization of the native state will be an effective approach for suppressing amyloid fibril formation of this mutant.	[Sakurai, Kazumasa] Kindai Univ, Fac Biol Oriented Sci & Technol, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama, Japan; [Sakurai, Kazumasa; Tomiyama, Ryosuke] Kindai Univ, Fac Biol Oriented Sci & Technol, Dept Biotechnol, Wakayama, Japan		Sakurai, K (corresponding author), Kindai Univ, Fac Biol Oriented Sci & Technol, Inst Adv Technol, High Pressure Prot Res Ctr, Wakayama, Japan.; Sakurai, K (corresponding author), Kindai Univ, Fac Biol Oriented Sci & Technol, Dept Biotechnol, Wakayama, Japan.	sakurai@waka.kindai.ac.jp			JSPS KAKENHI [JP15K07038]; JSPS Core-to-Core Program A (Advanced Research Networks)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core Program A (Advanced Research Networks)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS KAKENHI Grant Number JP15K07038 (to K. S.) and JSPS Core-to-Core Program A (Advanced Research Networks).	Akasaka K, 2006, CHEM REV, V106, P1814, DOI 10.1021/cr040440z; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Cattoni DI, 2009, BBA-PROTEINS PROTEOM, V1794, P1700, DOI 10.1016/j.bbapap.2009.08.007; Chatani E, 2005, J MOL BIOL, V352, P941, DOI 10.1016/j.jmb.2005.07.043; Chen CR, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms14561, 10.1038/ncomms15523]; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2001, J BIOL CHEM, V276, P46714, DOI 10.1074/jbc.M107040200; Chong SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13631; CHOU WY, 1989, J BIOL CHEM, V264, P18309; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hasegawa K, 2013, BBA-PROTEINS PROTEOM, V1834, P1624, DOI 10.1016/j.bbapap.2013.04.011; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Iwata K, 2007, J BIOCHEM, V142, P413, DOI 10.1093/jb/mvm148; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kameda A, 2005, J MOL BIOL, V348, P383, DOI 10.1016/j.jmb.2005.02.050; Kitahara R, 2013, PROG NUCL MAG RES SP, V71, P35, DOI 10.1016/j.pnmrs.2012.12.001; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Maeno A, 2013, BIOPHYS CHEM, V183, P57, DOI 10.1016/j.bpc.2013.07.008; Maeno Akihiro, 2009, Biophysics (Nagoya-shi), V5, P1; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Natalello A, 2016, J BIOL CHEM, V291, P9678, DOI 10.1074/jbc.M116.720573; Roche J, 2012, P NATL ACAD SCI USA, V109, P6945, DOI 10.1073/pnas.1200915109; Rouget JB, 2011, J AM CHEM SOC, V133, P6020, DOI 10.1021/ja200228w; Sakata M, 2008, J MOL BIOL, V382, P1242, DOI 10.1016/j.jmb.2008.08.003; Sakurai K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090491; Smith HI, 2020, J BIOL CHEM, V295, P12474, DOI 10.1074/jbc.RA120.014901; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yamaguchi KI, 2004, J MOL BIOL, V338, P559, DOI 10.1016/j.jmb.2004.02.067	33	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100333	10.1016/j.jbc.2021.100333	http://dx.doi.org/10.1016/j.jbc.2021.100333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33508321	Green Published, gold			2022-12-26	WOS:000672866400307
